PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ban, NC; Vincent, ACJ				Ban, Natalie C.; Vincent, Amanda C. J.			Beyond Marine Reserves: Exploring the Approach of Selecting Areas where Fishing Is Permitted, Rather than Prohibited	PLOS ONE			English	Article							PROTECTED AREAS; IMPACTS; POPULATIONS; DESIGN; SCALE; REEF; SIZE	Background: Marine populations have been declining at a worrying rate, due in large part to fishing pressures. The challenge is to secure a future for marine life while minimizing impacts on fishers and fishing communities. Methods and Principal Findings: Rather than selecting areas where fishing is banned - as is usually the case with spatial management - we assess the concept of designating areas where fishing is permitted. We use spatial catch statistics for thirteen commercial fisheries on Canada's west coast to determine the minimum area that would be needed to maintain a pre-ascribed target percentage of current catches. We found that small reductions in fisheries yields, if strategically allocated, could result in large unfished areas that are representative of biophysical regions and habitat types, and have the potential to achieve remarkable conservation gains. Conclusions: Our approach of selecting fishing areas instead of reserves could help redirect debate about the relative values that society places on conservation and extraction, in a framework that could gain much by losing little. Our ideas are intended to promote discussions about the current status quo in fisheries management, rather than providing a definitive solution.			Ban, NC (corresponding author), Univ British Columbia, Fisheries Ctr, Project Seahorse, Vancouver, BC V5Z 1M9, Canada.	natalie.ban@jcu.edu.au	Ban, Natalie/C-6938-2009	Ban, Natalie/0000-0002-4682-2144				Ball I., 2000, MARXAN V1 8 2 MARINE; COASE RH, 1960, J LAW ECON, V3, P1, DOI 10.1086/466560; Collie JS, 2001, CAN J FISH AQUAT SCI, V58, P2167, DOI 10.1139/cjfas-58-11-2167; Collie JS, 2000, J ANIM ECOL, V69, P785, DOI 10.1046/j.1365-2656.2000.00434.x; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Dayton PK, 1998, SCIENCE, V279, P821, DOI 10.1126/science.279.5352.821; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Game ET, 2008, MARXAN USER MANUAL M; Gaylord B, 2005, ECOL APPL, V15, P2180, DOI 10.1890/04-1810; *GOV BRIT COL, 2007, EC CONTR OC SECT BRI; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hastings A, 1999, SCIENCE, V284, P1537, DOI 10.1126/science.284.5419.1537; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johannes RE, 2000, FISH FISH, V1, P257, DOI 10.1046/j.1467-2979.2000.00019.x; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lindholm JB, 2001, CONSERV BIOL, V15, P424, DOI 10.1046/j.1523-1739.2001.015002424.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Polacheck T., 1990, NAT RESOUR MODEL, V4, P327; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 2005, PHILOS T R SOC B, V360, P123, DOI 10.1098/rstb.2004.1578; Russ GR, 1996, ECOL APPL, V6, P947, DOI 10.2307/2269497; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Samoilys MA, 2007, BIOL CONSERV, V136, P584, DOI 10.1016/j.biocon.2007.01.003; Schrank WE, 2007, MAR POLICY, V31, P299, DOI 10.1016/j.marpol.2006.09.001; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Stewart RR, 2003, MAR ECOL PROG SER, V253, P25, DOI 10.3354/meps253025; Sumaila U. Rashid, 2007, Journal of Bioeconomics, V9, P39, DOI 10.1007/s10818-007-9015-4; Tetreault I, 2007, ECOL APPL, V17, P2251, DOI 10.1890/06-0161.1; Walters C, 2000, B MAR SCI, V66, P745; Walters C., 1998, REINVENTING FISHERIE, P279; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; WOOD LJ, 2007, UBC FISHERIES CTR WO, P1; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zacharias MA, 1998, COAST MANAGE, V26, P105, DOI 10.1080/08920759809362347	44	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6258	10.1371/journal.pone.0006258	http://dx.doi.org/10.1371/journal.pone.0006258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623248	gold, Green Accepted, Green Published			2022-12-27	WOS:000268260100003
J	Lobo, FP; Mota, BEF; Pena, SDJ; Azevedo, V; Macedo, AM; Tauch, A; Machado, CR; Franco, GR				Lobo, Francisco P.; Mota, Bruno E. F.; Pena, Sergio D. J.; Azevedo, Vasco; Macedo, Andrea M.; Tauch, Andreas; Machado, Carlos R.; Franco, Gloria R.			Virus-Host Coevolution: Common Patterns of Nucleotide Motif Usage in Flaviviridae and Their Hosts	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SWINE-FEVER VIRUS; ANTIVIRAL RESPONSE; PHYLOGENETIC-RELATIONSHIPS; CYTOSINE METHYLATION; DISEASE ASSOCIATION; CODON USAGE; IN-VITRO; RNASE-L; INTERFERON	Virus-host biological interaction is a continuous coevolutionary process involving both host immune system and viral escape mechanisms. Flaviviridae family is composed of fast evolving RNA viruses that infects vertebrate (mammals and birds) and/or invertebrate (ticks and mosquitoes) organisms. These host groups are very distinct life forms separated by a long evolutionary time, so lineage-specific anti-viral mechanisms are likely to have evolved. Flaviviridae viruses which infect a single host lineage would be subjected to specific host-induced pressures and, therefore, selected by them. In this work we compare the genomic evolutionary patterns of Flaviviridae viruses and their hosts in an attempt to uncover coevolutionary processes inducing common features in such disparate groups. Especially, we have analyzed dinucleotide and codon usage patterns in the coding regions of vertebrate and invertebrate organisms as well as in Flaviviridae viruses which specifically infect one or both host types. The two host groups possess very distinctive dinucleotide and codon usage patterns. A pronounced CpG under-representation was found in the vertebrate group, possibly induced by the methylation-deamination process, as well as a prominent TpA decrease. The invertebrate group displayed only a TpA frequency reduction bias. Flaviviridae viruses mimicked host nucleotide motif usage in a host-specific manner. Vertebrate-infecting viruses possessed under-representation of CpG and TpA, and insect-only viruses displayed only a TpA under-representation bias. Single-host Flaviviridae members which persistently infect mammals or insect hosts (Hepacivirus and insect-only Flavivirus, respectively) were found to posses a codon usage profile more similar to that of their hosts than to related Flaviviridae. We demonstrated that vertebrates and mosquitoes genomes are under very distinct lineage-specific constraints, and Flaviviridae viruses which specifically infect these lineages appear to be subject to the same evolutionary pressures that shaped their host coding regions, evidencing the lineage-specific coevolutionary processes between the viral and host groups.			Lobo, FP (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	franciscolobo@gmail.com	Lobo, Francisco Pereira/AAG-3118-2021; Lobo, Francisco/A-1295-2011; Azevedo, Vasco/B-1556-2019; Macedo, Andréa M/C-1506-2013; Azevedo, Vasco A.C/F-4315-2011; MACHADO, CARLOS/AAW-1492-2020; Machado, Carlos Renato/H-1043-2015; Franco, Glória/I-3654-2013	Lobo, Francisco Pereira/0000-0002-9671-9313; Azevedo, Vasco/0000-0002-4775-2280; Azevedo, Vasco A.C/0000-0002-4775-2280; Machado, Carlos Renato/0000-0002-8724-3165; Franco, Glória/0000-0001-5245-2365; Mota, Bruno/0000-0003-0348-4875				Agrawal S, 2003, ANN NY ACAD SCI, V1002, P30, DOI 10.1196/annals.1281.005; Altenbach D, 2007, MOL PLANT MICROBE IN, V20, P1031, DOI 10.1094/MPMI-20-9-1031; Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; BAXEVANIS AD, 2008, CURR PROTOC BIOINFOR, pCH1; Belshaw R, 2009, NUCLEIC ACIDS RES, V37, pD431, DOI 10.1093/nar/gkn729; BENSON DA, 2008, NUCL ACIDS RES; Billoir F, 2000, J GEN VIROL, V81, P781, DOI 10.1099/0022-1317-81-3-781; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; BOUDRAA M, 1987, NUCLEIC ACIDS RES, V15, P5729; BuchenOsmond C, 1997, ARCH VIROL, V142, P1734; Bukh J, 1999, VIROLOGY, V262, P470, DOI 10.1006/viro.1999.9941; CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Ciota AT, 2007, VIROLOGY, V357, P165, DOI 10.1016/j.virol.2006.08.005; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6; de Lamballerie X, 2002, J GEN VIROL, V83, P2443, DOI 10.1099/0022-1317-83-10-2443; Dorn A, 2008, CURR OPIN MOL THER, V10, P10; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Forde SE, 2008, EVOLUTION, V62, P1830, DOI 10.1111/j.1558-5646.2008.00411.x; Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867; Grard G, 2006, J GEN VIROL, V87, P3273, DOI 10.1099/vir.0.82071-0; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005; Gregorio GV, 2003, CLIN EXP IMMUNOL, V133, P404, DOI 10.1046/j.1365-2249.2003.02229.x; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Han JQ, 2004, J INTERF CYTOK RES, V24, P664, DOI 10.1089/jir.2004.24.664; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039; Hu YW, 2005, VIROLOGY, V332, P538, DOI 10.1016/j.virol.2004.11.041; Iqbal M, 2004, J VIROL, V78, P136, DOI 10.1128/JVI.78.1.136-145.2004; Jenkins GM, 2001, J MOL EVOL, V52, P383, DOI 10.1007/s002390010168; Jernigan RW, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-23; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kim WM, 2008, ADV EXP MED BIOL, V640, P325, DOI 10.1007/978-0-387-09789-3_22; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Kow YW, 2002, FREE RADICAL BIO MED, V33, P886, DOI 10.1016/S0891-5849(02)00902-4; Kuno G, 2007, J MED ENTOMOL, V44, P93, DOI 10.1603/0022-2585(2007)44[93:HRSOFC]2.0.CO;2; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1101, DOI DOI 10.1016/0038-092X(88)90131-4; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Major L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004375; Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004; Mellor PS, 2000, J COMP PATHOL, V123, P231, DOI 10.1053/jcpa.2000.0434; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Moelling K, 2006, COLD SPRING HARB SYM, V71, P365, DOI 10.1101/sqb.2006.71.010; Mogensen TH, 2005, J MOL MED, V83, P180, DOI 10.1007/s00109-004-0620-6; Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0; Mrazek J, 1998, P NATL ACAD SCI USA, V95, P3720, DOI 10.1073/pnas.95.7.3720; NOVELLA IS, 1995, J VIROL, V69, P6805, DOI 10.1128/JVI.69.11.6805-6809.1995; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; R Core Team, 2021, R LANGUAGE ENV STAT; REMOLD SK, 2002, J ECOL, V90, P11; Rima BK, 1997, J GEN VIROL, V78, P2859, DOI 10.1099/0022-1317-78-11-2859; Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; Schweizer M, 2006, J VIROL, V80, P6926, DOI 10.1128/JVI.02443-05; Seago J, 2007, J GEN VIROL, V88, P3002, DOI 10.1099/vir.0.82934-0; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Shioiri C, 2001, J MOL EVOL, V53, P364, DOI 10.1007/s002390010226; SILVERMAN RH, 1994, J INTERFERON RES, V14, P101, DOI 10.1089/jir.1994.14.101; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; SIMMONDS P, 1995, HEPATOLOGY, V21, P570, DOI 10.1002/hep.1840210243; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Stram Y, 2006, VIRUS GENES, V32, P299, DOI 10.1007/s11262-005-6914-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Thimme R, 2006, ANTIVIR RES, V69, P129, DOI 10.1016/j.antiviral.2005.12.001; Thomas O, 1902, P ZOOL SOC LOND, V1902, P2; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Whittle CA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-169; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; YOMO T, 1989, P NATL ACAD SCI USA, V86, P8452, DOI 10.1073/pnas.86.21.8452; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	90	124	126	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6282	10.1371/journal.pone.0006282	http://dx.doi.org/10.1371/journal.pone.0006282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617912	gold, Green Published, Green Submitted			2022-12-27	WOS:000268119600002
J	Schleich, S; Teleman, AA				Schleich, Sibylle; Teleman, Aurelio A.			Akt Phosphorylates Both Tsc1 and Tsc2 in Drosophila, but Neither Phosphorylation Is Required for Normal Animal Growth	PLOS ONE			English	Article								Akt, an essential component of the insulin pathway, is a potent inducer of tissue growth. One of Akt's phosphorylation targets is Tsc2, an inhibitor of the anabolic kinase TOR. This could account for part of Akt's growth promoting activity. Although phosphorylation of Tsc2 by Akt does occur in vivo, and under certain circumstances can lead to reduced Tsc2 activity, the functional significance of this event is unclear since flies lacking Akt phosphorylation sites on Tsc2 are viable and normal in size and growth rate. Since Drosophila Tsc1, the obligate partner of Tsc2, has an Akt phosphorylation motif that is not conserved in mammals, we investigate here whether Akt redundantly phosphorylates the Tsc complex on Tsc1 and Tsc2. We provide evidence that Akt phosphorylates Tsc1 at Ser533. We show that flies lacking Akt phosphorylation sites on Tsc1 alone, or on both Tsc1 and Tsc2 concurrently, are viable and normal in size. This shows that phosphorylation of the Tsc1/2 complex by Akt is not required for Akt to activate TORC1 and to promote tissue growth in Drosophila.			Schleich, S (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	a.teleman@dkfz.de	Teleman, Aurelio A/E-6864-2013; Teleman, Aurelio/V-8470-2019	Teleman, Aurelio A/0000-0002-4237-9368; Teleman, Aurelio/0000-0002-4237-9368				Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Staveley BE, 1998, CURR BIOL, V8, P599, DOI 10.1016/S0960-9822(98)70231-3; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200	25	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6305	10.1371/journal.pone.0006305	http://dx.doi.org/10.1371/journal.pone.0006305			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609361	Green Submitted, gold, Green Published			2022-12-27	WOS:000268119500021
J	Windschiegl, B; Orth, A; Romer, W; Berland, L; Stechmann, B; Bassereau, P; Johannes, L; Steinem, C				Windschiegl, Barbara; Orth, Alexander; Roemer, Winfried; Berland, Ludwig; Stechmann, Bahne; Bassereau, Patricia; Johannes, Ludger; Steinem, Claudia			Lipid Reorganization Induced by Shiga Toxin Clustering on Planar Membranes	PLOS ONE			English	Article								The homopentameric B-subunit of bacterial protein Shiga toxin (STxB) binds to the glycolipid Gb(3) in plasma membranes, which is the initial step for entering cells by a clathrin-independent mechanism. It has been suggested that protein clustering and lipid reorganization determine toxin uptake into cells. Here, we elucidated the molecular requirements for STxB induced Gb(3) clustering and for the proposed lipid reorganization in planar membranes. The influence of binding site III of the B-subunit as well as the Gb(3) lipid structure was investigated by means of high resolution methods such as fluorescence and scanning force microscopy. STxB was found to form protein clusters on homogenous 1,2-dioleoyl-snglycero-3- phosphocholine (DOPC)/cholesterol/Gb(3) (65:30:5) bilayers. In contrast, membranes composed of DOPC/cholesterol/sphingomyelin/Gb(3) (40: 35: 20: 5) phase separate into a liquid ordered and liquid disordered phase. Dependent on the fatty acid composition of Gb(3), STxB-Gb(3) complexes organize within the liquid ordered phase upon protein binding. Our findings suggest that STxB is capable of forming a new membrane phase that is characterized by lipid compaction. The significance of this finding is discussed in the context of Shiga toxin-induced formation of endocytic membrane invaginations.			Windschiegl, B (corresponding author), Univ Gottingen, Inst Organ & Biomol Chem, Gottingen, Germany.	claudia.steinem@chemie.uni-goettingen.de	Johannes, Ludger/M-9778-2017; Steinem, Claudia/K-7534-2018; Steinem, Claudia/O-4801-2019; Johannes, Ludger/W-8593-2019; Bassereau, Patricia/P-8657-2018	Johannes, Ludger/0000-0002-2168-0004; Steinem, Claudia/0000-0001-8778-9283; Johannes, Ludger/0000-0002-2168-0004; Bassereau, Patricia/0000-0002-8544-6778				Arab S, 1996, GLYCOCONJUGATE J, V13, P159, DOI 10.1007/BF00731490; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Bast DJ, 1999, MOL MICROBIOL, V32, P953, DOI 10.1046/j.1365-2958.1999.01405.x; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Binder WH, 2003, ANGEW CHEM INT EDIT, V42, P5802, DOI 10.1002/anie.200300586; BOYD B, 1994, EUR J BIOCHEM, V223, P873, DOI 10.1111/j.1432-1033.1994.tb19064.x; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Falguieres T, 2006, FEBS J, V273, P5205, DOI 10.1111/j.1742-4658.2006.05516.x; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; Garcia-Saez AJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706162200; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Lacy DB, 1998, CURR OPIN STRUC BIOL, V8, P778; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Lipowsky R, 2002, J BIOL PHYS, V28, P195, DOI 10.1023/A:1019994628793; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Meder D., 2006, LIPID RAFTS CAVEOLAE, P1; Menke M, 2005, BIOCHEMISTRY-US, V44, P15296, DOI 10.1021/bi051585i; Menke M, 2002, EUR BIOPHYS J BIOPHY, V31, P317, DOI 10.1007/s00249-002-0232-4; Milhiet PE, 2002, J BIOL CHEM, V277, P875, DOI 10.1074/jbc.C100654200; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nyholm PG, 1996, CHEM BIOL, V3, P263, DOI 10.1016/S1074-5521(96)90106-4; PELLIZZARI A, 1992, BIOCHEMISTRY-US, V31, P1363, DOI 10.1021/bi00120a011; Pina DG, 2007, BBA-BIOMEMBRANES, V1768, P628, DOI 10.1016/j.bbamem.2006.12.011; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Rinia HA, 2001, FEBS LETT, V504, P194, DOI 10.1016/S0014-5793(01)02704-1; Rinia HA, 2001, FEBS LETT, V501, P92, DOI 10.1016/S0014-5793(01)02636-9; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Saslowsky DE, 2002, J BIOL CHEM, V277, P26966, DOI 10.1074/jbc.M204669200; Sens P, 2000, EUR PHYS J E, V1, P237, DOI 10.1007/s101890050026; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Smith DC, 2004, SEMIN CELL DEV BIOL, V15, P397, DOI 10.1016/j.semcdb.2004.03.005; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; WANG FY, 2004, J COMPLEX SYSTEMS CO, V1, P33	40	73	73	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6238	10.1371/journal.pone.0006238	http://dx.doi.org/10.1371/journal.pone.0006238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606209	Green Published, gold			2022-12-27	WOS:000268036000002
J	Kaczer, L; Maldonado, H				Kaczer, Laura; Maldonado, Hector			Contrasting Role of Octopamine in Appetitive and Aversive Learning in the Crab Chasmagnathus	PLOS ONE			English	Article								Background: Biogenic amines are implicated in reinforcing associative learning. Octopamine (OA) is considered the invertebrate counterpart of noradrenaline and several studies in insects converge on the idea that OA mediates the reward in appetitive conditioning. However, it is possible to assume that OA could have a different role in an aversive conditioning. Methodology/Principal Findings: Here we pharmacologically studied the participation of OA in two learning processes in the crab Chasmagnathus granulatus, one appetitive and one aversive. It is shown that the aversive memory is impaired by an OA injection applied immediately or 30 minutes after the last training trial. By contrast, the appetitive memory is blocked by OA antagonists epinastine and mianserine, but enhanced by OA when injected together with the supply of a minimum amount of reinforcement. Finally, double-learning experiments in which crabs are given the aversive and the appetitive learning either successively or simultaneously allow us to study the interaction between both types of learning and analyze the presumed action of OA. We found that the appetitive training offered immediately, but not one hour, after an aversive training has an amnesic effect on the aversive memory, mimicking the effect and the kinetic of an OA injection. Conclusions/Significance: Our results demonstrate that the role of OA is divergent in two memory processes of opposite signs: on the one hand it would mediate the reinforcement in appetitive learning, and on the other hand it has a deleterious effect over aversive memory consolidation.			Kaczer, L (corresponding author), Univ Buenos Aires, Lab Neurobiol Memoria, Dept Fisiol & Biol Mol & Celular, IFIBYNE,CONICET,Fac Ciencias Exactas & Nat, Pabellon 2,C1428EHA, Buenos Aires, DF, Argentina.	hector@fbmc.fcen.uba.ar						ABBOTT J, 1970, NATURE, V225, P291, DOI 10.1038/225291b0; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; Tano MC, 2009, NEUROSCIENCE, V158, P387, DOI 10.1016/j.neuroscience.2008.10.039; Degen J, 2000, BRIT J PHARMACOL, V130, P587, DOI 10.1038/sj.bjp.0703338; DIMANT B, 1992, J COMP PHYSIOL A, V170, P749; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Farooqui T, 2003, J NEUROSCI, V23, P5370; Frenkel L, 2005, EUR J NEUROSCI, V22, P1757, DOI 10.1111/j.1460-9568.2005.04373.x; Freudenthal R, 1998, NEUROSCI LETT, V242, P143, DOI 10.1016/S0304-3940(98)00059-7; Giurfa M, 2006, CURR BIOL, V16, pR892, DOI 10.1016/j.cub.2006.09.021; GLEESON RA, 1977, COMP BIOCHEM PHYS A, V56, P411, DOI 10.1016/0300-9629(77)90258-4; Hammer M, 1998, LEARN MEMORY, V5, P146; HOEGER U, 1989, COMP BIOCHEM PHYS C, V92, P323, DOI 10.1016/0742-8413(89)90062-5; Howell DC, 1987, STAT METHODS PSYCHOL; Kaczer L, 2007, NEUROBIOL LEARN MEM, V87, P140, DOI 10.1016/j.nlm.2006.08.002; Keene AC, 2005, CURR BIOL, V15, pR932, DOI 10.1016/j.cub.2005.10.058; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Locatelli F, 2002, NEUROBIOL LEARN MEM, V77, P234, DOI 10.1006/nlme.2001.4007; Maldonado H, 1997, BRAZ J MED BIOL RES, V30, P813, DOI 10.1590/S0100-879X1997000700001; Maldonado H, 2002, CRUSTACEAN NERVOUS SYSTEM, P314; Pedreira ME, 1996, PHARMACOL BIOCHEM BE, V54, P611; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; PEDREIRA ME, 1995, PHARMACOL BIOCHEM BE, V52, P385, DOI 10.1016/0091-3057(95)00124-F; Pedreira ME, 2002, J NEUROSCI, V22, P8305; Pereyra P, 2000, NEUROBIOL LEARN MEM, V74, P119, DOI 10.1006/nlme.1999.3945; Pereyra P, 1999, J COMP PHYSIOL A, V184, P301, DOI 10.1007/s003590050328; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Roeder T, 1998, EUR J PHARMACOL, V349, P171, DOI 10.1016/S0014-2999(98)00192-7; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Romano A, 2006, BIOL BULL-US, V210, P280, DOI 10.2307/4134564; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; SANDEMAN DC, 1967, PROC R SOC SER B-BIO, V168, P82, DOI 10.1098/rspb.1967.0052; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; ZIMMERFAUST RK, 1987, ECOLOGY, V68, P955, DOI 10.2307/1938367	43	31	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6223	10.1371/journal.pone.0006223	http://dx.doi.org/10.1371/journal.pone.0006223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603069	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035700004
J	Reynolds, V; Lloyd, AW; Babweteera, F; English, CJ				Reynolds, Vernon; Lloyd, Andrew W.; Babweteera, Fred; English, Christopher J.			Decaying Raphia farinifera Palm Trees Provide a Source of Sodium for Wild Chimpanzees in the Budongo Forest, Uganda	PLOS ONE			English	Article								For some years, chimpanzees have been observed eating the pith of decaying palm trees of Raphia farinifera in the Budongo Forest, Uganda. The reasons for doing this have until now been unknown. An analysis of the pith for mineral content showed high levels of sodium to be present in the samples. By contrast, lower levels were found in bark of other tree species, and also in leaf and fruit samples eaten by chimpanzees. The differences between the Raphia samples and the non-Raphia samples were highly significant (p < 0.001). It is concluded that Raphia provides a rich and possibly essential source of sodium for the Budongo chimpanzees. Comparison of a chewed sample (wadge) of Raphia pith with a sample from the tree showed a clear reduction in sodium content in the chewed sample. Black and white colobus monkeys in Budongo Forest also feed on the pith of Raphia. At present, the survival of Raphia palms in Budongo Forest is threatened by the use of this tree by local tobacco farmers.			Reynolds, V (corresponding author), Univ Oxford, Sch Anthropol, Oxford, England.	vreynolds@btopenworld.com	Lloyd, Andrew/D-1369-2011; Babweteera, Fred/AAC-3046-2022	Lloyd, Andrew/0000-0003-2778-8195; 				*BRIT GEOL SURV, 2001, GROUNDW QUAL; EGGELING WJ, 1947, J ECOL, V34, P20, DOI 10.2307/2256760; KYEYUNE S, 2003, THESIS MAKERERE U KA; Mahaney WC, 1996, PRIMATES, V37, P121, DOI 10.1007/BF02381400; Newton-Fisher NE, 1999, AFR J ECOL, V37, P344, DOI 10.1046/j.1365-2028.1999.00186.x; OATES JF, 1978, BIOTROPICA, V10, P241, DOI 10.2307/2387676; Reynolds V., 1965, PRIMATE BEHAV FIELD; Reynolds V., 2005, CHIMPANZEES BUDONGO; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Rothman JM, 2006, BIOL LETTERS, V2, P321, DOI 10.1098/rsbl.2006.0480	10	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6194	10.1371/journal.pone.0006194	http://dx.doi.org/10.1371/journal.pone.0006194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593451	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035300007
J	Schaaf, CA; Misulovin, Z; Sahota, G; Siddiqui, AM; Schwartz, YB; Kahn, TG; Pirrotta, V; Gause, M; Dorsett, D				Schaaf, Cheri A.; Misulovin, Ziva; Sahota, Gurmukh; Siddiqui, Akbar M.; Schwartz, Yuri B.; Kahn, Tatyana G.; Pirrotta, Vincenzo; Gause, Maria; Dorsett, Dale			Regulation of the Drosophila Enhancer of split and invected-engrailed Gene Complexes by Sister Chromatid Cohesion Proteins	PLOS ONE			English	Article							DE-LANGE-SYNDROME; NIPPED-B; CELL-CYCLE; POLYCOMB; EXPRESSION; MUTATIONS; BINDING; NOTCH; HEDGEHOG; HOMOLOG	The cohesin protein complex was first recognized for holding sister chromatids together and ensuring proper chromosome segregation. Cohesin also regulates gene expression, but the mechanisms are unknown. Cohesin associates preferentially with active genes, and is generally absent from regions in which histone H3 is methylated by the Enhancer of zeste [E(z)] Polycomb group silencing protein. Here we show that transcription is hypersensitive to cohesin levels in two exceptional cases where cohesin and the E(z)-mediated histone methylation simultaneously coat the entire Enhancer of split and invected-engrailed gene complexes in cells derived from Drosophila central nervous system. These gene complexes are modestly transcribed, and produce seven of the twelve transcripts that increase the most with cohesin knockdown genome-wide. Cohesin mutations alter eye development in the same manner as increased Enhancer of split activity, suggesting that similar regulation occurs in vivo. We propose that cohesin helps restrain transcription of these gene complexes, and that deregulation of similarly cohesin-hypersensitive genes may underlie developmental deficits in Cornelia de Lange syndrome.			Schaaf, CA (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	dorsettd@slu.edu		Dorsett, Dale/0000-0002-0507-2762	NHGRI NIH HHS [R01 HG00249, R01 HG000249] Funding Source: Medline; NICHD NIH HHS [P01 HD052683, P01 HD052860-030003, P01 HD052860, P01 HD052860-040003] Funding Source: Medline; NIGMS NIH HHS [T32 GM008802, R01 GM055683-09, R01 GM055683, R01 GM055683-10A2] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD052860] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008802, R01GM055683] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BARTKUHN M, 2009, EMBO J          0219; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Borck G, 2006, HUM MUTAT, V27, P731, DOI 10.1002/humu.20380; Bray SJ, 1997, PERSPECT DEV NEUROBI, V4, P313; BROWER DL, 1986, EMBO J, V5, P2649, DOI 10.1002/j.1460-2075.1986.tb04547.x; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; CELNIKER SE, 2002, GENOME BIOL, V0003; Chang CR, 2005, GENE DEV, V19, P3031, DOI 10.1101/gad.1356305; COLEMAN KG, 1987, GENE DEV, V1, P19, DOI 10.1101/gad.1.1.19; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; DeVido SK, 2008, DEVELOPMENT, V135, P669, DOI 10.1242/dev.014779; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; DREES B, 1987, EMBO J, V6, P2803, DOI 10.1002/j.1460-2075.1987.tb02576.x; Dubey RN, 2007, GENE DEV, V21, P2150, DOI 10.1101/gad.1583807; FELSENFELD AL, 1995, DEVELOPMENT, V121, P1; Fujioka M, 2008, DEVELOPMENT, V135, P4131, DOI 10.1242/dev.024554; Gause M, 2008, CHROMOSOMA, V117, P51, DOI 10.1007/s00412-007-0125-5; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; HADJUR S, 2009, NATURE          0520; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hallson G, 2008, P NATL ACAD SCI USA, V105, P12405, DOI 10.1073/pnas.0801698105; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kaur M, 2005, AM J MED GENET A, V138A, P27, DOI 10.1002/ajmg.a.30919; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; KNUST E, 1987, DEV BIOL, V122, P262, DOI 10.1016/0012-1606(87)90351-4; KORNBERG T, 1985, CELL, V40, P45, DOI 10.1016/0092-8674(85)90307-1; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Maeder ML, 2007, GENETICS, V177, P1377, DOI 10.1534/genetics.107.070425; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MISHIRO T, 2009, EMBO J          0326; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; MOAZED D, 1992, DEVELOPMENT, V116, P805; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nagel AC, 1999, DEV BIOL, V208, P406, DOI 10.1006/dbio.1999.9203; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Revenkova E, 2009, HUM MOL GENET, V18, P418, DOI 10.1093/hmg/ddn369; Rollins RA, 1999, GENETICS, V152, P577; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; SANICOLA M, 1995, GENETICS, V139, P745; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Schulze S, 2001, MOL GEN GENET, V264, P782, DOI 10.1007/s004380000367; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; SHEPARD SB, 1989, GENETICS, V122, P429; Stockard J, 2007, JUDGM DECIS MAK, V2, P9; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; UI K, 1994, IN VITRO CELL DEV-AN, V30A, P209; Vass S, 2003, CURR BIOL, V13, P208, DOI 10.1016/S0960-9822(03)00047-2; Vrouwe MG, 2007, HUM MOL GENET, V16, P1478, DOI 10.1093/hmg/ddm098; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Welshons WJ, 1956, DROS INFORM SERV, V30, P157; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	80	89	90	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6202	10.1371/journal.pone.0006202	http://dx.doi.org/10.1371/journal.pone.0006202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587787	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035100015
J	Adduri, CA; Marotta, JJ				Adduri, Cassandra A.; Marotta, Jonathan J.			Mental Rotation of Faces in Healthy Aging and Alzheimer's Disease	PLOS ONE			English	Article							UPSIDE-DOWN FACES; FUNCTIONAL ACTIVATION; OBJECT RECOGNITION; OLDER-ADULTS; DEMENTIA; BRAIN; INTERVENTIONS; ORIENTATION; INFORMATION; HIPPOCAMPUS	Background: Previous research has shown that individuals with Alzheimer's disease (AD) develop visuospatial difficulties that affect their ability to mentally rotate objects. Surprisingly, the existing literature has generally ignored the impact of this mental rotation deficit on the ability of AD patients to recognize faces from different angles. Instead, the devastating loss of the ability to recognize friends and family members in AD has primarily been attributed to memory loss and agnosia in later stages of the disorder. The impact of AD on areas of the brain important for mental rotation should not be overlooked by face processing investigations - even in early stages of the disorder. Methodology/Principal Findings: This study investigated the sensitivity of face processing in AD, young controls and older non-neurological controls to two changes of the stimuli - a rotation in depth and an inversion. The control groups showed a systematic effect of depth rotation, with errors increasing with the angle of rotation, and with inversion. The majority of the AD group was not impaired when faces were presented upright and no transformation in depth was required, and were most accurate when all faces were presented in frontal views, but accuracy was severely impaired with any rotation or inversion. Conclusions/Significance: These results suggest that with the onset of AD, mental rotation difficulties arise that affect the ability to recognize faces presented at different angles. The finding that a frontal view is "preferred'' by these patients provides a valuable communication strategy for health care workers.			Adduri, CA (corresponding author), Univ Manitoba, Dept Psychol, Percept & Act Lab, Winnipeg, MB R3T 2N2, Canada.	marotta@cc.umanitoba.ca		Marotta, Jonathan/0000-0001-6635-4694				Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Baddeley A. D., 1983, EVALUATING WITNESS E, P125; BALL MJ, 1977, ACTA NEUROPATHOL, V37, P111, DOI 10.1007/BF00692056; Blanz V, 1999, COMP GRAPH, P187, DOI 10.1145/311535.311556; Bourgeois MS, 1996, INT J AGING HUM DEV, V43, P35, DOI 10.2190/AN6L-6QBQ-76G0-0N9A; BRUCE V, 1987, APPL COGNITIVE PSYCH, V1, P109, DOI 10.1002/acp.2350010204; Bruce V., 1994, VIS COGN, V1, P141, DOI [DOI 10.1080/13506289408402299, 10.1080/13506289408402299]; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Caterini F, 2002, NEUROPSYCHOLOGY, V16, P146, DOI 10.1037//0894-4105.16.2.146; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; CRAIK FIM, 1992, PSYCHOL AGING, V7, P661, DOI 10.1037/0882-7974.7.4.661; DELLASALA S, 1995, NEUROPSYCHOLOGIA, V33, P675; Dror IE, 2005, EXP AGING RES, V31, P409, DOI 10.1080/03610730500206725; DROR IE, 1994, PSYCHOL AGING, V9, P90, DOI 10.1037/0882-7974.9.1.90; Fahlander K, 2002, J CLIN EXP NEUROPSYC, V24, P734, DOI 10.1076/jcen.24.6.734.8404; FIELDS RB, 1998, CLIN NEUROPSYCHOLOGY; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GRILLSPECTOR K, 2003, ATTENTION PERFORMANC; Habak C, 2008, VISION RES, V48, P9, DOI 10.1016/j.visres.2007.10.007; Hawley KS, 2004, BEHAV MODIF, V28, P276, DOI 10.1177/0145445503259283; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Jordan K, 2001, NEUROIMAGE, V13, P143, DOI 10.1006/nimg.2000.0677; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Lee ACH, 2006, J NEUROSCI, V26, P5198, DOI 10.1523/JNEUROSCI.3157-05.2006; Lineweaver TT, 2005, J INT NEUROPSYCH SOC, V11, P30, DOI 10.1017/S1355617705050034; Liu CH, 2002, COGNITION, V83, P31, DOI 10.1016/S0010-0277(01)00164-0; Marotta JJ, 2002, COGN NEUROPSYCHOL, V19, P31, DOI 10.1080/02643290143000079; Mattis S., 1973, DEMENTIA RATING SCAL; MURPHY KJ, 2000, VISUAL OBJECT PERCEP; Murray SO, 2008, J VISION, V8, DOI 10.1167/8.10.2; O'Toole AJ, 1998, VISION RES, V38, P2351, DOI 10.1016/S0042-6989(98)00042-X; Selwood A, 2007, J AFFECT DISORDERS, V101, P75, DOI 10.1016/j.jad.2006.10.025; Sharps MJ, 2002, CURR PSYCHOL, V21, P68; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; STEELE C, 1990, AM J PSYCHIAT, V147, P1049; TARR MJ, 1989, COGNITIVE PSYCHOL, V21, P233, DOI 10.1016/0010-0285(89)90009-1; Tippett LJ, 2003, NEUROPSYCHOLOGIA, V41, P453, DOI 10.1016/S0028-3932(02)00140-9; Troje NF, 1999, PERCEPTION, V28, P483, DOI 10.1068/p2901; Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; Vingerhoets G, 2001, NEUROIMAGE, V13, P381, DOI 10.1006/nimg.2000.0690; Visser PJ, 2002, J NEUROL NEUROSUR PS, V72, P491; von Gunten A, 2006, BRAIN RES REV, V51, P176, DOI 10.1016/j.brainresrev.2005.11.003; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	46	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6120	10.1371/journal.pone.0006120	http://dx.doi.org/10.1371/journal.pone.0006120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	468GX	19572013	gold, Green Published, Green Submitted			2022-12-27	WOS:000267806200003
J	Yamada, Y; Liu, XB; Fang, SG; Tay, FPL; Liu, DX				Yamada, Yoshiyuki; Liu, Xiao Bo; Fang, Shou Guo; Tay, Felicia P. L.; Liu, Ding Xiang			Acquisition of Cell-Cell Fusion Activity by Amino Acid Substitutions in Spike Protein Determines the Infectivity of a Coronavirus in Cultured Cells	PLOS ONE			English	Article							MOUSE HEPATITIS-VIRUS; N-TERMINAL DOMAIN; BRONCHITIS VIRUS; MURINE CORONAVIRUS; CONFORMATIONAL-CHANGES; AVIAN CORONAVIRUS; AMINOPEPTIDASE-N; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; HEPARAN-SULFATE	Coronavirus host and cell specificities are determined by specific interactions between the viral spike (S) protein and host cell receptor(s). Avian coronavirus infectious bronchitis (IBV) has been adapted to embryonated chicken eggs, primary chicken kidney (CK) cells, monkey kidney cell line Vero, and other human and animal cells. Here we report that acquisition of the cell-cell fusion activity by amino acid mutations in the S protein determines the infectivity of IBV in cultured cells. Expression of S protein derived from Vero-and CK-adapted strains showed efficient induction of membrane fusion. However, expression of S protein cloned from the third passage of IBV in chicken embryo (EP3) did not show apparent syncytia formation. By construction of chimeric S constructs and site-directed mutagenesis, a point mutation (L857-F) at amino acid position 857 in the heptad repeat 1 region of S protein was shown to be responsible for its acquisition of the cell-cell fusion activity. Furthermore, a G405-D point mutation in the S1 domain, which was acquired during further propagation of Vero-adapted IBV in Vero cells, could enhance the cell-cell fusion activity of the protein. Re-introduction of L857 back to the S gene of Vero-adapted IBV allowed recovery of variants that contain the introduced L857. However, compensatory mutations in S1 and some distant regions of S2 were required for restoration of the cell-cell fusion activity of S protein carrying L857 and for the infectivity of the recovered variants in cultured cells. This study demonstrates that acquisition of the cell-cell fusion activity in S protein determines the selection and/or adaptation of a coronavirus from chicken embryo to cultured cells of human and animal origins.	[Yamada, Yoshiyuki; Fang, Shou Guo; Tay, Felicia P. L.; Liu, Ding Xiang] Proteos, Inst Mol & Cell Biol, Singapore, Singapore; [Liu, Xiao Bo; Liu, Ding Xiang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yamada, Y (corresponding author), Proteos, Inst Mol & Cell Biol, Singapore, Singapore.	dxliu@imcb.a-star.edu.sg	Liu, Ding Xiang/A-2226-2011					ALONSOCAPLEN FV, 1984, VIRUS RES, V1, P153, DOI 10.1016/0168-1702(84)90070-4; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Butler N, 2006, VIROLOGY, V347, P410, DOI 10.1016/j.virol.2005.11.044; CAVANAGH D, 1986, VIRUS RES, V4, P133, DOI 10.1016/0168-1702(86)90037-7; Cavanagh D, 2002, AVIAN PATHOL, V31, P81, DOI 10.1080/03079450120106651; Chen HY, 2007, AVIAN PATHOL, V36, P269, DOI 10.1080/03079450701447291; de Haan CAM, 2005, J VIROL, V79, P14451, DOI 10.1128/JVI.79.22.14451-14456.2005; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991; Fang SG, 2005, BIOCHEM BIOPH RES CO, V336, P417, DOI 10.1016/j.bbrc.2005.08.105; Fang SG, 2007, VIROLOGY, V358, P136, DOI 10.1016/j.virol.2006.08.020; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Li FQ, 2007, VIROLOGY, V365, P435, DOI 10.1016/j.virol.2007.04.015; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; LIU DX, 1992, VIROLOGY, V186, P342, DOI 10.1016/0042-6822(92)90094-6; Madu IG, 2007, AVIAN DIS, V51, P45, DOI 10.1637/0005-2086(2007)051[0045:HSIASA]2.0.CO;2; Matsuyama S, 2002, J VIROL, V76, P11819, DOI 10.1128/JVI.76.23.11819-11826.2002; Miura HS, 2004, J VIROL, V78, P216, DOI 10.1128/JVI.78.1.216-223.2004; Ng LFP, 2002, J VIROL, V76, P6257, DOI 10.1128/JVI.76.12.6257-6267.2002; Ng LFP, 2000, VIROLOGY, V272, P27, DOI 10.1006/viro.2000.0330; SANCHEZ CM, 1992, VIROLOGY, V190, P92, DOI 10.1016/0042-6822(92)91195-Z; Shen S, 2004, VIROLOGY, V326, P288, DOI 10.1016/j.virol.2004.06.016; Shen S, 2003, VIROLOGY, V311, P16, DOI 10.1016/S0042-6822(03)00117-X; TAGUCHI F, 1993, ADV EXP MED BIOL, V342, P171; Tan YW, 2006, NUCLEIC ACIDS RES, V34, P4816, DOI 10.1093/nar/gkl650; TRACKRAY LB, 2004, VIROLOGY, V324, P510; Tresnan DB, 1996, J VIROL, V70, P8669, DOI 10.1128/JVI.70.12.8669-8674.1996; Tsai CW, 1999, J BIOL CHEM, V274, P26085, DOI 10.1074/jbc.274.37.26085; Tsai JC, 2003, J VIROL, V77, P841, DOI 10.1128/JVI.77.2.841-850.2003; Vijgen L, 2005, VIROLOGY, V337, P85, DOI 10.1016/j.virol.2005.04.010; WEGE H, 1982, CURR TOP MICROBIOL, V99, P165; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; Winter C, 2006, J GEN VIROL, V87, P1209, DOI 10.1099/vir.0.81651-0; Winter C, 2008, MICROBES INFECT, V10, P367, DOI 10.1016/j.micinf.2007.12.009; Xiao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001494; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200; Xu YH, 2004, J BIOL CHEM, V279, P30514, DOI 10.1074/jbc.M403760200; Yamada YK, 1997, VIROLOGY, V227, P215, DOI 10.1006/viro.1996.8313; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Youn S, 2005, VIROLOGY, V332, P206, DOI 10.1016/j.virol.2004.10.045; Zelus BD, 2003, J VIROL, V77, P830, DOI 10.1128/JVI.77.2.830-840.2003	44	30	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6130	10.1371/journal.pone.0006130	http://dx.doi.org/10.1371/journal.pone.0006130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GX	19572016	gold, Green Published, Green Submitted			2022-12-27	WOS:000267806200006
J	Lafourcade, CA; Zhang, LH; Alger, BE				Lafourcade, Carlos A.; Zhang, Longhua; Alger, Bradley E.			Novel mGluR- and CB1R-Independent Suppression of GABA Release Caused by a Contaminant of the Group I Metabotropic Glutamate Receptor Agonist, DHPG	PLOS ONE			English	Article								Background: Metabotropic glutamate receptors (mGluRs) are ubiquitous throughout the body, especially in brain, where they mediate numerous effects. MGluRs are classified into groups of which group I, comprising mGluRs 1 and 5, is especially important in neuronal communication. Group I actions are often investigated with the selective agonist, S-3,5-dihydroxyphenylglycine ( DHPG). Despite the selectivity of DHPG, its use has often led to contradictory findings. We now report that a particular commercial preparation of DHPG can produce mGluR-independent effects. These findings may help reconcile some discrepant reports. Methods: We carried out electrophysiological recordings in the rat in vitro hippocampal slice preparation, focusing mainly on pharmacologically isolated GABA(A)-receptor-mediated synaptic currents. Principal Findings: While preparations of DHPG from three companies suppressed GABAergic transmission in an mGluR-dependent way, one batch had an additional, unusual effect. Even in the presence of antagonists of mGluRs, it caused a reversible, profound suppression of inhibitory transmission. This mGluR - independent action was not due to a higher potency of the compound, or its ability to cause endocannabinoid-dependent responses. Field potential recordings revealed that glutamatergic transmission was not affected, and quantal analysis of GABA transmission confirmed the unusual effect was on GABA release, and not GABA(A) receptors. We have not identified the responsible factor in the DHPG preparation, but the samples were 99% pure as determined by HPLC and NMR analyses. Conclusions: In certain respects our observations with the anomalous batch strikingly resemble some published reports of unusual DHPG effects. The present findings could therefore contribute to explaining discrepancies in the literature. DHPG is widely employed to study mGluRs in different systems, hence rigorous controls should be performed before conclusions based on its use are drawn.			Lafourcade, CA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Program Neurosci, Baltimore, MD 21201 USA.	balgerlab@gmail.com	Zhang, Longhua/P-1417-2014	Lafourcade, Carlos/0000-0002-6728-1009	NIDA NIH HHS [R01 DA014625] Funding Source: Medline; NIMH NIH HHS [R01 MH07727] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014625] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AbdulGhani MA, 1996, J PHYSIOL-LONDON, V495, P113, DOI 10.1113/jphysiol.1996.sp021578; Alger BE, 2002, PROG NEUROBIOL, V68, P247; Ansah OB, 2009, EXP NEUROL, V216, P66, DOI 10.1016/j.expneurol.2008.11.005; BAIN AI, 1992, J PHYSIOL-LONDON, V450, P63, DOI 10.1113/jphysiol.1992.sp019116; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Edwards DA, 2006, J NEUROPHYSIOL, V95, P67, DOI 10.1152/jn.00813.2005; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Foldy C, 2007, NAT NEUROSCI, V10, P1128, DOI 10.1038/nn1952; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; GEREAU RW, 1995, J NEUROPHYSIOL, V74, P122, DOI 10.1152/jn.1995.74.1.122; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; ITO I, 1992, NEUROREPORT, V3, P1013, DOI 10.1097/00001756-199211000-00017; Karson MA, 2008, NEUROPHARMACOLOGY, V54, P117, DOI 10.1016/j.neuropharm.2007.06.023; Knopfel T, 2007, BRIT J PHARMACOL, V151, P723, DOI 10.1038/sj.bjp.0707289; Kohara A, 2005, J PHARMACOL EXP THER, V315, P163, DOI 10.1124/jpet.105.087171; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; Morishita W, 1997, J PHYSIOL-LONDON, V505, P307, DOI 10.1111/j.1469-7793.1997.307bb.x; Nadlewska A, 2002, POL J PHARMACOL, V54, P11; Park SY, 2007, ONCOL REP, V17, P81; Salt TE, 1999, BRIT J PHARMACOL, V127, P1057, DOI 10.1038/sj.bjp.0702677; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Watabe AM, 2002, J NEUROPHYSIOL, V87, P1395, DOI 10.1152/jn.00723.2001; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wisniewski K, 2002, CNS DRUG REV, V8, P101	28	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6122	10.1371/journal.pone.0006122	http://dx.doi.org/10.1371/journal.pone.0006122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568435	Green Submitted, Green Published, gold			2022-12-27	WOS:000267572200020
J	Goransson, H; Edlund, K; Rydaker, M; Rasmussen, M; Winquist, J; Ekman, S; Bergqvist, M; Thomas, A; Lambe, M; Rosenquist, R; Holmberg, L; Micke, P; Botling, J; Isaksson, A				Goransson, Hanna; Edlund, Karolina; Rydaker, Maria; Rasmussen, Markus; Winquist, Johan; Ekman, Simon; Bergqvist, Michael; Thomas, Andrew; Lambe, Mats; Rosenquist, Richard; Holmberg, Lars; Micke, Patrick; Botling, Johan; Isaksson, Anders			Quantification of Normal Cell Fraction and Copy Number Neutral LOH in Clinical Lung Cancer Samples Using SNP Array Data	PLOS ONE			English	Article								Background: Technologies based on DNA microarrays have the potential to provide detailed information on genomic aberrations in tumor cells. In practice a major obstacle for quantitative detection of aberrations is the heterogeneity of clinical tumor tissue. Since tumor tissue invariably contains genetically normal stromal cells, this may lead to a failure to detect aberrations in the tumor cells. Principal Finding: Using SNP array data from 44 non-small cell lung cancer samples we have developed a bioinformatic algorithm that accurately models the fractions of normal and tumor cells in clinical tumor samples. The proportion of normal cells in combination with SNP array data can be used to detect and quantify copy number neutral loss-of-heterozygosity (CNNLOH) in the tumor cells both in crude tumor tissue and in samples enriched for tumor cells by laser capture microdissection. Conclusion: Genome-wide quantitative analysis of CNNLOH using the CNNLOH Quantifier method can help to identify recurrent aberrations contributing to tumor development in clinical tumor samples. In addition, SNP-array based analysis of CNNLOH may become important for detection of aberrations that can be used for diagnostic and prognostic purposes.			Goransson, H (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	anders.isaksson@medsci.uu.se	Ekman, Simon/AAB-9387-2021; Botling, Johan/ABA-2586-2020; Wang, Weili/D-1546-2011	Botling, Johan/0000-0003-2226-3517; Rosenquist, Richard/0000-0002-0211-8788; Lambe, Mats/0000-0002-4624-3767; Isaksson, Anders/0000-0001-6576-7825				Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Assie G, 2008, AM J HUM GENET, V82, P903, DOI 10.1016/j.ajhg.2008.01.012; Beroukhim R, 2006, PLOS COMPUT BIOL, V2, P323, DOI 10.1371/journal.pcbi.0020041; Fitzgibbon J, 2005, CANCER RES, V65, P9152, DOI 10.1158/0008-5472.CAN-05-2017; Gunnarsson R, 2008, GENE CHROMOSOME CANC, V47, P697, DOI 10.1002/gcc.20575; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-83; Ishikawa S, 2005, BIOCHEM BIOPH RES CO, V333, P1309, DOI 10.1016/j.bbrc.2005.06.040; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; Laframboise T, 2007, BIOSTATISTICS, V8, P323, DOI 10.1093/biostatistics/kxl012; Lamy P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-434; Langdon JA, 2006, GENE CHROMOSOME CANC, V45, P47, DOI 10.1002/gcc.20262; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Micke P, 2005, EXPERT OPIN THER TAR, V9, P1217, DOI 10.1517/14728222.9.6.1217; Micke Patrick, 2005, Methods Mol Biol, V293, P151; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yi YJ, 2005, GENOMICS, V85, P401, DOI 10.1016/j.ygeno.2004.11.011; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	21	19	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6057	10.1371/journal.pone.0006057	http://dx.doi.org/10.1371/journal.pone.0006057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557126	Green Submitted, Green Published, gold			2022-12-27	WOS:000267424600005
J	Israel, A; Sharan, R; Ruppin, E; Galun, E				Israel, Ariel; Sharan, Roded; Ruppin, Eytan; Galun, Eithan			Increased MicroRNA Activity in Human Cancers	PLOS ONE			English	Article								MicroRNAs (miRNAs) are small regulatory RNAs that act by blocking the translation and increasing the degradation of target transcripts. MiRNAs play a critical role in many biological processes including development and differentiation and many studies have shown that major changes in miRNA levels occur in cancer. Since miRNAs degrade target messages, we used this property to develop a novel computational method aimed at determining the actual biological activity of miRNAs using variations in gene expression. Using the method described here, we quantified miRNA activity in papillary thyroid carcinoma and breast cancer, and found a strong and distinctive signal of increased global miRNA activity, embedded in the pertaining gene expression measurements. Interestingly, we found that in these two cancers, miRNA activity is globally increased, and is associated with a global downregulation of miRNA target genes. This downreguation of miRNA regulated genes is particularly noticeable for genes carrying multiple target sites for miRNAs. Among the miRNA-repressed genes, we found a significant enrichment of known tumor suppressors, thereby suggesting that the increased miRNA activity was indeed tumorigenic.			Israel, A (corresponding author), Hadassah Hebrew Univ Hosp, Goldyne Savad Gene Therapy Inst, Jerusalem, Israel.	eithang@hadassah.org.il	Israel, Ariel/AFL-8794-2022; Ruppin, Eytan/R-9698-2017; Galun, Eithan/AAD-9117-2022	Ruppin, Eytan/0000-0002-7862-3940; Galun, Eithan/0000-0002-6243-6702				Arora A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r82; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; FRANKEL LB, 2007, J BIOL CHEM; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabach Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000807; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	43	32	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6045	10.1371/journal.pone.0006045	http://dx.doi.org/10.1371/journal.pone.0006045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557174	Green Submitted, Green Published, gold			2022-12-27	WOS:000267356900007
J	Slipczuk, L; Bekinschtein, P; Katche, C; Cammarota, M; Izquierdo, I; Medina, JH				Slipczuk, Leandro; Bekinschtein, Pedro; Katche, Cynthia; Cammarota, Martin; Izquierdo, Ivan; Medina, Jorge H.			BDNF Activates mTOR to Regulate GluR1 Expression Required for Memory Formation	PLOS ONE			English	Article							LONG-TERM-MEMORY; ANISOMYCIN-INDUCED AMNESIA; LOCAL PROTEIN-SYNTHESIS; CONTEXTUAL FEAR MEMORY; 2 CRITICAL PERIODS; SYNAPTIC PLASTICITY; MESSENGER-RNA; NEUROTROPHIC FACTOR; TRANSLATIONAL CONTROL; MAMMALIAN TARGET	Background: The mammalian target of Rapamycin (mTOR) kinase plays a key role in translational control of a subset of mRNAs through regulation of its initiation step. In neurons, mTOR is present at the synaptic region, where it modulates the activity-dependent expression of locally-translated proteins independently of mRNA synthesis. Indeed, mTOR is necessary for different forms of synaptic plasticity and long-term memory (LTM) formation. However, little is known about the time course of mTOR activation and the extracellular signals governing this process or the identity of the proteins whose translation is regulated by this kinase, during mnemonic processing. Methodology/Principal Findings: Here we show that consolidation of inhibitory avoidance (IA) LTM entails mTOR activation in the dorsal hippocampus at the moment of and 3 h after training and is associated with a rapid and rapamycin-sensitive increase in AMPA receptor GluR1 subunit expression, which was also blocked by intra-hippocampal delivery of GluR1 antisense oligonucleotides (ASO). In addition, we found that pre- or post-training administration of function-blocking anti-BDNF antibodies into dorsal CA1 hampered IA LTM retention, abolished the learning-induced biphasic activation of mTOR and its readout, p70S6K and blocked GluR1 expression, indicating that BDNF is an upstream factor controlling mTOR signaling during fear-memory consolidation. Interestingly, BDNF ASO hindered LTM retention only when given into dorsal CA1 1 h after but not 2 h before training, suggesting that BDNF controls the biphasic requirement of mTOR during LTM consolidation through different mechanisms: an early one involving BDNF already available at the moment of training, and a late one, happening around 3 h post-training that needs de novo synthesis of this neurotrophin. Conclusions/Significance: In conclusion, our findings demonstrate that: 1) mTOR-mediated mRNA translation is required for memory consolidation during at least two restricted time windows; 2) this kinase acts downstream BDNF in the hippocampus and; 3) it controls the increase of synaptic GluR1 necessary for memory consolidation.			Slipczuk, L (corresponding author), Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencias, Buenos Aires, DF, Argentina.	jmedina@fmed.uba.ar	Cammarota, Martin/AAC-7478-2021; Neurociencia, Inct/I-1011-2013	Cammarota, Martin/0000-0001-9741-5074; Izquierdo, Ivan/0000-0002-7208-0869; Bekinschtein, Pedro/0000-0002-0004-9619; Katche, Cynthia/0000-0002-3428-7615				Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Asaki C, 2003, BRAIN RES, V972, P168, DOI 10.1016/S0006-8993(03)02523-X; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; BRAM RJ, 1993, MOL CELL BIOL, V13, P4760, DOI 10.1128/MCB.13.8.4760; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Caldeira MV, 2007, MOL CELL NEUROSCI, V35, P208, DOI 10.1016/j.mcn.2007.02.019; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Cammarota M, 1998, EUR J NEUROSCI, V10, P2669, DOI 10.1046/j.1460-9568.1998.t01-1-00254.x; CAMMAROTA M, 1995, NEUROBIOL LEARN MEM, V64, P257, DOI 10.1006/nlme.1995.0008; Carvalho AL, 2008, BRIT J PHARMACOL, V153, pS310, DOI 10.1038/sj.bjp.0707509; CASTREN E, 1993, NEUROREPORT, V4, P895, DOI 10.1097/00001756-199307000-00014; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; FREEMAN FM, 1995, NEUROBIOL LEARN MEM, V63, P291, DOI 10.1006/nlme.1995.1034; GRECKSCH G, 1980, PHARMACOL BIOCHEM BE, V12, P663, DOI 10.1016/0091-3057(80)90145-8; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hefferan MP, 2007, J NEUROSCI, V27, P11179, DOI 10.1523/JNEUROSCI.0989-07.2007; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002; HERNANDEZ PJ, 2007, NEUROBIOL LEARN MEM; Igaz LM, 2002, J NEUROSCI, V22, P6781; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005; Jain P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000287; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KOLTIN Y, 1991, MOL CELL BIOL, V11, P1718, DOI 10.1128/MCB.11.3.1718; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lorenzini CA, 1996, NEUROBIOL LEARN MEM, V66, P80, DOI 10.1006/nlme.1996.0045; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Myskiw JC, 2008, NEUROBIOL LEARN MEM, V89, P338, DOI 10.1016/j.nlm.2007.10.002; Narisawa-Saito M, 1999, NEUROSCIENCE, V88, P1009, DOI 10.1016/S0306-4522(98)00496-5; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parsons RG, 2006, J NEUROSCI, V26, P12977, DOI 10.1523/JNEUROSCI.4209-06.2006; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; PAXINOS G, 1997, RAT BRAIN STEREOTAXI, P33; Quevedo J, 1999, LEARN MEMORY, V6, P600, DOI 10.1101/lm.6.6.600; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Routtenberg A, 2008, NEUROBIOL LEARN MEM, V89, P225, DOI 10.1016/j.nlm.2007.10.012; Rudy JW, 2008, NEUROBIOL LEARN MEM, V89, P366, DOI 10.1016/j.nlm.2007.07.017; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Smart FM, 2003, P NATL ACAD SCI USA, V100, P14403, DOI 10.1073/pnas.2436349100; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stanciu M, 2001, MOL BRAIN RES, V94, P15, DOI 10.1016/S0169-328X(01)00174-7; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tang SJ, 2002, PHILOS T R SOC B, V357, P521, DOI 10.1098/rstb.2001.0887; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Tiunova AA, 1998, LEARN MEMORY, V4, P401, DOI 10.1101/lm.4.5.401; Trifilieff P, 2007, NEUROBIOL LEARN MEM, V88, P424, DOI 10.1016/j.nlm.2007.05.004; Trifilieff P, 2006, LEARN MEMORY, V13, P349, DOI 10.1101/lm.80206; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yang PC, 2008, J BIOL CHEM, V283, P2631, DOI 10.1074/jbc.M706954200; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64	83	195	198	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6007	10.1371/journal.pone.0006007	http://dx.doi.org/10.1371/journal.pone.0006007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462JI	19547753	Green Published, gold, Green Submitted			2022-12-27	WOS:000267347900006
J	Chiam, R; Sharp, E; Maan, S; Rao, S; Mertens, P; Blacklaws, B; Davis-Poynter, N; Wood, J; Castillo-Olivares, J				Chiam, Rachael; Sharp, Emma; Maan, Sushila; Rao, Shujing; Mertens, Peter; Blacklaws, Barbara; Davis-Poynter, Nick; Wood, James; Castillo-Olivares, Javier			Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)	PLOS ONE			English	Article								Background: African horse sickness virus (AHSV) causes a non-contagious, infectious disease in equids, with mortality rates that can exceed 90% in susceptible horse populations. AHSV vaccines play a crucial role in the control of the disease; however, there are concerns over the use of polyvalent live attenuated vaccines particularly in areas where AHSV is not endemic. Therefore, it is important to consider alternative approaches for AHSV vaccine development. We have carried out a pilot study to investigate the ability of recombinant modified vaccinia Ankara (MVA) vaccines expressing VP2, VP7 or NS3 genes of AHSV to stimulate immune responses against AHSV antigens in the horse. Methodology/Principal Findings: VP2, VP7 and NS3 genes from AHSV-4/Madrid87 were cloned into the vaccinia transfer vector pSC11 and recombinant MVA viruses generated. Antigen expression or transcription of the AHSV genes from cells infected with the recombinant viruses was confirmed. Pairs of ponies were vaccinated with MVAVP2, MVAVP7 or MVANS3 and both MVA vector and AHSV antigen-specific antibody responses were analysed. Vaccination with MVAVP2 induced a strong AHSV neutralising antibody response (VN titre up to a value of 2). MVAVP7 also induced AHSV antigen -specific responses, detected by western blotting. NS3 specific antibody responses were not detected. Conclusions: This pilot study demonstrates the immunogenicity of recombinant MVA vectored AHSV vaccines, in particular MVAVP2, and indicates that further work to investigate whether these vaccines would confer protection from lethal AHSV challenge in the horse is justifiable.			Chiam, R (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	javier.castillo-olivares@bbsrc.ac.uk	Castillo-Olivares, Javier/L-5337-2014; Castillo-Olivares, Javier/AAA-8837-2019; Blacklaws, Barbara A/AAF-6360-2019; Castillo-Olivares, Javier/AAA-7603-2019; Davis-Poynter, Nicholas/B-3811-2010	Castillo-Olivares, Javier/0000-0003-3453-8557; Castillo-Olivares, Javier/0000-0003-3453-8557; Blacklaws, Barbara A/0000-0001-5454-6496; Davis-Poynter, Nicholas/0000-0001-7368-1925; Wood, James/0000-0002-0258-3188; Mertens, Peter/0000-0002-3438-3738	Biotechnology and Biological Sciences Research Council [BBS/B/00654] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abaitua F, 2006, VIRUS RES, V116, P11, DOI 10.1016/j.virusres.2005.08.008; ANDREW M, 1995, VET IMMUNOL IMMUNOP, V47, P311, DOI 10.1016/0165-2427(94)05410-T; Boone JD, 2007, VACCINE, V25, P672, DOI 10.1016/j.vaccine.2006.08.025; Bougrine SI, 1998, ARCH VIROL, P329; Breathnach CC, 2006, VACCINE, V24, P1180, DOI 10.1016/j.vaccine.2005.08.091; Breathnach CC, 2005, VET IMMUNOL IMMUNOP, V103, P207, DOI 10.1016/j.vetimm.2004.09.024; Breathnach CC, 2004, VET IMMUNOL IMMUNOP, V98, P127, DOI 10.1016/j.vetimm.2003.11.004; BROCHIER B, 1994, VACCINE, V12, P1368, DOI 10.1016/0264-410X(94)90143-0; BURRAGE TG, 1993, VIROLOGY, V196, P799, DOI 10.1006/viro.1993.1537; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; DUPLESSIS DH, 1991, ONDERSTEPOORT J VET, V58, P1; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; GUIRAKHOO F, 1995, ARCH VIROL, V140, P967, DOI 10.1007/BF01314973; Hanke T, 1998, VACCINE, V16, P439, DOI 10.1016/S0264-410X(97)00226-0; House J.A., 1992, EFFICACY INACTIVATED, P891; House JA, 1998, ARCH VIROL, P297; HOUSE JA, 1994, VACCINE, V12, P142, DOI 10.1016/0264-410X(94)90052-3; HOWELL P. G., 1962, ONDERSTEPOORT JOUR VET RES, V29, P139; Janardhana V, 1999, RES VET SCI, V67, P213, DOI 10.1053/rvsc.1999.0306; KARBER G, 1931, BEITRAG KOLLEKTIVEN, P480; KUNDIG TM, 1993, VACCINE, V11, P1154, DOI 10.1016/0264-410X(93)90079-D; LAVIADA MD, 1995, VIRUS RES, V38, P205, DOI 10.1016/0168-1702(95)00061-T; Lubroth J., 1988, Equine Practice, V10, P26; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; MACLACHLAN NJ, 2007, VACCINE; Maree S, 2005, J VIROL METHODS, V125, P55, DOI 10.1016/j.jviromet.2004.12.002; MartinezTorrecuadrada JL, 1996, J GEN VIROL, V77, P1211, DOI 10.1099/0022-1317-77-6-1211; MartinezTorrecuadrada JL, 1997, J CLIN MICROBIOL, V35, P531; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Meiswinkel R, 2003, PREV VET MED, V60, P243, DOI 10.1016/S0167-5877(02)00231-3; MELLOR PS, 1995, ANN TROP MED PARASIT, V89, P1; MELLOR PS, 1990, EPIDEMIOL INFECT, V105, P447, DOI 10.1017/S0950268800048020; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; MELLOR PS, 1994, COMP IMMUNOL MICROB, V17, P287, DOI 10.1016/0147-9571(94)90048-5; MERTENS P, 2007, ISOLATES AFRICAN HOR; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; Minke JM, 2006, VET IMMUNOL IMMUNOP, V111, P47, DOI 10.1016/j.vetimm.2006.01.008; Minke JM, 2007, AM J VET RES, V68, P213, DOI 10.2460/ajvr.68.2.213; *OIE, 2005, TERR AN HLTH COD; POULET H, 2006, VACCINE; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; RANZ AI, 1992, VET MICROBIOL, V33, P143, DOI 10.1016/0378-1135(92)90042-R; Rocha CD, 2004, INT MICROBIOL, V7, P83; RODRIGUEZ M, 1992, VET MICROBIOL, V33, P129, DOI 10.1016/0378-1135(92)90041-Q; ROONEY JF, 1988, J VIROL, V62, P1530, DOI 10.1128/JVI.62.5.1530-1534.1988; Roy P, 1996, J GEN VIROL, V77, P2053, DOI 10.1099/0022-1317-77-9-2053; ROY P, 1994, COMP IMMUNOL MICROB, V17, P243, DOI 10.1016/0147-9571(94)90046-9; Sanchez-Vizcaino JM, 2004, DEV BIOLOGICALS, V119, P255; Sharpe S, 2001, J GEN VIROL, V82, P2215, DOI 10.1099/0022-1317-82-9-2215; StoneMarschat MA, 1996, VIROLOGY, V220, P219, DOI 10.1006/viro.1996.0304; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; Veronesi E, 2005, VACCINE, V23, P5509, DOI 10.1016/j.vaccine.2005.07.039; WadeEvans AM, 1997, J GEN VIROL, V78, P1611, DOI 10.1099/0022-1317-78-7-1611; Wittmann EJ, 2000, VET J, V160, P107, DOI 10.1053/tvjl.2000.0470; Zhang XG, 2007, J VIROL, V81, P7022, DOI 10.1128/JVI.02654-06	57	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5997	10.1371/journal.pone.0005997	http://dx.doi.org/10.1371/journal.pone.0005997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543394	Green Submitted, Green Published, gold			2022-12-27	WOS:000267237600010
J	Fagerholm, S; Ortegren, U; Karlsson, M; Ruishalme, I; Stralfors, P				Fagerholm, Siri; Ortegren, Unn; Karlsson, Margareta; Ruishalme, Iida; Stralfors, Peter			Rapid Insulin-Dependent Endocytosis of the Insulin Receptor by Caveolae in Primary Adipocytes	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CLATHRIN-INDEPENDENT ENDOCYTOSIS; HORMONE-SENSITIVE LIPASE; MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; TYROSINE PHOSPHORYLATION; RAT ADIPOCYTES; SURFACE REDISTRIBUTION; SIGNAL-TRANSDUCTION; IN-VIVO	Background: The insulin receptor is localized in caveolae and is dependent on caveolae or cholesterol for signaling in adipocytes. When stimulated with insulin, the receptor is internalized. Methodology/Principal Findings: We examined primary rat adipocytes by subcellular fractionation to examine if the insulin receptor was internalized in a caveolae-mediated process. Insulin induced a rapid, t(1/2)<3 min, endocytosis of the insulin receptor in parallel with receptor tyrosine autophosphorylation. Concomitantly, caveolin-1 was phosphorylated at tyrosine(14) and endocytosed. Vanadate increased the phosphorylation of caveolin-1 without affecting insulin receptor phosphorylation or endocytosis. Immunocapture of endosomal vesicles with antibodies against the insulin receptor co-captured caveolin-1 and immunocapture with antibodies against tyrosine(14)-phosphorylated caveolin-1 co-captured the insulin receptor, demonstrating that the insulin receptor was endocytosed together with tyrosine(14)-phosphorylated caveolin-1. By immunogold electron microscopy the insulin receptor and caveolin-1 were colocalized in endosome vesicles that resembled caveosomes. Clathrin was not endocytosed with the insulin receptor and the inhibitor of clathrin-coated pit-mediated endocytosis, chlorpromazine, did not inhibit internalization of the insulin receptor, while transferrin receptor internalization was inhibited. Conclusion: It is concluded that in response to insulin stimulation the autophosphorylated insulin receptor in primary adipocytes is rapidly endocytosed in a caveolae-mediated process, involving tyrosine phosphorylation of caveolin-1.			Fagerholm, S (corresponding author), Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Linkoping, Sweden.	peter.stralfors@liu.se		Stralfors, Peter/0000-0002-1196-1806				ABLER A, 1992, J BIOL CHEM, V267, P3946; Aboulaich N, 2006, BIOCHEM BIOPH RES CO, V350, P657, DOI 10.1016/j.bbrc.2006.09.094; Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; ASANTE A, 2003, AM J PHYSIOL, V284, pE663; BACKER JM, 1989, J BIOL CHEM, V264, P1694; Bevan AP, 1997, J BIOL CHEM, V272, P26833, DOI 10.1074/jbc.272.43.26833; BEVAN AP, 1995, J BIOL CHEM, V270, P10784, DOI 10.1074/jbc.270.18.10784; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; CARPENTIER JL, 1992, P NATL ACAD SCI USA, V89, P162, DOI 10.1073/pnas.89.1.162; CARPENTIER JL, 1981, J CELL BIOL, V91, P17, DOI 10.1083/jcb.91.1.17; CARPENTIER JL, 1993, J CELL BIOL, V122, P1243, DOI 10.1083/jcb.122.6.1243; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; Cheng ZJ, 2006, MOL MEMBR BIOL, V23, P101, DOI 10.1080/09687860500460041; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; CORLEYMASTICK C, 1997, J BIOL CHEM, V272, P20706; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Di Guglielmo GM, 1998, MOL CELL BIOCHEM, V182, P59, DOI 10.1023/A:1006883311233; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FAN JY, 1982, P NATL ACAD SCI-BIOL, V79, P7788, DOI 10.1073/pnas.79.24.7788; Foti M, 2007, P NATL ACAD SCI USA, V104, P1242, DOI 10.1073/pnas.0610523104; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; GEIGER D, 1989, EXP CELL RES, V185, P33, DOI 10.1016/0014-4827(89)90034-7; GOLDBERG RI, 1987, J CELL PHYSIOL, V133, P203, DOI 10.1002/jcp.1041330202; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Hamer I, 2002, DIABETOLOGIA, V45, P657, DOI 10.1007/s00125-002-0798-5; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Karlsson M, 2004, EUR J BIOCHEM, V271, P2471, DOI 10.1111/j.1432-1033.2004.04177.x; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; KHAN MN, 1986, J BIOL CHEM, V261, P8462; Kimura A, 2002, J BIOL CHEM, V277, P30153, DOI 10.1074/jbc.M203375200; KLEIN HH, 1987, J BIOL CHEM, V262, P10557; KUBLAOUI B, 1995, J BIOL CHEM, V270, P59, DOI 10.1074/jbc.270.1.59; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; LINDROTH M, 1991, J MICROSC-OXFORD, V161, P229, DOI 10.1111/j.1365-2818.1991.tb03086.x; MARSHALL S, 1985, J BIOL CHEM, V260, P3517; MARSHALL S, 1985, J BIOL CHEM, V260, P3524; MASTICK CC, 1995, J CELL BIOL, V129, P1523, DOI 10.1083/jcb.129.6.1523; MCCLAIN DA, 1988, DIABETES, V37, P806, DOI 10.2337/diabetes.37.6.806; MCKEEL DW, 1970, J CELL BIOL, V44, P417, DOI 10.1083/jcb.44.2.417; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Nomura R, 1999, MOL BIOL CELL, V10, P975, DOI 10.1091/mbc.10.4.975; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; OKA Y, 1984, J BIOL CHEM, V259, P8125; OLEFSKY JM, 1982, METABOLISM, V31, P670, DOI 10.1016/0026-0495(82)90197-4; Ortegren U, 2006, FEBS J, V273, P3381, DOI 10.1111/j.1742-4658.2006.05345.x; Ost A, 2005, J BIOL CHEM, V280, P5, DOI 10.1074/jbc.C400429200; PACCAUD JP, 1992, J BIOL CHEM, V267, P13101; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; SMITH RM, 1990, ENDOCRINOLOGY, V126, P1551, DOI 10.1210/endo-126-3-1551; SMITH RM, 1983, J CELL PHYSIOL, V115, P199, DOI 10.1002/jcp.1041150215; SMITH RM, 1988, LAB INVEST, V58, P613; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Souto RP, 2003, J BIOL CHEM, V278, P18321, DOI 10.1074/jbc.M211541200; Stralfors P, 1997, BIOESSAYS, V19, P327, DOI 10.1002/bies.950190410; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Stralfors P, 2005, ADV MOL CEL, V36, P138, DOI 10.1016/S0079-6603(05)36008-9; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; TOROSSIAN K, 1988, J BIOL CHEM, V263, P9353; Wang B, 1996, BIOCHEM BIOPH RES CO, V227, P27, DOI 10.1006/bbrc.1996.1462; Wang H, 2006, AM J PHYSIOL-ENDOC M, V291, pE323, DOI 10.1152/ajpendo.00047.2006; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Xue B, 2007, J BIOL CHEM, V282, P23829, DOI 10.1074/jbc.M609680200; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200	75	72	73	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5985	10.1371/journal.pone.0005985	http://dx.doi.org/10.1371/journal.pone.0005985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543529	Green Published, Green Submitted, gold			2022-12-27	WOS:000267237400011
J	van Swinderen, B; McCartney, A; Kauffman, S; Flores, K; Agrawal, K; Wagner, J				van Swinderen, Bruno; McCartney, Amber; Kauffman, Sarah; Flores, Kris; Agrawal, Kunal; Wagner, Jenee			Shared Visual Attention and Memory Systems in the Drosophila Brain	PLOS ONE			English	Article								Background: Selective attention and memory seem to be related in human experience. This appears to be the case as well in simple model organisms such as the fly Drosophila melanogaster. Mutations affecting olfactory and visual memory formation in Drosophila, such as in dunce and rutabaga, also affect short-term visual processes relevant to selective attention. In particular, increased optomotor responsiveness appears to be predictive of visual attention defects in these mutants. Methodology/Principal Findings: To further explore the possible overlap between memory and visual attention systems in the fly brain, we screened a panel of 36 olfactory long term memory (LTM) mutants for visual attention-like defects using an optomotor maze paradigm. Three of these mutants yielded high dunce-like optomotor responsiveness. We characterized these three strains by examining their visual distraction in the maze, their visual learning capabilities, and their brain activity responses to visual novelty. We found that one of these mutants, D0067, was almost completely identical to dunce(1) for all measures, while another, D0264, was more like wild type. Exploiting the fact that the LTM mutants are also Gal4 enhancer traps, we explored the sufficiency for the cells subserved by these elements to rescue dunce attention defects and found overlap at the level of the mushroom bodies. Finally, we demonstrate that control of synaptic function in these Gal4 expressing cells specifically modulates a 20-30 Hz local field potential associated with attention-like effects in the fly brain. Conclusions/Significance: Our study uncovers genetic and neuroanatomical systems in the fly brain affecting both visual attention and odor memory phenotypes. A common component to these systems appears to be the mushroom bodies, brain structures which have been traditionally associated with odor learning but which we propose might be also involved in generating oscillatory brain activity required for attention-like processes in the fly brain.			van Swinderen, B (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	b.vanswinderen@uq.edu.au		van Swinderen, Bruno/0000-0001-6552-7418				BRAND AH, 1993, DEVELOPMENT, V118, P401; Brembs B, 2006, LEARN MEMORY, V13, P618, DOI 10.1101/lm.318606; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; Dubnau J, 2003, J NEUROBIOL, V54, P238, DOI 10.1002/neu.10170; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; FOLKERS E, 1981, J INSECT PHYSIOL, V27, P615, DOI 10.1016/0022-1910(81)90109-8; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Gong ZF, 1998, J INSECT PHYSIOL, V44, P1149, DOI 10.1016/S0022-1910(98)00076-6; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Leung B, 2004, TRENDS NEUROSCI, V27, P511, DOI 10.1016/j.tins.2004.06.013; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Seugnet L., 2009, GENES BRAIN BEHAV; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; van Swinderen B, 2005, BIOESSAYS, V27, P321, DOI 10.1002/bies.20195; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; van Swinderen B., 2006, J NEUROBIOL; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; Villella A, 2005, P NATL ACAD SCI USA, V102, P16550, DOI 10.1073/pnas.0507056102; Wolf R, 1998, LEARN MEMORY, V5, P166; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357	31	40	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5989	10.1371/journal.pone.0005989	http://dx.doi.org/10.1371/journal.pone.0005989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543525	Green Submitted, Green Published, gold			2022-12-27	WOS:000267237400014
J	Ekstrom, F; Hornberg, A; Artursson, E; Hammarstrom, LG; Schneider, G; Pang, YP				Ekstrom, Fredrik; Hornberg, Andreas; Artursson, Elisabet; Hammarstrom, Lars-Gunnar; Schneider, Gunter; Pang, Yuan-Ping			Structure of HI-6 center dot Sarin-Acetylcholinesterase Determined by X-Ray Crystallography and Molecular Dynamics Simulation: Reactivator Mechanism and Design	PLOS ONE			English	Article							NORMAL-MODE-ANALYSIS; ACTIVE-SITE GORGE; CRYSTAL-STRUCTURES; HUMAN ACETYLCHOLINESTERASE; ORGANOPHOSPHORUS COMPOUNDS; DIFFRACTION DATA; BACK DOOR; OXIMES; HI-6; BUTYRYLCHOLINESTERASE	Organophosphonates such as isopropyl metylphosphonofluoridate (sarin) are extremely toxic as they phosphonylate the catalytic serine residue of acetylcholinesterase (AChE), an enzyme essential to humans and other species. Design of effective AChE reactivators as antidotes to various organophosphonates requires information on how the reactivators interact with the phosphonylated AChEs. However, such information has not been available hitherto because of three main challenges. First, reactivators are generally flexible in order to change from the ground state to the transition state for reactivation; this flexibility discourages determination of crystal structures of AChE in complex with effective reactivators that are intrinsically disordered. Second, reactivation occurs upon binding of a reactivator to the phosphonylated AChE. Third, the phosphorous conjugate can develop resistance to reactivation. We have identified crystallographic conditions that led to the determination of a crystal structure of the sarin(nonaged)-conjugated mouse AChE in complex with [(E)-[1-[(4-carbamoylpyridin-1-ium-1-yl)methoxymethyl]pyridin-2-ylidene]methyl]-oxoazanium dichloride (HI-6) at a resolution of 2.2 angstrom. In this structure, the carboxyamino-pyridinium ring of HI-6 is sandwiched by Tyr124 and Trp286, however, the oxime-pyridinium ring is disordered. By combining crystallography with microsecond molecular dynamics simulation, we determined the oxime-pyridinium ring structure, which shows that the oxime group of HI-6 can form a hydrogen-bond network to the sarin isopropyl ether oxygen, and a water molecule is able to form a hydrogen bond to the catalytic histidine residue and subsequently deprotonates the oxime for reactivation. These results offer insights into the reactivation mechanism of HI-6 and design of better reactivators.			Ekstrom, F (corresponding author), CBRN Def & Secur, Swedish Def Res Agcy, Umea, Sweden.	fredrik.ekstrom@foi.se; pang@mayo.edu		Pang, Yuan-Ping/0000-0003-0838-2560; Schneider, Gunter/0000-0003-0622-5713				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ASHANI Y, 1995, J BIOL CHEM, V270, P6370, DOI 10.1074/jbc.270.11.6370; AXELSEN PH, 1994, PROTEIN SCI, V3, P188; Bartolucci C, 1999, BIOCHEMISTRY-US, V38, P5714, DOI 10.1021/bi982723p; BENSCHOP HP, 1966, BIOCHIM BIOPHYS ACTA, V128, P586, DOI 10.1016/0926-6593(66)90023-3; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; Bourne Y, 2004, P NATL ACAD SCI USA, V101, P1449, DOI 10.1073/pnas.0308206100; BOURNE Y, 2006, J BIOL CHEM; Brimijoin S, 2008, NEUROPSYCHOPHARMACOL, V33, P2715, DOI 10.1038/sj.npp.1301666; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Choe J, 2002, CHEM BIOL, V9, P1189, DOI 10.1016/S1074-5521(02)00243-0; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ekstrom F, 2006, BIOCHEMISTRY-US, V45, P74, DOI 10.1021/bi051286t; Ekstrom FJ, 2007, CLIN PHARMACOL THER, V82, P282, DOI 10.1038/sj.clpt.6100151; Ekstrom F, 2006, BIOCHEM PHARMACOL, V72, P597, DOI 10.1016/j.bcp.2006.05.027; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; EYER P, 1988, ARCH TOXICOL, V62, P224, DOI 10.1007/BF00570145; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; FRISCH MJ, 1999, GAUSSIAN 94 REVISION; GILSON MK, 1994, SCIENCE, V263, P1276, DOI 10.1126/science.8122110; GINSBURG S, 1957, J AM CHEM SOC, V79, P481, DOI 10.1021/ja01559a067; Grosfeld H, 1996, MOL PHARMACOL, V50, P639; HALL CR, 1980, TETRAHEDRON, V36, P2059, DOI 10.1016/0040-4020(80)80096-2; Hammond PI, 2003, J PHARMACOL EXP THER, V307, P190, DOI 10.1124/jpet.103.053405; HARRIS LW, 1966, SCIENCE, V154, P404, DOI 10.1126/science.154.3747.404; HOBBIGER F, 1958, NATURE, V182, P1672, DOI 10.1038/1821672a0; Hornberg A, 2007, BIOCHEMISTRY-US, V46, P4815, DOI 10.1021/bi0621361; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koellner G, 2000, J MOL BIOL, V296, P713, DOI 10.1006/jmbi.1999.3468; Kovarik Z, 2004, BIOCHEMISTRY-US, V43, P3222, DOI 10.1021/bi036191a; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LORQUET V, 1959, B SOC CHIM BELG, V68, P336; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luo CY, 2003, BIOCHEM PHARMACOL, V66, P387, DOI 10.1016/S0006-2952(03)00237-5; Maragakis P, 2008, J PHYS CHEM B, V112, P6155, DOI 10.1021/jp077018h; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Millard CB, 1999, BIOCHEMISTRY-US, V38, P7032, DOI 10.1021/bi982678l; Mura C, 2008, NUCLEIC ACIDS RES, V36, P4941, DOI 10.1093/nar/gkn473; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odzak R, 2007, TOXICOLOGY, V233, P85, DOI 10.1016/j.tox.2006.08.003; Pang YP, 2003, CHEM BIOL, V10, P491, DOI 10.1016/S1074-5521(03)00126-1; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Raves ML, 1997, NAT STRUCT BIOL, V4, P57, DOI 10.1038/nsb0197-57; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; SPOHRER U, 1994, ARCH TOXICOL, V68, P480, DOI 10.1007/s002040050100; Sun H, 2002, MOL PHARMACOL, V62, P220, DOI 10.1124/mol.62.2.220; Sun H, 2001, J BIOL CHEM, V276, P9330, DOI 10.1074/jbc.M006676200; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; THOMPSON DF, 1987, DRUG INTEL CLIN PHAR, V21, P590, DOI 10.1177/1060028087021007-804; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001025; WILLIAMS D C, 1962, New Physician, V11, P182; WILSON IB, 1958, BIOCHEM PHARMACOL, V1, P200; Wong L, 2000, BIOCHEMISTRY-US, V39, P5750, DOI 10.1021/bi992906r; Worek F, 2004, BIOCHEM PHARMACOL, V68, P2237, DOI 10.1016/j.bcp.2004.07.038; Worek F, 2002, ARCH TOXICOL, V76, P523, DOI 10.1007/s00204-002-0375-1	67	75	78	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5957	10.1371/journal.pone.0005957	http://dx.doi.org/10.1371/journal.pone.0005957			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536291	Green Submitted, Green Published, gold			2022-12-27	WOS:000267079500007
J	Buffin, A; Denis, D; Van Simaeys, G; Goldman, S; Deneubourg, JL				Buffin, Aurelie; Denis, Damien; Van Simaeys, Gaetan; Goldman, Serge; Deneubourg, Jean-Louis			Feeding and Stocking Up: Radio-Labelled Food Reveals Exchange Patterns in Ants	PLOS ONE			English	Article							IMPORTED FIRE ANT; SOLENOPSIS-INVICTA; LABORATORY COLONIES; ARGENTINE ANT; TROPHALLAXIS; AGGREGATION; FLOW; HYMENOPTERA; BEHAVIOR; CASTE	Food sharing is vital for a large number of species, either solitary or social, and is of particular importance within highly integrated societies, such as in colonial organisms and in social insects. Nevertheless, the mechanisms that govern the distribution of food inside a complex organizational system remain unknown. Using scintigraphy, a method developed for medical imaging, we were able to describe the dynamics of food-flow inside an ant colony. We monitored the sharing process of a radio-labelled sucrose solution inside a nest of Formica fusca. Our results show that, from the very first load that enters the nest, food present within the colony acts as negative feedback to entering food. After one hour of the experiments, 70% of the final harvest has already entered the nest. The total foraged quantity is almost four times smaller than the expected storage capacity. A finer study of the spatial distribution of food shows that although all ants have been fed rapidly (within 30 minutes), a small area representing on average 8% of the radioactive surface holds more than 25% of the stored food. Even in rather homogeneous nests, we observed a strong concentration of food in few workers. Examining the position of these workers inside the nest, we found heavily loaded ants in the centre of the aggregate. The position of the centre of this high-intensity radioactive surface remained stable for the three consecutive hours of the experiments. We demonstrate that the colony simultaneously managed to rapidly feed all workers (200 ants fed within 30 minutes) and build up food stocks to prevent food shortage, something that occurs rather often in changing environments. Though we expected the colony to forage to its maximum capacity, the flow of food entering the colony is finely tuned to the colony's needs. Indeed the food-flow decreases proportionally to the food that has already been harvested, liberating the work-force for other tasks.			Buffin, A (corresponding author), Univ Libre Bruxelles, Unit Social Ecol, Brussels, Belgium.	aubuffin@ulb.ac.be	Van Simaeys, Gaetan/AAR-8082-2020	Van Simaeys, Gaetan/0000-0002-2678-542X; Goldman, Serge/0000-0002-9917-8735				Ame JM, 2004, ANIM BEHAV, V68, P793, DOI 10.1016/j.anbehav.2004.01.009; ANDERSEN M, 1991, AM MIDL NAT, V125, P29, DOI 10.2307/2426366; Anderson C, 2002, INSECT SOC, V49, P171, DOI 10.1007/s00040-002-8298-7; Aron S, 2001, J ANIM ECOL, V70, P831, DOI 10.1046/j.0021-8790.2001.00545.x; Backen SJ, 2000, BEHAV ECOL SOCIOBIOL, V48, P125, DOI 10.1007/s002650000219; BEASLEY TM, 1966, HEALTH PHYS, V12, P1425, DOI 10.1097/00004032-196610000-00004; Bell WJ, 2007, COCKROACHES ECOLOGY; Biesmeijer JC, 2003, BEHAV ECOL SOCIOBIOL, V53, P411, DOI 10.1007/s00265-003-0597-0; BONAVITACOUGOUR.A, 1978, LATR INSECTES SOC, V25, P275; Camazine S, 1998, APIDOLOGIE, V29, P113, DOI 10.1051/apido:19980107; CAMAZINE S, 1991, BEHAV ECOL SOCIOBIOL, V28, P61, DOI 10.1007/BF00172140; Camazine S, 2001, SELF ORG BIOL SYSTEM, P560; Cameron EZ, 1999, ANIM BEHAV, V57, P673, DOI 10.1006/anbe.1998.0997; Cassill D, 2003, BEHAV ECOL SOCIOBIOL, V54, P441, DOI 10.1007/s00265-003-0639-7; Cassill DL, 1999, J INSECT BEHAV, V12, P307, DOI 10.1023/A:1020835304713; Cassill DL, 1996, INSECT SOC, V43, P149, DOI 10.1007/BF01242567; Cassill DL, 1998, J THEOR BIOL, V195, P371, DOI 10.1006/jtbi.1998.0802; CEUSTER R, 1977, P 8 INT C IUSSI WAG, P111; Cohen I, 2000, PHYSICA A, V286, P321, DOI 10.1016/S0378-4371(00)00335-6; Cook SC, 2006, ENTOMOL EXP APPL, V118, P1, DOI 10.1111/j.1570-7458.2006.00374.x; COSTA JT, 2006, OTHER INSECT SOC, P676; Cox MD, 2000, J THEOR BIOL, V204, P223, DOI 10.1006/jtbi.2000.2010; CRAILSHEIM K, 1992, J COMP PHYSIOL B, V162, P681, DOI 10.1007/BF00301617; CRAILSHEIM K, 1991, J COMP PHYSIOL B, V161, P55, DOI 10.1007/BF00258746; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; Dahbi A, 1999, J INSECT BEHAV, V12, P559, DOI 10.1023/A:1020975009450; Debout G, 2007, BIOL J LINN SOC, V90, P319, DOI 10.1111/j.1095-8312.2007.00728.x; DeGrandi-Hoffman G, 2000, INSECT SOC, V47, P302, DOI 10.1007/PL00001720; Depickere S, 2004, J INSECT BEHAV, V17, P81, DOI 10.1023/B:JOIR.0000025134.06111.be; Depickere S, 2004, INSECT SOC, V51, P81, DOI 10.1007/s00040-003-0719-8; Dunn CW, 2005, DEV DYNAM, V234, P835, DOI 10.1002/dvdy.20483; Dussutour A, 2008, J EXP BIOL, V211, P2224, DOI 10.1242/jeb.017509; Farina WM, 1996, BEHAV ECOL SOCIOBIOL, V38, P59, DOI 10.1007/s002650050217; GUNDERMANN JL, 1991, J ARACHNOL, V19, P97; Hannonen M, 2003, BEHAV ECOL, V14, P870, DOI 10.1093/beheco/arg069; HENDERSON BA, 1975, CONDOR, V77, P488, DOI 10.2307/1366101; Holldobler B., 1990, pi; HOWARD DF, 1981, PHYSIOL ENTOMOL, V6, P297, DOI 10.1111/j.1365-3032.1981.tb00274.x; HOWARD DF, 1980, BEHAV ECOL SOCIOBIOL, V7, P293, DOI 10.1007/BF00300670; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Lenoir A, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P219; MACKIE GO, 1986, PHILOS T ROY SOC B, V313, P175, DOI 10.1098/rstb.1986.0032; Mailleux AC, 2003, P ROY SOC B-BIOL SCI, V270, P1609, DOI 10.1098/rspb.2003.2398; Mailleux AC, 2000, ANIM BEHAV, V59, P1061, DOI 10.1006/anbe.2000.1396; Mailleux AC, 2006, J EXP BIOL, V209, P4224, DOI 10.1242/jeb.02461; MARKIN GP, 1970, INSECT SOC, V17, P127, DOI 10.1007/BF02223074; McGlynn TP, 2002, INSECT SOC, V49, P8, DOI 10.1007/s00040-002-8270-6; Meer RKV, 2008, NATURWISSENSCHAFTEN, V95, P1155, DOI 10.1007/s00114-008-0432-6; Newman MEJ, 2006, STRUCTURE DYNAMICS N, P624; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; SEELEY TD, 1995, WISDOM HIVE SOCIAL P, P318; Sempo G, 2006, INSECT SOC, V53, P241, DOI 10.1007/s00040-006-0864-y; SENDOVAFRANKS AB, 1995, P ROY SOC LOND B BIO, V256, P305; SHUKLA SK, 1977, J CHROMATOGR, V143, P522, DOI 10.1016/S0378-4347(00)81799-5; SORENSEN AA, 1981, INSECT SOC, V28, P129, DOI 10.1007/BF02223701; SORENSEN AA, 1981, INSECT SOC, V28, P383, DOI 10.1007/BF02224195; SORENSEN AA, 1985, BEHAV ECOL SOCIOBIOL, V17, P191, DOI 10.1007/BF00300136; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; Tschinkel Walter R., 2004, Journal of Insect Science (Tucson), V4, P1; WALLIS D. I., 1962, ANIMAL BEHAVIOUR, V10, P267, DOI 10.1016/0003-3472(62)90050-7; Wcislo WT, 2006, INSECT SOC, V53, P220, DOI 10.1007/s00040-005-0861-6; WHEELER MW, 1918, P AM PHILOS SOC, V57, P293; WHEELER WM, 1910, ANTS THEIR STRUCTURE, P663; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; WILSON E. O., 1957, INSECTES SOCIAUX, V4, P157, DOI 10.1007/BF02224149; Wilson E.O, 1975, SOCIOBIOLOGY NEW SYN, P697; Wilson EO, 1971, INSECT SOC, P548	68	27	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5919	10.1371/journal.pone.0005919	http://dx.doi.org/10.1371/journal.pone.0005919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536275	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029700005
J	Blevins, T; Pontes, O; Pikaard, CS; Meins, F				Blevins, Todd; Pontes, Olga; Pikaard, Craig S.; Meins, Frederick, Jr.			Heterochromatic siRNAs and DDM1 Independently Silence Aberrant 5S rDNA Transcripts in Arabidopsis	PLOS ONE			English	Article							RNA-POLYMERASE-IV; NON-CG METHYLATION; DNA-METHYLATION; RIBOSOMAL-RNA; TRANSPOSABLE ELEMENTS; REPETITIVE SEQUENCES; NUCLEOLAR DOMINANCE; FUNCTIONAL-ANALYSIS; INTERFERING RNA; GENE	5S ribosomal RNA gene repeats are arranged in heterochromatic arrays (5S rDNA) situated near the centromeres of Arabidopsis chromosomes. The chromatin remodeling factor DDM1 is known to maintain 5S rDNA methylation patterns while silencing transcription through 5S rDNA intergenic spacers (IGS). We mapped small-interfering RNAs (siRNA) to a composite 5S rDNA repeat, revealing a high density of siRNAs matching silenced IGS transcripts. IGS transcript repression requires proteins of the heterochromatic siRNA pathway, including RNA polymerase IV (Pol IV), RNA-DEPENDENT RNA POLYMERASE 2 (RDR2) and DICER-LIKE 3 (DCL3). Using molecular and cytogenetic approaches, we show that the DDM1 and siRNA-dependent silencing effects are genetically independent. DDM1 suppresses production of the siRNAs, however, thereby limiting RNA-directed DNA methylation at 5S rDNA repeats. We conclude that DDM1 and siRNA-dependent silencing are overlapping processes that both repress aberrant 5S rDNA transcription and contribute to the heterochromatic state of 5S rDNA arrays.			Blevins, T (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	Frederick.Meins@fmi.ch	Pikaard, Craig S/K-8772-2012; Pontes, Olga MF/F-9768-2011	Pikaard, Craig S/0000-0001-8204-7459; Pontes, Olga MF/0000-0003-3316-1145; Blevins, Todd/0000-0002-4844-5434	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM077590] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ammons D, 1999, NUCLEIC ACIDS RES, V27, P637, DOI 10.1093/nar/27.2.637; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Brzeski J, 2003, J BIOL CHEM, V278, P823, DOI 10.1074/jbc.M209260200; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Cloix C, 2003, PLANT J, V35, P251, DOI 10.1046/j.1365-313X.2003.01793.x; Cloix C, 2002, GENOME RES, V12, P132, DOI 10.1101/gr.181301; Cloix C, 2000, GENOME RES, V10, P679, DOI 10.1101/gr.10.5.679; CREUSOT F, 1995, PLANT J, V8, P763, DOI 10.1046/j.1365-313X.1995.08050763.x; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; DOUET J, 2007, TRANSCRIPTION 5S RRN; DOUET J, 2008, PLANT CELL PHYSL; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Heslop-Harrison JS, 2000, PLANT CELL, V12, P617, DOI 10.1105/tpc.12.5.617; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kakutani T, 1999, GENETICS, V151, P831; Kankel MW, 2003, GENETICS, V163, P1109; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kanno T, 2008, NAT GENET, V40, P670, DOI 10.1038/ng.119; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Kiparisov S, 2005, MOL GENET GENOMICS, V274, P235, DOI 10.1007/s00438-005-0020-9; Kishimoto N, 2001, PLANT MOL BIOL, V46, P171, DOI 10.1023/A:1010636222327; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Mathieu O, 2003, PLANT CELL, V15, P2929, DOI 10.1105/tpc.017467; Mathieu O, 2002, PLANT J, V29, P313, DOI 10.1046/j.0960-7412.2001.01212.x; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; MATZKE M, 2007, CURR OPIN PLANT BIOL; Matzke M, 2005, ANNU PLANT REV, V19, P69, DOI 10.1002/9780470988626.ch3; Meins F, 2005, ANNU REV CELL DEV BI, V21, P297, DOI 10.1146/annurev.cellbio.21.122303.114706; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Pikaard CS, 2006, COLD SPRING HARB SYM, V71, P473, DOI 10.1101/sqb.2006.71.046; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Pikaard CS, 1999, TRENDS PLANT SCI, V4, P478, DOI 10.1016/S1360-1385(99)01501-0; Plohl M, 2008, GENE, V409, P72, DOI 10.1016/j.gene.2007.11.013; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; REAM TS, 2008, MOL CELL; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; Szymanski M, 2003, BIOCHEM J, V371, P641, DOI 10.1042/BJ20020872; TEIXEIRA FK, 2009, SCIENCE; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaillant I, 2007, CURR OPIN PLANT BIOL, V10, P528, DOI 10.1016/j.pbi.2007.06.008; Vaillant I, 2007, PLANT CELL PHYSIOL, V48, P745, DOI 10.1093/pcp/pcm043; Vaillant I, 2006, EMBO REP, V7, P1273, DOI 10.1038/sj.embor.7400791; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Woo HR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000156; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	81	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5932	10.1371/journal.pone.0005932	http://dx.doi.org/10.1371/journal.pone.0005932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529764	gold, Green Submitted, Green Published			2022-12-27	WOS:000267029500011
J	Werneburg, I				Werneburg, Ingmar			A Standard System to Study Vertebrate Embryos	PLOS ONE			English	Article							DEVELOPMENTAL SEQUENCES; COMPARATIVE PATTERNS; PHYLOTYPIC STAGE; NORMAL PLATES; EVOLUTION; HETEROCHRONY; TURTLE; SERIES; ONTOLOGIES; CHELONIA	Staged embryonic series are important as reference for different kinds of biological studies. I summarise problems that occur when using 'staging tables' of 'model organisms'. Investigations of developmental processes in a broad scope of taxa are becoming commonplace. Beginning in the 1990s, methods were developed to quantify and analyse developmental events in a phylogenetic framework. The algorithms associated with these methods are still under development, mainly due to difficulties of using non-independent characters. Nevertheless, the principle of comparing clearly defined newly occurring morphological features in development (events) in quantifying analyses was a key innovation for comparative embryonic research. Up to date no standard was set for how to define such events in a comparative approach. As a case study I compared the external development of 23 land vertebrate species with a focus on turtles, mainly based on reference staging tables. I excluded all the characters that are only identical for a particular species or general features that were only analysed in a few species. Based on these comparisons I defined 104 developmental characters that are common either for all vertebrates (61 characters), gnathostomes (26), tetrapods (3), amniotes (7), or only for sauropsids (7). Characters concern the neural tube, somite, ear, eye, limb, maxillary and mandibular process, pharyngeal arch, eyelid or carapace development. I present an illustrated guide listing all the defined events. This guide can be used for describing developmental series of any vertebrate species or for documenting specimen variability of a particular species. The guide incorporates drawings and photographs as well as consideration of species identifying developmental features such as colouration. The simple character-code of the guide is extendable to further characters pertaining to external and internal morphological, physiological, genetic or molecular development, and also for other vertebrate groups not examined here, such as Chondrichthyes or Actinopterygii. An online database to type in developmental events for different stages and species could be a basis for further studies in comparative embryology. By documenting developmental events with the standard code, sequence heterochrony studies (i.e. Parsimov) and studies on variability can use this broad comparative data set.			Werneburg, I (corresponding author), Univ Zurich, Palaontol Museum, Zurich, Switzerland.	ingmar_werneburg@yahoo.de		Werneburg, Ingmar/0000-0003-1359-2036				Agassiz L., 1857, CONTRIBUTIONS NATURA; Asher RJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-108; Baer v., 1828, ENTWICKLUNGSGESCHICH; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; Beggs K, 2000, CAN J ZOOL, V78, P373, DOI 10.1139/cjz-78-3-373; Bininda-Emonds ORP, 2003, P ROY SOC B-BIOL SCI, V270, P341, DOI 10.1098/rspb.2002.2242; Bininda-Emonds ORP, 2002, THEOR BIOSCI, V121, P297, DOI 10.1007/s12064-002-0016-5; BININDAEMONDS ORP, 2007, BMC EVOLUTIONARY BIO, V7, P108; Bodenreider O, 2006, BRIEF BIOINFORM, V7, P256, DOI 10.1093/bib/bbl027; Chipman AD, 2000, J EXP ZOOL, V288, P352, DOI 10.1002/1097-010X(20001215)288:4<352::AID-JEZ8>3.3.CO;2-U; COLBERT MW, 2008, J EXPT ZOOLOGY MOL B, V310; CRASTZ F, 1982, REV BIOL TROP, V30, P113; Cretekos CJ, 2005, DEV DYNAM, V233, P721, DOI 10.1002/dvdy.20400; Dendy A., 1899, Q J MICROSC SCI, Vs2-42, P1, DOI 10.1242/jcs.s2-42.165.1; DUFAURE JP, 1961, ARCH ANAT MICROSC MO, V50, P309; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Fiser C, 2008, ORG DIVERS EVOL, V8, P146, DOI 10.1016/j.ode.2007.06.002; GIERE P, 2006, MUSEUM NATURKUNDE HU, P15; Gilbert SF, 2006, DEV BIOL; Gosner K. L., 1960, Herpetologica, V16, P183; Greenbaum E, 2002, CAN J ZOOL, V80, P1350, DOI 10.1139/Z02-111; Greenbaum E, 2002, J MORPHOL, V254, P272, DOI 10.1002/jmor.10036; GUYOT G, 1994, ANN SCI NAT ZOOL, V15, P115; Haeckel E., 1896, SYSTEMATISCHE PHYLOG; Haeckel E., 1874, ANTHROPOGENIE ENTWIC; Haeckel E, 1868, NATURLICHE SCHOPFUNG; Hall BK, 1997, TRENDS ECOL EVOL, V12, P461, DOI 10.1016/S0169-5347(97)01222-6; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harrison LB, 2008, SYST BIOL, V57, P378, DOI 10.1080/10635150802164421; Harrison R.G, 1969, ORG DEV EMBRYO, V1, P44; His W., 1885, ANATOMIE MENSCHLICHE; Hopwood N, 2005, HIST SCI, V43, P239, DOI 10.1177/007327530504300302; Hopwood N, 2007, INT J DEV BIOL, V51, P1, DOI 10.1387/ijdb.062189nh; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Jeffery JE, 2005, SYST BIOL, V54, P230, DOI 10.1080/10635150590923227; Jeffery JE, 2002, EVOL DEV, V4, P292, DOI 10.1046/j.1525-142X.2002.02018.x; Jenner RA, 2007, NAT REV GENET, V8, P311, DOI 10.1038/nrg2062; Keibel F., 1897, NORMENTAFEL ENTWICKL; MABEE P, 1996, J MORPHOL, P249; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Mabee PM, 2000, EVOLUTION, V54, P2091; MAHMOUD IY, 1973, J MORPHOL, V141, P269, DOI 10.1002/jmor.1051410303; Maxwell EE, 2008, J MORPHOL, V269, P1056, DOI 10.1002/jmor.10633; Mehnert E., 1897, MORPHOL ARBEIT, V7, P1, DOI [10.1159/000393310, DOI 10.1159/000393310]; Miller J.D., 1985, Biology of Reptilia, V14, P269; Mitgutsch C, 2003, THEOR BIOSCI, V122, P204, DOI 10.1078/1431-7613-00084; MITGUTSCH C, J ZOOLOGICA IN PRESS; MITGUTSCH C, 2007, ACTA ZOOLOGICA, V88, P69; Muller W.A., 2003, ENTWICKLUNGSBIOLOGIE; Nye HLD, 2003, DEV DYNAM, V226, P555, DOI 10.1002/dvdy.10237; Oppel A., 1891, VERGLEICHUNG ENTWICK; PARKER WK, 1880, REPORT DEV GREEN TUR, P1; Rathke, 1848, UEBER ENTWICKELUNG S, DOI 10.5962/bhl.title.11123; RENOUS S, 1989, ANN SCI NAT ZOOL, V10, P197; Richardson MK, 2003, ANIM BIOL, V53, P303, DOI 10.1163/157075603322539462; Richardson MK, 2001, ZOOL-ANAL COMPLEX SY, V104, P278, DOI 10.1078/0944-2006-00033; Richardson MK, 2002, BIOL REV, V77, P495, DOI 10.1017/S1464793102005948; Richardson MK, 1995, DEV BIOL, V172, P412, DOI 10.1006/dbio.1995.8041; Richardson MK, 1997, ANAT EMBRYOL, V196, P91, DOI 10.1007/s004290050082; Richardson MK, 1999, EVOL DEV, V1, P5, DOI 10.1046/j.1525-142x.1999.00112.x; Richardson MK, 1999, INT J DEV BIOL, V43, P591; Richardson MK, 1998, DEVELOPMENT, V125, P151; Richardson MK, 2001, NATURE, V410, P144, DOI 10.1038/35065834; RICHARDSON MK, 2009, J EXPT ZOOLOGY MOL B, V310; Romeis B., 1989, ROMEIS MIKROSKOPISCH; Rosse C., 2007, ANATOMY ONTOLOGIES B, P63, DOI [10.1007/978-1-84628-885-2_4, DOI 10.1007/978-1-84628-885-2_4]; Sanchez-Villagra MR, 2008, EVOL DEV, V10, P519, DOI 10.1111/j.1525-142X.2008.00267.x; Sanchez-Villagra MR, 2008, AMPHIBIA-REPTILIA, V29, P85, DOI 10.1163/156853808783431505; Sanchez-Villagra MR, 2007, ZOOL SCI, V24, P257, DOI 10.2108/zsj.24.257; Sanchez-Villagra MR, 2007, ACTA ZOOL-STOCKHOLM, V88, P199, DOI 10.1111/j.1463-6395.2007.00267.x; Sanchez-Villagra MR, 2002, J EXP ZOOL, V294, P264, DOI 10.1002/jez.10147; Sanger TJ, 2008, J MORPHOL, V269, P129, DOI 10.1002/jmor.10563; Schlosser G, 2001, J EXP ZOOL, V291, P282, DOI 10.1002/jez.1104; Schoch RR, 2006, EVOL DEV, V8, P524, DOI 10.1111/j.1525-142X.2006.00125.x; SCHOENWOLF GC, 2008, ALTAS DESCRIPTIVE EM, P125; Schulmeister S, 2004, EVOL DEV, V6, P50, DOI 10.1111/j.1525-142X.2004.04005.x; Sellier N, 2006, J APPL POULTRY RES, V15, P219, DOI 10.1093/japr/15.2.219; Semon R., 1894, DENKSCHRIFTEN MED NA, V5, P61; Semon R., 1894, DENKSCHRIFTEN MED NA, V5, P3; Smirthwaite JJ, 2007, EVOL DEV, V9, P122, DOI 10.1111/j.1525-142X.2007.00143.x; Smith KK, 1997, EVOLUTION, V51, P1663, DOI 10.1111/j.1558-5646.1997.tb01489.x; Soemmerring STV, 1799, ICONES EMBRYONUM HUM; Tokita M, 2001, ZOOL SCI, V18, P705, DOI 10.2108/zsj.18.705; Velhagen WA, 1997, SYST BIOL, V46, P204, DOI 10.2307/2413644; Voeltzkow A, 1899, ABH SENCKENB NAT, V26, P1; WANEK N, 1989, J EXP ZOOL, V249, P41, DOI 10.1002/jez.1402490109; Weisbecker V, 2008, EVOLUTION, V62, P2027, DOI 10.1111/j.1558-5646.2008.00424.x; Werneburg I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-82; Wilson LAB, 2009, J ANAT, V214, P339, DOI 10.1111/j.1469-7580.2008.01031.x; Wolpert L, 2007, PRINCIPLES DEV; YNTEMA CL, 1968, J MORPHOL, V125, P219, DOI 10.1002/jmor.1051250207; Ziermann JM, 2007, J MORPHOL, V268, P791, DOI 10.1002/jmor.10552; Ziermann JM, 2008, THESIS F SCHILLER U	93	62	63	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5887	10.1371/journal.pone.0005887	http://dx.doi.org/10.1371/journal.pone.0005887			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521537	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029100005
J	Bombaci, M; Grifantini, R; Mora, M; Reguzzi, V; Petracca, R; Meoni, E; Balloni, S; Zingaretti, C; Falugi, F; Manetti, AGO; Margarit, I; Musser, JM; Cardona, F; Orefici, G; Grandi, G; Bensi, G				Bombaci, Mauro; Grifantini, Renata; Mora, Marirosa; Reguzzi, Valerio; Petracca, Roberto; Meoni, Eva; Balloni, Sergio; Zingaretti, Chiara; Falugi, Fabiana; Manetti, Andrea G. O.; Margarit, Immaculada; Musser, James M.; Cardona, Francesco; Orefici, Graziella; Grandi, Guido; Bensi, Giuliano			Protein Array Profiling of Tic Patient Sera Reveals a Broad Range and Enhanced Immune Response against Group A Streptococcus Antigens	PLOS ONE			English	Article							NEUROPSYCHIATRIC DISORDERS; CHILDREN; INFECTIONS; ANTIBODIES; IDENTIFICATION; EXACERBATIONS; PATHOGENESIS; MIMICRY; PANDAS; REACT	The human pathogen Group A Streptococcus (Streptococcus pyogenes, GAS) is widely recognized as a major cause of common pharyngitis as well as of severe invasive diseases and non-suppurative sequelae associated with the existence of GAS antigens eliciting host autoantibodies. It has been proposed that a subset of paediatric disorders characterized by tics and obsessive-compulsive symptoms would exacerbate in association with relapses of GAS-associated pharyngitis. This hypothesis is however still controversial. In the attempt to shed light on the contribution of GAS infections to the onset of neuropsychiatric or behavioral disorders affecting as many as 3% of children and adolescents, we tested the antibody response of tic patient sera to a representative panel of GAS antigens. In particular, 102 recombinant proteins were spotted on nitrocellulose-coated glass slides and probed against 61 sera collected from young patients with typical tic neuropsychiatric symptoms but with no overt GAS infection. Sera from 35 children with neither tic disorder nor overt GAS infection were also analyzed. The protein recognition patterns of these two sera groups were compared with those obtained using 239 sera from children with GAS-associated pharyngitis. This comparative analysis identified 25 antigens recognized by sera of the three patient groups and 21 antigens recognized by tic and pharyngitis sera, but poorly or not recognized by sera from children without tic. Interestingly, these antigens appeared to be, in quantitative terms, more immunogenic in tic than in pharyngitis patients. Additionally, a third group of antigens appeared to be preferentially and specifically recognized by tic sera. These findings provide the first evidence that tic patient sera exhibit immunological profiles typical of individuals who elicited a broad, specific and strong immune response against GAS. This may be relevant in the context of one of the hypothesis proposing that GAS antigen-dependent induction of autoantibodies in susceptible individuals may be involved the occurrence of tic disorders.			Bombaci, M (corresponding author), Fdn Ist Nazl Genet Mol INGM, Milan, Italy.	guido.grandi@novartis.com	Bombaci, Mauro/K-6106-2016; cardona, francesco/AAJ-9704-2021; Renata, Grifantini/AAB-9969-2022; Cardona, Francesco/K-4000-2018	Bombaci, Mauro/0000-0002-9887-4165; cardona, francesco/0000-0002-2050-632X; Renata, Grifantini/0000-0003-0024-3355; Cardona, Francesco/0000-0002-2050-632X; Grandi, Guido/0000-0001-9724-2185				BRONZE MS, 1993, J IMMUNOL, V151, P2820; Cardona F, 2001, J PEDIATR-US, V138, P71, DOI 10.1067/mpd.2001.110325; Church AJ, 2003, J NEUROL NEUROSUR PS, V74, P602, DOI 10.1136/jnnp.74.5.602; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Cunningham MW, 2004, MOL IMMUNOL, V40, P1121, DOI 10.1016/j.molimm.2003.11.023; Dale RC, 2006, J NEUROIMMUNOL, V172, P187, DOI 10.1016/j.jneuroim.2005.10.014; Dale RC, 2005, DEV MED CHILD NEUROL, V47, P785, DOI 10.1017/S0012162205001647; Dale RC, 2005, BRIT J PSYCHIAT, V187, P314, DOI 10.1192/bjp.187.4.314; Dale RC, 2001, ANN NEUROL, V50, P588, DOI 10.1002/ana.1250; Fontan PA, 2000, J INFECT DIS, V182, P1712, DOI 10.1086/317604; Garvey MA, 1998, J CHILD NEUROL, V13, P413, DOI 10.1177/088307389801300901; Guilherme L, 2007, CURR PROTEIN PEPT SC, V8, P39, DOI 10.2174/138920307779941488; Harris JW, 1998, HDB MATH COMPUTATION, P824; Harris K, 2006, J CHILD NEUROL, V21, P678, DOI 10.1177/08830738060210080901; Kansy JW, 2006, J NEUROIMMUNOL, V181, P165, DOI 10.1016/j.jneuroim.2006.08.007; Kirvan CA, 2003, NAT MED, V9, P914, DOI 10.1038/nm892; Kurlan R, 2008, PEDIATRICS, V121, P1188, DOI 10.1542/peds.2007-2657; Leckman James F, 2006, Adv Neurol, V99, P1; Lougee L, 2000, J AM ACAD CHILD PSY, V39, P1120, DOI 10.1097/00004583-200009000-00011; Luo F, 2004, PEDIATRICS, V113, pE578, DOI 10.1542/peds.113.6.e578; Martin JM, 2004, PEDIATRICS, V114, P1212, DOI 10.1542/peds.2004-0133; Martino Davide, 2005, Adv Neurol, V96, P320; Martins TB, 2008, INT IMMUNOL, V20, P445, DOI 10.1093/intimm/dxn004; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Muller N, 2001, PSYCHIAT RES, V101, P187, DOI 10.1016/S0165-1781(01)00215-3; Murphy ML, 2002, ARCH PEDIAT ADOL MED, V156, P356, DOI 10.1001/archpedi.156.4.356; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; Weiner SG, 2007, PEDIATR EMERG CARE, V23, P20, DOI 10.1097/01.pec.0000248688.73562.52; Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4	31	51	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6332	10.1371/journal.pone.0006332	http://dx.doi.org/10.1371/journal.pone.0006332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623252	gold, Green Published, Green Submitted			2022-12-27	WOS:000268260100010
J	Chen, CG; Kuehn, C; Bretzel, RG; Linn, T				Chen, Chunguang; Kuehn, Carina; Bretzel, Reinhard G.; Linn, Thomas			Anti-Inflammatory Thalidomide Improves Islet Grafts Survival and Functions in a Xenogenic Environment	PLOS ONE			English	Article								Thalidomide possesses both anti-inflammatory and anti-angiogenic properties. This study investigates its potential application in islet transplantation with a xenogenic transplantation model. Transplantation was performed using C57Bl/6 mice and NMRI nu/nu mice as recipients of porcine islets. Moreover, islet graft vasculature and inflammation were investigated to identify the mechanisms of thalidomide action. In the immunocompetent environment of C57Bl/6 mice, a fast graft rejection was observed. The group treated with thalidomide 200 mg/kg BW per day achieved and maintained euglycemia in the complete observation period for 42 days. The treated mice had more functional islet graft mass with less leukocyte infiltration. The pro-inflammatory TNF-alpha and VEGF content in islet grafted kidneys was significantly lowered by the treatment. By comparison, thalidomide was not effective in improving graft survival in immunocompromised nude mice. It strongly inhibited the VEGF and TNF-alpha-induced endothelial proliferation of isolated pig islets in a dose dependent manner. The magnitude of thalidomide's inhibitory effect was nearly identical to the effect of VEGF- receptor 2 inhibitor SU416 and anti-TNF-receptor 1 neutralizing antibody, and was reversed by sphingosine-1-phosphate. In conclusion, the anti-inflammatory effect of thalidomide improved islet graft survival and function in a transplantation model with a maximum immune barrier.			Chen, CG (corresponding author), Univ Giessen, Med Clin & Policlin 3, Giessen, Germany.	thomas.linn@innere.med.uni-giessen.de						Barshes NR, 2004, TRANSPL P, V36, P1127, DOI 10.1016/j.transproceed.2004.04.057; Behl Y, 2008, AM J PATHOL, V172, P1411, DOI 10.2353/ajpath.2008.071070; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059; Bennet W, 2000, TRANSPLANTATION, V69, P711; Bottino R, 1998, DIABETES, V47, P316, DOI 10.2337/diabetes.47.3.316; Brandhorst H, 1998, CELL TRANSPLANT, V7, P489, DOI 10.1016/S0963-6897(98)00028-1; Brandhorst H, 1999, TRANSPLANTATION, V68, P355, DOI 10.1097/00007890-199908150-00006; Carlsson PO, 2002, CELL TRANSPLANT, V11, P813; Cattan P, 2001, TRANSPLANTATION, V71, P857, DOI 10.1097/00007890-200104150-00006; Chandrasekar B, 2001, CIRCULATION, V103, P2296; Contreras JL, 2003, AM J TRANSPLANT, V3, P128, DOI 10.1034/j.1600-6143.2003.00031.x; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Franks ME, 2004, LANCET, V363, P1802, DOI 10.1016/S0140-6736(04)16308-3; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Goss JA, 2002, TRANSPLANTATION, V74, P1761, DOI 10.1097/01.TP.0000038968.06766.D6; Goto M, 2004, XENOTRANSPLANTATION, V11, P195, DOI 10.1046/j.1399-3089.2003.00107.x; Hanley S, 2006, TRANSPLANTATION, V82, P813, DOI 10.1097/01.tp.0000234787.05789.23; Hering BJ, 2006, NAT MED, V12, P301, DOI 10.1038/nm1369; Keifer JA, 2001, J BIOL CHEM, V276, P22382, DOI 10.1074/jbc.M100938200; Kirchhof N, 2004, XENOTRANSPLANTATION, V11, P396, DOI 10.1111/j.1399-3089.2004.00157.x; Korsgren O, 2005, TRANSPLANTATION, V79, P1289, DOI 10.1097/01.TP.0000157273.60147.7C; Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Linn T, 2006, CLIN EXP IMMUNOL, V144, P179, DOI 10.1111/j.1365-2249.2006.03066.x; Linn T, 2003, FASEB J, V17, P881, DOI 10.1096/fj.02-0615fje; Lundgren T, 2001, TRANSPLANT P, V33, P725, DOI 10.1016/S0041-1345(00)02800-1; Malleo G, 2008, SHOCK, V29, P89, DOI 10.1097/shk.0b013e318067df68; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; Moberg L, 2005, CLIN EXP IMMUNOL, V142, P125, DOI 10.1111/j.1365-2249.2005.02883.x; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Narang AS, 2006, PHARMACOL REV, V58, P194, DOI 10.1124/pr.58.2.6; Pickup JC, 2000, LIFE SCI, V67, P291, DOI 10.1016/S0024-3205(00)00622-6; Pileggi A, 2001, DIABETES, V50, P1983, DOI 10.2337/diabetes.50.9.1983; Rajashekhar G, 2006, J VASC RES, V43, P193, DOI 10.1159/000090949; Robinson SD, 2004, ARTERIOSCL THROM VAS, V24, P2108, DOI 10.1161/01.ATV.0000143857.27408.de; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; van der Windt DJ, 2007, XENOTRANSPLANTATION, V14, P288, DOI 10.1111/j.1399-3089.2007.00419.x; Yabu T, 2005, BLOOD, V106, P125, DOI 10.1182/blood-2004-09-3679; Yildirim ND, 2007, JPN J CLIN ONCOL, V37, P704, DOI 10.1093/jjco/hym092	43	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6312	10.1371/journal.pone.0006312	http://dx.doi.org/10.1371/journal.pone.0006312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617916	gold, Green Submitted, Green Published			2022-12-27	WOS:000268119600009
J	Zhang, J; Liu, B; Jiang, XP; Zhao, HZ; Fan, M; Fan, ZJ; Lee, JJ; Jiang, T; Jiang, TZ; Song, SYW				Zhang, Jing; Liu, Bing; Jiang, Xingpeng; Zhao, Huizhi; Fan, Ming; Fan, Zhenjie; Lee, J. Jack; Jiang, Tao; Jiang, Tianzi; Song, Sonya Wei			A Systems Biology-Based Gene Expression Classifier of Glioblastoma Predicts Survival with Solid Tumors	PLOS ONE			English	Article								Accurate prediction of survival of cancer patients is still a key open problem in clinical research. Recently, many large-scale gene expression clusterings have identified sets of genes reportedly predictive of prognosis; however, those gene sets shared few genes in common and were poorly validated using independent data. We have developed a systems biology-based approach by using either combined gene sets and the protein interaction network (Method A) or the protein network alone (Method B) to identify common prognostic genes based on microarray gene expression data of glioblastoma multiforme and compared with differential gene expression clustering (Method C). Validations of prediction performance show that the 23-prognostic gene classifier identified by Method A outperforms other gene classifiers identified by Methods B and C or previously reported for gliomas on 17 of 20 independent sample cohorts across five tumor types. We also find that among the 23 genes are 21 related to cellular proliferation and two related to response to stress/immune response. We further find that the increased expression of the 21 genes and the decreased expression of the other two genes are associated with poorer survival, which is supportive with the notion that cellular proliferation and immune response contribute to a significant portion of predictive power of prognostic classifiers. Our results demonstrate that the systems biology-based approach enables to identify common survival-associated genes.			Zhang, J (corresponding author), Chinese Acad Sci, LIAMA Ctr Computat Med, Natl Lab Pattern Recognit, Inst Automat, Beijing, Peoples R China.	jiangtz@nlpr.ia.ac.cn; weisonyasong@gmail.com	jiang, tao/GWC-7108-2022; Jiang, Tao/N-8142-2014; Lee, Jack/P-7331-2019; Xingpeng, Jiang/I-3818-2012; Zhang, Jing/F-4707-2015; Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Jiang, Tianzi/I-4256-2012	Lee, Jack/0000-0002-4584-929X; Xingpeng, Jiang/0000-0002-8848-9300; Zhang, Jing/0000-0001-5903-6487; Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Jiang, Tianzi/0000-0001-9531-291X				Als AB, 2007, CLIN CANCER RES, V13, P4407, DOI 10.1158/1078-0432.CCR-07-0109; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Desmedt C, 2006, CELL CYCLE, V5, P2198, DOI 10.4161/cc.5.19.3254; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hsieh WP, 2003, GENETICS, V165, P747; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Larsen JE, 2007, CARCINOGENESIS, V28, P760, DOI 10.1093/carcin/bgl207; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Nutt CL, 2003, CANCER RES, V63, P1602; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Prados Michael D., 2000, Seminars in Oncology, V27, P1; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; SOTIRIOU C, 2006, P AN M AM SOC CLIN, V24, P507; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Teschendorff AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r101; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	42	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6274	10.1371/journal.pone.0006274	http://dx.doi.org/10.1371/journal.pone.0006274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609451	Green Submitted, Green Published, gold			2022-12-27	WOS:000268119500009
J	Lee, MS; Bondugula, R; Desai, V; Zavaljevski, N; Yeh, IC; Wallqvist, A; Reifman, J				Lee, Michael S.; Bondugula, Rajkumar; Desai, Valmik; Zavaljevski, Nela; Yeh, In-Chul; Wallqvist, Anders; Reifman, Jaques			PSPP: A Protein Structure Prediction Pipeline for Computing Clusters	PLOS ONE			English	Article								Background: Protein structures are critical for understanding the mechanisms of biological systems and, subsequently, for drug and vaccine design. Unfortunately, protein sequence data exceed structural data by a factor of more than 200 to 1. This gap can be partially filled by using computational protein structure prediction. While structure prediction Web servers are a notable option, they often restrict the number of sequence queries and/or provide a limited set of prediction methodologies. Therefore, we present a standalone protein structure prediction software package suitable for high-throughput structural genomic applications that performs all three classes of prediction methodologies: comparative modeling, fold recognition, and ab initio. This software can be deployed on a user's own high-performance computing cluster. Methodology/Principal Findings: The pipeline consists of a Perl core that integrates more than 20 individual software packages and databases, most of which are freely available from other research laboratories. The query protein sequences are first divided into domains either by domain boundary recognition or Bayesian statistics. The structures of the individual domains are then predicted using template-based modeling or ab initio modeling. The predicted models are scored with a statistical potential and an all-atom force field. The top-scoring ab initio models are annotated by structural comparison against the Structural Classification of Proteins (SCOP) fold database. Furthermore, secondary structure, solvent accessibility, transmembrane helices, and structural disorder are predicted. The results are generated in text, tab-delimited, and hypertext markup language (HTML) formats. So far, the pipeline has been used to study viral and bacterial proteomes. Conclusions: The standalone pipeline that we introduce here, unlike protein structure prediction Web servers, allows users to devote their own computing assets to process a potentially unlimited number of queries as well as perform resource-intensive ab initio structure prediction.			Lee, MS (corresponding author), USA, Biotechnol HPC Software Applicat Inst, Telemed & Adv Technol Res Ctr, Med Res & Mat Command, Ft Detrick, MD USA.	jaques.reifman@us.army.mil	wallqvist, anders/W-2584-2019	wallqvist, anders/0000-0002-9775-7469				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BONDUGULA R, 2006, P COMP SYST BIO CSB2, P195; Bondugula R, 2007, PROTEINS, V66, P664, DOI 10.1002/prot.21177; Bondugula R, 2009, NUCLEIC ACIDS RES, V37, P452, DOI 10.1093/nar/gkn944; Bonneau R, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r52; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bujnicki JM, 2001, BIOINFORMATICS, V17, P750, DOI 10.1093/bioinformatics/17.8.750; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Feig M, 2002, PROTEINS, V49, P232, DOI 10.1002/prot.10217; Guo JT, 2004, NUCLEIC ACIDS RES, V32, pW522, DOI 10.1093/nar/gkh414; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jefferson ER, 2007, NUCLEIC ACIDS RES, V35, pD580, DOI 10.1093/nar/gkl836; Jiang XH, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-18; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kairys V, 2006, J CHEM INF MODEL, V46, P365, DOI 10.1021/ci050238c; Karplus K, 2005, PROTEINS, V61, P135, DOI 10.1002/prot.20730; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kim D, 2003, PROTEIN ENG, V16, P641, DOI 10.1093/protein/gzg081; Konc J, 2007, J CHEM INF MODEL, V47, P940, DOI 10.1021/ci6005257; Lee MS, 2007, J CHEM THEORY COMPUT, V3, P312, DOI 10.1021/ct600195f; Lee MS, 2009, J STRUCT BIOL, V167, P136, DOI 10.1016/j.jsb.2009.05.001; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; LEE MS, 2006, P 25 ARM SCI C ORL F, P423; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malmstrom L, 2007, PLOS BIOL, V5, P758, DOI 10.1371/journal.pbio.0050076; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; SHCHELKUNOV SN, 1993, FEBS LETT, V319, P80, DOI 10.1016/0014-5793(93)80041-R; SHCHELKUNOV SN, 1995, VIRUS GENES, V9, P231, DOI 10.1007/BF01702879; SHCHELKUNOV SN, 1994, VIRUS RES, V34, P207, DOI 10.1016/0168-1702(94)90125-2; Shchelkunov SN, 1996, VIRUS RES, V40, P169, DOI 10.1016/0168-1702(95)01269-9; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Torrance JW, 2005, J MOL BIOL, V347, P565, DOI 10.1016/j.jmb.2005.01.044; Venclovas C, 2003, PROTEINS, V53, P585, DOI 10.1002/prot.10530; Veretnik S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000136; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; Yu CG, 2009, PROTEINS, V74, P449, DOI 10.1002/prot.22167; Yu CG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-52; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	51	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6254	10.1371/journal.pone.0006254	http://dx.doi.org/10.1371/journal.pone.0006254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606223	Green Published, gold			2022-12-27	WOS:000268036000010
J	Vazquez-Martin, A; Oliveras-Ferraros, C; Menendez, JA				Vazquez-Martin, Alejandro; Oliveras-Ferraros, Cristina; Menendez, Javier A.			Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab	PLOS ONE			English	Article								Autophagy has been emerging as a novel cytoprotective mechanism to increase tumor cell survival under conditions of metabolic stress and hypoxia as well as to escape chemotherapy-induced cell death. To elucidate whether autophagy might also protect cancer cells from the growth inhibitory effects of targeted therapies, we evaluated the autophagic status of preclinical breast cancer models exhibiting auto-acquired resistance to the anti-HER2 monoclonal antibody trastuzumab (Tzb). We first examined the basal autophagic levels in Tzb-naive SKBR3 cells and in two pools of Tzb-conditioned SKBR3 cells (TzbR), which optimally grow in the presence of Tzb doses as high as 200 mu g/ml Tzb. Fluorescence microscopic analyses revealed that the number of punctate LC3 structures -a hallmark of autophagy-was drastically higher in Tzb-refractory cells than in Tzb-sensitive SKBR3 parental cells. Immunoblotting analyses confirmed that the lipidation product of the autophagic conversion of LC3 was accumulated to high levels in TzbR cells. High levels of the LC3 lipidated form in Tzb-refractory cells were accompanied by decreased p62/sequestosome-1 protein expression, a phenomenon characterizing the occurrence of increased autophagic flux. Moreover, increased autophagy was actively used to survive Tzb therapy as TzbR pools were exquisitely sensitive to chemical inhibitors of autophagosomal formation/function. Knockdown of LC3 expression via siRNA similarly resulted in reduced TzbR cell proliferation and supra-additively interacted with Tzb to resensitize TzbR cells. Sub-groups of Tzb-naive SKBR3 parental cells accumulated LC3 punctate structures and decreased p62 expression after treatment with high-dose Tzb, likely promoting their own resistance. This is the first report showing that HER2-overexpressing breast cancer cells chronically exposed to Tzb exhibit a bona fide up-regulation of the autophagic activity that efficiently works to protect breast cancer cells from the growth-inhibitory effects of Tzb. Therapeutic targeting autophagosome formation/function might represent a novel molecular avenue to reduce the emergence of Tzb resistance in HER2-dependent breast carcinomas.			Vazquez-Martin, A (corresponding author), ICO, Girona, Catalonia, Spain.	jmenendez@iconcologia.net	MENENDEZ, JAVIER A/C-6148-2016	MENENDEZ, JAVIER A/0000-0001-8733-4561				Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Altundag O, 2005, LUNG CANCER-J IASLC, V49, P279, DOI 10.1016/j.lungcan.2005.02.013; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Amaravadi RK, 2008, J CLIN INVEST, V118, P3837, DOI 10.1172/JCI37667; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Cappuzzo F, 2006, NEW ENGL J MED, V354, P2619, DOI 10.1056/NEJMc060020; Carew JS, 2007, AUTOPHAGY, V3, P464, DOI 10.4161/auto.4311; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; du Manoir JM, 2006, CLIN CANCER RES, V12, P904, DOI 10.1158/1078-0432.CCR-05-1109; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Esparis-Ogando A, 2008, ANN ONCOL, V19, P1860, DOI 10.1093/annonc/mdn406; Galluzzi L, 2008, BIOCHEM SOC T, V36, P786, DOI 10.1042/BST0360786; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jin Q, 2008, J MAMMARY GLAND BIOL, V13, P485, DOI 10.1007/s10911-008-9107-3; Jin SK, 2008, AUTOPHAGY, V4, P563, DOI 10.4161/auto.5830; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kar R, 2009, ONCOGENE, V28, P2556, DOI 10.1038/onc.2009.118; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lan KH, 2005, ANN NY ACAD SCI, V1059, P70, DOI 10.1196/annals.1339.026; Liu XD, 2006, CANCER BIOL THER, V5, P648, DOI 10.4161/cbt.5.6.2707; Lu CH, 2007, CLIN CANCER RES, V13, P5883, DOI 10.1158/1078-0432.CCR-06-2837; Lu YH, 2004, INT J CANCER, V108, P334, DOI 10.1002/ijc.11445; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Marino G, 2008, AUTOPHAGY, V4, P807, DOI 10.4161/auto.6478; Marino G, 2008, HUM MOL GENET, V17, P2196, DOI 10.1093/hmg/ddn120; Menendez JA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1773; Miselli F, 2008, TRANSL ONCOL, V1, P177, DOI 10.1593/tlo.08157; Mishima Y, 2008, CANCER SCI, V99, P2200, DOI 10.1111/j.1349-7006.2008.00932.x; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Molina MA, 2001, CANCER RES, V61, P4744; Moretti L, 2007, DRUG RESIST UPDATE, V10, P135, DOI 10.1016/j.drup.2007.05.001; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nagy P, 2005, CANCER RES, V65, P473; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Nahta R, 2004, CANCER RES, V64, P3981, DOI 10.1158/0008-5472.CAN-03-3900; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Narayan M, 2009, CANCER RES, V69, P2191, DOI 10.1158/0008-5472.CAN-08-1056; Ocana A, 2006, AM J CLIN ONCOL-CANC, V29, P90, DOI 10.1097/01.coc.0000190274.00570.0a; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parkash J, 2007, NEURON GLIA BIOL, V3, P299, DOI 10.1017/S1740925X07000701; Pegram M D, 2000, Cancer Treat Res, V103, P57; Price-Schiavi SA, 2002, INT J CANCER, V99, P783, DOI 10.1002/ijc.10410; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Ropero S, 2004, BREAST CANCER RES TR, V86, P125, DOI 10.1023/B:BREA.0000032981.20384.c6; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Samudio I, 2008, MOL CANCER THER, V7, P1130, DOI 10.1158/1535-7163.MCT-07-0553; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shingu T, 2009, AUTOPHAGY, V5, P537, DOI 10.4161/auto.5.4.8164; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Shvets E, 2008, AUTOPHAGY, V4, P1054, DOI 10.4161/auto.6823; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028; Zakeri Z, 2008, METHOD ENZYMOL, V442, P289, DOI 10.1016/S0076-6879(08)01415-8	76	192	210	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6251	10.1371/journal.pone.0006251	http://dx.doi.org/10.1371/journal.pone.0006251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606230	gold, Green Published, Green Submitted			2022-12-27	WOS:000268036000008
J	Li, Z; O'Doherty, JE; Hanson, TL; Lebedev, MA; Henriquez, CS; Nicolelis, MAL				Li, Zheng; O'Doherty, Joseph E.; Hanson, Timothy L.; Lebedev, Mikhail A.; Henriquez, Craig S.; Nicolelis, Miguel A. L.			Unscented Kalman Filter for Brain-Machine Interfaces	PLOS ONE			English	Article								Brain machine interfaces (BMIs) are devices that convert neural signals into commands to directly control artificial actuators, such as limb prostheses. Previous real-time methods applied to decoding behavioral commands from the activity of populations of neurons have generally relied upon linear models of neural tuning and were limited in the way they used the abundant statistical information contained in the movement profiles of motor tasks. Here, we propose an n-th order unscented Kalman filter which implements two key features: (1) use of a non-linear (quadratic) model of neural tuning which describes neural activity significantly better than commonly-used linear tuning models, and (2) augmentation of the movement state variables with a history of n-1 recent states, which improves prediction of the desired command even before incorporating neural activity information and allows the tuning model to capture relationships between neural activity and movement at multiple time offsets simultaneously. This new filter was tested in BMI experiments in which rhesus monkeys used their cortical activity, recorded through chronically implanted multielectrode arrays, to directly control computer cursors. The 10th order unscented Kalman filter outperformed the standard Kalman filter and the Wiener filter in both off-line reconstruction of movement trajectories and real-time, closed-loop BMI operation.			Li, Z (corresponding author), Duke Univ, Dept Comp Sci, Durham, NC 27706 USA.	nicoleli@neuro.duke.edu	Incemaq, Inct/J-8752-2013; Lebedev, Mikhail/H-5066-2016; O'Doherty, Joseph/D-5116-2009	Lebedev, Mikhail/0000-0003-0355-8723; O'Doherty, Joseph/0000-0001-8175-5699				ASHE J, 1994, CEREB CORTEX, V4, P590, DOI 10.1093/cercor/4.6.590; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Barbieri R, 2004, Conf Proc IEEE Eng Med Biol Soc, V2004, P4483; Bashashati A, 2007, J NEURAL ENG, V4, pR32, DOI 10.1088/1741-2560/4/2/R03; Black MJ, 2003, I IEEE EMBS C NEUR E, P580, DOI 10.1109/CNE.2003.1196893; BROCKWELL A, 2007, STAT SIGNAL PROCESSI, P881; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Donoghue JP, 2007, J PHYSIOL-LONDON, V579, P603, DOI 10.1113/jphysiol.2006.127209; DOUCET A, 2001, SEQUENTIAL MONTR CAR; Eden UT, 2004, P ANN INT IEEE EMBS, V26, P4017; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; FISHER J, 2005, C P IEEE ENG MED BIO, V2, P2130; FU QG, 1995, J NEUROPHYSIOL, V73, P836, DOI 10.1152/jn.1995.73.2.836; Gao Y., 2002, ADV NEURAL INFORM PR, V14; GAO Y, 2003, QUANTITATIVE COMPARI, P189; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GRANT BD, 2007, AUTOMATED SPIKE SORT; Hatsopoulos N, 2004, J NEUROPHYSIOL, V92, P1165, DOI 10.1152/jn.01245.2003; Haykin S., 2014, ADAPTIVE FILTER THEO, V5th ed.; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Isaacs RE, 2000, IEEE T REHABIL ENG, V8, P196, DOI 10.1109/86.847814; JULIER SJ, 1995, NEW APPROACH FILTERI; Kemere C, 2004, IEEE T BIO-MED ENG, V51, P925, DOI 10.1109/TBME.2004.826675; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Kim SP, 2006, J NEURAL ENG, V3, P145, DOI 10.1088/1741-2560/3/2/009; Kim SP, 2003, NEURAL NETWORKS, V16, P865, DOI 10.1016/S0893-6080(03)00108-4; KIM SP, 2003, MODELIN RELATION MOT, P66; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; LI Z, 2007, N TH ORDER KALMAN FI; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; Patil PG, 2004, NEUROSURGERY, V55, P27, DOI 10.1227/01.NEU.0000126872.23715.E5; Sanchez J C, 2004, Conf Proc IEEE Eng Med Biol Soc, V2004, P5321; Sanchez JC, 2002, NEURAL NETWORKS FOR SIGNAL PROCESSING XII, PROCEEDINGS, P139, DOI 10.1109/NNSP.2002.1030025; SANCHEZ JC, 2003, INTERPRETING NEURAL, P2160; SANCHEZ JC, 2003, LEARNING CONTRIBUTIO, P59; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shoham S, 2005, IEEE T BIO-MED ENG, V52, P1312, DOI 10.1109/TBME.2005.847542; Shpigelman L, 2005, NEURAL COMPUT, V17, P671, DOI 10.1162/0899766053019944; SHPIGELMAN L, 2008, LEARNING NOVEL VISUO; SHPIGELMAN L, 2004, ADV NEURAL INFORM PR, V17; SHPIGELMAN L, 2003, ADV NEURAL INFORM PR, V15; Srinivasan L, 2005, I IEEE EMBS C NEUR E, P352; Srinivasan L, 2007, J NEUROPHYSIOL, V98, P2456, DOI 10.1152/jn.01118.2006; Srinivasan L, 2006, NEURAL COMPUT, V18, P2465, DOI 10.1162/neco.2006.18.10.2465; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; TING JA, 2005, ADV NEURAL INFORM PR, V18; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Turner RS, 1997, J NEUROPHYSIOL, V77, P1051, DOI 10.1152/jn.1997.77.3.1051; Van Der Merwe R., 2004, THESIS OREGON HLTH S; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; WAHNOUN R, 2004, NEURON SELECTION VIS, P4607; Wahnoun R, 2006, J NEURAL ENG, V3, P162, DOI 10.1088/1741-2560/3/2/010; WAN EA, 2000, ADV NEURAL INFORM PR, V12; WANG Y, 2006, MONTE CARLO SEQUENTI, P2250; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wu W, 2004, P ANN INT IEEE EMBS, V26, P4126; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Wu W, 2004, IEEE T BIO-MED ENG, V51, P933, DOI 10.1109/TBME.2004.826666; Wu W., 2003, ADV NEURAL INFORM PR, V15	70	117	122	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6243	10.1371/journal.pone.0006243	http://dx.doi.org/10.1371/journal.pone.0006243			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603074	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035700007
J	DeLoid, GM; Sulahian, TH; Imrich, A; Kobzik, L				DeLoid, Glen M.; Sulahian, Timothy H.; Imrich, Amy; Kobzik, Lester			Heterogeneity in Macrophage Phagocytosis of Staphylococcus aureus Strains: High-Throughput Scanning Cytometry-Based Analysis	PLOS ONE			English	Article								Alveolar macrophages (AMs) can phagocytose unopsonized pathogens such as S. aureus via innate immune receptors, such as scavenger receptors (SRs). Cytoskeletal events and signaling pathways involved in phagocytosis of unopsonized bacteria likely govern the fate of ingested pathogens, but are poorly characterized. We have developed a high-throughput scanning cytometry-based assay to quantify phagocytosis of S. aureus by adherent human blood-derived AM-like macrophages in a 96-well microplate format. Differential fluorescent labeling of internalized vs. bound bacteria or beads allowed automated image analysis of collapsed confocal stack images acquired by scanning cytometry, and quantification of total particles bound and percent of particles internalized. We compared the effects of the classic SR blocker polyinosinic acid, the cytoskeletal inhibitors cytochalasin D and nocodazole, and the signaling inhibitors staurosporine, Go 6976, JNK Inhibitor I and KN-93, on phagocytosis of a panel of live unopsonized S. aureus strains, (Wood, Seattle 1945 (ATCC 25923), and RN6390), as well as a commercial killed Wood strain, heat-killed Wood strain and latex beads. Our results revealed failure of the SR inhibitor polyinosinic acid to block binding of any live S. aureus strains, suggesting that SR-mediated uptake of a commercial killed fluorescent bacterial particle does not accurately model interaction with viable bacteria. We also observed heterogeneity in the effects of cytoskeletal and signaling inhibitors on internalization of different S. aureus strains. The data suggest that uptake of unopsonized live S. aureus by human macrophages is not mediated by SRs, and that the cellular mechanical and signaling processes that mediate S. aureus phagocytosis vary. The findings also demonstrate the potential utility of high-throughput scanning cytometry techniques to study phagocytosis of S. aureus and other organisms in greater detail.			DeLoid, GM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA.	gdeloid@hsph.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011008, R01ES011903] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32-HL007118, T32 HL007118] Funding Source: Medline; NIEHS NIH HHS [R01 ES011903, R01 ES011008] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; ARESCHOUG T, 2008, EUR J IMMUNOL; Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Arredouani MS, 2005, J IMMUNOL, V175, P6058, DOI 10.4049/jimmunol.175.9.6058; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; BROWDER HP, 1965, BIOCHEM BIOPH RES CO, V19, P383, DOI 10.1016/0006-291X(65)90473-0; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cohen G, 2006, GLIA, V53, P538, DOI 10.1002/glia.20304; DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863; Elshourbagy MA, 2000, EUR J BIOCHEM, V267, P919, DOI 10.1046/j.1432-1327.2000.01077.x; GREENBERG S, 1994, J BIOL CHEM, V269, P3897; GREENBERG S, 1993, J EXP MED, V177, P529, DOI 10.1084/jem.177.2.529; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Larsen EC, 2002, J CELL BIOL, V159, P939, DOI 10.1083/jcb.200205140; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Moriwaki H, 1998, FEBS LETT, V440, P29, DOI 10.1016/S0014-5793(98)01414-8; Nakamura K, 2001, BIOCHEM BIOPH RES CO, V280, P1028, DOI 10.1006/bbrc.2000.4210; NEWMAN SL, 1991, J IMMUNOL, V146, P967; NINOMIYA N, 1994, J BIOL CHEM, V269, P22732; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497; Peiser L, 2000, INFECT IMMUN, V68, P1953, DOI 10.1128/IAI.68.4.1953-1963.2000; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Satoh H, 2008, J HISTOCHEM CYTOCHEM, V56, P773, DOI 10.1369/jhc.2008.950543; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Selman L, 2008, MOL IMMUNOL, V45, P3278, DOI 10.1016/j.molimm.2008.02.018; Shimaoka T, 2003, J IMMUNOL, V171, P1647, DOI 10.4049/jimmunol.171.4.1647; Shimaoka T, 2001, J IMMUNOL, V166, P5108, DOI 10.4049/jimmunol.166.8.5108; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; Sulahian TH, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-59; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; van der Laan LJW, 1999, J IMMUNOL, V162, P939; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009; Zhou HW, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-7	38	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6209	10.1371/journal.pone.0006209	http://dx.doi.org/10.1371/journal.pone.0006209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593389	Green Submitted, Green Published, gold			2022-12-27	WOS:000268035300016
J	Shimada, S; Fukuda, K; Hiraki, K				Shimada, Sotaro; Fukuda, Kensuke; Hiraki, Kazuo			Rubber Hand Illusion under Delayed Visual Feedback	PLOS ONE			English	Article							BODY OWNERSHIP; OBJECTS; LIMB	Background: Rubber hand illusion (RHI) is a subject's illusion of the self-ownership of a rubber hand that was touched synchronously with their own hand. Although previous studies have confirmed that this illusion disappears when the rubber hand was touched asynchronously with the subject's hand, the minimum temporal discrepancy of these two events for attenuation of RHI has not been examined. Methodology/Principal Findings: In this study, various temporal discrepancies between visual and tactile stimulations were introduced by using a visual feedback delay experimental setup, and RHI effects in each temporal discrepancy condition were systematically tested. The results showed that subjects felt significantly greater RHI effects with temporal discrepancies of less than 300 ms compared with longer temporal discrepancies. The RHI effects on reaching performance (proprioceptive drift) showed similar conditional differences. Conclusions/Significance: Our results first demonstrated that a temporal discrepancy of less than 300 ms between visual stimulation of the rubber hand and tactile stimulation to the subject's own hand is preferable to induce strong sensation of RHI. We suggest that the time window of less than 300 ms is critical for multi-sensory integration processes constituting the self-body image.			Shimada, S (corresponding author), Meiji Univ, Sch Sci & Technol, Dept Elect & Bioinformat, Kawasaki, Kanagawa, Japan.	sshimada@isc.meiji.ac.jp	Shimada, Sotaro/AAC-2484-2019					Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; Haans A, 2008, BODY IMAGE, V5, P389, DOI 10.1016/j.bodyim.2008.04.003; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Kanayama N, 2007, PSYCHOPHYSIOLOGY, V44, P392, DOI 10.1111/j.1469-8986.2007.00511.x; Leube DT, 2003, NEUROIMAGE, V20, P2084, DOI 10.1016/j.neuroimage.2003.07.033; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Press C, 2008, J COGNITIVE NEUROSCI, V20, P312, DOI 10.1162/jocn.2008.20022; Shimada S, 2005, NEUROIMAGE, V24, P1225, DOI 10.1016/j.neuroimage.2004.10.039; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131	15	170	174	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6185	10.1371/journal.pone.0006185	http://dx.doi.org/10.1371/journal.pone.0006185			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	471DL	19587780	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035100009
J	Reiss-Sklan, E; Levitzki, A; Naveh-Many, T				Reiss-Sklan, Ella; Levitzki, Alexander; Naveh-Many, Tally			The Complex Regulation of HIC (Human I-mfa Domain Containing Protein) Expression	PLOS ONE			English	Article								Human I-mfa domain containing protein (HIC) differentially regulates transcription from viral promoters. HIC affects the Wnt pathway, the JNK/SAPK pathway and the activity of positive transcription elongation factor-b (P-TEFb). Studies exploring HIC function in mammalian cells used ectopically expressed HIC due to undetected endogenous HIC protein. HIC mRNA contains exceptionally long 59 and 39 untranslated regions (UTRs) compared to the average length of mRNA UTRs. Here we show that HIC protein is subject to strict repression at multiple levels. The HIC mRNA UTRs reduce the expression of HIC or of a reporter protein: The HIC 3'-UTR decreases both HIC and reporter mRNA levels, whereas upstream open reading frames located in the 5'-UTR repress the translation of HIC or of the reporter protein. In addition, ectopically expressed HIC protein is degraded by the proteasome, with a half-life of approximately 1 h, suggesting that upon activation, HIC expression in cells may be transient. The strict regulation of HIC expression at the levels of mRNA stability, translation efficiency and protein stability suggests that expression of the HIC protein and its involvement in the various pathways is required only under specific cellular conditions.			Reiss-Sklan, E (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	tally@cc.huji.ac.il						Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; CHEN CYA, 1994, MOL CELL BIOL, V14, P8471, DOI 10.1128/MCB.14.12.8471; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Child SJ, 1999, J BIOL CHEM, V274, P24335, DOI 10.1074/jbc.274.34.24335; CIGOGNINI D, 2006, LEUK RES; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gautier VW, 2005, P NATL ACAD SCI USA, V102, P16362, DOI 10.1073/pnas.0503519102; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jin XP, 2003, J BIOL CHEM, V278, P25716, DOI 10.1074/jbc.M300316200; Kilav R, 2001, J BIOL CHEM, V276, P8727, DOI 10.1074/jbc.M005471200; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kusano S, 2002, MOL CELL BIOL, V22, P6393, DOI 10.1128/MCB.22.18.6393-6405.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu J, 2009, J BIOTECHNOL, V139, P152, DOI 10.1016/j.jbiotec.2008.10.008; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; Mitchell P, 2001, CURR OPIN CELL BIOL, V13, P320, DOI 10.1016/S0955-0674(00)00214-3; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; PETERSON C, 1991, GENE, V107, P279, DOI 10.1016/0378-1119(91)90328-9; Rajasekhar VK, 2004, ONCOGENE, V23, P3248, DOI 10.1038/sj.onc.1207546; Snider L, 2001, MOL CELL BIOL, V21, P1866, DOI 10.1128/MCB.21.5.1866-1873.2001; Suzuki Y, 2000, GENOMICS, V64, P286, DOI 10.1006/geno.2000.6076; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Thebault S, 2000, J BIOL CHEM, V275, P4848, DOI 10.1074/jbc.275.7.4848; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang Q, 2007, J MOL BIOL, V367, P630, DOI 10.1016/j.jmb.2007.01.020; Wilson GM, 1999, PROG NUCLEIC ACID RE, V62, P257; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Young TM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001010; Young TM, 2003, MOL CELL BIOL, V23, P6373, DOI 10.1128/MCB.23.18.6373-6384.2003	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6152	10.1371/journal.pone.0006152	http://dx.doi.org/10.1371/journal.pone.0006152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582149	gold, Green Published, Green Submitted			2022-12-27	WOS:000267806400008
J	Brockmeyer, J; Spelten, S; Kuczius, T; Bielaszewska, M; Karch, H				Brockmeyer, Jens; Spelten, Sabrina; Kuczius, Thorsten; Bielaszewska, Martina; Karch, Helge			Structure and Function Relationship of the Autotransport and Proteolytic Activity of EspP from Shiga Toxin-Producing Escherichia coli	PLOS ONE			English	Article							SERINE-PROTEASE; SECRETION; DOMAIN; RECOGNITION; CLEAVAGE	Background: The serine protease autotransporter EspP is a proposed virulence factor of Shiga toxin-producing Escherichia coli (STEC). We recently distinguished four EspP subtypes (EspP alpha, EspP beta, EspP gamma, and EspP delta), which display large differences in transport and proteolytic activities and differ widely concerning their distribution within the STEC population. The mechanisms underlying these functional variations in EspP subtypes are, however, unknown. Methodology/Principal Findings: The structural basis of proteolytic and autotransport activity was investigated using transposon-based linker scanning mutagenesis, site-directed mutagenesis and structure-function analysis derived from homology modelling of the EspP passenger domain. Transposon mutagenesis of the passenger domain inactivated autotransport when pentapeptide linker insertions occurred in regions essential for overall correct folding or in a loop protruding from the beta-helical core. Loss of proteolytic function was limited to mutations in Domain 1 in the N-terminal third of the EspP passenger. Site-directed mutagenesis demonstrated that His(127), Asp(156) and Ser(263) in Domain 1 form the catalytic triad of EspP. Conclusions/Significance: Our data indicate that in EspP i) the correct formation of the tertiary structure of the passenger domain is essential for efficient autotransport, and ii) an elastase-like serine protease domain in the N-terminal Domain 1 is responsible for the proteolytic phenotype. Lack of stabilizing interactions of Domain 1 with the core structure of the passenger domain ablates proteolytic activity in subtypes EspP beta and EspP delta.			Brockmeyer, J (corresponding author), Univ Munster, Inst Hyg, Munster, Germany.	Jens.Brockmeyer@ukmuenster.de	Bielaszewska, Martina/AAC-9812-2022					Aldick T, 2007, MICROBES INFECT, V9, P282, DOI 10.1016/j.micinf.2006.12.001; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bernstein HD, 2007, TRENDS MICROBIOL, V15, P441, DOI 10.1016/j.tim.2007.09.007; Bielaszewska M, 2005, THROMB HAEMOSTASIS, V94, P312, DOI 10.1160/TH05-04-0265; Bielaszewska M, 2005, INFECT IMMUN, V73, P552, DOI 10.1128/IAI.73.1.552-562.2005; Brockmeyer J, 2007, APPL ENVIRON MICROB, V73, P6351, DOI 10.1128/AEM.00920-07; Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046/j.1365-2958.1997.3871751.x; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; Deber CM, 2002, NAT STRUCT BIOL, V9, P318, DOI 10.1038/nsb0502-318; Dutta PR, 2003, J BIOL CHEM, V278, P39912, DOI 10.1074/jbc.M303595200; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Eslava C, 1998, INFECT IMMUN, V66, P3155, DOI 10.1128/IAI.66.7.3155-3163.1998; Ferns S, 2007, CHEM WORLD-UK, V4, P35; Fink DL, 2001, J BIOL CHEM, V276, P39492, DOI 10.1074/jbc.M106913200; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Ieva R, 2008, MOL MICROBIOL, V67, P188, DOI 10.1111/j.1365-2958.2007.06048.x; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Khan AB, 2009, INT J MED MICROBIOL, V299, P247, DOI 10.1016/j.ijmm.2008.08.006; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; KLAUSER T, 1993, J MOL BIOL, V234, P579, DOI 10.1006/jmbi.1993.1613; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Maurer J, 1999, J BACTERIOL, V181, P7014, DOI 10.1128/JB.181.22.7014-7020.1999; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; OHNISHI Y, 1994, J BIOL CHEM, V269, P32800; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Szczesny P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000119; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Velarde JJ, 2004, J BIOL CHEM, V279, P31495, DOI 10.1074/jbc.M404424200; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Yeo HJ, 2004, EMBO J, V23, P1245, DOI 10.1038/sj.emboj.7600142	50	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6100	10.1371/journal.pone.0006100	http://dx.doi.org/10.1371/journal.pone.0006100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568421	Green Published, Green Submitted, gold			2022-12-27	WOS:000267572200005
J	Palpant, NJ; Szatkowski, ML; Wang, W; Townsend, D; Bedada, FB; Koch, LG; Britton, SL; Metzger, JM				Palpant, Nathan J.; Szatkowski, Michael L.; Wang, Wang; Townsend, DeWayne; Bedada, Fikru B.; Koch, Lauren G.; Britton, Steven L.; Metzger, Joseph M.			Artificial Selection for Whole Animal Low Intrinsic Aerobic Capacity Co-Segregates with Hypoxia-Induced Cardiac Pump Failure	PLOS ONE			English	Article							METABOLIC SYNDROME; HEART-FAILURE; GENE-TRANSFER; CALCIUM; EXPRESSION; ENDURANCE; CA2+; DEFINITION; EXERCISE	Oxygen metabolism is a strong predictor of the general health and fitness of an organism. In this study, we hypothesized that a divergence in intrinsic aerobic fitness would co-segregate with susceptibility for cardiovascular dysfunction. To test this hypothesis, cardiac function was assessed in rats specifically selected over nineteen generations for their low (LCR) and high (HCR) intrinsic aerobic running capacity. As an integrative marker of native aerobic capacity, run time to exhaustion between LCR and HCR rats had markedly diverged by 436% at generation nineteen of artificial selection. In vivo assessment of baseline cardiac function by echocardiography and catheter-based conductance micromanometry showed no marked difference in cardiac performance. However, when challenged by exposure to acute hypoxia, cardiac pump failure occurred significantly earlier in LCR rats compared to HCR animals. Acute cardiac decompensation in LCR rats was exclusively due to the development of intractable irregular ventricular contractions. Analysis of isolated cardiac myocytes showed significantly slower sarcomeric relaxation and delayed kinetics of calcium cycling in LCR myocytes compared to HCR myocytes. This study also revealed that artificial selection for low native aerobic capacity is a novel pathologic stimulus that results in myosin heavy chain isoform switching in the heart as shown by increased levels of beta-MHC in LCR rats. Together, these results provide evidence that alterations in sub-cellular calcium handling and MHC isoform composition are associated with susceptibility to compensatory cardiac remodeling and hypoxia induced pump failure in animals with low intrinsic aerobic capacity.			Palpant, NJ (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	metzgerj@umn.edu	Palpant, Nathan/B-1641-2017; wang, wang/GWQ-7272-2022; Koch, Lauren/D-1258-2010	Palpant, Nathan/0000-0002-9334-8107; Wang, Wang/0000-0001-9093-412X	NCRR NIH HHS [R24 RR017718, R24 RR17718] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017718] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Apstein CS, 2005, EUR HEART J, V26, P956, DOI 10.1093/eurheartj/ehi200; Bers DM, 2003, CIRC RES, V93, P487, DOI 10.1161/01.RES.0000091871.54907.6B; Bers DM, 2006, ANN NY ACAD SCI, V1080, P165, DOI 10.1196/annals.1380.015; BOUCHARD C, 1986, MED SCI SPORT EXER, V18, P639; Britton SL, 2003, IUBMB LIFE, V55, P429, DOI 10.1080/1521654031000138578; Bye A, 2008, PHYSIOL GENOMICS, V33, P100, DOI 10.1152/physiolgenomics.00269.2007; BYRON KL, 1996, AM J PHYSIOL, V271; Coutu P, 2002, BIOPHYS J, V82, P2565, DOI 10.1016/S0006-3495(02)75599-9; Day SM, 2006, NAT MED, V12, P181, DOI 10.1038/nm1346; DELCAYRE C, 1992, AM J PHYSIOL, V263, pH1537, DOI 10.1152/ajpheart.1992.263.5.H1537; Diaz ME, 2002, CIRC RES, V91, P585, DOI 10.1161/01.RES.0000035527.53514.C2; Dibb KM, 2007, CELL CALCIUM, V42, P503, DOI 10.1016/j.ceca.2007.04.002; Ford Earl S, 2006, Expert Rev Cardiovasc Ther, V4, P897, DOI 10.1586/14779072.4.6.897; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; Ford ES, 2004, ATHEROSCLEROSIS, V173, P309, DOI 10.1016/j.atherosclerosis.2003.12.022; Ford ES, 2003, ETHNIC DIS, V13, P429; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gonzalez NC, 2006, J APPL PHYSIOL, V101, P1288, DOI 10.1152/japplphysiol.01527.2005; Gonzalez NC, 2006, RESP PHYSIOL NEUROBI, V151, P141, DOI 10.1016/j.resp.2005.09.012; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Haram PM, 2009, CARDIOVASC RES, V81, P723, DOI 10.1093/cvr/cvn332; Henderson KK, 2002, J APPL PHYSIOL, V93, P1265, DOI 10.1152/japplphysiol.00809.2001; Herron TJ, 2007, CIRC RES, V100, P1182, DOI 10.1161/01.RES.0000264102.00706.4e; Hieber S, 2009, EUR J ANAESTH, V26, P201, DOI 10.1097/EJA.0b013e3283212cbb; Howlett RA, 2008, J APPL PHYSL; Hunter CJ, 2008, FRONT BIOSCI-LANDMRK, V13, P347, DOI 10.2741/2684; Hussain SO, 2001, AM J PHYSIOL-REG I, V281, pR1787, DOI 10.1152/ajpregu.2001.281.6.R1787; IVESTER CT, 1995, J BIOL CHEM, V270, P21950, DOI 10.1074/jbc.270.37.21950; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kranias E. G., 2007, V45, P523; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Li Chaoyang, 2006, Metabolic Syndrome and Related Disorders, V4, P237, DOI 10.1089/met.2006.4.237; LOISELLE DS, 1982, J MUSCLE RES CELL M, V3, P5, DOI 10.1007/BF00711877; Lujan HL, 2006, AM J PHYSIOL-HEART C, V291, pH2933, DOI 10.1152/ajpheart.00514.2006; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; MORKIN E, 1991, ADV EXP MED BIOL, V308, P143; Oliver MF, 2002, AM J MED, V112, P305, DOI 10.1016/S0002-9343(01)01104-4; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Saupe KW, 2001, J MOL CELL CARDIOL, V33, P261, DOI 10.1006/jmcc.2000.1297; Tardiff JC, 2000, AM J PHYSIOL-HEART C, V278, pH412, DOI 10.1152/ajpheart.2000.278.2.H412; Venetucci LA, 2007, CIRC RES, V100, P105, DOI 10.1161/01.RES.0000252828.17939.00; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wilson GR, 2005, AM FAM PHYSICIAN, V72, P1517; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177	47	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6117	10.1371/journal.pone.0006117	http://dx.doi.org/10.1371/journal.pone.0006117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568432	Green Submitted, Green Published, gold			2022-12-27	WOS:000267572200016
J	Yang, JC; Madupu, R; Durkin, AS; Ekborg, NA; Pedamallu, CS; Hostetler, JB; Radune, D; Toms, BS; Henrissat, B; Coutinho, PM; Schwarz, S; Field, L; Trindade-Silva, AE; Soares, CAG; Elshahawi, S; Hanora, A; Schmidt, EW; Haygood, MG; Posfai, J; Benner, J; Madinger, C; Nove, J; Anton, B; Chaudhary, K; Foster, J; Holman, A; Kumar, S; Lessard, PA; Luyten, YA; Slatko, B; Wood, N; Wu, B; Teplitski, M; Mougous, JD; Ward, N; Eisen, JA; Badger, JH; Distel, DL				Yang, Joyce C.; Madupu, Ramana; Durkin, A. Scott; Ekborg, Nathan A.; Pedamallu, Chandra S.; Hostetler, Jessica B.; Radune, Diana; Toms, Bradley S.; Henrissat, Bernard; Coutinho, Pedro M.; Schwarz, Sandra; Field, Lauren; Trindade-Silva, Amaro E.; Soares, Carlos A. G.; Elshahawi, Sherif; Hanora, Amro; Schmidt, Eric W.; Haygood, Margo G.; Posfai, Janos; Benner, Jack; Madinger, Catherine; Nove, John; Anton, Brian; Chaudhary, Kshitiz; Foster, Jeremy; Holman, Alex; Kumar, Sanjay; Lessard, Philip A.; Luyten, Yvette A.; Slatko, Barton; Wood, Nicole; Wu, Bo; Teplitski, Max; Mougous, Joseph D.; Ward, Naomi; Eisen, Jonathan A.; Badger, Jonathan H.; Distel, Daniel L.			The Complete Genome of Teredinibacter turnerae T7901: An Intracellular Endosymbiont of Marine Wood-Boring Bivalves (Shipworms)	PLOS ONE			English	Article							VI-SECRETION-SYSTEM; LYRODUS-PEDICELLATUS BIVALVIA; CANDIDATUS ENDOBUGULA SERTULA; PROTEIN SECRETION; RIBOSOMAL-RNA; BURKHOLDERIA-PSEUDOMALLEI; RHIZOBIUM-LEGUMINOSARUM; BACTERIAL SYMBIONTS; MICROBIAL SYMBIONT; NITROGEN-FIXATION	Here we report the complete genome sequence of Teredinibacter turnerae T7901. T. turnerae is a marine gamma proteobacterium that occurs as an intracellular endosymbiont in the gills of wood-boring marine bivalves of the family Teredinidae (shipworms). This species is the sole cultivated member of an endosymbiotic consortium thought to provide the host with enzymes, including cellulases and nitrogenase, critical for digestion of wood and supplementation of the host's nitrogen-deficient diet. T. turnerae is closely related to the free-living marine polysaccharide degrading bacterium Saccharophagus degradans str. 2-40 and to as yet uncultivated endosymbionts with which it coexists in shipworm cells. Like S. degradans, the T. turnerae genome encodes a large number of enzymes predicted to be involved in complex polysaccharide degradation (>100). However, unlike S. degradans, which degrades a broad spectrum (>10 classes) of complex plant, fungal and algal polysaccharides, T. turnerae primarily encodes enzymes associated with deconstruction of terrestrial woody plant material. Also unlike S. degradans and many other eubacteria, T. turnerae dedicates a large proportion of its genome to genes predicted to function in secondary metabolism. Despite its intracellular niche, the T. turnerae genome lacks many features associated with obligate intracellular existence (e.g. reduced genome size, reduced %G+C, loss of genes of core metabolism) and displays evidence of adaptations common to free-living bacteria (e.g. defense against bacteriophage infection). These results suggest that T. turnerae is likely a facultative intracellular ensosymbiont whose niche presently includes, or recently included, free-living existence. As such, the T. turnerae genome provides insights into the range of genomic adaptations associated with intracellular endosymbiosis as well as enzymatic mechanisms relevant to the recycling of plant materials in marine environments and the production of cellulose-derived biofuels.			Yang, JC (corresponding author), Ocean Genome Legacy Inc, Ipswich, MA USA.	distel@oglf.org	Trindade-Silva, Amaro/AAO-5685-2020; Kumar, Sanjay/AAO-2593-2021; Elshahawi, Sherif/I-3595-2019; Henrissat, Bernard/J-2475-2012; Distel, Daniel/A-8047-2017; Hanora, Amro/HCI-0501-2022; Hanora, Amro/N-7957-2017; Soares, Carlos A G/H-9464-2016; Eisen, Jonathan A./H-2706-2019; Pedamallu, Chandra Sekhar/AAV-6723-2020; Pedamallu, Chandra Sekhar/AAV-6745-2020	Trindade-Silva, Amaro/0000-0003-4321-065X; Elshahawi, Sherif/0000-0003-1879-1552; Henrissat, Bernard/0000-0002-3434-8588; Distel, Daniel/0000-0002-3860-194X; Hanora, Amro/0000-0003-4937-7741; Hanora, Amro/0000-0003-4937-7741; Soares, Carlos A G/0000-0001-9058-9266; Eisen, Jonathan A./0000-0002-0159-2197; 				Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASCHTGEN MS, 2008, J BACTERIOL; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENTLEY SD, 2002, NATURE, V3, P417; Berger E, 2007, FEMS MICROBIOL LETT, V268, P194, DOI 10.1111/j.1574-6968.2006.00583.x; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bordenstein SR, 2005, NAT REV MICROBIOL, V3, P688, DOI 10.1038/nrmicro1233; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Burton EO, 2005, APPL ENVIRON MICROB, V71, P4906, DOI 10.1128/AEM.71.8.4906-4909.2005; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Clarke A J, 1997, BIODEGRADATION CELLU; Collin M, 2004, J BIOL CHEM, V279, P22558, DOI 10.1074/jbc.M402156200; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Das Soumita, 2003, In Silico Biology, V3, P287; Davidson SK, 2001, APPL ENVIRON MICROB, V67, P4531, DOI 10.1128/AEM.67.10.4531-4537.2001; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Distel DL, 2003, ACS SYM SER, V845, P253; Distel DL, 2002, INT J SYST EVOL MICR, V52, P2261, DOI 10.1099/00207713-52-6-2261; Distel DL, 2002, APPL ENVIRON MICROB, V68, P6292, DOI 10.1128/AEM.68.12.6292-6299.2002; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ekborg NA, 2007, APPL ENVIRON MICROB, V73, P7785, DOI 10.1128/AEM.00876-07; Ekborg NA, 2006, APPL ENVIRON MICROB, V72, P3396, DOI 10.1128/AEM.72.5.3396-3405.2006; Enos-Berlage JL, 2005, MOL MICROBIOL, V55, P1160, DOI 10.1111/j.1365-2958.2004.04453.x; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; GALLAGER SM, 1981, J EXP MAR BIOL ECOL, V52, P63, DOI 10.1016/0022-0981(81)90171-4; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; HALL J, 1989, MOL MICROBIOL, V3, P1211, DOI 10.1111/j.1365-2958.1989.tb00271.x; Haygood MG, 1997, APPL ENVIRON MICROB, V63, P4612, DOI 10.1128/AEM.63.11.4612-4616.1997; Higuchi T, 1985, BIOSYNTHESIS BIODEGR, P505, DOI DOI 10.1016/B978-0-12-347880-1.50022-2; Howard MB, 2004, PROTEIN SCI, V13, P1422, DOI 10.1110/ps.03511604; Howard MB, 2004, J BACTERIOL, V186, P1297, DOI 10.1128/JB.186.5.1297-1303.2004; Howard MB, 2003, J BACTERIOL, V185, P3352, DOI 10.1128/JB.185.11.3352-3360.2003; Hubber A, 2004, MOL MICROBIOL, V54, P561, DOI 10.1111/j.1365-2958.2004.04292.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Jeong H, 2005, NUCLEIC ACIDS RES, V33, P7066, DOI 10.1093/nar/gki1016; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kechris KJ, 2006, P NATL ACAD SCI USA, V103, P9584, DOI 10.1073/pnas.0603534103; Kobayashi M, 2000, CURR OPIN CHEM BIOL, V4, P95, DOI 10.1016/S1367-5931(99)00058-7; Kosugi A, 2002, APPL ENVIRON MICROB, V68, P6399, DOI 10.1128/AEM.68.12.6399-6402.2002; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Lee VT, 2001, GENE DEV, V15, P1725, DOI 10.1101/gad.896801; Lopanik N, 2004, OECOLOGIA, V139, P131, DOI 10.1007/s00442-004-1487-5; Lopanik N, 2004, J NAT PROD, V67, P1412, DOI 10.1021/np040007k; Luyten YA, 2006, APPL ENVIRON MICROB, V72, P412, DOI 10.1128/AEM.72.1.412-417.2006; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Pace HC, 2001, GENOME BIOL, V2; Parsons DA, 2005, INFECT IMMUN, V73, P4338, DOI 10.1128/IAI.73.7.4338-4345.2005; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Plague GR, 2008, J BACTERIOL, V190, P777, DOI 10.1128/JB.01082-07; Podar M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-42; POULSEN OM, 1992, BIOTECHNOL BIOENG, V39, P121, DOI 10.1002/bit.260390118; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Qi M, 2007, APPL ENVIRON MICROB, V73, P6098, DOI 10.1128/AEM.01037-07; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Robertson DE, 2004, APPL ENVIRON MICROB, V70, P2429, DOI 10.1128/AEM.70.4.2429-2436.2004; Sammut SJ, 2008, BRIEF BIOINFORM, V9, P210, DOI 10.1093/bib/bbn010; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Stewart FJ, 2007, J MOL EVOL, V65, P44, DOI 10.1007/s00239-006-0235-3; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Taylor LE, 2006, J BACTERIOL, V188, P3849, DOI 10.1128/JB.01348-05; TEPLITSKI M, 2004, GLOBAL REGULATORY NE; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; VANBRUSSEL AAN, 1986, J BACTERIOL, V165, P517, DOI 10.1128/jb.165.2.517-522.1986; WALSH CT, 1990, CHEM REV, V90, P1105, DOI 10.1021/cr00105a003; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WARREN RAJ, 1987, GENE, V61, P421, DOI 10.1016/0378-1119(87)90204-6; WATERBURY JB, 1983, SCIENCE, V221, P1401, DOI 10.1126/science.221.4618.1401; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; Wernegreen JJ, 2005, CURR OPIN GENET DEV, V15, P572, DOI 10.1016/j.gde.2005.09.013; Xie G, 2007, APPL ENVIRON MICROB, V73, P3536, DOI 10.1128/AEM.00225-07; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zuber S, 2003, MOL PLANT MICROBE IN, V16, P634, DOI 10.1094/MPMI.2003.16.7.634	104	73	322	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6085	10.1371/journal.pone.0006085	http://dx.doi.org/10.1371/journal.pone.0006085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568419	Green Published, Green Submitted, gold			2022-12-27	WOS:000267572200003
J	Blanchette, CD; Woo, YH; Thomas, C; Shen, N; Sulchek, TA; Hiddessen, AL				Blanchette, Craig D.; Woo, Youn-Hi; Thomas, Cynthia; Shen, Nan; Sulchek, Todd A.; Hiddessen, Amy L.			Decoupling Internalization, Acidification and Phagosomal-Endosomal/lysosomal Fusion during Phagocytosis of InlA Coated Beads in Epithelial Cells	PLOS ONE			English	Article							RICH REPEAT REGION; LISTERIA-MONOCYTOGENES; LEGIONELLA-PNEUMOPHILA; INTRACELLULAR FATE; LYSOSOME FUSION; CONCANAMYCIN-A; E-CADHERIN; V-TYPE; P-TYPE; MATURATION	Background: Phagocytosis has been extensively examined in 'professional' phagocytic cells using pH sensitive dyes. However, in many of the previous studies, a separation between the end of internalization, beginning of acidification and completion of phagosomal-endosomal/lysosomal fusion was not clearly established. In addition, very little work has been done to systematically examine phagosomal maturation in 'non-professional' phagocytic cells. Therefore, in this study, we developed a simple method to measure and decouple particle internalization, phagosomal acidification and phagosomalendosomal/lysosomal fusion in Madin-Darby Canine Kidney (MDCK) and Caco-2 epithelial cells. Methodology/Principal Findings: Our method was developed using a pathogen mimetic system consisting of polystyrene beads coated with Internalin A (InlA), a membrane surface protein from Listeria monocytogenes known to trigger receptor-mediated phagocytosis. We were able to independently measure the rates of internalization, phagosomal acidification and phagosomal-endosomal/lysosomal fusion in epithelial cells by combining the InlA-coated beads (InlA-beads) with antibody quenching, a pH sensitive dye and an endosomal/lysosomal dye. By performing these independent measurements under identical experimental conditions, we were able to decouple the three processes and establish time scales for each. In a separate set of experiments, we exploited the phagosomal acidification process to demonstrate an additional, real-time method for tracking bead binding, internalization and phagosomal acidification. Conclusions/Significance: Using this method, we found that the time scales for internalization, phagosomal acidification and phagosomal-endosomal/lysosomal fusion ranged from 23-32 min, 3-4 min and 74-120 min, respectively, for MDCK and Caco-2 epithelial cells. Both the static and real-time methods developed here are expected to be readily and broadly applicable, as they simply require fluorophore conjugation to a particle of interest, such as a pathogen or mimetic, in combination with common cell labeling dyes. As such, these methods hold promise for future measurements of receptor-mediated internalization in other cell systems, e. g. pathogen-host systems.			Blanchette, CD (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	hiddessen1@llnl.gov						Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; BONAZZI M, 2008, CELL MICROBIOL; BOUVIER G, 1994, J LEUKOCYTE BIOL, V55, P729, DOI 10.1002/jlb.55.6.729; Braun L, 2000, MICROBES INFECT, V2, P803, DOI 10.1016/S1286-4579(00)90365-4; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; deChastellier C, 1997, EUR J CELL BIOL, V74, P49; Desjardins M, 1997, J CELL SCI, V110, P2303; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Drose S, 2001, BIOCHEMISTRY-US, V40, P2816, DOI 10.1021/bi001759q; EISSENBERG LG, 1993, J EXP MED, V177, P1605, DOI 10.1084/jem.177.6.1605; FALKOW S, 1992, ANNU REV CELL BIOL, V8, P333, DOI 10.1146/annurev.cb.08.110192.002001; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; FRIIS RR, 1972, J BACTERIOL, V110, P706, DOI 10.1128/JB.110.2.706-721.1972; GEISOW MJ, 1981, J CELL BIOL, V89, P645, DOI 10.1083/jcb.89.3.645; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1984, J CELL BIOL, V99, P1936, DOI 10.1083/jcb.99.6.1936; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jankowski A, 2002, J BIOL CHEM, V277, P6059, DOI 10.1074/jbc.M110059200; JONES TC, 1972, J EXP MED, V136, P1157, DOI 10.1084/jem.136.5.1157; KIELIAN MC, 1986, EMBO J, V5, P3103, DOI 10.1002/j.1460-2075.1986.tb04616.x; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Kwiatkowska K, 1999, BIOESSAYS, V21, P422, DOI 10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Levitz SM, 1999, INFECT IMMUN, V67, P885, DOI 10.1128/IAI.67.2.885-890.1999; Lin SX, 2004, MOL BIOL CELL, V15, P721, DOI 10.1091/mbc.E03-07-0497; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; Mast SO, 1942, BIOL BULL-US, V83, P173, DOI 10.2307/1538142; MCNEIL PL, 1983, J CELL BIOL, V97, P692, DOI 10.1083/jcb.97.3.692; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Mengaud J, 1996, INFECT IMMUN, V64, P5430, DOI 10.1128/IAI.64.12.5430-5433.1996; Moon EK, 2006, EUKARYOT CELL, V5, P125, DOI 10.1128/EC.5.1.125-131.2006; Moreno A, 2005, CELL CALCIUM, V37, P555, DOI 10.1016/j.ceca.2005.02.002; Oh YK, 1996, INFECT IMMUN, V64, P319, DOI 10.1128/IAI.64.1.319-325.1996; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; SIBLEY LD, 1985, NATURE, V315, P416, DOI 10.1038/315416a0; Sousa S, 2004, J CELL SCI, V117, P2121, DOI 10.1242/jcs.01066; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; TYCKO B, 1982, CELL, V28, P643, DOI 10.1016/0092-8674(82)90219-7; Vergne I, 1998, ANAL BIOCHEM, V255, P127, DOI 10.1006/abio.1997.2466; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069	50	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6056	10.1371/journal.pone.0006056	http://dx.doi.org/10.1371/journal.pone.0006056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557127	Green Submitted, gold, Green Published			2022-12-27	WOS:000267424600004
J	Hanshaoworakul, W; Simmerman, JM; Narueponjirakul, U; Sanasuttipun, W; Shinde, V; Kaewchana, S; Areechokechai, D; Levy, J; Ungchusak, K				Hanshaoworakul, Wanna; Simmerman, James Mark; Narueponjirakul, Ubolrat; Sanasuttipun, Wiwan; Shinde, Vivek; Kaewchana, Suchada; Areechokechai, Darin; Levy, Jens; Ungchusak, Kumnuan			Severe Human Influenza Infections in Thailand: Oseltamivir Treatment and Risk Factors for Fatal Outcome	PLOS ONE			English	Article								Background: Influenza is often not recognized as an important cause of severe or fatal disease in tropical and subtropical countries in Southeast Asia. The extent to which Oseltamivir treatment may protect against a fatal outcome in severe influenza infections is not known. Thailand's National Avian Influenza Surveillance (NAIS) system affords a unique opportunity to describe the epidemiology of laboratory-confirmed severe and fatal human influenza infections. Methodology/Principal Findings: During January 2004 through December 2006, 11,641 notifications to the NAIS were investigated in 73 of 76 Thai provinces. Clinical and demographic data and respiratory swab specimens were collected and tested by PCR for influenza. Using the NAIS database, we identified all patients with laboratory confirmed human influenza (A/H3N2, A/H1N1 and Type B) infection. A retrospective medical record review was conducted on all fatal cases with laboratory confirmed influenza and from a sample of hospitalized cases in 28 provinces. The association of underlying risk factors, Oseltamivir treatment and risk of a fatal outcome were examined. Human influenza infections were identified in 2,075 (18%) cases. Twenty-two (1%) deaths occurred including seven deaths in children less than ten years of age. Thirty-five percent of hospitalized human influenza infections had chest X-ray confirmed pneumonia. Current or former smoking; advanced age, hypertension and underlying cardiovascular, pulmonary or endocrine disease were associated with a fatal outcome from human influenza infection. Treatment with Oseltamivir was statistically associated with survival with a crude OR of .11 (95% CI: 0.04-0.30) and .13 (95% CI: 0.04-0.40) after controlling for age. Conclusions: Severe and fatal human influenza infections were commonly identified in the NAIS designed to identify avian A/H5N1 cases. Treatment with Oseltamivir is associated with survival in hospitalized human influenza pneumonia patients.			Hanshaoworakul, W (corresponding author), Thailand Minist Publ Hlth, Bur Epidemiol, Nonthaburi, Thailand.	msimmerman@cdc.gov						Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Chunsuttiwat S, 2008, RESPIROLOGY, V13, pS36, DOI 10.1111/j.1440-1843.2008.01256.x; Enger C, 2004, PHARMACOEPIDEM DR S, V13, P227, DOI 10.1002/pds.845; EPIDEMIOLOGY B, 2007, ANN EPIDEMIOLOGY SUR, P477; FIORE AE, 2008, MORBIDITY MORTALITY, V57; Hayden FG, 2006, J INFECT DIS, V194, pS119, DOI 10.1086/507552; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Katz MA, 2007, VACCINE, V25, P3827, DOI 10.1016/j.vaccine.2007.01.109; Kitphati R, 2008, CLIN INFECT DIS, V46, P1394, DOI 10.1086/586752; Lee N, 2007, ANTIVIR THER, V12, P501; Li CK, 2006, PUBLIC HEALTH, V120, P517, DOI 10.1016/j.puhe.2006.03.004; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nicholson KG, 2006, VACCINE, V24, P102, DOI 10.1016/j.vaccine.2005.02.004; Nordstrom BL, 2005, CURR MED RES OPIN, V21, P761, DOI 10.1185/030079905X46214; Olsen SJ, 2006, INT J INFECT DIS, V10, P439, DOI 10.1016/j.ijid.2006.06.004; Prapasiri Prabda, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P706; Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x; Simmerman JM, 2006, VACCINE, V24, P4417, DOI 10.1016/j.vaccine.2005.12.060; SIMMERMAN JM, 2005, J CLIN MICROBIOLOGY; Suntarattiwong P, 2007, INFLUENZA OTHER RESP, V1, P177, DOI 10.1111/j.1750-2659.2007.00023.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; 2003, VACCINE, V23, P5133	25	123	133	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6051	10.1371/journal.pone.0006051	http://dx.doi.org/10.1371/journal.pone.0006051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557130	Green Submitted, gold, Green Published			2022-12-27	WOS:000267356900012
J	Labrousse, VF; Costes, L; Aubert, A; Darnaudery, M; Ferreira, G; Amedee, T; Laye, S				Labrousse, Virginie F.; Costes, Laurence; Aubert, Agnes; Darnaudery, Muriel; Ferreira, Guillaume; Amedee, Thierry; Laye, Sophie			Impaired Interleukin-1 beta and c-Fos Expression in the Hippocampus Is Associated with a Spatial Memory Deficit in P2X(7) Receptor-Deficient Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RECOGNITION MEMORY; OBJECT RECOGNITION; MICROGLIAL CELLS; GENE-EXPRESSION; IN-VITRO; SYNAPTIC-TRANSMISSION; COGNITIVE PERFORMANCE; CYTOKINE PRODUCTION; IL-1-BETA RELEASE	Recent evidence suggests that interleukin-1 beta (IL-1 beta), which was originally identified as a proinflammatory cytokine, is also required in the brain for memory processes. We have previously shown that IL-1 beta synthesis in the hippocampus is dependent on P2X(7) receptor (P2X(7)R), which is an ionotropic receptor of ATP. To substantiate the role of P2X(7)R in both brain IL-1 beta expression and memory processes, we examined the induction of IL-1 beta mRNA expression in the hippocampus of wildtype (WT) and homozygous P2X(7) receptor knockout mice (P2X(7)R(-/-)) following a spatial memory task. The spatial recognition task induced both IL-1 beta mRNA expression and c-Fos protein activation in the hippocampus of WT but not of P2X(7)R(-/-) mice. Remarkably, P2X(7)R(-/-) mice displayed spatial memory impairment in a hippocampal-dependant task, while their performances in an object recognition task were unaltered. Taken together, our results show that P2X(7)R plays a critical role in spatial memory processes and the associated hippocampal IL-1 beta mRNA synthesis and c-Fos activation.	[Labrousse, Virginie F.; Costes, Laurence; Aubert, Agnes; Darnaudery, Muriel; Ferreira, Guillaume; Amedee, Thierry; Laye, Sophie] Univ Bordeaux, CNRS, UMR 1286, INRA,UMR 5226, Bordeaux, France; [Darnaudery, Muriel] Univ Lille Nord France, NEUROSTRESS EA 4347, Villeneuve Dascq, France; [Ferreira, Guillaume] Univ Tours, CNRS, UMR 6175, INRA,UMR 85,Lab Comportement Neurobiol & Adaptat, Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite de Bordeaux; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE	Labrousse, VF (corresponding author), Univ Bordeaux, CNRS, UMR 1286, INRA,UMR 5226, Bordeaux, France.	sophie.laye@bordeaux.inra.fr	Laye, Sophie/AAX-2501-2020	Laye, Sophie/0000-0002-3843-1012; DARNAUDERY, Muriel/0000-0003-0209-3880; Ferreira, Guillaume/0000-0001-5984-8143				Armstrong JN, 2002, J NEUROSCI, V22, P5938; Avital A, 2003, HIPPOCAMPUS, V13, P826, DOI 10.1002/hipo.10135; Balschun D, 2003, ANN NY ACAD SCI, V992, P1, DOI 10.1111/j.1749-6632.2003.tb03132.x; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Boucsein C, 2003, EUR J NEUROSCI, V17, P2267, DOI 10.1046/j.1460-9568.2003.02663.x; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Brough D, 2002, MOL CELL NEUROSCI, V19, P272, DOI 10.1006/mcne.2001.1054; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Chen LF, 2006, CRIT REV IMMUNOL, V26, P499, DOI 10.1615/CritRevImmunol.v26.i6.30; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Colomar Aurore, 2003, Journal de la Societe de Biologie, V197, P113; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Contarino A, 1999, BRAIN RES, V835, P1, DOI 10.1016/S0006-8993(98)01158-5; Coogan AN, 1999, EUR J PHARMACOL, V374, P197, DOI 10.1016/S0014-2999(99)00320-9; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dellu F, 2000, NEUROBIOL LEARN MEM, V73, P31, DOI 10.1006/nlme.1999.3919; Depino AM, 2004, HIPPOCAMPUS, V14, P526, DOI 10.1002/hipo.10164; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Di Virgilio F, 2007, PURINERG SIGNAL, V3, P1, DOI 10.1007/s11302-006-9048-5; Di Virgilio Francesco, 2001, Trends in Pharmacological Sciences, V22, P5; Dillon GM, 2008, NEUROBIOL LEARN MEM, V90, P426, DOI 10.1016/j.nlm.2008.05.008; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Farivar R, 2004, FRONT BIOSCI-LANDMRK, V9, P104, DOI 10.2741/1198; Ferrari D, 1996, J IMMUNOL, V156, P1531; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Ireland MF, 2004, NEUROSCIENCE, V128, P269, DOI 10.1016/j.neuroscience.2004.06.014; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; MAYO W, 1993, BRAIN RES, V607, P324, DOI 10.1016/0006-8993(93)91524-V; Mingam R, 2008, BRAIN BEHAV IMMUN, V22, P234, DOI 10.1016/j.bbi.2007.08.007; Nadjar A, 2005, NEUROPSYCHOPHARMACOL, V30, P1492, DOI 10.1038/sj.npp.1300755; NIU L, 2008, HIPPOCAMPUS; Norenberg W, 2000, N-S ARCH PHARMACOL, V362, P324, DOI 10.1007/s002100000311; North RA, 2006, PFLUG ARCH EUR J PHY, V452, P479, DOI 10.1007/s00424-006-0060-y; Palin K, 2004, BRAIN BEHAV IMMUN, V18, P223, DOI 10.1016/j.bbi.2003.09.002; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Romagnoli R, 2008, EXPERT OPIN THER TAR, V12, P647, DOI 10.1517/14728222.12.5.647 ; ROTHWELL NJ, 1991, TRENDS PHARMACOL SCI, V12, P430, DOI 10.1016/0165-6147(91)90623-Z; Sanderson DJ, 2007, BEHAV NEUROSCI, V121, P559, DOI 10.1037/0735-7044.121.3.559; Sanz JM, 2000, J IMMUNOL, V164, P4893, DOI 10.4049/jimmunol.164.9.4893; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Sperlagh B, 1998, NEUROSCIENCE, V82, P511; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; Werry EL, 2006, J NEUROCHEM, V99, P924, DOI 10.1111/j.1471-4159.2006.04133.x; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Yirmiya R, 2002, NEUROBIOL LEARN MEM, V78, P379, DOI 10.1006/nlme.2002.4072; Yu Y, 2008, BRAIN RES, V1194, P45, DOI 10.1016/j.brainres.2007.11.064	60	79	82	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6006	10.1371/journal.pone.0006006	http://dx.doi.org/10.1371/journal.pone.0006006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462JI	19547756	Green Published, gold, Green Submitted			2022-12-27	WOS:000267347900005
J	Radstake, TRDJ; van Bon, L; Broen, J; Wenink, M; Santegoets, K; Deng, Y; Hussaini, A; Simms, R; Cruikshank, WW; Lafyatis, R				Radstake, Timothy R. D. J.; van Bon, Lenny; Broen, Jasper; Wenink, Mark; Santegoets, Kim; Deng, Yanhui; Hussaini, Anila; Simms, Robert; Cruikshank, William W.; Lafyatis, Robert			Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGF beta Expression	PLOS ONE			English	Article								Background: Regulatory T cells (Tregs) are essential in the control of tolerance. Evidence implicates Tregs in human autoimmune conditions. Here we investigated their role in systemic sclerosis (SSc). Methods/Principal Findings: Patients were subdivided as having limited cutaneous SSc (lcSSc, n = 20) or diffuse cutaneous SSc (dcSSc, n = 48). Further subdivision was made between early dcSSc (n = 24) and late dcSSc (n = 24) based upon the duration of disease. 26 controls were studied for comparison. CD3(+) cells were isolated using FACS and subsequently studied for the expression of CD4, CD8, CD25, FoxP3, CD127, CD62L, GITR, CD69 using flow cytometry. T cell suppression assays were performed using sorted CD4CD25(high)CD127(-) and CD4CD25(low)CD127(high) and CD3(+) cells. Suppressive function was correlated with CD69 surface expression and TGF beta secretion/expression. The frequency of CD4(+)CD25(+) and CD25(high)FoxP3(high)CD127(neg) T cells was highly increased in all SSc subgroups. Although the expression of CD25 and GITR was comparable between groups, expression of CD62L and CD69 was dramatically lower in SSc patients, which correlated with a diminished suppressive function. Co-incubation of Tregs from healthy donors with plasma from SSc patients fully abrogated suppressive activity. Activation of Tregs from healthy donors or SSc patients with PHA significantly up regulated CD69 expression that could be inhibited by SSc plasma. Conclusions/Significance: These results indicate that soluble factors in SSc plasma inhibit Treg function specifically that is associated with altered Treg CD69 and TGF beta expression. These data suggest that a defective Treg function may underlie the immune dysfunction in systemic sclerosis.			Radstake, TRDJ (corresponding author), Radboud Univ Nijmegen, Dept Rheumatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	T.Radstake@reuma.umcn.nl	Santegoets, Kim/S-4267-2017	Simms, Robert/0000-0002-0101-1807; Lafyatis, Robert/0000-0002-9398-5034	NIAMS NIH HHS [U01 AR055063, U01AR055063] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR055063] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; AFELTRA A, 1993, ANN RHEUM DIS, V52, P457, DOI 10.1136/ard.52.6.457; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bach JF, 2003, NAT REV IMMUNOL, V3, P189, DOI 10.1038/nri1026; Bagavant H, 2005, J IMMUNOL, V175, P944, DOI 10.4049/jimmunol.175.2.944; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Boin F, 2005, ANN NY ACAD SCI, V1062, P137, DOI 10.1196/annals.1358.016; Bonelli M, 2008, ANN RHEUM DIS, V67, P664, DOI 10.1136/ard.2007.074690; Chatenoud L, 2001, IMMUNOL REV, V182, P149, DOI 10.1034/j.1600-065X.2001.1820112.x; de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771; Del Galdo F, 2007, ARTHRITIS RHEUM-US, V56, P3478, DOI 10.1002/art.22877; Duan H, 2008, ARTHRITIS RHEUM-US, V58, P1465, DOI 10.1002/art.23451; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Esplugues E, 2003, J EXP MED, V197, P1093, DOI 10.1084/jem.20021337; FERNANDEZGUTIERREZ B, 1995, J RHEUMATOL, V22, P413; Fujii H, 2002, CLIN EXP IMMUNOL, V130, P548, DOI 10.1046/j.1365-2249.2002.02017.x; Fukaura H, 1996, J CLIN INVEST, V98, P70, DOI 10.1172/JCI118779; GUSTAFSSON R, 1990, ANN RHEUM DIS, V49, P40, DOI 10.1136/ard.49.1.40; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Hussein MR, 2005, J CLIN PATHOL, V58, P178, DOI 10.1136/jcp.2004.019224; Ishikawa S, 1998, J IMMUNOL, V161, P1267; Jaeckel E, 2008, HORM METAB RES, V40, P126, DOI 10.1055/s-2008-1042427; Kalogerou A, 2005, ANN RHEUM DIS, V64, P1233, DOI 10.1136/ard.2004.027094; KOMURA K, 2007, J RHEUMATOL; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; Lee HY, 2008, RHEUMATOLOGY, V47, P789, DOI 10.1093/rheumatology/ken108; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; MURATA M, 2008, J DERMATOL SCI; Nadkarni S, 2004, PHYS BIOL, V1, P35, DOI 10.1088/1478-3967/1/1/004; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Parel Y, 2007, ARTHRITIS RHEUM-US, V56, P3459, DOI 10.1002/art.22927; PortalesPerez D, 1997, LUPUS, V6, P48, DOI 10.1177/096120339700600107; Preliminary criteria for the classification of systemic sclerosis (scleroderma), ARTHRITIS RHEUM, V23, P581; Riccieri V, 2005, J RHEUMATOL, V32, P283; Sakaguchi S, 2001, MICROBES INFECT, V3, P911, DOI 10.1016/S1286-4579(01)01452-6; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Scalapino KJ, 2006, J IMMUNOL, V177, P1451, DOI 10.4049/jimmunol.177.3.1451; Scherer HU, 2006, ANN RHEUM DIS, V65, P1245, DOI 10.1136/ard.2005.046938; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shevach EM, 2008, IMMUNOLOGY, V123, P3, DOI 10.1111/j.1365-2567.2007.02777.x; Shevach EM, 2006, NAT REV IMMUNOL, V6, P613, DOI 10.1038/nri1867; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; van Amelsfort JMR, 2007, ARTHRITIS RHEUM, V56, P732, DOI 10.1002/art.22414; Venigalla RKC, 2008, ARTHRITIS RHEUM-US, V58, P2120, DOI 10.1002/art.23556; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Wu AJ, 2002, P NATL ACAD SCI USA, V99, P12287, DOI 10.1073/pnas.172382999; Yan B, 2008, ARTHRITIS RHEUM-US, V58, P801, DOI 10.1002/art.23268; Zheng SG, 2004, J IMMUNOL, V172, P1531, DOI 10.4049/jimmunol.172.3.1531; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	63	122	129	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5981	10.1371/journal.pone.0005981	http://dx.doi.org/10.1371/journal.pone.0005981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543397	gold, Green Published			2022-12-27	WOS:000267237600006
J	Zauberman, A; Tidhar, A; Levy, Y; Bar-Haim, E; Halperin, G; Flashner, Y; Cohen, S; Shafferman, A; Mamroud, E				Zauberman, Ayelet; Tidhar, Avital; Levy, Yinon; Bar-Haim, Erez; Halperin, Gideon; Flashner, Yehuda; Cohen, Sara; Shafferman, Avigdor; Mamroud, Emanuelle			Yersinia pestis Endowed with Increased Cytotoxicity Is Avirulent in a Bubonic Plague Model and Induces Rapid Protection against Pneumonic Plague	PLOS ONE			English	Article								An important virulence strategy evolved by bacterial pathogens to overcome host defenses is the modulation of host cell death. Previous observations have indicated that Yersinia pestis, the causative agent of plague disease, exhibits restricted capacity to induce cell death in macrophages due to ineffective translocation of the type III secretion effector YopJ, as opposed to the readily translocated YopP, the YopJ homologue of the enteropathogen Yersinia enterocolitica O:8. This led us to suggest that reduced cytotoxic potency may allow pathogen propagation within a shielded niche, leading to increased virulence. To test the relationship between cytotoxic potential and virulence, we replaced Y. pestis YopJ with YopP. The YopP-expressing Y. pestis strain exhibited high cytotoxic activity against macrophages in vitro. Following subcutaneous infection, this strain had reduced ability to colonize internal organs, was unable to induce septicemia and exhibited at least a 10(7)-fold reduction in virulence. Yet, upon intravenous or intranasal infection, it was still as virulent as the wild-type strain. The subcutaneous administration of the cytotoxic Y. pestis strain appears to activate a rapid and potent systemic, CTL-independent, immunoprotective response, allowing the organism to overcome simultaneous coinfection with 10,000 LD50 of virulent Y. pestis. Moreover, three days after subcutaneous administration of this strain, animals were also protected against septicemic or primary pneumonic plague. Our findings indicate that an inverse relationship exists between the cytotoxic potential of Y. pestis and its virulence following subcutaneous infection. This appears to be associated with the ability of the engineered cytotoxic Y. pestis strain to induce very rapid, effective and long-lasting protection against bubonic and pneumonic plague. These observations have novel implications for the development of vaccines/therapies against Y. pestis and shed new light on the virulence strategies of Y. pestis in nature.			Zauberman, A (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.	emmym@iibr.gov.il	Bar-Haim, Erez/AAA-6444-2020	Bar-Haim, Erez/0000-0003-3435-8599				Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; BENGURION R, 1981, PLASMID, V5, P183, DOI 10.1016/0147-619X(81)90019-6; Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998; Brodsky IE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000067; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; CAVANAUGH DC, 1959, J IMMUNOL, V83, P348; CHARNETZKY WT, 1985, INFECT IMMUN, V47, P234, DOI 10.1128/IAI.47.1.234-241.1985; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200; Derre I, 2004, INFECT IMMUN, V72, P6221, DOI 10.1128/IAI.72.11.6221-6229.2004; Erfurth SE, 2004, INFECT IMMUN, V72, P7045, DOI 10.1128/IAI.72.12.7045-7054.2004; FINEGOLD MJ, 1969, AM J PATHOL, V54, P167; Flashner Y, 2004, INFECT IMMUN, V72, P908, DOI 10.1128/IAI.72.2.908-915.2004; GALYOV EE, 1994, J BACTERIOL, V176, P4543, DOI 10.1128/JB.176.15.4543-4548.1994; Grosfeld H, 2003, INFECT IMMUN, V71, P374, DOI 10.1128/IAI.71.1.374-383.2003; HOLZMAN T, 2006, MICROB CELL FACT, V5, P98; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; JANSSEN WA, 1969, SCIENCE, V163, P950, DOI 10.1126/science.163.3870.950; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lemaitre N, 2006, INFECT IMMUN, V74, P5126, DOI 10.1128/IAI.00219-06; Lilo S, 2008, INFECT IMMUN, V76, P3911, DOI 10.1128/IAI.01695-07; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Monack DM, 1998, J EXP MED, V188, P2127, DOI 10.1084/jem.188.11.2127; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; REED LJ, 1938, AM J HYG, V27; Ruckdeschel K, 1997, INFECT IMMUN, V65, P4813, DOI 10.1128/IAI.65.11.4813-4821.1997; Ruckdeschel K, 1998, J EXP MED, V187, P1069, DOI 10.1084/jem.187.7.1069; Ruckdeschel K, 1997, J BIOL CHEM, V272, P15920, DOI 10.1074/jbc.272.25.15920; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; STRALEY SC, 1984, INFECT IMMUN, V45, P649, DOI 10.1128/IAI.45.3.649-654.1984; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Velan B, 2006, INFECT IMMUN, V74, P6365, DOI 10.1128/IAI.00974-06; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Weeks S, 2002, MICROB PATHOGENESIS, V32, P227, DOI 10.1006/mpat.2002.0498; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Winau F, 2004, CELL MICROBIOL, V6, P599, DOI 10.1111/j.1462-5822.2004.00408.x; Yrlid U, 2000, J EXP MED, V191, P613, DOI 10.1084/jem.191.4.613; Zauberman A, 2006, INFECT IMMUN, V74, P3239, DOI 10.1128/IAI.00097-06; Zauberman A, 2007, ADV EXP MED BIOL, V603, P312; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194	56	37	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5938	10.1371/journal.pone.0005938	http://dx.doi.org/10.1371/journal.pone.0005938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529770	gold, Green Submitted, Green Published			2022-12-27	WOS:000267029500016
J	Swistowski, A; Peng, J; Han, Y; Swistowska, AM; Rao, MS; Zeng, XM				Swistowski, Andrzej; Peng, Jun; Han, Yi; Swistowska, Anna Maria; Rao, Mahendra S.; Zeng, Xianmin			Xeno-Free Defined Conditions for Culture of Human Embryonic Stem Cells, Neural Stem Cells and Dopaminergic Neurons Derived from Them	PLOS ONE			English	Article							PARKINSONS-DISEASE; UNDIFFERENTIATED GROWTH; SUBSTANTIA-NIGRA; SELF-RENEWAL; TRANSPLANTATION; SURVIVAL; LINES; RATS; DIFFERENTIATION; GRAFTS	Background: Human embryonic stem cells (hESCs) may provide an invaluable resource for regenerative medicine. To move hESCs towards the clinic it is important that cells with therapeutic potential be reproducibly generated under completely defined conditions. Methodology/Principal Findings: Here we report a four-step scalable process that is readily transferable to a Good Manufacture Practice (GMP) facility for the production of functional dopaminergic neurons from hESCs for potential clinical uses. We show that each of the steps (propagation of ESC -> generation of neural stem cells (NSC)-> induction of dopaminergic precursors -> maturation of dopaminergic neurons) could utilize xeno-free defined media and substrate, and that cells could be stored at intermediate stages in the process without losing their functional ability. Neurons generated by this process expressed midbrain and A9 dopaminergic markers and could be transplanted at an appropriate time point in development to survive after transplant. Conclusions/Significance: hESCs and NSCs can be maintained in xeno-free defined media for a prolonged period of time while retaining their ability to differentiate into authentic dopaminergic neurons. Our defined medium system provides a path to a scalable GMP-applicable process of generation of dopaminergic neurons from hESCs for therapeutic applications, and a ready source of large numbers of neurons for potential screening applications.			Swistowski, A (corresponding author), Buck Inst Age Res, Novato, CA USA.	xzeng@buckinstitute.org						Ahrlund-Richter L, 2009, CELL STEM CELL, V4, P20, DOI 10.1016/j.stem.2008.11.012; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; BJORKLUND A, 1980, BRAIN RES, V199, P307, DOI 10.1016/0006-8993(80)90692-7; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Chiba S, 2008, STEM CELLS, V26, P2810, DOI 10.1634/stemcells.2008-0085; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; FREED CR, 1990, ARCH NEUROL-CHICAGO, V47, P505, DOI 10.1001/archneur.1990.00530050021007; FREED WJ, 1980, ANN NEUROL, V8, P510, DOI 10.1002/ana.410080508; ILIC D, 2009, STEM CELLS DEV; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; Liu YX, 2006, BIOCHEM BIOPH RES CO, V346, P131, DOI 10.1016/j.bbrc.2006.05.086; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Peng J, 2002, J BIOL CHEM, V277, P44285, DOI 10.1074/jbc.M207407200; Peng J, 2007, J NEUROSCI, V27, P6914, DOI 10.1523/JNEUROSCI.1569-07.2007; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; ROY NS, 2006, NAT MED; Schulz TC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-478; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; SWISTOWSKA AM, 2009, STEM CELLS IN PRESS; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Zeng XM, 2003, STEM CELLS, V21, P647, DOI 10.1634/stemcells.21-6-647	30	108	119	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6233	10.1371/journal.pone.0006233	http://dx.doi.org/10.1371/journal.pone.0006233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597550	Green Submitted, gold, Green Published			2022-12-27	WOS:000268035600007
J	Poffenberger, MC; Straka, N; El Warry, N; Fang, D; Shanina, I; Horwitz, MS				Poffenberger, Maya C.; Straka, Nadine; El Warry, Nahida; Fang, Dianne; Shanina, Iryna; Horwitz, Marc S.			Lack of IL-6 during Coxsackievirus Infection Heightens the Early Immune Response Resulting in Increased Severity of Chronic Autoimmune Myocarditis	PLOS ONE			English	Article								Background: Chronic myocarditis is often initiated by viral infection, the most common of which is coxsackievirus infection. The precise mechanism by which viral infection leads to chronic autoimmune pathology is poorly understood, however it is clear that the early immune response plays a critical role. Previous results have shown that the inflammatory cytokine interleukin (IL)-6 is integral to the development of experimental-induced autoimmune myocarditis. However, the function of IL-6 during viral-mediated autoimmunity has yet to be elucidated. Methods and Results: To address the requirement of IL-6 during disease induction, IL-6 deficient mice were infected with coxsackievirus B3 (CB3). Following infection, mice lacking IL-6 developed increased chronic autoimmune disease pathology compared to wild type controls without a corresponding change in the level of viral replication in the heart. This increase in disease severity was accompanied by elevated levels of TNF-alpha, MCP-1, IL-10, activated T cells and cardiac infiltrating macrophage/monocytes. Injection of recombinant IL-6 early following infection in the IL-6 deficient mice was sufficient to lower the serum cytokines TNF-alpha and IL-10 as well as the serum chemokines MCP-1, MIP-1 beta, RANTES and MIG with a corresponding decrease in the chronic disease pathology strongly suggests an important regulatory role for IL-6 during the early response. Conclusions: While IL-6 plays a pathogenic role in experimental-induced autoimmune disease, its function following viral-induced autoimmunity is not reprised. By regulating the early immune response and thereby controlling the severity of chronic disease, IL-6 directs the outcome of chronic autoimmune myocarditis.			Poffenberger, MC (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	mhorwitz@interchange.ubc.ca						Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Bettelli E, 2003, J AUTOIMMUN, V20, P265, DOI 10.1016/S0896-8411(03)00048-9; Betti M, 2006, ANN ONCOL, V17, P235; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; BROWN CA, 1995, AM J MED, V99, P309, DOI 10.1016/S0002-9343(99)80164-8; Calabrese F, 2004, MODERN PATHOL, V17, P1108, DOI 10.1038/modpathol.3800158; Deng CS, 2002, J IMMUNOL, V169, P1077, DOI 10.4049/jimmunol.169.2.1077; Eriksson U, 2003, CIRCULATION, V107, P320, DOI 10.1161/01.CIR.0000043802.38699.66; Girndt M, 2003, NEPHROL DIAL TRANSPL, V18, P1976, DOI 10.1093/ndt/gfg311; Gluck B, 2001, J MOL CELL CARDIOL, V33, P1615, DOI 10.1006/jmcc.2001.1416; Goser S, 2005, CIRCULATION, V112, P3400, DOI 10.1161/CIRCULATIONAHA.105.572396; Hofmann P, 2001, J MED VIROL, V64, P487, DOI 10.1002/jmv.1076; Horwitz MS, 2000, NAT MED, V6, P693, DOI 10.1038/76277; Kanda T, 2004, JPN HEART J, V45, P183, DOI 10.1536/jhj.45.183; Kanda T, 1996, CIRC RES, V78, P848, DOI 10.1161/01.RES.78.5.848; Kolattukudy PE, 1998, AM J PATHOL, V152, P101; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kopf M, 1995, ANN NY ACAD SCI, V762, P308; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kubota T, 1997, J Card Fail, V3, P117, DOI 10.1016/S1071-9164(97)90045-2; LANE JR, 1992, J EXP MED, V175, P1123, DOI 10.1084/jem.175.4.1123; LANE JR, 1991, CELL IMMUNOL, V136, P219, DOI 10.1016/0008-8749(91)90396-S; Nishii M, 2004, J AM COLL CARDIOL, V44, P1292, DOI 10.1016/j.jacc.2004.01.055; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Richards HB, 1998, J EXP MED, V188, P985, DOI 10.1084/jem.188.5.985; Richer MJ, 2007, FUTURE VIROL, V2, P283, DOI 10.2217/17460794.2.3.283; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; ROLLINS BJ, 1990, AM J PATHOL, V136, P1229; Samoilova EB, 1998, J IMMUNOL, V161, P6480; SCHMITT M, 2000, PATIENT CARE NURSE P, V3, P61; Shen Y, 2004, J VIROL, V78, P12548, DOI 10.1128/JVI.78.22.12548-12556.2004; Tanaka T, 2001, J MOL CELL CARDIOL, V33, P1627, DOI 10.1006/jmcc.2001.1428; Watanabe K, 2001, CIRCULATION, V104, P1098, DOI 10.1161/hc3501.096190; Yajima T, 2006, CIRCULATION, V114, P2364, DOI 10.1161/CIRCULATIONAHA.106.642454; Zhao HF, 2005, GUT, V54, P1759, DOI 10.1136/gut.2004.049403	36	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6207	10.1371/journal.pone.0006207	http://dx.doi.org/10.1371/journal.pone.0006207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587788	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035100018
J	Semmens, BX; Ward, EJ; Moore, JW; Darimont, CT				Semmens, Brice X.; Ward, Eric J.; Moore, Jonathan W.; Darimont, Chris T.			Quantifying Inter- and Intra-Population Niche Variability Using Hierarchical Bayesian Stable Isotope Mixing Models	PLOS ONE			English	Article							WIDTH; DELTA-C-13; ECOLOGY; UNCERTAINTY; DIMORPHISM; DIVERSITY; EVOLUTION; MARINE; RATIOS; PREY	Variability in resource use defines the width of a trophic niche occupied by a population. Intra-population variability in resource use may occur across hierarchical levels of population structure from individuals to subpopulations. Understanding how levels of population organization contribute to population niche width is critical to ecology and evolution. Here we describe a hierarchical stable isotope mixing model that can simultaneously estimate both the prey composition of a consumer diet and the diet variability among individuals and across levels of population organization. By explicitly estimating variance components for multiple scales, the model can deconstruct the niche width of a consumer population into relevant levels of population structure. We apply this new approach to stable isotope data from a population of gray wolves from coastal British Columbia, and show support for extensive intra-population niche variability among individuals, social groups, and geographically isolated subpopulations. The analytic method we describe improves mixing models by accounting for diet variability, and improves isotope niche width analysis by quantitatively assessing the contribution of levels of organization to the niche width of a population.			Semmens, BX (corresponding author), Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA USA.	Brice.Semmens@noaa.gov	Bond, Alexander L/A-3786-2010					Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Araujo MS, 2007, OECOLOGIA, V152, P643, DOI 10.1007/s00442-007-0687-1; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; BEST N, 1995, CODA MANUAL VERSION; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Bolnick DI, 2001, NATURE, V410, P463, DOI 10.1038/35068555; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Darimont CT, 2007, BIOL J LINN SOC, V90, P125, DOI 10.1111/j.1095-8312.2007.00716.x; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; Darimont CT, 2004, J BIOGEOGR, V31, P1867, DOI 10.1111/j.1365-2699.2004.01141.x; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Egozcue JJ, 2006, GEOL SOC SPEC PUBL, V264, P145, DOI 10.1144/GSL.SP.2006.264.01.11; Elton C., 1927, ANIMAL ECOLOGY; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; FRY B, 1978, ECOLOGY, V59, P498, DOI 10.2307/1936580; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Giraldeau L.A., 2000, MG BEH ECOL; GOSSCUSTARD JD, 1984, J ANIM ECOL, V53, P233, DOI 10.2307/4354; HUTCHINSON GE, 1957, S QUANTITATIVE BIOL, P415; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; JAENIKE J, 1991, AM NAT, V137, pS67, DOI 10.1086/285140; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; Lubetkin SC, 2004, J APPL ECOL, V41, P996, DOI 10.1111/j.0021-8901.2004.00957.x; Matthews B, 2004, OECOLOGIA, V140, P361, DOI 10.1007/s00442-004-1579-2; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; O'Reilly CM, 2002, LIMNOL OCEANOGR, V47, P306, DOI 10.4319/lo.2002.47.1.0306; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Plummer M., 2003, P 3 INT WORKSH DISTR; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; PRICE T, 1987, ECOLOGY, V68, P1015, DOI 10.2307/1938373; Radford AN, 2003, J ANIM ECOL, V72, P258, DOI 10.1046/j.1365-2656.2003.00697.x; Reimchen TE, 2008, BEHAVIOUR, V145, P561, DOI 10.1163/156853908792451449; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Roughgarden J., 1979, THEORY POPULATION GE; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x	49	162	162	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6187	10.1371/journal.pone.0006187	http://dx.doi.org/10.1371/journal.pone.0006187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587790	Green Published, gold			2022-12-27	WOS:000268035100011
J	Waite, AL; Schaner, P; Richards, N; Balci-Peynircioglu, B; Masters, SL; Brydges, SD; Fox, M; Hong, A; Yilmaz, E; Kastner, DL; Reinherz, EL; Gumucio, DL				Waite, Andrea L.; Schaner, Philip; Richards, Neil; Balci-Peynircioglu, Banu; Masters, Seth L.; Brydges, Susannah D.; Fox, Michelle; Hong, Arthur; Yilmaz, Engin; Kastner, Daniel L.; Reinherz, Ellis L.; Gumucio, Deborah L.			Pyrin Modulates the Intracellular Distribution of PSTPIP1	PLOS ONE			English	Article								PSTPIP1 is a cytoskeleton-associated adaptor protein that links PEST-type phosphatases to their substrates. Mutations in PSTPIP1 cause PAPA syndrome (Pyogenic sterile Arthritis, Pyoderma gangrenosum, and Acne), an autoinflammatory disease. PSTPIP1 binds to pyrin and mutations in pyrin result in familial Mediterranean fever (FMF), a related autoinflammatory disorder. Since disease-associated mutations in PSTPIP1 enhance pyrin binding, PAPA syndrome and FMF are thought to share a common pathoetiology. The studies outlined here describe several new aspects of PSTPIP1 and pyrin biology. We document that PSTPIP1, which has homology to membrane-deforming BAR proteins, forms homodimers and generates membrane-associated filaments in native and transfected cells. An extended FCH (Fes-Cip4 homology) domain in PSTPIP1 is necessary and sufficient for its self-aggregation. We further show that the PSTPIP1 filament network is dependent upon an intact tubulin cytoskeleton and that the distribution of this network can be modulated by pyrin, indicating that this is a dynamic structure. Finally, we demonstrate that pyrin can recruit PSTPIP1 into aggregations (specks) of ASC, another pyrin binding protein. ASC specks are associated with inflammasome activity. PSTPIP1 molecules with PAPA-associated mutations are recruited by pyrin to ASC specks with particularly high efficiency, suggesting a unique mechanism underlying the robust inflammatory phenotype of PAPA syndrome.			Waite, AL (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	dgumucio@umich.edu	YILMAZ, ENGIN/I-8278-2013; Masters, Seth L/N-2886-2013; PEYNIRCIOGLU, BANU/I-8337-2013; YILMAZ, Engin/W-4160-2018	Masters, Seth L/0000-0003-4763-576X; YILMAZ, Engin/0000-0001-8873-7645; Hong, Arthur/0000-0001-6516-6819	NHLBI NIH HHS [T32-HL07505] Funding Source: Medline; NIAID NIH HHS [R01- AI053262, R01 AI053262] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041083] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BALCIPEYNIRCIOG.B, 2008, J CELL PHYSL; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Cooper KM, 2008, MOL BIOL CELL, V19, P3180, DOI 10.1091/mbc.E08-02-0225; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Diaz A, 2004, ARTHRITIS RHEUM-US, V50, P3679, DOI 10.1002/art.20600; Ferguson PJ, 2006, BONE, V38, P41, DOI 10.1016/j.bone.2005.07.009; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Galon J, 2000, CURR OPIN IMMUNOL, V12, P479, DOI 10.1016/S0952-7915(00)00124-2; Golla A, 2002, EUR J HUM GENET, V10, P217, DOI 10.1038/sj.ejhg.5200789; Grosse J, 2006, BLOOD, V107, P3350, DOI 10.1182/blood-2005-09-3556; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Li J, 1998, EMBO J, V17, P7320, DOI 10.1093/emboj/17.24.7320; Meunier B, 2009, EUR J CELL BIOL, V88, P91, DOI 10.1016/j.ejcb.2008.08.006; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Ryan JG, 2008, CURR TOP MICROBIOL, V321, P169; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Spencer S, 1997, J CELL BIOL, V138, P845, DOI 10.1083/jcb.138.4.845; Tian L, 2000, J BIOL CHEM, V275, P7854, DOI 10.1074/jbc.275.11.7854; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961; Wu Y, 1998, J BIOL CHEM, V273, P30487, DOI 10.1074/jbc.273.46.30487; Wu Y, 1998, J BIOL CHEM, V273, P5765, DOI 10.1074/jbc.273.10.5765; Yeung YG, 1998, J BIOL CHEM, V273, P30638, DOI 10.1074/jbc.273.46.30638; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; NAT GENET, V17, P25; CELL, V90, P797	37	35	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6147	10.1371/journal.pone.0006147	http://dx.doi.org/10.1371/journal.pone.0006147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19584923	Green Published, gold			2022-12-27	WOS:000267806400004
J	Kock, I; Bulgakova, NA; Knust, E; Sinning, I; Panneels, V				Kock, Ines; Bulgakova, Natalia A.; Knust, Elisabeth; Sinning, Irmgard; Panneels, Valerie			Targeting of Drosophila Rhodopsin Requires Helix 8 but Not the Distal C-Terminus	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; POST-GOLGI TRAFFICKING; CRYSTAL-STRUCTURE; PROTEIN; RECEPTOR; MORPHOGENESIS; MUTATIONS; TRANSPORT; GENE; PHOTOTRANSDUCTION	Background: The fundamental role of the light receptor rhodopsin in visual function and photoreceptor cell development has been widely studied. Proper trafficking of rhodopsin to the photoreceptor membrane is of great importance. In human, mutations in rhodopsin involving its intracellular mislocalization, are the most frequent cause of autosomal dominant Retinitis Pigmentosa, a degenerative retinal pathology characterized by progressive blindness. Drosophila is widely used as an animal model in visual and retinal degeneration research. So far, little is known about the requirements for proper rhodopsin targeting in Drosophila. Methodology/Principal Findings: Different truncated fly-rhodopsin Rh1 variants were expressed in the eyes of Drosophila and their localization was analyzed in vivo or by immunofluorescence. A mutant lacking the last 23 amino acids was found to properly localize in the rhabdomeres, the light-sensing organelle of the photoreceptor cells. This constitutes a major difference to trafficking in vertebrates, which involves a conserved QVxPA motif at the very C-terminus. Further truncations of Rh1 indicated that proper localization requires the last amino acid residues of a region called helix 8 following directly the last transmembrane domain. Interestingly, the very C-terminus of invertebrate visual rhodopsins is extremely variable but helix 8 shows conserved amino acid residues that are not conserved in vertebrate homologs. Conclusions/Significance: Despite impressive similarities in the folding and photoactivation of vertebrate and invertebrate visual rhodopsins, a striking difference exists between mammalian and fly rhodopsins in their requirements for proper targeting. Most importantly, the distal part of helix 8 plays a central role in invertebrates. Since the last amino acid residues of helix 8 are dispensable for rhodopsin folding and function, we propose that this domain participates in the recognition of targeting factors involved in transport to the rhabdomeres.			Kock, I (corresponding author), Heidelberg Univ, Biochem Ctr BZH, INF328, Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de	Knust, Elisabeth/B-4338-2017; Sinning, Irmgard/A-2982-2010	Panneels, Valerie/0000-0001-8899-3366; Bulgakova, Natalia/0000-0002-3780-8164				Ahmad ST, 2007, FASEB J, V21, P449, DOI 10.1096/fj.06-6530com; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Arendt D, 2003, INT J DEV BIOL, V47, P563; Bentrop J, 2003, COMP SER PHOTOCHEM, V3, P40; Berger S, 2007, GENETICS, V176, P2189, DOI 10.1534/genetics.107.071449; Berson EL, 2002, INVEST OPHTH VIS SCI, V43, P3027; Cai KW, 1999, BIOCHEMISTRY-US, V38, P7925, DOI 10.1021/bi9900119; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; Concepcion F, 2002, VISION RES, V42, P417, DOI 10.1016/S0042-6989(01)00195-X; Deretic D, 1998, EYE, V12, P526, DOI 10.1038/eye.1998.141; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; Eroglu C, 2002, EMBO REP, V3, P491, DOI 10.1093/embo-reports/kvf088; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Lee ES, 2007, INVEST OPHTH VIS SCI, V48, P2868, DOI 10.1167/iovs.06-0035; Lehmann N, 2007, J MOL BIOL, V366, P1129, DOI 10.1016/j.jmb.2006.11.098; LEONARD DS, 1992, J NEUROBIOL, V23, P605, DOI 10.1002/neu.480230602; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pichaud F, 2001, DEVELOPMENT, V128, P815; Richard M, 2006, DEV DYNAM, V235, P895, DOI 10.1002/dvdy.20595; Rossner M, 2004, J CELL BIOL, V166, P11, DOI 10.1083/jcb.200406019; Sarfare S, 2005, J BIOL CHEM, V280, P11895, DOI 10.1074/jbc.M412236200; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Voie AM, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P510; Wang T, 2007, J AM CHEM SOC, V129, P6970, DOI 10.1021/ja0691977; Wang ZY, 2005, J BIOL CHEM, V280, P24293, DOI 10.1074/jbc.M502588200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WASHBURN T, 1989, J BIOL CHEM, V264, P15464; WEISS ER, 1994, BIOCHEMISTRY-US, V33, P7587, DOI 10.1021/bi00190a011; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010	48	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6101	10.1371/journal.pone.0006101	http://dx.doi.org/10.1371/journal.pone.0006101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GX	19572012	Green Accepted, Green Published, gold			2022-12-27	WOS:000267806200001
J	Aceves-Luquero, CI; Agarwal, A; Callejas-Valera, JL; Arias-Gonzalez, L; Esparis-Ogando, A; Ovalle, LD; Bellon-Echeverria, I; de la Cruz-Morcillo, MA; Moya, EMG; Gimeno, IM; Gomez, JC; Deininger, MW; Pandiella, A; Prieto, RS				Aceves-Luquero, Clara I.; Agarwal, Anupriya; Callejas-Valera, Juan L.; Arias-Gonzalez, Laura; Esparis-Ogando, Azucena; del Peso Ovalle, Luis; Bellon-Echeverria, Itxaso; de la Cruz-Morcillo, Miguel A.; Galan Moya, Eva M.; Moreno Gimeno, Inmaculada; Gomez, Juan C.; Deininger, Michael W.; Pandiella, Atanasio; Sanchez Prieto, Ricardo			ERK2, but Not ERK1, Mediates Acquired and "De novo" Resistance to Imatinib Mesylate: Implication for CML Therapy	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; KINASE DOMAIN MUTATIONS; ABL TYROSINE KINASE; BCR-ABL; JAK/STAT PATHWAYS; INHIBITOR STI571; ACTIVATION; CELLS; BCR/ABL; APOPTOSIS	Resistance to Imatinib Mesylate (IM) is a major problem in Chronic Myelogenous Leukaemia management. Most of the studies about resistance have focused on point mutations on BCR/ABL. However, other types of resistance that do not imply mutations in BCR/ABL have been also described. In the present report we aim to study the role of several MAPK in IM resistance not associate to BCR/ABL mutations. Therefore we used an experimental system of resistant cell lines generated by co-culturing with IM (K562, Lama 84) as well as primary material from resistant and responder patient without BCR/ABL mutations. Here we demonstrate that Erk5 and p38MAPK signaling pathways are not implicated in the acquired resistance phenotype. However, Erk2, but not Erk1, is critical for the acquired resistance to IM. In fact, Bcr/Abl activates preferentially Erk2 in transient transfection in a dose dependent fashion through the c-Abl part of the chimeric protein. Finally, we present evidences demonstrating how constitutive activation of Erk2 is a de novo mechanism of resistance to IM. In summary our data support the use of therapeutic approaches based on Erk2 inhibition, which could be added to the therapeutic armamentarium to fight CML, especially when IM resistance develops secondary to Erk2 activation.	[Aceves-Luquero, Clara I.; Callejas-Valera, Juan L.; Arias-Gonzalez, Laura; Bellon-Echeverria, Itxaso; de la Cruz-Morcillo, Miguel A.; Galan Moya, Eva M.; Moreno Gimeno, Inmaculada; Gomez, Juan C.; Sanchez Prieto, Ricardo] UCLM, Fac Med, CRIB, Albacete, Spain; [Agarwal, Anupriya; Deininger, Michael W.] Oregon Hlth & Sci Univ, Inst Canc, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Esparis-Ogando, Azucena; Pandiella, Atanasio] CSIC USAL, Inst Biol Mol & Celular Canc, Salamanca, Spain; [del Peso Ovalle, Luis] Univ Autonoma Madrid, Fac Med, Dept Bioquim, Madrid, Spain	Universidad de Castilla-La Mancha; Oregon Health & Science University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Autonomous University of Madrid	Aceves-Luquero, CI (corresponding author), UCLM, Fac Med, CRIB, Albacete, Spain.	ricardo.sanchez@uclm.es	Pandiella, Atanasio/O-5180-2014; Sanchez-Prieto, Ricardo/AAY-4271-2021; Esparís-Ogando, Aucena/O-5326-2017; Galan-Moya, Eva M/I-2912-2015; Sanchez-Prieto, Ricardo/B-6877-2008; 2009, Secribsal/A-1266-2012; Prieto, Ricardo/AAZ-7221-2021; del Peso, Luis/K-9391-2014; Moreno, Inmaculada/D-3955-2018; Arias-González, Laura/D-9517-2016; Romo, José A./J-3024-2012	Pandiella, Atanasio/0000-0002-4704-8971; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Esparís-Ogando, Aucena/0000-0003-4550-4192; Galan-Moya, Eva M/0000-0001-5758-7592; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; del Peso, Luis/0000-0003-4014-5688; Moreno, Inmaculada/0000-0001-6910-7509; Arias-González, Laura/0000-0003-2132-9350; Romo, José A./0000-0003-2907-580X; Bellon-Echeverria, Itxaso/0000-0002-3135-8799; de la Cruz-Morcillo, Miguel Angel/0000-0002-6674-1333				AGARWAL A, 2008, LEUKEMIA; Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Barnes DJ, 2005, ONCOGENE, V24, P6432, DOI 10.1038/sj.onc.1208796; Bonhoure E, 2008, LEUKEMIA, V22, P971, DOI 10.1038/leu.2008.95; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Buschbeck M, 2005, EMBO REP, V6, P63, DOI 10.1038/sj.embor.7400316; Chang IS, 2007, BLOOD, V110, P994, DOI 10.1182/blood-2007-03-078303; Chu S, 2004, BLOOD, V103, P3167, DOI 10.1182/blood-2003-04-1271; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; Dan S, 1998, CELL DEATH DIFFER, V5, P710, DOI 10.1038/sj.cdd.4400400; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; GAIGER A, 1995, BLOOD, V86, P2371, DOI 10.1182/blood.V86.6.2371.bloodjournal8662371; Galan-Moya EM, 2008, INT J CANCER, V122, P289, DOI 10.1002/ijc.23063; Garicochea B, 1998, LEUKEMIA RES, V22, P1003, DOI 10.1016/S0145-2126(98)00076-9; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; HWANG CY, 2009, MOL CELL BIOL; Konig H, 2008, LEUKEMIA, V22, P748, DOI 10.1038/sj.leu.2405086; Korus M, 2002, ONCOGENE, V21, P4601, DOI 10.1038/sj.onc.1205678; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Lahaye T, 2005, CANCER-AM CANCER SOC, V103, P1659, DOI 10.1002/cncr.20922; Lange T, 2005, CELL CYCLE, V4, P1761, DOI 10.4161/cc.4.12.2261; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; LIU E, 1988, P NATL ACAD SCI USA, V85, P1952, DOI 10.1073/pnas.85.6.1952; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Martinelli G, 2005, LEUKEMIA, V19, P1872, DOI 10.1038/sj.leu.2403950; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Melo JV, 2007, CANCER LETT, V249, P121, DOI 10.1016/j.canlet.2006.07.010; MONTIELDUARTE C, 2007, LEUK RES; Morinaga K, 2008, INT J CANCER, V122, P2621, DOI 10.1002/ijc.23435; Nguyen TK, 2007, BLOOD, V109, P4006, DOI 10.1182/blood-2006-09-045039; O'Hare T, 2007, CLIN LYMPHOMA MYELOM, V7, pS120, DOI 10.3816/CLM.2007.s.012; Parmar S, 2004, J BIOL CHEM, V279, P25345, DOI 10.1074/jbc.M400590200; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Sanchez-Arevalo LV, 2005, BIOCH J 1, V387, P231; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Sherbenou DW, 2007, LEUKEMIA, V21, P489, DOI 10.1038/sj.leu.2404554; Sonoyama J, 2002, J BIOL CHEM, V277, P8076, DOI 10.1074/jbc.M111501200; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Wong S, 2003, BLOOD, V101, P4088, DOI 10.1182/blood-2002-11-3376; Yu CR, 2002, CANCER RES, V62, P188	51	36	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6124	10.1371/journal.pone.0006124	http://dx.doi.org/10.1371/journal.pone.0006124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568437	Green Published, gold, Green Submitted			2022-12-27	WOS:000267572200022
J	Ackbarow, T; Sen, D; Thaulow, C; Buehler, MJ				Ackbarow, Theodor; Sen, Dipanjan; Thaulow, Christian; Buehler, Markus J.			Alpha-Helical Protein Networks Are Self-Protective and Flaw-Tolerant	PLOS ONE			English	Article								Alpha-helix based protein networks as they appear in intermediate filaments in the cell's cytoskeleton and the nuclear membrane robustly withstand large deformation of up to several hundred percent strain, despite the presence of structural imperfections or flaws. This performance is not achieved by most synthetic materials, which typically fail at much smaller deformation and show a great sensitivity to the existence of structural flaws. Here we report a series of molecular dynamics simulations with a simple coarse-grained multi-scale model of alpha-helical protein domains, explaining the structural and mechanistic basis for this observed behavior. We find that the characteristic properties of alpha-helix based protein networks are due to the particular nanomechanical properties of their protein constituents, enabling the formation of large dissipative yield regions around structural flaws, effectively protecting the protein network against catastrophic failure. We show that the key for these self protecting properties is a geometric transformation of the crack shape that significantly reduces the stress concentration at corners. Specifically, our analysis demonstrates that the failure strain of alpha-helix based protein networks is insensitive to the presence of structural flaws in the protein network, only marginally affecting their overall strength. Our findings may help to explain the ability of cells to undergo large deformation without catastrophic failure while providing significant mechanical resistance.			Ackbarow, T (corresponding author), MIT, Lab Atomist & Mol Mech, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mbuehler@mit.edu	Buehler, Markus J./C-4580-2008	Buehler, Markus J./0000-0002-4173-9659				Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104; Ackbarow T, 2007, J MATER SCI, V42, P8771, DOI 10.1007/s10853-007-1719-2; Ackbarow T, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/3/035111; AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; BUEHLER M, J ENG MECH ASCE, V135, P422; Buehler MJ, 2008, NANO RES, V1, P63, DOI 10.1007/s12274-008-8006-7; Buehler MJ, 2008, PROG MATER SCI, V53, P1101, DOI 10.1016/j.pmatsci.2008.06.002; Buehler MJ, 2007, J MECH MATER STRUCT, V2, P1019, DOI 10.2140/jomms.2007.2.1019; Buehler MJ, 2007, MATER TODAY, V10, P46, DOI 10.1016/S1369-7021(07)70208-0; Buehler MJ, 2006, NATURE, V439, P307, DOI 10.1038/nature04408; Buehler MJ, 2003, NATURE, V426, P141, DOI 10.1038/nature02096; BUEHLER MJ, 2007, PHYS REV LETT, V99; COURTNEY TH, 1990, MECH BEHAV MAT; Currey J, 2001, NATURE, V414, P699, DOI 10.1038/414699a; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Fantner GE, 2006, BIOPHYS J, V90, P1411, DOI 10.1529/biophysj.105.069344; Fantner GE, 2007, NANO LETT, V7, P2491, DOI 10.1021/nl0712769; Fudge D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002327; Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; GENT AN, 1991, J MATER SCI, V26, P3392, DOI 10.1007/BF01124691; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018; Hui CY, 2003, P ROY SOC A-MATH PHY, V459, P1489, DOI 10.1098/rspa.2002.1057; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Kageshima M, 2001, CHEM PHYS LETT, V343, P77, DOI 10.1016/S0009-2614(01)00678-9; Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670; Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826; Kreplak L, 2007, BIOESSAYS, V29, P26, DOI 10.1002/bies.20514; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lantz MA, 1999, CHEM PHYS LETT, V315, P61, DOI 10.1016/S0009-2614(99)01201-4; Lawn P.R, 1993, CAMBRIDGE SOLID STAT, Vsecond; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Pugno NM, 2004, PHILOS MAG, V84, P2829, DOI 10.1080/14786430412331280382; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a; TSAI DH, 1979, J CHEM PHYS, V70, P1375, DOI 10.1063/1.437577; Wang N, 2002, J MUSCLE RES CELL M, V23, P535, DOI 10.1023/A:1023470709071; Wietz DA, 2008, P NATL ACAD SCI USA, V105, P1105, DOI 10.1073/pnas.0711639105	45	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6015	10.1371/journal.pone.0006015	http://dx.doi.org/10.1371/journal.pone.0006015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547709	gold, Green Published, Green Submitted			2022-12-27	WOS:000267347900012
J	Ahmet, I; Spangler, E; Shukitt-Hale, B; Juhaszova, M; Sollott, SJ; Joseph, JA; Ingram, DK; Talan, M				Ahmet, Ismayil; Spangler, Edward; Shukitt-Hale, Barbara; Juhaszova, Magdalena; Sollott, Steven J.; Joseph, James A.; Ingram, Donald K.; Talan, Mark			Blueberry-Enriched Diet Protects Rat Heart from Ischemic Damage	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; OXIDATIVE STRESS; CARDIOVASCULAR INJURY; CARDIAC MYOCYTES; MYOCARDIAL-INFARCTION; BEHAVIORAL DEFICITS; BASIC MECHANISMS; RABBIT HEARTS; FREE-RADICALS; BRAIN-DAMAGE	Objectives: to assess the cardioprotective properties of a blueberry enriched diet (BD). Background: Reactive oxygen species (ROS) play a major role in ischemia-related myocardial injury. The attempts to use synthetic antioxidants to block the detrimental effects of ROS have produced mixed or negative results precipitating the interest in natural products. Blueberries are readily available product with the highest antioxidant capacity among fruits and vegetables. Methods and Results: Following 3-mo of BD or a regular control diet (CD), the threshold for mitochondrial permeability transition (tMPT) was measured in isolated cardiomyocytes obtained from young male Fischer-344 rats. Compared to CD, BD resulted in a 24% increase (p<0.001) of ROS indexed t(MPT). The remaining animals were subjected to a permanent ligation of the left descending coronary artery. 24 hrs later resulting myocardial infarction (MI) in rats on BD was 22% less than in CD rats (p<0.01). Significantly less TUNEL(+) cardiomyocytes (2% vs 9%) and 40% less inflammation cells were observed in the myocardial area at risk of BD compared to CD rats (p<0.01). In the subgroup of rats, after coronary ligation the original diet was either continued or switched to the opposite one, and cardiac remodeling and MI expansion were followed by serial echocardiography for 10 weeks. Measurements suggested that continuation of BD or its withdrawal after MI attenuated or accelerated rates of post MI cardiac remodeling and MI expansion. Conclusion: A blueberry-enriched diet protected the myocardium from induced ischemic damage and demonstrated the potential to attenuate the development of post MI chronic heart failure.			Ahmet, I (corresponding author), NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA.	talanm@grc.nia.nih.gov		Shukitt-Hale, Barbara/0000-0002-3810-1910	NATIONAL INSTITUTE ON AGING [ZIAAG000867, ZIAAG000302, Z01AG000302, ZIAAG000823, Z01AG000823, Z01AG000867, ZIAAG000866] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Ahmet I, 2004, CIRCULATION, V110, P1083, DOI 10.1161/01.CIR.0000139844.15045.F9; Akita Y, 2007, AM J PHYSIOL-HEART C, V292, pH2051, DOI 10.1152/ajpheart.01102.2006; AMBROSIO G, 1992, CARDIOVASC DRUG THER, V6, P623, DOI 10.1007/BF00052564; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Bandyopadhyay D, 2004, CURR MED CHEM, V11, P369, DOI 10.2174/0929867043456016; Bickford PC, 2000, BRAIN RES, V866, P211, DOI 10.1016/S0006-8993(00)02280-0; Briel M, 2005, CURR OPIN LIPIDOL, V16, P601; CAPOGROSSI MC, 1986, J GEN PHYSIOL, V88, P589, DOI 10.1085/jgp.88.5.589; Chen Jan-Kan, 2005, Chang Gung Med J, V28, P369; Cozma LS, 2004, CURR OPIN LIPIDOL, V15, P369, DOI 10.1097/00041433-200406000-00020; Das Undurti N, 2003, Curr Opin Crit Care, V9, P375, DOI 10.1097/00075198-200310000-00007; Diaz R, 1998, CIRCULATION, V98, P2227, DOI 10.1161/01.CIR.98.21.2227; Duffy KB, 2008, NEUROBIOL AGING, V29, P1680, DOI 10.1016/j.neurobiolaging.2007.04.002; Egger T, 2003, BIOCHEM J, V370, P459, DOI 10.1042/BJ20021358; Goyarzu F, 2004, NUTR NEUROSCI, V7, P75, DOI 10.1080/10284150410001710410; Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Hillsdon M, 2004, PUBLIC HEALTH NUTR, V7, P557, DOI 10.1079/PHN2003548; Joseph JA, 2005, NEUROCHEM RES, V30, P927, DOI 10.1007/s11064-005-6967-4; Juhaszova M, 2005, CARDIOVASC RES, V66, P233, DOI 10.1016/j.cardiores.2004.12.020; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kevin LG, 2003, AM J PHYSIOL-HEART C, V284, pH566, DOI 10.1152/ajpheart.00711.2002; Kitsis RN, 2008, HEART FAIL REV, V13, P107, DOI 10.1007/s10741-008-9080-3; Lau FC, 2007, J NEUROSCI RES, V85, P1010, DOI 10.1002/jnr.21205; Li SM, 2003, J MOL CELL CARDIOL, V35, P1145, DOI 10.1016/S0022-2828(03)00230-X; Marini M, 2007, EUR J APPL PHYSIOL, V99, P503, DOI 10.1007/s00421-006-0369-4; Martineau LC, 2006, PHYTOMEDICINE, V13, P612, DOI 10.1016/j.phymed.2006.08.005; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Moon C, 2003, P NATL ACAD SCI USA, V100, P11612, DOI 10.1073/pnas.1930406100; Neto CC, 2007, MOL NUTR FOOD RES, V51, P652, DOI 10.1002/mnfr.200600279; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Prior RL, 2000, J AOAC INT, V83, P950; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Shepherd J, 2006, J INTERN MED, V260, P305, DOI 10.1111/j.1365-2796.2006.01700.x; Shukitt-Hale B, 2008, NUTR NEUROSCI, V11, P172, DOI 10.1179/147683008X301487; Smith SH, 2004, J MED FOOD, V7, P450, DOI 10.1089/jmf.2004.7.450; Sweeney MI, 2002, NUTR NEUROSCI, V5, P427, DOI 10.1080/1028415021000055970; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; VILLARI B, 1993, AM HEART J, V125, P11, DOI 10.1016/0002-8703(93)90051-A; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140; Weisfeldt M L, 1988, Basic Life Sci, V49, P911; Yi WG, 2005, J AGR FOOD CHEM, V53, P7320, DOI 10.1021/jf051333o; Youdim KA, 2000, BBA-GEN SUBJECTS, V1523, P117, DOI 10.1016/S0304-4165(00)00109-4; Zhang HX, 2006, J CARDIOVASC PHARM, V48, P306, DOI 10.1097/01.fjc.0000249873.73197.c3; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029; ZWEIER JL, 1989, FEBS LETT, V252, P12, DOI 10.1016/0014-5793(89)80881-6; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	51	51	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5954	10.1371/journal.pone.0005954	http://dx.doi.org/10.1371/journal.pone.0005954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536295	Green Submitted, Green Published, gold			2022-12-27	WOS:000267079500004
J	Greenbaum, BD; Rabadan, R; Levine, AJ				Greenbaum, Benjamin D.; Rabadan, Raul; Levine, Arnold J.			Patterns of Oligonucleotide Sequences in Viral and Host Cell RNA Identify Mediators of the Host Innate Immune System	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; SINGLE-STRANDED RNA; INFLUENZA-VIRUS; RECOGNITION; CPG	The innate immune response provides a first line of defense against pathogens by targeting generic differential features that are present in foreign organisms but not in the host. These innate responses generate selection forces acting both in pathogens and hosts that further determine their co-evolution. Here we analyze the nucleic acid sequence fingerprints of these selection forces acting in parallel on both host innate immune genes and ssRNA viral genomes. We do this by identifying dinucleotide biases in the coding regions of innate immune response genes in plasmacytoid dendritic cells, and then use this signal to identify other significant host innate immune genes. The persistence of these biases in the orthologous groups of genes in humans and chickens is also examined. We then compare the significant motifs in highly expressed genes of the innate immune system to those in ssRNA viruses and study the evolution of these motifs in the H1N1 influenza genome. We argue that the significant under-represented motif pattern of CpG in an AU context - which is found in both the ssRNA viruses and innate genes, and has decreased throughout the history of H1N1 influenza replication in humans - is immunostimulatory and has been selected against during the co-evolution of viruses and host innate immune genes. This shows how differences in host immune biology can drive the evolution of viruses that jump into species with different immune priorities than the original host.			Greenbaum, BD (corresponding author), Inst Adv Study, Olden Lane, Princeton, NJ 08540 USA.	beng@ias.edu	Rabadan, Raul/AAZ-7367-2020	Rabadan, Raul/0000-0001-7946-9255				Akira S, 2003, SCAND J INFECT DIS, V35, P555, DOI 10.1080/00365540310015683; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HONGBO C, 2008, GENOME BIOL, V9, P211; Iparraguirre A, 2008, J LEUKOCYTE BIOL, V83, P610, DOI 10.1189/jlb.0807511; Jabbari K, 2004, GENE, V333, P143, DOI 10.1016/j.gene.2004.02.043; KARLIN S, 1994, ANNU REV MICROBIOL, V48, P619, DOI 10.1146/annurev.mi.48.100194.003155; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lowy RJ, 2003, INT REV IMMUNOL, V22, P425, DOI 10.1080/08830180305216; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; MARSHAKROTHSTEI.A, 2006, NATURE REV IMMUNOLOG, P822; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; NUSSINOV R, 1984, J MOL EVOL, V20, P111, DOI 10.1007/BF02257371; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; RAZ E, 2000, IMMUNOSTIMULATORY DN; Rothenfusser S, 2002, HUM IMMUNOL, V63, P1111, DOI 10.1016/S0198-8859(02)00749-8; SALSER W, 1977, COLD SPRING HARB SYM, V42, P985; Sugiyama T, 2005, J IMMUNOL, V175, P2026, DOI 10.4049/jimmunol.175.3.2026; Sugiyama T, 2005, J IMMUNOL, V174, P2273, DOI 10.4049/jimmunol.174.4.2273; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P588, DOI 10.1073/pnas.0806959106; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	34	62	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5969	10.1371/journal.pone.0005969	http://dx.doi.org/10.1371/journal.pone.0005969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536338	Green Published, gold, Green Submitted			2022-12-27	WOS:000267079500016
J	Thomassen, GOS; Rowe, AD; Lagesen, K; Lindvall, JM; Rognes, T				Thomassen, Gard O. S.; Rowe, Alexander D.; Lagesen, Karin; Lindvall, Jessica M.; Rognes, Torbjorn			Custom Design and Analysis of High-Density Oligonucleotide Bacterial Tiling Microarrays	PLOS ONE			English	Article								Background: High-density tiling microarrays are a powerful tool for the characterization of complete genomes. The two major computational challenges associated with custom-made arrays are design and analysis. Firstly, several genome dependent variables, such as the genome's complexity and sequence composition, need to be considered in the design to ensure a high quality microarray. Secondly, since tiling projects today very often exceed the limits of conventional array-experiments, researchers cannot use established computer tools designed for commercial arrays, and instead have to redesign previous methods or create novel tools. Principal Findings: Here we describe the multiple aspects involved in the design of tiling arrays for transcriptome analysis and detail the normalisation and analysis procedures for such microarrays. We introduce a novel design method to make two 280,000 feature microarrays covering the entire genome of the bacterial species Escherichia coli and Neisseria meningitidis, respectively, as well as the use of multiple copies of control probe-sets on tiling microarrays. Furthermore, a novel normalisation and background estimation procedure for tiling arrays is presented along with a method for array analysis focused on detection of short transcripts. The design, normalisation and analysis methods have been applied in various experiments and several of the detected novel short transcripts have been biologically confirmed by Northern blot tests. Conclusions: Tiling-arrays are becoming increasingly applicable in genomic research, but researchers still lack both the tools for custom design of arrays, as well as the systems and procedures for analysis of the vast amount of data resulting from such experiments. We believe that the methods described herein will be a useful contribution and resource for researchers designing and analysing custom tiling arrays for both bacteria and higher organisms.			Thomassen, GOS (corresponding author), Univ Oslo, Inst Med Microbiol, CMBN, Oslo, Norway.	torognes@ifi.uio.no	Rognes, Torbjørn/A-9692-2008; Lindvall, Jessica M/A-1762-2013	Rognes, Torbjørn/0000-0002-9329-9974; Thomassen, Gard Olav Sundby/0000-0002-6979-8474; Lindvall, Jessica/0000-0002-5042-8481; Lagesen, Karin/0000-0003-1329-9032				*AFF, 2003, GENECHIP CUSTOMEXPRE; Affymetrix, 2002, STAT ALG DESCR DOC; Albert TJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng035; Berman P, 2004, J COMPUT BIOL, V11, P766; Bertone P, 2006, GENOME RES, V16, P271, DOI 10.1101/gr.4455906; Bertone P, 2005, CHROMOSOME RES, V13, P259, DOI 10.1007/s10577-005-2165-0; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Du J, 2006, BIOINFORMATICS, V22, P3016, DOI 10.1093/bioinformatics/btl515; *GEN EXPR OMN, GSE13829 GEN EXPR OM; Graf S, 2007, BIOINFORMATICS, V23, pI195, DOI 10.1093/bioinformatics/btm200; Herold KE, 2003, BIOTECHNIQUES, V35, P1216, DOI 10.2144/03356bc02; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiao YL, 2005, PLANT CELL, V17, P1641, DOI 10.1105/tpc.105.031575; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Lemoine S, 2009, NUCLEIC ACIDS RES, V37, P1726, DOI 10.1093/nar/gkp053; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Li XY, 2005, NUCLEIC ACIDS RES, V33, P6114, DOI 10.1093/nar/gki914; MANBER U, 1993, SIAM J COMPUT, V22, P935, DOI 10.1137/0222058; Mei R, 2003, P NATL ACAD SCI USA, V100, P11237, DOI 10.1073/pnas.1534744100; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Nielsen HB, 2003, NUCLEIC ACIDS RES, V31, P3491, DOI 10.1093/nar/gkg622; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; *ROCH NIMBLEGEN PR, TNARAY0100 ROCH NIBL; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Royce TE, 2005, TRENDS GENET, V21, P466, DOI 10.1016/j.tig.2005.06.007; Royce TE, 2007, BIOINFORMATICS, V23, P988, DOI 10.1093/bioinformatics/btm052; Schliep A, 2008, IEEE ACM T COMPUT BI, V5, P557, DOI 10.1109/TCBB.2008.50; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Skotheim RI, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-5; Smit A, 1996, REPEATMASKER OPEN 30; Stolc V, 2005, P NATL ACAD SCI USA, V102, P4453, DOI 10.1073/pnas.0408203102; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; van Bakel H, 2004, EMBO REP, V5, P964, DOI 10.1038/sj.embor.7400253; Wernersson R, 2005, NUCLEIC ACIDS RES, V33, pW611, DOI 10.1093/nar/gki399; Wernersson R, 2007, NAT PROTOC, V2, P2677, DOI 10.1038/nprot.2007.370; Wu CL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni082; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5943	10.1371/journal.pone.0005943	http://dx.doi.org/10.1371/journal.pone.0005943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536279	gold, Green Submitted, Green Published			2022-12-27	WOS:000267029700013
J	Pryde, F; Jain, D; Kerr, A; Curley, R; Mariotti, FR; Vogelauer, M				Pryde, Fiona; Jain, Devanshi; Kerr, Alastair; Curley, Rebecca; Mariotti, Francesca Romana; Vogelauer, Maria			H3 K36 Methylation Helps Determine the Timing of Cdc45 Association with Replication Origins	PLOS ONE			English	Article								Background Replication origins fire at different times during S-phase. Such timing is determined by the chromosomal context, which includes the activity of nearby genes, telomeric position effects and chromatin structure, such as the acetylation state of the surrounding chromatin. Activation of replication origins involves the conversion of a pre-replicative complex to a replicative complex. A pivotal step during this conversion is the binding of the replication factor Cdc45, which associates with replication origins at approximately their time of activation in a manner partially controlled by histone acetylation. Methodology/Principal Findings: Here we identify histone H3 K36 methylation (H3 K36me) by Set2 as a novel regulator of the time of Cdc45 association with replication origins. Deletion of SET2 abolishes all forms of H3 K36 methylation. This causes a delay in Cdc45 binding to origins and renders the dynamics of this interaction insensitive to the state of histone acetylation of the surrounding chromosomal region. Furthermore, a decrease in H3 K36me3 and a concomitant increase in H3 K36me1 around the time of Cdc45 binding to replication origins suggests opposing functions for these two methylation states. Indeed, we find K36me3 depleted from early firing origins when compared to late origins genomewide, supporting a delaying effect of this histone modification for the association of replication factors with origins. Conclusions/Significance: We propose a model in which K36me1 together with histone acetylation advance, while K36me3 and histone deacetylation delay, the time of Cdc45 association with replication origins. The involvement of the transcriptionally induced H3 K36 methylation mark in regulating the timing of Cdc45 binding to replication origins provides a novel means of how gene expression may affect origin dynamics during S-phase.			Pryde, F (corresponding author), London Res Inst, Lincolns Inn Fields Labs, London, England.	mvogelauer@mednet.ucla.edu	Kerr, Alastair/B-3272-2010; Mariotti, Francesca Romana/Z-2998-2019	Mariotti, Francesca Romana/0000-0002-3421-6470; Kerr, Alastair/0000-0001-9207-6050	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust [MV37766] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Alvino GM, 2007, MOL CELL BIOL, V27, P6396, DOI 10.1128/MCB.00719-07; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Belyaev ND, 1996, EXP CELL RES, V225, P277, DOI 10.1006/excr.1996.0177; BICKMORE WA, 1995, J CELL SCI, V108, P2801; Biswas D, 2008, GENETICS, V178, P649, DOI 10.1534/genetics.107.084202; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Eisen A, 2001, J BIOL CHEM, V276, P3484, DOI 10.1074/jbc.M008159200; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; Friedman KL, 1996, GENE DEV, V10, P1595, DOI 10.1101/gad.10.13.1595; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Gregoire D, 2006, EMBO REP, V7, P812, DOI 10.1038/sj.embor.7400758; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; LAMAN H, 1995, MOL CELL BIOL, V15, P3608; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Lottersberger F, 2007, MOL CELL BIOL, V27, P3266, DOI 10.1128/MCB.01767-06; Lucchini R, 2001, EMBO J, V20, P7294, DOI 10.1093/emboj/20.24.7294; MANN RK, 1992, EMBO J, V11, P3297, DOI 10.1002/j.1460-2075.1992.tb05408.x; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Mori S, 2007, J BIOL CHEM, V282, P4447, DOI 10.1074/jbc.M609671200; Nieduszynski CA, 2007, NUCLEIC ACIDS RES, V35, pD40, DOI 10.1093/nar/gkl758; Nieduszynski CA, 2006, GENE DEV, V20, P1874, DOI 10.1101/gad.385306; Nourani A, 2001, MOL CELL BIOL, V21, P7629, DOI 10.1128/MCB.21.22.7629-7640.2001; OSBORNE BI, 1988, GENE DEV, V2, P766, DOI 10.1101/gad.2.6.766; PEDERSON DS, 1990, EMBO J, V9, P1873, DOI 10.1002/j.1460-2075.1990.tb08313.x; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Rhind N, 2006, NAT CELL BIOL, V8, P1313, DOI 10.1038/ncb1206-1313; Robyr D, 2004, METHOD ENZYMOL, V376, P289; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Suter B, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-38; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; TANAKA S, 1994, NUCLEIC ACIDS RES, V22, P3904, DOI 10.1093/nar/22.19.3904; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Theis JF, 2007, GENETICS, V177, P1445, DOI 10.1534/genetics.107.074690; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; White EJ, 2004, P NATL ACAD SCI USA, V101, P17771, DOI 10.1073/pnas.0408170101; Wood H, 2005, NAT REV NEUROSCI, V6, P172, DOI 10.1038/nrn1634; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000; Zou L, 1997, MOL CELL BIOL, V17, P553, DOI 10.1128/MCB.17.2.553	74	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5882	10.1371/journal.pone.0005882	http://dx.doi.org/10.1371/journal.pone.0005882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521516	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029100003
J	Spanier, B; Lasch, K; Marsch, S; Benner, J; Liao, WJ; Hu, H; Kienberger, H; Eisenreich, W; Daniel, H				Spanier, Britta; Lasch, Katrin; Marsch, Silke; Benner, Jacqueline; Liao, Wenjuan; Hu, Hao; Kienberger, Hermine; Eisenreich, Wolfgang; Daniel, Hannelore			How the Intestinal Peptide Transporter PEPT-1 Contributes to an Obesity Phenotype in Caenorhabditits elegans	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; INTRACELLULAR PH; MEMBRANE; PROTEINS; INSULIN; MODEL	Background: Amino acid absorption in the form of di- and tripeptides is mediated by the intestinal proton-coupled peptide transporter PEPT-1 (formally OPT-2) in Caenorhabditits elegans. Transporter-deficient animals (pept-1(lg601)) show impaired growth, slowed postembryonal development and major changes in amino acid status. Principal Findings: Here we demonstrate that abolished intestinal peptide transport also leads to major metabolic alterations that culminate in a two fold increase in total body fat content. Feeding of C. elegans with [U-C-13]-labelled E. coli revealed a decreased de novo synthesis of long-chain fatty acids in pept-1(lg601) and reduced levels of polyunsaturated fatty acids. mRNA profiling revealed increased transcript levels of enzymes/transporters needed for peroxisomal beta-oxidation and decreased levels for those required for fatty acid synthesis, elongation and desaturation. As a prime and most fundamental process that may account for the increased fat content in pept-1(lg601) we identified a highly accelerated absorption of free fatty acids from the bacterial food in the intestine. Conclusions: The influx of free fatty acids into intestinal epithelial cells is strongly dependent on alterations in intracellular pH which is regulated by the interplay of PEPT-1 and the sodium-proton exchanger NHX-2. We here provide evidence for a central mechanism by which the PEPT-1/NHX-2 system strongly influences the in vivo fat content of C. elegans. Loss of PEPT-1 decreases intestinal proton influx leading to a higher uptake of free fatty acids with fat accumulation whereas loss of NHX-2 causes intracellular acidification by the PEPT-1 mediated proton/dipeptide symport with an almost abolished uptake of fatty acids and a lean phenotype.			Spanier, B (corresponding author), Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Biochem Abt, D-8050 Freising Weihenstephan, Germany.	spanier@wzw.tum.de	Eisenreich, Wolfgang/A-1258-2013; Daniel, Hannelore/B-8982-2009; Spanier, Britta/C-2672-2009	Eisenreich, Wolfgang/0000-0002-9832-8279; Wallwitz, Jacqueline/0000-0002-7335-362X				Anderson CMH, 2007, BBA-BIOMEMBRANES, V1768, P1822, DOI 10.1016/j.bbamem.2007.04.006; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ashrafi Kaveh, 2007, WormBook, P1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobulescu IA, 2006, SEMIN NEPHROL, V26, P334, DOI 10.1016/j.semnephrol.2006.07.001; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Civelek VN, 1996, P NATL ACAD SCI USA, V93, P10139, DOI 10.1073/pnas.93.19.10139; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Elsing C, 1996, AM J PHYSIOL-GASTR L, V271, pG1067, DOI 10.1152/ajpgi.1996.271.6.G1067; Fei YJ, 1998, BIOCHEM J, V332, P565, DOI 10.1042/bj3320565; GANAPATHY V, 1983, J BIOL CHEM, V258, P4189; Gawenis LR, 2002, AM J PHYSIOL-GASTR L, V282, pG776, DOI 10.1152/ajpgi.00297.2001; Gurvitz A, 2000, YEAST, V17, P188, DOI 10.1002/1097-0061(20000930)17:3<188::AID-YEA27>3.0.CO;2-E; Hamilton JA, 1998, J LIPID RES, V39, P467; HAMILTON JA, 1994, J BIOL CHEM, V269, P20852; Hamilton JA, 2007, PROSTAG LEUKOTR ESS, V77, P355, DOI 10.1016/j.plefa.2007.10.020; Illarionov B, 2004, J ORG CHEM, V69, P5588, DOI 10.1021/jo0493222; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; McElwee JJ, 2006, MECH AGEING DEV, V127, P922, DOI 10.1016/j.mad.2006.10.002; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; REDDY JK, 1994, ANNU REV NUTR, V14, P343, DOI 10.1146/annurev.nu.14.070194.002015; Schaffer JE, 2002, AM J PHYSIOL-ENDOC M, V282, pE239, DOI 10.1152/ajpendo.00462.2001; SHEHATA AY, 1979, J CAN I FOOD TECHNOL, V3, P85; Thieringer H, 2003, J CELL SCI, V116, P1797, DOI 10.1242/jcs.00380; Thwaites DT, 2007, EXP PHYSIOL, V92, P603, DOI 10.1113/expphysiol.2005.029959; Thwaites DT, 2002, GASTROENTEROLOGY, V122, P1322, DOI 10.1053/gast.2002.32992; Veljkovic E, 2004, J BIOL CHEM, V279, P7655, DOI 10.1074/jbc.M309528200; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wood W B, 1988, Dev Biol (N Y 1985), V5, P57; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	40	48	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6279	10.1371/journal.pone.0006279	http://dx.doi.org/10.1371/journal.pone.0006279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621081	gold, Green Published, Green Submitted			2022-12-27	WOS:000268147200001
J	Cantrell, MA; Carstens, BC; Wichman, HA				Cantrell, Michael A.; Carstens, Bryan C.; Wichman, Holly A.			X Chromosome Inactivation and Xist Evolution in a Rodent Lacking LINE-1 Activity	PLOS ONE			English	Article								Dosage compensation in eutherian mammals occurs by inactivation of one X chromosome in females. Silencing of that X chromosome is initiated by Xist, a large non-coding RNA, whose coating of the chromosome extends in cis from the X inactivation center. LINE-1 (L1) retrotransposons have been implicated as possible players for propagation of the Xist signal, but it has remained unclear whether they are essential components. We previously identified a group of South American rodents in which L1 retrotransposition ceased over 8 million years ago and have now determined that at least one species of these rodents, Oryzomys palustris, still retains X inactivation. We have also isolated and analyzed the majority of the Xist RNA from O. palustris and a sister species retaining L1 activity, Sigmodon hispidus, to determine if evolution in these sequences has left signatures that might suggest a critical role for L1 elements in Xist function. Comparison of rates of Xist evolution in the two species fails to support L1 involvement, although other explanations are possible. Similarly, comparison of known repeats and potential RNA secondary structures reveals no major differences with the exception of a new repeat in O. palustris that has potential to form new secondary structures.			Cantrell, MA (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	hwichman@uidaho.edu	Carstens, Bryan C/B-8602-2013	Carstens, Bryan C/0000-0002-1552-227X	NCRR NIH HHS [P20 RR016454, P20 RR016448, RR016448, RR016454] Funding Source: Medline; NIGMS NIH HHS [GM38737] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448, P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038737] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen E, 2003, P NATL ACAD SCI USA, V100, P9940, DOI 10.1073/pnas.1737401100; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Baker RJ, 1994, CHROMOSOME RES, V2, P185, DOI 10.1007/BF01553318; BAKER RJ, 1990, EVOLUTION, V44, P2083, DOI 10.2307/2409617; Beletskii A, 2001, P NATL ACAD SCI USA, V98, P9215, DOI 10.1073/pnas.161173098; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BOYLE AL, 1990, P NATL ACAD SCI USA, V87, P7757, DOI 10.1073/pnas.87.19.7757; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Cantrell MA, 2005, J VIROL, V79, P14698, DOI 10.1128/JVI.79.23.14698-14707.2005; Cantrell MA, 2000, BIOTECHNIQUES, V29, P1310, DOI 10.2144/00296rr02; Caparros ML, 2002, CYTOGENET GENOME RES, V99, P99, DOI 10.1159/000071580; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carrel L, 2006, PLOS GENET, V2, P1477, DOI 10.1371/journal.pgen.0020151; CASAVANT NC, 1994, J MOL BIOL, V241, P390, DOI 10.1006/jmbi.1994.1515; Casavant NC, 1996, GENETICS, V142, P1289; Casavant NC, 1998, GENETICS, V150, P345; Casavant NC, 2000, GENETICS, V154, P1809; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chang SC, 2006, FRONT BIOSCI-LANDMRK, V11, P852, DOI 10.2741/1842; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chow JC, 2005, ANNU REV GENOM HUM G, V6, P69, DOI 10.1146/annurev.genom.6.080604.162350; Chow JC, 2007, P NATL ACAD SCI USA, V104, P10104, DOI 10.1073/pnas.0610946104; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Dobigny G, 2004, CHROMOSOMA, V113, P34, DOI 10.1007/s00412-004-0292-6; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Furano AV, 2000, PROG NUCLEIC ACID RE, V64, P255, DOI 10.1016/S0079-6603(00)64007-2; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GOLDMAN N, 1993, J MOL EVOL, V36, P182, DOI 10.1007/BF00166252; Grahn RA, 2005, CYTOGENET GENOME RES, V110, P407, DOI 10.1159/000084973; Hall LL, 2002, HUM MOL GENET, V11, P3157, DOI 10.1093/hmg/11.25.3157; Hansen RS, 2003, HUM MOL GENET, V12, P2559, DOI 10.1093/hmg/ddg268; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Hoki Y, 2009, DEVELOPMENT, V136, P139, DOI 10.1242/dev.026427; Hore TA, 2007, CHROMOSOME RES, V15, P147, DOI 10.1007/s10577-007-1119-0; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Ke X, 2003, ANN HUM GENET, V67, P242, DOI 10.1046/j.1469-1809.2003.00038.x; Keohane AM, 1999, HUM MOL GENET, V8, P377, DOI 10.1093/hmg/8.2.377; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Longmire JL, 1988, GENOMICS, V2, P14, DOI 10.1016/0888-7543(88)90104-8; LUOH SW, 1995, GENOMICS, V29, P353, DOI 10.1006/geno.1995.9994; Lyon MF, 2005, EUR J HUM GENET, V13, P796, DOI 10.1038/sj.ejhg.5201443; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Matarazzo MR, 2008, BIOL CELL, V100, P63, DOI 10.1042/BC20070073; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Noronha RCR, 2001, CARYOLOGIA, V54, P267, DOI 10.1080/00087114.2001.10589235; Parish DA, 2002, CYTOGENET GENOME RES, V96, P191, DOI 10.1159/000063038; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Popova BC, 2006, P NATL ACAD SCI USA, V103, P7706, DOI 10.1073/pnas.0602021103; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; RUSSELL LB, 1970, GENETICS, V64, P281; Salstrom JL, 2007, MOL GENET METAB, V92, P56, DOI 10.1016/j.ymgme.2007.05.015; Scott LA, 2006, CYTOGENET GENOME RES, V112, P261, DOI 10.1159/000089880; Sharp A, 2001, HUM GENET, V109, P295, DOI 10.1007/s004390100578; Sharp AJ, 2002, HUM MOL GENET, V11, P3145, DOI 10.1093/hmg/11.25.3145; Solari AJ, 2001, BIOCELL, V25, P155; Straub T, 2007, NAT REV GENET, V8, P47, DOI 10.1038/nrg2013; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TRIBIOLI C, 1992, NUCLEIC ACIDS RES, V20, P727, DOI 10.1093/nar/20.4.727; Tsuchiya KD, 2004, GENOME RES, V14, P1275, DOI 10.1101/gr.2575904; Valley CM, 2006, CURR OPIN GENET DEV, V16, P240, DOI 10.1016/j.gde.2006.04.008; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113; Waters PD, 2004, CHROMOSOMA, V113, P137, DOI 10.1007/s00412-004-0301-9; White WM, 1998, AM J HUM GENET, V63, P20, DOI 10.1086/301922; WICHMAN HA, 1992, GENETICA, V86, P287, DOI 10.1007/BF00133727; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2007, TRENDS GENET, V23, P457, DOI 10.1016/j.tig.2007.07.004	78	18	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6252	10.1371/journal.pone.0006252	http://dx.doi.org/10.1371/journal.pone.0006252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603076	gold, Green Published, Green Submitted			2022-12-27	WOS:000268035700008
J	Narayan, K; Perkins, EM; Murphy, GE; Dalai, SK; Edidin, M; Subramaniam, S; Sadegh-Nasseri, S				Narayan, Kedar; Perkins, Edward M.; Murphy, Gavin E.; Dalai, Sarat K.; Edidin, Michael; Subramaniam, Sriram; Sadegh-Nasseri, Scheherazade			Staphylococcal Enterotoxin A Induces Small Clusters of HLA-DR1 on B Cells	PLOS ONE			English	Article								The superantigen SEA causes non-specific hyperactivation of T and B cells at low concentrations. Studies of mutants or soluble proteins suggest SEA is bivalent for its ligand, MHC class II. However, the interaction between these molecules on intact cells is unknown. On primary mouse B cells expressing the MHC class II allele HLA-DR1, measurements of Forster Resonance Energy Transfer between HLA-DR1 molecules on SEA-treated cells indicated specific clustering, not observed in untreated or monovalent superantigen treated cells. Tomographic visualization and electron microscopy of immunogold-labeled SEA-treated B cells revealed small clusters of surface HLA-DR1 (<= 4 gold labels). These results present direct visual evidence of SEA-mediated clustering of MHC class II molecules on treated antigen presenting cells, and provide a new structural approach to addressing problems of this nature.			Narayan, K (corresponding author), Johns Hopkins Med Inst, Grad Program Immunol, Baltimore, MD 21205 USA.	ssadegh@jhmi.edu	Perkins, Edward/B-8276-2009	Sadegh-Nasseri, Scheherazade/0000-0002-8127-1720; Subramaniam, Sriram/0000-0003-4231-4115; Perkins, Edward/0000-0002-3077-7422	NATIONAL CANCER INSTITUTE [ZIABC010278, ZIABC010825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053549] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [1R01 AI063764, R01 AI063764] Funding Source: Medline; NIGMS NIH HHS [R01 GM 53549] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; CHOI YW, 1990, NATURE, V346, P471, DOI 10.1038/346471a0; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; Cuff L, 2003, J MOL GRAPH MODEL, V21, P473, DOI 10.1016/S1093-3263(02)00206-1; DELLABONA P, 1990, CELL, V62, P1115, DOI 10.1016/0092-8674(90)90388-U; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; DORNMAIR K, 1989, COLD SPRING HARB SYM, V54, P409; Dowd JE, 1996, MOL IMMUNOL, V33, P1267, DOI 10.1016/S0161-5890(96)00085-5; FAST DJ, 1989, INFECT IMMUN, V57, P291, DOI 10.1128/IAI.57.1.291-294.1989; Fooksman DR, 2006, J IMMUNOL, V176, P6673, DOI 10.4049/jimmunol.176.11.6673; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; Hakansson M, 2000, J MOL BIOL, V302, P527, DOI 10.1006/jmbi.2000.4093; HERMAN A, 1991, P NATL ACAD SCI USA, V88, P9954, DOI 10.1073/pnas.88.22.9954; HUDSON KR, 1995, J EXP MED, V182, P711, DOI 10.1084/jem.182.3.711; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; KOZONO H, 1995, IMMUNITY, V3, P187, DOI 10.1016/1074-7613(95)90088-8; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Lei L, 2001, J LEUKOCYTE BIOL, V70, P80; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MEHINDATE K, 1995, J EXP MED, V182, P1573, DOI 10.1084/jem.182.5.1573; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Natarajan SK, 1999, J IMMUNOL, V162, P3463; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; Papageorgiou AC, 2000, TRENDS MICROBIOL, V8, P369, DOI 10.1016/S0966-842X(00)01793-5; Perkins Edward M, 2007, Methods Mol Biol, V372, P467, DOI 10.1007/978-1-59745-365-3_33; Petersson K, 2004, SCAND J IMMUNOL, V59, P345, DOI 10.1111/j.0300-9475.2004.01404.x; Pless DD, 2005, INFECT IMMUN, V73, P5358, DOI 10.1128/IAI.73.9.5358-5366.2005; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Rosloniec EF, 2002, J IMMUNOL, V168, P253, DOI 10.4049/jimmunol.168.1.253; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; Sohn HW, 2006, P NATL ACAD SCI USA, V103, P8143, DOI 10.1073/pnas.0509858103; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Thibodeau J, 1997, RES IMMUNOL, V148, P217, DOI 10.1016/S0923-2494(97)80864-4; Thibodeau J, 1997, J IMMUNOL, V158, P3698; Tiedemann RE, 1996, J IMMUNOL, V157, P3958; Tiedemann RE, 1995, P NATL ACAD SCI USA, V92, P12156, DOI 10.1073/pnas.92.26.12156; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010	44	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6188	10.1371/journal.pone.0006188	http://dx.doi.org/10.1371/journal.pone.0006188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587800	gold, Green Published, Green Submitted			2022-12-27	WOS:000268035100012
J	Paparatto, D; Fletcher, D; Piwowar, K; Baldino, K; Morel, C; Dunaway, S				Paparatto, Domenica; Fletcher, Dane; Piwowar, Karen; Baldino, Kimberly; Morel, Charlotte; Dunaway, Stephen			The Schizosaccharomyces pombe Checkpoint Kinases Chk1 and Cds1 Are Important for Cell Survival in Response to Cisplatin	PLOS ONE			English	Article								Background: DNA damage checkpoints insure that the integrity of genomic DNA is faithfully maintained throughout the eukaryotic cell cycle. In the presence of damaged DNA, checkpoints are triggered to delay cell cycle progression to allow for DNA repair. In fission yeast, the kinases Chk1 and Cds1 are major components of these DNA damage checkpoint pathways. Both Chk1 and Cds1 are important for viability in the presence of several DNA damaging agents. In this study we hypothesized that Chk1 and Cds1 play a vital role in fission yeast cells ability to survive exposure to the DNA damaging agent cisplatin. Cisplatin is a potent chemotherapeutic drug that interacts with DNA and causes both inter-and intra-strand DNA cross-links. Methodology/Principal Findings: Here, we demonstrated that treatment with cisplatin in fission yeast causes a Chk1-dependent DNA damage signal. chk1(-) cells were sensitive to cisplatin and Chk1 was phosphorylated in response to cisplatin treatment. We also showed that a Chk1-dependent DNA damage checkpoint pathway is activated in a dose-dependent fashion in cells challenged with cisplatin. Furthermore the Cds1 checkpoint kinase was also important for viability in cisplatin challenged cells. In cds1(-) cells, cisplatin treatment reduced cell viability and this phenotype was exacerbated in a chk1(-)/cds1(-) background. Conclusions/Significance: Thus, we conclude that the concerted effort of both major checkpoint kinases in fission yeast, Chk1 and Cds1, protect cells from cisplatin induced DNA damage. These observations are significant because they suggest that various classes of inter-strand crosslinking agents may generate slightly different lesions as work by others did not observe loss of viability in cds1(-) cells treated with other crosslinking agents like nitrogen mustard.			Paparatto, D (corresponding author), Drew Univ, Dept Biol, Madison, NJ 07940 USA.	sdunaway@drew.edu	Baldino, Kimberly/HHS-1856-2022	Baldino, Kimberly/0000-0003-3935-4538				ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Baber-Furnari BA, 2000, MOL BIOL CELL, V11, P1; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Chen L, 1999, GENE DEV, V13, P675, DOI 10.1101/gad.13.6.675; Dunaway S, 2004, METHODS, V33, P260, DOI 10.1016/j.ymeth.2003.11.022; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Gaul L, 2008, J CANCER RES CLIN, V134, P245, DOI 10.1007/s00432-007-0278-x; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Grossmann KF, 1999, MUTAT RES-DNA REPAIR, V434, P29, DOI 10.1016/S0921-8777(99)00011-7; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Lambert S, 2003, MOL CELL BIOL, V23, P4728, DOI 10.1128/MCB.23.13.4728-4737.2003; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Liu QH, 2000, GENE DEV, V14, P1448; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perego P, 1998, MOL PHARMACOL, V54, P213, DOI 10.1124/mol.54.1.213; Qin J, 2003, RADIAT RES, V159, P139, DOI 10.1667/0033-7587(2003)159[0139:MAOTDD]2.0.CO;2; Rhind N, 1998, GENETICS, V149, P1729; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; Rhind N, 2000, J CELL SCI, V113, P3889; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wan S, 2001, CURR GENET, V38, P299, DOI 10.1007/s002940000172; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WEINERT TA, 1993, GENETICS, V134, P63; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6181	10.1371/journal.pone.0006181	http://dx.doi.org/10.1371/journal.pone.0006181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587778	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035100008
J	Soltis, BW; Sanders, JW; Putnam, SD; Tribble, DR; Riddle, MS				Soltis, Bryony W.; Sanders, John W.; Putnam, Shannon D.; Tribble, David R.; Riddle, Mark S.			Self Reported Incidence and Morbidity of Acute Respiratory Illness among Deployed US Military in Iraq and Afghanistan	PLOS ONE			English	Article								Background: Historically, respiratory infections have had a significant impact on U. S. military missions. Deployed troops are particularly at high risk due to close living conditions, stressful work environments and increased exposure to pathogens. To date, there are limited data available on acute respiratory illness (ARI) among troops deployed in support of ongoing military operations, specifically Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF). Methods: Using self-report data from two sources collected from troops deployed to Iraq, Afghanistan and the surrounding region, we analyzed incidence and risk factors for ARI. Military personnel on mid-deployment Rest & Recuperation (R&R) or during redeployment were eligible to participate in the voluntary self-report survey. Results: Overall, 39.5% reported having at least one ARI. Of these, 18.5% sought medical care and 33.8% reported having decreased job performance. The rate of self-reported ARI was 15 episodes per 100 person-months among those taking the voluntary survey, and 24.7 episodes per 100 person-months among those taking the clinic health questionnaire. Negative binomial regression analysis found female sex, Navy branch of service and lack of flush toilets to be independently associated with increased rates of ARI. Deployment to OIF, increasing age and higher rank were also positively associated with ARI risk. Conclusions: The overall percentage of deployed military personnel reporting at least one acute respiratory illness decreased since earlier parts of OIF/OEF. However, the reported effect on job performance increased tremendously. The most important factors associated with increased respiratory infection are female sex, Navy branch of service, lack of improved latrine facilities, deployment to OIF, increasing age and higher rank.			Soltis, BW (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med, Bethesda, MD 20814 USA.	mark.riddle@med.navy.mil	Putnam, Shan D/F-2345-2013; Riddle, Mark/A-8029-2011; Riddle, Mark/R-8788-2019	Putnam, Shan D/0000-0001-8353-4400; Riddle, Mark/0000-0002-0607-7880				Brundage JF, 1996, PEDIATRICS, V97, P964; CROSS ER, 1992, MIL MED, V157, P649, DOI 10.1093/milmed/157.12.649; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; HYAMS KC, 1995, CLIN INFECT DIS, V20, P1497, DOI 10.1093/clinids/20.6.1497; LIM ML, 2004, MIL MED; PAPARELLO SF, 1993, MIL MED, V158, P392, DOI 10.1093/milmed/158.6.392; RICHARDS AL, 1993, AM J PUBLIC HEALTH, V83, P1326, DOI 10.2105/AJPH.83.9.1326; Ryan MAK, 2001, AM J PREV MED, V21, P79, DOI 10.1016/S0749-3797(01)00323-3; Sanders JW, 2005, AM J TROP MED HYG, V73, P713, DOI 10.4269/ajtmh.2005.73.713; 1995, NCCE NEWS, V3, pS1	10	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6177	10.1371/journal.pone.0006177	http://dx.doi.org/10.1371/journal.pone.0006177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584919	Green Submitted, Green Published, gold			2022-12-27	WOS:000267806500008
J	Suvorova, ES; Lucas, O; Weisend, CM; Rollins, MF; Merrill, GF; Capecchi, MR; Schmidt, EE				Suvorova, Elena S.; Lucas, Olivier; Weisend, Carla M.; Rollins, MaryClare F.; Merrill, Gary F.; Capecchi, Mario R.; Schmidt, Edward E.			Cytoprotective Nrf2 Pathway Is Induced In Chronically Txnrd 1-Deficient Hepatocytes	PLOS ONE			English	Article								Background: Metabolically active cells require robust mechanisms to combat oxidative stress. The cytoplasmic thioredoxin reductase/thioredoxin (Txnrd1/Txn1) system maintains reduced protein dithiols and provides electrons to some cellular reductases, including peroxiredoxins. Principal Findings: Here we generated mice in which the txnrd1 gene, encoding Txnrd1, was specifically disrupted in all parenchymal hepatocytes. Txnrd1-deficient livers exhibited a transcriptome response in which 56 mRNAs were induced and 12 were repressed. Based on the global hybridization profile, this represented only 0.3% of the liver transcriptome. Since most liver mRNAs were unaffected, compensatory responses were evidently effective. Nuclear pre-mRNA levels indicated the response was transcriptional. Twenty-one of the induced genes contained known antioxidant response elements (AREs), which are binding sites for the oxidative and chemical stress-induced transcription factor Nrf2. Txnrd1-deficient livers showed increased accumulation of nuclear Nrf2 protein and chromatin immunoprecipitation on the endogenous nqo1 and aox1 promoters in fibroblasts indicated that Txnrd1 ablation triggered in vivo assembly of Nrf2 on each. Conclusions: Chronic deletion of Txnrd1 results in induction of the Nrf2 pathway, which contributes to an effective compensatory response.			Suvorova, ES (corresponding author), Montana State Univ, Bozeman, MT 59717 USA.	eschmidt@montana.edu			NCRR NIH HHS [2P20RR020285] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Arner E. S., 2009, BIOCH BIOPHYS ACTA; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Avellini C, 2007, TRANSPL P, V39, P1755, DOI 10.1016/j.transproceed.2007.05.082; Badea TC, 2003, J NEUROSCI, V23, P2314; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; BERNHEIM F, 1948, J BIOL CHEM, V174, P257; Bondareva AA, 2007, FREE RADICAL BIO MED, V43, P911, DOI 10.1016/j.freeradbiomed.2007.05.026; Camacho L, 2000, B ENVIRON CONTAM TOX, V64, P191, DOI 10.1007/s001289910029; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Carmel-Harel O, 2001, MOL MICROBIOL, V39, P595, DOI 10.1046/j.1365-2958.2001.02255.x; Cesaratto Laura, 2004, Ann Hepatol, V3, P86; Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Draculic T, 2000, MOL MICROBIOL, V36, P1167, DOI 10.1046/j.1365-2958.2000.01948.x; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Gladyshev VN, 1999, J BIOMED SCI, V6, P151, DOI 10.1007/BF02255899; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V168, P30, DOI 10.1016/j.cbi.2006.10.013; Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; Ikeda H, 2004, BIOCHEM J, V380, P515, DOI 10.1042/BJ20031948; Ishii T, 2002, METHOD ENZYMOL, V348, P182, DOI 10.1016/S0076-6879(02)48637-5; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Klaassen CD, 2005, CURR DRUG METAB, V6, P309, DOI 10.2174/1389200054633826; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; Lahoz A, 2008, RAPID COMMUN MASS SP, V22, P240, DOI 10.1002/rcm.3359; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Onai K, 1997, GENETICS, V146, P101; Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; RUSSEL M, 1988, P NATL ACAD SCI USA, V85, P990, DOI 10.1073/pnas.85.4.990; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Schmidt EE, 1997, J BIOL CHEM, V272, P5326, DOI 10.1074/jbc.272.8.5326; Schmidt EE, 2003, J BIOL CHEM, V278, P6168, DOI 10.1074/jbc.M211205200; SCHMIDT EE, 1995, J CELL BIOL, V128, P467, DOI 10.1083/jcb.128.4.467; Sengupta A, 2008, BIOCHEM J, V413, P151, DOI 10.1042/BJ20080277; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Suzuki T, 2008, J BIOL CHEM, V283, P2021, DOI 10.1074/jbc.M708352200; Umemura T, 2006, TOXICOL SCI, V90, P111, DOI 10.1093/toxsci/kfj076; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; WUARIN J, 1992, J CELL SCI, P123; Zaret KS, 2000, MECH DEVELOP, V92, P83, DOI 10.1016/S0925-4773(99)00326-3	60	72	72	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6158	10.1371/journal.pone.0006158	http://dx.doi.org/10.1371/journal.pone.0006158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19584930	gold, Green Published, Green Submitted			2022-12-27	WOS:000267806400013
J	Glazer, AN; Kechris, KJ				Glazer, Alexander N.; Kechris, Katerina J.			Conserved Amino Acid Sequence Features in the alpha Subunits of MoFe, VFe, and FeFe Nitrogenases	PLOS ONE			English	Article								Background: This study examines the structural features and phylogeny of the a subunits of 69 full-length NifD (MoFe subunit), VnfD (VFe subunit), and AnfD (FeFe subunit) sequences. Methodology/Principal Findings: The analyses of this set of sequences included BLAST scores, multiple sequence alignment, examination of patterns of covariant residues, phylogenetic analysis and comparison of the sequences flanking the conserved Cys and His residues that attach the FeMo cofactor to NifD and that are also conserved in the alternative nitrogenases. The results show that NifD nitrogenases fall into two distinct groups. Group I includes NifD sequences from many genera within Bacteria, including all nitrogen-fixing aerobes examined, as well as strict anaerobes and some facultative anaerobes, but no archaeal sequences. In contrast, Group II NifD sequences were limited to a small number of archaeal and bacterial sequences from strict anaerobes. The VnfD and AnfD sequences fall into two separate groups, more closely related to Group II NifD than to Group I NifD. The pattern of perfectly conserved residues, distributed along the full length of the Group I and II NifD, VnfD, and AnfD, confirms unambiguously that these polypeptides are derived from a common ancestral sequence. Conclusions/Significance: There is no indication of a relationship between the patterns of covariant residues specific to each of the four groups discussed above that would give indications of an evolutionary pathway leading from one type of nitrogenase to another. Rather the totality of the data, along with the phylogenetic analysis, is consistent with a radiation of Group I and II NifDs, VnfD and AnfD from a common ancestral sequence. All the data presented here strongly support the suggestion made by some earlier investigators that the nitrogenase family had already evolved in the last common ancestor of the Archaea and Bacteria.			Glazer, AN (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	glazer@berkeley.edu		Kechris, Katerina/0000-0002-3725-5459	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA016922] Funding Source: NIH RePORTER; NIAAA NIH HHS [K01-AA016922, K01 AA016922] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Betancourt DA, 2008, APPL ENVIRON MICROB, V74, P3471, DOI 10.1128/AEM.02694-07; Bickel PJ, 2002, P NATL ACAD SCI USA, V99, P14764, DOI 10.1073/pnas.222508899; Boison G, 2006, ARCH MICROBIOL, V186, P367, DOI 10.1007/s00203-006-0150-4; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; Eady RR, 2003, COORDIN CHEM REV, V237, P23, DOI 10.1016/S0010-8545(02)00248-5; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Fani R, 2000, J MOL EVOL, V51, P1; Henson BJ, 2004, J MOL EVOL, V58, P390, DOI 10.1007/s00239-003-2560-0; Kechris KJ, 2006, P NATL ACAD SCI USA, V103, P9584, DOI 10.1073/pnas.0603534103; KIM J, 1993, BIOCHEMISTRY-US, V32, P7104, DOI 10.1021/bi00079a006; KIRN J, 1992, NATURE, V360, P553, DOI DOI 10.1038/360553A0; NORMAND P, 1992, MOL BIOL EVOL, V9, P495; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Rees D. C., 2005, PHILOS T A, V363; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Schrock RR, 2005, PHILOS T R SOC A, V363, P959, DOI 10.1098/rsta.2004.1541; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; WANG SZ, 1988, BIOCHEMISTRY-US, V27, P2800, DOI 10.1021/bi00408a021; Young JPW, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P221	19	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6136	10.1371/journal.pone.0006136	http://dx.doi.org/10.1371/journal.pone.0006136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578539	Green Submitted, gold, Green Published			2022-12-27	WOS:000267806300008
J	Ozkucur, N; Monsees, TK; Perike, S; Do, HQ; Funk, RHW				Oezkucur, Nurdan; Monsees, Thomas K.; Perike, Srikanth; Do, Hoa Quynh; Funk, Richard H. W.			Local Calcium Elevation and Cell Elongation Initiate Guided Motility in Electrically Stimulated Osteoblast-Like Cells	PLOS ONE			English	Article								Background: Investigation of the mechanisms of guided cell migration can contribute to our understanding of many crucial biological processes, such as development and regeneration. Endogenous and exogenous direct current electric fields (dcEF) are known to induce directional cell migration, however the initial cellular responses to electrical stimulation are poorly understood. Ion fluxes, besides regulating intracellular homeostasis, have been implicated in many biological events, including regeneration. Therefore understanding intracellular ion kinetics during EF-directed cell migration can provide useful information for development and regeneration. Methodology/Principal Findings: We analyzed the initial events during migration of two osteogenic cell types, rat calvarial and human SaOS-2 cells, exposed to strong (10-15 V/cm) and weak (<= 5 V/cm) dcEFs. Cell elongation and perpendicular orientation to the EF vector occurred in a time- and voltage-dependent manner. Calvarial osteoblasts migrated to the cathode as they formed new filopodia or lamellipodia and reorganized their cytoskeleton on the cathodal side. SaOS-2 cells showed similar responses except towards the anode. Strong dcEFs triggered a rapid increase in intracellular calcium levels, whereas a steady state level of intracellular calcium was observed in weaker fields. Interestingly, we found that dcEF-induced intracellular calcium elevation was initiated with a local rise on opposite sides in calvarial and SaOS-2 cells, which may explain their preferred directionality. In calcium-free conditions, dcEFs induced neither intracellular calcium elevation nor directed migration, indicating an important role for calcium ions. Blocking studies using cadmium chloride revealed that voltage-gated calcium channels (VGCCs) are involved in dcEF-induced intracellular calcium elevation. Conclusion/Significance: Taken together, these data form a time scale of the morphological and physiological rearrangements underlying EF-guided migration of osteoblast-like cell types and reveal a requirement for calcium in these reactions. We show for the first time here that dcEFs trigger different patterns of intracellular calcium elevation and positional shifting in osteogenic cell types that migrate in opposite directions.			Ozkucur, N (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Anat, Dresden, Germany.	Nurdan.Oezkucur@tu-dresden.de	Ozkucur, Nurdan/D-4275-2011; Funk, Richard HW/I-1780-2013; Do, Hoa/AAL-1505-2020	Do, Hoa/0000-0001-7361-6066; Perike, Srikanth/0000-0002-3045-0278				Bai H, 2004, ARTERIOSCL THROM VAS, V24, P1234, DOI 10.1161/01.ATV.0000131265.76828.8a; BINDERMAN I, 1985, BIOCHIM BIOPHYS ACTA, V844, P273, DOI 10.1016/0167-4889(85)90127-2; BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117; Cho MR, 1996, FASEB J, V10, P1552, DOI 10.1096/fasebj.10.13.8940302; CIVITELLI R, 1987, J CELL PHYSIOL, V131, P434, DOI 10.1002/jcp.1041310316; COOPER MS, 1986, J CELL BIOL, V102, P1384, DOI 10.1083/jcb.102.4.1384; Curtze S, 2004, J CELL SCI, V117, P2721, DOI 10.1242/jcs.01119; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Fang KS, 1999, J CELL SCI, V112, P1967; FERRIER J, 1986, J CELL PHYSIOL, V129, P283, DOI 10.1002/jcp.1041290303; FERRIER J, 1987, J CELL PHYSIOL, V130, P344, DOI 10.1002/jcp.1041300306; Funk RHW, 2006, CELLS TISSUES ORGANS, V182, P59, DOI 10.1159/000093061; Funk RHW, 2009, PROG HISTOCHEM CYTO, V43, P177, DOI 10.1016/j.proghi.2008.07.001; Hausser HJ, 2005, BIOCHEM BIOPH RES CO, V333, P216, DOI 10.1016/j.bbrc.2005.05.097; Ho Mei-Ling, 1999, Kaohsiung Journal of Medical Sciences, V15, P248; Khatib L, 2004, FASEB J, V18, P1903, DOI 10.1096/fj.04-1814fje; Levin M, 2007, TRENDS CELL BIOL, V17, P261, DOI 10.1016/j.tcb.2007.04.007; Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Monsees TK, 2005, CELLS TISSUES ORGANS, V180, P81, DOI 10.1159/000086749; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; ONUMA EK, 1988, J CELL BIOL, V106, P2067, DOI 10.1083/jcb.106.6.2067; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; RODAN SB, 1987, CANCER RES, V47, P4961; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Stull JT, 1998, ACTA PHYSIOL SCAND, V164, P471, DOI 10.1111/j.1365-201X.1998.tb10699.x; Titushkin IA, 2004, IEEE T PLASMA SCI, V32, P1614, DOI 10.1109/TPS.2004.832625; Trollinger DR, 2002, J CELL PHYSIOL, V193, P1, DOI 10.1002/jcp.10144; Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; WILTINK A, 1994, CALCIFIED TISSUE INT, V54, P278, DOI 10.1007/BF00295951; Zhao M, 1996, INVEST OPHTH VIS SCI, V37, P2548; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	33	58	62	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6131	10.1371/journal.pone.0006131	http://dx.doi.org/10.1371/journal.pone.0006131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19584927	gold, Green Published, Green Submitted			2022-12-27	WOS:000267806300005
J	Morrow, G; Nicol, SC				Morrow, Gemma; Nicol, Stewart C.			Cool Sex? Hibernation and Reproduction Overlap in the Echidna	PLOS ONE			English	Article							BODY-TEMPERATURE; GROWTH	During hibernation there is a slowing of all metabolic processes, and thus it is normally considered to be incompatible with reproduction. In Tasmania the egg-laying mammal, the echidna (Tachyglossus aculeatus) hibernates for several months before mating in mid-winter, and in previous studies we observed males with females that were still hibernating. We monitored the reproductive activity of radio-tracked echidnas by swabbing the reproductive tract for sperm while external temperature loggers provided information on the timing of hibernation. Additional information was provided by camera traps and ultrasound imaging. More than a third of the females found in mating groups were torpid, and the majority of these had mated. Some females re-entered deep torpor for extended periods after mating. Ultrasound examination showed a developing egg in the uterus of a female that had repeatedly re-entered torpor. The presence of fresh sperm in cloacal swabs taken from this female on three occasions after her presumed date of fertilization indicated she mated several times after being fertilized. The mating of males with torpid females is the result of extreme competition between promiscuous males, while re-entry into hibernation by pregnant females could improve the possibility of mating with a better quality male.			Morrow, G (corresponding author), Univ Tasmania, Sch Zool, Hobart, Tas, Australia.	s.c.nicol@utas.edu.au		Morrow, Gemma/0000-0002-4391-0165				BARNES BM, 1986, BIOL REPROD, V35, P1289, DOI 10.1095/biolreprod35.5.1289; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Crichton Elizabeth G., 2000, P295, DOI 10.1016/B978-012195670-7/50008-4; Dausmann KH, 2005, J COMP PHYSIOL B, V175, P147, DOI 10.1007/s00360-004-0470-0; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F., 2008, HYPOMETABOLISM ANIMA, P297; Geiser Fritz, 1996, P81; GRIFFITHS M, 1999, ENCY REPROD, P295; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Johnston SD, 2007, AM NAT, V170, pE162, DOI 10.1086/522847; Jones R. C., 2004, Australian Mammalogy, V26, P199; Kilen SM, 1999, ENCY REPROD, P127; Koehler CE, 2000, J MAMMAL, V81, P234, DOI 10.1644/1545-1542(2000)081<0234:PNGABB>2.0.CO;2; Morrow GE, AUSTR J ZOO IN PRESS; Nicol S, 2002, COMP BIOCHEM PHYS B, V131, P603, DOI 10.1016/S1096-4959(02)00018-0; Nicol S, 2006, J THERM BIOL, V31, P483, DOI 10.1016/j.jtherbio.2006.05.001; Nicol SC, 2008, COMP BIOCHEM PHYS A, V150, P189, DOI 10.1016/j.cbpa.2006.08.039; RACEY PA, 1981, J REPROD FERTIL, V61, P123; RACEY PA, 2000, REPROD BIOL BATS, P361; Rismiller P.D., 1996, P23; Rismiller PD, 2003, COMP BIOCHEM PHYS A, V136, P851, DOI 10.1016/S1095-6433(03)00225-3; Rismiller PD, 2000, J MAMMAL, V81, P1, DOI 10.1644/1545-1542(2000)081<0001:FOBARI>2.0.CO;2; Rose RW, 1997, J ZOOL, V243, P523, DOI 10.1111/j.1469-7998.1997.tb02798.x; Schmid J, 2003, COMP BIOCHEM PHYS A, V136, P903, DOI 10.1016/S1095-6433(03)00240-X; STRAHAN R, 2008, MAMMALS AUSTR NEW HO, P880; TAGGART DA, 1998, SPERM COMPETITION SE; VANPE C, AUSTR J ZOO IN PRESS; Willis CKR, 2006, NATURWISSENSCHAFTEN, V93, P80, DOI 10.1007/s00114-005-0063-0	28	43	43	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6070	10.1371/journal.pone.0006070	http://dx.doi.org/10.1371/journal.pone.0006070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562080	Green Accepted, Green Published, gold			2022-12-27	WOS:000267465900006
J	Bilcke, J; Van Damme, P; Van Ranst, M; Hens, N; Aerts, M; Beutels, P				Bilcke, Joke; Van Damme, Pierre; Van Ranst, Marc; Hens, Niel; Aerts, Marc; Beutels, Philippe			Estimating the Incidence of Symptomatic Rotavirus Infections: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							POTENTIAL COST-EFFECTIVENESS; 1ST 2 YEARS; YOUNG-CHILDREN; CHILDHOOD DIARRHEA; EGYPTIAN CHILDREN; ESCHERICHIA-COLI; NIGERIAN INFANTS; RURAL BANGLADESH; URBAN-COMMUNITY; BIRTH COHORT	Background: We conducted for the first time a systematic review, including a meta-analysis, of the incidence of symptomatic rotavirus (RV) infections, because (1) it was shown to be an influential factor in estimating the cost-effectiveness of RV vaccination, (2) multiple community-based studies assessed it prospectively, (3) previous studies indicated, inconclusively, it might be similar around the world. Methodology: Pubmed (which includes Medline) was searched for surveys assessing prospectively symptomatic (diarrheal) episodes in a general population and situation, which also reported on the number of the episodes being tested RV+ and on the persons and the time period observed. A bias assessment tool was developed and used according to Cochrane guidelines by 4 researchers with different backgrounds. Heterogeneity was explored graphically and by comparing fits of study-homogenous 'fixed effects' and -heterogeneous 'random effects' models. Data were synthesized using these models. Sensitivity analysis for uncertainty regarding data abstraction, bias assessment and included studies was performed. Principal Findings: Variability between the incidences obtained from 20 studies is unlikely to be due to study groups living in different environments (tropical versus temperate climate, slums versus middle-class suburban populations), nor due to the year the study was conducted (from 1967 to 2003). A random effects model was used to incorporate unexplained heterogeneity and resulted in a global incidence estimate of 0.31 [0.19; 0.50] symptomatic RV infections per personyear of observation for children below 2 years of age, and of 0.24 [0.17; 0.34] when excluding the extreme high value of 0.84 reported for Mayan Indians in Guatemala. Apart from the inclusion/exclusion of the latter study, results were robust. Conclusions/Significance: Rather than assumptions based on an ad-hoc selection of one or two studies, these pooled estimates (together with the measure for variability between populations) should be used as an input in future cost-effectiveness analyses of RV vaccination.			Bilcke, J (corresponding author), Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, Ctr Evaluat Vaccinat, CHERMID, B-2020 Antwerp, Belgium.	joke.bilcke@ua.ac.be	Van Ranst, Marc/P-7522-2017; van damme, pierre/I-4846-2013; Bilcke, Joke M/A-7082-2012; Bilcke, Joke/AAC-8932-2019; Beutels, Philippe/A-1919-2010; Hens, Niel/M-4445-2017	Van Ranst, Marc/0000-0002-1674-4157; Bilcke, Joke/0000-0001-5720-5291; Beutels, Philippe/0000-0001-5034-3595; Hens, Niel/0000-0003-1881-0637; van damme, pierre/0000-0002-8642-1249				Agresti A., 2018, WILEY SERIES PROBABI; ARAYA M, 1985, J HYG-CAMBRIDGE, V95, P457, DOI 10.1017/S0022172400062884; Banerjee I, 2006, J CLIN MICROBIOL, V44, P2468, DOI 10.1128/JCM.01882-05; BHAN MK, 1989, B WORLD HEALTH ORGAN, V67, P281; Bilcke J, 2009, MED DECIS MAKING, V29, P33, DOI 10.1177/0272989X08324955; BLACK RE, 1982, AM J EPIDEMIOL, V115, P315, DOI 10.1093/oxfordjournals.aje.a113308; BLACK RE, 1981, LANCET, V1, P141; Block SL, 2007, PEDIATRICS, V119, P11, DOI 10.1542/peds.2006-2058; CALDERON SM, 1990, AN ESP PEDIATR, V32, P114; Constenla D, 2008, An Pediatr (Barc), V68, P128; Constenla D, 2006, REV MED CHILE, V134, P679; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; Cooper Nicola, 2005, J Health Serv Res Policy, V10, P245, DOI 10.1258/135581905774414187; CRAVIOTO A, 1988, EPIDEMIOL INFECT, V101, P123, DOI 10.1017/S0950268800029289; de Soarez PC, 2008, REV PANAM SALUD PUBL, V23, P221, DOI 10.1590/S1020-49892008000400001; DEZOYSA I, 1985, B WORLD HEALTH ORGAN, V63, P569; Espinoza F, 1997, PEDIATR INFECT DIS J, V16, P564, DOI 10.1097/00006454-199706000-00006; FAGBAMI AH, 1987, TROP GEOGR MED, V39, P341; Fischer TK, 2005, J INFECT DIS, V192, P1720, DOI 10.1086/497339; Fischer TK, 2002, J INFECT DIS, V186, P593, DOI 10.1086/342294; GEORGESCOURBOT MC, 1988, ANN INST PASTEUR VIR, V139, P421, DOI 10.1016/S0769-2617(88)80077-7; Goossens LMA, 2008, VACCINE, V26, P1118, DOI 10.1016/j.vaccine.2007.11.070; GRINSTEIN S, 1989, AM J EPIDEMIOL, V130, P300, DOI 10.1093/oxfordjournals.aje.a115336; GURWITH M, 1981, J INFECT DIS, V144, P218, DOI 10.1093/infdis/144.3.218; Haque R, 2003, AM J TROP MED HYG, V69, P398, DOI 10.4269/ajtmh.2003.69.398; Hasan KZ, 2006, J HEALTH POPUL NUTR, V24, P25; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Ho AMH, 2008, ARCH DIS CHILD, V93, P52, DOI 10.1136/adc.2007.117879; Isakbaeva ET, 2007, VACCINE, V25, P373, DOI 10.1016/j.vaccine.2006.07.029; JAYASHREE S, 1988, SCAND J INFECT DIS, V20, P249, DOI 10.3109/00365548809032447; Jiraphongsa C, 2005, J INFECT DIS, V192, pS87, DOI 10.1086/431508; Jit M, 2007, VACCINE, V25, P3971, DOI 10.1016/j.vaccine.2007.02.070; LINHARES AC, 1989, EPIDEMIOL INFECT, V102, P129, DOI 10.1017/S0950268800029769; Lorgelly PK, 2008, EPIDEMIOL INFECT, V136, P44, DOI 10.1017/S0950268807008151; MATA L, 1983, J INFECT DIS, V148, P452, DOI 10.1093/infdis/148.3.452; Melliez H, 2008, VACCINE, V26, P706, DOI 10.1016/j.vaccine.2007.11.064; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MOLBAK K, 1994, J INFECT DIS, V169, P581, DOI 10.1093/infdis/169.3.581; Mrukowicz J, 2008, J PEDIATR GASTR NUTR, V46, pS32, DOI 10.1097/MPG.0b013e31816f79b0; Naficy AB, 1999, AM J EPIDEMIOL, V150, P770, DOI 10.1093/oxfordjournals.aje.a010080; Newall AT, 2007, VACCINE, V25, P8851, DOI 10.1016/j.vaccine.2007.10.009; OYEJIDE CO, 1988, INT J EPIDEMIOL, V17, P908, DOI 10.1093/ije/17.4.908; OYEJIDE CO, 1988, INT J EPIDEMIOL, V17, P903, DOI 10.1093/ije/17.4.903; PANIGRAHI D, 1985, Journal of Diarrhoeal Diseases Research, V3, P20; Podewils LJ, 2005, J INFECT DIS, V192, pS133, DOI 10.1086/431513; PUNYARATABANDHU P, 1991, J DIARRHOEAL DIS RES, V9, P244; Qadri F, 2007, INFECT IMMUN, V75, P3961, DOI 10.1128/IAI.00459-07; REVES RR, 1989, AM J EPIDEMIOL, V130, P981, DOI 10.1093/oxfordjournals.aje.a115431; RODRIGUEZ WJ, 1987, PEDIATR INFECT DIS J, V6, P170, DOI 10.1097/00006454-198702000-00006; ROWLAND M G M, 1985, Annals of Tropical Paediatrics, V5, P23; SIMHON A, 1990, INT J EPIDEMIOL, V19, P160, DOI 10.1093/ije/19.1.160; SIMHON A, 1985, J INFECT DIS, V152, P1134, DOI 10.1093/infdis/152.6.1134; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutton AJAK, 2000, METHODS METAANALYSIS; TUFVESSON B, 1986, ACTA PAEDIATR SCAND, V75, P211, DOI 10.1111/j.1651-2227.1986.tb10186.x; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; VELAZQUEZ FR, 1993, PEDIATR INFECT DIS J, V12, P54, DOI 10.1097/00006454-199301000-00013; Vernacchio L, 2006, PEDIATR INFECT DIS J, V25, P2, DOI 10.1097/01.inf.0000195623.57945.87; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2004, PEDIATR INFECT DIS J, V23, P937, DOI 10.1097/01.inf.0000141722.10130.50; Vesikari T, 2006, VACCINE, V24, P4821, DOI 10.1016/j.vaccine.2006.03.025; WHO, 2008, WHO GUID STAND EC EV; Widdowson MA, 2007, PEDIATRICS, V119, P684, DOI 10.1542/peds.2006-2876; Yachha S K, 1994, Indian Pediatr, V31, P27; YANG CR, 1990, J DIARRHOEAL DIS RES, V8, P155; Yap K L, 1992, Med J Malaysia, V47, P303; ZHENG BJ, 1989, J CLIN MICROBIOL, V27, P2083, DOI 10.1128/JCM.27.9.2083-2090.1989	67	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6060	10.1371/journal.pone.0006060	http://dx.doi.org/10.1371/journal.pone.0006060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557133	Green Published, gold, Green Submitted			2022-12-27	WOS:000267424600008
J	Zhang, HM; Dang, HW; Yeh, CK; Zhang, BX				Zhang, Hong-Mei; Dang, Howard; Yeh, Chih-Ko; Zhang, Bin-Xian			Linoleic Acid-Induced Mitochondrial Ca2+ Efflux Causes Peroxynitrite Generation and Protein Nitrotyrosylation	PLOS ONE			English	Article								It is well known that excessive non-esterified fatty acids in diabetes contribute to the pathogenesis of renal complications although the mechanism remains elusive. Enhanced oxidative stress has been hypothesized as a unified factor contributing to diabetic complications and increased protein nitrotyrosylation has been reported in the kidneys of diabetic patients. In the current manuscript we described that linoleic acid (LA) caused mitochondrial Ca2+ efflux and peroxynitrite production, along with increased nitrotyrosine levels of cellular proteins in primary human mesangial cells. The peroxynitrite production by LA was found to depend on mitochondrial Ca2+ efflux. Downregulation of hsp90 beta 1, which has been previously shown to be essential for polyunsaturated fatty acid-induced mitochondrial Ca2+ efflux, significantly diminished LA-responsive mitochondrial Ca2+ efflux and the coupled peroxynitrite generation, implicating a critical role of hsp90 beta 1 in the LA responses. Our results further demonstrated that mitochondrial complexes I and III were directly involved in the LA-induced peroxynitrite generation. Using the well established type 2 diabetic animal model db/db mice, we observed a dramatically enhanced LA responsive mitochondrial Ca2+ efflux and protein nitrotyrosylation in the kidney. Our study thus demonstrates a cause-effect relationship between LA and peroxynitrite or protein nitrotyrosylation and provides a novel mechanism for lipid-induced nephropathy in diabetes.			Zhang, HM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	zhangb2@uthscsa.edu		Yeh, Chih-Ko/0000-0001-6611-9942	NHLBI NIH HHS [HL075011, R01 HL075011] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075011] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ali TK, 2008, DIABETES, V57, P889, DOI 10.2337/db07-1669; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Biden TJ, 2004, DIABETES, V53, pS159, DOI 10.2337/diabetes.53.2007.S159; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Ceriello A, 2001, DIABETOLOGIA, V44, P834; Chinen I, 2007, ENDOCRINOLOGY, V148, P160, DOI 10.1210/en.2006-1132; DAS AM, 1990, CARDIOVASC RES, V24, P411, DOI 10.1093/cvr/24.5.411; Drel VR, 2006, FREE RADICAL BIO MED, V40, P1454, DOI 10.1016/j.freeradbiomed.2005.12.034; Duplain H, 2008, J PHYSIOL-LONDON, V586, P4011, DOI 10.1113/jphysiol.2008.154302; Feldkamp T, 2006, AM J PHYSIOL-RENAL, V290, pF465, DOI 10.1152/ajprenal.00305.2005; Ghafourifar P, 2005, METHOD ENZYMOL, V396, P424, DOI 10.1016/S0076-6879(05)96036-9; Ha TS, 1999, J AM SOC NEPHROL, V10, P1931; Hansford RG, 1998, MOL CELL BIOCHEM, V184, P359, DOI 10.1023/A:1006893903113; Hendrickson SC, 1997, MOL CELL BIOCHEM, V166, P85, DOI 10.1023/A:1006886601825; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kanski J, 2005, J BIOL CHEM, V280, P24261, DOI 10.1074/jbc.M501773200; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kozlov AV, 1999, FEBS LETT, V454, P127, DOI 10.1016/S0014-5793(99)00788-7; Lacza Z, 2006, NITRIC OXIDE-BIOL CH, V14, P162, DOI 10.1016/j.niox.2005.05.011; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Manabe E, 2008, J CELL BIOCHEM, V103, P1925, DOI 10.1002/jcb.21583; Misko TP, 1998, J BIOL CHEM, V273, P15646, DOI 10.1074/jbc.273.25.15646; Pacher P, 2005, CURR MED CHEM, V12, P267, DOI 10.2174/0929867053363207; Parihar MS, 2008, BIOCHEM BIOPH RES CO, V366, P23, DOI 10.1016/j.bbrc.2007.11.056; Possel H, 1997, FEBS LETT, V416, P175, DOI 10.1016/S0014-5793(97)01197-6; Prabhakar S, 2007, J AM SOC NEPHROL, V18, P2945, DOI 10.1681/ASN.2006080895; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Sheu JN, 2006, FOOD CHEM TOXICOL, V44, P409, DOI 10.1016/j.fct.2005.08.014; SILVER BJ, 1989, P NATL ACAD SCI USA, V86, P1056, DOI 10.1073/pnas.86.3.1056; Thuraisingham RC, 2000, KIDNEY INT, V57, P1968, DOI 10.1046/j.1523-1755.2000.00046.x; Yi L, 2007, CHEM PHYS LIPIDS, V150, P204, DOI 10.1016/j.chemphyslip.2007.08.002; Zhang BX, 2006, AM J PHYSIOL-CELL PH, V290, pC1321, DOI 10.1152/ajpcell.00335.2005; Zhang H, 2008, J BIOL CHEM, V283, P7580, DOI 10.1074/jbc.M707192200; Zhang WK, 2007, AM J PHYSIOL-RENAL, V292, pF1054, DOI 10.1152/ajprenal.00286.2006; Zhou YP, 1996, DIABETES, V45, P580, DOI 10.2337/diabetes.45.5.580	37	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6048	10.1371/journal.pone.0006048	http://dx.doi.org/10.1371/journal.pone.0006048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557129	Green Published, Green Submitted, gold			2022-12-27	WOS:000267424600003
J	Wise, JL; Crout, RJ; McNeil, DW; Weyant, RJ; Marazita, ML; Wenger, SL				Wise, Jasen L.; Crout, Richard J.; McNeil, Daniel W.; Weyant, Robert J.; Marazita, Mary L.; Wenger, Sharon L.			Human Telomere Length Correlates to the Size of the Associated Chromosome Arm	PLOS ONE			English	Article								The majority of human telomere length studies have focused on the overall length of telomeres within a cell. In fact, very few studies have examined telomere length for individual chromosome arms. The objective of this study was to examine the relationship between chromosome arm size and the relative length of the associated telomere. Quantitative Fluorescence In Situ Hybridization (Q-FISH) was used to measure the relative telomere length of each chromosome arm in metaphases from cultured lymphocytes of 17 individuals. A statistically significant positive correlation (r = 0.6) was found between telomere length and the size of the associated chromosome arm, which was estimated based on megabase pair measurements from http://www.ncbi.nlm.nih.gov/projects/mapview/.			Wise, JL (corresponding author), W Virginia Univ, Dept Pathol, Morgantown, WV 26506 USA.	jasenwise@gmail.com		Weyant, Robert/0000-0002-5252-9120	NIDCR NIH HHS [5 R01-DE014899, R01 DE014899] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014899] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644; Graakjaer J, 2006, HUM GENET, V119, P344, DOI 10.1007/s00439-006-0137-x; Graakjaer J, 2004, AGING CELL, V3, P97, DOI 10.1111/j.1474-9728.2004.00093.x; Graakjaer J, 2003, MECH AGEING DEV, V124, P629, DOI 10.1016/S0047-6374(03)00081-2; *INT CTR BIOT INF, 2008, NAT CTR BIOT INF MAP; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Polk Deborah E, 2008, BMC Oral Health, V8, P18, DOI 10.1186/1472-6831-8-18; Shay JW, 2007, J PATHOL, V211, P114, DOI 10.1002/path.2090; Shay JW, 2001, RADIAT RES, V155, P188, DOI 10.1667/0033-7587(2001)155[0188:TATIFC]2.0.CO;2; Slijepcevic P, 1999, CYTOGENET CELL GENET, V85, P196, DOI 10.1159/000015292; Slijepcevic Predrag, 2001, Methods in Cell Science, V23, P17, DOI 10.1023/A:1013177128297; Sridevi V., 2002, Cytologia (Tokyo), V67, P185, DOI 10.1508/cytologia.67.185; Suda T, 2002, BIOCHEM BIOPH RES CO, V291, P210, DOI 10.1006/bbrc.2002.6425; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	15	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6013	10.1371/journal.pone.0006013	http://dx.doi.org/10.1371/journal.pone.0006013			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547752	Green Published, gold, Green Accepted			2022-12-27	WOS:000267347900011
J	Desprat, R; Bouhassira, EE				Desprat, Romain; Bouhassira, Eric E.			Gene Specificity of Suppression of Transgene-Mediated Insertional Transcriptional Activation by the Chicken HS4 Insulator	PLOS ONE			English	Article								Insertional mutagenesis has emerged as a major obstacle for gene therapy based on vectors that integrate randomly in the genome. Reducing the genotoxicity of genomic viral integration can, in first approximation, be equated with reducing the risk of oncogene activation, at least in the case of therapeutic payloads that have no known oncogenic potential, such as the globin genes. An attractive solution to the problem of oncogene activation is the inclusion of insulators/enhancer-blockers in the viral vectors. In this study we have used Recombinase-Mediated Cassette Exchange to characterize the effect of integration of globin therapeutic cassettes in the presence or absence of the chicken HS4 and three other putative insulators inserted near Stil, Tal1 and MAP17, three well-known cellular proto-oncogenes in the SCL/Tal1 locus. We show that insertion of a Locus Control Region-driven globin therapeutic globin transgene had a dramatic activating effect on Tal1 and Map17, the two closest genes, a minor effect on Stil, and no effect on Cyp4x1, a non-expressed gene. Of the four element tested, cHS4 was the only one that was able to suppress this transgene-mediated insertional transcriptional activation. cHS4 had a strong suppressive effect on the activation expression of Map17 but has little or no effect on expression of Tal1. The suppressive activity of cHS4 is therefore promoter specific. Importantly, the observed suppressive effect of cHS4 on Map17 activation did not depend on its intercalation between the LCR and the Map 17 promoter. Rather, presence of one or two copies of cHS4 anywhere within the transgene was sufficient to almost completely block the activation of Map17. Therefore, at this complex locus, suppression of transgene-mediated insertional transcriptional activation by cHS4 could not be adequately explained by models that predict that cHS4 can only suppress expression through an enhancer-blocking activity that requires intercalation between an enhancer and a promoter. This has important implications for our theoretical understanding of the possible effects of the insertion of cHS4 on gene therapy vectors. We also show that cHS4 decreased the level of expression of the globin transgene. Therefore, the benefits of partially preventing insertional gene activation are in part negated by the lower expression level of the transgene. A cost/benefit analysis of the utility of incorporation of insulators in gene therapy vectors will require further studies in which the effects of insulators on both the therapeutic gene and the flanking genes are determined at a large number of integration sites. Identification of insulators with minimal promoter specificity would also be of great value.			Desprat, R (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	bouhassi@aecom.yu.edu	Bouhassira, Eric/AAZ-4184-2021		NHLBI NIH HHS [R01 HL088467, R01-HL088467] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088467] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Alami R, 2000, HUM MOL GENET, V9, P631, DOI 10.1093/hmg/9.4.631; Begley CG, 1999, BLOOD, V93, P2760; Bouhassira EE, 1997, BLOOD, V90, P3332, DOI 10.1182/blood.V90.9.3332; Byrd K, 2003, J CELL BIOL, V162, P565, DOI 10.1083/jcb.200305013; Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Coffin J, 1997, RETROVIRUSES; Delabesse E, 2005, MOL CELL BIOL, V25, P5215, DOI 10.1128/MCB.25.12.5215-5225.2005; Emery DW, 2002, BLOOD, V100, P2012, DOI 10.1182/blood-2002-01-0219; Evans-Galea MV, 2007, MOL THER, V15, P801, DOI 10.1038/sj.mt.6300103; Feng YQ, 2006, PLOS GENET, V2, P461, DOI 10.1371/journal.pgen.0020065; Feng YQ, 2001, MOL CELL BIOL, V21, P298, DOI 10.1128/MCB.21.1.298-309.2001; Feng YQ, 2005, MOL CELL BIOL, V25, P3864, DOI 10.1128/MCB.25.10.3864-3874.2005; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; Fu HQ, 2006, NAT BIOTECHNOL, V24, P572, DOI 10.1038/nbt1202; Guijarro MV, 2007, CARCINOGENESIS, V28, P1646, DOI 10.1093/carcin/bgm083; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Iborra FJ, 1996, J CELL SCI, V109, P1427; Imren S, 2002, P NATL ACAD SCI USA, V99, P14380, DOI 10.1073/pnas.212507099; Kaufman RM, 1999, BLOOD, V94, P3178, DOI 10.1182/blood.V94.9.3178.421k23_3178_3184; KIM JH, 2008, HUMAN GAMMA SA UNPUB; Kohn DB, 2003, NAT REV CANCER, V3, P477, DOI 10.1038/nrc1122; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee C, 2000, CHROMOSOMA, V109, P381, DOI 10.1007/s004120000095; Levasseur DN, 2003, BLOOD, V102, P4312, DOI 10.1182/blood-2003-04-1251; LIN CC, 1993, CHROMOSOMA, V102, P333, DOI 10.1007/BF00661276; Malik P, 2005, ANN NY ACAD SCI, V1054, P238, DOI 10.1196/annals.1345.030; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nienhuis AW, 2008, BLOOD, V111, P4431, DOI 10.1182/blood-2007-11-078121; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; Pawliuk R, 1999, NAT MED, V5, P768, DOI 10.1038/10488; Persons DA, 2003, BLOOD, V102, P506, DOI 10.1182/blood-2003-03-0677; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Porcu S, 1997, BLOOD, V90, P4602, DOI 10.1182/blood.V90.11.4602.4602_4602_4609; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; Puthenveetil G, 2004, BLOOD, V104, P3445, DOI 10.1182/blood-2004-04-1427; Ramezani A, 2003, BLOOD, V101, P4717, DOI 10.1182/blood-2002-09-2991; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Ryu BY, 2007, BLOOD CELL MOL DIS, V39, P221, DOI 10.1016/j.bcmd.2007.05.003; Tanimoto K, 2003, MOL CELL BIOL, V23, P8946, DOI 10.1128/MCB.23.24.8946-8952.2003; Tuan D, 1987, Prog Clin Biol Res, V251, P211; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Wai AWK, 2003, EMBO J, V22, P4489, DOI 10.1093/emboj/cdg437; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Walters MC, 1999, MOL CELL BIOL, V19, P3714; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yannaki E, 2002, MOL THER, V5, P589, DOI 10.1006/mthe.2002.0582; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zang DY, 2001, BLOOD, V98, P3058, DOI 10.1182/blood.V98.10.3058	57	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5956	10.1371/journal.pone.0005956	http://dx.doi.org/10.1371/journal.pone.0005956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536296	Green Published, gold, Green Submitted			2022-12-27	WOS:000267079500006
J	Mace, MJM; Joubert, OR; Nespoulous, JL; Fabre-Thorpe, M				Mace, Marc J. -M.; Joubert, Olivier R.; Nespoulous, Jean-Luc; Fabre-Thorpe, Michele			The Time-Course of Visual Categorizations: You Spot the Animal Faster than the Bird	PLOS ONE			English	Article								Background: Since the pioneering study by Rosch and colleagues in the 70s, it is commonly agreed that basic level perceptual categories (dog, chair.) are accessed faster than superordinate ones (animal, furniture.). Nevertheless, the speed at which objects presented in natural images can be processed in a rapid go/no-go visual superordinate categorization task has challenged this "basic level advantage". Principal Findings: Using the same task, we compared human processing speed when categorizing natural scenes as containing either an animal (superordinate level), or a specific animal (bird or dog, basic level). Human subjects require an additional 40-65 ms to decide whether an animal is a bird or a dog and most errors are induced by non-target animals. Indeed, processing time is tightly linked with the type of non-targets objects. Without any exemplar of the same superordinate category to ignore, the basic level category is accessed as fast as the superordinate category, whereas the presence of animal non-targets induces both an increase in reaction time and a decrease in accuracy. Conclusions and Significance: These results support the parallel distributed processing theory (PDP) and might reconciliate controversial studies recently published. The visual system can quickly access a coarse/abstract visual representation that allows fast decision for superordinate categorization of objects but additional time-consuming visual analysis would be necessary for a decision at the basic level based on more detailed representations.			Mace, MJM (corresponding author), Univ Toulouse, UPS, Ctr Rech Cerveau & Cognit, Toulouse, France.	michele.fabre-thorpe@cerco.ups-tlse.fr	Fabre-Thorpe, Michèle/B-2698-2008					Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bowers JS, 2008, Q J EXP PSYCHOL, V61, P552, DOI 10.1080/17470210701798290; Bukach CM, 2006, TRENDS COGN SCI, V10, P159, DOI 10.1016/j.tics.2006.02.004; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Dell'Acqua R, 1999, COGNITION, V73, pB1, DOI 10.1016/S0010-0277(99)00049-9; Delorme A, 2000, VISION RES, V40, P2187, DOI 10.1016/S0042-6989(00)00083-3; Fabre-Thorpe M, 2001, J COGNITIVE NEUROSCI, V13, P171, DOI 10.1162/089892901564234; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; Fabre-Thorpe M, 2003, PHILOS T R SOC B, V358, P1215, DOI 10.1098/rstb.2003.1310; Fei-Fei L, 2007, J VISION, V7, DOI 10.1167/7.1.10; Genest C., 1986, STAT SCI, V1, P114, DOI [DOI 10.1214/SS/1177013825, DOI 10.1214/SS]; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; Hughes HC, 1996, J COGNITIVE NEUROSCI, V8, P197, DOI 10.1162/jocn.1996.8.3.197; Johnson KE, 1997, J EXP PSYCHOL GEN, V126, P248, DOI 10.1037/0096-3445.126.3.248; JOLICOEUR P, 1984, COGNITIVE PSYCHOL, V16, P243, DOI 10.1016/0010-0285(84)90009-4; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Joubert OR, 2008, J VISION, V8, DOI 10.1167/8.13.11; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Large ME, 2004, COGNITIVE BRAIN RES, V20, P415, DOI 10.1016/j.cogbrainres.2004.03.013; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Low A, 2003, PSYCHOL SCI, V14, P367, DOI 10.1111/1467-9280.24451; Mace MJM, 2005, EUR J NEUROSCI, V21, P2007, DOI 10.1111/j.1460-9568.2005.04029.x; Mack ML, 2008, PSYCHON B REV, V15, P28, DOI 10.3758/PBR.15.1.28; Mandler JM, 2000, J COGN DEV, V1, P379, DOI 10.1207/S15327647JCD0104_02; Martinovic J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003781; McClelland JL, 2003, NAT REV NEUROSCI, V4, P310, DOI 10.1038/nrn1076; MERVIS CB, 1982, CHILD DEV, V53; MURPHY GL, 1989, J EXP PSYCHOL LEARN, V15, P572, DOI 10.1037/0278-7393.15.4.572; MURPHY GL, 1985, J EXP PSYCHOL LEARN, V11, P70, DOI 10.1037/0278-7393.11.1.70; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; PARKER DM, 1992, PERCEPTION, V21, P147, DOI 10.1068/p210147; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Rogers TT, 2007, J EXP PSYCHOL GEN, V136, P451, DOI 10.1037/0096-3445.136.3.451; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Rousselet GA, 2003, J VISION, V3, P440, DOI 10.1167/3.6.5; Rousselet GA, 2002, NAT NEUROSCI, V5, P629, DOI 10.1038/nn866; Rousselet GA, 2005, VIS COGN, V12, P852, DOI 10.1080/13506280444000553; Rousselet GA, 2004, VISION RES, V44, P877, DOI 10.1016/j.visres.2003.11.014; Schyns P. G., 1994, PSYCHOL SCI; Schyns PG, 1998, COGNITION, V67, P147, DOI 10.1016/S0010-0277(98)00016-X; SERGENT J, 1985, J EXP PSYCHOL HUMAN, V11, P846, DOI 10.1037/0096-1523.11.6.846; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Thorpe SJ, 2001, EUR J NEUROSCI, V14, P869, DOI 10.1046/j.0953-816x.2001.01717.x; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Ullman S, 2002, NAT NEUROSCI, V5, P682, DOI 10.1038/nn870; Ullman S, 2007, TRENDS COGN SCI, V11, P58, DOI 10.1016/j.tics.2006.11.009; VanRullen R, 2001, PERCEPTION, V30, P655, DOI 10.1068/p3029	54	96	100	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5927	10.1371/journal.pone.0005927	http://dx.doi.org/10.1371/journal.pone.0005927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536292	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029700008
J	Hoang, TTKT; Nansen, A; Roy, S; Billeskov, R; Aagaard, C; Elvang, T; Dietrich, J; Andersen, P				Hoang, Truc Thi Kim Thanh; Nansen, Anneline; Roy, Sugata; Billeskov, Rolf; Aagaard, Claus; Elvang, Tara; Dietrich, Jes; Andersen, Peter			Distinct Differences in the Expansion and Phenotype of TB10.4 Specific CD8 and CD4 T Cells after Infection with Mycobacterium tuberculosis	PLOS ONE			English	Article								Background: Recently we and others have identified CD8 and CD4 T cell epitopes within the highly expressed M. tuberculosis protein TB10.4. This has enabled, for the first time, a comparative study of the dynamics and function of CD4 and CD8 T cells specific for epitopes within the same protein in various stages of TB infection. Methods and Findings: We focused on T cells directed to two epitopes in TB10.4; the MHC class I restricted epitope TB10.4 3-11 (CD8/10.4 T cells) and the MHC class II restricted epitope TB10.4(74-88) (CD4/10.4 T cells). CD4/10.4 and CD8/10.4 T cells displayed marked differences in terms of expansion and contraction in a mouse TB model. CD4/10.4 T cells dominated in the early phase of infection whereas CD8/10.4 T cells were expanded after week 16 and reached 5-8 fold higher numbers in the late phase of infection. In the early phase of infection both CD4/10.4 and CD8/10.4 T cells were characterized by 20-25% polyfunctional cells (IL-2(+), IFN-gamma(+), TNF-alpha(+)), but whereas the majority of CD4/10.4 T cells were maintained as polyfunctional T cells throughout infection, CD8/10.4 T cells differentiated almost exclusively into effector cells (IFN-gamma(+), TNF-alpha(+)). Both CD4/10.4 and CD8/10.4 T cells exhibited cytotoxicity in vivo in the early phase of infection, but whereas CD4/10.4 cell mediated cytotoxicity waned during the infection, CD8/10.4 T cells exhibited increasing cytotoxic potential throughout the infection. Conclusions/Significance: Our results show that CD4 and CD8 T cells directed to epitopes in the same antigen differ both in their kinetics and functional characteristics throughout an infection with M. tuberculosis. In addition, the observed strong expansion of CD8 T cells in the late stages of infection could have implications for the development of post exposure vaccines against latent TB.			Hoang, TTKT (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	JDI@ssi.dk; PA@ssi.dk		Billeskov, Rolf/0000-0003-4533-7304; Andersen, Peter/0000-0002-5869-2551; Roy, Sugata/0000-0001-7183-7957				Agger EM, 2008, IMMUNOLOGY, V124, P175, DOI 10.1111/j.1365-2567.2007.02751.x; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Beauvillain C, 2007, BLOOD, V110, P2965, DOI 10.1182/blood-2006-12-063826; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Geluk A, 2000, J IMMUNOL, V165, P6463, DOI 10.4049/jimmunol.165.11.6463; Ghosh S, 2006, J IMMUNOL, V176, P4914, DOI 10.4049/jimmunol.176.8.4914; GRIFFIN JP, 1994, INFECT IMMUN, V62, P1683, DOI 10.1128/IAI.62.5.1683-1690.1994; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Irwin SM, 2005, INFECT IMMUN, V73, P5809, DOI 10.1128/IAI.73.9.5809-5816.2005; Junqueira-Kipnis AP, 2004, INFECT IMMUN, V72, P570, DOI 10.1128/IAI.72.1.570-575.2004; Kamath AB, 2004, J EXP MED, V200, P1479, DOI 10.1084/jem.20041690; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Lazarevic V, 2005, J IMMUNOL, V175, P1107, DOI 10.4049/jimmunol.175.2.1107; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Majlessi L, 2003, INFECT IMMUN, V71, P7173, DOI 10.1128/IAI.71.12.7173-7177.2003; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; Mittendorf EA, 2005, BREAST CANCER RES TR, V92, P85, DOI 10.1007/s10549-005-0988-1; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Rivas-Santiago B, 2008, SCAND J IMMUNOL, V67, P448, DOI 10.1111/j.1365-3083.2008.02088.x; Rogerson BJ, 2006, IMMUNOLOGY, V118, P195, DOI 10.1111/j.1365-2567.2006.02355.x; Silva CL, 2000, INFECT IMMUN, V68, P3269, DOI 10.1128/IAI.68.6.3269-3274.2000; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Winau F, 2004, CELL MICROBIOL, V6, P599, DOI 10.1111/j.1462-5822.2004.00408.x	30	22	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5928	10.1371/journal.pone.0005928	http://dx.doi.org/10.1371/journal.pone.0005928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529765	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029500008
J	Kim, HP; Yoon, YK; Kim, JW; Han, SW; Hur, HS; Park, J; Lee, JH; Oh, DY; Im, SA; Bang, YJ; Kim, TY				Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Jin-Won; Han, Sae-Won; Hur, Hyung-Seok; Park, Jinah; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You			Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2	PLOS ONE			English	Article								Background: Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) has been shown to exert a synergistic antitumor effect when combined with fluoropyrimidine. This synergy may be attributable to the downregulation of thymidylate synthase (TS), which is frequently overexpressed in fluoropyrimidine-resistant cancer cells. However, the molecular mechanism underlying the downregulation of TS has yet to be clearly elucidated. Methodology and Principal Findings: In this study, we demonstrate that lapatinib, a dual TKI of EGFR and HER2 downregulates TS via inhibition of the nuclear translocation of EGFR and HER2. From our cDNA microarray experiments, we determined that a variety of nucleotide synthesis-related genes, including TS, were downregulated with lapatinib, and this was apparent in HER2-amplified cells. Targeted and pharmacologic inhibition assays confirmed that the dual inhibition of EGFR and HER2 is required for the more effective reduction of TS as compared to what was observed with gefitinib or trasutuzumab alone. Additionally, we determined that co-transfected EGFR and HER2 activate the TS gene promoter more profoundly than do either EGFR or HER2 alone. The translocation of EGFR and HER2 into the nucleus and the subsequent activation of the TS promoter were inhibited by lapatinib. Conclusions and Significance: These results demonstrate that lapatinib inhibits the nuclear translocation of EGFR and HER2 and downregulates TS, thus sensitizing cancer cells to fluoropyrimidine.			Kim, HP (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	kimty@snu.ac.kr	Lee, Ju-Hee/I-8608-2012; Im, Seock-Ah/J-5620-2012; Bang, Yung Jue/J-2759-2012; Kim, Tae-You/J-2750-2012	Bang, Yung Jue/0000-0001-6000-4597; 				Chen QQ, 2005, CELL RES, V15, P504, DOI 10.1038/sj.cr.7290320; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Eliason JF, 2004, CURR DRUG TARGETS, V5, P383, DOI 10.2174/1389450043345461; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gribaudo G, 2002, J GEN VIROL, V83, P2983, DOI 10.1099/0022-1317-83-12-2983; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Kim HP, 2008, MOL CANCER THER, V7, P607, DOI 10.1158/1535-7163.MCT-07-2068; Kim JW, 2008, CANCER LETT, V272, P296, DOI 10.1016/j.canlet.2008.07.018; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Ku Ja-Lok, 2005, Cancer Res Treat, V37, P1, DOI 10.4143/crt.2005.37.1.1; Lee DH, 2008, EJC SUPPL, V6, P68, DOI 10.1016/S1359-6349(08)72147-5; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Magne N, 2003, CLIN CANCER RES, V9, P4735; Mizutani Y, 2003, CLIN CANCER RES, V9, P1453; Nomura T, 2002, INT J UROL, V9, P368, DOI 10.1046/j.1442-2042.2002.00479.x; Okabe T, 2008, MOL CANCER THER, V7, P599, DOI 10.1158/1535-7163.MCT-07-0567; Rastogi S, 2006, MOL CELL BIOL, V26, P4161, DOI 10.1128/MCB.02142-05; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Rusnak DW, 2001, CANCER RES, V61, P7196; VANDERWILT CL, 1994, PHARM WORLD SCI, V16, P84; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Xia WL, 2007, CANCER RES, V67, P1170, DOI 10.1158/0008-5472.CAN-06-2101; Xia WL, 2004, ONCOGENE, V23, P646, DOI 10.1038/sj.onc.1207166; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Zhou YF, 2006, CANCER RES, V66, P404, DOI 10.1158/0008-5472.CAN-05-2506	33	77	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5933	10.1371/journal.pone.0005933	http://dx.doi.org/10.1371/journal.pone.0005933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529774	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029500012
J	Basak, SK; Veena, MS; Oh, S; Huang, G; Srivatsan, E; Min, H; Sharma, S; Batra, RK				Basak, Saroj K.; Veena, Mysore S.; Oh, Scott; Huang, Ge; Srivatsan, Eri; Min Huang; Sharma, Sherven; Batra, Raj K.			The Malignant Pleural Effusion as a Model to Investigate Intratumoral Heterogeneity in Lung Cancer	PLOS ONE			English	Article								Malignant Pleural Effusions (MPE) may be useful as a model to study hierarchical progression of cancer and/or intratumoral heterogeneity. To strengthen the rationale for developing the MPE-model for these purposes, we set out to find evidence for the presence of cancer stem cells (CSC) in MPE and demonstrate an ability to sustain intratumoral heterogeneity in MPE-primary cultures. Our studies show that candidate lung CSC-expression signatures (PTEN, OCT4, hTERT, Bmi1, EZH2 and SUZ12) are evident in cell pellets isolated from MPE, and MPE-cytopathology also labels candidate-CSC (CD44, cMET, MDR-1, ALDH) subpopulations. Moreover, in primary cultures that use MPE as the source of both tumor cells and the tumor microenvironment (TME), candidate CSC are maintained over time. This allows us to live-sort candidate CSC-fractions from the MPE-tumor mix on the basis of surface markers (CD44, c-MET, uPAR, MDR-1) or differences in xenobiotic metabolism (ALDH). Thus, MPE-primary cultures provide an avenue to extract candidate CSC populations from individual (isogenic) MPE-tumors. This will allow us to test whether these cells can be discriminated in functional bioassays. Tumor heterogeneity in MPE-primary cultures is evidenced by variable immunolabeling, differences in colony-morphology, and differences in proliferation rates of cell subpopulations. Collectively, these data justify the ongoing development of the MPE-model for the investigation of intratumoral heterogeneity, tumor-TME interactions, and phenotypic validation of candidate lung CSC, in addition to providing direction for the pre-clinical development of rational therapeutics.			Basak, SK (corresponding author), VAGLAHS, Wadsworth Stem Cell Inst, Los Angeles, CA USA.	rbatra@ucla.edu		Batra, Raj K./0000-0002-1126-543X				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Batra Raj K, 2003, Methods Mol Med, V75, P545; Batra RK, 2000, AM J RESP CELL MOL, V22, P613, DOI 10.1165/ajrcmb.22.5.3970; Batra RK, 1997, J BIOL CHEM, V272, P11736, DOI 10.1074/jbc.272.18.11736; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernal RM, 2002, CLIN CANCER RES, V8, P1915; BHATIA B, 2008, J BIOL CHEM; Bombi JA, 2002, ULTRASTRUCT PATHOL, V26, P211, DOI 10.1080/01913120290076892; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; COURTENAY VD, 1976, BRIT J CANCER, V34, P39, DOI 10.1038/bjc.1976.119; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dietrich S, 2005, J ENVIRON PATHOL TOX, V24, P149, DOI 10.1615/JEnvPathToxOncol.v24.i3.20; Donnenberg VS, 2007, J CONTROL RELEASE, V122, P385, DOI 10.1016/j.jconrel.2007.05.005; DUNNILL MS, 1986, HISTOPATHOLOGY, V10, P461, DOI 10.1111/j.1365-2559.1986.tb02498.x; ERAMO A, 2007, CELL DEATH DIFFER; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GATTER KC, 1987, HISTOPATHOLOGY, V11, P705, DOI 10.1111/j.1365-2559.1987.tb02684.x; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CAN-07-0718; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; KITTEN CM, 1982, J THORAC CARDIOV SUR, V83, P363; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; MENDELSOHN G, 1986, PATHOL ANNU, V21, P91; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Miller YE, 2005, AM J RESP CELL MOL, V33, P216, DOI 10.1165/rcmb.2005-0158OE; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Moreb JS, 2007, CYTOM PART B-CLIN CY, V72B, P281, DOI 10.1002/cyto.b.20161; MULLER KM, 1988, PATHOL RES PRACT, V184, P108; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohm JE, 2007, CELL CYCLE, V6, P1040, DOI 10.4161/cc.6.9.4210; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; PAVELIC ZP, 1983, J CANCER RES CLIN, V105, P94, DOI 10.1007/BF00391838; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; SAHN SA, 1993, CLIN CHEST MED, V14, P189; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; SELL S, 1994, LAB INVEST, V70, P6; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Simpson-Abelson MR, 2008, J IMMUNOL, V180, P7009, DOI 10.4049/jimmunol.180.10.7009; Soria JC, 2002, CLIN CANCER RES, V8, P1178; Soria JC, 2001, JNCI-J NATL CANCER I, V93, P1257, DOI 10.1093/jnci/93.16.1257; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; UCAR D, 2008, CHEM BIOL INTERACT; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; WALLS GA, 1985, BRIT J CANCER, V52, P505, DOI 10.1038/bjc.1985.221; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	61	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5884	10.1371/journal.pone.0005884	http://dx.doi.org/10.1371/journal.pone.0005884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19536353	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029100004
J	Hojman, P; Brolin, C; Gissel, H; Brandt, C; Zerahn, B; Pedersen, BK; Gehl, J				Hojman, Pernille; Brolin, Camilla; Gissel, Hanne; Brandt, Claus; Zerahn, Bo; Pedersen, Bente Klarlund; Gehl, Julie			Erythropoietin Over-Expression Protects against Diet-Induced Obesity in Mice through Increased Fat Oxidation in Muscles	PLOS ONE			English	Article								Erythropoietin can be over-expressed in skeletal muscles by gene electrotransfer, resulting in 100-fold increase in serum EPO and significant increases in haemoglobin levels. Earlier studies have suggested that EPO improves several metabolic parameters when administered to chronically ill kidney patients. Thus we applied the EPO over-expression model to investigate the metabolic effect of EPO in vivo. At 12 weeks, EPO expression resulted in a 23% weight reduction (P < 0.01) in EPO transfected obese mice; thus the mice weighed 21.9 +/- 0.8 g (control, normal diet,) 21.9 +/- 1.4 g (EPO, normal diet), 35.3 +/- 3.3 g (control, high-fat diet) and 28.8 +/- 2.6 g ( EPO, high-fat diet). Correspondingly, DXA scanning revealed that this was due to a 28% reduction in adipose tissue mass. The decrease in adipose tissue mass was accompanied by a complete normalisation of fasting insulin levels and glucose tolerance in the high-fat fed mice. EPO expression also induced a 14% increase in muscle volume and a 25% increase in vascularisation of the EPO transfected muscle. Muscle force and stamina were not affected by EPO expression. PCR array analysis revealed that genes involved in lipid metabolism, thermogenesis and inflammation were increased in muscles in response to EPO expression, while genes involved in glucose metabolism were down-regulated. In addition, muscular fat oxidation was increased 1.8-fold in both the EPO transfected and contralateral muscles. In conclusion, we have shown that EPO when expressed in supra-physiological levels has substantial metabolic effects including protection against diet-induced obesity and normalisation of glucose sensitivity associated with a shift to increased fat metabolism in the muscles.			Hojman, P (corresponding author), Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	Pernille.Hoejman.Moeller@rh.regionh.dk; juge@heh.regionh.dk	Pedersen, Bente Klarlund/AGR-3217-2022; Brandt, Claus/AAB-2695-2020	Pedersen, Bente Klarlund/0000-0001-6508-6288; Brandt, Claus/0000-0002-7871-7437; Zerahn, Bo/0000-0002-3457-6249; Gehl, Julie/0000-0003-3829-0210; Hjortkjaer, Camilla Brolin/0000-0003-2622-9770				Allegra V, 1996, AM J NEPHROL, V16, P304, DOI 10.1159/000169014; Allegra V, 1997, NEPHROL DIAL TRANSPL, V12, P924, DOI 10.1093/ndt/12.5.924; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; ANDRE F, 2007, HUM GENE THER, V19; BORISSOVA AM, 1993, NEPHROL DIAL TRANSPL, V8, P93, DOI 10.1093/oxfordjournals.ndt.a092282; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Cayla JL, 2008, INT J SPORTS MED, V29, P460, DOI 10.1055/s-2007-965359; CLAUSEN T, 1991, AM J PHYSIOL, V261, pC799, DOI 10.1152/ajpcell.1991.261.5.C799; DAVENPORT A, 1993, NEPHRON, V64, P89, DOI 10.1159/000187284; ESCHBACH JW, 1989, ANN INTERN MED, V111, P992, DOI 10.7326/0003-4819-111-12-992; FAGHER B, 1994, NEPHRON, V67, P167, DOI 10.1159/000187921; Gehl J, 2003, ACTA PHYSIOL SCAND, V177, P437, DOI 10.1046/j.1365-201X.2003.01093.x; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gunga HC, 2003, EUR J APPL PHYSIOL, V88, P497, DOI 10.1007/s00421-002-0734-x; Hojman P, 2007, GENE THER, V14, P950, DOI 10.1038/sj.gt.3302951; Hojman P, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-56; Hojman P, 2007, ANIM BIOTECHNOL, V18, P183, DOI 10.1080/10495390601105055; Hojman P, 2008, HUM GENE THER, V19, P1249, DOI 10.1089/hum.2008.059; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kokot F, 1998, NEPHROL DIAL TRANSPL, V13, P1200, DOI 10.1093/ndt/13.5.1200; Kreiss P, 1999, J GENE MED, V1, P245, DOI 10.1002/(SICI)1521-2254(199907/08)1:4<245::AID-JGM49>3.0.CO;2-G; Lamartina S, 2002, HUM GENE THER, V13, P199, DOI 10.1089/10430340252769734; Lundby C, 2008, J APPL PHYSIOL, V104, P1154, DOI 10.1152/japplphysiol.01211.2007; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Maruyama H, 2000, HUM GENE THER, V11, P429, DOI 10.1089/10430340050015897; Mounier R, 2006, MED SCI SPORT EXER, V38, P1410, DOI 10.1249/01.mss.0000228955.98215.a1; Muramatsu T, 2001, INT J MOL MED, V7, P37; Payen E, 2001, EXP HEMATOL, V29, P295, DOI 10.1016/S0301-472X(00)00679-2; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Rizzuto G, 1999, P NATL ACAD SCI USA, V96, P6417, DOI 10.1073/pnas.96.11.6417; Rosenbaum M, 1999, NEW ENGL J MED, V341, P913, DOI 10.1056/NEJM199909163411211; Schobersberger W, 2003, EUR J APPL PHYSIOL, V88, P506, DOI 10.1007/s00421-002-0736-8; Terada Y, 2001, AM J KIDNEY DIS, V38, pS50, DOI 10.1053/ajkd.2001.27398; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Tuzcu A, 2004, HORM METAB RES, V36, P716, DOI 10.1055/s-2004-826021	38	75	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5894	10.1371/journal.pone.0005894	http://dx.doi.org/10.1371/journal.pone.0005894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521513	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029100009
J	Rohrbeck, A; Muller, VS; Borlak, J				Rohrbeck, Astrid; Mueller, Volker Steffen; Borlak, Juergen			Molecular Characterization of Lung Dysplasia Induced by c-Raf-1	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; AUTOCRINE GROWTH-FACTOR; TRANSCRIPTION FACTOR; BREAST-CANCER; AMPHIREGULIN EXPRESSION; GLUCOSE-HOMEOSTASIS; SIGNALING PATHWAY; GENE-EXPRESSION; FACTOR-ALPHA; C-RAF	Background: Lung cancer is a multistage process with poor prognosis and high morbidity. Importantly, the genetics of dysplasia, a facultative cancer, at the edge of malignant transformation is unknown. Methodology/Principal Findings: We employed laser microdissection to harvest c-Raf1- induced dysplastic as opposed to transgenic but otherwise morphologically unaltered epithelium and compared findings to non-transgenic lung. We then employed microarrays to search genome wide for gene regulatory networks. A total of 120 and 287 genes were significantly regulated, respectively. Dysplasia was exclusive associated with up-regulation of genes coding for cell growth and proliferation, cell-to-cell signalling and interaction, lipid metabolism, development, and cancer. Likewise, when dysplasia was compared with non-transgenic cells up-regulation of cancer associated genes, tight junction proteins, xenobiotic defence and developmental regulators was observed. Further, in a comparison of the data sets of dysplasia vs transgenic and dysplasia vs non-transgenic 114 genes were regulated in common. We additionally confirmed regulation of some genes by immunohistochemistry and therefore demonstrate good concordance between gene regulation and coded protein. Conclusion: Our study identified transcriptional networks at successive stages of tumor-development, i.e. from histological unaltered but transgenic lungs to nuclear atypia. Our SP-C/c-raf transgenic mouse model revealed interesting and novel candidate genes and pathways that provide clues on the mechanism forcing respiratory epithelium into dysplasia and subsequently cancer, some of which might also be useful in the molecular imaging and flagging of early stages of disease.			Rohrbeck, A (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Dept Mol Med & Med Biotechnol, Hannover, Germany.	borlak@item.fraunhofer.de						ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; ANG SL, 1993, DEVELOPMENT, V119, P1301; Baba I, 2000, CANCER RES, V60, P6886; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Borlak J, 2008, MOL CANCER RES, V6, P1326, DOI 10.1158/1541-7786.MCR-08-0042; Boyle P, 2005, ANN ONCOL, V16, P1565, DOI 10.1093/annonc/mdi328; Chatterji B, 2007, PROTEOMICS, V7, P3980, DOI 10.1002/pmic.200700290; CORDERO A, 2005, NAT GENET, V37, P48; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; EBERT M, 1994, CANCER RES, V54, P3959; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fong KM, 2003, THORAX, V58, P892, DOI 10.1136/thorax.58.10.892; Garcia-Fernandez MO, 2004, CANCER LETT, V205, P189, DOI 10.1016/j.canlet.2003.10.008; Granville CA, 2005, AM J RESP CELL MOL, V32, P169, DOI 10.1165/rcmb.F290; Hakomori S, 2004, AN ACAD BRAS CIENC, V76, P553, DOI 10.1590/S0001-37652004000300010; Hurbin A, 2002, J BIOL CHEM, V277, P49127, DOI 10.1074/jbc.M207584200; HYLTANDER A, 1991, EUR J CANCER, V27, P9, DOI 10.1016/0277-5379(91)90050-N; Inoue A, 2005, PLOS MED, V2, P20, DOI 10.1371/journal.pmed.0020013; Ishikawa N, 2005, CANCER RES, V65, P9176, DOI 10.1158/0008-5472.CAN-05-1556; Isobe K, 2004, REGUL PEPTIDES, V123, P29, DOI 10.1016/j.regpep.2004.05.011; Iwamura M, 1999, CANCER, V86, P1028, DOI 10.1002/(SICI)1097-0142(19990915)86:6<1028::AID-CNCR19>3.0.CO;2-G; JACKSON DA, 1993, MOL CELL BIOL, V13, P2401, DOI 10.1128/MCB.13.4.2401; JOHNSON GR, 1991, BIOCHEM BIOPH RES CO, V180, P481, DOI 10.1016/S0006-291X(05)81090-3; Kalinichenko VV, 2001, AM J PHYSIOL-LUNG C, V280, pL695, DOI 10.1152/ajplung.2001.280.4.L695; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Kerr KM, 2001, J CLIN PATHOL, V54, P257, DOI 10.1136/jcp.54.4.257; Kissin M W, 1993, Eur J Surg Oncol, V19, P134; LI SW, 1992, J CELL PHYSIOL, V153, P103, DOI 10.1002/jcp.1041530114; Liu ZZ, 1996, DEV BIOL, V178, P133, DOI 10.1006/dbio.1996.0204; Mason RJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1, DOI 10.1152/ajplung.1998.275.1.L1; Mennecier G, 2008, MOL CARCINOGEN, V47, P391, DOI 10.1002/mc.20393; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1997, DEV BIOL, V183, P21, DOI 10.1006/dbio.1996.8485; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; NESBITT JC, 1995, ANN THORAC SURG, V60, P466, DOI 10.1016/0003-4975(95)00169-L; Niehof M, 2008, DIABETES, V57, P1069, DOI 10.2337/db07-1065; Nishihara M, 1999, J PATHOL, V187, P217, DOI 10.1002/(SICI)1096-9896(199901)187:2<217::AID-PATH210>3.0.CO;2-0; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pointis G, 2007, CURR MED CHEM, V14, P2288, DOI 10.2174/092986707781696564; REISHER SR, 1993, P NATL ACAD SCI USA, V90, P5757, DOI 10.1073/pnas.90.12.5757; Rutters H, 2006, PROTEOMICS, V6, P3127, DOI 10.1002/pmic.200500188; Rufibach LE, 2006, J LIPID RES, V47, P1463, DOI 10.1194/jlr.M600082-JLR200; Schultz IJ, 2006, INT J CANCER, V119, P1915, DOI 10.1002/ijc.22059; SEHGAL I, 1994, MOL BIOL CELL, V5, P339, DOI 10.1091/mbc.5.3.339; Shelly M, 1998, J BIOL CHEM, V273, P10496, DOI 10.1074/jbc.273.17.10496; Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; SHU W, 2001, JBC, V29, P27488; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Stahlman MT, 1998, J HISTOCHEM CYTOCHEM, V46, P955, DOI 10.1177/002215549804600809; Thogersen VB, 2001, CANCER RES, V61, P6227; Thomas RK, 2006, CLIN CANCER RES, V12, p4384S, DOI 10.1158/1078-0432.CCR-06-0098; THOMAS SE, 1981, CANCER RES, V41, P3786; Torring N, 2000, ANTICANCER RES, V20, P91; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wang X, 2008, CANCER RES, V68, P2259, DOI 10.1158/0008-5472.CAN-07-5544; Warren L, 1979, Dev Biol Stand, V42, P177; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wolman SR, 1997, FASEB J, V11, P535, DOI 10.1096/fasebj.11.7.9212077; WOODWORTH CD, 1995, P NATL ACAD SCI USA, V92, P2840, DOI 10.1073/pnas.92.7.2840; YAM D, 1994, BRIT J CANCER, V70, P1186, DOI 10.1038/bjc.1994.470; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228	69	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5637	10.1371/journal.pone.0005637	http://dx.doi.org/10.1371/journal.pone.0005637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19529782	Green Published, Green Submitted, gold			2022-12-27	WOS:000266234700023
J	Adler, H; El-Gogo, S; Guggemoos, S; Zimmermann, W; Beauchemin, N; Kammerer, R				Adler, Heiko; El-Gogo, Susanne; Guggemoos, Simone; Zimmermann, Wolfgang; Beauchemin, Nicole; Kammerer, Robert			Perturbation of Lytic and Latent Gammaherpesvirus Infection in the Absence of the Inhibitory Receptor CEACAM1	PLOS ONE			English	Article								Control of gammaherpesvirus infections requires a complex, well orchestrated immune response regulated by positive and negative co-signaling molecules. While the impact of co-stimulatory molecules has been addressed in various studies, the role of co-inhibitory receptors has not been tested. The ITIM-bearing CEACAM1 is an inhibitory receptor expressed by a variety of immune cells, including B, T and NK cells. Using Ceacam1(-/-) mice, we analyzed the in vivo function of CEACAM1 during acute and latent murine gammaherpesvirus 68 (MHV-68) infection. During acute lytic replication, we observed lower virus titers in the lungs of Ceacam1(-/-) mice than in WT mice. In contrast, during latency amplification, Ceacam1(-/-) mice displayed increased splenomegaly and a higher latent viral load in the spleen. Analysis of the immune response revealed increased virus-specific antibody levels in Ceacam1(-/-) mice, while the magnitude of the T cell-mediated antiviral immune response was reduced. These findings suggest that inhibitory receptors can modulate the efficacy of immune responses against gammaherpesvirus infections.			Adler, H (corresponding author), Helmholtz Zentrum Munchen, Natl Res Ctr Environm Hlth, Inst Mol Immunol, CCG HCT, Munich, Germany.	Robert.Kammerer@fli.bund.de	Adler, Heiko/M-7355-2014; Kammerer, Robert/AAQ-1338-2021; Zimmermann, Wolfgang/L-9277-2013	Adler, Heiko/0000-0002-6481-6709; Kammerer, Robert/0000-0003-3038-8205				Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Adler H, 2001, J VIROL, V75, P5692, DOI 10.1128/JVI.75.12.5692-5696.2001; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Brooks JW, 1999, J VIROL, V73, P9650, DOI 10.1128/JVI.73.11.9650-9654.1999; BRUMMER J, 1995, ONCOGENE, V11, P1649; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Chen DH, 2004, J IMMUNOL, V172, P3535, DOI 10.4049/jimmunol.172.6.3535; Chen T, 2001, J LEUKOCYTE BIOL, V70, P335; Donda A, 2000, EUR J IMMUNOL, V30, P2593, DOI 10.1002/1521-4141(200009)30:9<2593::AID-IMMU2593>3.0.CO;2-0; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Flano E, 2002, J EXP MED, V196, P1363, DOI 10.1084/jem.20020890; Fuse S, 2007, J IMMUNOL, V178, P5227, DOI 10.4049/jimmunol.178.8.5227; Fuse S, 2006, J VIROL, V80, P9159, DOI 10.1128/JVI.00422-06; Greicius G, 2003, J LEUKOCYTE BIOL, V74, P126, DOI 10.1189/jlb.1202594; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Iijima H, 2004, J EXP MED, V199, P471, DOI 10.1084/jem.20030437; Kammerer R, 2001, J IMMUNOL, V166, P6537, DOI 10.4049/jimmunol.166.11.6537; Kammerer R, 1998, EUR J IMMUNOL, V28, P3664, DOI 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D; Kim IJ, 2002, J IMMUNOL, V168, P3958, DOI 10.4049/jimmunol.168.8.3958; Lee BJ, 2002, J VIROL, V76, P3049, DOI 10.1128/JVI.76.6.3049-3053.2002; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Liu LZ, 1999, J VIROL, V73, P9849, DOI 10.1128/JVI.73.12.9849-9857.1999; Lyon AB, 2006, VIROLOGY, V356, P50, DOI 10.1016/j.virol.2006.06.039; Markel G, 2004, J IMMUNOL, V173, P3732, DOI 10.4049/jimmunol.173.6.3732; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Nakajima A, 2002, J IMMUNOL, V168, P1028, DOI 10.4049/jimmunol.168.3.1028; Nash AA, 2001, PHILOS T R SOC B, V356, P569, DOI 10.1098/rstb.2000.0779; REED LJ, 1938, AM J HYG, V27; Sarawar SR, 2004, VIRAL IMMUNOL, V17, P3, DOI 10.1089/088282404322875412; Sarawar SR, 2001, P NATL ACAD SCI USA, V98, P6325, DOI 10.1073/pnas.101136898; Schulz TF, 1998, J GEN VIROL, V79, P1573, DOI 10.1099/0022-1317-79-7-1573; Simas JP, 1998, TRENDS MICROBIOL, V6, P276; Singer BB, 2002, J IMMUNOL, V168, P5139, DOI 10.4049/jimmunol.168.10.5139; SKUBITZ KM, 1995, J IMMUNOL, V155, P5382; Speck SH, 1999, CURR OPIN MICROBIOL, V2, P403; Stevenson PG, 2002, MICROBES INFECT, V4, P1177, DOI 10.1016/S1286-4579(02)01643-X; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; Stewart JP, 1998, J EXP MED, V187, P1941, DOI 10.1084/jem.187.12.1941; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P3275, DOI 10.1099/0022-1317-73-12-3275; Thirion G, 2008, IMMUNOLOGY, V125, P535, DOI 10.1111/j.1365-2567.2008.02867.x; Thomson RC, 2008, SCAND J IMMUNOL, V67, P489, DOI 10.1111/j.1365-3083.2008.02100.x; Tibbetts SA, 2003, J VIROL, V77, P7696, DOI 10.1128/JVI.77.13.7696-7701.2003; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; Usherwood EJ, 2005, EUR J IMMUNOL, V35, P2956, DOI 10.1002/eji.200526245; Usherwood EJ, 1996, J GEN VIROL, V77, P627, DOI 10.1099/0022-1317-77-4-627; Vaerman JL, 2004, J BIOL REG HOMEOS AG, V18, P212; Virgin HW, 1999, CURR OPIN IMMUNOL, V11, P371, DOI 10.1016/S0952-7915(99)80063-6; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999; Weinberg JB, 2004, VIRAL IMMUNOL, V17, P69, DOI 10.1089/088282404322875467; Willer DO, 2005, J VIROL, V79, P2891, DOI 10.1128/JVI.79.5.2891-2899.2005; Willer DO, 2003, J VIROL, V77, P8310, DOI 10.1128/JVI.77.15.8310-8321.2003; Woodland DL, 2001, VIRAL IMMUNOL, V14, P217, DOI 10.1089/088282401753266747; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008	56	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6317	10.1371/journal.pone.0006317	http://dx.doi.org/10.1371/journal.pone.0006317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621080	Green Submitted, Green Published, gold			2022-12-27	WOS:000268147200011
J	Richardson, TE; Chapman, KM; Dann, CT; Hammer, RE; Hamra, FK				Richardson, Timothy E.; Chapman, Karen M.; Dann, Christina Tenenhaus; Hammer, Robert E.; Hamra, F. Kent			Sterile Testis Complementation with Spermatogonial Lines Restores Fertility to DAZL-Deficient Rats and Maximizes Donor Germline Transmission	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SELF-RENEWAL; MALE-INFERTILITY; MOUSE TESTIS; Y-CHROMOSOME; MICE; TRANSPLANTATION; GENE; DIFFERENTIATION; CULTURE	Despite remarkable advances in assisted reproductive capabilities similar to 4% of all couples remain involuntarily infertile. In almost half of these cases, a lack of conception can in some measure be attributed to the male partner, wherein de novo Y-chromosomal deletions of sperm-specific Deleted-in-Azoospermia (DAZ) genes are particularly prevalent. In the current study, long-term cultures of rat spermatogonial stem cells were evaluated after cryo-storage for their potential to restore fertility to rats deficient in the DAZ-like (DAZL) gene. Detailed histological analysis of DAZL-deficient rat testes revealed an apparently intact spermatogonial stem cell compartment, but clear failure to produce mature haploid gametes resulting in infertility. After proliferating > 1 million-fold in cell number during culture post-thaw, as few as 50,000 donor spermatogonia transplanted into only a single testis/recipient effectively restored fecundity to DAZL-deficient rats, yielding 100% germline transmission to progeny by natural mating. Based on these results, the potency and efficacy of this donor stem cell line for restoring fertility to azoospermic rodents is currently unprecedented. Prospectively, similar successes in humans could be directly linked to the feasibility of obtaining enough fully functional spermatogonial stem cells from minimal testis biopsies to be therapeutically effective. Thus, regeneration of sperm production in this sterile recipient provides an advanced preclinical model for optimizing the efficacy of stem cell therapies to cure a paradoxically increasing number of azoospermic men. This includes males that are rendered infertile by cancer therapies, specific types of endocrine or developmental defects, and germline-specific de novo mutations; all of whom may harbor healthy sources of their own spermatogonial stem cells for treatment.			Richardson, TE (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.	Kent.Hamra@UTSouthwestern.edu		Hammer, Robert E./0000-0001-5487-7551	NCRR NIH HHS [1 R21 RR023958, R21 RR023958] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR023958] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Barthold JS, 2003, J UROLOGY, V170, P2396, DOI 10.1097/01.ju.0000095793.04232.d8; BHASIN S, 1994, J CLIN ENDOCR METAB, V79, P1525, DOI 10.1210/jc.79.6.1525; Bhasin S, 2007, J CLIN ENDOCR METAB, V92, P1995, DOI 10.1210/jc.2007-0634; BLEYER WA, 1990, CA-CANCER J CLIN, V40, P355, DOI 10.3322/canjclin.40.6.355; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Clouthier DE, 1996, NATURE, V381, P418, DOI 10.1038/381418a0; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Cronkhite JT, 2005, DEV BIOL, V284, P171, DOI 10.1016/j.ydbio.2005.05.015; Dann CT, 2006, P NATL ACAD SCI USA, V103, P11246, DOI 10.1073/pnas.0604657103; deKretser DM, 1997, LANCET, V349, P787, DOI 10.1016/S0140-6736(96)08341-9; Geens M, 2008, HUM REPROD UPDATE, V14, P121, DOI 10.1093/humupd/dmm047; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Hamra FK, 2004, DEV BIOL, V269, P393, DOI 10.1016/j.ydbio.2004.01.027; Haston KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005654; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; HESS RA, 1990, BIOL REPROD, V43, P525, DOI 10.1095/biolreprod43.3.525; Honaramooz A, 2002, NATURE, V418, P778, DOI 10.1038/nature00918; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Meistrich ML, 2008, REPRODUCTION, V136, P691, DOI 10.1530/REP-08-0096; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; Oates RD, 2008, UROL CLIN N AM, V35, P257, DOI 10.1016/j.ucl.2008.01.015; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Orwig Kyle E, 2005, J Natl Cancer Inst Monogr, P51; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Sadeghi-Nejad Hossein, 2006, Urol J, V3, P193; Sadeghi-Nejad Hossein, 2007, Urol J, V4, P192; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Schlatt S, 1999, HUM REPROD, V14, P144, DOI 10.1093/humrep/14.1.144; Schlatt S, 2002, HUM REPROD, V17, P55, DOI 10.1093/humrep/17.1.55; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Shetty G, 2006, ENDOCRINOLOGY, V147, P472, DOI 10.1210/en.2005-0984; Shetty Gunapala, 2005, J Natl Cancer Inst Monogr, P36; Shindel AW, 2008, J UROLOGY, V179, P1056, DOI 10.1016/j.juro.2007.10.069; WU Z, 2009, BIOL REPROD     0318; Zhang Z, 2007, J CELL PHYSIOL, V211, P149, DOI 10.1002/jcp.20910	50	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6308	10.1371/journal.pone.0006308	http://dx.doi.org/10.1371/journal.pone.0006308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621088	Green Published, gold, Green Submitted			2022-12-27	WOS:000268147200008
J	Sheng, WY; Wang, TCV				Sheng, Wei-Yun; Wang, Tzu-Chien V.			Proteomic Analysis of the Differential Protein Expression Reveals Nuclear GAPDH in Activated T Lymphocytes	PLOS ONE			English	Article								Despite the important role of T cell activation in the adaptive immunity, very little is known about the functions of proteins that are differentially expressed in the activated T cells. In this study, we have employed proteomic approach to study the differentially expressed proteins in activated T cells. A total of 25 proteins was characterized that displayed a decreased expression, while a total of 20 proteins was characterized that displayed an increased expression in the activated T cells. Among them, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was identified unexpectedly as one of the up-regulated proteins. Western blot analysis of proteins separated by 2-dimensional gel electrophoresis had identified several modified GAPDHs which were detectable only in the activated T cells, but not in resting T cells. These modified GAPDHs had higher molecular mass and more basic PI, and were present in the nucleus of activated T cells. Promoter occupancy studies by chromatin immunoprecipitation assay revealed that nuclear GAPDH could be detected in the promoter of genes that were up-regulated during T cell activation, but not in the promoter of genes that were not unaffected or down-regulated. Our results suggest that nuclear GAPDH may function as transcriptional regulator in activated T cells.			Sheng, WY (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA.	tcvwg@mail.cgu.edu.tw		Wang, Tzu-Chien/0000-0002-6753-9639				Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Arendt CW, 2002, CURR OPIN IMMUNOL, V14, P323, DOI 10.1016/S0952-7915(02)00346-1; Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOSSER R, 1995, MOL CELL BIOL, V15, P661; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Caron M, 2002, J CHROMATOGR B, V771, P197, DOI 10.1016/S1570-0232(02)00040-5; Cha H, 2004, BIOCHEM J, V378, P857, DOI 10.1042/BJ20031173; Ellisen LW, 2001, EUR J CELL BIOL, V80, P321, DOI 10.1078/0171-9335-00162; Epner DE, 1999, BIOL REPROD, V61, P687, DOI 10.1095/biolreprod61.3.687; Germain RN, 2003, IMMUNOL RES, V27, P277, DOI 10.1385/IR:27:2-3:277; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Kim D, 1999, IEEE COMMUN LETT, V3, P9, DOI 10.1109/4234.740114; Liu SC, 2000, J CELL SCI, V113, P3563; Nyman TA, 2001, ELECTROPHORESIS, V22, P4375, DOI 10.1002/1522-2683(200112)22:20<4375::AID-ELPS4375>3.0.CO;2-P; Rautajoki K, 2004, PROTEOMICS, V4, P84, DOI 10.1002/pmic.200300510; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; RYZLAK MT, 1988, BIOCHIM BIOPHYS ACTA, V954, P309, DOI 10.1016/0167-4838(88)90086-6; Sheng WY, 2006, FEBS LETT, V580, P6819, DOI 10.1016/j.febslet.2006.11.044; Sheng WY, 2003, FEBS LETT, V540, P91, DOI 10.1016/S0014-5793(03)00230-8; Sirover MA, 1997, J CELL BIOCHEM, V66, P133, DOI 10.1002/(SICI)1097-4644(19970801)66:2<133::AID-JCB1>3.3.CO;2-V; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	26	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6322	10.1371/journal.pone.0006322	http://dx.doi.org/10.1371/journal.pone.0006322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621076	Green Published, gold, Green Submitted			2022-12-27	WOS:000268147200013
J	Zhang, J; Li, CJ; Shi, T; Chen, KX; Shen, X; Jiang, HL				Zhang, Jian; Li, Chenjing; Shi, Ting; Chen, Kaixian; Shen, Xu; Jiang, Hualiang			Lys169 of Human Glucokinase Is a Determinant for Glucose Phosphorylation: Implication for the Atomic Mechanism of Glucokinase Catalysis	PLOS ONE			English	Article								Glucokinase (GK), a glucose sensor, maintains plasma glucose homeostasis via phosphorylation of glucose and is a potential therapeutic target for treating maturity-onset diabetes of the young ( MODY) and persistent hyperinsulinemic hypoglycemia of infancy (PHHI). To characterize the catalytic mechanism of glucose phosphorylation by GK, we combined molecular modeling, molecular dynamics ( MD) simulations, quantum mechanics/molecular mechanics (QM/MM) calculations, experimental mutagenesis and enzymatic kinetic analysis on both wild-type and mutated GK. Our three-dimensional (3D) model of the GK-Mg2+-ATP-glucose (GMAG) complex, is in agreement with a large number of mutagenesis data, and elucidates atomic information of the catalytic site in GK for glucose phosphorylation. A 10-ns MD simulation of the GMAG complex revealed that Lys169 plays a dominant role in glucose phosphorylation. This prediction was verified by experimental mutagenesis of GK (K169A) and enzymatic kinetic analyses of glucose phosphorylation. QM/MM calculations were further used to study the role of Lys169 in the catalytic mechanism of the glucose phosphorylation and we found that Lys169 enhances the binding of GK with both ATP and glucose by serving as a bridge between ATP and glucose. More importantly, Lys169 directly participates in the glucose phosphorylation as a general acid catalyst. Our findings provide mechanistic details of glucose phorphorylation catalyzed by GK, and are important for understanding the pathogenic mechanism of MODY.			Zhang, J (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Ctr Drug Discovery & Design, Shanghai 200031, Peoples R China.	hljiang@mail.shcnc.ac.cn	Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X				Al-Hasani Hadi, 2003, Mol Interv, V3, P367, DOI 10.1124/mi.3.7.367; Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Aleshin AE, 2000, J MOL BIOL, V296, P1001, DOI 10.1006/jmbi.1999.3494; BARFORD D, 1989, NATURE, V340, P609, DOI 10.1038/340609a0; Barrett JP, 2002, CLIN DRUG INVEST, V22, P87, DOI 10.2165/00044011-200222020-00003; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHARLES RS, 1994, DIABETES, V43, P784, DOI 10.2337/diab.43.6.784; Christesen HBT, 2002, DIABETES, V51, P1240, DOI 10.2337/diabetes.51.4.1240; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; Frisch M. J., 2019, GAUSSIAN 16 REVISION; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; GIDHJAIN M, 1993, P NATL ACAD SCI USA, V90, P1932, DOI 10.1073/pnas.90.5.1932; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gloyn AL, 2003, HUM MUTAT, V22, P353, DOI 10.1002/humu.10277; Gloyn AL, 2005, J BIOL CHEM, V280, P14105, DOI 10.1074/jbc.M413146200; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; GROSSBARD L, 1966, J BIOL CHEM, V241, P3546; Humbel S, 1996, J CHEM PHYS, V105, P1959, DOI 10.1063/1.472065; IWATA S, 1994, NAT STRUCT BIOL, V1, P176, DOI 10.1038/nsb0394-176; JANNE M, 2008, FEBS J, V275, P2467; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; KANTROWITZ ER, 1988, SCIENCE, V241, P669, DOI 10.1126/science.3041592; Kuno M, 2003, CHEM PHYS LETT, V380, P456, DOI 10.1016/j.cplett.2003.09.030; MacRae IJ, 2002, NAT STRUCT BIOL, V9, P945, DOI 10.1038/nsb868; Mahalingam B, 1999, DIABETES, V48, P1698, DOI 10.2337/diabetes.48.9.1698; Marotta DE, 2005, ARCH BIOCHEM BIOPHYS, V436, P23, DOI 10.1016/j.abb.2005.01.018; MASERAS F, 1995, J COMPUT CHEM, V16, P1170, DOI 10.1002/jcc.540160911; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; Miller SP, 1999, DIABETES, V48, P1645, DOI 10.2337/diabetes.48.8.1645; PILKIS SJ, 1994, J BIOL CHEM, V269, P21925; Postic C, 2001, RECENT PROG HORM RES, V56, P195, DOI 10.1210/rp.56.1.195; Printz RL, 2005, ENDOCRINOLOGY, V146, P3693, DOI 10.1210/en.2005-0689; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; Sener A, 1996, ARCH BIOCHEM BIOPHYS, V328, P26, DOI 10.1006/abbi.1996.0138; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Svensson M, 1996, J PHYS CHEM-US, V100, P19357, DOI 10.1021/jp962071j; Svensson M, 1996, J CHEM PHYS, V105, P3654, DOI 10.1063/1.472235; VANSCHAFTINGEN E, 1994, DIABETOLOGIA, V37, pS43, DOI 10.1007/BF00400825; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Vreven T, 2001, J CHEM PHYS, V115, P62, DOI 10.1063/1.1376127; Vreven T, 2003, J COMPUT CHEM, V24, P760, DOI 10.1002/jcc.10156; Vreven T, 2000, J COMPUT CHEM, V21, P1419, DOI 10.1002/1096-987X(200012)21:16<1419::AID-JCC1>3.0.CO;2-C; XU LZ, 1995, BIOCHEMISTRY-US, V34, P6083, DOI 10.1021/bi00018a011; Zelent B, 2008, BIOCHEM J, V413, P269, DOI 10.1042/BJ20071718	52	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6304	10.1371/journal.pone.0006304	http://dx.doi.org/10.1371/journal.pone.0006304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617908	Green Published, gold, Green Submitted			2022-12-27	WOS:000268119600007
J	Cudney-Bueno, R; Basurto, X				Cudney-Bueno, Richard; Basurto, Xavier			Lack of Cross-Scale Linkages Reduces Robustness of Community-Based Fisheries Management	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; HEXAPLEX-NIGRITUS MOLLUSCA; BLACK MUREX SNAIL; CALCIFER CARPENTER; MARINE RESERVES; MEXICO; MURICIDAE; ECOLOGY; GROWTH	Community-based management and the establishment of marine reserves have been advocated worldwide as means to overcome overexploitation of fisheries. Yet, researchers and managers are divided regarding the effectiveness of these measures. The "tragedy of the commons'' model is often accepted as a universal paradigm, which assumes that unless managed by the State or privatized, common-pool resources are inevitably overexploited due to conflicts between the self-interest of individuals and the goals of a group as a whole. Under this paradigm, the emergence and maintenance of effective community-based efforts that include cooperative risky decisions as the establishment of marine reserves could not occur. In this paper, we question these assumptions and show that outcomes of commons dilemmas can be complex and scale-dependent. We studied the evolution and effectiveness of a community-based management effort to establish, monitor, and enforce a marine reserve network in the Gulf of California, Mexico. Our findings build on social and ecological research before (1997-2001), during (2002) and after (2003-2004) the establishment of marine reserves, which included participant observation in > 100 fishing trips and meetings, interviews, as well as fishery dependent and independent monitoring. We found that locally crafted and enforced harvesting rules led to a rapid increase in resource abundance. Nevertheless, news about this increase spread quickly at a regional scale, resulting in poaching from outsiders and a subsequent rapid cascading effect on fishing resources and locally-designed rule compliance. We show that cooperation for management of common-pool fisheries, in which marine reserves form a core component of the system, can emerge, evolve rapidly, and be effective at a local scale even in recently organized fisheries. Stakeholder participation in monitoring, where there is a rapid feedback of the systems response, can play a key role in reinforcing cooperation. However, without cross-scale linkages with higher levels of governance, increase of local fishery stocks may attract outsiders who, if not restricted, will overharvest and threaten local governance. Fishers and fishing communities require incentives to maintain their management efforts. Rewarding local effective management with formal cross-scale governance recognition and support can generate these incentives.			Cudney-Bueno, R (corresponding author), Univ Arizona, Sch Nat Resources, Tucson, AZ 85721 USA.	rcudney@packard.org						Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; BAQUEIRO E, 1988, SERIE DIVULGACIO, V11, P1; Basurto X, 2005, SOC NATUR RESOUR, V18, P643, DOI 10.1080/08941920590959631; Basurto X, 2008, ECOL SOC, V13; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; BERKES F, 2001, MANAGING SMALL SCALE, P311; BERNARD HR, 2001, RES METHODS ANTHR QU; Cudney-Bueno R, 2008, B MAR SCI, V83, P299; Cudney-Bueno R, 2008, B MAR SCI, V83, P285; Cudney-Bueno R, 2009, OCEAN COAST MANAGE, V52, P207, DOI 10.1016/j.ocecoaman.2008.12.005; Cudney-Bueno R, 2008, J SHELLFISH RES, V27, P625, DOI 10.2983/0730-8000(2008)27[625:EABFMO]2.0.CO;2; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004140; Dyer C. L., 1994, FOLK MANAGEMENT WORL; Finlayson A.C., 1994, FISHING TRUTH SOCIOL; HARDIN G, 1968, SCIENCE, V162, P1248; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johannes RE, 2002, ANNU REV ECOL SYST, V33, P317, DOI 10.1146/annurev.ecolsys.33.010802.150524; Lejano RP, 2007, ENVIRONMENT, V49, P18, DOI 10.3200/ENVT.49.9.18-27; Mansuri G, 2004, WORLD BANK RES OBSER, V19, P1, DOI 10.1093/wbro/lkh012; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Ostrom E., 1990, GOVERNING COMMONS EV; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 1997, AM FISH S S, V20, P40; PUTNAM RD, 1995, J DEMOCRACY, V0006; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; TURKBOYER PJ, 2007, DRY BORDERS GREAT NA, P548; Villalejo-Fuerte M, 2002, J SHELLFISH RES, V21, P103	27	102	102	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6253	10.1371/journal.pone.0006253	http://dx.doi.org/10.1371/journal.pone.0006253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	471DU	19606210	Green Published, gold			2022-12-27	WOS:000268036000009
J	Harbison, ST; Sehgal, A				Harbison, Susan T.; Sehgal, Amita			Energy Stores Are Not Altered by Long-Term Partial Sleep Deprivation in Drosophila melanogaster	PLOS ONE			English	Article							ELEVATED GHRELIN; DIURNAL RHYTHM; LEPTIN LEVELS; RISK-FACTOR; DURATION; OBESITY; REST; TRIACYLGLYCEROL; ASSOCIATION; RESISTANCE	Recent human studies reveal a widespread association between short sleep and obesity. Two hypotheses, which are not mutually exclusive, might explain this association. First, genetic factors that reduce endogenous sleep times might also impact energy stores, an assertion that we confirmed in a previous study. Second, metabolism may be altered by chronic partial sleep deprivation. Here we address the second assertion by measuring the impact of long-term partial sleep deprivation on energy stores using Drosophila as a model. We subjected flies to long-term partial sleep deprivation via two different methods: a mechanical stimulus and a light stimulus. We then measured whole-body triglycerides and glycogen, two important sources of energy for the fly, and compared them to un-stimulated controls. We also measured changes in energy stores in response to a random circadian clock shift. Sex and line-dependent alterations in glycogen and/or triglyceride levels occurred in response to the circadian clock shift and in flies subjected to a single night of sleep deprivation using light. Thus, consistent with previous studies, our findings suggest that acute sleep loss and changes to the circadian clock can alter metabolism. Significant changes in energy stores were also observed when flies were subjected to chronic sleep loss via the mechanical stimulus, although not the light stimulus. Interestingly, mechanical stimulation resulted in the same change in energy stores even when it was not associated with sleep deprivation, suggesting that the changes are caused by stress rather than sleep loss. These findings emphasize the importance of taking stress into account when evaluating the relationship between sleep loss and metabolism.			Harbison, ST (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	susan_harbison@ncsu.edu	Harbison, Susan T/P-2577-2016	Harbison, Susan T/0000-0001-7233-0947	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007713] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [T32 HL07713, T32 HL007713] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bjorvatn B, 2007, J SLEEP RES, V16, P66, DOI 10.1111/j.1365-2869.2007.00569.x; Bliwise DL, 1996, SLEEP, V19, P462, DOI 10.1093/sleep/19.6.462; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cizza G, 2005, SLEEP, V28, P1217, DOI 10.1093/sleep/28.10.1217; CLARK AG, 1988, GENETICS, V119, P595; De Luca M, 2005, OBES RES, V13, P1596, DOI 10.1038/oby.2005.196; Djawdan M, 1998, PHYSIOL ZOOL, V71, P584, DOI 10.1086/515963; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289; Harbison ST, 2008, GENETICS, V178, P2341, DOI 10.1534/genetics.107.081232; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; Hasler G, 2004, SLEEP, V27, P661, DOI 10.1093/sleep/27.4.661; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Ho KS, 2005, METHOD ENZYMOL, V393, P772, DOI 10.1016/S0076-6879(05)93041-3; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Kim Y, 2007, P NATL ACAD SCI USA, V104, P10697, DOI 10.1073/pnas.0610351104; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Martin-Blanco E, 2000, BIOESSAYS, V22, P637, DOI 10.1002/1521-1878(200007)22:7<637::AID-BIES6>3.0.CO;2-E; MCGOWAN MW, 1983, CLIN CHEM, V29, P538; Mullington JM, 2003, J NEUROENDOCRINOL, V15, P851, DOI 10.1046/j.1365-2826.2003.01069.x; *NAT SLEEP FDN, 2008, SLEEP AM POLL; National Sleep Foundation, 2005, SLEEP AM POLL; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Nuzhdin SV, 1997, P NATL ACAD SCI USA, V94, P9734, DOI 10.1073/pnas.94.18.9734; Patel SR, 2004, SLEEP, V27, P440, DOI 10.1093/sleep/27.3.440; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shigeta H, 2001, DIABETES CARE, V24, P608, DOI 10.2337/diacare.24.3.608; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Stronach BE, 1999, ONCOGENE, V18, P6172, DOI 10.1038/sj.onc.1203125; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vioque J, 2000, INT J OBESITY, V24, P1683, DOI 10.1038/sj.ijo.0801434; von Kries R, 2002, INT J OBESITY, V26, P710, DOI 10.1038/sj.ijo.0801980; Williams JA, 2007, SLEEP, V30, P389, DOI 10.1093/sleep/30.4.389; Wu MN, 2008, SLEEP, V31, P465, DOI 10.1093/sleep/31.4.465; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Zimmerman JE, 2004, J NEUROCHEM, V88, P32, DOI 10.1046/j.1471-4159.2003.02126.x	43	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6211	10.1371/journal.pone.0006211	http://dx.doi.org/10.1371/journal.pone.0006211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593430	Green Submitted, Green Published, gold			2022-12-27	WOS:000268035300017
J	Yang, CT; Zeng, XH; Xia, XM; Lingle, CJ				Yang, Cheng-Tao; Zeng, Xu-Hui; Xia, Xiao-Ming; Lingle, Christopher J.			Interactions between beta Subunits of the KCNMB Family and Slo3: beta 4 Selectively Modulates Slo3 Expression and Function	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; LARGE-CONDUCTANCE; POTASSIUM CHANNELS; SURFACE EXPRESSION; BK CHANNELS; VOLTAGE; CA2+; INACTIVATION; SPERMATOZOA; CURRENTS	Background: The pH and voltage-regulated Slo3 K+ channel, a homologue of the Ca2+- and voltage-regulated Slo1 K+ channel, is thought to be primarily expressed in sperm, but the properties of Slo3 studied in heterologous systems differ somewhat from the native sperm KSper pH-regulated current. There is the possibility that critical partners that regulate Slo3 function remain unidentified. The extensive amino acid identity between Slo3 and Slo1 suggests that auxiliary beta subunits regulating Slo1 channels might coassemble with and modulate Slo3 channels. Four distinct beta subunits composing the KCNMB family are known to regulate the function and expression of Slo1 Channels. Methodology/Principal Findings: To examine the ability of the KCNMB family of auxiliary beta subunits to regulate Slo3 function, we co-expressed Slo3 and each beta subunit in heterologous expression systems and investigated the functional consequences by electrophysiological and biochemical analyses. The beta 4 subunit produced an 8-10 fold enhancement of Slo3 current expression in Xenopus oocytes and a similar enhancement of Slo3 surface expression as monitored by YFP-tagged Slo3 or biotin labeled Slo3. Neither beta 1, beta 2, nor beta 3 mimicked the ability of beta 4 to increase surface expression, although biochemical tests suggested that all four beta subunits are competent to coassemble with Slo3. Fluorescence microscopy from beta 4 KO mice, in which an eGFP tag replaced the deleted exon, revealed that beta 4 gene promoter is active in spermatocytes. Furthermore, quantitative RT-PCR demonstrated that beta 4 and Slo3 exhibit comparable mRNA abundance in both testes and sperm. Conclusions/Significance: These results argue that, for native mouse Slo3 channels, the beta 4 subunit must be considered as a potential interaction partner and, furthermore, that KCNMB subunits may have functions unrelated to regulation of the Slo1 alpha subunit.			Yang, CT (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	zengx@morpheus.wustl.edu; clingle@morpheus.wustl.edu		Lingle, Christopher/0000-0002-9916-3795	NIGMS NIH HHS [R01 GM068580, GM081748, GM068580, R01 GM081748] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081748, R01GM068580] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Ho HC, 2001, REPRODUCTION, V122, P519, DOI 10.1530/rep.0.1220519; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; KNAUS HG, 1994, BIOCHEMISTRY-US, V33, P5819, DOI 10.1021/bi00185a021; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Koutsouki E, 2007, BIOCHEM BIOPH RES CO, V363, P18, DOI 10.1016/j.bbrc.2007.07.181; Li W, 2007, J CELL PHYSIOL, V212, P348, DOI 10.1002/jcp.21007; Lingle CJ, 2006, J NEUROSCI METH, V158, P121, DOI 10.1016/j.jneumeth.2006.05.027; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Strobaek D, 1996, NEUROPHARMACOLOGY, V35, P903, DOI 10.1016/0028-3908(96)00096-2; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; Uebele VN, 2000, J BIOL CHEM, V275, P23211, DOI 10.1074/jbc.M910187199; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Xia XM, 2004, J NEUROSCI, V24, P5585, DOI 10.1523/JNEUROSCI.1296-04.2004; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Xia XM, 2000, J NEUROSCI, V20, P4890; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932; Zeng XH, 2007, J NEUROSCI, V27, P4707, DOI 10.1523/JNEUROSCI.0758-07.2007; ZHANG X, J GEN PHYSL, V128, P301; Zhang X, 2006, J GEN PHYSIOL, V128, P317, DOI 10.1085/jgp.200609552	31	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6135	10.1371/journal.pone.0006135	http://dx.doi.org/10.1371/journal.pone.0006135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578543	Green Submitted, Green Published, gold			2022-12-27	WOS:000267806300007
J	Enyeart, JA; Enyeart, JJ				Enyeart, Judith A.; Enyeart, John J.			Metabolites of an Epac-Selective cAMP Analog Induce Cortisol Synthesis by Adrenocortical Cells through a cAMP-Independent Pathway	PLOS ONE			English	Article								Adrenal zona fasciculata (AZF) cells express a cAMP-activated guanine nucleotide exchange protein (Epac2) that may function in ACTH-stimulated cortisol synthesis. Experiments were done to determine whether cAMP analogs that selectively activate Epacs could induce cortisol synthesis and the expression of genes coding for steroidogenic proteins in bovine AZF cells. Treatment of AZF cells with the Epac-selective cAMP analog (ESCA) 8CPT-2'-OMe-cAMP induced large (>100 fold), concentration-dependent, delayed increases in cortisol synthesis and the expression of mRNAs coding for the steroid hydroxylases CYP11a1, CYP17, CYP21, and the steroid acute regulatory protein (StAR). However, a non-hydrolyzable analog of this ESCA, Sp-8CPT-2'-OMe-cAMP, failed to stimulate cortisol production even at concentrations that activated Rap1, a downstream effector of Epac2. Accordingly, putative metabolites of 8CPT-2'-OMe-cAMP, including 8CPT-2'-OMe-5'AMP, 8CPT-2'-OMe-adenosine, and 8CPT-adenine all induced cortisol synthesis and steroid hydroxylase mRNA expression with a temporal pattern, potency, and effectiveness similar to the parent compound. At concentrations that markedly stimulated cortisol production, none of these metabolites significantly activated cAMP-dependent protein kinase (PKA). These results show that one or more metabolites of the ESCA 8CPT-2'-OMe-cAMP induce cortico-steroidogenesis by activating a panel of genes that code for steroidogenic proteins. The remarkable increases in cortisol synthesis observed in this study appear to be mediated by a novel cAMP-, Epac- and PKA-independent signaling pathway.			Enyeart, JA (corresponding author), Ohio State Univ, Coll Med & Publ Hlth, Dept Neurosci, Columbus, OH 43210 USA.	enyeart.1@osu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047875] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK047875, R01-DK47875] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHLGREN R, 1990, J BIOL CHEM, V265, P3313; BARBARA JG, 1995, J PHYSIOL-LONDON, V488, P609, DOI 10.1113/jphysiol.1995.sp020994; BONDY P K, 1985, P816; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Enyeart JA, 2003, MOL PHARMACOL, V64, P132, DOI 10.1124/mol.64.1.132; Enyeart JJ, 1997, J GEN PHYSIOL, V110, P679, DOI 10.1085/jgp.110.6.679; Enyeart JJ, 1996, J GEN PHYSIOL, V108, P251, DOI 10.1085/jgp.108.4.251; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; JOHN ME, 1986, P NATL ACAD SCI USA, V83, P4715, DOI 10.1073/pnas.83.13.4715; KAGAWA N, 1990, J BIOL CHEM, V265, P11299; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Laxman S, 2006, P NATL ACAD SCI USA, V103, P19194, DOI 10.1073/pnas.0608971103; Liu HY, 2008, J GEN PHYSIOL, V132, P279, DOI 10.1085/jgp.200810003; LUND J, 1990, J BIOL CHEM, V265, P3304; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; MOYLE WR, 1973, J BIOL CHEM, V248, P2409; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Parker KL, 1995, VITAM HORM, V51, P339, DOI 10.1016/S0083-6729(08)61044-4; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PENHOAT A, 1989, P NATL ACAD SCI USA, V86, P4798; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Price N., 1999, FUNDAMENTALS ENZYMOL; RAIKHINSTEIN M, 1994, BBA-MOL CELL RES, V1220, P329, DOI 10.1016/0167-4889(94)90157-0; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; STOCCO DM, 2001, ANNU REV PHYSIOL, V63, P213; VENEPALLY P, 1995, J BIOL CHEM, V270, P25402, DOI 10.1074/jbc.270.43.25402; Wakeman CA, 2007, TRENDS BIOCHEM SCI, V32, P415, DOI 10.1016/j.tibs.2007.08.005; Waterman MR, 1997, FASEB J, V11, P419, DOI 10.1096/fasebj.11.6.9194522; WATERMAN MR, 1994, J BIOL CHEM, V269, P27783; WATERMAN MR, 1988, RECENT PROG HORM RES, V45, P532; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Yamazaki T, 1998, ENDOCRINOLOGY, V139, P4765, DOI 10.1210/en.139.12.4765; ZUBER MX, 1986, J BIOL CHEM, V261, P2475	42	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6088	10.1371/journal.pone.0006088	http://dx.doi.org/10.1371/journal.pone.0006088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564912	Green Published, Green Submitted, gold			2022-12-27	WOS:000267515700007
J	Merbl, Y; Itzchak, R; Vider-Shalit, T; Louzoun, Y; Quintana, FJ; Vadai, E; Eisenbach, L; Cohen, IR				Merbl, Yifat; Itzchak, Royi; Vider-Shalit, Tal; Louzoun, Yoram; Quintana, Francisco J.; Vadai, Ezra; Eisenbach, Lea; Cohen, Irun R.			A Systems Immunology Approach to the Host-Tumor Interaction: Large-Scale Patterns of Natural Autoantibodies Distinguish Healthy and Tumor-Bearing Mice	PLOS ONE			English	Article								Traditionally, immunology has considered a meaningful antibody response to be marked by large amounts of high-affinity antibodies reactive with the specific inciting antigen; the detection of small amounts of low-affinity antibodies binding to seemingly unrelated antigens has been considered to be beneath the threshold of immunological meaning. A systems-biology approach to immunology, however, suggests that large-scale patterns in the antibody repertoire might also reflect the functional state of the immune system. To investigate such global patterns of antibodies, we have used an antigen-microarray device combined with informatic analysis. Here we asked whether antibody-repertoire patterns might reflect the state of an implanted tumor. We studied the serum antibodies of inbred C57BL/6 mice before and after implantation of syngeneic 3LL tumor cells of either metastatic or non-metastatic clones. We analyzed patterns of IgG and IgM autoantibodies binding to over 300 self-antigens arrayed on slides using support vector machines and genetic algorithm techniques. We now report that antibody patterns, but not single antibodies, were informative: 1) mice, even before tumor implantation, manifest both individual and common patterns of low-titer natural autoantibodies; 2) the patterns of these autoantibodies respond to the growth of the tumor cells, and can distinguish between metastatic and non-metastatic tumor clones; and 3) curative tumor resection induces dynamic changes in these low-titer autoantibody patterns. The informative patterns included autoantibodies binding to self-molecules not known to be tumor-associated antigens (including insulin, DNA, myosin, fibrinogen) as well as to known tumor-associated antigens (including p53, cytokeratin, carbonic anhydrases, tyrosinase). Thus, low-titer autoantibodies that are not the direct products of tumor-specific immunization can still generate an immune biomarker of the body-tumor interaction. System-wide profiling of autoantibody repertoires can be informative.			Merbl, Y (corresponding author), Harvard Univ, Sch Med, Syst Biol Dept, Boston, MA 02115 USA.	Irun.cohen@weizmann.ac.il	Quintana, Francisco Javier/AAB-6915-2020; louzoun, yoram/F-5874-2011	louzoun, yoram/0000-0003-1714-6148; Eisenbach, Lea R/0000-0002-4816-1968; Merbl, Yifat/0000-0002-3465-2221	NIAID NIH HHS [1 R01 AI61062-01, R01 AI061062] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061062] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOSER B, 1992, P 5 ANN WORKSH COMP, V5, P144; Caron M, 2007, MOL CELL PROTEOMICS, V6, P1115, DOI 10.1074/mcp.R600016-MCP200; Cohen I. R., 2000, TENDING ADAMS GARDEN; COHEN IR, 1992, IMMUNOL TODAY, V13, P490, DOI 10.1016/0167-5699(92)90024-2; Cohen IR, 2007, J AUTOIMMUN, V29, P246, DOI 10.1016/j.jaut.2007.07.016; Cohen IR, 2007, NAT REV IMMUNOL, V7, P569, DOI 10.1038/nri2102; DRUCKER CJC, 1997, NIPS, V9, P155; EISENBACH L, 1983, INT J CANCER, V32, P113, DOI 10.1002/ijc.2910320118; FRANCISCO J, 2008, P NATL ACAD SCI US; Gunawardana CG, 2007, CANCER LETT, V249, P110, DOI 10.1016/j.canlet.2007.01.002; Harwanegg C, 2005, CLIN CHEM LAB MED, V43, P1321, DOI 10.1515/CCLM.2005.226; Haury M, 1997, EUR J IMMUNOL, V27, P1557, DOI 10.1002/eji.1830270635; HAURY M, 1994, SCAND J IMMUNOL, V39, P79, DOI 10.1111/j.1365-3083.1994.tb03343.x; Hueber W, 2005, ARTHRITIS RHEUM-US, V52, P2645, DOI 10.1002/art.21269; LYDYARD PM, 1990, SCAND J IMMUNOL, V31, P33, DOI 10.1111/j.1365-3083.1990.tb02740.x; Merbl Y, 2007, J CLIN INVEST, V117, P712, DOI 10.1172/JCI29943; MOUTHON L, 1995, J IMMUNOL, V154, P5769; PLAKSIN D, 1988, P NATL ACAD SCI USA, V85, P4463, DOI 10.1073/pnas.85.12.4463; Quintana FJ, 2006, LUPUS, V15, P428, DOI 10.1191/0961203306lu2328oa; Quintana FJ, 2004, P NATL ACAD SCI USA, V101, P14615, DOI 10.1073/pnas.0404848101; Quintana FJ, 2003, J AUTOIMMUN, V21, P65, DOI 10.1016/S0896-8411(03)00064-7; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; *THEOD EV MPAAE, 2004, MACHINE LEARNING, V55; Wilcox RR, 2001, FUNDAMENTALS MODERN	26	29	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6053	10.1371/journal.pone.0006053	http://dx.doi.org/10.1371/journal.pone.0006053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557135	Green Published, gold, Green Submitted			2022-12-27	WOS:000267356900013
J	Marlin, R; Nugeyre, MT; de Truchis, C; Berkane, N; Gervaise, A; Barre-Sinoussi, F; Menu, E				Marlin, Romain; Nugeyre, Marie-Therese; de Truchis, Claire; Berkane, Nadia; Gervaise, Amelie; Barre-Sinoussi, Francoise; Menu, Elisabeth			Antigen-Presenting Cells Represent Targets for R5 HIV-1 Infection in the First Trimester Pregnancy Uterine Mucosa	PLOS ONE			English	Article								Background: During the first trimester of pregnancy, HIV-1 mother-to-child transmission is relatively rare despite the permissivity of placental cells to cell-to-cell HIV-1 infection. The placenta interacts directly with maternal uterine cells (decidual cells) but the physiological role of the decidua in the control of HIV-1 transmission and whether decidua could be a source of infected cells is unknown. Methodology/Principal Findings: To answer to this question, decidual mononuclear cells were exposed to HIV-1 in vitro. Decidual cells were shown to be more susceptible to infection by an R5 HIV-1, as compared to an X4 HIV-1. Infected cells were identified by flow cytometry analysis. The results showed that CD14(+) cells were the main targets of HIV-1 infection in the decidua. These infected CD14+ cells expressed DC-SIGN, CD11b, CD11c, the Fc gamma receptor CD16, CD32 and CD64, classical MHC class-I and class-II and maturation and activation molecules CD83, CD80 and CD86. The permissivity of decidual tissue was also evaluated by histoculture. Decidual tissue was not infected by X4 HIV-1 but was permissive to R5 HIV-1. Different profiles of infection were observed depending on tissue localization. Conclusions/Significance: The presence of HIV-1 target cells in the decidua in vitro and the low rate of in utero mother-to-child transmission during the first trimester of pregnancy suggest that a natural control occurs in vivo limiting cell-to-cell infection of the placenta and consequently infection of the fetus.			Marlin, R (corresponding author), Inst Pasteur, Dept Virol, Regulat Retroviral Infect Unit, Paris, France.	elisabeth.menu@pasteur.fr	Barre-Sinoussi, Françoise/G-8355-2011; MENU, Elisabeth/B-2886-2010	MENU, Elisabeth/0000-0001-8844-9328				Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Arias RA, 2003, VIROLOGY, V307, P266, DOI 10.1016/S0042-6822(02)00040-5; Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37; BLOIS SM, 2007, BIOL REPROD; Cassol E, 2009, J IMMUNOL, V182, P6237, DOI 10.4049/jimmunol.0803447; Chaouat G, 2007, REPROD BIOMED ONLINE, V14, P256, DOI 10.1016/S1472-6483(10)60796-1; Chouquet C, 1997, AIDS, V11, P1183, DOI 10.1097/00002030-199709000-00015; David A, 2006, J IMMUNOL, V177, P6291, DOI 10.4049/jimmunol.177.9.6291; Derrien M, 2005, J VIROL, V79, P12304, DOI 10.1128/JVI.79.19.12304-12310.2005; Dolcini G, 2003, AIDS RES HUM RETROV, V19, P857, DOI 10.1089/088922203322493021; DOUGLAS GC, 1991, AIDS RES HUM RETROV, V7, P735, DOI 10.1089/aid.1991.7.735; Engert S, 2007, AM J REPROD IMMUNOL, V58, P129, DOI 10.1111/j.1600-0897.2007.00498.x; Faye A, 2005, PLACENTA, V26, P262, DOI 10.1016/j.placenta.2004.08.005; Gardner L, 2003, BIOL REPROD, V69, P1438, DOI 10.1095/biolreprod.103.017574; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Hanna J, 2007, TRENDS IMMUNOL, V28, P201, DOI 10.1126/scitranslmed.3006850; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Kammerer U, 2003, AM J PATHOL, V162, P887, DOI 10.1016/S0002-9440(10)63884-9; Kilani RT, 1997, J VIROL, V71, P6359, DOI 10.1128/JVI.71.9.6359-6372.1997; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Kourtis AP, 2006, LANCET INFECT DIS, V6, P726, DOI 10.1016/S1473-3099(06)70629-6; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Laskarin G, 2008, AM J REPROD IMMUNOL, V59, P433, DOI 10.1111/j.1600-0897.2008.00599.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Pereira L, 2003, J VIROL, V77, P13301, DOI 10.1128/JVI.77.24.13301-13314.2003; QIU X, 2008, INFECT IMMUN; REPNIK U, 2008, PLACENTA; Sargent IL, 2006, TRENDS IMMUNOL, V27, P399, DOI 10.1016/j.it.2006.06.009; Schmitt N, 2006, AIDS, V20, P533, DOI 10.1097/01.aids.0000210607.63138.bc; Schmitt N, 2007, IMMUNOBIOLOGY, V212, P167, DOI 10.1016/j.imbio.2007.01.008; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Scott-Algara D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001975; Shi Y, 2002, AIDS RES HUM RETROV, V18, P957, DOI 10.1089/088922202760265623; Tabiasco J, 2006, PLACENTA, V27, pS34, DOI 10.1016/j.placenta.2006.01.009; Trundley A, 2004, TISSUE ANTIGENS, V63, P1, DOI 10.1111/j.1399-0039.2004.00170.x; WILLIAMS PL, 1995, FETAL MEMBRANES PLAC, P158; Zachar V, 2002, AIDS RES HUM RETROV, V18, P839, DOI 10.1089/08892220260190317	38	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5971	10.1371/journal.pone.0005971	http://dx.doi.org/10.1371/journal.pone.0005971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543402	Green Submitted, Green Published, gold			2022-12-27	WOS:000267237600001
J	Brooks, CP; Holmes, C; Kramer, K; Barnett, B; Keitt, TH				Brooks, Christopher P.; Holmes, Christopher; Kramer, Karen; Barnett, Barry; Keitt, Timothy H.			The Role of Demography and Markets in Determining Deforestation Rates Near Ranomafana National Park, Madagascar	PLOS ONE			English	Article								The highland forests of Madagascar are home to some of the world's most unique and diverse flora and fauna and to some of its poorest people. This juxtaposition of poverty and biodiversity is continually reinforced by rapid population growth, which results in increasing pressure on the remaining forest habitat in the highland region, and the biodiversity therein. Here we derive a mathematical expression for the subsistence of households to assess the role of markets and household demography on deforestation near Ranomafana National Park. In villages closest to urban rice markets, households were likely to clear less land than our model predicted, presumably because they were purchasing food at market. This effect was offset by the large number of migrant households who cleared significantly more land between 1989-2003 than did residents throughout the region. Deforestation by migrant households typically occurred after a mean time lag of 9 years. Analyses suggest that while local conservation efforts in Madagascar have been successful at reducing the footprint of individual households, large-scale conservation must rely on policies that can reduce the establishment of new households in remaining forested areas.			Brooks, CP (corresponding author), Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA.	tkeitt@mail.utexas.edu	Kramer, Karen L/AAM-3022-2020; Keitt, Timothy/AAF-9787-2021	Keitt, Timothy/0000-0002-4587-1083				Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; [Anonymous], 2003, NATURAL HIST MADAGAS; Azariadis C, 2004, HDB EC GROWTH, P295; BARRETT CB, 2007, SMALLHOLDER MARKET P; Berkes F, 2004, CONSERV BIOL, V18, P621, DOI 10.1111/j.1523-1739.2004.00077.x; Brockington D, 2006, CONSERV BIOL, V20, P250, DOI 10.1111/j.1523-1739.2006.00335.x; Brockington Dan, 2002, FORTRESS CONSERVATIO; Chayanov A.V., 1925, THEORY PEASANT EC; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Cobb C.W., 1928, AM ECON REV, V18, P139, DOI DOI 10.2307/1811556; Fisher B, 2007, ECOL ECON, V62, P93, DOI 10.1016/j.ecolecon.2006.05.020; GOODMAN SM, 1993, BIOL CONSERV, V65, P205, DOI 10.1016/0006-3207(93)90054-5; Gorenflo LJ, 2006, BIOSCIENCE, V56, P723, DOI 10.1641/0006-3568(2006)56[723:KHDOGI]2.0.CO;2; GREEN GM, 1990, SCIENCE, V248, P212, DOI 10.1126/science.248.4952.212; HOLDREN JP, 1974, AM SCI, V62, P282; KISTLER P, 2003, NATURAL HIST MADAGAS; Kramer KL, 2002, HUM NATURE-INT BIOS, V13, P299, DOI 10.1007/s12110-002-1011-8; Kramer KL, 2005, MAYA CHILDREN HELPER; Kremen C, 1999, CONSERV BIOL, V13, P1055, DOI 10.1046/j.1523-1739.1999.98374.x; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Lufumpa CL, 2005, AFR DEV REV, V17, P366, DOI 10.1111/j.1017-6772.2006.00120.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; MYERS N, 1993, ENVIRON CONSERV, V20, P9, DOI 10.1017/S0376892900037176; Myers N, 1979, SINKING ARK NEW LOOK; Myers N., 1984, PRIMARY SOURCE TROPI; Plumwood V., 1982, Ecologist, V12, P4; *R DEV TEAM, 2007, R LANG ENV STAT COMP; RUDEL TK, 2005, CONS BIO, V20, P1604; Sanderson SE, 2003, ORYX, V37, P389, DOI 10.1017/S003060530300070X; Scott DM, 2006, BIOL CONSERV, V127, P72, DOI 10.1016/j.biocon.2005.07.014; SMITH AP, 1997, TROPICAL FOREST REMN; Vallan D, 2002, J TROP ECOL, V18, P725, DOI 10.1017/S026646740200247X	32	13	13	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5783	10.1371/journal.pone.0005783	http://dx.doi.org/10.1371/journal.pone.0005783			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536282	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029700001
J	Ward, A; Walker, VJ; Feng, ZY; Xu, XZS				Ward, Alex; Walker, Vyvyca J.; Feng, Zhaoyang; Xu, X. Z. Shawn			Cocaine Modulates Locomotion Behavior in C. elegans	PLOS ONE			English	Article								Cocaine, a potent addictive substance, is an inhibitor of monoamine transporters, including DAT (dopamine transporter), SERT (serotonin transporter) and NET (norepinephrine transporter). Cocaine administration induces complex behavioral alterations in mammals, but the underlying mechanisms are not well understood. Here, we tested the effect of cocaine on C. elegans behavior. We show for the first time that acute cocaine treatment evokes changes in C. elegans locomotor activity. Interestingly, the neurotransmitter serotonin, rather than dopamine, is required for cocaine response in C. elegans. The C. elegans SERT MOD-5 is essential for the effect of cocaine, consistent with the role of cocaine in targeting monoamine transporters. We further show that the behavioral response to cocaine is primarily mediated by the ionotropic serotonin receptor MOD-1. Thus, cocaine modulates locomotion behavior in C. elegans primarily by impinging on its serotoninergic system.			Ward, A (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022316] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA022316, R01 DA022316-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM078276, R01 GM078276-02] Funding Source: Medline; NINDS NIH HHS [T32 NS076401] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; AVERY L, 1993, GENETICS, V133, P897; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BEDFORD JA, 1980, PHARMACOL BIOCHEM BE, V13, P69, DOI 10.1016/0091-3057(80)90122-7; Carnell L, 2005, J NEUROSCI, V25, P10671, DOI 10.1523/JNEUROSCI.3399-05.2005; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chase D. L., 2007, WORMBOOK ONLINE REV, P1, DOI [10.1895/wormbook.1.132.1, DOI 10.1895/WORMBOOK.1.132.1]; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; GAWIN FH, 1991, SCIENCE, V251, P1580, DOI 10.1126/science.2011738; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Hall FS, 2004, ANN NY ACAD SCI, V1025, P47, DOI 10.1196/annals.1316.006; Hamdan FF, 1999, J NEUROCHEM, V72, P1372, DOI 10.1046/j.1471-4159.1999.721372.x; Harris GP, 2009, J NEUROSCI, V29, P1446, DOI 10.1523/JNEUROSCI.4585-08.2009; Higgins GA, 2003, EUR J PHARMACOL, V480, P151, DOI 10.1016/j.ejphar.2003.08.102; Hobson RJ, 2003, J NEUROCHEM, V87, P22, DOI 10.1046/j.1471-4159.2003.01967.x; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Howell LL, 2008, BIOCHEM PHARMACOL, V75, P196, DOI 10.1016/j.bcp.2007.08.003; HSU AL, 2008, NEUROBIOL AGING, DOI DOI 10.1016/J.NEUROBIOLAGING; Izenwasser S, 2004, NEUROTOX RES, V6, P379, DOI 10.1007/BF03033312; Jayanthi LD, 1998, MOL PHARMACOL, V54, P601; Jin YS, 1999, J NEUROSCI, V19, P539; Komuniecki RW, 2004, MOL BIOCHEM PARASIT, V137, P1, DOI 10.1016/j.molbiopara.2004.05.010; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lints R, 1999, DEVELOPMENT, V126, P5819; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; Muller CP, 2007, PROG NEUROBIOL, V81, P133, DOI 10.1016/j.pneurobio.2007.01.001; Olde B, 1997, J MOL NEUROSCI, V8, P53, DOI 10.1007/BF02736863; RAND JB, 1984, GENETICS, V106, P227; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Ranganathan R, 2001, J NEUROSCI, V21, P5871, DOI 10.1523/JNEUROSCI.21-16-05871.2001; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Scholz H, 2005, NATURE, V436, P845, DOI 10.1038/nature03864; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Thomsen M, 2009, J NEUROSCI, V29, P1087, DOI 10.1523/JNEUROSCI.4037-08.2009; Walsh SL, 1997, PSYCHOPHARMACOLOGY, V130, P41, DOI 10.1007/s002130050210; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Williams MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1779, DOI 10.1038/sj.npp.1301585; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zhao BB, 2003, J NEUROSCI, V23, P5319	50	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5946	10.1371/journal.pone.0005946	http://dx.doi.org/10.1371/journal.pone.0005946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536276	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029700016
J	Hayden, D; Lazar, P; Schoenfeld, D				Hayden, Douglas; Lazar, Peter; Schoenfeld, David		Inflammation Host Response Injury	Assessing Statistical Significance in Microarray Experiments Using the Distance Between Microarrays	PLOS ONE			English	Article							EXPRESSION DATA; GENES	We propose permutation tests based on the pairwise distances between microarrays to compare location, variability, or equivalence of gene expression between two populations. For these tests the entire microarray or some pre-specified subset of genes is the unit of analysis. The pairwise distances only have to be computed once so the procedure is not computationally intensive despite the high dimensionality of the data. An R software package, permtest, implementing the method is freely available from the Comprehensive R Archive Network at http://cran.r-project.org.			Hayden, D (corresponding author), Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA.	dhayden@partners.org		xiao, wenzhong/0000-0003-4944-6380; West, Michaela A/0000-0002-6598-4114	NIGMS NIH HHS [U54 GM062119, U54 GM-62119-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062119] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; [Anonymous], 1986, DESIGN ANAL CLIN EXP; BERRY KJ, 1983, AM ANTIQUITY, V48, P547, DOI 10.2307/280561; Chen JJ, 2007, BIOINFORMATICS, V23, P2104, DOI 10.1093/bioinformatics/btm310; Efron B, 1993, INTRO BOOTSTRAP, P202; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Hummel M, 2008, BIOINFORMATICS, V24, P78, DOI 10.1093/bioinformatics/btm531; Kong SW, 2006, BIOINFORMATICS, V22, P2373, DOI 10.1093/bioinformatics/btl401; MANTEL N, 1967, CANCER RES, V27, P209; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; PESARIN F, 2001, MULTIVARIATE PERMUTA, P43; Rajicic N, 2006, BIOINFORMATICS, V22, P2643, DOI 10.1093/bioinformatics/btl450; SAMUEL K, 1982, ENCY STAT SCI, V1, P205; Snedecor GW., 1989, STAT METHODS, P177	17	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5838	10.1371/journal.pone.0005838	http://dx.doi.org/10.1371/journal.pone.0005838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529777	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029500001
J	Kaur, P; Agarwal, S; Datta, S				Kaur, Parvinder; Agarwal, Saurabh; Datta, Santanu			Delineating Bacteriostatic and Bactericidal Targets in Mycobacteria Using IPTG Inducible Antisense Expression	PLOS ONE			English	Article								In order to identify novel high value antibacterial targets it is desirable to delineate whether the inactivation of the target enzyme will lead to bacterial death or stasis. This knowledge is particularly important in slow growing organisms, like mycobacteria, where most of the viable anti-tubercular agents are bactericidal. A bactericidal target can be identified through the conditional deletion or inactivation of the target gene at a relatively high cell number and subsequently following the time course of survival for the bacteria. A simple protocol to execute conditional inactivation of a gene is by antisense expression. We have developed a mycobacteria specific IPTG inducible vector system and monitored the effect of antisense inhibition of several known essential genes in mycobacteria by following their survival kinetics. By this method, we could differentiate between genes whose down regulation lead to bacteriostatic or bactericidal effect. Targets for standard anti-tubercular drugs like inhA for isoniazid, rpoB and C for rifampicin, and gyr A/B for flouroquinolones were shown to be bactericidal. In contrast targets like FtsZ behaved in a bacteriostatic manner. Induction of antisense expression in embB and ribosomal RNA genes, viz., rp/J and rpsL showed only a marginal growth inhibition. The specificity of the antisense inhibition was conclusively shown in the case of auxotrophic gene i/vB. The bactericidal activity following antisense expression of i/vB was completely reversed when the growth media was supplemented with the isoleucine, leucine, valine and pantothenate. Additionally, under these conditions the expression of several genes in branched chain amino acid pathway was severely suppressed indicating targeted gene inactivation.			Kaur, P (corresponding author), AstraZeneca India Pvt Ltd, Bangalore, Karnataka, India.	santanu.datta@astrazeneca.com						Amin AG, 2008, MICROBIOL-SGM, V154, P240, DOI 10.1099/mic.0.2007/012153-0; Argyrou A, 2007, J AM CHEM SOC, V129, P9582, DOI 10.1021/ja073160k; Bashyam MD, 1996, J BACTERIOL, V178, P4847, DOI 10.1128/jb.178.16.4847-4853.1996; BLOKPOEL MCJ, 2005, NUCLEIC ACIDS RES, V33, P1; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; FROEHLICH BJ, 1991, GENE, V108, P99, DOI 10.1016/0378-1119(91)90492-T; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jain P, 2002, J GENET, V81, P105, DOI 10.1007/BF02715907; JARSLAW D, 2003, MICROBIOLOGY, V149, P1593; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Levison ME, 2004, INFECT DIS CLIN N AM, V18, P451, DOI 10.1016/j.idc.2004.04.012; MULLERHILL B, 1968, P NATL ACAD SCI USA, V59, P1259, DOI 10.1073/pnas.59.4.1259; Parish T, 2001, BMC Microbiol, V1, P19, DOI 10.1186/1471-2180-1-19; PATEK M, MICROBIOL MONOGR, V5, DOI DOI 10.1007/7171_2006_70; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; SABINE E, 2005, NUCLEIC ACIDS RES, V33, P1; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shi R, 2007, ANTIMICROB AGENTS CH, V51, P4515, DOI 10.1128/AAC.00416-07; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Stolt P, 1996, J BACTERIOL, V178, P6693, DOI 10.1128/jb.178.23.6693-6700.1996; Stratton CW, 2003, EMERG INFECT DIS, V9, P10; Sullivan TJ, 2006, ACS CHEM BIOL, V1, P43, DOI 10.1021/cb0500042; Unniraman S, 2002, J BACTERIOL, V184, P5449, DOI 10.1128/JB.184.19.5449-5456.2002; YAGIL G, 1971, BIOPHYS J, V11, P11, DOI 10.1016/S0006-3495(71)86192-1	33	46	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5923	10.1371/journal.pone.0005923	http://dx.doi.org/10.1371/journal.pone.0005923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526063	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029300014
J	Tsunematsu, T; Kudo, Y; Iizuka, S; Ogawa, I; Fujita, T; Kurihara, H; Abiko, Y; Takata, T				Tsunematsu, Takaaki; Kudo, Yasusei; Iizuka, Shinji; Ogawa, Ikuko; Fujita, Tsuyoshi; Kurihara, Hidemi; Abiko, Yoshimitsu; Takata, Takashi			RUNX3 Has an Oncogenic Role in Head and Neck Cancer	PLOS ONE			English	Article								Background: Runt-related transcription factor 3 (RUNX3) is a tumor suppressor of cancer and appears to be an important component of the transforming growth factor-beta (TGF-beta)-induced tumor suppression pathway. Surprisingly, we found that RUNX3 expression level in head and neck squamous cell carcinoma (HNSCC) tissues, which is one of the most common types of human cancer, was higher than that in normal tissues by a previously published microarray dataset in our preliminary study. Therefore, here we examined the oncogenic role of RUNX3 in HNSCC. Principal Findings: Frequent RUNX3 expression and its correlation with malignant behavior were observed in HNSCC. Ectopic RUNX3 overexpression promoted cell growth and inhibited serum starvation-induced apoptosis and chemotherapeutic drug induced apoptosis in HNSCC cells. These findings were confirmed by RUNX3 knockdown. Moreover, RUNX3 overexpression enhanced tumorsphere formation. RUNX3 expression level was well correlated with the methylation status in HNSCC cells. Moreover, RUNX3 expression was low due to the methylation of its promoter in normal oral epithelial cells. Conclusions/Significance: Our findings suggest that i) RUNX3 has an oncogenic role in HNSCC, ii) RUNX3 expression observed in HNSCC may be caused in part by demethylation during cancer development, and iii) RUNX3 expression can be a useful marker for predicting malignant behavior and the effect of chemotherapeutic drugs in HNSCC.			Tsunematsu, T (corresponding author), Hiroshima Univ, Div Frontier Med Sci, Dept Oral & Maxillofacial Pathobiol, Grad Sch Biomed Sci, Hiroshima, Japan.	ykudo@hiroshima-u.ac.jp; ttakata@hiroshima-u.ac.jp		Kudo, Yasusei/0000-0002-0392-7720				BAE SC, 1995, GENE, V159, P245, DOI 10.1016/0378-1119(95)00060-J; BORRELLO MG, 1992, ONCOGENE, V7, P269; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; CHEAH MSC, 1984, JNCI-J NATL CANCER I, V73, P1057; Cheng CK, 2008, BLOOD, V112, P3391, DOI 10.1182/blood-2008-02-137083; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FIDLER IJ, 1990, CANCER RES, V50, P6130; FIENBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47; Francis-West P, 1998, MECH DEVELOP, V75, P3, DOI 10.1016/S0925-4773(98)00082-3; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Hoeflich A, 2001, CANCER RES, V61, P8601; Homma N, 2006, CANCER SCI, V97, P51, DOI 10.1111/j.1349-7006.2005.00133.x; Iiizumi M, 2006, CANCER SCI, V97, P1211, DOI 10.1111/j.1349-7006.2006.00313.x; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; JACOBSSON PA, 1973, ACTA RADIOL THER PHY, V12, P1; Kim TY, 2004, LAB INVEST, V84, P479, DOI 10.1038/labinvest.3700060; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; KIM YI, 1994, CANCER, V74, P893, DOI 10.1002/1097-0142(19940801)74:3<893::AID-CNCR2820740316>3.0.CO;2-B; Kitajima S, 2004, AM J PATHOL, V165, P2147, DOI 10.1016/S0002-9440(10)63264-6; Ku JL, 2004, ONCOGENE, V23, P6736, DOI 10.1038/sj.onc.1207731; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; LIPSANEN V, 1988, BLOOD, V72, P2042; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Mori T, 2005, LIVER INT, V25, P380, DOI 10.1111/j.1478-3231.2005.1059.x; Nam S, 2002, MOL CELL BIOL, V22, P547, DOI 10.1128/MCB.22.2.547-554.2002; Oshimo Y, 2004, PATHOBIOLOGY, V71, P137, DOI 10.1159/000076468; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Salto-Tellez M, 2006, ONCOGENE, V25, P7646, DOI 10.1038/sj.onc.1209739; Takahashi T, 2006, INT J CANCER, V118, P924, DOI 10.1002/ijc.21453; Wente MN, 2008, CANCER LETT, V259, P209, DOI 10.1016/j.canlet.2007.10.021; Yamamoto H, 2006, ANAT REC PART A, V288A, P695, DOI 10.1002/ar.a.20339; Yanada M, 2005, ONCOL REP, V14, P817; Yanagida M, 2005, ONCOGENE, V24, P4477, DOI 10.1038/sj.onc.1208675	38	63	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5892	10.1371/journal.pone.0005892	http://dx.doi.org/10.1371/journal.pone.0005892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521519	gold, Green Published			2022-12-27	WOS:000267029100008
J	Piazza, N; Gosangi, B; Devilla, S; Arking, R; Wessells, R				Piazza, Nicole; Gosangi, Babina; Devilla, Shawn; Arking, Robert; Wessells, Robert			Exercise-Training in Young Drosophila melanogaster Reduces Age-Related Decline in Mobility and Cardiac Performance	PLOS ONE			English	Article							LIFE-SPAN; CALORIC RESTRICTION; SKELETAL-MUSCLE; MITOCHONDRIAL-FUNCTION; NEGATIVE GEOTAXIS; PHYSICAL-ACTIVITY; OXIDATIVE STRESS; GENE-EXPRESSION; FLIGHT ACTIVITY; MALE RATS	Declining mobility is a major concern, as well as a major source of health care costs, among the elderly population. Lack of mobility is a primary cause of entry into managed care facilities, and a contributing factor to the frequency of damaging falls. Exercise-based therapies have shown great promise in sustaining mobility in elderly patients, as well as in rodent models. However, the genetic basis of the changing physiological responses to exercise during aging is not well understood. Here, we describe the first exercise-training paradigm in an invertebrate genetic model system. Flies are exercised by a mechanized platform, known as the Power Tower, that rapidly, repeatedly, induces their innate instinct for negative geotaxis. When young flies are subjected to a carefully controlled, ramped paradigm of exercise-training, they display significant reduction in age-related decline in mobility and cardiac performance. Fly lines with improved mitochondrial efficiency display some of the phenotypes observed in wild-type exercised flies. The exercise response in flies is influenced by the amount of protein and lipid, but not carbohydrate, in the diet. The development of an exercise-training model in Drosophila melanogaster opens the way to direct testing of single-gene based genetic therapies for improved mobility in aged animals, as well as unbiased genetic screens for loci involved in the changing response to exercise during aging.	[Piazza, Nicole; Gosangi, Babina; Devilla, Shawn; Wessells, Robert] Univ Michigan, Sch Med, Inst Gerontol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Arking, Robert] Wayne State Univ, Dept Biol, Detroit, MI USA	University of Michigan System; University of Michigan; Wayne State University	Piazza, N (corresponding author), Univ Michigan, Sch Med, Inst Gerontol, Dept Internal Med, Ann Arbor, MI 48109 USA.	wessells@med.umich.edu	Wessells, Robert/AAG-3406-2020	Wessells, Robert/0000-0002-4516-3183; gosangi, babina/0000-0003-4855-4232	American Heart Association [AHA 0630025N]; Glenn Foundation; Nathan Shock Center [NIA P30 A601328313]	American Heart Association(American Heart Association); Glenn Foundation; Nathan Shock Center	We acknowledge funding by the American Heart Association (americanheart.org, AHA 0630025N), the Glenn Foundation for the Study of Biological Mechanisms of Aging and the Nathan Shock Center for the Study of the Biology of Aging (Nathan Shock Center: grants.nih.gov, NIA P30 A601328313) (RW). The funders had no role in study collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2008, FRONT BIOSCI-LANDMRK, V13, P302, DOI 10.2741/2680; ANDERSON, 2003, AGING CELL, V7, P101; Arking R, 2002, AGEING RES REV, V1, P209, DOI 10.1016/S1568-1637(01)00010-1; Ascensao A, 2007, INT J CARDIOL, V117, P16, DOI 10.1016/j.ijcard.2006.04.076; Baar K, 2006, MED SCI SPORT EXER, V38, P1939, DOI 10.1249/01.mss.0000233799.62153.19; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; BEJNEI J, 2000, ACTA PHYSL SCAND, V169, P343; Benton CR, 2008, PHYSIOL GENOMICS, V35, P45, DOI 10.1152/physiolgenomics.90217.2008; Bhandari P, 2007, AGING CELL, V6, P631, DOI 10.1111/j.1474-9726.2007.00320.x; Buchman AS, 2007, MUSCLE NERVE, V35, P354, DOI 10.1002/mus.20702; Carter CS, 2007, APPL PHYSIOL NUTR ME, V32, P954, DOI 10.1139/H07-085; Cohen-Mansfield J, 2008, GERONTOLOGIST, V48, P505, DOI 10.1093/geront/48.4.505; Davidson SR, 2006, MED SCI SPORT EXER, V38, P250, DOI 10.1249/01.mss.0000183179.86594.4f; Dhahbi JM, 2006, J GERONTOL A-BIOL, V61, P218, DOI 10.1093/gerona/61.3.218; Drummond MJ, 2008, J APPL PHYSIOL, V104, P1452, DOI 10.1152/japplphysiol.00021.2008; Englander F, 1996, J FORENSIC SCI, V41, P733; Espeland MA, 2007, J GERONTOL A-BIOL, V62, P1237, DOI 10.1093/gerona/62.11.1237; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; FERRARA X, 2002, ARCH GERONTOL GERI S, V8, P115; GAEBLER S, 1993, J ADV NURS, V18, P1895, DOI 10.1046/j.1365-2648.1993.18121895.x; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; GOLLNICK PD, 1982, CLIN PHYSIOL, V2, P1, DOI 10.1111/j.1475-097X.1982.tb00001.x; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hollander J, 1999, AM J PHYSIOL-REG I, V277, pR856, DOI 10.1152/ajpregu.1999.277.3.R856; Holloszy JO, 1997, J APPL PHYSIOL, V82, P399, DOI 10.1152/jappl.1997.82.2.399; HOLLOSZY JO, 1985, J APPL PHYSIOL, V59, P826, DOI 10.1152/jappl.1985.59.3.826; Holloszy JO, 1998, MECH AGEING DEV, V100, P211, DOI 10.1016/S0047-6374(97)00140-1; HOLLOSZY JO, 1995, HDB PHYSL; Kemi OJ, 2008, FRONT BIOSCI-LANDMRK, V13, P356, DOI 10.2741/2685; Kruk J, 2007, ASIAN PAC J CANCER P, V8, P325; LEPAGE ML, 2008, EAT BEHAV, P423; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013; Magwere T, 2006, J GERONTOL A-BIOL, V61, P136, DOI 10.1093/gerona/61.2.136; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Merom D, 2004, J SCI MED SPORT, V7, P32, DOI 10.1016/S1440-2440(04)80041-0; Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; OBERDOERFFLER P, 2008, J BIOL CHEM, V135, P908; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Owen KL, 2009, CLIN SCI, V116, P365, DOI 10.1042/CS20080183; Paterson DH, 2007, APPL PHYSIOL NUTR ME, V32, pS69, DOI 10.1139/H07-111; Rennie MJ, 2007, BIOCHEM SOC T, V35, P1302, DOI 10.1042/BST0351302; Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011; Roberts CK, 2005, J APPL PHYSIOL, V98, P3, DOI 10.1152/japplphysiol.00852.2004; Saraceni C, 2007, CURR DIABETES REV, V3, P75, DOI 10.2174/157339907779802111; SATTIN RW, 1992, ANNU REV PUBL HEALTH, V13, P489, DOI 10.1146/annurev.pu.13.050192.002421; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Short KR, 2004, AM J PHYSIOL-ENDOC M, V286, pE92, DOI 10.1152/ajpendo.00366.2003; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001; Taghli-Lamallem O, 2008, AGING CELL, V7, P237, DOI 10.1111/j.1474-9726.2008.00367.x; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; TIDEIKSAAR R, 2002, FALLS ORDER PEOPLE P; TU K, 2007, EXP GERONTOL, V42, P1063; TUTISTALLL RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE66; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wessel RJ, 2004, BIOTECHNIQUES, V37, P58, DOI 10.2144/04371ST01; Wessells RJ, 2007, SEMIN CELL DEV BIOL, V18, P111, DOI 10.1016/j.semcdb.2006.12.011; WESSELS RJ, 2000, NAT GENET, V36, P1275; Yan LJ, 2000, FREE RADICAL BIO MED, V29, P1143, DOI 10.1016/S0891-5849(00)00423-8	69	86	91	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5886	10.1371/journal.pone.0005886	http://dx.doi.org/10.1371/journal.pone.0005886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YH	19517023	gold, Green Published, Green Submitted			2022-12-27	WOS:000207566400001
J	Ehren, J; Moron, B; Martin, E; Bethune, MT; Gray, GM; Khosla, C				Ehren, Jennifer; Moron, Belen; Martin, Edith; Bethune, Michael T.; Gray, Gary M.; Khosla, Chaitan			A Food-Grade Enzyme Preparation with Modest Gluten Detoxification Properties	PLOS ONE			English	Article								Background and Aims: Celiac sprue is a life-long disease characterized by an intestinal inflammatory response to dietary gluten. A gluten-free diet is an effective treatment for most patients, but accidental ingestion of gluten is common, leading to incomplete recovery or relapse. Food-grade proteases capable of detoxifying moderate quantities of dietary gluten could mitigate this problem. Methods: We evaluated the gluten detoxification properties of two food-grade enzymes, aspergillopepsin (ASP) from Aspergillus niger and dipeptidyl peptidase IV (DPPIV) from Aspergillus oryzae. The ability of each enzyme to hydrolyze gluten was tested against synthetic gluten peptides, a recombinant gluten protein, and simulated gastric digests of whole gluten and whole-wheat bread. Reaction products were analyzed by mass spectrometry, HPLC, ELISA with a monoclonal antibody that recognizes an immunodominant gluten epitope, and a T cell proliferation assay. Results: ASP markedly enhanced gluten digestion relative to pepsin, and cleaved recombinant alpha 2-gliadin at multiple sites in a non-specific manner. When used alone, neither ASP nor DPPIV efficiently cleaved synthetic immunotoxic gluten peptides. This lack of specificity for gluten was especially evident in the presence of casein, a competing dietary protein. However, supplementation of ASP with DPPIV enabled detoxification of moderate amounts of gluten in the presence of excess casein and in whole-wheat bread. ASP was also effective at enhancing the gluten-detoxifying efficacy of cysteine endoprotease EP-B2 under simulated gastric conditions. Conclusions: Clinical studies are warranted to evaluate whether a fixed dose ratio combination of ASP and DPPIV can provide near-term relief for celiac patients suffering from inadvertent gluten exposure. Due to its markedly greater hydrolytic activity against gluten than endogenous pepsin, food-grade ASP may also augment the activity of therapeutically relevant doses of glutenases such as EP-B2 and certain prolyl endopeptidases.			Ehren, J (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	khosla@stanford.edu		Khosla, Chaitan/0000-0001-6529-495X; Moron, Belen/0000-0003-4815-7536	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK063158, DK 063158] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abdulkarim AS, 2002, AM J GASTROENTEROL, V97, P2016; Bethune MT, 2006, CHEM BIOL, V13, P637, DOI 10.1016/j.chembiol.2006.04.008; Doumas A, 1998, APPL ENVIRON MICROB, V64, P4809; Gass J, 2005, BIOTECHNOL BIOENG, V92, P674, DOI 10.1002/bit.20643; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Hausch F, 2002, AM J PHYSIOL-GASTR L, V283, pG996, DOI 10.1152/ajpgi.00136.2002; Hischenhuber C, 2006, ALIMENT PHARM THER, V23, P559, DOI 10.1111/j.1365-2036.2006.02768.x; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Lee SK, 2003, GASTROINTEST ENDOSC, V57, P187, DOI 10.1067/mge.2003.54; Leffler DA, 2007, CLIN GASTROENTEROL H, V5, P445, DOI 10.1016/j.cgh.2006.12.006; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Mitea C, 2008, GUT, V57, P25, DOI 10.1136/gut.2006.111609; Moron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002294; Pyle GG, 2005, CLIN GASTROENTEROL H, V3, P679, DOI 10.1016/S1542-3565(05)00365-4; Shan L, 2005, J PROTEOME RES, V4, P1732, DOI 10.1021/pr050173t; Shan L, 2004, BIOCHEM J, V383, P311, DOI 10.1042/BJ20040907; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Siegel M, 2006, CHEM BIOL, V13, P649, DOI 10.1016/j.chembiol.2006.04.009; Stepniak D, 2006, AM J PHYSIOL-GASTR L, V291, pG621, DOI 10.1152/ajpgi.00034.2006; Takahashi K, 1997, BIOSCI BIOTECH BIOCH, V61, P381, DOI 10.1271/bbb.61.381; Xia J, 2005, BIOCHEMISTRY-US, V44, P4442, DOI 10.1021/bi047747c; Zhu LY, 2004, BIOSCI BIOTECH BIOCH, V68, P2607, DOI 10.1271/bbb.68.2607	22	69	81	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6313	10.1371/journal.pone.0006313	http://dx.doi.org/10.1371/journal.pone.0006313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621078	Green Published, Green Submitted, gold			2022-12-27	WOS:000268147200010
J	Brown, AK; Taylor, RC; Bhatt, A; Futterer, K; Besra, GS				Brown, Alistair K.; Taylor, Rebecca C.; Bhatt, Apoorva; Fuetterer, Klaus; Besra, Gurdyal S.			Platensimycin Activity against Mycobacterial beta-Ketoacyl-ACP Synthases	PLOS ONE			English	Article							MYCOLIC ACID BIOSYNTHESIS; FATTY-ACID; ENZYMATIC CHARACTERIZATION; CONDENSING ENZYMES; III MTFABH; BOVIS BCG; TUBERCULOSIS; INHA; KASA; ETHIONAMIDE	There is an urgent need for the discovery and development of new drugs against Mycobacterium tuberculosis, the causative agent of tuberculosis, especially due to the recent emergence of multi-drug and extensively-drug resistant strains. Herein, we have examined the susceptibility of mycobacteria to the natural product platensimycin. Methods and Findings: We have demonstrated that platensimycin has bacteriostatic activity against the fast growing Mycobacterium smegmatis (MIC = 14 mu g/ml) and against Mycobacterium tuberculosis (MIC = 12 mu g/ml). Growth in the presence of paltensimycin specifically inhibited the biosynthesis of mycolic acids suggesting that the antibiotic targeted the components of the mycolate biosynthesis complex. Given the inhibitory activity of platensimycin against beta-ketoacyl-ACP synthases from Staphylococcus aureus, M. tuberculosis KasA, KasB or FabH were overexpressed in M. smegmatis to establish whether these mycobacterial KAS enzymes were targets of platensimycin. In M. smegmatis overexpression of kasA or kasB increased the MIC of the strains from 14 mu g/ml, to 30 and 124 mu g/ml respectively. However, overexpression of fabH on did not affect the MIC. Additionally, consistent with the overexpression data, in vitro assays using purified proteins demonstrated that platensimycin inhibited Mt-KasA and Mt-KasB, but not Mt-FabH. Significance: Our results have shown that platensimycin is active against mycobacterial KasA and KasB and is thus an exciting lead compound against M. tuberculosis and the development of new synthetic analogues.			Brown, AK (corresponding author), Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham, W Midlands, England.	g.besra@bham.ac.uk		Futterer, Klaus/0000-0001-7445-5372; Besra, Gurdyal/0000-0002-5605-0395	Biotechnology and Biological Sciences Research Council [BB/E020615/1] Funding Source: Medline; Medical Research Council [G0500590, G0600105] Funding Source: Medline; Wellcome Trust Funding Source: Medline; BBSRC [BB/E020615/1] Funding Source: UKRI; MRC [G0600105, G0500590] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banerjee A, 1998, MICROBIOL-SGM, V144, P2697, DOI 10.1099/00221287-144-10-2697; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Baulard AR, 2000, J BIOL CHEM, V275, P28326; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Brown AK, 2005, J BIOL CHEM, V280, P32539, DOI 10.1074/jbc.M413216200; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Brown AK, 2007, MICROBIOL-SGM, V153, P3314, DOI 10.1099/mic.0.2007/009936-0; Choi KH, 2000, J BIOL CHEM, V275, P28201; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dobson G., 1985, CHEM METHODS BACTERI, P237; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Kaye K, 1996, EPIDEMIOL REV, V18, P52, DOI 10.1093/oxfordjournals.epirev.a017916; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Larsen MH, 2002, MOL MICROBIOL, V46, P453, DOI 10.1046/j.1365-2958.2002.03162.x; Parish T, 2007, J BACTERIOL, V189, P3721, DOI 10.1128/JB.01740-06; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Radmacher E, 2005, MICROBIOL-SGM, V151, P2421, DOI 10.1099/mic.0.28012-0; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; SINGH SB, 2008, Patent No. 2007020226; Singh SB, 2006, J AM CHEM SOC, V128, P11916, DOI 10.1021/ja062232p; Slayden RA, 1996, ANTIMICROB AGENTS CH, V40, P2813, DOI 10.1128/AAC.40.12.2813; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wang J, 2007, P NATL ACAD SCI USA, V104, P7612, DOI 10.1073/pnas.0700746104; Wright A, 2006, JAMA-J AM MED ASSOC, V295, P2349	35	47	49	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6306	10.1371/journal.pone.0006306	http://dx.doi.org/10.1371/journal.pone.0006306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609444	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000268119500022
J	Meier-Trummer, CS; Rehrauer, H; Franchini, M; Patrignani, A; Wagner, U; Ackermann, M				Meier-Trummer, Claudia S.; Rehrauer, Hubert; Franchini, Marco; Patrignani, Andrea; Wagner, Ulrich; Ackermann, Mathias			Malignant Catarrhal Fever of Cattle Is Associated with Low Abundance of IL-2 Transcript and a Predominantly Latent Profile of Ovine Herpesvirus 2 Gene Expression	PLOS ONE			English	Article								Background: Malignant catarrhal fever (MCF) is a lethal disease of cattle, characterized by vasculitis, necrosis, and accumulation of activated, dysregulated cytotoxic lymphocytes in various tissues. Ovine gamma herpesvirus 2 (OvHV-2) is a causative agent of MCF, which may trigger the disease through immunopathogenic pathways. Lymphocytes are the main target of the virus. However, the pathogenic basis of the disease is still mysterious. Methods/Findings: We hypothesized that the gene expression patterns of OvHV-2 and the relative abundances of host cell transcripts in lymphnodes may be used to identify pathways that help to explain the pathogenesis of MCF. Therefore, viral and host cell gene expression patterns in lymph nodes of animals with MCF and healthy controls were analyzed by microarray. Two regions on the viral genome were transcriptionally active, one encoding an orthologue to the latencyassociated nuclear antigen (ORF73) of other gamma herpesviruses, the other with no predicted open reading frame. A vast number of transcripts related to inflammatory processes, lymphocyte activation, cell proliferation and apoptosis were detected at different abundances. However, the IL-2 transcript was eminent among the transcripts, which were, compared to healthy controls, less abundant in animals with MCF. The ratio between CD4-and CD8-positive T-lymphocytes was decreased in the lymphnodes of animals with MCF compared to healthy controls. In contrast, the same ratio was stable, when peripheral blood lymphocytes were analyzed. Conclusions/Significance: The phenotype of mice with a deficient IL-2-system almost perfectly matches the clinical signs observed in cattle with MCF, which feature a significantly decreased IL-2 transcript abundance, compared to healthy cattle. This supports the hypothesis that immunopathogenic events are linked to the pathogenesis of MCF. IL-2- deficiency may play an important role in the process. Therefore, this work opens new avenues for research on MCF.			Meier-Trummer, CS (corresponding author), Inst Virol, Zurich, Switzerland.	email@vetvir.uzh.ch		Partigiani, Andrea/0000-0001-8019-3911				Abril C, 2004, J VIROL, V78, P3644, DOI 10.1128/JVI.78.7.3644-3653.2004; Abu Elzein EME, 2003, J VET MED B, V50, P53, DOI 10.1046/j.1439-0450.2003.00541.x; Ackermann M, 2006, VET MICROBIOL, V113, P211, DOI 10.1016/j.vetmic.2005.11.008; Ackermann M, 2005, SCHWEIZ ARCH TIERH, V147, P155, DOI 10.1024/0036-7281.147.4.155; Albini S, 2003, SCHWEIZ ARCH TIERH, V145, P61, DOI 10.1024/0036-7281.145.2.61; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Almeida PE, 2007, VET IMMUNOL IMMUNOP, V120, P234, DOI 10.1016/j.vetimm.2007.06.028; Arnold R, 2006, EUR J IMMUNOL, V36, P1654, DOI 10.1002/eji.200636197; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Babcock GJ, 2000, P NATL ACAD SCI USA, V97, P12250, DOI 10.1073/pnas.200366597; BAXTER SIF, 1993, ARCH VIROL, V132, P145, DOI 10.1007/BF01309849; Berezowski JA, 2005, J VET DIAGN INVEST, V17, P55, DOI 10.1177/104063870501700110; Borah S, 2004, J VIROL, V78, P10336, DOI 10.1128/JVI.78.19.10336-10347.2004; BRIDGEN A, 1991, RES VET SCI, V50, P38, DOI 10.1016/0034-5288(91)90051-O; BRIDGEN A, 1992, J COMP PATHOL, V106, P351, DOI 10.1016/0021-9975(92)90021-L; BROWN CC, 1992, J WILDLIFE DIS, V28, P301, DOI 10.7589/0090-3558-28.2.301; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Cai QL, 2006, PLOS PATHOG, V2, P1002, DOI 10.1371/journal.ppat.0020116; Collins JK, 2000, J VET DIAGN INVEST, V12, P406, DOI 10.1177/104063870001200503; Cunha CW, 2008, VIRUS RES, V132, P69, DOI 10.1016/j.virusres.2007.10.016; Damania B, 2004, NAT REV MICROBIOL, V2, P656, DOI 10.1038/nrmicro958; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; de Carcer G, 2007, CURR MED CHEM, V14, P969, DOI 10.2174/092986707780362925; Dewals B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001627; Dutcher J, 2002, ONCOLOGY-NY, V16, P4; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; GonzalezGarcia A, 1997, J IMMUNOL, V158, P4104; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Grell SN, 2005, VET IMMUNOL IMMUNOP, V103, P235, DOI 10.1016/j.vetimm.2004.09.025; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Haigh JC, 2002, REV SCI TECH OIE, V21, P219, DOI 10.20506/rst.21.2.1331; Hanichen T, 1998, TIERARZTL PRAX G N, V26, P294; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hart J, 2007, J GEN VIROL, V88, P28, DOI 10.1099/vir.0.82284-0; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Hussy D, 2002, J CLIN MICROBIOL, V40, P4700, DOI 10.1128/JCM.40.12.4700-4704.2002; Hussy D, 2001, CLIN DIAGN LAB IMMUN, V8, P123, DOI 10.1128/CDLI.8.1.123-128.2001; Jacobsen B, 2007, VET MICROBIOL, V124, P353, DOI 10.1016/j.vetmic.2007.04.037; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KRAMER S, 1995, J EXP MED, V182, P1769, DOI 10.1084/jem.182.6.1769; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Li H, 2001, J VET DIAGN INVEST, V13, P361, DOI 10.1177/104063870101300417; LIGGITT HD, 1980, J WILDLIFE DIS, V16, P299, DOI 10.7589/0090-3558-16.2.299; LIGGITT HD, 1980, VET PATHOL, V17, P73, DOI 10.1177/030098588001700108; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; MEIERTRUMMER CS, 2009, VET MICROBIOL; Moore PS, 2003, ANNU REV MICROBIOL, V57, P609, DOI 10.1146/annurev.micro.57.030502.090824; Muller-Doblies UU, 2001, SCHWEIZ ARCH TIERH, V143, P581; Muller-Doblies UU, 1998, J CLIN MICROBIOL, V36, P2970; Neilson JR, 2005, NAT METHODS, V2, P252, DOI 10.1038/nmeth0405-252; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; OTOOLE D, 1995, J VET DIAGN INVEST, V7, P108, DOI 10.1177/104063879500700118; Pahwa S, 1998, AIDS PATIENT CARE ST, V12, P187, DOI 10.1089/apc.1998.12.187; PATEL JR, 1980, J GEN VIROL, V48, P437, DOI 10.1099/0022-1317-48-2-437; Pati S, 2001, J VIROL, V75, P8660, DOI 10.1128/JVI.75.18.8660-8673.2001; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; PLOWRIGHT W, 1990, EXPT AEROSOL INFECT, P123; Prasad KVS, 1997, P NATL ACAD SCI USA, V94, P6346, DOI 10.1073/pnas.94.12.6346; Py B, 2004, J IMMUNOL, V172, P4008, DOI 10.4049/jimmunol.172.7.4008; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; REID HW, 1989, RES VET SCI, V47, P90, DOI 10.1016/S0034-5288(18)31237-2; REID HW, 1986, RES VET SCI, V41, P76, DOI 10.1016/S0034-5288(18)30575-7; REID HW, 1984, VET REC, V114, P581, DOI 10.1136/vr.114.24.581; Rosbottom J, 2002, J GEN VIROL, V83, P2999, DOI 10.1099/0022-1317-83-12-2999; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Samraj AK, 2006, ONCOGENE, V25, P186, DOI 10.1038/sj.onc.1209034; Sasik R, 2002, BIOINFORMATICS, V18, P1633, DOI 10.1093/bioinformatics/18.12.1633; Schindler AR, 2007, MOL CELL PROBE, V21, P47, DOI 10.1016/j.mcp.2006.08.001; Schock A, 1996, VET MICROBIOL, V53, P111, DOI 10.1016/S0378-1135(96)01239-4; Schultheiss PC, 1998, J VET DIAGN INVEST, V10, P255, DOI 10.1177/104063879801000305; Schwarz M, 2001, J IMMUNOL, V167, P505, DOI 10.4049/jimmunol.167.1.505; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Singer AL, 2002, SCIENCE, V296, P1639, DOI 10.1126/science.1071551; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stewart RJE, 2006, VET REC, V159, P668, DOI 10.1136/vr.159.20.668; Sugden B, 2006, NATURE, V442, P33, DOI 10.1038/442033a; Taus NS, 2006, VET MICROBIOL, V116, P29, DOI 10.1016/j.vetmic.2006.03.005; Thonur L, 2006, VIRUS GENES, V32, P27, DOI 10.1007/s11262-005-5842-3; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	86	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6265	10.1371/journal.pone.0006265	http://dx.doi.org/10.1371/journal.pone.0006265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603070	Green Published, gold			2022-12-27	WOS:000268035700011
J	Velamakanni, S; Lau, CHF; Gutmann, DAP; Venter, H; Barrera, NP; Seeger, MA; Woebking, B; Matak-Vinkovic, D; Balakrishnan, L; Yao, Y; Edmond, CYU; Shilling, RA; Robinson, CV; Thorn, P; van Veen, HW				Velamakanni, Saroj; Lau, Calvin H. F.; Gutmann, Daniel A. P.; Venter, Henrietta; Barrera, Nelson P.; Seeger, Markus A.; Woebking, Barbara; Matak-Vinkovic, Dijana; Balakrishnan, Lekshmy; Yao, Yao; Edmond, C. Y. U.; Shilling, Richard A.; Robinson, Carol V.; Thorn, Peter; van Veen, Hendrik W.			A Multidrug ABC Transporter with a Taste for Salt	PLOS ONE			English	Article							ESCHERICHIA-COLI; MECHANOSENSITIVE CHANNELS; LACTOBACILLUS-BREVIS; CHLORIDE CHANNELS; INTRACELLULAR PH; MOLECULAR-BASIS; EFFLUX PUMPS; RESISTANCE; BINDING; PROTEIN	Background: LmrA is a multidrug ATP-binding cassette (ABC) transporter from Lactococcus lactis with no known physiological substrate, which can transport a wide range of chemotherapeutic agents and toxins from the cell. The protein can functionally replace the human homologue ABCB1 (also termed multidrug resistance P-glycoprotein MDR1) in lung fibroblast cells. Even though LmrA mediates ATP-dependent transport, it can use the proton-motive force to transport substrates, such as ethidium bromide, across the membrane by a reversible, H+-dependent, secondary-active transport reaction. The mechanism and physiological context of this reaction are not known. Methodology/Principal Findings: We examined ion transport by LmrA in electrophysiological experiments and in transport studies using radioactive ions and fluorescent ion-selective probes. Here we show that LmrA itself can transport NaCl by a similar secondary-active mechanism as observed for ethidium bromide, by mediating apparent H+-Na+-Cl- symport. Remarkably, LmrA activity significantly enhances survival of high-salt adapted lactococcal cells during ionic downshift. Conclusions/Significance: The observations on H+-Na+-Cl- co-transport substantiate earlier suggestions of H+-coupled transport by LmrA, and indicate a novel link between the activity of LmrA and salt stress. Our findings demonstrate the relevance of investigations into the bioenergetics of substrate translocation by ABC transporters for our understanding of fundamental mechanisms in this superfamily. This study represents the first use of electrophysiological techniques to analyze substrate transport by a purified multidrug transporter.			Velamakanni, S (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	hwv20@cam.ac.uk	Thorn, Peter/F-7030-2010; Venter, Rietie/E-4795-2013; van Veen, Hendrik W./A-4162-2008	Thorn, Peter/0000-0002-3228-770X; Venter, Rietie/0000-0001-5569-7755; van Veen, Hendrik W./0000-0002-9658-8077; Barrera, Nelson/0000-0001-7825-1406; Seeger, Markus/0000-0003-1761-8571; U, Edmond Chun Ying/0000-0003-1672-6204; Gutmann, Daniel/0000-0001-7359-0206; Lau, Calvin (Ho-Fung)/0000-0003-3407-4924; robinson, carol/0000-0001-7829-5505	Biotechnology and Biological Sciences Research Council [BB/F008333/1, BB/C004663/1] Funding Source: Medline; Medical Research Council Funding Source: Medline; BBSRC [BB/F008333/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Balakrishnan L, 2004, J BIOL CHEM, V279, P11273, DOI 10.1074/jbc.M308494200; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Waard MA, 2006, PEST MANAG SCI, V62, P195, DOI 10.1002/ps.1150; Dutzler R, 2006, CURR OPIN STRUC BIOL, V16, P439, DOI 10.1016/j.sbi.2006.06.002; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hellmich UA, 2008, FEBS LETT, V582, P3557, DOI 10.1016/j.febslet.2008.09.033; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; HOFFMAN MM, 1999, BIOCHEMISTRY-US, V36, P11153; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Kolaczkowska A, 2008, FEBS LETT, V582, P977, DOI 10.1016/j.febslet.2008.02.045; Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Lubelski J, 2006, MOL MICROBIOL, V61, P771, DOI 10.1111/j.1365-2958.2006.05267.x; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; MCKAY LL, 1990, FEMS MICROBIOL LETT, V87, P3, DOI 10.1111/j.1574-6968.1990.tb04876.x; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; RIORDAN JR, 1992, BIOCHIM BIOPHYS ACTA, V1101, P221, DOI 10.1016/0005-2728(92)90230-Y; ROEPE PD, 1994, BIOCHEMISTRY-US, V33, P11008, DOI 10.1021/bi00202a021; Sakamoto K, 2001, J BACTERIOL, V183, P5371, DOI 10.1128/JB.183.18.5371-5375.2001; Sami M, 1998, J GEN APPL MICROBIOL, V44, P361, DOI 10.2323/jgam.44.361; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Shilling R, 2005, FASEB J, V19, P1698, DOI 10.1096/fj.04-3558fje; Shilling RA, 2006, TRENDS PHARMACOL SCI, V27, P195, DOI 10.1016/j.tips.2006.02.008; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; Thrower EC, 1999, METH MOL B, V114, P221; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; VANVEEN HW, 1993, J BIOL CHEM, V268, P19377; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Venter H, 2003, NATURE, V426, P866, DOI 10.1038/nature02173; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d	53	32	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6137	10.1371/journal.pone.0006137	http://dx.doi.org/10.1371/journal.pone.0006137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593434	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035300003
J	Sun, WJ; Sun, CK; Zhao, H; Lin, H; Han, QQ; Wang, JY; Ma, H; Chen, B; Xiao, ZF; Dai, JW				Sun, Wenjie; Sun, Changkai; Zhao, Hui; Lin, Hang; Han, Qianqian; Wang, Jingyu; Ma, Hui; Chen, Bing; Xiao, Zhifeng; Dai, Jianwu			Improvement of Sciatic Nerve Regeneration Using Laminin-Binding Human NGF-beta	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; GROWTH-FACTOR; WALLERIAN DEGENERATION; DOMAIN; CELLS; INJURY; MANAGEMENT; PERONEAL; GRAFTS; AGRIN	Background: Sciatic nerve injuries often cause partial or total loss of motor, sensory and autonomic functions due to the axon discontinuity, degeneration, and eventual death which finally result in substantial functional loss and decreased quality of life. Nerve growth factor (NGF) plays a critical role in peripheral nerve regeneration. However, the lack of efficient NGF delivery approach limits its clinical applications. We reported here by fusing with the N-terminal domain of agrin (NtA), NGF-beta could target to nerve cells and improve nerve regeneration. Methods: Laminin-binding assay and sustained release assay of NGF-beta fused with NtA (LBD-NGF) from laminin in vitro were carried out. The bioactivity of LBD-NGF on laminin in vitro was also measured. Using the rat sciatic nerve crush injury model, the nerve repair and functional restoration by utilizing LBD-NGF were tested. Findings: LBD-NGF could specifically bind to laminin and maintain NGF activity both in vitro and in vivo. In the rat sciatic nerve crush injury model, we found that LBD-NGF could be retained and concentrated at the nerve injury sites to promote nerve repair and enhance functional restoration following nerve damages. Conclusion: Fused with NtA, NGF-beta could bind to laminin specifically. Since laminin is the major component of nerve extracellular matrix, laminin binding NGF could target to nerve cells and improve the repair of peripheral nerve injuries.			Sun, WJ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol Dev Biol, Beijing, Peoples R China.	jwdai@genetics.ac.cn	Lin, Hang/AFO-8482-2022; Lin, Hang/D-3003-2012; SUN, CHANG/GXM-3680-2022	Lin, Hang/0000-0002-0781-6630; 				Apfel SC, 1998, NEUROLOGY, V51, P695, DOI 10.1212/WNL.51.3.695; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018; CHAUDHRY V, 1992, MUSCLE NERVE, V15, P687, DOI 10.1002/mus.880150610; Chen ZL, 2003, J CELL BIOL, V163, P889, DOI 10.1083/jcb.200307068; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; DELLON AL, 1989, ANN PLAS SURG, V23, P197, DOI 10.1097/00000637-198909000-00002; Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; George LT, 2003, J RECONSTR MICROSURG, V19, P41, DOI 10.1055/s-2003-37190; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gu ZY, 2002, PROTEIN EXPRES PURIF, V25, P174, DOI 10.1006/prep.2002.1624; Haller MF, 1998, J CONTROL RELEASE, V53, P1, DOI 10.1016/S0168-3659(97)00232-0; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; Kline DG, 1998, J NEUROSURG, V89, P13, DOI 10.3171/jns.1998.89.1.0013; Koeppen AH, 2004, J NEUROL SCI, V220, P115, DOI 10.1016/j.jns.2004.03.008; Kordower JH, 1996, NEUROSCIENCE, V72, P63, DOI 10.1016/0306-4522(95)00543-9; Korompilias AV, 2006, MICROSURG, V26, P288, DOI 10.1002/micr.20241; LANDER AD, 1985, J CELL BIOL, V101, P898, DOI 10.1083/jcb.101.3.898; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; Lin H, 2006, J BIOMED MATER RES A, V79A, P591, DOI 10.1002/jbm.a.30862; LONGO FM, 1984, BRAIN RES, V309, P105, DOI 10.1016/0006-8993(84)91014-X; Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165; MARKOWSKA AL, 1994, J NEUROSCI, V14, P4815; MartinezSerrano A, 1996, J NEUROSCI, V16, P4604; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; Martins RS, 2006, ARQ NEURO-PSIQUIAT, V64, P750, DOI 10.1590/S0004-282X2006000500010; Mascarenhas JB, 2003, EMBO J, V22, P529, DOI 10.1093/emboj/cdg041; Matsushita O, 1998, J BIOL CHEM, V273, P3643, DOI 10.1074/jbc.273.6.3643; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Pean JM, 2000, BIOMATERIALS, V21, P2097, DOI 10.1016/S0142-9612(00)00141-1; Petruska JC, 2004, NEUROSCI LETT, V361, P168, DOI 10.1016/j.neulet.2003.12.012; Rosberg HE, 2005, SCAND J PLAST RECONS, V39, P360, DOI 10.1080/02844310500340046; Rossi L, 2002, INT J RADIAT ONCOL, V53, P1319, DOI 10.1016/S0360-3016(02)02865-1; SHIH A, 1994, J BIOL CHEM, V269, P27679; Soussand J, 2001, NEUROREPORT, V12, P1073, DOI 10.1097/00001756-200104170-00041; Starr PA, 1999, CELL TRANSPLANT, V8, P37, DOI 10.1177/096368979900800113; Stetefeld J, 2001, NAT STRUCT BIOL, V8, P705, DOI 10.1038/90422; Stoll G, 1999, BRAIN PATHOL, V9, P313; Sun WJ, 2007, J BIOMED MATER RES A, V83A, P1054, DOI 10.1002/jbm.a.31417; TONG XJ, 1994, BRAIN RES, V663, P155, DOI 10.1016/0006-8993(94)90473-1; Tuszynski MH, 1996, GENE THER, V3, P305; Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4; Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117; Xu XY, 2003, BIOMATERIALS, V24, P2405, DOI 10.1016/S0142-9612(03)00109-1; YAMADA KM, 1983, ANNU REV BIOCHEM, V52, P761, DOI 10.1146/annurev.bi.52.070183.003553; Yurchenco PD, 2002, METHOD CELL BIOL, V69, P111, DOI 10.1016/S0091-679X(02)69010-7	48	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6180	10.1371/journal.pone.0006180	http://dx.doi.org/10.1371/journal.pone.0006180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587785	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035100007
J	Jubault, T; Monetta, L; Strafella, AP; Lafontaine, AL; Monchi, O				Jubault, Thomas; Monetta, Laura; Strafella, Antonio P.; Lafontaine, Anne-Louise; Monchi, Oury			L-Dopa Medication in Parkinson's Disease Restores Activity in the Motor Cortico-Striatal Loop but Does Not Modify the Cognitive Network	PLOS ONE			English	Article								Background: The goal of this study was to evaluate the effects of L-Dopa medication in Parkinson's disease (PD) on brain activation during the performance of a set-shifting task. Using fMRI, we have previously studied the patterns of activity observed in patients with PD after overnight removal of dopaminergic medication compared with control participants during the performance of different stages of the Wisconsin Card Sorting Task (WCST). The results revealed decreased cortical activity in the PD group compared to controls in the conditions that significantly required striatum, while increased cortical activity was observed when striatum was not involved. However, the effect of dopaminergic medication in PD patients on those patterns of activity has not yet been studied. Methodology/Principal Findings: Here, eleven PD patients at early stage of the disease taking L-Dopa medication were recruited and underwent two fMRI sessions while performing the WCST: one session while taking their normal dose of medication and the other following overnight dopaminergic medication withdrawal. We found that L-dopa medication helped restoring a normal pattern of activity when matching and not planning was required, by increasing cortical activity in the premotor cortex. This effect was even stronger in the motor loop, i.e. when the putamen was required for controls, when matching following negative feedback. However, the medication did not change the pattern of activity in conditions relying primarily on a cognitive loop, i.e. when the caudate nucleus was required. Conclusions/Significance: These studies provide explanation at the neural level regarding the relatively poor effects of L-Dopa on the cognitive deficits observed in PD.			Jubault, T (corresponding author), Inst Univ Geriatrie Montreal, Unite Neuroimagerie Fonct, Montreal, PQ, Canada.	oury.monchi@umontreal.ca	Monchi, Oury/N-8417-2019; Monetta, Laura/AAK-7657-2020	Monetta, Laura/0000-0002-4534-761X				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Cools R, 2002, BRAIN, V125, P584, DOI 10.1093/brain/awf052; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; Defer GL, 1999, MOVEMENT DISORD, V14, P572, DOI 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C; Emre M, 2004, CURR OPIN NEUROL, V17, P399, DOI 10.1097/01.wco.0000137529.30750.ab; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; Hirano S, 2008, J NEUROSCI, V28, P4201, DOI 10.1523/JNEUROSCI.0582-08.2008; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Huang CR, 2007, NEUROIMAGE, V34, P714, DOI 10.1016/j.neuroimage.2006.09.003; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; LANGE KW, 1992, PSYCHOPHARMACOLOGY, V107, P394, DOI 10.1007/BF02245167; Lange KW, 1995, J NEURAL TRANSM-SUPP, P423; LANGSTON JW, 1992, MOVEMENT DISORD, P2; LEES AJ, 1983, BRAIN, V106, P257, DOI 10.1093/brain/106.2.257; Mattay VS, 2002, ANN NEUROL, V51, P156, DOI 10.1002/ana.10078; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Monchi O, 2004, J NEUROSCI, V24, P702, DOI 10.1523/JNEUROSCI.4860-03.2004; Monchi O, 2007, BRAIN, V130, P233, DOI 10.1093/brain/awl326; Nagano-Saito A, 2008, J NEUROSCI, V28, P3697, DOI 10.1523/JNEUROSCI.3921-07.2008; Nandhagopal R, 2008, NEUROLOGY, V70, P1478, DOI 10.1212/01.wnl.0000310432.92489.90; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Rowe JB, 2008, BRAIN, V131, P2094, DOI 10.1093/brain/awn112; SCHUBERT T, 2002, EFFECTS PALLIDAL DEE, P8; TAYLOR AE, 1986, FRONTAL LOBE DYSFUNC, P845; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933	27	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6154	10.1371/journal.pone.0006154	http://dx.doi.org/10.1371/journal.pone.0006154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19584921	Green Published, Green Submitted, gold			2022-12-27	WOS:000267806400010
J	Dong, M; Fu, YF; Du, TT; Jing, CB; Fu, CT; Chen, Y; Jin, Y; Deng, M; Liu, TX				Dong, Mei; Fu, Yan-Fang; Du, Ting-Ting; Jing, Chang-Bin; Fu, Chun-Tang; Chen, Yi; Jin, Yi; Deng, Min; Liu, Ting Xi			Heritable and Lineage-Specific Gene Knockdown in Zebrafish Embryo	PLOS ONE			English	Article								Background: Reduced expression of developmentally important genes and tumor suppressors due to haploinsufficiency or epigenetic suppression has been shown to contribute to the pathogenesis of various malignancies. However, methodology that allows spatio-temporally knockdown of gene expression in various model organisms such as zebrafish has not been well established, which largely limits the potential of zebrafish as a vertebrate model of human malignant disorders. Principal Finding: Here, we report that multiple copies of small hairpin RNA (shRNA) are expressed from a single transcript that mimics the natural microRNA-30e precursor (mir-shRNA). The mir-shRNA, when microinjected into zebrafish embryos, induced an efficient knockdown of two developmentally essential genes chordin and alpha-catenin in a dose-controllable fashion. Furthermore, we designed a novel cassette vector to simultaneously express an intronic mir-shRNA and a chimeric red fluorescent protein driven by lineage-specific promoter, which efficiently reduced the expression of a chromosomally integrated reporter gene and an endogenously expressed gata-1 gene in the developing erythroid progenitors and hemangioblasts, respectively. Significance: This methodology provides an invaluable tool to knockdown developmental important genes in a tissue-specific manner or to establish animal models, in which the gene dosage is critically important in the pathogenesis of human disorders. The strategy should be also applicable to other model organisms.			Dong, M (corresponding author), Chinese Acad Sci, Lab Dev & Dis, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	mdeng@sibs.ac.cn; txliu@sibs.ac.cn	Jing, Changbin/X-2726-2019	Jing, Changbin/0000-0003-0037-2712; Du, Ting-Ting/0000-0003-0333-8739				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BAUER M, 2008, GENE THER; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Carradice D, 2008, BLOOD, V111, P3331, DOI 10.1182/blood-2007-10-052761; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Esengil H, 2007, NAT CHEM BIOL, V3, P154, DOI 10.1038/nchembio858; Fisher S, 1999, NAT GENET, V23, P442, DOI 10.1038/70557; FU YF, 2008, BLOOD; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Leung AYH, 2005, DEV BIOL, V277, P235, DOI 10.1016/j.ydbio.2004.09.032; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3; Long QM, 1997, DEVELOPMENT, V124, P4105; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; MENG X, 2008, NAT BIOTECHNOL; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang L, 2008, DEV DYNAM, V237, P2139, DOI 10.1002/dvdy.21630; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762; Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhu H, 2005, DEV BIOL, V281, P256, DOI 10.1016/j.ydbio.2005.01.034; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6125	10.1371/journal.pone.0006125	http://dx.doi.org/10.1371/journal.pone.0006125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19582161	Green Published, gold			2022-12-27	WOS:000267806300003
J	Sitkiewicz, I; Green, NM; Guo, N; Bongiovanni, AM; Witkin, SS; Musser, JM				Sitkiewicz, Izabela; Green, Nicole M.; Guo, Nina; Bongiovanni, Ann Marie; Witkin, Steven S.; Musser, James M.			Transcriptome Adaptation of Group B Streptococcus to Growth in Human Amniotic Fluid	PLOS ONE			English	Article								Background: Streptococcus agalactiae (group B Streptococcus) is a bacterial pathogen that causes severe intrauterine infections leading to fetal morbidity and mortality. The pathogenesis of GBS infection in this environment is poorly understood, in part because we lack a detailed understanding of the adaptation of this pathogen to growth in amniotic fluid. To address this knowledge deficit, we characterized the transcriptome of GBS grown in human amniotic fluid (AF) and compared it with the transcriptome in rich laboratory medium. Methods: GBS was grown in Todd Hewitt-yeast extract medium and human AF. Bacteria were collected at mid-logarithmic, late-logarithmic and stationary growth phase. We performed global expression microarray analysis using a custom-made Affymetrix GeneChip. The normalized hybridization values derived from three biological replicates at each growth point were obtained. AF/THY transcript ratios representing greater than a 2-fold change and P-value exceeding 0.05 were considered to be statistically significant. Principal Findings: We have discovered that GBS significantly remodels its transcriptome in response to exposure to human amniotic fluid. GBS grew rapidly in human AF and did not exhibit a global stress response. The majority of changes in GBS transcripts in AF compared to THY medium were related to genes mediating metabolism of amino acids, carbohydrates, and nucleotides. The majority of the observed changes in transcripts affects genes involved in basic bacterial metabolism and is connected to AF composition and nutritional requirements of the bacterium. Importantly, the response to growth in human AF included significant changes in transcripts of multiple virulence genes such as adhesins, capsule, and hemolysin and IL-8 proteinase what might have consequences for the outcome of host-pathogen interactions. Conclusions/Significance: Our work provides extensive new information about how the transcriptome of GBS responds to growth in AF, and thus new leads for pathogenesis research.			Sitkiewicz, I (corresponding author), Natl Med Inst, Dept Epidemiol & Clin Microbiol, Warsaw, Poland.	JMMusser@tmhs.org	Witkin, Steven/AAW-8602-2021; Witkin, Steven/AAF-3812-2019; Sitkiewicz, Izabela/G-5058-2011	Witkin, Steven/0000-0002-3502-3929; Sitkiewicz, Izabela/0000-0001-8228-9917; Bongiovanni, Ann Marie/0000-0001-9801-570X				APPELBAUM PC, 1977, AM J OBSTET GYNECOL, V128, P868, DOI 10.1016/0002-9378(77)90055-2; Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; Cho CKJ, 2007, MOL CELL PROTEOMICS, V6, P1406, DOI 10.1074/mcp.M700090-MCP200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Darmstadt GL, 2000, INFECT IMMUN, V68, P1215, DOI 10.1128/IAI.68.3.1215-1221.2000; Degnan BA, 1998, INFECT IMMUN, V66, P3050, DOI 10.1128/IAI.66.7.3050-3058.1998; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; EVANS HE, 1977, OBSTET GYNECOL, V49, P35; FARLEY MM, 1993, NEW ENGL J MED, V328, P1807, DOI 10.1056/NEJM199306243282503; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Hagio Y, 1985, Nihon Sanka Fujinka Gakkai Zasshi, V37, P2369; Harris TO, 2003, J CLIN INVEST, V111, P61, DOI 10.1172/JCI200316270; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; LARSEN B, 1983, GYNECOL OBSTET INVES, V15, P26, DOI 10.1159/000299390; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Lin X, 2008, J BACTERIOL, V190, P4367, DOI 10.1128/JB.01898-07; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Liu YL, 2008, APPL ENVIRON MICROB, V74, P5023, DOI 10.1128/AEM.00556-08; Loughman JA, 2006, EMBO J, V25, P5414, DOI 10.1038/sj.emboj.7601393; Malke H, 2007, J MED MICROBIOL, V56, P707, DOI 10.1099/jmm.0.46984-0; Malke H, 2006, INT J MED MICROBIOL, V296, P259, DOI 10.1016/j.ijmm.2005.11.008; MATHAI M, 1984, BRIT J OBSTET GYNAEC, V91, P560, DOI 10.1111/j.1471-0528.1984.tb04803.x; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003143; MESAVAGE WC, 1985, PEDIATR RES, V19, P1021, DOI 10.1203/00006450-198510000-00014; NATANSON S, 1995, J INFECT DIS, V171, P871, DOI 10.1093/infdis/171.4.871; NAZIR MA, 1987, AM J PERINAT, V4, P59, DOI 10.1055/s-2007-999738; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; Nyberg P, 2004, EMBO J, V23, P2166, DOI 10.1038/sj.emboj.7600214; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; PINE L, 1972, INFECT IMMUN, V5, P668, DOI 10.1128/IAI.5.5.668-680.1972; Samen U, 2004, J BACTERIOL, V186, P1398, DOI 10.1128/JB.186.5.1398-1408.2004; SCANE TMN, 1986, BRIT J OBSTET GYNAEC, V93, P577, DOI 10.1111/j.1471-0528.1986.tb07956.x; SCANE TMN, 1984, BRIT J OBSTET GYNAEC, V91, P342, DOI 10.1111/j.1471-0528.1984.tb05920.x; SCHUCHAT A, 1994, EPIDEMIOL REV, V16, P374, DOI 10.1093/oxfordjournals.epirev.a036159; Shelburne SA, 2005, P NATL ACAD SCI USA, V102, P16037, DOI 10.1073/pnas.0505839102; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shet A, 2004, INDIAN J MED RES, V120, P141; Sitkiewicz I, 2006, INFECT IMMUN, V74, P1339, DOI 10.1128/IAI.74.2.1339-1351.2006; Sitkiewicz Izabela, 2009, BMC Microbiol, V9, P32, DOI 10.1186/1471-2180-9-32; Sumby P, 2008, INFECT IMMUN, V76, P978, DOI 10.1128/IAI.01354-07; van Scheltema PNA, 2008, GYNECOL OBSTET INVES, V66, P227, DOI 10.1159/000147168	46	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6114	10.1371/journal.pone.0006114	http://dx.doi.org/10.1371/journal.pone.0006114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568429	Green Submitted, gold, Green Published			2022-12-27	WOS:000267572200013
J	De Blas, GA; Darszon, A; Ocampo, AY; Serrano, CJ; Castellano, LE; Hernandez-Gonzalez, EO; Chirinos, M; Larrea, F; Beltran, C; Trevino, CL				De Blas, Gerardo A.; Darszon, Alberto; Ocampo, Ana Y.; Serrano, Carmen J.; Castellano, Laura E.; Hernandez-Gonzalez, Enrique O.; Chirinos, Mayel; Larrea, Fernando; Beltran, Carmen; Trevino, Claudia L.			TRPM8, a Versatile Channel in Human Sperm	PLOS ONE			English	Article								Background: The transient receptor potential channel (TRP) family includes more than 30 proteins; they participate in various Ca2+ dependent processes. TRPs are functionally diverse involving thermal, chemical and mechanical transducers which modulate the concentration of intracellular Ca2+ ([Ca2+](i)). Ca2+ triggers and/or regulates principal sperm functions during fertilization such as motility, capacitation and the acrosome reaction. Nevertheless, the presence of the TRPM subfamily in sperm has not been explored. Principal Findings: Here we document with RT-PCR, western blot and immunocitochemistry analysis the presence of TRPM8 in human sperm. We also examined the participation of this channel in sperm function using specific agonists (menthol and temperature) and antagonists (BCTC and capsazepine). Computer-aided sperm analysis revealed that menthol did not significantly alter human sperm motility. In contrast, menthol induced the acrosome reaction in human sperm. This induction was inhibited about 70% by capsazepine (20 mM) and 80% by BCTC (1.6 mM). Activation of TRPM8 either by temperature or menthol induced [Ca2+](i) increases in human sperm measured by fluorescence in populations or individual sperm cells, effect that was also inhibited by capsazepine (20 mM) and BCTC (1.6 mM). However, the progesterone and ZP(3)-induced acrosome reaction was not inhibited by capsazepine or BCTC, suggesting that TRPM8 activation triggers this process by a different signaling pathway. Conclusions: This is the first report dealing with the presence of a thermo sensitive channel (TRPM8) in human sperm. This channel could be involved in cell signaling events such as thermotaxis or chemotaxis.			De Blas, GA (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62191, Morelos, Mexico.	ctrevino@ibt.unam.mx	Hernández-González, Enrique/AAU-8526-2020; Chirinos, Mayel/I-2896-2019; babakinejad, babak/G-2674-2012; Larrea, Fernando/AAC-1900-2021	Chirinos, Mayel/0000-0003-0023-5195; Darszon, Alberto/0000-0002-2502-0505; Trevino, Claudia L/0000-0002-7281-0534; SERRANO, CARMEN J./0000-0002-7047-9120	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038082] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD038082-07A1, R01 HD038082] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abe J, 2006, NEUROSCI LETT, V397, P140, DOI 10.1016/j.neulet.2005.12.005; Appendino G, 2008, CURR PHARM DESIGN, V14, P2, DOI 10.2174/138161208783330781; Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; Bahat A, 2003, NAT MED, V9, P149, DOI 10.1038/nm0203-149; Bahat A, 2006, MOL CELL ENDOCRINOL, V252, P115, DOI 10.1016/j.mce.2006.03.027; Benjamin ER, 2006, BIOCHEM PHARMACOL, V72, P770, DOI 10.1016/j.bcp.2006.06.003; Caballero-Campo P, 2006, BIOL REPROD, V74, P760, DOI 10.1095/biolreprod.105.047522; Castellano LE, 2003, FEBS LETT, V541, P69, DOI 10.1016/S0014-5793(03)00305-3; Chiu PCN, 2008, BIOL REPROD, V79, P869, DOI 10.1095/biolreprod.108.069344; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Corkidi G, 2008, BIOCHEM BIOPH RES CO, V373, P125, DOI 10.1016/j.bbrc.2008.05.189; Darszon A, 2007, Soc Reprod Fertil Suppl, V65, P229; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Henshall SM, 2003, CANCER RES, V63, P4196; Ishijima Sumio, 2007, Soc Reprod Fertil Suppl, V65, P327; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Montell C, 2008, CURR BIOL, V18, pR123, DOI 10.1016/j.cub.2007.12.001; MORENILLAPALAO C, 2009, J BIOL CHEM; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Okazawa M, 2000, NEUROREPORT, V11, P2151, DOI 10.1097/00001756-200007140-00018; PEDRETTI A, 2009, BIOCH BIOPHYS ACTA; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sabnis AS, 2008, AM J RESP CELL MOL, V39, P466, DOI 10.1165/rcmb.2007-0440OC; Salicioni Ana M, 2007, Soc Reprod Fertil Suppl, V65, P245; Sato Y, 2000, J ANDROL, V21, P99; SHI QX, 1995, BIOL REPROD, V52, P373, DOI 10.1095/biolreprod52.2.373; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Trevino CL, 2006, J CELL PHYSIOL, V206, P449, DOI 10.1002/jcp.20487; Trevino CL, 2001, FEBS LETT, V509, P119, DOI 10.1016/S0014-5793(01)03134-9; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Voets T., 2007, V179, P329; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; Wondergem R, 2008, BIOCHEM BIOPH RES CO, V372, P210, DOI 10.1016/j.bbrc.2008.05.032; Wood CD, 2007, DEV BIOL, V306, P525, DOI 10.1016/j.ydbio.2007.03.036; Woolley DM, 2007, BIOL CELL, V99, P663, DOI 10.1042/BC20070050; Yang XR, 2006, AM J PHYSIOL-LUNG C, V290, pL1267, DOI 10.1152/ajplung.00515.2005; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zhang L, 2004, AM J PHYSIOL-GASTR L, V286, pG983, DOI 10.1152/ajpgi.00441.2003; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146	52	81	81	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6095	10.1371/journal.pone.0006095	http://dx.doi.org/10.1371/journal.pone.0006095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19582168	Green Submitted, Green Published, gold			2022-12-27	WOS:000267515700013
J	Yan, YT; Kolachala, V; Dalmasso, G; Nguyen, H; Laroui, H; Sitaraman, SV; Merlin, D				Yan, Yutao; Kolachala, Vasantha; Dalmasso, Guillaume; Nguyen, Hang; Laroui, Hamed; Sitaraman, Shanthi V.; Merlin, Didier			Temporal and Spatial Analysis of Clinical and Molecular Parameters in Dextran Sodium Sulfate Induced Colitis	PLOS ONE			English	Article							CD4(+) T-CELLS; INTESTINAL INFLAMMATION; ANIMAL-MODELS; TNF-ALPHA; MICE; INDUCTION; DISEASE; STRESS; RATS; PERMEABILITY	Background: Inflammatory bowel diseases (IBD), including mainly ulcerative colitis (UC) and Crohn's disease (CD), are inflammatory disorders of the gastrointestinal tract caused by an interplay of genetic and environmental factors. Murine colitis model induced by Dextran Sulfate Sodium (DSS) is an animal model of IBD that is commonly used to address the pathogenesis of IBD as well as to test efficacy of therapies. In this study we systematically analyzed clinical parameters, histological changes, intestinal barrier properties and cytokine profile during the colitic and recovery phase. Methods: C57BL/6 mice were administered with 3.5% of DSS in drinking water for various times. Clinical and histological features were determined using standard criteria. Myeloperoxidase (MPO) activity, transepithelial permeability and proinflammatory mediators were determined in whole colon or proximal and distal parts of colon. Results: As expected after administration of DSS, mice manifest loss of body weight, shortening of colon length and bloody feces. Histological manifestations included shortening and loss of crypts, infiltration of lymphocytes and neutrophil, symptoms attenuated after DSS withdrawal. The MPO value, as inflammation indicator, also increases significantly at all periods of DSS treatment, and even after DSS withdrawal, it still held at very high levels. Trans-mucosal permeability increased during DSS treatment, but recovered to almost control level after DSS withdrawal. The production of proinflammatory mediators by colonic mucosa were enhanced during DSS treatment, and then recovered to pre-treated level after DSS withdrawal. Finally, enhanced expression of proinflammatory mediators also revealed a different profile feature in proximal and distal parts of the colon. Conclusion: Experimental colitis induced by DSS is a good animal model to study the mechanisms underlying the pathogenesis and intervention against IBD, especially UC.			Yan, YT (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	yyan2@emory.edu	Nguyen, Hang/N-2441-2018; Dalmasso, Guillaume/N-2443-2018	Nguyen, Hang/0000-0001-7431-5126; Dalmasso, Guillaume/0000-0002-3433-870X	NIDDK NIH HHS [R24-DK-064399, R01-DK55850, R24 DK064399, R01-DK-061941, R01 DK061941, R01 DK055850] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055850, R01DK061941, R24DK064399] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araki Y, 2000, CLIN EXP IMMUNOL, V119, P264; Azuma YT, 2008, J CELL PHYSIOL, V216, P111, DOI 10.1002/jcp.21381; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; COOPER HS, 1993, LAB INVEST, V69, P238; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Elson CO, 1996, AM J MED, V100, P656, DOI 10.1016/S0002-9343(96)00049-6; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Gewirtz AT, 2002, J IMMUNOL, V168, P5260, DOI 10.4049/jimmunol.168.10.5260; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Hartmann G, 2000, J PHARMACOL EXP THER, V292, P22; Hibi T, 2002, J GASTROENTEROL, V37, P409, DOI 10.1007/s005350200060; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Liu N, 2008, ENDOCRINOLOGY, V149, P4799, DOI 10.1210/en.2008-0060; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Nemeth ZH, 2002, AM J PATHOL, V161, P987, DOI 10.1016/S0002-9440(10)64259-9; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Ni J, 1996, GUT, V39, P234, DOI 10.1136/gut.39.2.234; Odashima M, 2005, GASTROENTEROLOGY, V129, P26, DOI 10.1053/j.gastro.2005.05.032; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Plevy SE, 1997, J IMMUNOL, V159, P6276; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SARTOR RB, 1988, INFECT IMMUN, V56, P2101, DOI 10.1128/IAI.56.8.2101-2108.1988; SARTOR RB, 1994, GASTROENTEROLOGY, V106, P533, DOI 10.1016/0016-5085(94)90614-9; Schwartz L, 2008, AM J PHYSIOL-GASTR L, V295, pG934, DOI 10.1152/ajpgi.90296.2008; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; Steinhoff U, 1999, IMMUNITY, V11, P349, DOI 10.1016/S1074-7613(00)80110-7; Venkatraman A, 2000, SCAND J GASTROENTERO, V35, P1053; Wirtz S, 1999, J IMMUNOL, V162, P1884; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758	37	265	273	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6073	10.1371/journal.pone.0006073	http://dx.doi.org/10.1371/journal.pone.0006073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562033	Green Published, gold, Green Submitted			2022-12-27	WOS:000267465900008
J	Prehn-Kristensen, A; Wiesner, C; Bergmann, TO; Wolff, S; Jansen, O; Mehdorn, HM; Ferstl, R; Pause, BM				Prehn-Kristensen, Alexander; Wiesner, Christian; Bergmann, Til Ole; Wolff, Stephan; Jansen, Olav; Mehdorn, Hubertus Maximilian; Ferstl, Roman; Pause, Bettina M.			Induction of Empathy by the Smell of Anxiety	PLOS ONE			English	Article								The communication of stress/anxiety between conspecifics through chemosensory signals has been documented in many vertebrates and invertebrates. Here, we investigate how chemosensory anxiety signals conveyed by the sweat of humans (N = 49) awaiting an academic examination are processed by the human brain, as compared to chemosensory control signals obtained from the same sweat donors in a sport condition. The chemosensory stimuli were pooled according to the donation condition and administered to 28 participants (14 males) synchronously to breathing via an olfactometer. The stimuli were perceived with a low intensity and accordingly only about half of the odor presentations were detected by the participants. The fMRI results (event-related design) show that chemosensory anxiety signals activate brain areas involved in the processing of social emotional stimuli (fusiform gyrus), and in the regulation of empathic feelings (insula, precuneus, cingulate cortex). In addition, neuronal activity within attentional (thalamus, dorsomedial prefrontal cortex) and emotional (cerebellum, vermis) control systems were observed. The chemosensory perception of human anxiety seems to automatically recruit empathy-related resources. Even though the participants could not attentively differentiate the chemosensory stimuli, emotional contagion seems to be effectively mediated by the olfactory system.			Prehn-Kristensen, A (corresponding author), Univ Kiel, Ctr Integrat Psychiat, Kiel, Germany.	bettina.pause@uni-duesseldorf.de	Mehdorn, Maximilian/D-2495-2010; Bergmann, Til Ole/F-9453-2010; Prehn-Kristensen, Alexander/A-3234-2019; Jansen, Olav/D-2547-2010	Bergmann, Til Ole/0000-0002-2282-6618; Prehn-Kristensen, Alexander/0000-0002-3510-9888; Wiesner, Christian/0000-0003-1287-4955; Lauwereyns, Jan/0000-0003-0551-2550				ABEL EL, 1994, HORM BEHAV, V28, P139, DOI 10.1006/hbeh.1994.1011; Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; [Anonymous], 2014, PHEROMONES ANIMAL BE; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brechbuhl J, 2008, SCIENCE, V321, P1092, DOI 10.1126/science.1160770; Britton JC, 2006, NEUROIMAGE, V31, P906, DOI 10.1016/j.neuroimage.2005.12.050; Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Chen D, 2006, CHEM SENSES, V31, P415, DOI 10.1093/chemse/bjj046; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Damasio Anthony, 2003, LOOKING SPINOZA SORR; Dicke M, 2003, TRENDS PLANT SCI, V8, P403, DOI 10.1016/S1360-1385(03)00183-3; FANSELOW MS, 1985, BEHAV NEUROSCI, V99, P589, DOI 10.1037/0735-7044.99.3.589; Frisch K. V., 1941, ZEITSCHR VERGLEICH PHYSIOL, V29, P46; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Hideaki IA, 2008, PHYSIOL BEHAV, V93, P606, DOI 10.1016/j.physbeh.2007.10.021; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; Kimberley TJ, 2008, J NEUROIMAGING, V18, P18, DOI 10.1111/j.1552-6569.2007.00163.x; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Kiyokawa Y, 2007, CHEM SENSES, V32, P57, DOI 10.1093/chemse/bjl036; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Krebs RM, 2009, BIOL PSYCHIAT, V65, P103, DOI 10.1016/j.biopsych.2008.08.019; LaBar KS, 2003, CEREB CORTEX, V13, P1023, DOI 10.1093/cercor/13.10.1023; Laux L., 1981, STATE TRAIT ANGSTINV; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lorig TS, 1999, BEHAV RES METH INS C, V31, P370, DOI 10.3758/BF03207734; Lukins R, 1997, J BEHAV THER EXP PSY, V28, P97, DOI 10.1016/S0005-7916(97)00006-2; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; LUNDSTROM JN, 2008, HUM BRAIN MAP   1209; Moynihan JA, 2000, J NEUROIMMUNOL, V102, P145, DOI 10.1016/S0165-5728(99)00173-3; MUJICAPARODI LR, 2008, NATURE P; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schutter DJLG, 2005, CEREBELLUM, V4, P290, DOI 10.1080/14734220500348584; Snow JC, 2009, P NATL ACAD SCI USA, V106, P4054, DOI 10.1073/pnas.0810086106; Sobel N, 1999, BRAIN, V122, P209, DOI 10.1093/brain/122.2.209; Sobel N., 2003, HDB OLFACTION GUSTAT, P251; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; van de Riet WAC, 2009, SOC NEUROSCI-UK, V4, P101, DOI 10.1080/17470910701865367; Vigouroux M, 2005, J NEUROSCI METH, V142, P35, DOI 10.1016/j.jneumeth.2004.07.010; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; ZALAQUETT C, 1991, PHYSIOL BEHAV, V50, P221, DOI 10.1016/0031-9384(91)90524-R; Zhou W, 2008, J NEUROSCI, V28, P14416, DOI 10.1523/JNEUROSCI.3148-08.2008	54	163	169	8	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e5987	10.1371/journal.pone.0005987	http://dx.doi.org/10.1371/journal.pone.0005987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551135	Green Published, gold, Green Submitted			2022-12-27	WOS:000267356500003
J	Ruf, IK; Houmani, JL; Sample, JT				Ruf, Ingrid K.; Houmani, Jennifer L.; Sample, Jeffery T.			Epstein-Barr Virus Independent Dysregulation of UBP43 Expression Alters Interferon-Stimulated Gene Expression in Burkitt Lymphoma	PLOS ONE			English	Article							UBIQUITIN-SPECIFIC PROTEASE; INDUCED APOPTOSIS; ENCODED RNAS; C-MYC; ISG15; CELLS; PHENOTYPE; USP18; TUMORIGENICITY; IDENTIFICATION	Epstein-Barr virus (EBV) persists as a life-long latent infection within memory B cells, but how EBV may circumvent the innate immune response within this virus reservoir is unclear. Recent studies suggest that the latency-associated non-coding RNAs of EBV may actually induce type I (antiviral) interferon production, raising the question of how EBV counters the negative consequences this is likely to have on viral persistence. We addressed this by examining the type I interferon response in Burkitt lymphoma (BL) cell lines, the only in vitro model of the restricted program of EBV latency-gene expression in persistently infected B cells in vivo. Importantly, we observed no effect of EBV on interferon alpha-induced signaling or evidence of type I interferon production, suggesting that EBV in this latent state is silent to the cell's innate antiviral surveillance. We did uncover, however, a defect in the negative feedback control of interferon signaling in a subpopulation of BL lines as was revealed by prolonged interferon-stimulated gene transcription consistent with sustained tyrosine phosphorylation on STAT1 and STAT2. This was due to inadequate induction of expression of the ubiquitin-specific protease UBP43, which removes the ubiquitin-like ISG15 polypeptide conjugated to proteins (ISGylation) in response to type I interferons. Results here are consistent with previous findings in genetically engineered Ubp43(-/-) murine cells that UBP43 down-regulates interferon signaling, independent of its ISG15 isopeptidase activity, by precluding the protein kinase JAK1 from the interferon receptor. This natural deficiency in UBP43 expression may therefore provide a useful model to further probe the biological roles of UBP43 and ISGylation.			Ruf, IK (corresponding author), Shriners Hosp Children, Div Res, Portland, OR 97201 USA.	iruf@uci.edu			NCI NIH HHS [R01 CA056639, CA62203, P30 CA062203, R01 CA073544, P30 CA021765, CA21765, CA056639, CA073544] Funding Source: Medline; NIAID NIH HHS [T32 AI007319, T32-AI007319] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA056639, P30CA062203, R01CA073544, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007319] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Geiger TR, 2006, J VIROL, V80, P11638, DOI 10.1128/JVI.01570-06; Hochberg D, 2004, P NATL ACAD SCI USA, V101, P239, DOI 10.1073/pnas.2237267100; Kang DC, 2001, GENE, V267, P233, DOI 10.1016/S0378-1119(01)00384-5; Kelly G, 2002, NAT MED, V8, P1098, DOI 10.1038/nm758; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; Kim KI, 2005, J IMMUNOL, V175, P847, DOI 10.4049/jimmunol.175.2.847; Knobeloch KP, 2005, MOL CELL BIOL, V25, P11030, DOI 10.1128/MCB.25.24.11030-11034.2005; Komano J, 1999, J VIROL, V73, P9827, DOI 10.1128/JVI.73.12.9827-9831.1999; Komano J, 1998, J VIROL, V72, P9150, DOI 10.1128/JVI.72.11.9150-9156.1998; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Li XL, 2001, CYTOKINE, V14, P247, DOI 10.1006/cyto.2001.0887; Liu LQ, 1999, MOL CELL BIOL, V19, P3029; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Nanbo A, 2002, EMBO J, V21, P954, DOI 10.1093/emboj/21.5.954; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; Rempel LA, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-13; Ritchie KJ, 2002, GENE DEV, V16, P2207, DOI 10.1101/gad.1010202; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Ruf IK, 2000, J VIROL, V74, P10223, DOI 10.1128/JVI.74.21.10223-10228.2000; Ruf IK, 2005, J VIROL, V79, P14562, DOI 10.1128/JVI.79.23.14562-14569.2005; Ruf IK, 1999, MOL CELL BIOL, V19, P1651; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; SAMPLE J, 1992, J VIROL, V66, P4654, DOI 10.1128/JVI.66.8.4654-4661.1992; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Schwer H, 2000, GENOMICS, V65, P44, DOI 10.1006/geno.2000.6148; SHIMIZU N, 1994, J VIROL, V68, P6069, DOI 10.1128/JVI.68.9.6069-6073.1994; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yan M, 2007, BLOOD, V110, P305, DOI 10.1182/blood-2006-07-033209; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143	41	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6023	10.1371/journal.pone.0006023	http://dx.doi.org/10.1371/journal.pone.0006023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551150	gold, Green Published, Green Submitted			2022-12-27	WOS:000267356500008
J	Seeba, F; Klump, GM				Seeba, Folkert; Klump, Georg M.			Stimulus Familiarity Affects Perceptual Restoration in the European Starling (Sturnus vulgaris)	PLOS ONE			English	Article							AUDITORY INDUCTION; BIRDSONG; ORGANIZATION; SIGNALS; SPEECH	Background: Humans can easily restore a speech signal that is temporally masked by an interfering sound (e.g., a cough masking parts of a word in a conversation), and listeners have the illusion that the speech continues through the interfering sound. This perceptual restoration for human speech is affected by prior experience. Here we provide evidence for perceptual restoration in complex vocalizations of a songbird that are acquired by vocal learning in a similar way as humans learn their language. Methodology/Principal Findings: European starlings were trained in a same/different paradigm to report salient differences between successive sounds. The birds' response latency for discriminating between a stimulus pair is an indicator for the salience of the difference, and these latencies can be used to evaluate perceptual distances using multidimensional scaling. For familiar motifs the birds showed a large perceptual distance if discriminating between song motifs that were muted for brief time periods and complete motifs. If the muted periods were filled with noise, the perceptual distance was reduced. For unfamiliar motifs no such difference was observed. Conclusions/Significance: The results suggest that starlings are able to perceptually restore partly masked sounds and, similarly to humans, rely on prior experience. They may be a suitable model to study the mechanism underlying experience-dependent perceptual restoration.			Seeba, F (corresponding author), Carl von Ossietzky Univ Oldenburg, Anim Physiol & Behav Grp, Inst Biol & Environm Sci, D-26111 Oldenburg, Germany.	folkert.seeba@uni-oldenburg.de						BASHFORD JA, 1987, PERCEPT PSYCHOPHYS, V42, P431, DOI 10.3758/BF03209750; Braaten RE, 1999, PSYCHOL SCI, V10, P162, DOI 10.1111/1467-9280.00125; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Bregman A.S., 1990, AUDITORY SCENE ANAL; Cooke M, 2008, J ACOUST SOC AM, V123, P414, DOI 10.1121/1.2804952; COULSON JC, 1960, J ANIM ECOL, V29, P251, DOI 10.2307/2203; Cousillas H, 2005, HEARING RES, V207, P10, DOI 10.1016/j.heares.2005.01.008; Dooling R.J., 1995, METHODS COMP PSYCHOA, P307; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EENS M, 1989, ARDEA, V77, P75; EENS M, 1992, ANIM BEHAV, V44, P1131, DOI 10.1016/S0003-3472(05)80325-2; Gentner TQ, 2008, J ACOUST SOC AM, V124, P1350, DOI 10.1121/1.2945705; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Gentner TQ, 2004, J COMP PHYSIOL A, V190, P1001, DOI 10.1007/s00359-004-0556-x; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; George I, 2005, NEUROSCIENCE, V136, P1, DOI 10.1016/j.neuroscience.2005.08.001; George I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002203; Hausberger M, 1995, BEHAV PROCESS, V35, P83, DOI 10.1016/0376-6357(95)00053-4; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; KLUMP GM, 1999, ARO MIDW RES M; LEWICKI MS, 1995, P NATL ACAD SCI USA, V92, P5582, DOI 10.1073/pnas.92.12.5582; Miller CT, 2001, NAT NEUROSCI, V4, P783, DOI 10.1038/90481; Mooney R, 2002, J COMP PHYSIOL A, V188, P879, DOI 10.1007/s00359-002-0353-3; Nagel KI, 2008, NEURON, V58, P938, DOI 10.1016/j.neuron.2008.04.028; Nottebohm F, 2005, PLOS BIOL, V3, P759, DOI 10.1371/journal.pbio.0030164; Petkov CI, 2007, NEURON, V54, P153, DOI 10.1016/j.neuron.2007.02.031; Petkov CI, 2003, J NEUROSCI, V23, P9155; Samuel AG, 1996, J EXP PSYCHOL GEN, V125, P28, DOI 10.1037/0096-3445.125.1.28; Sugita Y, 1997, NEUROREPORT, V8, P1155, DOI 10.1097/00001756-199703240-00019; Theunissen FE, 2006, CURR OPIN NEUROBIOL, V16, P400, DOI 10.1016/j.conb.2006.07.003; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1224, DOI 10.1152/jn.2000.84.3.1224; Warren RE, 1999, P SOC PHOTO-OPT INS, V3855, P134, DOI 10.1117/12.371271; WARREN RM, 1972, SCIENCE, V176, P1149, DOI 10.1126/science.176.4039.1149; WARREN RM, 1970, SCIENCE, V167, P392, DOI 10.1126/science.167.3917.392	34	22	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e5974	10.1371/journal.pone.0005974	http://dx.doi.org/10.1371/journal.pone.0005974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551146	Green Published, gold, Green Submitted			2022-12-27	WOS:000267356500002
J	Martin, R; Ibeas, E; Carvalho-Tavares, J; Hernandez, M; Ruiz-Gutierrez, V; Nieto, ML				Martin, Ruben; Ibeas, Elvira; Carvalho-Tavares, Juliana; Hernandez, Marita; Ruiz-Gutierrez, Valentina; Luisa Nieto, Maria			Natural Triterpenic Diols Promote Apoptosis in Astrocytoma Cells through ROS-Mediated Mitochondrial Depolarization and JNK Activation	PLOS ONE			English	Article							ACID-INDUCED APOPTOSIS; HUMAN-MELANOMA CELLS; URSOLIC ACID; MOLECULAR-MECHANISMS; ADHESION MOLECULE-1; INDUCE APOPTOSIS; PROTEIN-KINASES; OLEANOLIC ACID; GROWTH; INHIBITION	Background: Triterpene alcohols and acids are multifunctional compounds widely distributed throughout the plant kingdom that exhibit a variety of beneficial health properties, being synthetic analogs of oleanolic acid under clinical evaluation as anti-tumoral therapeutic agents. However, the antineoplastic activity of two natural occuring triterpenoid alcohols extracted from olive oil, erythrodiol (an intermediate from oleanolic acid), and its isomer, uvaol, has barely been reported, particularly on brain cancer cells. Astrocytomas are among the most common and aggressive type of primary malignant tumors in the neurological system lacking effective treatments, and in this study, we addressed the effect of these two triterpenic diols on the human 1321N1 astrocytoma cell line. Principal Findings: Erythrodiol and uvaol effectively affected cell proliferation, as well as cell cycle phases and induced 1321N1 cell death. Both triterpenes successfully modulated the apoptotic response, promoting nuclear condensation and fragmentation. They caused retraction and rounding of cultured cells, which lost adherence from their supports, while F-actin and vimentin filaments disappeared as an organized cytoplasmic network. At molecular level, changes in the expression of surface proteins associated with adhesion or death processes were also observed. Moreover, triterpene exposure resulted in the production of reactive oxygen species (ROS) with loss of mitochondrial transmembrane potential, and correlated with the activation of c-Jun N-terminal kinases (JNK). The presence of catalase reversed the triterpenic diols-induced mitochondrial depolarization, JNK activation, and apoptotic death, indicating the critical role of ROS in the action of these compounds. Conclusions: Overall, we provide a significant insight into the anticarcinogenic action of erythrodiol and uvaol that may have a potential in prevention and treatment of brain tumors and other cancers.	[Martin, Ruben; Ibeas, Elvira; Carvalho-Tavares, Juliana; Hernandez, Marita; Luisa Nieto, Maria] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid, Spain; [Ruiz-Gutierrez, Valentina] CSIC, Inst Grasa Sevilla, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG)	Martin, R (corresponding author), Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid, Spain.	mlnieto@ibgm.uva.es	hernández, marita/H-6122-2015; Nieto, Maria L/G-7492-2015	hernández, marita/0000-0002-3999-5653; Nieto, Maria L/0000-0001-6842-799X				Achiwa Y, 2007, BIOSCI BIOTECH BIOCH, V71, P31, DOI 10.1271/bbb.60288; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; CHAMBAZ EM, 1969, ANAL BIOCHEM, V30, P7, DOI 10.1016/0003-2697(69)90368-6; Chen YR, 2000, INT J ONCOL, V16, P651; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Doolittle ND, 2005, CLIN CANCER RES, V11, P421; Juan ME, 2006, J NUTR, V136, P2553, DOI 10.1093/jn/136.10.2553; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Fulda S, 1997, CANCER RES, V57, P4956; Gao X, 2007, J NEURO-ONCOL, V84, P147, DOI 10.1007/s11060-007-9364-9; GONZALEZ M, 1992, PLANTA MED, V58, P513, DOI 10.1055/s-2006-961538; GRANGE JM, 1990, J APPL BACTERIOL, V68, P587, DOI 10.1111/j.1365-2672.1990.tb05224.x; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hernandez M, 1998, J BIOL CHEM, V273, P606, DOI 10.1074/jbc.273.1.606; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Hill PA, 1997, ENDOCRINOLOGY, V138, P3849, DOI 10.1210/en.138.9.3849; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Hsu HY, 1997, CANCER LETT, V111, P7, DOI 10.1016/S0304-3835(96)04481-3; Hsu YL, 2004, LIFE SCI, V75, P2303, DOI 10.1016/j.lfs.2004.04.027; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Khayyal MT, 2002, ARZNEIMITTEL-FORSCH, V52, P797; Kim KA, 2004, LIFE SCI, V74, P2769, DOI 10.1016/j.lfs.2003.10.020; Lakshman M, 2004, EXP MOL PATHOL, V77, P18, DOI 10.1016/j.yexmp.2004.03.002; Lee-Huang S, 2003, BIOCHEM BIOPH RES CO, V307, P1029, DOI 10.1016/S0006-291X(03)01292-0; Lorenzon P, 1998, J CELL BIOL, V142, P1381, DOI 10.1083/jcb.142.5.1381; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; Mizukami S, 1999, FEBS LETT, V453, P356, DOI 10.1016/S0014-5793(99)00755-3; Montilla MP, 2003, PLANTA MED, V69, P472, DOI 10.1055/s-2003-39698; MOON H, 2007, PHYTOMEDICINE; Muceniece R, 2008, PHARMACOL BIOCHEM BE, V90, P712, DOI 10.1016/j.pbb.2008.05.015; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NORGAUER J, 1995, EXP CELL RES, V219, P15, DOI 10.1006/excr.1995.1199; Perez-Camino MC, 1999, J AGR FOOD CHEM, V47, P1558, DOI 10.1021/jf980881h; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Poulaki V, 2001, DRUG RESIST UPDATE, V4, P233, DOI 10.1054/drup.2001.0210; Punn A, 2000, BIOCHEM J, V350, P891, DOI 10.1042/0264-6021:3500891; Qiu LH, 2005, INT J ONCOL, V27, P823; Ramanathan M, 2007, INDIAN J EXP BIOL, V45, P425; Reyes FJ, 2006, FEBS LETT, V580, P6302, DOI 10.1016/j.febslet.2006.10.038; Riffkin CD, 2001, NEURO-ONCOLOGY, V3, P229, DOI 10.1093/neuonc/3.4.229; Rodriguez-Rodriguez R, 2006, J AGR FOOD CHEM, V54, P2096, DOI 10.1021/jf0528512; RUSSELL DS, 1989, PATHOLOGY TUMOURS NE, P219; Somova LI, 2004, PHYTOMEDICINE, V11, P121, DOI 10.1078/0944-7113-00329; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; Sugino T, 2000, J NEUROSCI, V20, P4506, DOI 10.1523/JNEUROSCI.20-12-04506.2000; Taketa ATC, 2004, J NAT PROD, V67, P1697, DOI 10.1021/np040059+; Tan YM, 2003, CLIN CANCER RES, V9, P2866; THENOT JP, 1972, ANAL LETT, V5, P801; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tong XH, 2004, BIOCHEM BIOPH RES CO, V321, P539, DOI 10.1016/j.bbrc.2004.07.004; Ukiya M, 2002, CANCER LETT, V177, P7, DOI 10.1016/S0304-3835(01)00769-8; Wick W, 1999, J PHARMACOL EXP THER, V289, P1306; Winking M, 2000, J NEURO-ONCOL, V46, P97, DOI 10.1023/A:1006387010528; Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293; Xia LJ, 2005, MOL CANCER THER, V4, P381; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu HX, 1996, J NAT PROD, V59, P643, DOI 10.1021/np960165e; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238	61	56	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5975	10.1371/journal.pone.0005975	http://dx.doi.org/10.1371/journal.pone.0005975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543395	Green Published, Green Submitted, gold			2022-12-27	WOS:000267237600004
J	Whelan, KT; Pathan, AA; Sander, CR; Fletcher, HA; Poulton, I; Alder, NC; Hill, AVS; McShane, H				Whelan, Kathryn T.; Pathan, Ansar A.; Sander, Clare R.; Fletcher, Helen A.; Poulton, Ian; Alder, Nicola C.; Hill, Adrian V. S.; McShane, Helen			Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A	PLOS ONE			English	Article								Objectives: To investigate the safety and immunogenicity of a booster BCG vaccination delivered intradermally in healthy, BCG vaccinated subjects and to compare with a previous clinical trial where BCG vaccinated subjects were boosted with a new TB vaccine, MVA85A. Design: Phase I open label observational trial, in the UK. Healthy, HIV-negative, BCG vaccinated adults were recruited and vaccinated with BCG. The primary outcome was safety; the secondary outcome was cellular immune responses to antigen 85, overlapping peptides of antigen 85A and tuberculin purified protein derivative (PPD) detected by ex vivo interferon-gamma (IFN-gamma) ELISpot assay and flow cytometry. Results and Conclusions: BCG revaccination (BCG-BCG) was well tolerated, and boosting of pre-existing PPD-specific T cell responses was observed. However, when these results were compared with data from a previous clinical trial, where BCG was boosted with MVA85A (BCG-MVA85A), MVA85A induced significantly higher levels (>2-fold) of antigen 85-specific CD4+ T cells (both antigen and peptide pool responses) than boosting with BCG, up to 52 weeks post-vaccination (p = 0.009). To identify antigen 85A-specific CD8+ T cells that were not detectable by ex vivo ELISpot and flow cytometry, dendritic cells (DC) were used to amplify CD8+ T cells from PBMC samples. We observed low, but detectable levels of antigen 85A-specific CD8+ T cells producing IFN gamma (1.5% of total CD8 population) in the BCG primed subjects after BCG boosting in 1 (20%) of 5 subjects. In contrast, in BCG-MVA85A vaccinated subjects, high levels of antigen 85A-specific CD8+ T cells (up to 14% total CD8 population) were observed after boosting with MVA85A, in 4 (50%) of 8 subjects evaluated. In conclusion, revaccination with BCG resulted in modest boosting of pre-existing immune responses to PPD and antigen 85, but vaccination with BCG-MVA85A induced a significantly higher response to antigen 85 and generated a higher frequency of antigen 85A-specific CD8+ T cells. Trial Registration: ClinicalTrials.gov NCT00654316 NCT00427830			Whelan, KT (corresponding author), Univ Oxford, Churchill Hosp, Jenner Inst, Oxford, England.	helen.mcshane@ndm.ox.ac.uk	Fletcher, Helen/D-1470-2011	Fletcher, Helen/0000-0002-0435-1006; McShane, Helen/0000-0002-2126-5142	Wellcome Trust [076943] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANTONUCCI G, 1995, JAMA-J AM MED ASSOC, V274, P143, DOI 10.1001/jama.274.2.143; Aronson NE, 2004, JAMA-J AM MED ASSOC, V291, P2086, DOI 10.1001/jama.291.17.2086; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barreto Mauricio L., 2006, J. Pediatr. (Rio J.), V82, ps45, DOI 10.1590/S0021-75572006000400006; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; CONOVER W. J, 1980, PRACTICAL NONPARAMET; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; Davids V, 2006, J INFECT DIS, V193, P531, DOI 10.1086/499825; Derrick SC, 2005, INFECT IMMUN, V73, P7727, DOI 10.1128/IAI.73.11.7727-7735.2005; Ellner JJ, 2000, CLIN INFECT DIS, V30, pS279, DOI 10.1086/313874; Feng CG, 2001, IMMUNOL CELL BIOL, V79, P569, DOI 10.1046/j.1440-1711.2001.01042.x; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Fulton SA, 2000, AM J RESP CELL MOL, V22, P333, DOI 10.1165/ajrcmb.22.3.3776; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; Jin X, 2000, AIDS RES HUM RETROV, V16, P67, DOI 10.1089/088922200309610; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Larsson M, 2002, AIDS, V16, P171, DOI 10.1097/00002030-200201250-00005; Larsson M, 2000, J IMMUNOL, V165, P1182, DOI 10.4049/jimmunol.165.3.1182; LAUNOIS P, 1994, INFECT IMMUN, V62, P3679, DOI 10.1128/IAI.62.9.3679-3687.1994; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; Morel C, 2008, EUR J IMMUNOL, V38, P437, DOI 10.1002/eji.200737905; Murray RA, 2006, J IMMUNOL, V177, P5647, DOI 10.4049/jimmunol.177.8.5647; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; Rhoades ER, 2005, TUBERCULOSIS, V85, P159, DOI 10.1016/j.tube.2004.10.001; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Serbina NV, 2000, J IMMUNOL, V165, P353, DOI 10.4049/jimmunol.165.1.353; Shacklett BL, 2002, AIDS RES HUM RETROV, V18, P805, DOI 10.1089/08892220260139558; Smith SM, 2000, J IMMUNOL, V165, P7088, DOI 10.4049/jimmunol.165.12.7088; Smith SM, 1999, INFECT IMMUN, V67, P5223, DOI 10.1128/IAI.67.10.5223-5230.1999; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; Subklewe M, 1999, BLOOD, V94, P1372, DOI 10.1182/blood.V94.4.1372.416k31_1372_1381; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Tully G, 2005, J IMMUNOL, V174, P2174, DOI 10.4049/jimmunol.174.4.2174; Turner J, 1996, IMMUNOLOGY, V87, P339, DOI 10.1046/j.1365-2567.1996.512590.x; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; *WHO, 2008, GLOB TUB CONTR 2008; World Health Organization, 1995, GLOB TUB PROGR GLOB, P229; LANCET, V348, P17	47	55	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5934	10.1371/journal.pone.0005934	http://dx.doi.org/10.1371/journal.pone.0005934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529780	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000267029500013
J	Quanz, M; Chassoux, D; Berthault, N; Agrario, C; Sun, JS; Dutreix, M				Quanz, Maria; Chassoux, Danielle; Berthault, Nathalie; Agrario, Celine; Sun, Jian-Sheng; Dutreix, Marie			Hyperactivation of DNA-PK by Double-Strand Break Mimicking Molecules Disorganizes DNA Damage Response	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; HOMOLOGY-DIRECTED REPAIR; HISTONE H2AX; CATALYTIC SUBUNIT; S-PHASE; ATM; RADIATION; PHOSPHORYLATION; REPLICATION; ACTIVATION	Cellular response to DNA damage involves the coordinated activation of cell cycle checkpoints and DNA repair. The early steps of DNA damage recognition and signaling in mammalian cells are not yet fully understood. To investigate the regulation of the DNA damage response (DDR), we designed short and stabilized double stranded DNA molecules (Dbait) mimicking double-strand breaks. We compared the response induced by these molecules to the response induced by ionizing radiation. We show that stable 32-bp long Dbait, induce pan-nuclear phosphorylation of DDR components such as H2AX, Rpa32, Chk1, Chk2, Nbs1 and p53 in various cell lines. However, individual cell analyses reveal that differences exist in the cellular responses to Dbait compared to irradiation. Responses to Dbait: (i) are dependent only on DNA-PK kinase activity and not on ATM, (ii) result in a phosphorylation signal lasting several days and (iii) are distributed in the treated population in an "all-or-none'' pattern, in a Dbait-concentration threshold dependant manner. Moreover, despite extensive phosphorylation of the DNA-PK downstream targets, Dbait treated cells continue to proliferate without showing cell cycle delay or apoptosis. Dbait treatment prior to irradiation impaired foci formation of Nbs1, 53BP1 and Rad51 at DNA damage sites and inhibited non-homologous end joining as well as homologous recombination. Together, our results suggest that the hyperactivation of DNA-PK is insufficient for complete execution of the DDR but induces a "false'' DNA damage signaling that disorganizes the DNA repair system.			Quanz, M (corresponding author), Inst Curie, Dept Transfert, F-91405 Orsay, France.	marie.dutreix@curie.u-psud.fr	Quanz, Maria/AAA-4424-2020					ALLALUNISTURNER MJ, 1993, RADIAT RES, V134, P349, DOI 10.2307/3578196; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chassoux D, 1999, ANAL QUANT CYTOL, V21, P489; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Dumay A, 2006, ONCOGENE, V25, P3196, DOI 10.1038/sj.onc.1209344; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Karagiannis TC, 2007, ONCOGENE, V26, P3963, DOI 10.1038/sj.onc.1210174; Lamas E, 2003, J HISTOCHEM CYTOCHEM, V51, P319, DOI 10.1177/002215540305100307; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lett J T, 1990, Prog Nucleic Acid Res Mol Biol, V39, P305, DOI 10.1016/S0079-6603(08)60630-3; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Ma H, 1998, J CELL BIOL, V143, P1415, DOI 10.1083/jcb.143.6.1415; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nimura Y, 2002, RADIAT RES, V157, P562, DOI 10.1667/0033-7587(2002)157[0562:DPAAAR]2.0.CO;2; Nur-E-Kamal A, 2003, J BIOL CHEM, V278, P12475, DOI 10.1074/jbc.M212915200; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Olive PL, 2004, METHOD CELL BIOL, V75, P355; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peng YL, 2005, CANCER RES, V65, P1670, DOI 10.1158/0008-5472.CAN-04-3451; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Quanz M, 2009, CLIN CANCER RES, V15, P1308, DOI 10.1158/1078-0432.CCR-08-2108; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; SIMONS JWIM, 1979, MUTAT RES, V59, P273, DOI 10.1016/0027-5107(79)90165-9; SPITZER S, 1988, NUCLEIC ACIDS RES, V16, P11691, DOI 10.1093/nar/16.24.11691; Stevens CW, 2001, INT J RADIAT BIOL, V77, P841, DOI 10.1080/09553000110053882; Veuger SJ, 2004, ONCOGENE, V23, P7322, DOI 10.1038/sj.onc.1207984; Wang S, 2000, P NATL ACAD SCI USA, V97, P1584, DOI 10.1073/pnas.97.4.1584; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; WARD JF, 1990, INT J RADIAT BIOL, V57, P1141, DOI 10.1080/09553009014551251; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Wu X, 2005, BIOCHEM J, V391, P473, DOI 10.1042/BJ20050379; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yarosh DB, 2001, ENVIRON MOL MUTAGEN, V38, P132, DOI 10.1002/em.1063; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	50	62	66	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6298	10.1371/journal.pone.0006298	http://dx.doi.org/10.1371/journal.pone.0006298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621083	gold, Green Submitted, Green Published			2022-12-27	WOS:000268147200006
J	Li, JH; Paredes-Sabja, D; Sarker, MR; McClane, BA				Li, Jihong; Paredes-Sabja, Daniel; Sarker, Mahfuzur R.; McClane, Bruce A.			Further Characterization of Clostridium perfringens Small Acid Soluble Protein-4 (Ssp4) Properties and Expression	PLOS ONE			English	Article								Background: Clostridium perfringens type A food poisoning ( FP) is usually caused by C. perfringens type A strains that carry chromosomal enterotoxin gene (cpe) and produce spores with exceptional resistance against heat and nitrites. Previous studies showed that the extreme resistance of spores made by most FP strains is mediated, in large part, by a variant of small acid soluble protein 4 (Ssp4) that has Asp at residue 36; in contrast, the sensitive spores made by other C. perfringens type A isolates contain an Ssp4 variant with Gly at residue 36. Methodology/Principal Findings: The current study has further characterized Ssp4 properties and expression. Spores made by cpe-positive type C and D strains were found to contain the Ssp4 variant with Gly at residue 36 and were shown to be heat- and nitrite-sensitive; this finding may help to explain why cpe-positive type C and D isolates rarely cause food poisoning. Saturation mutagenesis indicated that both amino acid size and charge at Ssp4 residue 36 are important for DNA binding and for spore resistance. C. perfringens Ssp2 was shown to bind preferentially to GC-rich DNA on gel-shift assays, while Ssp4 preferred binding to AT-rich DNA sequences. Maximal spore heat and nitrite resistance required production of all four C. perfringens Ssps, indicating that these Ssps act cooperatively to protect the spore's DNA, perhaps by binding to different chromosomal sequences. The Ssp4 variant with Asp at residue 36 was also shown to facilitate exceptional spore survival at freezer and refrigerator temperatures. Finally, Ssp4 expression was shown to be dependent upon Spo0A, a master regulator. Conclusions/Significance: Collectively, these results provide additional support for the importance of Ssps, particularly the Ssp4 variant with Asp at residue 36, for the extreme spore resistance phenotype that likely contributes to C. perfringens type A food poisoning transmission.			Li, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	bamcc@pitt.edu	Paredes-Sabja, Daniel/ABI-4293-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019844] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI019844, R37AI19844] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adak GK, 2002, GUT, V51, P832, DOI 10.1136/gut.51.6.832; Collie RE, 1998, J CLIN MICROBIOL, V36, P30, DOI 10.1128/JCM.36.1.30-36.1998; CORNILLOT E, 1995, MOL MICROBIOL, V15, P639, DOI 10.1111/j.1365-2958.1995.tb02373.x; Fisher DJ, 2006, INFECT IMMUN, V74, P5200, DOI 10.1128/IAI.00534-06; Grant KA, 2008, FOODBORNE PATHOG DIS, V5, P629, DOI 10.1089/fpd.2007.0066; Greene EA, 1996, J BIOL CHEM, V271, P11455, DOI 10.1074/jbc.271.19.11455; Huang IH, 2004, FEMS MICROBIOL LETT, V233, P233, DOI [10.1016/j.femsle.2004.02.014, 10.1111/j.1574-6968.2004.tb09487.x]; Lahti P, 2008, J CLIN MICROBIOL, V46, P371, DOI 10.1128/JCM.01650-07; Li JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000056; Li JH, 2006, APPL ENVIRON MICROB, V72, P4561, DOI 10.1128/AEM.00177-06; Li JH, 2006, APPL ENVIRON MICROB, V72, P7620, DOI 10.1128/AEM.01911-06; Lynch Michael, 2006, Morbidity and Mortality Weekly Report, V55, P1; MCCLANE BA, 2007, CLOSTRIDIUM PERFRING, P423; Miyamoto K, 2004, J CLIN MICROBIOL, V42, P1552, DOI 10.1128/JCM.42.4.1552-1558.2004; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Novak JS, 2003, INT J FOOD MICROBIOL, V86, P239, DOI 10.1016/S0168-1605(02)00550-0; Orsburn B, 2008, APPL ENVIRON MICROB, V74, P3328, DOI 10.1128/AEM.02629-07; Raju D, 2007, CAN J MICROBIOL, V53, P514, DOI 10.1139/W07-016; Raju D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-50; Raju D, 2007, APPL ENVIRON MICROB, V73, P2048, DOI 10.1128/AEM.02500-06; Sarker MR, 1999, MOL MICROBIOL, V33, P946, DOI 10.1046/j.1365-2958.1999.01534.x; Sarker MR, 2000, APPL ENVIRON MICROB, V66, P3234, DOI 10.1128/AEM.66.8.3234-3240.2000; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Sparks SG, 2001, J CLIN MICROBIOL, V39, P883, DOI 10.1128/JCM.39.3.883-888.2001; Tennen R, 2000, J APPL MICROBIOL, V89, P330, DOI 10.1046/j.1365-2672.2000.01114.x; Wen QY, 2004, APPL ENVIRON MICROB, V70, P2685, DOI 10.1128/AEM.70.5.2685-2691.2004; Zhao YL, 1998, J BACTERIOL, V180, P136, DOI 10.1128/JB.180.1.136-142.1998	28	38	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6249	10.1371/journal.pone.0006249	http://dx.doi.org/10.1371/journal.pone.0006249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609432	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000268119500002
J	Walker, MP; Tian, LP; Matera, AG				Walker, Michael P.; Tian, Liping; Matera, A. Gregory			Reduced Viability, Fertility and Fecundity in Mice Lacking the Cajal Body Marker Protein, Coilin	PLOS ONE			English	Article								Background: Coilin is the signature protein of the Cajal body, a conserved nuclear organelle involved in multiple aspects of small ribonucleoprotein (RNP) biogenesis. Coilin is required for Cajal body homeostasis in both plants and animals. Mice lacking coilin are viable when the mutation is crossed to an outbred strain but only partially viable when crossed to inbred lines. Methodology/Principal Findings: In order to clarify this issue, we backcrossed the coilin deletion onto the C57BL6/J background for ten generations and then investigated the consequences of coilin removal on overall viability and reproductive success. We conclude that semi-lethal phenotype observed in mixed-background crosses is due to loss of the Coilin gene (or a very tightly-linked locus). Interestingly, coilin knockout embryos die relatively late in gestation, between E13.5 and birth. We show that the maternal contribution of coilin is not important for organismal viability. Importantly, coilin knockout mice display significant fertility and fecundity defects. Mutant males that escape the embryonic lethality display reduced testis size, however, both males and females contribute to the observed reduction in reproductive fitness. Conclusions/Significance: The evolutionary conservation of coilin from plants to animals suggests that the protein plays an important role, perhaps coordinating the activities of various RNA-processing machineries. Our observations are consistent with the idea that coilin functions to ensure robust organismal development, especially during periods of rapid growth.			Walker, MP (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	matera@unc.edu		Matera, A. Gregory/0000-0002-6406-0630	NIGMS NIH HHS [T32-GM08613, T32 GM008613] Funding Source: Medline; NINDS NIH HHS [R01-NS041617, R01 NS041617] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041617] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; Bauer DW, 1997, MOL BIOL CELL, V8, P73, DOI 10.1091/mbc.8.1.73; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Collier S, 2006, MOL BIOL CELL, V17, P2942, DOI 10.1091/mbc.E05-12-1157; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Dundr M, 2004, J CELL BIOL, V164, P831, DOI 10.1083/jcb.200311121; Gall JG, 2003, NAT REV MOL CELL BIO, V4, P975, DOI 10.1038/nrm1262; Gall JG, 1999, MOL BIOL CELL, V10, P4385, DOI 10.1091/mbc.10.12.4385; Gangwani L, 2005, MOL CELL BIOL, V25, P2744, DOI 10.1128/MCB.25.7.2744-2756.2005; GREEN RC, 1991, EPILEPSIA, V32, P22, DOI 10.1111/j.1528-1157.1991.tb05605.x; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Jablonka S, 2002, P NATL ACAD SCI USA, V99, P10126, DOI 10.1073/pnas.152318699; Jady BE, 2003, EMBO J, V22, P1878, DOI 10.1093/emboj/cdg187; Kiss AM, 2002, NUCLEIC ACIDS RES, V30, P4643, DOI 10.1093/nar/gkf592; Klingauf M, 2006, MOL BIOL CELL, V17, P4972, DOI 10.1091/mbc.E06-06-0513; LAFARGA M, 2009, CHROMOSOMA IN PRESS; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Matera AG, 2006, CURR OPIN CELL BIOL, V18, P317, DOI 10.1016/j.ceb.2006.03.005; Matera AG, 1999, TRENDS CELL BIOL, V9, P302, DOI 10.1016/S0962-8924(99)01606-2; Nesic D, 2004, J CELL SCI, V117, P4423, DOI 10.1242/jcs.01308; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; RASKA I, 1991, EXP CELL RES, V195, P27, DOI 10.1016/0014-4827(91)90496-H; Richard P, 2003, EMBO J, V22, P4283, DOI 10.1093/emboj/cdg394; Schaffert N, 2004, EMBO J, V23, P3000, DOI 10.1038/sj.emboj.7600296; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Sleeman JE, 1999, CURR BIOL, V9, P1065, DOI 10.1016/S0960-9822(99)80475-8; Stanek D, 2004, J CELL BIOL, V166, P1015, DOI 10.1083/jcb.200405160; Stanek D, 2003, J CELL BIOL, V160, P505, DOI 10.1083/jcb.200210087; Stanek D, 2006, CHROMOSOMA, V115, P343, DOI 10.1007/s00412-006-0056-6; Sun J, 2005, J CELL SCI, V118, P4995, DOI 10.1242/jcs.02613; Tucker KE, 2000, J STRUCT BIOL, V129, P269, DOI 10.1006/jsbi.2000.4234; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Xu HZ, 2005, CHROMOSOMA, V114, P155, DOI 10.1007/s00412-005-0003-y	40	64	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6171	10.1371/journal.pone.0006171	http://dx.doi.org/10.1371/journal.pone.0006171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587784	gold, Green Published, Green Submitted			2022-12-27	WOS:000268035100003
J	Schaarschmidt, G; Wegner, F; Schwarz, SC; Schmidt, H; Schwarz, J				Schaarschmidt, Grit; Wegner, Florian; Schwarz, Sigrid C.; Schmidt, Hartmut; Schwarz, Johannes			Characterization of Voltage-Gated Potassium Channels in Human Neural Progenitor Cells	PLOS ONE			English	Article							K+ CHANNELS; TRANSIENT OUTWARD; DOPAMINERGIC DIFFERENTIATION; FUNCTIONAL-CHARACTERIZATION; DEVELOPMENTAL-CHANGES; COLORIMETRIC ASSAY; PEPTIDE INHIBITOR; DELAYED RECTIFIER; PRECURSOR CELLS; IONIC CURRENTS	Background: Voltage-gated potassium ( K-v) channels are among the earliest ion channels to appear during brain development, suggesting a functional requirement for progenitor cell proliferation and/or differentiation. We tested this hypothesis, using human neural progenitor cells (hNPCs) as a model system. Methodology/Principal Findings: In proliferating hNPCs a broad spectrum of Kv channel subtypes was identified using quantitative real-time PCR with a predominant expression of the A-type channel Kv4.2. In whole-cell patch-clamp recordings Kv currents were separated into a large transient component characteristic for fast-inactivating A-type potassium channels ( I-A) and a small, sustained component produced by delayed-rectifying channels (I-K). During differentiation the expression of I-A as well as A-type channel transcripts dramatically decreased, while IK producing delayed-rectifiers were upregulated. Both Kv currents were differentially inhibited by selective neurotoxins like phrixotoxin-1 and a-dendrotoxin as well as by antagonists like 4-aminopyridine, ammoniumchloride, tetraethylammonium chloride and quinidine. In viability and proliferation assays chronic inhibition of the A-type currents severely disturbed the cell cycle and precluded proper hNPC proliferation, while the blockade of delayed-rectifiers by a-dendrotoxin increased proliferation. Conclusions/Significance: These findings suggest that A-type potassium currents are essential for proper proliferation of immature multipotent hNPCs.			Schaarschmidt, G (corresponding author), Univ Leipzig, Dept Neurol, Leipzig, Germany.	grit.schaarschmidt@medizin.uni-leipzig.de	Schmidt, Hartmut/F-7058-2010					Alexander SPH, 2008, BRIT J PHARMACOL, V153, pS1, DOI 10.1038/sj.bjp.0707746; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; Bai XW, 2007, AM J PHYSIOL-CELL PH, V293, pC1539, DOI 10.1152/ajpcell.00089.2007; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; BELLUZZI O, 1985, J PHYSIOL-LONDON, V358, P91, DOI 10.1113/jphysiol.1985.sp015542; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENISHIN CG, 1988, MOL PHARMACOL, V34, P152; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chagot B, 2004, PROTEIN SCI, V13, P1197, DOI 10.1110/ps.03584304; CLARK RB, 1995, BRIT J PHARMACOL, V115, P335, DOI 10.1111/j.1476-5381.1995.tb15882.x; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Deng P, 2004, DEV BRAIN RES, V153, P97, DOI 10.1016/j.devbrainres.2004.08.001; Dieterlen MT, 2009, J NEUROSCI METH, V178, P15, DOI 10.1016/j.jneumeth.2008.11.007; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Engemaier E, 2006, GENOMICS, V87, P254, DOI 10.1016/j.ygeno.2005.10.001; FISHMAN MC, 1981, P NATL ACAD SCI-BIOL, V78, P5245, DOI 10.1073/pnas.78.8.5245; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; Harvey AL, 1997, GEN PHARMACOL-VASC S, V28, P7, DOI 10.1016/S0306-3623(96)00173-5; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Jelitai M, 2007, J NEUROSCI RES, V85, P1606, DOI 10.1002/jnr.21282; Johnston D., 1995, FDN CELLULAR NEUROPH, P676, DOI [10.1097/00004691-199703000-00009, DOI 10.1097/00004691-199703000-00009]; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; KEHL SJ, 1991, BRIT J PHARMACOL, V103, P1807, DOI 10.1111/j.1476-5381.1991.tb09867.x; Liebau S, 2006, J NEUROCHEM, V99, P426, DOI 10.1111/j.1471-4159.2006.03967.x; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; Milosevic J, 2006, CELL TISSUE RES, V324, P377, DOI 10.1007/s00441-005-0147-3; Milosevic J, 2005, J NEUROCHEM, V92, P718, DOI 10.1111/j.1471-4159.2004.02893.x; Milosevic J, 2002, INVEST NEW DRUG, V20, P229, DOI 10.1023/A:1016281109100; Milosevic J, 2007, STEM CELLS DEV, V16, P625, DOI 10.1089/scd.2006.0113; Milosevic J, 2006, J NEUROCHEM, V99, P913, DOI 10.1111/j.1471-4159.2006.04132.x; Milosevic J, 2009, NEUROTOX RES, V15, P367, DOI 10.1007/s12640-009-9043-z; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; PORSTMANN T, 1985, J IMMUNOL METHODS, V82, P169, DOI 10.1016/0022-1759(85)90236-4; Reiff DF, 1999, NEUROSCIENCE, V92, P1103, DOI 10.1016/S0306-4522(99)00044-5; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Ribera AB, 1999, ANN NY ACAD SCI, V868, P399, DOI 10.1111/j.1749-6632.1999.tb11301.x; Robertson B, 1997, TRENDS PHARMACOL SCI, V18, P474, DOI 10.1016/S0165-6147(97)90686-6; ROGAWSKI MA, 1985, ANN NY ACAD SCI, V448, P403, DOI 10.1111/j.1749-6632.1985.tb29934.x; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; Schaarschmidt G, 2009, J NEUROCHEM, V109, P238, DOI 10.1111/j.1471-4159.2009.05954.x; Schmidt H, 2000, J NEUROBIOL, V44, P392, DOI 10.1002/1097-4695(20000915)44:4<392::AID-NEU3>3.0.CO;2-M; Schmidt K, 1999, BRAIN RES, V843, P145, DOI 10.1016/S0006-8993(99)01938-1; Schwarz J, 2006, NEURODEGENER DIS, V3, P45, DOI 10.1159/000092092; Schwarz SC, 2006, PARKINSONISM RELAT D, V12, P302, DOI 10.1016/j.parkreldis.2006.01.003; Shi J, 2007, EUR J NEUROSCI, V25, P3499, DOI 10.1111/j.1460-9568.2007.05624.x; Shibata R, 2000, J NEUROSCI, V20, P4145; Smith DO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001604; Spitzer NC, 2002, CURR OPIN NEUROBIOL, V12, P315, DOI 10.1016/S0959-4388(02)00330-6; Spitzer NC, 2000, BRAIN RES BULL, V53, P547, DOI 10.1016/S0361-9230(00)00388-9; STANFIELD PR, 1983, REV PHYSIOL BIOCH P, V97, P1, DOI 10.1007/BFb0035345; Stephens GJ, 1996, PFLUG ARCH EUR J PHY, V431, P435, DOI 10.1007/BF02207283; STEWART RR, 1995, J NEUROBIOL, V28, P419, DOI 10.1002/neu.480280403; Storch A, 2004, CELL TISSUE RES, V318, P15, DOI 10.1007/s00441-004-0923-5; Storch A, 2003, J CHEM NEUROANAT, V26, P133, DOI 10.1016/S0891-0618(03)00067-X; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Vautier F, 2004, GLIA, V48, P337, DOI 10.1002/glia.20088; WALAAS SI, 1991, PHARMACOL REV, V43, P299; WANG ZG, 1995, J PHARMACOL EXP THER, V272, P184; Wegner F, 2008, J NEUROCHEM, V107, P1056, DOI 10.1111/j.1471-4159.2008.05688.x; Yasuda T, 2008, MOL CELL NEUROSCI, V37, P284, DOI 10.1016/j.mcn.2007.10.003	70	42	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6168	10.1371/journal.pone.0006168	http://dx.doi.org/10.1371/journal.pone.0006168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584922	Green Published, gold, Green Submitted			2022-12-27	WOS:000267806500005
J	Western, D; Russell, S; Cuthill, I				Western, David; Russell, Samantha; Cuthill, Innes			The Status of Wildlife in Protected Areas Compared to Non-Protected Areas of Kenya	PLOS ONE			English	Article							NAIROBI-NATIONAL-PARK; POPULATION TRENDS; RAINFALL; HERBIVORES; ECOSYSTEM; BIOMASS; MANAGEMENT	We compile over 270 wildlife counts of Kenya's wildlife populations conducted over the last 30 years to compare trends in national parks and reserves with adjacent ecosystems and country-wide trends. The study shows the importance of discriminating human-induced changes from natural population oscillations related to rainfall and ecological factors. National park and reserve populations have declined sharply over the last 30 years, at a rate similar to non-protected areas and country-wide trends. The protected area losses reflect in part their poor coverage of seasonal ungulate migrations. The losses vary among parks. The largest parks, Tsavo East, Tsavo West and Meru, account for a disproportionate share of the losses due to habitat change and the difficulty of protecting large remote parks. The losses in Kenya's parks add to growing evidence for wildlife declines inside as well as outside African parks. The losses point to the need to quantify the performance of conservation policies and promote integrated landscape practices that combine parks with private and community-based measures.			Western, D (corresponding author), African Conservat Ctr, Nairobi, Kenya.	dwestern@africaonline.co.ke						ANDERSON TL, 2001, POLITICS EC PARK MAN; [Anonymous], KRUGER EXPERIENCE; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; BRANDON K, 1998, PARKS PERIL; Caro T, 2007, AFR J ECOL, V45, P233, DOI 10.1111/j.1365-2028.2007.00814.x; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; CORFIELD T F, 1973, East African Wildlife Journal, V11, P339; DELEEUWJAN, 1998, INTERPRETATION DEP R; DOUGLASHAMILTON I, REPORT MERU NATL PAR; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; *ECOSYSTEMS LTD, 1982, AMB LOW RIFT REG STU; Ervin J, 2003, BIOSCIENCE, V53, P819, DOI 10.1641/0006-3568(2003)053[0819:PAAIP]2.0.CO;2; Estes RD, 2006, BIOL CONSERV, V131, P106, DOI 10.1016/j.biocon.2006.02.009; FOSTER JB, 1968, J ZOOL, V155, P413, DOI 10.1111/j.1469-7998.1968.tb03059.x; Gichohi H., 1990, THESIS U NAIROBI NAI; Goodman PS, 2003, BIOSCIENCE, V53, P843, DOI 10.1641/0006-3568(2003)053[0843:AMEASP]2.0.CO;2; Grant C. C., 2000, Koedoe, V43, P103; GRUNBLATT J, 1996, SUMMARY POP IN PRESS; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; HILLMAN J C, 1977, East African Wildlife Journal, V15, P1, DOI 10.1111/j.1365-2028.1977.tb00374.x; Hockings M, 2003, BIOSCIENCE, V53, P823, DOI 10.1641/0006-3568(2003)053[0823:SFATEO]2.0.CO;2; MacEwen Ann, 1982, NATL PARKS CONSERVAT; MUTU K, 2005, THESIS CLARKE U WORS, P56; Mwangi EM, 1998, BIODIVERS CONSERV, V7, P1; MYERS N, 1993, NATURE, V362, P30; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; OJWANG GO, 2006, 161 DEP RES SURV REM; OTTICHILO W, 2000, ITC PUBLICATION SERI, V70; Ottichilo WK, 2000, AFR J ECOL, V38, P202, DOI 10.1046/j.1365-2028.2000.00242.x; Owen-Smith N, 2006, ECOL MONOGR, V76, P73, DOI 10.1890/04-1101; Scholte P, 2007, AFR J ECOL, V45, P431, DOI 10.1111/j.1365-2028.2007.00774.x; SINCLAIR ARE, 1995, SERENGETI, V2; Stoner C, 2007, CONSERV BIOL, V21, P635, DOI 10.1111/j.1523-1739.2007.00705.x; Struhsaker TT, 2005, BIOL CONSERV, V123, P45, DOI 10.1016/j.biocon.2004.10.007; SUTHERLAND WJ, 2004, TRENDS ECOLOGY EVOLU, V19; Symstad AJ, 2003, BIOSCIENCE, V53, P89, DOI 10.1641/0006-3568(2003)053[0089:LTALSP]2.0.CO;2; Western D, 2004, AFR J ECOL, V42, P111, DOI 10.1111/j.1365-2028.2004.00506.x; WESTERN D, 1981, AFR J ECOL, V19, P7, DOI 10.1111/j.1365-2028.1981.tb00648.x; WESTERN D, 1993, AFR J ECOL, V31, P269, DOI 10.1111/j.1365-2028.1993.tb00541.x; Western D., 1994, NATURAL CONNECTIONS; WESTERN D, 1973, THESIS U NAIROBI, P385; WESTERN D, 2005, PEOPLE WILDLIFE CAMB; Western D., 1989, CONSERVATION 21 CENT; Wright R.G., 1992, WILDLIFE RES MANAGEM	46	185	193	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6140	10.1371/journal.pone.0006140	http://dx.doi.org/10.1371/journal.pone.0006140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584912	Green Published, gold, Green Submitted			2022-12-27	WOS:000267806500002
J	Kim, GH; Samant, SA; Earley, JU; Svensson, EC				Kim, Gene H.; Samant, Sadhana A.; Earley, Judy U.; Svensson, Eric C.			Translational Control of FOG-2 Expression in Cardiomyocytes by MicroRNA-130a	PLOS ONE			English	Article								MicroRNAs are increasingly being recognized as regulators of embryonic development; however, relatively few microRNAs have been identified to regulate cardiac development. FOG-2 (also known as zfpm2) is a transcriptional co-factor that we have previously shown is critical for cardiac development. In this report, we demonstrate that FOG-2 expression is controlled at the translational level by microRNA-130a. We identified a conserved region in the FOG-2 39 untranslated region predicted to be a target for miR-130a. To test the functional significance of this site, we generated an expression construct containing the luciferase coding region fused with the 39 untranslated region of FOG-2 or a mutant version lacking this microRNA binding site. When these constructs were transfected into NIH 3T3 fibroblasts (which are known to express miR-130a), we observed a 3.3-fold increase in translational efficiency when the microRNA target site was disrupted. Moreover, knockdown of miR-130a in fibroblasts resulted in a 3.6-fold increase in translational efficiency. We also demonstrate that cardiomyocytes express miR-130a and can attenuate translation of mRNAs with a FOG-2 39 untranslated region. Finally, we generated transgenic mice with cardiomyocyte over-expression of miR-130a. In the hearts of these mice, FOG-2 protein levels were reduced by as much as 80%. Histological analysis of transgenic embryos revealed ventricular wall hypoplasia and ventricular septal defects, similar to that seen in FOG-2 deficient hearts. These results demonstrate the importance of miR-130a for the regulation of FOG-2 protein expression and suggest that miR-130a may also play a role in the regulation of cardiac development.			Kim, GH (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	esvensso@medicine.bsd.uchicago.edu	Huang, H/E-9490-2010	Kim, Gene/0000-0001-6461-1992	NHLBI NIH HHS [R01 HL071063, F32 HL093992] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL093992, R01HL071063] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Hake S, 2003, CURR BIOL, V13, pR851, DOI 10.1016/j.cub.2003.10.021; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Holmes M, 1999, J BIOL CHEM, V274, P23491, DOI 10.1074/jbc.274.33.23491; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Knotts S, 1996, DEV DYNAM, V206, P182, DOI 10.1002/(SICI)1097-0177(199606)206:2<182::AID-AJA7>3.0.CO;2-E; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin AC, 2004, J BIOL CHEM, V279, P55017, DOI 10.1074/jbc.M411240200; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; PARMACEK MS, 1992, MOL CELL BIOL, V12, P1967, DOI 10.1128/MCB.12.5.1967; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; RINDT H, 1993, J BIOL CHEM, V268, P5332; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Svensson EC, 2000, J BIOL CHEM, V275, P20762, DOI 10.1074/jbc.M001522200; Svensson EC, 2000, NAT GENET, V25, P353, DOI 10.1038/77146; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; THUM T, 2008, CARDIOVASCULAR RES; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Walton RZ, 2006, DEV BIOL, V289, P482, DOI 10.1016/j.ydbio.2005.10.040; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	43	40	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6161	10.1371/journal.pone.0006161	http://dx.doi.org/10.1371/journal.pone.0006161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582148	Green Submitted, Green Published, gold			2022-12-27	WOS:000267806400016
J	Laskowski, M; McLeod, RD; Friesen, MR; Podaima, BW; Alfa, AS				Laskowski, Marek; McLeod, Robert D.; Friesen, Marcia R.; Podaima, Blake W.; Alfa, Attahiru S.			Models of Emergency Departments for Reducing Patient Waiting Times	PLOS ONE			English	Article								In this paper, we apply both agent-based models and queuing models to investigate patient access and patient flow through emergency departments. The objective of this work is to gain insights into the comparative contributions and limitations of these complementary techniques, in their ability to contribute empirical input into healthcare policy and practice guidelines. The models were developed independently, with a view to compare their suitability to emergency department simulation. The current models implement relatively simple general scenarios, and rely on a combination of simulated and real data to simulate patient flow in a single emergency department or in multiple interacting emergency departments. In addition, several concepts from telecommunications engineering are translated into this modeling context. The framework of multiple-priority queue systems and the genetic programming paradigm of evolutionary machine learning are applied as a means of forecasting patient wait times and as a means of evolving healthcare policy, respectively. The models' utility lies in their ability to provide qualitative insights into the relative sensitivities and impacts of model input parameters, to illuminate scenarios worthy of more complex investigation, and to iteratively validate the models as they continue to be refined and extended. The paper discusses future efforts to refine, extend, and validate the models with more data and real data relative to physical (spatial-topographical) and social inputs (staffing, patient care models, etc.). Real data obtained through proximity location and tracking system technologies is one example discussed.			Laskowski, M (corresponding author), Univ Manitoba, Internet Innovat Ctr, Winnipeg, MB, Canada.	mcleod@ee.umanitoba.ca						[Anonymous], The Canadian triage and acuity scale: combined adult/pediatric educational program: participant's manual; Blachowicz Dariusz, 2008, J Healthc Inf Manag, V22, P39; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; BORKOWSKI M, BMC PUBLIC IN PRESS; CARLEY K, 2003, BIOWAR SCALABLE MULT; *COUNT MAR, AMB DIV GUID; Daida J. M., 1996, Genetic Programming. Proceedings of the First Annual Conference 1996, P279; DOUPE M, INITIAL ANAL EMERGEN; EMRICH S, 2008, 30 INT C INF TECHN I, P709; EPSTEIN JM, 2008, ARTIFICIAL SOC GETTI; Floyd S, 1993, IEEE ACM T NETWORK, V1, P397, DOI 10.1109/90.251892; Green LV, 2008, OPER RES, V56, P1526, DOI 10.1287/opre.1080.0575; GREEN LV, 2003, INQUIRY, V39; GREEN LV, 2006, J ACAD EMERGENCY MED; Gunal M. M., 2005, P WINT SIM C ORL FL; Jones Spencer S, 2008, AMIA Annu Symp Proc, P338; KANAGARAJAH AK, 2006, INT C COMPL SYST BOS; KANTOWITZ BH, EMERGING TECHNOLOGIE; Koza J. R., 1996, Genetic Programming. Proceedings of the First Annual Conference 1996, P132; LASKOWSKI M, 2005, CAN C EL COMP ENG, P1014; Laskowski M, 2009, L N INST COMP SCI SO, V1, P25; MCLEOD RD, 2009, AGENT BASED MODELS N; Nordin P, 1996, ADAPT BEHAV, V5, P107, DOI 10.1177/105971239700500201; Ong BS, 2008, LECT NOTES COMPUT SC, V5101, P590; PATVIVATSIRI L, 2008, SIMULATION MODEL BIO; POYNTON MR, COMPUTER TERMINAL PL; Raymer M. L., 1996, Genetic Programming. Proceedings of the First Annual Conference 1996, P375; SANDERS D, 2008, 19 INT C SYST ENG LA; Spry C. W., 2005, P WINT SIM C ORL FL; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; White K. P., 2005, P WINT SIM C ORL FL; QT4; EMERGENCY DEP SIMULA; [No title captured]	34	38	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6127	10.1371/journal.pone.0006127	http://dx.doi.org/10.1371/journal.pone.0006127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GX	19572015	Green Published, Green Submitted, gold			2022-12-27	WOS:000267806200004
J	Stewart, L; Gosling, R; Griffin, J; Gesase, S; Campo, J; Hashim, R; Masika, P; Mosha, J; Bousema, T; Shekalaghe, S; Cook, J; Corran, P; Ghani, A; Riley, EM; Drakeley, C				Stewart, Laveta; Gosling, Roly; Griffin, Jamie; Gesase, Samwel; Campo, Joseph; Hashim, Ramadan; Masika, Paul; Mosha, Jacklin; Bousema, Teun; Shekalaghe, Seif; Cook, Jackie; Corran, Patrick; Ghani, Azra; Riley, Eleanor M.; Drakeley, Chris			Rapid Assessment of Malaria Transmission Using Age-Specific Sero-Conversion Rates	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; PARASITE PREVALENCE; AREA; INTENSITY; ENDEMICITY; ANTIBODIES; MORBIDITY; INFECTION; TANZANIA; AFRICA	Background: Malaria transmission intensity is a crucial determinant of malarial disease burden and its measurement can help to define health priorities. Rapid, local estimates of transmission are required to focus resources better but current entomological and parasitological methods for estimating transmission intensity are limited in this respect. An alternative is determination of antimalarial antibody age-specific sero-prevalence to estimate sero-conversion rates (SCR), which have been shown to correlate with transmission intensity. This study evaluated SCR generated from samples collected from health facility attendees as a tool for a rapid assessment of malaria transmission intensity. Methodology and Principal Findings: The study was conducted in north east Tanzania. Antibodies to Plasmodium falciparum merozoite antigens MSP-1(19) and AMA-1 were measured by indirect ELISA. Age-specific antibody prevalence was analysed using a catalytic conversion model based on maximum likelihood to generate SCR. A pilot study, conducted near Moshi, found SCRs for AMA-1 were highly comparable between samples collected from individuals in a conventional cross-sectional survey and those collected from attendees at a local health facility. For the main study, 3885 individuals attending village health facilities in Korogwe and Same districts were recruited. Both malaria parasite prevalence and sero-positivity were higher in Korogwe than in Same. MSP-1(19) and AMA-1 SCR rates for Korogwe villages ranged from 0.03 to 0.06 and 0.07 to 0.21 respectively. In Same district there was evidence of a recent reduction in transmission, with SCR among those born since 1998 [MSP-1(19) 0.002 to 0.008 and AMA-1 0.005 to 0.014] being 5 to 10 fold lower than among individuals born prior to 1998 [MSP-1(19) 0.02 to 0.04 and AMA-1 0.04 to 0.13]. Current health facility specific estimates of SCR showed good correlations with malaria incidence rates in infants in a contemporaneous clinical trial (MSP-1(19) r(2) = 0.78, p, 0.01 & AMA-1 r(2) = 0.91, p < 0.001). Conclusions: SCRs generated from age-specific anti-malarial antibody prevalence data collected via health facility surveys were robust and credible. Analysis of SCR allowed detection of a recent drop in malaria transmission in line with recent data from other areas in the region. This health facility-based approach represents a potential tool for rapid assessment of recent trends in malaria transmission intensity, generating valuable data for local and national malaria control programs to target, monitor and evaluate their control strategies.			Stewart, L (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	Chris.Drakeley@lshtm.ac.uk	Bousema, Teun/N-3574-2014; Riley, Eleanor M/C-8960-2013; Riley, Eleanor/AAL-1382-2020; Ghani, Azra/B-8560-2009	Bousema, Teun/0000-0003-2666-094X; Riley, Eleanor M/0000-0003-3447-3570; Riley, Eleanor/0000-0003-3447-3570; Mosha, Jacklin/0000-0001-7940-8903; Ghani, Azra/0000-0002-0007-4910	Medical Research Council [G0600719B] Funding Source: researchfish; Wellcome Trust [078925] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Brooker S, 2008, T ROY SOC TROP MED H, V102, P304, DOI 10.1016/j.trstmh.2008.01.010; BRUCECHWATT LJ, 1973, LANCET, V2, P547; Byass P, 2008, LANCET, V372, P1523, DOI 10.1016/S0140-6736(08)61631-1; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Cibulskis RE, 2007, AM J TROP MED HYG, V77, P133; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; DRAPER C. C., 1957, TRANS ROY SOC TROP MED AND HYG, V51, P137, DOI 10.1016/0035-9203(57)90058-5; DRAPER CC, 1972, AM J TROP MED HYG, V21, P696, DOI 10.4269/ajtmh.1972.21.696; DRUILHE P, 1986, INFECT IMMUN, V53, P393, DOI 10.1128/IAI.53.2.393-397.1986; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; GOSLING RD, 2009, LANCET IN PRESS; Grabowsky M, 2008, NATURE, V451, P1051, DOI 10.1038/4511051a; GREENWOOD BM, 2008, TRENDS PARASITOL; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Hamad AA, 2000, PARASITOLOGY, V120, P447, DOI 10.1017/S0031182099005818; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Jaworowski A, 2009, CLIN VACCINE IMMUNOL, V16, P312, DOI 10.1128/CVI.00356-08; Kachur SP, 2006, LANCET, V368, P10, DOI 10.1016/S0140-6736(06)68945-9; Lusingu JPA, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-26; Masika PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-120; MATOLA YG, 1981, T ROY SOC TROP MED H, V75, P811, DOI 10.1016/0035-9203(81)90418-1; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; McCullagh P, 1989, GEN LINEAR MODELS; Ned RM, 2008, J INFECT DIS, V198, P1609, DOI 10.1086/593066; NOOR AM, 2008, LANCET; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; O'Meara WP, 2007, AM J TROP MED HYG, V77, P246, DOI 10.4269/ajtmh.2007.77.246; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Paganotti GM, 2006, PARASITOLOGY, V132, P607, DOI 10.1017/S0031182005009601; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Schellenberg JRA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-194; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B	45	126	127	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6083	10.1371/journal.pone.0006083	http://dx.doi.org/10.1371/journal.pone.0006083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562032	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000267465900014
J	Oosterveer, MH; van Dijk, TH; Tietge, UJF; Boer, T; Havinga, R; Stellaard, F; Groen, AK; Kuipers, F; Reijngoud, DJ				Oosterveer, Maaike H.; van Dijk, Theo H.; Tietge, Uwe J. F.; Boer, Theo; Havinga, Rick; Stellaard, Frans; Groen, Albert K.; Kuipers, Folkert; Reijngoud, Dirk-Jan			High Fat Feeding Induces Hepatic Fatty Acid Elongation in Mice	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; LOW-DENSITY-LIPOPROTEIN; LIVER-X-RECEPTOR; ACETYL-COA CARBOXYLASE-1; ELEMENT-BINDING PROTEIN; POOL IN-VIVO; INSULIN-RESISTANCE; VLDL PRODUCTION; CHOLESTEROL; DIET	Background: High-fat diets promote hepatic lipid accumulation. Paradoxically, these diets also induce lipogenic gene expression in rodent liver. Whether high expression of these genes actually results in an increased flux through the de novo lipogenic pathway in vivo has not been demonstrated. Methodology/Principal Findings: To interrogate this apparent paradox, we have quantified de novo lipogenesis in C57Bl/6J mice fed either chow, a high-fat or a n-3 polyunsaturated fatty acid (PUFA)-enriched high-fat diet. A novel approach based on mass isotopomer distribution analysis (MIDA) following 1-C-13 acetate infusion was applied to simultaneously determine de novo lipogenesis, fatty acid elongation as well as cholesterol synthesis. Furthermore, we measured very low density lipoprotein-triglyceride (VLDL-TG) production rates. High-fat feeding promoted hepatic lipid accumulation and induced the expression of lipogenic and cholesterogenic genes compared to chow-fed mice: induction of gene expression was found to translate into increased oleate synthesis. Interestingly, this higher lipogenic flux (+74 mu g/g/h for oleic acid) in mice fed the high-fat diet was mainly due to an increased hepatic elongation of unlabeled palmitate (+66 mu g/g/h) rather than to elongation of de novo synthesized palmitate. In addition, fractional cholesterol synthesis was increased, i.e. 5.8 +/- 0.4% vs. 8.1 +/- 0.6% for control and high fat-fed animals, respectively. Hepatic VLDL-TG production was not affected by high-fat feeding. Partial replacement of saturated fat by fish oil completely reversed the lipogenic effects of high-fat feeding: hepatic lipogenic and cholesterogenic gene expression levels as well as fatty acid and cholesterol synthesis rates were normalized. Conclusions/Significance: High-fat feeding induces hepatic fatty acid synthesis in mice, by chain elongation and subsequent desaturation rather than de novo synthesis, while VLDL-TG output remains unaffected. Suppression of lipogenic fluxes by fish oil prevents from high fat diet-induced hepatic steatosis in mice.			Oosterveer, MH (corresponding author), Univ Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands.	m.h.oosterveer@med.umcg.nl	oosterveer, maaike h/C-3374-2013	Kuipers, Folkert/0000-0003-2518-737X; Reijngoud, Dirk-Jan/0000-0003-1157-4491				Alwayn IPJ, 2005, TRANSPLANTATION, V79, P606, DOI 10.1097/01.TP.0000150023.86487.44; Bandsma RHJ, 2001, DIABETES, V50, P2591, DOI 10.2337/diabetes.50.11.2591; Bassilian S, 2002, AM J PHYSIOL-ENDOC M, V282, pE507, DOI 10.1152/ajpendo.00211.2001; Bederman IR, 2004, J BIOL CHEM, V279, P43207, DOI 10.1074/jbc.M403838200; BENHIZIA F, 1994, AM J PHYSIOL-ENDOC M, V267, pE975, DOI 10.1152/ajpendo.1994.267.6.E975; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cheema SK, 1999, J NUTR, V129, P1718, DOI 10.1093/jn/129.9.1718; Davidson MH, 2006, AM J CARDIOL, V98, p27I, DOI 10.1016/j.amjcard.2005.12.024; DELGADO TC, 2008, NMR BIOMED; Doege H, 2008, J BIOL CHEM, V283, P22186, DOI 10.1074/jbc.M803510200; FRASER R, 1970, J LIPID RES, V11, P60; Gautier T, 2007, J LIPID RES, V48, P30, DOI 10.1194/jlr.M600205-JLR200; Gentile CL, 2008, J NUTR BIOCHEM, V19, P567, DOI 10.1016/j.jnutbio.2007.10.001; Gibbons GF, 2004, BIOCHEM SOC T, V32, P59, DOI 10.1042/BST0320059; GIBBONS GF, 1992, BIOCHEM J, V287, P749, DOI 10.1042/bj2870749; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; HELLERSTEIN MK, 1992, AM J PHYSIOL, V263, pE988; HELLERSTEIN MK, 1991, AM J PHYSIOL, V261, pE479, DOI 10.1152/ajpendo.1991.261.4.E479; HELLERSTEIN MK, 1991, J BIOL CHEM, V266, P10912; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Jung HR, 1999, BIOCHEM J, V343, P473, DOI 10.1042/0264-6021:3430473; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; LIN YG, 1995, BBA-LIPID LIPID MET, V1256, P88, DOI 10.1016/0005-2760(95)00006-X; Lombardo YB, 2006, J NUTR BIOCHEM, V17, P1, DOI 10.1016/j.jnutbio.2005.08.002; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; MURPHY MC, 1993, BRIT J NUTR, V70, P727, DOI 10.1079/BJN19930168; MUSKIET FAJ, 1983, J CHROMATOGR, V278, P231, DOI 10.1016/S0378-4347(00)84782-9; NEESE RA, 1993, AM J PHYSIOL, V264, pE136, DOI 10.1152/ajpendo.1993.264.1.E136; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; Park Y, 2003, J LIPID RES, V44, P455, DOI 10.1194/jlr.M200282-JLR200; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Qi KM, 2008, CLIN NUTR, V27, P424, DOI 10.1016/j.clnu.2008.02.001; RUMSEY SC, 1995, J BIOL CHEM, V270, P10008, DOI 10.1074/jbc.270.17.10008; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Schwarz JM, 1995, J CLIN INVEST, V96, P2735, DOI 10.1172/JCI118342; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Tamura S, 2005, J CLIN INVEST, V115, P1139, DOI 10.1172/JCI200524930; van der Meer RW, 2008, J CLIN ENDOCR METAB, V93, P2702, DOI 10.1210/jc.2007-2524; van der Veen JN, 2007, J LIPID RES, V48, P337, DOI 10.1194/jlr.M600170-JLR200; Westerbacka J, 2005, J CLIN ENDOCR METAB, V90, P2804, DOI 10.1210/jc.2004-1983; Wiegman CH, 2003, DIABETES, V52, P1081, DOI 10.2337/diabetes.52.5.1081; ZHANG Y, 1994, J BIOL CHEM, V269, P11025	52	113	118	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6066	10.1371/journal.pone.0006066	http://dx.doi.org/10.1371/journal.pone.0006066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557132	Green Published, Green Submitted, gold			2022-12-27	WOS:000267424600014
J	Vogtlander, NPJ; Visch, HJ; Bakker, MAH; Berden, JHM; van der Vlag, J				Vogtlander, Nils P. J.; Visch, Henk Jan; Bakker, Marinka A. H.; Berden, Jo H. M.; van der Vlag, Johan			Ligation of alpha-Dystroglycan on Podocytes Induces Intracellular Signaling: A New Mechanism for Podocyte Effacement?	PLOS ONE			English	Article								Background: alpha-Dystroglycan is a negatively charged glycoprotein that covers the apical and basolateral membrane of the podocyte. Its transmembrane binding to the cytoskeleton is regulated via tyrosine phosphorylation (pY892) of beta-dystroglycan. At the basolateral side alpha-dystroglycan binds the glomerular basement membrane. At the apical membrane, it plays a role in the maintenance of the filtration slit. In this study, we evaluated whether ligation of alpha-dystroglycan with specific antibodies or natural ligands induces intracellular signaling, and whether there is an effect on podocyte architecture. Methodology/Principal Findings: Conditionally immortalized podocytes were exposed in vitro to antibodies to alpha-dystroglycan, and to fibronectin, biglycan, laminin and agrin. Intracellular calcium fluxes, phosphorylation of beta-dystroglycan and podocyte architecture were studied. Antibodies to alpha-dystroglycan could specifically induce calcium signaling. Fibronectin also induced calcium signaling, and led to dephosphorylation of pY892 in beta-dystroglycan. Ligation of alpha-dystroglycan resulted in an altered actin architecture, a decreased number of podocyte pedicles and a more flattened appearance of the podocyte. Conclusions/Significance: We conclude that ligation of alpha-dystroglycan on podocytes induces intracellular calcium signaling, which leads to an altered cytoskeleton architecture akin to the situation of foot process effacement. In particular the ability of fibronectin to induce intracellular signaling events is of interest, since the expression and excretion of this protein is upregulated in several proteinuric diseases. Therefore, fibronectin-induced signaling via dystroglycan may be a novel mechanism for foot process effacement in proteinuric diseases.			Vogtlander, NPJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Div Nephrol, Nijmegen Ctr Mol Life Sci,Nephrol Res Lab, NL-6525 ED Nijmegen, Netherlands.	j.vandervlag@nier.umcn.nl	Van der Vlag, Johan/E-4636-2010; Berden, J.H.M./H-8009-2014	Van der Vlag, Johan/0000-0001-7843-5918; 				Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Granqvist ABR, 2006, AM J PHYSIOL-RENAL, V291, pF722, DOI 10.1152/ajprenal.00433.2005; Blattner SM, 2005, CURR OPIN NEPHROL HY, V14, P404, DOI 10.1097/01.mnh.0000172730.67746.5b; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; Cavaldesi M, 1999, J NEUROCHEM, V72, P1648, DOI 10.1046/j.1471-4159.1999.721648.x; Cohen MP, 2007, AM J PHYSIOL-RENAL, V292, pF789, DOI 10.1152/ajprenal.00201.2006; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Ferletta M, 2003, MOL BIOL CELL, V14, P2088, DOI 10.1091/mbc.E03-01-0852; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; Hall H, 2003, MOL CELL NEUROSCI, V24, P1062, DOI 10.1016/j.mcn.2003.08.007; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Hunt JL, 2005, J AM SOC NEPHROL, V16, P1593, DOI 10.1681/ASN.2004080679; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ilsley JL, 2001, CELL SIGNAL, V13, P625, DOI 10.1016/S0898-6568(01)00188-7; James M, 2000, J CELL SCI, V113, P1717; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; Kilis-Pstrusinska Katarzyna, 2002, Med Sci Monit, V8, pCR713; Kojima K, 2004, J AM SOC NEPHROL, V15, P2079, DOI 10.1097/01.ASN.0000133531.43177.21; Kretzler M, 2002, MICROSC RES TECHNIQ, V57, P247, DOI 10.1002/jemt.10083; Kubosawa H, 1998, VIRCHOWS ARCH, V433, P449, DOI 10.1007/s004280050273; Kucherenko MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002418; Kuroda M, 2004, CLIN NEPHROL, V61, P7; Kuroda M, 2002, KIDNEY INT, V62, P780, DOI 10.1046/j.1523-1755.2002.00524.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Lee S, 2007, NEPHROL DIAL TRANSPL, V22, P396, DOI 10.1093/ndt/gfl598; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Matsumura K, 1997, J BIOL CHEM, V272, P13904, DOI 10.1074/jbc.272.21.13904; Meier M, 2007, DIABETES, V56, P346, DOI 10.2337/db06-0891; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moss J, 1998, AMYLOID, V5, P43, DOI 10.3109/13506129809007289; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; OKUDA S, 1990, J CLIN INVEST, V86, P453, DOI 10.1172/JCI114731; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Raats CJI, 2000, AM J PATHOL, V156, P1749, DOI 10.1016/S0002-9440(10)65046-8; Regele HM, 2000, J AM SOC NEPHROL, V11, P403, DOI 10.1681/ASN.V113403; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rentschler S, 1999, BIOL CHEM, V380, P431, DOI 10.1515/BC.1999.057; Rudiger F, 1999, KIDNEY INT, V56, P1700, DOI 10.1046/j.1523-1755.1999.00729.x; Sadasivam G, 2005, J NEUROSCI, V25, P10479, DOI 10.1523/JNEUROSCI.2103-05.2005; Schaefer L, 2000, KIDNEY INT, V58, P1557, DOI 10.1046/j.1523-1755.2000.00317.x; Schaefer L, 2001, FASEB J, V15, P559; Senatorski G, 1998, RES EXP MED, V198, P199, DOI 10.1007/s004330050103; Sharma SK, 2002, ANAL BIOCHEM, V307, P187, DOI 10.1016/S0003-2697(02)00008-8; Sotgia F, 2000, J BIOL CHEM, V275, P38048, DOI 10.1074/jbc.M005321200; Sotgia F, 2003, BIOCHEMISTRY-US, V42, P7110, DOI 10.1021/bi0271289; Sotgia F, 2001, BIOCHEMISTRY-US, V40, P14585, DOI 10.1021/bi011247r; Soylemezoglu O, 1997, NEPHROL DIAL TRANSPL, V12, P1883, DOI 10.1093/ndt/12.9.1883; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Spence HJ, 2004, HUM MOL GENET, V13, P1657, DOI 10.1093/hmg/ddh170; Stokes MB, 2000, KIDNEY INT, V57, P487, DOI 10.1046/j.1523-1755.2000.00868.x; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Visch HJ, 2004, J BIOL CHEM, V279, P40328, DOI 10.1074/jbc.M408068200; Vogtlander NPJ, 2006, KIDNEY INT, V69, P1526, DOI 10.1038/sj.ki.5000138; Vogtlander NPJ, 2005, J HISTOCHEM CYTOCHEM, V53, P1345, DOI 10.1369/jhc.4A6596.2005; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711	65	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5979	10.1371/journal.pone.0005979	http://dx.doi.org/10.1371/journal.pone.0005979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543532	gold, Green Published, Green Submitted			2022-12-27	WOS:000267237400006
J	Carilli, JE; Norris, RD; Black, BA; Walsh, SM; McField, M				Carilli, Jessica E.; Norris, Richard D.; Black, Bryan A.; Walsh, Sheila M.; McField, Melanie			Local Stressors Reduce Coral Resilience to Bleaching	PLOS ONE			English	Article								Coral bleaching, during which corals lose their symbiotic dinoflagellates, typically corresponds with periods of intense heat stress, and appears to be increasing in frequency and geographic extent as the climate warms. A fundamental question in coral reef ecology is whether chronic local stress reduces coral resistance and resilience from episodic stress such as bleaching, or alternatively promotes acclimatization, potentially increasing resistance and resilience. Here we show that following a major bleaching event, Montastraea faveolata coral growth rates at sites with higher local anthropogenic stressors remained suppressed for at least 8 years, while coral growth rates at sites with lower stress recovered in 2-3 years. Instead of promoting acclimatization, our data indicate that background stress reduces coral fitness and resilience to episodic events. We also suggest that reducing chronic stress through local coral reef management efforts may increase coral resilience to global climate change.			Carilli, JE (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	jcarilli@ucsd.edu	Black, Bryan/A-7057-2009	Black, Bryan/0000-0001-6851-257X				Andrefouet S, 2002, CORAL REEFS, V21, P43, DOI 10.1007/s00338-001-0199-0; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Castillo KD, 2005, MAR BIOL, V148, P261, DOI 10.1007/s00227-005-0046-x; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; GOREAU TJ, 1990, CORAL REEFS, V8, P211, DOI 10.1007/BF00265013; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HELMLE KP, 2002, CORAL XRADIOGRAPHY D; *HLTH REEFS IN, 2008, ECOHEALTH REP CARD M; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; KOENIG A, COMP CHEM RECO UNPUB; Kramer P., 2000, STATUS CORAL REEFS W; LEDER JJ, 1991, CORAL REEFS, V10, P19, DOI 10.1007/BF00301902; MARAGOS JE, 1993, COAST MANAGE, V21, P235, DOI 10.1080/08920759309362207; MCFIELD M, 2005, STATUS CARIBBEAN COR; MCFIELD MD, 2000, P 9 INT COR REEF S, V1, P62; Omata T, 2006, GLOBAL PLANET CHANGE, V53, P137, DOI 10.1016/j.gloplacha.2006.01.009; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Strong A.E., 1997, P 8 INT COR REEF S, V2, P1495; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4	28	198	201	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6324	10.1371/journal.pone.0006324	http://dx.doi.org/10.1371/journal.pone.0006324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623250	Green Published, gold			2022-12-27	WOS:000268260100007
J	Palmer, SA; Moore, JD; Clapham, AJ; Rose, P; Allaby, RG				Palmer, Sarah A.; Moore, Jonathan D.; Clapham, Alan J.; Rose, Pamela; Allaby, Robin G.			Archaeogenetic Evidence of Ancient Nubian Barley Evolution from Six to Two-Row Indicates Local Adaptation	PLOS ONE			English	Article							GRAIN-YIELD; DNA; DOMESTICATION; INHERITANCE; LANDRACES; SPIKELETS; INSIGHTS; REGIONS; REMAINS; MAIZE	Background: Archaeobotanical samples of barley ( Hordeum vulgare L.) found at Qasr Ibrim display a two-row phenotype that is unique to the region of archaeological sites upriver of the first cataract of the Nile, characterised by the development of distinctive lateral bracts. The phenotype occurs throughout all strata at Qasr Ibrim, which range in age from 3000 to a few hundred years. Methodology and Findings: We extracted ancient DNA from barley samples from the entire range of occupancy of the site, and studied the Vrs1 gene responsible for row number in extant barley. Surprisingly, we found a discord between the genotype and phenotype in all samples; all the barley had a genotype consistent with the six-row condition. These results indicate a six-row ancestry for the Qasr Ibrim barley, followed by a reassertion of the two-row condition. Modelling demonstrates that this sequence of evolutionary events requires a strong selection pressure. Conclusions: The two-row phenotype at Qasr Ibrim is caused by a different mechanism to that in extant barley. The strength of selection required for this mechanism to prevail indicates that the barley became locally adapted in the region in response to a local selection pressure. The consistency of the genotype/phenotype discord over time supports a scenario of adoption of this barley type by successive cultures, rather than the importation of new barley varieties associated with individual cultures.			Palmer, SA (corresponding author), Univ Warwick, Warwick HRI, Wellesbourne, Warwick, England.	r.g.allaby@warwick.ac.uk	Moore, Jonathan D/D-1796-2013	Moore, Jonathan D/0000-0002-5486-0407	Natural Environment Research Council [NE/G005974/1] Funding Source: researchfish; NERC [NE/G005974/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Abdel-Ghani AH, 2004, THEOR APPL GENET, V109, P588, DOI 10.1007/s00122-004-1657-1; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; BROWN TA, 2006, DARWINS HARVEST NEW, P197; CLAPHAM AJ, 2007, GRONINGEN ARCHAEOLOG, V5, P157; Demissie A, 1996, HEREDITAS, V124, P17, DOI 10.1111/j.1601-5223.1996.00017.x; EVANS LT, 1976, ADV AGRON, V28, P301, DOI 10.1016/S0065-2113(08)60558-1; Forster BP, 2004, ANN APPL BIOL, V144, P157, DOI 10.1111/j.1744-7348.2004.tb00329.x; Freitas FO, 2003, J ARCHAEOL SCI, V30, P901, DOI 10.1016/S0305-4403(02)00269-8; Fuller D.Q., 2001, SUDAN NUBIA, V5, P97; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2005, AM J PHYS ANTHROPOL, V128, P110, DOI 10.1002/ajpa.20045; GRUNDBACHER FJ, 1963, BOT REV, V29, P366, DOI 10.1007/BF02860824; Gymer P. T., 1978, Barley Genetics Newsletter, V8, P44; Harris D. R, 1996, ORIGIN SPREAD AGR PA, P25; Helgason A, 2007, J MOL EVOL, V65, P92, DOI 10.1007/s00239-006-0259-8; Jarman RJ, 1996, PLANT VAR SEEDS, V9, P191; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; Kjaer B, 1996, EUPHYTICA, V90, P39; Knupffer H, 2003, DEV PL GEN, V7, P53, DOI 10.1016/S0168-7972(03)80006-3; Komatsuda T, 2002, THEOR APPL GENET, V105, P85, DOI 10.1007/s00122-001-0858-0; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Leonard WH, 1942, GENETICS, V27, P0299; Lia VV, 2007, P ROY SOC B-BIOL SCI, V274, P545, DOI 10.1098/rspb.2006.3747; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Lundqvist U, 1997, BARLEY GENET NEWSL, V26, P200; Marota I, 2002, AM J PHYS ANTHROPOL, V117, P310, DOI 10.1002/ajpa.10045; Murray M. A., 2000, ANCIENT EGYPTIAN MAT, P505; NECAS J, 1963, BIOL PLANTARUM, V5, P89, DOI 10.1007/BF02933639; ODonoghue K, 1996, P ROY SOC B-BIOL SCI, V263, P541, DOI 10.1098/rspb.1996.0082; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Weiss E, 2004, P NATL ACAD SCI USA, V101, P9551, DOI 10.1073/pnas.0402362101; WETTERSTROM W, 1993, ARCHAEOLOGY AFRICA F, P165; WIEBE GA, 1961, TECHNICAL B USDA, V1224; Willcox G, 2005, VEG HIST ARCHAEOBOT, V14, P534, DOI 10.1007/s00334-005-0075-x; Zink A, 2003, AM J PHYS ANTHROPOL, V121, P109, DOI 10.1002/ajpa.10213; ZOHARY D, 2000, DOMESTICATION PLANTS, P67	38	53	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6301	10.1371/journal.pone.0006301	http://dx.doi.org/10.1371/journal.pone.0006301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	474CN	19623249	Green Published, Green Submitted, gold			2022-12-27	WOS:000268260100005
J	Kobayashi, M; Kikuchi, D; Okamura, H				Kobayashi, Masaki; Kikuchi, Daisuke; Okamura, Hitoshi			Imaging of Ultraweak Spontaneous Photon Emission from Human Body Displaying Diurnal Rhythm	PLOS ONE			English	Article								The human body literally glimmers. The intensity of the light emitted by the body is 1000 times lower than the sensitivity of our naked eyes. Ultraweak photon emission is known as the energy released as light through the changes in energy metabolism. We successfully imaged the diurnal change of this ultraweak photon emission with an improved highly sensitive imaging system using cryogenic charge-coupled device (CCD) camera. We found that the human body directly and rhythmically emits light. The diurnal changes in photon emission might be linked to changes in energy metabolism.			Kobayashi, M (corresponding author), Tohoku Inst Technol, Dept Elect & Intelligent Syst, Sendai, Miyagi 982, Japan.	masaki@tohtech.ac.jp; okamurah@pharm.kyoto-u.ac.jp						CADENAS E, 1984, PHOTOCHEM PHOTOBIOL, V40, P823, DOI 10.1111/j.1751-1097.1984.tb04657.x; Kobayashi M, 1999, NEUROSCI RES, V34, P103, DOI 10.1016/S0168-0102(99)00040-1; Kobayashi T, 2003, KNEE, V10, P135, DOI 10.1016/S0968-0160(02)00055-8; Merrow M, 2001, CELL, V106, P141, DOI 10.1016/S0092-8674(01)00443-3; NAKANO M, 1989, J BIOLUM CHEMILUM, V4, P231, DOI 10.1002/bio.1170040133; Okamura H, 2004, J BIOL RHYTHM, V19, P388, DOI 10.1177/0748730404269169; POPP FA, 1988, EXPERIENTIA, V44, P543, DOI 10.1007/BF01953300; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Sauermann G, 1999, METHOD ENZYMOL, V300, P419; Schibler U, 2001, SCIENCE, V293, P437, DOI 10.1126/science.1063296; SCHWARTZ WJ, 1977, SCIENCE, V97, P89; Teuchner K, 1999, PHOTOCHEM PHOTOBIOL, V70, P146, DOI 10.1562/0031-8655(1999)070<0146:FTPEFO>2.3.CO;2; USA M, 1991, FINAL REPORT INABA B, P239; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	14	70	75	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6256	10.1371/journal.pone.0006256	http://dx.doi.org/10.1371/journal.pone.0006256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606225	gold, Green Published, Green Submitted			2022-12-27	WOS:000268036000012
J	Burnat, M; Diestra, E; Esteve, I; Sole, A				Burnat, Mireia; Diestra, Elia; Esteve, Isabel; Sole, Antonio			In Situ Determination of the Effects of Lead and Copper on Cyanobacterial Populations in Microcosms	PLOS ONE			English	Article								Background: Biomass has been studied as biomarker to evaluate the effect of heavy metals on microbial communities. Nevertheless, the most important methodological problem when working with natural and artificial microbial mats is the difficulty to evaluate changes produced on microorganism populations that are found in thicknesses of just a few mm depth. Methodology/Principal Findings: Here, we applied for first time a recently published new method based on confocal laser scanning microscopy and image-program analysis to determine in situ the effect of Pb and Cu stress in cyanobacterial populations. Conclusions/Significance: The results showed that both in the microcosm polluted by Cu and by Pb, a drastic reduction in total biomass for cyanobacterial and Microcoleus sp. (the dominant filamentous cyanobacterium in microbial mats) was detected within a week. According to the data presented in this report, this biomass inspection has a main advantage: besides total biomass, diversity, individual biomass of each population and their position can be analysed at microscale level. CLSM-IA could be a good method for analyzing changes in microbial biomass as a response to the addition of heavy metals and also to other kind of pollutants.			Burnat, M (corresponding author), Univ Autonoma Barcelona, Biosci Fac, Dept Genet & Microbiol, E-08193 Barcelona, Spain.	mireia.burnat@uab.cat	Burnat, Mireia/G-5502-2015; Solé, Antonio/L-4195-2014	Burnat, Mireia/0000-0001-5756-7794; Solé, Antonio/0000-0002-1151-319X				Abed RMM, 2002, ARCH MICROBIOL, V177, P361, DOI 10.1007/s00203-001-0390-2; Baath E, 2005, MICROB ECOL, V50, P496, DOI 10.1007/s00248-005-0008-3; Bauer K, 2008, FEMS MICROBIOL ECOL, V63, P205, DOI 10.1111/j.1574-6941.2007.00423.x; Becker JM, 2006, MICROB ECOL, V51, P220, DOI 10.1007/s00248-005-0002-9; BLOEM J, 1995, APPL ENVIRON MICROB, V61, P926, DOI 10.1128/AEM.61.3.926-936.1995; Boivin MEY, 2006, ENVIRON POLLUT, V140, P239, DOI 10.1016/j.envpol.2005.07.014; Castenholz RW, 2001, BERGEYS MANUAL SYSTE, P473, DOI DOI 10.1007/978-0-387-21609-6_27; De Philippis R, 2003, J APPL PHYCOL, V15, P155, DOI 10.1023/A:1023889410912; ESTEVE I, 1994, NATO ASI SERIES G, V35, P415; Fourans A, 2004, FEMS MICROBIOL ECOL, V51, P55, DOI 10.1016/j.femsec.2004.07.012; Fourcans A, 2006, FEMS MICROBIOL ECOL, V57, P367, DOI 10.1111/j.1574-6941.2006.00124.x; FRY JC, 1990, METHOD MICROBIOL, V22, P411; Gillan DC, 2005, APPL ENVIRON MICROB, V71, P679, DOI 10.1128/AEM.71.2.679-690.2005; Heng LY, 2004, B ENVIRON CONTAM TOX, V72, P373, DOI 10.1007/s00128-003-8923-9; Incharoensakdi A, 2002, CURR MICROBIOL, V45, P261, DOI 10.1007/s00284-002-3747-0; Joynt J, 2006, MICROB ECOL, V51, P209, DOI 10.1007/s00248-005-0205-0; KOMAREK J, 2004, CYANODB CZ ON LINE D; Konopka A, 1999, APPL ENVIRON MICROB, V65, P2256; Lliros M, 2008, SCI TOTAL ENVIRON, V393, P39, DOI 10.1016/j.scitotenv.2007.11.034; Massieux B, 2004, APPL ENVIRON MICROB, V70, P4512, DOI 10.1128/AEM.70.8.4512-4521.2004; Rajapaksha RMCP, 2004, APPL ENVIRON MICROB, V70, P2966, DOI 10.1128/AEM.70.5.2966-2973.2004; Rasband W.S., 1997, IMAGE J; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P1062, DOI 10.4319/lo.1983.28.6.1062; Sole A, 2007, ULTRAMICROSCOPY, V107, P669, DOI 10.1016/j.ultramic.2007.01.007; Sole A, 2009, MICROB ECOL, V57, P649, DOI 10.1007/s00248-008-9463-y; Sole A, 2001, J MICROSC-OXFORD, V204, P258, DOI 10.1046/j.1365-2818.2001.00951.x; Stal LJ, 1994, MICROBIAL MATS STRUC; Tripathi BN, 2003, ECOTOX ENVIRON SAFE, V56, P311, DOI 10.1016/S0147-6513(02)00164-1; Wieland A, 2003, MICROB ECOL, V46, P371, DOI 10.1007/s00248-002-0108-2; Yang YG, 2006, CHEMOSPHERE, V63, P1942, DOI 10.1016/j.chemosphere.2005.10.009	30	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6204	10.1371/journal.pone.0006204	http://dx.doi.org/10.1371/journal.pone.0006204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593432	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035300014
J	Kurian, SM; Heilman, R; Mondala, TS; Nakorchevsky, A; Hewel, JA; Campbell, D; Robison, EH; Wang, L; Lin, W; Gaber, L; Solez, K; Shidban, H; Mendez, R; Schaffer, RL; Fisher, JS; Flechner, SM; Head, SR; Horvath, S; Yates, JR; Marsh, CL; Salomon, DR				Kurian, Sunil M.; Heilman, Raymond; Mondala, Tony S.; Nakorchevsky, Aleksey; Hewel, Johannes A.; Campbell, Daniel; Robison, Elizabeth H.; Wang, Lin; Lin, Wen; Gaber, Lillian; Solez, Kim; Shidban, Hamid; Mendez, Robert; Schaffer, Randolph L.; Fisher, Jonathan S.; Flechner, Stuart M.; Head, Steve R.; Horvath, Steve; Yates, John R., III; Marsh, Christopher L.; Salomon, Daniel R.			Biomarkers for Early and Late Stage Chronic Allograft Nephropathy by Proteogenomic Profiling of Peripheral Blood	PLOS ONE			English	Article								Background: Despite significant improvements in life expectancy of kidney transplant patients due to advances in surgery and immunosuppression, Chronic Allograft Nephropathy (CAN) remains a daunting problem. A complex network of cellular mechanisms in both graft and peripheral immune compartments complicates the non-invasive diagnosis of CAN, which still requires biopsy histology. This is compounded by non-immunological factors contributing to graft injury. There is a pressing need to identify and validate minimally invasive biomarkers for CAN to serve as early predictors of graft loss and as metrics for managing long-term immunosuppression. Methods: We used DNA microarrays, tandem mass spectroscopy proteomics and bioinformatics to identify genomic and proteomic markers of mild and moderate/severe CAN in peripheral blood of two distinct cohorts (n = 77 total) of kidney transplant patients with biopsy-documented histology. Findings: Gene expression profiles reveal over 2400 genes for mild CAN, and over 700 for moderate/severe CAN. A consensus analysis reveals 393 (mild) and 63 (moderate/severe) final candidates as CAN markers with predictive accuracy of 80% (mild) and 92% (moderate/severe). Proteomic profiles show over 500 candidates each, for both stages of CAN including 302 proteins unique to mild and 509 unique to moderate/severe CAN. Conclusions: This study identifies several unique signatures of transcript and protein biomarkers with high predictive accuracies for mild and moderate/ severe CAN, the most common cause of late allograft failure. These biomarkers are the necessary first step to a proteogenomic classification of CAN based on peripheral blood profiling and will be the targets of a prospective clinical validation study.			Kurian, SM (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dsalomon@scripps.edu	Heilman, Raymond/AAW-5138-2020; Salomon, Daniel/E-9380-2012; Kurian, Sunil/C-4493-2008; Schaffer, Randolph/S-7432-2019	Kurian, Sunil/0000-0002-7782-7263; Marsh, Christopher/0000-0002-6517-076X	NIAID NIH HHS [R01 AI052349, R56 AI052349, U19 AI52349] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI052349, R01AI052349] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banasik Miroslaw, 2006, Ann Transplant, V11, P7; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brouard S, 2007, P NATL ACAD SCI USA, V104, P15448, DOI 10.1073/pnas.0705834104; CALNE RY, 1978, LANCET, V2, P1323; Clarke W, 2003, ANN SURG, V237, P660, DOI 10.1097/00000658-200305000-00008; Colvin RB, 2003, NEW ENGL J MED, V349, P2288, DOI 10.1056/NEJMp038178; de Mattos AM, 2000, AM J KIDNEY DIS, V35, P333, DOI 10.1016/S0272-6386(00)70348-9; Deng MC, 2006, AM J TRANSPLANT, V6, P150, DOI 10.1111/j.1600-6143.2005.01175.x; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Flechner SM, 2004, AM J TRANSPLANT, V4, P1475, DOI 10.1111/j.1600-6143.2004.00526.x; Flechner SM, 2004, AM J TRANSPLANT, V4, P1776, DOI 10.1111/j.1600-6143.2004.00627.x; Flechner SM, 2007, TRANSPLANTATION, V83, P883, DOI 10.1097/01.tp.0000258586.52777.4c; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; Horwitz PA, 2004, CIRCULATION, V110, P3815, DOI 10.1161/01.CIR.0000150539.72783.BF; Huang CC, 2006, PEDIATR BLOOD CANCER, V46, P728, DOI 10.1002/pbc.20773; Jevnikar AM, 2008, CLIN J AM SOC NEPHRO, V3, pS56, DOI 10.2215/CJN.03040707; KURIAN S, 2005, CURRENT OPINION ORGA, V10, P193; Kurian S, 2007, INT IMMUNOPHARMACOL, V7, P1948, DOI 10.1016/j.intimp.2007.07.017; Lachenbruch PA, 2004, AM J TRANSPLANT, V4, P451, DOI 10.1111/j.1600-6143.2004.00386.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Mas V, 2007, TRANSPLANTATION, V83, P448, DOI 10.1097/01.tp.0000251373.17997.9a; Meier-Kriesche HU, 2001, J AM SOC NEPHROL, V12, P1293, DOI 10.1681/ASN.V1261293; Nankivell BJ, 2006, TRANSPLANTATION, V81, P643, DOI 10.1097/01.tp.0000190423.82154.01; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Oetting WS, 2006, AM J KIDNEY DIS, V47, P898, DOI 10.1053/j.ajkd.2006.01.034; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Pascual M, 1998, IMMUNOL TODAY, V19, P514, DOI 10.1016/S0167-5699(98)01324-3; Pascual M, 1999, TRANSPLANTATION, V67, P737, DOI 10.1097/00007890-199903150-00016; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Schaub S, 2005, AM J TRANSPLANT, V5, P729, DOI 10.1111/j.1600-6143.2005.00766.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WOOLF SH, 1995, NEW ENGL J MED, V333, P1401, DOI 10.1056/NEJM199511233332107; Yates PJ, 2006, TRANSPL IMMUNOL, V16, P148, DOI 10.1016/j.trim.2006.10.001; Yilmaz S, 2007, TRANSPL INT, V20, P608, DOI 10.1111/j.1432-2277.2007.00494.x	39	63	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6212	10.1371/journal.pone.0006212	http://dx.doi.org/10.1371/journal.pone.0006212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593431	Green Submitted, Green Published, gold			2022-12-27	WOS:000268035300018
J	Yang, EH; Almon, RR; DuBois, DC; Jusko, WJ; Androulakis, IP				Yang, Eric H.; Almon, Richard R.; DuBois, Debra C.; Jusko, Willian J.; Androulakis, Ioannis P.			Identification of Global Transcriptional Dynamics	PLOS ONE			English	Article							GENE-EXPRESSION; INFLAMMATORY RESPONSE; PHARMACOGENOMICS; INJURY; MODEL	Background: One of the challenges in exploiting high throughput measurement techniques such as microarrays is the conversion of the vast amounts of data obtained into relevant knowledge. Of particular importance is the identification of the intrinsic response of a transcriptional experiment and the characterization of the underlying dynamics. Methodology and Findings: The proposed algorithmseeks to provide the researcher a summary as to various aspects relating to the dynamic progression of a biological system, rather than that of individual genes. The approach is based on the identification of smaller number of expression motifs that define the transcriptional state of the system which quantifies the deviation of the cellular response from a control state in the presence of an external perturbation. The approach is demonstrated with a number of data sets including a synthetic base case and four animal studies. The synthetic dataset will be used to establish the response of the algorithm on a "null'' dataset, whereas the four different experimental datasets represent a spectrum of possible time course experiments in terms of the degree of perturbation associated with the experiment as well as representing a wide range of temporal sampling strategies. This wide range of experimental datasets will thus allow us to explore the performance of the proposed algorithm and determine its ability identify relevant information. Conclusions and Significance: In this work, we present a computational approach which operates on high throughput temporal gene expression data to assess the information content of the experiment, identify dynamic markers of important processes associated with the experimental perturbation, and summarize in a concise manner the evolution of the system over time with respect to the experimental perturbation.			Yang, EH (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA.	yannis@rci.rutgers.edu	Jusko, William J/G-4885-2015		NIGMS NIH HHS [R37 GM024211, R01 GM024211, GM 24211] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024211, R37GM024211] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Almon Richard R., 2003, Functional & Integrative Genomics, V3, P171, DOI 10.1007/s10142-003-0090-x; Balasubramaniyan R, 2005, BIOINFORMATICS, V21, P1069, DOI 10.1093/bioinformatics/bti095; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bundy JG, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-25; Churchill GA, 2004, BIOTECHNIQUES, V37, P173, DOI 10.2144/04372TE01; DAYNEKA NL, 1993, J PHARMACOKINET BIOP, V21, P457, DOI 10.1007/BF01061691; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Fox RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-126; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gottenberg JE, 2005, ANN RHEUM DIS, V64, P913, DOI 10.1136/ard.2004.029694; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Jayaraman A, 2005, TISSUE ENG, V11, P50, DOI 10.1089/ten.2005.11.50; Jayaraman A, 2000, METAB ENG, V2, P239, DOI 10.1006/mben.2000.0153; Jin JY, 2003, J PHARMACOL EXP THER, V307, P93, DOI 10.1124/jpet.103.053256; KEOGH E, 2005, HOT SAX EFFICIENTLY; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Menger GJ, 2005, PHYSIOL GENOMICS, V21, P370, DOI 10.1152/physiolgenomics.00224.2004; *NIST, 1998, E HDB STAT METH; Peterson SN, 2001, GENOME BIOL, V2; Preiss B., 1999, WW SER COMP SCI; Ramakrishnan R, 2002, J PHARMACOL EXP THER, V300, P245, DOI 10.1124/jpet.300.1.245; Rassokhin DN, 2000, J MOL GRAPH MODEL, V18, P368, DOI 10.1016/S1093-3263(00)00063-2; Schliep A, 2003, BIOINFORMATICS, V19, pi255, DOI 10.1093/bioinformatics/btg1036; SPIEGEL MR, 1999, SCHAUMS OUTLINE THEO, pR17; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vemula M, 2004, PHYSIOL GENOMICS, V18, P87, DOI 10.1152/physiolgenomics.00189.2003; Yang E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-10	28	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e5992	10.1371/journal.pone.0005992	http://dx.doi.org/10.1371/journal.pone.0005992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593450	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035300001
J	Eroukhmanoff, F; Svensson, EI				Eroukhmanoff, Fabrice; Svensson, Erik I.			Contemporary Parallel Diversification, Antipredator Adaptations and Phenotypic Integration in an Aquatic Isopod	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; FRESH-WATER ISOPOD; SWIMMING PERFORMANCE; POECILIA-RETICULATA; ADAPTIVE EVOLUTION; PERCA-FLUVIATILIS; ASELLUS-AQUATICUS; LACERTID LIZARDS; UNIQUE FEATURES; PREY BEHAVIOR	It is increasingly being recognized that predation can be a strong diversifying agent promoting ecological divergence. Adaptations against different predatory regimes can emerge over short periods of time and include many different traits. We studied antipredator adaptations in two ecotypes of an isopod (Asellus aquaticus) that have, diverged in parallel in two Swedish lakes over the last two decades. We quantified differences in escape speed, morphology and behavior for isopods from different ecotypes present in these lakes. Isopods from the source habitat (reed) coexist with mainly invertebrate predators. They are more stream-profiled and have higher escape speeds than isopods in the newly colonized stonewort habitat, which has higher density of fish predators. Stonewort isopods also show more cautious behaviors and had higher levels of phenotypic integration between coloration and morphological traits than the reed isopods. Colonization of a novel habitat with a different predation regime has thus strengthened the correlations between pigmentation and morphology and weakened escape performance. The strong signature of parallelism for these phenotypic traits indicates that divergence is likely to be adaptive and is likely to have been driven by differences in predatory regimes. Furthermore, our results indicate that physical performance, behavior and morphology can change rapidly and in concert as new habitats are colonized.			Eroukhmanoff, F (corresponding author), Lund Univ, Sect Anim Ecol, Lund, Sweden.	fabrice.eroukhmanoff@zooekol.lu.se	eroukhmanoff, fabrice/D-1414-2015; Eroukhmanoff, Fabrice/F-8319-2010; Svensson, Erik/E-8324-2010	Svensson, Erik/0000-0001-9006-016X				Abram PA, 2000, AM NAT, V156, pS45, DOI 10.1086/303415; [Anonymous], [No title captured]; Bell MA, 2004, EVOLUTION, V58, P814; Eroukhmanoff F, 2008, J EVOLUTION BIOL, V21, P514, DOI 10.1111/j.1420-9101.2007.01488.x; Eroukhmanoff F, 2009, J EVOLUTION BIOL, V22, P1098, DOI 10.1111/j.1420-9101.2009.01723.x; Foster DJ, 2008, J EVOLUTION BIOL, V21, P263, DOI 10.1111/j.1420-9101.2007.01449.x; FRY JD, 1993, EVOLUTION, V47, P327, DOI 10.1111/j.1558-5646.1993.tb01224.x; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Ghalambor CK, 2003, INTEGR COMP BIOL, V43, P431, DOI 10.1093/icb/43.3.431; Gordon SP, 2009, AM NAT, V174, P34, DOI 10.1086/599300; Hansen TF, 2003, BIOSYSTEMS, V69, P83, DOI 10.1016/S0303-2647(02)00132-6; Hargeby A, 2005, FRESHWATER BIOL, V50, P2053, DOI 10.1111/j.1365-2427.2005.01446.x; Hargeby A, 2005, J EVOLUTION BIOL, V18, P713, DOI 10.1111/j.1420-9101.2004.00837.x; Hargeby A, 2004, EVOLUTION, V58, P81; HARGEBY A, 1994, HYDROBIOLOGIA, V280, P83; Hargeby A, 2007, ECOSYSTEMS, V10, P29, DOI 10.1007/s10021-006-9008-5; Hemmi JM, 2003, NATURE, V421, P160, DOI 10.1038/nature01247; HOULE D, 1991, EVOLUTION, V45, P630, DOI 10.1111/j.1558-5646.1991.tb04334.x; Johannesson K, 2001, TRENDS ECOL EVOL, V16, P148, DOI 10.1016/S0169-5347(00)02078-4; Johnson JB, 2008, EVOLUTION, V62, P1243, DOI 10.1111/j.1558-5646.2008.00343.x; Kuchta SR, 2008, EVOLUTION, V62, P984, DOI 10.1111/j.1558-5646.2008.00338.x; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; Langerhans RB, 2006, EVOLUTION, V60, P362; LYTHGOE JN, 1983, NATURE, V301, P656, DOI 10.1038/301656a0; Magwene PM, 2001, EVOLUTION, V55, P1734; Meyer JR, 2007, NATURE, V446, P432, DOI 10.1038/nature05599; Mikolajewski DJ, 2006, EVOLUTION, V60, P1306; Nosil P, 2007, AM NAT, V169, P151, DOI 10.1086/510634; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Pettersson LB, 1999, OECOLOGIA, V121, P12, DOI 10.1007/s004420050901; Pettersson LB, 2000, OIKOS, V88, P200, DOI 10.1034/j.1600-0706.2000.880122.x; Pigliucci M, 2003, ECOL LETT, V6, P265, DOI 10.1046/j.1461-0248.2003.00428.x; RASK M, 1985, HYDROBIOLOGIA, V121, P27, DOI 10.1007/BF00035226; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; Reznick DN, 1996, AM NAT, V147, P319, DOI 10.1086/285854; Rohlf FJ, 1996, SYST BIOL, V45, P344, DOI 10.2307/2413569; Rundle HD, 2003, P NATL ACAD SCI USA, V100, P14943, DOI 10.1073/pnas.2036360100; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Stoks R, 2003, EVOLUTION, V57, P574; Stoks R, 2006, AM NAT, V168, pS50, DOI 10.1086/509045; Svensson EI, 2007, AM NAT, V170, P101, DOI 10.1086/518181; Taylor JRA, 2003, SCIENCE, V301, P209, DOI 10.1126/science.1085987; Urban MC, 2007, P NATL ACAD SCI USA, V104, P14377, DOI 10.1073/pnas.0704645104; Vamosi SM, 2005, CAN J ZOOL, V83, P894, DOI 10.1139/Z05-063; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Vanhooydonck B, 2003, FUNCT ECOL, V17, P160, DOI 10.1046/j.1365-2435.2003.00716.x; Vanhooydonck B, 2001, EVOLUTION, V55, P1040, DOI 10.1554/0014-3820(2001)055[1040:SASTOI]2.0.CO;2; Wagner BMA, 1998, HYDROBIOLOGIA, V368, P75, DOI 10.1023/A:1003213224327; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Wang IJ, 2008, EVOLUTION, V62, P2742, DOI 10.1111/j.1558-5646.2008.00507.x; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wilson RS, 2002, J EXP BIOL, V205, P1145	54	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6173	10.1371/journal.pone.0006173	http://dx.doi.org/10.1371/journal.pone.0006173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587791	Green Submitted, Green Published, gold			2022-12-27	WOS:000268035100005
J	Gurry, T; Kahramanogullari, O; Endres, RG				Gurry, Thomas; Kahramanogullari, Ozan; Endres, Robert G.			Biophysical Mechanism for Ras-Nanocluster Formation and Signaling in Plasma Membrane	PLOS ONE			English	Article								Ras GTPases are lipid-anchored G proteins, which play a fundamental role in cell signaling processes. Electron micrographs of immunogold-labeled Ras have shown that membrane-bound Ras molecules segregate into nanocluster domains. Several models have been developed in attempts to obtain quantitative descriptions of nanocluster formation, but all have relied on assumptions such as a constant, expression-level independent ratio of Ras in clusters to Ras monomers (cluster/monomer ratio). However, this assumption is inconsistent with the law of mass action. Here, we present a biophysical model of Ras clustering based on short-range attraction and long-range repulsion between Ras molecules in the membrane. To test this model, we performed Monte Carlo simulations and compared statistical clustering properties with experimental data. We find that we can recover the experimentally-observed clustering across a range of Ras expression levels, without assuming a constant cluster/monomer ratio or the existence of lipid rafts. In addition, our model makes predictions about the signaling properties of Ras nanoclusters in support of the idea that Ras nanoclusters act as an analog-digital-analog converter for high fidelity signaling.			Gurry, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Integrated Syst Biol, London, England.	r.endres@imperial.ac.uk			Biotechnology and Biological Sciences Research Council [BB/G000131/1] Funding Source: Medline; BBSRC [BB/G000131/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abankwa D, 2007, SEMIN CELL DEV BIOL, V18, P599, DOI 10.1016/j.semcdb.2007.08.003; Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Arai Y, 2006, BIOCHEM BIOPH RES CO, V343, P809, DOI 10.1016/j.bbrc.2006.03.031; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BOS JL, 1989, CANCER RES, V49, P4682; BRUNGER AT, 1990, P NATL ACAD SCI USA, V87, P4849, DOI 10.1073/pnas.87.12.4849; Cheng XD, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe14; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Eisenberg S, 2008, CELL SIGNAL, V20, P31, DOI 10.1016/j.cellsig.2007.07.012; Endres RG, 2007, PLOS COMPUT BIOL, V3, P1385, DOI 10.1371/journal.pcbi.0030150; Endres RG, 2009, BIOPHYS J, V96, P453, DOI 10.1016/j.bpj.2008.10.021; Gorfe AA, 2004, J AM CHEM SOC, V126, P15277, DOI 10.1021/ja046607n; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Harding A, 2008, CELL CYCLE, V7, P127, DOI 10.4161/cc.7.2.5237; Harding AS, 2008, TRENDS CELL BIOL, V18, P364, DOI 10.1016/j.tcb.2008.05.006; HENIS YI, 2008, MOL MEMBR BIOL, V29, P1; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lommerse PHM, 2005, J CELL SCI, V118, P1799, DOI 10.1242/jcs.02300; Lommerse PHM, 2006, BIOPHYS J, V91, P1090, DOI 10.1529/biophysj.105.079053; Lundmark R, 2008, BIOCHEM J, V414, P189, DOI 10.1042/BJ20081237; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Mattfeldt T, 2006, J MICROSC-OXFORD, V223, P107, DOI 10.1111/j.1365-2818.2006.01604.x; Mattfeldt T, 2005, J MICROSC-OXFORD, V220, P131, DOI 10.1111/j.1365-2818.2005.01521.x; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006; NIV H, 2004, J CELL BIOL, V165, P725; Philips MR, 2005, BIOCHEM SOC T, V33, P657, DOI 10.1042/BST0330657; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; Sengupta P, 2007, SEMIN CELL DEV BIOL, V18, P583, DOI 10.1016/j.semcdb.2007.07.010; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SYMONS M, 2001, SCI STKE, V68, pPE1; Szymanska E, 2009, EXP CELL RES, V315, P981, DOI 10.1016/j.yexcr.2009.01.023; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tkacik G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002774; Weikl TR, 2004, BIOPHYS J, V87, P3665, DOI 10.1529/biophysj.104.045609	53	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6148	10.1371/journal.pone.0006148	http://dx.doi.org/10.1371/journal.pone.0006148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587789	Green Submitted, Green Published, gold			2022-12-27	WOS:000268035100002
J	Xu, YJ; Lei, ZY; Huang, H; Dui, W; Liang, XH; Ma, J; Jiao, RJ				Xu, Yanjuan; Lei, Zhiyong; Huang, Hai; Dui, Wen; Liang, Xuehong; Ma, Jun; Jiao, Renjie			dRecQ4 Is Required for DNA Synthesis and Essential for Cell Proliferation in Drosophila	PLOS ONE			English	Article								Background: The family of RecQ DNA helicases plays an important role in the maintenance of genomic integrity. Mutations in three of the five known RecQ family members in humans, BLM, WRN and RecQ4, lead to disorders that are characterized by predisposition to cancer and premature aging. Methodology/Principal Findings: To address the in vivo functions of Drosophila RecQ4 (dRecQ4), we generated mutant alleles of dRecQ4 using the targeted gene knock-out technique. Our data show that dRecQ4 mutants are homozygous lethal with defects in DNA replication, cell cycle progression and cell proliferation. Two sets of experiments suggest that dRecQ4 also plays a role in DNA double strand break repair. First, mutant animals exhibit sensitivity to gamma irradiation. Second, the efficiency of DsRed reconstitution via single strand annealing repair is significantly reduced in the dRecQ4 mutant animals. Rescue experiments further show that both the N-terminal domain and the helicase domain are essential to dRecQ4 function in vivo. The N-terminal domain is sufficient for the DNA repair function of dRecQ4. Conclusions/Significance: Together, our results show that dRecQ4 is an essential gene that plays an important role in not only DNA replication but also DNA repair and cell cycle progression in vivo.			Jiao, RJ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	rjiao@sun5.ibp.ac.cn	Ma, Jun/GLT-4809-2022; Huang, Hai/CZY-9855-2022; Jiao, Renjie/AAE-8902-2019	Ma, Jun/0000-0002-1609-3294; Huang, Hai/0000-0003-2331-6238; 				Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bagherieh-Najjar MB, 2005, PLANT J, V43, P789, DOI 10.1111/j.1365-313X.2005.02501.x; Balraj P, 2002, MUTAT RES-FUND MOL M, V508, P99, DOI 10.1016/S0027-5107(02)00189-6; BOUBRIAK I, 2008, BIOGERONTOLOGY; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Burks LM, 2007, GENE, V391, P26, DOI 10.1016/j.gene.2006.11.019; Cabral REC, 2008, MUTAT RES-FUND MOL M, V643, P41, DOI 10.1016/j.mrfmmm.2008.06.002; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Chou TB, 1996, GENETICS, V144, P1673; Dietschy T, 2007, CELL MOL LIFE SCI, V64, P796, DOI 10.1007/s00018-007-6468-5; Durand F, 2002, ANN DERMATOL VENER, V129, P892; Egli D, 2006, MOL CELL BIOL, V26, P2286, DOI 10.1128/MCB.26.6.2286-2296.2006; Egli D, 2003, EMBO J, V22, P100, DOI 10.1093/emboj/cdg012; Fan W, 2008, J BIOL CHEM, V283, P29037, DOI 10.1074/jbc.M801928200; Franchitto A, 2008, J CELL BIOL, V183, P241, DOI 10.1083/jcb.200803173; Hartung F, 2006, NUCLEIC ACIDS RES, V34, P4438, DOI 10.1093/nar/gkl576; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hoki Y, 2003, HUM MOL GENET, V12, P2293, DOI 10.1093/hmg/ddg254; Ichikawa Koji, 2002, Nihon Yakurigaku Zasshi, V119, P219; Jiao R, 2007, ONCOGENE, V26, P3811, DOI 10.1038/sj.onc.1210150; Jiao RJ, 2004, MOL CELL BIOL, V24, P4710, DOI 10.1128/MCB.24.11.4710-4719.2004; Jin WD, 2008, HUM GENET, V123, P643, DOI 10.1007/s00439-008-0518-4; Kawasaki K, 2002, NUCLEIC ACIDS RES, V30, P3682, DOI 10.1093/nar/gkf487; Kitao S, 1999, GENOMICS, V61, P268, DOI 10.1006/geno.1999.5959; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Kumata Y, 2007, BBA-MOL CELL RES, V1773, P556, DOI 10.1016/j.bbamcr.2007.01.005; Kusano K, 1999, GENETICS, V151, P1027; Kusano K, 2001, SCIENCE, V291, P2600, DOI 10.1126/science.291.5513.2600; Larizza L, 2006, CANCER LETT, V232, P107, DOI 10.1016/j.canlet.2005.07.042; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Mcvey M, 2007, GENETICS, V176, P1979, DOI 10.1534/genetics.106.070052; NAKAYAMA M, 2008, DNA REPAIR AMST; Ouyang KJ, 2008, MECH AGEING DEV, V129, P425, DOI 10.1016/j.mad.2008.03.003; Park SJ, 2006, DNA CELL BIOL, V25, P696, DOI 10.1089/dna.2006.25.696; Petkovic M, 2005, J CELL SCI, V118, P4261, DOI 10.1242/jcs.02556; Preston CR, 2006, GENETICS, V172, P1055, DOI 10.1534/genetics.105.050138; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Saunders RDC, 2008, AGING CELL, V7, P418, DOI 10.1111/j.1474-9726.2008.00388.x; Sekelsky JJ, 1999, NUCLEIC ACIDS RES, V27, P3762, DOI 10.1093/nar/27.18.3762; Siitonen HA, 2003, HUM MOL GENET, V12, P2837, DOI 10.1093/hmg/ddg306; SMITH PJ, 1982, MUTAT RES, V94, P213, DOI 10.1016/0027-5107(82)90183-X; Trowbridge K, 2007, GENETICS, V176, P1993, DOI 10.1534/genetics.106.070060; Van Maldergem L, 2006, J MED GENET, V43, P148, DOI 10.1136/jmg.2005.031781; Werner SR, 2006, BIOCHEM BIOPH RES CO, V345, P403, DOI 10.1016/j.bbrc.2006.04.093; Woo LL, 2006, EXP CELL RES, V312, P3443, DOI 10.1016/j.yexcr.2006.07.023; Wu JH, 2008, DEV BIOL, V323, P130, DOI 10.1016/j.ydbio.2008.08.006; Wu L, 2008, BIOESSAYS, V30, P291, DOI 10.1002/bies.20735; XU T, 1993, DEVELOPMENT, V117, P1223; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269	57	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6107	10.1371/journal.pone.0006107	http://dx.doi.org/10.1371/journal.pone.0006107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GX	19572017	gold, Green Published, Green Submitted			2022-12-27	WOS:000267806200002
J	Lai, WYY; Lane, T				Lai, William Yuk Yeu; Lane, Trevor			Characteristics of Medical Research News Reported on Front Pages of Newspapers	PLOS ONE			English	Article							SCIENTIFIC MEETINGS; INGELFINGER RULE; COVERAGE; SCIENCE; DISSEMINATION; EMBARGOES; ABSTRACTS; BENEFITS; JOURNALS; RISKS	Background: The placement of medical research news on a newspaper's front page is intended to gain the public's attention, so it is important to understand the source of the news in terms of research maturity and evidence level. Methodology/Principal Findings: We searched LexisNexis to identify medical research reported on front pages of major newspapers published from January 1, 2000 to December 31, 2002. We used MEDLINE and Google Scholar to find journal articles corresponding to the research, and determined their evidence level. Of 734 front-page medical research stories identified, 417 (57%) referred to mature research published in peer-reviewed journals. The remaining 317 stories referred to preliminary findings presented at scientific or press meetings; 144 (45%) of those stories mentioned studies that later matured (i.e. were published in journals within 3 years after news coverage). The evidence-level distribution of the 515 journal articles quoted in news stories reporting on mature research (3% level I, 21% level II, 42% level III, 4% level IV, and 31% level V) differed from that of the 170 reports of preliminary research that later matured (1%, 19%, 35%, 12%, and 33%, respectively; chi-square test, P = .0009). No news stories indicated evidence level. Fewer than 1 in 5 news stories reporting preliminary findings acknowledged the preliminary nature of their content. Conclusions/Significance: Only 57% of front-page stories reporting on medical research are based on mature research, which tends to have a higher evidence level than research with preliminary findings. Medical research news should be clearly referenced and state the evidence level and limitations to inform the public of the maturity and quality of the source.			Lai, WYY (corresponding author), Univ Hong Kong, Journalism & Media Studies Ctr, Pokfulam, Hong Kong, Peoples R China.	wyylai@yahoo.com	Lane, Trevor/B-2153-2009; Lane, Trevor/AAF-4871-2020	Lane, Trevor/0000-0001-8599-2173; 				Altman LK, 1996, LANCET, V347, P1382, DOI 10.1016/S0140-6736(96)91016-8; Altman LK, 1996, LANCET, V347, P1459, DOI 10.1016/S0140-6736(96)91689-X; ALTMAN LK, 2006, NY TIMES        0502; Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Cassels A., 2008, OPEN MED, V2; de Semir V, 1998, JAMA-J AM MED ASSOC, V280, P294, DOI 10.1001/jama.280.3.294; DOWIE M, 1998, WHATS WRONG NEW YORK, P13; *EQUATOR NETW, 2006, INTR REP GUID; *ICMJE, 1993, UN REQ BIOM J UNPUB; Jensen JD, 2008, HUM COMMUN RES, V34, P347, DOI 10.1111/j.1468-2958.2008.00324.x; Kiernan V, 2003, SCI COMMUN, V25, P3, DOI 10.1177/1075547003255297; Marshall E, 1998, SCIENCE, V280, P996, DOI 10.1126/science.280.5366.996; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; *NAT LIB HLTH, NLH HITT HEADL; National Health and Medical Research Council (NHMRC), 1999, GUID DEV IMPL EV CLI; Nelkin D, 1995, SELLING SCI PRESS CO; Phillips B, 2001, OXFORD CTR EVIDENCE; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; Pitkin RM, 1999, JAMA-J AM MED ASSOC, V281, P1110, DOI 10.1001/jama.281.12.1110; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; SCHERER RW, 1994, JAMA-J AM MED ASSOC, V272, P158, DOI 10.1001/jama.272.2.158; Schwartz LM, 2006, BMJ-BRIT MED J, V333, P1248, DOI 10.1136/bmj.38985.564317.7C; Schwartz LM, 2002, JAMA-J AM MED ASSOC, V287, P2859, DOI 10.1001/jama.287.21.2859; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Smith DE, 2005, MED J AUSTRALIA, V183, P190, DOI 10.5694/j.1326-5377.2005.tb06992.x; Stewart CN, 2003, NAT BIOTECHNOL, V21, P353, DOI 10.1038/nbt0403-353; Wager E, 2002, JAMA-J AM MED ASSOC, V287, P2821, DOI 10.1001/jama.287.21.2821; Weber EJ, 1998, JAMA-J AM MED ASSOC, V280, P257, DOI 10.1001/jama.280.3.257; Wilkes MS, 1997, J HEALTH COMMUN, V2, P3, DOI 10.1080/108107397127888; Wilkie T, 1996, LANCET, V347, P1308, DOI 10.1016/S0140-6736(96)90947-2; Woloshin S, 2006, JNCI-J NATL CANCER I, V98, P372, DOI 10.1093/jnci/djj115; Woloshin S, 2006, MED J AUSTRALIA, V184, P576, DOI 10.5694/j.1326-5377.2006.tb00384.x	33	37	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6103	10.1371/journal.pone.0006103	http://dx.doi.org/10.1371/journal.pone.0006103			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568422	Green Submitted, Green Published, gold			2022-12-27	WOS:000267572200006
J	Sober, S; Org, E; Kepp, K; Juhanson, P; Eyheramendy, S; Gieger, C; Lichtner, P; Klopp, N; Veldre, G; Viigimaa, M; Doring, A; Putku, M; Kelgo, P; Shaw-Hawkins, S; Howard, P; Onipinla, A; Dobson, RJ; Newhouse, SJ; Brown, M; Dominiczak, A; Connell, J; Samani, N; Farrall, M; Caulfield, MJ; Munroe, PB; Illig, T; Wichmann, HE; Meitinger, T; Laan, M				Sober, Siim; Org, Elin; Kepp, Katrin; Juhanson, Peeter; Eyheramendy, Susana; Gieger, Christian; Lichtner, Peter; Klopp, Norman; Veldre, Gudrun; Viigimaa, Margus; Doering, Angela; Putku, Margus; Kelgo, Piret; Shaw-Hawkins, Sue; Howard, Philip; Onipinla, Abiodun; Dobson, Richard J.; Newhouse, Stephen J.; Brown, Morris; Dominiczak, Anna; Connell, John; Samani, Nilesh; Farrall, Martin; Caulfield, Mark J.; Munroe, Patricia B.; Illig, Thomas; Wichmann, H. Erich; Meitinger, Thomas; Laan, Maris		Kooperative Gesundheitsforsch; HYPertens ESTonia Study; MRC British Genet Hypertens Study	Targeting 160 Candidate Genes for Blood Pressure Regulation with a Genome-Wide Genotyping Array	PLOS ONE			English	Article								The outcome of Genome-Wide Association Studies (GWAS) has challenged the field of blood pressure (BP) genetics as previous candidate genes have not been among the top loci in these scans. We used Affymetrix 500K genotyping data of KORA S3 cohort (n = 1,644; Southern-Germany) to address (i) SNP coverage in 160 BP candidate genes; (ii) the evidence for associations with BP traits in genome-wide and replication data, and haplotype analysis. In total, 160 gene regions (genic region +/- 10 kb) covered 2,411 SNPs across 11.4 Mb. Marker densities in genes varied from 0 (n = 11) to 0.6 SNPs/kb. On average 52.5% of the HAPMAP SNPs per gene were captured. No evidence for association with BP was obtained for 1,449 tested SNPs. Considerable associations (P < 10(-3)) were detected for the genes, where > 50% of HAPMAP SNPs were tagged. In general, genes with higher marker density (> 0.2 SNPs/ kb) revealed a better chance to reach close to significance associations. Although, none of the detected P-values remained significant after Bonferroni correction (P < 0.05/2319, P < 2.15 x 10(-5)), the strength of some detected associations was close to this level: rs10889553 (LEPR) and systolic BP (SBP) (P = 4.5 x 10(-5)) as well as rs10954174 (LEP) and diastolic BP (DBP) (P = 5.20 x 10(-5)). In total, 12 markers in 7 genes (ADRA2A, LEP, LEPR, PTGER3, SLC2A1, SLC4A2, SLC8A1) revealed considerable association (P < 10(-3)) either with SBP, DBP, and/or hypertension (HYP). None of these were confirmed in replication samples (KORA S4, HYPEST, BRIGHT). However, supportive evidence for the association of rs10889553 (LEPR) and rs11195419 (ADRA2A) with BP was obtained in meta-analysis across samples stratified either by body mass index, smoking or alcohol consumption. Haplotype analysis highlighted LEPR and PTGER3. In conclusion, the lack of associations in BP candidate genes may be attributed to inadequate marker coverage on the genome-wide arrays, small phenotypic effects of the loci and/or complex interaction with life-style and metabolic parameters.			Sober, S (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	maris.laan@ut.ee	Org, Elin/AAJ-9631-2021; Newhouse, Stephen J/C-9330-2011; Meitinger, Thomas/O-1318-2015; Dominiczak, Anna F/P-9390-2017; Wichmann, Heinz Erich/AAA-5695-2022; Dobson, Richard j/C-9269-2011; Viigimaa, Margus/AAX-3864-2020; Laan, Maris/A-4100-2011; Dominiczak, Anna F/D-2262-2009	Newhouse, Stephen J/0000-0002-1843-9842; Dominiczak, Anna F/0000-0003-4913-3608; Dobson, Richard j/0000-0003-4224-9245; Laan, Maris/0000-0002-8519-243X; Meitinger, Thomas/0000-0002-8838-8403; Org, Elin/0000-0001-8688-9717; Munroe, Patricia/0000-0002-4176-2947; Org, Elin/0000-0003-1451-9375; Eyheramendy, Susana/0000-0003-4723-9660; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Viigimaa, Margus/0000-0001-5575-5978; Gieger, Christian/0000-0001-6986-9554; Caulfield, Mark/0000-0001-9295-3594; Brown, Morris/0000-0001-8409-1082	British Heart Foundation [PG02/128, FS/05/061/19501] Funding Source: Medline; Howard Hughes Medical Institute [55005617] Funding Source: Medline; Medical Research Council [G9521010D, G9521010, G0400874] Funding Source: Medline; Wellcome Trust [070191/Z/03/Z, 076113/B/04/Z] Funding Source: Medline; Medical Research Council [G9817803B] Funding Source: researchfish; MRC [G0400874, G9521010] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Breyer MD, 2000, AM J PHYSIOL-RENAL, V279, pF12, DOI 10.1152/ajprenal.2000.279.1.F12; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; de Luis DA, 2008, J DIABETES COMPLICAT, V22, P199, DOI 10.1016/j.jdiacomp.2006.10.006; Ehret GB, 2008, EUR J HUM GENET, V16, P1507, DOI 10.1038/ejhg.2008.102; Finley JC, 2004, J APPL PHYSIOL, V96, P2231, DOI 10.1152/japplphysiol.00527.2003; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Garenc C, 2002, MOL MED, V8, P88, DOI 10.1007/BF03402078; Gaukrodger N, 2005, J MED GENET, V42, P474, DOI 10.1136/jmg.2004.027631; HARRAP SB, 1994, LANCET, V344, P169, DOI 10.1016/S0140-6736(94)92762-6; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Jiao Jie, 2004, Zhonghua Nei Ke Za Zhi, V43, P276; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Koh JM, 2002, EUR J ENDOCRINOL, V147, P777, DOI 10.1530/eje.0.1470777; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LOCKETTE W, 1995, AM J HYPERTENS, V8, P390, DOI 10.1016/0895-7061(95)00024-J; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mein CA, 2004, HUM MOL GENET, V13, pR169, DOI 10.1093/hmg/ddh078; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Org E, 2009, HUM MOL GENET, V18, P2288, DOI 10.1093/hmg/ddp135; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Rosmond R, 2002, J INTERN MED, V251, P252, DOI 10.1046/j.1365-2796.2002.00961.x; Rosmond R, 2000, J CLIN ENDOCR METAB, V85, P3126, DOI 10.1210/jc.85.9.3126; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tobin MD, 2008, HYPERTENSION, V51, P1658, DOI 10.1161/HYPERTENSIONAHA.108.112664; Ukkola O, 2001, INT J OBESITY, V25, P1604, DOI 10.1038/sj.ijo.0801810; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Zhang YY, 2007, ATHEROSCLEROSIS, V191, P121, DOI 10.1016/j.atherosclerosis.2006.02.043; Zheng Y, 1999, Zhonghua Nei Ke Za Zhi, V38, P174	40	88	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6034	10.1371/journal.pone.0006034	http://dx.doi.org/10.1371/journal.pone.0006034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562039	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000267465900002
J	Fulcoli, FG; Huynh, T; Scambler, PJ; Baldini, A				Fulcoli, F. Gabriella; Huynh, Tuong; Scambler, Peter J.; Baldini, Antonio			Tbx1 Regulates the BMP-Smad1 Pathway in a Transcription Independent Manner	PLOS ONE			English	Article								Tbx1 is a T-box transcription factor implicated in DiGeorge syndrome. The molecular function of Tbx1 is unclear although it can transactivate reporters with T-box binding elements. We discovered that Tbx1 binds Smad1 and suppresses the Bmp4/Smad1 signaling. Tbx1 interferes with Smad1 to Smad4 binding, and a mutation of Tbx1 that abolishes transactivation, does not affect Smad1 binding nor does affect the ability to suppress Smad1 activity. In addition, a disease-associated mutation of TBX1 that does not prevent transactivation, prevents the TBX1-SMAD1 interaction. Expression of Tbx1 in transgenic mice generates phenotypes similar to those associated with loss of a Bmp receptor. One phenotype could be rescued by transgenic Smad1 expression. Our data indicate that Tbx1 interferes with Bmp/Smad1 signaling and provide strong evidence that a T-box transcription factor has functions unrelated to transactivation.			Fulcoli, FG (corresponding author), Telethon Inst Genet & Med, Naples, Italy.	baldini@igb.cnr.it	Fulcoli, Filomena Gabriella/B-9466-2015; Scambler, Peter/AAZ-6026-2020; genes, anthony/F-2541-2012; Scambler, Peter J/C-4998-2008; Baldini, Antonio/M-2355-2015	Fulcoli, Filomena Gabriella/0000-0003-4192-6785; Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; Baldini, Antonio/0000-0002-5330-0256	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064832] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL064832, HL064832] Funding Source: Medline; Telethon [TGM06A05] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon(Fondazione Telethon)		Ataliotis P, 2005, DEV DYNAM, V232, P979, DOI 10.1002/dvdy.20276; Baldini A, 2006, THESCIENTIFICWORLDJO, V6, P1881, DOI 10.1100/tsw.2006.317; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Brugger SM, 2004, DEVELOPMENT, V131, P5153, DOI 10.1242/dev.01390; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Choi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000395; Guris DL, 2006, DEV CELL, V10, P81, DOI 10.1016/j.devcel.2005.12.002; Hu TH, 2004, DEVELOPMENT, V131, P5491, DOI 10.1242/dev.01399; IVINS S, 2005, DEV BIOL; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Liao J, 2008, DEV BIOL, V316, P524, DOI 10.1016/j.ydbio.2008.01.037; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Macatee TL, 2003, DEVELOPMENT, V130, P6361, DOI 10.1242/dev.00850; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Messenger NJ, 2005, DEV CELL, V8, P599, DOI 10.1016/j.devcel.2005.03.001; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; MONGE JC, 1995, J BIOL CHEM, V270, P15385, DOI 10.1074/jbc.270.25.15385; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Nowotschin S, 2006, DEVELOPMENT, V133, P1565, DOI 10.1242/dev.02309; Nudi M, 2005, MOL ENDOCRINOL, V19, P1329, DOI 10.1210/me.2004-0425; Park EJ, 2006, DEVELOPMENT, V133, P2419, DOI 10.1242/dev.02367; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roberts C, 2006, HUM MOL GENET, V15, P3394, DOI 10.1093/hmg/ddl416; Stennard FA, 2005, DEVELOPMENT, V132, P4897, DOI 10.1242/dev.02099; Stottmann RW, 2004, DEVELOPMENT, V131, P2205, DOI 10.1242/dev.01086; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Vitelli F, 2009, GENESIS, V47, P188, DOI 10.1002/dvg.20476; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Xu HS, 2007, DEV BIOL, V302, P670, DOI 10.1016/j.ydbio.2006.10.002; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Zhang SX, 2005, J BIOL CHEM, V280, P19115, DOI 10.1074/jbc.M413793200; Zhang Z, 2006, DEVELOPMENT, V133, P3587, DOI 10.1242/dev.02539; Zweier C, 2007, AM J HUM GENET, V80, P510, DOI 10.1086/511993	36	72	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6049	10.1371/journal.pone.0006049	http://dx.doi.org/10.1371/journal.pone.0006049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557177	Green Published, gold, Green Submitted			2022-12-27	WOS:000267356900010
J	Kim, K; Wang, L; Hwang, I				Kim, Kwangmi; Wang, Lin; Hwang, Inkyu			A Novel Flow Cytometric High Throughput Assay for a Systematic Study on Molecular Mechanisms Underlying T Cell Receptor-Mediated Integrin Activation	PLOS ONE			English	Article								Lymphocyte function-associated antigen 1 (LFA-1), a member of beta 2-integrin family, exerts multiple roles in host T cell immunity and has been identified as a useful drug-development target for inflammatory and autoimmune diseases. Applying the findings that primary resting T cells absorb nanometric membrane vesicles derived from antigen presenting cells (APC) via dual receptor/ligand interactions of T cell receptor (TCR) with cognate peptide-major histocompatibility complex (MHC) complex (pMHC) and LFA-1 with its ligand, intercellular adhesion molecule-1 (ICAM-1), and that signaling cascades triggered by TCR/pMHC interaction take a part in the vesicle-absorption, we established a cell-based high throughput assay for systematic investigation, via isolation of small molecules modulating the level of vesicle-absorption, of molecular mechanisms underlying the T cell absorption of APC-derived vesicles, i.e., structural basis of TCR/pMHC and LFA1/ICAM-1 interactions and TCR-mediated LFA-1 activation. As primary T cells along with physiological ligands expressed in biological membrane are used and also individual cells in assay samples are analyzed by flow cytometry, results obtained using the assay system hold superior physiological and therapeutic relevance as well as statistical precision.			Kim, K (corresponding author), Scripps Res Inst, Dept Chem & Biol Chem, La Jolla, CA 92037 USA.	inkyu@scripps.edu		Hwang, Inkyu/0000-0001-8997-6090	NIAID NIH HHS [R56 AI066146, AI066146, R01 AI066146] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066146, R56AI066146] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Boswell-Smith V, 2006, BRIT J PHARMACOL, V147, pS252, DOI 10.1038/sj.bjp.0706495; BROGDEN RN, 1986, DRUGS, V32, P27, DOI 10.2165/00003495-198600324-00004; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; Chan SC, 1998, PLANTA MED, V64, P153, DOI 10.1055/s-2006-957394; CHEETHAM SC, 1993, NEUROPHARMACOLOGY, V32, P737, DOI 10.1016/0028-3908(93)90181-2; Cho HJ, 2008, J NUTR, V138, P17, DOI 10.1093/jn/138.1.17; DUSTIN ML, 1992, J IMMUNOL, V148, P2654; Edgar VA, 1998, CELL SIGNAL, V10, P721, DOI 10.1016/S0898-6568(98)00016-3; Edwards BS, 2004, CURR OPIN CHEM BIOL, V8, P392, DOI 10.1016/j.cbpa.2004.06.007; Fang NB, 1998, P NATL ACAD SCI USA, V95, P3380, DOI 10.1073/pnas.95.7.3380; FANTUS IG, 1989, BIOCHEMISTRY-US, V28, P8864, DOI 10.1021/bi00448a027; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; GOLDBERG DE, 1983, J BIOL CHEM, V258, P3159; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Hwang I, 2001, J IMMUNOL, V166, P5099, DOI 10.4049/jimmunol.166.8.5099; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Kovar M, 2006, P NATL ACAD SCI USA, V103, P11671, DOI 10.1073/pnas.0603466103; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; Kupeli E, 2002, LIFE SCI, V72, P645, DOI 10.1016/S0024-3205(02)02200-2; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Molokanova E, 2000, J GEN PHYSIOL, V115, P685, DOI 10.1085/jgp.115.6.685; Mousa SA, 2004, METH MOLEC MED, V93, P157; Nishibori M, 2003, J PHARMACOL SCI, V92, P7; Nolz JC, 2007, MOL CELL BIOL, V27, P5986, DOI 10.1128/MCB.00136-07; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; Singh N, 2004, BIOCHEMISTRY-US, V43, P14577, DOI 10.1021/bi0483561; SLATER EC, 1973, BIOCHIM BIOPHYS ACTA, V301, P129, DOI 10.1016/0304-4173(73)90002-5; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; WANGE RL, 2000, SCI STKE, pRE1; WILEMAN T, 1991, CELL REGUL, V2, P753, DOI 10.1091/mbc.2.9.753; Zipfel PA, 2006, CURR BIOL, V16, P35, DOI 10.1016/j.cub.2005.12.024	45	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6044	10.1371/journal.pone.0006044	http://dx.doi.org/10.1371/journal.pone.0006044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557182	Green Published, gold, Green Submitted			2022-12-27	WOS:000267356900006
J	Scalapino, KJ; Daikh, DI				Scalapino, Kenneth J.; Daikh, David I.			Suppression of Glomerulonephritis in NZB/NZW Lupus Prone Mice by Adoptive Transfer of Ex Vivo Expanded Regulatory T Cells	PLOS ONE			English	Article								Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown cause characterized by expansion of autoreactive lymphocytes. Regulatory T cells (T(regs)) are a component of the normal immune system and contribute to the maintenance of peripheral tolerance. T(reg) abnormalities have been associated with several autoimmune diseases and there is interest in the role of T(regs) in SLE. We previously demonstrated that transfer of expanded CD4(+)CD25(+)CD62L(HI) T(regs) slows the development of lupus in (NZBxNZW)F(1) (B/W) mice. However in the absence of T(reg) specific surface antigens, cell purification remains a compromise between the breadth and purity of the population isolated. Importantly, purified populations always contain Foxp3(-) effector T cells (T(effs)) that theoretically could exacerbate autoimmunity in the recipient. Here we explore the impact of transferring the more comprehensive, but less pure T(reg) subset defined by CD4(+)CD25(+) expression on development of murine lupus. All cells were FACS sorted and expanded prior to adoptive transfer. Development of proteinuria and survival were measured. We found that exogenous expansion of CD4(+)CD25(+) cells produced a population containing 70-85% CD4(+)Foxp3(+) T(regs). Expanded T(regs) had higher CTLA-4 and Foxp3 expression, increased in vitro suppression capacity, and prolonged in vivo survival as compared to freshly isolated cells. Adoptive transfer of expanded CD4(+)CD25(+) T(regs) inhibited the onset of glomerulonephritis and prolonged survival in mice. Importantly the population of T(eff) contained within the adoptively transferred cells had reduced survival and proliferation capacity as compared to either co-transferred T(regs) or transferred T(effs) expanded in the absence of T(regs). These studies demonstrate that adoptive transfer of expanded CD4(+)CD25(+)Foxp3(+) T(regs) has the capacity to inhibit the onset of murine lupus and that this capacity is significant despite transfer of co-cultured T(eff) cells. These data indicate that when co-expanded with regulatory T cells, exogenously activated T(effs) from autoimmune patients may not pose a significant risk of promoting disease.			Scalapino, KJ (corresponding author), San Francisco VA Med Ctr, Arthrit Sect, San Francisco, CA USA.	daikh@itsa.ucsf.edu						Alvarado-Sanchez B, 2006, J AUTOIMMUN, V27, P110, DOI 10.1016/j.jaut.2006.06.005; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bach JF, 2001, ANNU REV IMMUNOL, V19, P131, DOI 10.1146/annurev.immunol.19.1.131; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Buenafe AC, 2004, J NEUROSCI RES, V76, P129, DOI 10.1002/jnr.20066; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; Cunnane G, 2004, ARTHRITIS RHEUM-US, V50, P1539, DOI 10.1002/art.20147; Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642; Ermann J, 2001, J IMMUNOL, V167, P4271, DOI 10.4049/jimmunol.167.8.4271; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Itoh M, 1999, J IMMUNOL, V162, P5317; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; La Cava A, 2004, J IMMUNOL, V173, P3542, DOI 10.4049/jimmunol.173.5.3542; Lepault F, 2000, J IMMUNOL, V164, P240, DOI 10.4049/jimmunol.164.1.240; Liu MF, 2004, SCAND J IMMUNOL, V59, P198, DOI 10.1111/j.0300-9475.2004.01370.x; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Mekala DJ, 2005, BLOOD, V105, P2090, DOI 10.1182/blood-2004-09-3579; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Monk CR, 2005, ARTHRITIS RHEUM, V52, P1180, DOI 10.1002/art.20976; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; Qiao M, 2007, IMMUNOLOGY, V120, P447, DOI 10.1111/j.1365-2567.2007.02544.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Scalapino KJ, 2006, J IMMUNOL, V177, P1451, DOI 10.4049/jimmunol.177.3.1451; Szanya V, 2002, J IMMUNOL, V169, P2461, DOI 10.4049/jimmunol.169.5.2461; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Valencia X, 2007, J IMMUNOL, V178, P2579, DOI 10.4049/jimmunol.178.4.2579; Wu AJ, 2002, P NATL ACAD SCI USA, V99, P12287, DOI 10.1073/pnas.172382999; Wu HY, 2004, LUPUS, V13, P192, DOI 10.1191/0961203303lu1002oa	36	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6031	10.1371/journal.pone.0006031	http://dx.doi.org/10.1371/journal.pone.0006031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551149	Green Submitted, Green Published, gold			2022-12-27	WOS:000267356500015
J	Corera, AT; Doucet, G; Fon, EA				Corera, Amadou T.; Doucet, Guy; Fon, Edward A.			Long-Term Potentiation in Isolated Dendritic Spines	PLOS ONE			English	Article								Background: In brain, N-methyl-D-aspartate ( NMDA) receptor ( NMDAR) activation can induce long-lasting changes in synaptic alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptor (AMPAR) levels. These changes are believed to underlie the expression of several forms of synaptic plasticity, including long-term potentiation (LTP). Such plasticity is generally believed to reflect the regulated trafficking of AMPARs within dendritic spines. However, recent work suggests that the movement of molecules and organelles between the spine and the adjacent dendritic shaft can critically influence synaptic plasticity. To determine whether such movement is strictly required for plasticity, we have developed a novel system to examine AMPAR trafficking in brain synaptosomes, consisting of isolated and apposed pre- and postsynaptic elements. Methodology/Principal Findings: We report here that synaptosomes can undergo LTP-like plasticity in response to stimuli that mimic synaptic NMDAR activation. Indeed, KCl-evoked release of endogenous glutamate from presynaptic terminals, in the presence of the NMDAR co-agonist glycine, leads to a long-lasting increase in surface AMPAR levels, as measured by [(3)H]-AMPA binding; the increase is prevented by an NMDAR antagonist 2-amino-5-phosphonopentanoic acid (AP5). Importantly, we observe an increase in the levels of GluR1 and GluR2 AMPAR subunits in the postsynaptic density (PSD) fraction, without changes in total AMPAR levels, consistent with the trafficking of AMPARs from internal synaptosomal compartments into synaptic sites. This plasticity is reversible, as the application of AMPA after LTP depotentiates synaptosomes. Moreover, depotentiation requires proteasome-dependent protein degradation. Conclusions/Significance: Together, the results indicate that the minimal machinery required for LTP is present and functions locally within isolated dendritic spines.			Corera, AT (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada.	ted.fon@mcgill.ca						Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103; BEIQUE JC, 2006, P NATL ACAD SCI US; BERNARD J, 1992, J NEUROCHEM, V58, P387, DOI 10.1111/j.1471-4159.1992.tb09323.x; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradshaw KD, 2003, EUR J NEUROSCI, V18, P3150, DOI 10.1111/j.1460-9568.2003.03054.x; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Feligioni M, 2006, J NEUROCHEM, V99, P549, DOI 10.1111/j.1471-4159.2006.04087.x; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Guo L, 2007, NEUROSCIENCE, V145, P100, DOI 10.1016/j.neuroscience.2006.11.042; Hunt CA, 1996, J NEUROSCI, V16, P1380; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Liang F, 2001, J NEUROCHEM, V77, P1626, DOI 10.1046/j.1471-4159.2001.00377.x; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MASSICOTTE G, 1990, MOL PHARMACOL, V37, P278; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Newpher TM, 2009, TRENDS CELL BIOL; NICHOLS RA, 1990, NATURE, V343, P647, DOI 10.1038/343647a0; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; RAO A, 1991, J NEUROSCI, V11, P2881; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Vaithianathan H, 2005, CELL BIOCHEM BIOPHYS, V42, P75, DOI 10.1385/CBB:42:1:075; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	55	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6021	10.1371/journal.pone.0006021	http://dx.doi.org/10.1371/journal.pone.0006021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547754	Green Submitted, Green Published, gold			2022-12-27	WOS:000267347900016
J	Ihalainen, TO; Niskanen, EA; Jylhava, J; Paloheimo, O; Dross, N; Smolander, H; Langowski, J; Timonen, J; Vihinen-Ranta, M				Ihalainen, Teemu O.; Niskanen, Einari A.; Jylhava, Juulia; Paloheimo, Outi; Dross, Nicolas; Smolander, Hanna; Langowski, Jorg; Timonen, Jussi; Vihinen-Ranta, Maija			Parvovirus Induced Alterations in Nuclear Architecture and Dynamics	PLOS ONE			English	Article								The nucleus of interphase eukaryotic cell is a highly compartmentalized structure containing the three-dimensional network of chromatin and numerous proteinaceous subcompartments. DNA viruses induce profound changes in the intranuclear structures of their host cells. We are applying a combination of confocal imaging including photobleaching microscopy and computational methods to analyze the modifications of nuclear architecture and dynamics in parvovirus infected cells. Upon canine parvovirus infection, expansion of the viral replication compartment is accompanied by chromatin marginalization to the vicinity of the nuclear membrane. Dextran microinjection and fluorescence recovery after photobleaching (FRAP) studies revealed the homogeneity of this compartment. Markedly, in spite of increase in viral DNA content of the nucleus, a significant increase in the protein mobility was observed in infected compared to non-infected cells. Moreover, analyzis of the dynamics of photoactivable capsid protein demonstrated rapid intranuclear dynamics of viral capsids. Finally, quantitative FRAP and cellular modelling were used to determine the duration of viral genome replication. Altogether, our findings indicate that parvoviruses modify the nuclear structure and dynamics extensively. Intranuclear crowding of viral components leads to enlargement of the interchromosomal domain and to chromatin marginalization via depletion attraction. In conclusion, parvoviruses provide a useful model system for understanding the mechanisms of virus-induced intranuclear modifications.			Ihalainen, TO (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, NanoSci Ctr, Jyvaskyla, Finland.	maija.vihinen-ranta@jyu.fi	Ihalainen, Teemu/C-9500-2016; Niskanen, Einari A/F-2883-2017; Niskanen, Einari/O-1379-2019; Langowski, Jörg/A-1843-2011	Niskanen, Einari A/0000-0001-9471-7026; Langowski, Jörg/0000-0001-8600-0666; Vihinen-Ranta, Maija/0000-0003-0959-1153; Ihalainen, Teemu/0000-0003-4351-8697; Jylhava, Juulia/0000-0003-0250-4491				Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; Bashir T, 2001, J VIROL, V75, P4394, DOI 10.1128/JVI.75.9.4394-4398.2001; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Blissard GW, 1996, CYTOTECHNOLOGY, V20, P73, DOI 10.1007/BF00350390; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Braga J, 2007, BIOPHYS J, V92, P2694, DOI 10.1529/biophysj.106.096693; Carter DRF, 2008, BIOCHEM SOC T, V36, P585, DOI 10.1042/BST0360585; Christensen J, 1997, J VIROL, V71, P1405, DOI 10.1128/JVI.71.2.1405-1416.1997; Christensen J, 2002, J VIROL, V76, P6518, DOI 10.1128/JVI.76.13.6518-6531.2002; CHRISTENSEN J, 1995, J VIROL, V69, P5422, DOI 10.1128/JVI.69.9.5422-5430.1995; Christensen J, 2001, J VIROL, V75, P7009, DOI 10.1128/JVI.75.15.7009-7017.2001; Cotmore SF, 2005, J VIROL, V79, P2287, DOI 10.1128/JVI.79.4.2287-2300.2005; COTMORE SF, 1995, J VIROL, V69, P1652, DOI 10.1128/JVI.69.3.1652-1660.1995; Cotmore SF, 2007, J VIROL, V81, P13015, DOI 10.1128/JVI.01703-07; Cremer C, 1996, MUTAT RES-REV GENET, V366, P97, DOI 10.1016/S0165-1110(96)90031-7; Cremer T, 2000, CRIT REV EUKAR GENE, V10, P179; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Cziepluch C, 2000, J VIROL, V74, P4807, DOI 10.1128/JVI.74.10.4807-4815.2000; Daikoku T, 2006, J BIOL CHEM, V281, P11422, DOI 10.1074/jbc.M510314200; de Oliveira AP, 2008, J VIROL, V82, P4974, DOI 10.1128/JVI.02431-07; Dross N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005041; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Gilbert L, 2004, BIOCHEM BIOPH RES CO, V313, P878, DOI 10.1016/j.bbrc.2003.11.176; Gilbert Leona, 2006, J Nanobiotechnology, V4, P13, DOI 10.1186/1477-3155-4-13; Gorisch SM, 2005, J CELL SCI, V118, P5825, DOI 10.1242/jcs.02689; Gorisch SM, 2004, P NATL ACAD SCI USA, V101, P13221, DOI 10.1073/pnas.0402958101; Gorisch SM, 2003, EXP CELL RES, V289, P282, DOI 10.1016/S0014-4827(03)00265-9; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hauck B, 2004, J VIROL, V78, P13678, DOI 10.1128/JVI.78.24.13678-13686.2004; Ihalainen TO, 2007, CELL MICROBIOL, V9, P1946, DOI 10.1111/j.1462-5822.2007.00926.x; Iwahori S, 2004, J GEN VIROL, V85, P2857, DOI 10.1099/vir.0.80114-0; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Janicki SM, 2003, CURR OPIN CELL BIOL, V15, P149, DOI 10.1016/S0955-0674(03)00012-7; JINDAL HK, 1994, J BIOL CHEM, V269, P3283; Kues T, 2001, BIOPHYS J, V80, P2954, DOI 10.1016/S0006-3495(01)76261-3; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Marenduzzo D, 2006, J CELL BIOL, V175, P681, DOI 10.1083/jcb.200609066; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Monier K, 2000, NAT CELL BIOL, V2, P661, DOI 10.1038/35023615; MULLER DE, 1983, J GEN VIROL, V64, P1055, DOI 10.1099/0022-1317-64-5-1055; Nagamine T, 2008, J VIROL, V82, P6409, DOI 10.1128/JVI.00490-08; Naryzhny SN, 2005, J BIOL CHEM, V280, P13888, DOI 10.1074/jbc.M500304200; Nash K, 2007, J VIROL, V81, P5777, DOI 10.1128/JVI.02651-06; Norio P, 2004, PLOS BIOL, V2, P816, DOI 10.1371/journal.pbio.0020152; NUESCH JPF, 1995, VIROLOGY, V209, P122, DOI 10.1006/viro.1995.1236; Oh J, 2008, J VIROL, V82, P3530, DOI 10.1128/JVI.00586-07; Parker JSL, 1997, J VIROL, V71, P9214, DOI 10.1128/JVI.71.12.9214-9222.1997; Parker JSL, 2001, J VIROL, V75, P3896, DOI 10.1128/JVI.75.8.3896-3902.2001; PARRISH CR, 1991, VIROLOGY, V183, P195, DOI 10.1016/0042-6822(91)90132-U; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; REED AP, 1988, J VIROL, V62, P266, DOI 10.1128/JVI.62.1.266-276.1988; Richter K, 2008, BBA-MOL CELL RES, V1783, P2100, DOI 10.1016/j.bbamcr.2008.07.017; Riolobos L, 2006, J MOL BIOL, V357, P1026, DOI 10.1016/j.jmb.2006.01.019; SAXTON MJ, 1989, BIOPHYS J, V56, P615, DOI 10.1016/S0006-3495(89)82708-0; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Solomon DA, 2004, J CELL BIOL, V166, P455, DOI 10.1083/jcb.200312048; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Suikkanen S, 2002, J VIROL, V76, P4401, DOI 10.1128/JVI.76.9.4401-4411.2002; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; TSAO J, 1991, SCIENCE, V251, P1456, DOI 10.1126/science.2006420; Tseng Y, 2004, J CELL SCI, V117, P2159, DOI 10.1242/jcs.01073; Verschure PJ, 2003, EMBO REP, V4, P861, DOI 10.1038/sj.embor.embor922; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wedemeier A, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2753158; Weitzman MD, 2004, DNA REPAIR, V3, P1165, DOI 10.1016/j.dnarep.2004.03.018; YAMASHITA T, 1975, J BIOL CHEM, V250, P3273; Young PJ, 2005, J GEN VIROL, V86, P1009, DOI 10.1099/vir.0.80564-0; Zeskind BJ, 2007, NAT METHODS, V4, P567, DOI 10.1038/NMETH1053	76	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5948	10.1371/journal.pone.0005948	http://dx.doi.org/10.1371/journal.pone.0005948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536327	gold, Green Submitted, Green Published			2022-12-27	WOS:000267029700018
J	Nickerson, DW; Presson, AP; Weigt, SS; Gregson, AL; Belperio, JA; Gomperts, BN				Nickerson, Derek W.; Presson, Angela P.; Weigt, Stephen S.; Gregson, Aric L.; Belperio, John A.; Gomperts, Brigitte N.			Quantification of Cytokeratin 5 mRNA Expression in the Circulation of Healthy Human Subjects and after Lung Transplantation	PLOS ONE			English	Article							BASAL-CELLS; BONE-MARROW; EPITHELIAL-CELLS; MULTIPOTENT; CHIMERISM	Background: Circulating epithelial progenitor cells are important for repair of the airway epithelium in a mouse model of tracheal transplantation. We therefore hypothesized that circulating epithelial progenitor cells would also be present in normal human subjects and could be important for repair of the airway after lung injury. As lung transplantation is associated with lung injury, which is severe early on and exacerbated during episodes of infection and rejection, we hypothesized that circulating epithelial progenitor cell levels could predict clinical outcome following lung transplantation. Methodology/Principal Findings: Quantitative Real Time PCR was performed to determine peripheral blood mRNA levels of cytokeratin 5, a previously characterized marker of circulating epithelial progenitor cells. Cytokeratin 5 levels were evaluated in healthy human subjects, in lung transplant recipients immediately post-transplant and serially thereafter, and in heart transplant recipients. All normal human subjects examined expressed cytokeratin 5 in their buffy coat in amounts that were not significantly influenced by age or gender. There was a profound, statistically significant decrease in cytokeratin 5 mRNA expression levels in lung transplant patients compared to healthy human subjects (p = 3.1 x 10(-13)) and to heart transplant recipients. There was a moderate negative correlation between improved circulating cytokeratin 5 mRNA levels in lung transplant recipients with recovering lung function, as measured by improved FEV1 values (rho = -0.39). Conclusions/Significance: Levels of cytokeratin 5 mRNA, a proxy marker for circulating epithelial progenitor cells, inversely correlated with disease status in lung transplant recipients. It may therefore serve as a biomarker of the clinical outcome of lung transplant patients and potentially other patients with airway injury.			Nickerson, DW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Hematol Oncol,Mattel Childrens Hosp, Los Angeles, CA 90095 USA.	bgomperts@mednet.ucla.edu		Gregson, Aric/0000-0001-6806-0868	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL074229] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL074229, 1 K08 HL074229-01A2] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Borthwick DW, 2001, AM J RESP CELL MOL, V24, P662, DOI 10.1165/ajrcmb.24.6.4217; ENGELHARDT JF, 1995, DEVELOPMENT, V121, P2031; Gomperts BN, 2006, J IMMUNOL, V176, P1916, DOI 10.4049/jimmunol.176.3.1916; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Kleeberger W, 2003, AM J PATHOL, V162, P1487, DOI 10.1016/S0002-9440(10)64281-2; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Kotton DN, 2005, AM J RESP CELL MOL, V33, P328, DOI 10.1165/rcmb.2005-0175RC; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mattson J, 2004, TRANSPLANTATION, V78, P154, DOI 10.1097/01.TP.0000132326.08628.74; Schoch KG, 2004, AM J PHYSIOL-LUNG C, V286, pL631, DOI 10.1152/ajplung.00112.2003; Suratt BT, 2003, AM J RESP CRIT CARE, V168, P318, DOI 10.1164/rccm.200301-145OC	14	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5925	10.1371/journal.pone.0005925	http://dx.doi.org/10.1371/journal.pone.0005925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529775	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029500007
J	Vernia, S; Rubio, T; Heredia, M; de Cordoba, SR; Sanz, P				Vernia, Santiago; Rubio, Teresa; Heredia, Miguel; Rodriguez de Cordoba, Santiago; Sanz, Pascual			Increased Endoplasmic Reticulum Stress and Decreased Proteasomal Function in Lafora Disease Models Lacking the Phosphatase Laforin	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; DUAL-SPECIFICITY PHOSPHATASE; GLYCOGEN-SYNTHESIS; INCLUSION-BODIES; UBIQUITIN-LIGASE; MALIN; DEGRADATION; PATHWAYS; PROTEINS; COMPLEX	Background: Lafora progressive myoclonus epilepsy (Lafora disease; LD) is a fatal autosomal recessive neurodegenerative disorder caused by loss-of-function mutations in either the EPM2A gene, encoding the dual specificity phosphatase laforin, or the EPM2B gene, encoding the E3-ubiquitin ligase malin. Previously, we and others have shown that both proteins form a functional complex that regulates glycogen synthesis by a novel mechanism involving ubiquitination and proteasomal degradation of at least two proteins, glycogen synthase and R5/PTG. Since laforin and malin localized at the endoplasmic reticulum (ER) and their regulatory role likely extend to other proteins unrelated to glycogen metabolism, we postulated that their absence may also affect the ER-unfolded protein response pathway. Methodology/Principal Findings: Here, we demonstrate that siRNA silencing of laforin in Hek293 and SH-SY5Y cells increases their sensitivity to agents triggering ER-stress, which correlates with impairment of the ubiquitin-proteasomal pathway and increased apoptosis. Consistent with these findings, analysis of tissue samples from a LD patient lacking laforin, and from a laforin knockout (Epm2a-/-) mouse model of LD, demonstrates constitutive high expression levels of ER-stress markers BIP/Grp78, CHOP and PDI, among others. Conclusions/Significance: We demonstrate that, in addition to regulating glycogen synthesis, laforin and malin play a role protecting cells from ER-stress, likely contributing to the elimination of unfolded proteins. These data suggest that proteasomal dysfunction and ER-stress play an important role in the pathogenesis of LD, which may offer novel therapeutic approaches for this fatal neurodegenerative disorder.	[Vernia, Santiago; Rubio, Teresa; Heredia, Miguel; Sanz, Pascual] CSIC, Inst Biomed Valencia, Valencia, Spain; [Vernia, Santiago; Rubio, Teresa; Heredia, Miguel; Sanz, Pascual] CIBER Enfermedades Raras CIBERER, Valencia, Spain; [Rodriguez de Cordoba, Santiago] CSIC, Ctr Invest Biol, Madrid, Spain; [Rodriguez de Cordoba, Santiago] CIBER Enfermedades Raras CIBERER, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Sanz, P (corresponding author), CSIC, Inst Biomed Valencia, Valencia, Spain.	sanz@ibv.csic.es	Vernia, Santiago/Q-7038-2017; Sanz, Pascual/K-2751-2014; de Cordoba, Santiago Rodriguez/K-6727-2014; Rubio, Teresa/ABC-6384-2020	Vernia, Santiago/0000-0001-6728-5555; Sanz, Pascual/0000-0002-2399-4103; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Rubio, Teresa/0000-0003-0843-528X				Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chan EM, 2004, NEUROLOGY, V63, P565, DOI 10.1212/01.WNL.0000133215.65836.03; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; Dikshit P, 2007, BIOCHEM BIOPH RES CO, V357, P761, DOI 10.1016/j.bbrc.2007.04.018; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gomez-Garre P, 2007, NEUROLOGY, V68, P1369, DOI 10.1212/01.wnl.0000260061.37559.67; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Ianzano L, 2004, HUM MUTAT, V23, P170, DOI 10.1002/humu.10306; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2000, NEUROLOGY, V55, P341, DOI 10.1212/WNL.55.3.341; Mittal S, 2007, HUM MOL GENET, V16, P753, DOI 10.1093/hmg/ddm006; Paschen W, 2003, CELL CALCIUM, V34, P365, DOI 10.1016/S0143-4160(03)00139-8; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Seki T, 2007, EUR J NEUROSCI, V26, P3126, DOI 10.1111/j.1460-9568.2007.05933.x; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang Y, 2008, CANCER RES, V68, P4039, DOI 10.1158/0008-5472.CAN-07-6314; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; YOKOI S, 1975, CLIN CHIM ACTA, V62, P415; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	42	59	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5907	10.1371/journal.pone.0005907	http://dx.doi.org/10.1371/journal.pone.0005907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529779	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029500005
J	Novak, CM; Escande, C; Gerber, SM; Chini, EN; Zhang, M; Britton, SL; Koch, LG; Levine, JA				Novak, Colleen M.; Escande, Carlos; Gerber, Susan M.; Chini, Eduardo N.; Zhang, Minzhi; Britton, Steven L.; Koch, Lauren G.; Levine, James A.			Endurance Capacity, Not Body Size, Determines Physical Activity Levels: Role of Skeletal Muscle PEPCK	PLOS ONE			English	Article								Some people remain lean despite pressure to gain weight. Lean people tend to have high daily activity levels, but the source of this increased activity is unknown. We found that leanness cannot be accounted for by increased weight-corrected food intake in two different types of lean rats. As previously reported in lean people, we found that lean rats had higher daily activity levels; lean rats also expended more energy. These lean rats were developed through artificial selection for high aerobic endurance capacity. To test whether our findings extended to a human population, we measured endurance capacity using a VO(2max) treadmill test and daily activity in a group of non-exercising individuals. Similar to lean rats selectively bred for endurance capacity, our study revealed that people with higher VO(2max) also spent more time active throughout the day. Hence, endurance capacity may be the trait that underlies both physical activity levels and leanness. We identified one potential mechanism for the lean, active phenotype in rats, namely high levels of skeletal muscle PEPCK. Therefore, the lean phenotype is characterized by high endurance capacity and high activity and may stem from altered skeletal muscle energetics.			Novak, CM (corresponding author), Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA.	novak.colleen@mayo.edu	Koch, Lauren/D-1258-2010	Novak, Colleen/0000-0002-8542-1677	NCRR NIH HHS [RR17718, R24 RR017718] Funding Source: Medline; NIDDK NIH HHS [R01 DK066270, R01 DK063226, DK66270, DK63226, R01 DK056650, DK56650] Funding Source: Medline; NINDS NIH HHS [NS55859] Funding Source: Medline; PHS HHS [R04-0771] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056650, R01DK063226, R01DK066270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055859] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; Brochu M, 1999, J CLIN ENDOCR METAB, V84, P3872, DOI 10.1210/jc.84.11.3872; Calsbeek R, 2007, EVOLUTION, V61, P2493, DOI 10.1111/j.1558-5646.2007.00206.x; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hambly C, 2005, OBES RES, V13, P556, DOI 10.1038/oby.2005.59; Hanson RW, 2008, BIOCHIMIE, V90, P838, DOI 10.1016/j.biochi.2008.03.009; Heini AF, 1997, AM J MED, V102, P259, DOI 10.1016/S0002-9343(96)00456-1; Hudson NJ, 2008, MED HYPOTHESES, V70, P693, DOI 10.1016/j.mehy.2007.05.042; Hunter GR, 2005, EUR J APPL PHYSIOL, V94, P558, DOI 10.1007/s00421-005-1370-z; Hunter GR, 2004, INT J OBESITY, V28, P1111, DOI 10.1038/sj.ijo.0802724; Johannsen DL, 2008, OBESITY, V16, P34, DOI 10.1038/oby.2007.15; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; LESHNER AI, 1972, PHYSIOL BEHAV, V9, P281, DOI 10.1016/0031-9384(72)90251-X; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Levine JA, 2005, ACTA PHYSIOL SCAND, V184, P309, DOI 10.1111/j.1365-201X.2005.01467.x; Levine JA, 2003, P NUTR SOC, V62, P667, DOI 10.1079/PNS2003281; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; Lucia A, 2002, MED SCI SPORT EXER, V34, P2079, DOI 10.1249/01.MSS.0000039306.92778.DF; Meijer EP, 2000, INT J SPORTS MED, V21, P499, DOI 10.1055/s-2000-7419; Meijer EP, 1999, EUR J APPL PHYSIOL O, V80, P16, DOI 10.1007/s004210050552; Meijer EP, 2001, INT J OBESITY, V25, P935, DOI 10.1038/sj.ijo.0801644; NEEL JV, 1962, AM J HUM GENET, V14, P353; Noakes TD, 2004, MED SCI SPORT EXER, V36, P1083, DOI 10.1249/01.MSS.0000128140.85727.2D; NOAKES TD, 2004, MED SCI SPORTS EXERC, V36, P1085; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE31, DOI 10.1152/ajpendo.00500.2006; Novak CM, 2007, J NEUROENDOCRINOL, V19, P923, DOI 10.1111/j.1365-2826.2007.01606.x; Novak CM, 2006, AM J PHYSIOL-ENDOC M, V290, pE396, DOI 10.1152/ajpendo.00293.2005; PATE RR, 1992, MED SCI SPORT EXER, V24, P1128; Popkin BM, 1996, NEW ENGL J MED, V335, P716, DOI 10.1056/NEJM199609053351006; Prentice AM, 2008, INT J OBESITY, V32, P1607, DOI 10.1038/ijo.2008.147; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; ROBERTS SB, 1988, NEW ENGL J MED, V318, P461, DOI 10.1056/NEJM198802253180801; SALTZMAN E, 1995, NUTR REV, V53, P209, DOI 10.1111/j.1753-4887.1995.tb01554.x; SIMS EAH, 1968, AM J CLIN NUTR, V21, P1455, DOI 10.1093/ajcn/21.12.1455; Speakman JR, 2008, INT J OBESITY, V32, P1611, DOI 10.1038/ijo.2008.161; Stratton E, 2009, INT J SPORTS MED, V30, P40, DOI 10.1055/s-2008-1038761; Teske JA, 2006, AM J PHYSIOL-REG I, V291, pR889, DOI 10.1152/ajpregu.00536.2005; Tidhar WL, 2007, HORM BEHAV, V52, P436, DOI 10.1016/j.yhbeh.2007.06.009; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; WEINSIER RL, 1995, J CLIN INVEST, V95, P980, DOI 10.1172/JCI117807; Weinsier RL, 2003, OBES RES, V11, P937, DOI 10.1038/oby.2003.129; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177	44	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5869	10.1371/journal.pone.0005869	http://dx.doi.org/10.1371/journal.pone.0005869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521512	gold, Green Published, Green Submitted			2022-12-27	WOS:000267029100002
J	Selcho, M; Pauls, D; Han, KA; Stocker, RF; Thum, AS				Selcho, Mareike; Pauls, Dennis; Han, Kyung-An; Stocker, Reinhard F.; Thum, Andreas S.			The Role of Dopamine in Drosophila Larval Classical Olfactory Conditioning	PLOS ONE			English	Article							CATECHOLAMINE-CONTAINING NEURONS; CANDIDATE TASTE RECEPTORS; TARGETED GENE-EXPRESSION; MUSHROOM BODIES; BIOGENIC-AMINES; FUNCTIONAL-CHARACTERIZATION; DECARBOXYLASE GENE; MOLECULAR-BIOLOGY; FEEDING-BEHAVIOR; NERVOUS-SYSTEM	Learning and memory is not an attribute of higher animals. Even Drosophila larvae are able to form and recall an association of a given odor with an aversive or appetitive gustatory reinforcer. As the Drosophila larva has turned into a particularly simple model for studying odor processing, a detailed neuronal and functional map of the olfactory pathway is available up to the third order neurons in the mushroom bodies. At this point, a convergence of olfactory processing and gustatory reinforcement is suggested to underlie associative memory formation. The dopaminergic system was shown to be involved in mammalian and insect olfactory conditioning. To analyze the anatomy and function of the larval dopaminergic system, we first characterize dopaminergic neurons immunohistochemically up to the single cell level and subsequent test for the effects of distortions in the dopamine system upon aversive (odor-salt) as well as appetitive (odor-sugar) associative learning. Single cell analysis suggests that dopaminergic neurons do not directly connect gustatory input in the larval suboesophageal ganglion to olfactory information in the mushroom bodies. However, a number of dopaminergic neurons innervate different regions of the brain, including protocerebra, mushroom bodies and suboesophageal ganglion. We found that dopamine receptors are highly enriched in the mushroom bodies and that aversive and appetitive olfactory learning is strongly impaired in dopamine receptor mutants. Genetically interfering with dopaminergic signaling supports this finding, although our data do not exclude on naive odor and sugar preferences of the larvae. Our data suggest that dopaminergic neurons provide input to different brain regions including protocerebra, suboesophageal ganglion and mushroom bodies by more than one route. We therefore propose that different types of dopaminergic neurons might be involved in different types of signaling necessary for aversive and appetitive olfactory memory formation respectively, or for the retrieval of these memory traces. Future studies of the dopaminergic system need to take into account such cellular dissociations in function in order to be meaningful.			Selcho, M (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	andreas.thum@unifr.ch	Thum, Andreas S/B-1083-2013	Selcho, Mareike/0000-0002-6405-2972; Pauls, Dennis/0000-0001-8330-8120; Thum, Andreas/0000-0002-3830-6596				Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Armstrong JD, 1998, LEARN MEMORY, V5, P102; Bachmann A, 2004, J CELL SCI, V117, P1899, DOI 10.1242/jcs.01029; Bader R, 2007, J COMP NEUROL, V502, P848, DOI 10.1002/cne.21342; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BEALL CJ, 1987, GENE DEV, V1, P510, DOI 10.1101/gad.1.5.510; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; BUDNIK V, 1986, J NEUROSCI, V6, P3682; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Colomb J, 2007, J COMP NEUROL, V502, P834, DOI 10.1002/cne.21312; CRAYMER L, 1984, GENETICS, V108, P573; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; DAMBLYCHAUDIERE C, 1992, INT J DEV BIOL, V36, P85; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Diegelmann S, 2002, GENESIS, V34, P95, DOI 10.1002/gene.10112; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Farooqui T, 2004, J INSECT PHYSIOL, V50, P701, DOI 10.1016/j.jinsphys.2004.04.014; Feng GP, 1996, J NEUROSCI, V16, P3925; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gendre N, 2004, DEVELOPMENT, V131, P83, DOI 10.1242/dev.00879; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Gerber B, 2006, P ROY SOC B-BIOL SCI, V273, P2965, DOI 10.1098/rspb.2006.3673; GOTZES F, 1994, RECEPTOR CHANNEL, V2, P131; Greer CL, 2005, J NEUROBIOL, V64, P239, DOI 10.1002/neu.20146; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hammer M, 1998, LEARN MEMORY, V5, P146; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Homberg U, 2002, MICROSC RES TECHNIQ, V56, P189, DOI 10.1002/jemt.10024; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Ishimoto H, 2004, CELL MOL LIFE SCI, V61, P10, DOI 10.1007/s00018-003-3182-9; Ito K, 1998, LEARN MEMORY, V5, P52; Iyengar BG, 2006, J COMP NEUROL, V499, P583, DOI 10.1002/cne.21133; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Jones Daryl, 2005, J Intensive Care Med, V20, P199, DOI 10.1177/0885066605276963; Kaun KR, 2007, LEARN MEMORY, V14, P342, DOI 10.1101/lm.505807; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KONRAD KD, 1987, DEV BIOL, V122, P172, DOI 10.1016/0012-1606(87)90343-5; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001391; Lee T, 1999, DEVELOPMENT, V126, P4065; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MACMILLAN CS, 1987, J COMP PHYSIOL A, V160, P359, DOI 10.1007/BF00613025; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Masuda-Nakagawa LM, 2005, P NATL ACAD SCI USA, V102, P19027, DOI 10.1073/pnas.0509643102; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Menzel R, 1999, BEHAV NEUROSCI, V113, P744, DOI 10.1037/0735-7044.113.4.744; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; Michels B, 2005, LEARN MEMORY, V12, P224, DOI 10.1101/lm.92805; MICHELSEN DB, 1988, COMP BIOCHEM PHYS C, V91, P479, DOI 10.1016/0742-8413(88)90063-1; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; Olsen SR, 2008, TRENDS NEUROSCI, V31, P512, DOI 10.1016/j.tins.2008.07.006; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Roeder T, 2002, MICROSC RES TECHNIQ, V56, P237, DOI 10.1002/jemt.10027; Scherer S, 2003, LEARN MEMORY, V10, P217, DOI 10.1101/lm.57903; Schroeter U, 2007, CELL TISSUE RES, V327, P647, DOI 10.1007/s00441-006-0197-1; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Vomel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001848; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5; Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131; Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	111	132	134	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5897	10.1371/journal.pone.0005897	http://dx.doi.org/10.1371/journal.pone.0005897			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458MW	19521527	gold, Green Published			2022-12-27	WOS:000267029100012
J	Muzumdar, RH; Huffman, DM; Atzmon, G; Buettner, C; Cobb, LJ; Fishman, S; Budagov, T; Cui, LG; Einstein, FH; Poduval, A; Hwang, D; Barzilai, N; Cohen, P				Muzumdar, Radhika H.; Huffman, Derek M.; Atzmon, Gil; Buettner, Christoph; Cobb, Laura J.; Fishman, Sigal; Budagov, Temuri; Cui, Lingguang; Einstein, Francine H.; Poduval, Aruna; Hwang, David; Barzilai, Nir; Cohen, Pinchas			Humanin: A Novel Central Regulator of Peripheral Insulin Action	PLOS ONE			English	Article								Background: Decline in insulin action is a metabolic feature of aging and is involved in the development of age-related diseases including Type 2 Diabetes Mellitus (T2DM) and Alzheimer's disease (AD). A novel mitochondria-associated peptide, Humanin (HN), has a neuroprotective role against AD-related neurotoxicity. Considering the association between insulin resistance and AD, we investigated if HN influences insulin sensitivity. Methods and Findings: Using state of the art clamp technology, we examined the role of central and peripheral HN on insulin action. Continuous infusion of HN intra-cerebro-ventricularly significantly improved overall insulin sensitivity. The central effects of HN on insulin action were associated with activation of hypothalamic STAT-3 signaling; effects that were negated by co-inhibition of hypothalamic STAT-3. Peripheral intravenous infusions of novel and potent HN derivatives reproduced the insulin-sensitizing effects of central HN. Inhibition of hypothalamic STAT-3 completely negated the effects of IV HN analog on liver, suggesting that the hepatic actions of HN are centrally mediated. This is consistent with the lack of a direct effect of HN on primary hepatocytes. Furthermore, single treatment with a highly-potent HN analog significantly lowered blood glucose in Zucker diabetic fatty rats. Based upon the link of HN with two age-related diseases, we examined if there were age associated changes in HN levels. Indeed, the amount of detectable HN in hypothalamus, skeletal muscle, and cortex was decreased with age in rodents, and circulating levels of HN were decreased with age in humans and mice. Conclusions: We conclude that the decline in HN with age could play a role in the pathogenesis of age-related diseases including AD and T2DM. HN represents a novel link between T2DM and neurodegeneration and along with its analogues offers a potential therapeutic tool to improve insulin action and treat T2DM.			Muzumdar, RH (corresponding author), Childrens Hosp Montefiore, Dept Pediat, Inst Aging Res, Diabet Res & Training Ctr,Albert Einstein Coll Me, Bronx, NY 10467 USA.	barzilai@aecom.yu.edu	Buettner, Christoph/F-5793-2013; Muzumdar, Radhika/D-9860-2014	Buettner, Christoph/0000-0003-0412-4062; 	NCI NIH HHS [R01 CA100938] Funding Source: Medline; NIA NIH HHS [T32 AG23475, K08 AG027462, R01 AG018381, R01 AG18381, P01 AG021654, T32 AG023475] Funding Source: Medline; NICHD NIH HHS [R01 HD047013] Funding Source: Medline; NIDDK NIH HHS [P60 DK020541, P60 DK20541, P30 DK063491, R01 DK083658] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047013] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA100938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK083658, P60DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023475, K08AG027462, P01AG021654, R01AG018381] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; BUETTNER C, 2006, CRITICAL ROLE STAT3, P49; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; Duanmu Z, 1999, CLIN EXP HYPERTENS, V21, P1239, DOI 10.3109/10641969909070847; FREDERIKSEN AL, 2009, J CLIN ENDOCRINOL ME; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Harada M, 2004, BIOCHEM BIOPH RES CO, V324, P255, DOI 10.1016/j.bbrc.2004.09.046; Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2004, EUR J NEUROSCI, V19, P2357, DOI 10.1111/j.1460-9568.2004.03298.x; Hashimoto Y, 2003, J NEUROCHEM, V84, P864, DOI 10.1046/j.1471-4159.2003.01585.x; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; HASHIMOTO Y, 2009, MOL BIOL CELL; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Jung SS, 2003, J NEUROCHEM, V84, P266, DOI 10.1046/j.1471-4159.2003.01524.x; Kariya S, 2002, NEUROREPORT, V13, P903, DOI 10.1097/00001756-200205070-00034; Kim HS, 2007, PEDIATR RES, V61, P159, DOI 10.1203/pdr.0b013e31802d8a30; Leffert H L, 1979, Methods Enzymol, V58, P536; Li ZG, 2007, DIABETES, V56, P1817, DOI 10.2337/db07-0171; Liu BR, 2000, J BIOL CHEM, V275, P33607, DOI 10.1074/jbc.M002547200; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Mamiya T, 2001, BRIT J PHARMACOL, V134, P1597, DOI 10.1038/sj.bjp.0704429; Miao JT, 2008, NEUROPEPTIDES, V42, P557, DOI 10.1016/j.npep.2008.08.004; Muzumdar R, 2003, FASEB J, V17, P1130, DOI 10.1096/fj.02-0991fje; Muzumdar RH, 2006, DIABETES, V55, P2788, DOI 10.2337/db06-0318; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Rensink AAM, 2002, ACTA NEUROPATHOL, V104, P525, DOI 10.1007/s00401-002-0585-x; Richards Robert J, 2003, Curr Cardiol Rep, V5, P453, DOI 10.1007/s11886-003-0106-0; Sponne I, 2004, MOL CELL NEUROSCI, V25, P95, DOI 10.1016/j.mcn.2003.09.017; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; Tajima H, 2005, J NEUROSCI RES, V79, P714, DOI 10.1002/jnr.20391; Terashita K, 2003, J NEUROCHEM, V85, P1521, DOI 10.1046/j.1471-4159.2003.01797.x; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Wang D, 2005, APOPTOSIS, V10, P963, DOI 10.1007/s10495-005-1191-x; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f	42	165	172	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6334	10.1371/journal.pone.0006334	http://dx.doi.org/10.1371/journal.pone.0006334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623253	gold, Green Published, Green Submitted			2022-12-27	WOS:000268260100012
J	Kobayashi, T; Washiyama, K; Ikeda, K				Kobayashi, Toru; Washiyama, Kazuo; Ikeda, Kazutaka			Pregnenolone Sulfate Potentiates the Inwardly Rectifying K+ Channel Kir2.3	PLOS ONE			English	Article								Background: Neurosteroids have various physiological and neuropsychopharmacological effects. In addition to the genomic effects of steroids, some neurosteroids modulate several neurotransmitter receptors and channels, such as N-methyl-D-aspartate receptors, gamma-aminobutyric acid type A (GABA(A)) receptors, and sigma(1) receptors, and voltage-gated Ca2+ and K+ channels. However, the molecular mechanisms underlying the various effects of neurosteroids have not yet been sufficiently clarified. In the nervous system, inwardly rectifying K+ (Kir) channels also play important roles in the control of resting membrane potential, cellular excitability and K+ homeostasis. Among constitutively active Kir2 channels in a major Kir subfamily, Kir2.3 channels are expressed predominantly in the forebrain, a brain area related to cognition, memory, emotion, and neuropsychiatric disorders. Methodology/Principal Findings: The present study examined the effects of various neurosteroids on Kir2.3 channels using the Xenopus oocyte expression assay. In oocytes injected with Kir2.3 mRNA, only pregnenolone sulfate (PREGS), among nine neurosteroids tested, reversibly potentiated Kir2.3 currents. The potentiation effect was concentration-dependent in the micromolar range, and the current-voltage relationship showed inward rectification. However, the potentiation effect of PREGS was not observed when PREGS was applied intracellularly and was not affected by extracellular pH conditions. Furthermore, although Kir1.1, Kir2.1, Kir2.2, and Kir3 channels were insensitive to PREGS, in oocytes injected with Kir2.1/Kir2.3 or Kir2.2/Kir2.3 mRNA, but not Kir2.1/Kir2.2 mRNA, PREGS potentiated Kir currents. These potentiation properties in the concentration-response relationships were less potent than for Kir2.3 channels, suggesting action of PREGS on Kir2.3-containing Kir2 heteromeric channels. Conclusions/Significance: The present results suggest that PREGS acts as a positive modulator of Kir2.3 channels. Kir2.3 channel potentiation may provide novel insights into the various effects of PREGS.			Kobayashi, T (corresponding author), Niigata Univ, Brain Res Inst, Dept Mol Neuropathol, Chuo Ku, Niigata, Japan.	torukoba@bri.niigata-u.ac.jp	Ikeda, Kazutaka/I-4694-2013	Ikeda, Kazutaka/0000-0001-8342-0278				AKWA Y, 1993, CR ACAD SCI III-VIE, V316, P410; Barbaccia ML, 1996, NEUROENDOCRINOLOGY, V63, P166, DOI 10.1159/000126953; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Bicikova M, 2000, NEUROCHEM RES, V25, P1623, DOI 10.1023/A:1026622704704; Caldeira JC, 2004, J NEUROCHEM, V90, P1530, DOI 10.1111/j.1471-4159.2004.02686.x; Chen SC, 2006, BIOCHEM BIOPH RES CO, V349, P626, DOI 10.1016/j.bbrc.2006.08.076; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; CORPECHOT C, 1983, BRAIN RES, V270, P119, DOI 10.1016/0006-8993(83)90797-7; COULTER KL, 1995, NEURON, V15, P1157, DOI 10.1016/0896-6273(95)90103-5; DEPERETTI E, 1986, ACTA ENDOCRINOL-COP, V113, P259; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; FFRENCHMULLEN JMH, 1994, J NEUROSCI, V14, P1963; Havlikova H, 2002, J CLIN ENDOCR METAB, V87, P2225, DOI 10.1210/jc.87.5.2225; Higashi T, 2003, BIOL PHARM BULL, V26, P709; Hill M, 2005, STEROIDS, V70, P515, DOI 10.1016/j.steroids.2005.02.013; Hill M, 2002, J STEROID BIOCHEM, V82, P241, DOI 10.1016/S0960-0760(02)00188-7; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Ikeda K, 2003, METH MOLEC MED, V84, P53; Inanobe A, 2002, AM J PHYSIOL-CELL PH, V282, pC1396, DOI 10.1152/ajpcell.00615.2001; IWAMORI M, 1976, J NEUROCHEM, V27, P1389, DOI 10.1111/j.1471-4159.1976.tb02620.x; Karschin C, 1996, J NEUROSCI, V16, P3559; Kimoto T, 2001, ENDOCRINOLOGY, V142, P3578, DOI 10.1210/en.142.8.3578; Kobayashi T, 2000, BRIT J PHARMACOL, V129, P1716, DOI 10.1038/sj.bjp.0703224; Kobayashi T, 2003, BRIT J PHARMACOL, V138, P1119, DOI 10.1038/sj.bjp.0705172; Kobayashi T, 2002, BRIT J PHARMACOL, V135, P313, DOI 10.1038/sj.bjp.0704475; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; KOYAMA H, 1994, FEBS LETT, V341, P303, DOI 10.1016/0014-5793(94)80478-8; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LeMaout S, 1997, P NATL ACAD SCI USA, V94, P13329, DOI 10.1073/pnas.94.24.13329; Liu SY, 2003, ANAL CHEM, V75, P5835, DOI 10.1021/ac0346297; Liu Y, 2002, EUR J PHARMACOL, V435, P153, DOI 10.1016/S0014-2999(01)01590-4; Liu Y, 2001, MOL PHARMACOL, V59, P1061, DOI 10.1124/mol.59.5.1061; Mameli M, 2005, J NEUROSCI, V25, P2285, DOI 10.1523/JNEUROSCI.3877-04.2005; Mayo W, 2001, HORM BEHAV, V40, P215, DOI 10.1006/hbeh.2001.1677; Mellon SH, 2002, TRENDS ENDOCRIN MET, V13, P35, DOI 10.1016/S1043-2760(01)00503-3; Melnyk P, 2002, AM J PHYSIOL-HEART C, V283, pH1123, DOI 10.1152/ajpheart.00934.2001; Mi HY, 1996, J NEUROSCI, V16, P2421; MORFIN R, 1992, P NATL ACAD SCI USA, V89, P6790, DOI 10.1073/pnas.89.15.6790; Munoz V, 2007, HEART RHYTHM, V4, P487, DOI 10.1016/j.hrthm.2006.12.033; Nguyen PN, 2004, J PHYSIOL-LONDON, V560, P593, DOI 10.1113/jphysiol.2004.069336; Park IH, 1997, J STEROID BIOCHEM, V62, P315, DOI 10.1016/S0960-0760(97)00042-3; PERIER F, 1994, P NATL ACAD SCI USA, V91, P6240, DOI 10.1073/pnas.91.13.6240; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; Pruss H, 2005, MOL BRAIN RES, V139, P63, DOI 10.1016/j.molbrainres.2005.05.006; Reddy DS, 1998, NEUROREPORT, V9, P3069, DOI 10.1097/00001756-199809140-00028; Reddy DS, 1997, BRAIN RES, V752, P61, DOI 10.1016/S0006-8993(96)01447-3; Reddy DS, 1997, METHOD FIND EXP CLIN, V19, P395; Reddy DS, 1997, EUR J PHARMACOL, V337, P19, DOI 10.1016/S0014-2999(97)01294-6; Reimann F, 1999, CURR OPIN CELL BIOL, V11, P503, DOI 10.1016/S0955-0674(99)80073-8; Rupprecht R, 1999, TRENDS NEUROSCI, V22, P410, DOI 10.1016/S0166-2236(99)01399-5; Schram G, 2003, CARDIOVASC RES, V59, P328, DOI 10.1016/S0008-6363(03)00366-3; Shirakawa H, 2005, EUR J NEUROSCI, V21, P2329, DOI 10.1111/j.1460-9568.2005.04079.x; Steckelbroeck S, 2004, J NEUROCHEM, V89, P403, DOI 10.1046/j.1471-4159.2004.02336.x; Stonehouse AH, 1999, HISTOCHEM CELL BIOL, V112, P457, DOI 10.1007/s004180050429; Tagawa N, 2000, CLIN CHEM, V46, P523; TAKAHASHI N, 1994, J BIOL CHEM, V269, P23274; Topert C, 1998, J NEUROSCI, V18, P4096; Torres JM, 2003, NEUROCHEM RES, V28, P1187, DOI 10.1023/A:1024276328127; Ureche ON, 2008, CELL PHYSIOL BIOCHEM, V21, P347, DOI 10.1159/000129629; Vallee M, 1997, P NATL ACAD SCI USA, V94, P14865, DOI 10.1073/pnas.94.26.14865; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Wang MD, 1997, J STEROID BIOCHEM, V62, P299, DOI 10.1016/S0960-0760(97)00041-1; Wang Q, 1998, PFLUG ARCH EUR J PHY, V437, P49, DOI 10.1007/s004240050745; Williamson J, 2004, NEUROPHARMACOLOGY, V46, P856, DOI 10.1016/j.neuropharm.2003.11.029; Yan CZ, 2004, ACTA PHARMACOL SIN, V25, P1285; Zhang HL, 2001, BIOPHYS J, V80, p629A	67	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6311	10.1371/journal.pone.0006311	http://dx.doi.org/10.1371/journal.pone.0006311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621089	Green Published, gold, Green Submitted			2022-12-27	WOS:000268147200009
J	Michelet, T; Bioulac, B; Guehl, D; Goillandeau, M; Burbaud, P				Michelet, Thomas; Bioulac, Bernard; Guehl, Dominique; Goillandeau, Michel; Burbaud, Pierre			Single Medial Prefrontal Neurons Cope with Error	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; OBSESSIVE-COMPULSIVE DISORDER; COGNITIVE CONTROL; LOCUS-COERULEUS; FRONTAL-CORTEX; NEURAL SYSTEM; MOTOR AREAS; PERFORMANCE; REWARD; SUPPLEMENTARY	Learning from mistakes is a key feature of human behavior. However, the mechanisms underlying short-term adaptation to erroneous action are still poorly understood. One possibility relies on the modulation of attentional systems after an error. To explore this possibility, we have designed a Stroop-like visuo-motor task in monkeys that favors incorrect action. Using this task, we previously found that single neurons recorded from the anterior cingulate cortex ( ACC) were closely tuned to behavioral performance and, more particularly, that the activity of most neurons was biased towards the evaluation of erroneous action. Here we describe single neurons engaged in both error detection and response alertness processing, whose activation is closely associated with the improvement of subsequent behavioral performance. Specifically, we show that the effect of a warning stimulus on neuronal firing is enhanced after an erroneous response rather than a successful one and that this outcome is correlated with an error rate decrease. Our results suggest that the anterior cingulate cortex, which exhibits this activity, serves as a powerful computational locus for rapid behavioral adaptation.			Michelet, T (corresponding author), Univ Victor Segalen Bordeaux 2, CNRS, UMR Mouvement Adaptat Cognit 5227, Bordeaux, France.	thomas.michelet@u-bordeaux2.fr		Michelet, Thomas/0000-0002-2104-2758				Adler CM, 2000, J PSYCHIATR RES, V34, P317, DOI 10.1016/S0022-3956(00)00022-4; Akkal D, 2002, EUR J NEUROSCI, V15, P887, DOI 10.1046/j.1460-9568.2002.01920.x; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Aouizerate B, 2004, PROG NEUROBIOL, V72, P195, DOI 10.1016/j.pneurobio.2004.02.004; Aston-Jones G, 2005, J COMP NEUROL, V493, P99, DOI 10.1002/cne.20723; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Garavan H, 2003, NEUROIMAGE, V20, P1132, DOI 10.1016/S1053-8119(03)00334-3; Gehring W. J., 1990, PSYCHOPHYSIOLOGY, V27, pS34, DOI DOI 10.1111/J.1469-8986.1990.TB02175.X; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GEMBA H, 1986, NEUROSCI LETT, V70, P223, DOI 10.1016/0304-3940(86)90467-2; HANES DP, 1995, EXP BRAIN RES, V103, P85; Hohnsbein J., 1989, J PSYCHOPHYSIOL, V3, P32; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LUPPINO G, 1991, J COMP NEUROL, V311, P463, DOI 10.1002/cne.903110403; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Michelet T, 2007, J NEUROSCI, V27, P7482, DOI 10.1523/JNEUROSCI.4718-06.2007; Norman D.A., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Paus T, 2000, PROG BRAIN RES, V126, P65; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Posner MI, 1998, PHILOS T R SOC B, V353, P1915, DOI 10.1098/rstb.1998.0344; Posner MI, 2008, ANN NY ACAD SCI, V1129, P193, DOI 10.1196/annals.1417.011; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549	42	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6240	10.1371/journal.pone.0006240	http://dx.doi.org/10.1371/journal.pone.0006240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	472GV	19609433	Green Submitted, Green Published, gold			2022-12-27	WOS:000268119500001
J	Duda, TF; Chang, D; Lewis, BD; Lee, TW				Duda, Thomas F., Jr.; Chang, Dan; Lewis, Brittany D.; Lee, Taehwan			Geographic Variation in Venom Allelic Composition and Diets of the Widespread Predatory Marine Gastropod Conus ebraeus	PLOS ONE			English	Article								Background: Members of the predatory gastropod genus Conus use a venom comprised of a cocktail of peptide neurotoxins, termed conotoxins or conopeptides, to paralyze prey and conotoxin gene family members diversify via strong positive selection. Because Conus venoms are used primarily to subdue prey, the evolution of venoms is likely affected by predator-prey interactions. Methodology/Principal Findings: To identify the selective forces that drive the differentiation of venoms within species of Conus, we examined the distribution of alleles of a polymorphic O-superfamily conotoxin locus of Conus ebraeus at Okinawa, Guam and Hawaii. Previous analyses of mitochondrial cytochrome oxidase I gene sequences suggest that populations of C. ebraeus, a worm-eating Conus, are not structured genetically in the western and central Pacific. Nonetheless, because the sample size from Guam was relatively low, we obtained additional data from this location and reexamined patterns of genetic variation at the mitochondrial gene at Okinawa, Guam and Hawaii. We also utilized a DNA-based approach to identify prey items of individuals of C. ebraeus from Guam and compared this information to published data on diets at Okinawa and Hawaii. Our results show that conotoxin allelic frequencies differ significantly among all three locations, with strongest differentiation at Hawaii. We also confirm previous inferences that C. ebraeus exhibits no genetic differentiation between Okinawa, Guam and Hawaii at the mitochondrial locus. Finally, DNA-based analyses show that eunicid polychaetes comprise the majority of the prey items of C. ebraeus at Guam; while this results compares well with observed diet of this species at Okinawa, C. ebraeus preys predominantly on nereid polychaetes at Hawaii. Conclusions/Significance: These results imply that strong selection pressures affect conotoxin allelic frequencies. Based on the dietary information, the selection may derive from geographic variation in dietary specialization and local coevolutionary arms races between Conus and their prey.			Duda, TF (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	tfduda@umich.edu		Chang, Dan/0000-0003-4942-3146				Adams DJ, 2003, J BIOL CHEM, V278, P4057, DOI 10.1074/jbc.M209969200; [Anonymous], [No title captured]; BIRKY CW, 1983, GENETICS, V103, P513; CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Conticello SG, 2001, MOL BIOL EVOL, V18, P120, DOI 10.1093/oxfordjournals.molbev.a003786; Creer S, 2003, J MOL EVOL, V56, P317, DOI 10.1007/s00239-002-2403-4; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Duda TF, 2008, MOL ECOL, V17, P3018, DOI 10.1111/j.1365-294X.2008.03804.x; Duda TF, 2004, P ROY SOC B-BIOL SCI, V271, P1165, DOI 10.1098/rspb.2004.2708; Duda TF, 2000, MOL BIOL EVOL, V17, P1286, DOI 10.1093/oxfordjournals.molbev.a026412; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; DUDA TF, 2009, CORAL REEFS IN PRESS; DUDA TF, GENETIC MORPHOLOGICA; Duda TF, 2008, J MOL EVOL, V67, P315, DOI 10.1007/s00239-008-9155-8; Duda TF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005558; EXCOFFIER L, 1992, GENETICS, V131, P491; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fry BG, 2001, TOXICOL APPL PHARM, V175, P140, DOI 10.1006/taap.2001.9233; HOSS M, 1992, NATURE, V359, P199, DOI 10.1038/359199a0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOHN AJ, 1975, MAR BIOL, V29, P211, DOI 10.1007/BF00391848; KOHN AJ, 1959, ECOL MONOGR, V29, P47, DOI 10.2307/1948541; KOHN AJ, 1978, ECOL MONOGR, V48, P323, DOI 10.2307/2937234; KOHN AJ, 1982, MAR ECOL PROG SER, V9, P147, DOI 10.3354/meps009147; Kohn AJ, 2001, CORAL REEFS, V20, P25; KOHN AJ, 1994, LIFE HIST BIOGEOGRAP, pR6; Kohn AJ, 1985, P 5 INT COR REEF C, P191; KOHN M, 1995, MOL ECOL, V4, P95, DOI 10.1111/j.1365-294X.1995.tb00196.x; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; Mackessy SP, 2006, TOXICON, V47, P537, DOI 10.1016/j.toxicon.2006.01.007; MARSH H, 1971, Veliger, V14, P45; MARTIN MF, 1987, TOXICON, V25, P569, DOI 10.1016/0041-0101(87)90293-5; Olivera BM, 1999, ANN NY ACAD SCI, V870, P223, DOI 10.1111/j.1749-6632.1999.tb08883.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Rockel D, 1995, MANUAL LIVING CONIDA; Sasa M, 1999, TOXICON, V37, P249, DOI 10.1016/S0041-0101(98)00121-4; SCHNEIDER S, 2000, ARLEQUIN VER 2 0 SOF; Schulze A, 2006, BIOL BULL-US, V210, P25, DOI 10.2307/4134534; Sjolin E, 2005, MOL PHYLOGENET EVOL, V35, P431, DOI 10.1016/j.ympev.2004.12.018; Sokal R. H., 1995, BIOMETRY PRINCIPLES; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TEMPLETON AR, 1992, GENETICS, V132, P619; WHITTAKER RH, 1952, ECOL MONOGR, V22, P1, DOI 10.2307/1948527; Wuster W, 1999, TOXICON, V37, P253	47	44	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6245	10.1371/journal.pone.0006245	http://dx.doi.org/10.1371/journal.pone.0006245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606224	gold, Green Published, Green Submitted			2022-12-27	WOS:000268036000005
J	Guerin, R; Beauregard, PB; Leroux, A; Rokeach, LA				Guerin, Renee; Beauregard, Pascale B.; Leroux, Alexandre; Rokeach, Luis A.			Calnexin Regulates Apoptosis Induced by Inositol Starvation in Fission Yeast	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; PROGRAMMED CELL-DEATH; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; TRISPHOSPHATE RECEPTOR; PHOSPHOLIPID-SYNTHESIS; CHAPERONE FUNCTION; SECRETORY PATHWAY	Inositol is a precursor of numerous phospholipids and signalling molecules essential for the cell. Schizosaccharomyces pombe is naturally auxotroph for inositol as its genome does not have a homologue of the INO1 gene encoding inositol-1-phosphate synthase, the enzyme responsible for inositol biosynthesis. In this work, we demonstrate that inositol starvation in S. pombe causes cell death with apoptotic features. This apoptotic death is dependent on the metacaspase Pca1p and is affected by the UPR transducer Ire1p. Previously, we demonstrated that calnexin is involved in apoptosis induced by ER stress. Here, we show that cells expressing a lumenal version of calnexin exhibit a 2-fold increase in the levels of apoptosis provoked by inositol starvation. This increase is reversed by co-expression of a calnexin mutant spanning the transmembrane domain and C-terminal cytosolic tail. Coherently, calnexin is physiologically cleaved at the end of its lumenal domain, under normal growth conditions when cells approach stationary phase. This cleavage suggests that the two naturally produced calnexin fragments are needed to continue growth into stationary phase and to prevent cell death. Collectively, our observations indicate that calnexin takes part in at least two apoptotic pathways in S. pombe, and suggest that the cleavage of calnexin has regulatory roles in apoptotic processes involving calnexin.			Guerin, R (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.	luis.rokeach@umontreal.ca						Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; ARUNACHALAM B, 1995, J BIOL CHEM, V270, P2784, DOI 10.1074/jbc.270.6.2784; Balzan R, 2004, MICROBIOL-SGM, V150, P109, DOI 10.1099/mic.0.26578-0; Beaulieu H, 1999, BIOCHEM J, V340, P813, DOI 10.1042/0264-6021:3400813; BELDE PJM, 1993, FEBS LETT, V323, P113, DOI 10.1016/0014-5793(93)81460-H; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Buttner S, 2006, J CELL BIOL, V175, P521, DOI 10.1083/jcb.200608098; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Burhans WC, 2007, MOL CELL, V25, P323, DOI 10.1016/j.molcel.2007.01.030; Carmody RJ, 2001, REDOX REP, V6, P77, DOI 10.1179/135100001101536085; Chang HJ, 2002, GENETICS, V162, P29; Chang Q, 2008, BBA-MOL CELL RES, V1783, P237, DOI 10.1016/j.bbamcr.2007.08.008; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Criollo A, 2007, AUTOPHAGY, V3, P350, DOI 10.4161/auto.4077; DEAN DC, 1989, AM J RESP CELL MOL, V1, P5, DOI 10.1165/ajrcmb/1.1.5; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Delom F, 2006, BIOCHEM BIOPH RES CO, V341, P39, DOI 10.1016/j.bbrc.2005.12.149; DELOM F, 2007, APOPTOSIS; DELOM F, 2006, CELL DEATH DIFFER; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; EISENBERG F, 1964, BIOCHEM BIOPH RES CO, V14, P419, DOI 10.1016/0006-291X(64)90079-8; Elagoz A, 1999, J CELL SCI, V112, P4449; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; Fernandez F, 1996, EMBO J, V15, P705, DOI 10.1002/j.1460-2075.1996.tb00406.x; FERNANDEZ S, 1986, J BACTERIOL, V166, P779, DOI 10.1128/jb.166.3.779-786.1986; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Frohlich KU, 2007, SEMIN CANCER BIOL, V17, P112, DOI 10.1016/j.semcancer.2006.11.006; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; Greenberg ML, 1996, MICROBIOL REV, V60, P1; Groenendyk J, 2006, BIOCHEMISTRY-US, V45, P13219, DOI 10.1021/bi061428z; Guerin R, 2008, MOL BIOL CELL, V19, P4404, DOI 10.1091/mbc.E08-02-0188; Hajjar F, 2007, YEAST, V24, P89, DOI 10.1002/yea.1440; Hamann A, 2008, TRENDS MICROBIOL, V16, P276, DOI 10.1016/j.tim.2008.03.003; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Harada Hisashi, 2003, Rev Clin Exp Hematol, V7, P117; Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Huh GH, 2002, PLANT J, V29, P649, DOI 10.1046/j.0960-7412.2001.01247.x; Ingavale SS, 1999, MICROBIOL-SGM, V145, P1903, DOI 10.1099/13500872-145-8-1903; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; JANNATIPOUR M, 1995, J BIOL CHEM, V270, P4845, DOI 10.1074/jbc.270.9.4845; Jannatipour M, 1998, BIOCHEMISTRY-US, V37, P17253, DOI 10.1021/bi981785c; Jannatipour M, 1998, BBA-GENE STRUCT EXPR, V1399, P67, DOI 10.1016/S0167-4781(98)00097-9; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jin C, 2002, NAT REV MOL CELL BIO, V3, P453, DOI 10.1038/nrm832; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; Kapoor M, 2003, J BIOL CHEM, V278, P6194, DOI 10.1074/jbc.M209132200; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kerr JFR, 2002, TOXICOLOGY, V181, P471, DOI 10.1016/S0300-483X(02)00457-2; King DA, 2004, ARCH BIOCHEM BIOPHYS, V423, P170, DOI 10.1016/j.abb.2003.12.012; KLIG LS, 1984, P NATL ACAD SCI-BIOL, V81, P3816, DOI 10.1073/pnas.81.12.3816; KLIG LS, 1991, YEAST, V7, P325, DOI 10.1002/yea.320070403; Knorre DA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P264, DOI 10.1007/s10541-005-0110-7; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lam D, 2008, AUTOPHAGY, V4, P349, DOI 10.4161/auto.5521; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Lim HW, 2007, CAN J MICROBIOL, V53, P1016, DOI 10.1139/W07-067; Low CP, 2008, J CELL SCI, V121, P2671, DOI 10.1242/jcs.028977; Low CP, 2005, FEMS YEAST RES, V5, P1199, DOI 10.1016/j.femsyr.2005.07.004; Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409; MacNeill SA, 2002, CURR BIOL, V12, pR294, DOI 10.1016/S0960-9822(02)00805-9; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; MAJERUS PW, 1986, SCIENCE, V234, P1519, DOI 10.1126/science.3024320; Majumder AL, 1997, BBA-LIPID LIPID MET, V1348, P245, DOI 10.1016/S0005-2760(97)00122-7; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marechal A, 2004, BIOCHEM J, V380, P441, DOI 10.1042/BJ20031546; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MINSKOFF SA, 1992, J BACTERIOL, V174, P4078, DOI 10.1128/jb.174.12.4078-4085.1992; Mitsui K, 2005, FEBS LETT, V579, P723, DOI 10.1016/j.febslet.2004.12.051; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Niederberger C, 1998, CURR GENET, V33, P255, DOI 10.1007/s002940050334; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; PARLATI F, 1995, EMBO J, V14, P3064, DOI 10.1002/j.1460-2075.1995.tb07309.x; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; PEREZSALA D, 1995, J CELL PHYSIOL, V163, P523, DOI 10.1002/jcp.1041630312; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Poitelea M, 1997, Rev Med Chir Soc Med Nat Iasi, V101, P87; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2008, MOL BIOSYST, V4, P895, DOI 10.1039/b804606a; Sarkar S, 2006, AUTOPHAGY, V2, P132, DOI 10.4161/auto.2387; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Severin FF, 2008, BBA-MOL CELL RES, V1783, P1350, DOI 10.1016/j.bbamcr.2008.02.001; Shahinian S, 1998, GENETICS, V149, P843; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; STEINER S, 1972, J BACTERIOL, V109, P81, DOI 10.1128/JB.109.1.81-88.1972; Sun Q, 2007, FEBS LETT, V581, P3991, DOI 10.1016/j.febslet.2007.07.030; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Takizawa T, 2004, J BIOCHEM, V136, P399, DOI 10.1093/jb/mvh133; Thammavongsa V, 2005, J BIOL CHEM, V280, P33497, DOI 10.1074/jbc.M503648200; Torgler CN, 1997, CELL DEATH DIFFER, V4, P263, DOI 10.1038/sj.cdd.4400239; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Turcotte C, 2007, FEMS YEAST RES, V7, P196, DOI 10.1111/j.1567-1364.2006.00145.x; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Voicu PM, 2002, ARCH MICROBIOL, V177, P251, DOI 10.1007/s00203-001-0383-1; WADA I, 1991, J BIOL CHEM, V266, P19599; Walter D, 2006, J CELL SCI, V119, P1843, DOI 10.1242/jcs.02902; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; YARBROUGH HF, 1957, J BACTERIOL, V73, P318, DOI 10.1128/JB.73.3.318-323.1957; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200; Zuppini A, 2002, BIOCHEMISTRY-US, V41, P2850, DOI 10.1021/bi015967+	130	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6244	10.1371/journal.pone.0006244	http://dx.doi.org/10.1371/journal.pone.0006244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606215	Green Submitted, Green Published, gold			2022-12-27	WOS:000268036000004
J	Kwon, T; Park, J; Yang, J; Yoon, DS; Na, S; Kim, CW; Suh, JS; Huh, YM; Haam, S; Eom, K				Kwon, Taeyun; Park, Jinsung; Yang, Jaemoon; Yoon, Dae Sung; Na, Sungsoo; Kim, Chang-Wan; Suh, Jin-Suck; Huh, Yong-Min; Haam, Seungjoo; Eom, Kilho			Nanomechanical In Situ Monitoring of Proteolysis of Peptide by Cathepsin B	PLOS ONE			English	Article								Characterization and control of proteolysis of peptides by specific cellular protease is a priori requisite for effective drug discovery. Here, we report the nanomechanical, in situ monitoring of proteolysis of peptide chain attributed to protease (Cathepsin B) by using a resonant nanomechanical microcantilever immersed in a liquid. Specifically, the detection is based on measurement of resonant frequency shift arising from proteolysis of peptides (leading to decrease of cantilever's overall mass, and consequently, increases in the resonance). It is shown that resonant microcantilever enables the quantification of proteolysis efficacy with respect to protease concentration. Remarkably, the nanomechanical, in situ monitoring of proteolysis allows us to gain insight into the kinetics of proteolysis of peptides, which is well depicted by Langmuir kinetic model. This implies that nanomechanical biosensor enables the characterization of specific cellular protease such as its kinetics.			Kwon, T (corresponding author), Korea Univ, Res Inst Engn Technol, Seoul, South Korea.	tykwon@korea.ac.kr; haam@yonsei.ac.kr; kilhoeom@korea.ac.kr	Yang, Jaemoon/S-3900-2019; Park, Jinsung/AAR-7393-2021; Haam, Seungjoo/G-8042-2012; Eom, Kilho/B-1552-2008	Yang, Jaemoon/0000-0001-7365-0395; Eom, Kilho/0000-0001-5135-8473; Kim, Chang-wan/0000-0003-2952-9453; Park, Jinsung/0000-0001-8096-7286; Huh, Yong-Min/0000-0002-9831-4475; Suh, jin-suck/0000-0001-9455-9240				Braun T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031907; Braun T, 2009, NAT NANOTECHNOL, V4, P179, DOI [10.1038/NNANO.2008.398, 10.1038/nnano.2008.398]; Bunimovich YL, 2006, J AM CHEM SOC, V128, P16323, DOI 10.1021/ja065923u; Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; DEFOEJONES D, 2000, NAT MED, V6, P1248; Eom K, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.113408; Etrych T, 2001, J CONTROL RELEASE, V73, P89, DOI 10.1016/S0168-3659(01)00281-4; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; Ghatkesar MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003610; GRAHAM NB, 1992, POLY ETHYLENE GLYCOL, P263; Gupta AK, 2006, P NATL ACAD SCI USA, V103, P13362, DOI 10.1073/pnas.0602022103; Hagan MF, 2002, J PHYS CHEM B, V106, P10163, DOI 10.1021/jp020972o; Heath JR, 2008, ANNU REV MED, V59, P251, DOI 10.1146/annurev.med.59.061506.185523; Ilic B, 2005, NANO LETT, V5, P925, DOI 10.1021/nl050456k; Kirstein S, 1998, J APPL PHYS, V84, P1782, DOI 10.1063/1.368335; Kodadek T, 2008, NATURE, V453, P861, DOI 10.1038/453861a; Kwon TY, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2741053; Kwon T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3006329; Lachut MJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.206102; Lee SH, 2002, J POLYM SCI POL CHEM, V40, P2545, DOI 10.1002/pola.10339; Li M, 2007, NAT NANOTECHNOL, V2, P114, DOI 10.1038/nnano.2006.208; Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t; McKendry R, 2002, P NATL ACAD SCI USA, V99, P9783, DOI 10.1073/pnas.152330199; Mertens J, 2008, NAT NANOTECHNOL, V3, P301, DOI 10.1038/nnano.2008.91; Ndieyira JW, 2008, NAT NANOTECHNOL, V3, P691, DOI 10.1038/nnano.2008.275; Stoney GG, 1909, P R SOC LOND A-CONTA, V82, P172, DOI 10.1098/rspa.1909.0021; Sushko ML, 2008, ADV MATER, V20, P3848, DOI 10.1002/adma.200801344; Tamayo J, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2388925; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Ulbrich K, 2004, INT J PHARM, V277, P63, DOI 10.1016/j.ijpharm.2003.02.001; Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856; Wu GH, 2001, P NATL ACAD SCI USA, V98, P1560, DOI 10.1073/pnas.031362498; Yang J, 2007, ANGEW CHEM INT EDIT, V46, P8836, DOI 10.1002/anie.200703554; Zhang J, 2006, NAT NANOTECHNOL, V1, P214, DOI 10.1038/nnano.2006.134	34	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6248	10.1371/journal.pone.0006248	http://dx.doi.org/10.1371/journal.pone.0006248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606222	Green Submitted, Green Published, gold			2022-12-27	WOS:000268036000007
J	Lerner, Y; Papo, D; Zhdanov, A; Belozersky, L; Hendler, T				Lerner, Yulia; Papo, David; Zhdanov, Andrey; Belozersky, Libi; Hendler, Talma			Eyes Wide Shut: Amygdala Mediates Eyes-Closed Effect on Emotional Experience with Music	PLOS ONE			English	Article								The perceived emotional value of stimuli and, as a consequence the subjective emotional experience with them, can be affected by context-dependent styles of processing. Therefore, the investigation of the neural correlates of emotional experience requires accounting for such a variable, a matter of an experimental challenge. Closing the eyes affects the style of attending to auditory stimuli by modifying the perceptual relationship with the environment without changing the stimulus itself. In the current study, we used fMRI to characterize the neural mediators of such modification on the experience of emotionality in music. We assumed that closed eyes position will reveal interplay between different levels of neural processing of emotions. More specifically, we focused on the amygdala as a central node of the limbic system and on its co-activation with the Locus Ceruleus (LC) and Ventral Prefrontal Cortex (VPFC); regions involved in processing of, respectively, 'low', visceral-, and 'high', cognitive-related, values of emotional stimuli. Fifteen healthy subjects listened to negative and neutral music excerpts with eyes closed or open. As expected, behavioral results showed that closing the eyes while listening to emotional music resulted in enhanced rating of emotionality, specifically of negative music. In correspondence, fMRI results showed greater activation in the amygdala when subjects listened to the emotional music with eyes closed relative to eyes open. More so, by using voxel-based correlation and a dynamic causal model analyses we demonstrated that increased amygdala activation to negative music with eyes closed led to increased activations in the LC and VPFC. This finding supports a system-based model of perceived emotionality in which the amygdala has a central role in mediating the effect of context- based processing style by recruiting neural operations involved in both visceral (i.e. 'low') and cognitive (i.e. 'high') related processes of emotions.			Lerner, Y (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	talma@tasmc.health.gov.il	Zhdanov, Andrey/I-7136-2012; hendler, talma/C-7677-2012	Papo, David/0000-0003-1889-2791; Zhadnov, Andrey/0000-0002-3379-0251				AMARAL D G, 1992, P1; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; Barrett LF, 2007, ANNU REV PSYCHOL, V58, P373, DOI 10.1146/annurev.psych.58.110405.085709; Baumgartner T, 2006, BRAIN RES, V1075, P151, DOI 10.1016/j.brainres.2005.12.065; Bechara A, 1999, J NEUROSCI, V19, P5473; Beck AT, 1997, BEHAV RES THER, V35, P49, DOI 10.1016/S0005-7967(96)00069-1; Beevers CG, 2005, CLIN PSYCHOL REV, V25, P975, DOI 10.1016/j.cpr.2005.03.003; Ben-Simon E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003984; Bennett MR, 2005, PROG NEUROBIOL, V75, P29, DOI 10.1016/j.pneurobio.2004.11.002; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Chaminade T, 2003, EUR J NEUROSCI, V18, P675, DOI 10.1046/j.1460-9568.2003.02787.x; Coull JT, 1999, NEUROIMAGE, V10, P705, DOI 10.1006/nimg.1999.0513; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Eldar E, 2007, CEREB CORTEX, V17, P2828, DOI 10.1093/cercor/bhm011; Ferguson ML, 1996, BIOL PSYCHOL, V42, P131, DOI 10.1016/0301-0511(95)05151-1; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRISTON J, 1994, HUM BRAIN MAPP, V2, P189; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; Gosselin N, 2005, BRAIN, V128, P628, DOI 10.1093/brain/awh420; Gosselin N, 2006, BRAIN, V129, P2585, DOI 10.1093/brain/awl240; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Iidaka T, 2001, J COGNITIVE NEUROSCI, V13, P1035, DOI 10.1162/089892901753294338; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; JACOBS BL, 1986, PROG NEUROBIOL, V27, P183, DOI 10.1016/0301-0082(86)90008-0; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Jeannerod M, 2004, NAT NEUROSCI, V7, P422, DOI 10.1038/nn0504-422; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Katkin ES, 2001, PSYCHOL SCI, V12, P366, DOI 10.1111/1467-9280.00368; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2005, NEUROIMAGE, V25, P1068, DOI 10.1016/j.neuroimage.2004.12.050; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lerner Y, 2002, CEREB CORTEX, V12, P163, DOI 10.1093/cercor/12.2.163; Levitin DJ, 2003, NEUROIMAGE, V20, P2142, DOI 10.1016/j.neuroimage.2003.08.016; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Nomura M, 2004, NEUROIMAGE, V21, P352, DOI 10.1016/j.neuroimage.2003.09.021; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Sander K, 2003, BRAIN RES PROTOC, V11, P81, DOI 10.1016/S1385-299X(03)00018-7; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Schmithorst VJ, 2003, NEUROSCI LETT, V348, P65, DOI 10.1016/S0304-3940(03)00714-6; Sterpenich V, 2006, J NEUROSCI, V26, P7416, DOI 10.1523/JNEUROSCI.1001-06.2006; Talairach J., 1988, COPLANAR STEREOTAXIC; VANHOESEN GW, 1985, ANN NY ACAD SCI, V444, P97; Williams LM, 2006, J NEUROSCI, V26, P9264, DOI 10.1523/JNEUROSCI.1016-06.2006; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	71	46	48	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6230	10.1371/journal.pone.0006230	http://dx.doi.org/10.1371/journal.pone.0006230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603072	gold, Green Submitted, Green Published			2022-12-27	WOS:000268035700005
J	Zoltewicz, JS; Ashique, AM; Choe, Y; Lee, G; Taylor, S; Phamluong, K; Solloway, M; Peterson, AS				Zoltewicz, J. Susie; Ashique, Amir M.; Choe, Youngshik; Lee, Gena; Taylor, Stacy; Phamluong, Khanhky; Solloway, Mark; Peterson, Andrew S.			Wnt Signaling Is Regulated by Endoplasmic Reticulum Retention	PLOS ONE			English	Article								Precise regulation of Wnt signaling is important in many contexts, as in development of the vertebrate forebrain, where excessive or ectopic Wnt signaling leads to severe brain defects. Mutation of the widely expressed oto gene causes loss of the anterior forebrain during mouse embryogenesis. Here we report that oto is the mouse ortholog of the gpi deacylase gene pgap1, and that the endoplasmic reticulum (ER)-resident Oto protein has a novel and deacylase-independent function during Wnt maturation. Oto increases the hydrophobicities of Wnt3a and Wnt1 by promoting the addition of glycophosphatidylinositol (gpi)-like anchors to these Wnts, which results in their retention in the ER. We also report that oto-deficient embryos exhibit prematurely robust Wnt activity in the Wnt1 domain of the early neural plate. We examine the effect of low oto expression on Wnt1 in vitro by knocking down endogenous oto expression in 293 and M14 melanoma cells using shRNA. Knockdown of oto results in increased Wnt1 secretion which is correlated with greatly enhanced canonical Wnt activity. These data indicate that oto deficiency increases Wnt signaling in vivo and in vitro. Finally, we address the mechanism of Oto-mediated Wnt retention under oto-abundant conditions, by cotransfecting Wnt1 with gpi-specific phospholipase D (GPI-PLD). The presence of GPI-PLD in the secretory pathway results in increased secretion of soluble Wnt1, suggesting that the gpi-like anchor lipids on Wnt1 mediate its retention in the ER. These data now provide a mechanistic framework for understanding the forebrain defects in oto mice, and support a role for Oto-mediated Wnt regulation during early brain development. Our work highlights a critical role for ER retention in regulating Wnt signaling in the mouse embryo, and gives insight into the notoriously inefficient secretion of Wnts.			Zoltewicz, JS (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.	susiezolt@gmail.com; peterson.andrew@gene.com			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017627] Funding Source: NIH RePORTER; NIDA NIH HHS [5 R01 DA017627-07, R01 DA017627] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Andoniadou CL, 2007, DEVELOPMENT, V134, P1499, DOI 10.1242/dev.02829; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Bischoff M, 2006, PLOS BIOL, V4, P2262, DOI 10.1371/journal.pbio.0040396; Braun MM, 2003, DEVELOPMENT, V130, P5579, DOI 10.1242/dev.00685; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BURRUS LW, 1995, EXP CELL RES, V220, P363, DOI 10.1006/excr.1995.1327; Castiglia D, 2008, GENE CHROMOSOME CANC, V47, P614, DOI 10.1002/gcc.20567; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Chou SJ, 2006, DEV BIOL, V292, P533, DOI 10.1016/j.ydbio.2005.12.053; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Danielian PS, 1997, DEV BIOL, V192, P300, DOI 10.1006/dbio.1997.8762; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Eisenhaber B, 2003, BIOESSAYS, V25, P367, DOI 10.1002/bies.10254; Erter CE, 2001, DEVELOPMENT, V128, P3571; Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333; Franch-Marro X, 2008, J CELL SCI, V121, P1587, DOI 10.1242/jcs.015958; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; Heeg-Truesdell E, 2006, DEV BIOL, V298, P71, DOI 10.1016/j.ydbio.2006.06.015; Hirata T, 2006, DEVELOPMENT, V133, P3993, DOI 10.1242/dev.02585; Hong Y, 2000, J BIOL CHEM, V275, P20911, DOI 10.1074/jbc.M001913200; Hooper NM, 2001, PROTEOMICS, V1, P748, DOI 10.1002/1615-9861(200106)1:6<748::AID-PROT748>3.3.CO;2-K; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Ikeya M, 2001, MECH DEVELOP, V103, P27, DOI 10.1016/S0925-4773(01)00338-0; Ishibashi M, 2002, DEVELOPMENT, V129, P4807; Jeong JY, 2007, DEVELOPMENT, V134, P127, DOI 10.1242/dev.02705; Kazanskaya O, 2000, DEVELOPMENT, V127, P4981; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Lewis SL, 2007, MECH DEVELOP, V124, P157, DOI 10.1016/j.mod.2006.10.001; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mann KJ, 2004, BIOCHEM J, V378, P641, DOI 10.1042/BJ20031326; Mann KJ, 2001, BIOCHEMISTRY-US, V40, P1205, DOI 10.1021/bi0024512; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Martinez-Barbera JP, 2000, DEV BIOL, V223, P422, DOI 10.1006/dbio.2000.9757; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; MCGREW LL, 1995, DEV BIOL, V172, P337, DOI 10.1006/dbio.1995.0027; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nambiar RM, 2004, DEV BIOL, V267, P165, DOI 10.1016/j.ydbio.2003.11.019; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Onai T, 2004, DEV CELL, V7, P95, DOI 10.1016/j.devcel.2004.06.004; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; PARKIN NT, 1993, GENE DEV, V7, P2181, DOI 10.1101/gad.7.11.2181; PARR BA, 1993, DEVELOPMENT, V119, P247; Popperl H, 1997, DEVELOPMENT, V124, P2997; Reilly KM, 1996, CELL, V86, P743, DOI 10.1016/S0092-8674(00)80149-X; Rhinn M, 2006, CURR OPIN NEUROBIOL, V16, P5, DOI 10.1016/j.conb.2006.01.005; Rhinn M, 2005, DEVELOPMENT, V132, P1261, DOI 10.1242/dev.01685; Rowitch DH, 1998, DEVELOPMENT, V125, P2735; Satoh K, 2004, P NATL ACAD SCI USA, V101, P8017, DOI 10.1073/pnas.0401733101; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Shinya M, 2000, MECH DEVELOP, V98, P3, DOI 10.1016/S0925-4773(00)00433-0; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; Ueda Y, 2007, J BIOL CHEM, V282, P30373, DOI 10.1074/jbc.M705601200; Umland SP, 2004, AM J RESP CELL MOL, V30, P530, DOI 10.1165/rcmb.2003-0220OC; URBANIAK MD, 2005, J BIOL CHEM; van de Water S, 2001, DEVELOPMENT, V128, P3877; Vieira C, 2005, DEV BIOL, V284, P351, DOI 10.1016/j.ydbio.2005.05.031; Wada S, 2008, DEV GROWTH DIFFER, V50, P215, DOI [10.1111/j.1440-169x.2008.01012.x, 10.1111/j.1440-169X.2008.01012.x]; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yamamoto A, 2005, CELL, V120, P223, DOI 10.1016/j.cell.2004.11.051; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200; Zoltewicz JS, 1999, DEVELOPMENT, V126, P5085; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	78	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6191	10.1371/journal.pone.0006191	http://dx.doi.org/10.1371/journal.pone.0006191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593386	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035300006
J	Haddow, AD; Odoi, A				Haddow, Andrew D.; Odoi, Agricola			The Incidence Risk, Clustering, and Clinical Presentation of La Crosse Virus Infections in the Eastern United States, 2003-2007	PLOS ONE			English	Article								Background: Although La Crosse virus (LACV) is one of the most common causes of pediatric arboviral infections in the United States, little has been done to assess its geographic distribution, identify areas of higher risk of disease, and to provide a national picture of its clinical presentation. Therefore, the objective of this study was to investigate the geographic distribution of LACV infections reported in the United States, to identify hot-spots of infection, and to present its clinical picture. Methods and Findings: Descriptive and cluster analyses were performed on probable and confirmed cases of LACV infections reported to the Centers for Disease Control and Prevention from 2003-2007. A total of 282 patients had reported confirmed LACV infections during the study period. Of these cases the majority (81 percent) presented during the summer, occurred in children 15 years and younger (83.3 percent), and were found in male children (64.9 percent). Clinically, the infections presented as meningioencephalitis (56.3 percent), encephalitis (20.7 percent), meningitis (17.2 percent), or uncomplicated fever (5 percent). Deaths occurred in 1.9 percent of confirmed cases, and in 8.6 percent of patients suffering from encephalitis. The majority of these deaths were in patients 15 years and younger. The county-level incidence risk among counties (n = 136) reporting both probable and confirmed cases for children 15 years and younger (n = 355) ranged from 0.2 to 228.7 per 100,000 persons. The southern United States experienced a significantly higher (p < 0.05) incidence risk during the months of June, July, August, and October then the northern United States. There was significant (p < 0.05) clustering of high risk in several geographic regions with three deaths attributed to complications from LAC encephalitis occurring in two of these hot-spots of infections. Conclusions: Both the incidence risk and case fatality rates were found to be higher than previously reported. We detected clustering in four geographic regions, a shift from the prior geographic distributions, and developed maps identifying high-risk areas. These findings are useful for raising awareness among health care providers regarding areas at a high risk of infections and for guiding targeted multifaceted interventions by public health officials.			Haddow, AD (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	adhaddow@gmail.com	Odoi, Agricola/I-9532-2019; Haddow, Andrew/A-7507-2011; Haddow, Andrew/C-5902-2008	Odoi, Agricola/0000-0001-5050-6737; Haddow, Andrew/0000-0002-8957-2608				ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; BALFOUR HH, 1973, PEDIATRICS, V52, P680; BATES M, 1946, AM J TROP MED, V26, P585, DOI 10.4269/ajtmh.1946.s1-26.585; BEATY BJ, 1991, CURR TOP MICROBIOL, V169, P27; BERNARDINELLI L, 1992, STAT MED, V11, P983, DOI 10.1002/sim.4780110802; Bithell JF, 2000, STAT MED, V19, P2203, DOI 10.1002/1097-0258(20000915/30)19:17/18<2203::AID-SIM564>3.0.CO;2-U; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; *CDC, 2004, NEUR NONN DOM ARB DI; CHUN RWM, 1968, NEUROLOGY, V18, P369; Darsie R.F. Jr, 1981, Mosquito Systematics Supplement, V1, P1; Gabitzsch ES, 2006, J MED ENTOMOL, V43, P850, DOI 10.1603/0022-2585(2006)43[850:EOLCVI]2.0.CO;2; Grimstad P. R., 1988, The arboviruses: epidemiology and ecology. Volume II., P99; GRIMSTAD PR, 1984, AM J EPIDEMIOL, V119, P913, DOI 10.1093/oxfordjournals.aje.a113814; Gundersen C B, 1983, Prog Clin Biol Res, V123, P169; HILTY MD, 1972, AM J DIS CHILD, V124, P530, DOI 10.1001/archpedi.1972.02110160068006; Huang C, 1997, VIRUS RES, V48, P143, DOI 10.1016/S0168-1702(97)01437-8; HURWITZ ES, 1983, VECTOR-BORNE ZOONOT, V32, P595; Jones TF, 1999, CLIN INFECT DIS, V28, P93, DOI 10.1086/515087; KAPPUS KD, 1982, AM J TROP MED HYG, V31, P556, DOI 10.4269/ajtmh.1982.31.556; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; KSIAZEK TG, 1977, AM J TROP MED HYG, V26, P815, DOI 10.4269/ajtmh.1977.26.815; LaBeaud AD, 2006, PEDIATR INFECT DIS J, V25, P751, DOI 10.1097/01.inf.0000227830.73271.65; McJunkin JE, 1998, INFECT DIS CLIN N AM, V12, P83, DOI 10.1016/S0891-5520(05)70410-4; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; MILLER BR, 1979, AM J TROP MED HYG, V28, P897, DOI 10.4269/ajtmh.1979.28.897; MONATH TPC, 1970, AM J EPIDEMIOL, V92, P40, DOI 10.1093/oxfordjournals.aje.a121178; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; MOULTON DW, 1971, AM J TROP MED HYG, V20, P474, DOI 10.4269/ajtmh.1971.20.474; Nasci RS, 2000, J MED ENTOMOL, V37, P559, DOI 10.1603/0022-2585-37.4.559; ODOI A, 2003, CANADA INT J HLTH GE, V2, P5, DOI DOI 10.1186/1476-072X-2-5; PANTUWATANA S, 1974, AM J TROP MED HYG, V23, P246; Reimann CA, 2008, AM J TROP MED HYG, V79, P974, DOI 10.4269/ajtmh.2008.79.974; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rust RS, 1999, J CHILD NEUROL, V14, P1, DOI 10.1177/088307389901400101; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P230, DOI 10.1093/oxfordjournals.aje.a120511; THOMPSON WH, 1977, SCIENCE, V196, P530, DOI 10.1126/science.850794; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P245, DOI 10.1093/oxfordjournals.aje.a120512; Tsai T F, 1991, Infect Dis Clin North Am, V5, P73; *US BUR CENS, 2000, DEC CENS SUM FIL 1; *US BUR CENS, CART BOUND FIL; WATTS DM, 1973, SCIENCE, V182, P1140, DOI 10.1126/science.182.4117.1140; WATTS DM, 1972, J MED ENTOMOL, V9, P125, DOI 10.1093/jmedent/9.2.125; MMWR MORB MORTAL WKL, V37, P79	43	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6145	10.1371/journal.pone.0006145	http://dx.doi.org/10.1371/journal.pone.0006145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19582158	gold, Green Published, Green Submitted			2022-12-27	WOS:000267806300014
J	Gundemir, S; Johnson, GVW				Gundemir, Soner; Johnson, Gail V. W.			Intracellular Localization and Conformational State of Transglutaminase 2: Implications for Cell Death	PLOS ONE			English	Article								Transglutaminase 2 (TG2) is a multifunctional enzyme that has guanine nucleotide binding and GTP hydrolyzing activity in addition to its transamidating function. Studies show that TG2 is a player in mediating cell death processes. However, there is far from a consensus about the role of this enzyme in cell death processes as it appears to be dependent upon the cell type, stimuli, subcellular localization and conformational state of the enzyme. The purpose of this study was to dissect the role of TG2 in the cell death processes. To this end, we created and characterized 4 distinct point mutants of TG2, each of which differs from the wild type by its conformation or by lacking an important function. We also prepared these mutants as nuclear targeted proteins. By overexpressing mutant or wild type forms of TG2 in HEK 293 cells, we investigated the modulatory role of the protein in the cell death process in response to three stressors: thapsigargin, hyperosmotic stress and oxygen/glucose deprivation (OGD). All of the TG2 constructs, except the R580A mutant (which cannot bind guanine nucleotides and is therefore more prone to exhibit transamidating activity), either did not significantly affect the cell death processes or were protective. However in the case of the R580A mutant, cell death in response to high thapsigargin concentrations, was significantly increased. Intriguingly, nuclear localization of R580A-TG2 was sufficient to counteract the pro-death role of cytoplasmic R580A-TG2. In addition, nuclear localization of TG2 significantly facilitated its protective role against OGD. Our data support the hypothesis that the transamidation activity of TG2, which is mostly quiescent except in extreme stress conditions, is necessary for its pro-death role. In addition, nuclear localization of TG2 generally plays a key role in its protective function against cell death processes, either counteracting the detrimental effect or strengthening the protective role of the protein.			Gundemir, S (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA.	gail_johnsonvoll@urmc.rochester.edu	Johnson, Gail V.W./K-4723-2012	Johnson, Gail V.W./0000-0003-3464-0404; Gundemir, Soner/0000-0002-9997-3552	NATIONAL INSTITUTE ON AGING [R01AG012396] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG012396, AG012396] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; Akar U, 2007, MOL CANCER RES, V5, P241, DOI 10.1158/1541-7786.MCR-06-0229; Akimov SS, 2001, J CELL SCI, V114, P2989; Antonyak MA, 2006, P NATL ACAD SCI USA, V103, P18609, DOI 10.1073/pnas.0604844103; Bailey CDC, 2004, MOL CELL NEUROSCI, V25, P493, DOI 10.1016/j.mcn.2003.11.016; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Boehm JE, 2002, J BIOL CHEM, V277, P20127, DOI 10.1074/jbc.C200147200; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Casadio R, 1999, EUR J BIOCHEM, V262, P672, DOI 10.1046/j.1432-1327.1999.00437.x; Chen JSK, 1999, INT J BIOCHEM CELL B, V31, P817, DOI 10.1016/S1357-2725(99)00045-X; Criollo A, 2007, APOPTOSIS, V12, P3, DOI 10.1007/s10495-006-0328-x; Datta S, 2007, BIOCHEMISTRY-US, V46, P14819, DOI 10.1021/bi701422h; Datta S, 2006, BIOCHEMISTRY-US, V45, P13163, DOI 10.1021/bi0606795; Fesus L, 2005, FEBS LETT, V579, P3297, DOI 10.1016/j.febslet.2005.03.063; Filiano AJ, 2008, FASEB J, V22, P2662, DOI 10.1096/fj.07-097709; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Hasegawa G, 2003, BIOCHEM J, V373, P793, DOI 10.1042/BJ20021084; Jones RA, 1997, J CELL SCI, V110, P2461; Korge P, 1999, EUR J BIOCHEM, V265, P273, DOI 10.1046/j.1432-1327.1999.00724.x; Krasnikov BF, 2005, BIOCHEMISTRY-US, V44, P7830, DOI 10.1021/bi0500877; Lai TS, 2007, FASEB J, V21, P4131, DOI 10.1096/fj.06-7598com; Lesort M, 1998, J BIOL CHEM, V273, P11991, DOI 10.1074/jbc.273.20.11991; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Milakovic T, 2004, J BIOL CHEM, V279, P8715, DOI 10.1074/jbc.M308479200; Mishra S, 2004, J BIOL CHEM, V279, P23863, DOI 10.1074/jbc.M311919200; Mishra S, 2007, J BIOL CHEM, V282, P18108, DOI 10.1074/jbc.M607413200; Murthy SNP, 2002, P NATL ACAD SCI USA, V99, P2738, DOI 10.1073/pnas.052715799; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Piacentini M, 2002, J NEUROCHEM, V81, P1061; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Ruan QM, 2008, INT J CLIN EXP MED, V1, P248; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Szondy Z, 2006, CELL DEATH DIFFER, V13, P1827, DOI 10.1038/sj.cdd.4401889; THORPE GHG, 1986, METHOD ENZYMOL, V133, P331; Tucholski J, 1999, J NEUROCHEM, V73, P1871; Tucholski J, 2002, J NEUROCHEM, V81, P780, DOI 10.1046/j.1471-4159.2002.00859.x; Tucholski J, 2001, NEUROSCIENCE, V102, P481, DOI 10.1016/S0306-4522(00)00482-6; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Yamaguchi H, 2006, MOL CELL BIOL, V26, P569, DOI 10.1128/MCB.26.2.569-579.2006; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288	43	58	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6123	10.1371/journal.pone.0006123	http://dx.doi.org/10.1371/journal.pone.0006123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568436	Green Published, gold, Green Submitted			2022-12-27	WOS:000267572200021
J	Deb, C; Lee, CM; Dubey, VS; Daniel, J; Abomoelak, B; Sirakova, TD; Pawar, S; Rogers, L; Kolattukudy, PE				Deb, Chirajyoti; Lee, Chang-Muk; Dubey, Vinod S.; Daniel, Jaiyanth; Abomoelak, Bassam; Sirakova, Tatiana D.; Pawar, Santosh; Rogers, Linda; Kolattukudy, Pappachan E.			A Novel In Vitro Multiple-Stress Dormancy Model for Mycobacterium tuberculosis Generates a Lipid-Loaded, Drug-Tolerant, Dormant Pathogen	PLOS ONE			English	Article								Background: Mycobacterium tuberculosis (Mtb) becomes dormant and phenotypically drug resistant when it encounters multiple stresses within the host. Inability of currently available drugs to kill latent Mtb is a major impediment to curing and possibly eradicating tuberculosis (TB). Most in vitro dormancy models, using single stress factors, fail to generate a truly dormant Mtb population. An in vitro model that generates truly dormant Mtb cells is needed to elucidate the metabolic requirements that allow Mtb to successfully go through dormancy, identify new drug targets, and to screen drug candidates to discover novel drugs that can kill dormant pathogen. Methodology/Principal Findings: We developed a novel in vitro multiple-stress dormancy model for Mtb by applying combined stresses of low oxygen (5%), high CO2 (10%), low nutrient (10% Dubos medium) and acidic pH (5.0), conditions Mtb is thought to encounter in the host. Under this condition, Mtb stopped replicating, lost acid-fastness, accumulated triacylglycerol (TG) and wax ester (WE), and concomitantly acquired phenotypic antibiotic-resistance. Putative neutral lipid biosynthetic genes were up-regulated. These genes may serve as potential targets for new antilatency drugs. The triacylglycerol synthase1 (tgs1) deletion mutant, with impaired ability to accumulate TG, exhibited a lesser degree of antibiotic tolerance and complementation restored antibiotic tolerance. Transcriptome analysis with microarray revealed the achievement of dormant state showing repression of energy generation, transcription and translation machineries and induction of stress-responsive genes. We adapted this model for drug screening using the Alamar Blue dye to quantify the antibiotic tolerant dormant cells. Conclusions/Significance: The new in vitro multiple stress dormancy model efficiently generates Mtb cells meeting all criteria of dormancy, and this method is adaptable to high-throughput screening for drugs that can kill dormant Mtb. A critical link between storage-lipid accumulation and development of phenotypic drug-resistance in Mtb was established. Storage lipid biosynthetic genes may be appropriate targets for novel drugs that can kill latent Mtb.			Deb, C (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	pk@mail.ucf.edu	Lee, ChangMuk/C-9988-2010; kolattukudy, pappachan e/A-1350-2012	Lee, ChangMuk/0000-0001-9258-395X; 	NIAID NIH HHS [R01 AI035272] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035272] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander PE, 2007, CAN J INFECT DIS MED, V18, P289, DOI 10.1155/2007/986794; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Betts JC, 2003, ANTIMICROB AGENTS CH, V47, P2903, DOI 10.1128/AAC.47.9.2903-2913.2003; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; BURDON KL, 1946, J BACTERIOL, V52, P665, DOI 10.1128/JB.52.6.665-678.1946; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; COOPER A, 2005, ANIMAL MODELS TUBERC; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; DANNENBERG AM, 1997, PATHOGENESIS PULMONA; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; DUBOS RJ, 1953, J EXP MED, V97, P357, DOI 10.1084/jem.97.3.357; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FIELDS RD, 1993, AM BIOTECHNOL LAB, V11, P48; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Gupta S, 2005, IUBMB LIFE, V57, P149, DOI 10.1080/15216540500090611; HAAPANEN JH, 1959, AM REV RESPIR DIS, V80, P1; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; JACKSON SK, 1989, BRIT J EXP PATHOL, V70, P435; Karakousis PC, 2008, J ANTIMICROB CHEMOTH, V61, P323, DOI 10.1093/jac/dkm485; Kendall SL, 2004, TRENDS MICROBIOL, V12, P537, DOI 10.1016/j.tim.2004.10.005; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; KIKUCHI S, 1992, ARCH BIOCHEM BIOPHYS, V295, P318, DOI 10.1016/0003-9861(92)90524-Z; KOLATTUK.PE, 1967, BIOCHEMISTRY-US, V6, P2705, DOI 10.1021/bi00861a010; KOLATTUK.PE, 1970, BIOCHEMISTRY-US, V9, P1095, DOI 10.1021/bi00807a007; Kolattukudy P.E., 1976, CHEM BIOCH NATURAL W; KORNBERG HL, 1957, NATURE, V180, P35, DOI 10.1038/180035a0; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; NYKA W, 1977, Materia Medica Polona, V9, P175; NYKA W, 1963, AM REV RESPIR DIS, V88, P670; NYKA W, 1974, INFECT IMMUN, V9, P843, DOI 10.1128/IAI.9.5.843-850.1974; Ohno H, 2003, CELL MICROBIOL, V5, P637, DOI 10.1046/j.1462-5822.2003.00307.x; Opie EL, 1927, ARCH PATHOL LAB MED, V4, P1; Palomino JC, 1999, EUR J CLIN MICROBIOL, V18, P380, DOI 10.1007/PL00015025; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Russell DG, 2003, NAT CELL BIOL, V5, P776, DOI 10.1038/ncb0903-776; Saviola B, 2003, INFECT IMMUN, V71, P1379, DOI 10.1128/IAI.71.3.1379-1388.2003; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Vioque J, 1997, ARCH BIOCHEM BIOPHYS, V340, P64, DOI 10.1006/abbi.1997.9932; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2004, TUBERCULOSIS, V84, P138, DOI 10.1016/j.tube.2003.12.008; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Waltermann M, 2007, BIOCHIMIE, V89, P230, DOI 10.1016/j.biochi.2006.07.013; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; *WHO, 2008, TUB FACTS, P5; YAJKO DM, 1995, J CLIN MICROBIOL, V33, P2324, DOI 10.1128/JCM.33.9.2324-2327.1995; Yang Y, 2002, MED PHYS, V29, P2024, DOI 10.1118/1.1500767; Zahrt TC, 2003, MICROBES INFECT, V5, P159, DOI 10.1016/S1286-4579(02)00083-7; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	66	285	296	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6077	10.1371/journal.pone.0006077	http://dx.doi.org/10.1371/journal.pone.0006077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562030	gold, Green Published, Green Submitted			2022-12-27	WOS:000267465900012
J	Robey, RC; Lagos, D; Gratrix, F; Henderson, S; Matthews, NC; Vart, RJ; Bower, M; Boshoff, C; Gotch, FM				Robey, Rebecca C.; Lagos, Dimitrios; Gratrix, Fiona; Henderson, Stephen; Matthews, Nick C.; Vart, Richard J.; Bower, Mark; Boshoff, Chris; Gotch, Frances M.			The CD8 and CD4 T-Cell Response against Kaposi's Sarcoma-Associated Herpesvirus Is Skewed Towards Early and Late Lytic Antigens	PLOS ONE			English	Article								Kaposi's sarcoma-associated herpesvirus (KSHV) is causally related to Kaposi's sarcoma (KS), the most common malignancy in untreated individuals with HIV/AIDS. The adaptive T-cell immune response against KSHV has not been fully characterized. To achieve a better understanding of the antigenic repertoire of the CD8 and CD4 T-cell responses against KSHV, we constructed a library of lentiviral expression vectors each coding for one of 31 individual KSHV open reading frames (ORFs). We used these to transduce monocyte-derived dendritic cells (moDCs) isolated from 14 KSHV-seropositive (12 HIV-positive) and 7 KSHV-seronegative (4 HIV-positive) individuals. moDCs were transduced with up to 3 KSHV ORFs simultaneously (ORFs grouped according to their expression during the viral life cycle). Transduced moDCs naturally process the KSHV genes and present the resulting antigens in the context of MHC class I and II. Transduced moDCs were cultured with purified autologous T cells and the CD8 and CD4 T-cell proliferative responses to each KSHV ORF (or group) was assessed using a CFSE dye-based assay. Two pools of early lytic KSHV genes ([ORF8/ORF49/ORF61] and [ORF59/ORF65/K4.1]) were frequently-recognized targets of both CD8 and CD4 T cells from KSHV seropositive individuals. One pool of late lytic KSHV genes ([ORF28/ORF36/ORF37]) was a frequently-recognized CD8 target and another pool of late genes ([ORF33/K1/K8.1]) was a frequently-recognized CD4 target. We report that both the CD8 and CD4 T-cell responses against KSHV are skewed towards genes expressed in the early and late phases of the viral lytic cycle, and identify some previously unknown targets of these responses. This knowledge will be important to future immunological investigations into KSHV and may eventually lead to the development of better immunotherapies for KSHV-related diseases.			Robey, RC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England.	f.gotch@imperial.ac.uk		Lagos, Dimitris/0000-0003-0637-281X; Bower, Mark/0000-0002-4077-6351; Henderson, Stephen/0000-0002-9032-3828	Medical Research Council [G0800168, G0501957] Funding Source: Medline; MRC [G0800168, G0501957] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barozzi P, 2008, TRANSPLANTATION, V86, P738, DOI 10.1097/TP.0b013e318184112c; Bihl F, 2007, AIDS, V21, P1245, DOI 10.1097/QAD.0b013e328182df03; Bihl F, 2007, J VIROL, V81, P4904, DOI 10.1128/JVI.02509-06; Boshoff C, 2002, NAT REV CANCER, V2, P373, DOI 10.1038/nrc797; Bourboulia D, 2004, AIDS, V18, P485, DOI 10.1097/00002030-200402200-00015; Brander C, 2001, J INFECT DIS, V184, P119, DOI 10.1086/322003; Breckpot K, 2004, J IMMUNOL, V172, P2232, DOI 10.4049/jimmunol.172.4.2232; Carlsson B, 2003, BRIT J HAEMATOL, V121, P428, DOI 10.1046/j.1365-2141.2003.04300.x; Cattelan AM, 1999, EUR J CANCER, V35, P1809, DOI 10.1016/S0959-8049(99)00161-6; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chen Xiaochuan, 2004, Retrovirology, V1, P37, DOI 10.1186/1742-4690-1-37; Chinnasamy N, 2000, HUM GENE THER, V11, P1901, DOI 10.1089/10430340050129512; Collins MK, 2004, TRENDS BIOTECHNOL, V22, P623, DOI 10.1016/j.tibtech.2004.10.006; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Dullaers M, 2004, MOL THER, V10, P768, DOI 10.1016/j.ymthe.2004.07.017; Dyall J, 2001, BLOOD, V97, P114, DOI 10.1182/blood.V97.1.114; Esslinger C, 2002, HUM GENE THER, V13, P1091, DOI 10.1089/104303402753812494; Firat H, 2002, J GENE MED, V4, P38, DOI 10.1002/jgm.243; Glaunsinger B, 2004, MOL CELL, V13, P713, DOI 10.1016/S1097-2765(04)00091-7; Gredmark-Russ S, 2008, J VIROL, V82, P12205, DOI 10.1128/JVI.01463-08; Gruber A, 2000, BLOOD, V96, P1327, DOI 10.1182/blood.V96.4.1327.h8001327_1327_1333; Guihot A, 2008, BLOOD, V111, P1387, DOI 10.1182/blood-2007-03-080648; Guihot A, 2006, J INFECT DIS, V194, P1078, DOI 10.1086/507648; Hamza MS, 2004, J BIOL CHEM, V279, P38325, DOI 10.1074/jbc.M400964200; He YK, 2005, J IMMUNOL, V174, P3808, DOI 10.4049/jimmunol.174.6.3808; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Jenne L, 2001, TRENDS IMMUNOL, V22, P102, DOI 10.1016/S1471-4906(00)01813-5; Jenner RG, 2002, BBA-REV CANCER, V1602, P1, DOI 10.1016/S0304-419X(01)00040-3; Jenner RG, 2001, J VIROL, V75, P891, DOI 10.1128/JVI.75.2.891-902.2001; Koya RC, 2003, J IMMUNOTHER, V26, P451, DOI 10.1097/00002371-200309000-00008; Lagos D, 2007, BLOOD, V109, P1550, DOI 10.1182/blood-2006-05-024034; Lambert M, 2006, BLOOD, V108, P3871, DOI 10.1182/blood-2006-03-014225; Landais E, 2005, INT J DEV BIOL, V49, P285, DOI 10.1387/ijdb.041947el; Lizee G, 2004, HUM GENE THER, V15, P393, DOI 10.1089/104303404322959542; Lopes L, 2006, CANCER IMMUNOL IMMUN, V55, P1011, DOI 10.1007/s00262-005-0095-5; Micheletti F, 2002, IMMUNOLOGY, V106, P395, DOI 10.1046/j.1365-2567.2002.01424.x; Osman M, 1999, J VIROL, V73, P6136, DOI 10.1128/JVI.73.7.6136-6140.1999; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Pudney VA, 2005, J EXP MED, V201, P349, DOI 10.1084/jem.20041542; Ribechini E, 2006, J IMMUNOL, V176, P923, DOI 10.4049/jimmunol.176.2.923; Schroers R, 2000, MOL THER, V1, P171, DOI 10.1006/mthe.2000.0027; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Stebbing J, 2003, J VIROL, V77, P4306, DOI 10.1128/JVI.77.7.4306-4314.2003; Steven NM, 1997, J EXP MED, V185, P1605, DOI 10.1084/jem.185.9.1605; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Vart RJ, 2007, CANCER RES, V67, P4042, DOI 10.1158/0008-5472.CAN-06-3321; Wang QJ, 2002, BLOOD, V99, P3360, DOI 10.1182/blood.V99.9.3360; Wang QJ, 2000, J INFECT DIS, V182, P928, DOI 10.1086/315777; Wilkinson J, 2002, J VIROL, V76, P2634, DOI 10.1128/JVI.76.6.2634-2640.2002; Woodberry T, 2005, J INFECT DIS, V192, P622, DOI 10.1086/432103; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005	51	23	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5890	10.1371/journal.pone.0005890	http://dx.doi.org/10.1371/journal.pone.0005890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536280	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029700003
J	Hawasli, AH; Koovakkattu, D; Hayashi, K; Anderson, AE; Powell, CM; Sinton, CM; Bibb, JA; Cooper, DC				Hawasli, Ammar H.; Koovakkattu, Della; Hayashi, Kanehiro; Anderson, Anne E.; Powell, Craig M.; Sinton, Christopher M.; Bibb, James A.; Cooper, Donald C.			Regulation of Hippocampal and Behavioral Excitability by Cyclin-Dependent Kinase 5	PLOS ONE			English	Article							FOCAL CORTICAL DYSPLASIA; SYNAPTIC VESICLE ENDOCYTOSIS; FEBRILE SEIZURES PLUS; GENERALIZED EPILEPSY; NEUROTROPHIC FACTOR; PYRAMIDAL NEURONS; SODIUM-CHANNELS; CDK5 ACTIVITY; NR2B SUBUNIT; MICE LACKING	Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/threonine kinase that has been implicated in learning, synaptic plasticity, neurotransmission, and numerous neurological disorders. We previously showed that conditional loss of Cdk5 in adult mice enhanced hippocampal learning and plasticity via modulation of calpain-mediated N-methyl-D-aspartic acid receptor ( NMDAR) degradation. In the present study, we characterize the enhanced synaptic plasticity and examine the effects of long-term Cdk5 loss on hippocampal excitability in adult mice. Field excitatory post-synaptic potentials (fEPSPs) from the Schaffer collateral CA1 subregion of the hippocampus (SC/CA1) reveal that loss of Cdk5 altered theta burst topography and enhanced post-tetanic potentiation. Since Cdk5 governs NMDAR NR2B subunit levels, we investigated the effects of long-term Cdk5 knockout on hippocampal neuronal excitability by measuring NMDAR-mediated fEPSP magnitudes and population-spike thresholds. Long-term loss of Cdk5 led to increased Mg2+-sensitive potentials and a lower threshold for epileptiform activity and seizures. Biochemical analyses were performed to better understand the role of Cdk5 in seizures. Induced-seizures in wild-type animals led to elevated amounts of p25, the Cdk5-activating cofactor. Long-term, but not acute, loss of Cdk5 led to decreased p25 levels, suggesting that Cdk5/p25 may be activated as a homeostatic mechanism to attenuate epileptiform activity. These findings indicate that Cdk5 regulates synaptic plasticity, controls neuronal and behavioral stimulus-induced excitability and may be a novel pharmacological target for cognitive and anticonvulsant therapies.			Hawasli, AH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	james.bibb@utsouthwestern.edu	Hayashi, Kanehiro/L-2777-2013	Powell, Craig/0000-0001-5451-2165	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH065975, R01MH081164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024040, K01DA017750] Funding Source: NIH RePORTER; NICHD NIH HHS [R21 HD065290-01, R21 HD065290, R21 HD065290-02] Funding Source: Medline; NIDA NIH HHS [R01 DA024040, K01 DA017750] Funding Source: Medline; NIMH NIH HHS [R01 MH081164-01A2, R01 MH081164-03, R01 MH081164-02, R01 MH081164, K08 MH065975, R01 MH081164-05, R01 MH081164-04] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arroyo S, 2002, EPILEPSIA, V43, P437, DOI 10.1046/j.1528-1157.2002.38501.x; Baulac S, 1999, AM J HUM GENET, V65, P1078, DOI 10.1086/302593; Benavides DR, 2007, J NEUROSCI, V27, P12967, DOI 10.1523/JNEUROSCI.4061-07.2007; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2003, NEUROSIGNALS, V12, P191, DOI 10.1159/000074620; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Buraei Z, 2007, NEUROPHARMACOLOGY, V52, P883, DOI 10.1016/j.neuropharm.2006.10.006; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cheng K, 2003, NEUROSIGNALS, V12, P180, DOI 10.1159/000074619; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Cooper DC, 2005, PLOS BIOL, V3, P1123, DOI 10.1371/journal.pbio.0030175; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; Evans GJO, 2007, J NEUROSCI, V27, P401, DOI 10.1523/JNEUROSCI.3809-06.2007; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2002, J NEUROSCI, V22, P3700; FISHER RS, 1991, NEUROTRANSMITTERS EP; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; FOCHTMANN LJ, 1994, PSYCHOPHARMACOL BULL, V30, P321; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gold SJ, 2002, J NEUROCHEM, V82, P828, DOI 10.1046/j.1471-4159.2002.01002.x; Graham ME, 2007, J BIOL CHEM, V282, P14695, DOI 10.1074/jbc.M609713200; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hawash Ammar H., 2007, Biotechnology Journal, V2, P941, DOI 10.1002/biot.200700093; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; Ketelaars SOM, 2001, NEUROSCIENCE, V105, P109, DOI 10.1016/S0306-4522(01)00176-2; Kramar EA, 2004, J NEUROSCI, V24, P5151, DOI 10.1523/JNEUROSCI.0800-04.2004; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lagace DC, 2008, P NATL ACAD SCI USA, V105, P18567, DOI 10.1073/pnas.0810137105; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LIANG S, 2007, J NEUROCHEM; Madeja M, 2000, EUR J NEUROSCI, V12, P1, DOI 10.1046/j.1460-9568.2000.00871.x; MCNAMARA JO, 2006, SCI STKE, pRE12, DOI DOI 10.1126/STKE.3562006RE12; Meyer DA, 2008, P NATL ACAD SCI USA, V105, P18561, DOI 10.1073/pnas.0806078105; Mikuni N, 1999, EPILEPSIA, V40, P1683, DOI 10.1111/j.1528-1157.1999.tb01584.x; Moddel G, 2005, BRAIN RES, V1046, P10, DOI 10.1016/j.brainres.2005.03.042; Mulley JC, 2003, CURR OPIN NEUROL, V16, P171, DOI 10.1097/00019052-200304000-00009; Najm IM, 2000, EPILEPSIA, V41, P971, DOI 10.1111/j.1528-1157.2000.tb00281.x; Ohmori H, 2004, ANESTH ANALG, V99, P1095, DOI 10.1213/01.ane.0000130356.22414.2b; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Patel LS, 2004, J NEUROSCI, V24, P9005, DOI 10.1523/JNEUROSCI.2943-04.2004; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; Powell CM, 2004, NEURON, V42, P143, DOI 10.1016/S0896-6273(04)00146-1; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; Sahin B, 2008, EUR J PHARMACOL, V581, P270, DOI 10.1016/j.ejphar.2007.11.061; Sananbenesi F, 2007, NAT NEUROSCI, V10, P1012, DOI 10.1038/nn1943; Sen A, 2006, J NEUROPATH EXP NEUR, V65, P55, DOI 10.1097/01.jnen.0000195940.48033.a2; Sen A, 2007, NEUROREPORT, V18, P511, DOI 10.1097/WNR.0b013e3280586879; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shuang RQ, 1998, J BIOL CHEM, V273, P4957, DOI 10.1074/jbc.273.9.4957; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Sisodiya SM, 2002, NEUROSCI LETT, V328, P217, DOI 10.1016/S0304-3940(02)00520-7; Swinyard E. A., 1972, EXPT MODELS EPILEPSY, P433; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Weber P, 2001, EUR J NEUROSCI, V14, P1777, DOI 10.1046/j.0953-816x.2001.01803.x; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Wenzel HJ, 2001, J NEUROSCI, V21, P983, DOI 10.1523/JNEUROSCI.21-03-00983.2001; Yan Z, 2002, J PHYSIOL-LONDON, V540, P761; Ying Z, 2004, EPILEPSIA, V45, P314, DOI 10.1111/j.0013-9580.2004.37703.x	69	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5808	10.1371/journal.pone.0005808	http://dx.doi.org/10.1371/journal.pone.0005808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19529798	gold, Green Submitted, Green Published			2022-12-27	WOS:000266716900013
J	George, MP; Kannass, M; Huang, L; Sciurba, FC; Morris, A				George, M. Patricia; Kannass, Mouhamed; Huang, Laurence; Sciurba, Frank C.; Morris, Alison			Respiratory Symptoms and Airway Obstruction in HIV-Infected Subjects in the HAART Era	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNODEFICIENCY-VIRUS-INFECTION; IMMUNE RECONSTITUTION; ANTIRETROVIRAL THERAPY; PULMONARY-FUNCTION; RISK-FACTORS; DISEASE; ASSOCIATION; AUTOANTIBODIES; COMPLICATIONS	Background: Prevalence and risk factors for respiratory symptoms and airway obstruction in HIV-infected subjects in the era of highly active antiretroviral therapy (HAART) are unknown. We evaluated respiratory symptoms and measured airway obstruction to identify the impact of HAART and other risk factors on respiratory symptoms and pulmonary function. Methodology/Principal Findings: Two hundred thirty-four HIV-infected adults without acute respiratory symptoms were recruited from an HIV clinic. All subjects were interviewed and performed spirometry. Multivariate linear and logistic regressions were performed to determine predictors of respiratory symptoms, forced expiratory volume in one second (FEV1) percent predicted, and FEV1/forced vital capacity (FEV1/FVC). Thirty- one percent of subjects reported at least one respiratory symptom. Smoking status (current or former versus never) (odds ratio [OR] = 2.7, 95% confidence interval [CI] = 1.41-5.22, p = 0.003), higher log plasma HIV viral levels (OR = 1.12, 95% CI = 1.02-1.24, p = 0.02), and lower FEV1/FVC (OR = 1.06 for every 0.01 decrease in FEV1/FVC, 95% CI = 1.02-1.14, p = 0.001) were independent predictors of respiratory symptoms. Age (p = 0.04), pack-year smoking history (p < 0.001), previous bacterial pneumonia (p = 0.007), and HAART use (p = 0.04) were independent predictors of decreased FEV1/FVC. Conclusions/Significance: Respiratory symptoms remain common in HIV-infected subjects, especially in those with a smoking history. Subjects who were older, had a greater pack- year history of smoking, or previous bacterial pneumonia had lower FEV1/FVC ratios. Interestingly, use of HAART was independently associated with a decreased FEV1/FVC, possibly secondary to an immune response to subclinical infections, increased autoimmunity, or other factors associated with HAART use.			George, MP (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA.	morrisa@upmc.edu	Huang, Laurence/AAZ-7120-2021; Sciurba, Frank/AAZ-9339-2021; Huang, Laurence/AAE-1590-2019	Huang, Laurence/0000-0003-3888-2195; sciurba, frank/0000-0001-7468-2225; George, Marjorie Patricia/0000-0002-6534-1020	NCRR NIH HHS [UL1 RR024153] Funding Source: Medline; NHLBI NIH HHS [HL087713, HL072837, R01 HL090335, K23 HL072837, P50 HL084948, K24 HL087713, K24 HL087713-03, HL090335, R01 HL090335-02] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL072837, P50HL084948, R01HL090335, K24HL087713] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agusti A, 2003, THORAX, V58, P832, DOI 10.1136/thorax.58.10.832; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Calabrese LH, 2005, SEMIN ARTHRITIS RHEU, V35, P166, DOI 10.1016/j.semarthrit.2005.03.007; Chen F, 2005, MEDICINE, V84, P98, DOI 10.1097/01.md.0000159082.45703.90; Crothers K, 2007, CLIN CHEST MED, V28, P575, DOI 10.1016/j.ccm.2007.06.004; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Diaz PT, 2003, CHEST, V123, P1977, DOI 10.1378/chest.123.6.1977; Diaz PT, 2000, ANN INTERN MED, V132, P369, DOI 10.7326/0003-4819-132-5-200003070-00006; Diaz PT, 1999, AM J RESP CRIT CARE, V160, P272, DOI 10.1164/ajrccm.160.1.9812089; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Ermann J, 2001, NAT IMMUNOL, V2, P759, DOI 10.1038/ni0901-759; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Hosmer DW, 1997, STAT MED, V16, P965; Huang L, 2003, J EUKARYOT MICROBIOL, V50, P616, DOI 10.1111/j.1550-7408.2003.tb00651.x; Imami N, 1999, AIDS RES HUM RETROV, V15, P1499, DOI 10.1089/088922299309784; Jubault V, 2000, J CLIN ENDOCR METAB, V85, P4254, DOI 10.1210/jc.85.11.4254; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Koppel K, 2002, J ACQ IMMUN DEF SYND, V29, P441, DOI 10.1097/00042560-200204150-00003; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Lipman M, 2006, CURR OPIN INFECT DIS, V19, P20, DOI 10.1097/01.qco.0000200543.80712.01; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MITCHELL DM, 1992, AM REV RESPIR DIS, V146, P745, DOI 10.1164/ajrccm/146.3.745; Mondal Debasis, 2004, Cardiovasc Toxicol, V4, P287, DOI 10.1385/CT:4:3:287; Morris A, 2004, AM J RESP CRIT CARE, V170, P408, DOI 10.1164/rccm.200401-094OC; Morris AM, 2000, AM J RESP CRIT CARE, V162, P612, DOI 10.1164/ajrccm.162.2.9912058; Morris DG, 2003, CHEST, V124, P929, DOI 10.1378/chest.124.3.929; O'Leary Jacqueline G, 2008, Clin Infect Dis, V46, pe12, DOI 10.1086/524082; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PAUWELS RA, 2001, AM J RESP CRIT CARE, V163, P1276; Retamales I, 2001, AM J RESP CRIT CARE, V164, P469, DOI 10.1164/ajrccm.164.3.2007149; ROSEN MJ, 1995, AM J RESP CRIT CARE, V152, P738, DOI 10.1164/ajrccm.152.2.7633736; Sethi S, 2000, CHEST, V117, p286S, DOI 10.1378/chest.117.5_suppl_1.286S; Sethi Sanjay, 2004, Proc Am Thorac Soc, V1, P109, DOI 10.1513/pats.2306029; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Wallace JM, 1997, AM J RESP CRIT CARE, V155, P72, DOI 10.1164/ajrccm.155.1.9001292; Wallace JM, 1997, CHEST, V111, P121, DOI 10.1378/chest.111.1.121; Zandman-Goddard Gisele, 2002, Autoimmunity Reviews, V1, P329, DOI 10.1016/S1568-9972(02)00086-1	41	110	114	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6328	10.1371/journal.pone.0006328	http://dx.doi.org/10.1371/journal.pone.0006328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621086	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000268147200015
J	Desclaux, M; Teigell, M; Amar, L; Vogel, R; Ribotta, MGY; Privat, A; Mallet, J				Desclaux, Mathieu; Teigell, Marisa; Amar, Lahouari; Vogel, Roland; Gimenez y Ribotta, Minerva; Privat, Alain; Mallet, Jacques			A Novel and Efficient Gene Transfer Strategy Reduces Glial Reactivity and Improves Neuronal Survival and Axonal Growth In Vitro	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; SULFATE PROTEOGLYCANS NEUROCAN; INTERMEDIATE-FILAMENT PROTEIN; PROMOTES FUNCTIONAL RECOVERY; ANTIGEN-PRESENTING CELLS; BRAIN-BARRIER PROPERTIES; LENTIVIRAL VECTORS; TENASCIN-C; T-CELLS; ASTROCYTES	Background: The lack of axonal regeneration in the central nervous system is attributed among other factors to the formation of a glial scar. This cellular structure is mainly composed of reactive astrocytes that overexpress two intermediate filament proteins, the glial fibrillary acidic protein (GFAP) and vimentin. Indeed, in vitro, astrocytes lacking GFAP or both GFAP and vimentin were shown to be the substrate for increased neuronal plasticity. Moreover, double knockout mice lacking both GFAP and vimentin presented lower levels of glial reactivity in vivo, significant axonal regrowth and improved functional recovery in comparison with wild-type mice after spinal cord hemisection. From these results, our objective was to develop a novel therapeutic strategy for axonal regeneration, based on the targeted suppression of astroglial reactivity and scarring by lentiviral-mediated RNA-interference (RNAi). Methods and Findings: In this study, we constructed two lentiviral vectors, Lv-shGFAP and Lv-shVIM, which allow efficient and stable RNAi-mediated silencing of endogenous GFAP or vimentin in vitro. In cultured cortical and spinal reactive astrocytes, the use of these vectors resulted in a specific, stable and highly significant decrease in the corresponding protein levels. In a second model - scratched primary cultured astrocytes - Lv-shGFAP, alone or associated with Lv-shVIM, decreased astrocytic reactivity and glial scarring. Finally, in a heterotopic coculture model, cortical neurons displayed higher survival rates and increased neurite growth when cultured with astrocytes in which GFAP and vimentin had been invalidated by lentiviral-mediated RNAi. Conclusions: Lentiviral-mediated knockdown of GFAP and vimentin in astrocytes show that GFAP is a key target for modulating reactive gliosis and monitoring neuron/glia interactions. Thus, manipulation of reactive astrocytes with the Lv-shGFAP vector constitutes a promising therapeutic strategy for increasing glial permissiveness and permitting axonal regeneration after central nervous system lesions.	[Desclaux, Mathieu; Amar, Lahouari; Vogel, Roland; Mallet, Jacques] Univ Paris 06, Hop La Pitie Salpetriere, INSERM,Ctr Rech,UMRS 975, CNRS,Inst Cerveau & Moelle Epiniere,UMR 7225, Paris, France; [Teigell, Marisa] NEUREVA Inc, Montpellier, France; [Gimenez y Ribotta, Minerva] Univ Miguel Hernandez UMH, Inst Neurociencias Alicante, CSIC, St Joan Dalacant Nacl, Spain; [Privat, Alain] Univ Montpellier 2, INSERM, Physiopathol & Therapie Deficits Sensoriels & Mot, U583, Montpellier, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Desclaux, M (corresponding author), Univ Paris 06, Hop La Pitie Salpetriere, INSERM,Ctr Rech,UMRS 975, CNRS,Inst Cerveau & Moelle Epiniere,UMR 7225, Paris, France.	privat@univ-montp2.fr						Amar L, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl034; Araque A, 2008, NEURON GLIA BIOL, V4, P3, DOI 10.1017/S1740925X09000064; BIGNAMI A, 1982, DEV BIOL, V91, P286, DOI 10.1016/0012-1606(82)90035-5; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; CHIU FC, 1984, J NEUROCHEM, V42, P166, DOI 10.1111/j.1471-4159.1984.tb09713.x; Couturier C, 2007, P NATL ACAD SCI USA, V104, P19476, DOI 10.1073/pnas.0706671104; DAHL D, 1981, EXP NEUROL, V73, P496, DOI 10.1016/0014-4886(81)90283-1; DAHL D, 1981, J NEUROSCI RES, V6, P741, DOI 10.1002/jnr.490060608; DRINGEN R, 1992, J NEUROCHEM, V58, P511, DOI 10.1111/j.1471-4159.1992.tb09750.x; El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; FIERZ W, 1985, J IMMUNOL, V134, P3785; FONTANA A, 1986, J NEUROIMMUNOL, V12, P15, DOI 10.1016/0165-5728(86)90093-7; Fuchs E, 1999, CELL, V98, P547, DOI 10.1016/S0092-8674(00)80041-0; Galou M, 1996, J CELL BIOL, V133, P853, DOI 10.1083/jcb.133.4.853; Ge SJ, 2004, J BIOL CHEM, V279, P6688, DOI 10.1074/jbc.M311769200; GHIRNIKAR RS, 1994, J NEUROSCI RES, V38, P376, DOI 10.1002/jnr.490380403; GIMENEZ YRM, 2000, GLIA, V31, P69, DOI DOI 10.1002/(SICI)1098-1136(200007)31:1<69::AID-GLIA70>3.0.C0;2-W; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Lefrancois T, 1997, J NEUROSCI, V17, P4121; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Menet V, 2000, GLIA, V31, P267, DOI 10.1002/1098-1136(200009)31:3<267::AID-GLIA80>3.0.CO;2-N; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Menet V, 2001, J NEUROSCI, V21, P6147; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morin-Richaud C, 1998, BRAIN RES, V783, P85, DOI 10.1016/S0006-8993(97)01282-1; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nishio T, 2005, NEUROSCIENCE, V132, P87, DOI 10.1016/j.neuroscience.2004.12.028; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 1998, GLIA, V22, P390, DOI 10.1002/(SICI)1098-1136(199804)22:4<390::AID-GLIA8>3.0.CO;2-7; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; PERTUSA M, 2007, NEUROBIOL AGING; Philippe S, 2006, P NATL ACAD SCI USA, V103, P17684, DOI 10.1073/pnas.0606197103; Potokar M, 2007, TRAFFIC, V8, P12, DOI 10.1111/j.1600-0854.2006.00509.x; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; REIER PJ, 1983, ASTROCYTIC SCAR IMPE, P163; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rozovsky I, 2005, NEUROBIOL AGING, V26, P705, DOI 10.1016/j.neurobiolaging.2004.06.009; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Vogel R, 2004, HUM GENE THER, V15, P157, DOI 10.1089/104303404772679968; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zennou V, 2001, NAT BIOTECHNOL, V19, P446, DOI 10.1038/88115; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	62	40	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6227	10.1371/journal.pone.0006227	http://dx.doi.org/10.1371/journal.pone.0006227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597552	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035600002
J	Lodes, MJ; Caraballo, M; Suciu, D; Munro, S; Kumar, A; Anderson, B				Lodes, Michael J.; Caraballo, Marcelo; Suciu, Dominic; Munro, Sandra; Kumar, Amit; Anderson, Brooke			Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray	PLOS ONE			English	Article							MICRORNA EXPRESSION; POLYMORPHISMS; BIOMARKERS; PATTERNS; SURVIVAL; TARGETS; COLON	Micro RNAs (miRNAs) are a class of small, non-coding RNA species that play critical roles throughout cellular development and regulation. miRNA expression patterns taken from various tissue types often point to the cellular lineage of an individual tissue type, thereby being a more invariant hallmark of tissue type. Recent work has shown that these miRNA expression patterns can be used to classify tumor cells, and that this classification can be more accurate than the classification achieved by using messenger RNA gene expression patterns. One aspect of miRNA biogenesis that makes them particularly attractive as a biomarker is the fact that they are maintained in a protected state in serum and plasma, thus allowing the detection of miRNA expression patterns directly from serum. This study is focused on the evaluation of miRNA expression patterns in human serum for five types of human cancer, prostate, colon, ovarian, breast and lung, using a pan-human microRNA, high density microarray. This microarray platform enables the simultaneous analysis of all human microRNAs by either fluorescent or electrochemical signals, and can be easily redesigned to include newly identified miRNAs. We show that sufficient miRNAs are present in one milliliter of serum to detect miRNA expression patterns, without the need for amplification techniques. In addition, we are able to use these expression patterns to correctly discriminate between normal and cancer patient samples.			Lodes, MJ (corresponding author), CombiMatrix Corp, Washington, DC USA.	mlodes@combimatrix.com	Munro, Sandra B/S-2611-2019	Munro, Sandra B/0000-0002-9643-0528				Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Asli NS, 2008, CURR MOL MED, V8, P698, DOI 10.2174/156652408786733739; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; CHIM SS, 2008, CLIN CHEM, V444, P291; Chin LJ, 2008, CELL RES, V18, P983, DOI 10.1038/cr.2008.290; Cleary JG, 1995, ED INN EC BUS ADM, P108; Corney DC, 2008, HISTOL HISTOPATHOL, V23, P1161, DOI 10.14670/HH-23.1161; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Eder M, 2005, NEW ENGL J MED, V352, P2446, DOI 10.1056/NEJMcibr051201; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Fontana L, 2008, BIOCHEM SOC T, V36, P1206, DOI 10.1042/BST0361206; Ghindilis AL, 2007, BIOSENS BIOELECTRON, V22, P1853, DOI 10.1016/j.bios.2006.06.024; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Jackson DB, 2009, P NATL ACAD SCI USA, V106, pE5, DOI 10.1073/pnas.0809999106; LAIOS A, 2008, MOL CANCER, V223, P7; Latronico MVG, 2008, PHYSIOL GENOMICS, V34, P239, DOI 10.1152/physiolgenomics.90254.2008; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Monzo M, 2008, CELL RES, V18, P823, DOI 10.1038/cr.2008.81; NEELY LA, 2008, UROL ONCOL      0915; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Shih KK, 2008, GYNECOL ONCOL, V110, P1, DOI 10.1016/j.ygyno.2008.05.020; Smith DD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-63; Tam W, 2008, J MOL DIAGN, V10, P411, DOI 10.2353/jmoldx.2008.080067; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Verghese ET, 2008, J PATHOL, V215, P214, DOI 10.1002/path.2359; WANG G, 2008, BIOMED GENOMICS, V9, P522; Witten I. H., 2005, DATA MINING PRACTICA; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	49	334	366	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6229	10.1371/journal.pone.0006229	http://dx.doi.org/10.1371/journal.pone.0006229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597549	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035600004
J	Fimbel, EJ; Michaud, R; Martin, M				Fimbel, Eric J.; Michaud, Rene; Martin, Mathieu			Certainty in Categorical Judgment of Size	PLOS ONE			English	Article							ABSOLUTE IDENTIFICATION; FUZZY SETS; NATURAL CATEGORIES; CONFIDENCE; MODEL; MAGNITUDE; PERCEPTION; RESOLUTION; CAPACITY; MEMORY	The certainty of judgment (or self-confidence) has been traditionally studied in relation with the accuracy. However, from an observer's viewpoint, certainty may be more closely related to the consistency of judgment than to its accuracy: consistent judgments are objectively certain in the sense that any external observer can rely on these judgments to happen. The regions of certain vs. uncertain judgment were determined in a categorical rating experiment. The participants rated the size of visual objects on a 5-point scale. There was no feedback so that there were no constraints of accuracy. Individual data was examined, and the ratings were characterized by their frequency distributions (or categories). The main result was that the individual categories always presented a core of certainty where judgment was totally consistent, and large peripheries where judgment was inconsistent. In addition, the geometry of cores and boundaries exhibited several phenomena compatible with the literature on visual categorical judgment. The ubiquitous presence of cores in absence of accuracy constraints provided insights about objective certainty that may complement the literature on subjective certainty (self-confidence) and the accuracy of judgment.			Fimbel, EJ (corresponding author), Fatronik Fdn Res Ctr, Donostia San Sebastian, Spain.	efimbel@fatronik.ca						Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Barsalou L. W., 1987, CONCEPTS CONCEPTUAL, P101; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; BILGIC T, 1999, HDB FUZZY SETS SYSTE, V1, P195; Blais AR, 2005, PERS INDIV DIFFER, V38, P1701, DOI 10.1016/j.paid.2004.11.004; BRAIDA LD, 1972, J ACOUST SOC AM, V51, P483, DOI 10.1121/1.1912868; Dale R, 2007, MEM COGNITION, V35, P15, DOI 10.3758/BF03195938; Ellison JW, 1997, J EXP PSYCHOL HUMAN, V23, P213, DOI 10.1037/0096-1523.23.1.213; Estes Z, 2004, PSYCHON B REV, V11, P1041, DOI 10.3758/BF03196734; Estes Z, 2003, MEM COGNITION, V31, P199, DOI 10.3758/BF03194379; FECHNER GT, 1860, CLASSICAL PSYCHOL, P562; Fimbel EJ, 2005, J NEUROSCI METH, V146, P183, DOI 10.1016/j.jneumeth.2005.02.007; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; GOLDSTONE R, 1994, J EXP PSYCHOL GEN, V123, P178, DOI 10.1037/0096-3445.123.2.178; Gonzalez-Vallejo C, 2007, ACTA PSYCHOL, V125, P221, DOI 10.1016/j.actpsy.2006.07.010; HAMPTON JAMES A, 1995, PSYCHOL BELG, V35, P103; Harvey N, 1997, TRENDS COGN SCI, V1, P78, DOI 10.1016/S1364-6613(97)01014-0; HAUBENSAK G, 1992, J EXP PSYCHOL HUMAN, V18, P303, DOI 10.1037/0096-1523.18.1.303; HERSH HM, 1976, J EXP PSYCHOL GEN, V105, P254, DOI 10.1037/0096-3445.105.3.254; Hornby Albert Sydney, 2005, OXFORD ADV LEARNERS, P1620; JESTEADT W, 1977, J EXP PSYCHOL HUMAN, V3, P92, DOI 10.1037/0096-1523.3.1.92; KANDEL A, 1978, P IEEE, V66, P1619, DOI 10.1109/PROC.1978.11171; Klir G.J., 1995, FUZZY SETS FUZZY LOG, DOI 10.1109/9780470544341.ch11; Koriat A, 2008, PSYCHON B REV, V15, P997, DOI 10.3758/PBR.15.5.997; Kvidera S, 2008, J BEHAV DECIS MAKING, V21, P253, DOI 10.1002/bdm.587; Lacouture Y, 1997, PSYCHOL RES-PSYCH FO, V60, P121, DOI 10.1007/BF00419760; Lacouture Y, 1995, J MATH PSYCHOL, V39, P383, DOI 10.1006/jmps.1995.1036; Lockhead GR, 2004, REV GEN PSYCHOL, V8, P265, DOI 10.1037/1089-2680.8.4.265; MARLEY AAJ, 1984, BRIT J MATH STAT PSY, V37, P136, DOI 10.1111/j.2044-8317.1984.tb00797.x; MCCLOSKEY ME, 1978, MEM COGNITION, V6, P462, DOI 10.3758/BF03197480; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; NORWICH AM, 1984, FUZZY SET SYST, V12, P1, DOI 10.1016/0165-0114(84)90047-2; Olsson H, 2000, FOOD QUAL PREFER, V11, P27, DOI 10.1016/S0950-3293(99)00026-9; PARDUCCI A, 1965, PSYCHOL REV, V72, P407, DOI 10.1037/h0022602; Pastore RE, 1987, CATEGORICAL PERCEPTI, P29; Petrov AA, 2005, PSYCHOL REV, V112, P383, DOI 10.1037/0033-295X.112.2.383; Rosch Eleanor H., 1973, COGNITIVE DEV ACQUIS, P111; Shoben EJ, 1998, J MEM LANG, V38, P94, DOI 10.1006/jmla.1997.2534; SMITH J, 1984, AM J PSYCHOL, V97, P343, DOI 10.2307/1422523; SPENCE I, 1990, J EXP PSYCHOL HUMAN, V16, P683, DOI 10.1037/0096-1523.16.4.683; STEVENS SS, 1958, AM J PSYCHOL, V71, P633, DOI 10.2307/1420322; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; WARD LM, 1972, J EXP PSYCHOL, V94, P179, DOI 10.1037/h0032754; Ward LM, 1996, PERCEPT PSYCHOPHYS, V58, P793, DOI 10.3758/BF03213110; WARD LM, 1987, J EXP PSYCHOL HUMAN, V13, P216, DOI 10.1037/0096-1523.13.2.216; Wong W, 1997, BIOSYSTEMS, V43, P189, DOI 10.1016/S0303-2647(97)00040-3; Zadeh LA, 2005, INFORM SCIENCES, V172, P1, DOI 10.1016/j.ins.2005.01.017; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6198	10.1371/journal.pone.0006198	http://dx.doi.org/10.1371/journal.pone.0006198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	471DN	19593428	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035300011
J	Jagarlamudi, K; Liu, L; Adhikari, D; Reddy, P; Idahl, A; Ottander, U; Lundin, E; Liu, K				Jagarlamudi, Krishna; Liu, Lian; Adhikari, Deepak; Reddy, Pradeep; Idahl, Annika; Ottander, Ulrika; Lundin, Eva; Liu, Kui			Oocyte-Specific Deletion of Pten in Mice Reveals a Stage-Specific Function of PTEN/PI3K Signaling in Oocytes in Controlling Follicular Activation	PLOS ONE			English	Article								Immature ovarian primordial follicles are essential for maintenance of the reproductive lifespan of female mammals. Recently, it was found that overactivation of the phosphatidylinositol 3-kinase (PI3K) signaling in oocytes of primordial follicles by an oocyte-specific deletion of Pten (phosphatase and tensin homolog deleted on chromosome ten), the gene encoding PI3K negative regulator PTEN, results in premature activation of the entire pool of primordial follicles, indicating that activation of the PI3K pathway in oocytes is important for control of follicular activation. To investigate whether PI3K signaling in oocytes of primary and further developed follicles also plays a role at later stages in follicular development and ovulation, we conditionally deleted the Pten gene from oocytes of primary and further developed follicles by using transgenic mice expressing zona pellucida 3 (Zp3) promoter-mediated Cre recombinase. Our results show that Pten was efficiently deleted from oocytes of primary and further developed follicles, as indicated by the elevated phosphorylation of the major PI3K downstream component Akt. However, follicular development was not altered and oocyte maturation was also normal, which led to normal fertility with unaltered litter size in the mutant mice. Our data indicate that properly controlled PTEN/PI3K-Akt signaling in oocytes is essential for control of the development of primordial follicles whereas overactivation of PI3K signaling in oocytes does not appear to affect the development of growing follicles. This suggests that there is a stage-specific function of PTEN/PI3K signaling in mouse oocytes that controls follicular activation.			Jagarlamudi, K (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	eva.lundin@medbio.umu.se; kui.liu@medchem.umu.se	Adhikari, Deepak/H-6176-2013; Reddy, Pradeep/G-1770-2014	Adhikari, Deepak/0000-0003-0656-9858; Reddy, Pradeep/0000-0002-9173-3845; Adhikari, Deepak/0000-0002-3404-8753; Liu, Lian/0000-0001-5868-4482				Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Han SJ, 2006, EMBO J, V25, P5716, DOI 10.1038/sj.emboj.7601431; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Hoshino Y, 2004, MOL REPROD DEV, V69, P77, DOI 10.1002/mrd.20150; Hoshino Y, 2008, DEV BIOL, V314, P215, DOI 10.1016/j.ydbio.2007.12.005; John GB, 2008, DEV BIOL, V321, P197, DOI 10.1016/j.ydbio.2008.06.017; John GB, 2007, REPRODUCTION, V133, P855, DOI 10.1530/REP-06-0051; Kalous J, 2006, BIOL CELL, V98, P111, DOI 10.1042/BC20050020; Kubiak JZ, 2008, INT J DEV BIOL, V52, P201, DOI 10.1387/ijdb.072337jk; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Liu K, 2006, FRONT BIOSCI-LANDMRK, V11, P126, DOI 10.2741/1785; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; Liu L, 2007, J MOL ENDOCRINOL, V38, P137, DOI 10.1677/jme.1.02027; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Reddy P, 2005, DEV BIOL, V281, P160, DOI 10.1016/j.ydbio.2005.02.013; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257	21	88	96	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6186	10.1371/journal.pone.0006186	http://dx.doi.org/10.1371/journal.pone.0006186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587782	Green Submitted, Green Published, gold			2022-12-27	WOS:000268035100010
J	Lone, AG; Deslandes, V; Nash, JHE; Jacques, M; MacInnes, JI				Lone, Abdul G.; Deslandes, Vincent; Nash, John H. E.; Jacques, Mario; MacInnes, Janet I.			Modulation of Gene Expression in Actinobacillus pleuropneumoniae Exposed to Bronchoalveolar Fluid	PLOS ONE			English	Article							DIMETHYL-SULFOXIDE REDUCTASE; NONTYPABLE HAEMOPHILUS-INFLUENZAE; ANAEROBIC NITRATE REDUCTASE; MYCOBACTERIUM-BOVIS BCG; NADH-QUINONE REDUCTASE; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; VIRULENCE PROPERTIES; SELECTIVE CAPTURE; FATTY-ACID	Background: Actinobacillus pleuropneumoniae, the causative agent of porcine contagious pleuropneumonia, is an important pathogen of swine throughout the world. It must rapidly overcome the innate pulmonary immune defenses of the pig to cause disease. To better understand this process, the objective of this study was to identify genes that are differentially expressed in a medium that mimics the lung environment early in the infection process. Methods and Principal Findings: Since bronchoalveolar lavage fluid (BALF) contains innate immune and other components found in the lungs, we examined gene expression of a virulent serovar 1 strain of A. pleuropneumoniae after a 30 min exposure to BALF, using DNA microarrays and real-time PCR. The functional classes of genes found to be up-regulated most often in BALF were those encoding proteins involved in energy metabolism, especially anaerobic metabolism, and in cell envelope, DNA, and protein biosynthesis. Transcription of a number of known virulence genes including apxIVA and the gene for SapF, a protein which is involved in resistance to antimicrobial peptides, was also up-regulated in BALF. Seventy-nine percent of the genes that were up-regulated in BALF encoded a known protein product, and of these, 44% had been reported to be either expressed in vivo and/or involved in virulence. Conclusions: The results of this study suggest that in early stages of infection, A. pleuropneumoniae may modulate expression of genes involved in anaerobic energy generation and in the synthesis of proteins involved in cell wall biogenesis, as well as established virulence factors. Given that many of these genes are thought to be expressed in vivo or involved in virulence, incubation in BALF appears, at least partially, to simulate in vivo conditions and may provide a useful medium for the discovery of novel vaccine or therapeutic targets.			Lone, AG (corresponding author), Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada.	macinnes@uoguelph.ca	Jacques, Mario/D-4901-2015; Deslandes, Vincent/AIF-4404-2022; Nash, John HE/P-2384-2017	Deslandes, Vincent/0000-0003-2970-5496; Nash, John HE/0000-0003-2925-8710				Baltes N, 2005, INFECT IMMUN, V73, P4614, DOI 10.1128/IAI.73.8.4614-4619.2005; Baltes N, 2004, INFECT IMMUN, V72, P6711, DOI 10.1128/IAI.72.11.6711-6716.2004; Baltes N, 2004, VET MICROBIOL, V102, P67, DOI 10.1016/j.vetmic.2004.05.002; Baltes N, 2003, INFECT IMMUN, V71, P6784, DOI 10.1128/IAI.71.12.6784-6792.2003; Baltes N, 2007, VET MICROBIOL, V123, P110, DOI 10.1016/j.vetmic.2007.03.026; Bandara AB, 2003, INFECT IMMUN, V71, P3320, DOI 10.1128/IAI.71.6.3320-3328.2003; BANNAN JD, 1993, J BACTERIOL, V175, P7228, DOI 10.1128/JB.175.22.7228-7235.1993; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; BILOUS PT, 1985, J BACTERIOL, V162, P1151, DOI 10.1128/JB.162.3.1151-1155.1985; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; BUETTNER FF, 2009, PROTEOMICS      0402; BYRD W, 1989, INFECT IMMUN, V57, P3901, DOI 10.1128/IAI.57.12.3901-3906.1989; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; Chen HY, 2000, BIOCHEM BIOPH RES CO, V269, P743, DOI 10.1006/bbrc.1999.1506; Chiu HC, 2007, HELICOBACTER, V12, P74; Cho WS, 2001, J COMP PATHOL, V125, P34, DOI 10.1053/jcpa.2001.0474; CLIFTON SW, 1994, GENE, V146, P95, DOI 10.1016/0378-1119(94)90840-0; Contreras I, 1997, MICROBIOL-UK, V143, P2665, DOI 10.1099/00221287-143-8-2665; COSTA C, 1990, FEBS LETT, V276, P67, DOI 10.1016/0014-5793(90)80508-G; Cruz WT, 1996, INFECT IMMUN, V64, P83, DOI 10.1128/IAI.64.1.83-90.1996; DeckersHebestreit G, 1996, ANNU REV MICROBIOL, V50, P791, DOI 10.1146/annurev.micro.50.1.791; Deslandes V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-72; DIDEBERG O, 1982, NATURE, V299, P469, DOI 10.1038/299469a0; DIESTERHAFT MD, 1973, J BIOL CHEM, V248, P6062; DiRita VJ, 2000, PHILOS T R SOC B, V355, P657, DOI 10.1098/rstb.2000.0606; Ekerhovd E, 2001, HUM REPROD, V16, P1334, DOI 10.1093/humrep/16.7.1334; Ellis G, 1998, CLIN BIOCHEM, V31, P195, DOI 10.1016/S0009-9120(98)00015-0; Fadeeva MS, 2008, FEMS MICROBIOL LETT, V279, P116, DOI 10.1111/j.1574-6968.2007.01015.x; Foote SJ, 2008, J BACTERIOL, V190, P1495, DOI 10.1128/JB.01845-07; Fritz C, 2002, INFECT IMMUN, V70, P286, DOI 10.1128/IAI.70.1.286-291.2002; Fuller TE, 1999, MICROB PATHOGENESIS, V27, P311, DOI 10.1006/mpat.1999.0309; Fuller TE, 2000, MICROB PATHOGENESIS, V29, P39, DOI 10.1006/mpat.2000.0364; Green J, 1997, MOL MICROBIOL, V24, P593, DOI 10.1046/j.1365-2958.1997.3801737.x; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; GUNSALUS RP, 1992, J BACTERIOL, V174, P7069, DOI 10.1128/jb.174.22.7069-7074.1992; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hughes J M B, 2007, Chron Respir Dis, V4, P205, DOI 10.1177/1479972307084446; INZANA TJ, 1988, INFECT IMMUN, V56, P1880, DOI 10.1128/IAI.56.8.1880-1889.1988; INZANA TJ, 1991, MICROB PATHOGENESIS, V11, P305, DOI 10.1016/0882-4010(91)90016-4; Jacobsen I, 2005, INFECT IMMUN, V73, P226, DOI 10.1128/IAI.73.1.226-234.2005; JENKINS DE, 1991, J BACTERIOL, V173, P1992, DOI 10.1128/jb.173.6.1992-1996.1991; Jolly L, 2000, J BACTERIOL, V182, P1280, DOI 10.1128/JB.182.5.1280-1285.2000; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; KELLY JA, 1985, J BIOL CHEM, V260, P6449; Kendall M, 2002, AM J PHYSIOL-LUNG C, V282, pL109, DOI 10.1152/ajplung.2002.282.1.L109; Kharat AS, 2006, ACTA BIOCHIM POL, V53, P729, DOI 10.18388/abp.2006_3300; Kizil G, 2000, J MED MICROBIOL, V49, P669, DOI 10.1099/0022-1317-49-7-669; Kogure K, 1998, CURR OPIN BIOTECH, V9, P278, DOI 10.1016/S0958-1669(98)80059-1; Kreuzer KN, 2005, ANNU REV MICROBIOL, V59, P43, DOI 10.1146/annurev.micro.59.030804.121255; Labrie J, 2002, J ENDOTOXIN RES, V8, P27, DOI [10.1179/096805102125000065, 10.1177/09680519020080010301]; Lee CR, 2007, P NATL ACAD SCI USA, V104, P4124, DOI 10.1073/pnas.0609897104; Maeda T, 2008, MICROB BIOTECHNOL, V1, P30, DOI 10.1111/j.1751-7915.2007.00003.x; Mason KM, 2006, MOL MICROBIOL, V62, P1357, DOI 10.1111/j.1365-2958.2006.05460.x; Mason KM, 2005, INFECT IMMUN, V73, P599, DOI 10.1128/IAI.73.1.599-608.2005; MAYES PA, 2000, HARPERS BIOCH, P190; MENGINLECREULX D, 2005, J BIOL CHEM, V272, P1243; Meyer KC, 2000, CHEST, V118, P164, DOI 10.1378/chest.118.1.164; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Munkelt D, 2004, J BACTERIOL, V186, P8036, DOI 10.1128/JB.186.23.8036-8043.2004; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; Oikawa T, 2006, J BIOTECHNOL, V125, P503, DOI 10.1016/j.jbiotec.2006.04.002; Osicka R, 2001, INFECT IMMUN, V69, P5509; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Potter LC, 1999, BIOCHEM J, V344, P77, DOI 10.1042/0264-6021:3440077; Rashid N, 2004, J BACTERIOL, V186, P4185, DOI 10.1128/JB.186.13.4185-4191.2004; Rycroft AN, 2000, VET J, V159, P18, DOI 10.1053/tvjl.1999.0403; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Sato H, 2009, INT J CHEM ENG, V2009, DOI 10.1155/2009/843274; Schaller A, 1999, MICROBIOL-SGM, V145, P2105, DOI 10.1099/13500872-145-8-2105; SCHELLENBERG GD, 1984, J BIOL CHEM, V259, P6826; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnapp D, 1998, AM J RESP CELL MOL, V19, P352, DOI 10.1165/ajrcmb.19.3.3384; Schulz H, 1999, P NATL ACAD SCI USA, V96, P6462, DOI 10.1073/pnas.96.11.6462; SCHUMANN P, 1998, MATURATION PHENOMENO, V3, P95; Schwab U, 2009, MICROB PATHOGENESIS, V46, P185, DOI 10.1016/j.micpath.2008.12.006; SEBUNYA TNK, 1983, J AM VET MED ASSOC, V182, P1331; Sheehan BJ, 2003, INFECT IMMUN, V71, P3960, DOI 10.1128/IAI.71.7.3960-3970.2003; Shelburne SA, 2008, MOL MICROBIOL, V69, P436, DOI 10.1111/j.1365-2958.2008.06290.x; SOLTES GA, 1994, MICROBIOL-SGM, V140, P839, DOI 10.1099/00221287-140-4-839; SPIRO S, 1990, FEMS MICROBIOL LETT, V75, P399, DOI 10.1016/0378-1097(90)90690-R; SWEET G, 1990, J BACTERIOL, V172, P424, DOI 10.1128/JB.172.1.424-430.1990; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; UNEMOTO T, 1993, J BIOENERG BIOMEMBR, V25, P385, DOI 10.1007/BF00762464; VANHELLEMOND JJ, 1994, BIOCHEM J, V304, P321, DOI 10.1042/bj3040321; Velayudhan J, 2007, MOL MICROBIOL, V63, P1495, DOI 10.1111/j.1365-2958.2007.05600.x; Wattiez R, 2005, J CHROMATOGR B, V815, P169, DOI 10.1016/j.jchromb.2004.10.029; Weber I, 2000, MOL MICROBIOL, V35, P1017, DOI 10.1046/j.1365-2958.2000.01794.x; WEINER JH, 1988, J BACTERIOL, V170, P1505, DOI 10.1128/jb.170.4.1505-1510.1988; Wood GE, 1998, GENE, V209, P51, DOI 10.1016/S0378-1119(98)00031-6; WREN JD, 2009, BIOINFORMATICS  0515; Wright JR, 2006, AM J PHYSIOL-LUNG C, V291, pL847, DOI 10.1152/ajplung.00261.2006; Xu ZF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001450; Yan AX, 2008, J BACTERIOL, V190, P8230, DOI 10.1128/JB.01242-08; Yu BJ, 2006, FEMS MICROBIOL LETT, V254, P245, DOI 10.1111/j.1574-6968.2005.00026.x; Zaas AK, 2005, TRENDS CARDIOVAS MED, V15, P195, DOI 10.1016/j.tcm.2005.07.001; ZEBALLOS GA, 1995, CIRCULATION, V91, P2982, DOI 10.1161/01.CIR.91.12.2982; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s	105	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6139	10.1371/journal.pone.0006139	http://dx.doi.org/10.1371/journal.pone.0006139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578537	Green Submitted, Green Published, gold			2022-12-27	WOS:000267806300009
J	Gombert, WM; Krumm, A				Gombert, Wendy M.; Krumm, Anton			Targeted Deletion of Multiple CTCF-Binding Elements in the Human C-MYC Gene Reveals a Requirement for CTCF in C-MYC Expression	PLOS ONE			English	Article								Background: Insulators and domain boundaries both shield genes from adjacent enhancers and inhibit intrusion of heterochromatin into transgenes. Previous studies examined the functional mechanism of the MYC insulator element MINE and its CTCF binding sites in the context of transgenes that were randomly inserted into the genome by transfection. However, the contribution of CTCF binding sites to both gene regulation and maintenance of chromatin has not been tested at the endogenous MYC gene. Methodology/Principal Findings: To determine the impact of CTCF binding on MYC expression, a series of mutant human chromosomal alleles was prepared in homologous recombination-efficient DT40 cells and individually transferred by microcell fusion into murine cells. Functional tests reported here reveal that deletion of CTCF binding elements within the MINE does not impact the capacity of this locus to correctly organize an 'accessible' open chromatin domain, suggesting that these sites are not essential for the formation of a competent, transcriptionally active locus. Moreover, deletion of the CTCF site at the MYC P2 promoter reduces transcription but does not affect promoter acetylation or serum-inducible transcription. Importantly, removal of either CTCF site leads to DNA methylation of flanking sequences, thereby contributing to progressive loss of transcriptional activity. Conclusions: These findings collectively demonstrate that CTCF-binding at the human MYC locus does not repress transcriptional activity but is required for protection from DNA methylation.			Gombert, WM (corresponding author), Black Lowe & Graham PLLC, Seattle, WA USA.	akrumm@u.washington.edu			NCI NIH HHS [CA109597, R01 CA109597] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109597] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ameres SL, 2005, EMBO J, V24, P358, DOI 10.1038/sj.emboj.7600531; Appanah R, 2007, PLOS GENET, V3, P241, DOI 10.1371/journal.pgen.0030027; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Butcher DT, 2007, EUR J CANCER, V43, P210, DOI 10.1016/j.ejca.2006.09.002; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; Caiafa P, 2009, J CELL PHYSIOL, V219, P265, DOI 10.1002/jcp.21691; Chung HJ, 2006, MOL CELL BIOL, V26, P6584, DOI 10.1128/MCB.00754-06; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Dieken Ellen S., 1996, Methods (Orlando), V9, P56, DOI 10.1006/meth.1996.0008; Dorman ER, 2007, SEMIN CELL DEV BIOL, V18, P682, DOI 10.1016/j.semcdb.2007.08.009; Farris SD, 2005, J BIOL CHEM, V280, P25298, DOI 10.1074/jbc.M501784200; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; LUGO TG, 1987, MOL CELL BIOL, V7, P2814, DOI 10.1128/MCB.7.8.2814; Marsden MD, 2003, MOL CELL BIOL, V23, P3516, DOI 10.1128/MCB.23.10.3516-3526.2003; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhao H, 2004, NUCLEIC ACIDS RES, V32, P4903, DOI 10.1093/nar/gkh832; ZLATANOVA J, 2009, CELL MOL LIFE SCI; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	38	30	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6109	10.1371/journal.pone.0006109	http://dx.doi.org/10.1371/journal.pone.0006109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568426	Green Published, gold, Green Submitted			2022-12-27	WOS:000267572200010
J	Theys, N; Clippe, A; Bouckenooghe, T; Reusens, B; Remacle, C				Theys, Nicolas; Clippe, Andre; Bouckenooghe, Thomas; Reusens, Brigitte; Remacle, Claude			Early Low Protein Diet Aggravates Unbalance between Antioxidant Enzymes Leading to Islet Dysfunction	PLOS ONE			English	Article								Background: Islets from adult rat possess weak antioxidant defense leading to unbalance between superoxide dismutase (SOD) and hydrogen peroxide-inactivating enzymatic activities, catalase (CAT) and glutathione peroxidase (GPX) rending them susceptible to oxidative stress. We have shown that this vulnerability is influenced by maternal diet during gestation and lactation. Methodology/Principal Findings: The present study investigated if low antioxidant activity in islets is already observed at birth and if maternal protein restriction influences the development of islet antioxidant defenses. Rats were fed a control diet (C group) or a low protein diet during gestation (LP) or until weaning (LPT), after which offspring received the control diet. We found that antioxidant enzymatic activities varied with age. At birth and after weaning, normal islets possessed an efficient GPX activity. However, the antioxidant capacity decreased thereafter increasing the potential vulnerability to oxidative stress. Maternal protein malnutrition changed the antioxidant enzymatic activities in islets of the progeny. At 3 months, SOD activity was increased in LP and LPT islets with no concomitant activation of CAT and GPX. This unbalance could lead to higher hydrogen peroxide production, which may concur to oxidative stress causing defective insulin gene expression due to modification of critical factors that modulate the insulin promoter. We found indeed that insulin mRNA level was reduced in both groups of malnourished offspring compared to controls. Analyzing the expression of such critical factors, we found that c-Myc expression was strongly increased in islets from both protein-restricted groups compared to controls. Conclusion and Significance: Modification in antioxidant activity by maternal low protein diet could predispose to pancreatic islet dysfunction later in life and provide new insights to define a molecular mechanism responsible for intrauterine programming of endocrine pancreas.			Theys, N (corresponding author), Univ Catholique Louvain, Inst Life Sci, Cell Biol Lab, B-1348 Louvain, Belgium.	claude.remacle@uclouvain.be						Boujendar S, 2003, J NUTR, V133, P2820, DOI 10.1093/jn/133.9.2820; Boujendar S, 2002, DIABETOLOGIA, V45, P856, DOI 10.1007/s00125-002-0833-6; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Dumortier O, 2007, DIABETOLOGIA, V50, P2495, DOI 10.1007/s00125-007-0811-0; EL KI, 2006, AM J PHYSIOL-ENDOC M, V291, pE835; Elouil H, 2005, DIABETOLOGIA, V48, P496, DOI 10.1007/s00125-004-1664-4; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Goosse K, 2009, J ENDOCRINOL, V200, P177, DOI 10.1677/JOE-08-0234; Gurgul E, 2004, DIABETES, V53, P2271, DOI 10.2337/diabetes.53.9.2271; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; Janssens BJ, 2000, J EXP BIOL, V203, P3717; Kaneto H, 2007, ANTIOXID REDOX SIGN, V9, P355, DOI 10.1089/ars.2006.1465; Kim JA, 2005, ANAL BIOCHEM, V338, P216, DOI 10.1016/j.ab.2004.12.008; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Lortz S, 2005, DIABETOLOGIA, V48, P1541, DOI 10.1007/s00125-005-1822-3; Merezak S, 2004, DIABETOLOGIA, V47, P669, DOI 10.1007/s00125-004-1357-z; Merezak S, 2001, J ENDOCRINOL, V171, P299, DOI 10.1677/joe.0.1710299; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V271, pE1128, DOI 10.1152/ajpendo.1996.271.6.E1128; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V270, pE559, DOI 10.1152/ajpendo.1996.270.4.E559; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; PALLARDO FV, 1991, BIOCHEM J, V274, P891, DOI 10.1042/bj2740891; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Petrik J, 1998, ENDOCRINOLOGY, V139, P2994, DOI 10.1210/en.139.6.2994; Remacle C, 2007, DIABETES OBES METAB, V9, P196, DOI 10.1111/j.1463-1326.2007.00790.x; Reusens B, 2008, DIABETOLOGIA, V51, P836, DOI 10.1007/s00125-008-0956-5; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Robertson RP, 2007, CELL BIOCHEM BIOPHYS, V48, P139, DOI 10.1007/s12013-007-0026-5; Robertson RP, 2007, FEBS LETT, V581, P3743, DOI 10.1016/j.febslet.2007.03.087; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Simmons RA, 2006, FREE RADICAL BIO MED, V40, P917, DOI 10.1016/j.freeradbiomed.2005.12.018; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Sparre T, 2003, DIABETOLOGIA, V46, P1497, DOI 10.1007/s00125-003-1208-3; SuarezPinzon WL, 1997, DIABETES, V46, P907, DOI 10.2337/diabetes.46.5.907; Tabatabaie T, 2003, DIABETES, V52, P1994, DOI 10.2337/diabetes.52.8.1994; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; TARRYADKINS JL, 2009, FASEB J; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Van de Casteele M, 2003, BIOCHEM BIOPH RES CO, V312, P937, DOI 10.1016/j.bbrc.2003.11.013; Vento M, 2003, J PEDIATR-US, V142, P240, DOI 10.1067/mpd.2003.91; Wu L, 2004, J BIOL CHEM, V279, P12126, DOI 10.1074/jbc.M307097200; Zraika S, 2006, DIABETOLOGIA, V49, P1254, DOI 10.1007/s00125-006-0212-9	52	46	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6110	10.1371/journal.pone.0006110	http://dx.doi.org/10.1371/journal.pone.0006110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568427	Green Published, gold, Green Submitted			2022-12-27	WOS:000267572200011
J	Westermark, P; Lundmark, K; Westermark, GT				Westermark, Per; Lundmark, Katarzyna; Westermark, Gunilla T.			Fibrils from Designed Non-Amyloid-Related Synthetic Peptides Induce AA-Amyloidosis during Inflammation in an Animal Model	PLOS ONE			English	Article								Background: Mouse AA-amyloidosis is a transmissible disease by a prion-like mechanism where amyloid fibrils act by seeding. Synthetic peptides with no amyloid relationship can assemble into amyloid-like fibrils and these may have seeding capacity for amyloid proteins. Principal Findings: Several synthetic peptides, designed for nanotechnology, have been examined for their ability to produce fibrils with Congo red affinity and concomitant green birefringence, affinity for thioflavin S and to accelerate AA-amyloidosis in mice. It is shown that some amphiphilic fibril-forming peptides not only produced Congo red birefringence and showed affinity for thioflavin S, but they also shortened the lag phase for systemic AA-amyloidosis in mice when they were given intravenously at the time of inflammatory induction with silver nitride. Peptides, not forming amyloid-like fibrils, did not have such properties. Conclusions: These observations should caution researchers and those who work with synthetic peptides and their derivatives to be aware of the potential health concerns.			Westermark, P (corresponding author), Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden.	Per.Westermark@genpat.uu.se						AXELRAD MA, 1982, LAB INVEST, V47, P139; Bergstrom J, 2006, BIOCHEM BIOPH RES CO, V348, P532, DOI 10.1016/j.bbrc.2006.07.140; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Cui D, 2002, PATHOL INT, V52, P40, DOI 10.1046/j.1440-1827.2002.01309.x; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Fu XY, 2004, FEBS LETT, V563, P179, DOI 10.1016/S0014-5793(04)00295-9; GANOWIAK K, 1994, BIOCHEM BIOPH RES CO, V199, P306, DOI 10.1006/bbrc.1994.1229; Ge FX, 2007, LAB INVEST, V87, P633, DOI 10.1038/labinvest.3700559; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; GLENNER GG, 1974, J HISTOCHEM CYTOCHEM, V22, P1141, DOI 10.1177/22.12.1141; GUSTAVSSON A, 1991, BIOCHEM BIOPH RES CO, V175, P1159, DOI 10.1016/0006-291X(91)91687-8; Hardt F, 1976, Int Rev Exp Pathol, V16, P273; HOFFMAN JS, 1984, J EXP MED, V159, P641, DOI 10.1084/jem.159.2.641; HUSBY G, 1994, AMYLOID, V1, P119, DOI 10.3109/13506129409148635; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558; Kisilevsky R, 1999, AMYLOID, V6, P98, DOI 10.3109/13506129909007309; Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; NGUYEN J, 1995, BIOCHEMISTRY-US, V34, P4186, DOI 10.1021/bi00013a006; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Solomon A, 2007, P NATL ACAD SCI USA, V104, P10998, DOI 10.1073/pnas.0700848104; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Stevens FJ, 2004, AMYLOID, V11, P71, DOI 10.1080/13506120412331272296; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; WESTERMARK P, 1974, HISTOCHEMISTRY, V38, P27, DOI 10.1007/BF00490217; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Xing YM, 2001, LAB INVEST, V81, P493, DOI 10.1038/labinvest.3780257; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y	35	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6041	10.1371/journal.pone.0006041	http://dx.doi.org/10.1371/journal.pone.0006041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19582162	Green Published, gold, Green Submitted			2022-12-27	WOS:000267515700002
J	Kuhn, L; Aldrovandi, GM; Sinkala, M; Kankasa, C; Semrau, K; Kasonde, P; Mwiya, M; Tsai, WY; Thea, DM				Kuhn, Louise; Aldrovandi, Grace M.; Sinkala, Moses; Kankasa, Chipepo; Semrau, Katherine; Kasonde, Prisca; Mwiya, Mwiya; Tsai, Wei-Yann; Thea, Donald M.		ZEBS	Differential Effects of Early Weaning for HIV-Free Survival of Children Born to HIV-Infected Mothers by Severity of Maternal Disease	PLOS ONE			English	Article								Background: We previously reported no benefit of early weaning for HIV-free survival of children born to HIV-infected mothers in intent-to-treat analyses. Since early weaning was poorly accepted, we conducted a secondary analysis to investigate whether beneficial effects may have been hidden. Methods: 958 HIV-infected women in Lusaka, Zambia, were randomized to abrupt weaning at 4 months (intervention) or to continued breastfeeding (control). Children were followed to 24 months with regular HIV PCR tests and examinations to determine HIV infection or death. Detailed behavioral data were collected on when all breastfeeding ended. Most participants were recruited before antiretroviral treatment (ART) became available. We compared outcomes among mother-child pairs who weaned earlier or later than intended by study design adjusting for potential confounders. Results: Of infants alive, uninfected and still breastfeeding at 4 months in the intervention group, 16.1% who weaned as instructed acquired HIV or died by 24 months compared to 16.0% who did not comply (p = 0.98). Children of women with less severe disease during pregnancy (not eligible for ART) had worse outcomes if their mothers weaned as instructed (RH = 2.60 95% CI: 1.06-6.36) compared to those who continued breastfeeding. Conversely, children of mothers with more severe disease (eligible for ART but did not receive it) who weaned early had better outcomes (p-value interaction = 0.002). In the control group, weaning before 15 months was associated with 3.94-fold (95% CI: 1.65-9.39) increase in HIV infection or death among infants of mothers with less severe disease. Conclusion: Incomplete adherence did not mask a benefit of early weaning. On the contrary, for women with less severe disease, early weaning was harmful and continued breastfeeding resulted in better outcomes. For women with more advanced disease, ART should be given during pregnancy for maternal health and to reduce transmission, including through breastfeeding.			Kuhn, L (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.	lk24@columbia.edu		Semrau, Katherine/0000-0002-8360-1391; Thea, Donald/0000-0002-6933-1030	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040777, R01HD039611] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD 40777, R01 HD 39611, R01 HD040777, R01 HD039611-01, R01 HD039611] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abrams EJ, 2007, AM J OBSTET GYNECOL, V197, pS101, DOI 10.1016/j.ajog.2007.03.068; Bahl R, 2005, B WORLD HEALTH ORGAN, V83, P418; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Collett D, 1994, MODELLING SURVIVAL D; Ekpini ER, 1997, LANCET, V349, P1054, DOI 10.1016/S0140-6736(96)06444-6; Fawzi W, 2002, JAIDS-J ACQ IMM DEF, V31, P331, DOI 10.1097/00126334-200211010-00010; Ghosh MK, 2003, J CLIN MICROBIOL, V41, P2465, DOI 10.1128/JCM.41.6.2465-2470.2003; Gray GE, 2008, NEW ENGL J MED, V359, P189, DOI 10.1056/NEJMe0803991; HABICHT JP, 1986, AM J EPIDEMIOL, V123, P279, DOI 10.1093/oxfordjournals.aje.a114236; Kilewo C, 2008, JAIDS-J ACQ IMM DEF, V48, P315, DOI 10.1097/QAI.0b013e31816e395c; Kuhn L, 1997, AM J PUBLIC HEALTH, V87, P926, DOI 10.2105/AJPH.87.6.926; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; NAGELKERKE NJD, 1995, J ACQ IMMUN DEF SYND, V8, P176; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Stringer JSA, 2005, AIDS, V19, P1309, DOI 10.1097/01.aids.0000180102.88511.7d; Taha TE, 2007, J INFECT DIS, V196, P10, DOI 10.1086/518511; Thea DM, 2004, CONTROL CLIN TRIALS, V25, P353, DOI 10.1016/j.cct.2004.06.005; Tonwe-Gold B, 2007, PLOS MED, V4, P1362, DOI 10.1371/journal.pmed.0040257; Walter J, 2006, J INFECT DIS, V194, P1510, DOI 10.1086/508996; *WHO, 2007, HIV INF FEED NEW EV; World Health Organization, 2006, PLANN GUID NAT IMPL	25	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6059	10.1371/journal.pone.0006059	http://dx.doi.org/10.1371/journal.pone.0006059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557167	Green Published, gold			2022-12-27	WOS:000267424600007
J	Wong, R; Piper, MDW; Wertheim, B; Partridge, L				Wong, Richard; Piper, Matthew D. W.; Wertheim, Bregje; Partridge, Linda			Quantification of Food Intake in Drosophila	PLOS ONE			English	Article							LIFE-SPAN; DIETARY RESTRICTION; FEEDING-BEHAVIOR; RECEPTOR GENE; POPULATIONS; RESISTANCE; DEMOGRAPHY; TREHALOSE; INSIGHTS; DEATH	Measurement of food intake in the fruit fly Drosophila melanogaster is often necessary for studies of behaviour, nutrition and drug administration. There is no reliable and agreed method for measuring food intake of flies in undisturbed, steady state, and normal culture conditions. We report such a method, based on measurement of feeding frequency by proboscis-extension, validated by short-term measurements of food dye intake. We used the method to demonstrate that (a) female flies feed more frequently than males, (b) flies feed more often when housed in larger groups and (c) fly feeding varies at different times of the day. We also show that alterations in food intake are not induced by dietary restriction or by a null mutation of the fly insulin receptor substrate chico. In contrast, mutation of takeout increases food intake by increasing feeding frequency while mutation of ovo(D) increases food intake by increasing the volume of food consumed per proboscis-extension. This approach provides a practical and reliable method for quantification of food intake in Drosophila under normal, undisturbed culture conditions.			Wong, R (corresponding author), UCL, Inst Healthy Ageing, London, England.	l.partridge@ucl.ac.uk	Partridge, Linda/A-5501-2010; Partridge, Linda/E-7342-2015; Piper, Matthew/C-1714-2008; Wertheim, Bregje/B-6436-2009; Wong, Richard/H-5189-2015	Piper, Matthew/0000-0003-3245-7219; Wertheim, Bregje/0000-0001-8555-1925; Wong, Richard/0000-0002-4382-1568; Partridge, Linda/0000-0001-9615-0094	Natural Environment Research Council [NE/C508085/1] Funding Source: researchfish; Medical Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Barnes AI, 2008, P ROY SOC B-BIOL SCI, V275, P1675, DOI 10.1098/rspb.2008.0139; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Bross TG, 2005, AGING CELL, V4, P309, DOI 10.1111/j.1474-9726.2005.00181.x; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Crawley M.J, 2005, STAT INTRO; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Ishimoto H, 2000, SCIENCE, V289, P116, DOI 10.1126/science.289.5476.116; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; JOHNSON MB, 1985, J MORPHOL, V184, P51, DOI 10.1002/jmor.1051840106; Kennington WJ, 2001, HEREDITY, V87, P363, DOI 10.1046/j.1365-2540.2001.00925.x; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KIMURA M T, 1977, Kontyu, V45, P571; KING RC, 1955, J EXP ZOOL, V130, P71, DOI 10.1002/jez.1401300105; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Lints F.A., 1988, DROSOPHILA MODEL ORG; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Min KJ, 2006, MECH AGEING DEV, V127, P93, DOI 10.1016/j.mad.2005.09.004; Oishi K, 2004, NEUROREPORT, V15, P739, DOI 10.1097/00001756-200403220-00034; OLIVER B, 1987, GENE DEV, V1, P913, DOI 10.1101/gad.1.9.913; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; R Foundation for Statistical Computing, R LANG ENV STAT COMP; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; TOMPKINS L, 1979, P NATL ACAD SCI USA, V76, P884, DOI 10.1073/pnas.76.2.884; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; Weindruch R., 1988, RETARDATION AGING DI; Wertheim B, 2006, ECOL ENTOMOL, V31, P216, DOI 10.1111/j.1365-2311.2006.00757.x; Wong R, 2008, NAT METHODS, V5, P214, DOI 10.1038/nmeth0308-214; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102	41	148	151	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6063	10.1371/journal.pone.0006063	http://dx.doi.org/10.1371/journal.pone.0006063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557170	Green Published, gold, Green Submitted			2022-12-27	WOS:000267424600011
J	Ross, TM; Mahmood, K; Crevar, CJ; Schneider-Ohrum, K; Heaton, PM; Bright, RA				Ross, Ted M.; Mahmood, Kutub; Crevar, Corey J.; Schneider-Ohrum, Kirsten; Heaton, Penny M.; Bright, Rick A.			A Trivalent Virus-Like Particle Vaccine Elicits Protective Immune Responses against Seasonal Influenza Strains in Mice and Ferrets	PLOS ONE			English	Article								There is need for improved human influenza vaccines, particularly for older adults who are at greatest risk for severe disease, as well as to address the continuous antigenic drift within circulating human subtypes of influenza virus. We have engineered an influenza virus-like particle (VLP) as a new generation vaccine candidate purified from the supernatants of Sf9 insect cells following infection by recombinant baculoviruses to express three influenza virus proteins, hemagglutinin (HA), neuraminidase (NA), and matrix 1 (M1). In this study, a seasonal trivalent VLP vaccine (TVV) formulation, composed of influenza A H1N1 and H3N2 and influenza B VLPs, was evaluated in mice and ferrets for the ability to elicit antigen-specific immune responses. Animals vaccinated with the TVV formulation had hemagglutination-inhibition (HAI) antibody titers against all three homologous influenza virus strains, as well as HAI antibodies against a panel of heterologous influenza viruses. HAI titers elicited by the TVV were statistically similar to HAI titers elicited in animals vaccinated with the corresponding monovalent VLP. Mice vaccinated with the TVV had higher level of influenza specific CD8+ T cell responses than a commercial trivalent inactivated vaccine (TIV). Ferrets vaccinated with the highest dose of the VLP vaccine and then challenged with the homologous H3N2 virus had the lowest titers of replicating virus in nasal washes and showed no signs of disease. Overall, a trivalent VLP vaccine elicits a broad array of immunity and can protect against influenza virus challenge.			Ross, TM (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.	tmr15@pitt.edu						Askonas BA, 1982, BASIC APPLIED INFLUE, P159; Bower JF, 2005, CURR HIV RES, V3, P191, DOI 10.2174/1570162053506937; Bower JF, 2004, VIROLOGY, V328, P292, DOI 10.1016/j.virol.2004.07.031; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Chen WS, 2002, J VIROL, V76, P10332, DOI 10.1128/JVI.76.20.10332-10337.2002; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Gillim-Ross L, 2006, CLIN MICROBIOL REV, V19, P614, DOI 10.1128/CMR.00005-06; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; GOTCH F, 1987, J EXP MED, V165, P408, DOI 10.1084/jem.165.2.408; Haynes JR, 2009, VACCINE, V27, P530, DOI 10.1016/j.vaccine.2008.11.011; KOVACSOVICSBANKOWSKI M, 1994, EUR J IMMUNOL, V24, P2421; LIN YL, 1981, J EXP MED, V154, P225, DOI 10.1084/jem.154.2.225; LUBECK MD, 1979, VIROLOGY, V95, P269, DOI 10.1016/0042-6822(79)90430-6; Mahmood K, 2008, VACCINE, V26, P5393, DOI 10.1016/j.vaccine.2008.07.084; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; McBurney SP, 2007, VIROLOGY, V358, P334, DOI 10.1016/j.virol.2006.08.032; MCMICHAEL AJ, 1986, J GEN VIROL, V67, P719, DOI 10.1099/0022-1317-67-4-719; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; MONTO AS, 1973, LANCET, V1, P623, DOI 10.1016/S0140-6736(73)92196-X; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Palese P., 2007, FIELDS VIROLOGY; Pushko P, 2005, VACCINE, V23, P5751, DOI 10.1016/j.vaccine.2005.07.098; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; SCHULMAN JL, 1977, J VIROL, V24, P170, DOI 10.1128/JVI.24.1.170-176.1977; SCHULMAN JL, 1969, P NATL ACAD SCI USA, V63, P326, DOI 10.1073/pnas.63.2.326; SCHULMAN JL, 1969, B WORLD HEALTH ORGAN, V41, P425; Szucs TD, 2001, INFECT CONT HOSP EP, V22, P472, DOI 10.1086/503405; TAYLOR PM, 1986, IMMUNOLOGY, V58, P417; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; TOWNSEND ARM, 1982, NATURE, V300, P655, DOI 10.1038/300655a0; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, 2001, WORLD HLTH REP 2001, P49; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0; Young KR, 2006, AIDS RES HUM RETROV, V22, P99, DOI 10.1089/aid.2006.22.99	37	62	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6032	10.1371/journal.pone.0006032	http://dx.doi.org/10.1371/journal.pone.0006032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19554101	Green Published, gold, Green Accepted			2022-12-27	WOS:000267356500016
J	Romanova, J; Krenn, BM; Wolschek, M; Ferko, B; Romanovskaja-Romanko, E; Morokutti, A; Shurygina, AP; Nakowitsch, S; Ruthsatz, T; Kiefmann, B; Konig, U; Bergmann, M; Sachet, M; Balasingam, S; Mann, A; Oxford, J; Slais, M; Kiselev, O; Muster, T; Egorov, A				Romanova, Julia; Krenn, Brigitte M.; Wolschek, Markus; Ferko, Boris; Romanovskaja-Romanko, Ekaterina; Morokutti, Alexander; Shurygina, Anna-Polina; Nakowitsch, Sabine; Ruthsatz, Tanja; Kiefmann, Bettina; Koenig, Ulrich; Bergmann, Michael; Sachet, Monika; Balasingam, Shobana; Mann, Alexander; Oxford, John; Slais, Martin; Kiselev, Oleg; Muster, Thomas; Egorov, Andrej			Preclinical Evaluation of a Replication-Deficient Intranasal Delta NS1 H5N1 Influenza Vaccine	PLOS ONE			English	Article							BROAD CROSS-PROTECTION; A VIRUS-INFECTION; WHOLE-VIRUS; HETEROSUBTYPIC IMMUNITY; NS1 PROTEIN; INACTIVATED VACCINES; YOUNG-CHILDREN; PHASE-I; SAFETY; IMMUNOGENICITY	Background: We developed a novel intranasal influenza vaccine approach that is based on the construction of replication-deficient vaccine viruses that lack the entire NS1 gene (Delta NS1 virus). We previously showed that these viruses undergo abortive replication in the respiratory tract of animals. The local release of type I interferons and other cytokines and chemokines in the upper respiratory tract may have a "self-adjuvant effect", in turn increasing vaccine immunogenicity. As a result, Delta NS1 viruses elicit strong B- and T-cell mediated immune responses. Methodology/Principal Findings: We applied this technology to the development of a pandemic H5N1 vaccine candidate. The vaccine virus was constructed by reverse genetics in Vero cells, as a 5: 3 reassortant, encoding four proteins HA, NA, M1, and M2 of the A/Vietnam/1203/04 virus while the remaining genes were derived from IVR-116. The HA cleavage site was modified in a trypsin dependent manner, serving as the second attenuation factor in addition to the deleted NS1 gene. The vaccine candidate was able to grow in the Vero cells that were cultivated in a serum free medium to titers exceeding 8 log(10) TCID(50/)ml. The vaccine virus was replication deficient in interferon competent cells and did not lead to viral shedding in the vaccinated animals. The studies performed in three animal models confirmed the safety and immunogenicity of the vaccine. Intranasal immunization protected ferrets and mice from being infected with influenza H5 viruses of different clades. In a primate model (Macaca mulatta), one dose of vaccine delivered intranasally was sufficient for the induction of antibodies against homologous A/Vietnam/1203/04 and heterologous A/Indonesia/5/05 H5N1 strains. Conclusion/Significance: Our findings show that intranasal immunization with the replication deficient H5N1 DNS1 vaccine candidate is sufficient to induce a protective immune response against H5N1 viruses. This approach might be attractive as an alternative to conventional influenza vaccines. Clinical evaluation of DNS1 pandemic and seasonal influenza vaccine candidates are currently in progress.			Egorov, A (corresponding author), Avir Green Hills Biotechnol AG, Vienna, Austria.	a.egorov@greenhillsbiotech.com	Romanovskaya-Romanko, Ekaterina/J-1022-2018; Bergmann, Michael/GZK-7700-2022; Romanova, Julia R/M-9490-2016; Shurygina, Anna-Polina/C-4948-2014	Romanovskaya-Romanko, Ekaterina/0000-0001-7560-398X; Romanova, Julia R/0000-0002-8114-4262; Shurygina, Anna-Polina/0000-0003-3685-7068; Koenig, Ulrich/0000-0002-6168-8326; Bergmann, Michael/0000-0001-8529-1166; FERKO, Boris/0000-0001-5340-4437				Asahi-Ozaki Y, 2004, J MED VIROL, V74, P328, DOI 10.1002/jmv.20173; Ashkenazi S, 2006, PEDIATR INFECT DIS J, V25, P870, DOI 10.1097/01.inf.0000237829.66310.85; Babai I, 2001, VACCINE, V20, P505, DOI 10.1016/S0264-410X(01)00326-7; Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Beyer WEP, 1998, CLIN DRUG INVEST, V15, P1, DOI 10.2165/00044011-199815010-00001; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Desheva JA, 2006, VACCINE, V24, P6859, DOI 10.1016/j.vaccine.2006.06.023; Egorov A, 1998, J VIROL, V72, P6437, DOI 10.1128/JVI.72.8.6437-6441.1998; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Ferko B, 2004, J VIROL, V78, P13037, DOI 10.1128/JVI.78.23.13037-13045.2004; Fernandez-Sesma A., 2007, Infectious Disorders - Drug Targets, V7, P336, DOI 10.2174/187152607783018754; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fries L, 2004, INT CONGR SER, V1263, P661, DOI 10.1016/j.ics.2004.02.024; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Holmgren J, 2003, VACCINE, V21, pS89, DOI 10.1016/S0264-410X(03)00206-8; Horimoto T, 2006, VACCINE, V24, P3669, DOI 10.1016/j.vaccine.2005.07.005; Jefferson T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub3; Karlsson H, 2002, INFECT IMMUN, V70, P6688, DOI 10.1128/IAI.70.12.6688-6696.2002; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kittel C, 2005, J VIROL, V79, P10672, DOI 10.1128/JVI.79.16.10672-10677.2005; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Lambkin R, 2004, VACCINE, V22, P4390, DOI 10.1016/j.vaccine.2003.10.054; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; LIANG SH, 1994, J IMMUNOL, V152, P1653; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; LLEONART R, 1990, BIO-TECHNOL, V8, P1263, DOI 10.1038/nbt1290-1263; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; MEITIN CA, 1991, VACCINE, V9, P751, DOI 10.1016/0264-410X(91)90292-E; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; NICHOLSON KG, 1979, J BIOL STAND, V7, P123, DOI 10.1016/S0092-1157(79)80044-X; Nolan T, 2008, VACCINE, V26, P6383, DOI 10.1016/j.vaccine.2008.08.046; Nolan TM, 2008, VACCINE, V26, P4160, DOI 10.1016/j.vaccine.2008.05.077; Palache A. M., 1997, Journal of Infectious Diseases, V176, pS20, DOI 10.1086/514169; Powell TJ, 2007, J IMMUNOL, V178, P1030, DOI 10.4049/jimmunol.178.2.1030; Puig-Barbera J, 2007, VACCINE, V25, P7313, DOI 10.1016/j.vaccine.2007.08.039; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Rumke HC, 2008, VACCINE, V26, P2378, DOI 10.1016/j.vaccine.2008.02.068; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Stephenson I, 2003, VACCINE, V21, P1687, DOI 10.1016/S0264-410X(02)00632-1; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; TAMURA S, 1992, EUR J IMMUNOL, V22, P477, DOI 10.1002/eji.1830220228; Tamura SI, 2005, JPN J INFECT DIS, V58, P195; TAMURA SI, 1992, J IMMUNOL, V149, P981; Treanor JJ, 2006, J INFECT DIS, V193, P1223, DOI 10.1086/503050; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Vesikari T, 2006, PEDIATR INFECT DIS J, V25, P590, DOI 10.1097/01.inf.0000220229.51531.47; Vesikari T, 2006, PEDIATRICS, V118, P2298, DOI 10.1542/peds.2006-0725; WRIGHT PF, 1977, J INFECT DIS, V136, pS731, DOI 10.1093/infdis/136.Supplement_3.S731; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; Yoshikawa T, 2004, J GEN VIROL, V85, P2339, DOI 10.1099/vir.0.79892-0	65	52	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5984	10.1371/journal.pone.0005984	http://dx.doi.org/10.1371/journal.pone.0005984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543385	gold, Green Submitted, Green Published			2022-12-27	WOS:000267237400010
J	Radstake, TRDJ; van Bon, L; Broen, J; Hussiani, A; Hesselstrand, R; Wuttge, DM; Deng, YH; Simms, R; Lubberts, E; Lafyatis, R				Radstake, Timothy R. D. J.; van Bon, Lenny; Broen, Jasper; Hussiani, Anila; Hesselstrand, Roger; Wuttge, Dirk M.; Deng, Yanhui; Simms, Robbert; Lubberts, Erik; Lafyatis, Robert			The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGF beta and IFN gamma Distinguishes SSc Phenotypes	PLOS ONE			English	Article								Background: Systemic sclerosis (SSc) is an autoimmune disease where controversy on Th1/Th2 balance dominates. We investigated whether the recently discovered Th17 pattern was present in SSc. Methodology and Principal Findings: Patients were subdivided as having limited cutaneous SSc (lcSSc, n = 12) or diffuse cutaneous SSc (dcSSc, n = 24). A further arbitrary subdivision was made between early dcSSc (n = 11) and late dcSSc (n = 13) based upon the duration of disease. As a comparator group 14 healthy controls were studied. CD3+ cells were isolated using FACS and subsequently studied for the expression of CD4, CD8, CD25, CD45Ro, CD45Ra, IL-23, GITR, CD69 and intracellular expression of IL-17, TGF beta and IFN gamma using flow cytometry. Levels of IL-17, IL-6, IL-1a and IL-23 were measured using Bioplex assays. SSc patients had more and more activated CD4+ cells. In addition, CD4, CD45Ro and CD45Ra cells from all SSc patients highly expressed the IL23R, which was associated with a higher IL-17 expression as well. In contrast, IFN gamma and TGFb were selectively up regulated in SSc subsets. In line with these observation, circulating levels of IL-17 inducing cytokines IL-6, IL-23 and IL-1a were increased in all or subsets of SSc patients. Conclusion and Significance: The combination of IL-17, IFN gamma and TGF beta levels in CD45Ro and CD45Ra cells from SSc patients is useful to distinguish between lSSc, ldSSc or edSSc. Blocking Th17 inducing cytokines such as IL-6 and IL-23 may provide a useful tool to intervene in the progression of SSc.			Radstake, TRDJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands.	tradstake73@gmail.com	Lubberts, Erik/AAI-4657-2020	Lafyatis, Robert/0000-0002-9398-5034	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR055063] Funding Source: NIH RePORTER; NIAMS NIH HHS [U01AR055063, U01 AR055063] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Betti M, 2006, ANN ONCOL, V17, P235; Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Del Galdo F, 2007, ARTHRITIS RHEUM-US, V56, P3478, DOI 10.1002/art.22877; Duan H, 2008, ARTHRITIS RHEUM-US, V58, P1465, DOI 10.1002/art.23451; Ferber IA, 1996, J IMMUNOL, V156, P5; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fujii H, 2002, CLIN EXP IMMUNOL, V130, P548, DOI 10.1046/j.1365-2249.2002.02017.x; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; GORLA R, 1994, CLIN RHEUMATOL, V13, P83, DOI 10.1007/BF02229871; GUSTAFSSON R, 1990, ANN RHEUM DIS, V49, P40, DOI 10.1136/ard.49.1.40; Hussein MR, 2005, J CLIN PATHOL, V58, P178, DOI 10.1136/jcp.2004.019224; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Kalogerou A, 2005, ANN RHEUM DIS, V64, P1233, DOI 10.1136/ard.2004.027094; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; KOMURA K, 2007, J RHEUMATOL; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; MURATA M, 2008, J DERMATOL SCI; Parel Y, 2007, ARTHRITIS RHEUM-US, V56, P3459, DOI 10.1002/art.22927; Riccieri V, 2005, J RHEUMATOL, V32, P283; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Roelofs MF, 2008, ARTHRITIS RHEUM-US, V58, P338, DOI 10.1002/art.23217; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Ye F, 2001, HUM MUTAT, V17, P305, DOI 10.1002/humu.28	37	141	156	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5903	10.1371/journal.pone.0005903	http://dx.doi.org/10.1371/journal.pone.0005903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536281	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029700004
J	Liu, WC; Wada, K; Nottebohm, F				Liu, Wan-chun; Wada, Kazuhiro; Nottebohm, Fernando			Variable Food Begging Calls Are Harbingers of Vocal Learning	PLOS ONE			English	Article							FOREBRAIN CIRCUIT; AUDITORY-FEEDBACK; NEURAL PATHWAYS; SONG SYSTEM; BRAIN; VOCALIZATIONS; EXPRESSION; SPARROWS; NEURONS; GENES	Vocal learning has evolved in only a few groups of mammals and birds. The developmental and evolutionary origins of vocal learning remain unclear. The imitation of a memorized sound is a clear example of vocal learning, but is that when vocal learning starts? Here we use an ontogenetic approach to examine how vocal learning emerges in a songbird, the chipping sparrow. The first vocalizations of songbirds, food begging calls, were thought to be innate, and vocal learning emerges later during subsong, a behavior reminiscent of infant babbling. Here we report that the food begging calls of male sparrows show several characteristics associated with learned song: male begging calls are highly variable between individuals and are altered by deafening; the production of food begging calls induces c-fos expression in a forebrain motor nucleus, RA, that is involved with the production of learned song. Electrolytic lesions of RA significantly reduce the variability of male calls. The male begging calls are subsequently incorporated into subsong, which in turn transitions into recognizable attempts at vocal imitation. Females do not sing and their begging calls are not affected by deafening or RA lesion. Our results suggest that, in chipping sparrows, intact hearing can influence the quality of male begging calls, auditory-sensitive vocal variability during food begging calls is the first step in a modification of vocal output that eventually culminates with vocal imitation.			Liu, WC (corresponding author), Rockefeller Univ, Lab Anim Behav, 1230 York Ave, New York, NY 10021 USA.	liuw@mail.rockefeller.edu	Wada, Kazuhiro/A-6548-2012	Wada, Kazuhiro/0000-0001-8137-9144				Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; CLEMENT CJ, 1996, SPOKEN LANGUAGE, V3, P1549; Farries MA, 2001, BRAIN BEHAV EVOLUT, V58, P80, DOI 10.1159/000047263; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; Jacobs EC, 1999, DEV NEUROSCI-BASEL, V21, P453, DOI 10.1159/000017413; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Konishi M., 1963, Z TIERPSYCHOL, V20, P349, DOI DOI 10.1111/J.1439-0310.1963.TB01156.X; KONISHI MASAKAZU, 1964, CONDOR, V66, P85, DOI 10.2307/1365388; Kroodsma D.E., 1982, ACOUSTIC COMMUNICATI, V2, P311; Kroodsma DE, 1999, AUK, V116, P373, DOI 10.2307/4089372; Kroodsma DE, 1997, ANIM BEHAV, V54, P457, DOI 10.1006/anbe.1996.0387; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; Kroodsma Don, 2004, P108, DOI 10.1016/B978-012473070-0/50007-4; Lanyon W. E., 1979, AM MUS NOVIT, V2666, P1; Liu WC, 2007, P NATL ACAD SCI USA, V104, P20398, DOI 10.1073/pnas.0710067104; Liu WC, 2006, CONDOR, V108, P509, DOI 10.1650/0010-5422(2006)108[509:SLBCSW]2.0.CO;2; Liu WC, 2005, P NATL ACAD SCI USA, V102, P10724, DOI 10.1073/pnas.0504677102; Locke JL, 2006, BEHAV BRAIN SCI, V29, P259, DOI 10.1017/S0140525X0600906X; MARGOLIASH D, 1985, P NATL ACAD SCI USA, V82, P5997, DOI 10.1073/pnas.82.17.5997; MARLER P, 1983, J NEUROSCI, V3, P517; Marler P, 1997, J NEUROBIOL, V33, P501; Marler P, 1982, ACOUSTIC COMMUNICATI, P25; MARLER P, 1972, ANIM BEHAV, V20, P58506; MARLER PETER, 1962, AUK, V79, P12; NOTTEBOHM F, 1971, ANIM BEHAV, V19, P313, DOI 10.1016/S0003-3472(71)80012-X; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; NOTTEBOHM F, 1972, AM NAT, V106, P116, DOI 10.1086/282756; OLLER DK, 1988, CHILD DEV, V59, P441, DOI 10.1111/j.1467-8624.1988.tb01479.x; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Schonweiler R, 1996, INT J PEDIATR OTORHI, V38, P1, DOI 10.1016/S0165-5876(96)01389-4; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; THORPE W. H., 1958, BRIT BIRDS, V51, P509; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Wermke K, 2002, MED ENG PHYS, V24, P501, DOI 10.1016/S1350-4533(02)00061-9; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A; WILLIAMS H, 1985, SCIENCE, V229, P279, DOI 10.1126/science.4012321; [No title captured]	43	20	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5929	10.1371/journal.pone.0005929	http://dx.doi.org/10.1371/journal.pone.0005929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529766	Green Published, gold			2022-12-27	WOS:000267029500009
J	Ramos, R; Gonzalez-Solis, J; Croxall, JP; Oro, D; Ruiz, X				Ramos, Rauel; Gonzalez-Solis, Jacob; Croxall, John P.; Oro, Daniel; Ruiz, Xavier			Understanding Oceanic Migrations with Intrinsic Biogeochemical Markers	PLOS ONE			English	Article							STABLE-ISOTOPE SIGNATURES; MOLT STRATEGIES; TRACE-METALS; CARBON; NITROGEN; PREDATORS; AREAS; DIET; SEX; DICHOTOMY	Migratory marine vertebrates move annually across remote oceanic water masses crossing international borders. Many anthropogenic threats such as overfishing, bycatch, pollution or global warming put millions of marine migrants at risk especially during their long-distance movements. Therefore, precise knowledge about these migratory movements to understand where and when these animals are more exposed to human impacts is vital for addressing marine conservation issues. Because electronic tracking devices suffer from several constraints, mainly logistical and financial, there is emerging interest in finding appropriate intrinsic markers, such as the chemical composition of inert tissues, to study long-distance migrations and identify wintering sites. Here, using tracked pelagic seabirds and some of their own feathers which were known to be grown at different places and times within the annual cycle, we proved the value of biogeochemical analyses of inert tissue as tracers of marine movements and habitat use. Analyses of feathers grown in summer showed that both stable isotope signatures and element concentrations can signal the origin of breeding birds feeding in distinct water masses. However, only stable isotopes signalled water masses used during winter because elements mainly accumulated during the long breeding period are incorporated into feathers grown in both summer and winter. Our findings shed new light on the simple and effective assignment of marine organisms to distinct oceanic areas, providing new opportunities to study unknown migration patterns of secretive species, including in relation to human-induced mortality on specific populations in the marine environment.	[Ramos, Rauel; Gonzalez-Solis, Jacob; Ruiz, Xavier] Univ Barcelona, Dept Biol Anim Vertebrats, Barcelona, Spain; [Gonzalez-Solis, Jacob; Croxall, John P.] British Antarctic Survey, Nat Environm Res Council, Cambridge, England; [Oro, Daniel] CSIC UIB, Inst Mediterraneo Estudios Avanzados IMEDEA, Mallorca, Spain	University of Barcelona; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Ramos, R (corresponding author), Univ Barcelona, Dept Biol Anim Vertebrats, Barcelona, Spain.	ramos@ub.edu	Ramos, Raül/S-3112-2016; Gonzalez-Solis, Jacob/AAZ-5338-2021; González-Solís, Jacob/AAB-1161-2019; Gonzalez-Solis, Jacob/C-3942-2008; Oro, Daniel/H-4208-2012	Ramos, Raül/0000-0002-0551-8605; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Oro, Daniel/0000-0003-4782-3007	Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alonso H, 2009, J ORNITHOL, V150, P329, DOI 10.1007/s10336-008-0354-2; BirdLife International, 2008, STAT WORLDS BIRDS IN; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bridge Eli S., 2006, Marine Ornithology, V34, P7; Caut S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001845; Cherel Y, 2000, OECOLOGIA, V122, P155, DOI 10.1007/PL00008843; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Edwards AE, 2008, J AVIAN BIOL, V39, P144, DOI 10.1111/j.2007.0908-8857.04139.x; Estrada JA, 2005, MAR BIOL, V147, P37, DOI 10.1007/s00227-004-1541-1; Forero MG, 2005, MAR ECOL PROG SER, V296, P107, DOI 10.3354/meps296107; Furness R.W., 1993, P86; GOEDE AA, 1991, ENVIRON MONIT ASSESS, V18, P203, DOI 10.1007/BF00398699; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Hall-Aspland SA, 2005, MAR ECOL PROG SER, V305, P249, DOI 10.3354/meps305249; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Helmers E, 1996, MAR CHEM, V53, P51, DOI 10.1016/0304-4203(96)00012-6; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2008, BIRD CONSERV INT, V18, pS174, DOI 10.1017/S0959270908000361; Jennings S, 2001, MARINE FISHERIES ECO, P417; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Luschi P, 1998, P ROY SOC B-BIOL SCI, V265, P2279, DOI 10.1098/rspb.1998.0571; MARRA PP, 2006, CONNECTIVITY CONSERV, P157; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; MOUGIN JL, 1988, OISEAU RFO, V58, P303; Olmos F, 1997, IBIS, V139, P685, DOI 10.1111/j.1474-919X.1997.tb04692.x; Pearson SF, 2003, OECOLOGIA, V135, P516, DOI 10.1007/s00442-003-1221-8; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Ramos R, 2009, OECOLOGIA, V160, P97, DOI 10.1007/s00442-008-1273-x; Ramos R, 2009, IBIS, V151, P151, DOI 10.1111/j.1474-919X.2008.00877.x; Ramos R, 2009, OECOLOGIA, V159, P345, DOI 10.1007/s00442-008-1215-7; Reich KJ, 2007, BIOL LETTERS, V3, P712, DOI 10.1098/rsbl.2007.0394; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Ristow D, 2000, CONDOR, V102, P696, DOI 10.1650/0010-5422(2000)102[0696:STOCSS]2.0.CO;2; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Semmens JM, 2007, REV FISH BIOL FISHER, V17, P401, DOI 10.1007/s11160-007-9048-8; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Thibault J. C., 1997, CORYS SHEARWATER; Wallace BP, 2006, MAR BIOL, V149, P953, DOI 10.1007/s00227-006-0247-y; Wang WX, 2002, MAR ECOL PROG SER, V243, P295, DOI 10.3354/meps243295; Wassenaar LI, 2001, ENVIRON SCI TECHNOL, V35, P1845, DOI 10.1021/es0010204; Wells BK, 2008, MAR ECOL PROG SER, V364, P15, DOI 10.3354/meps07486	47	34	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6236	10.1371/journal.pone.0006236	http://dx.doi.org/10.1371/journal.pone.0006236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623244	Green Published, gold, Green Accepted			2022-12-27	WOS:000268260100002
J	Basal, E; Eghbali-Fatourechi, GZ; Kalli, KR; Hartmann, LC; Goodman, KM; Goode, EL; Kamen, BA; Low, PS; Knutson, KL				Basal, Eati; Eghbali-Fatourechi, Guiti Z.; Kalli, Kimberly R.; Hartmann, Lynn C.; Goodman, Karin M.; Goode, Ellen L.; Kamen, Barton A.; Low, Philip S.; Knutson, Keith L.			Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients	PLOS ONE			English	Article								Background: Despite low incidence, ovarian cancer is the fifth leading cause of cancer deaths and it has the highest mortality rate of all gynecologic malignancies among US women. The mortality rate would be reduced with an early detection marker. The folate receptor alpha (FR alpha) is one logical choice for a biomarker because of its prevalent overexpression in ovarian cancer and its exclusive expression in only a few normal tissues. In prior work, it was observed that patients with ovarian cancer had elevated serum levels of a protein that bound to a FR alpha-specific monoclonal antibody relative to healthy individuals. However, it was not shown that the protein detected was intact functional FR alpha. In the current study, the goal was to determine whether ovarian cancer patients (n = 30) had elevated serum levels of a fully functional intact FR alpha compared to matched healthy controls (n = 30). Methodology/Principal Findings: FR alpha levels in serum were analyzed by two methods, immunoblotting analysis and a radiolabeled folic acid-based microfiltration binding assay. Using the immunoassay, we observed that levels of FR alpha were higher in serum of ovarian cancer patients as compared to controls. Similar results were also observed using the microfiltration binding assay, which showed that the circulating FR alpha is functional. Importantly, we also found that the levels of FR alpha were comparable between early and advanced stage patients. Conclusions: Our results demonstrate that ovarian cancer patients have elevated levels of functional intact FR alpha. These findings support the potential use of circulating FR alpha as a biomarker of early ovarian cancer.			Basal, E (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	knutson.keith@mayo.edu	jain, amita/ABA-9223-2020	Low, Philip/0000-0001-9042-5528	NATIONAL CANCER INSTITUTE [K01CA100764, R03CA121386] Funding Source: NIH RePORTER; NCI NIH HHS [K01-CA100764, R03 CA121386, R03-CA121386, K01 CA100764] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bueno R, 2001, J THORAC CARDIOV SUR, V121, P225, DOI 10.1067/mtc.2001.111176; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; ELWOOD PC, 1986, J BIOL CHEM, V261, P5416; Fields Margaret M, 2006, Clin J Oncol Nurs, V10, P77, DOI 10.1188/06.CJON.77-81; Hartmann LC, 2007, INT J CANCER, V121, P938, DOI 10.1002/ijc.22811; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kalli KR, 2008, GYNECOL ONCOL, V108, P619, DOI 10.1016/j.ygyno.2007.11.020; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; KAMEN BA, 1974, J LAB CLIN MED, V83, P164; KAMEN BA, 1975, P NATL ACAD SCI USA, V72, P4261, DOI 10.1073/pnas.72.11.4261; KANE MA, 1988, J CLIN INVEST, V81, P1398, DOI 10.1172/JCI113469; Kelemen LE, 2005, CANCER EPIDEM BIOMAR, V14, P2168, DOI 10.1158/1055-9965.EPI-05-0260; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Low PS, 2008, ACCOUNTS CHEM RES, V41, P120, DOI 10.1021/ar7000815; LUHRS CA, 1992, J CLIN INVEST, V90, P840, DOI 10.1172/JCI115959; MANTOVANI LT, 1994, EUR J CANCER, V30A, P363, DOI 10.1016/0959-8049(94)90257-7; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Toffoli G, 1998, INT J CANCER, V79, P121, DOI 10.1002/(SICI)1097-0215(19980417)79:2<121::AID-IJC4>3.0.CO;2-V; Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P105; Yang R, 2007, CLIN CANCER RES, V13, P2557, DOI 10.1158/1078-0432.CCR-06-1343	21	67	79	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6292	10.1371/journal.pone.0006292	http://dx.doi.org/10.1371/journal.pone.0006292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617914	gold, Green Published, Green Submitted			2022-12-27	WOS:000268119600005
J	Kyozuka, K; Chun, JT; Puppo, A; Gragnaniello, G; Garante, E; Santella, L				Kyozuka, Keiichiro; Chun, Jong T.; Puppo, Agostina; Gragnaniello, Gianni; Garante, Ezio; Santella, Luigia			Guanine Nucleotides in the Meiotic Maturation of Starfish Oocytes: Regulation of the Actin Cytoskeleton and of Ca2+ Signaling	PLOS ONE			English	Article								Background: Starfish oocytes are arrested at the first prophase of meiosis until they are stimulated by 1-methyladenine (1-MA). The two most immediate responses to the maturation-inducing hormone are the quick release of intracellular Ca2+ and the accelerated changes of the actin cytoskeleton in the cortex. Compared with the later events of oocyte maturation such as germinal vesicle breakdown, the molecular mechanisms underlying the early events involving Ca2+ signaling and actin changes are poorly understood. Herein, we have studied the roles of G-proteins in the early stage of meiotic maturation. Methodology/Principal Findings: By microinjecting starfish oocytes with nonhydrolyzable nucleotides that stabilize either active (GTP gamma S) or inactive (GDP beta S) forms of G-proteins, we have demonstrated that: i) GTP gamma S induces Ca2+ release that mimics the effect of 1-MA; ii) GDP beta S completely blocks 1-MA-induced Ca2+; iii) GDP beta S has little effect on the amplitude of the Ca2+ peak, but significantly expedites the initial Ca2+ waves induced by InsP(3) photoactivation, iv) GDP beta S induces unexpectedly striking modification of the cortical actin networks, suggesting a link between the cytoskeletal change and the modulation of the Ca2+ release kinetics; v) alteration of cortical actin networks with jasplakinolide, GDP beta S, or actinase E, all led to significant changes of 1-MA-induced Ca2+ signaling. Conclusions/Significance: Taken together, these results indicate that G-proteins are implicated in the early events of meiotic maturation and support our previous proposal that the dynamic change of the actin cytoskeleton may play a regulatory role in modulating intracellular Ca2+ release.			Kyozuka, K (corresponding author), Tohoku Univ, Res Ctr Marine Biol, Asamushi, Japan.	santella@szn.it	Chun, Jong Tai/AAM-3394-2020; Santella, Luigia/AAM-3524-2020	Chun, Jong Tai/0000-0002-6070-4953; Santella, Luigia/0000-0001-7159-0499				Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; CHIBA K, 1992, EUR J BIOCHEM, V207, P833, DOI 10.1111/j.1432-1033.1992.tb17114.x; CHIBA K, 1990, DEV BIOL, V140, P300, DOI 10.1016/0012-1606(90)90080-3; CHIBA K, 1993, MOL BIOL CELL, V4, P1027, DOI 10.1091/mbc.4.10.1027; CHUEH SH, 1987, J BIOL CHEM, V262, P13857; Chun JT, 2009, ACTA PHYSIOL, V195, P61, DOI 10.1111/j.1748-1716.2008.01921.x; Chun JT, 2007, N COMP BIOC, V41, P425; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CROSSLEY I, 1991, CELL REGUL, V2, P121, DOI 10.1091/mbc.2.2.121; FUJIMOTO T, 1995, J CELL SCI, V108, P7; HILL TD, 1987, BIOCHEM BIOPH RES CO, V149, P897, DOI 10.1016/0006-291X(87)90492-X; JAFFE LA, 1994, DEV BIOL, V164, P579, DOI 10.1006/dbio.1994.1225; JAFFE LA, 1993, J CELL BIOL, V121, P775, DOI 10.1083/jcb.121.4.775; Kalinowski RR, 2003, DEV BIOL, V253, P139, DOI 10.1006/dbio.2002.0860; KANATANI H, 1970, EXP CELL RES, V61, P280, DOI 10.1016/0014-4827(70)90448-9; KANATANI H, 1969, NATURE, V221, P273, DOI 10.1038/221273a0; Kumakiri J, 2003, DEV BIOL, V260, P522, DOI 10.1016/S0012-1606(03)00273-2; Lim D, 2003, J BIOL CHEM, V278, P42505, DOI 10.1074/jbc.M301851200; Mita M, 2005, ANN NY ACAD SCI, V1040, P413, DOI 10.1196/annals.1327.077; MORISAWA M, 1978, GAMETE RES, V1, P157, DOI 10.1002/mrd.1120010209; Nusco GA, 2006, BIOCHEM BIOPH RES CO, V348, P109, DOI 10.1016/j.bbrc.2006.07.023; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; Puppo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003588; RAKOW TL, 1990, P NATL ACAD SCI USA, V87, P9285, DOI 10.1073/pnas.87.23.9285; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sadler KC, 1998, DEV BIOL, V197, P25, DOI 10.1006/dbio.1998.8869; Santella L, 2008, INT J DEV BIOL, V52, P571, DOI 10.1387/ijdb.072560ls; SCHROEDER TE, 1983, DEV BIOL, V98, P373, DOI 10.1016/0012-1606(83)90366-4; SCHROEDER TE, 1981, J CELL BIOL, V90, P362, DOI 10.1083/jcb.90.2.362; SHIDA H, 1976, NATURE, V263, P77, DOI 10.1038/263077a0; SHILLING F, 1989, DEV BIOL, V133, P605, DOI 10.1016/0012-1606(89)90063-8; TADENUMA H, 1992, BIOCHEM BIOPH RES CO, V186, P114, DOI 10.1016/S0006-291X(05)80782-X; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TURNER PR, 1986, J CELL BIOL, V102, P70, DOI 10.1083/jcb.102.1.70; Ueda H, 1997, J CELL SCI, V110, P1503; Voronina E, 2004, J CELL SCI, V117, P5995, DOI 10.1242/jcs.01518; Wang Y, 2002, J NEUROCHEM, V82, P945, DOI 10.1046/j.1471-4159.2002.01059.x; Yozuka K, 2008, DEV BIOL, V320, P426, DOI 10.1016/j.ydbio.2008.05.549; Zeng WZ, 2003, CURR BIOL, V13, P872, DOI 10.1016/S0960-9822(03)00330-0	40	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6296	10.1371/journal.pone.0006296	http://dx.doi.org/10.1371/journal.pone.0006296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617909	Green Submitted, Green Published, gold			2022-12-27	WOS:000268119600006
J	Thye, T; Scarisbrick, G; Browne, ENL; Chinbuah, MA; Gyapong, J; Osei, I; Owusu-Dabo, E; Niemann, S; Rusch-Gerdes, S; Meyer, CG; Horstmann, RD				Thye, Thorsten; Scarisbrick, Genevieve; Browne, Edmund N. L.; Chinbuah, Margaret Amanua; Gyapong, John; Osei, Ivy; Owusu-Dabo, Ellis; Niemann, Stefan; Ruesch-Gerdes, Sabine; Meyer, Christian G.; Horstmann, Rolf D.			CTLA4 Autoimmunity-Associated Genotype Contributes to Severe Pulmonary Tuberculosis in an African Population	PLOS ONE			English	Article								The gene of Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA4), a negative regulator of T lymphocytes, contains a single-nucleotide polymorphism (SNP) at position +6230A->G (ct60A->G), which has been found associated with several autoimmune diseases and appears to reduce T-cell inhibitory activity. In Ghana, West Africa, we compared the frequencies of CTLA4 +6230 A/G and 6 haplotype-tagging SNPs in 2010 smear-positive, HIV-negative patients with pulmonary tuberculosis (TB) and 2346 controls matched for age, gender and ethnicity. We found no difference in allele frequencies between cases and controls. However, +6230A and a distinct CTLA4 haplotype and a diplotype comprising the +6230A allele were significantly less frequent among cases with large opacities in chest radiographs compared to those with small ones (P(corrected) ([cor]) = 0.002, P(cor) = 0.00045, P = 0.0005, respectively). This finding suggests that an increased T-cell activity associated with the CTLA4 +6230G allele contributes to pathology rather than to protection in pulmonary TB.			Thye, T (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany.	c.g.meyer@bni-hamburg.de	Niemann, Stefan/C-9327-2011	Gyapong, John/0000-0002-8415-1468; Niemann, Stefan/0000-0002-6604-0684				Bour-Jordan H, 2003, NAT IMMUNOL, V4, P182, DOI 10.1038/ni884; Darlington PJ, 2002, J EXP MED, V195, P1337, DOI 10.1084/jem.20011868; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Kavvoura FK, 2007, J CLIN ENDOCR METAB, V92, P3162, DOI 10.1210/jc.2007-0147; Kirman J, 1999, INFECT IMMUN, V67, P3786, DOI 10.1128/IAI.67.8.3786-3792.1999; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lee JY, 2000, J COMPUT ASSIST TOMO, V24, P691, DOI 10.1097/00004728-200009000-00005; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Maier LM, 2007, P NATL ACAD SCI USA, V104, P18607, DOI 10.1073/pnas.0706409104; Nasta F, 2006, IMMUNOLOGY, V117, P358, DOI 10.1111/j.1365-2567.2005.02309.x; Quinn KM, 2006, IMMUNOL CELL BIOL, V84, P467, DOI 10.1111/j.1440-1711.2006.01460.x; Ramirez-Soriano A, 2005, GENES IMMUN, V6, P646, DOI 10.1038/sj.gene.6364251; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Schneider H, 2005, P NATL ACAD SCI USA, V102, P12861, DOI 10.1073/pnas.0505802102; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Thio CL, 2004, J VIROL, V78, P11258, DOI 10.1128/JVI.78.20.11258-11262.2004; Thye T, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037960; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621	20	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6307	10.1371/journal.pone.0006307	http://dx.doi.org/10.1371/journal.pone.0006307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609446	Green Published, gold, Green Submitted			2022-12-27	WOS:000268119500023
J	Autiero, I; Costantini, S; Colonna, G				Autiero, Ida; Costantini, Susan; Colonna, Giovanni			Modeling of the Bacterial Mechanism of Methicillin-Resistance by a Systems Biology Approach	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; SIGNALING PATHWAY; INFECTIONS; VANCOMYCIN; ORFEOME; INVITRO; BINDING	Background: A microorganism is a complex biological system able to preserve its functional features against external perturbations and the ability of the living systems to oppose to these external perturbations is defined "robustness''. The antibiotic resistance, developed by different bacteria strains, is a clear example of robustness and of ability of the bacterial system to acquire a particular functional behaviour in response to environmental changes. In this work we have modeled the whole mechanism essential to the methicillin-resistance through a systems biology approach. The methicillin is a beta-lactamic antibiotic that act by inhibiting the penicillin-binding proteins (PBPs). These PBPs are involved in the synthesis of peptidoglycans, essential mesh-like polymers that surround cellular enzymes and are crucial for the bacterium survival. Methodology: The network of genes, mRNA, proteins and metabolites was created using CellDesigner program and the data of molecular interactions are stored in Systems Biology Markup Language (SBML). To simulate the dynamic behaviour of this biochemical network, the kinetic equations were associated with each reaction. Conclusions: Our model simulates the mechanism of the inactivation of the PBP by methicillin, as well as the expression of PBP2a isoform, the regulation of the SCCmec elements (SCC: staphylococcal cassette chromosome) and the synthesis of peptidoglycan by PBP2a. The obtained results by our integrated approach show that the model describes correctly the whole phenomenon of the methicillin resistance and is able to respond to the external perturbations in the same way of the real cell. Therefore, this model can be useful to develop new therapeutic approaches for the methicillin control and to understand the general mechanism regarding the cellular resistance to some antibiotics.			Autiero, I (corresponding author), Univ Naples 2, CRISCEB Interdept Res Ctr Computat & Biotechnol S, Naples, Italy.	susan.costantini@unina2.it	Autiero, Ida/P-7002-2018; Costantini, Susan/J-9914-2018; Autiero, Ida/HCI-1827-2022; Colonna, Giovanni/AAY-3568-2021	Autiero, Ida/0000-0001-8886-8063; Autiero, Ida/0000-0001-8886-8063; Colonna, Giovanni/0000-0002-0473-1455; Costantini, Susan/0000-0002-7538-4657				Ahn AC, 2006, PLOS MED, V3, P709, DOI 10.1371/journal.pmed.0030208; Bonten MJM, 2001, CLIN INFECT DIS, V33, P1739, DOI 10.1086/323761; Brandner CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-321; Brasch MA, 2004, GENOME RES, V14, P2001, DOI 10.1101/gr.2769804; CHAMBERS HF, 1994, BIOCHEM J, V301, P139, DOI 10.1042/bj3010139; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; Costantini S, 2008, BIOINFORMATION, V3, P238, DOI 10.6026/97320630003238; CRAIG WA, 1993, J ANTIMICROB CHEMOTH, V31, P149, DOI 10.1093/jac/31.suppl_D.149; Drager A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-39; Fridkin SK, 2003, CLIN INFECT DIS, V36, P429, DOI 10.1086/346207; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; Golemi-Kotra D, 2003, J BIOL CHEM, V278, P18419, DOI 10.1074/jbc.M300611200; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; HALEY RW, 1995, J INFECT DIS, V171, P614, DOI 10.1093/infdis/171.3.614; Hucka M., 2004, Systems Biology, V1, P41, DOI 10.1049/sb:20045008; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Murphy JT, 2008, J THEOR BIOL, V254, P284, DOI 10.1016/j.jtbi.2008.05.037; O'Hara FP, 2008, J INFECT DIS, V197, P187, DOI 10.1086/524684; Olsen RJ, 2008, J CLIN MICROBIOL, V46, P1144, DOI 10.1128/JCM.02029-07; Regoes RR, 2004, ANTIMICROB AGENTS CH, V48, P3670, DOI 10.1128/AAC.48.10.3670-3676.2004; Rehm SJ, 2008, CLEV CLIN J MED, V75, P177, DOI 10.3949/ccjm.75.3.177; Savic M, 2008, J BACTERIOL, V190, P5855, DOI 10.1128/JB.00076-08; Sheehy JE, 2008, NEW PHYTOL, V179, P579, DOI 10.1111/j.1469-8137.2008.02407.x; Smith TL, 1999, NEW ENGL J MED, V340, P493, DOI 10.1056/NEJM199902183400701; Stapleton Paul D., 2002, Science Progress, V85, P57, DOI 10.3184/003685002783238870; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; ZHANEL GG, 1991, DICP ANN PHARMAC, V25, P153, DOI 10.1177/106002809102500210; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144	31	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6226	10.1371/journal.pone.0006226	http://dx.doi.org/10.1371/journal.pone.0006226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593454	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035400010
J	Srivastava, N; Srivastava, PK				Srivastava, Nisheeth; Srivastava, Pramod K.			Modeling the Repertoire of True Tumor-Specific MHC I Epitopes in a Human Tumor	PLOS ONE			English	Article								DNA replication has a finite measurable error rate, net of repair, in all cells. Clonal proliferation of cancer cells leads therefore to accumulation of random mutations. A proportion of these mutational events can create new immunogenic epitopes that, if processed and presented by an MHC allele, may be recognized by the adaptive immune system. Here, we use probability theory to analyze the mutational and epitope composition of a tumor mass in successive division cycles and create a double Polya model for calculating the number of truly tumor-specific MHC I epitopes in a human tumor. We deduce that depending upon tumor size, the degree of genomic instability and the degree of death within a tumor, human tumors have several tens to low hundreds of new, truly tumor-specific epitopes. Parenthetically, cancer stem cells, due to the asymmetry in their proliferative properties, shall harbor significantly fewer mutations, and therefore significantly fewer immunogenic epitopes. As the overwhelming majority of the mutations in cancer cells are unrelated to malignancy, the mutation-generated epitopes shall be specific for each individual tumor, and constitute the antigenic fingerprint of each tumor. These calculations highlight the benefits for personalization of immunotherapy of human cancer, and in view of the substantial pre-existing antigenic repertoire of tumors, emphasize the enormous potential of therapies that modulate the anti-cancer immune response by liberating it from inhibitory influences.			Srivastava, N (corresponding author), Univ Minnesota, Dept Comp Sci, Minneapolis, MN 55455 USA.	srivastava@uchc.edu		Srivastava, Pramod/0000-0003-2837-2861				Andres A, 2005, CRIT REV ONCOL HEMAT, V56, P71, DOI 10.1016/j.critrevonc.2004.11.010; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; BASOMBRIO MA, 1970, CANCER RES, V30, P2458; Baurain JF, 2000, J IMMUNOL, V164, P6057, DOI 10.4049/jimmunol.164.11.6057; Beckman RA, 2005, SEMIN CANCER BIOL, V15, P423, DOI 10.1016/j.semcancer.2005.06.007; Chiari R, 1999, CANCER RES, V59, P5785; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; Dubey P, 1997, J EXP MED, V185, P695, DOI 10.1084/jem.185.4.695; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Echchakir H, 2001, CANCER RES, V61, P4078; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHEL R, 1993, CELL, V8, P167; Gatenby RA, 2002, CANCER RES, V62, P3675; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Ikeda H, 1997, P NATL ACAD SCI USA, V94, P6375, DOI 10.1073/pnas.94.12.6375; Karanikas V, 2001, CANCER RES, V61, P3718; Kretschmer K, 2006, IMMUNOL REV, V212, P163, DOI 10.1111/j.0105-2896.2006.00411.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Matsutake T, 2001, P NATL ACAD SCI USA, V98, P3992, DOI 10.1073/pnas.071523398; MONACH PA, 1995, IMMUNITY, V2, P45, DOI 10.1016/1074-7613(95)90078-0; Peggs KS, 2006, CURR OPIN IMMUNOL, V18, P206, DOI 10.1016/j.coi.2006.01.011; Rammensee HG, 2002, IMMUNOL REV, V188, P164, DOI 10.1034/j.1600-065X.2002.18815.x; SCANLAN M, 2004, CT GENE DATABASE; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Sensi M, 2005, CANCER RES, V65, P632; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Simpson AJG, 1997, ADV CANCER RES, V71, P209, DOI 10.1016/S0065-230X(08)60100-1; Srivastava P K, 1996, Semin Immunol, V8, P295, DOI 10.1006/smim.1996.0038; SRIVASTAVA PK, 1993, ADV CANCER RES, V62, P153, DOI 10.1016/S0065-230X(08)60318-8; SRIVASTAVA PK, 1988, IMMUNOL TODAY, V9, P78, DOI 10.1016/0167-5699(88)91269-8; Stoler DL, 1999, P NATL ACAD SCI USA, V96, P15121, DOI 10.1073/pnas.96.26.15121; *SYFPEITHI, SYFPEITHI DAT MHC LI; Takenoyama M, 2006, INT J CANCER, V118, P1992, DOI 10.1002/ijc.21594; TESTORI A, 2008, J CLIN ONCO IN PRESS; Tomlinson I, 2002, AM J PATHOL, V160, P755, DOI 10.1016/S0002-9440(10)64896-1; URBAN JL, 1992, ANNU REV IMMUNOL, V10, P617, DOI 10.1146/annurev.iy.10.040192.003153; VANDERBRUGGEN P, 2001, T CELL DEFINED TUMOR; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Zorn E, 1999, EUR J IMMUNOL, V29, P592, DOI 10.1002/(SICI)1521-4141(199902)29:02<592::AID-IMMU592>3.0.CO;2-2	45	18	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6094	10.1371/journal.pone.0006094	http://dx.doi.org/10.1371/journal.pone.0006094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593447	Green Submitted, Green Published, gold			2022-12-27	WOS:000268035300002
J	Ruedi, EA; Hughes, KA				Ruedi, Elizabeth A.; Hughes, Kimberly A.			Age, but Not Experience, Affects Courtship Gene Expression in Male Drosophila melanogaster	PLOS ONE			English	Article								Mutation screens in model organisms have helped identify the foundation of many fundamental organismal phenotypes. An emerging question in evolutionary and behavioral biology is the extent to which these "developmental'' genes contribute to the subtle individual variation that characterizes natural populations. A related question is whether individual differences arise from static differences in gene expression that arose during previous life stages, or whether they are due to dynamic regulation of expression during the life stage under investigation. Here, we address these questions using genes that have been discovered to control the development of normal courtship behavior in male Drosophila melanogaster. We examined whether these genes have static or dynamic expression in the heads of adult male flies of different ages and with different levels of social experience. We found that 16 genes of the 25 genes examined were statically expressed, and 9 genes were dynamically expressed with changes related to adult age. No genes exhibited rapid dynamic expression changes due to social experience or age*experience interaction. We therefore conclude that a majority of fly "courtship'' genes are statically expressed, while a minority are regulated in adults with respect to age, but not with respect to relevant social experience. These results are consistent with those from a recent microarray analysis that found none of the canonical courtship genes changed expression in male flies after brief exposure to females.			Ruedi, EA (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	earuedi@ncsu.edu	Ruedi, Elizabeth/L-4955-2013	Ruedi, Elizabeth/0000-0003-3025-1567				Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Billeter JC, 2002, ADV GENET, V47, P87, DOI 10.1016/S0065-2660(02)47003-4; Bogue CW, 2003, J APPL PHYSIOL, V94, P2502, DOI 10.1152/japplphysiol.00209.2003; CARNEY GE, 2007, BMC GENOMICS, V8; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; DEBELLE JS, 1987, BEHAV GENET, V17, P620; Devaud JM, 2003, J NEUROBIOL, V56, P13, DOI 10.1002/neu.10215; Diagana TT, 2002, J NEUROSCI, V22, P428, DOI 10.1523/JNEUROSCI.22-02-00428.2002; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Drapeau MD, 2006, GENETICS, V172, P1009, DOI 10.1534/genetics.105.045666; Drapeau MD, 2003, BIOCHEM BIOPH RES CO, V311, P1, DOI 10.1016/j.bbrc.2003.09.106; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Edwards AC, 2006, PLOS GENET, V2, P1386, DOI 10.1371/journal.pgen.0020154; Eisen JS, 1996, CELL, V87, P969, DOI 10.1016/S0092-8674(00)81792-4; Emmons SW, 2003, J NEUROBIOL, V54, P93, DOI 10.1002/neu.10163; Everitt B.S., 2005, R S PLUS COMPANION M; Fitzpatrick MJ, 2004, AM NAT, V163, P800, DOI 10.1086/386297; Gaines P, 2000, GENETICS, V154, P1627; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Grosjean Y, 2004, BEHAV PROCESS, V65, P7, DOI 10.1016/S0376-6357(03)00148-7; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Hafen E., 1997, NATURE, V389, P559; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hughes KA, 2002, P NATL ACAD SCI USA, V99, P14286, DOI 10.1073/pnas.222326199; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Johnson D., 1998, APPL MULTIVARIATE ME; Kaun KR, 2008, J EXP BIOL, V211, P3160, DOI 10.1242/jeb.010124; Kaun KR, 2007, J EXP BIOL, V210, P3547, DOI 10.1242/jeb.006924; Lam BJ, 2003, J BIOL CHEM, V278, P22740, DOI 10.1074/jbc.M301036200; Lee G, 2002, J NEUROGENET, V16, P229, DOI 10.1080/01677060216292; Leloup JC, 2000, BIOESSAYS, V22, P84; Liu WC, 2005, P NATL ACAD SCI USA, V102, P10724, DOI 10.1073/pnas.0504677102; Markow TA, 1996, EVOL BIOL, V29, P73; MCROBERT SP, 1988, EVOLUTION, V42, P1093, DOI 10.1111/j.1558-5646.1988.tb02528.x; MELLO CV, 1994, J NEUROSCI, V14, P6652; MEYER D, 2002, BENCHMARKING SUPPORT, P78; Moehring AJ, 2004, GENETICS, V167, P1249, DOI 10.1534/genetics.103.024372; Orgad S, 2000, GENETICS, V155, P1267; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Promislow DEL, 2000, J EVOLUTION BIOL, V13, P955, DOI 10.1046/j.1420-9101.2000.00240.x; Rosato E, 1997, BIOESSAYS, V19, P1075, DOI 10.1002/bies.950191206; Ruedi EA, 2008, BEHAV GENET, V38, P424, DOI 10.1007/s10519-008-9204-5; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Schug MD, 1998, MOL ECOL, V7, P57, DOI 10.1046/j.1365-294x.1998.00304.x; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Sinclair BJ, 2007, PHYSIOL ENTOMOL, V32, P322, DOI 10.1111/j.1365-3032.2007.00585.x; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Stern DL, 2000, NATURE, V408, P529, DOI 10.1038/35046183; Strambi C, 1999, INT REV CYTOL, V190, P137, DOI 10.1016/S0074-7696(08)62147-6; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tarone AM, 2005, GENET RES, V86, P31, DOI 10.1017/S0016672305007706; Tauber E, 2001, J COMP PHYSIOL A, V187, P341, DOI 10.1007/s003590100206; Toivonen JM, 2001, GENETICS, V159, P241; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Villella A, 2005, P NATL ACAD SCI USA, V102, P16550, DOI 10.1073/pnas.0507056102; White SA, 2002, J EXP BIOL, V205, P2567; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X	63	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6150	10.1371/journal.pone.0006150	http://dx.doi.org/10.1371/journal.pone.0006150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582156	gold, Green Submitted, Green Published			2022-12-27	WOS:000267806400006
J	Mailer, RKW; Falk, K; Rotzschke, O				Mailer, Reiner K. W.; Falk, Kirsten; Rotzschke, Olaf			Absence of Leucine Zipper in the Natural FOXP3 Delta 2 Delta 7 Isoform Does Not Affect Dimerization but Abrogates Suppressive Capacity	PLOS ONE			English	Article								Background: Phenotype and function of regulatory T cells (Treg) largely depend on the presence of the transcription factor FOXP3. In contrast to mice, human Treg cells express isoforms of this protein. Besides the full length version (FOXP3fl), an isoform lacking the exon 2 (FOXP3 Delta 2) is co-expressed in comparable amounts. Recently, a third splice variant has been described that in addition to exon 2 also misses exon 7 (FOXP3 Delta 2 Delta 7). Exon 7 encodes for a leucine zipper motif commonly used as structural dimerization element. Mutations in exon 7 have been linked to IPEX, a severe autoimmune disease suggested to be caused by impaired dimerization of the FOXP3 protein. Principal Findings: This study shows that the lack of exon 7 does not affect (homo-) dimerization. Moreover, the interaction of FOXP3 Delta 2 Delta 7 to RUNX1, NFAT and NF-kB appeared to be unchanged in co-immunoprecipitation experiments and reporter gene assays, when compared to FOXP3fl and FOXP3 Delta 2. Nevertheless, retroviral transduction with FOXP3 Delta 2 Delta 7 failed to induce the typical Treg-associated phenotype. The expression of FOXP3-induced surface molecules such as CD25 and CTLA-4 were not enhanced in FOXP3 Delta 2 Delta 7 transduced CD4+ T cells, which also failed to exhibit any suppressive capacity. Notably, however, co-expression of FOXP3fl with FOXP3 Delta 2 Delta 7 resulted in a reduction of CD25 expression by a dominant negative effect. Conclusions: The leucine zipper of FOXP3 does not mediate dimerization or interaction with NFAT, NF-kB and RUNX1, but is indispensable for the characteristic phenotype and function in Treg cells. FOXP3 Delta 2 Delta 7 could play a role in regulating the function of the other FOXP3 isoforms and may be involved in cancer pathogenesis, as it is overexpressed by certain malignant cells.			Mailer, RKW (corresponding author), Max Delbruck Ctr Mol Med, MDC, Berlin, Germany.	falk@mdc-berlin.de; olaf_rotzschke@immunol.a-star.edu.sg	Mailer, Reiner/AAC-1991-2022; Roetzschke, Olaf/GXH-0012-2022	Mailer, Reiner/0000-0001-8279-3355				Aarts-Riemens T, 2008, EUR J IMMUNOL, V38, P1381, DOI 10.1002/eji.200737590; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Krejsgaard T, 2008, LEUKEMIA, V22, P2230, DOI 10.1038/leu.2008.224; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lebel R, 2007, BIOCHEMISTRY-US, V46, P10279, DOI 10.1021/bi700076m; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Smith EL, 2006, IMMUNOLOGY, V119, P203, DOI 10.1111/j.1365-2567.2006.02425.x; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	34	31	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6104	10.1371/journal.pone.0006104	http://dx.doi.org/10.1371/journal.pone.0006104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568423	Green Published, gold, Green Accepted			2022-12-27	WOS:000267572200007
J	Smith, MR; Burgess, HJ; Fogg, LF; Eastman, CI				Smith, Mark R.; Burgess, Helen J.; Fogg, Louis F.; Eastman, Charmane I.			Racial Differences in the Human Endogenous Circadian Period	PLOS ONE			English	Article								The length of the endogenous period of the human circadian clock (tau) is slightly greater than 24 hours. There are individual differences in tau, which influence the phase angle of entrainment to the light/dark (LD) cycle, and in doing so contribute to morningness-eveningness. We have recently reported that tau measured in subjects living on an ultradian LD cycle averaged 24.2 hours, and is similar to tau measured using different experimental methods. Here we report racial differences in tau. Subjects lived on an ultradian LD cycle (1.5 hours sleep, 2.5 hours wake) for 3 days. Circadian phase assessments were conducted before and after the ultradian days to determine the change in circadian phase, which was attributed to tau. African American subjects had a significantly shorter tau than subjects of other races. We also tested for racial differences in our previous circadian phase advancing and phase delaying studies. In the phase advancing study, subjects underwent 4 days of a gradually advancing sleep schedule combined with a bright light pulse upon awakening each morning. In the phase delaying study, subjects underwent 4 days of a gradually delaying sleep schedule combined with evening light pulses before bedtime. African American subjects had larger phase advances and smaller phase delays, relative to Caucasian subjects. The racial differences in tau and circadian phase shifting have important implications for understanding normal phase differences between individuals, for developing solutions to the problems of jet lag and shift work, and for the diagnosis and treatment of circadian rhythm based sleep disorders such as advanced and delayed sleep phase disorder.			Smith, MR (corresponding author), Rush Univ, Med Ctr, Dept Behav Sci, Biol Rhythms Res Lab, Chicago, IL 60612 USA.	ceastman@rush.edu		Eastman, Charmane/0000-0002-4057-1233	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR007677] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL086934] Funding Source: Medline; NINR NIH HHS [R01 NR007677] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Aschoff J., 1981, HDB BEHAVIOURAL NEUR, V4, P81; Aschoff J., 1965, CIRCADIAN CLOCKS, P262; Burgess HJ, 2008, J BIOL RHYTHM, V23, P374, DOI 10.1177/0748730408318592; Burgess HJ, 2008, J PHYSIOL-LONDON, V586, P639, DOI 10.1113/jphysiol.2007.143180; CAMPBELL SS, 1993, SLEEP, V16, P638; Carskadon MA, 1999, NEUROSCI LETT, V260, P129, DOI 10.1016/S0304-3940(98)00971-9; Crosby B, 2005, PEDIATRICS, V115, P225, DOI 10.1542/peds.2004-0815D; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Durrence H Heith, 2006, Behav Sleep Med, V4, P29, DOI 10.1207/s15402010bsm0401_3; Hall MH, 2009, SLEEP, V32, P73; Hiddinga AE, 1997, J SLEEP RES, V6, P156, DOI 10.1046/j.1365-2869.1997.00047.x; Higuchi S, 2007, AM J PHYSIOL-REG I, V292, pR2352, DOI 10.1152/ajpregu.00355.2006; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Kendall AR, 2001, J BIOL RHYTHM, V16, P87, DOI 10.1177/074873040101600110; Lee C, 2006, CHRONOBIOL INT, V23, P859, DOI 10.1080/07420520600827160; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; PITTENDRIGH CS, 1989, J BIOL RHYTHM, V4, P217; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Profant J, 2002, AM J HUM BIOL, V14, P321, DOI 10.1002/ajhb.10032; Rao U, 1999, J PSYCHIATR RES, V33, P419, DOI 10.1016/S0022-3956(99)00019-9; Roenneberg T, 2007, CURR BIOL, V17, pR44, DOI 10.1016/j.cub.2006.12.011; SACK RL, 1992, J CLIN ENDOCR METAB, V75, P127, DOI 10.1210/jc.75.1.127; Smith MR, 2009, SLEEP MED, V10, P287, DOI 10.1016/j.sleep.2008.05.005; Smith MR, 2009, CHRONOBIOL INT, V26, P709, DOI 10.1080/07420520902927742; Stepnowsky CJ, 2003, SLEEP, V26, P329, DOI 10.1093/sleep/26.3.329; Voultsios A, 1997, J BIOL RHYTHM, V12, P457, DOI 10.1177/074873049701200507; WEITZMAN ED, 1982, NEUROBIOL AGING, V3, P299, DOI 10.1016/0197-4580(82)90018-5; Wever R.A., 1979, CIRCADIAN SYSTEM MAN; WEVER RA, 1984, EXPERIENTIA, V40, P1226, DOI 10.1007/BF01946652; White T. M., 2003, CHRONOBIOL INT, V20, P1193; WIRZJUSTICE A, 1984, NATURWISSENSCHAFTEN, V71, P316, DOI 10.1007/BF00396615; Wright KP, 2005, J BIOL RHYTHM, V20, P168, DOI 10.1177/0748730404274265	35	69	69	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6014	10.1371/journal.pone.0006014	http://dx.doi.org/10.1371/journal.pone.0006014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564915	Green Submitted, gold, Green Published			2022-12-27	WOS:000267515700001
J	Arsham, AM; Neufeld, TP				Arsham, Andrew M.; Neufeld, Thomas P.			A Genetic Screen in Drosophila Reveals Novel Cytoprotective Functions of the Autophagy- Lysosome Pathway	PLOS ONE			English	Article								The highly conserved autophagy-lysosome pathway is the primary mechanism for breakdown and recycling of macromolecular and organellar cargo in the eukaryotic cell. Autophagy has recently been implicated in protection against cancer, neurodegeneration, and infection, and interest is increasing in additional roles of autophagy in human health, disease, and aging. To search for novel cytoprotective features of this pathway, we carried out a genetic mosaic screen for mutations causing increased lysosomal and/or autophagic activity in the Drosophila melanogaster larval fat body. By combining Drosophila genetics with live-cell imaging of the fluorescent dye LysoTracker Red and fixed-cell imaging of autophagy-specific fluorescent protein markers, the screen was designed to identify essential metazoan genes whose disruption causes increased flux through the autophagy-lysosome pathway. The screen identified a large number of genes associated with the protein synthesis and ER-secretory pathways (e. g. aminoacyl tRNA synthetases, Oligosaccharyl transferase, Sec61 alpha), and with mitochondrial function and dynamics (e. g. Rieske iron-sulfur protein, Dynamin-related protein 1). We also observed that increased lysosomal and autophagic activity were consistently associated with decreased cell size. Our work demonstrates that disruption of the synthesis, transport, folding, or glycosylation of ER-targeted proteins at any of multiple steps leads to autophagy induction. In addition to illuminating cytoprotective features of autophagy in response to cellular damage, this screen establishes a genetic methodology for investigating cell biological phenotypes in live cells, in the context of viable wild type organisms.			Arsham, AM (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	neufe003@umn.edu		Arsham, Andrew/0000-0002-5274-8710; Neufeld, Thomas/0000-0001-5659-4811	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062509] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062509, GM62509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Arsham AM, 2006, CURR OPIN CELL BIOL, V18, P589, DOI 10.1016/j.ceb.2006.09.005; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Call GB, 2007, GENETICS, V177, P689, DOI 10.1534/genetics.107.077735; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chen J, 2005, PLOS BIOL, V3, P207, DOI 10.1371/journal.pbio.0030059; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; *FLYBASE, FLYBASE GEN REP DMEL; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kanuka H, 2005, BBA-GEN SUBJECTS, V1726, P225, DOI 10.1016/j.bbagen.2005.06.020; Kanuka H, 2003, P NATL ACAD SCI USA, V100, P11723, DOI 10.1073/pnas.1934748100; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oh SW, 2003, GENETICS, V163, P195; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; RODRIGUEZHERNAN.A, 2009, AUTOPHAGY, V5; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vellodi A, 2005, BRIT J HAEMATOL, V128, P413, DOI 10.1111/j.1365-2141.2004.05293.x; WINSLOW AR, 2008, BIOCH BIOPHYS ACTA; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Zhang G, 2008, J BIOL CHEM, V283, P24343, DOI 10.1074/jbc.M803444200	45	61	62	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6068	10.1371/journal.pone.0006068	http://dx.doi.org/10.1371/journal.pone.0006068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562034	Green Published, gold, Green Submitted			2022-12-27	WOS:000267465900004
J	Lightcap, CM; Kari, G; Arias-Romero, LE; Chernoff, J; Rodeck, U; Williams, JC				Lightcap, Christine M.; Kari, Gabor; Arias-Romero, Luis E.; Chernoff, Jonathan; Rodeck, Ulrich; Williams, John C.			Interaction with LC8 Is Required for Pak1 Nuclear Import and Is Indispensable for Zebrafish Development	PLOS ONE			English	Article								Pak1 (p21 activated kinase 1) is a serine/threonine kinase implicated in regulation of cell motility and survival and in malignant transformation of mammary epithelial cells. In addition, the dynein light chain, LC8, has been described to cooperate with Pak1 in malignant transformation of breast cancer cells. Pak1 itself may aid breast cancer development by phosphorylating nuclear proteins, including estrogen receptor alpha. Recently, we showed that the LC8 binding site on Pak1 is adjacent to the nuclear localization sequence (NLS) required for Pak1 nuclear import. Here, we demonstrate that the LC8-Pak1 interaction is necessary for epidermal growth factor (EGF)-induced nuclear import of Pak1 in MCF-7 cells, and that this event is contingent upon LC8-mediated Pak1 dimerization. In contrast, Pak2, which lacks an LC8 binding site but contains a nuclear localization sequence identical to that in Pak1, remains cytoplasmic upon EGF stimulation of MCF-7 cells. Furthermore, we show that severe developmental defects in zebrafish embryos caused by morpholino injections targeting Pak are partially rescued by co-injection of wild-type human Pak1, but not by co-injection of mutant Pak1 mRNA disrupting either the LC8 binding or the NLS site. Collectively, these results suggest that LC8 facilitates nuclear import of Pak1 and that this function is indispensable during vertebrate development.			Lightcap, CM (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	jwilliams@coh.org	Arias-Romero, Luis/A-5035-2010; Chernoff, Jonathan/I-7631-2014	Arias-Romero, Luis/0000-0002-1212-4049; Chernoff, Jonathan/0000-0002-4803-7836; Arias-Romero, Luis E./0000-0001-5676-2483	NCI NIH HHS [R01 CA117884, R01 CA81008, R01 CA081008] Funding Source: Medline; NCRR NIH HHS [S10-RR022316, S10 RR022316] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081008, R01CA117884] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022316] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Akinmade D, 2008, BRIT J CANCER, V98, P1132, DOI 10.1038/sj.bjc.6604261; ALLEN JD, 2009, BLOOD; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Cotteret S, 2006, MOL CELL BIOL, V26, P3215, DOI 10.1128/MCB.26.8.3215-3230.2006; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Davidson W, 2008, CELL CYCLE, V7, P1224, DOI 10.4161/cc.7.9.5786; Jacobs T, 2007, J NEUROSCI, V27, P8604, DOI 10.1523/JNEUROSCI.0765-07.2007; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Jakobi R, 2003, J BIOL CHEM, V278, P38675, DOI 10.1074/jbc.M306494200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Melen K, 2001, J BIOL CHEM, V276, P16447, DOI 10.1074/jbc.M008821200; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Singh RR, 2005, J BIOL CHEM, V280, P18130, DOI 10.1074/jbc.M412607200; Tharakan R, 2008, MOL CELL ENDOCRINOL, V295, P70, DOI 10.1016/j.mce.2008.07.018; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104	27	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6025	10.1371/journal.pone.0006025	http://dx.doi.org/10.1371/journal.pone.0006025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557173	Green Published, Green Submitted, gold			2022-12-27	WOS:000267424600002
J	Mckay, BR; De Lisio, M; Johnston, APW; O'Reilly, CE; Phillips, SM; Tarnopolsky, MA; Parise, G				Mckay, Bryon R.; De Lisio, Michael; Johnston, Adam P. W.; O'Reilly, Ciara E.; Phillips, Stuart M.; Tarnopolsky, Mark A.; Parise, Gianni			Association of Interleukin-6 Signalling with the Muscle Stem Cell Response Following Muscle-Lengthening Contractions in Humans	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; EXERCISE-INDUCED INCREASE; SATELLITE CELLS; MESSENGER-RNA; RECEPTOR EXPRESSION; CYCLE PROGRESSION; GENE-EXPRESSION; UP-REGULATION; IL-6 GENE; IN-VITRO	Background: The regulation of muscle stem cells in humans in response to muscle injury remains largely undefined. Recently, interleukin-6 (IL-6) has been implicated in muscle stem cell (satellite cell)-mediated muscle hypertrophy in animals; however, the role of IL-6 in the satellite cell (SC) response following muscle-lengthening contractions in humans has not been studied. Methodology/Principal Findings: Eight subjects (age 22 +/- 1 y; 79 +/- 8 kg) performed 300 maximal unilateral lengthening contractions (3.14 rad. s(-1)) of the knee extensors. Blood and muscle samples were collected before and at 4, 24, 72, and 120 hours post intervention. IL-6, IL-6 receptor (IL-6R alpha), cyclin D1, suppressor of cytokine signling-3 (SOCS3) mRNA were measured using quantitative RT-PCR and serum IL-6 protein was measured using an ELISA kit. JAK2 and STAT3 phosphorylated and total protein was measured using western blotting techniques. Immunohistochemical analysis of muscle cross-sections was performed for the quantification of SCs (Pax7(+) cells) as well as the expression of phosphorylated STAT3, IL-6, IL-6R alpha, and PCNA across all time-points. The SC response, as defined by an amplification of Pax7(+) cells, was rapid, increasing by 24 h and peaking 72 h following the intervention. Muscle IL-6 mRNA increased following the intervention, which correlated strongly (R-2 = 0.89, p, 0.002) with an increase in serum IL-6 concentration. SC IL-6R alpha protein was expressed on the fiber, but was also localized to the SC, and IL-6(+) SC increased rapidly following muscle-lengthening contractions and returned to basal levels by 72 h post-intervention, demonstrating an acute temporal expression of IL-6 with SC. Phosphorylated STAT3 was evident in SCs 4 h after lengthening contraction, and the downstream genes, cyclin D1 and SOCS3 were significantly elevated 24 hours after the intervention. Conclusions/Significance: The increased expression of STAT3 responsive genes and expression of IL-6 within SCs demonstrate that IL-6/STAT3 signaling occurred in SCs, correlating with an increase in SC proliferation, evidenced by increased Pax7(+)/PCNA(+) cell number in the early stages of the time-course. Collectively, these data illustrate that IL-6 is an important signaling molecule associated with the SC response to acute muscle-lengthening contractions in humans.			Mckay, BR (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	pariseg@mcmaster.ca	Phillips, Stuart/B-2343-2009	Phillips, Stuart/0000-0002-1956-4098				ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; Bamman MM, 2001, AM J PHYSIOL-ENDOC M, V280, pE383; Beaton LJ, 2002, J PHYSIOL-LONDON, V544, P849, DOI 10.1113/jphysiol.2002.022350; Beaton LJ, 2002, MED SCI SPORT EXER, V34, P798, DOI 10.1097/00005768-200205000-00012; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bruunsgaard H, 1997, J PHYSIOL-LONDON, V499, P833, DOI 10.1113/jphysiol.1997.sp021972; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; CANTINI M, 1995, BIOCHEM BIOPH RES CO, V216, P49, DOI 10.1006/bbrc.1995.2590; Chakravarthy MV, 2000, J BIOL CHEM, V275, P35942, DOI 10.1074/jbc.M005832200; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; Crameri RM, 2004, J PHYSIOL-LONDON, V558, P333, DOI 10.1113/jphysiol.2004.061846; Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Gallucci S, 1998, INT IMMUNOL, V10, P267, DOI 10.1093/intimm/10.3.267; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Helge JW, 2003, J PHYSIOL-LONDON, V546, P299, DOI 10.1113/jphysiol.2002.030437; Hennessey JV, 1997, J APPL PHYSIOL, V82, P1739, DOI 10.1152/jappl.1997.82.6.1739; Hiscock N, 2005, AM J PHYSIOL-ENDOC M, V289, pE2, DOI 10.1152/ajpendo.00274.2004; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Keller C, 2005, J APPL PHYSIOL, V99, P2075, DOI 10.1152/japplphysiol.00590.2005; Keller C, 2001, FASEB J, V15, P2748, DOI 10.1096/fj.01-0507fje; Keller P, 2005, FASEB J, V19, P1181, DOI 10.1096/fj.04-3278fje; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahoney DJ, 2008, AM J PHYSIOL-REG I, V294, pR1901, DOI 10.1152/ajpregu.00847.2007; Masuda M, 2002, CANCER RES, V62, P3351; McKay BR, 2008, J PHYSIOL-LONDON, V586, P5549, DOI 10.1113/jphysiol.2008.160176; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Naka T, 1999, TRENDS BIOCHEM SCI, V24, P394, DOI 10.1016/S0968-0004(99)01454-1; O'Reilly C, 2008, MUSCLE NERVE, V38, P1434, DOI 10.1002/mus.21146; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Spangenburg EE, 2002, AM J PHYSIOL-CELL PH, V283, pC204, DOI 10.1152/ajpcell.00574.2001; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Tomiya A, 2004, AM J SPORT MED, V32, P503, DOI 10.1177/0095399703258788; Trenerry MK, 2007, J APPL PHYSIOL, V102, P1483, DOI 10.1152/japplphysiol.01147.2006; ULLUM H, 1994, J APPL PHYSIOL, V77, P93, DOI 10.1152/jappl.1994.77.1.93; Wang X, 2008, CELL MOL NEUROBIOL, V28, P113, DOI 10.1007/s10571-007-9247-9; Wei Q, 2001, FEBS LETT, V490, P171, DOI 10.1016/S0014-5793(01)02120-2; Weigert C, 2007, AM J PHYSIOL-CELL PH, V293, pC1139, DOI 10.1152/ajpcell.00142.2007; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	62	105	106	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6027	10.1371/journal.pone.0006027	http://dx.doi.org/10.1371/journal.pone.0006027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19554087	Green Published, Green Submitted, gold			2022-12-27	WOS:000267356500011
J	Yamamoto, R; Ariely, D; Chi, W; Langleben, DD; Elman, I				Yamamoto, Rinah; Ariely, Dan; Chi, Won; Langleben, Daniel D.; Elman, Igor			Gender Differences in the Motivational Processing of Babies Are Determined by Their Facial Attractiveness	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; INFANT FACES; BEAUTIFUL; REWARD; BEHAVIOR; MOTHER; RAT	Background: This study sought to determine how esthetic appearance of babies may affect their motivational processing by the adults. Methodology and Principal Findings: Healthy men and women were administered two laboratory-based tasks: a) key pressing to change the viewing time of normal-looking babies and of those with abnormal facial features (e.g., cleft palate, strabismus, skin disorders, Down's syndrome and fetal alcohol syndrome) and b) attractiveness ratings of these images. Exposure to the babies' images produced two different response patterns: for normal babies, there was a similar effort by the two groups to extend the visual processing with lower attractiveness ratings by men; for abnormal babies, women exerted greater effort to shorten the viewing time despite attractiveness ratings comparable to the men. Conclusions: These results indicate that gender differences in the motivational processing of babies include excessive (relative to the esthetic valuation) motivation to extend the viewing time of normal babies by men vs. shortening the exposure to the abnormal babies by women. Such gender-specific incentive sensitization phenomenon may reflect an evolutionary-derived need for diversion of limited resources to the nurturance of healthy offspring.			Yamamoto, R (corresponding author), McLean Hosp, Clin Psychopathol Lab, Boston, MA USA.	ielman@partners.org	Langleben, Daniel D/K-7407-2014; Elman, Igor/O-2884-2017	Elman, Igor/0000-0002-1345-2677	NIDA NIH HHS [DA015036, DA017959] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017959, T32DA015036] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Badr LK, 2001, INFANT BEHAV DEV, V24, P129; BARDEN RC, 1989, CHILD DEV, V60, P819, DOI 10.1111/j.1467-8624.1989.tb03513.x; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; BERMAN PW, 1975, SEX ROLES, V1, P311; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; BRADSHAW CM, 1976, J EXP ANAL BEHAV, V26, P135, DOI 10.1901/jeab.1976.26-135; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Darwin C., 1871, P423; Elman I, 2005, PSYCHIAT RES, V135, P179, DOI 10.1016/j.psychres.2005.04.002; FELDMAN SS, 1978, CHILD DEV, V49, P617, DOI 10.1111/j.1467-8624.1978.tb02361.x; FLEMING AS, 1981, PHYSIOL BEHAV, V27, P863, DOI 10.1016/0031-9384(81)90054-8; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; GLOCKER ML, 2009, P NATL ACAD SCI US; Hibbard RA, 2007, PEDIATRICS, V119, P1018, DOI 10.1542/peds.2007-0565; Karlsgodt KH, 2003, AM J DRUG ALCOHOL AB, V29, P539, DOI 10.1081/ADA-120023457; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Lee A, 2000, BEHAV BRAIN RES, V108, P213, DOI 10.1016/s0166-4328(98)00109-0; Levy B, 2008, LEARN MOTIV, V39, P136, DOI 10.1016/j.lmot.2007.09.002; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Numan M, 2007, DEV PSYCHOBIOL, V49, P12, DOI 10.1002/dev.20198; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; REDELMEIER DA, 1993, JAMA-J AM MED ASSOC, V270, P72, DOI 10.1001/jama.270.1.72; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; STEPHAN CW, 1984, CHILD DEV, V55, P576, DOI 10.2307/1129969; Troisi A, 2001, PHYSIOL BEHAV, V73, P443, DOI 10.1016/S0031-9384(01)00459-0; Weiss Meira, 1994, CONDITIONAL LOVE PAR; WILSONCROFT WE, 1969, BEHAV RES METH INSTR, V1, P229	31	42	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6042	10.1371/journal.pone.0006042	http://dx.doi.org/10.1371/journal.pone.0006042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462MF	19554100	Green Published, gold, Green Submitted			2022-12-27	WOS:000267356500020
J	Costantini, M; Bernardi, G				Costantini, Maria; Bernardi, Giorgio			Mapping Insertions, Deletions and SNPs on Venter's Chromosomes	PLOS ONE			English	Article							I-HYPERSENSITIVE SITES; INTEGRATION SITES; SEQUENCE ORGANIZATION; INTERSPERSED REPEATS; PROVIRAL INTEGRATION; CHROMATIN-STRUCTURE; GENE DISTRIBUTION; GENOME; DNA; VIRUS	Background: The very recent availability of fully sequenced individual human genomes is a major revolution in biology which is certainly going to provide new insights into genetic diseases and genomic rearrangements. Results: We mapped the insertions, deletions and SNPs (single nucleotide polymorphisms) that are present in Craig Venter's genome, more precisely on chromosomes 17 to 22, and compared them with the human reference genome hg17. Our results show that insertions and deletions are almost absent in L1 and generally scarce in L2 isochore families (GC-poor L1+ L2 isochores represent slightly over half of the human genome), whereas they increase in GC-rich isochores, largely paralleling the densities of genes, retroviral integrations and Alu sequences. The distributions of insertions/ deletions are in striking contrast with those of SNPs which exhibit almost the same density across all isochore families with, however, a trend for lower concentrations in gene-rich regions. Conclusions: Our study strongly suggests that the distribution of insertions/ deletions is due to the structure of chromatin which is mostly open in gene-rich, GC-rich isochores, and largely closed in gene-poor, GC-poor isochores. The different distributions of insertions/ deletions and SNPs are clearly related to the two different responsible mechanisms, namely recombination and point mutations.			Costantini, M (corresponding author), Stn Zool A Dohrn, I-80121 Naples, Italy.	mcosta@szn.it; bernardi@szn.it	Bernardi, Giorgio/G-1639-2011; Costantini, Maria/AGH-4080-2022					Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; Bernardi G., 2004, STRUCTURAL EVOLUTION; Bernardi G, 2007, P NATL ACAD SCI USA, V104, P8385, DOI 10.1073/pnas.0701652104; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Di Filippo M, 2008, GENE, V419, P62, DOI 10.1016/j.gene.2008.02.012; Di Filippo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005010; Elleder D, 2002, FEBS LETT, V517, P285, DOI 10.1016/S0014-5793(02)02612-1; FINCHAM VJ, 1991, J VIROL, V65, P461, DOI 10.1128/JVI.65.1.461-463.1991; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Glukhova LA, 1999, CHROMOSOME RES, V7, P177, DOI 10.1023/A:1009243115039; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Jurka J, 2005, CYTOGENET GENOME RES, V110, P117, DOI 10.1159/000084943; Jurka J, 2004, CURR OPIN GENET DEV, V14, P603, DOI 10.1016/j.gde.2004.08.008; Jurka J, 2004, P NATL ACAD SCI USA, V101, P1268, DOI 10.1073/pnas.0308084100; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KETTMANN R, 1979, P NATL ACAD SCI USA, V76, P4822, DOI 10.1073/pnas.76.10.4822; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; MEUNIERROTIVAL M, 1982, P NATL ACAD SCI-BIOL, V79, P355, DOI 10.1073/pnas.79.2.355; Mok HP, 2005, GENE THER, V12, P1, DOI 10.1038/sj.gt.3302415; MOOSLEHNER K, 1990, J VIROL, V64, P3056, DOI 10.1128/JVI.64.6.3056-3058.1990; MOUCHIROUD D, 1991, GENE, V100, P181, DOI 10.1016/0378-1119(91)90364-H; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Paces J, 2004, GENE, V333, P135, DOI 10.1016/j.gene.2004.02.041; Pavlicek A, 2002, FEBS LETT, V511, P165, DOI 10.1016/S0014-5793(01)03283-5; ROHDEWOHLD H, 1987, J VIROL, V61, P336, DOI 10.1128/JVI.61.2.336-343.1987; RYNDITCH A, 1991, GENE, V106, P165, DOI 10.1016/0378-1119(91)90196-I; Rynditch AV, 1998, GENE, V222, P1, DOI 10.1016/S0378-1119(98)00451-X; Saccone S, 2002, GENE, V300, P169, DOI 10.1016/S0378-1119(02)01038-7; SALINAS J, 1986, EUR J BIOCHEM, V160, P469, DOI 10.1111/j.1432-1033.1986.tb10063.x; SCHERDIN U, 1990, J VIROL, V64, P907, DOI 10.1128/JVI.64.2.907-912.1990; SCHUBACH W, 1984, NATURE, V307, P702, DOI 10.1038/307702a0; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P1816, DOI 10.1073/pnas.80.7.1816; Tsyba L, 2004, CELL MOL LIFE SCI, V61, P721, DOI 10.1007/s00018-003-3436-6; VIJAYA S, 1986, J VIROL, V60, P683, DOI 10.1128/JVI.60.2.683-692.1986; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Webber C, 2005, GENOME RES, V15, P1787, DOI 10.1101/gr.3896805; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; ZERIAL M, 1986, NUCLEIC ACIDS RES, V14, P8373, DOI 10.1093/nar/14.21.8373; ZOUBAK B, 1994, GENE, V143, P155; Zoubak S, 1996, GENE, V174, P95, DOI 10.1016/0378-1119(96)00393-9; ZOUBAK S, 1992, GENE, V119, P207, DOI 10.1016/0378-1119(92)90273-R	50	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5972	10.1371/journal.pone.0005972	http://dx.doi.org/10.1371/journal.pone.0005972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543403	Green Published, Green Submitted, gold			2022-12-27	WOS:000267237600002
J	Tanaka, R; Shibata, Y; Manabe, A; Miyazaki, T				Tanaka, Reina; Shibata, Yo; Manabe, Atsufumi; Miyazaki, Takashi			Mineralization Potential of Polarized Dental Enamel	PLOS ONE			English	Article							REMINERALIZATION; LASER	Background: Management of human teeth has moved from a surgical to a more conservative approach of inhibiting or preventing lesion progression. Increasing enamel mineralization is crucial in this regard. A potential difficulty is the preferential mineralization of the outermost portion of the enamel that can prevent overall mineralization. We describe a strategy for increasing the mineralization potential of dental enamel. Methodology/Principal Findings: Extracted human premolar teeth enamel (n=5) were exposed to a high concentration of hydrogen peroxide with an energizing source. Samples were stored in artificial saliva at 37 degrees C for 1 wk. A desktop X-ray micro-CT system was used to evaluate the mineral density of samples. Mineral distribution was polarized between the lower and the higher mineralized portion of enamel by charged oxygen free radicals due to activation of permeated hydrogen peroxide. The kinetics of energy absorption in the deeper enamel region demonstrated improvement of preferential mineralization into the region without restricting overall mineralization of the enamel. Subsequent increasing mineralization, even in the dense mineralized outer portion of enamel, was also achieved. Conclusions/Significance: This increased mineralization may promote resistance to acidic deterioration of the structure. The present study is one of the primary steps towards the development of novel application in reparative and restorative dentistry.			Tanaka, R (corresponding author), Showa Univ, Sch Dent, Dept Oral Biomat & Technol, Tokyo 142, Japan.	yookun@dent.showa-u.ac.jp	SHIBATA, YO/C-7466-2009	Shibata, Yo/0000-0002-1876-3298				FOWLER BO, 1986, CALCIFIED TISSUE INT, V38, P197, DOI 10.1007/BF02556711; He LH, 2007, BIOMATERIALS, V28, P4512, DOI 10.1016/j.biomaterials.2007.06.020; Huang TTY, 2007, J DENT, V35, P737, DOI 10.1016/j.jdent.2007.06.001; LARSEN MJ, 1989, SCAND J DENT RES, V97, P285; PALAMARA J, 1987, J DENT RES, V66, P1742, DOI 10.1177/00220345870660120901; ROBINSON C, 1984, ARCH ORAL BIOL, V29, P479, DOI 10.1016/0003-9969(84)90066-9; SILVERSTONE LM, 1977, CARIES RES, V11, P59, DOI 10.1159/000260296; Simmelink J W, 1987, Adv Dent Res, V1, P356; Sulieman M, 2005, J DENT, V33, P33, DOI 10.1016/j.jdent.2004.07.008; WEATHERELL JA, 1977, CARIES RES, V11, P85, DOI 10.1159/000260297; Wojciak A, 2007, J PHYS CHEM A, V111, P10530, DOI 10.1021/jp074169b; Xie ZH, 2008, BIOMATERIALS, V29, P2697, DOI 10.1016/j.biomaterials.2008.02.022; Yamaguchi K, 2006, J DENT, V34, P230, DOI 10.1016/j.jdent.2005.06.005; YAMAMOTO H, 1974, J ORAL PATHOL MED, V3, P7, DOI 10.1111/j.1600-0714.1974.tb01693.x; Yamazaki H, 2008, J DENT RES, V87, P569, DOI 10.1177/154405910808700612	15	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5986	10.1371/journal.pone.0005986	http://dx.doi.org/10.1371/journal.pone.0005986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543391	Green Submitted, Green Published, gold			2022-12-27	WOS:000267237400012
J	Horwood, C; Vermaak, K; Rollins, N; Haskins, L; Nkosi, P; Qazi, S				Horwood, Christiane; Vermaak, Kerry; Rollins, Nigel; Haskins, Lyn; Nkosi, Phumla; Qazi, Shamim			An Evaluation of the Quality of IMCI Assessments among IMCI Trained Health Workers in South Africa	PLOS ONE			English	Article								Background: Integrated Management of Childhood Illness (IMCI) is a strategy to reduce mortality and morbidity in children under 5 years by improving case management of common and serious illnesses at primary health care level, and was adopted in South Africa in 1997. We report an evaluation of IMCI implementation in two provinces of South Africa. Methodology/Principal Findings: Seventy-seven IMCI trained health workers were randomly selected and observed in 74 health facilities; 1357 consultations were observed between May 2006 and January 2007. Each health worker was observed for up to 20 consultations with sick children presenting consecutively to the facility, each child was then reassessed by an IMCI expert to determine the correct findings. Observed health workers had been trained in IMCI for an average of 32.2 months, and were observed for a mean of 17.7 consultations; 50/77(65%) HW's had received a follow up visit after training. In most cases health workers used IMCI to assess presenting symptoms but did not implement IMCI comprehensively. All but one health worker referred to IMCI guidelines during the period of observation. 9(12%) observed health workers checked general danger signs in every child, and 14(18%) assessed all the main symptoms in every child. 51/109(46.8%) children with severe classifications were correctly identified. Nutritional status was not classified in 567/1357(47.5%) children. Conclusion/Significance: Health workers are implementing IMCI, but assessments were frequently incomplete, and children requiring urgent referral were missed. If coverage of key child survival interventions is to be improved, interventions are required to ensure competency in identifying specific signs and to encourage comprehensive assessments of children by IMCI practitioners. The role of supervision in maintaining health worker skills needs further investigation.			Horwood, C (corresponding author), Univ KwaZulu Natal, Ctr Rural Hlth, Durban, South Africa.	Christiane@telkomsa.net	Horwood, Christiane Marianne/GRF-4446-2022; Horwood, Christiane/F-8891-2011	Horwood, Christiane Marianne/0000-0003-4395-1423; Vermaak, Kerry/0000-0003-3402-8346				Adam T, 2005, B WORLD HEALTH ORGAN, V83, P369; Amaral João, 2004, Cad. Saúde Pública, V20, pS209, DOI 10.1590/S0102-311X2004000800016; Arifeen SE, 2005, B WORLD HEALTH ORGAN, V83, P260; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; Gouws E, 2004, B WORLD HEALTH ORGAN, V82, P509; Huicho L, 2005, HEALTH POLICY PLANN, V20, P14, DOI 10.1093/heapol/czi002; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; Rowe AK, 2001, AM J PUBLIC HEALTH, V91, P1625, DOI 10.2105/AJPH.91.10.1625; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Tulloch J, 1999, LANCET, V354, pS16; UNICEF, 2007, STAT WORLDS CHILDR 2; *WHO, 2004, CHILD AD HLTH DEV PR, P63; *WHO, 1999, GUID FOLL TRAIN	19	70	71	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5937	10.1371/journal.pone.0005937	http://dx.doi.org/10.1371/journal.pone.0005937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536288	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029700010
J	Mendum, TA; Newcombe, J; McNeilly, CL; McFadden, J				Mendum, Tom A.; Newcombe, Jane; McNeilly, Celia L.; McFadden, Johnjoe			Towards the Immunoproteome of Neisseria meningitidis	PLOS ONE			English	Article							MEMBRANE VESICLE VACCINE; L7/L12 RIBOSOMAL-PROTEIN; ELONGATION-FACTOR TU; SEROGROUP-B; MENINGOCOCCAL DISEASE; PROTEOMIC ANALYSIS; ESCHERICHIA-COLI; CANDIDA-ALBICANS; BINDING-PROTEINS; HUMAN IMMUNITY	Despite the introduction of conjugated polysaccharide vaccines for many of the Neisseria meningitidis serogroups, neisserial infections continue to cause septicaemia and meningitis across the world. This is in part due to the difficulties in developing a, cross-protective vaccine that is effective against all serogroups, including serogroup B meningococci. Although convalescent N. meningitidis patients develop a natural long-lasting cross-protective immunity, the antigens that mediate this response remain unknown. To help define the target of this protective immunity we identified the proteins recognized by IgG in sera from meningococcal patients by a combination of 2D protein gels, western blots and mass spectrometry. Although a number of outer membrane antigens were identified the majority of the antigens were cytoplasmic, with roles in cellular processes and metabolism. When recombinant proteins were expressed and used to raise sera in mice, none of the antigens elicited a positive SBA result, however flow cytometry did demonstrate that some, including the ribosomal protein, RplY were localised to the neisserial cell surface.			Mendum, TA (corresponding author), Univ Surrey, Fac Med & Hlth Sci, Guildford GU2 5XH, Surrey, England.	j.mcfadden@surrey.ac.uk		McFadden, Johnjoe/0000-0003-2145-0046				Abel A, 2007, INT MICROBIOL, V10, P5, DOI 10.2436/20.1501.01.2; ALVAREZ A, 2004, BIOTECNOL APL, V21, P137; Bernardini G, 2004, PROTEOMICS, V4, P2893, DOI 10.1002/pmic.200400946; BJORVATN B, 1984, J CLIN MICROBIOL, V19, P763, DOI 10.1128/JCM.19.6.763-765.1984; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; Borrow R, 2001, METH MOLEC MED, V66, P289, DOI 10.1385/1-59259-148-5:289; Connolly JP, 2006, PROTEOMICS, V6, P3767, DOI 10.1002/pmic.200500730; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Delpino MV, 2007, VACCINE, V25, P6721, DOI 10.1016/j.vaccine.2007.07.002; Fernandez-Arenas E, 2004, PROTEOMICS, V4, P3007, DOI 10.1002/pmic.200400929; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; FREDRIKSEN J H, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P67; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Guillen G, 1998, BIOTECHNOL APPL BIOC, V27, P189; Hsu CA, 2008, PROTEOMICS, V8, P2115, DOI 10.1002/pmic.200700574; KLUGMAN KP, 1989, INFECT IMMUN, V57, P2066, DOI 10.1128/IAI.57.7.2066-2071.1989; Knaust A, 2007, J BACTERIOL, V189, P3246, DOI 10.1128/JB.01966-06; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Li YW, 2004, INFECT IMMUN, V72, P345, DOI 10.1128/IAI.72.1.345-351.2004; Lin YF, 2006, MOL CELL PROTEOMICS, V5, P1484, DOI 10.1074/mcp.M600111-MCP200; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Litt DJ, 2004, J INFECT DIS, V190, P1488, DOI 10.1086/424464; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; MANDRELL RE, 1989, INFECT IMMUN, V57, P1590, DOI 10.1128/IAI.57.5.1590-1598.1989; Marques MAM, 1998, INFECT IMMUN, V66, P2625, DOI 10.1128/IAI.66.6.2625-2631.1998; MARTIN D, 2008, EPIDEMIOLOGY MENINGO; Mignogna G, 2005, J PROTEOME RES, V4, P1361, DOI 10.1021/pr0500511; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Mueller M, 2006, J CLIN MICROBIOL, V44, P3778, DOI 10.1128/JCM.00371-06; Muhonen J, 2008, ANAL BIOCHEM, V374, P133, DOI 10.1016/j.ab.2007.10.014; Nolte O, 2002, MED MICROBIOL IMMUN, V191, P41, DOI 10.1007/s00430-002-0113-6; Nowalk AJ, 2006, INFECT IMMUN, V74, P3864, DOI 10.1128/IAI.00189-06; Ohman R, 1996, TUBERCLE LUNG DIS, V77, P454, DOI 10.1016/S0962-8479(96)90120-3; Oliveira SC, 1996, VACCINE, V14, P959, DOI 10.1016/0264-410X(96)00018-7; Padmalayam I, 1997, J BACTERIOL, V179, P4545, DOI 10.1128/jb.179.14.4545-4552.1997; Pitarch A, 2004, PROTEOMICS, V4, P3084, DOI 10.1002/pmic.200400903; Pollard AJ, 2001, VACCINE, V19, P1327, DOI 10.1016/S0264-410X(00)00333-9; Rodriguez AP, 1999, MEM I OSWALDO CRUZ, V94, P433, DOI 10.1590/S0074-02761999000400002; Sanchez-Campillo M, 1999, ELECTROPHORESIS, V20, P2269, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2269::AID-ELPS2269>3.0.CO;2-D; Sellman BR, 2005, INFECT IMMUN, V73, P6591, DOI 10.1128/IAI.73.10.6591-6600.2005; Shah P, 2006, FEMS MICROBIOL LETT, V261, P235, DOI 10.1111/j.1574-6968.2006.00352.x; Sinha S, 2002, COMPAR FUNCT GENOM, V3, P470, DOI 10.1002/cfg.211; Spence JM, 2000, INFECT IMMUN, V68, P5002, DOI 10.1128/IAI.68.9.5002-5010.2000; Spence JM, 2002, MICROB PATHOGENESIS, V32, P117, DOI 10.1006/mpat.2001.0484; Uli L, 2006, PROTEOMICS, V6, P3389, DOI 10.1002/pmic.200500502; Vaughan TE, 2006, VACCINE, V24, P5277, DOI 10.1016/j.vaccine.2006.03.013; Vipond C, 2006, PROTEOMICS, V6, P4203, DOI 10.1002/pmic.200690086; Wheeler JX, 2007, PROTEOM CLIN APPL, V1, P1198, DOI 10.1002/prca.200700204; Wilkins JC, 2003, APPL ENVIRON MICROB, V69, P5290, DOI 10.1128/AEM.69.9.5290-5296.2003	53	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5940	10.1371/journal.pone.0005940	http://dx.doi.org/10.1371/journal.pone.0005940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529772	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029500017
J	Muccioli, GG; Sia, A; Muchowski, PJ; Stella, N				Muccioli, Giulio G.; Sia, Angela; Muchowski, Paul J.; Stella, Nephi			Genetic Manipulation of Palmitoylethanolamide Production and Inactivation in Saccharomyces cerevisiae	PLOS ONE			English	Article								Background: Lipids can act as signaling molecules, activating intracellular and membrane-associated receptors to regulate physiological functions. To understand how a newly discovered signaling lipid functions, it is necessary to identify and characterize the enzymes involved in their production and inactivation. The signaling lipid N-palmitoylethanolamine (PEA) is known to activate intracellular and membrane-associated receptors and regulate physiological functions, but little is known about the enzymes involved in its production and inactivation. Principal Findings: Here we show that Saccharomyces cerevisiae produce and inactivate PEA, suggesting that genetic manipulations of this lower eukaryote may be used to identify the enzymes involved in PEA metabolism. Accordingly, using single gene deletion mutants, we identified yeast genes that control PEA metabolism, including SPO14 (a yeast homologue of the mammalian phospholipase D) that controls PEA production and YJU3 (a yeast homologue of the mammalian monoacylglycerol lipase) that controls PEA inactivation. We also found that PEA metabolism is affected by heterologous expression of two mammalian proteins involved in neurodegenerative diseases, namely huntingtin and alpha-synuclein. Significance: Together these findings show that forward and reverse genetics in S. cerevisiae can be used to identify proteins involved in PEA production and inactivation, and suggest that mutated proteins causing neurodegenerative diseases might affect the metabolism of this important signaling lipid.			Muccioli, GG (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	pmuchowski@gladstone.ucsf.edu; nstella@u.washington.edu		Muccioli, Giulio/0000-0002-1600-9259	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA021389] Funding Source: NIH RePORTER; NIDA NIH HHS [R21 DA021389, DA021389] Funding Source: Medline; NINDS NIH HHS [R01 NS047237, NS47237] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 1999, J NEUROCHEM, V72, P2113, DOI 10.1046/j.1471-4159.1999.0722113.x; Bisogno T, 1997, J BIOL CHEM, V272, P3315, DOI 10.1074/jbc.272.6.3315; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Chapman KD, 2004, PROG LIPID RES, V43, P302, DOI 10.1016/j.plipres.2004.03.002; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; diMarzo V, 1996, BIOCHEM J, V316, P977, DOI 10.1042/bj3160977; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; Franklin A, 2003, J NEUROSCI, V23, P7767; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Goparaju SK, 1998, FEBS LETT, V422, P69, DOI 10.1016/S0014-5793(97)01603-7; HAMPSON AJ, 1995, BBA-LIPID LIPID MET, V1259, P173, DOI 10.1016/0005-2760(95)00157-8; HANUS L, 1993, J MED CHEM, V36, P3032, DOI 10.1021/jm00072a026; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; Kim TD, 2000, BIOCHEMISTRY-US, V39, P14839, DOI 10.1021/bi001441y; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2002, J BIOL CHEM, V277, P23278, DOI 10.1074/jbc.M201084200; Lambert DM, 2002, CURR MED CHEM, V9, P663, DOI 10.2174/0929867023370707; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Lichtman AH, 2002, J PHARMACOL EXP THER, V302, P73, DOI 10.1124/jpet.302.1.73; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; Maccarrone M, 2002, MOL CELL NEUROSCI, V21, P126, DOI 10.1006/mcne.2002.1164; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Martin CE, 2002, BIOCHEM SOC T, V30, P1080, DOI 10.1042/bst0301080; Matias I, 2001, MOL BRAIN RES, V87, P145, DOI 10.1016/S0169-328X(00)00290-4; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Moody JS, 2001, BIOCHEMISTRY-US, V40, P861, DOI 10.1021/bi002303b; Muccio GG, 2008, ANAL BIOCHEM, V373, P220, DOI 10.1016/j.ab.2007.09.030; Muccioli GG, 2008, NEUROPHARMACOLOGY, V54, P16, DOI 10.1016/j.neuropharm.2007.05.015; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; PERTWEE R, 1994, EUR J PHARMACOL, V259, P115, DOI 10.1016/0014-2999(94)90499-5; Phelps C, 2006, P NATL ACAD SCI USA, V103, P7077, DOI 10.1073/pnas.0510080103; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Stella N, 2001, EUR J PHARMACOL, V425, P189, DOI 10.1016/S0014-2999(01)01182-7; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; Walter L, 2002, J BIOL CHEM, V277, P20869, DOI 10.1074/jbc.M110813200; Weber A, 2004, J LIPID RES, V45, P757, DOI 10.1194/jlr.M300475-JLR200; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	51	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5942	10.1371/journal.pone.0005942	http://dx.doi.org/10.1371/journal.pone.0005942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529773	gold, Green Published, Green Submitted			2022-12-27	WOS:000267029500018
J	Wu, D; Li, CY; Yao, DZ				Wu, Dan; Li, Chao-Yi; Yao, De-Zhong			Scale-Free Music of the Brain	PLOS ONE			English	Article								Background: There is growing interest in the relation between the brain and music. The appealing similarity between brainwaves and the rhythms of music has motivated many scientists to seek a connection between them. A variety of transferring rules has been utilized to convert the brainwaves into music; and most of them are mainly based on spectra feature of EEG. Methodology/Principal Findings: In this study, audibly recognizable scale-free music was deduced from individual Electroencephalogram (EEG) waveforms. The translation rules include the direct mapping from the period of an EEG waveform to the duration of a note, the logarithmic mapping of the change of average power of EEG to music intensity according to the Fechner's law, and a scale-free based mapping from the amplitude of EEG to music pitch according to the power law. To show the actual effect, we applied the deduced sonification rules to EEG segments recorded during rapid-eye movement sleep (REM) and slow-wave sleep (SWS). The resulting music is vivid and different between the two mental states; the melody during REM sleep sounds fast and lively, whereas that in SWS sleep is slow and tranquil. 60 volunteers evaluated 25 music pieces, 10 from REM, 10 from SWS and 5 from white noise (WN), 74.3% experienced a happy emotion from REM and felt boring and drowsy when listening to SWS, and the average accuracy for all the music pieces identification is 86.8%(kappa = 0.800, P < 0.001). We also applied the method to the EEG data from eyes closed, eyes open and epileptic EEG, and the results showed these mental states can be identified by listeners. Conclusions/Significance: The sonification rules may identify the mental states of the brain, which provide a real-time strategy for monitoring brain activities and are potentially useful to neurofeedback therapy.			Wu, D (corresponding author), Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.	dyao@uestc.edu.cn	Wu, Dan/A-2436-2012	Yao, Dezhong/0000-0002-8042-879X				Adrian ED, 1934, BRAIN, V57, P355, DOI 10.1093/brain/57.4.355; [Anonymous], 1991, FRACTALS CHAOS POWER; BAIER G, 2004, P ICAD 04 10 M INT C; Baier G, 2007, CLIN NEUROPHYSIOL, V118, P1377, DOI 10.1016/j.clinph.2007.01.025; Beggs JM, 2003, J NEUROSCI, V23, P11167; CHAPEL RH, 2003, REALTIME ALGORITHMIC; Chen YQ, 1997, PHYS REV LETT, V79, P4501, DOI 10.1103/PhysRevLett.79.4501; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Eco Umberto, 1986, ART BEAUTY MIDDLE AG, P5; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Empson J, 2002, SLEEP DREAMING; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Freeman WJ, 2006, CLIN NEUROPHYSIOL, V117, P1228, DOI 10.1016/j.clinph.2006.03.012; Gao Tingting, 2007, J ELECT SCI TECH CHI, V5, P272; Gardner M, 1978, SCI AM, V238, P16, DOI 10.1038/scientificamerican0478-16; Hinterberger T, 2005, IEEE MULTIMEDIA, V12, P70, DOI 10.1109/MMUL.2005.36; HSU KJ, 1991, P NATL ACAD SCI USA, V88, P3507, DOI 10.1073/pnas.88.8.3507; Hwa RC, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021901; Lowen SB, 1999, PHYS REV E, V59, P5970, DOI 10.1103/PhysRevE.59.5970; Manaris B, 2005, COMPUT MUSIC J, V29, P55, DOI 10.1162/comj.2005.29.1.55; Miranda ER, 2005, LEONARDO, V38, P331, DOI 10.1162/0024094054762133; NIEDERMEYER E, 1998, ELECTROENCEPHALOGRAP; Peretz I, 2006, COGNITION, V100, P1, DOI 10.1016/j.cognition.2005.11.004; Rosenboom D, 1990, EXTENDED MUSICAL INT; Rosenboom D., 1976, BIOFEEDBACK ARTS RES; Teich MC, 1997, J OPT SOC AM A, V14, P529, DOI 10.1364/JOSAA.14.000529; Uchida S, 1999, PHYSIOL BEHAV, V67, P121, DOI 10.1016/S0031-9384(99)00049-9; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Yu YG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108103; Zatorre RJ, 2005, NATURE, V436, P1093, DOI 10.1038/4361093a	31	28	32	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5915	10.1371/journal.pone.0005915	http://dx.doi.org/10.1371/journal.pone.0005915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526057	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029300009
J	Luan, WJ; Chen, HZ; Fu, YP; Si, HM; Wen, P; Song, SS; Liu, WZ; Hu, GC; Sun, ZX; Xie, DX; Sun, CQ				Luan, Weijiang; Chen, Huizhe; Fu, Yaping; Si, Huamin; Wen Peng; Song, Susheng; Liu, Wenzhen; Hu, Guocheng; Sun, Zongxiu; Xie, Daoxin; Sun, Chuanqing			The Effect of the Crosstalk between Photoperiod and Temperature on the Heading-Date in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; FLOWERING RESPONSE; ARABIDOPSIS; CONSTANS; PROTEIN; VERNALIZATION; GENE; IDENTIFICATION; EXPRESSION; ENCODES	Photoperiod and temperature are two important environmental factors that influence the heading-date of rice. Although the influence of the photoperiod on heading has been extensively reported in rice, the molecular mechanism for the temperature control of heading remains unknown. This study reports an early heading mutant derived from tissue culture lines of rice and investigates the heading-date of wild type and mutant in different photoperiod and temperature treatments. The linkage analysis showed that the mutant phenotype cosegregated with the Hd1 locus. Sequencing analysis found that the mutant contained two insertions and several single-base substitutions that caused a dramatic reduction in Hd1mRNA levels compared with wild type. The expression patterns of Hd1 and Hd3a were also analyzed in different photoperiod and temperature conditions, revealing that Hd1 mRNA levels displayed similar expression patterns for different photoperiod and temperature treatments, with high expression levels at night and reduced levels in the daytime. In addition, Hd1 displayed a slightly higher expression level under long-day and low temperature conditions. Hd3a mRNA was present at a very low level under low temperature conditions regardless of the day-length. This result suggests that suppression of Hd3a expression is a principle cause of late heading under low temperature and long-day conditions.			Luan, WJ (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.	zxsun405@163.com; daoxinlab@tsinghua.edu.cn; suncq@cau.edu.cn	xie, daoxin d/C-8646-2017					Amasino RM, 2005, CURR OPIN BIOTECH, V16, P154, DOI 10.1016/j.copbio.2005.02.004; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Garner WW, 1923, J AGRIC RES, V23, P0871; Garner WW, 1919, J AGRIC RES, V18, P0553; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Hamner KC, 1938, BOT GAZ, V100, P388, DOI 10.1086/334793; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Ishikawa R, 2005, PLANT CELL, V17, P3326, DOI 10.1105/tpc.105.037028; Izawa T, 2000, PLANT J, V22, P391, DOI 10.1046/j.1365-313X.2000.00753.x; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Izawa T, 2007, INT REV CYTOL, V256, P191, DOI 10.1016/S0074-7696(07)56006-7; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Kim SL, 2007, PLANT PHYSIOL, V145, P1484, DOI 10.1104/pp.107.103291; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Lin HX, 2000, THEOR APPL GENET, V101, P1021, DOI 10.1007/s001220051576; Lin HX, 2003, BREEDING SCI, V53, P51, DOI 10.1270/jsbbs.53.51; Lin HX, 2002, BREEDING SCI, V52, P35, DOI 10.1270/jsbbs.52.35; Liu LJ, 2008, PLANT CELL, V20, P292, DOI 10.1105/tpc.107.057281; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Nakagawa H, 2005, THEOR APPL GENET, V110, P778, DOI 10.1007/s00122-004-1905-4; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2004, CURR OPIN PLANT BIOL, V7, P4, DOI 10.1016/j.pbi.2003.11.010; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; TAMAKI S, 2007, SCI EXPRESS, DOI DOI 10.1126/SCIENCE.1141753; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Yamamoto T, 1998, THEOR APPL GENET, V97, P37, DOI 10.1007/s001220050864; Yamamoto T, 2000, GENETICS, V154, P885; Yano M, 1997, THEOR APPL GENET, V95, P1025, DOI 10.1007/s001220050658; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473	37	40	52	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5891	10.1371/journal.pone.0005891	http://dx.doi.org/10.1371/journal.pone.0005891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521518	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029100007
J	Huszthy, PC; Giroglou, T; Tsinkalovsky, O; Euskirchen, P; Skaftnesmo, KO; Bjerkvig, R; von Laer, D; Miletic, H				Huszthy, Peter C.; Giroglou, Tsanan; Tsinkalovsky, Oleg; Euskirchen, Philipp; Skaftnesmo, Kai Ove; Bjerkvig, Rolf; von Laer, Dorothee; Miletic, Hrvoje			Remission of Invasive, Cancer Stem-Like Glioblastoma Xenografts Using Lentiviral Vector-Mediated Suicide Gene Therapy	PLOS ONE			English	Article								Background: Glioblastoma is the most frequent and most malignant primary brain tumor with a poor prognosis. The translation of therapeutic strategies for glioblastoma from the experimental phase into the clinic has been limited by insufficient animal models, which lack important features of human tumors. Lentiviral gene therapy is an attractive therapeutic option for human glioblastoma, which we validated in a clinically relevant animal model. Methodology/Principal Findings: We used a rodent xenograft model that recapitulates the invasive and angiogenic features of human glioblastoma to analyze the transduction pattern and therapeutic efficacy of lentiviral pseudotyped vectors. Both, lymphocytic choriomeningitis virus glycoprotein (LCMV-GP) and vesicular stomatitis virus glycoprotein (VSVG) pseudotyped lentiviral vectors very efficiently transduced human glioblastoma cells in vitro and in vivo. In contrast, pseudotyped gammaretroviral vectors, similar to those evaluated for clinical therapy of glioblastoma, showed inefficient gene transfer in vitro and in vivo. Both pseudotyped lentiviral vectors transduced cancer stem-like cells characterized by their CD133-, nestin- and SOX2-expression, the ability to form spheroids in neural stem cell medium and to express astrocytic and neuronal differentiation markers under serum conditions. In a therapeutic approach using the suicide gene herpes simplex virus thymidine kinase (HSV-1-tk) fused to eGFP, both lentiviral vectors mediated a complete remission of solid tumors as seen on MRI resulting in a highly significant survival benefit (p < 0.001) compared to control groups. In all recurrent tumors, surviving eGFP-positive tumor cells were found, advocating prodrug application for several cycles to even enhance and prolong the therapeutic effect. Conclusions/Significance: In conclusion, lentiviral pseudotyped vectors are promising candidates for gene therapy of glioma in patients. The inefficient gene delivery by gammaretroviral vectors is in line with the results obtained in clinical therapy for GBM and thus confirms the high reproducibility of the invasive glioma animal model for translational research.			Huszthy, PC (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	hrvoje.miletic@biomed.uib.no	Skaftnesmo, kai ove/AAF-6071-2021; Euskirchen, Philipp/AFL-2848-2022; Huszthy, Peter Csaba/H-1414-2016	Euskirchen, Philipp/0000-0002-9138-805X; Huszthy, Peter Csaba/0000-0003-0184-8989; von Laer, Dorothee/0000-0001-5825-7237				Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Benedetti S, 1999, CANCER RES, V59, P645; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Beyer WR, 2001, J VIROL, V75, P1061, DOI 10.1128/JVI.75.2.1061-1064.2001; BJERKVIG R, 1990, J NEUROSURG, V72, P463, DOI 10.3171/jns.1990.72.3.0463; Coil DA, 2004, J VIROL, V78, P10920, DOI 10.1128/JVI.78.20.10920-10926.2004; Ferguson Sherise, 2007, Current Drug Delivery, V4, P169, DOI 10.2174/156720107780362302; Fischer YH, 2007, J GENE MED, V9, P335, DOI 10.1002/jgm.1032; Galipeau J, 1999, CANCER RES, V59, P2384; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Giroglou T, 2004, J VIROL, V78, P9007, DOI 10.1128/JVI.78.17.9007-9015.2004; Huszthy PC, 2005, HUM GENE THER, V16, P381, DOI 10.1089/hum.2005.16.381; Huszthy PC, 2008, CLIN CANCER RES, V14, P1571, DOI 10.1158/1078-0432.CCR-07-2000; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kunkel P, 2001, CANCER RES, V61, P6624; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Mahesparan R, 2003, ACTA NEUROPATHOL, V105, P49, DOI 10.1007/s00401-002-0610-0; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Miletic H, 2004, HUM GENE THER, V15, P1091, DOI 10.1089/hum.2004.15.1091; Miletic H, 1999, J VIROL, V73, P6114, DOI 10.1128/JVI.73.7.6114-6116.1999; Miletic H, 2007, CLIN CANCER RES, V13, P6761, DOI 10.1158/1078-0432.CCR-07-1240; Miletic H, 2007, MOL THER, V15, P1373, DOI 10.1038/sj.mt.6300155; MINETA T, 1995, NAT MED, V1, P938, DOI 10.1038/nm0995-938; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nandi S, 2008, CANCER RES, V68, P5778, DOI 10.1158/0008-5472.CAN-07-6441; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rainov NG, 2003, J NEURO-ONCOL, V65, P227, DOI 10.1023/B:NEON.0000003652.71665.f2; Rainov NG, 2000, HUM GENE THER, V11, P2389, DOI 10.1089/104303400750038499; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Sandmair AM, 2000, HUM GENE THER, V11, P2197, DOI 10.1089/104303400750035726; Schambach A, 2000, MOL THER, V2, P435, DOI 10.1006/mthe.2000.0191; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skog J, 2007, MOL THER, V15, P2140, DOI 10.1038/sj.mt.6300315; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tai CK, 2005, MOL THER, V12, P842, DOI 10.1016/j.ymthe.2005.03.017; Tamura K, 2001, GENE THER, V8, P215, DOI 10.1038/sj.gt.3301371; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Wang WJ, 2003, HUM GENE THER, V14, P117, DOI 10.1089/104303403321070810; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564	42	43	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6314	10.1371/journal.pone.0006314	http://dx.doi.org/10.1371/journal.pone.0006314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617915	Green Published, Green Submitted, gold			2022-12-27	WOS:000268119600010
J	Bergholdt, R; Brorsson, C; Lage, K; Nielsen, JH; Brunak, S; Pociot, F				Bergholdt, Regine; Brorsson, Caroline; Lage, Kasper; Nielsen, Jens Hoiriis; Brunak, Soren; Pociot, Flemming			Expression Profiling of Human Genetic and Protein Interaction Networks in Type 1 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; METAANALYSIS; COMPLEXES; PTPN22; RISK; LOCI	Proteins contributing to a complex disease are often members of the same functional pathways. Elucidation of such pathways may provide increased knowledge about functional mechanisms underlying disease. By combining genetic interactions in Type 1 Diabetes (T1D) with protein interaction data we have previously identified sets of genes, likely to represent distinct cellular pathways involved in T1D risk. Here we evaluate the candidate genes involved in these putative interaction networks not only at the single gene level, but also in the context of the networks of which they form an integral part. mRNA expression levels for each gene were evaluated and profiling was performed by measuring and comparing constitutive expression in human islets versus cytokine-stimulated expression levels, and for lymphocytes by comparing expression levels among controls and T1D individuals. We identified differential regulation of several genes. In one of the networks four out of nine genes showed significant down regulation in human pancreatic islets after cytokine exposure supporting our prediction that the interaction network as a whole is a risk factor. In addition, we measured the enrichment of T1D associated SNPs in each of the four interaction networks to evaluate evidence of significant association at network level. This method provided additional support, in an independent data set, that two of the interaction networks could be involved in T1D and highlights the following processes as risk factors: oxidative stress, regulation of transcription and apoptosis. To understand biological systems, integration of genetic and functional information is necessary, and the current study has used this approach to improve understanding of T1D and the underlying biological mechanisms.			Bergholdt, R (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	rber@hagedorn.dk	; Brunak, Soren/O-6621-2016	Brorsson, Caroline Anna/0000-0003-3473-1744; Pociot, Flemming/0000-0003-3274-5448; Brunak, Soren/0000-0003-0316-5866; Nielsen, Jens Hoiriis/0000-0001-8252-3048	Wellcome Trust [076113] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adler HJ, 1999, GENOMICS, V56, P59, DOI 10.1006/geno.1998.5672; Allcock RJN, 2001, GENES CELLS, V6, P487, DOI 10.1046/j.1365-2443.2001.00435.x; Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bergholdt R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r253; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Concannon P, 2005, DIABETES, V54, P2995, DOI 10.2337/diabetes.54.10.2995; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; Cordell HJ, 2000, AM J HUM GENET, V66, P1273, DOI 10.1086/302847; D'Hertog W, 2007, MOL CELL PROTEOMICS, V6, P2180, DOI 10.1074/mcp.M700085-MCP200; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Holm P, 2001, AM J HUM GENET, V69, P1301; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; SHAU HG, 1994, IMMUNOGENETICS, V40, P129; Smyth DJ, 2008, DIABETES, V57, P1730, DOI 10.2337/db07-1131; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Zhang Q, 2007, NAT MED, V13, P1341, DOI 10.1038/nm1659	29	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6250	10.1371/journal.pone.0006250	http://dx.doi.org/10.1371/journal.pone.0006250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609442	gold, Green Published, Green Submitted			2022-12-27	WOS:000268119500003
J	Yamashita, H; Kobiyama, A; Koike, K				Yamashita, Hiroshi; Kobiyama, Atsushi; Koike, Kazuhiko			Do Uric Acid Deposits in Zooxanthellae Function as Eye-Spots?	PLOS ONE			English	Article								The symbiosis between zooxanthellae (dinoflagellate genus Symbiodinium) and corals is a fundamental basis of tropical marine ecosystems. However the physiological interactions of the hosts and symbionts are poorly understood. Recently, intracellular crystalline deposits in Symbiodinium were revealed to be uric acid functioning for nutrient storage. This is the first exploration of these enigmatic crystalline materials that had previously been misidentified as oxalic acid, providing new insights into the nutritional strategies of Symbiodinium in oligotrophic tropical waters. However, we believe these deposits also function as eye-spots on the basis of light and electron microscopic observations of motile cells of cultured Symbiodinium. The cells possessed crystalline deposit clusters in rows with each row 100-150 nm thick corresponding to 1/4 the wavelength of light and making them suitable for maximum wave interference and reflection of light. Crystalline clusters in cells observed with a light microscope strongly refracted and polarized light, and reflected or absorbed short wavelength light. The facts that purines, including uric acid, have been identified as the main constituents of light reflectors in many organisms, and that the photoreceptor protein, opsin, was detected in our Symbiodinium strain, support the idea that uric acid deposits in Symbiodinium motile cells may function as a component of an eye-spot.			Yamashita, H (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan.	kazkoike@hiroshima-u.ac.jp	Koike, Kazuhiko/A-3392-2019	Kazuhiko, Koike/0000-0001-5380-5839; Yamashita, Hiroshi/0000-0002-3909-5073				CAVENEY S, 1971, PROC R SOC SER B-BIO, V178, P205, DOI 10.1098/rspb.1971.0062; Clode PL, 2009, PLANT CELL ENVIRON, V32, P170, DOI 10.1111/j.1365-3040.2008.01909.x; CRAFTS CB, 1995, B MAR SCI, V56, P822; Dodge J.D., 1984, Biosystems, V16, P259; Doyle M. M., 1940, PAP TORTUGAS LAB, VXXXII, P129; FITT WK, 1983, NEW PHYTOL, V94, P421, DOI 10.1111/j.1469-8137.1983.tb03456.x; FITT WK, 1981, B MAR SCI, V31, P436; FITT WK, 1984, MAR BIOL, V81, P9, DOI 10.1007/BF00397620; FOSTER KW, 1984, NATURE, V311, P756, DOI 10.1038/311756a0; FREUDENTHAL HD, 1962, J PROTOZOOL, V9, P45, DOI 10.1111/j.1550-7408.1962.tb02579.x; Hirose M, 2008, MAR BIOL, V155, P105, DOI 10.1007/s00227-008-1011-2; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hollingsworth LL, 2005, CORAL REEFS, V24, P523, DOI 10.1007/s00338-005-0063-8; HORIGUCHI T, 1994, PROTOPLASMA, V179, P142, DOI 10.1007/BF01403952; Horiguchi Takeo, 1999, Phycological Research, V47, P101, DOI 10.1111/j.1440-1835.1999.tb00290.x; Horiguchi Takeo, 1994, Japanese Journal of Phycology, V42, P21; Koike K, 2004, BIOL BULL-US, V207, P80, DOI 10.2307/1543582; Kremp A, 2005, J PHYCOL, V41, P629, DOI 10.1111/j.1529-8817.2005.00070.x; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LAND MF, 1966, J EXP BIOL, V45, P433; Littman RA, 2008, J EXP MAR BIOL ECOL, V364, P48, DOI 10.1016/j.jembe.2008.06.034; MACLAUGHLIN JJA, 1957, P SOC EXP BIOL MED, V95, P115; MELKONIAN M, 1980, J ULTRA MOL STRUCT R, V72, P90, DOI 10.1016/S0022-5320(80)90138-0; Montresor M, 1999, J PHYCOL, V35, P186, DOI 10.1046/j.1529-8817.1999.3510186.x; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; NORTON JH, 1992, BIOL BULL, V183, P503, DOI 10.2307/1542028; Oh-Uchi, 2007, GALAXEA, V9, P1, DOI DOI 10.3755/JCRS.9.1; Porto I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002160; Savage AM, 2002, MAR ECOL PROG SER, V244, P17, DOI 10.3354/meps244017; Schwarz JA, 2002, MAR BIOL, V140, P471, DOI 10.1007/s00227-001-0736-y; TAYLOR DL, 1968, J MAR BIOL ASSOC UK, V48, P349, DOI 10.1017/S0025315400034548; TRENCH RK, 1995, EUR J PHYCOL, V30, P149, DOI 10.1080/09670269500650911; Yacobovitch T, 2004, J EXP MAR BIOL ECOL, V298, P35, DOI 10.1016/j.jembe.2003.08.003; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	34	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6303	10.1371/journal.pone.0006303	http://dx.doi.org/10.1371/journal.pone.0006303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609449	gold, Green Submitted, Green Published			2022-12-27	WOS:000268119500020
J	Chen, H; Simar, D; Morris, MJ				Chen, Hui; Simar, David; Morris, Margaret J.			Hypothalamic Neuroendocrine Circuitry is Programmed by Maternal Obesity: Interaction with Postnatal Nutritional Environment	PLOS ONE			English	Article								Objective: Early life nutrition is critical for the development of hypothalamic neurons involved in energy homeostasis. We previously showed that intrauterine and early postnatal overnutrition programmed hypothalamic neurons expressing the appetite stimulator neuropeptide Y (NPY) and suppressor proopiomelanocortin (POMC) in offspring at weaning. However, the long-term effects of such programming and its interactions with post-weaning high-fat-diet (HFD) consumption are unclear. Research Design and Methods: Female Sprague Dawley rats were exposed to chow or HFD for 5 weeks before mating, throughout gestation and lactation. On postnatal day 1, litters were adjusted to 3/litter to induce postnatal overnutrition (vs. 12 in control). At postnatal day 20, half of the rats from each maternal group were weaned onto chow or HFD for 15 weeks. Hypothalamic appetite regulators, and fuel (glucose and lipid) metabolic markers were measured. Results: Offspring from obese dams gained more weight than those from lean dams independent of post-weaning diet. Maternal obesity interacted with post-weaning HFD consumption to cause greater levels of hyperphagia, adiposity, hyperlipidemia, and glucose intolerance in offspring. This was linked to increased hypothalamic NPY signaling and leptin resistance in adult offspring. Litter size reduction had a detrimental impact on insulin and adiponectin, while hypothalamic NPY and POMC mRNA expression were suppressed in the face of normal energy intake and weight gain. Conclusions: Maternal obesity, postnatal litter size reduction and post-weaning HFD consumption caused obesity via different neuroendocrine mechanims. There were strong additive effects of maternal obesity and post-weaning HFD consumption to increase the metabolic disorders in offspring.			Chen, H (corresponding author), Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia.	m.morris@unsw.edu.au	Chen, Hui/D-2005-2014; Morris, Margaret J/J-4285-2013; Chen, Hui/R-6137-2019	Chen, Hui/0000-0001-6883-3752; Chen, Hui/0000-0001-6883-3752; Simar, David/0000-0002-3862-1932; Morris, Margaret/0000-0003-2285-5117				Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Banks WA, 2004, DIABETES, V53, P1253, DOI 10.2337/diabetes.53.5.1253; Bayol SA, 2008, J PHYSIOL-LONDON, V586, P3219, DOI 10.1113/jphysiol.2008.153817; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Bouret SG, 2006, CLIN GENET, V70, P295, DOI 10.1111/j.1399-0004.2006.00684.x; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Bruce CR, 2005, DIABETES, V54, P3154, DOI 10.2337/diabetes.54.11.3154; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; CHEN H, 2009, OBESITY, DOI DOI 10.1038/OBY.2009.1056; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Dulloo AG, 2005, ACTA PHYSIOL SCAND, V184, P295, DOI 10.1111/j.1365-201X.2005.01466.x; Fekete C, 2002, ENDOCRINOLOGY, V143, P4513, DOI 10.1210/en.2002-220574; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; Grove KL, 2005, PHYSIOL BEHAV, V86, P646, DOI 10.1016/j.physbeh.2005.08.063; Hansen MJ, 2005, BRAIN RES, V1039, P137, DOI 10.1016/j.brainres.2005.01.063; Hansen MJ, 2004, J NEUROCHEM, V88, P909, DOI 10.1046/j.1471-4159.2003.02217.x; Huang XF, 2003, BRAIN RES, V992, P9, DOI 10.1016/j.brainres.2003.08.019; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Levin BE, 1997, AM J PHYSIOL-REG I, V272, pR1365, DOI 10.1152/ajpregu.1997.272.5.R1365; Levine AS, 2003, J NUTR, V133, p831S, DOI 10.1093/jn/133.3.831S; Marshall E, 2004, SCIENCE, V304, P804, DOI 10.1126/science.304.5672.804; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morris MJ, 2008, INT J OBESITY, V32, P249, DOI 10.1038/sj.ijo.0803716; Oda N, 2008, METABOLISM, V57, P268, DOI 10.1016/j.metabol.2007.09.011; Pralong FP, 2002, FASEB J, V16, P712, DOI 10.1096/fj.01-0754fje; Prentice AM, 2005, PHYSIOL BEHAV, V86, P640, DOI 10.1016/j.physbeh.2005.08.055; SCHAALAN M, 2008, J DIABETES COMPLICAT, DOI DOI 10.1016/J.JDIACOMP.2008.1002.1003; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; STORLIEN LH, 1986, AM J PHYSIOL, V251, pE576, DOI 10.1152/ajpendo.1986.251.5.E576; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Tsuchida A, 2004, J BIOL CHEM, V279, P30817, DOI 10.1074/jbc.M402367200; Velkoska E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1236, DOI 10.1152/ajpendo.00505.2004; WHITE CL, 2009, AM J PHYSL REGUL INT; Xita N, 2007, METABOLISM, V56, P766, DOI 10.1016/j.metabol.2007.01.008; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	40	133	134	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6259	10.1371/journal.pone.0006259	http://dx.doi.org/10.1371/journal.pone.0006259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606226	Green Published, gold			2022-12-27	WOS:000268036000014
J	Conibear, TCR; Collins, SL; Webb, JS				Conibear, Tim C. R.; Collins, Samuel L.; Webb, Jeremy S.			Role of Mutation in Pseudomonas aeruginosa Biofilm Development	PLOS ONE			English	Article								The survival of bacteria in nature is greatly enhanced by their ability to grow within surface-associated communities called biofilms. Commonly, biofilms generate proliferations of bacterial cells, called microcolonies, which are highly recalcitrant, 3-dimensional foci of bacterial growth. Microcolony growth is initiated by only a subpopulation of bacteria within biofilms, but processes responsible for this differentiation remain poorly understood. Under conditions of crowding and intense competition between bacteria within biofilms, microevolutionary processes such as mutation selection may be important for growth; however their influence on microcolony-based biofilm growth and architecture have not previously been explored. To study mutation in-situ within biofilms, we transformed Pseudomonas aeruginosa cells with a green fluorescent protein gene containing a +1 frameshift mutation. Transformed P. aeruginosa cells were non-fluorescent until a mutation causing reversion to the wildtype sequence occurs. Fluorescence-inducing mutations were observed in microcolony structures, but not in other biofilm cells, or in planktonic cultures of P. aeruginosa cells. Thus microcolonies may represent important foci for mutation and evolution within biofilms. We calculated that microcolony-specific increases in mutation frequency were at least 100-fold compared with planktonically grown cultures. We also observed that mutator phenotypes can enhance microcolony-based growth of P. aeruginosa cells. For P. aeruginosa strains defective in DNA fidelity and error repair, we found that microcolony initiation and growth was enhanced with increased mutation frequency of the organism. We suggest that microcolony-based growth can involve mutation and subsequent selection of mutants better adapted to grow on surfaces within crowded-cell environments. This model for biofilm growth is analogous to mutation selection that occurs during neoplastic progression and tumor development, and may help to explain why structural and genetic heterogeneity are characteristic features of bacterial biofilm populations.			Conibear, TCR (corresponding author), Univ Southampton, Sch Biol Sci, Southampton, Hants, England.	j.s.webb@soton.ac.uk		Conibear, Tim C R/0000-0003-3779-3385; Webb, Jeremy/0000-0003-2068-8589; Collins, Samuel/0000-0003-4721-0040	BBSRC [BB/C520655/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C520655/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Allegrucci M, 2008, J BACTERIOL, V190, P6330, DOI 10.1128/JB.00707-08; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Bachl J, 1999, EUR J IMMUNOL, V29, P1383, DOI 10.1002/(SICI)1521-4141(199904)29:04<1383::AID-IMMU1383>3.3.CO;2-O; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Blazquez J, 2003, CLIN INFECT DIS, V37, P1201, DOI 10.1086/378810; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Boles BR, 2005, P NATL ACAD SCI USA, V102, P955, DOI 10.1073/pnas.0407460101; Burcham PC, 1999, MUTAT RES-GEN TOX EN, V443, P11, DOI 10.1016/S1383-5742(99)00008-3; CALOS MP, 1981, J MOL BIOL, V153, P39, DOI 10.1016/0022-2836(81)90525-8; Cariello NF, 1998, MUTAT RES-GEN TOX EN, V414, P95, DOI 10.1016/S1383-5718(98)00043-6; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; COSTERTON JW, 1983, REV INFECT DIS, V5, pS867; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Drake JW, 2007, CRIT REV BIOCHEM MOL, V42, P247, DOI 10.1080/10409230701495631; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Driffield K, 2008, J ANTIMICROB CHEMOTH, V61, P1053, DOI 10.1093/jac/dkn044; Haagensen JAJ, 2007, J BACTERIOL, V189, P28, DOI 10.1128/JB.00720-06; Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Hoffmann GR, 1996, MUTAT RES-FUND MOL M, V351, P33, DOI 10.1016/0027-5107(95)00206-5; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Klayman BJ, 2008, ENVIRON MICROBIOL, V10, P2344, DOI 10.1111/j.1462-2920.2008.01660.x; Koch B, 2001, J MICROBIOL METH, V45, P187, DOI 10.1016/S0167-7012(01)00246-9; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Lenski RE, 2003, J MOL EVOL, V56, P498, DOI 10.1007/s00239-002-2423-0; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Loeb LA, 2001, CANCER RES, V61, P3230; Macia MD, 2005, ANTIMICROB AGENTS CH, V49, P3382, DOI 10.1128/AAC.49.8.3382-3386.2005; Mai-Prochnow A, 2008, J BACTERIOL, V190, P5493, DOI 10.1128/JB.00549-08; MAIPROCHNOW A, 2008, J BACTERIOL; Marnett LJ, 2001, TRENDS GENET, V17, P214, DOI 10.1016/S0168-9525(01)02239-9; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Moller S, 1998, APPL ENVIRON MICROB, V64, P721; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Nivens DE, 2001, J BACTERIOL, V183, P1047, DOI 10.1128/JB.183.3.1047-1057.2001; Oliver A, 2004, ANTIMICROB AGENTS CH, V48, P4226, DOI 10.1128/AAC.48.11.4226-4233.2004; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Picioreanu C, 1998, BIOTECHNOL BIOENG, V58, P101, DOI 10.1002/(SICI)1097-0290(19980405)58:1<101::AID-BIT11>3.0.CO;2-M; Purevdorj-Gage B, 2005, MICROBIOL-SGM, V151, P1569, DOI 10.1099/mic.0.27536-0; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sauer K, 2001, J BACTERIOL, V183, P6579, DOI 10.1128/JB.183.22.6579-6589.2001; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Stoodley P, 2001, APPL ENVIRON MICROB, V67, P5608, DOI 10.1128/AEM.67.12.5608-5613.2001; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; Townsend JP, 2003, GENETICS, V164, P13; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2	55	85	86	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6289	10.1371/journal.pone.0006289	http://dx.doi.org/10.1371/journal.pone.0006289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606212	gold, Green Published, Green Accepted			2022-12-27	WOS:000268036000019
J	Schleinitz, N; Chiche, L; Guia, S; Bouvier, G; Vernier, J; Morice, A; Houssaint, E; Harle, JR; Kaplanski, G; Montero-Julian, FA; Vely, F				Schleinitz, Nicolas; Chiche, Laurent; Guia, Sophie; Bouvier, Gaelle; Vernier, Julie; Morice, Alexis; Houssaint, Elisabeth; Harle, Jean Robert; Kaplanski, Gilles; Montero-Julian, Felix A.; Vely, Frederic			Pattern of DAP12 Expression in Leukocytes from Both Healthy and Systemic Lupus Erythematosus Patients	PLOS ONE			English	Article								DAP12 is an ITAM-bearing transmembrane adaptor originally identified on the surface of Natural Killer cells. A broad expression among other immune cells was later found in myeloid and lymphoid cells. However, data on DAP12 expression pattern rely only on immunoblot and microarray analysis. Here, we describe the generation and the characterization of an anti-DAP12 monoclonal antibody. Using this novel reagent, we show that DAP12 expression is restricted to innate immune cells in basal condition. Since a decreased expression of DAP12 has been suggested in NK cells of systemic lupus erythematosus patients, we have further investigated the NK cell receptor repertoire and leukocyte expression of DAP12 in these patients and no major changes were detectable when compared to controls.			Schleinitz, N (corresponding author), CHU Concept, Dept Internal Med, AP HM, Marseille, France.	vely@univmed.fr	Vély, Frédéric/HHM-3894-2022; schleinitz, nicolas/AAL-6751-2020	schleinitz, nicolas/0000-0001-9449-3392; Vely, Frederic/0000-0002-1682-0949				Anfossi N, 2003, EUR J IMMUNOL, V33, P3514, DOI 10.1002/eji.200324573; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; ERKELLERYUKSEL F, 1993, LUPUS, V2, P227, DOI 10.1177/096120339300200404; Green MRJ, 2005, CLIN EXP IMMUNOL, V141, P165, DOI 10.1111/j.1365-2249.2005.02822.x; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Izumi Y, 2006, J LAB CLIN MED, V147, P242, DOI 10.1016/j.lab.2006.01.001; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Olcese L, 1997, J IMMUNOL, V158, P5083; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Pascal V, 2004, EUR J IMMUNOL, V34, P2930, DOI 10.1002/eji.200425146; Pellett F, 2007, TISSUE ANTIGENS, V69, P106, DOI 10.1111/j.1399-0039.2006.762_6.x; SCHEPIS D, 2008, IMMUNOLOGY; Sjolin H, 2006, J IMMUNOL, V177, P2908, DOI 10.4049/jimmunol.177.5.2908; Snyder MR, 2004, J IMMUNOL, V173, P3725, DOI 10.4049/jimmunol.173.6.3725; Snyder MR, 2003, J EXP MED, V197, P437, DOI 10.1084/jem.20020383; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tomasello E, 2005, EUR J IMMUNOL, V35, P1670, DOI 10.1002/eji.200425932; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Toyabe S, 2004, J AUTOIMMUN, V23, P371, DOI 10.1016/j.jaut.2004.09.003; van Bergen J, 2004, J IMMUNOL, V173, P6719, DOI 10.4049/jimmunol.173.11.6719; Vely F, 1997, HYBRIDOMA, V16, P519, DOI 10.1089/hyb.1997.16.519; Yabuhara A, 1996, J RHEUMATOL, V23, P171; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825	31	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6264	10.1371/journal.pone.0006264	http://dx.doi.org/10.1371/journal.pone.0006264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606219	Green Submitted, Green Published, gold			2022-12-27	WOS:000268036000017
J	Graessler, J; Schwudke, D; Schwarz, PEH; Herzog, R; Shevchenko, A; Bornstein, SR				Graessler, Juergen; Schwudke, Dominik; Schwarz, Peter E. H.; Herzog, Ronny; Shevchenko, Andrej; Bornstein, Stefan R.			Top-Down Lipidomics Reveals Ether Lipid Deficiency in Blood Plasma of Hypertensive Patients	PLOS ONE			English	Article								Background: Dyslipoproteinemia, obesity and insulin resistance are integrative constituents of the metabolic syndrome and are major risk factors for hypertension. The objective of this study was to determine whether hypertension specifically affects the plasma lipidome independently and differently from the effects induced by obesity and insulin resistance. Methodology/Principal Findings: We screened the plasma lipidome of 19 men with hypertension and 51 normotensive male controls by top-down shotgun profiling on a LTQ Orbitrap hybrid mass spectrometer. The analysis encompassed 95 lipid species of 10 major lipid classes. Obesity resulted in generally higher lipid load in blood plasma, while the content of tri- and diacylglycerols increased dramatically. Insulin resistance, defined by HOMA-IR.3.5 and controlled for BMI, had little effect on the plasma lipidome. Importantly, we observed that in blood plasma of hypertensive individuals the overall content of ether lipids decreased. Ether phosphatidylcholines and ether phosphatidylethanolamines, that comprise arachidonic (20: 4) and docosapentaenoic (22: 5) fatty acid moieties, were specifically diminished. The content of free cholesterol also decreased, although conventional clinical lipid homeostasis indices remained unaffected. Conclusions/Significance: Top-down shotgun lipidomics demonstrated that hypertension is accompanied by specific reduction of the content of ether lipids and free cholesterol that occurred independently of lipidomic alterations induced by obesity and insulin resistance. These results may form the basis for novel preventive and dietary strategies alleviating the severity of hypertension.			Graessler, J (corresponding author), Tech Univ Dresden, Dept Internal Med 3, Carl Gustav Carus Med Sch, Dresden, Germany.	shevchenko@mpi-cbg.de; Stefan.Bornstein@uniklinikum-dresden.de	Schwudke, Dominik/B-3478-2013	Schwudke, Dominik/0000-0002-1379-9451				Bergmann A, 2008, EXP CLIN ENDOCR DIAB, V116, pS50, DOI 10.1055/s-2008-1081492; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; BLANK ML, 1983, BIOCHEM BIOPH RES CO, V113, P666, DOI 10.1016/0006-291X(83)91778-3; Bo S, 2009, J HYPERTENS, V27, P102, DOI 10.1097/HJH.0b013e328317a7bb; CASTELLI WP, 1986, AM J MED, V80, P23, DOI 10.1016/0002-9343(86)90157-9; Ding J, 2008, J CHROMATOGR B, V871, P243, DOI 10.1016/j.jchromb.2008.04.040; Dullaart RPF, 2008, J CLIN ENDOCR METAB, V93, P4860, DOI 10.1210/jc.2008-1213; Ehrhart-Bornstein M, 2004, ENDOCR RES, V30, P865, DOI 10.1081/ERC-200044122; Ehrhart-Bornstein M, 2003, P NATL ACAD SCI USA, V100, P14211, DOI 10.1073/pnas.2336140100; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ejsing CS, 2006, J MASS SPECTROM, V41, P372, DOI 10.1002/jms.997; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Hermansson M, 2005, ANAL CHEM, V77, P2166, DOI 10.1021/ac048489s; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; Koh KK, 2006, DIABETES CARE, V29, P195, DOI 10.2337/diacare.29.02.06.dc05-1418; Kolodgie FD, 2007, CURR OPIN LIPIDOL, V18, P500, DOI 10.1097/MOL.0b013e3282efa35b; Kopprasch S, 2009, J ENDOCRINOL, V200, P45, DOI 10.1677/JOE-08-0293; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Lima NKC, 2009, AM J HYPERTENS, V22, P106, DOI 10.1038/ajh.2008.263; Maeba R, 2007, J ATHEROSCLER THROMB, V14, P12, DOI 10.5551/jat.14.12; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; MCGOWAN HM, 1988, CLIN SCI, V74, P393, DOI 10.1042/cs0740393; Natale F, 2009, EUR J ECHOCARDIOGR, V10, P549, DOI 10.1093/ejechocard/jep002; Neutel JM, 1998, AM J HYPERTENS, V11, p150S, DOI 10.1016/S0895-7061(98)00192-7; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Ponnuchamy B, 2009, AM J PHYSIOL-REG I, V296, pR1001, DOI 10.1152/ajpregu.90960.2008; REAVEN GM, 1991, DIABETES CARE, V14, P33, DOI 10.2337/diacare.14.4.33; Schwab U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002630; Schwudke D, 2006, ANAL CHEM, V78, P585, DOI 10.1021/ac051605m; Schwudke D, 2007, METHOD ENZYMOL, V433, P175, DOI 10.1016/S0076-6879(07)33010-3; Schwudke D, 2007, ANAL CHEM, V79, P4083, DOI 10.1021/ac062455y; SEIDELL JC, 1991, ATHEROSCLEROSIS, V87, P203, DOI 10.1016/0021-9150(91)90022-U; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5; Sironi AM, 2008, HYPERTENSION, V51, P282, DOI 10.1161/HYPERTENSIONAHA.107.098640; Sysi-Aho M, 2007, BIOINFORMATICS, V23, pI519, DOI 10.1093/bioinformatics/btm181; Sysi-Aho M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-93; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Yamagishi K, 2008, AM HEART J, V156, P965, DOI 10.1016/j.ahj.2008.06.017	47	247	255	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6261	10.1371/journal.pone.0006261	http://dx.doi.org/10.1371/journal.pone.0006261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603071	gold, Green Published			2022-12-27	WOS:000268035700009
J	Banerjee, A; Sammarco, MC; Ditch, S; Wang, J; Grabczyk, E				Banerjee, Ayan; Sammarco, Mimi C.; Ditch, Scott; Wang, Jeffrey; Grabczyk, Ed			A Novel Tandem Reporter Quantifies RNA Polymerase II Termination in Mammalian Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL TERMINATION; SACCHAROMYCES-CEREVISIAE; TRIPLET REPEAT; GENE; PURIFICATION; ELONGATION; EXPRESSION; INITIATION; CLEAVAGE; PROMOTER	Background: Making the correct choice between transcription elongation and transcription termination is essential to the function of RNA polymerase II, and fundamental to gene expression. This choice can be influenced by factors modifying the transcription complex, factors modifying chromatin, or signals mediated by the template or transcript. To aid in the study of transcription elongation and termination we have developed a transcription elongation reporter system that consists of tandem luciferase reporters flanking a test sequence of interest. The ratio of expression from the reporters provides a measure of the relative rates of successful elongation through the intervening sequence. Methodology/Principal Findings: Size matched fragments containing the polyadenylation signal of the human beta-actin gene (ACTB) and the human beta-globin gene (HBB) were evaluated for transcription termination using this new ratiometric tandem reporter assay. Constructs bearing just 200 base pairs on either side of the consensus poly(A) addition site terminated 98% and 86% of transcription for ACTB and HBB sequences, respectively. The nearly 10-fold difference in readthrough transcription between the two short poly(A) regions was eclipsed when additional downstream poly(A) sequence was included for each gene. Both poly(A) regions proved very effective at termination when 1100 base pairs were included, stopping 99.6% of transcription. To determine if part of the increased termination was simply due to the increased template length, we inserted several kilobases of heterologous coding sequence downstream of each poly(A) region test fragment. Unexpectedly, the additional length reduced the effectiveness of termination of HBB sequences 2-fold and of ACTB sequences 3- to 5-fold. Conclusions/Significance: The tandem construct provides a sensitive measure of transcription termination in human cells. Decreased Xrn2 or Senataxin levels produced only a modest release from termination. Our data support overlap in allosteric and torpedo mechanisms of transcription termination and suggest that efficient termination is ensured by redundancy.			Banerjee, A (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA.	egrabc@lsuhsc.edu		Sammarco, Mimi/0000-0001-9491-5735	NINDS NIH HHS [R01 NS046567-01A2, R01 NS046567, R01NS046567, R01 NS046567-03, R01 NS046567-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046567] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Ditlevson JV, 2008, NUCLEIC ACIDS RES, V36, P3163, DOI 10.1093/nar/gkn136; Dye MJ, 2001, CELL, V105, P669, DOI 10.1016/S0092-8674(01)00372-5; Grabczyk E, 1999, ANAL BIOCHEM, V267, P241, DOI 10.1006/abio.1998.2962; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Marzluff W F Jr, 1978, Methods Cell Biol, V19, P317; Rougemaille M, 2008, CELL, V135, P308, DOI 10.1016/j.cell.2008.08.005; Rozen S, 2000, Methods Mol Biol, V132, P365; Sammarco MC, 2005, ANAL BIOCHEM, V346, P210, DOI 10.1016/j.ab.2005.08.033; Sammarco MC, 2008, J BIOL CHEM, V283, P4578, DOI 10.1074/jbc.M703456200; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; STEVENS A, 1980, J BIOL CHEM, V255, P3080; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; West S, 2006, RNA, V12, P655, DOI 10.1261/rna.2232406; West S, 2009, MOL CELL, V33, P354, DOI 10.1016/j.molcel.2009.01.008; Weston RJ, 2004, Z NATURFORSCH C, V59, P39; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8	33	21	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6193	10.1371/journal.pone.0006193	http://dx.doi.org/10.1371/journal.pone.0006193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587781	gold, Green Submitted, Green Published			2022-12-27	WOS:000268035100014
J	Fleming, JN; Shulman, HM; Nash, RA; Johnson, PY; Wight, TN; Gown, A; Schwartz, SM				Fleming, Jo Nadine; Shulman, Howard M.; Nash, Richard A.; Johnson, Pamela Y.; Wight, Thomas N.; Gown, Allen; Schwartz, Stephen M.			Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis	PLOS ONE			English	Article							CONSENSUS DEVELOPMENT PROJECT; BONE-MARROW-TRANSPLANTATION; GROWTH-FACTOR; STIMULATORY AUTOANTIBODIES; GASTROINTESTINAL-TRACT; CLINICAL-TRIALS; CELL APOPTOSIS; PDGF RECEPTOR; IN-VIVO; BETA	Background: The clinical and histologic appearance of fibrosis in cutaneous lesions in chronic graft-versus-host disease (c-GVHD) resembles the appearance of fibrosis in scleroderma (SSc). Recent studies identified distinctive structural changes in the superficial dermal microvasculature and matrix of SSc skin. We compared the dermal microvasculature in human c-GVHD to SSc to determine if c-GVHD is a suitable model for SSc. Methodology/Principal Findings: We analyzed skin biopsies of normal controls (n = 24), patients with SSc (n = 30) and c-GVHD with dermal fibrosis (n = 133)). Immunostaining was employed to identify vessels, vascular smooth muscle, dermal matrix, and cell proliferation. C-GVHD and SSc had similar dermal matrix composition and vascular smooth muscle pathology, including intimal hyperplasia. SSc, however, differed significantly from c-GVHD in three ways. First, there were significantly fewer (p = 0.00001) average vessels in SSc biopsies (9.8) when compared with c-GVHD (16.5). Second, in SSc, endothelial markers were decreased significantly (19/19 and 12/14 for VE cadherin and vWF (p = <0.0001 and <0.05), respectively). In contrast, 0/13 c-GVHD biopsies showed loss of staining with canonical endothelial markers. Third, c-GVHD contained areas of microvascular endothelial proliferation not present in the SSc biopsies. Conclusions/Significance: The sclerosis associated with c-GVHD appears to resemble wound healing. Focal capillary proliferation occurs in early c-GVHD. In contrast, loss of canonical endothelial markers and dermal capillaries is seen in SSc, but not in c-GVHD. The loss of VE cadherin in SSc, in particular, may be related to microvascular rarefaction because VE cadherin is necessary for angiogenesis. C-GVHD is a suitable model for studying dermal fibrosis but may not be applicable for studying the microvascular alterations characteristic of SSc.			Fleming, JN (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	flemij@u.washington.edu			NCI NIH HHS [P01 CA018029, CA-18029] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Biedermann BC, 2002, LANCET, V359, P2078, DOI 10.1016/S0140-6736(02)08907-9; Brat DJ, 2001, AM J PATHOL, V158, P789, DOI 10.1016/S0002-9440(10)64025-4; Choi JJ, 2003, J RHEUMATOL, V30, P1529; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; DANGELO WA, 1969, AM J MED, V46, P428, DOI 10.1016/0002-9343(69)90044-8; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Eilertsen AL, 2008, J THROMB HAEMOST, V6, P928, DOI 10.1111/j.1538-7836.2008.02970.x; Fernandez-Mateos P, 1998, VOX SANG, V75, P37; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Hymes SR, 2006, BIOL BLOOD MARROW TR, V12, P1101, DOI 10.1016/j.bbmt.2006.08.043; Janin A, 2002, BLOOD, V99, P2940, DOI 10.1182/blood.V99.8.2940; Jass JR, 2001, J CELL MOL MED, V5, P327, DOI 10.1111/j.1582-4934.2001.tb00169.x; Jimenez SA, 2002, CURR OPIN RHEUMATOL, V14, P671, DOI 10.1097/00002281-200211000-00008; Kaur H, 2009, EXP EYE RES, V88, P960, DOI 10.1016/j.exer.2008.12.006; KIELTY CM, 1992, J CELL SCI, V103, P445; Lakos G, 2004, METH MOLEC MED, V102, P377; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; Leask A, 2002, ARTHRITIS RHEUM-US, V46, P1857, DOI 10.1002/art.10333; LeRoy EC, 1996, RHEUM DIS CLIN N AM, V22, P675, DOI 10.1016/S0889-857X(05)70295-7; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; McGaha T, 2001, J INVEST DERMATOL, V116, P136, DOI 10.1046/j.1523-1747.2001.00217.x; Mitchell RN, 2007, CIRC RES, V100, P967, DOI 10.1161/01.RES.0000261982.76892.09; Nash RA, 2007, BLOOD, V110, P1388, DOI 10.1182/blood-2007-02-072389; Nash RA, 2006, ARTHRITIS RHEUM-US, V54, P1982, DOI 10.1002/art.21908; Nishida T, 2004, BONE MARROW TRANSPL, V33, P1143, DOI 10.1038/sj.bmt.1704512; Pan DS, 2002, J CLIN INVEST, V110, P1349, DOI 10.1172/JCI200215614; POTTINGER BE, 1989, THROMB RES, V53, P387, DOI 10.1016/0049-3848(89)90317-4; Ratanatharathorn V, 2003, BIOL BLOOD MARROW TR, V9, P505, DOI 10.1016/S1083-8791(03)00216-7; RIESSEN R, 1994, AM J PATHOL, V144, P962; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Sackstein R, 2006, BIOL BLOOD MARROW TR, V12, P2, DOI 10.1016/j.bbmt.2005.09.015; Sgonc R, 1999, ARTHRITIS RHEUM-US, V42, P581, DOI 10.1002/1529-0131(199904)42:3<581::AID-ANR28>3.0.CO;2-9; Shiao SL, 2007, J IMMUNOL, V179, P4397, DOI 10.4049/jimmunol.179.7.4397; Shimura K, 2008, BIOL BLOOD MARROW TR, V14, P426, DOI 10.1016/j.bbmt.2008.02.001; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Shulman HM, 2006, BIOL BLOOD MARROW TR, V12, P31, DOI 10.1016/j.bbmt.2005.10.023; Socie G, 2004, BLOOD, V103, P50, DOI 10.1182/blood-2003-03-0909; Svegliati S, 2007, BLOOD, V110, P237, DOI 10.1182/blood-2007-01-071043; Wallez Y, 2006, TRENDS CARDIOVAS MED, V16, P55, DOI 10.1016/j.tcm.2005.11.008; Zhang Y, 2002, J IMMUNOL, V168, P3088, DOI 10.4049/jimmunol.168.6.3088	45	36	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6203	10.1371/journal.pone.0006203	http://dx.doi.org/10.1371/journal.pone.0006203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587802	gold, Green Published, Green Submitted			2022-12-27	WOS:000268035100016
J	Pistollato, F; Rampazzo, E; Abbadi, S; Della Puppa, A; Scienza, R; D'Avella, D; Denaro, L; Kronnie, GT; Panchision, DM; Basso, G				Pistollato, Francesca; Rampazzo, Elena; Abbadi, Sara; Della Puppa, Alessandro; Scienza, Renato; D'Avella, Domenico; Denaro, Luca; Kronnie, Geertruy te; Panchision, David M.; Basso, Giuseppe			Molecular Mechanisms of HIF-1 alpha Modulation Induced by Oxygen Tension and BMP2 in Glioblastoma Derived Cells	PLOS ONE			English	Article								Background: Glioblastoma multiforme (GBM) is one of most common and still poorly treated primary brain tumors. In search for new therapeutic approaches, Bone Morphogenetic Proteins (BMPs) induce astroglial commitment in GBM-derived cells in vitro. However, we recently suggested that hypoxia, which is characteristic of the brain niche where GBM reside, strongly counter-acts BMP effects. It seems apparent that a more complete understanding of the biology of GBM cells is needed, in particular considering the role played by hypoxia as a signaling pathways regulator. HIF-1 alpha is controlled at the transcriptional and translational level by mTOR and, alike BMP, also mTOR pathway modulates glial differentiation in central nervous system (CNS) stem cells. Methodology/Principal Findings: Here, we investigate the role of mTOR signaling in the regulation of HIF-1 alpha stability in primary GBM-derived cells maintained under hypoxia (2% oxygen). We found that GBM cells, when acutely exposed to high oxygen tension, undergo Akt/mTOR pathway activation and that BMP2 acts in an analogous way. Importantly, repression of Akt/mTOR signaling is maintained by HIF-1 alpha through REDD1 upregulation. On the other hand, BMP2 counter-acts HIF-1 alpha stability by modulating intracellular succinate and by controlling proline hydroxylase 2 (PHD2) protein through inhibition of FKBP38, a PHD2 protein regulator. Conclusions/Significance: In this study we elucidate the molecular mechanisms by which two pro-differentiating stimuli, BMP2 and acute high oxygen exposure, control HIF-1 alpha stability. We previously reported that both these stimuli, by inducing astroglial differentiation, affect GBM cells growth. We also found differences in high oxygen and BMP2 sensitivity between GBM cells and normal cells that should be further investigated to better define tumor cell biology.			Pistollato, F (corresponding author), Univ Padua, Dept Pediat, Hemato Oncol Lab, Padua, Italy.	francesca.pistollato@unipd.it	Kronnie, Geertruy te/L-1014-2016; Della+Puppa, Alessandro/AAL-1050-2021	D'AVELLA, Domenico/0000-0001-9077-412X; BASSO, GIUSEPPE/0000-0002-2634-9302; /0000-0001-5636-1006; DENARO, LUCA/0000-0002-2529-6149; te Kronnie, Geertruy/0000-0001-7143-4795				Arsham AM, 2002, J BIOL CHEM, V277, P15162, DOI 10.1074/jbc.M111162200; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Birner P, 2001, CANCER, V92, P165, DOI 10.1002/1097-0142(20010701)92:1<165::AID-CNCR1305>3.0.CO;2-F; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chen HL, 2007, STEM CELLS, V25, P2291, DOI 10.1634/stemcells.2006-0609; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; de la Iglesia N, 2008, J NEUROSCI, V28, P5870, DOI 10.1523/JNEUROSCI.5385-07.2008; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Diabira S, 2008, MED HYPOTHESES, V70, P96, DOI 10.1016/j.mehy.2007.04.024; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Fuh B, 2009, BRIT J CANCER, V100, P106, DOI 10.1038/sj.bjc.6604793; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; GARCIA JA, 2006, SCI STKE, pPE25; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Gillespie DL, 2007, CLIN CANCER RES, V13, P2441, DOI 10.1158/1078-0432.CCR-06-2692; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Indraccolo S, 2002, GENE, V283, P199, DOI 10.1016/S0378-1119(01)00857-5; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; KAMEGAI A, 1990, ACTA HISTOCHEM, V89, P25, DOI 10.1016/S0065-1281(11)80310-7; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Levine S, 2002, J APPL PHYSIOL, V92, P1205, DOI 10.1152/japplphysiol.00116.2001; Ljungkvist ASE, 2007, RADIAT RES, V167, P127, DOI 10.1667/RR0719.1; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Nakashima K, 1999, FEBS LETT, V457, P43, DOI 10.1016/S0014-5793(99)00997-7; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; PISTOLLATO F, 2008, STEM CELLS      1002; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Razorenova OV, 2005, GENE, V350, P89, DOI 10.1016/j.gene.2005.02.006; Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Schwarzer R, 2005, ONCOGENE, V24, P1138, DOI 10.1038/sj.onc.1208236; Semenza GL, 2002, INTERNAL MED, V41, P79, DOI 10.2169/internalmedicine.41.79; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; WARBURG O, 1956, SCIENCE, V124, P269; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537	42	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6206	10.1371/journal.pone.0006206	http://dx.doi.org/10.1371/journal.pone.0006206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587783	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035100017
J	Karagatzides, JD; Butler, JL; Ellison, AM				Karagatzides, Jim D.; Butler, Jessica L.; Ellison, Aaron M.			The Pitcher Plant Sarracenia purpurea Can Directly Acquire Organic Nitrogen and Short-Circuit the Inorganic Nitrogen Cycle	PLOS ONE			English	Article								Background: Despite the large stocks of organic nitrogen in soil, nitrogen availability limits plant growth in many terrestrial ecosystems because most plants take up only inorganic nitrogen, not organic nitrogen. Although some vascular plants can assimilate organic nitrogen directly, only recently has organic nitrogen been found to contribute significantly to the nutrient budget of any plant. Carnivorous plants grow in extremely nutrient-poor environments and carnivory has evolved in these plants as an alternative pathway for obtaining nutrients. We tested if the carnivorous pitcher plant Sarracenia purpurea could directly take up intact amino acids in the field and compared uptake of organic and inorganic forms of nitrogen across a gradient of nitrogen deposition. We hypothesized that the contribution of organic nitrogen to the nitrogen budget of the pitcher plant would decline with increasing nitrogen deposition. Methodology and Principal Findings: At sites in Canada (low nitrogen deposition) and the United States (high nitrogen deposition), individual pitchers were fed two amino acids, glycine and phenylalanine, and inorganic nitrogen (as ammonium nitrate), individually and in mixture. Plants took up intact amino acids. Acquisition of each form of nitrogen provided in isolation exceeded uptake of the same form in mixture. At the high deposition site, uptake of organic nitrogen was higher than uptake of inorganic nitrogen. At the low deposition site, uptake of all three forms of nitrogen was similar. Completeness of the associated detritus-based food web that inhabits pitcher-plant leaves and breaks down captured prey had no effect on nitrogen uptake. Conclusions and Significance: By taking up intact amino acids, Sarracenia purpurea can short-circuit the inorganic nitrogen cycle, thus minimizing potential bottlenecks in nitrogen availability that result from the plant's reliance for nitrogen mineralization on a seasonally reconstructed food web operating on infrequent and irregular prey capture.			Karagatzides, JD (corresponding author), Harvard Univ, Petersham, MA USA.	aellison@fas.harvard.edu		Ellison, Aaron/0000-0003-4151-6081				ADDICOTT JF, 1974, ECOLOGY, V55, P475, DOI 10.2307/1935141; Atkin OK, 1996, PLANT CELL ENVIRON, V19, P695, DOI 10.1111/j.1365-3040.1996.tb00404.x; Bedford BL, 1999, ECOLOGY, V80, P2151, DOI 10.1890/0012-9658(1999)080[2151:PINAAP]2.0.CO;2; Bledzki LA, 1998, HYDROBIOLOGIA, V385, P193, DOI 10.1023/A:1003566729588; BRADSHAW WE, 1984, AM MIDL NAT, V112, P294, DOI 10.2307/2425436; Bridgham SD, 1996, WETLANDS, V16, P45, DOI 10.1007/BF03160645; Butler JL, 2007, FUNCT ECOL, V21, P835, DOI 10.1111/j.1365-2435.2007.01307.x; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; CHAPIN CT, 1995, CAN J BOT, V73, P728, DOI 10.1139/b95-079; CHAPIN FS, 1993, NATURE, V361, P150, DOI 10.1038/361150a0; CLARKSON DT, 1985, ANNU REV PLANT PHYS, V36, P77, DOI 10.1146/annurev.pp.36.060185.000453; Clemmensen KE, 2008, OECOLOGIA, V155, P771, DOI 10.1007/s00442-008-0962-9; Cochran-Stafira DL, 1998, ECOLOGY, V79, P880, DOI 10.1890/0012-9658(1998)079[0880:IBIFWS]2.0.CO;2; DAMMAN A W H, 1990, Aquilo Ser Botanica, V28, P5; Darwin C., 1875, INSECTIVOROUS PLANTS; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Ellison AM, 2003, ADV ECOL RES, V33, P1, DOI 10.1016/S0065-2504(03)33009-0; Ellison AM, 2002, P NATL ACAD SCI USA, V99, P4409, DOI 10.1073/pnas.022057199; Ellison AM, 2001, TRENDS ECOL EVOL, V16, P623, DOI 10.1016/S0169-5347(01)02269-8; Environment Canada, 2004, CAN AC DEP SCI ASS; Finzi AC, 2005, ECOLOGY, V86, P3345, DOI 10.1890/04-1460; FISH D, 1978, AM MIDL NAT, V99, P172, DOI 10.2307/2424941; Gallie DR, 1997, PLANT PHYSIOL, V115, P1461, DOI 10.1104/pp.115.4.1461; GIVNISH TJ, 1989, PLANT ANIMAL INTERAC, P242; Gotelli NJ, 2006, PLOS BIOL, V4, P1869, DOI 10.1371/journal.pbio.0040324; Gotelli NJ, 2002, ECOLOGY, V83, P2758, DOI 10.2307/3072013; Harrison KA, 2007, ECOLOGY, V88, P989, DOI 10.1890/06-1018; Heard SB, 1998, AM MIDL NAT, V139, P79, DOI 10.1674/0003-0031(1998)139[0079:CROIPB]2.0.CO;2; HEARD SB, 1994, ECOLOGY, V75, P1647, DOI 10.2307/1939625; Henry HAL, 2002, PLANT CELL ENVIRON, V25, P665, DOI 10.1046/j.1365-3040.2002.00849.x; Hepburn JS S., 1927, T WAGNER FREE I SCI, V11, P1; Hodge A, 2000, TRENDS PLANT SCI, V5, P304, DOI 10.1016/S1360-1385(00)01656-3; Jones D. L., 2004, WATER AIR SOIL POLL, V4, P169; KIELLAND K, 1994, ECOLOGY, V75, P2373, DOI 10.2307/1940891; Lipson D, 2001, OECOLOGIA, V128, P305, DOI 10.1007/s004420100693; Lipson DA, 1999, BIOL FERT SOILS, V29, P257, DOI 10.1007/s003740050550; Lloyd F.E., 1942, CARNIVOROUS PLANTS; LUTTGE U, 1965, PLANTA, V66, P331, DOI 10.1007/BF00387533; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; MELIN E, 1953, NATURE, V171, P134, DOI 10.1038/171134a0; Miller AE, 2003, PLANT SOIL, V250, P283, DOI 10.1023/A:1022867103109; Miller AE, 2007, ECOLOGY, V88, P1832, DOI 10.1890/06-0946.1; MILLER ROBERT H., 1965, SOIL SCI, V100, P323, DOI 10.1097/00010694-196511000-00006; Nadelhoffer K., 1994, STABLE ISOTOPES ECOL, P22; *NADP PROGR OFF, 2009, NRSP3 NADP; NAEEM S, 1988, ECOL MONOGR, V58, P215, DOI 10.2307/2937026; Nasholm T, 1998, NATURE, V392, P914, DOI 10.1038/31921; Neff JC, 2003, FRONT ECOL ENVIRON, V1, P205, DOI 10.1890/1540-9295(2003)001[0205:BITCDO]2.0.CO;2; Newell SJ, 1998, AM J BOT, V85, P88, DOI 10.2307/2446558; Nordin A, 2004, ECOLOGY, V85, P955, DOI 10.1890/03-0084; Nordin A, 2001, OECOLOGIA, V129, P125, DOI 10.1007/s004420100698; Persson J, 2003, OECOLOGIA, V137, P252, DOI 10.1007/s00442-003-1334-0; Persson J, 2001, ECOL LETT, V4, P434, DOI 10.1046/j.1461-0248.2001.00260.x; Peterson CN, 2008, ENVIRON MICROBIOL, V10, P2257, DOI 10.1111/j.1462-2920.2008.01648.x; PLUMMER GL, 1964, BOT GAZ, V125, P245, DOI 10.1086/336280; POREMBSKI S, 2000, INSELBERGS BIOTIC DI, P524; Raab TK, 1999, ECOLOGY, V80, P2408, DOI 10.1890/0012-9658(1999)080[2408:SAAUAS]2.0.CO;2; Schnell D.E., 2002, CARNIVOROUS PLANTS U; Schulze W, 1997, OECOLOGIA, V112, P464, DOI 10.1007/s004420050333; Senwo ZN, 1998, BIOL FERT SOILS, V26, P235, DOI 10.1007/s003740050373; Stark JM, 2000, METHODS IN ECOSYSTEM SCIENCE, P215; SWAN JMA, 1970, ECOLOGY, V51, P829, DOI 10.2307/1933975; VIRTANEN AI, 1946, NATURE, V158, P515, DOI 10.1038/158515a0; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; von Felten S, 2008, ECOLOGY, V89, P878, DOI 10.1890/07-1015.1; Weigelt A, 2005, OECOLOGIA, V142, P627, DOI 10.1007/s00442-004-1765-2; [No title captured]	67	26	26	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6164	10.1371/journal.pone.0006164	http://dx.doi.org/10.1371/journal.pone.0006164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582167	Green Submitted, gold, Green Published			2022-12-27	WOS:000267806400018
J	Farin, K; Di Segni, A; Mor, A; Pinkas-Kramarski, R				Farin, Keren; Di Segni, Ayelet; Mor, Adam; Pinkas-Kramarski, Ronit			Structure-Function Analysis of Nucleolin and ErbB Receptors Interactions	PLOS ONE			English	Article								Background: The ErbB receptor tyrosine kinases and nucleolin are major contributors to malignant transformation. Recently we have found that cell-surface ErbB receptors interact with nucleolin via their cytoplasmic tail. Overexpression of ErbB1 and nucleolin leads to receptor phosphorylation, dimerization and anchorage independent growth. Methodology/Principal Findings: In the present study we explored the regions of nucleolin and ErbB responsible for their interaction. Using mutational analyses, we addressed the structure-function relationship of the interaction between ErbB1 and nucleolin. We identified the ErbB1 nuclear localization domain as nucleolin interacting region. This region is important for nucleolin-associated receptor activation. Notably, though the tyrosine kinase domain is important for nucleolin-associated receptor activation, it is not involved in nucleolin/ErbB interactions. In addition, we demonstrated that the 212 c-terminal portion of nucleolin is imperative for the interaction with ErbB1 and ErbB4. This region of nucleolin is sufficient to induce ErbB1 dimerization, phosphorylation and growth in soft agar. Conclusions/Significance: The oncogenic potential of ErbB depends on receptor levels and activation. Nucleolin affects ErbB dimerization and activation leading to enhanced cell growth. The C-terminal region of nucleolin and the ErbB1 NLS-domain mediate this interaction. Moreover, when the C-terminal 212 amino acids region of nucleolin is expressed with ErbB1, it can enhance anchorage independent cell growth. Taken together these results offer new insight into the role of ErbB1 and nucleolin interaction in malignant cells.			Farin, K (corresponding author), Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel.	lironit@post.tau.ac.il		Pinkas-Kramarski, Ronit/0000-0002-1000-369X				Aifa S, 2005, EXP CELL RES, V302, P108, DOI 10.1016/j.yexcr.2004.08.032; Alete DE, 2006, FEBS J, V273, P4668, DOI 10.1111/j.1742-4658.2006.05471.x; Bacharach E, 2000, J VIROL, V74, P11027, DOI 10.1128/JVI.74.23.11027-11039.2000; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; BUGLER B, 1982, EUR J BIOCHEM, V128, P475; Casalini P, 2004, J CELL PHYSIOL, V200, P343, DOI 10.1002/jcp.20007; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Di Segni A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002310; FANG SH, 1993, EXP CELL RES, V208, P48, DOI 10.1006/excr.1993.1221; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Ginisty H, 1999, J CELL SCI, V112, P761; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Huang Y, 2006, BLOOD, V107, P3564, DOI 10.1182/blood-2005-07-2961; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nisole S, 1999, J BIOL CHEM, V274, P27875, DOI 10.1074/jbc.274.39.27875; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schulz M, 2001, BIOCHEM BIOPH RES CO, V280, P476, DOI 10.1006/bbrc.2000.4141; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Shibata Y, 2002, MOL CELL BIOL, V22, P6788, DOI 10.1128/MCB.22.19.6788-6796.2002; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Stepanova V, 2008, BLOOD, V112, P100, DOI 10.1182/blood-2007-07-104455; Storck S, 2008, BIOL CELL; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	48	23	25	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6128	10.1371/journal.pone.0006128	http://dx.doi.org/10.1371/journal.pone.0006128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578540	Green Published, Green Submitted, gold			2022-12-27	WOS:000267806300004
J	Aton, SJ; Seibt, J; Dumoulin, MC; Coleman, T; Shiraishi, M; Frank, MG				Aton, Sara J.; Seibt, Julie; Dumoulin, Michelle C.; Coleman, Tammi; Shiraishi, Mia; Frank, Marcos G.			The Sedating Antidepressant Trazodone Impairs Sleep-Dependent Cortical Plasticity	PLOS ONE			English	Article							SLOW-WAVE SLEEP; MEMORY CONSOLIDATION; OCULAR DOMINANCE; VISUAL-CORTEX; PREFRONTAL CORTEX; LOCUS-COERULEUS; ZOLPIDEM; RECEPTORS; TRANSIENT; BLOCKADE	Background: Recent findings indicate that certain classes of hypnotics that target GABA(A) receptors impair sleep-dependent brain plasticity. However, the effects of hypnotics acting at monoamine receptors (e.g., the antidepressant trazodone) on this process are unknown. We therefore assessed the effects of commonly-prescribed medications for the treatment of insomnia (trazodone and the non-benzodiazepine GABAA receptor agonists zaleplon and eszopiclone) in a canonical model of sleep-dependent, in vivo synaptic plasticity in the primary visual cortex (V1) known as ocular dominance plasticity. Methodology/Principal Findings: After a 6-h baseline period of sleep/wake polysomnographic recording, cats underwent 6 h of continuous waking combined with monocular deprivation (MD) to trigger synaptic remodeling. Cats subsequently received an i.p. injection of either vehicle, trazodone (10 mg/kg), zaleplon (10 mg/kg), or eszopiclone (1-10 mg/kg), and were allowed an 8-h period of post-MD sleep before ocular dominance plasticity was assessed. We found that while zaleplon and eszopiclone had profound effects on sleeping cortical electroencephalographic (EEG) activity, only trazodone (which did not alter EEG activity) significantly impaired sleep-dependent consolidation of ocular dominance plasticity. This was associated with deficits in both the normal depression of V1 neuronal responses to deprived-eye stimulation, and potentiation of responses to non-deprived eye stimulation, which accompany ocular dominance plasticity. Conclusions/Significance: Taken together, our data suggest that the monoamine receptors targeted by trazodone play an important role in sleep-dependent consolidation of synaptic plasticity. They also demonstrate that changes in sleep architecture are not necessarily reliable predictors of how hypnotics affect sleep-dependent neural functions.			Aton, SJ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	mgf@mail.med.upenn.edu		Bridi, Michelle/0000-0001-5533-5092; Seibt, Julie/0000-0002-1081-9680; Aton, Sara/0000-0002-2921-0509	NATIONAL EYE INSTITUTE [T32EY007143, F32EY017766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007517] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY017766, T32 EY007143, F32 EY017766-02] Funding Source: Medline; NIGMS NIH HHS [T32 GM007517] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; Benca RM, 2005, PSYCHIAT SERV, V56, P332, DOI 10.1176/appi.ps.56.3.332; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Drover DR, 2004, CLIN PHARMACOKINET, V43, P227, DOI 10.2165/00003088-200443040-00002; DYCK RH, 1993, J NEUROSCI, V13, P4316; Eiland LS, 2007, ANN PHARMACOTHER, V41, P1181, DOI 10.1345/aph.1K049; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Eschenko O, 2008, CEREB CORTEX, V18, P2596, DOI 10.1093/cercor/bhn020; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Frank MG, 2006, NEUROSCIENTIST, V12, P477, DOI 10.1177/1073858406293552; Frank MG, 2006, NEUROREPORT, V17, P1459, DOI 10.1097/01.wnr.0000233100.05408.e4; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gais S, 2004, P NATL ACAD SCI USA, V101, P2140, DOI 10.1073/pnas.0305404101; Gais S, 2008, J NEUROSCI, V28, P5513, DOI 10.1523/JNEUROSCI.5374-07.2008; Gauthier P, 1997, PSYCHOPHARMACOLOGY, V130, P139, DOI 10.1007/s002130050221; Giorgetti M, 2004, EUR J PHARMACOL, V488, P1, DOI 10.1016/j.ejphar.2004.01.036; Greenblatt DJ, 1998, CLIN PHARMACOL THER, V64, P553, DOI 10.1016/S0009-9236(98)90139-4; GREENBLATT DJ, 1987, CLIN PHARMACOL THER, V42, P193, DOI 10.1038/clpt.1987.132; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; GU W, 1994, EUR J NEUROSCI, V7, P1146; HARIA M, 1994, DRUG AGING, V4, P331, DOI 10.2165/00002512-199404040-00006; Higashima M, 1998, NEUROSCI LETT, V245, P77, DOI 10.1016/S0304-3940(98)00178-5; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Jha SK, 2005, J NEUROSCI, V25, P9266, DOI 10.1523/JNEUROSCI.2722-05.2005; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Judge SJ, 2006, EUR NEUROPSYCHOPHARM, V16, P612, DOI 10.1016/j.euroneuro.2006.01.010; Kallepalli BR, 1997, J CHILD ADOL PSYCHOP, V7, P97, DOI 10.1089/cap.1997.7.97; KANEKO M, 2008, TRKB KINASE REQUIRED; KASAMATSU T, 1985, EXP BRAIN RES, V59, P507; Kemppainen RJ, 1996, EUR J ENDOCRINOL, V134, P602, DOI 10.1530/eje.0.1340602; Kirkwood A, 2000, P NATL ACAD SCI USA, V97, P1951, DOI 10.1073/pnas.070044697; Kojic L, 1997, DEV BRAIN RES, V101, P299, DOI 10.1016/S0165-3806(97)00083-7; Kraus RL, 2007, NEUROPHARMACOLOGY, V53, P308, DOI 10.1016/j.neuropharm.2007.05.011; LANCEL M, 1991, BRAIN RES, V548, P206, DOI 10.1016/0006-8993(91)91123-I; Lenhart SE, 2001, ANN PHARMACOTHER, V35, P1449; Levi G, 1997, ISRAEL J PSYCHIAT, V34, P187; LIAO DS, 2004, J NEUROPHYSIOL; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Mohler H, 2006, CELL TISSUE RES, V326, P505, DOI 10.1007/s00441-006-0284-3; Morin AK, 2007, PHARMACOTHERAPY, V27, P89, DOI 10.1592/phco.27.1.89; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Mukaida K, 2007, ANESTH ANALG, V104, P836, DOI 10.1213/01.ane.0000255200.42574.22; Najib J, 2006, CLIN THER, V28, P491, DOI 10.1016/j.clinthera.2006.04.014; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; NISHIKAWA T, 1986, BRAIN RES, V371, P123, DOI 10.1016/0006-8993(86)90817-6; Owens JA, 2003, PEDIATRICS, V111, pE628, DOI 10.1542/peds.111.5.e628; Penalva RG, 2003, EUR J NEUROSCI, V17, P1896, DOI 10.1046/j.1460-9568.2003.02612.x; Petroski RE, 2006, J PHARMACOL EXP THER, V317, P369, DOI 10.1124/jpet.105.096701; PETTIGREW JD, 1978, NATURE, V271, P761, DOI 10.1038/271761a0; RANDALL W, 1985, BEHAV NEUROSCI, V99, P1162, DOI 10.1037/0735-7044.99.6.1162; RASCH B, 2008, NAT NEUROSCI; Rasch BH, 2006, J COGNITIVE NEUROSCI, V18, P793, DOI 10.1162/jocn.2006.18.5.793; Roth T, 2001, SLEEP MED, V2, P379, DOI 10.1016/S1389-9457(01)00071-5; Saccomani L, 2000, J CHILD ADOL PSYCHOP, V10, P307, DOI 10.1089/cap.2000.10.307; SATO H, 1989, J NEUROPHYSIOL, V62, P946, DOI 10.1152/jn.1989.62.4.946; SCATTON B, 1986, J PHARMACOL EXP THER, V237, P659; Seibi J, 2008, SLEEP, V31, P1381; Shinomiya K, 2003, EUR J PHARMACOL, V460, P139, DOI 10.1016/S0014-2999(02)02915-1; TAYLOR DP, 1986, RECEPTOR BINDING DRU; Tesoro S, 2007, PEDIATR ANESTH, V17, P1008, DOI 10.1111/j.1460-9592.2007.02267.x; Tronel S, 2004, LEARN MEMORY, V11, P453, DOI 10.1101/lm.74504; UEBELE VN, NEUROREPORT IN PRESS; Urbain N, 2006, J PHYSIOL-LONDON, V573, P679, DOI 10.1113/jphysiol.2006.108514; Wagner J, 2000, SLEEP MED REV, V4, P551, DOI 10.1053/smrv.2000.0126; Wan H, 2004, EUR J NEUROSCI, V20, P2214, DOI 10.1111/j.1460-9568.2004.03688.x; Wang YC, 1997, EXP BRAIN RES, V114, P321, DOI 10.1007/PL00005640; Yoshimoto Y, 1999, EUR NEUROPSYCHOPHARM, V9, P29, DOI 10.1016/S0924-977X(97)00102-8; Yoshimura Y, 2008, EUR J NEUROSCI, V28, P730, DOI 10.1111/j.1460-9568.2008.06384.x; ZUBIETA JK, 1992, J CLIN PSYCHOPHARM, V12, P346	72	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6078	10.1371/journal.pone.0006078	http://dx.doi.org/10.1371/journal.pone.0006078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568418	Green Published, gold, Green Submitted			2022-12-27	WOS:000267572200002
J	Clar, C; Royle, P; Waugh, N				Clar, Christine; Royle, Pamela; Waugh, Norman			Adding Pioglitazone to Insulin Containing Regimens in Type 2 Diabetes: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							COMBINATION THERAPY; GLYCEMIC CONTROL; ROSIGLITAZONE; MELLITUS; METFORMIN; RISK; THIAZOLIDINEDIONES; MEDICATION; EFFICACY; DISEASE	Background: Type 2 diabetes is treated in a stepwise manner, progressing from diet and physical activity to oral antidiabetic agents and insulin. The oral agent pioglitazone is licensed for use with insulin when metformin is contraindicated or not tolerated. This systematic review and meta-analysis investigates the extent to which adding pioglitazone to insulin-containing regimens produces benefits in terms of patient-relevant outcomes. Methodology/Principal Findings: Medline, Embase, and the Cochrane Library were searched for randomised controlled trials comparing pioglitazone in combination with any insulin-containing regimen in comparison with the same insulin regimen alone in patients with type 2 diabetes. Outcomes investigated included HbA1c, hypoglycaemia, weight, and adverse events. Studies were selected, assessed and summarised according to standard systematic review methodology and in a meta-analysis. We included eight trials that examined the benefits of adding pioglitazone to an insulin regimen and studied a total of 3092 patients with type 2 diabetes. All studies included patients with previously inadequate glucose control. Trial duration was between 12 weeks and 34.5 months. The trials used pioglitazone doses of up to 45 mg/day. In our meta-analysis, the mean reduction in HbA1c was 0.58% (95% CI: -0.70, -0.46, p<0.00001). Hypoglycaemic episodes were slightly more frequent in the pioglitazone arms ( relative risk 1.27; 95% CI: 0.99, 1.63, p = 0.06). Where reported, HDL-cholesterol tended to be increased with pioglitazone. Patients on pioglitazone tended to gain more weight than those who were not, with an average difference of almost 3 kg. Peripheral oedema was more frequent in the pioglitazone groups. None of the studies reported on fractures in women, and data on cardiovascular events were inconclusive, with most studies being too short or too small to assess these long-term outcomes. Conclusions/Significance: When added to insulin regimens, pioglitazone confers a small advantage in terms of HbA1c in type 2 diabetes patients with previous inadequate glucose control, but at the cost of increased hypoglycaemia and weight gain. Other considerations include the risk of heart failure, fractures in women, a reduced insulin dose, and the net financial cost.			Clar, C (corresponding author), Univ Aberdeen, Dept Publ Hlth, Aberdeen, Scotland.	cclar@gmx.de			Department of Health Funding Source: Medline	Department of Health		[Anonymous], 1995, Diabetes, V44, P1249; Asnani Sunil, 2006, Metabolic Syndrome and Related Disorders, V4, P179, DOI 10.1089/met.2006.4.179; Bailey CJ, 2005, DIABETES OBES METAB, V7, P675, DOI 10.1111/j.1463-1326.2005.00497.x; Berhanu P, 2007, DIABETES OBES METAB, V9, P512, DOI 10.1111/j.1463-1326.2006.00633.x; Berneis K, 2008, EXPERT OPIN PHARMACO, V9, P343, DOI 10.1517/14656566.9.3.343 ; Chappuis B, 2007, DIABETES-METAB RES, V23, P392, DOI 10.1002/dmrr.715; Davis JK, 2005, J MED PHILOS, V30, P27, DOI 10.1080/03605310590907048; Deeg MA, 2007, DIABETES CARE, V30, P2458, DOI 10.2337/dc06-1903; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Erdmann E, 2007, DIABETES CARE, V30, P2773, DOI 10.2337/dc07-0717; *EUR MED AG, 2007, ACT EUR PUBL ASS REP; Fernandez M, 2008, DIABETES CARE, V31, P121, DOI 10.2337/dc07-0711; *INF CTR YORKSH HU, 2007, PRESCR DIAB ENGL AN; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Mannucci E, 2008, DIABETES OBES METAB, V10, P1221, DOI 10.1111/j.1463-1326.2008.00892.x; Mattoo V, 2005, CLIN THER, V27, P554, DOI 10.1016/j.clinthera.2005.05.005; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; Monami M, 2008, DIABETES RES CLIN PR, V82, P48, DOI 10.1016/j.diabres.2008.08.002; Morris AD, 2001, INT J CLIN PRACT, P32; *NAT COLL CTR CHRO, 2008, TYP 2 DIAB NAT CLIN; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; National Institute for Health and Clinical Excellence, 2007, GUID MAN; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Odegard PS, 2007, DIABETES EDUCATOR, V33, P1014, DOI 10.1177/0145721707308407; Raz I, 2005, CLIN THER, V27, P1432, DOI 10.1016/j.clinthera.2005.09.001; Richter B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006060.pub2; Rosenstock J, 2002, INT J CLIN PRACT, V56, P251; Scheen A, 2006, DIABETES, V55, pA134; Schwartz AV, 2008, PPAR RES, V2008, DOI 10.1155/2008/297893; Shah PK, 2007, J INVEST MED, V55, pS95, DOI 10.1097/00042871-200701010-00121; Strowig SM, 2005, DIABETES OBES METAB, V7, P633, DOI 10.1111/j.1463-1326.2004.00440.x; *TAK PHARM, 2007, OBS INCR INC FRACT F; Turner R, 1996, ANN INTERN MED, V124, P136, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00011; TURNER RC, 1988, DIABETIC MED, V5, P444	37	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6112	10.1371/journal.pone.0006112	http://dx.doi.org/10.1371/journal.pone.0006112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568428	Green Published, Green Submitted, gold			2022-12-27	WOS:000267572200012
J	Zhou, HZ; Wang, YB; Wang, W; Jia, JY; Li, Y; Wang, QY; Wu, YF; Tang, J				Zhou, Hongzhe; Wang, Yunbo; Wang, Wei; Jia, Junying; Li, Yuan; Wang, Qiyu; Wu, Yanfang; Tang, Jie			Generation of Monoclonal Antibodies against Highly Conserved Antigens	PLOS ONE			English	Article								Background: Therapeutic antibody development is one of the fastest growing areas of the pharmaceutical industry. Generating high-quality monoclonal antibodies against a given therapeutic target is very crucial for the success of the drug development. However, due to immune tolerance, some proteins that are highly conserved between mice and humans are not very immunogenic in mice, making it difficult to generate antibodies using a conventional approach. Methodology/Principal Findings: In this report, the impaired immune tolerance of NZB/W mice was exploited to generate monoclonal antibodies against highly conserved or self-antigens. Using two highly conserved human antigens (MIF and HMGB1) and one mouse self-antigen (TNF-alpha) as examples, we demonstrate here that multiple clones of high affinity, highly specific antibodies with desired biological activities can be generated, using the NZB/W mouse as the immunization host and a T cell-specific tag fused to a recombinant antigen to stimulate the immune system. Conclusions/Significance: We developed an efficient and universal method for generating surrogate or therapeutic antibodies against "difficult antigens" to facilitate the development of therapeutic antibodies.			Zhou, HZ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Key Lab Biomacromol, Ctr Infect & Immun, Beijing 100080, Peoples R China.	jtang@ibp.ac.cn						Andrievskaia O, 2006, CLIN VACCINE IMMUNOL, V13, P98, DOI 10.1128/CVI.13.1.98-105.2006; BELL DA, 1973, CLIN IMMUNOL IMMUNOP, V1, P293, DOI 10.1016/0090-1229(73)90046-9; Cvetkovic I, 2006, INT IMMUNOPHARMACOL, V6, P1527, DOI 10.1016/j.intimp.2006.06.009; DOBERSEN MJ, 1985, NEUROCHEM RES, V10, P499, DOI 10.1007/BF00964654; FISHER CL, 1988, CLIN IMMUNOL IMMUNOP, V46, P205, DOI 10.1016/0090-1229(88)90183-3; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GOLDINGS EA, 1980, J EXP MED, V152, P730, DOI 10.1084/jem.152.3.730; HURPIN CM, 1992, HYBRIDOMA, V11, P677, DOI 10.1089/hyb.1992.11.677; JACQUEMART F, 1988, HYBRIDOMA, V7, P323, DOI 10.1089/hyb.1988.7.323; Larson DF, 2006, CRIT CARE, V10, DOI 10.1186/cc4899; Lohnas GL, 1998, J IMMUNOL, V161, P6518; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PENNINGTON JE, 1993, CLIN INFECT DIS, V17, pS515, DOI 10.1093/clinids/17.Supplement_2.S515; RATHJEN DA, 1986, HYBRIDOMA, V5, P255, DOI 10.1089/hyb.1986.5.255; Shlomchik MJ, 2001, NAT REV IMMUNOL, V1, P147, DOI 10.1038/35100573; Sinclair NRS, 2004, FRONT BIOSCI-LANDMRK, V9, P3019, DOI 10.2741/1456; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; VORDERMEIER HM, 1991, J IMMUNOL, V147, P1023; Wither J, 2000, IMMUNOLOGY, V99, P345, DOI 10.1046/j.1365-2567.2000.00981.x; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019	20	38	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6087	10.1371/journal.pone.0006087	http://dx.doi.org/10.1371/journal.pone.0006087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564921	Green Published, Green Submitted, gold			2022-12-27	WOS:000267515700006
J	Elias, J; Mazzi, D; Dorn, S				Elias, Jan; Mazzi, Dominique; Dorn, Silvia			No Need to Discriminate? Reproductive Diploid Males in a Parasitoid with Complementary Sex Determination	PLOS ONE			English	Article								Diploid males in hymenopterans are generally either inviable or sterile, thus imposing a severe genetic load on populations. In species with the widespread single locus complementary sex determination (sl-CSD), sex depends on the genotype at one single locus with multiple alleles. Haploid (hemizygous) individuals are always males. Diploid individuals develop into females when heterozygous and into males when homozygous at the sex determining locus. Our comparison of the mating and reproductive success of haploid and diploid males revealed that diploid males of the braconid parasitoid Cotesia glomerata sire viable and fertile diploid daughters. Females mated to diploid males, however, produced fewer daughters than females mated to haploid males. Nevertheless, females did not discriminate against diploid males as mating partners. Diploid males initiated courtship display sooner than haploid males and were larger in body size. Although in most species so far examined diploid males were recognized as genetic dead ends, we present a second example of a species with sl-CSD and commonly occurring functionally reproductive diploid males. Our study suggests that functionally reproductive diploid males might not be as rare as hitherto assumed. We argue that the frequent occurrence of inbreeding in combination with imperfect behavioural adaptations towards its avoidance promote the evolution of diploid male fertility.			Elias, J (corresponding author), ETH, Inst Plant Sci, Swiss Fed Inst Technol Zurich, CH-8092 Zurich, Switzerland.	dominique.mazzi@ipw.agrl.ethz.ch						ADAMS J, 1977, GENETICS, V86, P583; ANTOLIN MF, 1992, ECOL ENTOMOL, V17, P1, DOI 10.1111/j.1365-2311.1992.tb01032.x; Antolin MF, 2003, HEREDITY, V91, P373, DOI 10.1038/sj.hdy.6800337; Ayabe T, 2004, CHROMOSOME RES, V12, P215, DOI 10.1023/B:CHRO.0000021880.83639.4b; Beukeboom LW, 2000, GENOME, V43, P939, DOI 10.1139/gen-43-6-939; BEUKEBOOM LW, 1995, BIOESSAYS, V17, P813, DOI 10.1002/bies.950170911; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Cowan DP, 2004, P NATL ACAD SCI USA, V101, P10374, DOI 10.1073/pnas.0402481101; de Boer JG, 2007, HEREDITY, V99, P288, DOI 10.1038/sj.hdy.6800995; De Boer JG, 2007, J EVOLUTION BIOL, V20, P340, DOI 10.1111/j.1420-9101.2006.01193.x; de Boer JG, 2008, GENETICS, V180, P1525, DOI 10.1534/genetics.107.083907; Dorn S, 2007, PHYSIOL ENTOMOL, V32, P199, DOI 10.1111/j.1365-3032.2007.00576.x; ELAGOZE M, 1994, B ENTOMOL RES, V84, P213, DOI 10.1017/S0007485300039717; FOSTER RL, 1992, J KANSAS ENTOMOL SOC, V65, P238; Gu HN, 2003, ECOL ENTOMOL, V28, P422, DOI 10.1046/j.1365-2311.2003.00535.x; Gu HN, 2003, ANIM BEHAV, V66, P259, DOI 10.1006/anbe.2003.2185; Hartley Christopher S., 2003, Journal of Hymenoptera Research, V12, P272; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Herzner G, 2006, BIOL J LINN SOC, V89, P433, DOI 10.1111/j.1095-8312.2006.00684.x; HOAGE TR, 1968, J ULTRA MOL STRUCT R, V24, P6, DOI 10.1016/S0022-5320(68)80014-0; HOGGE MAF, 1975, J SUBMICR CYTOL PATH, V7, P81; HUNG ACF, 1974, ANN ENTOMOL SOC AM, V67, P909, DOI 10.1093/aesa/67.6.909; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Krieger MJB, 1999, HEREDITY, V82, P142, DOI 10.1038/sj.hdy.6884600; Laing J.E., 1982, Biocontrol News and Information, V3, P7; Lee JM, 1998, J INSECT BEHAV, V11, P419, DOI 10.1023/A:1020958831972; Liebert AE, 2005, BIOL LETT-UK, V1, P200, DOI 10.1098/rsbl.2004.0284; Manolakou P, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-59; Mattiacci L, 2001, J CHEM ECOL, V27, P2233, DOI 10.1023/A:1012278804105; MORITZ RFA, 1994, HEREDITY, V73, P98, DOI 10.1038/hdy.1994.104; NAITO T, 1991, J HERED, V82, P101, DOI 10.1093/oxfordjournals.jhered.a111042; Niyibigira EI, 2004, APPL ENTOMOL ZOOL, V39, P705, DOI 10.1303/aez.2004.705; NUR U, 1988, SCIENCE, V240, P512, DOI 10.1126/science.3358129; ODE PJ, 1995, ANIM BEHAV, V49, P1239, DOI 10.1006/anbe.1995.0156; Oldroyd BP, 2008, GENETICS, V180, P359, DOI 10.1534/genetics.108.090415; OWEN RE, 1994, HEREDITY, V72, P219, DOI 10.1038/hdy.1994.31; PAGE RE, 1980, GENETICS, V96, P263; PETTERS RM, 1980, J HERED, V71, P353, DOI 10.1093/oxfordjournals.jhered.a109385; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; R Core Team, 2018, R LANG ENV STAT COMP; Reece SE, 2007, ANIM BEHAV, V74, P1163, DOI 10.1016/j.anbehav.2006.10.027; Sarkar D., 2008, LATTICE LATTICE GRAP; SMITH SG, 1971, CAN J GENET CYTOL, V13, P617, DOI 10.1139/g71-089; Stahlhut JK, 2004, HEREDITY, V92, P189, DOI 10.1038/sj.hdy.6800394; Stahlhut JK, 2004, MOL ECOL, V13, P631, DOI 10.1046/j.1365-294X.2004.02090.x; STOUTHAMER R, 1992, ENVIRON ENTOMOL, V21, P427, DOI 10.1093/ee/21.3.427; Stouthamer R, 2001, P ROY SOC B-BIOL SCI, V268, P617, DOI 10.1098/rspb.2000.1404; Tagawa J, 2000, ENTOMOL EXP APPL, V97, P193, DOI 10.1023/A:1004007802543; TAGAWA J, 1981, APPL ENTOMOL ZOOL, V16, P345, DOI 10.1303/aez.16.345; Takahashi NC, 2001, EVOLUTION, V55, P1897, DOI 10.1111/j.0014-3820.2001.tb00839.x; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; van Vugt JFA, 2003, GENOME, V46, P580, DOI [10.1139/g03-044, 10.1139/G03-044]; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; VERMA S, 1983, APIDOLOGIE, V14, P41, DOI 10.1051/apido:19830104; Wang Q, 2003, HEREDITY, V91, P430, DOI 10.1038/sj.hdy.6800340; Wanner H, 2007, AGR ECOSYST ENVIRON, V118, P143, DOI 10.1016/j.agee.2006.05.005; WERREN JH, 1981, NATURE, V293, P467, DOI 10.1038/293467a0; Whiting PW, 1940, J MORPHOL, V66, P323, DOI 10.1002/jmor.1050660208; Whiting PW, 1943, GENETICS, V28, P365; Woyke J., 1963, Journal of Apicultural Research London, V2, P73; Wu Zhishan, 2003, Entomologia Sinica, V10, P81; Yamauchi K, 2001, INSECT SOC, V48, P28, DOI 10.1007/PL00001741; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250; Zhou Y, 2007, BIOL CONTROL, V40, P273, DOI 10.1016/j.biocontrol.2006.11.002; Zhou Y, 2006, HEREDITY, V96, P487, DOI 10.1038/sj.hdy.6800829	68	38	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6024	10.1371/journal.pone.0006024	http://dx.doi.org/10.1371/journal.pone.0006024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551142	Green Submitted, gold, Green Published			2022-12-27	WOS:000267356500009
J	Suomela, S; Elomaa, O; Skoog, T; Ala-Aho, R; Jeskanen, L; Parssinen, J; Latonen, L; Grenman, R; Kere, J; Kahari, VM; Saarialho-Kere, U				Suomela, Sari; Elomaa, Outi; Skoog, Tiina; Ala-aho, Risto; Jeskanen, Leila; Parssinen, Jenita; Latonen, Leena; Grenman, Reidar; Kere, Juha; Kahari, Veli-Matti; Saarialho-Kere, Ulpu			CCHCR1 Is Up-Regulated in Skin Cancer and Associated with EGFR Expression	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; OKADAIC ACID; GENE-EXPRESSION; CANDIDATE GENE; MATRIX METALLOPROTEINASE-21; KERATINOCYTE PROLIFERATION; PSORIATIC PLAQUES; SQUAMOUS-CELL; TISSUE-REPAIR; ACTIVATION	Despite chronic inflammation, psoriatic lesions hardly ever progress to skin cancer. Aberrant function of the CCHCR1 gene (Coiled-Coil alpha-Helical Rod protein 1, HCR) within the PSORS1 locus may contribute to the onset of psoriasis. As CCHCR1 is expressed in certain cancers and regulates keratinocyte (KC) proliferation in a transgenic mouse model, we studied its relation to proliferation in cutaneous squamous cell cancer (SCC) cell lines by expression arrays and quantitative RT-PCR and in skin tumors by immunohistochemistry. CCHCR1 protein was detected in the pushing border of SCC and lining basal cell carcinoma islands. Different from psoriasis, Ki67 had a similar expression pattern as CCHCR1. The most intense CCHCR1 staining occurred in areas positive for epidermal growth factor receptor (EGFR). Expression of CCHCR1 mRNA was upregulated 30-80% in SCC lines when compared to normal KCs and correlated positively with Ki67 expression. The most aggressive and invasive tumor cell lines (RT3, FaDu) expressed CCHCR1 mRNA less than non-tumorigenic HaCaT cells. Moreover, the tumor promoters okadaic acid and menadione downregulated CCHCR1 mRNA. We conclude that both in psoriasis and the early stages of KC transformation, CCHCR1 may function as a negative regulator of proliferation, but beyond a certain point in oncogenesis cannot control this phenomenon any longer.			Suomela, S (corresponding author), Univ Helsinki, Cent Hosp, Dept Dermatol, FIN-00170 Helsinki, Finland.	ulpu.saarialho-kere@helsinki.fi	Kahari, Veli-Matti/T-4925-2019; Skoog, Tiina/B-8598-2014; Latonen, Leena/C-8787-2016; Kere, Juha/AAX-9117-2021; Skoog, Tiina/N-3525-2019; Kähäri, Veli-Matti/E-5144-2011; Kere, Juha/A-9179-2008	Kahari, Veli-Matti/0000-0003-2421-9368; Latonen, Leena/0000-0003-4502-2193; Kere, Juha/0000-0003-1974-0271; Skoog, Tiina/0000-0002-0148-0654; Kähäri, Veli-Matti/0000-0003-2421-9368; Kere, Juha/0000-0003-1974-0271				Ahokas K, 2003, LAB INVEST, V83, P1887, DOI 10.1097/01.LAB.0000106721.86126.39; Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Asumalahti K, 2000, HUM MOL GENET, V9, P1533, DOI 10.1093/hmg/9.10.1533; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Beier JI, 2006, FEBS LETT, V580, P1859, DOI 10.1016/j.febslet.2006.02.048; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Corbi N, 2005, J CELL SCI, V118, P4253, DOI 10.1242/jcs.02545; Cordero JB, 2002, J BIOL CHEM, V277, P38965, DOI 10.1074/jbc.M203736200; De Angelis R, 2003, FEBS LETT, V547, P15, DOI 10.1016/S0014-5793(03)00659-8; De Angelis T, 2002, J INVEST DERMATOL, V118, P759, DOI 10.1046/j.1523-1747.2002.01755.x; El-Abaseri TB, 2006, CARCINOGENESIS, V27, P225, DOI 10.1093/carcin/bgi220; Elomaa O, 2004, HUM MOL GENET, V13, P1551, DOI 10.1093/hmg/ddh178; Freeman MR, 2007, STEROIDS, V72, P210, DOI 10.1016/j.steroids.2006.11.012; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; LANSFORD CD, 1999, HUMAN CELL CULTURE, V2, P185; Lebeau S, 2005, BRIT J DERMATOL, V152, P1248, DOI 10.1111/j.1365-2133.2005.06687.x; Matias WG, 1999, HUM EXP TOXICOL, V18, P634, DOI 10.1191/096032799678839473; Meves A, 2002, ARCH DERMATOL RES, V294, P243, DOI 10.1007/s00403-002-0315-1; Mielnicki LM, 1996, BIOCHEM BIOPH RES CO, V228, P586, DOI 10.1006/bbrc.1996.1702; Nickoloff BJ, 2001, J CUTAN PATHOL, V28, P57, DOI 10.1034/j.1600-0560.2001.280201.x; Nickoloff BJ, 2006, J INVEST DERM SYMP P, V11, P16, DOI 10.1038/sj.jidsymp.5650010; Paltiel O, 2004, ARCH DERMATOL, V140, P805, DOI 10.1001/archderm.140.7.805; Pivarcsi A, 2001, ARCH DERMATOL RES, V293, P206, DOI 10.1007/s004030100217; Quadros MRD, 2004, CANCER RES, V64, P3934, DOI 10.1158/0008-5472.CAN-04-0214; Rittie L, 2007, AM J PATHOL, V170, P2089, DOI 10.2353/ajpath.2007.060537; Rosenberger SF, 1999, J BIOL CHEM, V274, P1124, DOI 10.1074/jbc.274.2.1124; SCHMIDT KN, 1995, J BIOL CHEM, V270, P27136, DOI 10.1074/jbc.270.45.27136; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; SCHONTHAL AH, 1995, SEMIN CANCER BIOL, V6, P239, DOI 10.1006/scbi.1995.0031; Skoog T, 2006, EXP DERMATOL, V15, P775, DOI 10.1111/j.1600-0625.2006.00460.x; Skoog T, 2009, J INVEST DERMATOL, V129, P119, DOI 10.1038/jid.2008.206; Suomela S, 2003, J INVEST DERMATOL, V121, P1360, DOI 10.1046/j.1523-1747.2003.12642.x; Tiala I, 2008, HUM MOL GENET, V17, P1043, DOI 10.1093/hmg/ddm377; Tiala I, 2007, J MOL MED, V85, P589, DOI 10.1007/s00109-006-0155-0; Verdier-Sevain S, 2004, FASEB J, V18, P1252, DOI 10.1096/fj.03-1088fje; Westermarck J, 1998, MATRIX BIOL, V17, P547, DOI 10.1016/S0945-053X(98)90107-X; WESTERMARCK J, 1994, CELL GROWTH DIFFER, V5, P1205; Wierzbicka E, 2006, BRIT J DERMATOL, V155, P213, DOI 10.1111/j.1365-2133.2006.07299.x; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zorzou MP, 2004, ACTA DERM-VENEREOL, V84, P308, DOI 10.1080/00015550410024634	42	27	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6030	10.1371/journal.pone.0006030	http://dx.doi.org/10.1371/journal.pone.0006030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551138	Green Published, Green Submitted, gold			2022-12-27	WOS:000267356500014
J	Lubelchek, RJ; Max, B; Sandusky, CJ; Hota, B; Barker, DE				Lubelchek, Ronald J.; Max, Blake; Sandusky, Caroline J.; Hota, Bala; Barker, David E.			Reliability at the Lower Limits of HIV-1 RNA Quantification in Clinical Samples: A Comparison of RT-PCR versus bDNA Assays	PLOS ONE			English	Article								Introduction: To explore whether an assay change was responsible for an increasing proportion of patients with undetectable HIV viral loads at our urban HIV clinic, we selected highly stable patients, examining their viral loads before and after changing assays. We compared the proportion with detectable viremia during RT-PCR vs. bDNA periods. Methodology/Principal Findings: We selected patients with >= 1 viral loads assessed during both RT-PCR and bDNA periods. We included patients with stable CD4 counts, excluding patients with viral loads >= 1,000 copies/ml or any significant changes in therapy. Out of 4500 clinic patients, 419 patients (1588 viral loads) were included. 39% of viral loads were reported as detectable by RT-PCR vs. 5% reported as detectable by bDNA. The mean coefficient of variation was higher before vs. after assay change. We found an odds' ratio of 16.7 for having a viral load >75 copies/ml during the RT-PCR vs. bDNA periods. Discussion: These data support previous reports, suggesting that bDNA may more reliably discriminate between viral suppression and low level viremia in stable patients on therapy. Low-level viremia, noted more with RT-PCR, may promote unneeded testing, while differences in viral load reliability may impact antiretroviral trial and quality assurance endpoints. Commonly used plasma separator tubes may differentially affect RT-PCR and bDNA results.			Lubelchek, RJ (corresponding author), Jr Hosp Cook Cty, Div Infect Dis, Chicago, IL USA.	rlubel@gmail.com	Max, Blake/CAA-0261-2022					*DEP HHS, 2006, GUID US ANT AG HIV 1; Elbeik T, 2002, J ACQ IMMUN DEF SYND, V29, P330; Elbeik T, 2000, J CLIN MICROBIOL, V38, P1113, DOI 10.1128/JCM.38.3.1113-1120.2000; *FDA CDER DIV ANT, GUID IND ANT DRUGS U; Galli R, 2005, J CLIN VIROL, V34, P245, DOI 10.1016/j.jcv.2004.12.012; Giordano M, 2006, J CLIN VIROL, V35, P420, DOI 10.1016/j.jcv.2005.10.011; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Murphy DG, 2000, J CLIN MICROBIOL, V38, P4034, DOI 10.1128/JCM.38.11.4034-4041.2000; MURPHY R, 2005, 12 C RETR OPP INF FE; Nettles RE, 2004, CLIN INFECT DIS, V39, P1030, DOI 10.1086/423388; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Nolte FS, 1998, J CLIN MICROBIOL, V36, P716, DOI 10.1128/JCM.36.3.716-720.1998; Peter JB, 2002, J ACQ IMMUN DEF SYND, V30, P261; Ribaudo H, 2009, 16 C RETR OPP INF FE; Salimnia H, 2005, J CLIN MICROBIOL, V43, P4635, DOI 10.1128/JCM.43.9.4635-4639.2005; Sungkanuparph S, 2005, CLIN INFECT DIS, V41, P1326, DOI 10.1086/496985	16	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6008	10.1371/journal.pone.0006008	http://dx.doi.org/10.1371/journal.pone.0006008			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547711	Green Published, Green Submitted, gold			2022-12-27	WOS:000267347900007
J	Wertheim, HFL; Nguyen, HN; Taylor, W; Lien, TTM; Ngo, HT; Nguyen, TQ; Nguyen, BNT; Nguyen, HH; Nguyen, HM; Nguyen, CT; Dao, TT; Nguyen, TV; Fox, A; Farrar, J; Schultsz, C; Nguyen, HD; Van Nguyen, K; Horby, P				Wertheim, Heiman F. L.; Nguyen, Huyen Nguyen; Taylor, Walter; Lien, Trinh Thi Minh; Ngo, Hoa Thi; Nguyen, Thai Quoc; Nguyen, Bich Ngoc Thi; Nguyen, Ha Hong; Nguyen, Ha Minh; Nguyen, Cap Trung; Dao, Trinh Tuyet; Nguyen, Trung Vu; Fox, Annette; Farrar, Jeremy; Schultsz, Constance; Nguyen, Hien Duc; Van Nguyen, Kinh; Horby, Peter			Streptococcus suis, an Important Cause of Adult Bacterial Meningitis in Northern Vietnam	PLOS ONE			English	Article								Background: Streptococcus suis can cause severe systemic infection in adults exposed to infected pigs or after consumption of undercooked pig products. S. suis is often misdiagnosed, due to lack of awareness and improper testing. Here we report the first fifty cases diagnosed with S. suis infection in northern Viet Nam. Methodology/Principal Findings: In 2007, diagnostics for S. suis were set up at a national hospital in Hanoi. That year there were 43 S. suis positive cerebrospinal fluid samples, of which S. suis could be cultured in 32 cases and 11 cases were only positive by PCR. Seven patients were blood culture positive for S. suis but CSF culture and PCR negative; making a total of 50 patients with laboratory confirmed S. suis infection in 2007. The number of S. suis cases peaked during the warmer months. Conclusions/Significance: S. suis was commonly diagnosed as a cause of bacterial meningitis in adults in northern Viet Nam. In countries where there is intense and widespread exposure of humans to pigs, S. suis can be an important human pathogen.			Wertheim, HFL (corresponding author), Natl Inst Infect & Trop Dis, Oxford Univ Clin Res Unit, Hanoi, Vietnam.	Hwertheim@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Wertheim, Heiman FL/F-3338-2016; Horby, Peter/D-1585-2013	Wertheim, Heiman FL/0000-0002-5003-5565; Horby, Peter/0000-0002-9822-1586; Farrar, Jeremy/0000-0002-2700-623X; Fox, Annette/0000-0002-0565-7146; Ngo, Hoa/0000-0001-9320-4050	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARENDS JP, 1988, REV INFECT DIS, V10, P131; BELTRANALCRUDO D, 2007, PORCINE REPROD RESP, P1; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; DONE SH, 1995, VET REC, V136, P32, DOI 10.1136/vr.136.2.32; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Wang G, 2007, INT J CLIN PRACT, V61, P1056, DOI 10.1111/j.1742-1241.2007.01369.x; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763	9	98	102	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5973	10.1371/journal.pone.0005973	http://dx.doi.org/10.1371/journal.pone.0005973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543404	gold, Green Published			2022-12-27	WOS:000267237600003
J	Ma, LH; Punnamoottil, B; Rinkwitz, S; Baker, R				Ma, Leung-Hang; Punnamoottil, Beena; Rinkwitz, Silke; Baker, Robert			Mosaic hoxb4a Neuronal Pleiotropism in Zebrafish Caudal Hindbrain	PLOS ONE			English	Article								To better understand how individual genes and experience influence behavior, the role of a single homeotic unit, hoxb4a, was comprehensively analyzed in vivo by clonal and retrograde fluorescent labeling of caudal hindbrain neurons in a zebrafish enhancer-trap YFP line. A quantitative spatiotemporal neuronal atlas showed hoxb4a activity to be highly variable and mosaic in rhombomere 7-8 reticular, motoneuronal and precerebellar nuclei with expression decreasing differentially in all subgroups through juvenile stages. The extensive Hox mosaicism and widespread pleiotropism demonstrate that the same transcriptional protein plays a role in the development of circuits that drive behaviors from autonomic through motor function including cerebellar regulation. We propose that the continuous presence of hoxb4a positive neurons may provide a developmental plasticity for behavior-specific circuits to accommodate experience- and growth-related changes. Hence, the ubiquitous hoxb4a pleitropism and modularity likely offer an adaptable transcriptional element for circuit modification during both growth and evolution.			Ma, LH (corresponding author), NYU, Med Ctr, Dept Physiol & Neurosci, New York, NY 10016 USA.	robert.baker@nyumc.org		Baker, Robert/0000-0001-7920-1769	NATIONAL EYE INSTITUTE [R01EY002007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS013742] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY002007, EY-02007] Funding Source: Medline; NINDS NIH HHS [P01 NS013742, NS-13742] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bass AH, 1997, BRAIN BEHAV EVOLUT, V50, P3, DOI 10.1159/000113351; Bass AH, 2008, SCIENCE, V321, P417, DOI 10.1126/science.1157632; Beck JC, 2006, J NEUROPHYSIOL, V96, P1370, DOI 10.1152/jn.00335.2006; Beck JC, 2004, J NEUROPHYSIOL, V92, P3546, DOI 10.1152/jn.00311.2004; Beslu N, 2004, BLOOD, V104, P2307, DOI 10.1182/blood-2004-04-1653; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Davenne M, 1999, NEURON, V22, P677, DOI 10.1016/S0896-6273(00)80728-X; del Toro ED, 2001, J NEUROSCI, V21, P5637, DOI 10.1523/JNEUROSCI.21-15-05637.2001; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Dupont E, 2007, J BIOL CHEM, V282, P8994, DOI 10.1074/jbc.M609246200; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Gaufo GO, 2004, DEVELOPMENT, V131, P1259, DOI 10.1242/dev.01029; Gilland E, 2005, BRAIN BEHAV EVOLUT, V66, P234, DOI 10.1159/000088128; Glover JC, 2006, J NEUROBIOL, V66, P705, DOI 10.1002/neu.20272; Hadrys T, 2006, DEV BIOL, V297, P26, DOI 10.1016/j.ydbio.2006.04.446; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hurley IA, 2007, EVOL DEV, V9, P540, DOI 10.1111/j.1525-142X.2007.00195.x; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; KIMMEL CB, 1985, J COMP NEUROL, V233, P365, DOI 10.1002/cne.902330306; KIMMEL CB, 1982, PROG BRAIN RES, V57, P1, DOI 10.1016/S0079-6123(08)64122-9; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Manley NR, 2001, DEV BIOL, V237, P130, DOI 10.1006/dbio.2001.0365; MENDELSON B, 1986, J COMP NEUROL, V251, P160, DOI 10.1002/cne.902510203; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; Moens CB, 2002, DEV DYNAM, V224, P1, DOI 10.1002/dvdy.10086; Murakami Y, 2005, DEV BIOL, V280, P249, DOI 10.1016/j.ydbio.2005.02.008; Nicolay DJ, 2004, CELL MOL NEUROBIOL, V24, P357, DOI 10.1023/B:CEMN.0000022768.34389.4e; Nieuwenhuys R, 1999, EUR J MORPHOL, V37, P81, DOI 10.1076/ejom.37.2.81.4746; Olsson C, 2008, J COMP NEUROL, V508, P756, DOI 10.1002/cne.21705; Oury F, 2006, SCIENCE, V313, P1408, DOI 10.1126/science.1130042; PASTOR AM, 1994, J NEUROPHYSIOL, V72, P1383, DOI 10.1152/jn.1994.72.3.1383; Prince VE, 1998, DEVELOPMENT, V125, P407; Prince VE, 1998, DEVELOPMENT, V125, P393; Prochiantz A, 2003, NAT REV MOL CELL BIO, V4, P814, DOI 10.1038/nrm1227; PUNNAMOOTTIL B, 2008, DEV DYN; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Rohrschneider MR, 2007, DEV BIOL, V309, P358, DOI 10.1016/j.ydbio.2007.06.012; Sotelo C, 1997, PERSPECT DEV NEUROBI, V5, P57; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Straka H, 2006, J NEUROPHYSIOL, V96, P1963, DOI 10.1152/jn.00334.2006; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Takio Y, 2004, NATURE, V429, DOI 10.1038/nature02616; Takio Y, 2007, DEV BIOL, V308, P606, DOI 10.1016/j.ydbio.2007.05.009; Tawk M, 2007, NATURE, V446, P797, DOI 10.1038/nature05722; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thorsen DH, 2007, J COMP NEUROL, V504, P168, DOI 10.1002/cne.21425; Thorsen DH, 2005, J MORPHOL, V266, P241, DOI 10.1002/jmor.10374; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; Wagner GP, 2008, NATURE, V452, P470, DOI 10.1038/nature06756; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Walshe J, 2002, CURR BIOL, V12, P1117, DOI 10.1016/S0960-9822(02)00899-0; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Woo K, 1998, DEV BIOL, V197, P283, DOI 10.1006/dbio.1998.8870; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225	58	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5944	10.1371/journal.pone.0005944	http://dx.doi.org/10.1371/journal.pone.0005944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536294	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029700014
J	Lidzbarsky, GA; Shkolnik, T; Nevo, E				Lidzbarsky, Gabriel A.; Shkolnik, Tamar; Nevo, Eviatar			Adaptive Response to DNA-Damaging Agents in Natural Saccharomyces cerevisiae Populations from "Evolution Canyon'', Mt. Carmel, Israel	PLOS ONE			English	Article							CYANOBACTERIUM NOSTOC-LINCKIA; GENOME EVOLUTION; MOUNT-CARMEL; WILD BARLEY; REPAIR; DIVERSITY; STRAINS; ADAPTATION; DIVERGENCE; STRESS	Background: Natural populations of most organisms, especially unicellular microorganisms, are constantly exposed to harsh environmental factors which affect their growth. UV radiation is one of the most important physical parameters which influences yeast growth in nature. Here we used 46 natural strains of Saccharomyces cerevisiae isolated from several natural populations at the "Evolution Canyon'' microsite (Nahal Oren, Mt. Carmel, Israel). The opposing slopes of this canyon share the same geology, soil, and macroclimate, but they differ in microclimatic conditions. The interslope differences in solar radiation (200%-800% more on the "African'' slope) caused the development of two distinct biomes. The south-facing slope is sunnier and has xeric, savannoid "African'' environment while the north-facing slope is represented by temperate, "European'' forested environment. Here we studied the phenotypic response of the S. cerevisiae strains to UVA and UVC radiations and to methyl methanesulfonate (MMS) in order to evaluate the interslope effect on the strains' ability to withstand DNA-damaging agents. Methodology/Principal Findings: We exposed our strains to the different DNA-damaging agents and measured survival by counting colony forming units. The strains from the "African'' slope were more resilient to both UVA and MMS than the strains from the "European'' slope. In contrast, we found that there was almost no difference between strains (with similar ploidy) from the opposite slopes, in their sensitivity to UVC radiation. These results suggest that the "African'' strains are more adapted to higher solar radiation than the "European'' strains. We also found that the tetraploids strains were more tolerant to all DNA-damaging agents than their neighboring diploid strains, which suggest that high ploidy level might be a mechanism of adaptation to high solar radiation. Conclusions/Significance: Our results and the results of parallel studies with several other organisms, suggest that natural selection appears to select, at a microscale, for adaptive complexes that can tolerate the higher UV radiation on the "African'' slope.			Lidzbarsky, GA (corresponding author), Univ Haifa, Inst Evolut, Dept Evolutionary & Environm Biol, Fac Sci & Sci Educ, IL-31999 Haifa, Israel.	nevo@research.haifa.ac.il						Andreyuk E. I., 1999, Mikrobiologichnii Zhurnal, V61, P3; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Hanway D, 2002, P NATL ACAD SCI USA, V99, P10605, DOI 10.1073/pnas.152264899; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Krugman T, 2001, EVOL ECOL RES, V3, P899; Lamb BC, 1998, GENETICS, V149, P87; Landry CR, 2006, MOL ECOL, V15, P575, DOI 10.1111/j.1365-294X.2006.02778.x; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Lupu A, 2004, MUTAGENESIS, V19, P383, DOI 10.1093/mutage/geh045; Lupu A, 2006, GENETICA, V127, P121, DOI 10.1007/s10709-005-2611-0; Mable BK, 2001, GENET RES, V77, P9, DOI 10.1017/S0016672300004821; Miyazaki S, 2003, MONATSH CHEM, V134, P1465, DOI 10.1007/s00706-003-0072-7; MORTIMER RK, 1986, GENETICS, V113, P35; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Nagornaya SS, 2003, ISRAEL J PLANT SCI, V51, P55, DOI 10.1560/RMNC-XLYU-456X-V6E5; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E, 2006, ISR J ECOL EVOL, V52, P485; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; SASAKI T, 1992, APPL ENVIRON MICROB, V58, P948, DOI 10.1128/AEM.58.3.948-952.1992; Satish N, 2001, MICROB ECOL, V42, P306, DOI 10.1007/s00248-001-0013-0; Scharer OD, 2003, ANGEW CHEM INT EDIT, V42, P2946, DOI 10.1002/anie.200200523; Sikorski J, 2005, P NATL ACAD SCI USA, V102, P15924, DOI 10.1073/pnas.0507944102; Singaravelan N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002993; Singh SR, 2005, BEHAV GENET, V35, P753, DOI 10.1007/s10519-005-6119-2; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e	31	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5914	10.1371/journal.pone.0005914	http://dx.doi.org/10.1371/journal.pone.0005914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526052	Green Submitted, Green Published, gold			2022-12-27	WOS:000267029300008
J	Breslauer, DN; Maamari, RN; Switz, NA; Lam, WA; Fletcher, DA				Breslauer, David N.; Maamari, Robi N.; Switz, Neil A.; Lam, Wilbur A.; Fletcher, Daniel A.			Mobile Phone Based Clinical Microscopy for Global Health Applications	PLOS ONE			English	Article							FLUORESCENCE; TUBERCULOSIS; TELEMEDICINE	Light microscopy provides a simple, cost-effective, and vital method for the diagnosis and screening of hematologic and infectious diseases. In many regions of the world, however, the required equipment is either unavailable or insufficiently portable, and operators may not possess adequate training to make full use of the images obtained. Counterintuitively, these same regions are often well served by mobile phone networks, suggesting the possibility of leveraging portable, camera-enabled mobile phones for diagnostic imaging and telemedicine. Toward this end we have built a mobile phone-mounted light microscope and demonstrated its potential for clinical use by imaging P. falciparum-infected and sickle red blood cells in brightfield and M. tuberculosis-infected sputum samples in fluorescence with LED excitation. In all cases resolution exceeded that necessary to detect blood cell and microorganism morphology, and with the tuberculosis samples we took further advantage of the digitized images to demonstrate automated bacillus counting via image analysis software. We expect such a telemedicine system for global healthcare via mobile phone - offering inexpensive brightfield and fluorescence microscopy integrated with automated image analysis - to provide an important tool for disease diagnosis and screening, particularly in the developing world and rural areas where laboratory facilities are scarce but mobile phone infrastructure is extensive.			Breslauer, DN (corresponding author), Univ Calif Berkeley, UCSF, Bioengn Grad Grp, Berkeley, CA 94720 USA.	fletch@berkeley.edu		Switz, Neil/0000-0002-3639-4588				[Anonymous], 2008, AM FAM PHYSICIAN, V77, P1300; [Anonymous], 2008, DIG IM COMM MED DICO; Braun RP, 2005, ARCH DERMATOL, V141, P254, DOI 10.1001/archderm.141.2.254; CHUI DHK, 2004, LAB DIAGNOSIS HEMOGL; Frean J, 2007, T ROY SOC TROP MED H, V101, P1053, DOI 10.1016/j.trstmh.2007.06.008; Granot Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002075; Hanscheid T, 2007, LANCET INFECT DIS, V7, P236, DOI 10.1016/S1473-3099(07)70058-0; Hendry C, 2009, J CLIN MICROBIOL, V47, P1206, DOI 10.1128/JCM.02097-08; Hung NV, 2007, LANCET INFECT DIS, V7, P238; International Union Against Tuberculosis and Lung Disease, 2000, SPUT EX TUB DIR MICR; Jones D, 2007, TRENDS PARASITOL, V23, P468, DOI 10.1016/j.pt.2007.08.003; Murray CK, 2006, MIL MED, V171, P1167; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rasband W., 2006, IMAGEJ; *SCI DEV LAB I, 2007, PACK INS RAP MOD AUR; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Streetly A, 2008, J MED SCREEN, V15, P9, DOI 10.1258/jms.2008.007063; Tachakra S, 2003, TELEMED J E-HEALTH, V9, P247, DOI 10.1089/153056203322502632; Tshilolo L, 2008, PUBLIC HEALTH, V122, P933, DOI 10.1016/j.puhe.2007.12.005; *WHO, 2006, INF CONS QUAL CONTR; *WHO REG OFF W PAC, 2003, QUAL ASS SPUT MICR D; *WHO SEARO WPRO, 2005, WHO SEARO WPRO WORKS; Woodward B, 2001, IEEE T INF TECHNOL B, V5, P13, DOI 10.1109/4233.908361; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Zimic M, 2009, T ROY SOC TROP MED H, V103, P638, DOI 10.1016/j.trstmh.2008.10.015	25	482	513	5	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6320	10.1371/journal.pone.0006320	http://dx.doi.org/10.1371/journal.pone.0006320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623251	Green Published, gold, Green Submitted			2022-12-27	WOS:000268260100006
J	Okuno, T; Nakayama, T; Konishi, N; Michibata, H; Wakimoto, K; Suzuki, Y; Nito, S; Inaba, T; Nakano, I; Muramatsu, S; Takano, M; Kondo, Y; Inoue, N				Okuno, Tsuyoshi; Nakayama, Takashi; Konishi, Nae; Michibata, Hideo; Wakimoto, Koji; Suzuki, Yutaka; Nito, Shinji; Inaba, Toshio; Nakano, Imaharu; Muramatsu, Shin-ichi; Takano, Makoto; Kondo, Yasushi; Inoue, Nobuo			Self-Contained Induction of Neurons from Human Embryonic Stem Cells	PLOS ONE			English	Article							DOPAMINERGIC-NEURONS; IN-VITRO; ES CELLS; DIFFERENTIATION; BLASTOCYSTS; GROWTH; LINES	Background: Neurons and glial cells can be efficiently induced from mouse embryonic stem (ES) cells in a conditioned medium collected from rat primary-cultured astrocytes (P-ACM). However, the use of rodent primary cells for clinical applications may be hampered by limited supply and risk of contamination with xeno-proteins. Methodology/Principal Findings: We have developed an alternative method for unimpeded production of human neurons under xeno-free conditions. Initially, neural stem cells in sphere-like clusters were induced from human ES (hES) cells after being cultured in P-ACM under free-floating conditions. The resultant neural stem cells could circumferentially proliferate under subsequent adhesive culture, and selectively differentiate into neurons or astrocytes by changing the medium to PACM or G5, respectively. These hES cell-derived neurons and astrocytes could procure functions similar to those of primary cells. Interestingly, a conditioned medium obtained from the hES cell-derived astrocytes (ES-ACM) could successfully be used to substitute P-ACM for induction of neurons. Neurons made by this method could survive in mice brain after xeno-transplantation. Conclusion/Significance: By inducing astrocytes from hES cells in a chemically defined medium, we could produce human neurons without the use of P-ACM. This self-serving method provides an unlimited source of human neural cells and may facilitate clinical applications of hES cells for neurological diseases.			Okuno, T (corresponding author), Mitsubishi Tanabe Pharma Corp, Adv Med Res Lab, Osaka, Japan.	kondo.yasushi@mc.mt-pharma.co.jp	Muramatsu, Shin-ichi/K-9420-2013; Muramatsu, Shinichi/ABC-6093-2021	Muramatsu, Shin-ichi/0000-0002-3185-7790; Muramatsu, Shinichi/0000-0002-3185-7790				BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Nakayama T, 2004, NEUROREPORT, V15, P487, DOI 10.1097/00001756-200403010-00021; Nakayama T, 2003, NEUROSCI RES, V46, P241, DOI 10.1016/S0168-0102(03)00063-4; Nakayama T, 2006, NEUROREPORT, V17, P1519, DOI 10.1097/01.wnr.0000234747.73312.e7; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Ueno M, 2006, P NATL ACAD SCI USA, V103, P9554, DOI 10.1073/pnas.0600104103	15	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6318	10.1371/journal.pone.0006318	http://dx.doi.org/10.1371/journal.pone.0006318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621077	Green Published, gold, Green Submitted			2022-12-27	WOS:000268147200012
J	Singh, S; Taneja, B; Salvi, SS; Agrawal, A				Singh, Suchita; Taneja, Bhupesh; Salvi, Sundeep Santosh; Agrawal, Anurag			Physical Properties of Intact Proteins May Predict Allergenicity or Lack Thereof	PLOS ONE			English	Article								Background: Predicting the allergenicity of proteins is challenging. We considered the possibility that the properties of the intact protein that may alter the likelihood of being taken up by antigen presenting cells, may be useful adjuncts in predicting allergens and non-allergens in silico. It has been shown that negatively charged acidic proteins are preferentially processed by dendritic cells. Methodology: Datasets (aeroallergen, food-allergen and non-allergen) for in-silico study were obtained from public databases. Isoelectric point (pI), net charge, and electrostatic potential (EP) were calculated from the protein sequence ( for pI and net charge) or predicted structure (for EP). Result: Allergens and non allergens differed significantly in pI, net charge, and EP (p < 0.0001). Cluster analysis based on these parameters resulted in well defined clusters. Non-allergens were characterized by neutral to basic pI (mean +/- SE, 7.6 +/- 0.16) and positive charge. In contrast allergens were acidic (5.7 +/- 0.15) and negatively charged. Surface electrostatic potentials calculated from predicted structures were mostly negative for allergens and mostly positive for non-allergens. The classification accuracy for non-allergens was superior to that for allergens. Thus neutral to basic pI, positive charge, and positive electrostatic potentials characterize non-allergens, and seem rare in allergens (p<0.0001). It may be possible to predict reduced likelihood of allergenicity in such proteins, but this needs to be prospectively validated.			Singh, S (corresponding author), Inst Genom & Integrat Biol, Delhi, India.	a.agrawal@igib.res.in	Eckhardt, Erik/G-1567-2010; Agrawal, Anurag/GZL-5821-2022	Agrawal, Anurag/0000-0002-0340-5252				Agresti A., 1996, INTRO CATEGORICAL DA; Bailey AG, 1997, J ELECTROSTAT, V42, P25, DOI 10.1016/S0304-3886(97)00134-4; Balachandran W, 1997, J ELECTROSTAT, V40-1, P579, DOI 10.1016/S0304-3886(97)00106-X; Brusic V, 2003, TRENDS IMMUNOL, V24, P225, DOI 10.1016/S1471-4906(03)00075-9; Furmonaviciene R, 2005, BIOINFORMATICS, V21, P4201, DOI 10.1093/bioinformatics/bti700; Harshyne LA, 2003, J IMMUNOL, V170, P2302, DOI 10.4049/jimmunol.170.5.2302; Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I; JANSEN JJN, 1994, J ALLERGY CLIN IMMUN, V93, P446; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kanny G, 2001, J ALLERGY CLIN IMMUN, V108, P133, DOI 10.1067/mai.2001.116427; LEARY M, 2005, IND APPL C 2005 40 I, V2, P778; Lin HH, 2006, J LIPID RES, V47, P824, DOI 10.1194/jlr.M500530-JLR200; Malandain H, 2004, ALLERGY, V59, P1011, DOI 10.1111/j.1398-9995.2004.00462.x; Miteva MA, 2005, NUCLEIC ACIDS RES, V33, pW372, DOI 10.1093/nar/gki365; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343; Shakushiro K, 2004, IMMUNOLOGY, V112, P211, DOI 10.1111/j.1365-2567.2004.01871.x; TEITELBAUM D, 1975, J EXP MED, V42, P701; Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Veronesi B, 2003, NEUROTOXICOLOGY, V24, P463, DOI 10.1016/S0161-813X(03)00022-6; WILLOUGHBY DA, 1994, LANCET, V344, P413, DOI 10.1016/S0140-6736(94)91442-7	22	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6273	10.1371/journal.pone.0006273	http://dx.doi.org/10.1371/journal.pone.0006273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609445	Green Published, gold, Green Submitted			2022-12-27	WOS:000268119500008
J	Zhou, HB; Yu, ZJ; Hu, Y; Tu, JG; Zou, W; Peng, YP; Zhu, JP; Li, YT; Zhang, AD; Yu, ZN; Ye, ZP; Chen, HC; Jin, ML				Zhou, Hongbo; Yu, Zhengjun; Hu, Yong; Tu, Jiagang; Zou, Wei; Peng, Yaping; Zhu, Jiping; Li, Yongtao; Zhang, Anding; Yu, Ziniu; Ye, Zhiping; Chen, Huanchun; Jin, Meilin			The Special Neuraminidase Stalk-Motif Responsible for Increased Virulence and Pathogenesis of H5N1 Influenza A Virus	PLOS ONE			English	Article								The variation of highly pathogenic avian influenza H5N1 virus results in gradually increased virulence in poultry, and human cases continue to accumulate. The neuraminidase (NA) stalk region of influenza virus varies considerably and may associate with its virulence. The NA stalk region of all N1 subtype influenza A viruses can be divided into six different stalk-motifs, H5N1/2004-like (NA-wt), WSN-like, H5N1/97-like, PR/8-like, H7N1/99-like and H5N1/96-like. The NA-wt is a special NA stalk-motif which was first observed in H5N1 influenza virus in 2000, with a 20-amino acid deletion in the 49(th) to 68(th) positions of the stalk region. Here we show that there is a gradual increase of the special NA stalk-motif in H5N1 isolates from 2000 to 2007, and notably, the special stalk-motif is observed in all 173 H5N1 human isolates from 2004 to 2007. The recombinant H5N1 virus with the special stalk-motif possesses the highest virulence and pathogenicity in chicken and mice, while the recombinant viruses with the other stalk-motifs display attenuated phenotype. This indicates that the special stalk-motif has contributed to the high virulence and pathogenicity of H5N1 isolates since 2000. The gradually increasing emergence of the special NA stalk-motif in H5N1 isolates, especially in human isolates, deserves attention by all.			Zhou, HB (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Vet Med, Wuhan, Peoples R China.	chenhch@mail.hzau.edu.cn; jinmeilin@mail.hzau.edu.cn	Zou, Wei/L-9082-2019; zhu, ji/HDM-1538-2022	Zou, Wei/0000-0001-8292-5127; 				Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Bin L, 2005, J VIROL, V79, P6763, DOI 10.1128/JVI.79.11.6763-6771.2005; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Chen H, 2007, VIRUS RES, V128, P159, DOI 10.1016/j.virusres.2007.04.017; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; ELS MC, 1985, VIROLOGY, V142, P241, DOI 10.1016/0042-6822(85)90332-0; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; GRIFFIN JA, 1983, VIROLOGY, V125, P324, DOI 10.1016/0042-6822(83)90205-2; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Guan Y, 2002, VIROLOGY, V292, P16, DOI 10.1006/viro.2001.1207; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Lee CW, 2004, AVIAN PATHOL, V33, P288, DOI 10.1080/0307945042000203407; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li Y, 2006, ARCH VIROL, V151, P1615, DOI 10.1007/s00705-006-0738-7; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; LUO GX, 1993, VIRUS RES, V29, P141; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Ohuchi M, 1997, J VIROL, V71, P8377, DOI 10.1128/JVI.71.11.8377-8384.1997; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Wagner R, 2000, J VIROL, V74, P6316, DOI 10.1128/JVI.74.14.6316-6323.2000; Yu ZJ, 2007, EMERG INFECT DIS, V13, P772, DOI 10.3201/eid1305.061209; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zhou HB, 2006, VIRUS GENES, V32, P85, DOI 10.1007/s11262-005-5849-9	32	102	107	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6277	10.1371/journal.pone.0006277	http://dx.doi.org/10.1371/journal.pone.0006277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609439	Green Submitted, Green Published, gold			2022-12-27	WOS:000268119500012
J	Low, DHP; Ang, ZW; Yuan, Q; Frecer, V; Ho, B; Chen, JZ; Ding, JL				Low, Diana Hooi Ping; Ang, Zhiwei; Yuan, Quan; Frecer, Vladimir; Ho, Bow; Chen, Jianzhu; Ding, Jeak Ling			A Novel Human Tectonin Protein with Multivalent beta-Propeller Folds Interacts with Ficolin and Binds Bacterial LPS	PLOS ONE			English	Article							IMMUNE MOLECULE; INNATE IMMUNITY; PLASMA LECTINS; CONSERVATION; RECOGNITION; SEQUENCE; DOMAINS; CLONING	Background: Although the human genome database has been completed a decade ago, similar to 50% of the proteome remains hypothetical as their functions are unknown. The elucidation of the functions of these hypothetical proteins can lead to additional protein pathways and revelation of new cascades. However, many of these inferences are limited to proteins with substantial sequence similarity. Of particular interest here is the Tectonin domain-containing family of proteins. Methodology/Principal Findings: We have identified hTectonin, a hypothetical protein in the human genome database, as a distant ortholog of the limulus galactose binding protein (GBP). Phylogenetic analysis revealed strong evolutionary conservation of hTectonin homologues from parasite to human. By computational analysis, we showed that both the hTectonin and GBP form beta-propeller structures with multiple Tectonin domains, each containing beta-sheets of 4 strands per beta-sheet. hTectonin is present in the human leukocyte cDNA library and immune-related cell lines. It interacts with M-ficolin, a known human complement protein whose ancient homolog, carcinolectin (CL5), is the functional protein partner of GBP during infection. Yeast 2-hybrid assay showed that only the Tectonin domains of hTectonin recognize the fibrinogen-like domain of the M-ficolin. Surface plasmon resonance analysis showed real-time interaction between the Tectonin domains 6 & 11 and bacterial LPS, indicating that despite forming 2 beta-propellers with its different Tectonin domains, the hTectonin molecule could precisely employ domains 6 & 11 to recognise bacteria. Conclusions/Significance: By virtue of a recent finding of another Tectonin protein, leukolectin, in the human leukocyte, and our structure-function analysis of the hypothetical hTectonin, we propose that Tectonin domains of proteins could play a vital role in innate immune defense, and that this function has been conserved over several hundred million years, from invertebrates to vertebrates. Furthermore, the approach we have used could be employed in unraveling the characteristics and functions of other hypothetical proteins in the human proteome.			Low, DHP (corresponding author), Singapore MIT Alliance, Singapore, Singapore.	dbsdjl@nus.edu.sg	Frecer, Vladimir/AAY-3030-2021; Ding, Jeak/H-8057-2012; yuan, quan/GZM-5597-2022	Low, Diana/0000-0002-6054-8524; Ang, Zhiwei/0000-0001-6583-4733				Basak S, 2009, BIOCHEM BIOPH RES CO, V379, P803, DOI 10.1016/j.bbrc.2009.01.025; Bogdanov YF, 2007, INT REV CYTOL, V257, P83, DOI 10.1016/S0074-7696(07)57003-8; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chen SC, 2001, J BIOL CHEM, V276, P9631, DOI 10.1074/jbc.M008414200; Chiou ST, 2000, J BIOL CHEM, V275, P1630, DOI 10.1074/jbc.275.3.1630; Frecer V, 2004, ANTIMICROB AGENTS CH, V48, P3349, DOI 10.1128/AAC.48.9.3349-3357.2004; Frecer V, 2000, EUR J BIOCHEM, V267, P837, DOI 10.1046/j.1432-1327.2000.01069.x; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Galliano M, 2003, BIOCHEM J, V376, P433, DOI 10.1042/BJ20030413; Huh CG, 1998, J BIOL CHEM, V273, P6565, DOI 10.1074/jbc.273.11.6565; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Iwanaga S, 2002, CURR OPIN IMMUNOL, V14, P87, DOI 10.1016/S0952-7915(01)00302-8; Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kawabata S, 2002, BBA-GEN SUBJECTS, V1572, P414, DOI 10.1016/S0304-4165(02)00322-7; Kawai F, 1999, J IND MICROBIOL BIOT, V23, P400, DOI 10.1038/sj.jim.2900730; Kuo TH, 2006, BIOCHEM J, V393, P757, DOI 10.1042/BJ20051108; Le Saux A, 2008, J MOL BIOL, V377, P902, DOI 10.1016/j.jmb.2008.01.045; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Mali B, 2006, DEV COMP IMMUNOL, V30, P275, DOI 10.1016/j.dci.2005.04.004; MIFTARI MH, 2009, MOL CLONING CHARACTE; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Ponting CP, 2001, GENOME RES, V11, P1996, DOI 10.1101/gr.198701; Retief J D, 2000, Methods Mol Biol, V132, P243; SAITO T, 1995, J BIOL CHEM, V270, P14493, DOI 10.1074/jbc.270.24.14493; Schroder HC, 2003, J BIOL CHEM, V278, P32810, DOI 10.1074/jbc.M304116200; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Thomas O, 1902, P ZOOL SOC LOND, V1902, P2; *US DOE, HUM GEN PROJ INF; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yadid I, 2007, J MOL BIOL, V365, P10, DOI 10.1016/j.jmb.2006.09.055; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	33	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6260	10.1371/journal.pone.0006260	http://dx.doi.org/10.1371/journal.pone.0006260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606221	Green Published, Green Submitted, gold			2022-12-27	WOS:000268036000015
J	Holden, MTG; Hauser, H; Sanders, M; Thi, HN; Cherevach, I; Cronin, A; Goodhead, I; Mungall, K; Quail, MA; Price, C; Rabbinowitsch, E; Sharp, S; Croucher, NJ; Tran, BC; Nguyen, THM; To, SD; Nguyen, TC; Kehoe, M; Leigh, JA; Ward, PN; Dowson, CG; Whatmore, AM; Chanter, N; Iversen, P; Gottschalk, M; Slater, JD; Smith, HE; Spratt, BG; Xu, JG; Ye, CY; Bentley, S; Barrell, BG; Schultsz, C; Maskell, DJ; Parkhill, J				Holden, Matthew T. G.; Hauser, Heidi; Sanders, Mandy; Thi Hoa Ngo; Cherevach, Inna; Cronin, Ann; Goodhead, Ian; Mungall, Karen; Quail, Michael A.; Price, Claire; Rabbinowitsch, Ester; Sharp, Sarah; Croucher, Nicholas J.; Tran Bich Chieu; Nguyen Thi Hoang Mai; To Song Diep; Nguyen Tran Chinh; Kehoe, Michael; Leigh, James A.; Ward, Philip N.; Dowson, Christopher G.; Whatmore, Adrian M.; Chanter, Neil; Iversen, Pernille; Gottschalk, Marcelo; Slater, Josh D.; Smith, Hilde E.; Spratt, Brian G.; Xu, Jianguo; Ye, Changyun; Bentley, Stephen; Barrell, Barclay G.; Schultsz, Constance; Maskell, Duncan J.; Parkhill, Julian			Rapid Evolution of Virulence and Drug Resistance in the Emerging Zoonotic Pathogen Streptococcus suis	PLOS ONE			English	Article								Background: Streptococcus suis is a zoonotic pathogen that infects pigs and can occasionally cause serious infections in humans. S. suis infections occur sporadically in human Europe and North America, but a recent major outbreak has been described in China with high levels of mortality. The mechanisms of S. suis pathogenesis in humans and pigs are poorly understood. Methodology/Principal Findings: The sequencing of whole genomes of S. suis isolates provides opportunities to investigate the genetic basis of infection. Here we describe whole genome sequences of three S. suis strains from the same lineage: one from European pigs, and two from human cases from China and Vietnam. Comparative genomic analysis was used to investigate the variability of these strains. S. suis is phylogenetically distinct from other Streptococcus species for which genome sequences are currently available. Accordingly, similar to 40% of the similar to 2 Mb genome is unique in comparison to other Streptococcus species. Finer genomic comparisons within the species showed a high level of sequence conservation; virtually all of the genome is common to the S. suis strains. The only exceptions are three similar to 90 kb regions, present in the two isolates from humans, composed of integrative conjugative elements and transposons. Carried in these regions are coding sequences associated with drug resistance. In addition, small-scale sequence variation has generated pseudogenes in putative virulence and colonization factors. Conclusions/Significance: The genomic inventories of genetically related S. suis strains, isolated from distinct hosts and diseases, exhibit high levels of conservation. However, the genomes provide evidence that horizontal gene transfer has contributed to the evolution of drug resistance.			Holden, MTG (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	mh3@sanger.ac.uk	Gottschalk, Marcelo/I-8116-2012; Parkhill, Julian/G-4703-2011; Whatmore, Adrian M/C-7744-2011; Dowson, Chris/N-6195-2014; Holden, Matthew TG/K-6449-2014; Leigh, James/G-9282-2011; Dowson, Christopher/ABG-5083-2021; Quail, michael/ABE-6131-2020; Goodhead, Ian/ABC-9200-2020	Parkhill, Julian/0000-0002-7069-5958; Whatmore, Adrian M/0000-0003-4218-156X; Dowson, Chris/0000-0002-8294-8836; Holden, Matthew TG/0000-0002-4958-2166; Leigh, James/0000-0002-0307-2814; Dowson, Christopher/0000-0002-8294-8836; Croucher, Nicholas/0000-0001-6303-8768; Goodhead, Ian/0000-0002-3110-9442; Ward, Philip/0000-0003-2546-3426	BBSRC [BB/G019274/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G019274/1] Funding Source: Medline; Wellcome Trust [089472] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Agniswamy J, 2004, J BIOL CHEM, V279, P52789, DOI 10.1074/jbc.M410698200; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Allen AG, 2001, INFECT IMMUN, V69, P2732, DOI 10.1128/IAI.69.4.2732-2735.2001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Baker C., 1995, INFECT DIS FETUS NEW, V4th ed., P980; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Baums CG, 2006, INFECT IMMUN, V74, P6154, DOI 10.1128/IAI.00359-06; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Billington SJ, 2000, FEMS MICROBIOL LETT, V182, P197, DOI 10.1016/S0378-1097(99)00536-4; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Broadbent JR, 2003, J DAIRY SCI, V86, P407, DOI 10.3168/jds.S0022-0302(03)73619-4; Burrus V, 2002, PLASMID, V48, P77, DOI 10.1016/S0147-619X(02)00102-6; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Clifton-Hadley FA, 1981, STUDIES STREPTOCOCCU; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Dear S, 1998, GENOME RES, V8, P260, DOI 10.1101/gr.8.3.260; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; ELLIOTT SD, 1978, J EXP MED, V148, P1699, DOI 10.1084/jem.148.6.1699; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Fittipaldi N, 2007, APPL ENVIRON MICROB, V73, P4359, DOI 10.1128/AEM.00258-07; Frishman D, 1998, NUCLEIC ACIDS RES, V26, P2941, DOI 10.1093/nar/26.12.2941; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gottschalk M, 1998, CAN J VET RES, V62, P75; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; GUENZI E, 1994, MOL MICROBIOL, V12, P505, DOI 10.1111/j.1365-2958.1994.tb01038.x; Higgins R, 2001, CAN VET J, V42, P223; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Holden MTG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000346; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; Jacobs AAC, 1996, VET REC, V139, P225, DOI 10.1136/vr.139.10.225; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Jobin MC, 2006, MICROB PATHOGENESIS, V40, P29, DOI 10.1016/j.micpath.2005.10.003; King SJ, 2004, J BACTERIOL, V186, P4740, DOI 10.1128/JB.186.14.4740-4747.2004; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; King SJ, 2001, INFECT IMMUN, V69, P7572, DOI 10.1128/IAI.69.12.7572-7582.2001; KOEDEL U, 1995, ANN NEUROL, V37, P313, DOI 10.1002/ana.410370307; Kornelisse RF, 1996, J INFECT DIS, V174, P120, DOI 10.1093/infdis/174.1.120; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lannergard J, 2006, FEMS MICROBIOL LETT, V262, P230, DOI 10.1111/j.1574-6968.2006.00404.x; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Lei BF, 2001, NAT MED, V7, P1298, DOI 10.1038/nm1201-1298; Lei BF, 2002, INFECT IMMUN, V70, P6880, DOI 10.1128/IAI.70.12.6880-6890.2002; Leppert D, 2000, CLIN INFECT DIS, V31, P80, DOI 10.1086/313922; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martin V, 1997, INFECT IMMUN, V65, P2074, DOI 10.1128/IAI.65.6.2074-2079.1997; Nghia HDT, 2008, EMERG INFECT DIS, V14, P155, DOI 10.3201/eid1401.070534; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Novak R, 2000, MOL MICROBIOL, V36, P366, DOI 10.1046/j.1365-2958.2000.01854.x; Oggioni MR, 2003, MOL MICROBIOL, V49, P795, DOI 10.1046/j.1365-2958.2003.03596.x; Osaki M, 2002, J BACTERIOL, V184, P971, DOI 10.1128/jb.184.4.971-982.2002; Ozaki K, 2002, FEBS LETT, V532, P159, DOI 10.1016/S0014-5793(02)03661-X; Paul R, 1998, ANN NEUROL, V44, P592, DOI 10.1002/ana.410440404; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERCH B, 1968, ACTA PATHOL MIC SC, V74, P69; Phelps HA, 2007, INFECT IMMUN, V75, P4541, DOI 10.1128/IAI.00518-07; Planet PJ, 2001, P NATL ACAD SCI USA, V98, P2503, DOI 10.1073/pnas.051436598; Poulsen K, 1996, INFECT IMMUN, V64, P3957, DOI 10.1128/IAI.64.10.3957-3966.1996; Rocha EPC, 1999, MOL MICROBIOL, V32, P11, DOI 10.1046/j.1365-2958.1999.01334.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shibata Y, 2002, INFECT IMMUN, V70, P2891, DOI 10.1128/IAI.70.6.2891-2898.2002; Short, 2000, Curr Infect Dis Rep, V2, P327, DOI 10.1007/s11908-000-0011-2; Sleator RD, 2005, MOL MICROBIOL, V55, P1183, DOI 10.1111/j.1365-2958.2004.04454.x; Smith HE, 2000, MICROB PATHOGENESIS, V29, P127, DOI 10.1006/mpat.2000.0372; Smith HE, 1996, INFECT IMMUN, V64, P4409, DOI 10.1128/IAI.64.10.4409-4412.1996; SMITH HE, 1993, INFECT IMMUN, V61, P3318, DOI 10.1128/IAI.61.8.3318-3326.1993; Smith HE, 1999, INFECT IMMUN, V67, P1750; SMITH HE, 1992, INFECT IMMUN, V60, P2361, DOI 10.1128/IAI.60.6.2361-2367.1992; SOELL M, 1995, J IMMUNOL, V154, P851; Sriskandan S, 2006, PLOS MED, V3, P595, DOI 10.1371/journal.pmed.0030187; TAKAMATSU D, 2009, VET MICROBI IN PRESS; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; TIMONEY JF, 2007, VET IMMUNOL IMMUNOPA; Tsuda H, 2000, INFECT IMMUN, V68, P644, DOI 10.1128/IAI.68.2.644-650.2000; Tsukioka Y, 1997, J BACTERIOL, V179, P1126, DOI 10.1128/jb.179.4.1126-1134.1997; Tsukioka Y, 1997, J BACTERIOL, V179, P4411, DOI 10.1128/jb.179.13.4411-4414.1997; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; Vincents B, 2004, BIOCHEMISTRY-US, V43, P15540, DOI 10.1021/bi048284d; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Ward PN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-54; Weiser JN, 2003, P NATL ACAD SCI USA, V100, P4215, DOI 10.1073/pnas.0637469100; Wellmer A, 2002, INFECT IMMUN, V70, P6504, DOI 10.1128/IAI.70.11.6504-6508.2002; Wilm A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn174; Wisselink HJ, 2000, VET MICROBIOL, V74, P237, DOI 10.1016/S0378-1135(00)00188-7; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Yamashita Y, 1999, J BACTERIOL, V181, P6556, DOI 10.1128/JB.181.20.6556-6559.1999; Yamashita Y, 1998, MICROBIOL-SGM, V144, P1235, DOI 10.1099/00221287-144-5-1235; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Ye CY, 2006, EMERG INFECT DIS, V12, P1203, DOI 10.3201/eid1708.060232; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zwijnenburg RJG, 2001, J INFECT DIS, V183, P1143, DOI 10.1086/319271	111	184	199	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6072	10.1371/journal.pone.0006072	http://dx.doi.org/10.1371/journal.pone.0006072			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603075	Green Published, gold			2022-12-27	WOS:000268035700001
J	Hocknull, SA; White, MA; Tischler, TR; Cook, AG; Calleja, ND; Sloan, T; Elliott, DA				Hocknull, Scott A.; White, Matt A.; Tischler, Travis R.; Cook, Alex G.; Calleja, Naomi D.; Sloan, Trish; Elliott, David A.			New Mid-Cretaceous (Latest Albian) Dinosaurs from Winton, Queensland, Australia	PLOS ONE			English	Article							CARNOSAUR DINOSAURIA; SP NOV.; THEROPODA; SAUROPOD; GEN.; PHYLOGENY	Background: Australia's dinosaurian fossil record is exceptionally poor compared to that of other similar-sized continents. Most taxa are known from fragmentary isolated remains with uncertain taxonomic and phylogenetic placement. A better understanding of the Australian dinosaurian record is crucial to understanding the global palaeobiogeography of dinosaurian groups, including groups previously considered to have had Gondwanan origins, such as the titanosaurs and carcharodontosaurids. Methodology/Principal Findings: We describe three new dinosaurs from the late Early Cretaceous (latest Albian) Winton Formation of eastern Australia, including; Wintonotitan wattsi gen. et sp. nov., a basal titanosauriform; Diamantinasaurus matildae gen. et sp. nov., a derived lithostrotian titanosaur; and Australovenator wintonensis gen. et sp. nov., an allosauroid. We compare an isolated astragalus from the Early Cretaceous of southern Australia; formerly identified as Allosaurus sp., and conclude that it most-likely represents Australovenator sp. Conclusion/Significance: The occurrence of Australovenator from the Aptian to latest Albian confirms the presence in Australia of allosauroids basal to the Carcharodontosauridae. These new taxa, along with the fragmentary remains of other taxa, indicate a diverse Early Cretaceous sauropod and theropod fauna in Australia, including plesiomorphic forms (e. g. Wintonotitan and Australovenator) and more derived forms (e. g. Diamantinasaurus).			Hocknull, SA (corresponding author), Queensland Museum, Hendra, Qld, Australia.	scott.hocknull@qm.qld.gov.au	Calleja, Neville/E-3895-2019	Calleja, Neville/0000-0003-1800-2103; Hocknull, Scott/0000-0003-4157-8434; White, Matt/0000-0002-4765-0356				AGNOLIN FL, 2005, AMEGHINIANA S4, V42, pR13; Apesteguia S, 2005, LIFE O PAST, P321; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; BLAKEY R, 2009, MOLLEWIDE PLATE TECT; Brusatte SL, 2008, J SYST PALAEONTOL, V6, P155, DOI 10.1017/S1477201907002404; BURGER D, 1986, GEOL SOC AUST SPEC P, V12, P53; Canudo JI, 2008, J VERTEBR PALEONTOL, V28, P712, DOI 10.1671/0272-4634(2008)28[712:ANSTSG]2.0.CO;2; Clifford HT, 2005, REV PALAEOBOT PALYNO, V134, P71, DOI 10.1016/j.revpalbo.2004.12.001; Cook Alex G., 2005, Memoirs of the Queensland Museum, V51, P406; COOMBS W P JR, 1981, Memoirs of the Queensland Museum, V20, P351; Currie Philip J., 2006, Journal of the Paleontological Society of Korea, V22, P173; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Dettmann ME, 2009, CRETACEOUS RES, V30, P339, DOI 10.1016/j.cretres.2008.07.015; Dettmann Mary E., 2000, Memoirs of the Queensland Museum, V45, P285; Riga BJG, 2009, CRETACEOUS RES, V30, P135, DOI 10.1016/j.cretres.2008.06.006; Harris JD, 1998, NEW MEXICO MUSEUM NA, V13, P1, DOI DOI 10.1080/0022293460865417; HOCKNULL S, 2006, AUSTR AGE DINOSAURS, V4, P67; HOCKNULL S, 2005, AUSTR AGE DINOSAURS, V3, P27; Hocknull S. A., 2008, Memoirs of the Queensland Museum, V52, P212; Hocknull Scott A., 1997, Memoirs of the Queensland Museum, V42, P223; Hocknull Scott A., 2000, Memoirs of the Queensland Museum, V45, P405; Jell P. A., 2004, Memoirs of the Queensland Museum, V50, P1; Kemp A, 1997, J VERTEBR PALEONTOL, V17, P26, DOI 10.1080/02724634.1997.10010949; LONG J.A., 1998, DINOSAURS AUSTR NZ O; Longman H. A., 1933, Memoirs of the Queensland Museum, V10, P131; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P137; McLoughlin Stephen, 1995, Memoirs of the Queensland Museum, V38, P273; MOLNAR RE, 1981, ALCHERINGA, V5, P141, DOI 10.1080/03115518108565427; MOLNAR RE, 1985, J PALEONTOL, V59, P1511; MOLNAR RE, 2000, ASOCIACION PALEONTOL, V7, P139; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Salisbury S, 2007, J VERTEBR PALEONTOL, V27, p138A; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; SCANLON J, 2006, EVOLUTION BIOGEOGRAP, pCH15; Scanlon J.D., 2008, T KANSAS ACAD SCI, P131; SENIOR BR, 1978, GEOLOGY GEOPHYS B, V167, P1; Smith JB, 2005, ANAT REC PART A, V285A, P699, DOI 10.1002/ar.a.20206; Smith ND, 2008, P ROYAL SOC B, V275, P1647; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; THULBORN R A, 1984, Memoirs of the Queensland Museum, V21, P413; Vickers-Rich P., 1993, WILDLIFE GONDWANA; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P1; WELLES SP, 1983, J PALEONTOL, V57, P196; Wilson J.H., 2009, THE J, V1, P1; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2003, J SYST PALAEONTOL, V1, P125, DOI 10.1017/S1477201903001044; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; WILSON JA, 1998, SOC VERTEBRATE PALEO, V5, P1, DOI DOI 10.2307/3889325	51	166	171	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6190	10.1371/journal.pone.0006190	http://dx.doi.org/10.1371/journal.pone.0006190			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19584929	Green Published, Green Submitted, gold			2022-12-27	WOS:000267806300016
J	Abbas, AR; Wolslegel, K; Seshasayee, D; Modrusan, Z; Clark, HF				Abbas, Alexander R.; Wolslegel, Kristen; Seshasayee, Dhaya; Modrusan, Zora; Clark, Hilary F.			Deconvolution of Blood Microarray Data Identifies Cellular Activation Patterns in Systemic Lupus Erythematosus	PLOS ONE			English	Article								Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease with a complex spectrum of cellular and molecular characteristics including several dramatic changes in the populations of peripheral leukocytes. These changes include general leukopenia, activation of B and T cells, and maturation of granulocytes. The manifestation of SLE in peripheral blood is central to the disease but is incompletely understood. A technique for rigorously characterizing changes in mixed populations of cells, microarray expression deconvolution, has been applied to several areas of biology but not to SLE or to blood. Here we demonstrate that microarray expression deconvolution accurately quantifies the constituents of real blood samples and mixtures of immune-derived cell lines. We characterize a broad spectrum of peripheral leukocyte cell types and states in SLE to uncover novel patterns including: specific activation of NK and T helper lymphocytes, relationships of these patterns to each other, and correlations to clinical variables and measures. The expansion and activation of monocytes, NK cells, and T helper cells in SLE at least partly underlie this disease's prominent interferon signature. These and other patterns of leukocyte dynamics uncovered here correlate with disease severity and treatment, suggest potential new treatments, and extend our understanding of lupus pathology as a complex autoimmune disease involving many arms of the immune system.			Abbas, AR (corresponding author), Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA.	abbas@gene.com						Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P23, DOI 10.1093/bioinformatics/bth915; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bonelli M, 2009, J IMMUNOL, V182, P1689, DOI 10.4049/jimmunol.182.3.1689; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Chan RWY, 2006, RHEUMATOLOGY, V45, P951, DOI 10.1093/rheumatology/kel029; Crow MK, 2007, CURR TOP MICROBIOL, V316, P359; DAVIS P, 1977, ANN RHEUM DIS, V36, P157, DOI 10.1136/ard.36.2.157; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Green MRJ, 2007, ARTHRITIS RHEUM-US, V56, P303, DOI 10.1002/art.22326; Green MRJ, 2005, CLIN EXP IMMUNOL, V141, P165, DOI 10.1111/j.1365-2249.2005.02822.x; Hahn BH, 2005, ANN NY ACAD SCI, V1051, P433, DOI 10.1196/annals.1361.085; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Lahdesmaki H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-54; Lit LCW, 2007, J RHEUMATOL, V34, P89; Lu P, 2003, P NATL ACAD SCI USA, V100, P10370, DOI 10.1073/pnas.1832361100; Lub-de Hooge MN, 2005, ANN RHEUM DIS, V64, P854, DOI 10.1136/ard.2004.029058; Maas K, 2002, J IMMUNOL, V169, P5, DOI 10.4049/jimmunol.169.1.5; Papadimitraki ED, 2006, ARTHRITIS RHEUM-US, V54, P3601, DOI 10.1002/art.22197; Pisetsky DS, 2008, AUTOIMMUN REV, V8, P69, DOI 10.1016/j.autrev.2008.07.028; Rastin Maryam, 2007, Iran J Immunol, V4, P110; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Richez C, 2009, J IMMUNOL, V182, P820, DOI 10.4049/jimmunol.182.2.820; RIVERO SJ, 1978, ARTHRITIS RHEUM, V21, P295, DOI 10.1002/art.1780210302; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Speed T., 2003, STAT ANAL GENE EXPRE; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Team RDC, 2019, R LANG ENV STAT COMP; Wang M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-328; Xu LT, 2004, NAT MED, V10, P411, DOI 10.1038/nm1005; Zimmer J, 2008, EUR J IMMUNOL, V38, P2942, DOI 10.1002/eji.200838813	35	271	277	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6098	10.1371/journal.pone.0006098	http://dx.doi.org/10.1371/journal.pone.0006098			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568420	Green Published, Green Submitted, gold			2022-12-27	WOS:000267572200004
J	Liu, DH; Shen, XD; Zhai, Y; Lam, WS; Liao, JY; Busuttil, RW; Ghobrial, RM				Liu, Dahai; Shen, Xiu-Da; Zhai, Yuan; Lam, Wengsi; Liao, Jingying; Busuttil, Ronald W.; Ghobrial, Rafik M.			Intragraft Selection of the T Cell Receptor Repertoire by Class I MHC Sequences in Tolerant Recipients	PLOS ONE			English	Article							EXTRACTED HISTOCOMPATIBILITY ANTIGEN; INFECTIOUS TOLERANCE; ALLOGRAFT-REJECTION; IMMUNE-RESPONSE; PEPTIDES; TRANSPLANTATION; DETERMINANT; CYCLOSPORINE; RECOGNITION; MULTIPLE	Background: Allograft tolerance of ACI (RT1(a)) recipients to WF (RT1(u)) hearts can be induced by allochimeric class I MHC molecules containing donor-type (RT1A(u)) immunogenic epitopes displayed on recipient-type (RT1A(a)) sequences. Here, we sought the mechanisms by which allochimeric sequences may affect responding T cells through T cell receptor (TCA) repertoire restriction. Methodology/Principal Findings: The soluble [alpha(u)(1h)]-RT1.A(a) allochimeric molecule was delivered into ACI recipients of WF hearts in the presence of sub-therapeutic dose of cyclosporine (CsA). The TCR V beta spectrotyping of the splenocytes and cardiac allografts showed that the V beta gene families were differentially expressed within the TCR repertoire in allochimericor high-dose CsA-treated tolerant recipients at day + 5 and + 7 of post-transplantation. However, at day 30 of post-transplantation the allochimeric molecule-treated rats showed the restriction of TCR repertoire with altered dominant size peaks representing preferential clonal expansion of V beta 7, V beta 11, V beta 13, V beta 14, and V beta 15 genes. Moreover, we found a positive correlation between the alteration of Vb profile, restriction of TCR repertoire, and the establishment of allograft tolerance. Conclusions: Our findings indicate that presentation of allochimeric MHC class I sequences that partially mimic donor and recipient epitopes may induce unique tolerant state by selecting alloresponsive V beta genes.			Liu, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dumont UCLA Transplant Ctr, Div Liver & Pancreas Transplantat,Dept Surg, Los Angeles, CA 90095 USA.	RMGhobrial@tmhs.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042223, R01AI023847, R01AI049945] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI042223, R01 AI049945, R01 AI023847, R01 AI49945, AI42223, R01 AI23847] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENICHOU G, 1994, J IMMUNOL, V153, P938; Binder J, 1996, TRANSPLANTATION, V61, P804, DOI 10.1097/00007890-199603150-00022; Bradley J A, 1996, Int Rev Immunol, V13, P245, DOI 10.3109/08830189609061751; Brouard S, 1999, J IMMUNOL, V162, P3367; CLAYTON JP, 1989, J EXP MED, V169, P1681, DOI 10.1084/jem.169.5.1681; COCHET M, 1992, EUR J IMMUNOL, V22, P2639, DOI 10.1002/eji.1830221025; Colovai A I, 1996, Int Rev Immunol, V13, P161, DOI 10.3109/08830189609061745; DIDLAKE R, 1988, TRANSPLANTATION, V46, P743, DOI 10.1097/00007890-198811000-00022; Frasca L, 2000, TRANSPLANTATION, V70, P631, DOI 10.1097/00007890-200008270-00017; Gagne K, 2000, J IMMUNOL, V164, P1553, DOI 10.4049/jimmunol.164.3.1553; GAMMON G, 1990, J IMMUNOL, V144, P1571; GAMMON G, 1987, IMMUNOL REV, V98, P53; Ghobrial RR, 1996, TRANSPLANTATION, V62, P1002, DOI 10.1097/00007890-199610150-00020; GOTO S, 1992, TRANSPLANTATION, V53, P705; Guillet M, 2002, J IMMUNOL, V168, P5088, DOI 10.4049/jimmunol.168.10.5088; ITO T, 1990, TRANSPLANTATION, V49, P422, DOI 10.1097/00007890-199002000-00038; Kumar V, 1996, J EXP MED, V184, P1609, DOI 10.1084/jem.184.5.1609; Liu ZR, 1996, J CLIN INVEST, V98, P1150, DOI 10.1172/JCI118898; LIU ZR, 1993, J IMMUNOL, V150, P3180; Maini MK, 1999, IMMUNOL TODAY, V20, P262, DOI 10.1016/S0167-5699(99)01472-3; Melchior B, 2005, EXP NEUROL, V192, P373, DOI 10.1016/j.expneurol.2004.11.031; Murphy B, 1999, J AM SOC NEPHROL, V10, P1346; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Onodera K, 1997, J IMMUNOL, V158, P1572; Onodera K, 1997, TRANSPL P, V29, P1290, DOI 10.1016/S0041-1345(96)00522-2; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; REEMTSEN B, 1999, SURG FORUM, V3, P395; Sayegh M H, 1996, Int Rev Immunol, V13, P221, DOI 10.3109/08830189609061749; Schneider SC, 2000, J IMMUNOL, V165, P20, DOI 10.4049/jimmunol.165.1.20; Sebille F, 2001, J IMMUNOL, V167, P3082, DOI 10.4049/jimmunol.167.6.3082; Semiletova NV, 2005, TRANSPLANTATION, V80, P1535, DOI 10.1097/01.tp.0000188952.10692.18; SHIRWAN H, 1995, TRANSPLANTATION, V59, P401, DOI 10.1097/00007890-199502150-00016; SHIRWAN H, 1993, J IMMUNOL, V151, P5228; SHOSKES DA, 1994, IMMUNOL TODAY, V15, P32, DOI 10.1016/0167-5699(94)90023-X; Singer JS, 2001, TRANSPLANTATION, V72, P1408, DOI 10.1097/00007890-200110270-00014; Sitaru AG, 2002, HUM IMMUNOL, V63, P871, DOI 10.1016/S0198-8859(02)00452-4; SOLINGER AM, 1979, J EXP MED, V150, P830, DOI 10.1084/jem.150.4.830; Steinman L, 2001, J CLIN IMMUNOL, V21, P93, DOI 10.1023/A:1011020225433; Vella JP, 1997, TRANSPLANTATION, V64, P795, DOI 10.1097/00007890-199709270-00001; Vignes C, 2000, J IMMUNOL, V165, P96, DOI 10.4049/jimmunol.165.1.96; von Boehmer H, 2006, J IMMUNOL, V176, P3, DOI 10.4049/jimmunol.176.1.3; Waldmann H, 2001, IMMUNITY, V14, P399, DOI 10.1016/S1074-7613(01)00120-0; Zhai Y, 1999, CURR OPIN IMMUNOL, V11, P497, DOI 10.1016/S0952-7915(99)00007-2; Zhai Y, 2001, TRANSPLANTATION, V71, P1701, DOI 10.1097/00007890-200106270-00001	44	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6076	10.1371/journal.pone.0006076	http://dx.doi.org/10.1371/journal.pone.0006076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562081	gold, Green Submitted, Green Published			2022-12-27	WOS:000267465900011
J	Trudel, S; Kelly, M; Fritsch, J; Nguyen-Khoa, T; Therond, P; Couturier, M; Dadlez, M; Debski, J; Touqui, L; Vallee, B; Ollero, M; Edelman, A; Brouillard, F				Trudel, Stephanie; Kelly, Mairead; Fritsch, Janine; Nguyen-Khoa, Thao; Therond, Patrice; Couturier, Martine; Dadlez, Michal; Debski, Janusz; Touqui, Lhousseine; Vallee, Benoit; Ollero, Mario; Edelman, Aleksander; Brouillard, Franck			Peroxiredoxin 6 Fails to Limit Phospholipid Peroxidation in Lung from Cftr-Knockout Mice Subjected to Oxidative Challenge	PLOS ONE			English	Article								Oxidative stress plays a prominent role in the pathophysiology of cystic fibrosis (CF). Despite the presence of oxidative stress markers and a decreased antioxidant capacity in CF airway lining fluid, few studies have focused on the oxidant/antioxidant balance in CF cells. The aim of the current study was to investigate the cellular levels of reactive oxygen species (ROS), oxidative damage and enzymatic antioxidant defenses in the lung of Cftr-knockout mice in basal conditions and as a response to oxidative insult. The results show that endogenous ROS and lipid peroxidation levels are higher in Cftr(-/-) lung when compared to wild-type (Cftr(+/+)) in basal conditions, despite a strong enzymatic antioxidant response involving superoxide dismutases, glutathione peroxidases and peroxiredoxin 6 (Prdx6). The latter has the unique capacity to directly reduce membrane phospholipid hydroperoxides (PL-OOH). A dramatic increase in PL-OOH levels in Cftr(-/-) lung consecutive to in vivo oxidative challenge by paraquat (PQ) unmasks a susceptibility to phospholipid peroxidation. PQ strongly decreases Prdx6 expression in Cftr(-/-) mice compared to Cftr(+/+). Similar results were obtained after P. aeruginosa LPS challenge. Two-dimensional gel analysis of Prdx6 revealed one main molecular form in basal conditions and a PQ-induced form only detected in Cftr(+/+) lung. Mass spectrometry experiments suggested that, as opposed to the main basal form, the one induced by PQ is devoid of overoxidized catalytic Cys47 and could correspond to a fully active form that is not induced in Cftr(-/-) lung. These results highlight a constitutive redox imbalance and a vulnerability to oxidative insult in Cftr(-/-) lung and present Prdx6 as a key component in CF antioxidant failure. This impaired PL-OOH detoxification mechanism may enhance oxidative damage and stress-related signaling, contributing to an exaggerated inflammatory response in CF lung.			Trudel, S (corresponding author), Univ Paris 05, Fac Med, INSERM, U845, Paris, France.	aleksander.edelman@inserm.fr	Ollero, Mario/AAJ-3545-2020; Debski, Janusz/I-4721-2015; Debski, Janusz/D-8138-2015; Ollero, Mario/Q-6147-2018	Debski, Janusz/0000-0002-8898-7692; Debski, Janusz/0000-0002-0171-7797; Ollero, Mario/0000-0003-3590-706X; Dadlez, Michal/0000-0001-8811-5176; NGUYEN-KHOA, Thao/0000-0003-3738-7299				Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200; Bensalem N, 2005, MOL CELL PROTEOMICS, V4, P1591, DOI 10.1074/mcp.M500019-MCP200; Brouillard F, 2005, MOL CELL PROTEOMICS, V4, P1762, DOI 10.1074/mcp.M500098-MCP200; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Cantin AM, 2006, AM J PHYSIOL-CELL PH, V290, pC262, DOI 10.1152/ajpcell.00070.2005; Chen JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003367; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; Cottart CH, 2007, PEDIATR RES, V62, P528, DOI 10.1203/PDR.0b013e318155a61d; deHaan JB, 1996, HUM MOL GENET, V5, P283, DOI 10.1093/hmg/5.2.283; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Dinis-Oliveira RJ, 2007, FREE RADICAL BIO MED, V42, P1017, DOI 10.1016/j.freeradbiomed.2006.12.031; Fisher AB, 1999, J BIOL CHEM, V274, P21326, DOI 10.1074/jbc.274.30.21326; Fujii T, 2001, EUR J BIOCHEM, V268, P218, DOI 10.1046/j.1432-1033.2001.01843.x; Fukuhara R, 2005, COMP BIOCHEM PHYS B, V141, P428, DOI 10.1016/j.cbpc.2005.05.002; Gallagher BM, 2007, FREE RADICAL BIO MED, V42, P1270, DOI 10.1016/j.freeradbiomed.2007.01.023; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Halliwell B, 1997, J NEUROCHEM, V69, P1330; JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4; Kettle AJ, 2004, AM J RESP CRIT CARE, V170, P1317, DOI 10.1164/rccm.200311-1516OC; Kim HS, 2003, AM J PHYSIOL-LUNG C, V285, pL363, DOI 10.1152/ajplung.00078.2003; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; Linsdell P, 1998, AM J PHYSIOL-CELL PH, V275, pC323, DOI 10.1152/ajpcell.1998.275.1.C323; Manevich Y, 2002, P NATL ACAD SCI USA, V99, P11599, DOI 10.1073/pnas.182384499; Medjane S, 2005, AM J PHYSIOL-LUNG C, V289, pL816, DOI 10.1152/ajplung.00466.2004; Montuschi P, 2000, THORAX, V55, P205, DOI 10.1136/thorax.55.3.205; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ollero M, 2006, PROTEOMICS, V6, P4084, DOI 10.1002/pmic.200600028; Pak JH, 2006, EXP EYE RES, V82, P899, DOI 10.1016/j.exer.2005.10.017; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; QU F, 2008, CHEM BIOL INTERACT; Roede JR, 2008, FREE RADICAL BIO MED, V45, P1551, DOI 10.1016/j.freeradbiomed.2008.08.032; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; ROVERI A, 1994, METHOD ENZYMOL, V233, P202; Saadane A, 2005, J ALLERGY CLIN IMMUN, V115, P405, DOI 10.1016/j.jaci.2004.10.044; Saadane A, 2006, J ALLERGY CLIN IMMUN, V117, P1163, DOI 10.1016/j.jaci.2006.01.052; Schwarzer C, 2008, FREE RADICAL BIO MED, V45, P1653, DOI 10.1016/j.freeradbiomed.2008.09.011; Simpson D, 2000, MOL VIS, V6, P178; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Starosta V, 2006, CHEST, V129, P431, DOI 10.1378/chest.129.2.431; THEROND P, 1993, LIPIDS, V28, P245, DOI 10.1007/BF02536647; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van der Vliet A, 2000, AM J PHYSIOL-LUNG C, V279, pL537, DOI 10.1152/ajplung.2000.279.3.L537; Velsor LW, 2006, AM J RESP CELL MOL, V35, P579, DOI 10.1165/rcmb.2005-0473OC; Velsor LW, 2001, AM J PHYSIOL-LUNG C, V281, pL31, DOI 10.1152/ajplung.2001.281.1.L31; Wang XS, 2003, J BIOL CHEM, V278, P25179, DOI 10.1074/jbc.M302706200; Wang Y, 2006, AM J RESP CELL MOL, V34, P481, DOI 10.1165/rcmb.2005-0333OC; Wang Y, 2004, FREE RADICAL BIO MED, V37, P1736, DOI 10.1016/j.freeradbiomed.2004.09.006; Wang Y, 2004, AM J PHYSIOL-LUNG C, V286, pL1188, DOI 10.1152/ajplung.00288.2003; WHEELER CR, 1990, ANAL BIOCHEM, V184, P193, DOI 10.1016/0003-2697(90)90668-Y; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	56	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6075	10.1371/journal.pone.0006075	http://dx.doi.org/10.1371/journal.pone.0006075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562038	gold, Green Submitted, Green Published			2022-12-27	WOS:000267465900010
J	Baker, ME; Chang, DJ; Chandsawangbhuwana, C				Baker, Michael E.; Chang, David J.; Chandsawangbhuwana, Charlie			3D Model of Lamprey Estrogen Receptor with Estradiol and 15 alpha-Hydroxy-Estradiol	PLOS ONE			English	Article								Background: Lamprey, basal vertebrate, is an important model system for understanding early events in vertebrate evolution. Lamprey contains orthologs of the estrogen receptor [ER], progesterone receptor and corticoid receptor. A perplexing property of lamprey is that 15 alpha-hydroxy-steroids are active steroids. For example, 15 alpha-hydroxy-estradiol [15 alpha-OH-E2] is the estrogen, instead of estradiol [E2]. To investigate how 15 alpha-OH-E2 binds lamprey ER, we constructed a 3D model of the lamprey ER with E2 and 15 alpha-OH-E2. Methodology: We used the 3D structure of human ER alpha as a template to construct a 3D model of lamprey ER. E2 and 15 alpha-OH-E2 were inserted into the 3D model of lamprey ER and 15 alpha-OH-E2 was inserted into human ERa. Then the each steroid-protein complex was refined using Discover 3 from Insight II software. To determine if lamprey ER had some regions that were unique among vertebrate ERs, we used the ligand-binding domain of lamprey ER as a query for a BLAST search of GenBank. Principal Findings: Our 3D model of lamprey ER with 15 alpha-OH-E2 shows that Sd on Met-409 can form a hydrogen bond with the 15 alpha-hydroxyl on 15 alpha-OH-E2. In human ER alpha, the corresponding residue Ile-424 has a van der Waals contact with 15 alpha-OH-E2. BLAST analysis of GenBank indicates that among vertebrate ERs, only lamprey ER contains a methionine at this position. Thus, the contact between S delta on Met-409 and 15 alpha-OH-E2 is unique. Interestingly, BLAST finds that five New World monkeys and a sturgeon contain a valine instead of isoleucine. Significance: In addition to shedding light on the structure of the ER in a basal vertebrate, our 3D model of lamprey ER should prove useful in virtual screening of chemical libraries to identify compounds for controlling reproduction in sea lamprey, an environmental pest in Lake Michigan.			Baker, ME (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mbaker@ucsd.edu	Baker, Michael/ABB-8508-2020	Baker, Michael/0000-0003-4387-3269				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker ME, 2003, BIOESSAYS, V25, P396, DOI 10.1002/bies.10252; Baker ME, 2001, J MOL ENDOCRINOL, V26, P119, DOI 10.1677/jme.0.0260119; Baker ME, 1997, MOL CELL ENDOCRINOL, V135, P101, DOI 10.1016/S0303-7207(97)00207-4; Baker ME, 2008, BIOCHEM BIOPH RES CO, V371, P724, DOI 10.1016/j.bbrc.2008.04.152; Baker ME, 2007, ENDOCRINOLOGY, V148, P3551, DOI 10.1210/en.2007-0547; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Bridgham JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000191; Bryan MB, 2006, GEN COMP ENDOCR, V146, P149, DOI 10.1016/j.ygcen.2005.11.003; Bryan MB, 2004, STEROIDS, V69, P473, DOI 10.1016/j.steroids.2004.04.004; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Doolittle RF, 2008, J MOL EVOL, V66, P185, DOI 10.1007/s00239-008-9074-8; Escriva H, 1997, P NATL ACAD SCI USA, V94, P6803, DOI 10.1073/pnas.94.13.6803; Escriva H, 2000, BIOESSAYS, V22, P717; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Hsieh RW, 2008, STEROIDS, V73, P59, DOI 10.1016/j.steroids.2007.08.014; Katsu Y, 2008, ENDOCRINOLOGY, V149, P6300, DOI 10.1210/en.2008-0670; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Lowartz S, 2003, COMP BIOCHEM PHYS A, V134, P365, DOI 10.1016/S1095-6433(02)00285-4; Lowartz SM, 2004, COMP BIOCHEM PHYS B, V138, P119, DOI 10.1016/j.cbpc.2004.02.015; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Mizuta T, 2007, ENDOCRINOLOGY, V148, P3554, DOI 10.1210/en.2007-0109; Osorio J, 2008, DEV GENES EVOL, V218, P221, DOI 10.1007/s00427-008-0208-1; Paris M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-219; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauka-Spengler T, 2008, BIOL BULL-US, V214, P303, DOI 10.2307/25470671; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775	31	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6038	10.1371/journal.pone.0006038	http://dx.doi.org/10.1371/journal.pone.0006038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557178	Green Published, gold, Green Submitted			2022-12-27	WOS:000267356900002
J	Teng, NJ; Jin, B; Wang, QL; Hao, HQ; Ceulemans, R; Kuang, TY; Lin, JX				Teng, Nianjun; Jin, Biao; Wang, Qinli; Hao, Huaiqing; Ceulemans, Reinhart; Kuang, Tingyun; Lin, Jinxing			No Detectable Maternal Effects of Elevated CO2 on Arabidopsis thaliana Over 15 Generations	PLOS ONE			English	Article								Maternal environment has been demonstrated to produce considerable impact on offspring growth. However, few studies have been carried out to investigate multi-generational maternal effects of elevated CO2 on plant growth and development. Here we present the first report on the responses of plant reproductive, photosynthetic, and cellular characteristics to elevated CO2 over 15 generations using Arabidopsis thaliana as a model system. We found that within an individual generation, elevated CO2 significantly advanced plant flowering, increased photosynthetic rate, increased the size and number of starch grains per chloroplast, reduced stomatal density, stomatal conductance, and transpiration rate, and resulted in a higher reproductive mass. Elevated CO2 did not significantly influence silique length and number of seeds per silique. Across 15 generations grown at elevated CO2 concentrations, however, there were no significant differences in these traits. In addition, a reciprocal sowing experiment demonstrated that elevated CO2 did not produce detectable maternal effects on the offspring after fifteen generations. Taken together, these results suggested that the maternal effects of elevated CO2 failed to extend to the offspring due to the potential lack of genetic variation for CO2 responsiveness, and future plants may not evolve specific adaptations to elevated CO2 concentrations.	[Teng, Nianjun; Wang, Qinli; Hao, Huaiqing; Kuang, Tingyun; Lin, Jinxing] Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Environm Mol Physiol, Beijing, Peoples R China; [Teng, Nianjun] Nanjing Agr Univ, Coll Horticulture, Nanjing, Peoples R China; [Jin, Biao] Yangzhou Univ, Coll Horticulture & Plant Protect, Yangzhou, Peoples R China; [Ceulemans, Reinhart] Univ Antwerp, Dept Biol, Antwerp, Belgium	Chinese Academy of Sciences; Institute of Botany, CAS; Nanjing Agricultural University; Yangzhou University; University of Antwerp	Teng, NJ (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Environm Mol Physiol, Beijing, Peoples R China.	kuangty@ibcas.ac.cn; linjx@ibcas.ac.cn	Ceulemans, Reinhart J M/F-2109-2016	Ceulemans, Reinhart J M/0000-0003-4773-9358; Lin, Jinxing/0000-0001-9338-1356	National Science Fund of China [30700081, 30730009, 30870436, 90211005, 30225005]; International Foundation for Science [C/4560-1]	National Science Fund of China(National Natural Science Foundation of China (NSFC)); International Foundation for Science(International Foundation for Science)	This work was supported by the National Science Fund of China (30700081, 30730009, 30870436, 90211005), the National Science Fund of China for Distinguished Young Scholars (30225005), and funding from the International Foundation for Science for Dr. Nianjun Teng (Reference No.C/4560-1).	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; [Anonymous], 2001, CLIMATE CHANGE 2001; BAZZAZ FA, 1995, P NATL ACAD SCI USA, V92, P8161, DOI 10.1073/pnas.92.18.8161; Bezemer TM, 1998, GLOB CHANGE BIOL, V4, P687, DOI 10.1046/j.1365-2486.1998.00184.x; Ceulemans R, 2002, GLOBAL CHANGE BIOL, V8, P153, DOI 10.1046/j.1354-1013.2001.00461.x; Cheng SH, 1998, PLANT PHYSIOL, V116, P715, DOI 10.1104/pp.116.2.715; Collins S, 2006, ECOL LETT, V9, P129, DOI 10.1111/j.1461-0248.2005.00854.x; Collins S, 2004, NATURE, V431, P566, DOI 10.1038/nature02945; Donohue K, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P137; Edwards GR, 2001, NEW PHYTOL, V150, P359, DOI 10.1046/j.1469-8137.2001.00100.x; Erhardt A, 2005, OECOLOGIA, V146, P311, DOI 10.1007/s00442-005-0182-5; Ferris R, 2001, PLANT CELL ENVIRON, V24, P305, DOI 10.1046/j.1365-3040.2001.00684.x; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; Gibeaut DM, 2001, J PLANT PHYSIOL, V158, P569, DOI 10.1078/0176-1617-00229; HATTENSCHWILER S, 1997, GLOBAL CHANGE BIOL, V3, P436; He JS, 2003, NEW PHYTOL, V157, P229, DOI 10.1046/j.1469-8137.2003.00660.x; Hou GuiLing, 2007, Acta Botanica Boreali-Occidentalia Sinica, V27, P1499; Idso SB, 1997, GLOB CHANGE BIOL, V3, P89, DOI 10.1046/j.1365-2486.1997.00053.x; Jablonski LM, 2002, NEW PHYTOL, V156, P9, DOI 10.1046/j.1469-8137.2002.00494.x; Jitla DS, 1997, PLANT PHYSIOL, V115, P15, DOI 10.1104/pp.115.1.15; Korner C, 2006, NEW PHYTOL, V172, P393, DOI 10.1111/j.1469-8137.2006.01886.x; Kohut R, 2003, ENVIRON INT, V29, P171, DOI 10.1016/S0160-4120(02)00160-5; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977; LaDeau SL, 2001, SCIENCE, V292, P95, DOI 10.1126/science.1057547; Leishman MR, 1999, NEW PHYTOL, V144, P455, DOI 10.1046/j.1469-8137.1999.00544.x; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Norby RJ, 2004, P NATL ACAD SCI USA, V101, P9689, DOI 10.1073/pnas.0403491101; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Rasse DP, 2005, GLOBAL CHANGE BIOL, V11, P369, DOI 10.1111/j.1365-2486.2005.00913.x; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Steinger T, 2000, OECOLOGIA, V123, P475, DOI 10.1007/s004420000342; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Teng Nian-Jun, 2006, Zhiwu Shengtai Xuebao, V30, P1054; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Thurig B, 2003, GLOBAL CHANGE BIOL, V9, P873, DOI 10.1046/j.1365-2486.2003.00581.x; Wang XZ, 2005, AM J BOT, V92, P826, DOI 10.3732/ajb.92.5.826; Ward JK, 2000, OECOLOGIA, V123, P330, DOI 10.1007/s004420051019; Ward JK, 2004, ECOL LETT, V7, P427, DOI 10.1111/j.1461-0248.2004.00589.x; Wieneke S, 2004, GLOBAL CHANGE BIOL, V10, P1389, DOI 10.1111/j.1365-2486.2004.00813.x; WOODWARD FI, 1995, NEW PHYTOL, V131, P311, DOI 10.1111/j.1469-8137.1995.tb03067.x; Woodward FI, 2002, CURR OPIN PLANT BIOL, V5, P207, DOI 10.1016/S1369-5266(02)00253-4; WU L, 1972, NATURE, V238, P167, DOI 10.1038/238167a0	45	20	24	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6035	10.1371/journal.pone.0006035	http://dx.doi.org/10.1371/journal.pone.0006035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557175	Green Published, Green Submitted, gold			2022-12-27	WOS:000267356900001
J	Niino, Y; Hotta, K; Oka, K				Niino, Yusuke; Hotta, Kohji; Oka, Kotaro			Simultaneous Live Cell Imaging Using Dual FRET Sensors with a Single Excitation Light	PLOS ONE			English	Article								Fluorescence resonance energy transfer (FRET) between fluorescent proteins is a powerful tool for visualization of signal transduction in living cells, and recently, some strategies for imaging of dual FRET pairs in a single cell have been reported. However, these necessitate alteration of excitation light between two different wavelengths to avoid the spectral overlap, resulting in sequential detection with a lag time. Thus, to follow fast signal dynamics or signal changes in highly motile cells, a single-excitation dual-FRET method should be required. Here we reported this by using four-color imaging with a single excitation light and subsequent linear unmixing to distinguish fluorescent proteins. We constructed new FRET sensors with Sapphire/RFP to combine with CFP/YFP, and accomplished simultaneous imaging of cAMP and cGMP in single cells. We confirmed that signal amplitude of our dual FRET measurement is comparable to of conventional single FRET measurement. Finally, we demonstrated to monitor both intracellular Ca(2+) and cAMP in highly motile cardiac myocytes. To cancel out artifacts caused by the movement of the cell, this method expands the applicability of the combined use of dual FRET sensors for cell samples with high motility.			Niino, Y (corresponding author), Keio Univ, Sch Fundamental Sci & Technol, Ctr Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 223, Japan.	oka@bio.keio.ac.jp	Oka, Kotaro/C-4918-2014; Hotta, Kohji/D-1162-2014	Hotta, Kohji/0000-0003-4614-7473				Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Ducros M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004418; Garini Y, 2006, CYTOM PART A, V69A, P735, DOI 10.1002/cyto.a.20311; GATTI G, 1988, BIOCHEM J, V255, P753, DOI 10.1042/bj2550753; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Grant DM, 2008, BIOPHYS J, V95, pL69, DOI 10.1529/biophysj.108.139204; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Hartley R., 2004, ROBOTICA; Hiraoka Y, 2002, CELL STRUCT FUNCT, V27, P367, DOI 10.1247/csf.27.367; Honda A, 2001, P NATL ACAD SCI USA, V98, P2437, DOI 10.1073/pnas.051631298; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mizuno H, 2001, BIOCHEMISTRY-US, V40, P2502, DOI 10.1021/bi002263b; Morel E, 2005, CIRC RES, V97, P1296, DOI 10.1161/01.RES.0000194325.31359.86; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; Piljic A, 2008, ACS CHEM BIOL, V3, P156, DOI 10.1021/cb700247q; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Sato M, 2000, ANAL CHEM, V72, P5918, DOI 10.1021/ac0006167; Sawano A, 2002, BIOPHYS J, V82, P1076, DOI 10.1016/S0006-3495(02)75467-2; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Yaroslavsky L. P., 1985, DIGITAL PICTURE PROC; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0	35	87	87	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6036	10.1371/journal.pone.0006036	http://dx.doi.org/10.1371/journal.pone.0006036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551140	gold, Green Published, Green Submitted			2022-12-27	WOS:000267356500018
J	Williams, AE; Larner-Svensson, H; Perry, MM; Campbell, GA; Herrick, SE; Adcock, IM; Erjefalt, JS; Chung, KF; Lindsay, MA				Williams, Andrew E.; Larner-Svensson, Hanna; Perry, Mark M.; Campbell, Gaynor A.; Herrick, Sarah E.; Adcock, Ian M.; Erjefalt, Jonas S.; Chung, Kian Fan; Lindsay, Mark A.			MicroRNA Expression Profiling in Mild Asthmatic Human Airways and Effect of Corticosteroid Therapy	PLOS ONE			English	Article							IN-VIVO; RNA-INTERFERENCE; MESSENGER-RNA; RAPID CHANGES; LUNG; INFLAMMATION; LET-7; REPRESSION; APOPTOSIS; PROTEIN	Background: Asthma is a common disease characterised by reversible airflow obstruction, bronchial hyperresponsiveness and chronic inflammation, which is commonly treated using corticosteroids such as budesonide. MicroRNAs (miRNAs) are a recently identified family of non-protein encoding genes that regulate protein translation by a mechanism entitled RNA interference. Previous studies have shown lung-specific miRNA expression profiles, although their importance in regulating gene expression is unresolved. We determined whether miRNA expression was differentially expressed in mild asthma and the effect of corticosteroid treatment. Methodology/Principal Findings: We have examined changes in miRNA using a highly sensitive RT-PCR based approach to measure the expression of 227 miRNAs in airway biopsies obtained from normal and mild asthmatic patients. We have also determined whether the anti-inflammatory action of corticosteroids are mediated through miRNAs by determining the profile of miRNA expression in mild asthmatics, before and following 1 month twice daily treatment with inhaled budesonide. Furthermore, we have analysed the expression of miRNAs from individual cell populations from the airway and lung. We found no significant difference in the expression of 227 miRNAs in the airway biopsies obtained from normal and mild asthmatic patients. In addition, despite improved lung function, we found no significant difference in the miRNA expression following one month treatment with the corticosteroid, budesonide. However, analysis of bronchial and alveolar epithelial cells, airway smooth muscle cells, alveolar macrophages and lung fibroblasts demonstrate a miRNA expression profile that is specific to individual cell types and demonstrates the complex cellular heterogeneity within whole tissue samples. Conclusions: Changes in miRNA expression do not appear to be involved in the development of a mild asthmatic phenotype or in the anti-inflammatory action of the corticosteroid budesonide.			Williams, AE (corresponding author), Imperial Coll Sch Med, Biopharmaceut Res Grp, Natl Heart & Lung Inst, London, England.	a.williams@imperial.ac.uk; mark.lindsay@manchester.ac.uk	herrick, sarah e/A-3121-2015; Adcock, Ian/L-3217-2019; Campbell, Gaynor/B-8914-2012; Chung, Kian Fan/B-1872-2012; Chung, Kian Fan/I-8456-2019	herrick, sarah e/0000-0002-9085-5664; Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; Adcock, Ian/0000-0003-2101-8843; Perry, Mark/0000-0002-8145-8042; Lindsay, Mark/0000-0003-4807-5506; Erjefalt, Jonas/0000-0002-6716-3010	Wellcome Trust [076111] Funding Source: Medline; Medical Research Council [G0400503B, G0801056B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Berkman N, 1996, AM J RESP CRIT CARE, V154, P1804, DOI 10.1164/ajrccm.154.6.8970374; Chen C, 2005, AM J PHYSIOL-LUNG C, V288, pL1033, DOI 10.1152/ajplung.00277.2004; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; DJUKANOVIC R, 1992, AM REV RESPIR DIS, V145, P669, DOI 10.1164/ajrccm/145.3.669; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Kiriakidou M, 2005, METH MOL B, V309, P295; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Luo XB, 2008, J BIOL CHEM, V283, P20045, DOI 10.1074/jbc.M801035200; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Moschos SA, 2007, BIOCONJUGATE CHEM, V18, P1450, DOI 10.1021/bc070077d; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schulman BRM, 2005, DEV DYNAM, V234, P1046, DOI 10.1002/dvdy.20599; Schwarz DS, 2002, GENE DEV, V16, P1025, DOI 10.1101/gad.992502; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Tang GL, 2005, TRENDS BIOCHEM SCI, V30, P106, DOI 10.1016/j.tibs.2004.12.007; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; VATHENEN AS, 1991, AM REV RESPIR DIS, V143, P1317, DOI 10.1164/ajrccm/143.6.1317; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	45	163	173	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5889	10.1371/journal.pone.0005889	http://dx.doi.org/10.1371/journal.pone.0005889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521514	Green Submitted, Green Published, gold			2022-12-27	WOS:000267029100006
J	Abranches, E; Silva, M; Pradier, L; Schulz, H; Hummel, O; Henrique, D; Bekman, E				Abranches, Elsa; Silva, Margarida; Pradier, Laurent; Schulz, Herbert; Hummel, Oliver; Henrique, Domingos; Bekman, Evguenia			Neural Differentiation of Embryonic Stem Cells In Vitro: A Road Map to Neurogenesis in the Embryo	PLOS ONE			English	Article							ADULT SUBVENTRICULAR ZONE; VERTEBRATE BODY AXIS; NEURONAL DIFFERENTIATION; NEUROEPITHELIAL CELLS; RETINOID PATHWAYS; OPPOSING FGF; ES CELLS; EXPRESSION; INDUCTION; GENES	Background: The in vitro generation of neurons from embryonic stem (ES) cells is a promising approach to produce cells suitable for neural tissue repair and cell-based replacement therapies of the nervous system. Available methods to promote ES cell differentiation towards neural lineages attempt to replicate, in different ways, the multistep process of embryonic neural development. However, to achieve this aim in an efficient and reproducible way, a better knowledge of the cellular and molecular events that are involved in the process, from the initial specification of neuroepithelial progenitors to their terminal differentiation into neurons and glial cells, is required. Methodology/Principal Findings: In this work, we characterize the main stages and transitions that occur when ES cells are driven into a neural fate, using an adherent monolayer culture system. We established improved conditions to routinely produce highly homogeneous cultures of neuroepithelial progenitors, which organize into neural tube-like rosettes when they acquire competence for neuronal production. Within rosettes, neuroepithelial progenitors display morphological and functional characteristics of their embryonic counterparts, namely, apico-basal polarity, active Notch signalling, and proper timing of production of neurons and glia. In order to characterize the global gene activity correlated with each particular stage of neural development, the full transcriptome of different cell populations that arise during the in vitro differentiation protocol was determined by microarray analysis. By using embryo-oriented criteria to cluster the differentially expressed genes, we define five gene expression signatures that correlate with successive stages in the path from ES cells to neurons. These include a gene signature for a primitive ectoderm-like stage that appears after ES cells enter differentiation, and three gene signatures for subsequent stages of neural progenitor development, from an early stage that follows neural induction to a final stage preceding terminal differentiation. Conclusions/Significance: Overall, our work confirms and extends the cellular and molecular parallels between monolayer ES cell neural differentiation and embryonic neural development, revealing in addition novel aspects of the genetic network underlying the multistep process that leads from uncommitted cells to differentiated neurons.			Abranches, E (corresponding author), Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal.	henrique@fm.ul.pt	Abranches, Elsa/D-4324-2012; Bekman, Evguenia/O-9840-2017; Henrique, Domingos M/E-5460-2010; Bekman, Evguenia Pavlovna/AAC-3218-2019	Abranches, Elsa/0000-0003-4493-6065; Bekman, Evguenia/0000-0002-3963-1358; Henrique, Domingos M/0000-0001-8869-1894; Bekman, Evguenia Pavlovna/0000-0002-3963-1358				Afonso C, 2006, J CELL SCI, V119, P4293, DOI 10.1242/jcs.03170; Aiba K, 2009, DNA RES, V16, P73, DOI 10.1093/dnares/dsn035; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Bae YK, 2005, DEVELOPMENT, V132, P1375, DOI 10.1242/dev.01710; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Cai C, 2007, DEV DYNAM, V236, P3255, DOI 10.1002/dvdy.21306; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Chung ACK, 2001, MOL CELL BIOL, V21, P663, DOI 10.1128/MCB.21.2.663-677.2001; Coffinier C, 2001, MECH DEVELOP, V100, P119, DOI 10.1016/S0925-4773(00)00507-4; Conti L, 2005, TRENDS NEUROSCI, V28, P57, DOI 10.1016/j.tins.2004.11.005; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Diez del Corral R, 2001, NAT REV NEUROSCI, V2, P835; Diez del Corral R, 2002, DEVELOPMENT, V129, P1681; Edwards YJK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002712; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hoang BH, 1998, DEV DYNAM, V212, P364, DOI 10.1002/(SICI)1097-0177(199807)212:3<364::AID-AJA4>3.0.CO;2-F; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; MAGAVI SS, 2008, IMMUNOCYTOCHEMICAL A, P345; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216; Pelton TA, 2002, J CELL SCI, V115, P329; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pollard SM, 2006, REGEN MED, V1, P111, DOI 10.2217/17460751.1.1.111; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rathjen J, 1999, J CELL SCI, V112, P601; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Stavridis MP, 2003, BIOCHEM SOC T, V31, P45, DOI 10.1042/bst0310045; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Webb SE, 2005, CELL CALCIUM, V37, P375, DOI 10.1016/j.ceca.2005.01.005; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	58	156	164	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6286	10.1371/journal.pone.0006286	http://dx.doi.org/10.1371/journal.pone.0006286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621087	Green Published, gold, Green Accepted			2022-12-27	WOS:000268147200003
J	Palaninathan, SK; Mohamedmohaideen, NN; Orlandini, E; Ortore, G; Nencetti, S; Lapucci, A; Rossello, A; Freundlich, JS; Sacchettini, JC				Palaninathan, Satheesh K.; Mohamedmohaideen, Nilofar N.; Orlandini, Elisabetta; Ortore, Gabriella; Nencetti, Susanna; Lapucci, Annalina; Rossello, Armando; Freundlich, Joel S.; Sacchettini, James C.			Novel Transthyretin Amyloid Fibril Formation Inhibitors: Synthesis, Biological Evaluation, and X-Ray Structural Analysis	PLOS ONE			English	Article								Transthyretin (TTR) is one of thirty non-homologous proteins whose misfolding, dissociation, aggregation, and deposition is linked to human amyloid diseases. Previous studies have identified that TTR amyloidogenesis can be inhibited through stabilization of the native tetramer state by small molecule binding to the thyroid hormone sites of TTR. We have evaluated a new series of beta-aminoxypropionic acids (compounds 5-21), with a single aromatic moiety (aryl or fluorenyl) linked through a flexible oxime tether to a carboxylic acid. These compounds are structurally distinct from the native ligand thyroxine and typical halogenated biaryl NSAID-like inhibitors to avoid off-target hormonal or anti-inflammatory activity. Based on an in vitro fibril formation assay, five of these compounds showed significant inhibition of TTR amyloidogenesis, with two fluorenyl compounds displaying inhibitor efficacy comparable to the well-known TTR inhibitor diflunisal. Fluorenyl 15 is the most potent compound in this series and importantly does not show off-target anti-inflammatory activity. Crystal structures of the TTR: inhibitor complexes, in agreement with molecular docking studies, revealed that the aromatic moiety, linked to the sp(2)-hybridized oxime carbon, specifically directed the ligand in either a forward or reverse binding mode. Compared to the aryl family members, the bulkier fluorenyl analogs achieved more extensive interactions with the binding pockets of TTR and demonstrated better inhibitory activity in the fibril formation assay. Preliminary optimization efforts are described that focused on replacement of the C-terminal acid in both the aryl and fluorenyl series (compounds 22-32). The compounds presented here constitute a new class of TTR inhibitors that may hold promise in treating amyloid diseases associated with TTR misfolding.			Palaninathan, SK (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	eorlandini@farm.unipi.it; sacchett@tamu.edu	Nencetti, Susanna/AAF-3442-2021; Rossello, Armando/C-5803-2014; Rossello, Armando/S-7332-2019; Ortore, Gabriella/ABF-8828-2020	Rossello, Armando/0000-0002-6795-8091; Rossello, Armando/0000-0002-6795-8091; Ortore, Gabriella/0000-0002-1541-6258; NENCETTI, SUSANNA/0000-0002-3547-7277; LAPUCCI, ANNALINA/0000-0003-2348-0871; ORLANDINI, Elisabetta/0000-0003-3398-2787				Adamski-Werner SL, 2004, J MED CHEM, V47, P355, DOI 10.1021/jm030347n; Almeida M. R., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P587, DOI 10.2174/156800705774322076; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; Balsamo A, 2001, EUR J MED CHEM, V36, P799, DOI 10.1016/S0223-5234(01)01275-2; Baures PW, 1998, BIOORGAN MED CHEM, V6, P1389, DOI 10.1016/S0968-0896(98)00130-8; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Buxbaum JN, 2000, ANNU REV MED, V51, P543, DOI 10.1146/annurev.med.51.1.543; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; CORNWELL GG, 1988, BIOCHEM BIOPH RES CO, V154, P648, DOI 10.1016/0006-291X(88)90188-X; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; Gambetti P, 1998, NEPHROL DIAL TRANSPL, V13, P33, DOI 10.1093/ndt/13.suppl_7.33; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Johnson SM, 2005, J MED CHEM, V48, P1576, DOI 10.1021/jm049274d; JOHNSON SM, 2009, J MED CHEM; Julius RL, 2008, DRUG NEWS PERSPECT, V21, P258, DOI 10.1358/dnp.2008.21.5.1219011; Julius RL, 2007, P NATL ACAD SCI USA, V104, P4808, DOI 10.1073/pnas.0700316104; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kelly JW, 1997, STRUCTURE, V5, P595, DOI 10.1016/S0969-2126(97)00215-3; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; LAPUCCI A, 1994, EUR J MED CHEM, V29, P33, DOI 10.1016/0223-5234(94)90123-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maccarrone M, 1999, EUR J BIOCHEM, V265, P27, DOI 10.1046/j.1432-1327.1999.00630.x; MACCHIA B, 1990, J MED CHEM, V33, P1423, DOI 10.1021/jm00167a023; Mairal T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004124; McCammon MG, 2002, STRUCTURE, V10, P851, DOI 10.1016/S0969-2126(02)00771-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NILSSON SF, 1975, J BIOL CHEM, V250, P8554; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Peterson SA, 1998, P NATL ACAD SCI USA, V95, P12956, DOI 10.1073/pnas.95.22.12956; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Purkey HE, 2004, CHEM BIOL, V11, P1719, DOI 10.1016/j.chembiol.2004.10.009; Purkey HE, 2001, P NATL ACAD SCI USA, V98, P5566, DOI 10.1073/pnas.091431798; Razgulin AV, 2006, J MED CHEM, V49, P7902, DOI 10.1021/jm0600702; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; RICHARDSON SJ, 1994, AM J PHYSIOL, V266, pR1359, DOI 10.1152/ajpregu.1994.266.4.R1359; SARAIVA MJM, 1995, HUM MUTAT, V5, P191; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Tojo K, 2006, NEUROSCI RES, V56, P441, DOI 10.1016/j.neures.2006.08.014; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wojtczak A, 1996, ACTA CRYSTALLOGR D, V52, P758, DOI 10.1107/S0907444996003046; ZANOTTI G, 1995, EUR J BIOCHEM, V234, P563, DOI 10.1111/j.1432-1033.1995.563_b.x	52	35	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6290	10.1371/journal.pone.0006290	http://dx.doi.org/10.1371/journal.pone.0006290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621084	Green Submitted, Green Published, gold			2022-12-27	WOS:000268147200004
J	Srivastava, SS; Pany, S; Sneh, A; Ahmed, N; Rahman, A; Musti, KV				Srivastava, Saumya S.; Pany, Satyabrata; Sneh, Amita; Ahmed, Neesar; Rahman, Aejazur; Musti, Krishnasastry V.			Membrane Bound Monomer of Staphylococcal alpha-Hemolysin Induces Caspase Activation and Apoptotic Cell Death despite Initiation of Membrane Repair Pathway	PLOS ONE			English	Article								Background: Wild type Staphylococcal alpha-hemolysin (alpha-HL) assembly on target mammalian cells usually results in necrotic form of cell death; however, caspase activation also occurs. The pathways of caspase activation due to binding/partial assembly by alpha-HL are unknown till date. Results: Cells treated with H35N (a mutant of alpha-HL that remains as membrane bound monomer), have been shown to accumulate hypodiploid nuclei, activate caspases and induce intrinsic mitochondrial apoptotic pathway. We have earlier shown that the binding and assembly of alpha-HL requires functional form of Caveolin-1 which is an integral part of caveolae. In this report, we show that the caveolae of mammalian cells, which undergo a continuous cycle of 'kiss and run' dynamics with the plasma membrane, have become immobile upon the binding of the monomer. The cells treated with H35N were unable to recover despite activation of membrane repair mechanism involving caspase-1 dependent activation of sterol regulatory element binding protein-1. Conclusions: This is for the first time we show the range of cellular changes and responses that take place immediately after the binding of the monomeric form of staphylococcal alpha-hemolysin.			Srivastava, SS (corresponding author), Univ Pune Campus, Natl Ctr Cell Sci, Pune, Maharashtra, India.	mvks@nccs.res.in	Ahmed, Neesar/AAW-5473-2021; Rhaman, Aejazur/AAC-5104-2019	Rhaman, Aejazur/0000-0002-2616-3372; Ahmed, Neesar/0000-0002-7367-2188				Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Essmann F, 2003, CELL DEATH DIFFER, V10, P1260, DOI 10.1038/sj.cdd.4401301; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kahl BC, 2000, INFECT IMMUN, V68, P5385, DOI 10.1128/IAI.68.9.5385-5392.2000; KRISHNASASTRY M, 1994, FEBS LETT, V356, P66, DOI 10.1016/0014-5793(94)01240-7; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Nuzzo I, 2000, FEMS IMMUNOL MED MIC, V27, P235, DOI 10.1111/j.1574-695X.2000.tb01435.x; Pany S, 2004, BIOCHEM BIOPH RES CO, V322, P29, DOI 10.1016/j.bbrc.2004.07.073; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Shajahan AN, 2007, J BIOL CHEM, V282, P5934, DOI 10.1074/jbc.M608857200; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Vandana S, 2003, FEBS LETT, V535, P71, DOI 10.1016/S0014-5793(02)03862-0; Vandana S, 1997, J BIOL CHEM, V272, P24858, DOI 10.1074/jbc.272.40.24858; Vijayvargia R, 2004, BIOCHEM BIOPH RES CO, V325, P344, DOI 10.1016/j.bbrc.2004.10.038; Vijayvargia R, 2004, BIOCHEM BIOPH RES CO, V324, P1130, DOI 10.1016/j.bbrc.2004.09.164; Vijayvargia R, 2004, BIOCHEM BIOPH RES CO, V324, P1124, DOI 10.1016/j.bbrc.2004.09.165; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8	22	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6293	10.1371/journal.pone.0006293	http://dx.doi.org/10.1371/journal.pone.0006293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621082	Green Published, gold, Green Submitted			2022-12-27	WOS:000268147200005
J	Cousin, B; Ravet, E; Poglio, S; De Toni, F; Bertuzzi, M; Lulka, H; Touil, I; Andre, M; Grolleau, JL; Peron, JM; Chavoin, JP; Bourin, P; Penicaud, L; Casteilla, L; Buscail, L; Cordelier, P				Cousin, Beatrice; Ravet, Emmanuel; Poglio, Sandrine; De Toni, Fabienne; Bertuzzi, Melanie; Lulka, Hubert; Touil, Ismahane; Andre, Mireille; Grolleau, Jean-Louis; Peron, Jean-Marie; Chavoin, Jean-Pierre; Bourin, Philippe; Penicaud, Luc; Casteilla, Louis; Buscail, Louis; Cordelier, Pierre			Adult Stromal Cells Derived from Human Adipose Tissue Provoke Pancreatic Cancer Cell Death both In Vitro and In Vivo	PLOS ONE			English	Article								Background: Normal tissue homeostasis is maintained by dynamic interactions between epithelial cells and their microenvironment. Disrupting this homeostasis can induce aberrant cell proliferation, adhesion, function and migration that might promote malignant behavior. Indeed, aberrant stromal-epithelial interactions contribute to pancreatic ductal adenocarcinoma (PDAC) spread and metastasis, and this raises the possibility that novel stroma-targeted therapies represent additional approaches for combating this malignant disease. The aim of the present study was to determine the effect of human stromal cells derived from adipose tissue (ADSC) on pancreatic tumor cell proliferation. Principal Findings: Co-culturing pancreatic tumor cells with ADSC and ADSC-conditioned medium sampled from different donors inhibited cancer cell viability and proliferation. ADSC-mediated inhibitory effect was further extended to other epithelial cancer-derived cell lines (liver, colon, prostate). ADSC conditioned medium induced cancer cell necrosis following G1-phase arrest, without evidence of apoptosis. In vivo, a single intra-tumoral injection of ADSC in a model of pancreatic adenocarcinoma induced a strong and long-lasting inhibition of tumor growth. Conclusion: These data indicate that ADSC strongly inhibit PDAC proliferation, both in vitro and in vivo and induce tumor cell death by altering cell cycle progression. Therefore, ADSC may constitute a potential cell-based therapeutic alternative for the treatment of PDAC for which no effective cure is available.			Cousin, B (corresponding author), Univ Toulouse, UPS, UMR Metab Plast & Mitochondrie 5241, BP 84225, Toulouse, France.	beatrice.cousin@inserm.fr	Bourin, Philippe/J-2693-2019; LULKA, Hubert/M-7382-2014; Cordelier, Pierre/D-1150-2014	Bourin, Philippe/0000-0002-9652-4380; Cordelier, Pierre/0000-0003-2096-7967; Poglio, Sandrine/0000-0001-8783-0709; Cousin, Beatrice/0000-0003-2952-4601; Casteilla, Louis/0000-0001-9647-3248				Al-Khaldi A, 2003, ANN THORAC SURG, V75, P204, DOI 10.1016/S0003-4975(02)04291-1; Bai XW, 2007, FEBS LETT, V581, P4681, DOI 10.1016/j.febslet.2007.08.063; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Carrere N, 2005, HUM GENE THER, V16, P1175, DOI 10.1089/hum.2005.16.1175; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Cordelier P, 2007, CANCER GENE THER, V14, P19, DOI 10.1038/sj.cgt.7700987; Cui D, 2007, J EXP NANOSCI, V2, P13, DOI 10.1080/17458080600935590; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; Estes BT, 2006, ARTHRITIS RHEUM-US, V54, P1222, DOI 10.1002/art.21779; Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024; Lamfers M, 2009, CANCER LETT, V274, P78, DOI 10.1016/j.canlet.2008.08.035; Lin YF, 2006, MOL CELL BIOCHEM, V291, P1, DOI 10.1007/s11010-006-9188-5; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Muehlberg FL, 2009, CARCINOGENESIS, V30, P589, DOI 10.1093/carcin/bgp036; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Noel D, 2008, EXP CELL RES, V314, P1575, DOI 10.1016/j.yexcr.2007.12.022; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103; Safioleas MC, 2004, HEPATO-GASTROENTEROL, V51, P862; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Scadden DT, 2004, NAT IMMUNOL, V5, P701, DOI 10.1038/ni0704-701; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; Sirach E, 2007, CELL DEATH DIFFER, V14, P1202, DOI 10.1038/sj.cdd.4402114; Song YH, 2007, BIOCHEM BIOPH RES CO, V354, P999, DOI 10.1016/j.bbrc.2007.01.095; Suga H, 2009, STEM CELLS DEV; Sun B, 2005, STEM CELLS DEV, V14, P292, DOI 10.1089/scd.2005.14.292; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Torrisani J, 2001, GASTROENTEROLOGY, V120, P200, DOI 10.1053/gast.2001.21192; Vilalta M, 2009, GENE THER, V16, P547, DOI 10.1038/gt.2008.176; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Yu JM, 2008, STEM CELLS DEV, V17, P463, DOI 10.1089/scd.2007.0181; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	53	162	176	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6278	10.1371/journal.pone.0006278	http://dx.doi.org/10.1371/journal.pone.0006278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609435	gold, Green Published			2022-12-27	WOS:000268119500013
J	DiMezzo, TL; Ruthel, G; Brueggemann, EE; Hines, HB; Ribot, WJ; Chapman, CE; Powell, BS; Welkos, SL				DiMezzo, Tracy L.; Ruthel, Gordon; Brueggemann, Ernst E.; Hines, Harry B.; Ribot, Wilson J.; Chapman, Carol E.; Powell, Bradford S.; Welkos, Susan L.			In Vitro Intracellular Trafficking of Virulence Antigen during Infection by Yersinia pestis	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; INNATE IMMUNE-RESPONSE; V-ANTIGEN; SHIGA TOXIN; RETROGRADE TRANSPORT; DIPHTHERIA-TOXIN; COLOCALIZATION ANALYSIS; PROTEIN TOXINS; FUSION PEPTIDE; ANTHRAX TOXIN	Yersinia pestis, the causative agent of plague, encodes several essential virulence factors on a 70 kb plasmid, including the Yersinia outer proteins (Yops) and a multifunctional virulence antigen (V). V is uniquely able to inhibit the host immune response; aid in the expression, secretion, and injection of the cytotoxic Yops via a type III secretion system (T3SS)dependent mechanism; be secreted extracellularly; and enter the host cell by a T3SS-independent mechanism, where its activity is unknown. To elucidate the intracellular trafficking and target(s) of V, time-course experiments were performed with macrophages (MWs) infected with Y. pestis or Y. pseudotuberculosis at intervals from 5 min to 6 h. The trafficking pattern was discerned from results of parallel microscopy, immunoblotting, and flow cytometry experiments. The MWs were incubated with fluorescent or gold conjugated primary or secondary anti-V (antibodies [Abs]) in conjunction with organelle-associated Abs or dyes. The samples were observed for co-localization by immuno-fluorescence and electron microscopy. For fractionation studies, uninfected and infected MWs were lysed and subjected to density gradient centrifugation coupled with immunoblotting with Abs to V or to organelles. Samples were also analyzed by flow cytometry after lysis and dual-staining with anti-V and anti-organelle Abs. Our findings indicate a co-localization of V with (1) endosomal proteins between 10-45 min of infection, (2) lysosomal protein(s) between 1-2 h of infection, (3) mitochondrial proteins between 2.5-3 h infection, and (4) Golgi protein(s) between 4-6 h of infection. Further studies are being performed to determine the specific intracellular interactions and role in pathogenesis of intracellularly localized V.			DiMezzo, TL (corresponding author), USAMRIID, Bacteriol Div, Ft Detrick, MD USA.	susan.welkos@amedd.army.mil	Ruthel, Gordon/GYU-9133-2022	Welkos, Susan/0000-0002-7254-3480; Ruthel, Gordon/0000-0001-9193-5589; Ribot, Wilson/0000-0002-9691-4004				Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; AlvarezDominguez C, 1997, J CELL SCI, V110, P731; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Bashaw J, 2007, CLIN VACCINE IMMUNOL, V14, P605, DOI 10.1128/CVI.00398-06; Blanke SR, 1996, P NATL ACAD SCI USA, V93, P8437, DOI 10.1073/pnas.93.16.8437; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BURROWS TW, 1958, BRIT J EXP PATHOL, V39, P278; BURROWS TW, 1963, ERG MIKROBIOL IMM E, V37, P59; Butler T, 1983, PLAGUE OTHER YERSINI; Cataldo AM, 2008, AM J PATHOL, V173, P370, DOI 10.2353/ajpath.2008.071053; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2002, INT J MED MICROBIOL, V291, P455; Falnes PO, 2000, CURR OPIN CELL BIOL, V12, P407, DOI 10.1016/S0955-0674(00)00109-5; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; FERBER DM, 1981, INFECT IMMUN, V31, P839, DOI 10.1128/IAI.31.2.839-841.1981; Fields KA, 1999, INFECT IMMUN, V67, P4801, DOI 10.1128/IAI.67.9.4801-4813.1999; FRIEDLANDER AM, 1995, CLIN INFECT DIS, V21, pS178, DOI 10.1093/clinids/21.Supplement_2.S178; GALYOV EE, 1990, FEBS LETT, V277, P230, DOI 10.1016/0014-5793(90)80852-A; GALYOV EE, 1991, FEBS LETT, V286, P79, DOI 10.1016/0014-5793(91)80945-Y; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Hehnly H, 2006, MOL BIOL CELL, V17, P4379, DOI 10.1091/mbc.E06-04-0310; Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035; Johannes L, 2000, TRAFFIC, V1, P119, DOI 10.1034/j.1600-0854.2000.010204.x; Johannes L, 2005, GENE THER, V12, P1360, DOI 10.1038/sj.gt.3302557; Johannes L, 2002, AM J PHYSIOL-GASTR L, V283, pG1, DOI 10.1152/ajpgi.00088.2002; Johannes L, 2002, TRAFFIC, V3, P443, DOI 10.1034/j.1600-0854.2002.30701.x; KARLYSHEV AV, 1992, FEBS LETT, V305, P37, DOI 10.1016/0014-5793(92)80650-6; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; Khine AA, 2004, GLYCOBIOLOGY, V14, P701, DOI 10.1093/glycob/cwh085; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lin SX, 2004, MOL BIOL CELL, V15, P721, DOI 10.1091/mbc.E03-07-0497; Lindler LE, 1998, INFECT IMMUN, V66, P5731, DOI 10.1128/IAI.66.12.5731-5742.1998; Lord JM, 1998, CURR BIOL, V8, pR56, DOI 10.1016/S0960-9822(98)70034-X; MacAry PA, 2001, P NATL ACAD SCI USA, V98, P3982, DOI 10.1073/pnas.071477498; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MORRIS RE, 1985, INFECT IMMUN, V50, P721, DOI 10.1128/IAI.50.3.721-727.1985; MOYA M, 1985, J CELL BIOL, V101, P548, DOI 10.1083/jcb.101.2.548; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; NAKAJIMA R, 1995, INFECT IMMUN, V63, P3021, DOI 10.1128/IAI.63.8.3021-3029.1995; NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993; Nedialkov YA, 1997, INFECT IMMUN, V65, P1196, DOI 10.1128/IAI.65.4.1196-1203.1997; Nilles ML, 1998, J BACTERIOL, V180, P3410, DOI 10.1128/JB.180.13.3410-3420.1998; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Perry RD, 1998, INFECT IMMUN, V66, P4611, DOI 10.1128/IAI.66.10.4611-4623.1998; Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x; Powell BS, 2005, BIOTECHNOL PROGR, V21, P1490, DOI 10.1021/bp050098r; Ricci V, 2000, MOL BIOL CELL, V11, P3897, DOI 10.1091/mbc.11.11.3897; RYNING FW, 1978, INFECT IMMUN, V20, P739, DOI 10.1128/IAI.20.3.739-743.1978; Sanchez JA, 2001, J PHYSIOL-LONDON, V536, P387, DOI 10.1111/j.1469-7793.2001.0387c.xd; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; Sandvig K, 2000, INT J MED MICROBIOL, V290, P415; Shin JS, 2001, SCIENCE, V293, P1447, DOI 10.1126/science.1061079; Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315; Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Takizawa T, 2003, J HISTOCHEM CYTOCHEM, V51, P31, DOI 10.1177/002215540305100105; Terebiznik MR, 2006, INFECT IMMUN, V74, P6599, DOI 10.1128/IAI.01085-06; Tuma PL, 2001, J CELL BIOL, V154, P1197, DOI 10.1083/jcb.200105138; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Une T, 1987, Contrib Microbiol Immunol, V9, P179; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Weeks S, 2002, MICROB PATHOGENESIS, V32, P227, DOI 10.1006/mpat.2002.0498; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; Welkos SL, 2004, PLASMID, V51, P1, DOI 10.1016/j.plasmid.2003.09.003; Willhite DC, 2004, CELL MICROBIOL, V6, P143, DOI 10.1046/j.1462-5822.2003.00347.x; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	80	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6281	10.1371/journal.pone.0006281	http://dx.doi.org/10.1371/journal.pone.0006281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609450	gold, Green Submitted, Green Published			2022-12-27	WOS:000268119500015
J	Ling, YC; Vjestica, A; Oliferenko, S				Ling, Yuen Chyao; Vjestica, Aleksandar; Oliferenko, Snezhana			Nucleocytoplasmic Shuttling of the TACC Protein Mia1p/Alp7p Is Required for Remodeling of Microtubule Arrays during the Cell Cycle	PLOS ONE			English	Article								Microtubule arrays are remodeled as cells proceed through the cell cycle. It is important to understand how remodeling is regulated in time and space. In fission yeast, the conserved microtubule associated TACC/TOG complex plays an important role in organizing microtubules throughout the cell cycle. Here we show that this complex undergoes nucleocytoplasmic shuttling through the nuclear import and export signals located in the TACC protein Mia1p/Alp7p. When the Crm1p-dependent nuclear export signal of Mia1p is disabled, Mia1p accumulates in the nucleus while its partner protein Alp14p/TOG is restricted to the cytoplasm. This leads to defects in assembly of both interphase arrays and the mitotic spindle. Artificial targeting of Alp14p to the nucleus partially rescues the mitotic spindle defects caused by lack of Mia1p nuclear export. Interestingly, the nuclear export sequence of Mia1p appears to overlap with the Alp14p binding site. We propose that intricate regulation of the subcellular distribution of TACC/TOG complexes drives microtubule array remodeling as cells progress through the cell cycle.			Ling, YC (corresponding author), Temasek Life Sci Lab, Singapore, Singapore.	snejana@tll.org.sg		Oliferenko, Snezhana/0000-0002-8138-6851; Vjestica, Aleksandar/0000-0002-3095-4169				ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Albee AJ, 2006, J BIOL CHEM, V281, P38293, DOI 10.1074/jbc.M607203200; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Bratman SV, 2007, DEV CELL, V13, P812, DOI 10.1016/j.devcel.2007.10.015; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Grallert A, 2006, GENE DEV, V20, P2421, DOI 10.1101/gad.381306; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Sato M, 2004, MOL BIOL CELL, V15, P1609, DOI 10.1091/mbc.e03-11-0837; Sato M, 2007, NATURE, V447, P334, DOI 10.1038/nature05773; SAZER S, 1994, EMBO J, V13, P606, DOI 10.1002/j.1460-2075.1994.tb06298.x; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Zheng LF, 2006, MOL BIOL CELL, V17, P2212, DOI 10.1091/mbc.E05-08-0811	19	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6255	10.1371/journal.pone.0006255	http://dx.doi.org/10.1371/journal.pone.0006255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606211	Green Submitted, gold, Green Published			2022-12-27	WOS:000268036000011
J	Nicholls, B; Racey, PA				Nicholls, Barry; Racey, Paul A.			The Aversive Effect of Electromagnetic Radiation on Foraging Bats-A Possible Means of Discouraging Bats from Approaching Wind Turbines	PLOS ONE			English	Article							PIPISTRELLUS-PIPISTRELLUS; BUFFALO RIDGE; FIELDS; CHIROPTERA; THRESHOLDS; MICROWAVES; MORTALITY	Large numbers of bats are killed by collisions with wind turbines and there is at present no accepted method of reducing or preventing this mortality. Following our demonstration that bat activity is reduced in the vicinity of large air traffic control and weather radars, we tested the hypothesis that an electromagnetic signal from a small portable radar can act as a deterrent to foraging bats. From June to September 2007 bat activity was compared at 20 foraging sites in northeast Scotland during experimental trials (radar switched on) and control trials (no radar signal). Starting 45 minutes after sunset, bat activity was recorded for a period of 30 minutes during each trial and the order of trials were alternated between nights. From July to September 2008 aerial insects at 16 of these sites were sampled using two miniature light-suction traps. At each site one of the traps was exposed to a radar signal and the other functioned as a control. Bat activity and foraging effort per unit time were significantly reduced during experimental trials when the radar antenna was fixed to produce a unidirectional signal therefore maximising exposure of foraging bats to the radar beam. However, although bat activity was significantly reduced during such trials, the radar had no significant effect on the abundance of insects captured by the traps.			Nicholls, B (corresponding author), Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland.	b.nicholls@abdn.ac.uk						ADAIR ER, 1983, MICROWAVES THERMOREG, P359; Ahlen I., 2007, BATS OFFSHORE WIND T; Arnett E.B., 2005, RELATIONSHIPS UNPUB; Arnett E.B., 2009, EFFECTIVENESS CHANGI; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; BAERWALD EF, 2009, J WILDL MAN IN PRESS, V73; Balmori A, 2005, ELECTROMAGN BIOL MED, V24, P109, DOI 10.1080/15368370500205472; Barlow J, 2003, MAR MAMMAL SCI, V19, P265, DOI 10.1111/j.1748-7692.2003.tb01108.x; Burchard JF, 1996, J DAIRY SCI, V79, P1549, DOI 10.3168/jds.S0022-0302(96)76516-5; CURRY RC, 2000, P NAT AV WIND POW PL, V3, P18; DOWNNS NC, 1999, BAT RES NEWS, V40, P69; Erickson WP, 2001, AVIAN COLLISIONS WIN; GREENBERG B, 1981, BIOELECTROMAGNETICS, V2, P315, DOI 10.1002/bem.2250020404; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Hayes JP, 1997, J MAMMAL, V78, P514, DOI 10.2307/1382902; HENSHAW RE, 1966, PHYSIOL ZOOL, V39, P223, DOI 10.1086/physzool.39.3.30152849; HODOS W, 2001, NAT AV WIND POW PLAN, V4, P88; Horn JW, 2008, TESTING EFFECTIVENES; Johnson GD, 2002, WILDLIFE SOC B, V30, P879; Jones G, 2005, CURR BIOL, V15, pR484, DOI 10.1016/j.cub.2005.06.051; Jones Gareth, 2003, P345; JUSTESEN DR, 1979, B NEW YORK ACAD MED, V55, P1058; Kraus SD, 1997, NATURE, V388, P525, DOI 10.1038/41451; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Lai H, 2005, ELECTROMAGN BIOL MED, V24, P23, DOI 10.1081/JBC-200055046; LAI H, 1987, J NEUROCHEM, V48, P40, DOI 10.1111/j.1471-4159.1987.tb13124.x; LIN J C, 1976, Journal of Microwave Power, V11, P295; LIN JC, 1977, RADIO SCI, V12, P237, DOI 10.1029/RS012i06Sp00237; MELLOR PS, 1985, VET REC, V116, P589, DOI 10.1136/vr.116.22.589; Musters CJM, 1996, BIRD STUDY, V43, P124, DOI 10.1080/00063659609461003; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; Nicholls B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000297; Orloff S., 1992, WIND TURBINE EFFECTS; Osborn RG, 2000, AM MIDL NAT, V143, P41, DOI 10.1674/0003-0031(2000)143[0041:BMAWWT]2.0.CO;2; RACEY PA, 1985, J ANIM ECOL, V54, P205, DOI 10.2307/4631; REEDER WG, 1951, J MAMMAL, V32, P389, DOI 10.2307/1375787; Ryan BF, 1994, MINITAB HDB; Sienkiewicz Z, 1998, POWER ENG J, V12, P131, DOI 10.1049/pe:19980306; Spanjer G. R., 2006, RESPONSES BIG UNPUB; SPEAKMAN JR, 1994, J THEOR BIOL, V171, P325, DOI 10.1006/jtbi.1994.1235; Trippel EA, 1999, CAN J FISH AQUAT SCI, V56, P113, DOI 10.1139/cjfas-56-1-113; *UNEP EUROBATS, 2006, AGR CONS POP EUR BAT; Vaughan N, 1997, J APPL ECOL, V34, P716, DOI 10.2307/2404918; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wang BM, 2000, BIOELECTROMAGNETICS, V21, P52, DOI 10.1002/(SICI)1521-186X(200001)21:1<52::AID-BEM8>3.0.CO;2-6	45	35	38	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6246	10.1371/journal.pone.0006246	http://dx.doi.org/10.1371/journal.pone.0006246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606214	Green Published, Green Submitted, gold			2022-12-27	WOS:000268036000006
J	Skinner, AM; O'Neill, SL; Kurre, P				Skinner, Amy M.; O'Neill, S. Lee; Kurre, Peter			Cellular Microvesicle Pathways Can Be Targeted to Transfer Genetic Information between Non-Immune Cells	PLOS ONE			English	Article								Eukaryotic cell communication is based on protein signaling cascades that require direct cell-cell apposition, or receptor engagement by secreted molecules. The transmission of genetic information is thought to be uncommon, apart from recent reports of exosomal RNA transfer in immune and glioblastoma cells. We wished to examine if existing microvesicle pathways could be directly targeted for the horizontal transfer of RNA genomes in less specialized cell types. Using replication-deficient retrovirus vector, studies herein confirm that a range of cells routinely sequester a small population of these RNA genomes in a non-canonical compartment, refractory to antibody neutralization and unaffected by specific pharmacological inhibition of pathways involved in conventional viral trafficking. Our experiments further reveal the cytoplasmic colocalization of vector genomes with tetraspanin proteins as well as the PI-3-kinase sensitive trafficking and subsequent transmission to 2 degrees targets. Collectively, our results indicate a scalable process whereby cells route vector genomes to multivesicular bodies (MVB) for cytoplasmic trafficking and exosomal release. Our findings imply that cells can serve to deliver recombinant payload, targeted for the stable genetic modification of 2 degrees target cells.			Skinner, AM (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97201 USA.	kurrepe@ohsu.edu			NCRR NIH HHS [S10 RR023432, RR23432] Funding Source: Medline; NHLBI NIH HHS [R01 HL090765, F32 HL095351, HL90765, K08 HL077231, HL77231] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023432] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL077231, R01HL090765, F32HL095351] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Blomer U, 2005, GENE THER, V12, P67, DOI 10.1038/sj.gt.3302384; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; Coffin J, 1997, RETROVIRUSES; Cristiano Richard J., 1998, Frontiers in Bioscience, V3, pD1161; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; de Gassart A, 2004, TRAFFIC, V5, P896, DOI 10.1111/j.1600-0854.2004.00223.x; Fahrbach KM, 2007, J VIROL, V81, P6858, DOI 10.1128/JVI.02472-06; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; Fomina AF, 2003, EXP CELL RES, V291, P150, DOI 10.1016/S0014-4827(03)00372-0; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Greenwalt TJ, 2006, TRANSFUSION, V46, P143, DOI 10.1111/j.1537-2995.2006.00692.x; Haas DL, 2000, MOL THER, V2, P71, DOI 10.1006/mthe.2000.0094; Jain R, 2002, THEOR POPUL BIOL, V61, P489, DOI 10.1006/tpbi.2002.1596; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Jolly C, 2007, J VIROL, V81, P7873, DOI 10.1128/JVI.01845-06; KOK JW, 1990, EUR J CELL BIOL, V53, P173; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Logan AC, 2004, J VIROL, V78, P8421, DOI 10.1128/JVI.78.16.8421-8436.2004; MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8; Meng YR, 2005, CANCER IMMUNOL IMMUN, V54, P807, DOI 10.1007/s00262-004-0642-5; Pan YW, 2007, J VIROL, V81, P639, DOI 10.1128/JVI.01089-06; PAUZA CD, 1994, VIROLOGY, V205, P470, DOI 10.1006/viro.1994.1667; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Schaeffer E, 2004, J VIROL, V78, P1375, DOI 10.1128/JVI.78.3.1375-1383.2004; Sharova N, 2005, EMBO J, V24, P2481, DOI 10.1038/sj.emboj.7600707; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Maele B, 2003, J VIROL, V77, P4685, DOI 10.1128/JVI.77.8.4685-4694.2003; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Vidal M, 1997, J CELL SCI, V110, P1867; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Yunta M, 2003, CELL SIGNAL, V15, P559, DOI 10.1016/S0898-6568(02)00147-X; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	41	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6219	10.1371/journal.pone.0006219	http://dx.doi.org/10.1371/journal.pone.0006219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593443	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035400004
J	Schmidt, F; Champy, P; Seon-Meniel, B; Franck, X; Raisman-Vozari, R; Figadere, B				Schmidt, Fanny; Champy, Pierre; Seon-Meniel, Blandine; Franck, Xavier; Raisman-Vozari, Rita; Figadere, Bruno			Chemicals Possessing a Neurotrophin-Like Activity on Dopaminergic Neurons in Primary Culture	PLOS ONE			English	Article								Background: Neurotrophic factors have been shown to possess strong neuroprotective and neurorestaurative properties in Parkinson's disease patients. However the issues to control their delivery into the interest areas of the brain and their surgical administration linked to their unability to cross the blood brain barrier are many drawbacks responsible of undesirable side effects limiting their clinical use. A strategy implying the use of neurotrophic small molecules could provide an interesting alternative avoiding neurotrophin administration and side effects. In an attempt to develop drugs mimicking neurotrophic factors, we have designed and synthesized low molecular weight molecules that exhibit neuroprotective and neuritogenic potential for dopaminergic neurons. Principal Findings: A cell-based screening of an in-house quinoline-derived compound collection led to the characterization of compounds exhibiting both activities in the nanomolar range on mesencephalic dopaminergic neurons in spontaneous or 1-methyl-4-phenylpyridinium (MPP+)-induced neurodegeneration. This study provides evidence that rescued neurons possess a functional dopamine transporter and underlines the involvement of the extracellular signal-regulated kinase 1/2 signaling pathway in these processes. Conclusion: Cell-based screening led to the discovery of a potent neurotrophic compound possessing expected physicochemical properties for blood brain barrier penetration as a serious candidate for therapeutic use in Parkinson disease.			Schmidt, F (corresponding author), Univ Paris 11, Fac Pharm, CNRS, Lab Pharmacognosie, F-92290 Chatenay Malabry, France.	fanny.schmidt@gmail.com; bruno.figadere@u-psud.fr	Franck, Xavier/A-9049-2010	Franck, Xavier/0000-0002-5615-7504				Aoki S, 2002, TETRAHEDRON, V58, P5417, DOI 10.1016/S0040-4020(02)00519-7; Aoki S, 2001, BIOCHEM BIOPH RES CO, V289, P558, DOI 10.1006/bbrc.2001.6012; Barker RA, 2006, LANCET NEUROL, V5, P285, DOI 10.1016/S1474-4422(06)70386-6; BROWN CA, 1975, J AM CHEM SOC, V97, P891, DOI 10.1021/ja00837a034; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Champy P, 2004, J NEUROCHEM, V88, P63, DOI 10.1046/j.1471-4159.2003.02138.x; Chun J, 2003, J ORG CHEM, V68, P348, DOI 10.1021/jo026240+; Coowar D, 2004, J MED CHEM, V47, P6270, DOI 10.1021/jm0493616; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Desrivot J, 2007, J CHROMATOGR B, V854, P230, DOI 10.1016/j.jchromb.2007.04.029; Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; Fahn S., 2000, MERRITTS NEUROLOGY, P679; Fakhfakh MA, 2003, BIOORGAN MED CHEM, V11, P5013, DOI 10.1016/j.bmc.2003.09.007; Franck X, 2004, BIOORG MED CHEM LETT, V14, P3635, DOI 10.1016/j.bmcl.2004.05.026; Ghosha J, 2008, INT J ANTIMICROB AG, V32, P349, DOI 10.1016/j.ijantimicag.2008.05.001; Guerreiro S, 2008, MOL PHARMACOL, V74, P980, DOI 10.1124/mol.108.048207; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Lannuzel A, 2002, MOVEMENT DISORD, V17, P84, DOI 10.1002/mds.1246; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LUCHETTI F, 2008, FREE RADIC BIOL MED; MICHEL PP, 1990, J NEUROCHEM, V54, P1102, DOI 10.1111/j.1471-4159.1990.tb01935.x; Michel PP, 1996, J NEUROCHEM, V67, P1633; Michel PP, 1997, J NEUROCHEM, V69, P1499; Miloso M, 2008, CURR MED CHEM, V15, P538, DOI 10.2174/092986708783769731; Mizuno Y, 2008, PHILOS T R SOC B, V363, P2215, DOI 10.1098/rstb.2008.2273; Mourlevat S, 2003, MOL PHARMACOL, V64, P578, DOI 10.1124/mol.64.3.578; Musiol R, 2007, BIOORGAN MED CHEM, V15, P1280, DOI 10.1016/j.bmc.2006.11.020; OMURA K, 1978, TETRAHEDRON, V34, P1651, DOI 10.1016/0040-4020(78)80197-5; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Patel NK, 2005, ANN NEUROL, V57, P298, DOI 10.1002/ana.20374; Price RD, 2007, PHARMACOL THERAPEUT, V115, P292, DOI 10.1016/j.pharmthera.2007.03.005; Quinn NP, 1998, NEUROLOGY, V51, pS25, DOI 10.1212/WNL.51.2_Suppl_2.S25; Riederer P, 2007, PARKINSONISM RELAT D, V13, P466, DOI 10.1016/j.parkreldis.2007.06.015; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; SARAGOVI HU, 1991, SCIENCE, V253, P792, DOI 10.1126/science.1876837; Seong CM, 2008, BIOORG MED CHEM LETT, V18, P738, DOI 10.1016/j.bmcl.2007.11.045; Sonogashira K., 1975, TETRAHEDRON LETT, V16, P4467, DOI DOI 10.1016/S0040-4039(00)91094-3; Troadec JD, 2002, MOL PHARMACOL, V62, P1043, DOI 10.1124/mol.62.5.1043; Weinreb O, 2005, ANN NY ACAD SCI, V1053, P348, DOI 10.1196/annals.1344.030; Yogev-Falach M, 2003, FASEB J, V17, P2325, DOI 10.1096/fj.03-0078fje; Youdim MBH, 2007, PARKINSONISM RELAT D, V13, pS281, DOI 10.1016/S1353-8020(08)70017-8; Zhang LX, 2004, J NEUROCHEM, V91, P1358, DOI 10.1111/j.1471-4159.2004.02817.x; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092	50	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6215	10.1371/journal.pone.0006215	http://dx.doi.org/10.1371/journal.pone.0006215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593444	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035300021
J	Kao, J; Salari, K; Bocanegra, M; Choi, YL; Girard, L; Gandhi, J; Kwei, KA; Hernandez-Boussard, T; Wang, P; Gazdar, AF; Minna, JD; Pollack, JR				Kao, Jessica; Salari, Keyan; Bocanegra, Melanie; Choi, Yoon-La; Girard, Luc; Gandhi, Jeet; Kwei, Kevin A.; Hernandez-Boussard, Tina; Wang, Pei; Gazdar, Adi F.; Minna, John D.; Pollack, Jonathan R.			Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery	PLOS ONE			English	Article							ESTROGEN-RECEPTOR EXPRESSION; COPY NUMBER ALTERATION; BASAL-LIKE SUBTYPE; STEM-CELLS; SIGNALING PATHWAY; INTERFERON-ALPHA; PROTEIN; KINASE; ACTIVATION; GENOME	Background: Breast cancer cell lines have been used widely to investigate breast cancer pathobiology and new therapies. Breast cancer is a molecularly heterogeneous disease, and it is important to understand how well and which cell lines best model that diversity. In particular, microarray studies have identified molecular subtypes-luminal A, luminal B, ERBB2-associated, basal-like and normal-like-with characteristic gene-expression patterns and underlying DNA copy number alterations (CNAs). Here, we studied a collection of breast cancer cell lines to catalog molecular profiles and to assess their relation to breast cancer subtypes. Methods: Whole-genome DNA microarrays were used to profile gene expression and CNAs in a collection of 52 widely-used breast cancer cell lines, and comparisons were made to existing profiles of primary breast tumors. Hierarchical clustering was used to identify gene-expression subtypes, and Gene Set Enrichment Analysis (GSEA) to discover biological features of those subtypes. Genomic and transcriptional profiles were integrated to discover within high-amplitude CNAs candidate cancer genes with coordinately altered gene copy number and expression. Findings: Transcriptional profiling of breast cancer cell lines identified one luminal and two basal-like (A and B) subtypes. Luminal lines displayed an estrogen receptor (ER) signature and resembled luminal-A/B tumors, basal-A lines were associated with ETS-pathway and BRCA1 signatures and resembled basal-like tumors, and basal-B lines displayed mesenchymal and stem/progenitor-cell characteristics. Compared to tumors, cell lines exhibited similar patterns of CNA, but an overall higher complexity of CNA (genetically simple luminal-A tumors were not represented), and only partial conservation of subtype-specific CNAs. We identified 80 high-level DNA amplifications and 13 multi-copy deletions, and the resident genes with concomitantly altered gene-expression, highlighting known and novel candidate breast cancer genes. Conclusions: Overall, breast cancer cell lines were genetically more complex than tumors, but retained expression patterns with relevance to the luminal-basal subtype distinction. The compendium of molecular profiles defines cell lines suitable for investigations of subtype-specific pathobiology, cancer stem cell biology, biomarkers and therapies, and provides a resource for discovery of new breast cancer genes.			Kao, J (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	pollack1@stanford.edu	Califano, Andrea/F-7239-2012	Wang, Pei/0000-0002-6890-6453; Salari, Keyan/0000-0001-7940-4558	NATIONAL CANCER INSTITUTE [T32CA009302, R01CA097139, T32CA009151] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009302, R01 CA097139, T32 CA009151, CA97139] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; BAE SN, 1993, BREAST CANCER RES TR, V24, P241, DOI 10.1007/BF01833264; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bergamaschi A, 2008, MOL ONCOL, V2, P327, DOI 10.1016/j.molonc.2008.09.004; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Boulay A, 2008, CANCER RES, V68, P3743, DOI 10.1158/0008-5472.CAN-07-5100; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Charafe-Jauffret E, 2007, INT J CANCER, V121, P1779, DOI 10.1002/ijc.22923; Cheng A, 2001, J BIOL CHEM, V276, P25848, DOI 10.1074/jbc.M009734200; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Cho DH, 2007, ONCOGENE, V26, P2809, DOI 10.1038/sj.onc.1210080; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Dorsey JF, 2002, BLOOD, V99, P1388, DOI 10.1182/blood.V99.4.1388; Draviam VM, 2007, NAT CELL BIOL, V9, P556, DOI 10.1038/ncb1569; Dumon N, 2003, J BIOL CHEM, V278, P3275, DOI 10.1074/jbc.M204623200; French CA, 2002, J BIOL CHEM, V277, P19322, DOI 10.1074/jbc.M201402200; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; GUDAS JM, 1995, CLIN CANCER RES, V1, P235; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; HolstHansen C, 1996, CLIN EXP METASTAS, V14, P297; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; HULLEMAN E, 2008, J CELL MOL MED; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Inoue A, 2004, J MOL ENDOCRINOL, V32, P649, DOI 10.1677/jme.0.0320649; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; JELTSCH JM, 1987, NUCLEIC ACIDS RES, V15, P1401, DOI 10.1093/nar/15.4.1401; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kawabe T, 2000, ONCOGENE, V19, P4764, DOI 10.1038/sj.onc.1203841; Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lindvall C, 2003, CANCER RES, V63, P1743; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Manabe R, 2002, J CELL SCI, V115, P1497; Marhaba R, 2004, J MOL HISTOL, V35, P211; Mazzocca A, 2005, CANCER RES, V65, P4728, DOI 10.1158/0008-5472.CAN-04-4449; Molyneux G, 2007, CELL MOL LIFE SCI, V64, P3248, DOI 10.1007/s00018-007-7391-5; Neuzil J, 2007, BIOCHEM BIOPH RES CO, V355, P855, DOI 10.1016/j.bbrc.2007.01.159; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Oikawa T, 2004, CANCER SCI, V95, P626, DOI 10.1111/j.1349-7006.2004.tb03320.x; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Potemski P, 2007, HISTOPATHOLOGY, V51, P829, DOI 10.1111/j.1365-2559.2007.02886.x; Qi C, 2005, BIOCHEM BIOPH RES CO, V328, P393, DOI 10.1016/j.bbrc.2004.12.187; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; REYNOLDS JE, 1994, CANCER RES, V54, P6348; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Ross DT, 2001, DIS MARKERS, V17, P99, DOI 10.1155/2001/850531; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Samanta AK, 2004, J BIOL CHEM, V279, P7576, DOI 10.1074/jbc.M311659200; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; Schuler GD, 1997, J MOL MED, V75, P694, DOI 10.1007/s001090050155; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sims AH, 2007, NAT CLIN PRACT ONCOL, V4, P516, DOI 10.1038/ncponc0908; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Streicher KL, 2007, ONCOGENE, V26, P2104, DOI 10.1038/sj.onc.1210002; Subramaniam Deepa S, 2005, Curr Treat Options Oncol, V6, P147, DOI 10.1007/s11864-005-0022-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tari AM, 1999, ONCOGENE, V18, P1325, DOI 10.1038/sj.onc.1202422; Tibshirani R, 2008, BIOSTATISTICS, V9, P18, DOI 10.1093/biostatistics/kxm013; Tomlinson GE, 1998, CANCER RES, V58, P3237; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Volkmer E, 1999, J BIOL CHEM, V274, P567, DOI 10.1074/jbc.274.2.567; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; Wistuba II, 1998, CLIN CANCER RES, V4, P2931; Woodfield GW, 2007, CANCER RES, V67, P8439, DOI 10.1158/0008-5472.CAN-07-2293; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Zhang H T, 1999, Angiogenesis, V3, P211, DOI 10.1023/A:1009085422384; ZHANG L, 2008, J BIOL CHEM	102	523	538	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6146	10.1371/journal.pone.0006146	http://dx.doi.org/10.1371/journal.pone.0006146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19582160	Green Submitted, Green Published, gold			2022-12-27	WOS:000267806300015
J	Bate, R; Tren, R; Mooney, L; Hess, K; Mitra, B; Debroy, B; Attaran, A				Bate, Roger; Tren, Richard; Mooney, Lorraine; Hess, Kimberly; Mitra, Barun; Debroy, Bibek; Attaran, Amir			Pilot Study of Essential Drug Quality in Two Major Cities in India	PLOS ONE			English	Article								Background: India is an increasingly influential player in the global pharmaceutical market. Key parts of the drug regulatory system are controlled by the states, each of which applies its own standards for enforcement, not always consistent with others. A pilot study was conducted in two major cities in India, Delhi and Chennai, to explore the question/hypothesis/extent of substandard and counterfeit drugs available in the market and to discuss how the Indian state and federal governments could improve drug regulation and more importantly regulatory enforcement to combat these drugs. Methodology/Principal Findings: Random samples of antimalarial, antibiotic, and antimycobacterial drugs were collected from pharmacies in urban and peri-urban areas of Delhi and Chennai, India. Semi-quantitative thin-layer chromatography and disintegration testing were used to measure the concentration of active ingredients against internationally acceptable standards. 12% of all samples tested from Delhi failed either one or both tests, and were substandard. 5% of all samples tested from Chennai failed either one or both tests, and were substandard. Spatial heterogeneity between pharmacies was observed, with some having more or less substandard drugs (30% and 0% respectively), as was product heterogeneity, with some drugs being more or less frequently substandard (12% and 7% respectively). Conclusions/Significance: In a study using basic field-deployable techniques of lesser sensitivity rather than the most advanced laboratory-based techniques, the prevalence of substandard drugs in Delhi and Chennai is confirmed to be roughly in accordance with the Indian government's current estimates. However, important spatial and product heterogeneity exists, which suggests that India's substandard drug problem is not ubiquitous, but driven by a subset of manufacturers and pharmacies which thrive in an inadequately regulated environment. It is likely that the drug regulatory system in India needs to be improved for domestic consumption, and because India is an increasingly important exporter of drugs for both developed and developing countries. Some poor countries with high burdens of disease have weak drug regulatory systems and import many HIV/AIDS, tuberculosis and malaria drugs from India.			Bate, R (corresponding author), Africa Fighting Malaria, Washington, DC USA.	RBate@aei.org						Bate R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002132; European Commission Taxation and Customs Union, 2007, REP COMM CUST ACT CO; Global Pharma Health Fund E.V, 2008, GPHF MIN MAN; *GOV IND MIN HLTH, 2003, REP EXP COMM COMPR E; Lon CT, 2006, T ROY SOC TROP MED H, V100, P1019, DOI 10.1016/j.trstmh.2006.01.003; *WHO GLOB MAL PROG, 2008, WORLD MAL REP; World Health Organization, 2002, EFF DRUG REG MULT ST; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization (WHO), 2006, COUNT MED	9	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6003	10.1371/journal.pone.0006003	http://dx.doi.org/10.1371/journal.pone.0006003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547757	gold, Green Published			2022-12-27	WOS:000267347900002
J	Espinosa, E; Sanchez-Navarro, I; Gamez-Pozo, A; Marin, AP; Hardisson, D; Madero, R; Redondo, A; Zamora, P; Valiente, BS; Mendiola, M; Baron, MG; Vara, JAF				Espinosa, Enrique; Sanchez-Navarro, Iker; Gamez-Pozo, Angelo; Pinto Marin, Alvaro; Hardisson, David; Madero, Rosario; Redondo, Andres; Zamora, Pilar; San Jose Valiente, Belen; Mendiola, Marta; Gonzalez Baron, Manuel; Fresno Vara, Juan Angel			Comparison of Prognostic Gene Profiles Using qRT-PCR in Paraffin Samples: A Retrospective Study in Patients with Early Breast Cancer	PLOS ONE			English	Article							PREDICTIVE ACCURACY; SURVIVAL ANALYSIS; EXPRESSION; MODEL; VALIDATION; SIGNATURE; UTILITY; GRADE; WOMEN; INDEX	Introduction: Gene profiling may improve prognostic accuracy in patients with early breast cancer, but this technology is not widely available. We used commercial assays for qRT-PCR to assess the performance of the gene profiles included in the 70-Gene Signature, the Recurrence Score and the Two-Gene Ratio. Methods: 153 patients with early breast cancer and a minimum follow-up of 5 years were included. All tumours were positive for hormonal receptors and 38% had positive lymph nodes; 64% of patients received adjuvant chemotherapy. RNA was extracted from formalin-fixed paraffin-embedded (FFPE) specimens using a specific kit. qRT-PCR amplifications were performed with TaqMan Gene Expression Assays products. We applied the three gene-expression-based models to our patient cohort to compare the predictions derived from these gene sets. Results: After a median follow-up of 91 months, 22% of patients relapsed. The distant metastasis-free survival (DMFS) at 5 years was calculated for each profile. For the 70-Gene Signature, DMFS was 95% -good prognosis-versus 66% -poor prognosis. In the case of the Recurrence Score, DMFS was 98%, 81% and 69% for low, intermediate and high-risk groups, respectively. Finally, for the Two-Gene Ratio, DMFS was 86% versus 70%. The 70-Gene Signature and the Recurrence Score were highly informative in identifying patients with distant metastasis, even in multivariate analysis. Conclusion: Commercially available assays for qRT-PCR can be used to assess the prognostic utility of previously published gene expression profiles in FFPE material from patients with early breast cancer. Our results, with the use of a different platform and with different material, confirm the robustness of the 70-Gene Signature and represent an independent test for the Recurrence Score, using different primer/probe sets.			Espinosa, E (corresponding author), Hosp La Paz, Serv Oncol, Madrid, Spain.	eespinosa00@terra.es	Fresno Vara, Juan Angel/F-6702-2010; Hardisson, David/E-2832-2010; Gamez-Pozo, Angelo/N-2506-2014; Zamora, Pilar/AAM-9336-2021; Hardisson, David/AAN-3833-2020; Hardisson, David/A-6259-2011; Vara, Juan Ángel Fresno/Y-9928-2019	Fresno Vara, Juan Angel/0000-0003-1527-1252; Hardisson, David/0000-0002-2183-3699; Gamez-Pozo, Angelo/0000-0002-8931-0624; Vara, Juan Ángel Fresno/0000-0003-1527-1252; Espinosa Arranz, Enrique/0000-0001-6562-7902; Redondo Sanchez, Andres/0000-0002-7257-5642				ALBAIN K, 2007, PROGNOSTIC PREDICTIV; Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; Bergh J, 2001, J Natl Cancer Inst Monogr, P103; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Dunkler D, 2007, EUR J CANCER, V43, P745, DOI 10.1016/j.ejca.2006.11.018; Espinosa E, 2005, J CLIN ONCOL, V23, P7278, DOI 10.1200/JCO.2005.01.4746; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldstein LJ, 2008, J CLIN ONCOL, V26, P4063, DOI 10.1200/JCO.2007.14.4501; Habel LA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1412; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Koscielny S, 2008, CURR OPIN OBSTET GYN, V20, P47, DOI 10.1097/GCO.0b013e3282f39d9e; Lusa L, 2007, COMPUT METH PROG BIO, V87, P132, DOI 10.1016/j.cmpb.2007.05.009; Ma XJ, 2008, CLIN CANCER RES, V14, P2601, DOI 10.1158/1078-0432.CCR-07-5026; Ma XJ, 2006, J CLIN ONCOL, V24, P4611, DOI 10.1200/JCO.2006.06.6944; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; MOOK S, 2007, BREAST CANC PATIENTS; MOOK S, 2008, BREAST CANC RES TREA; Olivotto IA, 2005, J CLIN ONCOL, V23, P2716, DOI 10.1200/JCO.2005.06.178; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Schemper M, 2000, BIOMETRICS, V56, P249, DOI 10.1111/j.0006-341X.2000.00249.x; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	31	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5911	10.1371/journal.pone.0005911	http://dx.doi.org/10.1371/journal.pone.0005911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19547727	Green Published, gold			2022-12-27	WOS:000267029300005
J	Xu, F; Du, P; Shen, HB; Hu, HR; Wu, Q; Xie, J; Yu, L				Xu, Feng; Du, Pan; Shen, Hongbo; Hu, Hairong; Wu, Qi; Xie, Jun; Yu, Long			Correlated Mutation Analysis on the Catalytic Domains of Serine/Threonine Protein Kinases	PLOS ONE			English	Article								Background: Protein kinases (PKs) have emerged as the largest family of signaling proteins in eukaryotic cells and are involved in every aspect of cellular regulation. Great progresses have been made in understanding the mechanisms of PKs phosphorylating their substrates, but the detailed mechanisms, by which PKs ensure their substrate specificity with their structurally conserved catalytic domains, still have not been adequately understood. Correlated mutation analysis based on large sets of diverse sequence data may provide new insights into this question. Methodology/Principal Findings: Statistical coupling, residue correlation and mutual information analyses along with clustering were applied to analyze the structure-based multiple sequence alignment of the catalytic domains of the Ser/Thr PK family. Two clusters of highly coupled sites were identified. Mapping these positions onto the 3D structure of PK catalytic domain showed that these two groups of positions form two physically close networks. We named these two networks as theta-shaped and gamma-shaped networks, respectively. Conclusions/Significance: The theta-shaped network links the active site cleft and the substrate binding regions, and might participate in PKs recognizing and interacting with their substrates. The gamma-shaped network is mainly situated in one side of substrate binding regions, linking the activation loop and the substrate binding regions. It might play a role in supporting the activation loop and substrate binding regions before catalysis, and participate in product releasing after phosphoryl transfer. Our results exhibit significant correlations with experimental observations, and can be used as a guide to further experimental and theoretical studies on the mechanisms of PKs interacting with their substrates.			Xu, F (corresponding author), Fudan Univ, Inst Genet, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China.	xu_feng@fudan.edu.cn; longyu@fudan.edu.cn						Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Chen YH, 2006, J BIOL CHEM, V281, P18184, DOI 10.1074/jbc.M600349200; Cheng XD, 1998, BIOCHEMISTRY-US, V37, P14005, DOI 10.1021/bi981057p; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Eyal E, 2007, PROTEINS, V67, P142, DOI 10.1002/prot.21223; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Getz G, 2003, BIOINFORMATICS, V19, P1079, DOI 10.1093/bioinformatics/btf876; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Gum RJ, 1999, BIOCHEM BIOPH RES CO, V266, P284, DOI 10.1006/bbrc.1999.1787; Halperin I, 2006, PROTEINS, V63, P832, DOI 10.1002/prot.20933; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Hawkins J, 2000, ARCH BIOCHEM BIOPHYS, V382, P310, DOI 10.1006/abbi.2000.2005; Hoffman NG, 2003, VIROLOGY, V314, P536, DOI 10.1016/S0042-6822(03)00484-7; Horner DS, 2008, BRIEF BIOINFORM, V9, P46, DOI 10.1093/bib/bbm052; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ilouz R, 2006, J BIOL CHEM, V281, P30621, DOI 10.1074/jbc.M604633200; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kobe B, 2005, BBA-PROTEINS PROTEOM, V1754, P200, DOI 10.1016/j.bbapap.2005.07.036; Li F, 2002, J MOL BIOL, V315, P459, DOI 10.1006/jmbi.2001.5256; Lieser SA, 2005, BBA-PROTEINS PROTEOM, V1754, P191, DOI 10.1016/j.bbapap.2005.07.024; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; MCLACHLAN AD, 1971, J MOL BIOL, V61, P409, DOI 10.1016/0022-2836(71)90390-1; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Noivirt O, 2005, PROTEIN ENG DES SEL, V18, P247, DOI 10.1093/protein/gzi029; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nolen B, 2003, BIOCHEMISTRY-US, V42, P9575, DOI 10.1021/bi0344331; OLAH GA, 1993, BIOCHEMISTRY-US, V32, P3649, DOI 10.1021/bi00065a018; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Saraf MC, 2003, PROTEIN ENG, V16, P397, DOI 10.1093/protein/gzg053; Sayar K, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-23; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Stebbings LA, 2004, NUCLEIC ACIDS RES, V32, pD203, DOI 10.1093/nar/gkh027; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Wong L, 2004, ACCOUNTS CHEM RES, V37, P304, DOI 10.1021/ar020128g; Wu TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003; Zhu GZ, 2005, CELL CYCLE, V4, P52, DOI 10.4161/cc.4.1.1353	67	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5913	10.1371/journal.pone.0005913	http://dx.doi.org/10.1371/journal.pone.0005913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526051	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029300007
J	Hida, N; Awais, M; Takeuchi, M; Ueno, N; Tashiro, M; Takagi, C; Singh, T; Hayashi, M; Ohmiya, Y; Ozawa, T				Hida, Naoki; Awais, Muhammad; Takeuchi, Masaki; Ueno, Naoto; Tashiro, Mayuri; Takagi, Chiyo; Singh, Tanuja; Hayashi, Makoto; Ohmiya, Yoshihiro; Ozawa, Takeaki			High-Sensitivity Real-Time Imaging of Dual Protein-Protein Interactions in Living Subjects Using Multicolor Luciferases	PLOS ONE			English	Article								Networks of protein-protein interactions play key roles in numerous important biological processes in living subjects. An effective methodology to assess protein-protein interactions in living cells of interest is protein-fragment complement assay (PCA). Particularly the assays using fluorescent proteins are powerful techniques, but they do not directly track interactions because of its irreversibility or the time for chromophore formation. By contrast, PCAs using bioluminescent proteins can overcome these drawbacks. We herein describe an imaging method for real-time analysis of protein-protein interactions using multicolor luciferases with different spectral characteristics. The sensitivity and signal-to-background ratio were improved considerably by developing a carboxy-terminal fragment engineered from a click beetle luciferase. We demonstrate its utility in spatiotemporal characterization of Smad1-Smad4 and Smad2-Smad4 interactions in early developing stages of a single living Xenopus laevis embryo. We also describe the value of this method by application of specific protein-protein interactions in cell cultures and living mice. This technique supports quantitative analyses and imaging of versatile protein-protein interactions with a selective luminescence wavelength in opaque or strongly auto-fluorescent living subjects.	[Hida, Naoki; Takeuchi, Masaki; Tashiro, Mayuri; Ozawa, Takeaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 113, Japan; [Awais, Muhammad] Univ Liverpool, Sch Biol Sci, Ctr Cell Imaging, Liverpool, Merseyside, England; [Ueno, Naoto; Takagi, Chiyo; Singh, Tanuja; Hayashi, Makoto] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi, Japan; [Ohmiya, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, Osaka, Japan; [Ohmiya, Yoshihiro] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Ozawa, Takeaki] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan	University of Tokyo; University of Liverpool; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institute of Advanced Industrial Science & Technology (AIST); Hokkaido University; Japan Science & Technology Agency (JST)	Hida, N (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 113, Japan.	ozawa@chem.s.u-tokyo.ac.jp	Ohmiya, Yoshihiro/J-7143-2013; Awais, Muhammad/HCI-3725-2022	Ohmiya, Yoshihiro/0000-0002-4944-509X; Ueno, Naoto/0000-0002-8375-2317	Grants-in-Aid for Scientific Research [21675001] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Grinberg AV, 2004, MOL CELL BIOL, V24, P4294, DOI 10.1128/MCB.24.10.4294-4308.2004; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kaihara A, 2003, ANAL CHEM, V75, P4176, DOI 10.1021/ac0300800; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Kim SB, 2007, ACS CHEM BIOL, V2, P484, DOI 10.1021/cb7000439; Kurata T, 2001, DIFFERENTIATION, V67, P33, DOI 10.1046/j.1432-0436.2001.067001033.x; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Mervine SM, 2006, MOL PHARMACOL, V70, P194, DOI 10.1124/mol.106.022616; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Nakajima Y, 2005, BIOTECHNIQUES, V38, P891, DOI 10.2144/05386ST03; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Saka Y, 2007, DEVELOPMENT, V134, P4209, DOI 10.1242/dev.010645; Sato M, 2002, NAT BIOTECHNOL, V20, P287, DOI 10.1038/nbt0302-287; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; VIVIANI VR, 2007, LUCIFERASES FLUORESC, P151	28	60	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5868	10.1371/journal.pone.0005868	http://dx.doi.org/10.1371/journal.pone.0005868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19536355	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029100001
J	Butler, DC; Haramizu, S; Williamson, DL; Always, SE				Butler, David C.; Haramizu, Satoshi; Williamson, David L.; Always, Stephen E.			Phospho-Ablated Id2 Is Growth Suppressive and Pro-Apoptotic in Proliferating Myoblasts	PLOS ONE			English	Article								Inhibitor of differentiation protein-2 (Id2) is a dominant negative helix-loop-helix (HLH) protein, and a positive regulator of proliferation, in various cells. The N-terminal region of Id2 contains a consensus cdk2 phosphorylation sequence SPVR, which may be involved with the induction of apoptosis, at least in myeloid 32d. 3 cells. However, the role of Id2 phosphorylation at serine 5 in skeletal muscle cells is unknown. The objective of this study was to determine if the phosphorylation of Id2 at serine 5 alters its cellular localization and its role in apoptosis in C2C12 myoblasts. Overexpression of wild type Id2 decreased MyoD protein expression, which corresponded to the increased binding of Id2 to basic HLH proteins E47 and E12. Bromodeoxyuridine incorporation was significantly decreased by the overexpression of phospho-ablated Id2 ( S5A); conversely, overexpression of wild type Id2 increased cellular proliferation. The subcellular localization of Id2 and phospho-mimicking Id2 (S5D) were predominantly nuclear compared to S5A. The decreased nuclear localization of S5A corresponded to a decrease in cellular proliferation, and an increase in apoptosis. These data suggest that unphosphorylated Id2 is primarily localized in the cytosol, where it is growth suppressive and potentially pro-apoptotic. These results imply that reducing unphosphorylated Id2 may improve the pool of myoblasts available for differentiation by increasing proliferation and inhibiting apoptosis.			Butler, DC (corresponding author), David Axelrod Inst, Wadsworth Ctr NYS DOH, Albany, NY USA.	salway@hsc.wvu.edu		Alway, Stephen/0000-0002-0378-4707	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020866, P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021530] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR016440, RR020866, RR16440, S10 RR020866] Funding Source: Medline; NIA NIH HHS [R01 AG021530, R01 AG021530-04] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alway SE, 2003, AM J PHYSIOL-REG I, V284, pR540, DOI 10.1152/ajpregu.00550.2002; Alway SE, 2002, AM J PHYSIOL-REG I, V282, pR411, DOI 10.1152/ajpregu.00332.2001; Alway SE, 2002, AM J PHYSIOL-CELL PH, V283, pC66, DOI 10.1152/ajpcell.00598.2001; Alway SE, 2008, EXERC SPORT SCI REV, V36, P51, DOI 10.1097/JES.0b013e318168e9dc; Atherton GT, 1996, CELL GROWTH DIFFER, V7, P1059; BENEZRA R, 1990, ANN NY ACAD SCI, V599, P1; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Ferrari D, 1998, J EXP MED, V188, P979, DOI 10.1084/jem.188.5.979; Florio M, 1998, MOL CELL BIOL, V18, P5435, DOI 10.1128/MCB.18.9.5435; GRANT B, 1998, JAVA REP, V3, P6; Hara E, 1997, EMBO J, V16, P332, DOI 10.1093/emboj/16.2.332; HARA E, 1994, J BIOL CHEM, V269, P2139; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Jackman M, 2002, MOL BIOL CELL, V13, P1030, DOI 10.1091/mbc.01-07-0361; Jansen KM, 2008, CELL DEATH DIFFER, V15, P1619, DOI 10.1038/cdd.2008.90; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 1996, MOL CELL BIOL, V16, P2570; Lingbeck JM, 2005, ONCOGENE, V24, P6376, DOI 10.1038/sj.onc.1208789; Liu J, 2000, BIOCHEM BIOPH RES CO, V273, P1042, DOI 10.1006/bbrc.2000.3055; Matsumura ME, 2002, J BIOL CHEM, V277, P7293, DOI 10.1074/jbc.M108986200; NAGATA Y, 1995, BIOCHEM BIOPH RES CO, V207, P916, DOI 10.1006/bbrc.1995.1273; Norton JD, 1998, MOL CELL BIOL, V18, P2371, DOI 10.1128/MCB.18.4.2371; O'Flaherty J, 2006, APOPTOSIS, V11, P2103, DOI 10.1007/s10495-006-0196-4; Pagliuca A, 2000, CANCER RES, V60, P1376; Pirnia F, 2002, CELL DEATH DIFFER, V9, P905, DOI 10.1038/sj.cdd.4401062; Pistilli EE, 2006, J GERONTOL A-BIOL, V61, P245, DOI 10.1093/gerona/61.3.245; Shaltouki A, 2007, APOPTOSIS, V12, P2143, DOI 10.1007/s10495-007-0135-z; Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC1058, DOI 10.1152/ajpcell.00495.2004; Siu PM, 2006, J APPL PHYSIOL, V100, P907, DOI 10.1152/japplphysiol.01012.2005; Siu PM, 2005, J APPL PHYSIOL, V99, P1897, DOI 10.1152/japplphysiol.00374.2005; Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083; Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC338, DOI 10.1152/ajpcell.00239.2004; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; van Genderen H, 2006, NAT PROTOC, V1, P363, DOI 10.1038/nprot.2006.55; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042	42	8	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6302	10.1371/journal.pone.0006302	http://dx.doi.org/10.1371/journal.pone.0006302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609365	gold, Green Published, Green Submitted			2022-12-27	WOS:000268119500019
J	Zhu, Q; Li, XB; Chow, K; Liu, J				Zhu, Qi; Li, Xiaobai; Chow, Kari; Liu, Jia			The Part Task of the Part-Spacing Paradigm Is Not a Pure Measurement of Part-Based Information of Faces	PLOS ONE			English	Article								Background: Faces are arguably one of the most important object categories encountered by human observers, yet they present one of the most difficult challenges to both the human and artificial visual systems. A variety of experimental paradigms have been developed to study how faces are represented and recognized, among which is the part-spacing paradigm. This paradigm is presumed to characterize the processing of both the featural and configural information of faces, and it has become increasingly popular for testing hypotheses on face specificity and in the diagnosis of face perception in cognitive disorders. Methodology/Principal Findings: In two experiments we questioned the validity of the part task of this paradigm by showing that, in this task, measuring pure information about face parts is confounded by the effect of face configuration on the perception of those parts. First, we eliminated or reduced contributions from face configuration by either rearranging face parts into a non-face configuration or by removing the low spatial frequencies of face images. We found that face parts were no longer sensitive to inversion, suggesting that the previously reported inversion effect observed in the part task was due in fact to the presence of face configuration. Second, self-reported prosopagnosic patients who were selectively impaired in the holistic processing of faces failed to detect part changes when face configurations were presented. When face configurations were scrambled, however, their performance was as good as that of normal controls. Conclusions/Significance: In sum, consistent evidence from testing both normal and prosopagnosic subjects suggests the part task of the part-spacing paradigm is not an appropriate task for either measuring how face parts alone are processed or for providing a valid contrast to the spacing task. Therefore, conclusions from previous studies using the part-spacing paradigm may need re-evaluation with proper paradigms.			Zhu, Q (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	liujia@bnu.edu.cn	Zhu, Qi/AAW-9090-2021; Liu, Jia/C-5630-2011	Zhu, Qi/0000-0002-0993-3400; Liu, Jia/0000-0003-0383-0934				BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; Barton JJS, 2001, BRIT J PSYCHOL, V92, P527, DOI 10.1348/000712601162329; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Boutet I, 2003, PERCEPT PSYCHOPHYS, V65, P1078, DOI 10.3758/BF03194835; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Butler PD, 2008, SCHIZOPHR RES, V103, P283, DOI 10.1016/j.schres.2008.03.007; Cabeza R, 2000, PSYCHOL SCI, V11, P429, DOI 10.1111/1467-9280.00283; Collin CA, 2004, J EXP PSYCHOL HUMAN, V30, P975, DOI 10.1037/0096-1523.30.5.975; Duchaine BC, 2006, CURR OPIN NEUROBIOL, V16, P166, DOI 10.1016/j.conb.2006.03.003; Duchaine B, 2007, SOC COGN AFFECT NEUR, V2, P104, DOI 10.1093/scan/nsm003; Duchaine B, 2007, COGN NEUROPSYCHOL, V24, P419, DOI 10.1080/02643290701380491; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Farkas L.G., 1981, ANTHROPOMETRY HEAD F; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Gaspar C, 2008, VISION RES, V48, P2817, DOI 10.1016/j.visres.2008.09.015; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Goffaux V, 2005, PERCEPTION, V34, P77, DOI 10.1068/p5370; Goffaux V, 2008, ACTA PSYCHOL, V128, P119, DOI 10.1016/j.actpsy.2007.11.005; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; Goffaux V, 2007, J EXP PSYCHOL HUMAN, V33, P995, DOI 10.1037/0096-1523.33.4.995; Gruter T, 2008, J NEUROPSYCHOL, V2, P79, DOI 10.1348/174866407X231001; HOSIE JA, 1988, PERCEPTION, V17, P461, DOI 10.1068/p170461; Kennerknecht I, 2007, J HUM GENET, V52, P230, DOI 10.1007/s10038-006-0101-6; Kress T, 2003, BEHAV NEUROL, V14, P109, DOI 10.1155/2003/520476; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Le Grand R, 2003, NAT NEUROSCI, V6, P1108, DOI 10.1038/nn1121; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Leder H, 2006, BRIT J PSYCHOL, V97, P19, DOI 10.1348/000712605X54794; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Li XB, 2007, PROG NAT SCI, V17, P165; Liu J., 2009, J COGNITIVE NEUROSCI; Macho S, 1998, J EXP PSYCHOL HUMAN, V24, P1486, DOI 10.1037/0096-1523.24.5.1486; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; Nishimura M, 2008, VIS COGN, V16, P859, DOI 10.1080/13506280701538514; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; Rhodes G, 2006, PSYCHON B REV, V13, P499, DOI 10.3758/BF03193876; Riesenhuber M, 2004, P ROY SOC B-BIOL SCI, V271, pS448, DOI 10.1098/rsbl.2004.0216; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Searcy JH, 1996, J EXP PSYCHOL HUMAN, V22, P904, DOI 10.1037/0096-1523.22.4.904; Shin YW, 2008, SCHIZOPHRENIA BULL, V34, P538, DOI 10.1093/schbul/sbm118; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Yovel G, 2006, J COGNITIVE NEUROSCI, V18, P580, DOI 10.1162/jocn.2006.18.4.580; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7; Yovel G, 2008, PSYCHON B REV, V15, P933, DOI 10.3758/PBR.15.5.933	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6239	10.1371/journal.pone.0006239	http://dx.doi.org/10.1371/journal.pone.0006239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603077	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035700006
J	Kornblatt, JA				Kornblatt, Jack A.			Reduction of Canine Plasminogen Leads to an Expanded Molecule which Precipitates	PLOS ONE			English	Article								Canine plasminogen is made up of seven domains. In each domain there are several cysteines that are linked by disulfide bonds. Reduction of a limited number of the cystines destabilizes the protein such that it precipitates. The bond or bonds that are broken provide about 14 kcal of stabilization energy. Circular dichroism and dynamic light scattering indicate that there is probably an intermediate that is formed prior to precipitation and that the intermediate is somewhat larger than the compact form of plasminogen.			Kornblatt, JA (corresponding author), Concordia Univ, Dept Biol, Enzyme Res Grp, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	krnbltt@alcor.concordia.ca		kornblatt, jack/0000-0002-9802-8321				Abad MC, 2002, J MOL BIOL, V318, P1009, DOI 10.1016/S0022-2836(02)00211-5; ALKJAERSIG N, 1959, J BIOL CHEM, V234, P832; AZNAR J, 1980, THROMB HAEMOSTASIS, V43, P182; BACHMANN F, 1994, HAEMOSTASIS THROMBOS, P525; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Carter DM, 2005, CELL MOL BIOL, V51, pOL755, DOI 10.1170/90; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; CASTELLINO FJ, 1973, BIOCHEMISTRY-US, V12, P2787, DOI 10.1021/bi00739a002; Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Cockburn T, 1998, CHILDHOOD, V5, P99, DOI 10.1177/0907568298005001007; DANIEL E, 1966, BIOCHEMISTRY-US, V5, P1893, DOI 10.1021/bi00870a016; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Epple G, 2004, J THROMB HAEMOST, V2, P962, DOI 10.1111/j.1538-7836.2004.00675.x; ESTELLES A, 1980, THROMB RES, V18, P513, DOI 10.1016/0049-3848(80)90347-3; Getz EB, 1999, ANAL BIOCHEM, V273, P73, DOI 10.1006/abio.1999.4203; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2183; Kahn P C, 1979, Methods Enzymol, V61, P339; Kornblatt JA, 2005, BIOCHEMISTRY-US, V44, P13122, DOI 10.1021/bi050895y; Kornblatt JA, 2003, BIOCHEM BIOPH RES CO, V305, P518, DOI 10.1016/S0006-291X(03)00804-0; Kornblatt JA, 2001, BIOCHEMISTRY-US, V40, P3639, DOI 10.1021/bi001857b; Kornblatt JA, 2000, BBA-PROTEIN STRUCT M, V1481, P1, DOI 10.1016/S0167-4838(00)00119-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Markus G, 1996, FIBRINOLYSIS, V10, P75, DOI 10.1016/S0268-9499(96)80082-8; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; Miles LA, 2003, TRENDS CARDIOVAS MED, V13, P21, DOI 10.1016/S1050-1738(02)00190-1; MULICHAK AM, 1991, BIOCHEMISTRY-US, V30, P10576, DOI 10.1021/bi00107a029; OKAMOTO S, 1968, ANN NY ACAD SCI, V146, P414, DOI 10.1111/j.1749-6632.1968.tb20303.x; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Praus M, 2003, THROMB HAEMOSTASIS, V89, P812, DOI 10.1055/s-0037-1613466; PTITSYN OB, 1995, TRENDS BIOCHEM SCI, V20, P376, DOI 10.1016/S0968-0004(00)89081-7; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; Salmona M, 2005, J VIROL, V79, P11225, DOI 10.1128/JVI.79.17.11225-11230.2005; SAWYER JT, 1994, J BIOL CHEM, V269, P22440; SCHICK LA, 1974, BIOCHEM BIOPH RES CO, V57, P47, DOI 10.1016/S0006-291X(74)80355-4; Steven L.G., 2001, FRONT BIOSCI-LANDMRK, V6, pd1403, DOI [10.2741/gonias, DOI 10.2741/GONIAS]; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Wang XQ, 2000, J MOL BIOL, V295, P903, DOI 10.1006/jmbi.1999.3397; WEBER G, 1966, BIOCHEMISTRY-US, V5, P1900, DOI 10.1021/bi00870a017; WIMAN B, 1975, EUR J BIOCHEM, V57, P387, DOI 10.1111/j.1432-1033.1975.tb02312.x; WIMAN B, 1975, THROMB DIATH HAEMOST, V34, P350; YILLA M, 1992, J CELL BIOL, V118, P245, DOI 10.1083/jcb.118.2.245	47	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6196	10.1371/journal.pone.0006196	http://dx.doi.org/10.1371/journal.pone.0006196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593387	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035300009
J	Muller, KM; Schillinger, F; Do, DH; Leopold, DA				Mueller, Kai-Markus; Schillinger, Frieder; Do, David H.; Leopold, David A.			Dissociable Perceptual Effects of Visual Adaptation	PLOS ONE			English	Article							TILTED LINES; CORTEX; ORIENTATION; CONTRAST; CURVATURE; RESPONSES; DISCRIMINATION; REPRESENTATION; NORMALIZATION; MACAQUE	Neurons in the visual cortex are responsive to the presentation of oriented and curved line segments, which are thought to act as primitives for the visual processing of shapes and objects. Prolonged adaptation to such stimuli gives rise to two related perceptual effects: a slow change in the appearance of the adapting stimulus (perceptual drift), and the distortion of subsequently presented test stimuli (adaptational aftereffects). Here we used a psychophysical nulling technique to dissociate and quantify these two classical observations in order to examine their underlying mechanisms and their relationship to one another. In agreement with previous work, we found that during adaptation horizontal and vertical straight lines serve as attractors for perceived orientation and curvature. However, the rate of perceptual drift for different stimuli was not predictive of the corresponding aftereffect magnitudes, indicating that the two perceptual effects are governed by distinct neural processes. Finally, the rate of perceptual drift for curved line segments did not depend on the spatial scale of the stimulus, suggesting that its mechanisms lie outside strictly retinotopic processing stages. These findings provide new evidence that the visual system relies on statistically salient intrinsic reference stimuli for the processing of visual patterns, and point to perceptual drift as an experimental window for studying the mechanisms of visual perception.			Muller, KM (corresponding author), NIMH, NIH, Unit Cognit Neurophysiol & Imaging, Neuropsychol Lab, Bethesda, MD 20892 USA.	leopoldd@mail.nih.gov	Schillinger, Frieder/AAE-9088-2021	Schillinger, Frieder/0000-0002-3499-9313; Leopold, David/0000-0002-1345-6360	Intramural NIH HHS [Z01 MH002898-02] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002838, ZIAMH002898] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; BARLOW H, 1989, COMP NEUR S, P54; BURGESS AE, 1981, SCIENCE, V214, P93, DOI 10.1126/science.7280685; CAMPBELL FW, 1971, VISION RES, V11, P833, DOI 10.1016/0042-6989(71)90005-8; Clifford C.W.G., 2005, FITTING MIND WORLD A; Clifford CWG, 2007, VISION RES, V47, P3125, DOI 10.1016/j.visres.2007.08.023; Clifford CWG, 2000, P ROY SOC B-BIOL SCI, V267, P1705, DOI 10.1098/rspb.2000.1198; COLTHEART M, 1971, PSYCHOL REV, V78, P114, DOI 10.1037/h0030639; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; COREN S, 1967, PERCEPT PSYCHOPHYS, V2, P621, DOI 10.3758/BF03210280; CORNSWEET TN, 1962, AM J PSYCHOL, V75, P485, DOI 10.2307/1419876; DOBBINS A, 1989, VISION RES, V29, P1371, DOI 10.1016/0042-6989(89)90193-4; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P271, DOI 10.1113/jphysiol.1973.sp010308; FAHLE M, 1991, VISION RES, V31, P2149, DOI 10.1016/0042-6989(91)90170-A; Frisby J.P., 1979, SEEING ILLUSION BRAI; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; Gibson JJ, 1937, J EXP PSYCHOL, V20, P553, DOI 10.1037/h0057585; GREENLEE MW, 1987, VISION RES, V27, P1041, DOI 10.1016/0042-6989(87)90017-4; HARTMANN L, 1923, SOURCE BOOK GESTALT; Hegde J, 2000, J NEUROSCI, V20, part. no.; Hegde J, 2007, CEREB CORTEX, V17, P1100, DOI 10.1093/cercor/bhl020; HELD R, 1963, AM J PSYCHOL, V76, P146, DOI 10.2307/1420015; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1228, DOI 10.1073/pnas.0409311102; Howe CQ, 2002, P NATL ACAD SCI USA, V99, P13184, DOI 10.1073/pnas.162474299; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Jiang F, 2006, PSYCHOL SCI, V17, P493, DOI 10.1111/j.1467-9280.2006.01734.x; Jin DZ, 2005, J NEUROPHYSIOL, V94, P4038, DOI 10.1152/jn.00571.2004; Kohler Wolfgang, 1944, PROC AMER PHIL SOC, V88, P269; Leopold DA, 2005, P ROY SOC B-BIOL SCI, V272, P897, DOI 10.1098/rspb.2004.3022; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Liu T, 2007, NEURON, V55, P313, DOI 10.1016/j.neuron.2007.06.030; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; MANSFIELD RJ, 1974, SCIENCE, V186, P1133, DOI 10.1126/science.186.4169.1133; Meng X, 2005, VISION RES, V45, P3402, DOI 10.1016/j.visres.2005.05.016; MILLER EK, 1991, VISUAL NEUROSCI, V7, P357, DOI 10.1017/S0952523800004843; MITCHELL DE, 1976, VISION RES, V16, P609, DOI 10.1016/0042-6989(76)90007-9; MORANT RB, 1965, AM J PSYCHOL, V78, P218, DOI 10.2307/1420493; MULLER KM, 2009, VISUAL ADAPTATION CO; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; PRENTICE WCH, 1950, J EXP PSYCHOL, V40, P355, DOI 10.1037/h0058231; Rhodes G, 2006, VISION RES, V46, P2977, DOI 10.1016/j.visres.2006.03.002; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; SEKULER R, 1974, VISION RES, V14, P151, DOI 10.1016/0042-6989(74)90133-3; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Suzuki S, 2001, VISION RES, V41, P3883, DOI 10.1016/S0042-6989(01)00249-8; Suzuki S, 1998, J EXP PSYCHOL HUMAN, V24, P1315, DOI 10.1037/0096-1523.24.5.1315; SWITKES E, 1978, VISION RES, V18, P1393, DOI 10.1016/0042-6989(78)90232-8; TAYLOR MM, 1972, 72RP818 DCIEM; TEMPLETON WB, 1972, PERCEPT PSYCHOPHYS, V12, P422, DOI 10.3758/BF03205853; Webster M. A., 2005, FITTING MIND WORLD A; Wenderoth P, 1999, AUST NZ J OPHTHALMOL, V27, P271, DOI 10.1046/j.1440-1606.1999.00191.x; WENDEROTH P, 1989, PERCEPT PSYCHOPHYS, V46, P338, DOI 10.3758/BF03204987; Westheimer G, 1998, VISION RES, V38, P1097, DOI 10.1016/S0042-6989(97)00248-4; WOLFE JM, 1984, VISION RES, V24, P1959, DOI 10.1016/0042-6989(84)90030-0; WOLFE JM, 1986, INVEST OPHTH VIS SCI, V27, P538; Xu XM, 2007, J COMP NEUROL, V501, P741, DOI 10.1002/cne.21277	63	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6183	10.1371/journal.pone.0006183	http://dx.doi.org/10.1371/journal.pone.0006183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	471DN	19593384	Green Submitted, Green Published, gold			2022-12-27	WOS:000268035300004
J	Kategaya, LS; Changkakoty, B; Biechele, T; Conrad, WH; Kaykas, A; DasGupta, R; Moon, RT				Kategaya, Lorna S.; Changkakoty, Binita; Biechele, Travis; Conrad, William H.; Kaykas, Ajamete; DasGupta, Ramanuj; Moon, Randall T.			Bili Inhibits Wnt/beta-Catenin Signaling by Regulating the Recruitment of Axin to LRP6	PLOS ONE			English	Article								Background: Insights into how the Frizzled/LRP6 receptor complex receives, transduces and terminates Wnt signals will enhance our understanding of the control of the Wnt/beta-catenin pathway. Methodology/Principal Findings: In pursuit of such insights, we performed a genome-wide RNAi screen in Drosophila cells expressing an activated form of LRP6 and a beta-catenin-responsive reporter. This screen resulted in the identification of Bili, a Band4.1-domain containing protein, as a negative regulator of Wnt/beta-catenin signaling. We found that the expression of Bili in Drosophila embryos and larval imaginal discs significantly overlaps with the expression of Wingless (Wg), the Drosophila Wnt ortholog, which is consistent with a potential function for Bili in the Wg pathway. We then tested the functions of Bili in both invertebrate and vertebrate animal model systems. Loss-of-function studies in Drosophila and zebrafish embryos, as well as human cultured cells, demonstrate that Bili is an evolutionarily conserved antagonist of Wnt/beta-catenin signaling. Mechanistically, we found that Bili exerts its antagonistic effects by inhibiting the recruitment of AXIN to LRP6 required during pathway activation. Conclusions: These studies identify Bili as an evolutionarily conserved negative regulator of the Wnt/beta-catenin pathway.			Kategaya, LS (corresponding author), Univ Washington, Howard Hughes Med Inst, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.	rtmoon@u.washington.edu	Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Dasgupta, Ramanuj/0000-0001-9015-3729				Bejsovec A, 2006, ONCOGENE, V25, P7442, DOI 10.1038/sj.onc.1210051; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; BEJSOVEC A, 1993, DEVELOPMENT, V119, P501; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Erter CE, 2001, DEVELOPMENT, V128, P3571; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hendriksen J, 2005, J CELL BIOL, V171, P785, DOI 10.1083/jcb.200502141; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	24	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6129	10.1371/journal.pone.0006129	http://dx.doi.org/10.1371/journal.pone.0006129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GX	19572019	Green Published, gold, Green Submitted			2022-12-27	WOS:000267806200005
J	Airoldi, I; Di Carlo, E; Cocco, C; Caci, E; Cilli, M; Sorrentino, C; Sozzi, G; Ferrini, S; Rosini, S; Bertolini, G; Truini, M; Grossi, F; Galietta, LJV; Ribatti, D; Pistoia, V				Airoldi, Irma; Di Carlo, Emma; Cocco, Claudia; Caci, Emanuela; Cilli, Michele; Sorrentino, Carlo; Sozzi, Gabriella; Ferrini, Silvano; Rosini, Sandra; Bertolini, Giulia; Truini, Mauro; Grossi, Francesco; Galietta, Luis Juan Vicente; Ribatti, Domenico; Pistoia, Vito			IL-12 Can Target Human Lung Adenocarcinoma Cells and Normal Bronchial Epithelial Cells Surrounding Tumor Lesions	PLOS ONE			English	Article								Background: Non small cell lung cancer (NSCLC) is a leading cause of cancer death. We have shown previously that IL-12rb2 KO mice develop spontaneously lung adenocarcinomas or bronchioalveolar carcinomas. Aim of the study was to investigate i) IL-12Rb2 expression in human primary lung adenocarcinomas and in their counterparts, i. e. normal bronchial epithelial cells (NBEC), ii) the direct anti-tumor activity of IL-12 on lung adenocarcinoma cells in vitro and vivo, and the mechanisms involved, and iii) IL-12 activity on NBEC. Methodology/Principal Findings: Stage I lung adenocarcinomas showed significantly (P = 0.012) higher frequency of IL-12Rb2 expressing samples than stage II/III tumors. IL-12 treatment of IL-12R(+) neoplastic cells isolated from primary adenocarcinoma (n = 6) inhibited angiogenesis in vitro through down-regulation of different pro-angiogenic genes (e. g. IL-6, VEGF-C, VEGF-D, and laminin-5), as assessed by chorioallantoic membrane (CAM) assay and PCR array. In order to perform in vivo studies, the Calu6 NSCLC cell line was transfected with the IL-12RB2 containing plasmid (Calu6/beta 2). Similar to that observed in primary tumors, IL-12 treatment of Calu6/beta 2(+) cells inhibited angiogenesis in vitro. Tumors formed by Calu6/beta 2 cells in SCID/NOD mice, inoculated subcutaneously or orthotopically, were significantly smaller following IL-12 vs PBS treatment due to inhibition of angiogenesis, and of IL-6 and VEGF-C production. Explanted tumors were studied by histology, immuno-histochemistry and PCR array. NBEC cells were isolated and cultured from lung specimens of non neoplastic origin. NBEC expressed IL-12R and released constitutively tumor promoting cytokines (e. g. IL-6 and CCL2). Treatment of NBEC with IL-12 down-regulated production of these cytokines. Conclusions: This study demonstrates that IL-12 inhibits directly the growth of human lung adenocarcinoma and targets the adjacent NBEC. These novel anti-tumor activities of IL-12 add to the well known immune-modulatory properties of the cytokine and may provide a rational basis for the development of a clinical trial.			Airoldi, I (corresponding author), G Gaslini Inst Children, Dept Expt & Lab Med, AIRC Tumor Immunol Unit, Genoa, Italy.	irmaairoldi@ospedale-gaslini.ge.it	Grossi, Francesco/AAL-5024-2021; Bertolini, Giulia/K-7165-2016; Cilli, Michele/AAB-8529-2019; Galietta, Luis JV/HCG-8692-2022; Di Carlo, Emma/L-1024-2016; Cocco, Claudia/K-8595-2018; airoldi, irma/I-6169-2017; sozzi, gabriella/G-8259-2011	Grossi, Francesco/0000-0001-8412-3136; Bertolini, Giulia/0000-0002-8495-4594; Cocco, Claudia/0000-0003-0120-0955; airoldi, irma/0000-0002-4352-8396; sozzi, gabriella/0000-0001-9360-6914; Galietta, Luis/0000-0001-8686-3461; Grossi, Francesco/0000-0003-2694-968X; Cilli, Michele/0000-0003-4083-8986; Sorrentino, Carlo/0000-0002-6553-7429; Ferrini, Silvano/0000-0001-7254-2616; DI CARLO, EMMA/0000-0001-7778-1042	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Airoldi I, 2006, CANCER RES, V66, P3978, DOI 10.1158/0008-5472.CAN-05-4418; Airoldi I, 2005, BLOOD, V106, P3846, DOI 10.1182/blood-2005-05-2034; Airoldi I, 2004, J CLIN INVEST, V113, P1651, DOI 10.1172/JCI20042303; AIROLDI I, 2008, BLOOD; Airoldi I, 2007, P NATL ACAD SCI USA, V104, P3996, DOI 10.1073/pnas.0609028104; Bonomi P, 2000, J CLIN ONCOL, V18, P623, DOI 10.1200/JCO.2000.18.3.623; Broderick L, 2006, CLIN IMMUNOL, V118, P159, DOI 10.1016/j.clim.2005.09.008; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Cascone T, 2006, CURR OPIN ONCOL, V18, P151, DOI 10.1097/01.cco.0000208788.99570.0e; Chen JJW, 2003, CLIN CANCER RES, V9, P729; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Dias S, 1998, INT J CANCER, V78, P361, DOI 10.1002/(SICI)1097-0215(19981029)78:3<361::AID-IJC17>3.0.CO;2-9; Duda DG, 2000, CANCER RES, V60, P1111; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Galietta LJV, 2002, J IMMUNOL, V168, P839, DOI 10.4049/jimmunol.168.2.839; Galietta LJV, 1998, AM J PHYSIOL-LUNG C, V275, pL917, DOI 10.1152/ajplung.1998.275.5.L917; Galietta LJV, 1998, IN VITRO CELL DEV-AN, V34, P478; Galietta LJV, 2000, AM J PHYSIOL-LUNG C, V278, pL1186, DOI 10.1152/ajplung.2000.278.6.L1186; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gollob JA, 2000, CLIN CANCER RES, V6, P1678; Halin C, 2002, NAT BIOTECHNOL, V20, P264, DOI 10.1038/nbt0302-264; Kaspar M, 2007, CANCER RES, V67, P4940, DOI 10.1158/0008-5472.CAN-07-0283; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Krubasik D, 2008, INT J CANCER, V122, P1261, DOI 10.1002/ijc.23234; LANDIS JR, 1977, BIOMETRICS, V33, P174; Luppi F, 2007, LUNG CANCER, V56, P25, DOI 10.1016/j.lungcan.2006.11.014; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Ribatti D, 1997, J VASC RES, V34, P455, DOI 10.1159/000159256; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Saintigny P, 2007, LUNG CANCER, V58, P205, DOI 10.1016/j.lungcan.2007.06.021; Scavelli C, 2004, LEUKEMIA, V18, P1054, DOI 10.1038/sj.leu.2403355; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Seike M, 2007, JNCI-J NATL CANCER I, V99, P1257, DOI 10.1093/jnci/djm083; Sgadari C, 1996, BLOOD, V87, P3877, DOI 10.1182/blood.V87.9.3877.bloodjournal8793877; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sobin, 2009, UICC TNM CLASSIFICAT; Spinella F, 2009, CANCER RES, V69, P2669, DOI 10.1158/0008-5472.CAN-08-1879; Stormes KA, 2005, BREAST CANCER RES TR, V89, P209, DOI 10.1007/s10549-004-5328-3; Suzuki M, 2007, ANN SURG ONCOL, V14, P2636, DOI 10.1245/s10434-006-9310-7; Takizawa H, 2006, BRIT J CANCER, V95, P75, DOI 10.1038/sj.bjc.6603209; TRAVIS WD, 1999, HISTOLOGIC TYPING TU; VOEST EE, 1995, J NATL CANCER I, V87, P581, DOI 10.1093/jnci/87.8.581; Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Zhu YM, 2004, BRIT J CANCER, V91, P1970, DOI 10.1038/sj.bjc.6602227	45	31	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6119	10.1371/journal.pone.0006119	http://dx.doi.org/10.1371/journal.pone.0006119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19582164	Green Published, gold, Green Submitted			2022-12-27	WOS:000267572200018
J	Fahrenfort, I; Steijaert, M; Sjoerdsma, T; Vickers, E; Ripps, H; van Asselt, J; Endeman, D; Klooster, J; Numan, R; ten Eikelder, H; von Gersdorff, H; Kamermans, M				Fahrenfort, Iris; Steijaert, Marvin; Sjoerdsma, Trijntje; Vickers, Evan; Ripps, Harris; van Asselt, Jorrit; Endeman, Duco; Klooster, Jan; Numan, Robert; ten Eikelder, Huub; von Gersdorff, Henrique; Kamermans, Maarten			Hemichannel-Mediated and pH-Based Feedback from Horizontal Cells to Cones in the Vertebrate Retina	PLOS ONE			English	Article								Background: Recent studies designed to identify the mechanism by which retinal horizontal cells communicate with cones have implicated two processes. According to one account, horizontal cell hyperpolarization induces an increase in pH within the synaptic cleft that activates the calcium current (Ca2+-current) in cones, enhancing transmitter release. An alternative account suggests that horizontal cell hyperpolarization increases the Ca2+-current to promote transmitter release through a hemichannel-mediated ephaptic mechanism. Methodology/Principal Findings: To distinguish between these mechanisms, we interfered with the pH regulating systems in the retina and studied the effects on the feedback responses of cones and horizontal cells. We found that the pH buffers HEPES and Tris partially inhibit feedback responses in cones and horizontal cells and lead to intracellular acidification of neurons. Application of 25 mM acetate, which does not change the extracellular pH buffer capacity, does lead to both intracellular acidification and inhibition of feedback. Because intracellular acidification is known to inhibit hemichannels, the key experiment used to test the pH hypothesis, i.e. increasing the extracellular pH buffer capacity, does not discriminate between a pH-based feedback system and a hemichannel-mediated feedback system. To test the pH hypothesis in a manner independent of artificial pH-buffer systems, we studied the effect of interfering with the endogenous pH buffer, the bicarbonate/carbonic anhydrase system. Inhibition of carbonic anhydrase allowed for large changes in pH in the synaptic cleft of bipolar cell terminals and cone terminals, but the predicted enhancement of the cone feedback responses, according to the pH-hypothesis, was not observed. These experiments thus failed to support a proton mediated feedback mechanism. The alternative hypothesis, the hemichannel-mediated ephaptic feedback mechanism, was therefore studied experimentally, and its feasibility was buttressed by means of a quantitative computer model of the cone/horizontal cell synapse. Conclusion: We conclude that the data presented in this paper offers further support for physiologically relevant ephaptic interactions in the retina.			Fahrenfort, I (corresponding author), Netherlands Inst Neurosci, Res Unit Retinal Signal Proc, Amsterdam, Netherlands.	m.kamermans@nin.knaw.nl		Vickers, Evan/0000-0002-7053-4740	NEI NIH HHS [F32 EY006516, EY-06516, EY14043, R01 EY014043, R01 EY006516] Funding Source: Medline; NIDDK NIH HHS [T32 DK007680, 2 T32 DK007680-16] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006516, F32EY006516, R01EY014043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; Bevans CG, 1999, J BIOL CHEM, V274, P3711, DOI 10.1074/jbc.274.6.3711; BYZOV AL, 1986, VISION RES, V26, P33, DOI 10.1016/0042-6989(86)90069-6; Cadetti L, 2006, J NEUROPHYSIOL, V95, P1992, DOI 10.1152/jn.01042.2005; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Davenport CM, 2008, J NEUROSCI, V28, P456, DOI 10.1523/JNEUROSCI.2735-07.2008; David Rose B, 2001, CLIN PHYSL ACID BASE; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Dmitriev AV, 2006, J NEUROPHYSIOL, V95, P1419, DOI 10.1152/jn.00098.2005; Dmitriev AV, 2004, J NEUROPHYSIOL, V91, P2404, DOI 10.1152/jn.00881.2003; Fahrenfort I, 2004, VISUAL NEUROSCI, V21, P501, DOI 10.1017/S095252380421402X; FAHRENFORT I, 2004, PROG BRAIN RES, V147; GERSCHENFELD HM, 1980, PROC R SOC SER B-BIO, V206, P465, DOI 10.1098/rspb.1980.0008; Gunawardana SC, 2002, DIABETES, V51, P105, DOI 10.2337/diabetes.51.1.105; Hanitzsch R, 2001, VISION RES, V41, P2165, DOI 10.1016/S0042-6989(01)00116-X; Hille B., 1992, IONIC CHANNELS EXCIT; Hirasawa H, 2003, J GEN PHYSIOL, V122, P657, DOI 10.1085/jgp.200308863; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; KAMERMANS M, 1991, J GEN PHYSIOL, V97, P819, DOI 10.1085/jgp.97.4.819; Kamermans M, 1999, VISION RES, V39, P2449, DOI 10.1016/S0042-6989(99)00043-7; Kamermans M, 1996, VISION RES, V36, P4105, DOI 10.1016/S0042-6989(96)00143-5; Kamermans M, 2001, J PHYSIOL-LONDON, V534, P489, DOI 10.1111/j.1469-7793.2001.t01-1-00489.x; KAMERMANS M, 2002, INVEST OPHTHALMOL VI, V43; Klooster J, 2004, J COMP NEUROL, V474, P58, DOI 10.1002/cne.20114; Klooster J, 2001, J COMP NEUROL, V441, P155, DOI 10.1002/cne.1404; Kraaij DA, 2000, J GEN PHYSIOL, V115, P3, DOI 10.1085/jgp.115.1.3; Kraaij DA, 2000, J NEUROPHYSIOL, V84, P1256, DOI 10.1152/jn.2000.84.3.1256; MALCHOW RP, 1993, J NEUROSCI RES, V35, P237, DOI 10.1002/jnr.490350303; MAREN TH, 1967, PHYSIOL REV, V47, P595, DOI 10.1152/physrev.1967.47.4.595; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nagelhus EA, 2005, P NATL ACAD SCI USA, V102, P8030, DOI 10.1073/pnas.0503021102; NAHAS GG, 1962, PHARMACOL REV, V14, P447; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; OAKLEY B, 1989, J PHYSIOL-LONDON, V419, P353, DOI 10.1113/jphysiol.1989.sp017876; Ochrietor JD, 2005, EXP EYE RES, V81, P492, DOI 10.1016/j.exer.2005.03.010; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Parkkila S, 2001, P NATL ACAD SCI USA, V98, P1918, DOI 10.1073/pnas.98.4.1918; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Ripps H, 2002, J NEUROSCI METH, V121, P81, DOI 10.1016/S0165-0270(02)00243-1; Rusakov DA, 1998, P NATL ACAD SCI USA, V95, P8975, DOI 10.1073/pnas.95.15.8975; Shields CR, 2007, J COMP NEUROL, V501, P765, DOI 10.1002/cne.21282; STELL WK, 1975, J COMP NEUROL, V159, P473, DOI 10.1002/cne.901590404; Stryer L, 1981, Biochem Soc Symp, P39; TACHIBANA M, 1983, J PHYSIOL-LONDON, V345, P329, DOI 10.1113/jphysiol.1983.sp014981; TAKAHASHI K, 1995, ZOOL SCI, V12, P29, DOI 10.2108/zsj.12.29; TAKAHASHI KI, 1993, J GEN PHYSIOL, V101, P695, DOI 10.1085/jgp.101.5.695; Tatsukawa T, 2005, VISUAL NEUROSCI, V22, P317, DOI 10.1017/S0952523805223076; Thoreson WB, 2008, J NEUROSCI, V28, P5691, DOI 10.1523/JNEUROSCI.0403-08.2008; THORESON WB, 1990, VISUAL NEUROSCI, V5, P571, DOI 10.1017/S0952523800000730; Tombaugh GC, 1997, J NEUROPHYSIOL, V77, P639, DOI 10.1152/jn.1997.77.2.639; TORNQVIST K, 1988, J NEUROSCI, V8, P2279; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; Vigh J, 2005, J NEUROSCI, V25, P11412, DOI 10.1523/JNEUROSCI.2203-05.2005; Vigh J, 1999, VISUAL NEUROSCI, V16, P159, DOI 10.1017/S095252389916111X; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; Watson AJM, 2005, GASTROENTEROLOGY, V129, P902, DOI 10.1053/j.gastro.2005.06.015; WEILER R, 1984, BRAIN RES, V298, P1, DOI 10.1016/0006-8993(84)91141-7; WINKLER BS, 1986, EXP EYE RES, V42, P585, DOI 10.1016/0014-4835(86)90048-5; WITKOVSKY P, 1995, P NATL ACAD SCI USA, V92, P3556, DOI 10.1073/pnas.92.8.3556; WU SM, 1994, ANNU REV PHYSIOL, V56, P141; WU SM, 1991, J NEUROPHYSIOL, V65, P1197, DOI 10.1152/jn.1991.65.5.1197; Yamamoto K, 2008, ZOOL SCI, V25, P419, DOI 10.2108/zsj.25.419; YANG XL, 1988, J NEUROSCI, V8, P2269; YANG XL, 1988, J NEUROSCI, V8, P2259; Yu JS, 2007, J BIOL CHEM, V282, P8895, DOI 10.1074/jbc.M609317200	70	60	60	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6090	10.1371/journal.pone.0006090	http://dx.doi.org/10.1371/journal.pone.0006090			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564917	gold, Green Submitted, Green Published			2022-12-27	WOS:000267515700009
J	Liszekova, D; Polakovicova, M; Beno, M; Farkas, R				Liszekova, Denisa; Polakovicova, Maja; Beno, Milan; Farkas, Robert			Molecular Determinants of Juvenile Hormone Action as Revealed by 3D QSAR Analysis in Drosophila	PLOS ONE			English	Article							QUANTITATIVE STRUCTURE-ACTIVITY; GROWTH-REGULATORS; ADULT DEVELOPMENT; NUCLEAR RECEPTOR; DRUG-DELIVERY; BINDING; METAMORPHOSIS; INHIBITORS; MIMICS; INSECTICIDES	Background: Postembryonic development, including metamorphosis, of many animals is under control of hormones. In Drosophila and other insects these developmental transitions are regulated by the coordinate action of two principal hormones, the steroid ecdysone and the sesquiterpenoid juvenile hormone (JH). While the mode of ecdysone action is relatively well understood, the molecular mode of JH action remains elusive. Methodology/Principal Findings: To gain more insights into the molecular mechanism of JH action, we have tested the biological activity of 86 structurally diverse JH agonists in Drosophila melanogaster. The results were evaluated using 3D QSAR analyses involving CoMFA and CoMSIA procedures. Using this approach we have generated both computer-aided and species-specific pharmacophore fingerprints of JH and its agonists, which revealed that the most active compounds must possess an electronegative atom (oxygen or nitrogen) at both ends of the molecule. When either of these electronegative atoms are replaced by carbon or the distance between them is shorter than 11.5 angstrom or longer than 13.5 angstrom, their biological activity is dramatically decreased. The presence of an electron-deficient moiety in the middle of the JH agonist is also essential for high activity. Conclusions/Significance: The information from 3D QSAR provides guidelines and mechanistic scope for identification of steric and electrostatic properties as well as donor and acceptor hydrogen-bonding that are important features of the ligand-binding cavity of a JH target protein. In order to refine the pharmacophore analysis and evaluate the outcomes of the CoMFA and CoMSIA study we used pseudoreceptor modeling software PrGen to generate a putative binding site surrogate that is composed of eight amino acid residues corresponding to the defined molecular interactions.			Liszekova, D (corresponding author), Slovak Acad Sci, Inst Expt Endocrinol, Lab Dev Genet, Bratislava, Slovakia.	ueenfark@savba.sk	Beňová Liszeková, Denisa/ABB-1723-2021; Beno, Milan/ABA-4161-2021; Farkas, Robert/ABB-1990-2021	Farkas, Robert/0000-0002-9138-7567; Beno, Milan/0000-0003-3838-791X				ASHBURNE.M, 1970, NATURE, V227, P187, DOI 10.1038/227187a0; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Basak SC, 2006, J CHEM INF MODEL, V46, P65, DOI 10.1021/ci050215y; Bassoli A, 1998, J CHEM SOC PERK T 2, P1449, DOI 10.1039/a709167b; BOWNES M, 1989, J INSECT PHYSIOL, V35, P409, DOI 10.1016/0022-1910(89)90115-7; Carlberg C, 2006, CURR TOP MED CHEM, V6, P1243, DOI 10.2174/156802606777864908; Chang CEA, 2007, P NATL ACAD SCI USA, V104, P1534, DOI 10.1073/pnas.0610494104; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Ghafourian T, 2004, J CONTROL RELEASE, V99, P113, DOI 10.1016/j.jconrel.2004.06.010; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Gohlke H, 2002, ANGEW CHEM INT EDIT, V41, P2645; Gurrath M, 1998, PERSPECT DRUG DISCOV, V12, P135, DOI 10.1023/A:1017034122059; HENRICK CA, 1973, J AGR FOOD CHEM, V21, P354, DOI 10.1021/jf60187a043; HENRICK CA, 1995, AGROCHEMICALS NATURA, P47; Holdgate GA, 2005, DRUG DISCOV TODAY, V10, P1543, DOI 10.1016/S1359-6446(05)03610-X; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; IWAMURA H, 1985, ENVIRON HEALTH PERSP, V61, P307, DOI 10.2307/3430081; Jones G, 1997, P NATL ACAD SCI USA, V94, P13499, DOI 10.1073/pnas.94.25.13499; JUDY KJ, 1973, P NATL ACAD SCI USA, V70, P1509, DOI 10.1073/pnas.70.5.1509; KAZNOWSKI CE, 1985, J INSECT PHYSIOL, V31, P801, DOI 10.1016/0022-1910(85)90073-3; Kelly MD, 2005, J MED CHEM, V48, P1069, DOI 10.1021/jm049524q; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Klebe G, 1999, J COMPUT AID MOL DES, V13, P1, DOI 10.1023/A:1008047919606; Li JW, 2002, J CONTROL RELEASE, V82, P1, DOI 10.1016/S0168-3659(02)00007-X; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; MADHAVAN K, 1973, J INSECT PHYSIOL, V19, P441, DOI 10.1016/0022-1910(73)90119-4; Manivannan E, 2005, BIOORG MED CHEM LETT, V15, P4496, DOI 10.1016/j.bmcl.2005.07.014; MARENGO E, 1992, CHEMOMETR INTELL LAB, V16, P37, DOI 10.1016/0169-7439(92)80076-G; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Muthas D, 2005, BIOORGAN MED CHEM, V13, P5371, DOI 10.1016/j.bmc.2005.06.048; NAKAYAMA A, 1984, J MED CHEM, V27, P1493, DOI 10.1021/jm00377a019; NIWA A, 1989, J AGR FOOD CHEM, V37, P462, DOI 10.1021/jf00086a042; Olsson TSG, 2008, J MOL BIOL, V384, P1002, DOI 10.1016/j.jmb.2008.09.073; PECHINE JM, 1985, ANAL BIOCHEM, V145, P177, DOI 10.1016/0003-2697(85)90344-6; POSTLETHWAIT JH, 1974, BIOL BULL-US, V147, P119, DOI 10.2307/1540573; PUNJA N, 1973, NATURE-NEW BIOL, V242, P94, DOI 10.1038/newbio242094a0; Recanatini M, 2000, J MED CHEM, V43, P2007, DOI 10.1021/jm990971t; Reichelt J, 2005, BIOINFORMATICS, V21, P1291, DOI 10.1093/bioinformatics/bti138; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; RIDDIFORD LM, 1991, GEN COMP ENDOCR, V82, P172, DOI 10.1016/0016-6480(91)90181-5; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; Rochel N, 2006, CURR TOP MED CHEM, V6, P1229, DOI 10.2174/156802606777864926; Rogerson FM, 2004, MOL CELL ENDOCRINOL, V217, P203, DOI 10.1016/j.mce.2003.10.021; ROLLER H, 1967, ANGEW CHEM INT EDIT, V6, P179, DOI 10.1002/anie.196701792; SCHMIALEK P, 1961, Z NATURFORSCH PT B, VB 16, P461; SEHNAL F, 1976, J INSECT PHYSIOL, V22, P673, DOI 10.1016/0022-1910(76)90232-8; Slama K., 1985, P357; Slama K., 1974, INSECT HORMONES BIOA; Spitz IM, 1996, ANNU REV PHARMACOL, V36, P47; STAAL GB, 1975, ANNU REV ENTOMOL, V20, P417, DOI 10.1146/annurev.en.20.010175.002221; Stanton DT, 2004, J CHEM INF COMP SCI, V44, P1010, DOI 10.1021/ci034284t; Tervo AJ, 2003, J COMPUT AID MOL DES, V17, P797, DOI 10.1023/B:JCAM.0000021831.47952.a7; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; VEDANI A, 1995, J AM CHEM SOC, V117, P4987, DOI 10.1021/ja00122a030; Whitesides GM, 2005, Q REV BIOPHYS, V38, P385, DOI 10.1017/S0033583506004240; Wilcox RE, 2000, J MED CHEM, V43, P3005, DOI 10.1021/jm990526y; Wilson TG, 2004, J INSECT PHYSIOL, V50, P111, DOI 10.1016/j.jinsphys.2003.12.004; Zamora I, 2003, J MED CHEM, V46, P25, DOI 10.1021/jm011051p; Zbinden P, 1998, QUANT STRUCT-ACT REL, V17, P122, DOI 10.1002/(SICI)1521-3838(199804)17:02<122::AID-QSAR122>3.3.CO;2-C; Zhou XF, 2005, PHARM RES-DORDR, V22, P1989, DOI 10.1007/s11095-005-8112-0; Zhou XF, 2002, DEVELOPMENT, V129, P2259	64	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6001	10.1371/journal.pone.0006001	http://dx.doi.org/10.1371/journal.pone.0006001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547707	Green Published, gold, Green Submitted			2022-12-27	WOS:000267347900001
J	Cluff, T; Balasubramaniam, R				Cluff, Tyler; Balasubramaniam, Ramesh			Motor Learning Characterized by Changing Levy Distributions	PLOS ONE			English	Article							TIME SCALES; CONVERGENCE; FLIGHTS; MODELS	The probability distributions for changes in transverse plane fingertip speed are Levy distributed in human pole balancing. Six subjects learned to balance a pole on their index finger over three sessions while sitting and standing. The Levy or decay exponent decreased as a function of learning, showing reduced decay in the probability for large speed steps and was significantly smaller in the sitting condition. However, the probability distribution for changes in fingertip speed was truncated so that the probability for large steps was reduced in this condition. These results show a learning-induced tolerance for large speed step sizes and demonstrate that motor learning in continuous tasks may be characterized by changing distributions that reflect sensorimotor skill acquisition.			Cluff, T (corresponding author), McMaster Univ, Sensorimotor Neurosci Lab, Dept Kinesiol, Hamilton, ON, Canada.	clufft@mcmaster.ca	Balasubramaniam, Ramesh/GWC-4248-2022	Balasubramaniam, Ramesh/0000-0001-7575-3080				Bar-Shalom Y., 2002, ESTIMATION APPL TRAC; Cabrera JL, 2006, CONDENS MATTER PHYS, V9, P373, DOI 10.5488/CMP.9.2.373; Cabrera JL, 2004, CHAOS, V14, P691, DOI 10.1063/1.1785453; Cabrera JL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158702; CABRERA JL, 2004, J NONLINEAR STUD, V11, P305; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; CROSSMAN ERF, 1958, ERGONOMICS, V2, P153; ERMENTROUT GB, 2009, DS WEB MAGAZINE  JAN; Gupta HM, 2002, PHYSICA A, V309, P381, DOI 10.1016/S0378-4371(02)00545-9; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hosaka T, 2006, PROG THEOR PHYS SUPP, P314, DOI 10.1143/PTPS.161.314; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; KOPONEN I, 1995, PHYS REV E, V52, P1197, DOI 10.1103/PhysRevE.52.1197; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LEE TD, 1991, PHYS THER, V71, P150, DOI 10.1093/ptj/71.2.150; MANTEGNA RN, 1994, PHYS REV LETT, V73, P2946, DOI 10.1103/PhysRevLett.73.2946; Marthaler D, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016220; Mehta B, 2002, J NEUROPHYSIOL, V88, P942, DOI 10.1152/jn.2002.88.2.942; Milner TE, 2006, J NEUROPHYSIOL, V95, P893, DOI 10.1152/jn.00198.2005; Milner TE, 2007, NEUROIMAGE, V36, P388, DOI 10.1016/j.neuroimage.2007.01.057; Milton JG, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/48001; Milton J, 2008, METHODS, V45, P336, DOI 10.1016/j.ymeth.2008.05.002; Newell KM, 2001, PSYCHOL REV, V108, P57, DOI 10.1037//0033-295X.108.1.57; Petersen I. R, 1999, ROBUST KALMAN FILTER; Puttemans V, 2005, J NEUROSCI, V25, P4270, DOI 10.1523/JNEUROSCI.3866-04.2005; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Snoddy GS, 1926, J APPL PSYCHOL, V10, P1, DOI 10.1037/h0075814; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Witney AG, 2001, NEUROREPORT, V12, P649, DOI 10.1097/00001756-200103260-00007; Witney AG, 2000, J NEUROPHYSIOL, V84, P334, DOI 10.1152/jn.2000.84.1.334; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Zatsiorsky VM, 1999, MOTOR CONTROL, V3, P28, DOI 10.1123/mcj.3.1.28; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185	40	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5998	10.1371/journal.pone.0005998	http://dx.doi.org/10.1371/journal.pone.0005998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	461BB	19543399	Green Submitted, gold, Green Published			2022-12-27	WOS:000267237600011
J	Li, YJ; Cui, YJ; Hauck, Y; Platonov, ME; Dai, E; Song, YJ; Guo, ZB; Pourcel, C; Dentovskaya, SV; Anisimov, AP; Yang, RF; Vergnaud, G				Li, Yanjun; Cui, Yujun; Hauck, Yolande; Platonov, Mikhail E.; Dai, Erhei; Song, Yajun; Guo, Zhaobiao; Pourcel, Christine; Dentovskaya, Svetlana V.; Anisimov, Andrey P.; Yang, Ruifu; Vergnaud, Gilles			Genotyping and Phylogenetic Analysis of Yersinia pestis by MLVA: Insights into the Worldwide Expansion of Central Asia Plague Foci	PLOS ONE			English	Article								Background: The species Yersinia pestis is commonly divided into three classical biovars, Antiqua, Medievalis, and Orientalis, belonging to subspecies pestis pathogenic for human and the (atypical) non-human pathogenic biovar Microtus (alias Pestoides) including several non-pestis subspecies. Recent progress in molecular typing methods enables large-scale investigations in the population structure of this species. It is now possible to test hypotheses about its evolution which were proposed decades ago. For instance the three classical biovars of different geographical distributions were suggested to originate from Central Asia. Most investigations so far have focused on the typical pestis subspecies representatives found outside of China, whereas the understanding of the emergence of this human pathogen requires the investigation of strains belonging to subspecies pestis from China and to the Microtus biovar. Methodology/Principal Findings: Multi-locus VNTR analysis (MLVA) with 25 loci was performed on a collection of Y. pestis isolates originating from the majority of the known foci worldwide and including typical rhamnose-negative subspecies pestis as well as rhamnose-positive subspecies pestis and biovar Microtus. More than 500 isolates from China, the Former Soviet Union (FSU), Mongolia and a number of other foci around the world were characterized and resolved into 350 different genotypes. The data revealed very close relationships existing between some isolates from widely separated foci as well as very high diversity which can conversely be observed between nearby foci. Conclusions/Significance: The results obtained are in full agreement with the view that the Y. pestis subsp. pestis pathogenic for humans emerged in the Central Asia region between China, Kazakhstan, Russia and Mongolia, only three clones of which spread out of Central Asia. The relationships among the strains in China, Central Asia and the rest of the world based on the MLVA25 assay provide an unprecedented view on the expansion and microevolution of Y. pestis.			Li, YJ (corresponding author), Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Lab Analyt Microbiol, Beijing, Peoples R China.	gilles.vergnaud@u-psud.fr	Song, Yajun/GQQ-0476-2022; Platonov, Mikhail E/S-1209-2016; Cui, Yujun/E-7015-2012; Anisimov, Andrey P/D-2217-2009; Anisimov, Andrey P./H-5257-2012; Pourcel, Christine/E-4949-2017; Vergnaud, Gilles/AAC-1162-2020; Vergnaud, Gilles/P-1304-2015; Dentovskaya, Svetlana/F-4623-2017; Michael, Platonov/GZG-8615-2022; Song, Yajun/F-3714-2011	Song, Yajun/0000-0002-6628-2747; Anisimov, Andrey P/0000-0002-5499-7999; Anisimov, Andrey P./0000-0002-5499-7999; Pourcel, Christine/0000-0002-8951-466X; Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X; Dentovskaya, Svetlana/0000-0002-1996-8949; Song, Yajun/0000-0002-6628-2747; Platonov, Mihail/0000-0003-3946-1755				Achtman M, 2000, P NATL ACAD SCI USA, V97, P8192; Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Adair DM, 2000, J CLIN MICROBIOL, V38, P1516, DOI 10.1128/JCM.38.4.1516-1519.2000; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; BALTAZARD M, 1952, ANN I PASTEUR PARIS, V83, P241; BALTAZARD M, 1960, WHO CHRON, V14, P419; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; CHEN TH, 1949, J INFECT DIS, V85, P97, DOI 10.1093/infdis/85.1.97; Ciammaruconi A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-21; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Davis S, 2008, NATURE, V454, P634, DOI 10.1038/nature07053; DEVIGNAT R, 1951, Bull World Health Organ, V4, P247; Drancourt M, 2004, EMERG INFECT DIS, V10, P1585, DOI 10.3201/eid1009.030933; Eisen RJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008039; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; Guiyoule A, 1997, J CLIN MICROBIOL, V35, P2826, DOI 10.1128/JCM.35.11.2826-2833.1997; Hinchliffe SJ, 2003, GENOME RES, V13, P2018, DOI 10.1101/gr.1507303; Huang XZ, 2002, J CLIN MICROBIOL, V40, P1164, DOI 10.1128/JCM.40.4.1164-1173.2002; Ji S, 1990, CHI J EPIDEMIOL, V11, P1; Jiang W, 2005, CHINESE J ZOONOSES, V21, P1051; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Le Fleche P, 2001, BMC Microbiol, V1, P2; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; LUCIER TS, 1992, J BACTERIOL, V174, P2078, DOI 10.1128/JB.174.7.2078-2086.1992; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1186; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1168; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pourcel C, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-22; Sokurenko EV, 2006, NAT REV MICROBIOL, V4, P548, DOI 10.1038/nrmicro1446; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Tong ZZ, 2005, J MED MICROBIOL, V54, P259, DOI 10.1099/jmm.0.45752-0; Tong ZZ, 2005, J GEN APPL MICROBIOL, V51, P11, DOI 10.2323/jgam.51.11; Vergnaud G, 2005, EMERG INFECT DIS, V11, P1317; Vergnaud G, 2006, MOL IDENTIFICATION S, P83; Vergnaud G, 2007, ADV EXP MED BIOL, V603, P327; WANG S, 2008, ENDEMIC DIS B, V23, P13; Zhan YL, 2008, CHEM J CHINESE U, V29, P144; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]; Zhou DS, 2004, MICROBES INFECT, V6, P1226, DOI 10.1016/j.micinf.2004.08.002; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004; Zhou DS, 2004, MICROBIOL IMMUNOL, V48, P263, DOI 10.1111/j.1348-0421.2004.tb03522.x	44	78	103	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e6000	10.1371/journal.pone.0006000	http://dx.doi.org/10.1371/journal.pone.0006000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543392	Green Published, Green Submitted, gold			2022-12-27	WOS:000267237600013
J	Schwab, R; Maizel, A; Ruiz-Ferrer, V; Garcia, D; Bayer, M; Crespi, M; Voinnet, O; Martienssen, RA				Schwab, Rebecca; Maizel, Alexis; Ruiz-Ferrer, Virginia; Garcia, Damien; Bayer, Martin; Crespi, Martin; Voinnet, Olivier; Martienssen, Robert A.			Endogenous TasiRNAs Mediate Non-Cell Autonomous Effects on Gene Regulation in Arabidopsis thaliana	PLOS ONE			English	Article							TRANS-ACTING SIRNAS; DEPENDENT RNA-POLYMERASE; INTERFERING RNA; IN-VIVO; BIOGENESIS; DICER; DICER-LIKE-4; MICRORNAS; PATHWAY; TARGETS	Background: Different classes of small RNAs (sRNAs) refine the expression of numerous genes in higher eukaryotes by directing protein partners to complementary nucleic acids, where they mediate gene silencing. Plants encode a unique class of sRNAs, called trans-acting small interfering RNAs (tasiRNAs), which post-transcriptionally regulate protein-coding transcripts, as do microRNAs (miRNAs), and both sRNA classes control development through their targets. TasiRNA biogenesis requires multiple components of the siRNA pathway and also miRNAs. But while 21mer siRNAs originating from transgenes can mediate silencing across several cell layers, miRNA action seems spatially restricted to the producing or closely surrounding cells. Principal Findings: We have previously described the isolation of a genetrap reporter line for TAS3a, the major locus producing AUXIN RESPONS FACTOR (ARF)-regulating tasiRNAs in the Arabidopsis shoot. Its activity is limited to the adaxial (upper) side of leaf primordia, thus spatially isolated from ARF-activities, which are located in the abaxial (lower) side. We show here by in situ hybridization and reporter fusions that the silencing activities of ARF-regulating tasiRNAs are indeed manifested non-cell autonomously to spatially control ARF activities. Conclusions/Significance: Endogenous tasiRNAs are thus mediators of a mobile developmental signal and might provide effective gene silencing at a distance beyond the reach of most miRNAs.			Schwab, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Bayer, Martin/AAP-3372-2020; Garcia, Damien/AAR-2531-2020; Maizel, Alexis/D-3560-2012; Schwab, Rebecca/I-9352-2012; Crespi, Martin/AAB-1424-2020	Bayer, Martin/0000-0001-5806-2253; Garcia, Damien/0000-0001-6142-1974; Maizel, Alexis/0000-0001-6843-1059; Schwab, Rebecca/0000-0001-9933-9669; Crespi, Martin/0000-0002-5698-9482; Voinnet, Olivier/0000-0001-6982-9544; Ruiz-Ferrer, Virginia/0000-0002-7840-297X				Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hunter C, 2006, DEVELOPMENT, V133, P2973, DOI 10.1242/dev.02491; Li H, 2005, PLANT CELL, V17, P2157, DOI 10.1105/tpc.105.033449; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Nakazawa Y, 2007, PLANT MOL BIOL, V63, P777, DOI 10.1007/s11103-006-9125-8; Nogueira FTS, 2007, GENE DEV, V21, P750, DOI 10.1101/gad.1528607; Nogueira FTS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000320; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Poethig RS, 2006, COLD SPRING HARB SYM, V71, P165, DOI 10.1101/sqb.2006.71.030; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Tretter EM, 2008, PLANT PHYSIOL, V147, P58, DOI 10.1104/pp.108.117119; VAUCHERET H, 2005, SCI STKE, pPE43, DOI DOI 10.1126/STKE.3002005PE42; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Weigel D., 2002, ARABIDOPSIS LAB MANU; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605	30	74	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5980	10.1371/journal.pone.0005980	http://dx.doi.org/10.1371/journal.pone.0005980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543387	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000267237400007
J	Zheng, MZ; Beck, M; Muller, J; Chen, T; Wang, XH; Wang, F; Wang, QL; Wang, YQ; Baluska, F; Logan, DC; Samaj, J; Lin, JX				Zheng, Maozhong; Beck, Martina; Mueller, Jens; Chen, Tong; Wang, Xiaohua; Wang, Feng; Wang, Qinli; Wang, Yuqing; Baluska, Frantisek; Logan, David C.; Samaj, Jozef; Lin, Jinxing			Actin Turnover Is Required for Myosin-Dependent Mitochondrial Movements in Arabidopsis Root Hairs	PLOS ONE			English	Article								Background: Previous studies have shown that plant mitochondrial movements are myosin-based along actin filaments, which undergo continuous turnover by the exchange of actin subunits from existing filaments. Although earlier studies revealed that actin filament dynamics are essential for many functions of the actin cytoskeleton, there are little data connecting actin dynamics and mitochondrial movements. Methodology/Principal Findings: We addressed the role of actin filament dynamics in the control of mitochondrial movements by treating cells with various pharmaceuticals that affect actin filament assembly and disassembly. Confocal microscopy of Arabidopsis thaliana root hairs expressing GFP-FABD2 as an actin filament reporter showed that mitochondrial distribution was in agreement with the arrangement of actin filaments in root hairs at different developmental stages. Analyses of mitochondrial trajectories and instantaneous velocities immediately following pharmacological perturbation of the cytoskeleton using variable-angle evanescent wave microscopy and/or spinning disk confocal microscopy revealed that mitochondrial velocities were regulated by myosin activity and actin filament dynamics. Furthermore, simultaneous visualization of mitochondria and actin filaments suggested that mitochondrial positioning might involve depolymerization of actin filaments on the surface of mitochondria. Conclusions/Significance: Base on these results we propose a mechanism for the regulation of mitochondrial speed of movements, positioning, and direction of movements that combines the coordinated activity of myosin and the rate of actin turnover, together with microtubule dynamics, which directs the positioning of actin polymerization events.			Zheng, MZ (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photosynthesis & Mol Environm Physiol, Beijing, Peoples R China.	linjx@ibcas.ac.cn	Chen, Tong/C-5684-2014; Wang, Xiaohua/AAH-5067-2020; Samaj, Jozef/AAD-4206-2022; Wang, yuqing/HIR-1604-2022; Baluska, Frantisek/AAQ-1358-2021	Chen, Tong/0000-0002-2456-7170; Wang, Xiaohua/0000-0003-2320-4543; Samaj, Jozef/0000-0003-4750-2123; Logan, David/0000-0002-8980-240X; Lin, Jinxing/0000-0001-9338-1356				Anthony RG, 1999, TRENDS PLANT SCI, V4, P112, DOI 10.1016/S1360-1385(99)01378-3; Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Bereiter-Hahn J., 1990, International Review of Cytology, V122, P1, DOI 10.1016/S0074-7696(08)61205-X; Boldogh IR, 2001, P NATL ACAD SCI USA, V98, P3162, DOI 10.1073/pnas.051494698; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Cheung AY, 2004, PLANT CELL, V16, P257, DOI 10.1105/tpc.016550; Christensen CA, 2002, PLANT CELL, V14, P2215, DOI 10.1105/tpc.002170; de Win AHN, 1999, BIOPHYS J, V76, P1648, DOI 10.1016/S0006-3495(99)77324-8; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Doniwa Y, 2007, PLANT BIOTECHNOL-NAR, V24, P441, DOI 10.5511/plantbiotechnology.24.441; Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; FERGUSON IB, 1985, PLANT PHYSIOL, V77, P877, DOI 10.1104/pp.77.4.877; Funaki K, 2004, PLANT CELL PHYSIOL, V45, P1342, DOI 10.1093/pcp/pch154; He X, 2006, ANN BOT-LONDON, V98, P49, DOI 10.1093/aob/mcl084; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; HUGDAHL JD, 1993, PLANT PHYSIOL, V102, P725, DOI 10.1104/pp.102.3.725; Kamasaki T, 2005, NAT CELL BIOL, V7, P916, DOI 10.1038/ncb1295; Ketelaar T, 2003, PLANT CELL, V15, P285, DOI 10.1105/tpc.007039; Konopka CA, 2008, PLANT CELL, V20, P1363, DOI 10.1105/tpc.108.059428; Konopka CA, 2008, PLANT J, V53, P186, DOI 10.1111/j.1365-313X.2007.03306.x; KOONCE MP, 1986, CELL MOTIL CYTOSKEL, V6, P521, DOI 10.1002/cm.970060511; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; KUZNETSOV SA, 1992, NATURE, V356, P722, DOI 10.1038/356722a0; Ligon LA, 2000, J COMP NEUROL, V427, P351, DOI 10.1002/1096-9861(20001120)427:3<351::AID-CNE3>3.0.CO;2-R; Logan DC, 2000, J EXP BOT, V51, P865, DOI 10.1093/jexbot/51.346.865; Logan DC, 2003, PLANT PHYSIOL, V133, P21, DOI 10.1104/pp.103.026047; LUVISETTO S, 1992, J BIOL CHEM, V267, P15348; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; MCCABE M, 1967, NATURE, V213, P280, DOI 10.1038/213280b0; MENZEL D, 1989, BOT ACTA, V102, P241, DOI 10.1111/j.1438-8677.1989.tb00100.x; Minin AA, 2006, J CELL SCI, V119, P659, DOI 10.1242/jcs.02762; Olyslaegers G, 1998, J MICROSC-OXFORD, V192, P73, DOI 10.1046/j.1365-2818.1998.00398.x; Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863; Peremyslov VV, 2008, PLANT PHYSIOL, V146, P1109, DOI 10.1104/pp.107.113654; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Prokhnevsky AI, 2008, P NATL ACAD SCI USA, V105, P19744, DOI 10.1073/pnas.0810730105; Reisen D, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-6; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Scott I, 2008, NEW PHYTOL, V177, P90, DOI 10.1111/j.1469-8137.2007.02255.x; Sedbrook JC, 2004, CURR OPIN PLANT BIOL, V7, P632, DOI 10.1016/j.pbi.2004.09.017; Sheahan MB, 2005, PLANT J, V44, P744, DOI 10.1111/j.1365-313X.2005.02561.x; Sheahan MB, 2004, PLANT J, V37, P379, DOI 10.1046/j.1365-313X.2003.01967.x; Sieberer BJ, 2005, NEW PHYTOL, V167, P711, DOI 10.1111/j.1469-8137.2005.01506.x; Staiger CJ, 2009, J CELL BIOL, V184, P269, DOI 10.1083/jcb.200806185; STURMER K, 1995, J CELL SCI, V108, P2273; Taraska JW, 2004, P NATL ACAD SCI USA, V101, P8780, DOI 10.1073/pnas.0401316101; Tominaga M, 2000, PROTOPLASMA, V213, P46, DOI 10.1007/BF01280504; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Tsuboi T, 2003, BIOCHEM SOC T, V31, P833, DOI 10.1042/BST0310833; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Van Gestel K, 2002, J EXP BOT, V53, P659, DOI 10.1093/jexbot/53.369.659; Visegrady B, 2004, FEBS LETT, V565, P163, DOI 10.1016/j.febslet.2004.03.096; Voigt B, 2005, EUR J CELL BIOL, V84, P609, DOI 10.1016/j.ejcb.2004.12.029; Voigt B, 2005, EUR J CELL BIOL, V84, P595, DOI 10.1016/j.ejcb.2004.11.011; Wang XH, 2006, PLANT PHYSIOL, V141, P1591, DOI 10.1104/pp.106.080168; Wang ZY, 2004, CELL MOTIL CYTOSKEL, V57, P218, DOI 10.1002/cm.10168; Wasteneys GO, 2004, PLANT PHYSIOL, V136, P3884, DOI 10.1104/pp.104.900133; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Wilsen KL, 2006, SEX PLANT REPROD, V19, P51, DOI 10.1007/s00497-006-0021-9; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Zablocki K, 2003, CELL CALCIUM, V33, P91, DOI 10.1016/S0143-4160(02)00202-6	66	44	47	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5961	10.1371/journal.pone.0005961	http://dx.doi.org/10.1371/journal.pone.0005961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536333	Green Published, gold, Green Submitted			2022-12-27	WOS:000267079500010
J	Martin-Loeches, M; Sel, A; Casado, P; Jimenez, L; Castellanos, L				Martin-Loeches, Manuel; Sel, Alejandra; Casado, Pilar; Jimenez, Laura; Castellanos, Luis			Encouraging Expressions Affect the Brain and Alter Visual Attention	PLOS ONE			English	Article								Background: Very often, encouraging or discouraging expressions are used in competitive contexts, such as sports practice, aiming at provoking an emotional reaction on the listener and, consequently, an effect on subsequent cognition and/or performance. However, the actual efficiency of these expressions has not been tested scientifically. Methodology/Principal Findings: To fill this gap, we studied the effects of encouraging, discouraging, and neutral expressions on event-related brain electrical activity during a visual selective attention task in which targets were determined by location, shape, and color. Although the expressions preceded the attentional task, both encouraging and discouraging messages elicited a similar long-lasting brain emotional response present during the visuospatial task. In addition, encouraging expressions were able to alter the customary working pattern of the visual attention system for shape selection in the attended location, increasing the P1 and the SP modulations while simultaneously fading away the SN. Conclusions/Significance: This was interpreted as an enhancement of the attentional processes for shape in the attended location after an encouraging expression. It can be stated, therefore, that encouraging expressions, as those used in sport practice, as well as in many other contexts and situations, do seem to be efficient in exerting emotional reactions and measurable effects on cognition.			Martin-Loeches, M (corresponding author), UCM ISCIII, Ctr Human Evolut & Behav, Madrid, Spain.	mmartinloeches@edu.ucm.es	Martin-Loeches, Manuel/G-4288-2017; Casado, Pilar/GPX-1002-2022; Jimenez-Ortega, Laura/F-5590-2016	Martin-Loeches, Manuel/0000-0002-3487-8423; Jimenez-Ortega, Laura/0000-0001-8002-5563; Casado, PILAR/0000-0002-3991-4155; Sel, Alex/0000-0002-1601-8833				American Electroencephalographic Society, 1991, J CLIN NEUROPHYSIOL, V3, P38; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; BACHOROWSKI J, 2009, ENCY NEUROSCIENCE, P897; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9; Brosch T, 2008, COGNITION, V106, P1497, DOI 10.1016/j.cognition.2007.05.011; Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carretie L, 2009, NEUROPSYCHOLOGIA, V47, P364, DOI 10.1016/j.neuropsychologia.2008.09.007; Chen J, 2008, NEUROSCI LETT, V445, P135, DOI 10.1016/j.neulet.2008.08.061; Clark L, 2001, J AFFECT DISORDERS, V63, P179, DOI 10.1016/S0165-0327(00)00183-X; Clore G.L., 1994, NATURE EMOTION FUNDA, P285; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CRITCHLEY HD, 2004, NAT NEUROSCI, V13, P1202; Federmeier KD, 2001, NEUROSCI LETT, V305, P149, DOI 10.1016/S0304-3940(01)01843-2; Fenske MJ, 2003, EMOTION, V3, P327, DOI 10.1037/1528-3542.3.4.327; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; Gray JR, 2001, J EXP PSYCHOL GEN, V130, P436, DOI 10.1037//0096-3445.130.3.436; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; ISEN AM, 1985, J PERS SOC PSYCHOL, V48, P1413, DOI 10.1037/0022-3514.48.6.1413; ISEN AM, 1987, ADV EXP SOC PSYCHOL, V20, P203, DOI 10.1016/s0065-2601(08)60415-3; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; KENEALY PM, 1986, MOTIV EMOTION, V10, P315, DOI 10.1007/BF00992107; Lambie JA, 2002, PSYCHOL REV, V109, P219, DOI 10.1037//0033-295X.109.2.219; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Mangun GR, 1998, HUM BRAIN MAPP, V6, P383, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<383::AID-HBM10>3.0.CO;2-Z; MANGUN GR, 1995, OX PSYCH S, P40; Martin-Loeches M, 1999, PSYCHOPHYSIOLOGY, V36, P721, DOI 10.1111/1469-8986.3660721; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Mitchell RLC, 2007, NEUROPSYCHOLOGIA, V45, P617, DOI 10.1016/j.neuropsychologia.2006.06.030; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pham MT, 2007, REV GEN PSYCHOL, V11, P155, DOI 10.1037/1089-2680.11.2.155; Phillips L.H., 2002, EMOTION, V2, P21, DOI DOI 10.1037//1528-3542.2.1.12; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Posner M. I., 1994, IMAGES MIND; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rolls E. T., 2005, EMOTION EXPLAINED; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Soto D, 2009, P NATL ACAD SCI USA, V106, P6011, DOI 10.1073/pnas.0811681106; Spies K, 1996, Z PSYCHOL, V204, P367; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor JG, 2005, NEURAL NETWORKS, V18, P353, DOI 10.1016/j.neunet.2005.03.005; Vastfjall D, 2002, MUSIC SCI, V6, P308, DOI 10.1177/102986490200600211; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003556	50	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5920	10.1371/journal.pone.0005920	http://dx.doi.org/10.1371/journal.pone.0005920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536283	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000267029700006
J	Aldhous, MC; Noble, CL; Satsangi, J				Aldhous, Marian C.; Noble, Colin L.; Satsangi, Jack			Dysregulation of Human beta-Defensin-2 Protein in Inflammatory Bowel Disease	PLOS ONE			English	Article							COPY NUMBER VARIATION; NF-KAPPA-B; CROHNS-DISEASE; ULCERATIVE-COLITIS; ANTIMICROBIAL PEPTIDES; ESCHERICHIA-COLI; DEFENSIN EXPRESSION; CIGARETTE-SMOKING; EPITHELIAL-CELLS; ALPHA-DEFENSIN	Background: Human beta-defensin-2 (HBD2) is an antimicrobial peptide implicated in the pathogenesis of inflammatory bowel disease (IBD). Low copy number and concomitant low mRNA expression of the HBD2 gene have been implicated in susceptibility to colonic Crohn's Disease ( CD). We investigated the colonic distribution of HBD2 mRNA expression, and the contributions of genetic and environmental factors on HBD2 protein production. Methodology/Principal Findings: We examined HBD2 mRNA expression at three colonic locations by microarray analysis of biopsies from 151 patients ( 53 CD, 67 ulcerative colitis [UC], 31 controls). We investigated environmental and genetic influences on HBD2 protein production using ex vivo cultured sigmoid colon biopsies from 69 patients (22 CD, 26 UC, 21 controls) stimulated with lipopolysaccharide (LPS) and/or nicotine for 24 hours. HBD2 and cytokines were measured in culture supernatants. Using DNA samples from these patients, regions in the HBD2 gene promoter were sequenced for NF-kappa B binding-sites and HBD2 gene copy number was determined. HBD2 mRNA expression was highest in inflamed (vs. uninflamed p = 0.0122) ascending colon in CD and in inflamed (vs. uninflamed p < 0.0001) sigmoid colon in UC. HBD2 protein production was increased in inflamed UC biopsies (p = 0.0078). There was no difference in HBD2 protein production from unstimulated biopsies of CD, UC and controls. LPS-induced HBD2 production was significantly increased in CD (p = 0.0375) but not UC (p = 0.2017); this LPS-induced response was augmented by nicotine in UC (p = 0.0308) but not CD (p = 0.6872). Nicotine alone did not affect HBD2 production. HBD2 production correlated with IL8 production in UC (p < 0.001) and with IL10 in CD (p < 0.05). Variations in the HBD2 promoter and HBD2 gene copy number did not affect HBD2 production. Significance/Conclusions: Colonic HBD2 was dysregulated at mRNA and protein level in IBD. Inflammatory status and stimulus but not germline variations influenced these changes.			Aldhous, MC (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Gastrointestinal Unit,Sch Clin & Mol Med, Edinburgh, Midlothian, Scotland.	maldhous@ed.ac.uk			MRC [G0600329] Funding Source: UKRI; Medical Research Council [G0600329] Funding Source: Medline; Chief Scientist Office [CBZ/4/68] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office		Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Aldhous MC, 2008, INFLAMM BOWEL DIS, V14, P1469, DOI 10.1002/ibd.20523; Aldhous MC, 2007, AM J GASTROENTEROL, V102, P589, DOI 10.1111/j.1572-0241.2007.01065.x; Aldhous MC, 2007, AM J GASTROENTEROL, V102, P577, DOI 10.1111/j.1572-0241.2007.01064.x; Armitage EL, 2004, GASTROENTEROLOGY, V127, P1051, DOI 10.1053/j.gastro.2004.06.024; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Arnott IDR, 2004, GENES IMMUN, V5, P417, DOI 10.1038/sj.gene.6364111; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Beaugerie L, 2001, AM J GASTROENTEROL, V96, P2113, DOI 10.1016/S0002-9270(01)02507-2; Birrenbach T, 2004, INFLAMM BOWEL DIS, V10, P848, DOI 10.1097/00054725-200411000-00019; Brant SR, 2003, INFLAMM BOWEL DIS, V9, P281, DOI 10.1097/00054725-200309000-00001; Cosnes J, 1999, ALIMENT PHARM THERAP, V13, P1403; Dhaliwal W, 2009, CLIN EXP IMMUNOL, V156, P263, DOI 10.1111/j.1365-2249.2008.03808.x; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Eliakim R, 2002, EUR J GASTROEN HEPAT, V14, P607, DOI 10.1097/00042737-200206000-00005; Eliakim R, 2001, INT J COLORECTAL DIS, V16, P14, DOI 10.1007/s003840000262; Elphick DA, 2005, GUT, V54, P1802, DOI 10.1136/gut.2005.068601; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Geng YM, 1995, TOXICOL APPL PHARM, V135, P268, DOI 10.1006/taap.1995.1233; Groth M, 2008, HUM MUTAT, V29, P1247, DOI 10.1002/humu.20751; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Jansen PAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004725; Joly S, 2005, MOL IMMUNOL, V42, P1073, DOI 10.1016/j.molimm.2004.11.001; Kanda N, 2008, EUR J IMMUNOL, V38, P1287, DOI 10.1002/eji.200738051; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kiehne K, 2007, SCAND J GASTROENTERO, V42, P1063, DOI 10.1080/00365520701320489; Kiehne K, 2006, WORLD J GASTROENTERO, V12, P1056, DOI 10.3748/wjg.v12.i7.1056; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Marks DJB, 2006, GUT, V55, P1662, DOI 10.1136/gut.2006.104943; MCCANN MF, 1992, CANCER EPIDEM BIOMAR, V1, P125; MCGRATH J, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004722.PUB2; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Nuding S, 2007, GUT, V56, P1240, DOI 10.1136/gut.2006.118646; Paone G, 2002, P NATL ACAD SCI USA, V99, P8231, DOI 10.1073/pnas.122238899; Paone G, 2006, J BIOL CHEM, V281, P17054, DOI 10.1074/jbc.M603042200; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Peyrin-Biroulet L, 2006, TRENDS MICROBIOL, V14, P432, DOI 10.1016/j.tim.2006.08.008; PULLAN RD, 1994, NEW ENGL J MED, V330, P811, DOI 10.1056/NEJM199403243301202; Rubin GP, 2000, ALIMENT PHARM THER, V14, P1553, DOI 10.1046/j.1365-2036.2000.00886.x; Schlee M, 2008, CLIN EXP IMMUNOL, V151, P528, DOI 10.1111/j.1365-2249.2007.03587.x; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; SCHUG J, 1997, CBILTR19971001V00; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; STEINER AA, 2009, NICOTINE ADM WITHDRA; VANDIJK JPM, 1995, EUR J PHARMACOL, V278, pR11, DOI 10.1016/0014-2999(95)00211-3; Vassallo R, 2008, MOL IMMUNOL, V45, P3321, DOI 10.1016/j.molimm.2008.04.014; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Wu WKK, 2004, J PHARMACOL SCI, V94, P348, DOI 10.1254/jphs.94.348	61	57	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6285	10.1371/journal.pone.0006285	http://dx.doi.org/10.1371/journal.pone.0006285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617917	Green Published, Green Submitted, gold			2022-12-27	WOS:000268119600003
J	Chiari, Y; Hyseni, C; Fritts, TH; Glaberman, S; Marquez, C; Gibbs, JP; Claude, J; Caccone, A				Chiari, Ylenia; Hyseni, Chaz; Fritts, Tom H.; Glaberman, Scott; Marquez, Cruz; Gibbs, James P.; Claude, Julien; Caccone, Adalgisa			Morphometrics Parallel Genetics in a Newly Discovered and Endangered Taxon of Galapagos Tortoise	PLOS ONE			English	Article							POPULATION-STRUCTURE; DARWINS FINCHES; GIANT TORTOISES; HARDY-WEINBERG; F-STATISTICS; CONSERVATION; DIVERGENCE; MITOCHONDRIAL; SOFTWARE; TURTLES	Galapagos tortoises represent the only surviving lineage of giant tortoises that exhibit two different types of shell morphology. The taxonomy of Galapagos tortoises was initially based mainly on diagnostic morphological characters of the shell, but has been clarified by molecular studies indicating that most islands harbor monophyletic lineages, with the exception of Isabela and Santa Cruz. On Santa Cruz there is strong genetic differentiation between the two tortoise populations (Cerro Fatal and La Reserva) exhibiting domed shell morphology. Here we integrate nuclear microsatellite and mitochondrial data with statistical analyses of shell shape morphology to evaluate whether the genetic distinction and variability of the two domed tortoise populations is paralleled by differences in shell shape. Based on our results, morphometric analyses support the genetic distinction of the two populations and also reveal that the level of genetic variation is associated with morphological shell shape variation in both populations. The Cerro Fatal population possesses lower levels of morphological and genetic variation compared to the La Reserva population. Because the turtle shell is a complex heritable trait, our results suggest that, for the Cerro Fatal population, non-neutral loci have probably experienced a parallel decrease in variability as that observed for the genetic data.			Chiari, Y (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	yle@yleniachiari.it	Chiari, Ylenia/L-5397-2013; Caccone, Adalgisa/AAE-4238-2021; Claude, julien/G-7411-2016; Hyseni, Chaz/I-7633-2018; Chiari, Ylenia/AAW-3108-2020	Chiari, Ylenia/0000-0003-2338-8602; Caccone, Adalgisa/0000-0002-8949-9260; Claude, julien/0000-0002-9267-1228; Hyseni, Chaz/0000-0003-2567-8013; Chiari, Ylenia/0000-0003-2338-8602; Glaberman, Scott/0000-0003-0594-4732				Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beheregaray LB, 2004, P NATL ACAD SCI USA, V101, P6514, DOI 10.1073/pnas.0400393101; Beheregaray LB, 2003, CONSERV GENET, V4, P31, DOI 10.1023/A:1021864214375; Bonnet X, 2001, BIOL J LINN SOC, V72, P357, DOI 10.1006/bijl.2000.0504; Burns KJ, 2002, EVOLUTION, V56, P1240; Caccone A, 2002, EVOLUTION, V56, P2052; Carretero MA, 2005, ANIM BIOL, V55, P259, DOI 10.1163/1570756054472854; Chiari Y, 2006, CONSERV GENET, V7, P473, DOI 10.1007/s10592-005-9057-x; Ciofi C, 2002, MOL ECOL, V11, P2265, DOI 10.1046/j.1365-294X.2002.01617.x; Clabaut C, 2007, EVOLUTION, V61, P560, DOI 10.1111/j.1558-5646.2007.00045.x; Claude J, 2004, SYST BIOL, V53, P933, DOI 10.1080/10635150490889498; Claude J, 2008, MORPHOMETRICS R; CORRAL MDT, 2002, THESIS PONTIFICA U C; DOMOKOS G, 2008, P R SOC B, V1630, P11; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Fritts T.H., 1983, P107; Fritz U, 2005, MOL PHYLOGENET EVOL, V37, P389, DOI 10.1016/j.ympev.2005.03.007; Fritz Uwe, 2007, Vertebrate Zoology, V57, P149; Gilbert Scott F., 2008, P1; Grant PR, 2004, EVOLUTION, V58, P1588; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hendry AP, 2004, EVOLUTION, V58, P2319; Hoffmann AA, 2000, BIOSCIENCE, V50, P217, DOI 10.1641/0006-3568(2000)050[0217:ESAAEF]2.3.CO;2; Huxley J., 1932, PROBLEMS RELATIVE GR; Le M, 2006, MOL PHYLOGENET EVOL, V40, P517, DOI 10.1016/j.ympev.2006.03.003; LOUIS EJ, 1987, BIOMETRICS, V43, P805, DOI 10.2307/2531534; MACFARLAND C G, 1974, Biological Conservation, V6, P118, DOI 10.1016/0006-3207(74)90024-X; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Myers EM, 2006, EVOLUTION, V60, P563; Olafsdottir GA, 2007, J EVOLUTION BIOL, V20, P603, DOI 10.1111/j.1420-9101.2006.01250.x; Posada D, 2004, COLLAPSE VERSION 3 1; Poulakakis N, 2008, P NATL ACAD SCI USA, V105, P15464, DOI 10.1073/pnas.0805340105; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard Peter C.H., 1996, Chelonian Research Monographs, V1, P1; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; R Core Team, 2021, R LANGUAGE ENV STAT; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Russello MA, 2005, BIOL LETT-UK, V1, P287, DOI 10.1098/rsbl.2005.0317; Russello MA, 2007, CURR BIOL, V17, pR317, DOI 10.1016/j.cub.2007.03.002; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Salzburger W, 2009, MOL ECOL, V18, P169, DOI 10.1111/j.1365-294X.2008.03981.x; SEIDEL ME, 1981, COPEIA, P119; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; SWINGLAND IR, 1989, J ANIM ECOL, V58, P971, DOI 10.2307/5136; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Denburgh J., 1914, Proceedings of the California Academy of Science (4th Series), V2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wikelski M, 2000, NATURE, V403, P37, DOI 10.1038/47396; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zani PA, 1995, COPEIA, P735, DOI 10.2307/1446772; Zuffi MAL, 2006, ITAL J ZOOL, V73, P363, DOI 10.1080/11250000600971323; Zug George R., 1997, Chelonian Conservation and Biology, V2, P618	59	28	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6272	10.1371/journal.pone.0006272	http://dx.doi.org/10.1371/journal.pone.0006272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609441	Green Published, gold			2022-12-27	WOS:000268119500007
J	Rochais, F; Dandonneau, M; Mesbah, K; Jarry, T; Mattei, MG; Kelly, RG				Rochais, Francesca; Dandonneau, Mathieu; Mesbah, Karim; Jarry, Therese; Mattei, Marie-Genevieve; Kelly, Robert G.			Hes1 Is Expressed in the Second Heart Field and Is Required for Outflow Tract Development	PLOS ONE			English	Article								Background: Rapid growth of the embryonic heart occurs by addition of progenitor cells of the second heart field to the poles of the elongating heart tube. Failure or perturbation of this process leads to congenital heart defects. In order to provide further insight into second heart field development we characterized the insertion site of a transgene expressed in the second heart field and outflow tract as the result of an integration site position effect. Results: Here we show that the integration site of the A17-Myf5-nlacZ-T55 transgene lies upstream of Hes1, encoding a basic helix-loop-helix containing transcriptional repressor required for the maintenance of diverse progenitor cell populations during embryonic development. Transgene expression in a subset of Hes1 expression sites, including the CNS, pharyngeal epithelia, pericardium, limb bud and lung endoderm suggests that Hes1 is the endogenous target of regulatory elements trapped by the transgene. Hes1 is expressed in pharyngeal endoderm and mesoderm including the second heart field. Analysis of Hes1 mutant hearts at embryonic day 15.5 reveals outflow tract alignment defects including ventricular septal defects and overriding aorta. At earlier developmental stages, Hes1 mutant embryos display defects in second heart field proliferation, a reduction in cardiac neural crest cells and failure to completely extend the outflow tract. Conclusions: Hes1 is expressed in cardiac progenitor cells in the early embryo and is required for development of the arterial pole of the heart.			Rochais, F (corresponding author), Univ Aix Marseille 2, Dev Biol Inst Marseilles Luminy, CNRS, UMR 6216, Campus Luminy, Marseille, France.	kelly@ibdml.univ-mrs.fr	Rochais, Francesca/A-5326-2017; Rochais, Francesca/ABF-4675-2021; Kelly, Robert G/F-2523-2013	Rochais, Francesca/0000-0001-9355-8916; Rochais, Francesca/0000-0001-9355-8916; Kelly, Robert G/0000-0003-4357-0073; Mattei, Marie-Genevieve/0000-0002-6027-7058				Bajolle F, 2008, DEV BIOL, V313, P25, DOI 10.1016/j.ydbio.2007.09.023; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Fukuda A, 2006, J CLIN INVEST, V116, P1484, DOI 10.1172/JCI27704; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; Hutson MR, 2007, SEMIN CELL DEV BIOL, V18, P101, DOI 10.1016/j.semcdb.2006.12.004; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Iso T, 2002, J BIOL CHEM, V277, P6598, DOI 10.1074/jbc.M110495200; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kokubo H, 2005, TRENDS CARDIOVAS MED, V15, P190, DOI 10.1016/j.tcm.2005.05.005; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Mesbah K, 2006, MOL CELL BIOL, V26, P7760, DOI 10.1128/MCB.00913-06; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Raetzman LT, 2007, DEV BIOL, V304, P455, DOI 10.1016/j.ydbio.2006.11.010; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Theveniau-Ruissy M, 2008, CIRC RES, V103, P142, DOI 10.1161/CIRCRESAHA.108.172189; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; Waldo KL, 2005, DEV BIOL, V281, P66, DOI 10.1016/j.ydbio.2005.02.011; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174	37	59	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6267	10.1371/journal.pone.0006267	http://dx.doi.org/10.1371/journal.pone.0006267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609448	Green Published, gold, Green Submitted			2022-12-27	WOS:000268119500004
J	Comellas, G; Kaczmarska, Z; Tarrago, T; Teixido, M; Giralt, E				Comellas, Gemma; Kaczmarska, Zusanna; Tarrago, Teresa; Teixido, Meritxell; Giralt, Ernest			Exploration of the One-Bead One-Compound Methodology for the Design of Prolyl Oligopeptidase Substrates	PLOS ONE			English	Article							SUPPORTS	Here we describe the design, synthesis and evaluation of the first solid-phase substrates for prolyl oligopeptidase ( POP), a cytosolic serine peptidase associated with schizophrenia, bipolar affective disorder and related neuropsychiatric disorders. This study seeks to contribute to the future design of a one-bead one-compound (OBOC) peptide library of POP substrates, based on an intramolecular energy transfer substrate. Unexpectedly, the enzymatic evaluation of the substrates attached on solid-phase by means of the HMBA linker were cleaved through the ester bond, thereby suggesting an unknown esterase activity of POP, in addition to its known peptidase activity. By performing multiple activity assays, we have confirmed the esterase activity of this enzyme and its capacity to process the substrates on solid-phase. Finally, we tested a new linker, compatible with both the solid-phase peptide-synthesis used and the enzymatic assay, for application in the future design of an OBOC library.			Comellas, G (corresponding author), Inst Recerca Biomed IRB Barcelona, Parc Cient Barcelona, Barcelona, Spain.	ernest.giralt@irbbarcelona.org	giralt, ernest/N-1669-2014; teixido, meritxell/I-3282-2015	giralt, ernest/0000-0001-8381-1797; teixido, meritxell/0000-0002-7825-3695; Kaczmarska, Zuzanna/0000-0002-7668-1442				Farrera-Sinfreu J, 2002, TETRAHEDRON LETT, V43, P7813, DOI 10.1016/S0040-4039(02)01605-2; Felix A M, 1970, J Am Chem Soc, V92, P1385, DOI 10.1021/ja00708a046; Fulop V, 2001, J BIOL CHEM, V276, P1262, DOI 10.1074/jbc.M007003200; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; Gershkovich A, 1996, J BIOCHEM BIOPH METH, V33, P135, DOI 10.1016/S0165-022X(96)00023-1; Halling PJ, 2006, BIOCHEM SOC T, V34, P309, DOI 10.1042/BST0340309; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kress J, 2002, CHEM-EUR J, V8, P3769, DOI 10.1002/1521-3765(20020816)8:16<3769::AID-CHEM3769>3.0.CO;2-V; Lam KS, 1997, CHEM REV, V97, P411, DOI 10.1021/cr9600114; Leger R, 1998, TETRAHEDRON LETT, V39, P4171, DOI 10.1016/S0040-4039(98)00777-1; Leon S, 1998, BIOORG MED CHEM LETT, V8, P2997, DOI 10.1016/S0960-894X(98)00534-4; LETSINGER RL, 1963, J AM CHEM SOC, V85, P3045, DOI 10.1021/ja00902a054; Madder A, 1999, EUR J ORG CHEM, V1999, P2787; MAES M, 1995, PSYCHIAT RES, V58, P217, DOI 10.1016/0165-1781(95)02698-V; Marani MM, 2007, J COMB CHEM, V9, P395, DOI 10.1021/cc070012h; Meldal M, 2005, QSAR COMB SCI, V24, P1141, DOI 10.1002/qsar.200540008; NANTEULI D, 1998, DRUGS FUTURE, V23, P167; Pastor JJ, 2007, J AM CHEM SOC, V129, P14922, DOI 10.1021/ja073969x; Renil M, 1998, J PEPT SCI, V4, P195, DOI 10.1002/(SICI)1099-1387(199805)4:3<195::AID-PSC141>3.3.CO;2-I; Sauerbrei B, 1998, ANGEW CHEM INT EDIT, V37, P1143, DOI 10.1002/(SICI)1521-3773(19980504)37:8<1143::AID-ANIE1143>3.0.CO;2-E; Shin DS, 2008, J COMB CHEM, V10, P20, DOI 10.1021/cc7001217; Tarrago T, 2005, J PEPT SCI, V11, P283, DOI 10.1002/psc.676; Tarrago T, 2007, CHEMMEDCHEM, V2, P354, DOI 10.1002/cmdc.200600303; Tarrago T, 2006, CHEMBIOCHEM, V7, P827, DOI 10.1002/cbic.200500424; Vazquez JV, 2003, METHOD ENZYMOL, V369, P21; YAO N, 2008, PEPTIDE SCI, V9, P421	27	6	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6222	10.1371/journal.pone.0006222	http://dx.doi.org/10.1371/journal.pone.0006222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593439	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035400007
J	Asai, Y; Tasaka, Y; Nomura, K; Nomura, T; Casadio, M; Morasso, P				Asai, Yoshiyuki; Tasaka, Yuichi; Nomura, Kunihiko; Nomura, Taishin; Casadio, Maura; Morasso, Pietro			A Model of Postural Control in Quiet Standing: Robust Compensation of Delay-Induced Instability Using Intermittent Activation of Feedback Control	PLOS ONE			English	Article							CONTROLLING CHAOS; ANKLE STIFFNESS; BALANCE CONTROL; BODY SWAY; MOVEMENTS; SYSTEMS; STABILITY; WALKING; STANCE; BRAIN	The main purpose of this study is to compare two different feedback controllers for the stabilization of quiet standing in humans, taking into account that the intrinsic ankle stiffness is insufficient and that there is a large delay inducing instability in the feedback loop: 1) a standard linear, continuous-time PD controller and 2) an intermittent PD controller characterized by a switching function defined in the phase plane, with or without a dead zone around the nominal equilibrium state. The stability analysis of the first controller is carried out by using the standard tools of linear control systems, whereas the analysis of the intermittent controllers is based on the use of Poincare maps defined in the phase plane. When the PD-control is off, the dynamics of the system is characterized by a saddle-like equilibrium, with a stable and an unstable manifold. The switching function of the intermittent controller is implemented in such a way that PD-control is 'off' when the state vector is near the stable manifold of the saddle and is 'on' otherwise. A theoretical analysis and a related simulation study show that the intermittent control model is much more robust than the standard model because the size of the region in the parameter space of the feedback control gains ( P vs. D) that characterizes stable behavior is much larger in the latter case than in the former one. Moreover, the intermittent controller can use feedback parameters that are much smaller than the standard model. Typical sway patterns generated by the intermittent controller are the result of an alternation between slow motion along the stable manifold of the saddle, when the PD-control is off, and spiral motion away from the upright equilibrium determined by the activation of the PD-control with low feedback gains. Remarkably, overall dynamic stability can be achieved by combining in a smart way two unstable regimes: a saddle and an unstable spiral. The intermittent controller exploits the stabilizing effect of one part of the saddle, letting the system evolve by alone when it slides on or near the stable manifold; when the state vector enters the strongly unstable part of the saddle it switches on a mild feedback which is not supposed to impose a strict stable regime but rather to mitigate the impending fall. The presence of a dead zone in the intermittent controller does not alter the stability properties but improves the similarity with biological sway patterns. The two types of controllers are also compared in the frequency domain by considering the power spectral density (PSD) of the sway sequences generated by the models with additive noise. Different from the standard continuous model, whose PSD function is similar to an over-damped second order system without a resonance, the intermittent control model is capable to exhibit the two power law scaling regimes that are typical of physiological sway movements in humans.			Asai, Y (corresponding author), Osaka Univ, Ctr Adv Med Engn & Informat, Osaka, Japan.	taishin@bpe.es.osaka-u.ac.jp	Casadio, Maura/AAH-2861-2022; Nomura, Taishin/J-8408-2012; Taylor, Graham/A-4027-2012; Casadio, Maura/AFM-0496-2022	Nomura, Taishin/0000-0002-6545-2097; 				BAHILL AT, 1979, SCI AM, V240, P108, DOI 10.1038/scientificamerican0179-108; Bottaro A, 2005, HUM MOVEMENT SCI, V24, P588, DOI 10.1016/j.humov.2005.07.006; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Cabrera JL, 2004, CHAOS, V14, P691, DOI 10.1063/1.1785453; Cabrera JL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158702; Casadio M, 2005, GAIT POSTURE, V21, P410, DOI 10.1016/j.gaitpost.2004.05.005; CHOW CC, 1995, PHYS REV E, V52, P907, DOI 10.1103/PhysRevE.52.907; Chow CC, 1999, HUM MOVEMENT SCI, V18, P725, DOI 10.1016/S0167-9457(99)00035-4; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; Gibson JJ, 1950, PERCEPTION VISUAL WO; Hanneton S, 1997, BIOL CYBERN, V77, P381, DOI 10.1007/s004220050398; Insperger T, 2006, IEEE T CONTR SYST T, V14, P974, DOI 10.1109/TCST.2006.876938; Kloeden P. E., 1992, APPL MATH NEW YORK, V23, DOI [10.1007/978-3-662-12616-5, DOI 10.1007/978-3-662-12616-5]; Loram ID, 2002, J PHYSIOL-LONDON, V545, P1041, DOI 10.1113/jphysiol.2002.025049; Loram ID, 2005, J PHYSIOL-LONDON, V564, P281, DOI 10.1113/jphysiol.2004.073437; Loram ID, 2005, J PHYSIOL-LONDON, V564, P295, DOI 10.1113/jphysiol.2004.076307; Masani K, 2003, J NEUROPHYSIOL, V90, P3774, DOI 10.1152/jn.00730.2002; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Meyer PF, 2004, EXP BRAIN RES, V156, P505, DOI 10.1007/s00221-003-1804-y; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; Milton JG, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/48001; Milton J, 2009, PHILOS T R SOC A, V367, P1181, DOI 10.1098/rsta.2008.0257; MORASSO P, 1983, ACTA PSYCHOL, V54, P83, DOI 10.1016/0001-6918(83)90025-2; Nomura K, 2009, GAIT POSTURE, V29, P654, DOI 10.1016/j.gaitpost.2009.02.001; OTT E, 1990, PHYS REV LETT, V64, P1196, DOI 10.1103/PhysRevLett.64.1196; Peterka RJ, 2000, BIOL CYBERN, V82, P335, DOI 10.1007/s004220050587; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; SCHIFF SJ, 1994, NATURE, V370, P615, DOI 10.1038/370615a0; Slotine J.J.E., 1991, APPL NONLINEAR CONTR; Stepan G, 2000, MATH COMPUT MODEL, V31, P199, DOI 10.1016/S0895-7177(00)00039-X; Tanaka G, 2008, PHYSICA D, V237, P2616, DOI 10.1016/j.physd.2008.03.044; Utkin V., 1992, SLIDING MODES CONTRO; van der Kooij H, 2005, J NEUROSCI METH, V145, P175, DOI 10.1016/j.jneumeth.2005.01.003; Yamasaki T, 2003, BIOL CYBERN, V88, P468, DOI 10.1007/s00422-003-0402-1	36	201	202	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6169	10.1371/journal.pone.0006169	http://dx.doi.org/10.1371/journal.pone.0006169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	468HA	19584944	Green Published, Green Submitted, gold			2022-12-27	WOS:000267806500006
J	Boda, C; Courtioux, B; Roques, P; Pervieux, L; Vatunga, G; Josenando, T; Ayenengoye, CR; Bouteille, B; Jauberteau, MO; Bisser, S				Boda, Caroline; Courtioux, Bertrand; Roques, Pierre; Pervieux, Lynda; Vatunga, Gedeon; Josenando, Theophile; Ayenengoye, Constant Roger; Bouteille, Bernard; Jauberteau, Marie-Odile; Bisser, Sylvie			Immunophenotypic Lymphocyte Profiles in Human African Trypanosomiasis	PLOS ONE			English	Article								Human African trypanosomiasis ( HAT) is a deadly vector-born disease caused by an extracellular parasite, the trypanosome. Little is known about the cellular immune responses elicited by this parasite in humans. We used multiparameter flow cytometry to characterize leukocyte immunophenotypes in the blood and cerebrospinal fluid ( CSF) of 33 HAT patients and 27 healthy controls identified during a screening campaign in Angola and Gabon. We evaluated the subsets and activation markers of B and T lymphocytes. Patients had a higher percentage of CD19(+) B lymphocytes and activated B lymphocytes in the blood than did controls, but lacked activated CD4+ T lymphocytes ( CD25(+)). Patients displayed no increase in the percentage of activated CD8+ T cells (HLA-DR(+), CD69(+) or CD25(+)), but memory CD8 T-cell levels (CD8(+)CD45RA(-)) were significantly lower in patients than in controls, as were effector CD8 T-cell levels ( CD8(+)CD45RA(+)CD62L(-)). No relationship was found between these blood immunophenotypes and disease severity ( stage 1 vs 2). However, CD19(+) B-cell levels in the CSF increased with disease severity. The patterns of T and B cell activation in HAT patients suggest that immunomodulatory mechanisms may operate during infection. Determinations of CD19(+) B-cell levels in the CSF could improve disease staging.			Boda, C (corresponding author), Univ Limoges, Inst Neurol Trop, Fac Med, IFR GEIST 145,EA NeuroEpidemiol Trop & Comparee 3, Limoges, France.	bertrand.courtioux@unilim.fr	Roques, Pierre/M-2212-2013; Bouteille, Bernard/T-6519-2019; Bouteille, Bernard/M-4547-2018	Roques, Pierre/0000-0003-1825-1054; Bouteille, Bernard/0000-0001-9661-0302; Jauberteau, Marie-Odile/0000-0002-8811-8948				Acosta-Rodriguez EV, 2004, J IMMUNOL, V172, P493, DOI 10.4049/jimmunol.172.1.493; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; AMEVIGBE MDD, 1992, AM J TROP MED HYG, V47, P652, DOI 10.4269/ajtmh.1992.47.652; ANTHOONS JAMS, 1986, Z PARASITENKD, V72, P443, DOI 10.1007/BF00927888; Ayed Z, 1997, AM J TROP MED HYG, V57, P1; Bakhiet M, 1996, J INTERF CYTOK RES, V16, P427, DOI 10.1089/jir.1996.16.427; Barrett MP, 2006, LANCET, V367, P1377, DOI 10.1016/S0140-6736(06)68591-7; Bisser S, 2006, INT J PARASITOL, V36, P529, DOI 10.1016/j.ijpara.2006.02.001; Bisser S, 2002, J NEUROL SCI, V193, P127, DOI 10.1016/S0022-510X(01)00655-4; BODA C, 2005, TRIVANDRUM RES SIGNP, P255; BOUTEILLE B, 2003, ENCY NEUROLOGICAL SC, V2, P587; De Baetselier P, 2001, INT J PARASITOL, V31, P575, DOI 10.1016/S0020-7519(01)00170-9; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Gobert AP, 2000, INFECT IMMUN, V68, P4653, DOI 10.1128/IAI.68.8.4653-4657.2000; Grab DJ, 2008, J NEUROVIROL, V14, P344, DOI 10.1080/13550280802282934; Guilliams M, 2007, J IMMUNOL, V179, P2748, DOI 10.4049/jimmunol.179.5.2748; Heinrich A, 2006, ACTA NEUROL SCAND, V113, P248, DOI 10.1111/j.1600-0404.2005.00562.x; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; KAZYUMBA G, 1986, CLIN EXP IMMUNOL, V65, P10; Kennedy PGE, 2006, INT J PARASITOL, V36, P505, DOI 10.1016/j.ijpara.2006.01.012; LUMSDEN WHR, 1977, T ROY SOC TROP MED H, V71, P421, DOI 10.1016/0035-9203(77)90043-8; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Miezan TW, 2000, T ROY SOC TROP MED H, V94, P293, DOI 10.1016/S0035-9203(00)90327-4; Millar AE, 1999, INFECT IMMUN, V67, P3334, DOI 10.1128/IAI.67.7.3334-3338.1999; MINOPRIO P, 1989, IMMUNOL REV, V112, P183, DOI 10.1111/j.1600-065X.1989.tb00558.x; Mirkin GA, 1997, CLIN EXP IMMUNOL, V107, P328, DOI 10.1111/j.1365-2249.1997.267-ce1166.x; Mohri H, 1998, SCIENCE, V279, P1223, DOI 10.1126/science.279.5354.1223; Namangala B, 2000, PARASITE IMMUNOL, V22, P361, DOI 10.1046/j.1365-3024.2000.00314.x; Namangala B, 2001, J LEUKOCYTE BIOL, V69, P387; Piedras J, 1997, CYTOMETRY, V30, P28, DOI 10.1002/(SICI)1097-0320(19970215)30:1<28::AID-CYTO4>3.0.CO;2-B; Radwanska M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000078; REINITZ DM, 1990, INFECT IMMUN, V58, P2337, DOI 10.1128/IAI.58.7.2337-2342.1990; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; SENDASHONGA CN, 1986, PARASITE IMMUNOL, V8, P443, DOI 10.1111/j.1365-3024.1986.tb00860.x; SILEGHEM M, 1989, EUR J IMMUNOL, V19, P119, DOI 10.1002/eji.1830190119; SILEGHEM M, 1989, EUR J IMMUNOL, V19, P829, DOI 10.1002/eji.1830190508; Tabel H, 2008, IMMUNOL REV, V225, P128, DOI 10.1111/j.1600-065X.2008.00675.x; Vincendeau P, 2006, AN ACAD BRAS CIENC, V78, P645, DOI 10.1590/S0001-37652006000400004; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Zuniga E, 2000, CLIN EXP IMMUNOL, V119, P507, DOI 10.1046/j.1365-2249.2000.01150.x	40	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6184	10.1371/journal.pone.0006184	http://dx.doi.org/10.1371/journal.pone.0006184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584913	Green Published, gold, Green Submitted			2022-12-27	WOS:000267806500011
J	Boualem, A; Troadec, C; Kovalski, I; Sari, MA; Perl-Treves, R; Bendahmane, A				Boualem, Adnane; Troadec, Christelle; Kovalski, Irina; Sari, Marie-Agnes; Perl-Treves, Rafael; Bendahmane, Abdelhafid			A Conserved Ethylene Biosynthesis Enzyme Leads to Andromonoecy in Two Cucumis Species	PLOS ONE			English	Article							1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE; SEX EXPRESSION; MULTIGENE FAMILY; ACID SYNTHASE; ACC SYNTHASE; SATIVUS; GENE; FLOWERS; FRUIT; CUCURBITACEAE	Andromonoecy is a widespread sexual system in angiosperms, characterized by plants carrying both male and bisexual flowers. Monoecy is characterized by the presence of both male and female flowers on the same plant. In cucumber, these sexual forms are controlled by the identity of the alleles at the M locus. In melon, we recently showed that the transition from monoecy to andromonoecy result from a mutation in 1-aminocyclopropane-1-carboxylic acid synthase (ACS) gene, CmACS-7. To isolate the andromonoecy gene in cucumber we used a candidate gene approach in combination with genetical and biochemical analysis. We demonstrated co-segregation of CsACS2, a close homolog of CmACS-7, with the M locus. Sequence analysis of CsACS2 in cucumber accessions identified four CsACS2 isoforms, three in andromonoecious and one in monoecious lines. To determine whether the andromonoecious phenotype is due to a loss of ACS enzymatic activity, we expressed the four isoforms in Escherichia coli and assayed their activity in vitro. Like in melon, the isoforms from the andromonoecious lines showed reduced to no enzymatic activity and the isoform from the monoecious line was active. Consistent with this, the mutations leading andromonoecy were clustered in the active site of the enzyme. Based on this, we concluded that active CsACS2 enzyme leads to the development of female flowers in monoecious lines, whereas a reduction of enzymatic activity yields hermaphrodite flowers. Consistent with this, CsACS2, like CmACS-7 in melon, is expressed specifically in carpel primordia of buds determined to develop carpels. Following ACS expression, inter-organ communication is likely responsible for the inhibition of stamina development. In both melon and cucumber, flower unisexuality seems to be the ancestral situation, as the majority of Cucumis species are monoecious. Thus, the ancestor gene of CmACS-7/CsACS2 likely have controlled the stamen development before speciation of Cucumis sativus (cucumber) and Cucumis melo (melon) that have diverged over 40 My ago. The isolation of the genes for andromonoecy in Cucumis species provides a molecular basis for understanding how sexual systems arise and are maintained within and between species.	[Boualem, Adnane; Troadec, Christelle; Bendahmane, Abdelhafid] CNRS, INRA, Unite Rech Genom Vegetale, UMR1165, Evry, France; [Kovalski, Irina; Perl-Treves, Rafael] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Sari, Marie-Agnes] Univ Paris 05, CNRS, Lab Chim & Biochim Pharmacol & Toxicol, UMR 8601, F-75270 Paris, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Bar Ilan University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Boualem, A (corresponding author), CNRS, INRA, Unite Rech Genom Vegetale, UMR1165, Evry, France.	bendahm@evry.inra.fr	Boualem, Adnane/ABC-5019-2021	Boualem, Adnane/0000-0003-4428-6496; Bendahmane, Abdelhafid/0000-0003-3246-868X; Berger, Frederic/0000-0002-3609-8260; TROADEC, Christelle/0000-0003-1927-7352				Bai SL, 2004, PLANTA, V220, P230, DOI 10.1007/s00425-004-1342-2; BAUDRACCOARNAS S, 1995, 18 CUC GEN COOP, P50; BERTIN R I, 1982, Evolutionary Theory, V6, P25; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; FRIEDLANDER M, 1977, PLANT CELL PHYSIOL, V18, P1343, DOI 10.1093/oxfordjournals.pcp.a075556; GALUN E, 1961, GENETICA, V32, P134, DOI 10.1007/BF01816091; Huai Q, 2001, J BIOL CHEM, V276, P38210; Kamachi S, 1997, PLANT CELL PHYSIOL, V38, P1197, DOI 10.1093/oxfordjournals.pcp.a029106; Kater MM, 2001, PLANT CELL, V13, P481, DOI 10.1105/tpc.13.3.481; Kirkbride JH, 1993, BIOSYSTEMATIC MONOGR; Knopf RR, 2006, PLANT CELL PHYSIOL, V47, P1217, DOI 10.1093/pcp/pcj092; Kocyan A, 2007, MOL PHYLOGENET EVOL, V44, P553, DOI 10.1016/j.ympev.2006.12.022; KUBICKI B, 1969, GENET POL, V10, P101; Little HA, 2007, SEX PLANT REPROD, V20, P123, DOI 10.1007/s00497-007-0049-5; LLOYD DG, 1980, NEW PHYTOL, V86, P69, DOI 10.1111/j.1469-8137.1980.tb00780.x; MALEPSZY S, 1991, PLANT SCI, V80, P39, DOI 10.1016/0168-9452(91)90271-9; Mibus H, 2004, THEOR APPL GENET, V109, P1669, DOI 10.1007/s00122-004-1793-7; MIBUS H, 2000, INVESTIGATIONS SEX E; Miller JS, 2003, AM J BOT, V90, P707, DOI 10.3732/ajb.90.5.707; OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603; Papadopoulou E, 2005, SEX PLANT REPROD, V18, P131, DOI 10.1007/s00497-005-0006-0; Perl-Treves R., 2006, FLOWER DEV MANIPULAT, P117; PERLTREVES R, 1999, SEX DETERMINATION PL, P189; Ralph SG, 2007, PLANT PHYSIOL, V143, P410, DOI 10.1104/pp.106.089425; Renner SS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-58; ROTTMANN WH, 1991, J MOL BIOL, V222, P937, DOI 10.1016/0022-2836(91)90587-V; Saito S, 2007, J EXP BOT, V58, P2897, DOI 10.1093/jxb/erm141; Tarun AS, 1998, P NATL ACAD SCI USA, V95, P9796, DOI 10.1073/pnas.95.17.9796; Trebitsh T, 1997, PLANT PHYSIOL, V113, P987, DOI 10.1104/pp.113.3.987; Vallejo-Marin M, 2007, EVOLUTION, V61, P404, DOI 10.1111/j.1558-5646.2007.00031.x; WHITE MF, 1994, P NATL ACAD SCI USA, V91, P12428, DOI 10.1073/pnas.91.26.12428; WOLFENDEN R, 1967, J BIOL CHEM, V242, P977; Xu SL, 2008, PLANT CELL, V20, P3065, DOI 10.1105/tpc.108.063354; Yamasaki S, 2000, PLANT CELL PHYSIOL, V41, P608, DOI 10.1093/pcp/41.5.608; Yamasaki S, 2003, SEX PLANT REPROD, V16, P103, DOI 10.1007/s00497-003-0183-7; Yamasaki S, 2003, PLANT CELL ENVIRON, V26, P537, DOI 10.1046/j.1365-3040.2003.00984.x; Yamasaki S, 2001, PLANT CELL PHYSIOL, V42, P608, DOI 10.1093/pcp/pce076; Yampolsky C., 1922, BIBLIOTHECA GENETICA, V3, P1; Yin TJ, 1995, AM J BOT, V82, P1537, DOI 10.2307/2446182	40	91	108	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6144	10.1371/journal.pone.0006144	http://dx.doi.org/10.1371/journal.pone.0006144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578542	Green Published, gold			2022-12-27	WOS:000267806300013
J	Dormuth, CR; Maclure, M; Carney, G; Schneeweiss, S; Bassett, K; Wright, JM				Dormuth, Colin R.; Maclure, Malcolm; Carney, Greg; Schneeweiss, Sebastian; Bassett, Ken; Wright, James M.			Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin	PLOS ONE			English	Article								Objective: Rosiglitazone was found associated with approximately a 43% increase in risk of acute myocardial infarction (AMI) in a two meta-analyses of clinical trials. Our objective is to estimate the magnitude of the association in real-world patients previously treated with metformin. Research Design and Methods: We conducted a nested case control study in British Columbia using health care databases on 4.3 million people. Our cohort consisted of 158,578 patients with Type 2 diabetes who used metformin as first-line drug treatment. We matched 2,244 cases of myocardial infarction (AMI) with up to 4 controls. Conditional logistic regression models were used to estimate matched odds ratios for AMI associated with treatment with rosiglitazone, pioglitazone and sulfonylureas. Results: In our cohort of prior metformin users, adding rosiglitazone for up to 6 months was not associated with an increased risk of AMI compared to adding a sulfonylurea (odds ratio [OR] 1.38; 95% confidence interval [CI], 0.91-2.10), or compared to adding pioglitazone (OR for rosi versus pio 1.41; 95% CI, 0.74-2.66). There were also no significant differences between rosiglitazone, pioglitazone and sulfonylureas for longer durations of treatment. Though not significantly different from sulfonylureas, there was a transient increase in AMI risk associated with the first 6 months of treatment with a glitazone compared to not using the treatment (OR 1.53; 95% CI, 1.13-2.07) Conclusions: In our British Columbia cohort of patients who received metformin as first-line pharmacotherapy for Type 2 diabetes mellitus, further treatment with rosiglitazone did not increase the risk of AMI compared to patients who were treated with pioglitazone or a sulfonylurea. Though not statistically significantly different compared from each other, an increased risk of AMI observed after starting rosiglitazone or sulfonylureas is a matter of concern that requires more research.			Dormuth, CR (corresponding author), Univ British Columbia, Therapeut Initiat, Vancouver, BC V5Z 1M9, Canada.	colin.dormuth@ti.ubc.ca	Carney, Greg/T-5180-2019; Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X; Dormuth, Colin/0000-0001-8577-8783				Diamond GA, 2007, ANN INTERN MED, V147, P578, DOI 10.7326/0003-4819-147-8-200710160-00182; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; Fowles J B, 1995, Health Care Financ Rev, V16, P189; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Glynn RJ, 1999, AM J EPIDEMIOL, V149, P541; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; McAfee AT, 2007, PHARMACOEPIDEM DR S, V16, P711, DOI 10.1002/pds.1443; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; ROMANO PS, 1994, MED CARE, V32, P81, DOI 10.1097/00005650-199401000-00006; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; *UGDP, 1970, DIABETES S2, V19, P747; Williams JI, 1996, INVENTORY STUDIES AC; 2006, BC HLTH DATA WAREHOU	17	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2009	4	6							e6080	10.1371/journal.pone.0006080	http://dx.doi.org/10.1371/journal.pone.0006080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463IE	19562036	Green Published, Green Submitted, gold			2022-12-27	WOS:000267424700001
J	Ricketts, C; Zeegers, MP; Lubinski, J; Maher, ER				Ricketts, Christopher; Zeegers, Maurice P.; Lubinski, Jan; Maher, Eamonn R.			Analysis of Germline Variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in Familial and Sporadic Renal Cell Carcinoma	PLOS ONE			English	Article								Background: The investigation of rare familial forms of kidney cancer has provided important insights into the biology of sporadic renal cell carcinoma (RCC). In particular, the identification of the von Hippel Lindau (VHL) familial cancer syndrome gene (VHL) provided the basis for the discovery that VHL is somatically inactivated in most sporadic clear cell RCC. Many cases of familial RCC do not have mutations in known RCC susceptibility genes and there is evidence that genetic modifiers may influence the risk of RCC in VHL disease patients. Hence we hypothesised that low- penetrance functional genetic variants in pathways related to the VHL protein (pVHL) function might (a) modify the phenotypic expression of VHL disease and/or (b) predispose to sporadic RCC. Methodology/Principal Findings: We tested this hypothesis for functional polymorphisms in CDH1 (rs16260), IGFBP3 (rs2854744), MMP1 (rs1799750), MMP3 (rs679620), STK15 (rs2273535) and VEGF (rs1570360). We observed that variants of MMP1 and MMP3 were significant modifiers of RCC risk (and risks of retinal angioma and cerebellar haemangioblastoma) in VHL disease patients. In addition, higher frequencies of the MMP1 rs1799750 2G allele (p = 0.017, OR 1.49, 95% CI 1.06-2.08) and the MMP1/MMP3 rs1799750/rs679620 2G/G haplotype (OR 1.45, 95% CI 1.01-2.10) were detected in sporadic RCC patients than in controls (n = 295). Conclusions/Significance: These findings (a) represent the first example of genetic modifiers of RCC risk in VHL disease, (b) replicate a previous report of an association between MMP1/MMP3 variants and sporadic RCC and (c) further implicate MMP1/MMP3-related pathways in the pathogenesis of familial and sporadic RCC.			Ricketts, C (corresponding author), Univ Birmingham, Sch Med, Canc Res UK Renal Mol Oncol Grp, Dept Med & Mol Genet, Birmingham, W Midlands, England.	e.r.maher@bham.ac.uk	MAHER, EAMONN R/A-9507-2008; Ricketts, Christopher/AAV-9580-2020	MAHER, EAMONN R/0000-0002-6226-6918; Lubinski, Jan/0000-0003-2931-3003; Zeegers, Maurice/0000-0002-2387-083X	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Basset P, 1997, MATRIX BIOL, V15, P535, DOI 10.1016/S0945-053X(97)90028-7; Deal C, 2001, J CLIN ENDOCR METAB, V86, P1274, DOI 10.1210/jc.86.3.1274; DiCioccio RA, 2004, CANCER EPIDEM BIOMAR, V13, P1589; Ewart-Toland A, 2005, CARCINOGENESIS, V26, P1368, DOI 10.1093/carcin/bgi085; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; Foster RE, 2007, GENE CHROMOSOME CANC, V46, P311, DOI 10.1002/gcc.20403; Ghilardi G, 2001, CLIN CANCER RES, V7, P2344; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Hammerschmied CG, 2007, ONCOL REP, V17, P3; Heighway J, 2005, ANN HUM GENET, V69, P127, DOI 10.1046/j.1529-8817.2004.00135.x; Hirata H, 2004, CARCINOGENESIS, V25, P2379, DOI 10.1093/carcin/bgh254; Hirata H, 2003, INT J CANCER, V106, P372, DOI 10.1002/ijc.11229; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Hung RJ, 2005, JNCI-J NATL CANCER I, V97, P567, DOI 10.1093/jnci/dji101; Ito T, 1999, MODERN PATHOL, V12, P669; Kaelin WG, 1998, TRENDS GENET, V14, P423, DOI 10.1016/S0168-9525(98)01558-3; Kanamori Y, 1999, CANCER RES, V59, P4225; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Kimura MT, 2005, CANCER RES, V65, P3548, DOI 10.1158/0008-5472.CAN-04-2149; Koochekpour S, 1999, MOL CELL BIOL, V19, P5902; Krippl P, 2004, CLIN CANCER RES, V10, P3518, DOI 10.1158/1078-0432.CCR-04-0010; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; LI LC, 2000, CANCER RES, P873; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Murray GI, 1998, J PATHOL, V185, P256; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Ollerenshaw M, 2004, CANCER GENET CYTOGEN, V153, P122, DOI 10.1016/j.cancergencyto.2004.01.014; Ong KR, 2007, HUM MUTAT, V28, P143, DOI 10.1002/humu.20385; Pavlovich CP, 2004, NAT REV CANCER, V4, P381, DOI 10.1038/nrc1364; Prior SJ, 2006, AM J PHYSIOL-HEART C, V290, pH1848, DOI 10.1152/ajpheart.01033.2005; Ricketts C, 2008, J NATL CANCER I, V100, P1260, DOI 10.1093/jnci/djn254; RIGEL DS, 1991, DERMATOL CLIN, V9, P631; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Rutter JL, 1998, CANCER RES, V58, P5321; *STATACORP, 2005, STAT SOFTW REL 9 0 C; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Teh BT, 1997, LANCET, V349, P848, DOI 10.1016/S0140-6736(05)61751-5; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang W, 2007, CLIN CANCER RES, V13, P5974, DOI 10.1158/1078-0432.CCR-07-0113; Webster AR, 1998, AM J HUM GENET, V63, P1025, DOI 10.1086/302037; Woodward ER, 2000, J MED GENET, V37, P348, DOI 10.1136/jmg.37.5.348; Zatyka M, 2002, CANCER RES, V62, P3803; Zhang JH, 2004, CARCINOGENESIS, V25, P2519, DOI 10.1093/carcin/bgh269; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Zhu Y, 2001, CANCER RES, V61, P7825; Zinzindohoue F, 2004, ANTICANCER RES, V24, P2021	50	34	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6037	10.1371/journal.pone.0006037	http://dx.doi.org/10.1371/journal.pone.0006037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551141	gold, Green Published, Green Submitted			2022-12-27	WOS:000267356500019
J	Henderson, K; Stella, SL; Kobylewski, S; Eckhert, CD				Henderson, Kimberly; Stella, Salvatore L., Jr.; Kobylewski, Sarah; Eckhert, Curtis D.			Receptor Activated Ca2+ Release Is Inhibited by Boric Acid in Prostate Cancer Cells	PLOS ONE			English	Article							DIETARY BORON; CALCIUM; BORATE; GROWTH; TOXICITY; CHANNELS; STORES; ENTRY; POOL	Background: The global disparity in cancer incidence remains a major public health problem. We focused on prostate cancer since microscopic disease in men is common, but the incidence of clinical disease varies more than 100 fold worldwide. Ca2+ signaling is a central regulator of cell proliferation, but has received little attention in cancer prevention. We and others have reported a strong dose-dependent reduction in the incidence of prostate and lung cancer within populations exposed to boron (B) in drinking water and food; and in tumor and cell proliferation in animal and cell culture models. Methods/Principal Findings: We examined the impact of B on Ca2+ stores using cancer and non-cancer human prostate cell lines, Ca2+ indicators Rhod-2 AM and Indo-1 AM and confocal microscopy. In DU-145 cells, inhibition of Ca2+ release was apparent following treatment with Ringers containing RyR agonists cADPR, 4CmC or caffeine and respective levels of BA (50 mu M), (1, 10 mu M) or (10, 20, 50,150 mu M). Less aggressive LNCaP cancer cells required 20 mu M BA and the non-tumor cell line PWR1E required 150 mu M BA to significantly inhibit caffeine stimulated Ca2+ release. BA (10 mu M) and the RyR antagonist dantroline (10 beta M) were equivalent in their ability to inhibit ER Ca2+ loss. Flow cytometry and confocal microscopy analysis showed exposure of DU-145 cells to 50 mu M BA for 1 hr decreased stored [Ca2+] by 32%. Conclusion/Significance: We show B causes a dose dependent decrease of Ca2+ release from ryanodine receptor sensitive stores. This occurred at BA concentrations present in blood of geographically disparate populations. Our results suggest higher BA blood levels lower the risk of prostate cancer by reducing intracellular Ca2+ signals and storage.			Henderson, K (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA.	ceckhert@ucla.edu		Stella Jr., Salvatore/0000-0003-1971-2537				[Anonymous], 1995, CALCIUM CELL CYCLES, P1; BARR RD, 1993, J LAB CLIN MED, V121, P614; Barranco WT, 2007, CANCER CAUSE CONTROL, V18, P583, DOI 10.1007/s10552-007-9023-7; Barranco WT, 2009, CELL BIOL TOXICOL, V25, P309, DOI 10.1007/s10565-008-9085-7; Barranco WT, 2004, CANCER LETT, V216, P21, DOI 10.1016/j.canlet.2004.06.001; Barranco WT, 2006, BRIT J CANCER, V94, P884, DOI 10.1038/sj.bjc.6603009; Bennett A, 1999, J NUTR, V129, P2236, DOI 10.1093/jn/129.12.2236; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Chameau P, 2001, PFLUG ARCH EUR J PHY, V443, P289, DOI 10.1007/s004240100691; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Corey E. J, 2003, CHEM ENG NEWS, V81, P40; Cui Y, 2004, ONCOL REP, V11, P887; Eckhert CD, 1998, J NUTR, V128, P2488, DOI 10.1093/jn/128.12.2488; Fessenden JD, 2006, J BIOL CHEM, V281, P21022, DOI 10.1074/jbc.M600670200; Gallardo-Williams MT, 2004, TOXICOL PATHOL, V32, P73, DOI 10.1080/01926230490260899; Golovina VA, 1999, AM J PHYSIOL-CELL PH, V277, pC343, DOI 10.1152/ajpcell.1999.277.2.C343; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; Gonzalez A, 2007, CANCER CAUSE CONTROL, V18, P1131, DOI 10.1007/s10552-007-9052-2; Humez S, 2004, J CELL PHYSIOL, V201, P201, DOI 10.1002/jcp.20049; Hunt CD, 2001, J AM DIET ASSOC, V101, P1058, DOI 10.1016/S0002-8223(01)00260-7; *IPCS, 1998, BOR ENV HLTH CRIT WH, P61; Kaufmann A, 2008, ANESTHESIOLOGY, V109, P457, DOI 10.1097/ALN.0b013e318182a93b; Kim DH, 2006, J CHROMATOGR A, V1115, P246, DOI 10.1016/j.chroma.2006.02.066; Kim DH, 2004, J MASS SPECTROM, V39, P743, DOI 10.1002/jms.645; Kim DH, 2003, J MASS SPECTROM, V38, P632, DOI 10.1002/jms.476; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; Legrand G, 2001, J BIOL CHEM, V276, P47608, DOI 10.1074/jbc.M107011200; Li N, 2008, J CELL PHYSIOL, V216, P172, DOI 10.1002/jcp.21385; LIOU J, 2005, CURRENT BIO, P1235; Lopez JJ, 2008, BIOCHEM PHARMACOL, V75, P2157, DOI 10.1016/j.bcp.2008.03.010; Mahabir S, 2008, AM J EPIDEMIOL, V167, P1070, DOI 10.1093/aje/kwn021; Mariot P, 2000, PROSTATE, V43, P205; Matsumoto Hiroko, 2003, J Oral Sci, V45, P139; MINTA A, 1989, J BIOL CHEM, V264, P8171; Mironov SL, 2005, J BIOL CHEM, V280, P715, DOI 10.1074/jbc.M409819200; MORITA K, 2006, J PHARM SCI; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Pahl MV, 2001, TOXICOL SCI, V60, P252, DOI 10.1093/toxsci/60.2.252; Park M, 2004, MOL CELL, V16, P331, DOI 10.1016/j.molcel.2004.09.030; Rowe RI, 1999, J EXP BIOL, V202, P1649; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Takano J, 2008, TRENDS PLANT SCI, V13, P451, DOI 10.1016/j.tplants.2008.05.007; TANKANO J, 2005, P NATL ACAD SCI USA, V102, P12276; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Watson WD, 2003, J NEUROCHEM, V87, P30, DOI 10.1046/j.1471-4159.2003.01962.x; Wayman CP, 1996, BRIT J PHARMACOL, V117, P566, DOI 10.1111/j.1476-5381.1996.tb15228.x; WOODS WG, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3431956; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k	51	33	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6009	10.1371/journal.pone.0006009	http://dx.doi.org/10.1371/journal.pone.0006009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19554099	Green Published, gold, Green Submitted			2022-12-27	WOS:000267347900008
J	Mikkelsen, H; Ball, G; Giraud, C; Filloux, A				Mikkelsen, Helga; Ball, Genevieve; Giraud, Caroline; Filloux, Alain			Expression of Pseudomonas aeruginosa CupD Fimbrial Genes Is Antagonistically Controlled by RcsB and the EAL-Containing PvrR Response Regulators	PLOS ONE			English	Article								Pseudomonas aeruginosa is a gram-negative pathogenic bacterium with a high adaptive potential that allows proliferation in a broad range of hosts or niches. It is also the causative agent of both acute and chronic biofilm-related infections in humans. Three cup gene clusters (cupA-C), involved in the assembly of cell surface fimbriae, have been shown to be involved in biofilm formation by the P. aeruginosa strains PAO1 or PAK. In PA14 isolates, a fourth cluster, named cupD, was identified within a pathogenicity island, PAPI-I, and may contribute to the higher virulence of this strain. Expression of the cupA genes is controlled by the HNS-like protein MvaT, whereas the cupB and cupC genes are under the control of the RocS1A1R two-component system. In this study, we show that cupD gene expression is positively controlled by the response regulator RcsB. As a consequence, CupD fimbriae are assembled on the cell surface, which results in a number of phenotypes such as a small colony morphotype, increased biofilm formation and decreased motility. These behaviors are compatible with the sessile bacterial lifestyle. The balance between planktonic and sessile lifestyles is known to be linked to the intracellular levels of c-di-GMP with high levels favoring biofilm formation. We showed that the EAL domain-containing PvrR response regulator counteracts the activity of RcsB on cupD gene expression. The action of PvrR is likely to involve c-di-GMP degradation through phosphodiesterase activity, confirming the key role of this second messenger in the balance between bacterial lifestyles. The regulatory network between RcsB and PvrR remains to be elucidated, but it stands as a potential model system to study how the equilibrium between the two lifestyles could be influenced by therapeutic agents that favor the planktonic lifestyle. This would render the pathogen accessible for the immune system or conventional antibiotic treatment.			Mikkelsen, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, S Kensington Campus, London, England.	a.filloux@imperial.ac.uk		Giraud, Caroline/0000-0002-8294-3218	BBSRC [BB/F019645/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019645/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alibaud L, 2008, CELL MICROBIOL, V10, P729, DOI 10.1111/j.1462-5822.2007.01080.x; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Cao H, 2001, ANNU REV PHYTOPATHOL, V39, P259, DOI 10.1146/annurev.phyto.39.1.259; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Da Re S, 2007, APPL ENVIRON MICROB, V73, P3391, DOI 10.1128/AEM.02625-06; Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Haussler S, 1999, CLIN INFECT DIS, V29, P621, DOI 10.1086/598644; Haussler S, 2004, ENVIRON MICROBIOL, V6, P546, DOI 10.1111/j.1462-2920.2004.00618.x; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jonas K, 2009, FUTURE MICROBIOL, V4, P341, DOI [10.2217/fmb.09.7, 10.2217/FMB.09.7]; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Mahajan-Miklos S, 2000, MOL MICROBIOL, V37, P981, DOI 10.1046/j.1365-2958.2000.02056.x; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Roux A, 2005, J BACTERIOL, V187, P1001, DOI 10.1128/JB.187.3.1001-1013.2005; Ruer S, 2008, EMBO J, V27, P2669, DOI 10.1038/emboj.2008.197; Ruer S, 2007, J BACTERIOL, V189, P3547, DOI 10.1128/JB.00093-07; Sambrook J., 2002, MOL CLONING LAB MANU; Sarker MR, 1997, MOL MICROBIOL, V23, P410, DOI 10.1046/j.1365-2958.1997.t01-1-00190.x; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; STARKEY M, 2009, J BACTERIOLOGY  0327; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; STOUT V, 1990, J BACTERIOL, V172, P659, DOI 10.1128/jb.172.2.659-669.1990; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898; Vallet I, 2004, J BACTERIOL, V186, P2880, DOI 10.1128/JB.186.9.2880-2890.2004; Vallet-Gely I, 2005, P NATL ACAD SCI USA, V102, P11082, DOI 10.1073/pnas.0502663102; Vallet-Gely I, 2007, J BACTERIOL, V189, P8667, DOI 10.1128/JB.01344-07; VENTRE I, 2004, VIRULENCE GENE REGUL, V2, P257; Virlogeux I, 1996, J BACTERIOL, V178, P1691, DOI 10.1128/jb.178.6.1691-1698.1996; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004	50	65	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6018	10.1371/journal.pone.0006018	http://dx.doi.org/10.1371/journal.pone.0006018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547710	gold, Green Published, Green Submitted			2022-12-27	WOS:000267347900014
J	Allen, L; Jones, C; Dolby, K; Lynn, D; Walport, M				Allen, Liz; Jones, Ceri; Dolby, Kevin; Lynn, David; Walport, Mark			Looking for Landmarks: The Role of Expert Review and Bibliometric Analysis in Evaluating Scientific Publication Outputs	PLOS ONE			English	Article								Objective: To compare expert assessment with bibliometric indicators as tools to assess the quality and importance of scientific research papers. Methods and Materials: Shortly after their publication in 2005, the quality and importance of a cohort of nearly 700 Wellcome Trust (WT) associated research papers were assessed by expert reviewers; each paper was reviewed by two WT expert reviewers. After 3 years, we compared this initial assessment with other measures of paper impact. Results: Shortly after publication, 62 (9%) of the 687 research papers were determined to describe at least a 'major addition to knowledge' - 6 were thought to be 'landmark' papers. At an aggregate level, after 3 years, there was a strong positive association between expert assessment and impact as measured by number of citations and F1000 rating. However, there were some important exceptions indicating that bibliometric measures may not be sufficient in isolation as measures of research quality and importance, and especially not for assessing single papers or small groups of research publications. Conclusion: When attempting to assess the quality and importance of research papers, we found that sole reliance on bibliometric indicators would have led us to miss papers containing important results as judged by expert review. In particular, some papers that were highly rated by experts were not highly cited during the first three years after publication. Tools that link expert peer reviews of research paper quality and importance to more quantitative indicators, such as citation analysis would be valuable additions to the field of research assessment and evaluation.			Allen, L (corresponding author), Wellcome Trust Res Labs, London, England.	l.allen@wellcome.ac.uk	Allen, Liz/AAK-3137-2020; Allen, Liz/B-2625-2012	Allen, Liz/0000-0002-9298-3168; Allen, Liz/0000-0002-9298-3168; Walport, Mark/0000-0001-7220-5273; Dolby, Kevin/0000-0002-7912-4676; Lynn, David/0000-0001-6303-330X				Adam D, 2002, NATURE, V415, P726, DOI 10.1038/415726a; Adams J, 2007, SCIENTOMETRICS, V72, P325, DOI 10.1007/s11192-007-1696-x; Berghmans T, 2003, ANN ONCOL, V14, P715, DOI 10.1093/annonc/mdg203; Evans JA, 2008, SCIENCE, V321, P395, DOI 10.1126/science.1150473; Flanagin A, 2006, JAMA-J AM MED ASSOC, V296, P220, DOI 10.1001/jama.296.2.220; Gallagher R, 2005, SCIENTIST, V19, P6; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Giles CL, 2004, P NATL ACAD SCI USA, V101, P17599, DOI 10.1073/pnas.0407743101; Hobbs FDR, 2006, BRIT MED J, V332, P983, DOI 10.1136/bmj.332.7548.983; Ioannidis JPA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002778; Mahdi S., 2008, CITATION COUNTS ARE; Moed HF, 2008, SCIENTOMETRICS, V74, P153, DOI 10.1007/s11192-008-0108-1; Papatheodorou SI, 2008, J CLIN EPIDEMIOL, V61, P546, DOI 10.1016/j.jclinepi.2007.07.017; Parthasarathy H, 2006, PLOS BIOL, V4, P1093, DOI 10.1371/journal.pbio.0040257; Research Information Network, 2008, ACKN FUND SCHOL J AR; Rinia EJ, 1998, RES POLICY, V27, P95, DOI 10.1016/S0048-7333(98)00026-2; Ross JS, 2006, JAMA-J AM MED ASSOC, V295, P1675, DOI 10.1001/jama.295.14.1675; Seglen PO, 1997, BRIT MED J, V314, P498; Stacy KM, 2005, SCIENTIST, V19, P17; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; 2009, NATURE, V457, P7	21	90	99	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5910	10.1371/journal.pone.0005910	http://dx.doi.org/10.1371/journal.pone.0005910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536339	Green Published, gold, Green Submitted			2022-12-27	WOS:000267079500001
J	Benvegnu, S; Franciotta, D; Sussman, J; Bachi, A; Zardini, E; Torreri, P; Govaerts, C; Pizzo, S; Legname, G				Benvegnu, Stefano; Franciotta, Diego; Sussman, Josh; Bachi, Angela; Zardini, Elisabetta; Torreri, Paola; Govaerts, Cedric; Pizzo, Salvatore; Legname, Giuseppe			Prion Protein Paralog Doppel Protein Interacts with Alpha-2-Macroglobulin: A Plausible Mechanism for Doppel-Mediated Neurodegeneration	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; PRP-DEFICIENT MICE; CELLULAR PRION; APOLIPOPROTEIN-E; ALPHA(2)-MACROGLOBULIN; DISEASE; EXPRESSION; BINDING; ATAXIA; CELLS	Doppel protein (Dpl) is a paralog of the cellular form of the prion protein (PrPC), together sharing common structural and biochemical properties. Unlike PrPC, which is abundantly expressed throughout the central nervous system (CNS), Dpl protein expression is not detectable in the CNS. Interestingly, its ectopic expression in the brain elicits neurodegeneration in transgenic mice. Here, by combining native isoelectric focusing plus non-denaturing polyacrylamide gel electrophoresis and mass spectrometry analysis, we identified two Dpl binding partners: rat alpha-1-inhibitor-3 (alpha I-1(3)) and, by sequence homology, alpha-2-macroglobulin (alpha M-2), two known plasma metalloproteinase inhibitors. Biochemical investigations excluded the direct interaction of PrPC with either alpha I-1(3) or alpha M-2. Nevertheless, enzyme-linked immunosorbent assays and surface plasmon resonance experiments revealed a high affinity binding occurring between PrPC and Dpl. In light of these findings, we suggest a mechanism for Dpl-induced neurodegeneration in mice expressing Dpl ectopically in the brain, linked to a withdrawal of natural inhibitors of metalloproteinase such as alpha M-2. Interestingly, alpha M-2 has been proven to be a susceptibility factor in Alzheimer's disease, and as our findings imply, it may also play a relevant role in other neurodegenerative disorders, including prion diseases.			Benvegnu, S (corresponding author), SISSA, ISAS, I-34014 Trieste, Italy.	legname@sissa.it	Franciotta, Diego/ABE-0957-2022; Legname, Giuseppe/C-1723-2012; bachi, angela/B-3527-2015; Sussman, Josh/AAU-1219-2021; TORRERI, PAOLA/A-6656-2015; Franciotta, Diego/K-8262-2016	Franciotta, Diego/0000-0002-3014-3913; Legname, Giuseppe/0000-0003-0716-4393; bachi, angela/0000-0003-4842-6556; TORRERI, PAOLA/0000-0002-0488-956X; Franciotta, Diego/0000-0002-3014-3913; BENVEGNU, STEFANO/0000-0002-0904-1592	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024066, R37HL024066] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL024066, R01 HL024066, HL-24066] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adler V, 2007, AMYLOID, V14, P1, DOI 10.1080/13506120600960452; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atarashi R, 2003, J BIOL CHEM, V278, P28944, DOI 10.1074/jbc.M303655200; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; Behrens A, 2003, BRIT MED BULL, V66, P35, DOI 10.1093/bmb/66.1.35; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chacon MA, 2003, MOL PSYCHIATR, V8, P853, DOI [10.1038/sj.mp.4001400, 10.1038/sj.mp.4001414]; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; CHU CT, 1994, LAB INVEST, V71, P792; Dodel RC, 2000, NEUROLOGY, V54, P438, DOI 10.1212/WNL.54.2.438; ENGHILD JJ, 1989, BIOCHEMISTRY-US, V28, P1406, DOI 10.1021/bi00429a069; GEIGER T, 1987, BIOCHEM J, V245, P493, DOI 10.1042/bj2450493; Harlow E., 1988, ANTIBODIES LAB MANUA, VVolume 1, P726; Hyman BT, 2000, ARCH NEUROL-CHICAGO, V57, P646, DOI 10.1001/archneur.57.5.646; HYMAN BT, 1994, ANN NY ACAD SCI, V737, P88, DOI 10.1111/j.1749-6632.1994.tb44303.x; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Legname G, 2002, P NATL ACAD SCI USA, V99, P16285, DOI 10.1073/pnas.242611999; Li AM, 2000, AM J PATHOL, V157, P1447, DOI 10.1016/S0002-9440(10)64782-7; Liao A, 1998, HUM MOL GENET, V7, P1953, DOI 10.1093/hmg/7.12.1953; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Narita M, 1997, J NEUROCHEM, V69, P1904; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paisley D, 2004, AM J PATHOL, V164, P2279, DOI 10.1016/S0002-9440(10)63784-4; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1998, PRIX NOBEL, P268; REBECK GW, 1995, ANN NEUROL, V37, P211, DOI 10.1002/ana.410370212; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Ryou C, 2003, J MOL BIOL, V329, P323, DOI 10.1016/S0022-2836(03)00342-5; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; SARAVIS CA, 1979, J IMMUNOL METHODS, V29, P97, DOI 10.1016/0022-1759(79)90131-5; Saunders AJ, 2003, EXP NEUROL, V184, P50, DOI 10.1016/j.expneurol.2003.09.004; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Silverman GL, 2000, J BIOL CHEM, V275, P26834; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; STRAUSS S, 1992, LAB INVEST, V66, P223; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALKER RWH, 1983, J NEUROIMMUNOL, V4, P141, DOI 10.1016/0165-5728(83)90018-8; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; WILLOUGHBY EW, 1983, ANAL BIOCHEM, V130, P353, DOI 10.1016/0003-2697(83)90599-7; Wong CH, 2005, ENDOCRINOLOGY, V146, P1893, DOI 10.1210/en.2004-1464; ZHU LJ, 1994, J ANDROL, V15, P575	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5968	10.1371/journal.pone.0005968	http://dx.doi.org/10.1371/journal.pone.0005968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536284	Green Published, gold, Green Submitted			2022-12-27	WOS:000267079500015
J	Lighthall, NR; Mather, M; Gorlick, MA				Lighthall, Nichole R.; Mather, Mara; Gorlick, Marissa A.			Acute Stress Increases Sex Differences in Risk Seeking in the Balloon Analogue Risk Task	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; FINANCIAL DECISION-MAKING; INNER-CITY ADOLESCENTS; PSYCHOLOGICAL STRESS; GENDER-DIFFERENCES; TAKING PROPENSITY; MEMORY CONSOLIDATION; ANTICIPATORY STRESS; CORTISOL RESPONSES; BRAIN	Background: Decisions involving risk often must be made under stressful circumstances. Research on behavioral and brain differences in stress responses suggest that stress might have different effects on risk taking in males and females. Methodology/Principal Findings: In this study, participants played a computer game designed to measure risk taking (the Balloon Analogue Risk Task) fifteen minutes after completing a stress challenge or control task. Stress increased risk taking among men but decreased it among women. Conclusions/Significance: Acute stress amplifies sex differences in risk seeking; making women more risk avoidant and men more risk seeking. Evolutionary principles may explain these stress-induced sex differences in risk taking behavior.			Lighthall, NR (corresponding author), Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90024 USA.	nichole.lighthall@usc.edu	Mather, Mara/E-3232-2010	Mather, Mara/0000-0003-4331-6112; Lighthall, Nichole/0000-0002-8131-8373	NATIONAL INSTITUTE ON AGING [R21AG030758, T32AG000037] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG000037, T32 AG000037-31, R21 AG030758] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahs F, 2006, PSYCHOSOM MED, V68, P859, DOI 10.1097/01.psy.0000242120.91030.d8; Aklin WM, 2005, BEHAV RES THER, V43, P215, DOI 10.1016/j.brat.2003.12.007; Andreano JM, 2006, PSYCHOL SCI, V17, P466, DOI 10.1111/j.1467-9280.2006.01729.x; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Brand M, 2006, NEURAL NETWORKS, V19, P1266, DOI 10.1016/j.neunet.2006.03.001; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; Campbell A, 2008, BIOL PSYCHOL, V77, P1, DOI 10.1016/j.biopsycho.2007.09.001; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; CLARK RL, 2003, PENSION DESIGN STRUC; d'Acremont M, 2006, INT J BEHAV DEV, V30, P352, DOI 10.1177/0165025406066740; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio A, 2006, DAEDALUS-US, V135, P15, DOI 10.1162/daed.2006.135.3.15; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Endres ML, 2006, THEOR DECIS, V61, P129, DOI 10.1007/s11238-006-0006-z; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Girdler SS, 1997, INT J BEHAV MED, V4, P242, DOI 10.1207/s15327558ijbm0403_4; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hill EM, 2002, ADDICTION, V97, P401, DOI 10.1046/j.1360-0443.2002.00020.x; Hopko DR, 2006, J PSYCHOPATHOL BEHAV, V28, P95, DOI 10.1007/s10862-006-7487-5; Miranda MI, 2008, LEARN MEMORY, V15, P468, DOI 10.1101/lm.964708; Jianakoplos NA, 1998, ECON INQ, V36, P620, DOI 10.1111/j.1465-7295.1998.tb01740.x; JONES LK, 2009, NATURE PRECEDINGS; Karakowsky L, 2001, SMALL GR RES, V32, P94, DOI 10.1177/104649640103200105; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Labus JS, 2008, NEUROIMAGE, V41, P1032, DOI 10.1016/j.neuroimage.2008.03.009; Lejuez CW, 2007, J CLIN CHILD ADOLESC, V36, P106, DOI 10.1207/s15374424jccp3601_11; Lejuez CW, 2005, NICOTINE TOB RES, V7, P71, DOI 10.1080/14622200412331328484; Lejuez CW, 2004, ADDICT BEHAV, V29, P1643, DOI 10.1016/j.addbeh.2004.02.035; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Mather M, 2009, PSYCHOL SCI, V20, P174, DOI 10.1111/j.1467-9280.2009.02275.x; MAXIM PS, 1992, CAN REV SOC ANTHROP, V29, P329, DOI 10.1111/j.1755-618X.1992.tb02442.x; Naliboff BD, 2003, GASTROENTEROLOGY, V124, P1738, DOI 10.1016/S0016-5085(03)00400-1; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Porcelli AJ, 2009, PSYCHOL SCI, V20, P278, DOI 10.1111/j.1467-9280.2009.02288.x; Preston SD, 2007, BEHAV NEUROSCI, V121, P257, DOI 10.1037/0735-7044.121.2.257; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Radley JJ, 2005, AGEING RES REV, V4, P271, DOI 10.1016/j.arr.2005.03.004; Rao H, 2008, NEUROIMAGE, V42, P902, DOI 10.1016/j.neuroimage.2008.05.046; SANDERS G, 1990, PSYCHONEUROENDOCRINO, V15, P47, DOI 10.1016/0306-4530(90)90046-C; Sapolsky RM, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1031; Sinha R, 2005, PSYCHOPHARMACOLOGY, V183, P171, DOI 10.1007/s00213-005-0147-8; Starcke K, 2008, BEHAV NEUROSCI, V122, P1352, DOI 10.1037/a0013281; Sunden AE, 1998, AM ECON REV, V88, P207; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; van Stegeren AH, 2008, INT J PSYCHOPHYSIOL, V69, P33, DOI 10.1016/j.ijpsycho.2008.02.008; Wang JJ, 2007, SOC COGN AFFECT NEUR, V2, P227, DOI 10.1093/scan/nsm018; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Weller JA, 2007, PSYCHOL SCI, V18, P958, DOI 10.1111/j.1467-9280.2007.02009.x; Zimmer C, 2003, CLIN J PAIN, V19, P233, DOI 10.1097/00002508-200307000-00006	55	183	193	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6002	10.1371/journal.pone.0006002	http://dx.doi.org/10.1371/journal.pone.0006002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	465HA	19568417	gold, Green Published			2022-12-27	WOS:000267572200001
J	Shemon, AN; Eves, EM; Clark, MC; Heil, G; Granovsky, A; Zeng, LC; Imamoto, A; Koide, S; Rosner, MR				Shemon, Anne N.; Eves, Eva M.; Clark, Matthew C.; Heil, Gary; Granovsky, Alexey; Zeng, Lingchun; Imamoto, Akira; Koide, Shohei; Rosner, Marsha Rich			Raf Kinase Inhibitory Protein Protects Cells against Locostatin-Mediated Inhibition of Migration	PLOS ONE			English	Article								Background: Raf Kinase Inhibitory Protein (RKIP, also PEBP1), a member of the Phosphatidylethanolamine Binding Protein family, negatively regulates growth factor signaling by the Raf/MAP kinase pathway. Since an organic compound, locostatin, was reported to bind RKIP and inhibit cell migration by a Raf-dependent mechanism, we addressed the role of RKIP in locostatin function. Methods/Findings: We analyzed locostatin interaction with RKIP and examined the biological consequences of locostatin binding on RKIP function. NMR studies show that a locostatin precursor binds to the conserved phosphatidylethanolamine binding pocket of RKIP. However, drug binding to the pocket does not prevent RKIP association with its inhibitory target, Raf-1, nor affect RKIP phosphorylation by Protein Kinase C at a regulatory site. Similarly, exposure of wild type, RKIP-depleted HeLa cells or RKIP-deficient (RKIP(-/-)) mouse embryonic fibroblasts (MEFs) to locostatin has no effect on MAP kinase activation. Locostatin treatment of wild type MEFs causes inhibition of cell migration following wounding. RKIP deficiency impairs migration further, indicating that RKIP protects cells against locostatin-mediated inhibition of migration. Locostatin treatment of depleted or RKIP(-/-)MEFs reveals cytoskeletal disruption and microtubule abnormalities in the spindle. Conclusions/Significance: These results suggest that locostatin's effects on cytoskeletal structure and migration are caused through mechanisms independent of its binding to RKIP and Raf/MAP kinase signaling. The protective effect of RKIP against drug inhibition of migration suggests a new role for RKIP in potentially sequestering toxic compounds that may have deleterious effects on cells.			Shemon, AN (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	skoide@uchicago.edu; m-rosner@uchicago.edu		Koide, Shohei/0000-0001-5473-4358	NATIONAL CANCER INSTITUTE [R01CA112310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033858] Funding Source: NIH RePORTER; NCI NIH HHS [CA112310, R01 CA112310] Funding Source: Medline; NINDS NIH HHS [R01 NS033858, NS033858] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banfield MJ, 1998, STRUCTURE, V6, P1245, DOI 10.1016/S0969-2126(98)00125-7; Clark MC, 2006, J BIOMOL NMR, V36, P4, DOI 10.1007/s10858-005-4424-y; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; DANGIGARIMELLA S, 2009, EMBO J; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; GRANOVSKY AE, 2009, MOL CELL BIOL; Granovsky AE, 2008, CELL RES, V18, P452, DOI 10.1038/cr.2008.43; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kuo PH, 2008, ALCOHOL CLIN EXP RES, V32, P785, DOI 10.1111/j.1530-0277.2008.00642.x; Lee HC, 2006, GASTROENTEROLOGY, V131, P1208, DOI 10.1053/j.gastro.2006.07.012; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Mc Henry KT, 2008, J CELL BIOCHEM, V103, P972, DOI 10.1002/jcb.21470; Mc Henry KT, 2002, CHEMBIOCHEM, V3, P1105, DOI 10.1002/1439-7633(20021104)3:11<1105::AID-CBIC1105>3.0.CO;2-S; Schuierer MM, 2006, BIOCHEM BIOPH RES CO, V342, P1083, DOI 10.1016/j.bbrc.2006.02.083; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Theroux S, 2007, BRAIN RES BULL, V71, P559, DOI 10.1016/j.brainresbull.2006.11.010; Trakul N, 2005, J BIOL CHEM, V280, P24931, DOI 10.1074/jbc.M413929200; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Zeng LC, 2008, EXPERT OPIN THER TAR, V12, P1275, DOI [10.1517/14728222.12.10.1275, 10.1517/14728222.12.10.1275 ]; Zhu ST, 2005, CHEM BIOL, V12, P981, DOI 10.1016/j.chembiol.2005.07.007	25	22	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6028	10.1371/journal.pone.0006028	http://dx.doi.org/10.1371/journal.pone.0006028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551145	Green Published, gold			2022-12-27	WOS:000267356500012
J	Stetak, A; Horndli, F; Maricq, AV; van den Heuvel, S; Hajnal, A				Stetak, Attila; Hoerndli, Frederic; Maricq, Andres V.; van den Heuvel, Sander; Hajnal, Alex			Neuron-Specific Regulation of Associative Learning and Memory by MAGI-1 in C. elegans	PLOS ONE			English	Article								Background: Identifying the molecular mechanisms and neural circuits that control learning and memory are major challenges in neuroscience. Mammalian MAGI/S-SCAM is a multi-PDZ domain synaptic scaffolding protein that interacts with a number of postsynaptic signaling proteins and is thereby thought to regulate synaptic plasticity [1,2,3]. Principal Findings: While investigating the behavioral defects of C. elegans nematodes carrying a mutation in the single MAGI ortholog magi-1, we have identified specific neurons that require MAGI-1 function for different aspects of associative learning and memory. Various sensory stimuli and a food deprivation signal are associated in RIA interneurons during learning, while additional expression of MAGI-1 in glutamatergic AVA, AVD and possibly AVE interneurons is required for efficient memory consolidation, i.e. the ability to retain the conditioned changes in behavior over time. During associative learning, MAGI-1 in RIA neurons controls in a cell non-autonomous fashion the dynamic remodeling of AVA, AVD and AVE synapses containing the ionotropic glutamate receptor (iGluR) GLR-1 [4]. During memory consolidation, however, MAGI-1 controls GLR-1 clustering in AVA and AVD interneurons cell-autonomously and depends on the ability to interact with the beta-catenin HMP-2. Significance: Together, these results indicate that different aspects of associative learning and memory in C. elegans are likely carried out by distinct subsets of interneurons. The synaptic scaffolding protein MAGI-1 plays a critical role in these processes in part by regulating the clustering of iGluRs at synapses.			Stetak, A (corresponding author), Univ Basel, Biozentrum Pharmazentrum, Basel, Switzerland.	a.stetak@unibas.ch	van den Heuvel, Sander J.L./B-8892-2011	van den Heuvel, Sander J.L./0000-0001-9015-7463; Hajnal, Alex/0000-0002-4098-3721	NCI NIH HHS [CA095281, P01 CA095281] Funding Source: Medline; NINDS NIH HHS [R01 NS035812] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA095281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035812] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Cassata G, 2000, GENESIS, V27, P141, DOI 10.1002/1526-968X(200008)27:4<141::AID-GENE20>3.0.CO;2-K; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Emtage L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004613; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Kano T, 2008, CURR BIOL, V18, P1010, DOI 10.1016/j.cub.2008.05.051; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002; Kuhara A, 2006, J NEUROSCI, V26, P9355, DOI 10.1523/JNEUROSCI.0517-06.2006; Lisman J., 2006, SCI STKE, V2006, pr; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; Morrison GE, 2001, BEHAV NEUROSCI, V115, P640, DOI 10.1037//0735-7044.115.3.640; Morrison GE, 1997, BEHAV NEUROSCI, V111, P564, DOI 10.1037/0735-7044.111.3.564; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Rose JK, 2003, J NEUROSCI, V23, P9595; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shoji H, 2000, J BIOL CHEM, V275, P5485, DOI 10.1074/jbc.275.8.5485; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686	32	42	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6019	10.1371/journal.pone.0006019	http://dx.doi.org/10.1371/journal.pone.0006019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551147	Green Published, gold			2022-12-27	WOS:000267356500007
J	Vitali, SH; Mitsialis, SA; Liang, OD; Liu, XL; Fernandez-Gonzalez, A; Christou, H; Wu, XQ; McGowan, FX; Kourembanas, S				Vitali, Sally H.; Mitsialis, S. Alex; Liang, Olin D.; Liu, Xiaoli; Fernandez-Gonzalez, Angeles; Christou, Helen; Wu, Xinqi; McGowan, Francis X.; Kourembanas, Stella			Divergent Cardiopulmonary Actions of Heme Oxygenase Enzymatic Products in Chronic Hypoxia	PLOS ONE			English	Article								Background: Hypoxia and pressure-overload induce heme oxygenase-1 (HO-1) in cardiomyocytes and vascular smooth muscle cells (VSMCs). HO-1(-/-) mice exposed to chronic hypoxia develop pulmonary arterial hypertension (PAH) with exaggerated right ventricular (RV) injury consisting of dilation, fibrosis, and mural thrombi. Our objective was to indentify the HO-1 product(s) mediating RV protection from hypoxic injury in HO-1(-/-) mice. Methodology/Principal Findings: HO-1(-/-) mice were exposed to seven weeks of hypoxia and treated with inhaled CO or biliverdin injections. CO reduced right ventricular systolic pressure (RVSP) and prevented hypoxic pulmonary arteriolar remodeling in both HO-1(-/-) and control mice. Biliverdin had no significant effect on arteriolar remodeling or RVSP in either genotype. Despite this, biliverdin prevented RV failure in the hypoxic HO-1(-/-) mice (0/14 manifested RV wall fibrosis or thrombus), while CO-treated HO-1(-/-) mice developed RV insults similar to untreated controls. In vitro, CO inhibited hypoxic VSMC proliferation and migration but did not prevent cardiomyocyte death from anoxia-reoxygenation (A-R). In contrast, bilirubin limited A-R-induced cardiomyocyte death but did not inhibit VSMC proliferation and migration. Conclusions/Significance: CO and bilirubin have distinct protective actions in the heart and pulmonary vasculature during chronic hypoxia. Moreover, reducing pulmonary vascular resistance may not prevent RV injury in hypoxia-induced PAH; supporting RV adaptation to hypoxia and preventing RV failure must be a therapeutic goal.			Vitali, SH (corresponding author), Childrens Hosp, Div Crit Care Med, 300 Longwood Ave, Boston, MA 02115 USA.	stella.kourembanas@childrens.harvard.edu	Liu, Xiaoli/HGE-7614-2022	Mitsialis, S. Alex/0000-0001-8315-7828; Christou, Helen/0000-0002-3104-4570; Liu, Xiaoli/0000-0003-2904-4413	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055454, K08HL077344, R01HL085446] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL077344, R01 HL085446, R01 HL055454, HL085446] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; BRUNE B, 1987, MOL PHARMACOL, V32, P497; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Clark JE, 2000, AM J PHYSIOL-HEART C, V278, pH643, DOI 10.1152/ajpheart.2000.278.2.H643; DELCAYRE C, 1988, J CLIN INVEST, V82, P460, DOI 10.1172/JCI113619; Dolinay T, 2004, AM J RESP CRIT CARE, V170, P613, DOI 10.1164/rccm.200401-023OC; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Foo JJ, 2006, BIOMED MATER, V1, P1, DOI 10.1088/1748-6041/1/1/001; Foresti R, 2001, AM J PHYSIOL-HEART C, V281, pH1976, DOI 10.1152/ajpheart.2001.281.5.H1976; Gautier M, 2007, AM J PHYSIOL-HEART C, V293, pH1046, DOI 10.1152/ajpheart.01040.2006; Guo YR, 2004, AM J PHYSIOL-HEART C, V286, pH1649, DOI 10.1152/ajpheart.00971.2003; Hartsfield CL, 2004, AM J PHYSIOL-HEART C, V287, pH2009, DOI 10.1152/ajpheart.00394.2002; Hu CM, 2004, CIRCULATION, V110, P309, DOI 10.1161/01.CIR.0000135475.35758.23; Kacimi R, 2000, CARDIOVASC RES, V46, P139, DOI 10.1016/S0008-6363(00)00007-9; KATARIA AK, 1993, INDIAN VET J, V70, P191; Kim HP, 2005, P NATL ACAD SCI USA, V102, P11319, DOI 10.1073/pnas.0501345102; Liu XL, 2005, DIABETES, V54, P778, DOI 10.2337/diabetes.54.3.778; Minamino T, 2001, P NATL ACAD SCI USA, V98, P8798, DOI 10.1073/pnas.161272598; Morita T, 1997, J BIOL CHEM, V272, P32804, DOI 10.1074/jbc.272.52.32804; MORITA T, 1995, P NATL ACAD SCI USA, V92, P1475, DOI 10.1073/pnas.92.5.1475; Motterlini R, 1998, CIRC RES, V83, P568, DOI 10.1161/01.RES.83.5.568; Nakao A, 2005, CIRCULATION, V112, P587, DOI 10.1161/CIRCULATIONAHA.104.509778; Ollinger R, 2005, CIRCULATION, V112, P1030, DOI 10.1161/CIRCULATIONAHA.104.528802; Otterbein LE, 1999, AM J PHYSIOL-LUNG C, V276, pL688; Overhaus M, 2006, AM J PHYSIOL-GASTR L, V290, pG695, DOI 10.1152/ajpgi.00152.2005; Alok SP, 2007, J MOL CELL CARDIOL, V43, P580, DOI 10.1016/j.yjmcc.2007.08.003; Peyton KJ, 2002, BLOOD, V99, P4443, DOI 10.1182/blood.V99.12.4443; Redout EM, 2007, CARDIOVASC RES, V75, P770, DOI 10.1016/j.cardiores.2007.05.012; Sarady-Andrews JK, 2005, AM J PHYSIOL-LUNG C, V289, pL1131, DOI 10.1152/ajplung.00458.2004; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Stanford SJ, 2003, EUR J PHARMACOL, V473, P135, DOI 10.1016/S0014-2999(03)02001-6; Stein AB, 2005, J MOL CELL CARDIOL, V38, P127, DOI 10.1016/j.yjmcc.2004.10.006; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tongers J, 2004, CARDIOVASC RES, V63, P545, DOI 10.1016/j.cardiores.2004.04.015; Wagner CT, 1997, J CLIN INVEST, V100, P589, DOI 10.1172/JCI119569; Wang HD, 2002, AM J RESP CRIT CARE, V165, P406, DOI 10.1164/ajrccm.165.3.2003149; Yamashita K, 2004, FASEB J, V18, P765, DOI 10.1096/fj.03-0839fje; Yamboliev IA, 2001, AM J PHYSIOL-CELL PH, V280, pC1680, DOI 10.1152/ajpcell.2001.280.6.C1680; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; ZHANG H, 2002, IEEE T MOBILE COMPUT, V1, P132, DOI DOI 10.1109/TVT.2006.877695; Zhen GH, 2003, CHINESE MED J-PEKING, V116, P1804; Zuckerbraun BS, 2006, J EXP MED, V203, P2109, DOI 10.1084/jem.20052267	44	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5978	10.1371/journal.pone.0005978	http://dx.doi.org/10.1371/journal.pone.0005978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543386	gold, Green Submitted, Green Published			2022-12-27	WOS:000267237400005
J	Karnezis, TT; Smith, A; Whittier, S; Haddad, J; Saiman, L				Karnezis, Tom Theodore; Smith, Ann; Whittier, Susan; Haddad, Joseph, Jr.; Saiman, Lisa			Antimicrobial Resistance among Isolates Causing Invasive Pneumococcal Disease before and after Licensure of Heptavalent Conjugate Pneumococcal Vaccine	PLOS ONE			English	Article								Background: The impact of the pneumococcal conjugate vaccine (PCV-7) on antibiotic resistance among pneumococcal strains causing invasive pneumococcal disease (IPD) has varied in different locales in the United States. We assessed trends in IPD including trends for IPD caused by penicillin non-susceptible strains before and after licensure of PCV-7 and the impact of the 2008 susceptibility breakpoints for penicillin on the epidemiology of resistance. Methodology/Principal Findings: We performed a retrospective review of IPD cases at Morgan Stanley Children's Hospital of NewYork-Presbyterian, Columbia University Medical Center. Subjects were <= 18 years of age with Streptococcus pneumoniae isolated from sterile body sites from January 1995-December 2006. The rate of IPD from 1995-1999 versus 2002-2006 significantly decreased from 4.1 (CI95 3.4, 4.8) to 1.7 (CI95 1.3, 2.2) per 1,000 admissions. Using the breakpoints in place during the study period, the proportion of penicillin non-susceptible strains increased from 27% to 49% in the pre-vs. post-PCV-7 era, respectively (p = 0.001), although the rate of IPD caused by non-susceptible strains did not change from 1995-1999 (1.1 per 1,000 admissions, CI95 0.8, 1.5) when compared with 2002-2006 (0.8 per 1,000 admissions, CI95 0.6, 1.2). In the multivariate logistic regression model controlling for the effects of age, strains causing IPD in the post-PCV-7 era were significantly more likely to be penicillin non-susceptible compared with strains in the pre-PCV-7 era (OR 2.46, CI95 1.37, 4.40). However, using the 2008 breakpoints for penicillin, only 8% of strains were non-susceptible in the post-PCV-7 era. Conclusions/Significance: To date, there are few reports that document an increase in the relative proportion of penicillin non-susceptible strains of pneumococci causing IPD following the introduction of PCV-7. Active surveillance of pneumococcal serotypes and antibiotic resistance using the new penicillin breakpoints is imperative to assess potential changes in the epidemiology of IPD.			Karnezis, TT (corresponding author), Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA.	ls5@columbia.edu						*AM AC PED, 2000, NEW ENGL J MED, V343, P362; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; *CLSI, 2008, PERF STAND ANT SUSC; Jacobs MR, 2008, J CLIN MICROBIOL, V46, P982, DOI 10.1128/JCM.02321-07; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Messina AF, 2007, PEDIATR INFECT DIS J, V26, P461, DOI 10.1097/INF.0b013e31805cdbeb; *NAT COMM CLIN LAB, 2007, PERF STAND ANT SUSC, V27; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Shah SS, 2006, CLIN INFECT DIS, V42, DOI 10.1086/498745; Steenhoff AP, 2006, CLIN INFECT DIS, V42, P907, DOI 10.1086/500941; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Wooten K. G., 2007, Morbidity and Mortality Weekly Report, V56, P880	12	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5965	10.1371/journal.pone.0005965	http://dx.doi.org/10.1371/journal.pone.0005965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536335	gold, Green Submitted, Green Published			2022-12-27	WOS:000267079500014
J	Legrand, F; Driss, V; Woerly, G; Loiseau, S; Hermann, E; Fournie, JJ; Heliot, L; Mattot, V; Soncin, F; Gougeon, ML; Dombrowicz, D; Capron, M				Legrand, Fanny; Driss, Virginie; Woerly, Gaetane; Loiseau, Sylvie; Hermann, Emmanuel; Fournie, Jean-Jacques; Heliot, Laurent; Mattot, Virginie; Soncin, Fabrice; Gougeon, Marie-Lise; Dombrowicz, David; Capron, Monique			A Functional gamma delta TCR/CD3 Complex Distinct from gamma delta T Cells Is Expressed by Human Eosinophils	PLOS ONE			English	Article								Background: Eosinophils are effector cells during parasitic infections and allergic responses. However, their contribution to innate immunity has been only recently unravelled. Methodology/Principal Findings: Here we show that human eosinophils express CD3 and gamma delta T Cell Receptor (TCR) but not ab TCR. Surface expression of gamma delta TCR/CD3 is heterogeneous between eosinophil donors and inducible by mycobacterial ligands. Surface immunoprecipitation revealed expression of the full gamma delta TCR/CD3 complex. Real-time PCR amplification for CD3, gamma and delta TCR constant regions transcripts showed a significantly lower expression in eosinophils than in gamma delta T cells. Limited TCR rearrangements occur in eosinophils as shown by spectratyping analysis of CDR3 length profiles and in situ hybridization. Release by eosinophils of Reactive Oxygen Species, granule proteins, Eosinophil Peroxidase and Eosinophil-Derived Neurotoxin and cytokines (IFN-gamma and TNF-alpha) was observed following activation by gamma delta TCR-specific agonists or by mycobacteria. These effects were inhibited by anti-gamma delta TCR blocking antibodies and antagonists. Moreover, gamma delta TCR/CD3 was involved in eosinophil cytotoxicity against tumor cells. Conclusions/Significance: Our results provide evidence that human eosinophils express a functional gamma delta TCR/CD3 with similar, but not identical, characteristics to gamma delta TCR from gamma delta T cells. We propose that this receptor contributes to eosinophil innate responses against mycobacteria and tumors and may represent an additional link between lymphoid and myeloid lineages.			Legrand, F (corresponding author), INSERM, U547, F-59045 Lille, France.	monique.capron@pasteur-lille.fr	Dombrowicz, David/F-7044-2013; Fournie, Jean-Jacques/J-7805-2013; Capron, monique/Z-2207-2019; HERMANN, Emmanuel/X-6168-2019; SONCIN, Fabrice/A-1475-2009; Hermann, Emmanuel/C-6376-2008; Legrand, Fanny/I-4880-2017	Dombrowicz, David/0000-0002-0485-8923; Fournie, Jean-Jacques/0000-0001-6542-6908; Capron, monique/0000-0001-5625-5158; HERMANN, Emmanuel/0000-0003-0971-4918; SONCIN, Fabrice/0000-0001-6312-0673; Hermann, Emmanuel/0000-0003-0971-4918; Legrand, Fanny/0000-0001-9373-7789				Bennouna J, 2008, CANCER IMMUNOL IMMUN, V57, P1599, DOI 10.1007/s00262-008-0491-8; Bolton SJ, 2003, J LEUKOCYTE BIOL, V74, P60, DOI 10.1189/jlb.0702351; Borelli V, 2003, INFECT IMMUN, V71, P605, DOI 10.1128/IAI.71.2.605-613.2003; Boullier S, 1998, EUR J IMMUNOL, V28, P3399, DOI 10.1002/(SICI)1521-4141(199811)28:11<3399::AID-IMMU3399>3.0.CO;2-W; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; CHOY MY, 1990, LANCET, V336, P126, DOI 10.1016/0140-6736(90)91651-P; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Couedel C, 2004, J IMMUNOL, V172, P5544, DOI 10.4049/jimmunol.172.9.5544; deAndres B, 1997, BLOOD, V89, P3826, DOI 10.1182/blood.V89.10.3826.3826_3826_3836; Decot V, 2005, J IMMUNOL, V174, P628, DOI 10.4049/jimmunol.174.2.628; Douillard P, 1998, INT IMMUNOL, V10, P71, DOI 10.1093/intimm/10.1.71; DRISS V, 2008, BLOOD IN PRESS; Espinosa E, 2001, J BIOL CHEM, V276, P18337, DOI 10.1074/jbc.M100495200; Fernandez-Acenero MJ, 2000, CANCER, V88, P1544, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1544::AID-CNCR7>3.0.CO;2-S; Fronkova E, 2005, J IMMUNOL, V175, P2495, DOI 10.4049/jimmunol.175.4.2495; Giembycz MA, 1999, PHARMACOL REV, V51, P213; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; HSU SYL, 1980, ANN TROP MED PARASIT, V74, P179; Jacobsen EA, 2008, J EXP MED, V205, P699, DOI 10.1084/jem.20071840; Jacobsen EA, 2007, J ALLERGY CLIN IMMUN, V119, P1313, DOI 10.1016/j.jaci.2007.03.043; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Kawamoto H, 2006, TRENDS IMMUNOL, V27, P169, DOI 10.1016/j.it.2006.02.004; Kayaba H, 2001, J IMMUNOL, V167, P995, DOI 10.4049/jimmunol.167.2.995; Krejci O, 2003, J IMMUNOL, V171, P524, DOI 10.4049/jimmunol.171.2.524; Lasco TM, 2004, INFECT IMMUN, V72, P1147, DOI 10.1128/IAI.72.2.1147-1149.2004; Lee JJ, 2005, CLIN EXP ALLERGY, V35, P986, DOI 10.1111/j.1365-2222.2005.02302.x; LEGRAND F, 2007, METHOD MOL BIOL, P215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUCEY DR, 1989, P NATL ACAD SCI USA, V86, P1348, DOI 10.1073/pnas.86.4.1348; LUCEY DR, 1989, J EXP MED, V169, P327, DOI 10.1084/jem.169.1.327; Melo RCN, 2008, J LEUKOCYTE BIOL, V83, P229, DOI 10.1189/jlb.0707503; Metso T, 2002, THORAX, V57, P449, DOI 10.1136/thorax.57.5.449; Miike S, 2001, J IMMUNOL, V167, P6615, DOI 10.4049/jimmunol.167.11.6615; Munitz A, 2005, J IMMUNOL, V174, P110, DOI 10.4049/jimmunol.174.1.110; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; O'Brien RL, 2007, IMMUNOL REV, V215, P77, DOI 10.1111/j.1600-065X.2006.00477.x; Phipps S, 2007, BLOOD, V110, P1578, DOI 10.1182/blood-2007-01-071340; Plager DA, 2006, J IMMUNOL, V177, P7340, DOI 10.4049/jimmunol.177.10.7340; PLUMAS J, 1991, EUR J IMMUNOL, V21, P1265, DOI 10.1002/eji.1830210525; Puellmann K, 2006, P NATL ACAD SCI USA, V103, P14441, DOI 10.1073/pnas.0603406103; RAND TH, 1991, J CLIN INVEST, V88, P825, DOI 10.1172/JCI115383; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; ROWLEY AF, 1985, CELL TISSUE RES, V240, P705, DOI 10.1007/BF00216359; Sehmi R, 2000, CHEM IMMUNOL, V76, P29; Seton K, 2003, RESP MED, V97, P893, DOI 10.1016/S0954-6111(03)00112-4; Shi HZ, 2000, J CLIN INVEST, V105, P945, DOI 10.1172/JCI8945; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Simon HU, 2003, EUR J IMMUNOL, V33, P834, DOI 10.1002/eji.200323727; Stenfeldt AL, 2004, IMMUNOLOGY, V112, P605, DOI 10.1111/j.1365-2567.2004.01906.x; Svensson L, 2007, EUR J IMMUNOL, V37, P1966, DOI 10.1002/eji.200636936; TEPPER RI, 1994, J ALLERGY CLIN IMMUN, V94, P1225, DOI 10.1016/0091-6749(94)90336-0; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; Thedrez A, 2007, IMMUNOL REV, V215, P123, DOI 10.1111/j.1600-065X.2006.00468.x; Thompson K, 2006, BLOOD, V107, P651, DOI 10.1182/blood-2005-03-1025; Walsh ER, 2008, J EXP MED, V205, P1285, DOI 10.1084/jem.20071836; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Woerly G, 1999, J EXP MED, V190, P487, DOI 10.1084/jem.190.4.487; Woerly G, 2002, J LEUKOCYTE BIOL, V72, P769; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; YOUNG JD, 1986, NATURE, V321, P613, DOI 10.1038/321613a0; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	67	43	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5926	10.1371/journal.pone.0005926	http://dx.doi.org/10.1371/journal.pone.0005926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536290	gold, Green Published, Green Submitted			2022-12-27	WOS:000267029700007
J	Lower, M; Schneider, G				Loewer, Martin; Schneider, Gisbert			Prediction of Type III Secretion Signals in Genomes of Gram-Negative Bacteria	PLOS ONE			English	Article							PROTEIN SECRETION; EFFECTOR PROTEINS; SEQUENCE; BIOINFORMATICS; IDENTIFICATION; EVOLUTION; YERSINIA; SYSTEMS	Background: Pathogenic bacteria infecting both animals as well as plants use various mechanisms to transport virulence factors across their cell membranes and channel these proteins into the infected host cell. The type III secretion system represents such a mechanism. Proteins transported via this pathway ("effector proteins'') have to be distinguished from all other proteins that are not exported from the bacterial cell. Although a special targeting signal at the N-terminal end of effector proteins has been proposed in literature its exact characteristics remain unknown. Methodology/Principal Findings: In this study, we demonstrate that the signals encoded in the sequences of type III secretion system effectors can be consistently recognized and predicted by machine learning techniques. Known protein effectors were compiled from the literature and sequence databases, and served as training data for artificial neural networks and support vector machine classifiers. Common sequence features were most pronounced in the first 30 amino acids of the effector sequences. Classification accuracy yielded a cross-validated Matthews correlation of 0.63 and allowed for genome-wide prediction of potential type III secretion system effectors in 705 proteobacterial genomes (12% predicted candidates protein), their chromosomes (11%) and plasmids (13%), as well as 213 Firmicute genomes (7%). Conclusions/Significance: We present a signal prediction method together with comprehensive survey of potential type III secretion system effectors extracted from 918 published bacterial genomes. Our study demonstrates that the analyzed signal features are common across a wide range of species, and provides a substantial basis for the identification of exported pathogenic proteins as targets for future therapeutic intervention. The prediction software is publicly accessible from our web server (www.modlab.org).			Lower, M (corresponding author), Goethe Univ Frankfurt, Chair Chem & Bioinformat, Frankfurt, Germany.	gisbert.schneider@modlab.de		Schneider, Gisbert/0000-0001-6706-1084				Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Barla A, 2008, BRIEF BIOINFORM, V9, P119, DOI 10.1093/bib/bbn008; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004; Byvatov Evgeny, 2003, Appl Bioinformatics, V2, P67; Casadio Rita, 2008, Briefings in Functional Genomics & Proteomics, V7, P63, DOI 10.1093/bfgp/eln003; Chin K. K., 1998, THESIS; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Duda R.O., 2006, PATTERN CLASSIFICATI; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Joachims T., 1999, ADV KERNEL METHODS S; Lindeberg M, 2005, MOL PLANT MICROBE IN, V18, P275, DOI 10.1094/MPMI-18-0275; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; *MATHWORKS, MATLAB VERS 2007B; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Pallen MJ, 2006, NAT REV MICROBIOL, V4, P784, DOI 10.1038/nrmicro1493; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Qian N, 1988, J MOL BIOL, V202, P865, DOI 10.1016/0022-2836(88)90564-5; Russell S.J., 2016, ARTIF INTELL; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Schneider G, 2004, PROTEOMICS, V4, P1571, DOI 10.1002/pmic.200300786; Scholkopf B., 2002, LEARNING KERNELS; SHENG YH, 2004, BIOCHIM BIOPHYS ACTA, V1694, P181; Sorg JA, 2005, CELL MICROBIOL, V7, P1217, DOI 10.1111/j.1462-5822.2005.00563.x; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; VANROSSUM G, 1995, CSR9525 CWI; Vapnik V., 2013, NATURE STAT LAERNING; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954	49	99	102	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5917	10.1371/journal.pone.0005917	http://dx.doi.org/10.1371/journal.pone.0005917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526054	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029300010
J	Weidenbacher, U; Neumann, H				Weidenbacher, Ulrich; Neumann, Heiko			Extraction of Surface-Related Features in a Recurrent Model of V1-V2 Interactions	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; NEURAL MECHANISMS; AREA V2; RECEPTIVE-FIELDS; APERTURE PROBLEM; CORTICOCORTICAL CONNECTIONS; FUNCTIONAL ARCHITECTURE; HORIZONTAL CONNECTIONS; CONTOUR INTEGRATION	Background: Humans can effortlessly segment surfaces and objects from two-dimensional (2D) images that are projections of the 3D world. The projection from 3D to 2D leads partially to occlusions of surfaces depending on their position in depth and on viewpoint. One way for the human visual system to infer monocular depth cues could be to extract and interpret occlusions. It has been suggested that the perception of contour junctions, in particular T-junctions, may be used as cue for occlusion of opaque surfaces. Furthermore, X-junctions could be used to signal occlusion of transparent surfaces. Methodology/Principal Findings: In this contribution, we propose a neural model that suggests how surface-related cues for occlusion can be extracted from a 2D luminance image. The approach is based on feedforward and feedback mechanisms found in visual cortical areas V1 and V2. In a first step, contours are completed over time by generating groupings of like-oriented contrasts. Few iterations of feedforward and feedback processing lead to a stable representation of completed contours and at the same time to a suppression of image noise. In a second step, contour junctions are localized and read out from the distributed representation of boundary groupings. Moreover, surface-related junctions are made explicit such that they are evaluated to interact as to generate surface-segmentations in static images. In addition, we compare our extracted junction signals with a standard computer vision approach for junction detection to demonstrate that our approach outperforms simple feedforward computation-based approaches. Conclusions/Significance: A model is proposed that uses feedforward and feedback mechanisms to combine contextually relevant features in order to generate consistent boundary groupings of surfaces. Perceptually important junction configurations are robustly extracted from neural representations to signal cues for occlusion and transparency. Unlike previous proposals which treat localized junction configurations as 2D image features, we link them to mechanisms of apparent surface segregation. As a consequence, we demonstrate how junctions can change their perceptual representation depending on the scene context and the spatial configuration of boundary fragments.			Weidenbacher, U (corresponding author), Univ Ulm, Inst Neural Informat Proc, Ulm, Germany.	ulrich.weidenbacher@uni-ulm.de						Anderson BL, 1997, PERCEPTION, V26, P419, DOI 10.1068/p260419; Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Bayerl P, 2004, NEURAL COMPUT, V16, P2041, DOI 10.1162/0899766041732404; Baylis GC, 2001, NAT NEUROSCI, V4, P937, DOI 10.1038/nn0901-937; Bosking WH, 1997, J NEUROSCI, V17, P2112; Boynton GM, 2004, CURR BIOL, V14, pR523, DOI 10.1016/j.cub.2004.06.044; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eckhorn R, 1990, NEURAL COMPUT, V2, P293, DOI 10.1162/neco.1990.2.3.293; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GOVE A, 1995, VISUAL NEUROSCI, V12, P1027, DOI 10.1017/S0952523800006702; GROSSBERG S, 1985, PSYCHOL REV, V92, P173, DOI 10.1037/0033-295X.92.2.173; Guo K, 2006, NEUROSCIENCE, V138, P1397, DOI 10.1016/j.neuroscience.2005.12.016; Hamker FH, 2005, COMPUT VIS IMAGE UND, V100, P64, DOI 10.1016/j.cviu.2004.09.005; Hansen T, 2004, NEURAL COMPUT, V16, P1013, DOI 10.1162/089976604773135087; Harris C., 1988, P ALVEY VISION C, DOI DOI 10.5244/C.2.23; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Heitger F, 1998, IMAGE VISION COMPUT, V16, P407, DOI 10.1016/S0262-8856(97)00083-8; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Kanizsa G., 1955, RIV PSICOL, V49, P7; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kersten D., 1991, COMPUTATIONAL MODELS, P209; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; LESHER GW, 1993, VISION RES, V33, P2253, DOI 10.1016/0042-6989(93)90104-5; Li ZP, 2000, SPATIAL VISION, V13, P25, DOI 10.1163/156856800741009; LORENCEAU J, 1992, VISION RES, V32, P263, DOI 10.1016/0042-6989(92)90137-8; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; McDermott J, 2004, J VISION, V4, P944, DOI 10.1167/4.10.9; METELLI F, 1974, SCI AM, V230, P91, DOI 10.1038/scientificamerican0474-90; Mundhenk TN, 2003, NEUROCOMPUTING, V52-4, P599, DOI 10.1016/S0925-2312(02)00853-6; Nakayama K., 1995, INVITATION COGNITIVE, P1; Neumann H, 1999, BIOL CYBERN, V81, P425, DOI 10.1007/s004220050573; NOWLAN SJ, 1995, J NEUROSCI, V15, P1195; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; PETERHANS E, 1989, J NEUROSCI, V9, P1749; PETERHANS E, 1997, EXTRASTRIATE CORTEX, P335; Ponce CR, 2008, CURR BIOL, V18, pR845, DOI 10.1016/j.cub.2008.07.006; Ross WD, 2000, NEURAL NETWORKS, V13, P571, DOI 10.1016/S0893-6080(00)00040-X; Rubin N, 2001, NAT NEUROSCI, V4, P857, DOI 10.1038/nn0901-857; Rubin N, 2001, PERCEPTION, V30, P339, DOI 10.1068/p3173; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Schmid C, 2000, INT J COMPUT VISION, V37, P151, DOI 10.1023/A:1008199403446; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; SHIPLEY TF, 2001, COMPUTATIONAL NEURAL, P353; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; SPERLING G, 1970, PERCEPT PSYCHOPHYS, V8, P143, DOI 10.3758/BF03210193; Thielscher A, 2005, SPATIAL VISION, V18, P227, DOI 10.1163/1568568053320594; Thielscher A, 2008, BIOL CYBERN, V98, P305, DOI 10.1007/s00422-008-0211-7; Tolhurst DJ, 1997, VISUAL NEUROSCI, V14, P293, DOI 10.1017/S0952523800011433; TSO DY, 1986, J NEUROSCI, V6, P1160; Varin D., 1971, RIV PSICOL, V65, P101; VONDERHEYDT R, 1993, BIOMED RES-TOKYO, V14, P1; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; WATANABE T, 1993, VISION RES, V33, P2339, DOI 10.1016/0042-6989(93)90111-9; WILLIAMS D, 1987, J OPT SOC AM A, V4, P878, DOI 10.1364/JOSAA.4.000878; Wolfe JM, 2005, J VISION, V5, P257, DOI 10.1167/5.3.9; Zhao GZ, 2005, INT J NUMER ANAL MOD, V2, P153; Zhaoping L, 2005, NEURON, V47, P143, DOI 10.1016/j.neuron.2005.04.005; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; [No title captured]	80	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5909	10.1371/journal.pone.0005909	http://dx.doi.org/10.1371/journal.pone.0005909			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458MY	19526061	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029300004
J	Massion, PP; Zou, Y; Uner, H; Kiatsimkul, P; Wolf, HJ; Baron, AE; Byers, T; Jonsson, S; Lam, S; Hirsch, FR; Miller, YE; Franklin, WA; Varella-Garcia, M				Massion, Pierre P.; Zou, Yong; Uner, Hasmet; Kiatsimkul, Porntip; Wolf, Holly J.; Baron, Anna E.; Byers, Tim; Jonsson, Steinn; Lam, Stephen; Hirsch, Fred R.; Miller, York E.; Franklin, Wilbur A.; Varella-Garcia, Marileila			Recurrent Genomic Gains in Preinvasive Lesions as a Biomarker of Risk for Lung Cancer	PLOS ONE			English	Article								Lung carcinoma development is accompanied by field changes that may have diagnostic significance. We have previously shown the importance of chromosomal aneusomy in lung cancer progression. Here, we tested whether genomic gains in six specific loci, TP63 on 3q28, EGFR on 7p12, MYC on 8q24, 5p15.2, and centromeric regions for chromosomes 3 (CEP3) and 6 (CEP6), may provide further value in the prediction of lung cancer. Bronchial biopsy specimens were obtained by LIFE bronchoscopy from 70 subjects (27 with prevalent lung cancers and 43 individuals without lung cancer). Twenty six biopsies were read as moderate dysplasia, 21 as severe dysplasia and 23 as carcinoma in situ (CIS). Four-micron paraffin sections were submitted to a 4-target FISH assay (LAVysion, Abbott Molecular) and reprobed for TP63 and CEP 3 sequences. Spot counts were obtained in 30-50 nuclei per specimen for each probe. Increased gene copy number in 4 of the 6 probes was associated with increased risk of being diagnosed with lung cancer both in unadjusted analyses (odds ratio = 11, p, 0.05) and adjusted for histology grade (odds ratio = 17, p, 0.05). The most informative 4 probes were TP63, MYC, CEP3 and CEP6. The combination of these 4 probes offered a sensitivity of 82% for lung cancer and a specificity of 58%. These results indicate that specific cytogenetic alterations present in preinvasive lung lesions are closely associated with the diagnosis of lung cancer and may therefore have value in assessing lung cancer risk.			Massion, PP (corresponding author), Vet Adm Med Ctr, Vanderbilt Ingram Canc Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN 37203 USA.	pierre.massion@vanderbilt.edu			NATIONAL CANCER INSTITUTE [P50CA058187, R01CA102353, P30CA046934, R01CA055769, P50CA090949, U01CA085070] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA055769, P50 CA090949, U01-CA85070, CA55769, U01 CA085070, CA46934, P30 CA046934, P50 CA058187, CA58187, R01 CA102353, CA90949] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; AUERBACH O, 1961, NEW ENGL J MED, V265, P253, DOI 10.1056/NEJM196108102650601; Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Balsara BR, 1997, CANCER RES, V57, P2116; BERGH JCS, 1990, AM REV RESPIR DIS, V142, pS20, DOI 10.1164/ajrccm/142.6_Pt_2.S20; Bota S, 2001, AM J RESP CRIT CARE, V164, P1688, DOI 10.1164/ajrccm.164.9.2012147; BROERS JLV, 1993, AM J RESP CELL MOL, V9, P33, DOI 10.1165/ajrcmb/9.1.33; Bubendorf L, 2005, AM J CLIN PATHOL, V123, P516, DOI 10.1309/F5ADJUWVD2WFL8J5; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Choi YW, 2007, LUNG CANCER, V55, P43, DOI 10.1016/j.lungcan.2006.09.018; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; FRANKLIN WA, 2004, TUMOURS LUNG PLEURA, P68; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; Garnis C, 2004, GENE CHROMOSOME CANC, V39, P93, DOI 10.1002/gcc.10294; Garnis C, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-9; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Halling KC, 2006, CHEST, V130, P694, DOI 10.1378/chest.130.3.694; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Hirsch FR, 2008, CLIN CANCER RES, V14, P6317, DOI 10.1158/1078-0432.CCR-08-0539; Jonsson S, 2008, AM J RESP CRIT CARE, V177, P342, DOI 10.1164/rccm.200708-1142OC; Kaneko M, 1996, RADIOLOGY, V201, P798, DOI 10.1148/radiology.201.3.8939234; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim TM, 2005, CLIN CANCER RES, V11, P8235, DOI 10.1158/1078-0432.CCR-05-1157; Lockwood WW, 2008, ONCOGENE, V27, P4615, DOI 10.1038/onc.2008.98; Luk C, 2001, CANCER GENET CYTOGEN, V125, P87, DOI 10.1016/S0165-4608(00)00363-0; Massion PP, 2003, CANCER RES, V63, P7113; Massion PP, 2002, CANCER RES, V62, P3636; MASSION PP, 2002, GENOMIC TECHNOLOGIES; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Mulshine JL, 2005, NEW ENGL J MED, V352, P2714, DOI 10.1056/NEJMcp042630; NAU MM, 1986, P NATL ACAD SCI USA, V83, P1092, DOI 10.1073/pnas.83.4.1092; Prudkin Ludmila, 2006, Ann Diagn Pathol, V10, P306, DOI 10.1016/j.anndiagpath.2006.06.011; Rahman SMJ, 2005, AM J RESP CRIT CARE, V172, P1556, DOI 10.1164/rccm.200502-274OC; Ried T, 1997, J MOL MED-JMM, V75, P801, DOI 10.1007/s001090050169; Salaun M, 2008, AM J RESP CRIT CARE, V177, P880, DOI 10.1164/rccm.200704-598OC; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Sobue T, 2002, J CLIN ONCOL, V20, P911, DOI 10.1200/JCO.2002.20.4.911; Sokolova IA, 2002, CANCER CYTOPATHOL, V96, P306, DOI 10.1002/cncr.10720; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/ajrccm.165.4.2107006; TESTA JR, 1994, GENE CHROMOSOME CANC, V11, P178, DOI 10.1002/gcc.2870110307; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Varella-Garcia M, 2003, ONCOLOGIST, V8, P45, DOI 10.1634/theoncologist.8-1-45; Varella-Garcia M, 2007, AM J RESP CRIT CARE, V176, P505, DOI 10.1164/rccm.200609-1329OC; Varella-Garcia M, 2009, J THORAC ONCOL, V4, P318, DOI 10.1097/JTO.0b013e31819667a3; Wardwell NR, 2005, SEMIN ONCOL, V32, P259, DOI 10.1053/j.seminoncol.2005.02.009; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wistuba II, 2007, CURR MOL MED, V7, P3, DOI 10.2174/156652407779940468; Yakut T, 2006, LUNG CANCER, V54, P293, DOI 10.1016/j.lungcan.2006.08.011; Ye CJ, 2007, CYTOGENET GENOME RES, V118, P237, DOI 10.1159/000108306; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	55	40	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5611	10.1371/journal.pone.0005611	http://dx.doi.org/10.1371/journal.pone.0005611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19547694	Green Submitted, Green Published, gold			2022-12-27	WOS:000267228800001
J	Coudeville, L; Van Rie, A; Getsios, D; Caro, JJ; Crepey, P; Nguyen, V				Coudeville, Laurent; Van Rie, Annelies; Getsios, Denis; Caro, J. Jaime; Crepey, Pascal; Nguyen, Van Hung			Adult Vaccination Strategies for the Control of Pertussis in the United States: An Economic Evaluation Including the Dynamic Population Effects	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; ADVISORY-COMMITTEE; COST-EFFECTIVENESS; COMPUTER-SIMULATIONS; PREVENTING TETANUS; ADOLESCENTS; IMMUNIZATION; RECOMMENDATIONS; DIPHTHERIA; VACCINES	Background: Prior economic evaluations of adult and adolescent vaccination strategies against pertussis have reached disparate conclusions. Using static approaches only, previous studies failed to analytically include the indirect benefits derived from herd immunity as well as the impact of vaccination on the evolution of disease incidence over time. Methods: We assessed the impact of different pertussis vaccination strategies using a dynamic compartmental model able to consider pertussis transmission. We then combined the results with economic data to estimate the relative cost-effectiveness of pertussis immunization strategies for adolescents and adults in the US. The analysis compares combinations of programs targeting adolescents, parents of newborns (i.e. cocoon strategy), or adults of various ages. Results: In the absence of adolescent or adult vaccination, pertussis incidence among adults is predicted to more than double in 20 years. Implementing an adult program in addition to childhood and adolescent vaccination either based on 1) a cocoon strategy and a single booster dose or 2) a decennial routine vaccination would maintain a low level of pertussis incidence in the long run for all age groups (respectively 30 and 20 cases per 100,000 person years). These strategies would also result in significant reductions of pertussis costs (between -77% and -80% including additional vaccination costs). The cocoon strategy complemented by a single booster dose is the most cost-effective one, whereas the decennial adult vaccination is slightly more effective in the long run. Conclusions: By providing a high level of disease control, the implementation of an adult vaccination program against pertussis appears to be highly cost-effective and often cost-saving.			Coudeville, L (corresponding author), Sanofi Pasteur, Lyon, France.	Pascal.Crepey@sanofipasteur.com	Crépey, Pascal/G-5422-2011; Van Rie, Annelies/C-2082-2017; Datta, Samik/S-3822-2016	Crépey, Pascal/0000-0003-1852-0752; Van Rie, Annelies/0000-0001-7666-3263; Caro, Jaime/0000-0001-5470-3754				ANDERSON R M, 1991; Armstrong GL, 2007, PEDIATRICS, V119, pE22, DOI 10.1542/peds.2006-1572; Baron S, 1997, ARCH PEDIATRIE, V4, P744, DOI 10.1016/S0929-693X(97)83413-6; Barton Pelham, 2004, J Health Serv Res Policy, V9, P110, DOI 10.1258/135581904322987535; Bisgard KM, 2005, PEDIATRICS, V116, pE285, DOI 10.1542/peds.2004-2759; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Brisson M, 2006, MED DECIS MAKING, V26, P434, DOI 10.1177/0272989X06290485; Brisson M, 2003, MED DECIS MAKING, V23, P76, DOI 10.1177/0272989X02239651; Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; Caro J, 2005, PEDIATRICS, V116, P1263, DOI 10.1542/peds.2005-1829; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS75, DOI 10.1097/01.inf.0000160918.72953.51; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS48, DOI 10.1097/01.inf.0000160929.35004.86; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P616; COUDEVILLE L, 2007, EPIDEMIOL INFECT, P1; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; DEEN JL, 1995, CLIN INFECT DIS, V21, P1211, DOI 10.1093/clinids/21.5.1211; Drummond MF., 2005, METHODS EC EVALUATIO, P55; EDWARDS KM, 2004, VACCINES, P471; Halperin SA, 1999, CLIN INFECT DIS, V28, P1238, DOI 10.1086/514792; Halperin SA, 2007, NEW ENGL J MED, V356, P110, DOI 10.1056/NEJMp068288; Hethcote HW, 2004, VACCINE, V22, P2181, DOI 10.1016/j.vaccine.2003.11.053; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; Hethcote HW, 1999, MATH BIOSCI, V158, P47, DOI 10.1016/S0025-5564(99)00004-8; Koopman J, 2004, ANNU REV PUBL HEALTH, V25, P303, DOI 10.1146/annurev.publhealth.25.102802.124353; Kretsinger Katrina, 2006, Morbidity and Mortality Weekly Report, V55, P1; Lee GM, 2005, PEDIATRICS, V115, P1675, DOI 10.1542/peds.2004-2509; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Lee GM, 2007, AM J PREV MED, V32, P186, DOI 10.1016/j.amepre.2006.10.016; McNabb Scott J. N., 2006, Morbidity and Mortality Weekly Report, V55, P1; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; *NAT CTR IMM RESP, 2009, IMM COV US; Ortega-Sanchez IR, 2008, PEDIATRICS, V121, pS63, DOI 10.1542/peds.2007-1115H; Purdy KW, 2004, CLIN INFECT DIS, V39, P20, DOI 10.1086/421091; Strebel P, 2001, J INFECT DIS, V183, P1353, DOI 10.1086/319853; SUTTER RW, 1992, JAMA-J AM MED ASSOC, V267, P386, DOI 10.1001/jama.267.3.386; Trotter CL, 2006, MED DECIS MAKING, V26, P38, DOI 10.1177/0272989X05284109; Van Rie A, 2004, VACCINE, V22, P3154, DOI 10.1016/j.vaccine.2004.01.067; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Ward JI, 2006, CLIN INFECT DIS, V43, P151, DOI 10.1086/504803; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; 2005, MMWR MORB MORTAL WKL, V54, P1283; 2002, MMWR MORB MORTAL WKL, V51, P73	42	56	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6284	10.1371/journal.pone.0006284	http://dx.doi.org/10.1371/journal.pone.0006284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606227	gold, Green Published, Green Submitted			2022-12-27	WOS:000268036000018
J	Davis, SL; Be, NA; Lamichhane, G; Nimmagadda, S; Pomper, MG; Bishai, WR; Jain, SK				Davis, Stephanie L.; Be, Nicholas A.; Lamichhane, Gyanu; Nimmagadda, Sridhar; Pomper, Martin G.; Bishai, William R.; Jain, Sanjay K.			Bacterial Thymidine Kinase as a Non-Invasive Imaging Reporter for Mycobacterium tuberculosis in Live Animals	PLOS ONE			English	Article							INFECTIONS; MACROPHAGE	Background: Bacteria can be selectively imaged in experimentally-infected animals using exogenously administered 1-(2'deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-[(125)I]-iodouracil ([(125)I]-FIAU), a nucleoside analog substrate for bacterial thymidine kinase (TK). Our goal was to use this reporter and develop non-invasive methods to detect and localize Mycobacterium tuberculosis. Methodology/Principal Findings: We engineered a M. tuberculosis strain with chromosomally integrated bacterial TK under the control of hsp60 - a strong constitutive mycobacterial promoter. [(125)I] FIAU uptake, antimicrobial susceptibilities and in vivo growth characteristics were evaluated for this strain. Using single photon emission computed tomography (SPECT), M. tuberculosis P(hsp60) TK strain was evaluated in experimentally-infected BALB/c and C3HeB/FeJ mice using the thigh inoculation or low-dose aerosol infection models. M. tuberculosis P(hsp60) TK strain actively accumulated [(125)I] FIAU in vitro. Growth characteristics of the TK strain and susceptibility to common anti-tuberculous drugs were similar to the wild-type parent strain. M. tuberculosis P(hsp60) TK strain was stable in vivo and SPECT imaging could detect and localize this strain in both animal models tested. Conclusion: We have developed a novel tool for non-invasive assessment of M. tuberculosis in live experimentally-infected animals. This tool will allow real-time pathogenesis studies in animal models of TB and has the potential to simplify preclinical studies and accelerate TB research.			Davis, SL (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	sjain5@jhmi.edu	Nimmagadda, Sridhar/D-6135-2011	Nimmagadda, Sridhar/0000-0002-6413-7191; Jain, Sanjay/0000-0001-9620-7070; Davis, Stephanie/0000-0001-9606-5594; Lamichhane, Gyanu/0000-0002-2214-0114	NCI NIH HHS [U24 CA092871, CA92871, R24 CA092871] Funding Source: Medline; NIAID NIH HHS [AI079590, R01 AI079590, N01 AI030036] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U24CA092871, R24CA092871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079590] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal N, 2006, NUCLEIC ACIDS RES, V34, P4245, DOI 10.1093/nar/gkl521; Bettegowda C, 2005, P NATL ACAD SCI USA, V102, P1145, DOI 10.1073/pnas.0408861102; CANETTI G, 1965, AM REV RESPIR DIS, V92, P687; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; DAVIS S, 2008, COMMUNICATION    SEP; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Jain SK, 2005, CLIN PEDIATR, V44, P443, DOI 10.1177/000992280504400510; Lewinsohn DM, 2006, MICROBES INFECT, V8, P2587, DOI 10.1016/j.micinf.2006.07.007; NIMMAGADDA S, 2009, EUR J NUCL MED MOL I; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; TIMM J, 1994, MOL MICROBIOL, V12, P491, DOI 10.1111/j.1365-2958.1994.tb01037.x; ZHANG Y, 2007, CANC RES	14	53	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6297	10.1371/journal.pone.0006297	http://dx.doi.org/10.1371/journal.pone.0006297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606217	Green Submitted, Green Published, gold			2022-12-27	WOS:000268036000020
J	Hvidsten, TR; Laegreid, A; Kryshtafovych, A; Andersson, G; Fidelis, K; Komorowski, J				Hvidsten, Torgeir R.; Laegreid, Astrid; Kryshtafovych, Andriy; Andersson, Gunnar; Fidelis, Krzysztof; Komorowski, Jan			A Comprehensive Analysis of the Structure-Function Relationship in Proteins Based on Local Structure Similarity	PLOS ONE			English	Article								Background: Sequence similarity to characterized proteins provides testable functional hypotheses for less than 50% of the proteins identified by genome sequencing projects. With structural genomics it is believed that structural similarities may give functional hypotheses for many of the remaining proteins. Methodology/Principal Findings: We provide a systematic analysis of the structure-function relationship in proteins using the novel concept of local descriptors of protein structure. A local descriptor is a small substructure of a protein which includes both short-and long-range interactions. We employ a library of commonly reoccurring local descriptors general enough to assemble most existing protein structures. We then model the relationship between these local shapes and Gene Ontology using rule-based learning. Our IF-THEN rule model offers legible, high resolution descriptions that combine local substructures and is able to discriminate functions even for functionally versatile folds such as the frequently occurring TIM barrel and Rossmann fold. By evaluating the predictive performance of the model, we provide a comprehensive quantification of the structure-function relationship based only on local structure similarity. Our findings are, among others, that conserved structure is a stronger prerequisite for enzymatic activity than for binding specificity, and that structure-based predictions complement sequence-based predictions. The model is capable of generating correct hypotheses, as confirmed by a literature study, even when no significant sequence similarity to characterized proteins exists. Conclusions/Significance: Our approach offers a new and complete description and quantification of the structure-function relationship in proteins. By demonstrating how our predictions offer higher sensitivity than using global structure, and complement the use of sequence, we show that the presented ideas could advance the development of meta-servers in function prediction.			Hvidsten, TR (corresponding author), Uppsala Univ, Linnaeus Ctr Bioinformat, Uppsala, Sweden.	jan.komorowski@lcb.uu.se	Hvidsten, Torgeir R./A-3409-2009; Komorowski, Jan/A-9175-2010; Komorowski, Jan/M-2667-2013; Komorowski, Jan/AAP-1685-2020	Hvidsten, Torgeir R./0000-0001-6097-2539; Komorowski, Jan/0000-0002-0766-8789; Komorowski, Jan/0000-0002-0766-8789; Kryshtafoych, Andriy/0000-0001-5066-7178	NLM NIH HHS [P41 LM007085, LM007085] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [P41LM007085] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Di Gennaro JA, 2001, J STRUCT BIOL, V134, P232, DOI 10.1006/jsbi.2001.4391; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Ferre F, 2004, NUCLEIC ACIDS RES, V32, pD240, DOI 10.1093/nar/gkh054; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HOLTE RC, 1993, MACH LEARN, V11, P63, DOI 10.1023/A:1022631118932; Hvidsten TR, 2003, BIOINFORMATICS, V19, pII81, DOI 10.1093/bioinformatics/btg1064; Hvidsten TR, 2009, PROTEINS, V75, P870, DOI 10.1002/prot.22296; Hvidsten TR, 2003, BIOINFORMATICS, V19, P1116, DOI 10.1093/bioinformatics/btg047; Jonassen I, 1999, PROTEINS, V34, P206, DOI 10.1002/(SICI)1097-0134(19990201)34:2<206::AID-PROT6>3.3.CO;2-E; Kasuya A, 1999, J MOL BIOL, V286, P1673, DOI 10.1006/jmbi.1999.2581; Kinoshita K, 2003, CURR OPIN STRUC BIOL, V13, P396, DOI 10.1016/S0959-440X(03)00074-5; KOMOROWSKI J, 2002, HDB DATA MINING KNOW, P554; Kopp J, 2007, PROTEINS, V69, P38, DOI 10.1002/prot.21753; Laegreid A, 2003, GENOME RES, V13, P965, DOI 10.1101/gr.1144503; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Murzin AG, 1999, CURR OPIN STRUC BIOL, V9, P359, DOI 10.1016/S0959-440X(99)80048-7; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Orengo CA, 1999, CURR OPIN STRUC BIOL, V9, P374, DOI 10.1016/S0959-440X(99)80051-7; Ouzounis CA, 2003, NAT REV GENET, V4, P508, DOI 10.1038/nrg1113; Pal D, 2005, STRUCTURE, V13, P121, DOI 10.1016/j.str.2004.10.015; PAWLAK Z, 1991, THEORY DECISION LIBR, P229; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; Polacco BJ, 2006, BIOINFORMATICS, V22, P723, DOI 10.1093/bioinformatics/btk038; Rarey M, 1999, BIOINFORMATICS, V15, P243, DOI 10.1093/bioinformatics/15.3.243; Russell RB, 1998, J MOL BIOL, V279, P1211, DOI 10.1006/jmbi.1998.1844; Shakhnovich BE, 2003, J MOL BIOL, V326, P1, DOI 10.1016/S0022-2836(02)01362-1; Skolnick J, 2000, TRENDS BIOTECHNOL, V18, P34, DOI 10.1016/S0167-7799(99)01398-0; Thornton JM, 2000, NAT STRUCT BIOL, V7, P991, DOI 10.1038/80784; Watson JD, 2007, J MOL BIOL, V367, P1511, DOI 10.1016/j.jmb.2007.01.063; Zhang C, 2003, CURR OPIN CHEM BIOL, V7, P28, DOI 10.1016/S1367-5931(02)00015-7	42	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6266	10.1371/journal.pone.0006266	http://dx.doi.org/10.1371/journal.pone.0006266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603073	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000268035700012
J	Cinnamon, Y; Feine, O; Hochegger, H; Bershadsky, A; Brandeis, M				Cinnamon, Yuval; Feine, Oren; Hochegger, Helfrid; Bershadsky, Alexander; Brandeis, Michael			Cellular Contractility Requires Ubiquitin Mediated Proteolysis	PLOS ONE			English	Article							CLEAVAGE FURROW FORMATION; RHO-GTPASES; ANIMAL CYTOKINESIS; EXCHANGE FACTOR; HUMAN ECT2; CELLS; ADHESION; MICROTUBULES; ACTIN; DEPOLYMERIZATION	Background: Cellular contractility, essential for cell movement and proliferation, is regulated by microtubules, RhoA and actomyosin. The RhoA dependent kinase ROCK ensures the phosphorylation of the regulatory Myosin II Light Chain (MLC) Ser19, thereby activating actomyosin contractions. Microtubules are upstream inhibitors of contractility and their depolymerization or depletion cause cells to contract by activating RhoA. How microtubule dynamics regulates RhoA remains, a major missing link in understanding contractility. Principal Findings: We observed that contractility is inhibited by microtubules not only, as previously reported, in adherent cells, but also in non-adhering interphase and mitotic cells. Strikingly we observed that contractility requires ubiquitin mediated proteolysis by a Cullin-RING ubiquitin ligase. Inhibition of proteolysis, ubiquitination and neddylation all led to complete cessation of contractility and considerably reduced MLC Ser19 phosphorylation. Conclusions: Our results imply that cells express a contractility inhibitor that is degraded by ubiquitin mediated proteolysis, either constitutively or in response to microtubule depolymerization. This degradation seems to depend on a Cullin-RING ubiquitin ligase and is required for cellular contractions.			Cinnamon, Y (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	brandeis@cc.huji.ac.il		Hochegger, Helfrid/0000-0001-8366-6198; Bershadsky, Alexander/0000-0002-9571-7375				Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; CHENG SN, 2000, P INT WORKSH ANN COM, V1, P275; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; DANOWSKI BA, 1989, J CELL SCI, V93, P255; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Elbaum M, 1999, BIOCHEM SOC SYMP, V65, P147; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; HANDELI S, 1992, CELL, V71, P599, DOI 10.1016/0092-8674(92)90594-3; Harris AK, 1999, BIOCHEM SOC SYMP, V65, P315; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HIRSCHBERG J, 1982, J CELL PHYSIOL, V113, P159, DOI 10.1002/jcp.1041130125; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Komatsu S, 2004, J CELL BIOL, V165, P243, DOI 10.1083/jcb.200309056; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Listovsky T, 2000, EXP CELL RES, V255, P184, DOI 10.1006/excr.1999.4788; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; LYASS LA, 1988, P NATL ACAD SCI USA, V85, P9538, DOI 10.1073/pnas.85.24.9538; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Oceguera-Yanez F, 2005, J CELL BIOL, V168, P221, DOI 10.1083/jcb.200408085; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012.abs; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Wadsworth P, 2005, CURR BIOL, V15, pR871, DOI 10.1016/j.cub.2005.10.021; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; Wolf F, 2006, EMBO J, V25, P2802, DOI 10.1038/sj.emboj.7601163; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427; Yonemura S, 2004, EXP CELL RES, V295, P300, DOI 10.1016/j.yexcr.2004.01.005; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	47	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6155	10.1371/journal.pone.0006155	http://dx.doi.org/10.1371/journal.pone.0006155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597551	gold, Green Published, Green Submitted			2022-12-27	WOS:000268035600001
J	Vidal, JE; Chen, JM; Li, JH; McClane, BA				Vidal, Jorge E.; Chen, Jianming; Li, Jihong; McClane, Bruce A.			Use of an EZ-Tn5-Based Random Mutagenesis System to Identify a Novel Toxin Regulatory Locus in Clostridium perfringens Strain 13	PLOS ONE			English	Article							VIRR RESPONSE REGULATOR; ALPHA-TOXIN; PERFRINGOLYSIN-O; VIRR/VIRS SYSTEM; VIRULENCE GENES; THETA-TOXIN; EXPRESSION; TRANSPOSITION; ELECTROPORATION; IDENTIFICATION	Background: Although useful for probing bacterial pathogenesis and physiology, current random mutagenesis systems suffer limitations for studying the toxin-producing bacterium Clostridium perfringens. Methodology/Principal Findings: An EZ-Tn5-based random mutagenesis approach was developed for use in C. perfringens. This mutagenesis system identified a new regulatory locus controlling toxin production by strain 13, a C. perfringens type A strain. The novel locus, encoding proteins with homology to the AgrB and AgrD components of the Agr quorum sensing system of Staphylococcus aureus and two hypothetical proteins, was found to regulate early production of both alpha toxin and perfringolysin O (PFO) by strain 13. PFO production by the strain 13 Delta agrB mutant could be restored by genetic complementation or by physical complementation, i.e. by co-culture of the strain 13 Delta agrB mutant with a pfoA mutant of either strain 13 or C. perfringens type C CN3685. A similar AgrB- and AgrD-encoding locus is identifiable in all sequenced C. perfringens strains, including type B, C, D, and E isolates, suggesting this regulatory locus contributes to toxin regulation by most C. perfringens strains. In strain 13, the agrB and agrD genes were found to be co-transcribed in an operon with two upstream genes encoding hypothetical proteins. Conclusions/Significance: The new Tn5-based random mutagenesis system developed in this study is more efficient and random than previously reported C. perfringens random mutagenesis approaches. It allowed identification of a novel C. perfringens toxin regulatory locus with homology to the Agr system of S. aureus and which functions as expected of an Agr-like quorum sensing system. Since previous studies have shown that alpha toxin and perfringolysin O are responsible for strain 13-induced clostridial myonecrosis in the mouse model, the new agr regulatory locus may have importance for strain 13 virulence.			Vidal, JE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	bamcc@pitt.edu	Chen, Jianming/F-4980-2012	Chen, Jianming/0000-0003-3004-9828	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056177] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI056177-06, R01 AI056177] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AWAD MM, 1995, MOL MICROBIOL, V15, P191, DOI 10.1111/j.1365-2958.1995.tb02234.x; Awad MM, 1997, MICROB PATHOGENESIS, V22, P275, DOI 10.1006/mpat.1996.0115; BANNAM TL, 1993, PLASMID, V29, P233, DOI 10.1006/plas.1993.1025; BaThein W, 1996, J BACTERIOL, V178, P2514, DOI 10.1128/jb.178.9.2514-2520.1996; Briancesco Rossella, 2005, Ann Ist Super Sanita, V41, P353; Briolat V, 2002, J BACTERIOL, V184, P2333, DOI 10.1128/JB.184.9.2333-2343.2002; Carman RJ, 2008, ANAEROBE, V14, P102, DOI 10.1016/j.anaerobe.2008.01.003; CHEN CK, 1996, B FEMS MICROBIOL LET, V140, P185; Chen Y, 2005, APPL ENVIRON MICROB, V71, P7542, DOI 10.1128/AEM.71.11.7542-7547.2005; Chen Y, 2007, PLASMID, V58, P182, DOI 10.1016/j.plasmid.2007.04.002; Cheung JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005849; Cheung JK, 2000, J BACTERIOL, V182, P57, DOI 10.1128/JB.182.1.57-66.2000; Cheung JK, 2004, J BACTERIOL, V186, P3321, DOI 10.1128/JB.186.11.3321-3330.2004; Fisher DJ, 2006, INFECT IMMUN, V74, P5200, DOI 10.1128/IAI.00534-06; Garmory HS, 2000, EPIDEMIOL INFECT, V124, P61, DOI 10.1017/S0950268899003295; Gupta Phaguni, 2008, V435, P217, DOI 10.1007/978-1-59745-232-8_16; Heap John T., 2009, P179; Hickey MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000045; Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055; Koenig RL, 2004, J BACTERIOL, V186, P7549, DOI 10.1128/JB.186.22.7549-7555.2004; Lanckriet A, 2009, APPL ENVIRON MICROB, V75, P2638, DOI 10.1128/AEM.02214-08; Li JH, 2007, APPL ENVIRON MICROB, V73, P7218, DOI 10.1128/AEM.01075-07; Li JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000056; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYRISTIS M, 1994, MOL MICROBIOL, V12, P761, DOI 10.1111/j.1365-2958.1994.tb01063.x; McClane BA, 2004, PROKARYOTES, V4, P698; McGowan S, 2003, J BACTERIOL, V185, P6205, DOI 10.1128/JB.185.20.6205-6208.2003; McGowan S, 2002, J MOL BIOL, V322, P997, DOI 10.1016/S0022-2836(02)00850-1; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; Ohtani K, 2003, FEMS MICROBIOL LETT, V222, P137, DOI 10.1016/S0378-1097(03)00255-6; Ohtani K, 2002, MOL MICROBIOL, V44, P171, DOI 10.1046/j.1365-2958.2002.02863.x; Okumura K, 2008, J BACTERIOL, V190, P7719, DOI 10.1128/JB.01573-07; Pajunen MI, 2005, MICROBIOL-SGM, V151, P1209, DOI 10.1099/mic.0.27807-0; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Sayeed S, 2008, MOL MICROBIOL, V67, P15, DOI 10.1111/j.1365-2958.2007.06007.x; Shimizu T, 2002, J BACTERIOL, V184, P2587, DOI 10.1128/JB.184.10.2587-2594.2002; SHIMIZU T, 1994, J BACTERIOL, V176, P1616, DOI 10.1128/jb.176.6.1616-1623.1994; Shimizu T, 2002, MOL MICROBIOL, V43, P257, DOI 10.1046/j.1365-2958.2002.02743.x; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Smidt H, 1999, J BACTERIOL, V181, P6882, DOI 10.1128/JB.181.22.6882-6888.1999; Vidal JE, 2009, CELL MICROBIOL, V11, P1306, DOI 10.1111/j.1462-5822.2009.01332.x; Wuster A, 2008, J BACTERIOL, V190, P743, DOI 10.1128/JB.01135-07	45	59	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6232	10.1371/journal.pone.0006232	http://dx.doi.org/10.1371/journal.pone.0006232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597556	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000268035600006
J	Geng, J; Song, YJ; Yang, L; Feng, YY; Qiu, YF; Li, G; Guo, JY; Bi, YJ; Qu, Y; Wang, W; Wang, XY; Guo, ZB; Yang, RF; Han, YP				Geng, Jing; Song, Yajun; Yang, Lei; Feng, Yanyan; Qiu, Yefeng; Li, Gang; Guo, Jingyu; Bi, Yujing; Qu, Yi; Wang, Wang; Wang, Xiaoyi; Guo, Zhaobiao; Yang, Ruifu; Han, Yanping			Involvement of the Post-Transcriptional Regulator Hfq in Yersinia pestis Virulence	PLOS ONE			English	Article								Background: Yersinia pestis is the causative agent of plague, which is transmitted primarily between fleas and mammals and is spread to humans through the bite of an infected flea or contact with afflicted animals. Hfq is proposed to be a global post-transcriptional regulator that acts by mediating interactions between many regulatory small RNAs (sRNAs) and their mRNA targets. Sequence comparisons revealed that Y. pestis appears to produce a functional homologue of E. coli Hfq. Methodology and Principal Findings: Phenotype comparisons using in vitro assays demonstrated that Y. pestis Hfq was involved in resistance to H2O2, heat and polymyxin B and contributed to growth under nutrient-limiting conditions. The role of Hfq in Y. pestis virulence was also assessed using macrophage and mouse infection models, and the gene expression affected by Hfq was determined using microarray-based transcriptome and real time PCR analysis. The macrophage infection assay showed that the Y. pestis hfq deletion strain did not have any significant difference in its ability to associate with J774A.1 macrophage cells. However, hfq deletion appeared to significantly impair the ability of Y. pestis to resist phagocytosis and survive within macrophages at the initial stage of infection. Furthermore, the hfq deletion strain was highly attenuated in mice after subcutaneous or intravenous injection. Transcriptome analysis supported the results concerning the attenuated phenotype of the hfq mutant and showed that the deletion of the hfq gene resulted in significant alterations in mRNA abundance of 243 genes in more than 13 functional classes, about 23% of which are known or hypothesized to be involved in stress resistance and virulence. Conclusions and Significance: Our results indicate that Hfq is a key regulator involved in Y. pestis stress resistance, intracellular survival and pathogenesis. It appears that Hfq acts by controlling the expression of many virulence- and stress-associated genes, probably in conjunction with small noncoding RNAs.			Geng, J (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	ruifuyang@gmail.com; yanpinghan@gmail.com	Song, Yajun/F-3714-2011; Song, Yajun/GQQ-0476-2022	Song, Yajun/0000-0002-6628-2747; Song, Yajun/0000-0002-6628-2747; Geng, Jing/0000-0002-5930-0388				Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Brown L, 1996, J BACTERIOL, V178, P3763, DOI 10.1128/jb.178.13.3763-3770.1996; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; CHARNETZKY WT, 1985, INFECT IMMUN, V47, P234, DOI 10.1128/IAI.47.1.234-241.1985; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Fan Z L.Y., 1995, CHIN J CONTROL ENDEM, V10, P56; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; FRANZE MT, 1968, NATURE, V219, P588, DOI 10.1038/219588a0; Han YP, 2008, DNA CELL BIOL, V27, P453, DOI 10.1089/dna.2007.0657; Han YP, 2005, MICROBES INFECT, V7, P335, DOI 10.1016/j.micinf.2004.11.005; Han YP, 2004, MICROBIOL IMMUNOL, V48, P791, DOI 10.1111/j.1348-0421.2004.tb03605.x; Huang XZ, 2004, INFECT IMMUN, V72, P7212, DOI 10.1128/IAI.72.12.7212-7219.2004; Koleva RI, 2006, BIOCHEM BIOPH RES CO, V348, P662, DOI 10.1016/j.bbrc.2006.07.102; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Makoveichuk E, 2003, J LIPID RES, V44, P320, DOI 10.1194/jlr.M200182-JLR200; McArthur SD, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-52; McNealy TL, 2005, J BACTERIOL, V187, P1527, DOI 10.1128/JB.187.4.1527-1532.2005; Mitobe J, 2008, J BIOL CHEM, V283, P5738, DOI 10.1074/jbc.M710108200; Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702; Monk IR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-96; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Nakano M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-155; Nakao H, 1995, MOL MICROBIOL, V18, P859, DOI 10.1111/j.1365-2958.1995.18050859.x; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; REED LJ, 1938, AM J HYG, V27; Robertson GT, 1999, MOL MICROBIOL, V34, P690, DOI 10.1046/j.1365-2958.1999.01629.x; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Sharma AK, 2006, MOL MICROBIOL, V62, P469, DOI 10.1111/j.1365-2958.2006.05376.x; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Sonnleitner E, 2006, MOL MICROBIOL, V59, P1542, DOI 10.1111/j.1365-2958.2006.05032.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; STRALEY SC, 1984, INFECT IMMUN, V45, P655, DOI 10.1128/IAI.45.3.655-659.1984; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; Zavyalov VP, 1996, FEMS IMMUNOL MED MIC, V14, P53, DOI 10.1111/j.1574-695X.1996.tb00267.x; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004	51	81	87	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6213	10.1371/journal.pone.0006213	http://dx.doi.org/10.1371/journal.pone.0006213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593436	Green Submitted, Green Published, gold			2022-12-27	WOS:000268035300019
J	Singh, A; Kong, QZ; Luo, X; Petersen, RB; Meyerson, H; Singh, N				Singh, Ajay; Kong, Qingzhong; Luo, Xiu; Petersen, Robert B.; Meyerson, Howard; Singh, Neena			Prion Protein (PrP) Knock-Out Mice Show Altered Iron Metabolism: A Functional Role for PrP in Iron Uptake and Transport	PLOS ONE			English	Article								Despite overwhelming evidence implicating the prion protein (PrP) in prion disease pathogenesis, the normal function of this cell surface glycoprotein remains unclear. In previous reports we demonstrated that PrP mediates cellular iron uptake and transport, and aggregation of PrP to the disease causing PrP-scrapie (PrP(Sc)) form results in imbalance of iron homeostasis in prion disease affected human and animal brains. Here, we show that selective deletion of PrP in transgenic mice (PrP(KO)) alters systemic iron homeostasis as reflected in hematological parameters and levels of total iron and iron regulatory proteins in the plasma, liver, spleen, and brain of PrP(KO) mice relative to matched wild type controls. Introduction of radiolabeled iron ((59)FeCl(3)) to Wt and PrP(KO) mice by gastric gavage reveals inefficient transport of (59)Fe from the duodenum to the blood stream, an early abortive spike of erythropoiesis in the long bones and spleen, and eventual decreased (59)Fe content in red blood cells and all major organs of PrP(KO) mice relative to Wt controls. The iron deficient phenotype of PrP(KO) mice is reversed by expressing Wt PrP in the PrP(KO) background, demonstrating a functional role for PrP in iron uptake and transport. Since iron is required for essential metabolic processes and is also potentially toxic if mismanaged, these results suggest that loss of normal function of PrP due to aggregation to the PrP(Sc) form induces imbalance of brain iron homeostasis, resulting in disease associated neurotoxicity.			Singh, A (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	neena.singh@case.edu	Petersen, Robert/B-5075-2011	Petersen, Robert/0000-0002-3154-0072	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035962, R29NS035962, R01NS039089] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS039089, NS35962, R01 NS035962, NS39089, R29 NS035962] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Basu S, 2007, MOL BIOL CELL, V18, P3302, DOI 10.1091/mbc.E07-04-0317; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Burdo JR, 2003, BIOMETALS, V16, P63, DOI 10.1023/A:1020718718550; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; CHUNG MCM, 1985, ANAL BIOCHEM, V148, P498, DOI 10.1016/0003-2697(85)90258-1; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; HANAZAWA S, 1991, INFECT IMMUN, V59, P1972, DOI 10.1128/IAI.59.6.1972-1977.1991; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; Miura T, 2005, BIOCHEMISTRY-US, V44, P8712, DOI 10.1021/bi0501784; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Moos T, 2004, ANN NY ACAD SCI, V1012, P14, DOI 10.1196/annals.1306.002; Moos T, 1998, J COMP NEUROL, V398, P420; Morel E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003000; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Nazor KE, 2007, BBA-MOL BASIS DIS, V1772, P645, DOI 10.1016/j.bbadis.2007.04.004; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; PEPPRIELL JE, 1982, BLOOD, V60, P635; Prestori F, 2008, J NEUROSCI, V28, P7091, DOI 10.1523/JNEUROSCI.0409-08.2008; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Sarnataro D, 2002, TRAFFIC, V3, P810, DOI 10.1034/j.1600-0854.2002.31106.x; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000336; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Vyoral D, 1998, BIOL TRACE ELEM RES, V61, P263, DOI 10.1007/BF02789087; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zivny JH, 2008, BLOOD CELL MOL DIS, V40, P302, DOI 10.1016/j.bcmd.2007.09.009	30	74	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6115	10.1371/journal.pone.0006115	http://dx.doi.org/10.1371/journal.pone.0006115			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568430	Green Published, gold, Green Submitted			2022-12-27	WOS:000267572200014
J	VerMilyea, MD; O'Neill, LP; Turner, BM				VerMilyea, Matthew D.; O'Neill, Laura P.; Turner, Bryan M.			Transcription-Independent Heritability of Induced Histone Modifications in the Mouse Preimplantation Embryo	PLOS ONE			English	Article							CHROMATIN MODIFICATIONS; NUCLEAR REORGANIZATION; EPIGENETIC MEMORY; VALPROIC ACID; DEACETYLASE; CELL; ACETYLATION; PLURIPOTENCY; METHYLATION; INHIBITION	Enzyme-catalyzed, post-translational modifications of core histones have been implicated in the complex changes in gene expression that drive early mammalian development. However, until recently the small number of cells available from the preimplantation embryo itself has prevented quantitative analysis of histone modifications at key regulator genes. The possible involvement of histone modifications in the embryo's response to extracellular signals, or as determinants of cell fate or lineage progression, remains unclear. Here we describe the use of a recently-developed chromatin immunoprecipitation technique (CChIP) to assay histone modification levels at key regulator genes (Pou5f1, Nanog, Cdx2, Hoxb1, Hoxb9) as mouse embryos progress from 8-cell to blastocyst in culture. Only by the blastocyst stage, when the embryonic (Inner Cell Mass) and extra-embryonic (Trophoblast) lineages are compared, do we see the expected association between histone modifications previously linked to active and silent chromatin, and transcriptional state. To explore responses to an environmental signal, we exposed embryos to the histone deacetylase inhibitor, anti-epileptic and known teratogen valproic acid (VPA), during progression from 8-cell to morula stage. Such treatment increased H4 acetylation and H3 lysine 4 methylation at the promoters of Hoxb1 and Hoxb9, but not the promoters of Pou5f1, Nanog, Cdx2 or the housekeeping gene Gapdh. Despite the absence of detectable Hoxb transcription, these VPA-induced changes were heritable, following removal of the inhibitor, at least until the blastocyst stage. The selective hyperacetylation of Hoxb promoters in response to a histone deacetylase inhibitor, suggests that Hox genes have a higher turnover of histone acetates than other genes in the preimplantation embryo. To explain the heritability, through mitosis, of VPA-induced changes in histone modification at Hoxb promoters, we describe how an epigenetic feed-forward loop, based on cross-talk between H3 acetylation and H3K4 methylation, might generate a persistently increased steady-state level of histone acetylation in response to a transient signal.			VerMilyea, MD (corresponding author), RIKEN, Ctr Dev Biol, Lab Mammalian Mol Embryol, Kobe, Hyogo, Japan.	b.m.turner@bham.ac.uk			Biotechnology and Biological Sciences Research Council Funding Source: Medline; Cancer Research UK [C1015/A9077] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)		Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Faiella A, 2000, HUM MOL GENET, V9, P227, DOI 10.1093/hmg/9.2.227; Gerstner T, 2008, EXPERT OPIN PHARMACO, V9, P285, DOI 10.1517/14656566.9.2.285 ; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Gurvich N, 2005, FASEB J, V19, P1166, DOI 10.1096/fj.04-3425fje; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; MARMORSTEIN R, 2008, BIOCH BIOPH IN PRESS; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Perucca E, 2005, LANCET NEUROL, V4, P781, DOI 10.1016/S1474-4422(05)70224-6; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thorne JL, 2009, INT J BIOCHEM CELL B, V41, P164, DOI 10.1016/j.biocel.2008.08.029; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; White DA, 1999, METHODS, V19, P417, DOI 10.1006/meth.1999.0878; WORRAD DM, 1995, DEVELOPMENT, V121, P2949; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844	41	54	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6086	10.1371/journal.pone.0006086	http://dx.doi.org/10.1371/journal.pone.0006086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564914	Green Published, Green Submitted, gold			2022-12-27	WOS:000267515700005
J	Demongeot, J; Fouquet, Y; Tayyab, M; Vuillerme, N				Demongeot, Jacques; Fouquet, Yannick; Tayyab, Muhammad; Vuillerme, Nicolas			Understanding Physiological and Degenerative Natural Vision Mechanisms to Define Contrast and Contour Operators	PLOS ONE			English	Article							LATERAL INHIBITION; LIENARD SYSTEMS; CONE FUNCTION; TREE-REPRESENTATION; NEURAL-NETWORKS; VELOCITY-FIELD; EDGE-DETECTION; ROD; ENHANCEMENT; IMAGES	Background: Dynamical systems like neural networks based on lateral inhibition have a large field of applications in image processing, robotics and morphogenesis modeling. In this paper, we will propose some examples of dynamical flows used in image contrasting and contouring. Methodology: First we present the physiological basis of the retina function by showing the role of the lateral inhibition in the optical illusions and pathologic processes generation. Then, based on these biological considerations about the real vision mechanisms, we study an enhancement method for contrasting medical images, using either a discrete neural network approach, or its continuous version, i.e. a non-isotropic diffusion reaction partial differential system. Following this, we introduce other continuous operators based on similar biomimetic approaches: a chemotactic contrasting method, a viability contouring algorithm and an attentional focus operator. Then, we introduce the new notion of mixed potential Hamiltonian flows; we compare it with the watershed method and we use it for contouring. Conclusions: We conclude by showing the utility of these biomimetic methods with some examples of application in medical imaging and computed assisted surgery.			Demongeot, J (corresponding author), Univ Grenoble 1, TIMC IMAG, CNRS, UJF,UMR 5525, La Tronche, France.	Jacques.Demongeot@imag.fr	Nicolas, Vuillerme/C-6692-2009; Demongeot, Jacques/AAZ-2539-2020; Demongeot, Jacques/GQI-1558-2022; VUILLERME, Nicolas/U-5767-2019	Nicolas, Vuillerme/0000-0002-5202-4173; Demongeot, Jacques/0000-0002-8335-9240; VUILLERME, Nicolas/0000-0003-3773-393X				AIRES JOV, 2003, ICAR 03 COIMBRA, P638; Amor HB, 2008, LECT NOTES ARTIF INT, V5317, P973, DOI 10.1007/978-3-540-88636-5_92; Arkachar P, 2007, NEUROCOMPUTING, V70, P991, DOI 10.1016/j.neucom.2006.03.017; ATTWELL D, 1983, J PHYSIOL-LONDON, V336, P313, DOI 10.1113/jphysiol.1983.sp014583; BAINVILLE E, 1995, 3D RECONSTRUCTION US; Benabid A L, 1992, Acta Neurochir Suppl (Wien), V54, P93; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P153; BENABID AL, 1991, ADV TECHNICAL STANDA, P4; Benabid AL, 1992, COMPUTERS STEREOTACT, P230; BENABID AL, 1992, IEEE NEUROSCIENCES T, P157; BENABID AL, 1992, COMPUTERS STEREOTACT, P330; BERTHOMMIER F, 1989, IEE CONF PUBL, P287; BERTHOMMIER F, 1991, NATO ADV SCI I B-PHY, V260, P219; BERTHOMMIER F, 1993, P PARCO 93 PAR COMP, P477; Bertrand G, 1997, J ELECTRON IMAGING, V6, P395, DOI 10.1117/12.276856; BERTRAND G, 1997, SPIE, V3168, P136; Bertrand G, 2007, IMAGE VISION COMPUT, V25, P447, DOI 10.1016/j.imavis.2006.04.017; Beucher S., 1993, MATH MORPHOLOGY IMAG, P433, DOI DOI 10.1201/9781482277234-12; BILOTTA J, 1991, VISION RES, V31, P577, DOI 10.1016/0042-6989(91)90108-H; BLANKENSHIP T, 1987, ACOUST IMAGING, P187; Bosch H., 1998, ICANN 98. Proceedings of the 8th International Conference on Artificial Neural Networks, P1021; Brunie L, 1995, Technol Health Care, V3, P91; BURR DC, 1990, VISION CODING EFFICI, P185; BURR EG, 1947, ROYAL SOC CANADA, V41, P45; Bzostek A, 1998, LECT NOTES COMPUT SC, V1496, P1041, DOI 10.1007/BFb0056293; CATTE F, 1992, SIAM J NUMER ANAL, V29, P182, DOI 10.1137/0729012; CHEN Y, 1995, COMPUT VIS IMAGE UND, V61, P325, DOI 10.1006/cviu.1995.1026; CHOU WS, 1993, PATTERN RECOGN, V26, P351, DOI 10.1016/0031-3203(93)90043-V; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; CINQUIN P, 1989, IARP 89 MED HEALTHCA, P63; CINQUIN P, 1992, INNOV TECH BIOL MED, V13, P373; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; COSNARD M, 1985, CR ACAD SCI I-MATH, V300, P551; COTTET GH, 1993, MATH COMPUT, V61, P659, DOI 10.1090/S0025-5718-1993-1195422-2; COTTET GH, 1991, CR ACAD SCI I-MATH, V312, P217; COTTET GH, 1995, IMAGE SEGMENTATION U; Demongeot J, 1996, CR ACAD SCI II B, V323, P747; Demongeot J, 2003, CR BIOL, V326, P487, DOI 10.1016/S1631-0691(03)00114-8; Demongeot J, 2003, P IEEE, V91, P1723, DOI 10.1109/JPROC.2003.817878; Demongeot J, 2002, 2002 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING, PROCEEDINGS, P50, DOI 10.1109/ISBI.2002.1029190; Demongeot J, 2002, CR BIOL, V325, P367, DOI 10.1016/S1631-0691(02)01459-2; DEMONGEOT J, 1989, CR ACAD SCI I-MATH, V309, P699; DEMONGEOT J, 2005, SURGETICA 04, P301; DEMONGEOT J, 2000, 16 IM WORLD C 2000 E, P127; DEMONGEOT J, 1995, CHIRURGIE, V120, P300; DEMONGEOT J, 1995, ICANN 95, P41; DEMONGEOT J, 2004, WSEAS T BIOL INF SC, V1, P618; DEMONGEOT J, 2007, IEEE EMBC 07, P3474; Demongeot J, 2007, CR MATH, V344, P121, DOI 10.1016/j.crma.2006.10.016; Demongeot J, 2007, CR MATH, V344, P191, DOI 10.1016/j.crma.2006.10.013; DERICHE R, 1990, IEEE T PATTERN ANAL, V12, P78, DOI 10.1109/34.41386; Dickinson SJ, 1997, COMPUT VIS IMAGE UND, V67, P239, DOI 10.1006/cviu.1997.0532; Doyen L., 1995, Journal of Mathematical Imaging and Vision, V5, P99, DOI 10.1007/BF01250522; ELENA A, 2008, IEEE BIBE 08, P234; EMMECHE C, 1991, SEMIOTICA, V84, P1, DOI 10.1515/semi.1991.84.1-2.1; EYSEL UT, 1987, EXP BRAIN RES, V68, P606; Fabre-Thorpe M, 2001, J COGNITIVE NEUROSCI, V13, P171, DOI 10.1162/089892901564234; FANG N, 1993, PATTERN RECOGN LETT, V14, P397, DOI 10.1016/0167-8655(93)90118-W; FAUGERAS O, 1999, LECT NOTES COMPUTER, V1406, P379; Fay D. A., 1991, IJCNN-91-Seattle: International Joint Conference on Neural Networks (Cat. No.91CH3049-4), P621, DOI 10.1109/IJCNN.1991.155250; Forest L, 2006, B MATH BIOL, V68, P753, DOI 10.1007/s11538-005-9004-5; Forest L, 2006, J THEOR BIOL, V241, P241, DOI 10.1016/j.jtbi.2005.11.029; Forest L, 2008, ACTA BIOTHEOR, V56, P51, DOI 10.1007/s10441-008-9030-4; FORTIN T, 1997, DENTOMAXILLOFAC RAD, V26, P284; Fourier J., 1808, NOUVEAU B SCI SOC PH, VI, P112; FRANCOIS O, 1992, NEURAL NETWORKS, V5, P277, DOI 10.1016/S0893-6080(05)80025-5; Girman S, 2005, VISION RES, V45, P343, DOI 10.1016/j.visres.2004.08.023; Glade N, 2007, CR MATH, V344, P253, DOI 10.1016/j.crma.2006.11.014; GOLDBERG SH, 1983, SCIENCE, V221, P180, DOI 10.1126/science.6857279; HAMMOND P, 1971, J PHYSIOL-LONDON, V213, P475, DOI 10.1113/jphysiol.1971.sp009394; HERVE T, 1990, P NATL ACAD SCI USA, V87, P806, DOI 10.1073/pnas.87.2.806; HERVE T, 1988, NEURAL NETWORKS, V1, P297; Ionescu G, 1999, LECT NOTES COMPUT SC, V1679, P768; Jiang TT, 2006, LECT NOTES COMPUT SC, V3953, P633, DOI 10.1007/11744078_49; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; KERGOSIEN YL, 1985, 4 SEM EC BIOL THEOR, P11; KHELLAF A, 1991, IEEE T MED IMAGING, V10, P589, DOI 10.1109/42.108593; KICHENASSAMY S, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P810, DOI 10.1109/ICCV.1995.466855; KOBAYASHI H, 1993, NEURAL NETWORKS, V6, P327, DOI 10.1016/0893-6080(93)90002-E; KOBAYASHI H, 1991, IEEE IJCNN, P1007, DOI 10.1109/IJCNN.1991.170530; Kobayashi N., 1994, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ77D-II, P502; KOBAYASHI Y, 1999, MULTIMEDIA COMPUTING, P578; KOENDERINK JJ, 1979, BIOL CYBERN, V32, P211, DOI 10.1007/BF00337644; KWON TM, 1992, C SYST MAN CYB, P416; Lavallee S., 1989, MEDINFO 89. Proceedings of the Sixth Conference on Medical Informatics, P613; LAVALLEE S, 1989, COMPUTER ASSISTED RA, P416; Leitner F, 1995, ACTA BIOTHEOR, V43, P299, DOI 10.1007/BF00713555; LEITNER F, 1990, CURVES SURFACES, P279; LEITNER F, 1991, PIXELS FEATURES, V2, P253; LENEGRATE A, 1992, CVGIP-GRAPH MODEL IM, V54, P13, DOI 10.1016/1049-9652(92)90030-2; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Li ZP, 2000, SPATIAL VISION, V13, P25, DOI 10.1163/156856800741009; Lorenz T., 2001, Computing and Visualization in Science, V4, P41, DOI 10.1007/s007910100056; LU JA, 1994, OPT ENG, V33, P2151, DOI 10.1117/12.172254; Lyubarsky AL, 2002, VISION RES, V42, P401, DOI 10.1016/S0042-6989(01)00214-0; MAILLOUX GE, 1989, IEEE T MED IMAGING, V8, P143, DOI 10.1109/42.24862; MARTIN JP, 1988, DIAGN IMAG MAG, V1, P194; Mattes J, 2001, PROC SPIE, V4322, P602, DOI 10.1117/12.431134; Mattes J., 1998, Parallel Processing Letters, V8, P63, DOI 10.1142/S0129626498000092; Mattes J, 2000, LECT NOTES COMPUT SC, V1953, P392; Mattes J, 1999, LECT NOTES COMPUT SC, V1568, P298; Mattes J, 1999, LECT NOTES COMPUT SC, V1679, P646; Mattes J, 1999, ST CLASS DAT ANAL, P205; Mattes J, 1995, LECT NOTES COMPUT SC, V919, P275, DOI 10.1007/BFb0046640; MATTES J, 2000, ICARCV 2000, P3; MEIGNEN S, 1998, APPL CONTRASTAGE DIM; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; MEUNIER J, 1988, SPIE MED IMAG, V914, P20; MEYER F, 1992, 8 C REC FORM INT ART, P847; Michon F, 2008, DEVELOPMENT, V135, P2797, DOI 10.1242/dev.018341; Moini A., 2000, VISION CHIPS; MONTANVERT A, 1991, IEEE T PATTERN ANAL, V13, P307, DOI 10.1109/34.88566; Mumford D., 1985, Proceedings CVPR '85: IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No. 85CH2145-1), P22; NABET B, 1992, NEURAL NETWORKS, V5, P891, DOI 10.1016/S0893-6080(05)80085-1; NAKAHIRA H, 1993, J VLSI SIGNAL PROC, V5, P133, DOI 10.1007/BF01581290; NEYCENSSAC F, 1993, CVGIP-GRAPH MODEL IM, V55, P447, DOI 10.1006/cgip.1993.1034; OSHER S, 2006, J COMPUT PHYS, V169, P463; Ouchchane L, 2007, LECT NOTES COMPUT SC, V4370, P137; OUTRATA JV, 1990, MATH OPER RES, V15, P626, DOI 10.1287/moor.15.4.626; PATTEE HH, 1977, INT J GEN SYST, V3, P259, DOI 10.1080/03081077708934771; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; RADCLIFFE T, 1994, MED PHYS, V21, P761, DOI 10.1118/1.597336; RICHARD M, 2000, SPIE, V3831, P125; Rizzi A, 2003, PATTERN RECOGN LETT, V24, P1663, DOI 10.1016/S0167-8655(02)00323-9; Robineau F, 2007, IEEE T BIO-MED ENG, V54, P711, DOI 10.1109/TBME.2006.889180; Sethian JA, 1999, CAMBRIDGE MONOGRAPHS; SHI BE, 1993, IEEE T CIRCUITS-II, V40, P320, DOI 10.1109/82.227372; SOLOMON JA, 1993, VISION RES, V33, P2671, DOI 10.1016/0042-6989(93)90227-N; TAYYAB M, 2008, THESIS U J FOURIER G; Thom R., 1983, PARABOLES CATASTROPH; TOBORG ST, 1991, IEEE T COMPUT, V40, P1368, DOI 10.1109/12.106222; TOET A, 1992, OPT ENG, V31, P1026, DOI 10.1117/12.56155; Tonnelier A, 1999, NEURAL NETWORKS, V12, P1213, DOI 10.1016/S0893-6080(99)00068-4; Tschumperle D, 2002, IEEE SIGNAL PROC MAG, V19, P16, DOI 10.1109/MSP.2002.1028349; TSCHUMPERLE D, 2000, 12 C RFIA 00 PAR FEB, V2, P247; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; VINOD VV, 1994, IEEE T SYST MAN CYB, V24, P365, DOI 10.1109/21.278988; VONBEKESY G, 1967, J GEN PHYSIOL, V50, P519, DOI 10.1085/jgp.50.3.519; WAXMAN AM, 1988, SPIE, V1001, P1093; Weickert J, 1999, INT J COMPUT VISION, V31, P111, DOI 10.1023/A:1008009714131; Williams GA, 2005, VISUAL NEUROSCI, V22, P807, DOI 10.1017/S095252380522610X; SIGNAL PROCESSING IN; [No title captured]	147	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6010	10.1371/journal.pone.0006010	http://dx.doi.org/10.1371/journal.pone.0006010			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547712	Green Submitted, gold, Green Published			2022-12-27	WOS:000267347900009
J	Raizada, N; Chauhan, LS; Babu, BS; Thakur, R; Khera, A; Wares, DF; Sahu, S; Bachani, D; Rewari, BB; Dewan, PK				Raizada, Neeraj; Chauhan, Lakbir Singh; Babu, B. Sai; Thakur, Rahul; Khera, Ajay; Wares, D. Fraser; Sahu, Suvanand; Bachani, D.; Rewari, B. B.; Dewan, Puneet K.			Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India	PLOS ONE			English	Article								Background: HIV-infected persons suffering from tuberculosis experience high mortality. No programmatic studies from India have documented the delivery of mortality-reducing interventions, such as cotrimoxazole prophylactic treatment (CPT) and antiretroviral treatment (ART). To guide TB-HIV policy in India we studied the effectiveness of delivering CPT and ART to HIV-infected persons treated for tuberculosis in three districts in Andhra Pradesh, India, and evaluated factors associated with death. Methods and Findings: We retrospectively abstracted data for all HIV-infected tuberculosis patients diagnosed from March 2007 through August 2007 using standard treatment outcome definitions. 734 HIV-infected tuberculosis patients were identified; 493 (67%) were males and 569 (80%) were between the ages of 24-44 years. 710 (97%) initiated CPT, and 351 (50%) collected >60% of their monthly cotrimoxazole pouches provided throughout TB treatment. Access to ART was documented in 380 (51%) patients. Overall 130 (17%) patients died during TB treatment. Patients receiving ART were less likely to die (adjusted hazard ratio [HR] 0.4, 95% confidence interval [CI] 0.3-0.6), while males and those with pulmonary TB were more likely to die (HR 1.7, 95% CI 1.1-2.7, and HR 1.9, 95% CI 1.1-3.2 respectively). Conclusions: Among HIV-infected TB patients in India death was common despite the availability of free cotrimoxazole locally and ART from referral centres. Death was strongly associated with the absence of ART during TB treatment. To minimize death, programmes should promote high levels of ART uptake and closely monitor progress in implementation.				dewanp@searo.who.int		Raizada, Neeraj/0000-0003-2116-332X				Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Boeree MJ, 2005, TROP MED INT HEALTH, V10, P723, DOI 10.1111/j.1365-3156.2005.01433.x; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; El-Sadr WM, 2008, SEMIN RESP CRIT CARE, V29, P525, DOI 10.1055/s-0028-1085703; *GOV IND MIN HLTH, 2008, NACO NEWS NEWSL NAT; *GOV IND MIN HLTH, 2008, NAT FRAM JOINT TB HI; *GOV IND MIN HLTH, 2005, TECHN OP GUID TUB CO; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Grimwade K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003508.pub2; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Kolappan C, 2006, B WORLD HEALTH ORGAN, V84, P555, DOI 10.2471/BLT.05.022087; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Ministry of Health and Family Welfare Government of India 2008, 2006, HIV SENT SURV HIV ES; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; NACO, 2007, GUIDELINES PREVENTIO; Narain JP, 2004, INDIAN J MED RES, V120, P277; *NAT AIDS CONTR OR, 2007, ANT TREATM GUID AD A; Pednekar MS, 2007, PREV MED, V44, P496, DOI 10.1016/j.ypmed.2007.02.017; Raizada N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002970; Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e; Swaminathan S, 2008, NATL MED J INDIA, V21, P3; Swaminathan S, 2006, TROP DOCT, V36, P73, DOI 10.1258/004947506776593387; TRINH TT, 2007, PLOS ONE, V2, pE507; *WHO, 2006, GUID COTR PROP HIV R; *WHO, 2004, INT POL COLL TB HIV; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organization, 2008, GLOB TUB CONTR SURV; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015	30	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5999	10.1371/journal.pone.0005999	http://dx.doi.org/10.1371/journal.pone.0005999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543396	gold, Green Published, Green Submitted			2022-12-27	WOS:000267237600012
J	Ripoll, F; Pasek, S; Schenowitz, C; Dossat, C; Barbe, V; Rottman, M; Macheras, E; Heym, B; Herrmann, JL; Daffe, M; Brosch, R; Risler, JL; Gaillard, JL				Ripoll, Fabienne; Pasek, Sophie; Schenowitz, Chantal; Dossat, Carole; Barbe, Valerie; Rottman, Martin; Macheras, Edouard; Heym, Beate; Herrmann, Jean-Louis; Daffe, Mamadou; Brosch, Roland; Risler, Jean-Loup; Gaillard, Jean-Louis			Non Mycobacterial Virulence Genes in the Genome of the Emerging Pathogen Mycobacterium abscessus	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; NONTUBERCULOUS MYCOBACTERIA; CYSTIC-FIBROSIS; BURKHOLDERIA-CENOCEPACIA; SEQUENCE; DNA; RESISTANCE; IDENTIFICATION; TUBERCULOSIS; SURVIVAL	Mycobacterium abscessus is an emerging rapidly growing mycobacterium (RGM) causing a pseudotuberculous lung disease to which patients with cystic fibrosis (CF) are particularly susceptible. We report here its complete genome sequence. The genome of M. abscessus (CIP 104536T) consists of a 5,067,172-bp circular chromosome including 4920 predicted coding sequences (CDS), an 81-kb full-length prophage and 5 IS elements, and a 23-kb mercury resistance plasmid almost identical to pMM23 from Mycobacterium marinum. The chromosome encodes many virulence proteins and virulence protein families absent or present in only small numbers in the model RGM species Mycobacterium smegmatis. Many of these proteins are encoded by genes belonging to a "mycobacterial'' gene pool (e.g. PE and PPE proteins, MCE and YrbE proteins, lipoprotein LpqH precursors). However, many others ( e. g. phospholipase C, MgtC, MsrA, ABC Fe(3+) transporter) appear to have been horizontally acquired from distantly related environmental bacteria with a high G+C content, mostly actinobacteria (e.g. Rhodococcus sp., Streptomyces sp.) and pseudomonads. We also identified several metabolic regions acquired from actinobacteria and pseudomonads (relating to phenazine biosynthesis, homogentisate catabolism, phenylacetic acid degradation, DNA degradation) not present in the M. smegmatis genome. Many of the "non mycobacterial'' factors detected in M. abscessus are also present in two of the pathogens most frequently isolated from CF patients, Pseudomonas aeruginosa and Burkholderia cepacia. This study elucidates the genetic basis of the unique pathogenicity of M. abscessus among RGM, and raises the question of similar mechanisms of pathogenicity shared by unrelated organisms in CF patients.			Ripoll, F (corresponding author), Univ Versailles St Quentin, UFR Med Paris Ile France, EA3647, Garches, France.	jean-louis.gaillard@apr.aphp.fr	Rottman, Martin/AAD-9075-2021; Rottman, Martin/I-3005-2012; Brosch, Roland/AAZ-3850-2021; Brosch, Roland/ABB-4108-2021	Rottman, Martin/0000-0001-5953-3344; Brosch, Roland/0000-0003-2587-3863; Herrmann, Jean-Louis/0000-0003-2347-6418; neulat-ripoll, fabienne/0000-0001-5387-0382				Adekambi T, 2006, INT J SYST EVOL MICR, V56, P133, DOI 10.1099/ijs.0.63969-0; Adekambi T, 2004, J CLIN MICROBIOL, V42, P5493, DOI 10.1128/JCM.42.12.5493-5501.2004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Blanc-Potard AB, 2003, J MOL EVOL, V57, P479, DOI 10.1007/s00239-003-2496-4; Brodin P, 2002, INFECT IMMUN, V70, P5568, DOI 10.1128/IAI.70.10.5568-5578.2002; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Byrd TF, 1999, INFECT IMMUN, V67, P4700, DOI 10.1128/IAI.67.9.4700-4707.1999; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; Chalermskulrat W, 2006, THORAX, V61, P507, DOI 10.1136/thx.2005.049247; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Danelishvili L, 2007, P NATL ACAD SCI USA, V104, P11038, DOI 10.1073/pnas.0610746104; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ernst RK, 2003, ENVIRON MICROBIOL, V5, P1341, DOI 10.1111/j.1462-2920.2003.00518.x; Frank AC, 2000, BIOINFORMATICS, V16, P560, DOI 10.1093/bioinformatics/16.6.560; Galil K, 1999, EMERG INFECT DIS, V5, P681, DOI 10.3201/eid0505.990509; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Glemet E, 1997, COMPUT APPL BIOSCI, V13, P137; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Griffith DE, 2003, AM J RESP CRIT CARE, V167, P810, DOI 10.1164/rccm.2301001; GRIFFITH DE, 1993, AM REV RESPIR DIS, V147, P1271, DOI 10.1164/ajrccm/147.5.1271; Guina T, 2003, P NATL ACAD SCI USA, V100, P2771, DOI 10.1073/pnas.0435846100; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall-Stoodley L, 1998, FEMS MICROBIOL LETT, V168, P77, DOI 10.1016/S0378-1097(98)00422-4; Howard ST, 2002, MICROBIOL-SGM, V148, P2987, DOI 10.1099/00221287-148-10-2987; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Hunt TA, 2004, INFECT IMMUN, V72, P4010, DOI 10.1128/IAI.72.7.4010-4022.2004; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; Jang J, 2008, TRENDS MICROBIOL, V16, P303, DOI 10.1016/j.tim.2008.04.005; Jonsson BE, 2007, J CLIN MICROBIOL, V45, P1497, DOI 10.1128/JCM.02592-06; Kim HY, 2007, J CLIN MICROBIOL, V45, P3127, DOI 10.1128/JCM.00608-07; Kim SJ, 2008, BIODEGRADATION, V19, P859, DOI 10.1007/s10532-008-9189-z; KUBICA GP, 1972, J GEN MICROBIOL, V73, P55, DOI 10.1099/00221287-73-1-55; KUSUNOKI S, 1992, INT J SYST BACTERIOL, V42, P240, DOI 10.1099/00207713-42-2-240; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Le Dantec C, 2002, APPL ENVIRON MICROB, V68, P5318, DOI 10.1128/AEM.68.11.5318-5325.2002; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luc N, 2003, COMPUT BIOL CHEM, V27, P59, DOI 10.1016/S1476-9271(02)00097-X; Luengo JM, 2001, MOL MICROBIOL, V39, P1434, DOI 10.1046/j.1365-2958.2001.02344.x; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Maloney KE, 2006, INFECT IMMUN, V74, P5477, DOI 10.1128/IAI.00798-06; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Mohseni-Zadeh S, 2004, COMPUT BIOL CHEM, V28, P211, DOI 10.1016/j.compbiolchem.2004.03.002; Moncrief MBC, 1998, INFECT IMMUN, V66, P3802, DOI 10.1128/IAI.66.8.3802-3809.1998; MOORE M, 1953, J INVEST DERMATOL, V20, P133, DOI 10.1038/jid.1953.18; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pierre-Audigier C, 2005, J CLIN MICROBIOL, V43, P3467, DOI 10.1128/JCM.43.7.3467-3470.2005; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Prammananan T, 1998, J INFECT DIS, V177, P1573, DOI 10.1086/515328; Prithiviraj B, 2005, INFECT IMMUN, V73, P5319, DOI 10.1128/IAI.73.9.5319-5328.2005; Raynaud C, 2002, MOL MICROBIOL, V45, P203, DOI 10.1046/j.1365-2958.2002.03009.x; RODRIGUEZZARAGOZA S, 1994, CRIT REV MICROBIOL, V20, P225, DOI 10.3109/10408419409114556; Rosas-Magallanes V, 2006, MOL BIOL EVOL, V23, P1129, DOI 10.1093/molbev/msj120; Rottman M, 2007, INFECT IMMUN, V75, P5898, DOI 10.1128/IAI.00014-07; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sanguinetti M, 2001, J CLIN MICROBIOL, V39, P816, DOI 10.1128/JCM.39.2.816-819.2001; Sermet-Gaudelus I, 2003, EMERG INFECT DIS, V9, P1587, DOI 10.3201/eid0912.020774; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; Tomashefski JF, 1996, AM J RESP CRIT CARE, V154, P523, DOI 10.1164/ajrccm.154.2.8756832; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Viana-Niero C, 2008, J CLIN MICROBIOL, V46, P850, DOI 10.1128/JCM.02052-07; Villanueva A, 1997, CLIN INFECT DIS, V24, P1147, DOI 10.1086/513656; Weingart CL, 1999, CURR MICROBIOL, V38, P233, DOI 10.1007/PL00006793; Zhang YS, 2004, J CLIN MICROBIOL, V42, P5582, DOI 10.1128/JCM.42.12.5582-5587.2004; Zhou XF, 2005, MOL MICROBIOL, V57, P1428, DOI 10.1111/j.1365-2958.2005.04764.x	86	249	488	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5660	10.1371/journal.pone.0005660	http://dx.doi.org/10.1371/journal.pone.0005660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543527	Green Submitted, Green Published, gold			2022-12-27	WOS:000267237400001
J	Tayo, BO; DiCioccio, RA; Liang, YL; Trevisan, M; Cooper, RS; Lele, S; Sucheston, L; Piver, SM; Odunsi, K				Tayo, Bamidele O.; DiCioccio, Richard A.; Liang, Yulan; Trevisan, Maurizio; Cooper, Richard S.; Lele, Shashikant; Sucheston, Lara; Piver, Steven M.; Odunsi, Kunle			Complex Segregation Analysis of Pedigrees from the Gilda Radner Familial Ovarian Cancer Registry Reveals Evidence for Mendelian Dominant Inheritance	PLOS ONE			English	Article								Background: Familial component is estimated to account for about 10% of ovarian cancer. However, the mode of inheritance of ovarian cancer remains poorly understood. The goal of this study was to investigate the inheritance model that best fits the observed transmission pattern of ovarian cancer among 7669 members of 1919 pedigrees ascertained through probands from the Gilda Radner Familial Ovarian Cancer Registry at Roswell Park Cancer Institute, Buffalo, New York. Methodology/Principal Findings: Using the Statistical Analysis for Genetic Epidemiology program, we carried out complex segregation analyses of ovarian cancer affection status by fitting different genetic hypothesis-based regressive multivariate logistic models. We evaluated the likelihood of sporadic, major gene, environmental, general, and six types of Mendelian models. Under each hypothesized model, we also estimated the susceptibility allele frequency, transmission probabilities for the susceptibility allele, baseline susceptibility and estimates of familial association. Comparisons between models were carried out using either maximum likelihood ratio test in the case of hierarchical models, or Akaike information criterion for non-nested models. When assessed against sporadic model without familial association, the model with both parent-offspring and sib-sib residual association could not be rejected. Likewise, the Mendelian dominant model that included familial residual association provided the best-fitting for the inheritance of ovarian cancer. The estimated disease allele frequency in the dominant model was 0.21. Conclusions/Significance: This report provides support for a genetic role in susceptibility to ovarian cancer with a major autosomal dominant component. This model does not preclude the possibility of polygenic inheritance of combined effects of multiple low penetrance susceptibility alleles segregating dominantly.			Tayo, BO (corresponding author), Loyola Univ, Med Ctr, Dept Prevent Med & Epidemiol, Chicago, IL 60611 USA.	kunle.odunsi@roswellpark.org		trevisan, maurizio/0000-0001-5479-0050	NCI NIH HHS [CA016156] Funding Source: Medline; NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Auranen A, 1998, BRIT J CANCER, V77, P1537, DOI 10.1038/bjc.1998.252; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CANNINGS C, 1977, CLIN GENET, V12, P208; Cui JS, 2001, AM J HUM GENET, V68, P420, DOI 10.1086/318187; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; Eccles DM, 1997, ANN HUM GENET, V61, P243; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Essioux L, 1998, AM J MED GENET, V79, P175, DOI 10.1002/(SICI)1096-8628(19980923)79:3<175::AID-AJMG5>3.0.CO;2-M; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gayther SA, 1999, AM J HUM GENET, V65, P1021, DOI 10.1086/302583; Gayther SA, 1997, AM J HUM GENET, V60, P1239; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; GO RCP, 1978, AM J HUM GENET, V30, P28; Hopper JL, 2005, LANCET, V366, P1397, DOI 10.1016/S0140-6736(05)67570-8; HOULSTON RS, 1991, ANN HUM GENET, V55, P291, DOI 10.1111/j.1469-1809.1991.tb00856.x; Jarvik GP, 1998, AM J HUM GENET, V63, P942, DOI 10.1086/302075; Karlan BY, 2007, OBSTET GYNECOL, V110, P155, DOI 10.1097/01.AOG.0000269050.79143.84; Karunaratne PM, 1998, AM J MED GENET, V76, P428, DOI 10.1002/(SICI)1096-8628(19980413)76:5<428::AID-AJMG12>3.0.CO;2-O; Kaufman DJ, 2003, CANCER EPIDEM BIOMAR, V12, P1045; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1995, AM J HUM GENET, V56, P254; Pharoah PDP, 1998, BRIT MED BULL, V54, P823; Piver M. S., 1996, European Journal of Gynaecological Oncology, V17, P169; PIVER MS, 1984, OBSTET GYNECOL, V64, P195; Piver MS, 2000, GYNECOL ONCOL, V78, P166, DOI 10.1006/gyno.2000.5840; Piver MS, 2002, GYNECOL ONCOL, V85, P9, DOI 10.1006/gyno.2001.6465; Ramus SJ, 2003, CANCER RES, V63, P417; RAMUS SJ, 2007, HUM MUTAT; *SAGE, 2006, STAT AN GEN EPID US; SAS Institute, 2008, SAS STAT US GUID; South SA, 2009, CANCER-AM CANCER SOC, V115, P324, DOI 10.1002/cncr.24012; Stratton JF, 1997, NEW ENGL J MED, V336, P1125, DOI 10.1056/NEJM199704173361602; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; TRAGER EH, 2004, MADELINE VERSION 0 9	38	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5939	10.1371/journal.pone.0005939	http://dx.doi.org/10.1371/journal.pone.0005939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536330	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029700011
J	Aagaard, C; Hoang, TTKT; Izzo, A; Billeskov, R; Troudt, J; Arnett, K; Keyser, A; Elvang, T; Andersen, P; Dietrich, J				Aagaard, Claus; Hoang, Truc Thi Kim Thanh; Izzo, Angelo; Billeskov, Rolf; Troudt, JoLynn; Arnett, Kim; Keyser, Andrew; Elvang, Tara; Andersen, Peter; Dietrich, Jes			Protection and Polyfunctional T Cells Induced by Ag85B-TB10.4/IC31 (R) against Mycobacterium tuberculosis Is Highly Dependent on the Antigen Dose	PLOS ONE			English	Article								Background: Previously we have shown that Ag85B-TB10.4 is a highly efficient vaccine against tuberculosis when delivered in a Th1 inducing adjuvant based on cationic liposomes. Another Th1 inducing adjuvant, which has shown a very promising profile in both preclinical and clinical trials, is IC31 (R). In this study, we examined the potential of Ag85B-TB10.4 delivered in the adjuvant IC31 (R) for the ability to induce protection against infection with Mycobacterium tuberculosis. In addition, we examined if the antigen dose could influence the phenotype of the induced T cells. Methods and Findings: We found that vaccination with the combination of Ag85B-TB10.4 and IC31 (R) resulted in high numbers of polyfunctional CD4 T cells co-expressing IL-2, IFN-gamma and TNF-alpha. This correlated with protection against subsequent challenge with M.tb in the mouse TB model. Importantly, our results also showed that both the vaccine induced T cell response, and the protective efficacy, was highly dependent on the antigen dose. Thus, whereas antigen doses of 5 and 15 mu g did not induce significant protection against M.tb, reducing the dose to 0.5 mu g selectively increased the number of polyfunctional T cells and induced a strong protection against infection with M.tb. The influence of antigen dose was also observed in the guinea pig model of aerosol infection with M.tb. In this model a 2.5 fold increase in the antigen dose reduced the protection against infection with M.tb to the level observed in non-vaccinated animals. Conclusions/Significance: Small changes in the antigen dose can greatly influence the induction of specific T cell subpopulations and the dose is therefore a crucial factor when testing new vaccines. However, the adjuvant IC31 (R) can, with the optimal dose of Ag85B-TB10.4, induce strong protection against Mycobacterium tuberculosis. This vaccine has now entered clinical trials.			Aagaard, C (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	JDI@ssi.dk	Izzo, Angelo A/F-1229-2017	Izzo, Angelo A/0000-0003-3208-2330; Andersen, Peter/0000-0002-5869-2551; Billeskov, Rolf/0000-0003-4533-7304	NIAID NIH HHS [N01AI40091] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agger EM, 2006, VACCINE, V24, P5452, DOI 10.1016/j.vaccine.2006.03.072; Bekker LG, 2001, J IMMUNOL, V166, P6728, DOI 10.4049/jimmunol.166.11.6728; BOGDAN C, 1990, EUR J IMMUNOL, V20, P1131, DOI 10.1002/eji.1830200528; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brock I, 2004, J CLIN MICROBIOL, V42, P2379, DOI 10.1128/JCM.42.6.2379-2387.2004; Christensen D, 2007, BBA-BIOMEMBRANES, V1768, P2120, DOI 10.1016/j.bbamem.2007.05.009; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Irwin SM, 2008, CLIN VACCINE IMMUNOL, V15, P750, DOI 10.1128/CVI.00018-08; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; WEINRICH OA, 2001, INFECT IMMUN, V69, P2773, DOI DOI 10.1128/IAI.69.5.2773-2778.2001; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433	25	127	134	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5930	10.1371/journal.pone.0005930	http://dx.doi.org/10.1371/journal.pone.0005930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529771	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029500010
J	Dubrulle, M; Mousson, L; Moutailler, S; Vazeille, M; Failloux, AB				Dubrulle, Mathieu; Mousson, Laurence; Moutailler, Sara; Vazeille, Marie; Failloux, Anna-Bella			Chikungunya Virus and Aedes Mosquitoes: Saliva Is Infectious as soon as Two Days after Oral Infection	PLOS ONE			English	Article								Background: Aedes aegypti and Aedes albopictus are potential vectors of chikungunya virus (CHIKV). The recent CHIKV outbreaks were caused by a new variant characterized by a mutation in the E1 glycoprotein gene (E1-226V) which has favored a better transmissibility by Ae. albopictus. As Ae. albopictus tends to replace Ae. aegypti in many regions, one question remained: is Ae. albopictus as efficient as Ae. aegypti to transmit the variant E1-226V of CHIKV? Methodology and Findings: We infected orally both species with the variant E1-226V and estimated the infection, the viral dissemination, and the transmission rate by real time RT-PCR. Additionally, we used an in vitro assay to determine the amount of virus delivered by mosquitoes in their saliva. We found that Ae. aegypti as well as Ae. albopictus ensured a high replication of the virus which underwent an efficient dissemination as detectable in the salivary glands at day 2 post-infection (pi). Infectious CHIKV particles were delivered by salivary glands from day 2 with a maximum at day 6 pi for Ae. albopictus (10(3.3) PFU) and day 7 pi for Ae. aegypti (10(2.5) PFU). Conclusions: Ae. albopictus is slightly more efficient than Ae. aegypti to transmit the variant E1-226V of CHIKV. These results will help to design an efficient vector control to limit transmission as soon as the first human cases are diagnosed.			Dubrulle, M (corresponding author), Inst Pasteur, Paris, France.	afaillou@pasteur.fr	Sara, Moutailler/J-9633-2019	Sara, Moutailler/0000-0003-3010-6968				AITKEN THG, 1977, MOSQ NEWS, V37, P130; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; DEVINE TERRY L., 1965, J INSECT PHYSIOL, V11, P347, DOI 10.1016/0022-1910(65)90082-X; FARAN ME, 1988, AM J TROP MED HYG, V39, P206, DOI 10.4269/ajtmh.1988.39.206; Gaidamovich S Y, 1973, Intervirology, V1, P193, DOI 10.1159/000148846; GUBLER DJ, 1976, AM J TROP MED HYG, V25, P146, DOI 10.4269/ajtmh.1976.25.146; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; Higgs S., 2004, Microbe-vector interactions in vector-borne diseases, P103, DOI 10.1017/CBO9780511754845.008; HURBULT HS, 1966, J TROP MED HYG, V15, P989; KUBERSKI TT, 1977, AM J TROP MED HYG, V26, P533, DOI 10.4269/ajtmh.1977.26.533; Kumarasamy V, 2006, Med J Malaysia, V61, P221; Mourya DT, 2001, ACTA VIROL, V45, P305; Renault P, 2007, AM J TROP MED HYG, V77, P727; Ribeiro JMC, 2000, MED VET ENTOMOL, V14, P142, DOI 10.1046/j.1365-2915.2000.00227.x; ROSS RW, 1955, ANN REPORT, P192; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Smith DR, 2005, AM J TROP MED HYG, V73, P33, DOI 10.4269/ajtmh.2005.73.33; Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132; Styer LM, 2006, AM J TROP MED HYG, V75, P337, DOI 10.4269/ajtmh.2006.75.337; Sumanochitrapon W, 1998, AM J TROP MED HYG, V58, P283, DOI 10.4269/ajtmh.1998.58.283; Vanlandingham DL, 2004, AM J TROP MED HYG, V71, P120, DOI 10.4269/ajtmh.2004.71.120; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168	28	231	237	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5895	10.1371/journal.pone.0005895	http://dx.doi.org/10.1371/journal.pone.0005895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521520	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029100010
J	Peric, M; Koglin, S; Dombrowski, Y; Gross, K; Bradac, E; Buchau, A; Steinmeyer, A; Zugel, U; Ruzicka, T; Schauber, J				Peric, Mark; Koglin, Sarah; Dombrowski, Yvonne; Gross, Katrin; Bradac, Eva; Buechau, Amanda; Steinmeyer, Andreas; Zuegel, Ulrich; Ruzicka, Thomas; Schauber, Juergen			Vitamin D Analogs Differentially Control Antimicrobial Peptide/"Alarmin" Expression in Psoriasis	PLOS ONE			English	Article								Antimicrobial peptides (AMPs) are strongly expressed in lesional skin in psoriasis and play an important role as proinflammatory "alarmins" in this chronic skin disease. Vitamin D analogs like calcipotriol have antipsoriatic effects and might mediate this effect by changing AMP expression. In this study, keratinocytes in lesional psoriatic plaques showed decreased expression of the AMPs beta-defensin (HBD) 2 and HBD3 after topical treatment with calcipotriol. At the same time, calcipotriol normalized the proinflammatory cytokine milieu and decreased interleukin (IL)-17A, IL-17F and IL-8 transcript abundance in lesional psoriatic skin. In contrast, cathelicidin antimicrobial peptide expression was increased by calcipotriol while psoriasin expression remained unchanged. In cultured human epidermal keratinocytes the effect of different vitamin D analogs on the expression of AMPs was further analyzed. All vitamin D analogs tested blocked IL-17A induced HBD2 expression by increasing I kappa B-alpha protein and inhibition of NF-kappa B signaling. At the same time vitamin D analogs induced cathelicidin through activation of the vitamin D receptor and MEK/ERK signaling. These studies suggest that vitamin D analogs differentially alter AMP expression in lesional psoriatic skin and cultured keratinocytes. Balancing AMP "alarmin" expression might be a novel goal in treatment of chronic inflammatory skin diseases.			Peric, M (corresponding author), Univ Munich, Dept Dermatol & Allergol, Munich, Germany.	juergen.schauber@med.uni-muenchen.de	Dombrowski, Yvonne/N-7020-2019	Dombrowski, Yvonne/0000-0003-1732-6288				Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Brown AJ, 2008, MOL ASPECTS MED, V29, P433, DOI 10.1016/j.mam.2008.04.001; Caproni M, 2009, J CLIN IMMUNOL, V29, P210, DOI 10.1007/s10875-008-9233-0; Carlberg C, 2003, J CELL BIOCHEM, V88, P274, DOI 10.1002/jcb.10337; CHAMORRO CI, 2008, J INVEST DERMATOL; Charakida A, 2006, EXPERT OPIN PHARMACO, V7, P597, DOI 10.1517/14656566.7.5.597; Duweb G, 2005, INT J TISSUE REACT, V27, P163; Fogh K, 1997, CLIN DERMATOL, V15, P705, DOI 10.1016/S0738-081X(97)00021-7; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gambichler T, 2008, INT ARCH ALLERGY IMM, V147, P17, DOI 10.1159/000128582; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Glaser R, 2009, J INVEST DERMATOL, V129, P641, DOI 10.1038/jid.2008.268; Hata TR, 2008, J ALLERGY CLIN IMMUN, V122, P829, DOI 10.1016/j.jaci.2008.08.020; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; McCarroll SA, 2008, NAT GENET, V40, P5, DOI 10.1038/ng0108-5; Nijenhuis T, 2006, FASEB J, V20, P2171, DOI 10.1096/fj.06-5515fje; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Oppenheim JJ, 2007, ADV EXP MED BIOL, V601, P185; Penna G, 2007, J IMMUNOL, V178, P145, DOI 10.4049/jimmunol.178.1.145; Peric M, 2009, DEUT MED WOCHENSCHR, V134, P35, DOI 10.1055/s-0028-1105888; Peric M, 2008, J IMMUNOL, V181, P8504, DOI 10.4049/jimmunol.181.12.8504; Riis JL, 2004, ARCH DERMATOL RES, V296, P195, DOI 10.1007/s00403-004-0509-9; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Schauber J, 2008, J ALLERGY CLIN IMMUN, V122, P261, DOI 10.1016/j.jaci.2008.03.027; Schauber J, 2008, J INVEST DERMATOL, V128, P816, DOI 10.1038/sj.jid.5701102; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Schauber J, 2006, IMMUNOLOGY, V118, P509, DOI 10.1111/j.1365-2567.2006.02399.x; Schittek Birgit, 2008, Infectious Disorders - Drug Targets, V8, P135; Toell A, 2001, MOL PHARMACOL, V59, P1478, DOI 10.1124/mol.59.6.1478; van Beelen AJ, 2007, CURR OPIN ALLERGY CL, V7, P374, DOI 10.1097/ACI.0b013e3282ef869e; vanderVleuten CJM, 1996, ARCH DERMATOL RES, V288, P366, DOI 10.1007/s004030050065; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Watanabe H, 2009, J INVEST DERMATOL, V129, P650, DOI 10.1038/jid.2008.294; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zheng Y, 2008, IMMUNOLOGY, V124, P357, DOI 10.1111/j.1365-2567.2007.02782.x; Zugel U, 2002, J INVEST DERMATOL, V119, P1434, DOI 10.1046/j.1523-1747.2002.19623.x	45	98	107	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6340	10.1371/journal.pone.0006340	http://dx.doi.org/10.1371/journal.pone.0006340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623255	Green Submitted, gold, Green Published			2022-12-27	WOS:000268260100016
J	Haimel, M; Proll, K; Rebhan, M				Haimel, Matthias; Proell, Karin; Rebhan, Michael			ProteinArchitect: Protein Evolution above the Sequence Level	PLOS ONE			English	Article								Background: While many authors have discussed models and tools for studying protein evolution at the sequence level, molecular function is usually mediated by complex, higher order features such as independently folding domains and linear motifs that are based on or embedded in a particular arrangment of features such as secondary structure elements, transmembrane domains and regions with intrinsic disorder. This 'protein architecture' can, in its most simplistic representation, be visualized as domain organization cartoons that can be used to compare proteins in terms of the order of their mostly globular domains. Methodology: Here, we describe a visual approach and a webserver for protein comparison that extend the domain organization cartoon concept. By developing an information-rich, compact visualization of different protein features above the sequence level, potentially related proteins can be compared at the level of propensities for secondary structure, transmembrane domains and intrinsic disorder, in addition to PFAM domains. A public Web server is available at www.proteinarchitect.net, while the code is provided at protarchitect.sourceforge.net. Conclusions/Significance: Due to recent advances in sequencing technologies we are now flooded with millions of predicted proteins that await comparative analysis. In many cases, mature tools focused on revealing hits with considerable global or local similarity to well-characterized proteins will not be able to lead us to testable hypotheses about a protein's function, or the function of a particular region. The visual comparison of different types of protein features with ProteinArchitect will be useful when assessing the relevance of similarity search hits, to discover subgroups in protein families and superfamilies, and to understand protein regions with conserved features outside globular regions. Therefore, this approach is likely to help researchers to develop testable hypotheses about a protein's function even if is somewhat distant from the more characterized proteins, by facilitating the discovery of features that are conserved above the sequence level for comparison and further experimental investigation.			Haimel, M (corresponding author), European Bioinformat Inst, Cambridge, England.	michael.rebhan@novartis.com		Haimel, Matthias/0000-0002-0320-0214				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Chang GS, 2008, P NATL ACAD SCI USA, V105, P13474, DOI 10.1073/pnas.0803860105; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Coggill Penny, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0205s23; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; *UNIPROT CONS, 2009, NUCL ACIDS RES 2008; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	14	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6176	10.1371/journal.pone.0006176	http://dx.doi.org/10.1371/journal.pone.0006176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603068	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035700002
J	Laridjani, M; Leboucher, P				Laridjani, Morteza; Leboucher, Pierre			The Structural Dilemma of Bulk Polyethylene: An Intermediary Structure	PLOS ONE			English	Article							X-RAY-DIFFRACTION; CRYSTALLINITY	Background: The Fourier space (reciprocal space) image of bulk polyethylene consists of lines superimposed on the coherent diffuse background. The mixed character of the image indicates the complex nature of these compounds. The inability in detecting full images of reciprocal space of polymeric substances without Compton radiation and the other undesirable diffuse scatterings has misled the structural analysis (structural characterisation) of these materials. Principal Findings: We propose the use of anomalous diffractometry where, it is possible to obtain a real image of reciprocal space without Compton radiation and other undesirable scatterings. By using classical diffractometry techniques this procedure is not possible. This methodology permitted us to obtain the "Direct Delta function'', in the case of polycrystalline substances that was not previously detected. A new procedure was proposed to interpret the image of reciprocal space of bulk polyethylene. The results show the predominance of the geometry of local order determination compared to the crystal unit cell. The analysis of x-ray diffraction images illustrates that the elementary structural unit is a tetrahedron. This structural unit illustrates the atoms in the network scatter in a coherent diffuse manner. Moreover, the interference function derived from the coherent diffuse scattering dampens out quickly and the degree of randomness is superior to a liquid state. The radial distribution function derived from this interference function shows bond shortening in the tetrahedron configuration. It is this particular effect, which stabilises polyethylene. Conclusion: Here we show by anomalous diffractometry that the traditional concept of the two-phase or the crystal-defect model is an oversimplification of the complex reality. The exploitation of anomalous diffractometry has illustrated that polyethylene has an intermediate ordered structure.			Laridjani, M (corresponding author), Univ Paris Sud, Phys Solides Lab, Orsay, France.	pierre.leboucher@college-de-france.fr						Bernal JD, 1964, P R SOC A, P284; BRIDLEY GW, 1961, XRAY IDENTIFICATION; BUNN CW, 1945, T FARADAY SOC, V41, P317, DOI 10.1039/tf9454100317; Bunn CW, 1939, T FARADAY SOC, V35, P0482, DOI 10.1039/tf9393500482; CHAMPETIER G, 1969, INTRO CHIMIE MACROMO, P403; CULLITY BD, 1956, HANWALT METHOD, P379; Eyring H, 1932, PHYS REV, V39, P746, DOI 10.1103/PhysRev.39.746; FINNEY JL, 1970, PROC R SOC LON SER-A, V319, P479, DOI [10.1098/rspa.1970.0189, 10.1098/rspa.1970.0190]; FLORY PG, 1956, PRINCIPLE POLYM CHEM, P400; FLORY PG, 1980, STAT MECH CHAIN MOL, P10; GANDER W, 1992, SOLVING PROBLEMS SCI; GUINIER A, 1952, XRAY CRYSTALLOGRAPHI, P231; GUINIER A, 1981, INTERMEDIARY STATES, P420; GUINIER A, 1963, XRAY STUDIES MAT, P71; HOLMES DR, 1953, NATURE, V171, P1104, DOI 10.1038/1711104b0; Hosemann R., 1962, DIRECT ANAL DIFFRACT; HUMEROTHERY W, 1954, ADV PHYS, V3, P149, DOI 10.1080/00018735400101193; JACCODINE R, 1955, NATURE, V176, P305, DOI 10.1038/176305b0; KAPLOW R, 1965, PHYS REV, P138; KELLER A, 1957, PHILOS MAG, V2, P1171, DOI 10.1080/14786435708242746; Klug BP, 1974, XRAY DIFFRACTION PRO, P144; LARIDJANI M, 1989, J PHYS-PARIS, V50, P1953, DOI 10.1051/jphys:0198900500140195300; LARIDJANI M, 1987, J NON-CRYST SOLIDS, V91, P217, DOI 10.1016/S0022-3093(87)80305-8; Laridjani M, 2004, J APPL CRYSTALLOGR, V37, P716, DOI 10.1107/S0021889804014657; Laridjani M, 2002, STRUCT CHEM, V13, P385, DOI 10.1023/A:1015832511433; Laridjani M, 1996, J PHYS I, V6, P1347, DOI 10.1051/jp1:1996140; LARIDJANI M, 1999, EUROPEAN PHYS J B, P585; LARIDJANI M, 1998, SPECTRA, V16, P128; LEBO M, 1974, METALL TRANS, V5, P1547, DOI 10.1007/BF02646325; LEBOUCHER P, 1985, 1337 ANVAR; Muller A, 1928, P R SOC LOND A-CONTA, V120, P437, DOI 10.1098/rspa.1928.0158; NARTEN AH, 1989, J CHEM PHYS, V90, P5857, DOI 10.1063/1.456391; RULAND W, 1961, ACTA CRYSTALLOGR, V14, P1180, DOI 10.1107/S0365110X61003429; SCHUUR G, 1955, COMMUNICATION; STATTON WO, 1967, J POLYMER SCI      C, V18, P33; Tsuneo S., 1968, JPN J APPL PHYS, V7, P31; Turnbull D., 1964, PHYSICS NONCRYSTALLI, P41; VONK CG, 1973, J APPL CRYSTALLOGR, V6, P148, DOI 10.1107/S0021889873008332; WALTER ER, 1956, J POLYM SCI, V21, P561, DOI 10.1002/pol.1956.120219925; Wolff P. M. de, 1957, ACTA CRYST, V10, P590; YOON DY, 1977, POLYMER, V18, P509, DOI 10.1016/0032-3861(77)90170-7; [No title captured]	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6228	10.1371/journal.pone.0006228	http://dx.doi.org/10.1371/journal.pone.0006228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597553	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035600003
J	Liu, X; Li, YM				Liu, Xuan; Li, Yiming			Aquaculture Enclosures Relate to the Establishment of Feral Populations of Introduced Species	PLOS ONE			English	Article							PROPAGULE PRESSURE; PLANT INVASIONS; FISH; CONSERVATION; BULLFROGS; DECLINE; BIOLOGY; DETERMINANTS; INFORMATION; AMPHIBIANS	Many species introduced by humans for social and economic benefits have invaded new ranges by escaping from captivity. Such invasive species can negatively affect biodiversity and economies. Understanding the factors that relate to the establishment of feral populations of introduced species is therefore of great importance for managing introduced species. The American Bullfrog (Lithobates catesbeianus) is one species that has escaped from farms, and it is now found in the wild in China. In this study, we examined influences of two types of bullfrog farm ( termed simple and elaborate farm enclosures) on the establishment of feral populations of this species in 137 water bodies in 66 plots in four provinces of China. The likelihood of establishment of bullfrog populations in water bodies in plots with simple enclosures (49/89 = 55.1%) was higher than those with elaborate enclosures (3/48 = 6.3%). Based on the Akaike Information Criterion, the minimum adequate model of generalized linear mixed models with a binomial error structure and a logit link function showed that the establishment or failure of bullfrog populations in water bodies was positively correlated with the presence of a simple enclosure, the number of bullfrogs raised and the presence of permanent water in a plot, but negatively correlated with distance from a bullfrog farm and the occurrence of frequent hunting. Results therefore suggest that a simple farm enclosure can increase the establishment of feral bullfrog populations compared with an elaborate enclosure. Our findings are the first to quantify the importance of improving farming enclosures to control and minimize the risk from introduced species.			Liu, X (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	liym@ioz.ac.cn	Liu, Xuan/AAF-3703-2020	Liu, Xuan/0000-0003-1572-1268				Adams MJ, 2003, ECOL LETT, V6, P343, DOI 10.1046/j.1461-0248.2003.00435.x; Adams MJ, 1999, J WILDLIFE MANAGE, V63, P1162, DOI 10.2307/3802834; Alcaraz C, 2005, DIVERS DISTRIB, V11, P289, DOI 10.1111/j.1366-9516.2005.00170.x; Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Austin JD, 2004, GENETICS, V168, P1491, DOI 10.1534/genetics.104.027987; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Boone MD, 2007, ECOL APPL, V17, P291, DOI 10.1890/1051-0761(2007)017[0291:MSIACE]2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Byers JE, 2001, ECOLOGY, V82, P1330, DOI 10.1890/0012-9658(2001)082[1330:ETMATO]2.0.CO;2; Colautti RI, 2007, BIOL INVASIONS, V9, P885, DOI 10.1007/s10530-006-9007-7; Dehnen-Schmutz K, 2007, CONSERV BIOL, V21, P224, DOI 10.1111/j.1523-1739.2006.00538.x; Doubledee RA, 2003, J WILDLIFE MANAGE, V67, P424, DOI 10.2307/3802783; Duggan IC, 2006, BIOL INVASIONS, V8, P377, DOI 10.1007/s10530-004-2310-2; Duncan RP, 2001, J ANIM ECOL, V70, P621, DOI 10.1046/j.1365-2656.2001.00517.x; Elton C., 1958; Fei L., 1999, ATLAS AMPHIBIANS CHI; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fisher DO, 2004, TRENDS ECOL EVOL, V19, P391, DOI 10.1016/j.tree.2004.05.004; Fisher RN, 1996, CONSERV BIOL, V10, P1387, DOI 10.1046/j.1523-1739.1996.10051387.x; Gertzen E, 2008, CAN J FISH AQUAT SCI, V65, P1265, DOI 10.1139/F08-056; Goldburg R, 2005, FRONT ECOL ENVIRON, V3, P21, DOI 10.2307/3868441; Govindarajulu P, 2005, ECOL APPL, V15, P2161, DOI 10.1890/05-0486; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Ingram William Marcus, 1943, AMER MIDLAND NAT, V29, P239, DOI 10.2307/2420996; JAEGER R, 1994, STANDARD TECHNIQUES, P97; Jeschke JM, 2006, GLOBAL CHANGE BIOL, V12, P1608, DOI 10.1111/j.1365-2486.2006.01213.x; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; Kiesecker JM, 2001, ECOLOGY, V82, P1964, DOI 10.1890/0012-9658(2001)082[1964:PMUTDO]2.0.CO;2; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kupferberg SJ, 1997, ECOLOGY, V78, P1736; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Li YM, 2006, OECOLOGIA, V148, P129, DOI 10.1007/s00442-006-0355-x; Li Z., 2002, INVASIVE ALIEN SPECI; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lodge DM, 2003, CONSERV BIOL, V17, P31, DOI 10.1046/j.1523-1739.2003.02366.x; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Maret TJ, 2006, BIOL CONSERV, V127, P129, DOI 10.1016/j.biocon.2005.08.003; Moe H, 2007, AQUAC RES, V38, P91, DOI 10.1111/j.1365-2109.2006.01638.x; MOYLE PB, 1973, COPEIA, P18; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naylor R, 2005, BIOSCIENCE, V55, P427, DOI 10.1641/0006-3568(2005)055[0427:FSATRO]2.0.CO;2; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Pearl CA, 2005, WETLANDS, V25, P76, DOI 10.1672/0277-5212(2005)025[0076:AOAAII]2.0.CO;2; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Ricciardi A, 2004, ECOL LETT, V7, P781, DOI 10.1111/j.1461-0248.2004.00642.x; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Rixon CAM, 2005, BIODIVERS CONSERV, V14, P1365, DOI 10.1007/s10531-004-9663-9; Rubbo MJ, 2005, CONSERV BIOL, V19, P504, DOI 10.1111/j.1523-1739.2005.000101.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Skelly DK, 1999, ECOLOGY, V80, P2326, DOI 10.1890/0012-9658(1999)080[2326:LTDDOA]2.0.CO;2; Stohlgren TJ, 2003, FRONT ECOL ENVIRON, V1, P11; Taylor BW, 2004, P NATL ACAD SCI USA, V101, P17725, DOI 10.1073/pnas.0405176101; Verling E, 2005, P ROY SOC B-BIOL SCI, V272, P1249, DOI 10.1098/rspb.2005.3090; Wang YH, 2009, J HERPETOL, V43, P205, DOI 10.1670/0022-1511-43.2.205; Weigle SM, 2005, CONSERV BIOL, V19, P213, DOI 10.1111/j.1523-1739.2005.00412.x; WERNER EE, 1994, ECOLOGY, V75, P1368, DOI 10.2307/1937461; Whelan, 1985, ECOLOGY MANAGEMENT B; Wilcove DS, 1998, CONSERV BIOL, V12, P1405, DOI 10.1046/j.1523-1739.1998.97451.x; Willis Y. L., 1956, Copeia, P30; Wonham MJ, 2001, MAR ECOL PROG SER, V215, P1, DOI 10.3354/meps215001; Xie F, 2007, SCI CHINA SER C, V50, P265, DOI 10.1007/s11427-007-0021-5; Xie P, 2001, SCIENCE, V294, P999; Yang D., 1991, AMPHIBIAN FAUNA YUNN; Zampella RA, 2000, J HERPETOL, V34, P210, DOI 10.2307/1565417	69	37	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6199	10.1371/journal.pone.0006199	http://dx.doi.org/10.1371/journal.pone.0006199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593446	gold, Green Published, Green Submitted			2022-12-27	WOS:000268035400001
J	Hubbard, RE; Fallah, N; Searle, SD; Mitnitski, A; Rockwood, K				Hubbard, Ruth E.; Fallah, Nader; Searle, Samuel D.; Mitnitski, Arnold; Rockwood, Kenneth			Impact of Exercise in Community-Dwelling Older Adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; FUNCTIONAL DECLINE; ELDERLY SUBJECTS; HEALTH-STATUS; FRAILTY; PERFORMANCE; PROGRAM; PEOPLE; RISK; ACCUMULATION	Background: Concern has been expressed that preventive measures in older people might increase frailty by increasing survival without improving health. We investigated the impact of exercise on the probabilities of health improvement, deterioration and death in community-dwelling older people. Methods and Principal Findings: In the Canadian Study of Health and Aging, health status was measured by a frailty index based on the number of health deficits. Exercise was classified as either high or low/no exercise, using a validated, self-administered questionnaire. Health status and survival were re-assessed at 5 years. Of 6297 eligible participants, 5555 had complete data. Across all grades of frailty, death rates for both men and women aged over 75 who exercised were similar to their peers aged 65 to 75 who did not exercise. In addition, while all those who exercised had a greater chance of improving their health status, the greatest benefits were in those who were more frail ( e. g. improvement or stability was observed in 34% of high exercisers versus 26% of low/no exercisers for those with 2 deficits compared with 40% of high exercisers versus 22% of low/no exercisers for those with 9 deficits at baseline). Conclusions: In community-dwelling older people, exercise attenuated the impact of age on mortality across all grades of frailty. Exercise conferred its greatest benefits to improvements in health status in those who were more frail at baseline. The net effect of exercise should therefore be to improve health status at the population level.			Hubbard, RE (corresponding author), Dalhousie Univ, Geriatr Med Res Unit, Halifax, NS, Canada.	ruth.hubbard@cdha.nshealth.ca	Fallah, Nader/D-4145-2012; Mitnitski, Arnold/C-7543-2012; Rockwood, Kenneth/AAD-8951-2019; Hubbard, Ruth E/G-5414-2010	Fallah, Nader/0000-0002-7746-4773; Hubbard, Ruth E/0000-0002-8688-5836				Abate M, 2007, Eura Medicophys, V43, P407; ADDISON J, SPECTATOR       0712, P1711; Binder EF, 2002, J AM GERIATR SOC, V50, P1921, DOI 10.1046/j.1532-5415.2002.50601.x; Bulat T, 2007, CLIN INTERV AGING, V2, P655; Davis HS, 2001, INT PSYCHOGERIATR, V13, P177, DOI 10.1017/S1041610202008128; Dupre ME, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1175; Faber MJ, 2006, ARCH PHYS MED REHAB, V87, P885, DOI 10.1016/j.apmr.2006.04.005; FOOTMAN T, 2008, POSTPONING INEVITABL; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Goggins WB, 2005, J GERONTOL A-BIOL, V60, P1046, DOI 10.1093/gerona/60.8.1046; Heyn PC, 2008, J NUTR HEALTH AGING, V12, P401, DOI 10.1007/BF02982674; Hubbard RE, 2009, AGE AGEING, V38, P115, DOI 10.1093/ageing/afn252; Izaks Gerbrand J, 2003, BMC Geriatr, V3, P7, DOI 10.1186/1471-2318-3-7; Kulminski AM, 2008, J AM GERIATR SOC, V56, P898, DOI 10.1111/j.1532-5415.2008.01656.x; Landi F, 2007, J CLIN EPIDEMIOL, V60, P518, DOI 10.1016/j.jclinepi.2006.09.010; Lang IA, 2007, J AM GERIATR SOC, V55, P1836, DOI 10.1111/j.1532-5415.2007.01426.x; Latham NK, 2004, J GERONTOL A-BIOL, V59, P48; Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lee Y, 2008, INT J GERIATR PSYCH, V23, P249, DOI 10.1002/gps.1870; Mangin D, 2007, BMJ-BRIT MED J, V335, P285, DOI 10.1136/bmj.39241.630741.BE1; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; MCDOWELL I, 1994, CAN MED ASSOC J, V150, P899; Middleton LE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003124; Mitnitski A, 2006, MECH AGEING DEV, V127, P490, DOI 10.1016/j.mad.2006.01.007; Mitnitski A, 2005, J AM GERIATR SOC, V53, P2184, DOI 10.1111/j.1532-5415.2005.00506.x; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Mitnitski AB, 2004, J GERONTOL A-BIOL, V59, P627, DOI 10.1093/gerona/59.6.M627; Mitnitski A, 2007, EXP GERONTOL, V42, P1109, DOI 10.1016/j.exger.2007.08.002; NELSON ME, 1994, JAMA-J AM MED ASSOC, V272, P1909, DOI 10.1001/jama.272.24.1909; Pel-Littel RE, 2009, J NUTR HEALTH AGING, V13, P390, DOI 10.1007/s12603-009-0051-8; Reznick A Z, 1992, EXS, V62, P423; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P738, DOI 10.1093/gerona/62.7.738; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rockwood K, 2007, ALZHEIMERS DEMENT, V3, pS38, DOI 10.1016/j.jalz.2007.01.003; Rockwood K, 2007, AGE AGEING, V36, P225, DOI 10.1093/ageing/afl160; Rydwik E, 2004, AGE AGEING, V33, P13, DOI 10.1093/ageing/afh001; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Song XW, 2007, AGING CLIN EXP RES, V19, P145; Tudor-Locke C, 2002, SPORTS MED, V32, P795, DOI 10.2165/00007256-200232120-00004; Weerdesteyn V, 2006, GERONTOLOGY, V52, P131, DOI 10.1159/000091822; Wolf SL, 2006, J GERONTOL A-BIOL, V61, P184, DOI 10.1093/gerona/61.2.184	44	63	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6174	10.1371/journal.pone.0006174	http://dx.doi.org/10.1371/journal.pone.0006174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	468HA	19584926	Green Submitted, Green Published, gold			2022-12-27	WOS:000267806500007
J	Ramirez-Gomez, F; Ortiz-Pineda, PA; Rivera-Cardona, G; Garcia-Arraras, JE				Ramirez-Gomez, Francisco; Ortiz-Pineda, Pablo A.; Rivera-Cardona, Gabriela; Garcia-Arraras, Jose E.			LPS-Induced Genes in Intestinal Tissue of the Sea Cucumber Holothuria glaberrima	PLOS ONE			English	Article							MAJOR YOLK PROTEIN; EXPRESSED SEQUENCE TAGS; IMMUNE-SYSTEM; URCHIN; REGENERATION; DIVERSITY; DEFENSE; FAMILY; DOMAIN; LIVER	Metazoan immunity is mainly associated with specialized cells that are directly involved with the immune response. Nevertheless, both in vertebrates and invertebrates other organs might respond to immune activation and participate either directly or indirectly in the ongoing immune process. However, most of what is known about invertebrate immunity has been restricted to immune effector cells and little information is available on the immune responses of other tissues or organs. We now focus on the immune reactions of the intestinal tissue of an echinoderm. Our study employs a non-conventional model, the echinoderm Holothuria glaberrima, to identify intestinal molecules expressed after an immune challenge presented by an intra-coelomic injection of lipopolysaccharides ( LPS). The expression profiles of intestinal genes expressed differentially between LPS-injected animals and control sea water-injected animals were determined using a custom-made Agilent microarray with 7209 sea cucumber intestinal ESTs. Fifty ( 50) unique sequences were found to be differentially expressed in the intestine of LPS-treated sea cucumbers. Seven ( 7) of these sequences represented homologues of known proteins, while the remaining ( 43) had no significant similarity with any protein, EST or RNA database. The known sequences corresponded to cytoskeletal proteins ( Actin and alpha-actinin), metabolic enzymes ( GAPDH, Ahcy and Gnmt), metal ion transport/metabolism ( major yolk protein) and defense/recognition ( fibrinogen-like protein). The expression pattern of 11 genes was validated using semi-quantitative RT-PCR. Nine of these corroborated the microarray results and the remaining two showed a similar trend but without statistical significance. Our results show some of the molecular events by which the holothurian intestine responds to an immune challenge and provide important information to the study of the evolution of the immune response.			Ramirez-Gomez, F (corresponding author), Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA.	jegarcia@hpcf.upr.edu		Ortiz-Pineda, Pablo Andres/0000-0003-3945-2023	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM084770, S06GM008102] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR016470, P20RR16470] Funding Source: Medline; NIGMS NIH HHS [S06GM08102, S06 GM008102, 1SC1GM084770-01, SC1 GM084770] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams DH, 2008, GUT, V57, P838, DOI 10.1136/gut.2007.122168; Adema CM, 1997, P NATL ACAD SCI USA, V94, P8691, DOI 10.1073/pnas.94.16.8691; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARMANT DR, 1986, DEV BIOL, V113, P342, DOI 10.1016/0012-1606(86)90169-7; Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; Brockton V, 2008, J CELL SCI, V121, P339, DOI 10.1242/jcs.012096; Brooks JM, 2002, DEV BIOL, V245, P1, DOI 10.1006/dbio.2002.0611; Buckley KM, 2008, J MOL BIOL, V379, P912, DOI 10.1016/j.jmb.2008.04.037; Buijs RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003152; Cao Honghe, 2006, BMC Vet Res, V2, P34, DOI 10.1186/1746-6148-2-34; De Zoysa M, 2009, FISH SHELLFISH IMMUN, V26, P625, DOI 10.1016/j.fsi.2008.10.004; Dudoit S, 2002, STAT SINICA, V12, P111; ENDEAN R, 1966, PHYSL ECHINODERMATA; Erdmann VA, 2001, CELL MOL LIFE SCI, V58, P960, DOI 10.1007/PL00000913; Feldhaar H, 2008, MICROBES INFECT, V10, P1082, DOI 10.1016/j.micinf.2008.07.010; Fischereder M, 2009, FRONT BIOSCI-LANDMRK, V14, P1807, DOI 10.2741/3342; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Garcia-Arraras JE, 2001, MICROSC RES TECHNIQ, V55, P438, DOI 10.1002/jemt.1189; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HARRINGTON FE, 1986, CELL DIFFER DEV, V19, P51, DOI 10.1016/0045-6039(86)90025-4; HARRINGTON FE, 1982, DEV BIOL, V94, P505, DOI 10.1016/0012-1606(82)90367-0; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Holm K, 2008, J EXP BIOL, V211, P2551, DOI 10.1242/jeb.018507; Jeng RL, 2001, CURR BIOL, V11, pR691, DOI 10.1016/S0960-9822(01)00410-9; Johansson KC, 2005, EXP CELL RES, V305, P145, DOI 10.1016/j.yexcr.2004.12.018; Ju LY, 2009, FISH SHELLFISH IMMUN, V26, P235, DOI 10.1016/j.fsi.2008.10.015; KARI BE, 1985, DEV BIOL, V108, P18, DOI 10.1016/0012-1606(85)90004-1; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; Kinsey GR, 2008, NEPHRON EXP NEPHROL, V109, pE102, DOI 10.1159/000142934; Liu ZL, 2008, BIOCHEM BIOPH RES CO, V365, P729, DOI 10.1016/j.bbrc.2007.11.069; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Matsushita M, 2002, IMMUNOBIOLOGY, V205, P490, DOI 10.1078/0171-2985-00149; Min W, 2003, APPL MICROBIOL BIOT, V62, P392, DOI 10.1007/s00253-003-1303-x; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nagoshi H, 2006, MOL IMMUNOL, V43, P2061, DOI 10.1016/j.molimm.2005.12.009; Nair SV, 2005, PHYSIOL GENOMICS, V22, P33, DOI 10.1152/physiolgenomics.00052.2005; Newman MA, 2007, J ENDOTOXIN RES, V13, P69, DOI 10.1177/0968051907079399; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Ogawa H, 1998, INT J BIOCHEM CELL B, V30, P13, DOI 10.1016/S1357-2725(97)00105-2; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; PALMER JL, 1979, J BIOL CHEM, V254, P1217; Pancer Z, 1999, IMMUNOGENETICS, V49, P773, DOI 10.1007/s002510050551; Parrinello N, 2008, CELL TISSUE RES, V334, P305, DOI 10.1007/s00441-008-0695-4; Perna AF, 2001, KIDNEY INT, V59, pS230, DOI 10.1046/j.1523-1755.2001.07853.x; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Ramirez-Gomez F, 2008, IMMUNOGENETICS, V60, P57, DOI 10.1007/s00251-007-0258-y; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Rast JP, 2000, CURR TOP MICROBIOL, V248, P3; Rojas-Cartagena C, 2007, PHYSIOL GENOMICS, V31, P203, DOI 10.1152/physiolgenomics.00228.2006; Roth J, 2001, BRAZ J MED BIOL RES, V34, P301, DOI 10.1590/S0100-879X2001000300003; Rozen S, 2000, Methods Mol Biol, V132, P365; Santiago P, 2000, J EXP ZOOL, V288, P335, DOI 10.1002/1097-010X(20001215)288:4<335::AID-JEZ6>3.0.CO;2-1; Santiago-Cardona PG, 2003, DEV COMP IMMUNOL, V27, P105, DOI 10.1016/S0145-305X(02)00068-X; Shalev I, 2008, J IMMUNOL, V180, P249, DOI 10.4049/jimmunol.180.1.249; SHETERLINE P, 1998, PROTEIN PROFILE ACTI; Shu S, 2006, P NATL ACAD SCI USA, V103, P19788, DOI 10.1073/pnas.0609385103; Smith LC, 2006, ISJ-INVERT SURVIV J, V3, P25; Smith LC, 1996, J IMMUNOL, V156, P593; Smith LC, 2001, IMMUNOL REV, V180, P16, DOI 10.1034/j.1600-065X.2001.1800102.x; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Szymanski M, 2002, GENOME BIOL, V3; Terwilliger DP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-16; Terwilliger DP, 2006, PHYSIOL GENOMICS, V26, P134, DOI 10.1152/physiolgenomics.00011.2006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tisdale EJ, 2007, TRAFFIC, V8, P733, DOI 10.1111/j.1600-0854.2007.00569.x; UNUMA T, 2008, MOL REPROD DEV; Unuma T, 2007, FEBS J, V274, P4985, DOI 10.1111/j.1742-4658.2007.06014.x; Wang X, 2004, INSECT MOL BIOL, V13, P273, DOI 10.1111/j.0962-1075.2004.00484.x; Wershil BK, 2008, J ALLERGY CLIN IMMUN, V121, pS380, DOI 10.1016/j.jaci.2007.10.023; Wiesel P, 2000, CIRCULATION, V102, P3015, DOI 10.1161/01.cir.102.24.3015; Wu QL, 2005, J PHARMACOL EXP THER, V313, P705, DOI 10.1124/jpet.104.080416; XUN X, 1990, P NATL ACAD SCI USA, V87, P2097, DOI 10.1073/pnas.87.6.2097; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	79	31	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6178	10.1371/journal.pone.0006178	http://dx.doi.org/10.1371/journal.pone.0006178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584914	gold, Green Published, Green Submitted			2022-12-27	WOS:000267806500009
J	Joshi, H; Dave, R; Venugopalan, VP				Joshi, Hiren; Dave, Rachna; Venugopalan, Vayalam P.			Competition Triggers Plasmid-Mediated Enhancement of Substrate Utilisation in Pseudomonas putida	PLOS ONE			English	Article							CONTACT-DEPENDENT INHIBITION; BACTERIA; GROWTH; GENE	Competition between species plays a central role in the activity and structure of communities. Stable co-existence of diverse organisms in communities is thought to be fostered by individual tradeoffs and optimization of competitive strategies along resource gradients. Outside the laboratory, microbes exist as multispecies consortia, continuously interacting with one another and the environment. Survival and proliferation of a particular species is governed by its competitive fitness. Therefore, bacteria must be able to continuously sense their immediate environs for presence of competitors and prevailing conditions. Here we present results of our investigations on a novel competition sensing mechanism in the rhizosphere-inhabiting Pseudomonas putida KT2440, harbouring gfpmut3b-modified Kan(R) TOL plasmid. We monitored benzyl alcohol (BA) degradation rate, along with GFP expression profiling in mono species and dual species cultures. Interestingly, enhanced plasmid expression (monitored using GFP expression) and consequent BA degradation were observed in dual species consortia, irrespective of whether the competitor was a BA degrader (Pseudomonas aeruginosa) or a non-degrader (E. coli). Attempts at elucidation of the mechanistic aspects of induction indicated the role of physical interaction, but not of any diffusible compounds emanating from the competitors. This contention is supported by the observation that greater induction took place in presence of increasing number of competitors. Inert microspheres mimicking competitor cell size and concentration did not elicit any significant induction, further suggesting the role of physical cell-cell interaction. Furthermore, it was also established that cell wall compromised competitor had minimal induction capability. We conclude that P. putida harbouring pWW0 experience a competitive stress when grown as dual-species consortium, irrespective of the counterpart being BA degrader or not. The immediate effect of this stress is a marked increase in expression of TOL, leading to rapid utilization of the available carbon source and massive increase in its population density. The plausible mechanisms behind the phenomenon are hypothesised and practical implications are indicated and discussed.			Joshi, H (corresponding author), BARC Facil, Water & Steam Chem Div, Biofouling & Biofilm Proc Sect, Kalpakkam, Tamil Nadu, India.	vpv@igcar.gov.in	Joshi, Hiren/AGJ-2262-2022	Joshi, Hiren/0000-0002-2774-7695				An DD, 2006, P NATL ACAD SCI USA, V103, P3828, DOI 10.1073/pnas.0511323103; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; Camesano TA, 2002, BIOMACROMOLECULES, V3, P661, DOI 10.1021/bm015648y; Depardieu F, 2007, CLIN MICROBIOL REV, V20, P79, DOI 10.1128/CMR.00015-06; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Hsu SB, 2002, MATH BIOSCI, V179, P183, DOI 10.1016/S0025-5564(02)00105-0; Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005; Jena SS, 2006, BIOPHYS J, V91, P2699, DOI 10.1529/biophysj.106.086520; Kaiser D, 2004, ANNU REV MICROBIOL, V58, P75, DOI 10.1146/annurev.micro.58.030603.123620; Kojic M, 1999, BBA-GENE STRUCT EXPR, V1489, P413, DOI 10.1016/S0167-4781(99)00210-9; LEVIN BR, 1980, GENETICS, V94, P425; Maselli A, 2002, MICROBIOL-SGM, V148, P413, DOI 10.1099/00221287-148-2-413; Miao JW, 2003, P NATL ACAD SCI USA, V100, P110, DOI 10.1073/pnas.232691299; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nancharaiah YV, 2003, APPL ENVIRON MICROB, V69, P4846, DOI 10.1128/AEM.69.8.4846-4852.2003; Ramos-Gonzalez MI, 1998, J BACTERIOL, V180, P3421; SELVA L, 2009, P NATL ACAD IN PRESS; SHARON N, 1987, FEBS LETT, V217, P145, DOI 10.1016/0014-5793(87)80654-3; Slechta ES, 2006, TRENDS MICROBIOL, V14, P58, DOI 10.1016/j.tim.2005.12.003; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; Wegrzyn G, 2002, MICROB CELL FACT, V1, DOI 10.1186/1475-2859-1-2; Yuan SL, 2006, MATH BIOSCI, V202, P1, DOI 10.1016/j.mbs.2006.04.003	24	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6065	10.1371/journal.pone.0006065	http://dx.doi.org/10.1371/journal.pone.0006065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557171	Green Published, gold, Green Submitted			2022-12-27	WOS:000267424600013
J	Mure, LS; Cornut, PL; Rieux, C; Drouyer, E; Denis, P; Gronfier, C; Cooper, HM				Mure, Ludovic S.; Cornut, Pierre-Loic; Rieux, Camille; Drouyer, Elise; Denis, Philippe; Gronfier, Claude; Cooper, Howard M.			Melanopsin Bistability: A Fly's Eye Technology in the Human Retina	PLOS ONE			English	Article								In addition to rods and cones, the human retina contains light-sensitive ganglion cells that express melanopsin, a photopigment with signal transduction mechanisms similar to that of invertebrate rhabdomeric photopigments (IRP). Like fly rhodopsins, melanopsin acts as a dual-state photosensitive flip-flop in which light drives both phototransduction responses and chromophore photoregeneration that bestows independence from the retinoid cycle required by rods and cones to regenerate photoresponsiveness following bleaching by light. To explore the hypothesis that melanopsin in humans expresses the properties of a bistable photopigment in vivo we used the pupillary light reflex (PLR) as a tool but with methods designed to study invertebrate photoreceptors. We show that the pupil only attains a fully stabilized state of constriction after several minutes of light exposure, a feature that is consistent with typical IRP photoequilibrium spectra. We further demonstrate that previous exposure to long wavelength light increases, while short wavelength light decreases the amplitude of pupil constriction, a fundamental property of IRP difference spectra. Modelling these responses to invertebrate photopigment templates yields two putative spectra for the underlying R and M photopigment states with peaks at 481 nm and 587 nm respectively. Furthermore, this bistable mechanism may confer a novel form of "photic memory'' since information of prior light conditions is retained and shapes subsequent responses to light. These results suggest that the human retina exploits fly-like photoreceptive mechanisms that are potentially important for the modulation of non-visual responses to light and highlights the ubiquitous nature of photoswitchable photosensors across living organisms.			Mure, LS (corresponding author), INSERM, Stem Cell & Brain Res Inst, Dept Chronobiol, U846, F-69500 Bron, France.	howard.cooper@inserm.fr	Mure, Ludovic/AAR-9132-2021; COOPER, HOWARD/M-7304-2014; Gronfier, Claude/C-1243-2008	Mure, Ludovic/0000-0002-2485-1032; Gronfier, Claude/0000-0002-6549-799X				ALPERN M, 1962, J PHYSIOL-LONDON, V164, P478, DOI 10.1113/jphysiol.1962.sp007033; Arendt D, 2003, INT J DEV BIOL, V47, P563; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; Clarke RJ, 2003, J NEUROPHYSIOL, V89, P3179, DOI 10.1152/jn.01131.2002; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dkhissi-Benyabya O, 2006, INVEST OPHTH VIS SCI, V47, P1636, DOI 10.1167/iovs.05-1459; Drouyer E, 2007, J NEUROSCI, V27, P9623, DOI 10.1523/JNEUROSCI.1391-07.2007; Drouyer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003931; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Giesbers ME, 2008, PHOTOCHEM PHOTOBIOL, V84, P990, DOI 10.1111/j.1751-1097.2008.00347.x; GOLDMAN LJ, 1975, J GEN PHYSIOL, V66, P383, DOI 10.1085/jgp.66.3.383; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Link B, 2006, INVEST OPHTH VIS SCI, V47, P4947, DOI 10.1167/iovs.06-0021; LISMAN JE, 1976, J GEN PHYSIOL, V68, P487, DOI 10.1085/jgp.68.5.487; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2006, P NATL ACAD SCI USA, V103, P10153, DOI 10.1073/pnas.0603955103; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; PEPE IM, 1992, J PHOTOCH PHOTOBIO B, V13, P5, DOI 10.1016/1011-1344(92)80035-T; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rollag MD, 2008, J BIOL RHYTHM, V23, P396, DOI 10.1177/0748730408323067; Sekaran S, 2007, J NEUROSCI, V27, P3981, DOI 10.1523/JNEUROSCI.4716-06.2007; STAVENGA DG, 1975, PHOTOCHEM PHOTOBIOL, V21, P105, DOI 10.1111/j.1751-1097.1975.tb06636.x; STAVENGA DG, 1976, J COMP PHYSIOL, V111, P137, DOI 10.1007/BF00605529; Stockman A, 1999, VISION RES, V39, P2901, DOI 10.1016/S0042-6989(98)00225-9; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Torii M, 2007, FEBS LETT, V581, P5327, DOI 10.1016/j.febslet.2007.10.019; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Young RSL, 2008, VISION RES, V48, P862, DOI 10.1016/j.visres.2007.12.016; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zhu YL, 2007, INVEST OPHTH VIS SCI, V48, P1268, DOI 10.1167/iovs.06-0925	42	126	133	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e5991	10.1371/journal.pone.0005991	http://dx.doi.org/10.1371/journal.pone.0005991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551136	gold, Green Published, Green Submitted			2022-12-27	WOS:000267356500004
J	Bonnedahl, J; Drobni, M; Gauthier-Clerc, M; Hernandez, J; Granholm, S; Kayser, Y; Melhus, A; Kahlmeter, G; Waldenstrom, J; Johansson, A; Olsen, B				Bonnedahl, Jonas; Drobni, Mirva; Gauthier-Clerc, Michel; Hernandez, Jorge; Granholm, Susanne; Kayser, Yves; Melhus, Asa; Kahlmeter, Gunnar; Waldenstrom, Jonas; Johansson, Anders; Olsen, Bjorn			Dissemination of Escherichia coli with CTX-M Type ESBL between Humans and Yellow-Legged Gulls in the South of France	PLOS ONE			English	Article								Extended Spectrum beta-Lactamase (ESBL) producing Enterobacteriaceae started to appear in the 1980s, and have since emerged as some of the most significant hospital-acquired infections with Escherichia coli and Klebsiella being main players. More than 100 different ESBL types have been described, the most widespread being the CTX-M beta-lactamase enzymes (bla(CTX-M) genes). This study focuses on the zoonotic dissemination of ESBL bacteria, mainly CTX-M type, in the southern coastal region of France. We found that the level of general antibiotic resistance in single randomly selected E. coli isolates from wild Yellow-legged Gulls in France was high. Nearly half the isolates (47,1%) carried resistance to one or more antibiotics (in a panel of six antibiotics), and resistance to tetracycline, ampicillin and streptomycin was most widespread. In an ESBL selective screen, 9,4% of the gulls carried ESBL producing bacteria and notably, 6% of the gulls carried bacteria harboring CTX-M-1 group of ESBL enzymes, a recently introduced and yet the most common clinical CTX-M group in France. Multi locus sequence type and phylogenetic group designations were established for the ESBL isolates, revealing that birds and humans share E. coli populations. Several ESBL producing E. coli isolated from birds were identical to or clustered with isolates with human origin. Hence, wild birds pick up E. coli of human origin, and with human resistance traits, and may accordingly also act as an environmental reservoir and melting pot of bacterial resistance with a potential to re-infect human populations.			Bonnedahl, J (corresponding author), Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden.	mirva.drobni@medsci.uu.se	Johansson, Anders/H-9362-2017; Johansson, Anders/D-2928-2012; Bonnedahl, Jonas/GZG-8435-2022; Waldenström, Jonas/E-4460-2013	Johansson, Anders/0000-0003-0548-5943; Johansson, Anders/0000-0003-0548-5943; Waldenström, Jonas/0000-0002-1152-4235; Bonnedahl, Jonas/0000-0002-3182-389X; Olsen, Bjorn/0000-0002-4646-691X				Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Costa D, 2006, J ANTIMICROB CHEMOTH, V58, P1311, DOI 10.1093/jac/dkl415; Crowley B, 2003, J ANTIMICROB CHEMOTH, V51, P1316, DOI 10.1093/jac/dkg206; Dolejska M, 2007, J APPL MICROBIOL, V103, P11, DOI 10.1111/j.1365-2672.2006.03241.x; Edelstein M, 2003, ANTIMICROB AGENTS CH, V47, P3724, DOI 10.1128/AAC.47.12.3724-3732.2003; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Galas M, 2008, ANTIMICROB AGENTS CH, V52, P786, DOI 10.1128/AAC.00906-07; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Gordon DM, 2003, MICROBIOL-SGM, V149, P3575, DOI 10.1099/mic.0.26486-0; Higgins J, 2007, J MICROBIOL METH, V70, P227, DOI 10.1016/j.mimet.2007.04.009; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Lau SH, 2008, J CLIN MICROBIOL, V46, P1076, DOI 10.1128/JCM.02065-07; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Melhus A, 1996, MED MICROBIOL LETT, V5, P74; Middleton JH, 2005, J WILDLIFE DIS, V41, P334, DOI 10.7589/0090-3558-41.2.334; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Osterblad M, 2001, NATURE, V409, P37, DOI 10.1038/35051173; Pitout JDD, 2004, J CLIN MICROBIOL, V42, P5715, DOI 10.1128/JCM.42.12.5715-5721.2004; Pitout JDD, 1998, ANTIMICROB AGENTS CH, V42, P1350, DOI 10.1128/AAC.42.6.1350; Poeta P, 2008, APPL ENVIRON MICROB, V74, P7439, DOI 10.1128/AEM.00949-08; Sjolund M, 2008, EMERG INFECT DIS, V14, P70, DOI 10.3201/eid1401.070704; Sorum H, 2001, VET RES, V32, P227, DOI 10.1051/vetres:2001121; Tartof SY, 2005, J CLIN MICROBIOL, V43, P5860, DOI 10.1128/JCM.43.12.5860-5864.2005; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	26	162	170	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5958	10.1371/journal.pone.0005958	http://dx.doi.org/10.1371/journal.pone.0005958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536298	Green Published, gold, Green Submitted			2022-12-27	WOS:000267079500008
J	Banerjee, K; Chabris, CF; Johnson, VE; Lee, JJ; Tsao, F; Hauser, MD				Banerjee, Konika; Chabris, Christopher F.; Johnson, Valen E.; Lee, James J.; Tsao, Fritz; Hauser, Marc D.			General Intelligence in Another Primate: Individual Differences across Cognitive Task Performance in a New World Monkey (Saguinus oedipus)	PLOS ONE			English	Article								Background: Individual differences in human cognitive abilities show consistently positive correlations across diverse domains, providing the basis for the trait of "general intelligence" (g). At present, little is known about the evolution of g, in part because most comparative studies focus on rodents or on differences across higher-level taxa. What is needed, therefore, are experiments targeting nonhuman primates, focusing on individual differences within a single species, using a broad battery of tasks. To this end, we administered a large battery of tasks, representing a broad range of cognitive domains, to a population of captive cotton-top tamarin monkeys (Saguinus oedipus). Methodology and Results: Using a Bayesian latent variable model, we show that the pattern of correlations among tasks is consistent with the existence of a general factor accounting for a small but significant proportion of the variance in each task (the lower bounds of 95% Bayesian credibility intervals for correlations between g and task performance all exceed 0.12). Conclusion: Individual differences in cognitive abilities within at least one other primate species can be characterized by a general intelligence factor, supporting the hypothesis that important aspects of human cognitive function most likely evolved from ancient neural substrates.			Banerjee, K (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	kbanerg@wjh.harvard.edu						ANDERSON B, 1993, NEUROSCI LETT, V153, P98, DOI 10.1016/0304-3940(93)90086-Z; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Chabris CF, 2007, INTEGRATING THE MIND: DOMAIN GENERAL VERSUS DOMAIN SPECIFIC PROCESSES IN HIGHER COGNITION, P449; Deaner R. O., 2006, EVOL PSYCHOL, V4, DOI [10.1177/147470490600400114, DOI 10.1177/147470490600400114]; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Deary IJ, 2006, EUR J HUM GENET, V14, P690, DOI 10.1038/sj.ejhg.5201588; Fagan J. F., 1992, J APPL DEV PSYCHOL, V13, P173, DOI DOI 10.1016/0193-3973(92)90028-G; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Galsworthy MJ, 2005, BEHAV GENET, V35, P675, DOI 10.1007/s10519-005-3423-9; Galsworthy MJ, 2002, GENES BRAIN BEHAV, V1, P88, DOI 10.1034/j.1601-183X.2002.10204.x; GUTTMAN L, 1991, INTELLIGENCE, V15, P79, DOI 10.1016/0160-2896(91)90023-7; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Jensen A. R., 2000, PSYCHOLOQUY, V11; Jensen A.R., 1980, BIAS MENTAL TESTING; JENSEN AR, 1980, AM EDUC RES J, V17, P153, DOI 10.2307/1162480; Jensen AR, 1998, FACTOR SCI MENTAL AB; Johnson VE, 2002, J AM STAT ASSOC, V97, P8, DOI 10.1198/016214502753479185; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Klein R. G., 1999, HUMAN CAREER HUMAN B; Kruse W, 2002, CEREB CORTEX, V12, P466, DOI 10.1093/cercor/12.5.466; Locurto C, 1998, J COMP PSYCHOL, V112, P344, DOI 10.1037/0735-7036.112.4.344; Locurto C., 1997, ADV COGNITION ED, V4, P79; Matzel LD, 2003, J NEUROSCI, V23, P6423; Matzel LD, 2006, NEUROBIOL LEARN MEM, V86, P228, DOI 10.1016/j.nlm.2006.03.004; McDaniel MA, 2005, INTELLIGENCE, V33, P337, DOI 10.1016/j.intell.2004.11.005; NAGOSHI CT, 1987, INTELLIGENCE, V11, P305, DOI 10.1016/0160-2896(87)90014-6; Pinker S., 1997, MIND WORKS; Plomin R, 2001, NAT REV NEUROSCI, V2, P136, DOI 10.1038/35053584; Pretz, 2005, COGNITION INTELLIGEN, P188, DOI DOI 10.1017/CB09780511607073.011; Savastano Gina, 2003, Journal of Applied Animal Welfare Science, V6, P247, DOI 10.1207/S15327604JAWS0603_09; Spearman C.E., 1927, ABILITIES MAN THEIR; Stevens JR, 2007, ANIM COGN, V10, P429, DOI 10.1007/s10071-007-0081-8; THOMAS MSC, 2003, MODELS INTELLIGENCE, P133; Van Schaik C, 2004, ORANGUTANS RED APES; Weiss DJ, 2001, J COMP PSYCHOL, V115, P258, DOI 10.1037/0735-7036.115.3.258; Wood JN, 2008, COGNITION, V106, P207, DOI 10.1016/j.cognition.2007.01.004	36	48	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5883	10.1371/journal.pone.0005883	http://dx.doi.org/10.1371/journal.pone.0005883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536274	Green Submitted, Green Published, gold			2022-12-27	WOS:000267029700002
J	Hashimoto, H; Miyamoto, R; Watanabe, N; Shiba, D; Ozato, K; Inoue, C; Kubo, Y; Koga, A; Jindo, T; Narita, T; Naruse, K; Ohishi, K; Nogata, K; Shin-I, T; Asakawa, S; Shimizu, N; Miyamoto, T; Mochizuki, T; Yokoyama, T; Hori, H; Takeda, H; Kohara, Y; Wakamatsu, Y				Hashimoto, Hisashi; Miyamoto, Rieko; Watanabe, Naoki; Shiba, Dai; Ozato, Kenjiro; Inoue, Chikako; Kubo, Yuko; Koga, Akihiko; Jindo, Tomoko; Narita, Takanori; Naruse, Kiyoshi; Ohishi, Kazuko; Nogata, Keiko; Shin-I, Tadasu; Asakawa, Shuichi; Shimizu, Nobuyoshi; Miyamoto, Tomotsune; Mochizuki, Toshio; Yokoyama, Takahiko; Hori, Hiroshi; Takeda, Hiroyuki; Kohara, Yuji; Wakamatsu, Yuko			Polycystic Kidney Disease in the Medaka (Oryzias latipes) pc Mutant Caused by a Mutation in the Gli-Similar3 (glis3) Gene	PLOS ONE			English	Article								Polycystic kidney disease (PKD) is a common hereditary disease in humans. Recent studies have shown an increasing number of ciliary genes that are involved in the pathogenesis of PKD. In this study, the Gli-similar3 (glis3) gene was identified as the causal gene of the medaka pc mutant, a model of PKD. In the pc mutant, a transposon was found to be inserted into the fourth intron of the pc/glis3 gene, causing aberrant splicing of the pc/glis3 mRNA and thus a putatively truncated protein with a defective zinc finger domain. pc/glis3 mRNA is expressed in the epithelial cells of the renal tubules and ducts of the pronephros and mesonephros, and also in the pancreas. Antisense oligonucleotide-mediated knockdown of pc/glis3 resulted in cyst formation in the pronephric tubules of medaka fry. Although three other glis family members, glis1a, glis1b and glis2, were found in the medaka genome, none were expressed in the embryonic or larval kidney. In the pc mutant, the urine flow rate in the pronephros was significantly reduced, which was considered to be a direct cause of renal cyst formation. The cilia on the surface of the renal tubular epithelium were significantly shorter in the pc mutant than in wild-type, suggesting that shortened cilia resulted in a decrease in driving force and, in turn, a reduction in urine flow rate. Most importantly, EGFP-tagged pc/glis3 protein localized in primary cilia as well as in the nucleus when expressed in mouse renal epithelial cells, indicating a strong connection between pc/glis3 and ciliary function. Unlike human patients with GLIS3 mutations, the medaka pc mutant shows none of the symptoms of a pancreatic phenotype, such as impaired insulin expression and/or diabetes, suggesting that the pc mutant may be suitable for use as a kidney-specific model for human GLIS3 patients.			Hashimoto, H (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	hsshsmt@bio.nagoya-u.ac.jp	Narita, Takanori/F-1092-2011	Narita, Takanori/0000-0003-0295-5014				Ainsworth C, 2007, NATURE, V448, P638, DOI 10.1038/448638a; Andoh T, 2007, GEN COMP ENDOCR, V151, P308, DOI 10.1016/j.ygcen.2007.01.015; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Bubenshchikova E, 2008, CLONING STEM CELLS, V10, P443, DOI 10.1089/clo.2008.0014; Calvet JP, 2003, NAT GENET, V33, P113, DOI 10.1038/ng1078; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Fedorova S, 2008, DEV DYNAM, V237, P2342, DOI 10.1002/dvdy.21687; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Hashimoto H, 2004, DEVELOPMENT, V131, P1741, DOI 10.1242/dev.01070; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Hostetter CL, 2003, DEV DYNAM, V228, P514, DOI 10.1002/dvdy.10371; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Hyodo-Taguchi Y, 1996, FISH BIOL J MEDAKA, V8, P11; Igarashi P, 2007, J AM SOC NEPHROL, V18, P1371, DOI 10.1681/ASN.2007030299; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Jacob L, 2007, SCIENCE, V318, P66, DOI 10.1126/science.1147314; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kim SC, 2005, NUCLEIC ACIDS RES, V33, P6805, DOI 10.1093/nar/gki985; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; Kim YS, 2002, J BIOL CHEM, V277, P30901, DOI 10.1074/jbc.M203563200; Kimura T, 2004, MECH DEVELOP, V121, P915, DOI 10.1016/j.mod.2004.03.033; Kondo S, 2001, CURR BIOL, V11, P1202, DOI 10.1016/S0960-9822(01)00324-4; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Liu SM, 2002, DEVELOPMENT, V129, P5839, DOI 10.1242/dev.00173; Marshall WF, 2004, CURR BIOL, V14, pR913, DOI 10.1016/j.cub.2004.10.011; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Mochizuki E, 2005, KIDNEY INT, V68, P23, DOI 10.1111/j.1523-1755.2005.00378.x; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nakashima M, 2002, MECH DEVELOP, V119, P21, DOI 10.1016/S0925-4773(02)00291-5; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Obara T, 2006, J AM SOC NEPHROL, V17, P2706, DOI 10.1681/ASN.2006040412; Ogoshi M, 2006, PEPTIDES, V27, P3154, DOI 10.1016/j.peptides.2006.09.011; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; SAEKI H, 1984, J UROLOGY, V132, P1165, DOI 10.1016/S0022-5347(17)50080-4; SAKAIZUMI M, 1983, COPEIA, P311, DOI 10.2307/1444373; Schottenfeld J, 2007, DEVELOPMENT, V134, P1605, DOI 10.1242/dev.02827; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; Simons M, 2006, KIDNEY INT, V70, P854, DOI 10.1038/sj.ki.5001534; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Taha D, 2003, AM J MED GENET A, V122A, P269, DOI 10.1002/ajmg.a.20267; Tobin JL, 2007, PEDIATR NEPHROL, V22, P926, DOI 10.1007/s00467-007-0435-0; Wang SX, 2004, J AM SOC NEPHROL, V15, P592, DOI 10.1097/01.ASN.0000113793.12558.1D; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; YAMAGAMI K, 1972, DEV BIOL, V29, P343, DOI 10.1016/0012-1606(72)90074-7; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zhang MZ, 2004, P NATL ACAD SCI USA, V101, P2311, DOI 10.1073/pnas.0400073101	68	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6299	10.1371/journal.pone.0006299	http://dx.doi.org/10.1371/journal.pone.0006299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609364	Green Submitted, gold, Green Published			2022-12-27	WOS:000268119500018
J	Graf, J; Scherzer, R; Grunfeld, C; Imboden, J				Graf, Jonathan; Scherzer, Rebecca; Grunfeld, Carl; Imboden, John			Levels of C-Reactive Protein Associated with High and Very High Cardiovascular Risk Are Prevalent in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article								Objective: C-reactive protein (CRP) levels>3 mg/L and>10 mg/L are associated with high and very high cardiovascular risk, respectively, in the general population. Because rheumatoid arthritis (RA) confers excess cardiovascular mortality, we determined the prevalence of these CRP levels among RA patients stratified on the basis of their RA disease activity. Methods: We evaluated physician and patient global assessments of disease activity, tender and swollen 28 joint counts, erythrocyte sedimentation rate (ESR), and CRP measured in a single clinic visit for 151 RA patients. Disease activity was calculated using the Clinical Disease Activity Index (CDAI) and the Disease Activity Score 28 Joints (DAS28-ESR and DAS28-CRP). Results: Median CRP level was 5.3 mg/L. 68% of patients had CRP>3 mg/L, and 25% had CRP>10 mg/L. Of those with 0-1 swollen joints (n = 56), or 0-1 tender joints (n = 81), 64% and 67%, respectively, had CRP>3 mg/L, and 23% and 20%, respectively, had CRP>10 mg/L. Of those with remission or mildly active disease by CDAI (n = 58), DAS28-ESR (n = 39), or DAS28-CRP (n = 70), 49-66% had CRP>3 mg/L, and 10-14% had CRP>10 mg/L. Of patients with moderate disease activity by CDAI (n = 51), DAS28-ESR (n = 78), or DAS28-CRP (n = 66), 67-73% had CRP>3 mg/L, and 25-33% had CRP>10 mg/L. Conclusion: Even among RA patients whose disease is judged to be controlled by joint counts or standardized disease scores, a substantial proportion have CRP levels that are associated high or very high risk for future cardiovascular events in the general population.			Graf, J (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	jimboden@medsfgh.ucsf.edu						Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Aletaha D, 2007, BEST PRACT RES CL RH, V21, P663, DOI 10.1016/j.berh.2007.02.004; Baldassarre D, 2008, ANN MED, V40, P21, DOI 10.1080/07853890701645399; Book C, 2005, J RHEUMATOL, V32, P430; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; del Rincon I, 2003, ARTHRITIS RHEUM, V48, P1833, DOI 10.1002/art.11078; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Dessein PH, 2006, ARTHRITIS RHEUM-US, V54, P2765, DOI 10.1002/art.22053; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2905, DOI 10.1002/art.22809; Fries JF, 1997, J RHEUMATOL, V24, P1697; Galarraga B, 2008, RHEUMATOLOGY, V47, P1780, DOI 10.1093/rheumatology/ken386; Giles JT, 2008, ARTHRITIS RHEUM, V58, P2632, DOI 10.1002/art.23766; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gonzalez-Gay MA, 2005, J RHEUMATOL, V32, P1219; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Goodson NJ, 2005, ARTHRITIS RHEUM-US, V52, P2293, DOI 10.1002/art.21204; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Maki-Petaja KM, 2006, CIRCULATION, V114, P1185, DOI 10.1161/CIRCULATIONAHA.105.601641; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Naranjo A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2383; *NAT I HLTH CLIN E, 2007, RHEUM ARTHR AD ET IN; Pahor A, 2006, RHEUMATOL INT, V27, P119, DOI 10.1007/s00296-006-0176-6; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Solomon DH, 2006, ANN RHEUM DIS, V65, P1608, DOI 10.1136/ard.2005.050377; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; van Halm VP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2045; Vaudo G, 2004, ANN RHEUM DIS, V63, P31, DOI 10.1136/ard.2003.007740; Wang TJ, 2002, CIRCULATION, V106, P1189, DOI 10.1161/01.CIR.0000032135.98011.C4; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Young A, 2007, RHEUMATOLOGY, V46, P350, DOI 10.1093/rheumatology/kel253	42	58	60	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6242	10.1371/journal.pone.0006242	http://dx.doi.org/10.1371/journal.pone.0006242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606218	Green Submitted, Green Published, gold			2022-12-27	WOS:000268036000003
J	Nielsen, OH; Bjerrum, JT; Csillag, C; Nielsen, FC; Olsen, J				Nielsen, Ole Haagen; Bjerrum, Jacob Tveiten; Csillag, Claudio; Nielsen, Finn Cilius; Olsen, Jorgen			Influence of Smoking on Colonic Gene Expression Profile in Crohn's Disease	PLOS ONE			English	Article								Background: The development and course of Crohn's disease (CD) is related to both genetic and environmental factors. Smoking has been found to exacerbate the course of CD by increasing the risk of developing fistulas and strictures as well as the need for surgery, possibly because of an interaction between smoking or nicotine on macrophage function and the intestinal microvasculature. Several genes are involved in the pathogenesis of CD, and in this study the gene expression differences of the descending colonic mucosa were investigated in CD (smokers or never smokers) and controls (smokers or never smokers). Aim: To identify any difference in gene expression of the descending colonic mucosa between smoking and never-smoking CD patients (and controls) by determining genetic expression profiles from microarray analysis. Methods: Fifty-seven specimens were obtained by routine colonoscopy from the included material: CD smokers (n = 28) or never-smokers (n = 14) as compared to fifteen healthy controls (8 smokers and 7 never-smokers). RNA was isolated and gene expression assessed with Affymetrix GeneChip Human Genome U133 Plus 2.0. Data were analyzed by principal component analysis (PCA), Wilcoxon rank sum test and multiple linear regressions. Real-time (RT) PCR was subsequently applied to verify microarray results. Results: The PCA analysis showed no intrinsic clustering of smokers versus never-smokers. However, when Wilcoxon rank sum test corrected with Q values were performed, six known genes were significantly expressed differently in the inflamed CD smokers as compared to the inflamed CD never-smokers: ring finger protein 138 (RNF138), metalothionein 2A (MT2A) and six transmembrane epithelial antigen of the prostate 3 (STEAP3), SA hypertension-associated homolog, PGM2L1 and KCNJ2. The subsequent RT-PCR-analyses verified, however, that only RNF138, MT2A and STEAP3 were significantly upregulated in CD smokers in specimens with inflammatory activity of the descending colon. Conclusions: The present study demonstrates that the genes, RNF138, MT2A, and STEAP3 are differently expressed in the inflamed descending colon of smoking versus never-smoking CD patients, which might be of relevance for the poorer clinical course among CD smokers. Many gastroenterologists are still not totally aware of the benefits of smoking cessation in relation to CD, and do not put much effort into getting the patients to quit, therefore more information on the negative effects of smoking, seems warranted.			Nielsen, OH (corresponding author), Univ Copenhagen, Dept Gastroenterol, Med Sect, Herlev Hosp, Copenhagen, Denmark.	ohn@dadlnet.dk	Nielsen, Finn Cilius/AAA-4926-2020; Nielsen, Ole Haagen/AAK-2482-2021; Olsen, Jørgen/K-5355-2019	Nielsen, Ole Haagen/0000-0003-4612-8635; Olsen, Jørgen/0000-0003-1974-6446; Nielsen, Finn Cilius/0000-0002-9829-1031; Bjerrum, Jacob/0000-0002-6249-3889				Aldhous MC, 2008, INFLAMM BOWEL DIS, V14, P1469, DOI 10.1002/ibd.20523; Amoruso A, 2007, LIFE SCI, V81, P906, DOI 10.1016/j.lfs.2007.07.017; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Bentley E, 2002, J CLIN PATHOL, V55, P955, DOI 10.1136/jcp.55.12.955; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Blokzijl H, 2008, J BIOL CHEM, V283, P35630, DOI 10.1074/jbc.M804374200; Bridger S, 2002, GUT, V51, P21, DOI 10.1136/gut.51.1.21; CALKINS BM, 1989, DIGEST DIS SCI, V34, P1841, DOI 10.1007/BF01536701; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Cosnes J, 2004, BEST PRACT RES CL GA, V18, P481, DOI 10.1016/j.bpg.2003.12.003; Cosnes J, 2004, CLIN GASTROENTEROL H, V2, P41, DOI 10.1016/S1542-3565(03)00290-8; Csillag C, 2005, SCAND J GASTROENTERO, V40, P369, DOI 10.1080/00365520510012226; Csillag C, 2007, SCAND J GASTROENTERO, V42, P834, DOI 10.1080/00365520601127166; Csillag C, 2007, SCAND J GASTROENTERO, V42, P454, DOI 10.1080/00365520600976266; Csillag C, 2007, AM J PHYSIOL-GASTR L, V292, pG298, DOI 10.1152/ajpgi.00321.2006; Cui YP, 2003, BIOCHEM BIOPH RES CO, V302, P904, DOI 10.1016/S0006-291X(03)00122-0; Genser D, 1999, EUR J CLIN NUTR, V53, P675, DOI 10.1038/sj.ejcn.1600764; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Halliwell B., 2006, CIGARETTE SMOKE OXID; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Hatoum OA, 2003, GASTROENTEROLOGY, V125, P58, DOI 10.1016/S0016-5085(03)00699-1; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson GJ, 2005, ALIMENT PHARM THER, V21, P921, DOI 10.1111/j.1365-2036.2005.02424.x; Karban A, 2007, WORLD J GASTROENTERO, V13, P2150, DOI 10.3748/wjg.v13.i15.2150; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lewis CM, 2007, J MED GENET, V44, P689, DOI 10.1136/jmg.2007.051672; Mahid SS, 2007, DIGEST DIS SCI, V52, P2897, DOI 10.1007/s10620-006-9624-0; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; McGilligan VE, 2007, INFLAMM BOWEL DIS, V13, P108, DOI 10.1002/ibd.20020; McKie AT, 2005, NAT GENET, V37, P1159, DOI 10.1038/ng1105-1159; MUNKHOLM P, 1992, SCAND J GASTROENTERO, V27, P609, DOI 10.3109/00365529209000127; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reinecke F, 2006, BIOCHEM J, V395, P405, DOI 10.1042/BJ20051253; Ronco AM, 2006, TOXICOLOGY, V223, P46, DOI 10.1016/j.tox.2006.03.002; Russel MGVM, 1998, INFLAMM BOWEL DIS, V4, P182, DOI 10.1097/00054725-199808000-00002; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Telerman A, 2009, NAT REV CANCER, V9, P206, DOI 10.1038/nrc2589; Thomas GAO, 2005, NAT CLIN PRACT GASTR, V2, P536, DOI 10.1038/ncpgasthep0316; THOMAS GAO, 1995, J ROY COLL PHYS LOND, V29, P392; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; WAKEFIELD AJ, 1989, LANCET, V2, P1057; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang L, 2007, BIOCONJUGATE CHEM, V18, P610, DOI 10.1021/bc060365u; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; Yamamoto T, 2005, WORLD J GASTROENTERO, V11, P3971, DOI 10.3748/wjg.v11.i26.3971; Yang F, 2007, PROTEIN EXPRES PURIF, V53, P186, DOI 10.1016/j.pep.2006.12.007	49	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6210	10.1371/journal.pone.0006210	http://dx.doi.org/10.1371/journal.pone.0006210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603079	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035700003
J	Khalil, A; Jauniaux, E; Cooper, D; Harrington, K				Khalil, Asma; Jauniaux, Eric; Cooper, Derek; Harrington, Kevin			Pulse Wave Analysis in Normal Pregnancy: A Prospective Longitudinal Study	PLOS ONE			English	Article							CENTRAL ARTERIAL-PRESSURE; AUGMENTATION INDEX; HYPERTENSIVE DISORDERS; AORTIC PRESSURE; STIFFNESS; REFLECTIONS; FORM	Background: Outside pregnancy, arterial pulse wave analysis provides valuable information in hypertension and vascular disease. Studies in pregnancy using this technique show that vascular stiffness is raised in women with established pre-eclampsia. We aimed to establish normal ranges for parameters of pulse wave analysis in normal pregnancy and to compare different ethnic groups. Methodology/Principal Findings: This prospective study was conducted at The Homerton University Hospital, London between January 2006 and March 2007. Using applanation tonometry, the radial artery pulse waveform was recorded and the aortic waveform derived. Augmentation pressure (AP) and Augmentation Index at heart rate 75/min (AIx-75), measures of arterial stiffness, were calculated. We recruited 665 women with singleton pregnancies. Women who developed pre-eclampsia (n = 24, 3.6%) or gestational hypertension (n = 36, 5.4%) were excluded. We also excluded 47 women with other pregnancy complications or incomplete follow-up, leaving 541 healthy normotensive pregnant women for subsequent analysis. In the overall group of 541 women, there were no significant changes in AP or AIx-75 as pregnancy progressed. In 45 women followed longitudinally, AP and AIx-75 fell significantly from the first to the second trimester, then rose again in the third (P<0.001). The two main ethnic groups represented were Caucasian (n = 229) and Afrocaribbean (n = 216). There were no significant differences in AP or AIx-75 in any trimester between these two ethnic groups. Conclusions: This study is the largest to date of pulse wave analysis in normal pregnancy, the first to report on a subset of women studied longitudinally, and the first to investigate the effect of ethnicity. These data provide the foundation for further investigation into the potential role of this technique in vascular disorders in pregnancy.			Khalil, A (corresponding author), Univ London, Univ London Queen Mary & Westfield Coll, Homerton Univ Hosp NHS Trust, London E1 4NS, England.	asmakhalil79@googlemail.com	Khall, Asma/AAC-1459-2020	Khall, Asma/0000-0003-2802-7670				Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chen CH, 1997, CIRCULATION, V95, P1827; Covic A, 2000, KIDNEY INT, V57, P2634, DOI 10.1046/j.1523-1755.2000.00124.x; Elvan-Taspinar A, 2005, AM J HYPERTENS, V18, P337, DOI 10.1016/j.amjhyper.2004.10.020; Elvan-Taspinar A, 2004, AM J HYPERTENS, V17, P941, DOI 10.1016/j.amjhyper.2004.05.018; IZZO OL, 2005, AM J HYPERTENS S 2, V18, pS1, DOI DOI 10.1016/j.amjhyper.2004.10.008; KARAMANOGLU M, 1993, EUR HEART J, V14, P160, DOI 10.1093/eurheartj/14.2.160; Kelly R, 1989, J VASC MED BIOL, V3, P142; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; Macedo ML, 2008, HYPERTENSION, V51, P1047, DOI 10.1161/HYPERTENSIONAHA.107.106062; Nichols W, 1998, MCDONALDS BLOOD FLOW; Nichols WW, 2005, AM J HYPERTENS, V18, p3S, DOI 10.1016/j.amjhyper.2004.10.009; Nichols WW, 2002, CURR OPIN CARDIOL, V17, P543, DOI 10.1097/00001573-200209000-00016; Nurnberger J, 2002, J HYPERTENS, V20, P2407, DOI 10.1097/00004872-200212000-00020; O'Rourke M, 1994, Blood Press, V3, P33, DOI 10.3109/08037059409101519; O'Rourke M F, 2003, Minerva Med, V94, P229; O'Rourke MF, 2004, BLOOD PRESS MONIT, V9, P179, DOI 10.1097/00126097-200408000-00002; O'Rourke MF, 2004, J HYPERTENS, V22, P431, DOI 10.1097/00004872-200402000-00030; O'Rourke MF, 2003, HYPERTENSION, V42, pE15, DOI 10.1161/01.HYP.0000095611.09419.F2; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; ORourke MF, 1996, J HYPERTENS, V14, pS147; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; Ronnback M, 2005, HYPERTENS PREGNANCY, V24, P171, DOI 10.1081/PRG-200059871; Smith SA, 2004, AM J OBSTET GYNECOL, V190, P472, DOI 10.1016/j.ajog.2003.08.028; Spasojevic M, 2005, BJOG-INT J OBSTET GY, V112, P1475, DOI 10.1111/j.1471-0528.2005.00701.x; Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3; Wilkinson IB, 2000, J PHYSIOL-LONDON, V525, P263, DOI 10.1111/j.1469-7793.2000.t01-1-00263.x	27	70	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6134	10.1371/journal.pone.0006134	http://dx.doi.org/10.1371/journal.pone.0006134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578538	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000267806300006
J	Tomasi, D; Volkow, ND; Wang, RL; Telang, F; Wang, GJ; Chang, L; Ernst, T; Fowler, JS				Tomasi, Dardo; Volkow, Nora D.; Wang, Ruiliang; Telang, Frank; Wang, Gene-Jack; Chang, Linda; Ernst, Thomas; Fowler, Joanna S.			Dopamine Transporters in Striatum Correlate with Deactivation in the Default Mode Network during Visuospatial Attention	PLOS ONE			English	Article								Background: Dopamine and dopamine transporters (DAT, which regulate extracellular dopamine in the brain) are implicated in the modulation of attention but their specific roles are not well understood. Here we hypothesized that dopamine modulates attention by facilitation of brain deactivation in the default mode network (DMN). Thus, higher striatal DAT levels, which would result in an enhanced clearance of dopamine and hence weaker dopamine signals, would be associated to lower deactivation in the DMN during an attention task. Methodology/Principal Findings: For this purpose we assessed the relationship between DAT in striatum (measured with positron emission tomography and [C-11] cocaine used as DAT radiotracer) and brain activation and deactivation during a parametric visual attention task (measured with blood oxygenation level dependent functional magnetic resonance imaging) in healthy controls. We show that DAT availability in caudate and putamen had a negative correlation with deactivation in ventral parietal regions of the DMN (precuneus, BA 7) and a positive correlation with deactivation in a small region in the ventral anterior cingulate gyrus (BA 24/32). With increasing attentional load, DAT in caudate showed a negative correlation with load-related deactivation increases in precuneus. Conclusions/Significance: These findings provide evidence that dopamine transporters modulate neural activity in the DMN and anterior cingulate gyrus during visuospatial attention. Our findings suggest that dopamine modulates attention in part by regulating neuronal activity in posterior parietal cortex including precuneus (region involved in alertness) and cingulate gyrus (region deactivated in proportion to emotional interference). These findings suggest that the beneficial effects of stimulant medications (increase dopamine by blocking DAT) in inattention reflect in part their ability to facilitate the deactivation of the DMN.			Tomasi, D (corresponding author), NIAAA, Bethesda, MD USA.	tomasi@bnl.gov	Tomasi, Dardo/J-2127-2015		NCRR NIH HHS [5-M01-RR-10710, M01 RR010710] Funding Source: Medline; NIAAA NIH HHS [2 R01 AA09481, R01 AA009481] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550, R01AA009481] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adler CM, 2001, SYNAPSE, V42, P266, DOI 10.1002/syn.1112; Arrington CM, 2000, J COGNITIVE NEUROSCI, V12, P106, DOI 10.1162/089892900563975; BERGER B, 1988, J COMP NEUROL, V273, P99, DOI 10.1002/cne.902730109; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Caparelli EC, 2008, BIOMED SIGNAL PROCES, V3, P107, DOI 10.1016/j.bspc.2007.11.003; Caparelli EC, 2003, NEUROIMAGE, V20, P1411, DOI 10.1016/S1053-8119(03)00339-2; Carmona S, 2005, NEUROSCI LETT, V389, P88, DOI 10.1016/j.neulet.2005.07.020; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Chang L, 2006, BRAIN, V129, P1096, DOI 10.1093/brain/awl064; Chang L, 2004, ANN NEUROL, V56, P259, DOI 10.1002/ana.20190; Chang L, 2001, NEUROLOGY, V57, P1001, DOI 10.1212/WNL.57.6.1001; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; CULHAM JC, 1997, INVEST OPHTH VIS SCI, V38, pS1174; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; DREHER J, 2008, P NAT ACAD IN PRESS; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Gainetdinov RR, 1999, BIOL PSYCHIAT, V46, P303, DOI 10.1016/S0006-3223(99)00122-5; Hennig J, 2001, MAGNET RESON MED, V46, P6, DOI 10.1002/mrm.1153; HERRERAMARSCHITZ M, 1989, NEUROSCI LETT, V97, P266, DOI 10.1016/0304-3940(89)90608-3; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Janssen MJ, 2009, J NEUROSCI, V29, P5116, DOI 10.1523/JNEUROSCI.4737-08.2009; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Kiyatkin EA, 1996, J NEUROPHYSIOL, V75, P142, DOI 10.1152/jn.1996.75.1.142; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Landau SM, 2009, CEREB CORTEX, V19, P445, DOI 10.1093/cercor/bhn095; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; LEE JH, 1995, MAGN RESON MED, V34, P308, DOI 10.1002/mrm.1910340305; Leonards U, 2000, J COGNITIVE NEUROSCI, V12, P61, DOI 10.1162/089892900564073; LEWIS MS, 1979, BRAIN RES, V164, P328, DOI 10.1016/0006-8993(79)90031-3; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Nagahama Y, 1999, NEUROIMAGE, V10, P193, DOI 10.1006/nimg.1999.0451; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; ROLLS ET, 1984, NEUROSCIENCE, V12, P1201, DOI 10.1016/0306-4522(84)90014-9; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Siessmeier T, 2006, EUR J NEUROSCI, V24, P305, DOI 10.1111/j.1460-9568.2006.04903.x; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P683, DOI 10.1073/pnas.98.2.683; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P688, DOI 10.1073/pnas.98.2.688; Solanto MV, 1998, BEHAV BRAIN RES, V94, P127, DOI 10.1016/S0166-4328(97)00175-7; Swanson JM, 2002, BEHAV BRAIN RES, V130, P73, DOI 10.1016/S0166-4328(01)00433-8; Tomasi D, 2008, NEUROSCIENCE, V151, P1006, DOI 10.1016/j.neuroscience.2007.08.040; Tomasi D, 2007, BRAIN RES, V1171, P83, DOI 10.1016/j.brainres.2007.06.102; Tomasi D, 2007, BRAIN RES, V1132, P158, DOI 10.1016/j.brainres.2006.11.030; Tomasi D, 2004, NEUROIMAGE, V23, P1414, DOI 10.1016/j.neuroimage.2004.07.065; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Tomasi D, 2005, NEUROIMAGE, V27, P377, DOI 10.1016/j.neuroimage.2005.04.010; Tomasi D, 2007, PSYCHIAT RES-NEUROIM, V155, P189, DOI 10.1016/j.pscychresns.2007.03.002; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Tomasi DG, 2007, J MAGN RESON IMAGING, V26, P1340, DOI 10.1002/jmri.21143; Tomasi DG, 2007, J CEREBR BLOOD F MET, V27, P33, DOI 10.1038/sj.jcbfm.9600314; VOLKOW ND, 1995, J NUCL MED, V36, P2162; Volkow ND, 2002, EUR NEUROPSYCHOPHARM, V12, P557, DOI 10.1016/S0924-977X(02)00104-9; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Volkow ND, 2007, NEUROIMAGE, V34, P1182, DOI 10.1016/j.neuroimage.2006.10.014; Volkow ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002017; Wong AC, 1999, NEUROSCIENCE, V89, P221, DOI 10.1016/S0306-4522(98)00284-X; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	75	110	110	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6102	10.1371/journal.pone.0006102	http://dx.doi.org/10.1371/journal.pone.0006102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564918	gold, Green Published, Green Submitted			2022-12-27	WOS:000267515700016
J	Le, T; Chiarella, J; Simen, BB; Hanczaruk, B; Egholm, M; Landry, ML; Dieckhaus, K; Rosen, MI; Kozal, MJ				Le, Thuy; Chiarella, Jennifer; Simen, Birgitte B.; Hanczaruk, Bozena; Egholm, Michael; Landry, Marie L.; Dieckhaus, Kevin; Rosen, Marc I.; Kozal, Michael J.			Low-Abundance HIV Drug-Resistant Viral Variants in Treatment-Experienced Persons Correlate with Historical Antiretroviral Use	PLOS ONE			English	Article								Background: It is largely unknown how frequently low-abundance HIV drug-resistant variants at levels under limit of detection of conventional genotyping (< 20% of quasi-species) are present in antiretroviral-experienced persons experiencing virologic failure. Further, the clinical implications of low-abundance drug-resistant variants at time of virologic failure are unknown. Methodology/Principal Findings: Plasma samples from 22 antiretroviral-experienced subjects collected at time of virologic failure (viral load 1380 to 304,000 copies/mL) were obtained from a specimen bank (from 2004-2007). The prevalence and profile of drug-resistant mutations were determined using Sanger sequencing and ultra-deep pyrosequencing. Genotypes were interpreted using Stanford HIV database algorithm. Antiretroviral treatment histories were obtained by chart review and correlated with drug-resistant mutations. Low-abundance drug-resistant mutations were detected in all 22 subjects by deep sequencing and only in 3 subjects by Sanger sequencing. In total they accounted for 90 of 247 mutations (36%) detected by deep sequencing; the majority of these (95%) were not detected by standard genotyping. A mean of 4 additional mutations per subject were detected by deep sequencing (p < 0.0001, 95% Cl: 2.85-5.53). The additional low-abundance drug-resistant mutations increased a subject's genotypic resistance to one or more antiretrovirals in 17 of 22 subjects (77%). When correlated with subjects' antiretroviral treatment histories, the additional low-abundance drug-resistant mutations correlated with the failing antiretroviral drugs in 21% subjects and correlated with historical antiretroviral use in 79% subjects (OR, 13.73; 95% Cl, 2.5-74.3, p = 0.0016). Conclusions/Significance: Low-abundance HIV drug-resistant mutations in antiretroviral-experienced subjects at time of virologic failure can increase a subject's overall burden of resistance, yet commonly go unrecognized by conventional genotyping. The majority of unrecognized resistant mutations correlate with historical antiretroviral use. Ultra-deep sequencing can provide important historical resistance information for clinicians when planning subsequent antiretroviral regimens for highly treatment-experienced patients, particularly when their prior treatment histories and longitudinal genotypes are not available.			Le, T (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	Thuy.Le@yale.edu	Simen, Birgitte/A-3574-2010	Simen, Birgitte/0000-0003-0503-0973; , Michael/0000-0002-7719-7396; Kozal, Michael/0000-0002-3100-8254	NATIONAL INSTITUTE ON DRUG ABUSE [K02DA017277] Funding Source: NIH RePORTER; NIDA NIH HHS [K02 DA017277] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Devereux HL, 2001, J MED VIROL, V65, P218, DOI 10.1002/jmv.2023; Dykes C, 2004, J INFECT DIS, V189, P1091, DOI 10.1086/382033; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Hanna GJ, 2000, J INFECT DIS, V181, P904, DOI 10.1086/315329; Harrigan PR, 2005, J INFECT DIS, V191, P1325, DOI 10.1086/428852; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kapoor A, 2004, J VIROL, V78, P7112, DOI 10.1128/JVI.78.13.7112-7123.2004; Korn K, 2003, J CLIN MICROBIOL, V41, P3559, DOI 10.1128/JCM.41.8.3559-3565.2003; Kozal Michael J, 2006, MedGenMed, V8, P72; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; Kuritzkes DR, 2001, P NATL ACAD SCI USA, V98, P13485, DOI 10.1073/pnas.251559398; Lalonde MS, 2007, J CLIN MICROBIOL, V45, P2604, DOI 10.1128/JCM.00431-07; Lecossier D, 2005, JAIDS-J ACQ IMM DEF, V38, P37, DOI 10.1097/00126334-200501010-00007; Marcelin AG, 2004, J MED VIROL, V72, P162, DOI 10.1002/jmv.10550; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; PAREDES R, 2008, 15 C RETR OPP INF BO; Paredes R, 2009, J VIROL, V83, P2038, DOI 10.1128/JVI.02154-08; Roquebert B, 2006, AIDS, V20, P287, DOI 10.1097/01.aids.0000202650.03279.69; Rosen MI, 2007, AIDS PATIENT CARE ST, V21, P30, DOI 10.1089/apc.2006.0028; Schuurman R, 2002, AIDS RES HUM RETROV, V18, P243, DOI 10.1089/088922202753472801; Shafer RW, 1997, J CLIN MICROBIOL, V35, P520, DOI 10.1128/JCM.35.2.520-522.1997; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Stenman J, 2003, BIOTECHNIQUES, V34, P172, DOI 10.2144/03341dd05; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Yerly S, 2008, ANTIVIR THER, V13, pA110; ZACCARELLI M, 2008, 6 EUR HIV DRUG RES W	35	102	105	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6079	10.1371/journal.pone.0006079	http://dx.doi.org/10.1371/journal.pone.0006079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562031	Green Submitted, gold, Green Published			2022-12-27	WOS:000267465900013
J	Zhao, HJ; Ma, ZM; Tibshirani, R; Higgins, JPT; Ljungberg, B; Brooks, JD				Zhao, Hongjuan; Ma, Zongming; Tibshirani, Robert; Higgins, John P. T.; Ljungberg, Borje; Brooks, James D.			Alteration of Gene Expression Signatures of Cortical Differentiation and Wound Response in Lethal Clear Cell Renal Cell Carcinomas	PLOS ONE			English	Article								Clear cell renal cell carcinoma (ccRCC) is the most common malignancy of the adult kidney and displays heterogeneity in clinical outcomes. Through comprehensive gene expression profiling, we have identified previously a set of transcripts that predict survival following nephrectomy independent of tumor stage, grade, and performance status. These transcripts, designated as the SPC (supervised principal components) gene set, show no apparent biological or genetic features that provide insight into renal carcinogenesis or tumor progression. We explored the relationship of this gene list to a set of genes expressed in different anatomical segments of the normal kidney including the cortex (cortex gene set) and the glomerulus (glomerulus gene set), and a gene set expressed after serum stimulation of quiescent fibroblasts (the core serum response or CSR gene set). Interestingly, the normal cortex, glomerulus (part of the normal renal cortex), and CSR gene sets captured more than 1/5 of the genes in the highly prognostic SPC gene set. Based on gene expression patterns alone, the SPC gene set could be used to sort samples from normal adult kidneys by the anatomical regions from which they were dissected. Tumors whose gene expression profiles most resembled the normal renal cortex or glomerulus showed better survival than those that did not, and those with expression features more similar to CSR showed poorer survival. While the cortex, glomerulus, and CSR signatures predicted survival independent of traditional clinical parameters, they were not independent of the SPC gene list. Our findings suggest that critical biological features of lethal ccRCC include loss of normal cortical differentiation and activation of programs associated with wound healing.			Zhao, HJ (corresponding author), Stanford Univ, Dept Neurol, Stanford, CA 94305 USA.	jdbrooks@stanford.edu		Ljungberg, Borje/0000-0002-4121-3753	NCI NIH HHS [K01 CA123532, CA123532, CA111782, R01 CA111782, K01 CA123532-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA123532, R01CA111782] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bates RC, 2005, CANCER BIOL THER, V4, P365; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; De Mulder PHM, 2007, ANN ONCOL, V18, P98, DOI 10.1093/annonc/mdm303; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Galfano A, 2008, UROL INT, V80, P113, DOI 10.1159/000112599; Higgins JPT, 2004, MOL BIOL CELL, V15, P649, DOI 10.1091/mbc.E03-06-0432; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Katoh M, 2005, INT J ONCOL, V27, P1677; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Mancini V, 2008, UROL ONCOL-SEMIN ORI, V26, P225, DOI 10.1016/j.urolonc.2007.05.017; OBERLING C, 1960, NATURE, V186, P402, DOI 10.1038/186402a0; Riss J, 2006, CANCER RES, V66, P7216, DOI 10.1158/0008-5472.CAN-06-0040; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Tannenbaum M, 1971, Pathol Annu, V6, P249; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	23	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6039	10.1371/journal.pone.0006039	http://dx.doi.org/10.1371/journal.pone.0006039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557179	Green Published, gold, Green Submitted			2022-12-27	WOS:000267356900003
J	Hawn, TR; Scholes, D; Li, SYS; Wang, HW; Yang, Y; Roberts, PL; Stapleton, AE; Janer, M; Aderem, A; Stamm, WE; Zhao, LP; Hooton, TM				Hawn, Thomas R.; Scholes, Delia; Li, Shuying S.; Wang, Hongwei; Yang, Yin; Roberts, Pacita L.; Stapleton, Ann E.; Janer, Marta; Aderem, Alan; Stamm, Walter E.; Zhao, Lue Ping; Hooton, Thomas M.			Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women	PLOS ONE			English	Article								Background: Although behavioral risk factors are strongly associated with urinary tract infection (UTI) risk, the role of genetics in acquiring this disease is poorly understood. Methodology/Principal Findings: To test the hypothesis that polymorphisms in Toll-like receptor (TLR) pathway genes are associated with susceptibility to UTIs, we conducted a population-based case-control study of women ages 18-49 years. We examined DNA variants in 9 TLR pathway genes in 431 recurrent cystitis (rUTI) cases, 400 pyelonephritis cases, and 430 controls with no history of UTIs. In the Caucasian subgroup of 987 women, polymorphism TLR4_A896G was associated with protection from rUTI, but not pyelonephritis, with an odds ratio (OR) of 0.54 and a 95% confidence interval (CI) of 0.31 to 0.96. Polymorphism TLR5_C1174T, which encodes a variant that abrogates flagellin-induced signaling, was associated with an increased risk of rUTI (OR(95% CI): 1.81 (1.00-3.08)), but not pyelonephritis. Polymorphism TLR1_G1805T was associated with protection from pyelonephritis (OR(95% CI): 0.53 (0.29-0.96)). Conclusions: These results provide the first evidence of associations of TLR5 and TLR1 variants with altered risks of acquiring rUTI and pyelonephritis, respectively. Although these data suggest that TLR polymorphisms are associated with adult susceptibility to UTIs, the statistical significance was modest and will require further study including validation with independent cohorts.			Hawn, TR (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	thawn@u.washington.edu	Stapleton, Ann E/N-2428-2015	Stapleton, Ann E/0000-0003-0130-8659	NIDDK NIH HHS [R01 DK070906, 1 PO1 DK53369-06, R01 DK062863, P01 DK053369] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053369, R01DK062863, R01DK070906] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Artifoni L, 2007, J UROLOGY, V177, P1102, DOI 10.1016/j.juro.2006.10.037; Backhed F, 2001, CELL MICROBIOL, V3, P153, DOI 10.1046/j.1462-5822.2001.00101.x; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HAGBERG L, 1985, J IMMUNOL, V134, P4118; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P2487, DOI 10.1073/pnas.0409831102; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hedlund M, 2001, MOL MICROBIOL, V39, P542, DOI 10.1046/j.1365-2958.2001.02205.x; HOOTEN TM, 1994, CLIN INFECT DIS, V19, P274, DOI 10.1093/clinids/19.2.274; Hooton TM, 1996, NEW ENGL J MED, V335, P468, DOI 10.1056/NEJM199608153350703; Hopkins WJ, 1999, AM J MED GENET, V83, P422, DOI 10.1002/(SICI)1096-8628(19990423)83:5<422::AID-AJMG16>3.0.CO;2-1; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798, DOI 10.1128/IAI.66.6.2798-2802.1998; Ikaheimo R, 1996, CLIN INFECT DIS, V22, P91, DOI 10.1093/clinids/22.1.91; Ishitoya S, 2002, BJU INT, V89, P851, DOI 10.1046/j.1464-410X.2002.02782.x; Jerde TJ, 2000, UROL RES, V28, P269, DOI 10.1007/s002400000114; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Karoly E, 2007, PEDIATR RES, V61, P371, DOI 10.1203/pdr.0b013e318030d1f4; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; KINANE DF, 1982, BRIT MED J, V285, P7, DOI 10.1136/bmj.285.6334.7; Liu ZQ, 2005, GENET EPIDEMIOL, V29, P353, DOI 10.1002/gepi.20092; LOMBERG H, 1983, NEW ENGL J MED, V308, P1189, DOI 10.1056/NEJM198305193082003; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Ragnarsdottir B, 2007, J INFECT DIS, V196, P475, DOI 10.1086/518893; Samuelsson P, 2004, INFECT IMMUN, V72, P3179, DOI 10.1128/IAI.72.6.3179-3186.2004; Schilling JD, 2003, INFECT IMMUN, V71, P1470, DOI 10.1128/IAI.71.3.1470-1480.2003; Scholes D, 2000, J INFECT DIS, V182, P1177, DOI 10.1086/315827; Scholes D, 2005, ANN INTERN MED, V142, P20, DOI 10.7326/0003-4819-142-1-200501040-00008; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; SHEINFELD J, 1989, NEW ENGL J MED, V320, P773, DOI 10.1056/NEJM198903233201205; Smithson A, 2005, CLIN DIAGN LAB IMMUN, V12, P1358, DOI 10.1128/CDLI.12.12.1358-1363.2005; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Stein PC, 1996, J UROLOGY, V155, P1133, DOI 10.1016/S0022-5347(01)66406-1; Storm Niels, 2003, Methods Mol Biol, V212, P241; Svanborg C, 2006, CURR OPIN MICROBIOL, V9, P33, DOI 10.1016/j.mib.2005.12.012; Tabel Y, 2007, INT J IMMUNOGENET, V34, P399, DOI 10.1111/j.1744-313X.2007.00709.x; TOMISAWA S, 1989, SCAND J INFECT DIS, V21, P403, DOI 10.3109/00365548909167444; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhao LP, 2003, AM J HUM GENET, V72, P1231, DOI 10.1086/375140	57	148	156	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5990	10.1371/journal.pone.0005990	http://dx.doi.org/10.1371/journal.pone.0005990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543401	Green Published, Green Submitted, gold			2022-12-27	WOS:000267237600007
J	Ding, XD; Goldberg, MS				Ding, Xiaodong; Goldberg, Matthew S.			Regulation of LRRK2 Stability by the E3 Ubiquitin Ligase CHIP	PLOS ONE			English	Article								Dominantly inherited mutations in the leucine-rich repeat kinase 2 gene (LRRK2) are the most common cause of familial Parkinson's disease (PD) and have also been identified in individuals with sporadic PD. Although the exact cellular function of LRRK2 remains unknown, most PD-linked mutations appear to be toxic to cells in culture via mechanisms that depend on the kinase activity of LRRK2 or on the formation of cytoplasmic inclusions. Here we show that the E3 ubiquitin ligase CHIP physically associates with LRRK2 and regulates the cellular abundance of LRRK2. We further show that LRRK2 forms a complex with overexpressed and endogenous CHIP and Hsp90. Our data indicates that the destabilization of LRRK2 by CHIP is due to ubiquitination and proteasome-dependent degradation. Hsp90 can attenuate CHIP-mediated degradation and this can be blocked by the Hsp90 inhibitor geldanamycin. These findings provide important insight into the cellular regulation of LRRK2 stability and may lead to the development of therapeutics to treat PD based on controlling LRRK2 stability.			Ding, XD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.	matthew.goldberg@utsouthwestern.edu	Goldberg, Matthew/T-7827-2019	Goldberg, Matthew/0000-0002-5172-9841				Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Beal MF, 2003, ANN NY ACAD SCI, V991, P120; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Chiosis G, 2004, DRUG DISCOV TODAY, V9, P881, DOI 10.1016/S1359-6446(04)03245-3; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Ding Xiaodong, 2007, Methods Mol Biol, V354, P85; Giasson BI, 2008, NEUROSIGNALS, V16, P99, DOI 10.1159/000109764; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; HAN BS, 2008, NEUROSCI LETT; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Klein C, 2007, CURR OPIN NEUROL, V20, P453, DOI 10.1097/WCO.0b013e3281e6692b; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; Lesage S, 2007, PATHOL BIOL, V55, P107, DOI 10.1016/j.patbio.2006.06.001; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Mata I.F., 2006, TRENDS NEUROSCI; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Moore Darren J, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS92, DOI 10.1016/j.parkreldis.2008.04.010; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	51	72	76	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5949	10.1371/journal.pone.0005949	http://dx.doi.org/10.1371/journal.pone.0005949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536328	Green Submitted, Green Published, gold			2022-12-27	WOS:000267029700019
J	Vader, D; Kabla, A; Weitz, D; Mahadevan, L				Vader, David; Kabla, Alexandre; Weitz, David; Mahadevan, Lakshminarayana			Strain-Induced Alignment in Collagen Gels	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; I COLLAGEN; EXTRACELLULAR-MATRIX; CONFINED COMPRESSION; EQUIVALENTS; MOLECULES; MIGRATION; RHEOLOGY; TISSUES; DESIGN	Collagen is the most abundant extracellular-network-forming protein in animal biology and is important in both natural and artificial tissues, where it serves as a material of great mechanical versatility. This versatility arises from its almost unique ability to remodel under applied loads into anisotropic and inhomogeneous structures. To explore the origins of this property, we develop a set of analysis tools and a novel experimental setup that probes the mechanical response of fibrous networks in a geometry that mimics a typical deformation profile imposed by cells in vivo. We observe strong fiber alignment and densification as a function of applied strain for both uncrosslinked and crosslinked collagenous networks. This alignment is found to be irreversibly imprinted in uncrosslinked collagen networks, suggesting a simple mechanism for tissue organization at the microscale. However, crosslinked networks display similar fiber alignment and the same geometrical properties as uncrosslinked gels, but with full reversibility. Plasticity is therefore not required to align fibers. On the contrary, our data show that this effect is part of the fundamental non-linear properties of fibrous biological networks.			Vader, D (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	lm@seas.harvard.edu	Kabla, Alexandre/AAF-3993-2019	Kabla, Alexandre/0000-0002-0280-3531	NATIONAL CANCER INSTITUTE [R01CA085139] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barocas VH, 1998, J BIOMECH ENG-T ASME, V120, P660, DOI 10.1115/1.2834759; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Billiar KL, 1997, J BIOMECH, V30, P753, DOI 10.1016/S0021-9290(97)00019-5; Bozec L, 2005, BIOPHYS J, V88, P4223, DOI 10.1529/biophysj.104.055228; Brightman AO, 2000, BIOPOLYMERS, V54, P222; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Chandran PL, 2004, J BIOMECH ENG-T ASME, V126, P152, DOI 10.1115/1.1688774; Cheng T, 2007, J BIOMECH ENG-T ASME, V129, P913, DOI 10.1115/1.2800837; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0; Girton TS, 2002, J BIOMECH ENG-T ASME, V124, P568, DOI 10.1115/1.1504099; Gov N, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.228101; Gunzer M, 1997, ADV EXP MED BIOL, V417, P97; Guo C, 2007, BIOMATERIALS, V28, P1105, DOI 10.1016/j.biomaterials.2006.10.010; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Head DA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108102; Heussinger C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.105501; Ivancic PC, 2007, SPINE J, V7, P659, DOI 10.1016/j.spinee.2006.10.014; Janmey PA, 2007, METHOD CELL BIOL, V83, P3, DOI 10.1016/S0091-679X(07)83001-9; Kabla A, 2007, J R SOC INTERFACE, V4, P99, DOI 10.1098/rsif.2006.0151; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009; Knapp DM, 1997, J RHEOL, V41, P971, DOI 10.1122/1.550817; Krishnan L, 2004, TISSUE ENG, V10, P241, DOI 10.1089/107632704322791880; Lazar T., 2003, ANN BOT-LONDON, V91, P750, DOI DOI 10.1093/AOB/MCG079; Lee P, 2006, BIOMED MICRODEVICES, V8, P35, DOI 10.1007/s10544-006-6380-z; Lee T, 1997, J MATER SCI, V32, P2397, DOI 10.1023/A:1018557107786; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102; Ozerdem B, 1995, J BIOMECH ENG-T ASME, V117, P397, DOI 10.1115/1.2794198; Palsson B. O., 2003, TISSUE ENG; Parsons JW, 2002, J BIOMECH ENG-T ASME, V124, P145, DOI 10.1115/1.1448822; Persikov AV, 2002, P NATL ACAD SCI USA, V99, P1101, DOI 10.1073/pnas.042707899; Pizzo AM, 2005, J APPL PHYSIOL, V98, P1909, DOI 10.1152/japplphysiol.01137.2004; Raub CB, 2007, BIOPHYS J, V92, P2212, DOI 10.1529/biophysj.106.097998; Roeder BA, 2004, J BIOMECH ENG-T ASME, V126, P699, DOI 10.1115/1.1824127; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671; Shadwick RE, 1999, J EXP BIOL, V202, P3305; Shah JV, 1997, RHEOL ACTA, V36, P262, DOI 10.1007/BF00366667; Star A, 2006, P NATL ACAD SCI USA, V103, P921, DOI 10.1073/pnas.0504146103; STOPAK D, 1985, P NATL ACAD SCI USA, V82, P2804, DOI 10.1073/pnas.82.9.2804; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Tower TT, 2002, ANN BIOMED ENG, V30, P1221, DOI 10.1114/1.1527047; Tranquillo RT, 1999, BIOCHEM SOC SYMP, V65, P27; Velegol D, 2001, BIOPHYS J, V81, P1786, DOI 10.1016/S0006-3495(01)75829-8; Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029; Wilhelm J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108103; Wille JJ, 2006, ANN BIOMED ENG, V34, P1678, DOI 10.1007/s10439-006-9153-1; Wyart M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.215501	51	273	277	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5902	10.1371/journal.pone.0005902	http://dx.doi.org/10.1371/journal.pone.0005902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529768	Green Published, gold			2022-12-27	WOS:000267029500003
J	Mayburd, AL				Mayburd, Anatoly L.			Expression Variation: Its Relevance to Emergence of Chronic Disease and to Therapy	PLOS ONE			English	Article								Background: Stochastic fluctuations in the protein turnover underlie the random emergence of neural precursor cells from initially homogenous cell population. If stochastic alteration of the levels in signal transduction networks is sufficient to spontaneously alter a phenotype, can it cause a sporadic chronic disease as well - including cancer? Methods: Expression in >80 disease-free tissue environments was measured using Affymetrix microarray platform comprising 54675 probe-sets. Steps were taken to suppress the technical noise inherent to microarray experiment. Next, the integrated expression and expression variability data were aligned with the mechanistic data covering major human chronic diseases. Results: Measured as class average, variability of expression of disease associated genes measured in health was higher than variability of random genes for all chronic pathologies. Anti-cancer FDA approved targets were displaying much higher variability as a class compared to random genes. Same held for magnitude of gene expression. The genes known to participate in multiple chronic disorders demonstrated the highest variability. Disease-related gene categories displayed on average more intricate regulation of biological function vs random reference, were enriched in adaptive and transient functions as well as positive feedback relationships. Conclusions: A possible causative link can be suggested between normal (healthy) state gene expression variation and inception of major human pathologies, including cancer. Study of variability profiles may lead to novel diagnostic methods, therapies and better drug target prioritization. The results of the study suggest the need to advance personalized therapy development.			Mayburd, AL (corresponding author), CPA Global, Alexandria, VA USA.	AMayburd@cpaglobal.com						ADELINE R, 2003, PNAS, V100, P1896; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bassett DE, 1999, NAT GENET, V21, P51, DOI 10.1038/4478; Buckingham JC, 2006, BRIT J PHARMACOL, V147, pS258, DOI 10.1038/sj.bjp.0706456; Caricasole A, 2005, BIOSCIENCE REP, V25, P309, DOI 10.1007/s10540-005-2893-6; COLIN C, 2001, PNAS, V98, P13266; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Farmer A, 2008, BRIT J PSYCHIAT, V192, P351, DOI 10.1192/bjp.bp.107.038380; Glinsky GV, 2004, CLIN CANCER RES, V10, P2272, DOI 10.1158/1078-0432.CCR-03-0522; Hainfeld JF, 2004, PHYS MED BIOL, V49, pN309, DOI 10.1088/0031-9155/49/18/N03; Harris Randall E, 2007, Subcell Biochem, V42, P93; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Kumar S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001189; Lechin F, 2006, NEUROENDOCRINOLOGY, V84, P222, DOI 10.1159/000098005; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Mayburd AL, 2008, BIOINFORMATICS, V24, P389, DOI 10.1093/bioinformatics/btm447; Middleton FA, 2005, AM J MED GENET B, V136B, P12, DOI 10.1002/ajmg.b.30171; Prieto C, 2006, BIOINFORMATICS, V22, P1103, DOI 10.1093/bioinformatics/btl053; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rosmond R, 2004, MED HYPOTHESES, V62, P976, DOI 10.1016/j.mehy.2003.12.030; Schulz KR, 2007, CURR PROTOC IMMUNOL; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Simpson P, 1997, CURR OPIN GENET DEV, V7, P537, DOI 10.1016/S0959-437X(97)80083-4; Singleton A, 2004, HUM MOL GENET, V13, pR123, DOI 10.1093/hmg/ddh093; Stockholm D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000394; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Taylor DL, 2007, METH MOL B, V356, P3; Vaiserman AM, 2008, REJUV RES, V11, P39, DOI 10.1089/rej.2007.0579; Willemse MJ, 2002, BLOOD, V99, P4386, DOI 10.1182/blood.V99.12.4386; Wolf NI, 2005, BRAIN, V128, P743, DOI 10.1093/brain/awh409; Zheng CJ, 2006, PHARMACOL REV, V58, P259, DOI 10.1124/pr.58.2.4	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5921	10.1371/journal.pone.0005921	http://dx.doi.org/10.1371/journal.pone.0005921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526064	Green Submitted, Green Published, gold			2022-12-27	WOS:000267029300012
J	Salerno-Goncalves, R; Sztein, MB				Salerno-Goncalves, Rosangela; Sztein, Marcelo B.			Priming of Salmonella enterica Serovar Typhi-Specific CD8(+) T Cells by Suicide Dendritic Cell Cross-Presentation in Humans	PLOS ONE			English	Article								Background: The emergence of antibiotic-resistant strains of Salmonella enterica serovar Typhi (S. Typhi), the etiologic agent of typhoid fever, has aggravated an already important public health problem and added new urgency to the development of more effective typhoid vaccines. To this end it is critical to better understand the induction of immunity to S. Typhi. CD8(+) T cells are likely to play an important role in host defense against S. Typhi by several effector mechanisms, including killing of infected cells and IFN-gamma secretion. However, how S. Typhi regulates the development of specific CD8(+) responses in humans remains unclear. Recent studies in mice have shown that dendritic cells (DC) can either directly (upon uptake and processing of Salmonella) or indirectly (by bystander mechanisms) elicit Salmonella-specific CD8(+) T cells. Methodology/Principal Findings: We report here that upon infection with live S. Typhi, human DC produced high levels of pro-inflammatory cytokines IL-6, IL-8 and TNF-alpha, but low levels of IL-12 p70 and IFN-gamma. In contrast, DC co-cultured with S. Typhi-infected cells, through suicide cross-presentation, uptake S. Typhi-infected human cells and release high levels of IFN-gamma and IL-12p70, leading to the subsequent presentation of bacterial antigens and triggering the induction of memory T cells, mostly CD3(+)CD8(+)CD45RA(-)CD62L(-) effector/memory T cells. Conclusions/Significance: This study is the first to demonstrate the effect of S. Typhi on human DC maturation and on their ability to prime CD8(+) cells and highlights the significance of these phenomena in eliciting adaptive immunity to S. Typhi.			Salerno-Goncalves, R (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	rmezghan@medicine.umaryland.edu	Salerno-Goncalves, Rosangela/AAW-8922-2020	Salerno-Goncalves, Rosangela/0000-0003-2999-4275	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030028, R01AI036525] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI036525, N01AI30028, R01 AI36525] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Dunstan SJ, 2001, J INFECT DIS, V183, P1156, DOI 10.1086/319289; Grant AJ, 2008, IMMUNOLOGY, V125, P28, DOI 10.1111/j.1365-2567.2008.02814.x; Guermonprez P, 2005, SPRINGER SEMIN IMMUN, V26, P257, DOI 10.1007/s00281-004-0176-0; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Hess J, 1996, J IMMUNOL, V156, P3321; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021; Marriott I, 1999, EUR J IMMUNOL, V29, P1107, DOI 10.1002/(SICI)1521-4141(199904)29:04<1107::AID-IMMU1107>3.0.CO;2-0; Mastroeni P, 1998, INFECT IMMUN, V66, P4767, DOI 10.1128/IAI.66.10.4767-4776.1998; Mitchell DH, 1997, MED J AUSTRALIA, V167, P172, DOI 10.5694/j.1326-5377.1997.tb138827.x; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Pasetti MF, 2003, VACCINE, V21, P401, DOI 10.1016/S0264-410X(02)00472-3; Prost LR, 2007, IMMUNOL REV, V219, P55, DOI 10.1111/j.1600-065X.2007.00557.x; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rovere P, 1998, J IMMUNOL, V161, P4467; Rowe B, 1997, CLIN INFECT DIS, V24, pS106, DOI 10.1093/clinids/24.Supplement_1.S106; Salerno-Goncalves R, 2002, J IMMUNOL, V169, P2196, DOI 10.4049/jimmunol.169.4.2196; Salerno-Goncalves R, 2005, INFECT IMMUN, V73, P3521, DOI 10.1128/IAI.73.6.3521-3530.2005; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Salerno-Goncalves R, 2003, J IMMUNOL, V170, P2734, DOI 10.4049/jimmunol.170.5.2734; Salerno-Goncalves R, 2006, TRENDS MICROBIOL, V14, P536, DOI 10.1016/j.tim.2006.10.004; Schakel K, 1998, EUR J IMMUNOL, V28, P4084, DOI 10.1002/(SICI)1521-4141(199812)28:12<4084::AID-IMMU4084>3.0.CO;2-4; Stoycheva M, 2005, SCAND J INFECT DIS, V37, P11, DOI 10.1080/00365540410026068; Sundquist M, 2004, CELL MICROBIOL, V6, P1, DOI 10.1046/j.1462-5822.2003.00336.x; Svensson M, 2000, INFECT IMMUN, V68, P6311, DOI 10.1128/IAI.68.11.6311-6320.2000; SZTEIN MB, 1994, J INFECT DIS, V170, P1508, DOI 10.1093/infdis/170.6.1508; SZTEIN MB, 1995, J IMMUNOL, V155, P3987; Tacket CO, 2004, J INFECT DIS, V190, P565, DOI 10.1086/421469; Tacket CO, 2000, CLIN IMMUNOL, V97, P146, DOI 10.1006/clim.2000.4924; Wahid R, 2008, MUCOSAL IMMUNOL, V1, P389, DOI 10.1038/mi.2008.30; Wahid R, 2007, VACCINE, V25, P1416, DOI 10.1016/j.vaccine.2006.10.040; Wick MJ, 2003, IMMUNOL LETT, V85, P99, DOI 10.1016/S0165-2478(02)00230-4; Wong KL, 2008, EUR J IMMUNOL, V38, P2251, DOI 10.1002/eji.200838199; Yrlid U, 2000, J EXP MED, V191, P613, DOI 10.1084/jem.191.4.613	44	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5879	10.1371/journal.pone.0005879	http://dx.doi.org/10.1371/journal.pone.0005879			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517022	gold, Green Published, Green Submitted			2022-12-27	WOS:000266873100012
J	Morales-Johansson, H; Puria, R; Brautigan, DL; Cardenas, ME				Morales-Johansson, Helena; Puria, Rekha; Brautigan, David L.; Cardenas, Maria E.			Human Protein Phosphatase PP6 Regulatory Subunits Provide Sit4-Dependent and Rapamycin-Sensitive Sap Function in Saccharomyces cerevisiae	PLOS ONE			English	Article							GENE-EXPRESSION; CELL-CYCLE; NUCLEAR-LOCALIZATION; MAMMALIAN PROTEIN; MASTER REGULATOR; TOR FUNCTION; YEAST; PATHWAY; SIT4P; 2A	In the budding yeast Saccharomyces cerevisiae the protein phosphatase Sit4 and four associated proteins (Sap4, Sap155, Sap185, and Sap190) mediate G(1) to S cell cycle progression and a number of signaling events controlled by the target of rapamycin TOR signaling cascade. Sit4 and the Sap proteins are ubiquitously conserved and their human orthologs, PP6 and three PP6R proteins, share significant sequence identity with their yeast counterparts. However, relatively little is known about the functions of the PP6 and PP6R proteins in mammalian cells. Here we demonstrate that the human PP6R proteins physically interact with Sit4 when expressed in yeast cells. Remarkably, expression of PP6R2 and PP6R3 but not expression of PP6R1 rescues the growth defect and rapamycin hypersensitivity of yeast cells lacking all four Saps, and these effects require Sit4. Moreover, PP6R2 and PP6R3 enhance cyclin G(1) gene expression and DNA synthesis, and partially abrogate the G(1) cell cycle delay and the budding defect of the yeast quadruple sap mutant strain. In contrast, the human PP6R proteins only modestly support nitrogen catabolite gene expression and are unable to restore normal levels of eIF2 alpha phosphorylation in the quadruple sap mutant strain. These results illustrate that the human PP6-associated proteins are capable of providing distinct rapamycin-sensitive and Sit4-dependent Sap functions in the heterologous context of the yeast cell. We hypothesize that the human Saps may play analogous roles in mTORC1-PP6 signaling events in metazoans.			Morales-Johansson, H (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	carde004@mc.duke.edu			NCI NIH HHS [R01 CA40024, R01 CA114107] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA114107] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alarcon CM, 1996, GENE DEV, V10, P279, DOI 10.1101/gad.10.3.279; Bastians H, 1996, J CELL SCI, V109, P2865; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; De Virgilio C, 2006, INT J BIOCHEM CELL B, V38, P1476, DOI 10.1016/j.biocel.2006.02.013; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Dolinski K, 1997, MOL BIOL CELL, V8, P2267, DOI 10.1091/mbc.8.11.2267; FERNANDEZSARABIA MJ, 1992, GENE DEV, V6, P2417, DOI 10.1101/gad.6.12a.2417; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Jablonowski D, 2004, MOL BIOL CELL, V15, P1459, DOI 10.1091/mbc.E03-10-0750; Jablonowski D, 2001, GENETICS, V159, P1479; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Krauss S, 2008, CANCER RES, V68, P4658, DOI 10.1158/0008-5472.CAN-07-6174; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Luke MM, 1996, MOL CELL BIOL, V16, P2744; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Manlandro CMA, 2005, EUKARYOT CELL, V4, P1041, DOI 10.1128/EC.4.6.1041-1049.2005; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Rohde JR, 2004, MOL CELL BIOL, V24, P8332, DOI 10.1128/MCB.24.19.8332-8341.2004; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Stefansson B, 2007, CELL CYCLE, V6, P1386, DOI 10.4161/cc.6.11.4276; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; SUTTON A, 1991, MOL CELL BIOL, V11, P2133, DOI 10.1128/MCB.11.4.2133; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988	40	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6331	10.1371/journal.pone.0006331	http://dx.doi.org/10.1371/journal.pone.0006331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621075	Green Published, Green Submitted, gold			2022-12-27	WOS:000268147200016
J	Wang, J; Vernier, G; Fischer, A; Collier, RJ				Wang, Jie; Vernier, Gregory; Fischer, Audrey; Collier, R. John			Functions of Phenylalanine Residues within the beta-Barrel Stem of the Anthrax Toxin Pore	PLOS ONE			English	Article								Background: A key step of anthrax toxin action involves the formation of a protein-translocating pore within the endosomal membrane by the Protective Antigen (PA) moiety. Formation of this transmembrane pore by PA involves interaction of the seven 2 beta 2-2 beta 3 loops of the heptameric precursor to generate a 14-strand transmembrane beta barrel. Methodology/Principal Findings: We examined the effects on pore formation, protein translocation, and cytotoxicity, of mutating two phenylalanines, F313 and F314, that lie at the tip the b barrel, and a third one, F324, that lies part way up the barrel. Conclusions/Significance: Our results show that the function of these phenylalanine residues is to mediate membrane insertion and formation of stable transmembrane channels. Unlike F427, a key luminal residue in the cap of the pore, F313, F314, and F324 do not directly affect protein translocation through the pore. Our findings add to our knowledge of structure-function relationships of a key virulence factor of the anthrax bacillus.			Wang, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	jcollier@hms.harvard.edu		Collier, R John/0000-0002-2427-4239	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R01AI022021] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI022021, AI057159, U54 AI057159, R01 AI022021] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aulinger BA, 2005, INFECT IMMUN, V73, P3408, DOI 10.1128/IAI.73.6.3408-3414.2005; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; Katayama H, 2008, NAT STRUCT MOL BIOL, V15, P754, DOI 10.1038/nsmb.1442; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Schulz GE, 1993, CURR OPIN CELL BIOL, V5, P701, DOI 10.1016/0955-0674(93)90143-E; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sun JJ, 2007, J BIOL CHEM, V282, P1059, DOI 10.1074/jbc.M609869200; Vogt J, 1999, STRUCTURE, V7, P1301, DOI 10.1016/S0969-2126(00)80063-5; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101	13	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6280	10.1371/journal.pone.0006280	http://dx.doi.org/10.1371/journal.pone.0006280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609431	Green Published, Green Submitted, gold			2022-12-27	WOS:000268119500014
J	Bischerour, J; Chalmers, R				Bischerour, Julien; Chalmers, Ronald			Base Flipping in Tn10 Transposition: An Active Flip and Capture Mechanism	PLOS ONE			English	Article								The bacterial Tn5 and Tn10 transposases have a single active site that cuts both strands of DNA at their respective transposon ends. This is achieved using a hairpin intermediate that requires the DNA to change conformation during the reaction. In Tn5 these changes are controlled in part by a flipped nucleoside that is stacked on a tryptophan residue in a hydrophobic pocket of the transposase. Here we have investigated the base flipping mechanism in Tn10 transposition. As in Tn5 transposition, we find that base flipping takes place after the first nick and is required for efficient hairpin formation and resolution. Experiments with an abasic substrate show that the role of base flipping in hairpin formation is to remove the base from the DNA helix. Specific interactions between the flipped base and the stacking tryptophan residue are required for hairpin resolution later in the reaction. We show that base flipping in Tn10 transposition is not a passive reaction in which a spontaneously flipped base is captured and retained by the protein. Rather, it is driven in part by a methionine probe residue that helps to force the flipped base from the base stack. Overall, it appears that base flipping in Tn10 transposition is similar to that in Tn5 transposition.			Bischerour, J (corresponding author), CNRS, Ctr Genet Mol, UPR2167, Gif Sur Yvette, France.	chalmers@nottingham.ac.uk		chalmers, ronald/0000-0002-1395-7173	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ason B, 2002, J BIOL CHEM, V277, P11284, DOI 10.1074/jbc.M111119200; Bhasin A, 1999, J BIOL CHEM, V274, P37021, DOI 10.1074/jbc.274.52.37021; Bischerour J, 2007, NUCLEIC ACIDS RES, V35, P2584, DOI 10.1093/nar/gkm186; Chalmers R, 2000, J BACTERIOL, V182, P2970, DOI 10.1128/JB.182.10.2970-2972.2000; Chalmers R, 1998, CELL, V93, P897, DOI 10.1016/S0092-8674(00)81449-X; CHALMERS RM, 1994, J BIOL CHEM, V269, P8029; Chalmers RM, 1996, EMBO J, V15, P5112, DOI 10.1002/j.1460-2075.1996.tb00892.x; Cheng CC, 1996, CONTROL ENG PRACT, V4, P645, DOI 10.1016/0967-0661(96)00046-9; Correll CC, 2004, J SYNCHROTRON RADIAT, V11, P93, DOI 10.1107/S0909049503023896; Crellin P, 2004, MOL CELL, V13, P537, DOI 10.1016/S1097-2765(04)00052-8; Crellin P, 2001, EMBO J, V20, P3882, DOI 10.1093/emboj/20.14.3882; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Grundy GJ, 2007, P NATL ACAD SCI USA, V104, P3078, DOI 10.1073/pnas.0611293104; Hickman AB, 2005, NAT STRUCT MOL BIOL, V12, P715, DOI 10.1038/nsmb970; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Kennedy AK, 1998, CELL, V95, P125, DOI 10.1016/S0092-8674(00)81788-2; Klimasauskas S, 1998, EMBO J, V17, P317, DOI 10.1093/emboj/17.1.317; Liu D, 2005, NUCLEIC ACIDS RES, V33, P1982, DOI 10.1093/nar/gki348; Liu DX, 2006, MOL MICROBIOL, V62, P1522, DOI 10.1111/j.1365-2958.2006.05432.x; Lu CP, 2006, NAT STRUCT MOL BIOL, V13, P1010, DOI 10.1038/nsmb1154; Lynch TW, 2003, J MOL BIOL, V330, P493, DOI 10.1016/S0022-2836(03)00529-1; Mulcair MD, 2006, CELL, V125, P1309, DOI 10.1016/j.cell.2006.04.040; Parikh Sudip S., 1999, Current Opinion in Structural Biology, V9, P37, DOI 10.1016/S0959-440X(99)80006-2; RAMSDEN DA, 1995, GENE DEV, V9, P2409, DOI 10.1101/gad.9.19.2409; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; RUBIN CM, 1980, NUCLEIC ACIDS RES, V8, P4613, DOI 10.1093/nar/8.20.4613; SAKAI J, 1995, EMBO J, V14, P4374, DOI 10.1002/j.1460-2075.1995.tb00112.x; Serva S, 1998, NUCLEIC ACIDS RES, V26, P3473, DOI 10.1093/nar/26.15.3473; Sewitz S, 2003, NUCLEIC ACIDS RES, V31, P5868, DOI 10.1093/nar/gkg797; Stivers JT, 2008, CHEM-EUR J, V14, P786, DOI 10.1002/chem.200701501; Stivers JT, 2004, PROG NUCLEIC ACID RE, V77, P37, DOI 10.1016/S0079-6603(04)77002-6; Szczepanowski RH, 2008, NUCLEIC ACIDS RES, V36, P6109, DOI 10.1093/nar/gkn622; Tamulaitis G, 2008, NUCLEIC ACIDS RES, V36, P6101, DOI 10.1093/nar/gkn621; Tamulaitis G, 2007, NUCLEIC ACIDS RES, V35, P4792, DOI 10.1093/nar/gkm513; Tubbs JL, 2007, DNA REPAIR, V6, P1100, DOI 10.1016/j.dnarep.2007.03.011; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; Wong I, 2002, J BIOL CHEM, V277, P19424, DOI 10.1074/jbc.M201198200; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157; Zhu ZY, 2004, J MOL BIOL, V337, P573, DOI 10.1016/j.jmb.2004.02.003	40	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6201	10.1371/journal.pone.0006201	http://dx.doi.org/10.1371/journal.pone.0006201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593448	Green Published, gold, Green Submitted			2022-12-27	WOS:000268035300013
J	Barrio, AM; Eriksson, O; Badhai, J; Frojmark, AS; Bongcam-Rudloff, E; Dahl, N; Schuster, J				Barrio, Alvaro Martinez; Eriksson, Oskar; Badhai, Jitendra; Frojmark, Anne-Sophie; Bongcam-Rudloff, Erik; Dahl, Niklas; Schuster, Jens			Targeted Resequencing and Analysis of the Diamond-Blackfan Anemia Disease Locus RPS19	PLOS ONE			English	Article								Background: The Ribosomal protein S19 gene locus (RPS19) has been linked to two kinds of red cell aplasia, Diamond-Blackfan Anemia (DBA) and Transient Erythroblastopenia in Childhood (TEC). Mutations in RPS19 coding sequences have been found in 25% of DBA patients, but not in TEC patients. It has been suggested that non-coding RPS19 sequence variants contribute to the considerable clinical variability in red cell aplasia. We therefore aimed at identifying non-coding variations associated with DBA or TEC phenotypes. Methodology/Principal Findings: We targeted a region of 19'980 bp encompassing the RPS19 gene in a cohort of 89 DBA and TEC patients for resequencing. We provide here a catalog of the considerable, previously unrecognized degree of variation in this region. We identified 73 variations (65 SNPs, 8 indels) that all are located outside of the RPS19 open reading frame, and of which 67.1% are classified as novel. We hypothesize that specific alleles in non-coding regions of RPS19 could alter the binding of regulatory proteins or transcription factors. Therefore, we carried out an extensive analysis to identify transcription factor binding sites (TFBS). A series of putative interaction sites coincide with detected variants. Sixteen of the corresponding transcription factors are of particular interest, as they are housekeeping genes or show a direct link to hematopoiesis, tumorigenesis or leukemia (e. g. GATA-1/2, PU.1, MZF-1). Conclusions: Specific alleles at predicted TFBSs may alter the expression of RPS19, modify an important interaction between transcription factors with overlapping TFBS or remove an important stimulus for hematopoiesis. We suggest that the detected interactions are of importance for hematopoiesis and could provide new insights into individual response to treatment.			Barrio, AM (corresponding author), Uppsala Univ, Swedish Univ Agr Sci, Linnaeus Ctr Bioinformat, Uppsala, Sweden.	jens.schuster@genpat.uu.se	Schuster, Jens/D-2005-2010	Schuster, Jens/0000-0002-4383-9880; Badhai, Jitendra/0000-0002-9526-3748; Bongcam-Rudloff, Erik/0000-0002-1947-8288	NHLBI NIH HHS [R01 HL079567, 5R01-HL079567-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079567] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; ALTER BP, 1996, ONCOLOGIST, V1, P361; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Bairagya BB, 2008, INFECT GENET EVOL, V8, P360, DOI 10.1016/j.meegid.2008.02.009; Blake JA, 2008, DEV DYNAM, V237, P2791, DOI 10.1002/dvdy.21711; Campagnoli MF, 2008, HUM MUTAT; Chaudhary J, 1999, MOL ENDOCRINOL, V13, P774, DOI 10.1210/me.13.5.774; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; CMEJLA R, 2007, HUM MUTAT; Da Costa L, 2003, BLOOD, V101, P318, DOI 10.1182/blood-2002-04-1131; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Ellis SR, 2006, MED HYPOTHESES, V66, P643, DOI 10.1016/j.mehy.2005.09.010; Ellis SR, 2008, CURR TOP DEV BIOL, V82, P217, DOI 10.1016/S0070-2153(07)00008-7; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; FISCHER KD, 1993, J BIOL CHEM, V268, P23915; Fullerton SM, 2004, HUM GENET, V115, P36, DOI 10.1007/s00439-004-1106-x; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gingras ME, 2009, INVEST OPHTH VIS SCI, V50, P57, DOI 10.1167/iovs.08-2059; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; GRILLI M, 1993, INT REV CYTOL, V143, P1; Gustavsson P, 1997, NAT GENET, V16, P368, DOI 10.1038/ng0897-368; Gustavsson P, 1998, AM J HUM GENET, V63, P1388, DOI 10.1086/302100; Gustavsson P, 2002, BRIT J HAEMATOL, V119, P261, DOI 10.1046/j.1365-2141.2002.03776.x; Hall BK, 1995, INT J DEV BIOL, V39, P881; Hromas R, 1996, CURR TOP MICROBIOL, V211, P159; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Kastner P, 2008, INT J BIOCHEM CELL B, V40, P22, DOI 10.1016/j.biocel.2007.01.026; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kronke G, 2007, ARTERIOSCL THROM VAS, V27, P1276, DOI 10.1161/ATVBAHA.107.142638; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; LARSSON L, 2008, GENES IMMUN; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; Miller RD, 2005, GENOMICS, V86, P117, DOI 10.1016/j.ygeno.2005.04.012; MILTENBERGER RJ, 1995, MOL CELL BIOL, V15, P2527; NAN H, 2008, CANC CAUSES CONTROL; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Ohene-Abuakwa Y, 2005, BLOOD, V105, P838, DOI 10.1182/blood-2004-03-1016; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pozzi A, 2007, J BIOL CHEM, V282, P17685, DOI 10.1074/jbc.M701429200; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Ryan DP, 2008, PROTEINS, V70, P1461, DOI 10.1002/prot.21638; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692; Shoulders CC, 2004, NAT GENET, V36, P322, DOI 10.1038/ng0404-322; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; SKEPPNER G, 1993, ACTA PAEDIATR, V82, P574, DOI 10.1111/j.1651-2227.1993.tb12757.x; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Stojanovic N, 1999, NUCLEIC ACIDS RES, V27, P3899, DOI 10.1093/nar/27.19.3899; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; Todd JA, 1996, NATURE, V384, P407, DOI 10.1038/384407a0; VLACHOS A, 2008, BR J HAEMATOL; Wickrema A, 2007, ONCOGENE, V26, P6803, DOI 10.1038/sj.onc.1210763; Willig TN, 1999, BLOOD, V94, P4294; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	64	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6172	10.1371/journal.pone.0006172	http://dx.doi.org/10.1371/journal.pone.0006172			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587786	gold, Green Published, Green Submitted			2022-12-27	WOS:000268035100004
J	Johansson, S; Salmon-Divon, M; Johansson, MH; Pickman, Y; Brodin, P; Karre, K; Mehr, R; Hoglund, P				Johansson, Sofia; Salmon-Divon, Mali; Johansson, Maria H.; Pickman, Yishai; Brodin, Petter; Karre, Klas; Mehr, Ramit; Hoglund, Petter			Probing Natural Killer Cell Education by Ly49 Receptor Expression Analysis and Computational Modelling in Single MHC Class I Mice	PLOS ONE			English	Article								Murine natural killer (NK) cells express inhibitory Ly49 receptors for MHC class I molecules, which allows for "missing self" recognition of cells that downregulate MHC class I expression. During murine NK cell development, host MHC class I molecules impose an "educating impact" on the NK cell pool. As a result, mice with different MHC class I expression display different frequency distributions of Ly49 receptor combinations on NK cells. Two models have been put forward to explain this impact. The two-step selection model proposes a stochastic Ly49 receptor expression followed by selection for NK cells expressing appropriate receptor combinations. The sequential model, on the other hand, proposes that each NK cell sequentially expresses Ly49 receptors until an interaction of sufficient magnitude with self-class I MHC is reached for the NK cell to mature. With the aim to clarify which one of these models is most likely to reflect the actual biological process, we simulated the two educational schemes by mathematical modelling, and fitted the results to Ly49 expression patterns, which were analyzed in mice expressing single MHC class I molecules. Our results favour the two-step selection model over the sequential model. Furthermore, the MHC class I environment favoured maturation of NK cells expressing one or a few self receptors, suggesting a possible step of positive selection in NK cell education. Based on the predicted Ly49 binding preferences revealed by the model, we also propose, that Ly49 receptors are more promiscuous than previously thought in their interactions with MHC class I molecules, which was supported by functional studies of NK cell subsets expressing individual Ly49 receptors.			Johansson, S (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	mehrra@mail.biu.ac.il; petter.hoglund@ki.se	Johansson, Sofia/B-9043-2011; Höglund, Petter/AAV-7443-2021; Salmon-Divon, Mali/AAG-4479-2019; Brodin, Petter/C-3317-2011	Johansson, Sofia/0000-0002-9295-6266; Salmon-Divon, Mali/0000-0002-7272-0846; Brodin, Petter/0000-0002-8103-0046; Mehr, Ramit/0000-0002-4303-6834				Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Borrego F, 2006, IMMUNOL RES, V35, P263, DOI 10.1385/IR:35:3:263; Brennan J, 1996, J EXP MED, V183, P1553, DOI 10.1084/jem.183.4.1553; BRODIN P, 2009, TRENDS IMMUNOL; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Fahlen L, 2001, J IMMUNOL, V166, P6585, DOI 10.4049/jimmunol.166.11.6585; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Gorfine M, 2003, B MATH BIOL, V65, P1131, DOI 10.1016/S0092-8240(03)00062-4; Gumperz JE, 1996, J EXP MED, V183, P1817, DOI 10.1084/jem.183.4.1817; Hanke T, 2001, EUR J IMMUNOL, V31, P3370, DOI 10.1002/1521-4141(200111)31:11<3370::AID-IMMU3370>3.0.CO;2-2; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Held W, 1997, J EXP MED, V185, P2079, DOI 10.1084/jem.185.12.2079; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; HOGLUND P, 1991, J EXP MED, V174, P327, DOI 10.1084/jem.174.2.327; HOGLUND P, 1988, J EXP MED, V168, P1469, DOI 10.1084/jem.168.4.1469; HOGLUND P, 1991, P NATL ACAD SCI USA, V88, P10332, DOI 10.1073/pnas.88.22.10332; Ioannidis V, 2001, J IMMUNOL, V167, P6256, DOI 10.4049/jimmunol.167.11.6256; Johansson MH, 1997, J EXP MED, V186, P353, DOI 10.1084/jem.186.3.353; Johansson MH, 1998, EUR J IMMUNOL, V28, P4198, DOI 10.1002/(SICI)1521-4141(199812)28:12<4198::AID-IMMU4198>3.0.CO;2-9; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; Kase A, 1998, J IMMUNOL, V161, P6133; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Michaelsson J, 2000, EUR J IMMUNOL, V30, P300; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; OLSSON MY, 1995, P NATL ACAD SCI USA, V92, P1649, DOI 10.1073/pnas.92.5.1649; Ortaldo JR, 2005, MOL IMMUNOL, V42, P445, DOI 10.1016/j.molimm.2004.07.024; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Raulet DH, 1997, IMMUNOL REV, V155, P41, DOI 10.1111/j.1600-065X.1997.tb00938.x; Salcedo M, 1997, J IMMUNOL, V158, P3174; Salmon-Divon M, 2003, B MATH BIOL, V65, P199, DOI 10.1016/S0092-8240(02)00093-9; Salmon-Divon Mali, 2003, Clin Dev Immunol, V10, P183, DOI 10.1080/10446670310001642140; Scarpellino L, 2007, J IMMUNOL, V178, P1277, DOI 10.4049/jimmunol.178.3.1277; Vahlne G, 2008, SCAND J IMMUNOL, V67, P1, DOI 10.1111/j.1365-3083.2007.02026.x; Valiante NM, 1997, IMMUNOL REV, V155, P155, DOI 10.1111/j.1600-065X.1997.tb00948.x; Wu MF, 1997, J IMMUNOL, V158, P1628; Yokoyama WM, 2006, IMMUNITY, V24, P249, DOI 10.1016/j.immuni.2006.03.006; YOKOYAMA WM, 1990, J IMMUNOL, V145, P2353; Zimmer J, 1998, J EXP MED, V187, P117, DOI 10.1084/jem.187.1.117	44	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6046	10.1371/journal.pone.0006046	http://dx.doi.org/10.1371/journal.pone.0006046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557128	gold, Green Submitted, Green Published			2022-12-27	WOS:000267356900008
J	Phuchareon, J; Ohta, Y; Woo, JM; Eisele, DW; Tetsu, O				Phuchareon, Janyaporn; Ohta, Yoshihito; Woo, Jonathan M.; Eisele, David W.; Tetsu, Osamu			Genetic Profiling Reveals Cross-Contamination and Misidentification of 6 Adenoid Cystic Carcinoma Cell Lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2	PLOS ONE			English	Article								Adenoid cystic carcinoma (ACC) is the second most common malignant neoplasm of the salivary glands. Most patients survive more than 5 years after surgery and postoperative radiation therapy. The 10 year survival rate, however, drops to 40%, due to locoregional recurrences and distant metastases. Improving long-term survival in ACC requires the development of more effective systemic therapies based on a better understanding of the biologic behavior of ACC. Much preclinical research in this field involves the use of cultured cells and, to date, several ACC cell lines have been established. Authentication of these cell lines, however, has not been reported. We performed DNA fingerprint analysis on six ACC cell lines using short tandem repeat (STR) examinations and found that all six cell lines had been contaminated with other cells. ACC2, ACC3, and ACCM were determined to be cervical cancer cells (HeLa cells), whereas the ACCS cell line was composed of T24 urinary bladder cancer cells. ACCNS and CAC2 cells were contaminated with cells derived from non-human mammalian species: the cells labeled ACCNS were mouse cells and the CAC2 cells were rat cells. These observations suggest that future studies using ACC cell lines should include cell line authentication to avoid the use of contaminated or non-human cells.			Phuchareon, J (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, Sch Med, Head & Neck Canc Res Lab, San Francisco, CA 94143 USA.	otetsu@ohns.ucsf.edu		Tetsu, Osamu/0000-0003-1820-7539				Azari S, 2007, BIOLOGICALS, V35, P195, DOI 10.1016/j.biologicals.2006.10.001; Bradley Patrick J, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P127, DOI 10.1097/00020840-200404000-00013; Brown J, 2000, LAB INVEST, V80, P37, DOI 10.1038/labinvest.3780006; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; CARLSON ER, 2008, ORAL PATHOLOGY CLIN, P179; Chatterjee R, 2007, SCIENCE, V315, P928, DOI 10.1126/science.315.5814.928; Chen AM, 2007, INT J RADIAT ONCOL, V67, P988, DOI 10.1016/j.ijrobp.2006.10.044; Choi S, 2008, CLIN CANCER RES, V14, P5081, DOI 10.1158/1078-0432.CCR-08-0245; Chummun S, 2001, BRIT J PLAST SURG, V54, P476, DOI 10.1054/bjps.2001.3636; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Dirks WG, 1999, IN VITRO CELL DEV-AN, V35, P558; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; Franca CM, 2000, ORAL ONCOL, V36, P248, DOI 10.1016/S1368-8375(99)00087-1; GARTLER SM, 1968, NATURE, V217, P750, DOI 10.1038/217750a0; GEY GO, 1952, CANCER RES, V12, P264; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; Guan XF, 1997, INT J ORAL MAX SURG, V26, P116, DOI 10.1016/S0901-5027(05)80830-6; Harding MA, 2002, CANCER RES, V62, P6981; HE RG, 1986, J W CHINA STOMATOL, V6, P1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hotte SJ, 2005, J CLIN ONCOL, V23, P585, DOI 10.1200/JCO.2005.06.125; Hu YC, 2002, CANCER GENET CYTOGEN, V135, P120, DOI 10.1016/S0165-4608(01)00580-5; Hughes P, 2007, BIOTECHNIQUES, V43, P575, DOI 10.2144/000112598; KHAFIF A, 2005, ENT-EAR NOSE THROAT, V84; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Laurie SA, 2006, J CLIN ONCOL, V24, P2673, DOI 10.1200/JCO.2005.05.3025; LI SL, 1990, CHUNG HUA KOU CHIANG, V25, P29; Lins AM, 1998, J FORENSIC SCI, V43, P1168; MacLeod RAF, 1999, INT J CANCER, V83, P555; Markovic O, 1998, IN VITRO CELL DEV-AN, V34, P1; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Nardone RM, 2007, CELL BIOL TOXICOL, V23, P367, DOI 10.1007/s10565-007-9019-9; NELSONREES WA, 1981, SCIENCE, V212, P446, DOI 10.1126/science.6451928; OTOOLE CM, 1983, NATURE, V301, P429, DOI 10.1038/301429a0; Parodi B, 2002, BIOTECHNIQUES, V32, P432, DOI 10.2144/02322rr05; Parson W, 2005, FASEB J, V19, P434, DOI 10.1096/fj.04-3062fje; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; SEIFERT G, 1990, PATHOL RES PRACT, V186, P555, DOI 10.1016/S0344-0338(11)80220-7; SHIRASUNA K, 1990, CANCER RES, V50, P4139; Suda K, 2001, IN VITRO CELL DEV-AN, V37, P505; TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265; Takata T, 1999, CANCER, V86, P928, DOI 10.1002/(SICI)1097-0142(19990915)86:6<928::AID-CNCR6>3.3.CO;2-O; TANABE H, 1999, TISSUE CULT RES COMM, V18, P329, DOI DOI 10.11418/JTCA1981.18.4_329; Tanaka N, 2007, ONCOL REP, V17, P335; Yang Ming-liang, 2006, Zhonghua Kou Qiang Yi Xue Za Zhi, V41, P358	47	74	74	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6040	10.1371/journal.pone.0006040	http://dx.doi.org/10.1371/journal.pone.0006040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557180	Green Published, Green Submitted, gold			2022-12-27	WOS:000267356900004
J	Souquiere, S; Mouinga-Ondeme, A; Makuwa, M; Hermine, O; Kazanji, M				Souquiere, Sandrine; Mouinga-Ondeme, Augustin; Makuwa, Maria; Hermine, Olivier; Kazanji, Mirdad			Dynamic Interaction between STLV-1 Proviral Load and T-Cell Response during Chronic Infection and after Immunosuppression in Non-Human Primates	PLOS ONE			English	Article								We used mandrills (Mandrillus sphinx) naturally infected with simian T-cell leukemia virus type 1 (STLV-1) as a model for evaluating the influence of natural STLV-1 infection on the dynamics and evolution of the immune system during chronic infection. Furthermore, in order to evaluate the role of the immune system in controlling the infection during latency, we induced immunosuppression in the infected monkeys. We first showed that the STLV-1 proviral load was higher in males than in females and increased significantly with the duration of infection: mandrills infected for 10-6 years had a significantly higher proviral load than those infected for 2-4 years. Curiously, this observation was associated with a clear reduction in CD4+ T-cell number with age. We also found that the percentage of CD4(+) T cells co-expressing the activation marker HLA-DR and the mean percentage of CD25(+) in CD4(+) and CD8(+) T cells were significantly higher in infected than in uninfected animals. Furthermore, the STLV-1 proviral load correlated positively with T-cell activation but not with the frequency of T cells secreting interferon gamma in response to Tax peptides. Lastly, we showed that, during immunosuppression in infected monkeys, the percentages of CD8(+) T cells expressing HLA-DR+ and of CD4(+) T cells expressing the proliferation marker Ki67 decreased significantly, although the percentage of CD8(+) T cells expressing HLA-DR+ and Ki67 increased significantly by the end of treatment. Interestingly, the proviral load increased significantly after immunosuppression in the monkey with the highest load. Our study demonstrates that mandrills naturally infected with STLV-1 could be a suitable model for studying the relations between host and virus. Further studies are needed to determine whether the different compartments of the immune response during infection induce the long latency by controlling viral replication over time. Such studies would provide important information for the development of immune-based therapeutic strategies.			Souquiere, S (corresponding author), Ctr Int Rech Med Franceville, Unite Retrovirol, BP 769, Franceville, Gabon.	m.kazanji@cirmf.org	Hermine, Olivier/Q-7072-2018	Hermine, Olivier/0000-0003-2574-3874				Akari H, 1998, AIDS RES HUM RETROV, V14, P367, DOI 10.1089/aid.1998.14.367; Asquith B, 2007, P NATL ACAD SCI USA, V104, P8035, DOI 10.1073/pnas.0608832104; Chen SM, 2006, INT IMMUNOL, V18, P269, DOI 10.1093/intimm/dxh366; d'Offay JM, 2007, COMPARATIVE MED, V57, P105; Etenna SLD, 2008, J CLIN MICROBIOL, V46, P3607, DOI 10.1128/JCM.01249-08; Fultz PN, 1997, VIROLOGY, V235, P271, DOI 10.1006/viro.1997.8705; Gabet AS, 2003, INT J CANCER, V107, P74, DOI 10.1002/ijc.11329; GeorgesCourbot MC, 1996, J MED PRIMATOL, V25, P313, DOI 10.1111/j.1600-0684.1996.tb00023.x; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 1996, J ACQ IMMUN DEF SYND, V13, pS132, DOI 10.1097/00042560-199600001-00022; Gessain A., 1996, HUMAN T CELL LYMPHOT, P33; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; HAYAMI M, 1984, INT J CANCER, V33, P179, DOI 10.1002/ijc.2910330205; HOMMA T, 1984, SCIENCE, V225, P716, DOI 10.1126/science.6087453; HUBBARD GB, 1993, LAB ANIM SCI, V43, P301; IJICHI S, 1990, ANN RHEUM DIS, V49, P718, DOI 10.1136/ard.49.9.718; Jacobson S, 2002, J INFECT DIS, V186, pS187, DOI 10.1086/344269; JENKS PJ, 1995, CLIN INFECT DIS, V21, P992, DOI 10.1093/clinids/21.4.992; Kawano N, 2006, TRANSPLANTATION, V82, P840, DOI 10.1097/01.tp.0000235186.30113.c7; Kazanji M, 2006, J GEN VIROL, V87, P1331, DOI 10.1099/vir.0.81582-0; Kazanji M, 2000, J VIROL, V74, P4860, DOI 10.1128/JVI.74.10.4860-4867.2000; Kohno T, 2005, CANCER SCI, V96, P527, DOI 10.1111/j.1349-7006.2005.00080.x; LAGRENADE L, 1990, LANCET, V336, P1345; LEE RV, 1985, NEW ENGL J MED, V312, P118; Li HC, 2004, J INFECT DIS, V190, P1275, DOI 10.1086/423941; Mahieux R, 1998, J VIROL, V72, P10316, DOI 10.1128/JVI.72.12.10316-10322.1998; Mahieux R, 1997, J VIROL, V71, P1317, DOI 10.1128/JVI.71.2.1317-1333.1997; Makuwa M, 2004, AIDS RES HUM RETROV, V20, P1137, DOI 10.1089/aid.2004.20.1137; Manns A, 1999, J INFECT DIS, V180, P1487, DOI 10.1086/315088; MAYHALL CG, 1981, J MED PRIMATOL, V10, P302; MOCHIZUKI M, 1992, AM J OPHTHALMOL, V114, P123, DOI 10.1016/S0002-9394(14)73974-1; MONE J, 1992, AIDS RES HUM RETROV, V8, P1653, DOI 10.1089/aid.1992.8.1653; MORGAN OS, 1989, LANCET, V2, P1184; Nakamura N, 1998, TRANSPLANT P, V30, P1324, DOI 10.1016/S0041-1345(98)00261-9; Nerrienet E, 1998, AIDS RES HUM RETROV, V14, P785, DOI 10.1089/aid.1998.14.785; PARKER CE, 1992, VIROLOGY, V188, P628, DOI 10.1016/0042-6822(92)90517-S; SAKAKIBARA I, 1986, J MED PRIMATOL, V15, P311; SAKSENA NK, 1994, VIROLOGY, V198, P297, DOI 10.1006/viro.1994.1033; Slattery JP, 1999, GENOME RES, V9, P525; Souquiere S, 2001, J VIROL, V75, P7086, DOI 10.1128/JVI.75.15.7086-7096.2001; Souquiere S, 2009, J MED PRIMATOL, V38, P279, DOI 10.1111/j.1600-0684.2009.00356.x; Soyama A, 2008, LIVER TRANSPLANT, V14, P647, DOI 10.1002/lt.21414; Toulza F, 2008, BLOOD, V111, P5047, DOI 10.1182/blood-2007-10-118539; TRAINADORGE V, 1992, AIDS RES HUM RETROV, V8, P97, DOI 10.1089/aid.1992.8.97; TSUJIMOTO H, 1985, JPN J CANCER RES, V76, P911; TSUJIMOTO H, 1987, CANCER RES, V47, P269; TSURUMI H, 1992, AM J HEMATOL, V41, P292, DOI 10.1002/ajh.2830410414; Ureta-Vidal A, 1999, INT J CANCER, V82, P832, DOI 10.1002/(SICI)1097-0215(19990909)82:6&lt;832::AID-IJC11&gt;3.0.CO;2-P; VAN DS, 2001, MOL BIOL EVOL, V18, P661; Yamakov V, 2002, NAT MATER, V1, P45, DOI 10.1038/nmat700; Yamano Y, 2005, J CLIN INVEST, V115, P1361, DOI [10.1172/JCI200523913, 10.1172/JCI23913]; YOSHIDA M, 1983, GANN, V74, P777; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475	53	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6050	10.1371/journal.pone.0006050	http://dx.doi.org/10.1371/journal.pone.0006050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557183	Green Published, gold, Green Submitted			2022-12-27	WOS:000267356900011
J	Owens, GL; Windsor, DJ; Mui, J; Taylor, JS				Owens, Gregory L.; Windsor, Diana J.; Mui, Justin; Taylor, John S.			A Fish Eye Out of Water: Ten Visual Opsins in the Four-Eyed Fish, Anableps anableps	PLOS ONE			English	Article							COLOR-VISION; MOLECULAR-BASIS; FUNCTIONAL-CHARACTERIZATION; BLUEFIN KILLIFISH; GENE-EXPRESSION; PIGMENT GENE; GREEN; EVOLUTION; RED; DNA	The "four-eyed'' fish Anableps anableps has numerous morphological adaptations that enable above and below-water vision. Here, as the first step in our efforts to identify molecular adaptations for aerial and aquatic vision in this species, we describe the A. anableps visual opsin repertoire. We used PCR, cloning, and sequencing to survey cDNA using unique primers designed to amplify eight sequences from five visual opsin gene subfamilies, SWS1, SWS2, RH1, RH2, and LWS. We also used Southern blotting to count opsin loci in genomic DNA digested with EcoR1 and BamH1. Phylogenetic analyses confirmed the identity of all opsin sequences and allowed us to map gene duplication and divergence events onto a tree of teleost fish. Each of the gene-specific primer sets produced an amplicon from cDNA, indicating that A. anableps possessed and expressed at least eight opsin genes. A second PCR-based survey of genomic and cDNA uncovered two additional LWS genes. Thus, A. anableps has at least ten visual opsins and all but one were expressed in the eyes of the single adult surveyed. Among these ten visual opsins, two have key site haplotypes not found in other fish. Of particular interest is the A. anableps-specific opsin in the LWS subfamily, S180 gamma, with a SHYAA five key site haplotype. Although A. anableps has a visual opsin gene repertoire similar to that found in other fishes in the suborder Cyprinodontoidei, the LWS opsin subfamily has two loci not found in close relatives, including one with a key site haplotype not found in any other fish species. A. anableps opsin sequence data will be used to design in situ probes allowing us to test the hypothesis that opsin gene expression differs in the distinct ventral and dorsal retinas found in this species.			Owens, GL (corresponding author), Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada.	taylorjs@uvic.ca		Tayor, John/0000-0001-6960-9293; Rennison, Diana/0000-0002-5944-0743; Owens, Gregory/0000-0002-4019-5215; Mui, Justin/0000-0001-8546-4266				Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Archer S, 1995, P ROY SOC B-BIOL SCI, V262, P289, DOI 10.1098/rspb.1995.0208; AVERY JA, 1982, NATURE, V298, P62, DOI 10.1038/298062a0; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Bridges CDB, 1972, HDB SENSORY PHYSIOLO, P417, DOI DOI 10.1007/978-3-642-65066-6_11; Carleton KL, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-22; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; Chinen A, 2003, GENETICS, V163, P663; Davies WL, 2007, FASEB J, V21, P2713, DOI 10.1096/fj.06-8057com; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fuller RC, 2004, J COMP PHYSIOL A, V190, P147, DOI 10.1007/s00359-003-0478-z; Hope AJ, 1998, P ROY SOC B-BIOL SCI, V265, P869, DOI 10.1098/rspb.1998.0372; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Kawamura Satoru, 1995, P105; Leonard DW, 1997, BIOPHYS J, V72, P1382, DOI 10.1016/S0006-3495(97)78784-8; Levenson DH, 2006, J COMP PHYSIOL A, V192, P833, DOI 10.1007/s00359-006-0121-x; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Mass AM, 2007, ANAT REC, V290, P701, DOI 10.1002/ar.20529; Matsumoto Y, 2006, GENE, V371, P268, DOI 10.1016/j.gene.2005.12.005; Meyer-Rochow VB, 2003, FISH ADAPTATIONS, P337; MILLER RR, 1979, COPEIA, P82; Minamoto T, 2005, COMP BIOCHEM PHYS B, V140, P197, DOI 10.1016/j.cbpc.2004.09.028; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Neafsey DE, 2005, GENE, V350, P161, DOI 10.1016/j.gene.2005.02.011; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHWASSMANN HORST O., 1965, VISION RES, V5, P269, DOI 10.1016/0042-6989(65)90004-0; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; SIVAK J, 1987, PROC R SOC SER B-BIO, V229, P467, DOI 10.1098/rspb.1987.0005; Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Temple SE, 2006, J COMP PHYSIOL A, V192, P301, DOI 10.1007/s00359-005-0068-3; Ward MN, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-210; YOKOYAMA R, 1990, VISION RES, V30, P807, DOI 10.1016/0042-6989(90)90049-Q; Yokoyama S, 1999, GENETICS, V153, P919; Yokoyama S, 1999, P NATL ACAD SCI USA, V96, P6279, DOI 10.1073/pnas.96.11.6279; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Yokoyama S, 2008, GENETICS, V179, P2037, DOI 10.1534/genetics.108.090449; Yokoyama S, 2007, GENE, V396, P196, DOI 10.1016/j.gene.2007.03.019; ZAHL PA, 1977, COPEIA, P791; Zhang H, 2000, FEBS LETT, V469, P39, DOI 10.1016/S0014-5793(00)01233-3; Zylstra P, 1998, IMMUNOL CELL BIOL, V76, P395, DOI 10.1046/j.1440-1711.1998.00772.x	49	29	29	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e5970	10.1371/journal.pone.0005970	http://dx.doi.org/10.1371/journal.pone.0005970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551143	Green Published, Green Submitted, gold			2022-12-27	WOS:000267356500001
J	Haren, L; Stearns, T; Luders, J				Haren, Laurence; Stearns, Tim; Luders, Jens			Plk1-Dependent Recruitment of gamma-Tubulin Complexes to Mitotic Centrosomes Involves Multiple PCM Components	PLOS ONE			English	Article								The nucleation of microtubules requires protein complexes containing gamma-tubulin, which are present in the cytoplasm and associate with the centrosome and with the mitotic spindle. We have previously shown that these interactions require the gamma-tubulin targeting factor GCP-WD/NEDD1, which has an essential role in spindle formation. The recruitment of additional gamma-tubulin to the centrosomes occurs during centrosome maturation at the G2/M transition and is regulated by the mitotic kinase Plk1. However, the molecular details of this important pathway are unknown and a Plk1 substrate that controls gamma-tubulin recruitment has not been identified. Here we show that Plk1 associates with GCP-WD in mitosis and Plk1 activity contributes to phosphorylation of GCP-WD. Plk1 depletion or inhibition prevents accumulation of GCP-WD at mitotic centrosomes, but GCP-WD mutants that are defective in Plk1-binding and -phosphorylation still accumulate at mitotic centrosomes and recruit gamma-tubulin. Moreover, Plk1 also controls the recruitment of other PCM proteins implicated in centrosomal gamma-tubulin attachment (Cep192/hSPD2, pericentrin, Cep215/Cdk5Rap2). Our results support a model in which Plk1-dependent recruitment of c-tubulin to mitotic centrosomes is regulated upstream of GCP-WD, involves multiple PCM proteins and therefore potentially multiple Plk1 substrates.			Haren, L (corresponding author), CNRS Pierre Fabre, Inst Sci & Technol Medicament Toulouse, Toulouse, France.	stearns@stanford.edu; jens.luders@irbbarcelona.org	Lüders, Jens/H-2812-2015	Lüders, Jens/0000-0002-9018-7977; Stearns, Tim/0000-0002-0671-6582	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052022] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM052022-14, GM52022, R01 GM052022] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Casenghi M, 2005, J CELL SCI, V118, P5101, DOI 10.1242/jcs.02622; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; LAJOIEMAZENC I, 1994, J CELL SCI, V107, P2825; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; LAWO S, 2009, CURR BIOL; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Peters U, 2006, NAT CHEM BIOL, V2, P618, DOI 10.1038/nchembio826; Rapley J, 2005, MOL CELL BIOL, V25, P1309, DOI 10.1128/MCB.25.4.1309-1324.2005; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Terada Y, 2003, J CELL BIOL, V162, P757, DOI 10.1083/jcb.200305048; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	37	149	152	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5976	10.1371/journal.pone.0005976	http://dx.doi.org/10.1371/journal.pone.0005976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543530	gold, Green Published, Green Submitted			2022-12-27	WOS:000267237400004
J	Makiguchi, Y; Nagata, S; Kojima, T; Ichimura, M; Konno, Y; Murata, H; Ueda, H				Makiguchi, Yuya; Nagata, Shinya; Kojima, Takahito; Ichimura, Masaki; Konno, Yoshifumi; Murata, Hideki; Ueda, Hiroshi			Cardiac Arrest during Gamete Release in Chum Salmon Regulated by the Parasympathetic Nerve System	PLOS ONE			English	Article								Cardiac arrest caused by startling stimuli, such as visual and vibration stimuli, has been reported in some animals and could be considered as an extraordinary case of bradycardia and defined as reversible missed heart beats. Variability of the heart rate is established as a balance between an autonomic system, namely cholinergic vagus inhibition, and excitatory adrenergic stimulation of neural and hormonal action in teleost. However, the cardiac arrest and its regulating nervous mechanism remain poorly understood. We show, by using electrocardiogram ( ECG) data loggers, that cardiac arrest occurs in chum salmon ( Oncorhynchus keta) at the moment of gamete release for 7.39 +/- 1.61 s in females and for 5.20 +/- 0.97 s in males. The increase in heart rate during spawning behavior relative to the background rate during the resting period suggests that cardiac arrest is a characteristic physiological phenomenon of the extraordinarily high heart rate during spawning behavior. The ECG morphological analysis showed a peaked and tall T-wave adjacent to the cardiac arrest, indicating an increase in potassium permeability in cardiac muscle cells, which would function to retard the cardiac action potential. Pharmacological studies showed that the cardiac arrest was abolished by injection of atropine, a muscarinic receptor antagonist, revealing that the cardiac arrest is a reflex response of the parasympathetic nerve system, although injection of sotalol, a beta-adrenergic antagonist, did not affect the cardiac arrest. We conclude that cardiac arrest during gamete release in spawning release in spawning chum salmon is a physiological reflex response controlled by the parasympathetic nervous system. This cardiac arrest represents a response to the gaping behavior that occurs at the moment of gamete release.			Makiguchi, Y (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, Sapporo, Hokkaido, Japan.	hueda@fsc.hokudai.ac.jp	Ueda, Hiroshi/G-4446-2010; Makiguchi, Yuya/D-6350-2012	Ueda, Hiroshi/0000-0002-4706-8665; Makiguchi, Yuya/0000-0001-8148-9394				BARHAM WT, 1985, COMP BIOCHEM PHYS A, V82, P549, DOI 10.1016/0300-9629(85)90431-1; BURLESON ML, 1993, RESP PHYSIOL, V93, P97, DOI 10.1016/0034-5687(93)90071-H; Campbell HA, 2004, J EXP BIOL, V207, P1969, DOI 10.1242/jeb.00972; Cohn AE, 1941, AM HEART J, V21, P356, DOI 10.1016/S0002-8703(41)90908-0; CUADRAS J, 1980, COMP BIOCHEM PHYS A, V66, P113, DOI 10.1016/0300-9629(80)90366-7; ESPMARK Y, 1979, BEHAV PROCESS, V4, P179, DOI 10.1016/0376-6357(79)90032-9; Esteve M, 2005, REV FISH BIOL FISHER, V15, P1, DOI 10.1007/s11160-005-7434-7; Farrell AP, 2007, J EXP BIOL, V210, P1715, DOI 10.1242/jeb.02781; FARRELL AP, 1980, AM J PHYSIOL, pR428; GARY GM, 2000, NEUROBIOLOGY MOL CEL, P236; GROOT C, 1996, PRINCIPLES SALMONID, P97; Healey MC, 2003, BEHAVIOUR, V140, P161, DOI 10.1163/156853903321671488; Ide LM, 2002, PHYSIOL BEHAV, V75, P119, DOI 10.1016/S0031-9384(01)00633-3; JACOBSEN NK, 1979, COMP BIOCHEM PHYS A, V62, P885, DOI 10.1016/0300-9629(79)90022-7; King AJ, 2006, J EXP BIOL, V209, P1101, DOI 10.1242/jeb.02116; Kojima Takahito, 2003, Polar Bioscience, V16, P104; LAMING PR, 1981, COMP BIOCHEM PHYS A, V68, P515, DOI 10.1016/0300-9629(81)90084-0; LIEBOW IM, 1951, AM HEART J, V41, P266, DOI 10.1016/0002-8703(51)90105-6; LOEB JM, 1985, J ELECTROCARDIOL, V18, P287, DOI 10.1016/S0022-0736(85)80053-4; Nilsson S, 1998, COMP BIOCHEM PHYS A, V119, P137, DOI 10.1016/S1095-6433(97)00397-8; Olson KR, 2002, J EXP ZOOL, V293, P320, DOI 10.1002/jez.10126; OLSON KR, 2006, PHYSL FISHES, P119; RANDALL D, 1982, J EXP BIOL, V100, P275; Reid SG, 2006, PHYSL TROPICAL FISHE, P225; Sandblom E, 2005, J EXP BIOL, V208, P821, DOI 10.1242/jeb.01470; Soivio A., 1975, J EXP BIOL, V62, P207; Somers MP, 2002, AM J EMERG MED, V20, P243, DOI 10.1053/ajem.2002.32630; Sundin L, 1997, AM J PHYSIOL-REG I, V272, pR576, DOI 10.1152/ajpregu.1997.272.2.R576; SUNDIN LI, 1995, AM J PHYSIOL-REG I, V268, pR771, DOI 10.1152/ajpregu.1995.268.3.R771; Taylor E. W., 1992, P343; Taylor EW, 1999, PHYSIOL REV, V79, P855, DOI 10.1152/physrev.1999.79.3.855; UEMATSU K, 1983, COMP BIOCHEM PHYS A, V74, P899, DOI 10.1016/0300-9629(83)90365-1; UEMATSU K, 1980, B JPN SOC SCI FISH, V46, P395; WELLS MJ, 1979, J EXP BIOL, V78, P87; WOOD CM, 1980, J EXP BIOL, V87, P271	35	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5993	10.1371/journal.pone.0005993	http://dx.doi.org/10.1371/journal.pone.0005993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543389	Green Published, gold			2022-12-27	WOS:000267237400015
J	Quaye, L; Tyrer, J; Ramus, SJ; Song, HL; Wozniak, E; DiCioccio, RA; McGuire, V; Hogdall, E; Hogdall, C; Blaakaer, J; Goode, EL; Schildkraut, JM; Easton, DF; Kruger-Kjaer, S; Whittemore, AS; Gayther, SA; Pharoah, PDP				Quaye, Lydia; Tyrer, Jonathan; Ramus, Susan J.; Song, Honglin; Wozniak, Eva; DiCioccio, Richard A.; McGuire, Valerie; Hogdall, Estrid; Hogdall, Claus; Blaakaer, Jan; Goode, Ellen L.; Schildkraut, Joellen M.; Easton, Douglas F.; Krueger-Kjaer, Susanne; Whittemore, Alice S.; Gayther, Simon A.; Pharoah, Paul D. P.			Association between Common Germline Genetic Variation in 94 Candidate Genes or Regions and Risks of Invasive Epithelial Ovarian Cancer	PLOS ONE			English	Article								Background: Recent studies have identified several single nucleotide polymorphisms (SNPs) in the population that are associated with variations in the risks of many different diseases including cancers such as breast, prostate and colorectal. For ovarian cancer, the known highly penetrant susceptibility genes (BRCA1 and BRCA2) are probably responsible for only 40% of the excess familial ovarian cancer risks, suggesting that other susceptibility genes of lower penetrance exist. Methods: We have taken a candidate approach to identifying moderate risk susceptibility alleles for ovarian cancer. To date, we have genotyped 340 SNPs from 94 candidate genes or regions, in up to 1,491 invasive epithelial ovarian cancer cases and 3,145 unaffected controls from three different population based studies from the UK, Denmark and USA. Results: After adjusting for population stratification by genomic control, 18 SNPs (5.3%) were significant at the 5% level, and 5 SNPs (1.5%) were significant at the 1% level. The most significant association was for the SNP rs2107425, located on chromosome 11p15.5, which has previously been identified as a susceptibility allele for breast cancer from a genome wide association study (P-trend = 0.0012). When SNPs/genes were stratified into 7 different pathways or groups of validation SNPs, the breast cancer associated SNPs were the only group of SNPs that were significantly associated with ovarian cancer risk (P-heterogeneity = 0.0003; P-trend = 0.0028; adjusted (for population stratification) P-trend = 0.006). We did not find statistically significant associations when the combined data for all SNPs were analysed using an admixture maximum likelihood (AML) experiment- wise test for association (P-heterogeneity = 0.051; P-trend = 0.068). Conclusion: These data suggest that a proportion of the SNPs we evaluated were associated with ovarian cancer risk, but that the effect sizes were too small to detect associations with individual SNPs.			Quaye, L (corresponding author), UCL, UCL EGA Inst Womens Hlth, Gynaecol Canc Res Labs, London, England.	s.ramus@ucl.ac.uk	Pharoah, Paul/V-6658-2019; Ramus, Susan/AAG-8352-2019	Pharoah, Paul/0000-0001-8494-732X; Ramus, Susan/0000-0003-0005-7798; Kjaer, Susanne/0000-0002-8347-1398; Hogdall, Claus/0000-0002-5959-8874; Hogdall, Estrid/0000-0003-4689-5658	MRC [G0801875] Funding Source: UKRI; The Francis Crick Institute [10119, 10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; Cancer Research UK [10124, 11021, C8804/A7058, 10118, A10124, 11022, 10119, A10119] Funding Source: Medline; Medical Research Council [G0801875] Funding Source: Medline; NCI NIH HHS [CA71766, P30 CA016056, CA16056] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aktas D, 2002, GYNECOL ONCOL, V86, P124, DOI 10.1006/gyno.2002.6720; Antoniou Antonis C, 2006, Future Oncol, V2, P257, DOI 10.2217/14796694.2.2.257; Auranen A, 1996, BRIT J CANCER, V74, P280, DOI 10.1038/bjc.1996.352; Auranen A, 2005, INT J CANCER, V117, P611, DOI 10.1002/ijc.21047; Baffa R, 1996, CANCER RES, V56, P268; Baxter SW, 2001, CARCINOGENESIS, V22, P63, DOI 10.1093/carcin/22.1.63; Bepler G, 1998, CANCER DETECT PREV, V22, P14; Berchuck A, 2008, ADV EXP MED BIOL, V622, P53, DOI 10.1007/978-0-387-68969-2_5; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; DiCioccio RA, 2004, CANCER EPIDEM BIOMAR, V13, P1589; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Dunning AM, 2009, HUM MOL GENET, V18, P1131, DOI 10.1093/hmg/ddn429; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Gayther SA, 1999, AM J HUM GENET, V65, P1021, DOI 10.1086/302583; Gayther SA, 2007, CANCER RES, V67, P3027, DOI 10.1158/0008-5472.CAN-06-3261; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; GUDMUNDSSON J, 1995, BRIT J CANCER, V72, P696, DOI 10.1038/bjc.1995.396; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Imura M, 2006, CANCER LETT, V241, P213, DOI 10.1016/j.canlet.2005.10.010; Karnik P, 1998, HUM MOL GENET, V7, P895, DOI 10.1093/hmg/7.5.895; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Palmieri RT, 2008, CANCER EPIDEM BIOMAR, V17, P3567, DOI 10.1158/1055-9965.EPI-08-0548; Pearce CL, 2008, BRIT J CANCER, V98, P282, DOI 10.1038/sj.bjc.6604170; Pharoah PDP, 2007, PLOS GENET, V3, P401, DOI 10.1371/journal.pgen.0030042; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; QUAYE L, 2009, BR J CANC IN PRESS; RAMUS SJ, 2007, CONTRIBUTION BRCA1 B; Ramus SJ, 2008, INT J CANCER, V123, P380, DOI 10.1002/ijc.23448; Schaid DJ, 2005, AM J HUM GENET, V76, P780, DOI 10.1086/429838; SHAW ME, 1995, GENE CHROMOSOME CANC, V13, P1, DOI 10.1002/gcc.2870130102; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; SONG H, HUM MOL GENET UNPUB; Song HL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000268; Song HL, 2006, CARCINOGENESIS, V27, P2235, DOI 10.1093/carcin/bgl089; Song HL, 2006, CANCER RES, V66, P10220, DOI 10.1158/0008-5472.CAN-06-2222; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tyrer J, 2006, GENET EPIDEMIOL, V30, P636, DOI 10.1002/gepi.20175; VIEL A, 1992, BRIT J CANCER, V66, P1030, DOI 10.1038/bjc.1992.405; Xu XL, 2001, CANCER RES, V61, P7943; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042	49	35	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5983	10.1371/journal.pone.0005983	http://dx.doi.org/10.1371/journal.pone.0005983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543528	Green Published, Green Submitted, gold			2022-12-27	WOS:000267237400009
J	Buhusi, CV; Meck, WH				Buhusi, Catalin V.; Meck, Warren H.			Relativity Theory and Time Perception: Single or Multiple Clocks?	PLOS ONE			English	Article							PEAK-INTERVAL PROCEDURE; DIVIDED ATTENTION; FRONTAL-CORTEX; PIGEONS; MEMORY; GAP; METHAMPHETAMINE; DURATION; SIGNALS; TRIALS	Background: Current theories of interval timing assume that humans and other animals time as if using a single, absolute stopwatch that can be stopped or reset on command. Here we evaluate the alternative view that psychological time is represented by multiple clocks, and that these clocks create separate temporal contexts by which duration is judged in a relative manner. Two predictions of the multiple-clock hypothesis were tested. First, that the multiple clocks can be manipulated (stopped and/or reset) independently. Second, that an event of a given physical duration would be perceived as having different durations in different temporal contexts, i.e., would be judged differently by each clock. Methodology/Principal Findings: Rats were trained to time three durations (e. g., 10, 30, and 90 s). When timing was interrupted by an unexpected gap in the signal, rats reset the clock used to time the "short" duration, stopped the "medium" duration clock, and continued to run the "long" duration clock. When the duration of the gap was manipulated, the rats reset these clocks in a hierarchical order, first the "short", then the "medium", and finally the "long" clock. Quantitative modeling assuming re-allocation of cognitive resources in proportion to the relative duration of the gap to the multiple, simultaneously timed event durations was used to account for the results. Conclusions/Significance: These results indicate that the three event durations were effectively timed by separate clocks operated independently, and that the same gap duration was judged relative to these three temporal contexts. Results suggest that the brain processes the duration of an event in a manner similar to Einstein's special relativity theory: A given time interval is registered differently by independent clocks dependent upon the context.			Buhusi, CV (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	buhusi@musc.edu		Meck, Warren/0000-0002-6120-4790	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065561, R01MH073057] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH073057-02, R01 MH073057, R01 MH065561-08, R01 MH065561] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Buhusi CV, 2007, BEHAV PROCESS, V74, P159, DOI 10.1016/j.beproc.2006.10.004; Buhusi CV, 2006, J EXP PSYCHOL-ANIM B, V32, P329, DOI 10.1037/0097-7403.32.3.329; Buhusi CV, 2006, BEHAV PROCESS, V71, P116, DOI 10.1016/j.beproc.2005.10.006; Buhusi CV, 2006, BEHAV PROCESS, V71, P107, DOI 10.1016/j.beproc.2005.11.017; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buhusi CV, 2005, J EXP PSYCHOL-ANIM B, V31, P18, DOI 10.1037/0097-7403.31.1.18; Buhusi CV, 2002, J COMP PSYCHOL, V116, P381, DOI 10.1037//0735-7036.116.4.381; Buhusi CV, 2002, BEHAV NEUROSCI, V116, P291, DOI 10.1037//0735-7044.116.2.291; Buhusi CV, 2000, J EXP PSYCHOL ANIM B, V26, P305, DOI 10.1037//0097-7403.26.3.305; BUHUSI CV, 2003, METH NE FRO NEUROSCI, P317; BUHUSI CV, 2009, PHILOS T R SOC B, P1875; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Burr D, 2006, CURR BIOL, V16, pR171, DOI 10.1016/j.cub.2006.02.038; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; CHENG K, 1993, J EXP PSYCHOL ANIM B, V19, P56, DOI 10.1037/0097-7403.19.1.56; Church R.M., 1978, COGNITIVE PROCESS, P277; CHURCH RM, 1984, ANN NY ACAD SCI, V423, P566, DOI 10.1111/j.1749-6632.1984.tb23459.x; Church RM, 2003, TIME AND MIND II: INFORMATION PROCESSING PERSPECTIVES, P3; CHURCH RM, 1994, J EXP PSYCHOL ANIM B, V20, P135, DOI 10.1037/0097-7403.20.2.135; Coull JT, 1998, J NEUROSCI, V18, P7426; DEVACA SC, 1994, J EXP PSYCHOL ANIM B, V20, P184; Einstein A, 1905, ANN PHYS-BERLIN, V17, P891; EINSTEIN A, J EXOTHERMIC SCI TEC, V1; FORTIN C, 2003, METH NE FRO NEUROSCI, P235; Kaiser DH, 2002, J EXP PSYCHOL ANIM B, V28, P416, DOI 10.1037//0097-7403.28.4.416; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Matell MS, 2006, PSYCHOPHARMACOLOGY, V188, P201, DOI 10.1007/s00213-006-0489-x; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Matell MS, 2004, BEHAV NEUROSCI, V118, P150, DOI 10.1037/0735-7044.118.1.150; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Matell MS, 1999, BEHAV PROCESS, V45, P159, DOI 10.1016/S0376-6357(99)00016-9; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Meck WH, 2007, BEHAV NEUROSCI, V121, P707, DOI 10.1037/0735-7044.121.4.707; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; MECK WH, 1984, BEHAV NEUROSCI, V98, P3, DOI 10.1037/0735-7044.98.1.3; MECK WH, 1984, J EXP PSYCHOL ANIM B, V10, P1, DOI 10.1037/0097-7403.10.1.1; MECK WH, 1987, BEHAV BRAIN RES, V23, P147, DOI 10.1016/0166-4328(87)90051-9; Mirsky S, 2002, SCI AM, V287, P102, DOI 10.1038/scientificamerican0902-102; OLTON DS, 1988, NEUROPSYCHOLOGIA, V26, P307, DOI 10.1016/0028-3932(88)90083-8; Pang KCH, 2001, NEUROSCIENCE, V103, P615, DOI 10.1016/S0306-4522(01)00018-5; Penney T.B., 2003, METH NE FRO NEUROSCI, P209, DOI 10.1080/17470218.2015.1023735; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; ROBERTS S, 1978, J EXP PSYCHOL ANIM B, V4, P318, DOI 10.1037/0097-7403.4.4.318; ROBERTS S, 1981, J EXP PSYCHOL ANIM B, V7, P242, DOI 10.1037/0097-7403.7.3.242; ROBERTS WA, 1989, J EXP PSYCHOL ANIM B, V15, P23, DOI 10.1037/0097-7403.15.1.23; SPETCH ML, 1992, LEARN MOTIV, V23, P117, DOI 10.1016/0023-9690(92)90013-C; SPETCH ML, 1992, COGNITIVE ASPECTS OF STIMULUS CONTROL, P47; SPETCH ML, 1983, DISS ABSTR INT, V43; Zakay D., 1989, TIME HUMAN COGNITION, P365, DOI [10.1016/S0166-4115(08)61047-X, DOI 10.1016/S0166-4115(08)61047-X]	49	75	78	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6268	10.1371/journal.pone.0006268	http://dx.doi.org/10.1371/journal.pone.0006268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	474CN	19623247	Green Published, Green Submitted, gold			2022-12-27	WOS:000268260100004
J	Basile, M; Lemasson, A; Blois-Heulin, C				Basile, Muriel; Lemasson, Alban; Blois-Heulin, Catherine			Social and Emotional Values of Sounds Influence Human (Homo sapiens) and Non-Human Primate (Cercopithecus campbelli) Auditory Laterality	PLOS ONE			English	Article							CAPTIVE GROUP; HEMISPHERIC-SPECIALIZATION; NEURAL LATERALIZATION; JAPANESE MACAQUES; MONKEYS; BRAIN; COMMUNICATION; VOCALIZATIONS; RECOGNITION; ASYMMETRIES	The last decades evidenced auditory laterality in vertebrates, offering new important insights for the understanding of the origin of human language. Factors such as the social (e. g. specificity, familiarity) and emotional value of sounds have been proved to influence hemispheric specialization. However, little is known about the crossed effect of these two factors in animals. In addition, human-animal comparative studies, using the same methodology, are rare. In our study, we adapted the head turn paradigm, a widely used non invasive method, on 8-9-year-old schoolgirls and on adult female Campbell's monkeys, by focusing on head and/or eye orientations in response to sound playbacks. We broadcast communicative signals (monkeys: calls, humans: speech) emitted by familiar individuals presenting distinct degrees of social value ( female monkeys: conspecific group members vs heterospecific neighbours, human girls: from the same vs different classroom) and emotional value (monkeys: contact vs threat calls; humans: friendly vs aggressive intonation). We evidenced a crossed-categorical effect of social and emotional values in both species since only "negative" voices from same class/group members elicited a significant auditory laterality (Wilcoxon tests: monkeys, T = 0 p = 0.03; girls: T = 4.5 p = 0.03). Moreover, we found differences between species as a left and right hemisphere preference was found respectively in humans and monkeys. Furthermore while monkeys almost exclusively responded by turning their head, girls sometimes also just moved their eyes. This study supports theories defending differential roles played by the two hemispheres in primates' auditory laterality and evidenced that more systematic species comparisons are needed before raising evolutionary scenario. Moreover, the choice of sound stimuli and behavioural measures in such studies should be the focus of careful attention.			Basile, M (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Paimpont, France.	basilemuriel@hotmail.com						ASBJORNSEN A, 1990, BRAIN LANG, V39, P447, DOI 10.1016/0093-934X(90)90150-F; BASILE M, 2009, SOCIALLY DEPENDENT A, DOI DOI 10.1007/S10071-009-0220-5; BERNDT TJ, 1985, DEV PSYCHOL, V21, P1007, DOI 10.1037/0012-1649.21.6.1007; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; BOROD JC, 1992, NEUROPSYCHOLOGIA, V30, P827, DOI 10.1016/0028-3932(92)90086-2; Bosacki SL, 2004, SEX ROLES, V50, P659, DOI 10.1023/B:SERS.0000027568.26966.27; BOYE M, 2005, EUR J NEUROSCI, DOI DOI 10.1111/1460-9568.2005.04005.X; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Buzzard PJ, 2006, PRIMATES, V47, P336, DOI 10.1007/s10329-006-0188-6; Casperd JM, 1996, BEHAV PROCESS, V37, P57, DOI 10.1016/0376-6357(95)00075-5; Chapelain AS, 2009, ANIM COGN, V12, P11, DOI 10.1007/s10071-008-0164-1; Csermely D, 2004, BEHAV PROCESS, V67, P511, DOI 10.1016/j.beproc.2004.08.008; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1372, DOI 10.1073/pnas.89.4.1372; Dadda M, 2006, ANIM BEHAV, V72, P523, DOI 10.1016/j.anbehav.2005.10.019; Des Roches ADB, 2008, PHYSIOL BEHAV, V94, P487, DOI 10.1016/j.physbeh.2008.03.002; EcklundFlores L, 1996, DEV PSYCHOBIOL, V29, P205, DOI 10.1002/(SICI)1098-2302(199604)29:3<205::AID-DEV2>3.0.CO;2-V; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Fernandez-Carriba S, 2002, BRAIN RES BULL, V57, P561, DOI 10.1016/S0361-9230(01)00685-2; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; Gautier J.-P., 1977, ANIMALS COMMUNICATE, P890; GAUTIER JP, 1975, THESIS RENNES U; GEISSLER GB, 2006, EUR J NEUROSCI, V19, P1027; George I, 2005, J COMP NEUROL, V488, P48, DOI 10.1002/cne.20584; George I, 2004, BEHAV NEUROSCI, V118, P597, DOI 10.1037/0735-7044.118.3.597; Ghazanfar AA, 2001, BRAIN BEHAV EVOLUT, V58, P163, DOI 10.1159/000047270; Gil-da-Costa R, 2006, P ROY SOC B-BIOL SCI, V273, P2313, DOI 10.1098/rspb.2006.3580; HAMMER M, 1977, THESIS CITY U NEW YO; HARPER LV, 1986, DEV PSYCHOL, V22, P553, DOI 10.1037/0012-1649.22.4.553; HARRINGTON A, 1995, BRAIN ASYM; HAUSER MD, 1994, P NATL ACAD SCI USA, V91, P3946, DOI 10.1073/pnas.91.9.3946; Hauser MD, 2001, ANIM BEHAV, V61, P391, DOI 10.1006/anbe.2000.1588; HEFFNER HE, 1995, CURRENT TOPICS IN PRIMATE VOCAL COMMUNICATION, P207; HEFFNER HE, 1989, J NEUROPHYSIOL, V62, P789, DOI 10.1152/jn.1989.62.3.789; HISCOCK M, 1985, BRAIN COGNITION, V4, P140, DOI 10.1016/0278-2626(85)90066-1; Hopkins William D., 2002, P445, DOI 10.1017/CBO9780511546372.014; HORTACSU N, 1992, J NONVERBAL BEHAV, V16, P231, DOI 10.1007/BF01462004; KAHANAKALMAN R, 1998, INFANT BEHAV DEV, DOI DOI 10.1016/S0163-6383(98)91453-9; Lee V, 2002, J NONVERBAL BEHAV, V26, P3, DOI 10.1023/A:1014479919684; Lemasson A, 2005, J COMP PSYCHOL, V119, P220, DOI 10.1037/0735-7036.119.2.220; Lemasson A, 2005, APPL ANIM BEHAV SCI, V91, P289, DOI 10.1016/j.applanim.2004.10.011; Lemasson A, 2004, J COMP PSYCHOL, V118, P347, DOI 10.1037/0735-7036.118.3.347; Lemasson A, 2003, CR BIOL, V326, P1185, DOI 10.1016/j.crvi.2003.10.005; Lemasson A, 2006, AM J PRIMATOL, V68, P1161, DOI 10.1002/ajp.20315; Ley R G, 1982, Brain Cogn, V1, P3, DOI 10.1016/0278-2626(82)90002-1; MOLFESE DL, 1979, DEV PSYCHOL, V15, P505, DOI 10.1037/0012-1649.15.5.505; Otake R, 2007, ACTA OTO-LARYNGOL, V127, P34, DOI 10.1080/03655230701595337; Palleroni A, 2003, SCIENCE, V299, P1195, DOI 10.1126/science.1078813; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; PETERSEN MR, 1984, BEHAV NEUROSCI, V98, P779, DOI 10.1037/0735-7044.98.5.779; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Range F, 2004, ETHOLOGY, V110, P301, DOI 10.1111/j.1439-0310.2004.00973.x; Richard J-P, 1991, BIOACOUSTICS, V3, P45, DOI DOI 10.1080/09524622.1991.9753156; Rogers LJ, 2000, BRAIN LANG, V73, P236, DOI 10.1006/brln.2000.2305; ROGERS LJ, 2004, P ROY SOC LOND B BIO, V271, P420, DOI DOI 10.1098/RSBL.2004.0200; Sato W, 2006, BRAIN COGNITION, V62, P261, DOI 10.1016/j.bandc.2006.06.006; SAXBY L, 1984, DEV PSYCHOL, V20, P72, DOI 10.1037/0012-1649.20.1.72; Scheumann M, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-3; SCHWARTZ GE, 1975, SCIENCE, V190, P286, DOI 10.1126/science.1179210; SHIPLEYBROWN F, 1988, BRAIN LANG, V33, P16, DOI 10.1016/0093-934X(88)90051-X; Siniscalchi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003349; STIFTER CA, 1987, J NONVERBAL BEHAV, V11, P43, DOI 10.1007/BF00999606; STRERI A, 2004, DROITIERS GAUCHERS A, P49; Taglialatela JP, 2009, CEREB CORTEX, V19, P1151, DOI 10.1093/cercor/bhn157; TAGLIALATELA JP, 2004, THESIS GEORGIA STATE; TEUFEL C, 2007, ANIM BEHAV, DOI DOI 10.1016/2006.04.011; TURKEWITZ G, 1975, DEV PSYCHOBIOL, V8, P85, DOI 10.1002/dev.420080112; Vallortigara G, 1999, BRAIN RES REV, V30, P164, DOI 10.1016/S0165-0173(99)00012-0; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; WALKERANDREWS AS, 1991, INFANT BEHAV DEV, V14, P131, DOI 10.1016/0163-6383(91)90001-9; Wang XQ, 2000, P NATL ACAD SCI USA, V97, P11843, DOI 10.1073/pnas.97.22.11843; Wernicke C., 1874, WERNICKES WORKS APHA, P91; Wolters S, 2003, BEHAVIOUR, V140, P371, DOI 10.1163/156853903321826684; Zuberbuhler K, 2000, P ROY SOC B-BIOL SCI, V267, P713, DOI 10.1098/rspb.2000.1061; Zuberbuhler K, 2002, ANIM BEHAV, V63, P293, DOI 10.1006/anbe.2001.1914	77	17	17	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6295	10.1371/journal.pone.0006295	http://dx.doi.org/10.1371/journal.pone.0006295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	472GV	19609434	Green Published, gold, Green Submitted			2022-12-27	WOS:000268119500017
J	Saini, V; Raghuvanshi, S; Talwar, GP; Ahmed, N; Khurana, JP; Hasnain, SE; Tyagi, AK; Tyagi, AK				Saini, Vikram; Raghuvanshi, Saurabh; Talwar, Gursaran P.; Ahmed, Niyaz; Khurana, Jitendra P.; Hasnain, Seyed E.; Tyagi, Akhilesh K.; Tyagi, Anil K.			Polyphasic Taxonomic Analysis Establishes Mycobacterium indicus pranii as a Distinct Species	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; SP-NOV.; W VACCINE; TUBERCULOSIS; GENE; SEQUENCE; IDENTIFICATION; PROPOSAL; STRAINS; COMPLEX	Background: Mycobacterium indicus pranii (MIP), popularly known as Mw, is a cultivable, non-pathogenic organism, which, based on its growth and metabolic properties, is classified in Runyon Group IV along with M. fortuitum, M. smegmatis and M. vaccae. The novelty of this bacterium was accredited to its immunological ability to undergo antigen driven blast transformation of leukocytes and delayed hypersensitivity skin test in leprosy patients, a disease endemic in the Indian subcontinent. Consequently, MIP has been extensively evaluated for its biochemical and immunological properties leading to its usage as an immunomodulator in leprosy and tuberculosis patients. However, owing to advances in sequencing and culture techniques, the citing of new strains with almost 100% similarity in the sequences of marker genes like 16S rRNA, has compromised the identity of MIP as a novel species. Hence, to define its precise taxonomic position, we have carried out polyphasic taxonomic studies on MIP that integrate its phenotypic, chemotaxonomic and molecular phylogenetic attributes. Methodology/Principal Findings: The comparative analysis of 16S rRNA sequence of MIP by using BLAST algorithm at NCBI (nr database) revealed a similarity of >= 99% with M. intracellulare, M. arosiense, M. chimaera, M. seoulense, M. avium subsp. hominissuis, M. avium subsp. paratuberculosis and M. bohemicum. Further analysis with other widely used markers like rpoB and hsp65 could resolve the phylogenetic relationship between MIP and other closely related mycobacteria apart from M. intracellulare and M. chimaera, which shares >= 99% similarity with corresponding MIP orthologues. Molecular phylogenetic analysis, based on the concatenation of candidate orthologues of 16S rRNA, hsp65 and rpoB, also substantiated its distinctiveness from all the related organisms used in the analysis excluding M. intracellulare and M. chimaera with which it exhibited a close proximity. This necessitated further analysis of MIP with more sensitive and segregating parameters to ascertain its precise taxonomic position as a new species. The analysis of MIP and its comparison with other mycobacterial reference strains based on cellular and biochemical features, growth characteristics and chemotaxonomic studies like FAME profiling confirmed that MIP is uniquely endowed with diverse metabolic attributes that effectively distinguishes it from all the closely related mycobacteria including M. intracellulare and M. chimaera. Conclusion: The results presented in this study coupled with the non-pathogenic nature and different biochemical and immunomodulatory properties of MIP affirm it as a distinct species belonging to M. avium complex (MAC). It is further proposed to use an earlier suggested name Mycobacterium indicus pranii for this newly established mycobacterial species. This study also exemplifies the growing need for a uniform, consensus based broader polyphasic frame work for the purpose of taxonomy and speciation, particularly in the genus Mycobacterium.			Saini, V (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	aniltyagi@south.du.ac.in	Saini, Vikram/B-4547-2009; Ahmed, Niyaz/D-2589-2010	Saini, Vikram/0000-0002-0258-2871; Ahmed, Niyaz/0000-0001-6425-7583; Hasnain, Seyed/0000-0002-2967-0791				Adekambi T, 2008, INT J SYST EVOL MICR, V58, P1807, DOI 10.1099/ijs.0.65440-0; Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Ahmed N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000968; Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Bang D, 2008, INT J SYST EVOL MICR, V58, P2398, DOI 10.1099/ijs.0.65503-0; BARROW WW, 1993, INFECT IMMUN, V61, P5286, DOI 10.1128/IAI.61.12.5286-5293.1993; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; Chaudhuri Prabir, 2003, J Indian Med Assoc, V101, P559; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gupta A, 2009, INFECT IMMUN, V77, P223, DOI 10.1128/IAI.00526-08; Gupta S, 2008, J EUR ACAD DERMATOL, V22, P1089, DOI 10.1111/j.1468-3083.2008.02719.x; HAACK SK, 1994, APPL ENVIRON MICROB, V60, P2483, DOI 10.1128/AEM.60.7.2483-2493.1994; Janda JM, 2002, J CLIN MICROBIOL, V40, P1887, DOI 10.1128/JCM.40.6.1887-1891.2002; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Katoch V M, 1981, Lepr India, V53, P385; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kharkar Rajendra, 2002, J Indian Med Assoc, V100, P578; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Kremer K, 2001, Methods Mol Med, V54, P359, DOI 10.1385/1-59259-147-7:359; Kumar M, 2008, INT J SYST EVOL MICR, V58, P861, DOI 10.1099/ijs.0.65574-0; Mun HS, 2007, INT J SYST EVOL MICR, V57, P594, DOI 10.1099/ijs.0.64744-0; Neumann M, 1997, APPL ENVIRON MICROB, V63, P547, DOI 10.1128/AEM.63.2.547-552.1997; Ozbek A, 2003, J INT MED RES, V31, P133, DOI 10.1177/147323000303100210; Patel Naresh, 2002, J Indian Med Assoc, V100, P191; Pineiro-Vidal M, 2008, LETT APPL MICROBIOL, V46, P548, DOI 10.1111/j.1472-765X.2008.02348.x; REDDI PP, 1994, INT J LEPROSY, V62, P229; Reischl U, 1998, INT J SYST BACTERIOL, V48, P1349, DOI 10.1099/00207713-48-4-1349; RUYON EH, 1967, AM REV RESPIR DIS, V95, P861; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALAH B, 2008, MICROBIOLOGY, V154, P3715; Saxena V K, 1978, Lepr India, V50, P588; Selvarangan R, 2004, J CLIN MICROBIOL, V42, P52, DOI 10.1128/JCM.42.1.52-59.2004; Senna SG, 2008, J CLIN MICROBIOL, V46, P3822, DOI 10.1128/JCM.00451-08; Sharma P, 2005, LEPROSY REV, V76, P127; SINGH IG, 1992, INFECT IMMUN, V60, P257, DOI 10.1128/IAI.60.1.257-263.1992; SINGH IG, 1991, VACCINE, V9, P10, DOI 10.1016/0264-410X(91)90309-T; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Talwar G P, 1978, Lepr India, V50, P492; Talwar G P, 1999, Int Rev Immunol, V18, P229, DOI 10.3109/08830189909043027; TALWAR GP, 1990, VACCINE, V8, P121, DOI 10.1016/0264-410X(90)90134-8; Talwar GP, 2008, INFECT GENET EVOL, V8, P100, DOI 10.1016/j.meegid.2007.07.009; THIERRY D, 1993, J CLIN MICROBIOL, V31, P1048, DOI 10.1128/JCM.31.5.1048-1054.1993; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tonjum T, 1998, J CLIN MICROBIOL, V36, P918; Tortoli E, 2004, INT J SYST EVOL MICR, V54, P1277, DOI 10.1099/ijs.0.02777-0; Wayne LG, 1986, BERGEYS MANUAL SYSTE, V2, P1435; YADAVA A, 1991, SCAND J IMMUNOL, V34, P23, DOI 10.1111/j.1365-3083.1991.tb01517.x; ZAHEER SA, 1993, J INFECT DIS, V167, P401, DOI 10.1093/infdis/167.2.401; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0	52	66	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6263	10.1371/journal.pone.0006263	http://dx.doi.org/10.1371/journal.pone.0006263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606228	gold, Green Published, Green Submitted			2022-12-27	WOS:000268036000016
J	Gu, L; Waliany, S; Kane, SE				Gu, Long; Waliany, Sarah; Kane, Susan E.			Darpp-32 and Its Truncated Variant t-Darpp Have Antagonistic Effects on Breast Cancer Cell Growth and Herceptin Resistance	PLOS ONE			English	Article							TRASTUZUMAB RESISTANCE; MONOCLONAL-ANTIBODY; FACTOR-RECEPTOR; PROTEIN-KINASE; PI3K PATHWAY; EFFICACY; GENE; AKT; CHEMOTHERAPY; CONTRIBUTES	Background: Herceptin ( trastuzumab) is a humanized monoclonal antibody that is approved for the treatment of metastatic breast cancer patients whose tumors overexpress Her2 (erbB2/neu). Up to 70% of Her2-positive breast cancers demonstrate a response to Herceptin-based therapies, but resistance almost inevitably arises within a year of the initial response. To help understand the mechanism of Herceptin resistance, we isolated clonal variants of Her2-positive BT474 human breast cancer cells (BT/Her(R)) that are highly resistant to Herceptin. These cell lines exhibit sustained PI3K/Akt signaling as an essential component of Herceptin-resistant proliferation. Several genes in the protein kinase A (PKA) signaling network have altered expression in BT/Her(R) cells, including PPP1R1B, which encodes a 32 kDa protein known as Darpp-32 and its amino-terminal truncated variant, t-Darpp. The purpose of the current work was to determine the role of Darpp-32 and t-Darpp in Herceptin resistance. Methodology and Results: We determined expression of Darpp-32 and t-Darpp in BT/Her(R) cells selected for resistance to Herceptin. Subsequently, cDNAs encoding the two isoforms of Darpp-32 were transfected, separately and together, into Her2-positive SK-Br-3 breast cancer cells. Transfected cells were tested for resistance to Herceptin and Herceptin-mediated dephosphorylation of Akt. DNA binding activity by the cAMP response element binding protein (CREB) was also measured. We found that BT/Her(R) cells overexpressed t-Darpp but not Darpp-32. Moreover, t-Darpp overexpression in SK-Br-3 cells was sufficient for conferring resistance to Herceptin and Herceptin-mediated dephosphorylation of Akt. Darpp-32 co-expression reversed t-Darpp's effects on Herceptin resistance and Akt phosphorylation. t-Darpp overexpression led to increased CREB binding activity, which was also reversible by Darpp-32. Conclusions: t-Darpp and Darpp-32 appear to have antagonistic effects on Herceptin resistance. We present a unified model by which these effects might be mediated via the PKA regulatory network.			Gu, L (corresponding author), Beckman Res Inst City Hope, Div Tumor Cell Biol, Duarte, CA USA.	skane@coh.org		Waliany, Sarah/0000-0001-5960-8801				Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Beckler A, 2003, CANCER, V98, P1547, DOI 10.1002/cncr.11654; Belkhiri A, 2005, CANCER RES, V65, P6583, DOI 10.1158/0008-5472.CAN-05-1433; Belkhiri A, 2008, CLIN CANCER RES, V14, P4564, DOI 10.1158/1078-0432.CCR-08-0121; Belkhiri A, 2008, CANCER RES, V68, P395, DOI 10.1158/0008-5472.CAN-07-1580; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brady MJ, 1997, J BIOL CHEM, V272, P20198, DOI 10.1074/jbc.272.32.20198; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chan CT, 2005, BREAST CANCER RES TR, V91, P187, DOI 10.1007/s10549-004-7715-1; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Collins SP, 1997, J BIOL CHEM, V272, P18169, DOI 10.1074/jbc.272.29.18169; El-Rifai W, 2002, CANCER RES, V62, P4061; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Fujita T, 2006, BRIT J CANCER, V94, P247, DOI 10.1038/sj.bjc.6602926; Giuliani R, 2007, EUR J CANCER, V43, P725, DOI 10.1016/j.ejca.2006.11.019; HAMEL S, 2009, BREAST CANC RES TREA; Hung MC, 1999, SEMIN ONCOL, V26, P51; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Miller KD, 2004, ONCOLOGIST, V9, P16, DOI 10.1634/theoncologist.9-suppl_3-16; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2004, CANCER RES, V64, P3981, DOI 10.1158/0008-5472.CAN-03-3900; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Seidman AD, 2001, J CLIN ONCOL, V19, P2587, DOI 10.1200/JCO.2001.19.10.2587; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Xu WP, 2003, CANCER RES, V63, P7777; Yakes FM, 2002, CANCER RES, V62, P4132; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	35	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6220	10.1371/journal.pone.0006220	http://dx.doi.org/10.1371/journal.pone.0006220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593441	gold, Green Submitted, Green Published			2022-12-27	WOS:000268035400005
J	Hou, P; Liu, DX; Ji, MJ; Liu, Z; Engles, JM; Wahl, RL; Xing, MZ				Hou, Peng; Liu, Dingxie; Ji, Meiju; Liu, Zhi; Engles, James M.; Wahl, Richard L.; Xing, Mingzhao			Induction of Thyroid Gene Expression and Radioiodine Uptake in Melanoma Cells: Novel Therapeutic Implications	PLOS ONE			English	Article							SODIUM/IODIDE SYMPORTER; SIGNALING PATHWAYS; CUTANEOUS MELANOMA; BRAF MUTATIONS; CANCER; RAS; RAS/RAF/MEK/ERK; PROLIFERATION; INHIBITION; CARCINOMA	Both the MAP kinase and PI3K/Akt pathways play an important role in the pathogenesis of melanoma. We conducted the present study to test the hypothesis that targeting the two pathways to potently induce cell inhibition accompanied with thyroid iodide-handling gene expression for adjunct radioiodine ablation could be a novel effective therapeutic strategy for melanoma. We used specific shRNA approaches and inhibitors to individually or dually suppress the MAP kinase and PI3K/Akt pathways and examined the effects on a variety of molecular and cellular responses of melanoma cells that harbored activating genetic alterations in the two pathways. Suppression of the MAP kinase and PI3K/Akt pathways showed potent anti-melanoma cell effects, including the inhibition of cell proliferation, transformation and invasion, induction of G(0)/G(1) cell cycle arrest and, when the two pathways were dually suppressed, cell apoptosis. Remarkably, suppression of the two pathways, particularly simultaneous suppression of them, also induced expression of genes that are normally expressed in the thyroid gland, such as the genes for sodium/iodide symporter and thyroid-stimulating hormone receptor. Melanoma cells were consequently conferred the ability to take up radioiodide. We conclude that dually targeting the MAP kinase and PI3K/Akt pathways for potent cell inhibition coupled with induction of thyroid gene expression for adjunct radioiodine ablation therapy may prove to be a novel and effective therapeutic strategy for melanoma.			Hou, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Baltimore, MD 21205 USA.	mxing1@jhmi.edu	Hou, Peng/H-8073-2015; Liu, Zhi/D-2759-2012; Liu, Dingxie/C-2181-2011	Liu, Dingxie/0000-0002-8061-5704; WAHL, RICHARD L./0000-0002-7306-2590	NCI NIH HHS [R0-1 CA113507-01, R01 CA113507] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113507] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baker C. H., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P167, DOI 10.2174/1568008043339839; Ball DW, 2007, J CLIN ENDOCR METAB, V92, P4712, DOI 10.1210/jc.2007-1184; Boisvert-Adamo K, 2006, ONCOGENE, V25, P4848, DOI 10.1038/sj.onc.1209493; Buchsbaum DJ, 2005, J NUCL MED, V46, p179S; Cass LA, 2000, ONCOGENE, V19, P924, DOI 10.1038/sj.onc.1203393; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Cristotaro J, 2006, ENDOCR-RELAT CANCER, V13, P485, DOI 10.1677/erc.1.01164; Duntas LH, 2008, THYROID, V18, P509, DOI 10.1089/thy.2007.0331; Durante C, 2007, J CLIN ENDOCR METAB, V92, P2840, DOI 10.1210/jc.2006-2707; Dwyer RM, 2005, CLIN CANCER RES, V11, P1483, DOI 10.1158/1078-0432.CCR-04-1636; Ellerhorst JA, 2006, ENDOCR-RELAT CANCER, V13, P1269, DOI 10.1677/erc.1.01239; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Faivre J, 2004, CANCER RES, V64, P8045, DOI 10.1158/0008-5472.CAN-04-0893; Flaherty KT, 2006, CLIN CANCER RES, V12, p2366S, DOI 10.1158/1078-0432.CCR-05-2505; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Garcia B, 2002, MOL ENDOCRINOL, V16, P342, DOI 10.1210/me.16.2.342; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; He SJ, 2005, MOL CANCER THER, V4, P996, DOI 10.1158/1535-7163.MCT-04-0252; Jemal A, 2001, JNCI-J NATL CANCER I, V93, P678, DOI 10.1093/jnci/93.9.678; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kwong Lawrence, 2007, Adv Dermatol, V23, P99, DOI 10.1016/j.yadr.2007.07.015; Lasithiotakis KG, 2006, CANCER-AM CANCER SOC, V107, P1331, DOI 10.1002/cncr.22126; Liu DX, 2007, J CLIN ENDOCR METAB, V92, P2264, DOI 10.1210/jc.2006-1613; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marquette A, 2007, ARCH IMMUNOL THER EX, V55, P363, DOI 10.1007/s00005-007-0043-5; Mazzaferri EL, 2006, PRACTICAL MANAGEMENT OF THYROID CANCER: MULTIDISCIPLINARY APPROACH, P1, DOI 10.1007/1-84628-013-3_1; Meier F, 2007, BRIT J DERMATOL, V156, P1204, DOI 10.1111/j.1365-2133.2007.07821.x; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Mian C, 2001, EXP CLIN ENDOCR DIAB, V109, P47, DOI 10.1055/s-2001-11012; Mian C, 2008, CLIN ENDOCRINOL, V68, P108, DOI 10.1111/j.1365-2265.2007.03008.x; Nilsson M, 2001, EXP CLIN ENDOCR DIAB, V109, P13, DOI 10.1055/s-2001-11014; Pohlenz J, 2000, J CLIN ENDOCR METAB, V85, P2366, DOI 10.1210/jc.85.7.2366; Ries L MD, 2008, SEER CANC STAT REV 1; Riesco-Eizaguirre G, 2006, ENDOCR-RELAT CANCER, V13, P257, DOI 10.1677/erc.1.01119; Riesco-Eizaguirre G, 2006, EUR J ENDOCRINOL, V155, P495, DOI 10.1530/eje.1.02257; Satyamoorthy K, 2003, CANCER RES, V63, P756; Schipper ML, 2007, EUR J NUCL MED MOL I, V34, P638, DOI 10.1007/s00259-006-0254-8; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Tawbi HA, 2007, SEMIN ONCOL, V34, P532, DOI 10.1053/j.seminoncol.2007.09.008; Willhauck M, 2008, GENE THER, V15, P214, DOI 10.1038/sj.gt.3303057; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987	47	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6200	10.1371/journal.pone.0006200	http://dx.doi.org/10.1371/journal.pone.0006200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593429	gold, Green Submitted, Green Published			2022-12-27	WOS:000268035300012
J	Stepanian, A; Benchenni, S; Beillat-Lucas, T; Omnes, S; Defay, F; Peynaud-Debayle, E; Baron, G; Le Querrec, A; Dreyfus, M; Salomon, L; Tsatsaris, V; de Prost, D; Mandelbrot, L				Stepanian, Alain; Benchenni, Soraya; Beillat-Lucas, Tiphaine; Omnes, Sophie; Defay, Fannie; Peynaud-Debayle, Edith; Baron, Gabriel; Le Querrec, Agnes; Dreyfus, Michel; Salomon, Laurence; Tsatsaris, Vassilis; de Prost, Dominique; Mandelbrot, Laurent		ECLAXIR Study Grp	Search for an Association between V249I and T280M CX3CR1 Genetic Polymorphisms, Endothelial Injury and Preeclampsia: The ECLAXIR Study	PLOS ONE			English	Article							FRACTALKINE RECEPTOR CX3CR1; MIGRATION; DISEASE; RISK; TROPHOBLAST; DYSFUNCTION; CX(3)CR1; REVEALS; VARIANT; CCL14	Background: Preeclampsia and coronary-artery disease share risk factors, suggesting common pathophysiological mechanisms. CX3CR1/CX3CL1 mediates leukocyte migration and adhesion and has been implicated in the pathophysiology of several inflammatory diseases. M280/I249 variants of CX3CR1 are associated with an atheroprotective effect and reduced endothelial dysfunction. The aim of this study was to search for an association between V249I and T280M polymorphisms of CX3CR1, preeclampsia and endothelial dysfunction. Methodology/Principal Findings: We explored these polymorphisms with real-time polymerase chain reaction in a case-control study (184 white women with preeclampsia and 184 matched normotensive pregnant women). Endothelial dysfunction biomarkers including von Willebrand factor, VCAM-1 and thrombomodulin, as well as the soluble form of CX3CL1 were measured by enzyme-linked immunosorbent assays (ELISA). The I249 and M280 alleles were associated neither with preeclampsia, nor with its more severe form or with endothelial injury. In contrast, we found a trend toward increased CX3CL1 levels in preeclampsia patients, especially in early-onset-preeclampsia as compared to its level in later-onset-preeclampsia. Conclusions/Significance: This is the first study to characterize the CX3CR1 gene polymorphisms in patients with preeclampsia. We found no differences in genotype or haplotype frequencies between patients with PE and normal pregnancies, suggesting that maternal CX3CR1 V249I and T280M polymorphisms do not increase susceptibility to preeclampsia. Further studies should be performed to directly evaluate the pathophysiological role of CX3CL1, a molecule abundantly expressed in endometrium, which has been shown to stimulate human trophoblast migration.			Stepanian, A (corresponding author), Hop Louis Mourier, AP HP, Serv Hematol Biol, F-92701 Colombes, France.	dominique.de-prost@lmr.aphp.fr	Mandelbrot, Laurent/AAD-3554-2019	Mandelbrot, Laurent/0000-0002-5883-7597; Stepanian, Alain/0000-0002-2942-0901				ACOG, 2002, INT J GYNECOL OBSTET, V76, P95; Chappell S, 2006, CLIN SCI, V110, P443, DOI 10.1042/CS20050323; Cockwell P, 2002, J PATHOL, V196, P85, DOI 10.1002/path.1010; Cybulsky MI, 2003, J CLIN INVEST, V111, P1118, DOI 10.1172/JCI200318237; Daoudi M, 2004, J BIOL CHEM, V279, P19649, DOI 10.1074/jbc.M313457200; DeVries ME, 2003, J BIOL CHEM, V278, P11985, DOI 10.1074/jbc.M211422200; Dominguez F, 2005, FASEB J, V19, P1056, DOI 10.1096/fj.05-3781hyp; Faure S, 2000, SCIENCE, V287, P2274, DOI 10.1126/science.287.5461.2274; Granger JP, 2001, HYPERTENSION, V38, P718, DOI 10.1161/01.HYP.38.3.718; Hannan NJ, 2008, BIOL REPROD, V79, P58, DOI 10.1095/biolreprod.107.066480; Hannan NJ, 2006, BIOL REPROD, V74, P896, DOI 10.1095/biolreprod.105.045518; Hannan NJ, 2004, J CLIN ENDOCR METAB, V89, P6119, DOI 10.1210/jc.2003-031379; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Haukkamaa L, 2004, AM J CARDIOL, V93, P805, DOI 10.1016/j.amjcard.2003.11.065; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; LABARRERE CA, 1988, PLACENTA, V9, P95, DOI 10.1016/0143-4004(88)90076-8; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lee SJ, 2006, AM J PHYSIOL-HEART C, V291, pH2836, DOI 10.1152/ajpheart.00113.2006; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Maho A, 1999, CYTOGENET CELL GENET, V87, P265, DOI 10.1159/000015443; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Muetze S, 2008, J PERINAT MED, V36, P38, DOI 10.1515/JPM.2008.004; Poston Lucilla, 2006, Pharmacol Rep, V58 Suppl, P69; Ramsay JE, 2003, BJOG-INT J OBSTET GY, V110, P1029, DOI 10.1111/j.1471-0528.2003.02069.x; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Sabate JM, 2008, EUR J GASTROEN HEPAT, V20, P748, DOI 10.1097/MEG.0b013e3282f824c9; Salomon LJ, 2007, ULTRASOUND OBST GYN, V29, P550, DOI 10.1002/uog.4019; Shimoya K, 2003, MOL HUM REPROD, V9, P97, DOI 10.1093/molehr/gag009; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TJOA ML, 2007, FRONT BIOSCI, V12, P2402; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F; Zintzaras E, 2006, HUM GENET, V120, P360, DOI 10.1007/s00439-006-0214-1	39	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6192	10.1371/journal.pone.0006192	http://dx.doi.org/10.1371/journal.pone.0006192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587779	gold, Green Published, Green Submitted			2022-12-27	WOS:000268035100013
J	Redhu, NS; Saleh, A; Shan, LY; Gerthoffer, WT; Kung, SK; Halayko, AJ; Lamkhioued, B; Gounni, AS				Redhu, Naresh Singh; Saleh, Ali; Shan, Lianyu; Gerthoffer, William T.; Kung, Sam K.; Halayko, Andrew J.; Lamkhioued, Bouchaib; Gounni, Abdelilah S.			Proinflammatory and Th2 Cytokines Regulate the High Affinity IgE Receptor (Fc epsilon RI) and IgE-Dependant Activation of Human Airway Smooth Muscle Cells	PLOS ONE			English	Article								Background: The high affinity IgE receptor (Fc epsilon RI) is a crucial structure for IgE-mediated allergic reactions. We have previously demonstrated that human airway smooth muscle (ASM) cells express the tetrameric (alpha beta gamma 2) Fc epsilon RI, and its activation leads to marked transient increases in intracellular Ca2+ concentration, release of Th-2 cytokines and eotaxin-1/CCL11. Therefore, it was of utmost importance to delineate the factors regulating the expression of Fc epsilon RI in human (ASM) cells. Methodology/Principal Findings: Incubation of human bronchial and tracheal smooth muscle (B/TSM) cells with TNF-alpha, IL-1 beta or IL-4 resulted in a significant increase in Fc epsilon RI-alpha chain mRNA expression (p<0.05); and TNF-alpha, IL-4 enhanced the Fc epsilon RI-alpha protein expression compared to the unstimulated control at 24, 72 hrs after stimulation. Interestingly, among all other cytokines, only TNF-alpha upregulated the Fc epsilon RI-gamma mRNA expression. Fc epsilon RI-gamma protein expression remained unchanged despite the nature of stimulation. Of note, as a functional consequence of Fc epsilon RI upregulation, TNF-alpha pre-sensitization of B/TSM potentially augmented the CC (eotaxin-1/CCL11 and RANTES/CCL5, but not TARC/CCL17) and CXC (IL-8/CXCL8, IP-10/CXCL10) chemokines release following IgE stimulation (p<0.05, n = 3). Furthermore, IgE sensitization of B/TSM cells significantly enhanced the transcription of selective CC and CXC chemokines at promoter level compared to control, which was abolished by Lentivirus-mediated silencing of Syk expression. Conclusions/Significance: Our data depict a critical role of B/TSM in allergic airway inflammation via potentially novel mechanisms involving proinflammatory, Th2 cytokines and IgE/Fc epsilon RI complex.			Redhu, NS (corresponding author), Univ Manitoba, Sect Resp Dis, Dept Immunol, Winnipeg, MB, Canada.	gounni@cc.umanitoba.ca	LAMKHIOUED, Bouchaib/AAL-4201-2021; Gounni, Abdelilah Soussi/AAH-3456-2020	Halayko, Andrew/0000-0002-7865-4552; Gerthoffer, William/0000-0001-5154-4962; Soussi Gounni, Abdelilah/0000-0002-7282-0388; Gounni, Abdelilah/0000-0003-1265-6560	NHLBI NIH HHS [R01 HL077726] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077726] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alphonse MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001921; Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; Banerjee A, 2008, BRIT J PHARMACOL, V155, P84, DOI 10.1038/bjp.2008.232; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Dragon S, 2007, AM J PHYSIOL-LUNG C, V292, pL1023, DOI 10.1152/ajplung.00306.2006; Ganguly S, 2007, J BIOL CHEM, V282, P32758, DOI 10.1074/jbc.M705950200; Gomez G, 2005, J IMMUNOL, V174, P5987, DOI 10.4049/jimmunol.174.10.5987; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gounni AS, 2006, AM J PHYSIOL-LUNG C, V291, pL312, DOI 10.1152/ajplung.00005.2006; Gounni AS, 2005, J IMMUNOL, V175, P2613, DOI 10.4049/jimmunol.175.4.2613; Hakonarson H, 1998, P NATL ACAD SCI USA, V95, P5257, DOI 10.1073/pnas.95.9.5257; Halayko AJ, 2003, RESP PHYSIOL NEUROBI, V137, P209, DOI 10.1016/S1569-9048(03)00148-4; Hirst SJ, 2002, AM J RESP CRIT CARE, V165, P1161, DOI 10.1164/ajrccm.165.8.2107158; Holgate ST, 2004, J ROY SOC MED, V97, P103, DOI 10.1258/jrsm.97.3.103; Jarai G, 2004, EUR J PHARMACOL, V497, P255, DOI 10.1016/j.ejphar.2004.06.055; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Katoh N, 2000, J CLIN INVEST, V105, P183, DOI 10.1172/JCI6895; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kraft S, 1998, J IMMUNOL, V161, P1000; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kung SKP, 2000, J VIROL, V74, P3668, DOI 10.1128/JVI.74.8.3668-3681.2000; Leath TM, 2005, DRUG DISCOV TODAY, V10, P1647, DOI 10.1016/S1359-6446(05)03646-9; LETOURNEUR O, 1995, J BIOL CHEM, V270, P8249, DOI 10.1074/jbc.270.14.8249; MacGlashan DW, 2007, J LEUKOCYTE BIOL, V82, P1003, DOI 10.1189/jlb.0207103; Mirkina I, 2007, IMMUNOL LETT, V109, P120, DOI 10.1016/j.imlet.2007.02.003; Moore PE, 2002, AM J PHYSIOL-LUNG C, V282, pL847, DOI 10.1152/ajplung.00245.2001; Nag SS, 2003, J ALLERGY CLIN IMMUN, V111, P558, DOI 10.1067/mai.2003.131; Nakae S, 2007, J ALLERGY CLIN IMMUN, V119, P680, DOI 10.1016/j.jaci.2006.11.701; Naureckas ET, 1999, AM J RESP CRIT CARE, V160, P2062, DOI 10.1164/ajrccm.160.6.9903131; Nechansky A, 1997, HYBRIDOMA, V16, P441, DOI 10.1089/hyb.1997.16.441; Novak N, 2003, J CLIN INVEST, V111, P1047, DOI 10.1172/JCI200315932; Oltmanns U, 2003, BRIT J PHARMACOL, V139, P1228, DOI 10.1038/sj.bjp.0705345; Peat JK, 1996, ALLERGY, V51, P804, DOI 10.1111/j.1398-9995.1996.tb00026.x; Rahman MS, 2006, J IMMUNOL, V177, P4064, DOI 10.4049/jimmunol.177.6.4064; Saffar AS, 2007, J IMMUNOL, V178, P2535, DOI 10.4049/jimmunol.178.4.2535; Schmidt D, 2000, J ALLERGY CLIN IMMUN, V105, P673, DOI 10.1067/mai.2000.105705; Terada N, 1995, J ALLERGY CLIN IMMUN, V96, P1161, DOI 10.1016/S0091-6749(95)70201-6; Thomas LH, 2007, CLIN IMMUNOL, V122, P229, DOI 10.1016/j.clim.2006.10.004; Tirumurugaan KG, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-26; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; Widegren H, 2007, RESP MED, V101, P1982, DOI 10.1016/j.rmed.2007.04.005; Xia HZ, 1997, J IMMUNOL, V159, P2911; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6	48	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6153	10.1371/journal.pone.0006153	http://dx.doi.org/10.1371/journal.pone.0006153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582151	Green Submitted, gold, Green Published			2022-12-27	WOS:000267806400009
J	Majhi, SK; Hattori, RS; Yokota, M; Watanabe, S; Struessmann, CA				Majhi, Sullip K.; Hattori, Ricardo S.; Yokota, Masashi; Watanabe, Seiichi; Struessmann, Carlos A.			Germ Cell Transplantation Using Sexually Competent Fish: An Approach for Rapid Propagation of Endangered and Valuable Germlines	PLOS ONE			English	Article							SPERMATOGONIAL TRANSPLANTATION; ODONTESTHES-BONARIENSIS; STEM-CELLS; SPERMATOGENESIS; TESTIS; AQUACULTURE; DEFICIENCY; GENERATION; FERTILITY; TILAPIA	The transplantation of germ cells into adult recipient gonads is a tool with wide applications in animal breeding and conservation of valuable and/or endangered species; it also provides a means for basic studies involving germ cell (GC) proliferation and differentiation. Here we describe the establishment of a working model for xenogeneic germ cell transplantation (GCT) in sexually competent fish. Spermatogonial cells isolated from juveniles of one species, the pejerrey Odontesthes bonariensis (Atherinopsidae), were surgically transplanted into the gonads of sexually mature Patagonian pejerrey O. hatcheri, which have been partially depleted of endogenous GCs by a combination of Busulfan (40 mg/kg) and high water temperature (25 degrees C) treatments. The observation of the donor cells' behavior showed that transplanted spermatogonial cells were able to recolonize the recipients' gonads and resume spermatogenesis within 6 months from the GCT. The presence of donor-derived gametes was confirmed by PCR in 20% of the surrogate O. hatcheri fathers at 6 months and crosses with O. bonariensis mothers produced hybrids and pure O. bonariensis, with donor-derived germline transmission rates of 1.2 - 13.3%. These findings indicate that transplantation of spermatogonial cells into sexually competent fish can shorten considerably the production time of donor-derived gametes and offspring and could play a vital role in germline conservation and propagation of valued and/or endangered fish species.			Majhi, SK (corresponding author), Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Tokyo, Japan.	carlos@kaiyodai.ac.jp	Hattori, Ricardo S/K-2870-2012; Strussmann, Carlos A/O-1932-2014; YOKOTA, Masashi/O-1947-2014; Wei, Qiwei/B-6928-2014	YOKOTA, Masashi/0000-0002-4121-4115; Wei, Qiwei/0000-0002-6366-1020; Majhi, Dr. Sullip Kumar/0000-0001-9389-7467				Arai K, 2001, AQUACULTURE, V197, P205, DOI 10.1016/S0044-8486(01)00588-9; Bouma GJ, 2005, J EXP ZOOL PART A, V303A, P698, DOI 10.1002/jez.a.197; Brinster CJ, 2003, BIOL REPROD, V69, P412, DOI 10.1095/biolreprod.103.016519; Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Hamra FK, 2002, P NATL ACAD SCI USA, V99, P14931, DOI 10.1073/pnas.222561399; Jiang FX, 1995, INT J ANDROL, V18, P326, DOI 10.1111/j.1365-2605.1995.tb00570.x; Lacerda S. M. S. N., 2006, Animal Reproduction, V3, P146; Lacerda SMSN, 2008, CYBIUM, V32, P115; Maclean N, 2002, GENE, V295, P265, DOI 10.1016/S0378-1119(02)00735-7; Majhi SK, 2009, THERIOGENOLOGY, V71, P1162, DOI 10.1016/j.theriogenology.2008.12.008; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagler JJ, 2001, BIOL REPROD, V64, P644, DOI 10.1095/biolreprod64.2.644; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Nobrega RH, 2009, FISH PHYSIOL BIOCHEM, V35, P197, DOI 10.1007/s10695-008-9252-z; Ogawa T, 1999, TISSUE CELL, V31, P461, DOI 10.1054/tice.1999.0060; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ogawa T, 2001, J MOL MED-JMM, V79, P368, DOI 10.1007/s001090100228; Okutsu T, 2006, P NATL ACAD SCI USA, V103, P2725, DOI 10.1073/pnas.0509218103; Okutsu T, 2007, SCIENCE, V317, P1517, DOI 10.1126/science.1145626; Parenti LR, 2004, INTEGR COMP BIOL, V44, P333, DOI 10.1093/icb/44.5.333; Pukazhenthi B, 2006, REPROD FERT DEVELOP, V18, P77, DOI 10.1071/RD05117; Saito T, 2008, BIOL REPROD, V78, P159, DOI 10.1095/biolreprod.107.060038; Schulz Rudiger Winfried, 2003, ARBS Annual Review of Biomedical Sciences, V5, P57; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinomiya A, 2001, J EXP ZOOL, V290, P402, DOI 10.1002/jez.1081; Somoza GM, 2008, AQUAC RES, V39, P784, DOI 10.1111/j.1365-2109.2008.01930.x; Strussmann CA, 1998, COMP BIOCHEM PHYS A, V119, P637, DOI 10.1016/S1095-6433(97)00477-7; Strussmann CA, 1997, AQUAC RES, V28, P291, DOI 10.1111/j.1365-2109.1997.tb01045.x; Takeuchi Y, 2004, NATURE, V430, P629, DOI 10.1038/430629a; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624; Wang CQF, 2007, J CELL BIOL, V178, P549, DOI 10.1083/jcb.200704061	33	57	65	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6132	10.1371/journal.pone.0006132	http://dx.doi.org/10.1371/journal.pone.0006132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GX	19572014	Green Published, Green Submitted, gold			2022-12-27	WOS:000267806200007
J	Yang, X; Xie, L; Li, YX; Wei, CC				Yang, Xing; Xie, Lu; Li, Yixue; Wei, Chaochun			More than 9,000,000 Unique Genes in Human Gut Bacterial Community: Estimating Gene Numbers Inside a Human Body	PLOS ONE			English	Article							MICROBIOME; OBESITY; DIVERSITY; DIET	Background: Estimating the number of genes in human genome has been long an important problem in computational biology. With the new conception of considering human as a super-organism, it is also interesting to estimate the number of genes in this human super-organism. Principal Findings: We presented our estimation of gene numbers in the human gut bacterial community, the largest microbial community inside the human super-organism. We got 552,700 unique genes from 202 complete human gut bacteria genomes. Then, a novel gene counting model was built to check the total number of genes by combining culture-independent sequence data and those complete genomes. 16S rRNAs were used to construct a three-level tree and different counting methods were introduced for the three levels: strain-to-species, species-to-genus, and genus-and-up. The model estimates that the total number of genes is about 9,000,000 after those with identity percentage of 97% or up were merged. Conclusion: By combining completed genomes currently available and culture-independent sequencing data, we built a model to estimate the number of genes in human gut bacterial community. The total number of genes is estimated to be about 9 million. Although this number is huge, we believe it is underestimated. This is an initial step to tackle this gene counting problem for the human super-organism. It will still be an open problem in the near future. The list of genomes used in this paper can be found in the supplementary table.			Yang, X (corresponding author), Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China.	yxli@sibs.ac.cn; ccwei@sjtu.edu.cn	wei, chaochun/AAW-2846-2020	Wei, Chaochun/0000-0002-1031-034X				Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Das M, 2001, GENOMICS, V77, P71, DOI 10.1006/geno.2001.6620; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FIELDS C, 1994, NAT GENET, V7, P345, DOI 10.1038/ng0794-345; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wei CC, 2005, GENOME RES, V15, P577, DOI 10.1101/gr.3329005; Wei CC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-327; Zhu J, 2008, ADV GENET, V60, P603, DOI 10.1016/S0065-2660(07)00421-X	24	98	106	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6074	10.1371/journal.pone.0006074	http://dx.doi.org/10.1371/journal.pone.0006074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562079	Green Published, gold, Green Submitted			2022-12-27	WOS:000267465900009
J	Kang, JI; Vaucher, E				Kang, Jun Il; Vaucher, Elvire			Cholinergic Pairing with Visual Activation Results in Long-Term Enhancement of Visual Evoked Potentials	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; EXCITATORY POSTSYNAPTIC POTENTIALS; IN-VIVO; SYNAPTIC PLASTICITY; NUCLEUS BASALIS; RAT HIPPOCAMPUS; CORTEX; MODULATION; STIMULATION; NEURONS	Acetylcholine (ACh) contributes to learning processes by modulating cortical plasticity in terms of intensity of neuronal activity and selectivity properties of cortical neurons. However, it is not known if ACh induces long term effects within the primary visual cortex (V1) that could sustain visual learning mechanisms. In the present study we analyzed visual evoked potentials (VEPs) in V1 of rats during a 4-8 h period after coupling visual stimulation to an intracortical injection of ACh analog carbachol or stimulation of basal forebrain. To clarify the action of ACh on VEP activity in V1, we individually pre-injected muscarinic (scopolamine), nicotinic (mecamylamine), alpha 7 (methyllycaconitine), and NMDA (CPP) receptor antagonists before carbachol infusion. Stimulation of the cholinergic system paired with visual stimulation significantly increased VEP amplitude (56%) during a 6 h period. Pre-treatment with scopolamine, mecamylamine and CPP completely abolished this long-term enhancement, while alpha 7 inhibition induced an instant increase of VEP amplitude. This suggests a role of ACh in facilitating visual stimuli responsiveness through mechanisms comparable to LTP which involve nicotinic and muscarinic receptors with an interaction of NMDA transmission in the visual cortex.			Kang, JI (corresponding author), Univ Montreal, Ecole Optometrie, Montreal, PQ H3C 3J7, Canada.	elvire.vaucher@umontreal.ca		Vaucher, Elvire/0000-0001-7075-5263				AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alenda A, 2007, BRAIN RES, V1133, P158, DOI 10.1016/j.brainres.2006.11.092; BROCHER S, 1992, BRAIN RES, V573, P27, DOI 10.1016/0006-8993(92)90110-U; Christophe E, 2002, J NEUROPHYSIOL, V88, P1318, DOI 10.1152/jn.2002.88.3.1318; Clapp WC, 2006, NEUROREPORT, V17, P511, DOI 10.1097/01.wnr.0000209004.63352.10; Colgin LL, 2003, P NATL ACAD SCI USA, V100, P2872, DOI 10.1073/pnas.0530289100; CREUTZFELDT OD, 1975, SCIENCE, V188, P1025, DOI 10.1126/science.1145187; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Dotigny F, 2008, NEUROSCIENCE, V154, P1607, DOI 10.1016/j.neuroscience.2008.04.030; Dringenberg HC, 2007, CEREB CORTEX, V17, P839, DOI 10.1093/cercor/bhk038; Erisir A, 2001, J COMP NEUROL, V441, P168, DOI 10.1002/cne.1405; Ge SY, 2005, J NEUROSCI, V25, P6084, DOI 10.1523/JNEUROSCI.0542-05.2005; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; GREUEL JM, 1988, SCIENCE, V242, P74, DOI 10.1126/science.2902687; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Kawai H, 2007, NAT NEUROSCI, V10, P1168, DOI 10.1038/nn1956; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Kuczewski N, 2005, EUR J NEUROSCI, V21, P1807, DOI 10.1111/j.1460-9568.2005.04014.x; Laplante F, 2005, NEUROSCIENCE, V132, P501, DOI 10.1016/j.neuroscience.2004.11.059; LEVEY AI, 1991, J NEUROSCI, V11, P3218; Levy RB, 2006, J NEUROPHYSIOL, V95, P2155, DOI 10.1152/jn.00603.2005; Li S, 2007, NEUROSCIENCE, V144, P754, DOI 10.1016/j.neuroscience.2006.10.001; MARKRAM H, 1990, J PHYSIOL-LONDON, V427, P381, DOI 10.1113/jphysiol.1990.sp018177; MCCORMICK DA, 1985, P NATL ACAD SCI USA, V82, P6344, DOI 10.1073/pnas.82.18.6344; McCoy PA, 2007, J NEUROPHYSIOL, V98, P1862, DOI 10.1152/jn.00510.2007; Metherate R, 2004, LEARN MEMORY, V11, P50, DOI 10.1101/lm.69904; Miasnikov AA, 2008, NEUROBIOL LEARN MEM, V90, P443, DOI 10.1016/j.nlm.2008.05.010; Mrzljak L, 1998, J COMP NEUROL, V390, P112; Oldford E, 2003, NEUROSCIENCE, V117, P769, DOI 10.1016/S0306-4522(02)00663-2; Origlia N, 2008, ARCH ITAL BIOL, V146, P165; Origlia N, 2006, J PHYSIOL-LONDON, V577, P829, DOI 10.1113/jphysiol.2006.117119; Papke RL, 2001, J PHARMACOL EXP THER, V297, P646; Penschuck S, 2002, J COMP NEUROL, V452, P38, DOI 10.1002/cne.10361; PFISTER M, 1994, J NEURAL TRANSM-GEN, V97, P13, DOI 10.1007/BF01277959; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Roberts MJ, 2005, J NEUROPHYSIOL, V93, P2062, DOI 10.1152/jn.00911.2004; Rodriguez R, 2004, J NEUROSCI, V24, P10369, DOI 10.1523/JNEUROSCI.1839-04.2004; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Salgado H, 2007, J NEUROPHYSIOL, V98, P952, DOI 10.1152/jn.00060.2007; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Vaucher E, 1997, J CEREBR BLOOD F MET, V17, P686; Verdier D, 2001, EXP BRAIN RES, V137, P71, DOI 10.1007/s002210000646; Wang Y, 2006, NEUROSCI LETT, V406, P183, DOI 10.1016/j.neulet.2006.06.075; Yamazaki Y, 2005, EUR J NEUROSCI, V22, P845, DOI 10.1111/j.1460-9568.2005.04259.x; Yoshimura Y, 2003, J NEUROSCI, V23, P6557; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	55	38	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5995	10.1371/journal.pone.0005995	http://dx.doi.org/10.1371/journal.pone.0005995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543405	Green Published, gold			2022-12-27	WOS:000267237600009
J	Nie, MH; Xie, YM; Loo, JA; Courey, AJ				Nie, Minghua; Xie, Yongming; Loo, Joseph A.; Courey, Albert J.			Genetic and Proteomic Evidence for Roles of Drosophila SUMO in Cell Cycle Control, Ras Signaling, and Early Pattern Formation	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; RECEPTOR TYROSINE KINASE; POLO-LIKE KINASES; EGF RECEPTOR; SACCHAROMYCES-CEREVISIAE; CONJUGATING ENZYME; SUMOYLATION; IDENTIFICATION; NUCLEAR; PATHWAY	SUMO is a protein modifier that is vital for multicellular development. Here we present the first system-wide analysis, combining multiple approaches, to correlate the sumoylated proteome (SUMO-ome) in a multicellular organism with the developmental roles of SUMO. Using mass-spectrometry-based protein identification, we found over 140 largely novel SUMO conjugates in the early Drosophila embryo. Enriched functional groups include proteins involved in Ras signaling, cell cycle, and pattern formation. In support of the functional significance of these findings, sumo germline clone embryos exhibited phenotypes indicative of defects in these same three processes. Our cell culture and immunolocalization studies further substantiate roles for SUMO in Ras signaling and cell cycle regulation. For example, we found that SUMO is required for efficient Ras-mediated MAP kinase activation upstream or at the level of Ras activation. We further found that SUMO is dynamically localized during mitosis to the condensed chromosomes, and later also to the midbody. Polo kinase, a SUMO substrate found in our screen, partially colocalizes with SUMO at both sites. These studies show that SUMO coordinates multiple regulatory processes during oogenesis and early embryogenesis. In addition, our database of sumoylated proteins provides a valuable resource for those studying the roles of SUMO in development.			Nie, MH (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	courey@chem.ucla.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063596] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63596, R01 GM063596] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bauer DC, 2008, LECT N BIOINFORMAT, V5265, P28, DOI 10.1007/978-3-540-88436-1_3; Bhaskar V, 2000, J BIOL CHEM, V275, P4033, DOI 10.1074/jbc.275.6.4033; Bhaskar V, 2002, MOL CELL BIOL, V22, P492, DOI 10.1128/MCB.22.2.492-504.2002; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Capelson M, 2006, EMBO J, V25, P1906, DOI 10.1038/sj.emboj.7601068; Chou TB, 1996, GENETICS, V144, P1673; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Delanoue R, 2004, CELL DEATH DIFFER, V11, P110, DOI 10.1038/sj.cdd.4401321; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Epps JL, 1998, CURR BIOL, V8, P1277, DOI 10.1016/S0960-9822(07)00538-6; FOGARTY P, 1994, DEVELOPMENT, V120, P2131; FREEMAN M, 1986, CELL, V46, P457, DOI 10.1016/0092-8674(86)90666-5; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ghiglione C, 2002, DEVELOPMENT, V129, P175; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; Hashiyama K, 2009, GENE EXPR PATTERNS, V9, P50, DOI 10.1016/j.gep.2008.08.001; HEUER JG, 1995, DEVELOPMENT, V121, P3861; Huang HW, 1998, BIOCHEM MOL BIOL INT, V46, P775; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Jones D, 2002, GENOME BIOL, V3; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Legent K, 2006, GENES CELLS, V11, P907, DOI 10.1111/j.1365-2443.2006.00993.x; Lehembre F, 2000, MOL CELL BIOL, V20, P1072, DOI 10.1128/MCB.20.3.1072-1082.2000; Loevenich SN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-59; Long XM, 2000, J BIOL CHEM, V275, P40765, DOI 10.1074/jbc.M003949200; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Mencia M, 2004, PROTEIN EXPRES PURIF, V37, P409, DOI 10.1016/j.pep.2004.07.001; Miles WO, 2008, GENE DEV, V22, P2578, DOI 10.1101/gad.494808; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Nowak M, 2006, MOL BIOL CELL, V17, P5324, DOI 10.1091/mbc.E06-05-0413; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Perez-Mongiovi D, 2005, DEVELOPMENT, V132, P4509, DOI 10.1242/dev.02028; Poulin G, 2005, EMBO J, V24, P2613, DOI 10.1038/sj.emboj.7600726; RAFF JW, 1988, J CELL BIOL, V107, P2009, DOI 10.1083/jcb.107.6.2009; Ray RP, 1996, GENE DEV, V10, P1711, DOI 10.1101/gad.10.14.1711; Rebay I, 2002, DEV BIOL, V251, P1, DOI 10.1006/dbio.2002.0806; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sapir A, 1998, DEVELOPMENT, V125, P191; Savare J, 2005, MOL BIOL CELL, V16, P2660, DOI 10.1091/mbc.e04-12-1062; Schnorr JD, 2001, GENETICS, V159, P609; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shayeghi M, 1997, NUCLEIC ACIDS RES, V25, P1162, DOI 10.1093/nar/25.6.1162; Shih HP, 2002, J CELL SCI, V115, P1259; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Smith M, 2004, J BIOL CHEM, V279, P43805, DOI 10.1074/jbc.M404942200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Su TT, 2001, J CELL SCI, V114, P3445; Takanaka Y, 2005, MECH DEVELOP, V122, P1130, DOI 10.1016/j.mod.2005.05.004; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; Van Buskirk C, 1999, TRENDS CELL BIOL, V9, P1, DOI 10.1016/S0962-8924(98)01413-5; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Wohlschlegel JA, 2006, J PROTEOME RES, V5, P761, DOI 10.1021/pr050451o; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Xu JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-8; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4; Zhao YM, 2004, J BIOL CHEM, V279, P20999, DOI 10.1074/jbc.M401541200; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	86	99	99	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5905	10.1371/journal.pone.0005905	http://dx.doi.org/10.1371/journal.pone.0005905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529778	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029500004
J	Wang, XM; Liu, M; Li, WD; Suh, CD; Zhu, ZY; Jin, YS; Fan, QC				Wang, Xiangming; Liu, Min; Li, Weida; Suh, Christopher D.; Zhu, Zuoyan; Jin, Yishi; Fan, Qichang			The Function of a Spindle Checkpoint Gene bub-1 in C. elegans Development	PLOS ONE			English	Article								Background: The serine/threonine kinase BUB1 (Budding Uninhibited by Benzimidazole 1) was originally identified in yeast as a checkpoint protein, based on its mutant's incapacity of delaying the cell cycle in response to loss of microtubules. Our understanding of its function is primarily from studies carried out in yeast S. cerevisiae. It has been shown that it is a component of the mitotic spindle checkpoint and regulates the separation of sister chromatids through its downstream molecules. However, its roles in multi-cellular organisms remain unclear. Methods and Findings: In nematode C. elegans, rapid cell divisions primarily occur in embryos and in germline of postembryonic larvae and adults. In addition, a select set of cells undergo a few rounds of cell division postembryonically. One common phenotype associated with impaired cell division is described as Stu (Sterile and Uncoordinated) [1,2]. We conducted a genetic screen for zygotic mutants that displayed Stu phenotype in C. elegans. We isolated seven Stu mutants that fell into five complementation groups. We report here that two mutations, FanWang5 (fw5) and FanWang8 (fw8) affect the bub-1 gene, a homolog of yeast BUB1. Both mutant alleles of fw5 and fw8 exhibited variable behavioral defects, including developmental arrest, uncoordination and sterility. The number of postembryonically born neurons in the ventral cord decreased and their axon morphology was abnormal. Also, the decrease of neurons in the ventral cord phenotype could not be suppressed by a caspase-3 loss-of-function mutant. In addition, bub-1(fw5 and fw8) mutants showed widespread effects on postembryonic development in many cell lineages. We found that bub-1 functioned maternally in several developmental lineages at the embryonic stage in C. elegans. Studies in yeast have shown that BUB1 functions as a spindle checkpoint protein by regulating the anaphase promoting complex/cyclosome (APC/C). We performed double mutant analysis and observed that bub-1 genetically interacted with several downstream genes, including fzy-1/CDC20, mat-2/APC1 and emb-27/APC6. Conclusions: Our results demonstrate a conserved role of bub-1 in cell-cycle regulation and reveal that C. elegans bub-1 is required both maternally and zygotically. Further, our genetic analysis is consistent with that the function of bub-1 in C. elegans is likely similar to its yeast and mammalian homologs.			Wang, XM (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	qfan@pku.edu.cn	Li, Weida/M-4700-2013	Jin, Yishi/0000-0002-9371-9860; Liu, Min/0000-0002-8077-0130	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Altun Z, 2005, HDB C ELEGANS ANATOM; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Baker DJ, 2005, CURR OPIN CELL BIOL, V17, P583, DOI 10.1016/j.ceb.2005.09.011; Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Boxem M, 1999, DEVELOPMENT, V126, P2227; BRENNER S, 1974, GENETICS, V77, P71; Brodigan TM, 2003, DEV BIOL, V254, P102, DOI 10.1016/S0012-1606(02)00032-5; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chen RH, 2004, EMBO J, V23, P3113, DOI 10.1038/sj.emboj.7600308; Eastman C, 1999, J NEUROSCI, V19, P6225; Encalada SE, 2005, MOL BIOL CELL, V16, P1056, DOI 10.1091/mbc.E04-08-0712; Fay DS, 2000, DEVELOPMENT, V127, P4049; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Furuta T, 2000, MOL BIOL CELL, V11, P1401, DOI 10.1091/mbc.11.4.1401; Furuta T, 2002, GENESIS, V34, P244, DOI 10.1002/gene.10157; Hajeri VA, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-6; Hallam S, 2000, DEVELOPMENT, V127, P4239; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hong FD, 1999, CARCINOGENESIS, V20, P1161, DOI 10.1093/carcin/20.7.1161; HORVITZ HR, 1980, GENETICS, V96, P435; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kitagawa R, 1999, NAT CELL BIOL, V1, P514, DOI 10.1038/70309; Kitagawa R, 2002, CURR BIOL, V12, P2118, DOI 10.1016/S0960-9822(02)01392-1; Kostic I, 2003, DEV BIOL, V263, P242, DOI 10.1016/S0012-1606(03)00452-4; Kostic I, 2002, DEVELOPMENT, V129, P2155; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lengauer C, 2004, NAT GENET, V36, P1144, DOI 10.1038/ng1104-1144; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Lozano E, 2006, CURR BIOL, V16, P493, DOI 10.1016/j.cub.2006.01.048; MADURO M, 1995, GENETICS, V141, P977; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Niikura Y, 2007, J CELL BIOL, V178, P283, DOI 10.1083/jcb.200702134; O'Connell KF, 1998, GENETICS, V149, P1303; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Pellis-van Berkel W, 2005, MOL BIOL CELL, V16, P106, DOI 10.1091/mbc.E04-06-0492; Pilon M, 2000, MOL BIOL CELL, V11, P3277, DOI 10.1091/mbc.11.10.3277; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Stein KK, 2007, GENETICS, V175, P107, DOI 10.1534/genetics.106.059105; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tarailo M, 2007, GENETICS, V175, P1665, DOI 10.1534/genetics.106.067918; Wang XM, 2007, BIOCHEM BIOPH RES CO, V359, P965, DOI 10.1016/j.bbrc.2007.05.203; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Woollard A, 1999, MECH DEVELOP, V82, P95, DOI 10.1016/S0925-4773(99)00020-9; Yu HT, 2005, CELL CYCLE, V4, P262; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	58	4	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5912	10.1371/journal.pone.0005912	http://dx.doi.org/10.1371/journal.pone.0005912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526056	Green Submitted, Green Published, gold			2022-12-27	WOS:000267029300006
J	Aarssen, LW; Lortie, CJ; Budden, AE; Koricheva, J; Leimu, R; Tregenza, T				Aarssen, Lonnie W.; Lortie, Christopher J.; Budden, Amber E.; Koricheva, Julia; Leimu, Roosa; Tregenza, Tom			Does Publication in Top-Tier Journals Affect Reviewer Behavior?	PLOS ONE			English	Article								We show that when ecologists act as reviewers their reported rejection rates recommended for manuscripts increases with their publication frequency in high impact factor journals. Rejection rate however does not relate to reviewer age. These results indicate that the likelihood of getting a paper accepted for publication may depend upon factors in addition to scientific merit. Multiple reviewer selection for a given manuscript therefore should consider not only appropriate expertise, but also reviewers that have variable publication experience with a range of different journals to ensure balanced treatment. Interestingly since age did not relate to rejection rates, more senior scientists are not necessarily more jaded in reviewing practices.			Aarssen, LW (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	aarssenl@queensu.ca	Aarssen, Lonnie W./K-5778-2012; Budden, Amber/A-2829-2010; Koricheva, Julia/G-6754-2011; lortie, christopher j/F-6241-2014	Budden, Amber/0000-0003-2885-3980; Koricheva, Julia/0000-0002-9033-0171; lortie, christopher j/0000-0002-4291-7023; Tregenza, Thomas/0000-0003-4182-2222				Aarssen L.W., 2008, OPEN ECOL J, V1, P14, DOI [10.2174/1874213000801010014, DOI 10.2174/1874213000801010014]; Antonakis J, 2008, J AM SOC INF SCI TEC, V59, P956, DOI 10.1002/asi.20802; Cassey P, 2004, BIOSCIENCE, V54, P234, DOI 10.1641/0006-3568(2004)054[0234:PARASE]2.0.CO;2; Cassey P, 2003, TRENDS ECOL EVOL, V18, P375, DOI 10.1016/S0169-5347(03)00160-5; Grace J, 2007, FRONT ECOL ENVIRON, V5, P49, DOI 10.1890/1540-9295(2007)5[49:TBPATB]2.0.CO;2; Grimm D, 2005, SCIENCE, V309, P1974, DOI 10.1126/science.309.5743.1974; Grod ON, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003202; Lawrence PA, 2003, NATURE, V422, P259, DOI 10.1038/422259a; Lortie CJ, 2007, OIKOS, V116, P1247, DOI 10.1111/j.0030-1299.2007.15686.x; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x	10	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6283	10.1371/journal.pone.0006283	http://dx.doi.org/10.1371/journal.pone.0006283			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621085	gold, Green Published, Green Submitted			2022-12-27	WOS:000268147200002
J	Otaegui, D; Baranzini, SE; Armananzas, R; Calvo, B; Munoz-Culla, M; Khankhanian, P; Inza, I; Lozano, JA; Castillo-Trivino, T; Asensio, A; Olaskoaga, J; de Munain, AL				Otaegui, David; Baranzini, Sergio E.; Armananzas, Ruben; Calvo, Borja; Munoz-Culla, Maider; Khankhanian, Puya; Inza, Inaki; Lozano, Jose A.; Castillo-Trivino, Tamara; Asensio, Ana; Olaskoaga, Javier; Lopez de Munain, Adolfo			Differential Micro RNA Expression in PBMC from Multiple Sclerosis Patients	PLOS ONE			English	Article								Differences in gene expression patterns have been documented not only in Multiple Sclerosis patients versus healthy controls but also in the relapse of the disease. Recently a new gene expression modulator has been identified: the microRNA or miRNA. The aim of this work is to analyze the possible role of miRNAs in multiple sclerosis, focusing on the relapse stage. We have analyzed the expression patterns of 364 miRNAs in PBMC obtained from multiple sclerosis patients in relapse status, in remission status and healthy controls. The expression patterns of the miRNAs with significantly different expression were validated in an independent set of samples. In order to determine the effect of the miRNAs, the expression of some predicted target genes of these were studied by qPCR. Gene interaction networks were constructed in order to obtain a co-expression and multivariate view of the experimental data. The data analysis and later validation reveal that two miRNAs (hsa-miR-18b and hsa-miR-599) may be relevant at the time of relapse and that another miRNA (hsa-miR-96) may be involved in remission. The genes targeted by hsa-miR-96 are involved in immunological pathways as Interleukin signaling and in other pathways as wnt signaling. This work highlights the importance of miRNA expression in the molecular mechanisms implicated in the disease. Moreover, the proposed involvement of these small molecules in multiple sclerosis opens up a new therapeutic approach to explore and highlight some candidate biomarker targets in MS.			Otaegui, D (corresponding author), Biodonostia Inst, Multiple Sclerosis Unit, San Sebastian, Spain.	david.otaegibichot@osakidetza.net	Armañanzas, Rubén/C-2735-2013; Baranzini, Sergio/A-9422-2013; Armañanzas, Rubén/O-7403-2019; Muñoz-Culla, Maider/D-1668-2018; Otaegui, David/H-4390-2013; Lozano, Jose A. A/F-5120-2010; Calvo, Borja/AAB-2278-2019; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; Calvo, Borja/AAV-1319-2021; Castillo, Tamara/GYQ-5428-2022; Castillo, Tamara/ABH-4121-2020	Armañanzas, Rubén/0000-0003-4049-0000; Baranzini, Sergio/0000-0003-0067-194X; Armañanzas, Rubén/0000-0003-4049-0000; Otaegui, David/0000-0002-6625-5976; Lozano, Jose A. A/0000-0002-4683-8111; Calvo, Borja/0000-0001-9969-9664; INZA CANO, INAKI/0000-0003-4674-1755; /0000-0002-9509-4032; Castillo-Trivino, Tamara/0000-0002-9249-3185				Achiron A, 2004, ANN NEUROL, V55, P410, DOI 10.1002/ana.20008; Alcina A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004137; Armananzas R, 2008, COMPUT METH PROG BIO, V91, P110, DOI 10.1016/j.cmpb.2008.02.010; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Baranzini SE, 2005, PLOS BIOL, V3, P166, DOI 10.1371/journal.pbio.0030002; Baranzini SE, 2005, J IMMUNOL, V174, P7412, DOI 10.4049/jimmunol.174.11.7412; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002360; DEYEBENES V, 2008, J EXP MED; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Hall MA, 1997, P 4 INT C NEUR INF P, P855; Ibanez-Ventoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002818; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Matute C, 2007, NEURON GLIA BIOL, V3, P281, DOI 10.1017/S1740925X08000033; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Oksenberg JR, 2005, GENES IMMUN, V6, P375, DOI 10.1038/sj.gene.6364237; Otaegui D, 2007, J IMMUNOL, V179, P4074, DOI 10.4049/jimmunol.179.6.4074; Poser CM, 2006, ANN NEUROL, V59, P727, DOI 10.1002/ana.20826; Ramanathan M, 2001, J NEUROIMMUNOL, V116, P213, DOI 10.1016/S0165-5728(01)00308-3; Ross JS, 2007, AM J CLIN PATHOL, V128, P830, DOI 10.1309/2JK279BU2G743MWJ; Sahami M., 1996, P 2 INT C KNOWL DISC, P335; Satoh J, 2008, DIS MARKERS, V25, P27, DOI 10.1155/2008/824640; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Thomas MC, 2006, ELEMENTS INFORM THEO; Vallejo-Illarramendi A, 2006, NEUROBIOL DIS, V21, P154, DOI 10.1016/j.nbd.2005.06.017; Weber MJ, 2005, FEBS J, V272, P59, DOI 10.1111/j.1432-1033.2004.04389.x	39	197	210	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6309	10.1371/journal.pone.0006309	http://dx.doi.org/10.1371/journal.pone.0006309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617918	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000268119600008
J	Buchhave, P; Blennow, K; Zetterberg, H; Stomrud, E; Londos, E; Andreasen, N; Minthon, L; Hansson, O				Buchhave, Peder; Blennow, Kaj; Zetterberg, Henrik; Stomrud, Erik; Londos, Elisabet; Andreasen, Niels; Minthon, Lennart; Hansson, Oskar			Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; TAU LEVELS; FOLLOW-UP; STABILITY; BETA-AMYLOID((1-42)); PROGRESSION; PREDICTION; DECLINE; RATIO	Background: The CSF biomarkers tau and A beta 42 can identify patients with AD, even during the preclinical stages. However, previous studies on longitudinal changes of tau and A beta 42 in individual patients with AD and elderly controls report somewhat inconsistent results. Methodology/Principal Findings: We investigated the levels of tau and A beta 42 at baseline and after 1 year in 100 patients with AD. In a second cohort of 45 AD patients we measured the CSF biomarkers at baseline and after 2 years. Moreover, in 34 healthy elderly controls the CSF biomarkers were followed for 4 years. The baseline levels of tau were increased with >60% in AD patients compared to controls (p<0.001), while baseline A beta 42 levels were decreased with >50% (p<0.001). In the AD group followed for 2 years, tau increased with 16% compared to the baseline levels (p<0.05). However, the levels of tau were stable over 4 years in the controls. The levels of A beta 42 did not change significantly over time in any of the groups. In the patients with AD, tau was moderately associated with worse cognitive performance already at baseline (p<0.05). Conclusions/Significance: Tau and A beta 42 in CSF seem to reflect the underlying disease state in both early and late stages of AD. The slight increase in tau over time observed in the patients with AD is modest when compared to the relatively large difference in absolute tau levels between AD patients and controls. Therefore, these markers maintain their usefulness as state markers over time and might serve as surrogate markers for treatment efficacy in clinical trials.			Buchhave, P (corresponding author), Lund Univ, Clin Memory Res Unit, Dept Clin Sci Malmo, Lund, Sweden.	oskar.hansson@med.lu.se	Hansson, Oskar/A-7134-2013	Hansson, Oskar/0000-0001-8467-7286				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Andreasen N, 1999, NEUROLOGY, V53, P1488, DOI 10.1212/WNL.53.7.1488; Andreasen N, 1999, ARCH NEUROL-CHICAGO, V56, P673, DOI 10.1001/archneur.56.6.673; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Blennow K, 2007, NEUROSCI LETT, V419, P18, DOI 10.1016/j.neulet.2007.03.064; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bouwman FH, 2007, NEUROLOGY, V69, P1006, DOI 10.1212/01.wnl.0000271375.37131.04; Engler H, 2006, BRAIN, V129, P2856, DOI 10.1093/brain/awl178; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fleisher AS, 2007, NEUROLOGY, V68, P1588, DOI 10.1212/01.wnl.0000258542.58725.4c; Fox N, 2004, NEURORX, DOI [10.1602/neurorx.1.2.181, DOI 10.1602/NEURORX.1.2.181]; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Hampel H, 2004, MOL PSYCHIATR, V9, P705, DOI 10.1038/sj.mp.4001473; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hansson O, 2007, DEMENT GERIATR COGN, V23, P316, DOI 10.1159/000100926; Hansson O, 2009, NEUROBIOL AGING, V30, P165, DOI 10.1016/j.neurobiolaging.2007.06.009; Huey ED, 2006, DEMENT GERIATR COGN, V22, P48, DOI 10.1159/000093261; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Kanai M, 1998, ANN NEUROL, V44, P17, DOI 10.1002/ana.410440108; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Stefani A, 2006, J NEUROL SCI, V251, P124, DOI 10.1016/j.jns.2006.09.014; Stomrud E, 2007, DEMENT GERIATR COGN, V24, P118, DOI 10.1159/000105017; Sunderland T, 1999, BIOL PSYCHIAT, V46, P750, DOI 10.1016/S0006-3223(99)00143-2; Zetterberg H, 2007, J ALZHEIMERS DIS, V12, P255, DOI 10.3233/jad-2007-12307; Zetterberg Henrik, 2008, Handb Clin Neurol, V89, P261, DOI 10.1016/S0072-9752(07)01224-9	27	68	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6294	10.1371/journal.pone.0006294	http://dx.doi.org/10.1371/journal.pone.0006294			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609443	gold, Green Published, Green Submitted			2022-12-27	WOS:000268119500016
J	Paruthiyil, S; Cvoro, A; Zhao, XY; Wu, ZJ; Sui, YX; Staub, RE; Baggett, S; Herber, CB; Griffin, C; Tagliaferri, M; Harris, HA; Cohen, I; Bjeldanes, LF; Speed, TP; Schaufele, F; Leitman, DC				Paruthiyil, Sreenivasan; Cvoro, Aleksandra; Zhao, Xiaoyue; Wu, Zhijin; Sui, Yunxia; Staub, Richard E.; Baggett, Scott; Herber, Candice B.; Griffin, Chandi; Tagliaferri, Mary; Harris, Heather A.; Cohen, Isaac; Bjeldanes, Leonard F.; Speed, Terence P.; Schaufele, Fred; Leitman, Dale C.			Drug and Cell Type-Specific Regulation of Genes with Different Classes of Estrogen Receptor beta-Selective Agonists	PLOS ONE			English	Article								Estrogens produce biological effects by interacting with two estrogen receptors, ER alpha and ER beta. Drugs that selectively target ERa or ERb might be safer for conditions that have been traditionally treated with non-selective estrogens. Several synthetic and natural ER beta-selective compounds have been identified. One class of ER beta-selective agonists is represented by ERB-041 (WAY-202041) which binds to ER beta much greater than ER alpha. A second class of ER beta-selective agonists derived from plants include MF101, nyasol and liquiritigenin that bind similarly to both ERs, but only activate transcription with ER beta. Diarylpropionitrile represents a third class of ER beta-selective compounds because its selectivity is due to a combination of greater binding to ER beta and transcriptional activity. However, it is unclear if these three classes of ER beta-selective compounds produce similar biological activities. The goals of these studies were to determine the relative ER beta selectivity and pattern of gene expression of these three classes of ER beta-selective compounds compared to estradiol (E(2)), which is a non-selective ER agonist. U2OS cells stably transfected with ER alpha or ER beta were treated with E(2) or the ER beta-selective compounds for 6 h. Microarray data demonstrated that ERB-041, MF101 and liquiritigenin were the most ER beta-selective agonists compared to estradiol, followed by nyasol and then diarylpropionitrile. FRET analysis showed that all compounds induced a similar conformation of ER beta, which is consistent with the finding that most genes regulated by the ER beta-selective compounds were similar to each other and E(2). However, there were some classes of genes differentially regulated by the ER beta agonists and E(2). Two ER beta-selective compounds, MF101 and liquiritigenin had cell type-specific effects as they regulated different genes in HeLa, Caco-2 and Ishikawa cell lines expressing ER beta. Our gene profiling studies demonstrate that while most of the genes were commonly regulated by ER beta-selective agonists and E(2), there were some genes regulated that were distinct from each other and E(2), suggesting that different ER beta-selective agonists might produce distinct biological and clinical effects.			Paruthiyil, S (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA.	dale@leitmanlab.com	wu, zhijin/J-4995-2016; Speed, Terence P/B-8085-2009; wu, zhijin/J-2282-2014	wu, zhijin/0000-0002-9596-9134; Speed, Terence P/0000-0002-5403-7998; 	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER; NCCIH NIH HHS [R01 AT002173, AT002173] Funding Source: Medline; NIGMS NIH HHS [R01 GM083084-03, R01 GM083084] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bowe J, 2006, J ENDOCRINOL, V191, P399, DOI 10.1677/joe.1.06919; Carpenter KD, 2006, ANN NY ACAD SCI, V1092, P361, DOI 10.1196/annals.1365.033; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Cvoro A, 2008, J IMMUNOL, V180, P630, DOI 10.4049/jimmunol.180.1.630; Cvoro A, 2007, ENDOCRINOLOGY, V148, P538, DOI 10.1210/en.2006-0803; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Forster C, 2002, P NATL ACAD SCI USA, V99, P15578, DOI 10.1073/pnas.192561299; Grady D, 2009, MENOPAUSE, V16, P458, DOI 10.1097/gme.0b013e31818e64dd; Han SJ, 2006, MOL ENDOCRINOL, V20, P45, DOI 10.1210/me.2005-0310; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; HARRIS HA, 2006, NUCL RECEPT SIGNAL, V4; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Imwalle DB, 2005, PHYSIOL BEHAV, V84, P157, DOI 10.1016/j.physbeh.2004.11.002; Katzenellenbogen BS, 2000, RECENT PROG HORM RES, V55, P163; KIAN TM, 2004, MOL BIOL CELL, V15, P1262; Koehler KF, 2005, ENDOCR REV, V26, P465, DOI 10.1210/er.2004-0027; Kofoed EM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940366; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Levy N, 2008, MOL ENDOCRINOL, V22, P287, DOI 10.1210/me.2007-0340; Levy N, 2007, ENDOCRINOLOGY, V148, P3449, DOI 10.1210/en.2006-1632; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; MacLennan AH, 2006, MENOPAUSE, V13, P28, DOI 10.1097/01.gme.0000191204.38664.61; Malamas MS, 2004, J MED CHEM, V47, P5021, DOI 10.1021/jm049719y; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Mersereau JE, 2008, MOL CELL ENDOCRINOL, V283, P49, DOI 10.1016/j.mce.2007.11.020; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Michalides R, 2004, CANCER CELL, V5, P597, DOI 10.1016/j.ccr.2004.05.016; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Rissman EF, 2002, P NATL ACAD SCI USA, V99, P3996, DOI 10.1073/pnas.012032699; Rocha BA, 2005, PSYCHOPHARMACOLOGY, V179, P637, DOI 10.1007/s00213-004-2078-1; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shim GJ, 2003, P NATL ACAD SCI USA, V100, P6694, DOI 10.1073/pnas.0731830100; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882	51	58	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6271	10.1371/journal.pone.0006271	http://dx.doi.org/10.1371/journal.pone.0006271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609440	gold, Green Published			2022-12-27	WOS:000268119500006
J	Fan, J; Shu, M; Zhang, G; Zhou, W; Jiang, YM; Zhu, Y; Chen, GH; Peacock, SJ; Wan, CM; Pan, WB; Feil, EJ				Fan, Juan; Shu, Min; Zhang, Ge; Zhou, Wei; Jiang, Yongmei; Zhu, Yu; Chen, Guihua; Peacock, Sharon J.; Wan, Chaomin; Pan, Wubin; Feil, Edward J.			Biogeography and Virulence of Staphylococcus aureus	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; CASSETTE CHROMOSOME MEC; METHICILLIN-RESISTANT; SKIN INFECTIONS; EVOLUTION; GENES; HOSPITALS; CLONES; COMBINATION; PREVALENCE	Background: Staphylococcus aureus is commonly carried asymptomatically in the human anterior nares and occasionally enters the bloodstream to cause invasive disease. Much of the global diversity of S. aureus remains uncharacterised, and is not clear how disease propensity varies between strains, and between host populations. Methodology: We compared 147 isolates recovered from five kindergartens in Chengdu, China, with 51 isolates contemporaneously recovered from cases of pediatric infection from the main hospital serving this community. The samples were characterised by MLST, the presence/absence of PVL, and antibiotic resistance profiling. Principal Findings: Genotype frequencies within individual kindergartens differ, but the sample recovered from cases of disease shows a general enrichment of certain MLST genotypes and PVL positive isolates. Genotypes under-represented in the disease sample tend to correspond to a single sequence cluster, and this cluster is more common in China than in other parts of the world. Conclusions/Significance: Virulence propensity likely reflects a synergy between variation in the core genome (MLST) and accessory genome (PVL). By combining evidence form biogeography and virulence we demonstrate the existence of a "native'' clade in West China which has lowered virulence, possibility due to acquired host immunity.			Fan, J (corresponding author), Sichuan Univ, W China Hosp 2, Dept Pediat, Chengdu 610064, Sichuan, Peoples R China.	wcm0220@sina.com; wbpan@163.com; e.feil@bath.ac.uk	Peacock, Sharon J/ABE-6331-2020	Peacock, Sharon/0000-0002-1718-2782				BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Berglund C, 2008, ANTIMICROB AGENTS CH, V52, P3512, DOI 10.1128/AAC.00087-08; Chen CJ, 2007, DIAGN MICR INFEC DIS, V59, P287, DOI 10.1016/j.diagmicrobio.2007.05.015; Cooper JE, 2006, MICROBIOL-SGM, V152, P1297, DOI 10.1099/mic.0.28620-0; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; de Sousa MA, 2005, J CLIN MICROBIOL, V43, P5150, DOI 10.1128/JCM.43.10.5150-5157.2005; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x; Fraser C, 2005, P NATL ACAD SCI USA, V102, P1968, DOI 10.1073/pnas.0406993102; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jolley KA, 2000, J CLIN MICROBIOL, V38, P4492, DOI 10.1128/JCM.38.12.4492-4498.2000; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lo WT, 2008, PEDIATR INFECT DIS J, V27, P713, DOI 10.1097/INF.0b013e31816f63b5; Lo WT, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-51; Ma XX, 2006, J CLIN MICROBIOL, V44, P4515, DOI 10.1128/JCM.00985-06; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; Martinez-Aguilar G, 2004, PEDIATR INFECT DIS J, V23, P701, DOI 10.1097/01.inf.0000133044.79130.2a; Nickerson EK, 2006, LANCET INFECT DIS, V6, P70, DOI 10.1016/S1473-3099(06)70363-2; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Nygaard TK, 2008, CURR OPIN INFECT DIS, V21, P147, DOI 10.1097/QCO.0b013e3282f64819; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Paez Armando, 2008, Curr Infect Dis Rep, V10, P14, DOI 10.1007/s11908-008-0005-z; Robinson DA, 2004, CLIN MICROBIOL INFEC, V10, P92, DOI 10.1111/j.1469-0691.2004.00768.x; Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07; Said-Salim B, 2003, INFECT CONT HOSP EP, V24, P451, DOI 10.1086/502231; SAKWINSKA O, 2008, APPL ENV MICROBIOL; Sakwinska O, 2009, APPL ENVIRON MICROB, V75, P175, DOI 10.1128/AEM.01860-08; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Takano T, 2007, MICROBIOL IMMUNOL, V51, P627, DOI 10.1111/j.1348-0421.2007.tb03949.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang CT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000822; Turner KME, 2007, INT J ANTIMICROB AG, V29, P129, DOI 10.1016/j.ijantimicag.2006.11.002; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Yu F, 2008, CLIN MICROBIOL INFEC, V14, P381, DOI 10.1111/j.1469-0691.2007.01927.x; Zhang KY, 2009, ANTIMICROB AGENTS CH, V53, P531, DOI 10.1128/AAC.01118-08	47	50	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6216	10.1371/journal.pone.0006216	http://dx.doi.org/10.1371/journal.pone.0006216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593449	Green Submitted, Green Published, gold			2022-12-27	WOS:000268035400002
J	Toomey, D; Hoppe, HC; Brennan, MP; Nolan, KB; Chubb, AJ				Toomey, David; Hoppe, Heinrich C.; Brennan, Marian P.; Nolan, Kevin B.; Chubb, Anthony J.			Genomes2Drugs: Identifies Target Proteins and Lead Drugs from Proteome Data	PLOS ONE			English	Article								Background: Genome sequencing and bioinformatics have provided the full hypothetical proteome of many pathogenic organisms. Advances in microarray and mass spectrometry have also yielded large output datasets of possible target proteins/genes. However, the challenge remains to identify new targets for drug discovery from this wealth of information. Further analysis includes bioinformatics and/or molecular biology tools to validate the findings. This is time consuming and expensive, and could fail to yield novel drugs if protein purification and crystallography is impossible. To pre-empt this, a researcher may want to rapidly filter the output datasets for proteins that show good homology to proteins that have already been structurally characterised or proteins that are already targets for known drugs. Critically, those researchers developing novel antibiotics need to select out the proteins that show close homology to any human proteins, as future inhibitors are likely to cross-react with the host protein, causing off-target toxicity effects later in clinical trials. Methodology/Principal Findings: To solve many of these issues, we have developed a free online resource called Genomes2Drugs which ranks sequences to identify proteins that are (i) homologous to previously crystallized proteins or (ii) targets of known drugs, but are (iii) not homologous to human proteins. When tested using the Plasmodium falciparum malarial genome the program correctly enriched the ranked list of proteins with known drug target proteins. Conclusions/Significance: Genomes2Drugs rapidly identifies proteins that are likely to succeed in drug discovery pipelines. This free online resource helps in the identification of potential drug targets. Importantly, the program further highlights proteins that are likely to be inhibited by FDA-approved drugs. These drugs can then be rapidly moved into Phase IV clinical studies under 'change-of-application' patents.			Toomey, D (corresponding author), Royal Coll Surgeons Ireland, Mol Modelling Grp, Dublin 2, Ireland.	achubb@rcsi.ie	Brennan, Marian/D-7564-2013; Nolan, Kevin/D-7669-2012	Brennan, Marian/0000-0003-2368-5383; Hoppe, Heinrich/0000-0003-4409-1955; Chubb, Anthony/0000-0003-1875-7100				Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez JC, 2004, CURR OPIN CHEM BIOL, V8, P365, DOI 10.1016/j.cbpa.2004.05.001; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Kersey P, 2005, NUCLEIC ACIDS RES, V33, pD297, DOI 10.1093/nar/gri039; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	10	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6195	10.1371/journal.pone.0006195	http://dx.doi.org/10.1371/journal.pone.0006195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593435	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035300008
J	Xu, XL; Lou, ZY; Ma, YL; Chen, XH; Yang, ZS; Tong, XH; Zhao, Q; Xu, YY; Deng, HY; Bartlam, M; Rao, ZH				Xu, Xiaoling; Lou, Zhiyong; Ma, Yanlin; Chen, Xuehui; Yang, Zhangsheng; Tong, Xiaohang; Zhao, Qi; Xu, Yuanyuan; Deng, Hongyu; Bartlam, Mark; Rao, Zihe			Crystal Structure of the C-Terminal Cytoplasmic Domain of Non-Structural Protein 4 from Mouse Hepatitis Virus A59	PLOS ONE			English	Article								Background: The replication of coronaviruses takes place on cytoplasmic double membrane vesicles (DMVs) originating in the endoplasmic reticulum (ER). Three trans-membrane non-structural proteins, nsp3, nsp4 and nsp6, are understood to be membrane anchors of the coronavirus replication complex. Nsp4 is localized to the ER membrane when expressed alone but is recruited into the replication complex in infected cells. It is revealed to contain four trans-membrane regions and its N- and C-termini are exposed to the cytosol. Methodology/Principal Findings: We have determined the crystal structures of the C-terminal hydrophilic domain of nsp4 (nsp4C) from MHV strain A59 and a C425S site-directed mutant. The highly conserved 89 amino acid region from T408 to Q496 is shown to possess a new fold. The wild-type (WT) structure features two monomers linked by a Cys425-Cys425 disulfide bond in one asymmetric unit. The monomers are arranged with their N- and C-termini in opposite orientations to form an "open'' conformation. Mutation of Cys425 to Ser did not affect the monomer structure, although the mutant dimer adopts strikingly different conformations by crystal packing, with the cross-linked C-termini and parallel N- termini of two monomers forming a "closed'' conformation. The WT nsp4C exists as a dimer in solution and can dissociate easily into monomers in a reducing environment. Conclusions/Significance: As nsp4C is exposed in the reducing cytosol, the monomer of nsp4C should be physiological. This structure may serve as a basis for further functional studies of nsp4.			Xu, XL (corresponding author), Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China.	raozh@xtal.tsinghua.edu.cn	Zhao, Qi/H-7974-2012; Xu, Xiaoling/ABC-2449-2021; Yang, Zhangsheng/N-4080-2013; Zhao, Qi/C-6344-2013; Rao, Zihe/HCH-6944-2022	Xu, Xiaoling/0000-0001-8995-1213; Yang, Zhangsheng/0000-0003-2208-8632; Bartlam, Mark/0000-0001-5173-5080				Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; ALDABE R, 1995, BIOCHEM BIOPH RES CO, V206, P64, DOI 10.1006/bbrc.1995.1010; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329; Clementz MA, 2008, VIROLOGY, V375, P118, DOI 10.1016/j.virol.2008.01.018; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deming DJ, 2007, J VIROL, V81, P10280, DOI 10.1128/JVI.00017-07; Denison MR, 1999, J VIROL, V73, P6862, DOI 10.1128/JVI.73.8.6862-6871.1999; Denison MR, 1998, ADV EXP MED BIOL, V440, P121; Gonzaalez JM, 2003, ARCH VIROL, V148, P2207, DOI 10.1007/s00705-003-0162-1; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Harcourt BH, 2004, J VIROL, V78, P13600, DOI 10.1128/JVI.78.24.13600-13612.2004; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Imberta I, 2008, VIRUS RES, V133, P136, DOI 10.1016/j.virusres.2007.11.017; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanjanahaluethai A, 2007, VIROLOGY, V361, P391, DOI 10.1016/j.virol.2006.12.009; KOOLEN MJM, 1987, J GEN VIROL, V68, P703, DOI 10.1099/0022-1317-68-3-703; LAVI E, 1984, NEUROLOGY, V34, P597, DOI 10.1212/WNL.34.5.597; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; OOSTRA M, 2007, J VIROL; Oostra M, 2008, J VIROL, V82, P12392, DOI 10.1128/JVI.01219-08; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Prentice E, 2004, J VIROL, V78, P9977, DOI 10.1128/JVI.78.18.9977-9986.2004; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Sawicki SG, 2005, PLOS PATHOG, V1, P310, DOI 10.1371/journal.ppat.0010039; Shi ST, 1999, J VIROL, V73, P5957, DOI 10.1128/JVI.73.7.5957-5969.1999; Sims AC, 2000, J VIROL, V74, P5647, DOI 10.1128/JVI.74.12.5647-5654.2000; SITIA R, 2004, SCI STKE, pPE27; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; SPARKS JS, 2007, J VIROL; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijms MA, 2003, J GEN VIROL, V84, P2317, DOI 10.1099/vir.0.19297-0; van der Meer Y, 1998, J VIROL, V72, P6689, DOI 10.1128/JVI.72.8.6689-6698.1998; van Hemert MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000054; Versteeg GA, 2007, VIROLOGY, V361, P18, DOI 10.1016/j.virol.2007.01.020; von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459; Ziebuhr J, 2005, CURR TOP MICROBIOL, V287, P57, DOI 10.1007/3-540-26765-4_3; Ziebuhr J, 2006, ADV EXP MED BIOL, V581, P3	49	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6217	10.1371/journal.pone.0006217	http://dx.doi.org/10.1371/journal.pone.0006217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593433	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035300022
J	Chetrit, J; Ballion, B; Laquitaine, S; Belujon, P; Morin, S; Taupignon, A; Bioulac, B; Gross, CE; Benazzouz, A				Chetrit, Jonathan; Ballion, Berangere; Laquitaine, Steeve; Belujon, Pauline; Morin, Stephanie; Taupignon, Anne; Bioulac, Bernard; Gross, Christian E.; Benazzouz, Abdelhamid			Involvement of Basal Ganglia Network in Motor Disabilities Induced by Typical Antipsychotics	PLOS ONE			English	Article								Background: Clinical treatments with typical antipsychotic drugs (APDs) are accompanied by extrapyramidal motor side-effects (EPS) such as hypokinesia and catalepsy. As little is known about electrophysiological substrates of such motor disturbances, we investigated the effects of a typical APD, alpha-flupentixol, on the motor behavior and the neuronal activity of the whole basal ganglia nuclei in the rat. Methods and Findings: The motor behavior was examined by the open field actimeter and the neuronal activity of basal ganglia nuclei was investigated using extracellular single unit recordings on urethane anesthetized rats. We show that alpha-flupentixol induced EPS paralleled by a decrease in the firing rate and a disorganization of the firing pattern in both substantia nigra pars reticulata (SNr) and subthalamic nucleus (STN). Furthermore, alpha-flupentixol induced an increase in the firing rate of globus pallidus (GP) neurons. In the striatum, we recorded two populations of medium spiny neurons (MSNs) after their antidromic identification. At basal level, both striato-pallidal and striato-nigral MSNs were found to be unaffected by alpha-flupentixol. However, during electrical cortico-striatal activation only striato-pallidal, but not striato-nigral, MSNs were found to be inhibited by alpha-flupentixol. Together, our results suggest that the changes in STN and SNr neuronal activity are a consequence of increased neuronal activity of globus pallidus (GP). Indeed, after selective GP lesion, alpha-flupentixol failed to induce EPS and to alter STN neuronal activity. Conclusion: Our study reports strong evidence to show that hypokinesia and catalepsy induced by alpha-flupentixol are triggered by dramatic changes occurring in basal ganglia network. We provide new insight into the key role of GP in the pathophysiology of APD-induced EPS suggesting that the GP can be considered as a potential target for the treatment of EPS.			Chetrit, J (corresponding author), Univ Bordeaux, Bordeaux, France.	Abdelhamid.Benazzouz@u-bordeaux2.fr	Benazzouz, Abdelhamid/E-5050-2016	BALLION, Berengere/0000-0001-5210-2445; Laquitaine, Steeve/0000-0002-9647-3149; Taupignon, Anne/0000-0002-4662-7971; belujon, pauline/0000-0002-7966-8657				ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ban T A, 1974, Adv Biochem Psychopharmacol, V9, P481; Belujon P, 2007, J NEUROSCI, V27, P9595, DOI 10.1523/JNEUROSCI.2583-07.2007; Billings LM, 2003, BRAIN RES, V964, P237, DOI 10.1016/S0006-8993(02)04060-X; Boraud T, 1998, BRAIN RES, V787, P157, DOI 10.1016/S0006-8993(97)01563-1; Boulay D, 2000, EUR J PHARMACOL, V391, P63, DOI 10.1016/S0014-2999(99)00916-4; BURBAUD P, 1995, EXP BRAIN RES, V105, P48; COSTALL B, 1972, NEUROPHARMACOLOGY, V11, P645, DOI 10.1016/0028-3908(72)90073-1; COSTALL B, 1971, NEUROPHARMACOLOGY, V10, P581, DOI 10.1016/0028-3908(71)90024-4; DELFS JM, 1995, NEUROSCIENCE, V66, P67, DOI 10.1016/0306-4522(94)00572-M; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Eltayb A, 2005, BIOL PSYCHIAT, V58, P337, DOI 10.1016/j.biopsych.2005.03.038; FARDE L, 1988, ARCH GEN PSYCHIAT, V45, P71; FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538; FARDE L, 1992, BR J PSYCHIAT SUPPL, P30; FEGER J, 1991, EUR J NEUROSCI, V3, P947, DOI 10.1111/j.1460-9568.1991.tb00030.x; FOWLER SC, 1990, BEHAV NEUROSCI, V104, P449, DOI 10.1037/0735-7044.104.3.449; FUJIMOTO K, 1992, NEUROSCI LETT, V142, P105, DOI 10.1016/0304-3940(92)90630-P; Galvan A, 2001, J NEURAL TRANSM, V108, P153, DOI 10.1007/s007020170085; Gerfen CR, 2000, TRENDS NEUROSCI, V23, pS64, DOI 10.1016/S1471-1931(00)00019-7; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; Hassani OK, 1996, NEUROSCIENCE, V72, P105, DOI 10.1016/0306-4522(95)00535-8; Hauber W, 1999, BEHAV BRAIN RES, V106, P143, DOI 10.1016/S0166-4328(99)00102-3; Hauber W, 1998, NEUROSCIENCE, V86, P147, DOI 10.1016/S0306-4522(98)00009-8; Hauber W, 2001, EUR J NEUROSCI, V14, P1287, DOI 10.1046/j.0953-816x.2001.01759.x; HESS EJ, 1988, J NEUROSCI, V8, P2361; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; Kapur S, 2000, AM J PSYCHIAT, V157, P514, DOI 10.1176/appi.ajp.157.4.514; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; Marshall JF, 2001, NEUROSCIENCE, V105, P365, DOI 10.1016/S0306-4522(01)00180-4; Mukherjee J, 2001, NEUROPSYCHOPHARMACOL, V25, P476, DOI 10.1016/S0893-133X(01)00251-2; Murer MG, 1997, SYNAPSE, V27, P278, DOI 10.1002/(SICI)1098-2396(199712)27:4<278::AID-SYN2>3.3.CO;2-S; Ni ZG, 2000, EUR J NEUROSCI, V12, P4338, DOI 10.1111/j.1460-9568.2000.01346.x; OSSOWSKA K, 1983, PHARMACOL BIOCHEM BE, V19, P169, DOI 10.1016/0091-3057(83)90035-7; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Pitts SM, 2000, PHARMACOL BIOCHEM BE, V65, P433, DOI 10.1016/S0091-3057(99)00249-X; Reimold M, 2007, PSYCHOPHARMACOLOGY, V190, P241, DOI 10.1007/s00213-006-0611-0; RICHELSON E, 1984, J CLIN PSYCHIAT, V45, P331; Ruskin DN, 1997, NEUROSCIENCE, V81, P79, DOI 10.1016/S0306-4522(97)00113-9; SANBERG PR, 1984, PSYCHOPHARMACOLOGY, V82, P406, DOI 10.1007/BF00427696; SMITH Y, 1990, J COMP NEUROL, V296, P47, DOI 10.1002/cne.902960105; SMITH Y, 1989, BRAIN RES, V493, P160, DOI 10.1016/0006-8993(89)91011-1; Tai CH, 2003, FASEB J, V17, P1820, DOI 10.1096/fj.03-0163com; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Tseng KY, 2005, EUR J NEUROSCI, V22, P2579, DOI 10.1111/j.1460-9568.2005.04456.x; Wu YN, 2007, NEUROSCIENCE, V147, P183, DOI 10.1016/j.neuroscience.2007.02.045	51	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6208	10.1371/journal.pone.0006208	http://dx.doi.org/10.1371/journal.pone.0006208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587792	gold, Green Published, Green Submitted			2022-12-27	WOS:000268035100019
J	Huang, XG; Hui, MNY; Liu, Y; Yuen, DSH; Zhang, Y; Chan, WY; Lin, HR; Cheng, SH; Cheng, CHK				Huang, Xigui; Hui, Michelle N. Y.; Liu, Yun; Yuen, Don S. H.; Zhang, Yong; Chan, Wood Yee; Lin, Hao Ran; Cheng, Shuk Han; Cheng, Christopher H. K.			Discovery of a Novel Prolactin in Non-Mammalian Vertebrates: Evolutionary Perspectives and Its Involvement in Teleost Retina Development	PLOS ONE			English	Article							RECOMBINANT GOLDFISH PROLACTIN; GROWTH-HORMONE; HOMEOBOX GENE; IDENTIFICATION; EXPRESSION; SEQUENCES; BIPOLAR	Background: The three pituitary hormones, viz. prolactin ( PRL), growth hormone ( GH) and somatolactin ( SL), together with the mammalian placental lactogen ( PL), constitute a gene family of hormones with similar gene structure and encoded protein sequences. These hormones are believed to have evolved from a common ancestral gene through several rounds of gene duplication and subsequent divergence. Principal Findings: In this study, we have identified a new PRL-like gene in non-mammalian vertebrates through bioinformatics and molecular cloning means. Phylogenetic analyses showed that this novel protein is homologous to the previously identified PRL. A receptor transactivation assay further showed that this novel protein could bind to PRL receptor to trigger the downstream post-receptor event, indicating that it is biologically active. In view of its close phylogenetic relationship with PRL and also its ability to activate PRL receptor, we name it as PRL2 and the previously identified PRL as PRL1. All the newly discovered PRL2 sequences possess three conserved disulfide linkages with the exception of the shark PRL2 which has only two. In sharp contrast to the classical PRL1 which is predominantly expressed in the pituitary, PRL2 was found to be mainly expressed in the eye and brain of the zebrafish but not in the pituitary. A largely reduced inner nuclear layer of the retina was observed after morpholino knockdown of zebrafish PRL2, indicating its role on retina development in teleost. Significance: The discovery of this novel PRL has revitalized our understanding on the evolution of the GH/PRL/SL/PL gene family. Its unique expression and functions in the zebrafish eye also provide a new avenue of research on the neuroendocrine control of retina development in vertebrates.			Huang, XG (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	chkcheng@cuhk.edu.hk	lin, haoran/GXH-3030-2022; Cheng, Shuk Han/F-9943-2012; Chan, Wood Yee/R-6692-2018; CHENG, Ki Christopher/R-9641-2018	Chan, Wood Yee/0000-0002-7114-1463; CHENG, Ki Christopher/0000-0001-8970-9048; Cheng, Shuk Han/0000-0002-5822-7238				ANTHONY RV, 1995, J ANIM SCI, V73, P1861; Chan YH, 1996, BBA-GENE STRUCT EXPR, V1307, P8, DOI 10.1016/0167-4781(96)00032-2; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; Cheng CW, 2006, MECH DEVELOP, V123, P252, DOI 10.1016/j.mod.2005.12.001; Cheng CW, 2005, DEV BIOL, V287, P48, DOI 10.1016/j.ydbio.2005.08.029; Cheung HYS, 2002, COMP BIOCHEM PHYS B, V131, P37, DOI 10.1016/S1096-4959(01)00478-X; Chow ESH, 2008, AQUAT TOXICOL, V87, P157, DOI 10.1016/j.aquatox.2008.01.019; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Force A, 1999, GENETICS, V151, P1531; Forsyth IA, 2002, J MAMMARY GLAND BIOL, V7, P291, DOI 10.1023/A:1022804817104; Huang XG, 2007, J ENDOCRINOL, V194, P373, DOI 10.1677/JOE-07-0076; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; KAWAUCHI H, 1988, INT CONGR SER, V819, P61; Kawauchi H, 2002, ENDOCRINOLOGY, V143, P4916, DOI 10.1210/en.2002-220810; KAWAUCHI H, 1988, ADV GROWTH HORMONE G, P51; Kawauchi H, 2006, GEN COMP ENDOCR, V148, P3, DOI 10.1016/j.ygcen.2005.10.011; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lin J, 2000, RECENT PROG HORM RES, V55, P37; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Manzon LA, 2002, GEN COMP ENDOCR, V125, P291, DOI 10.1006/gcen.2001.7746; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; NOSO T, 1993, GEN COMP ENDOCR, V91, P90, DOI 10.1006/gcen.1993.1108; Ohno S., 1970, P1; Rand-Weaver Mariann, 1993, Biochemistry and Molecular Biology of Fishes, V2, P39; RENTIERDELRUE F, 1989, DNA-J MOLEC CELL BIO, V8, P261, DOI 10.1089/dna.1.1989.8.261; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SHIGEHIROKURAKU, 2009, MOL BIOL EVOL, V26, P47; SUZUKI R, 1991, GEN COMP ENDOCR, V81, P391, DOI 10.1016/0016-6480(91)90166-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teilum K, 2005, J MOL BIOL, V351, P810, DOI 10.1016/j.jmb.2005.06.042; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wallis OC, 2005, J MOL EVOL, V60, P606, DOI 10.1007/s00239-004-0239-9; Wiemers DO, 2003, ENDOCRINOLOGY, V144, P313, DOI 10.1210/en.2002-220724; Wong AOL, 2002, GEN COMP ENDOCR, V126, P75, DOI 10.1006/gcen.2001.7771; Wullimann M.F., 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7; YAMAGUCHI K, 1988, J BIOL CHEM, V263, P9113; YAMASHITA K, 1993, GEN COMP ENDOCR, V91, P307, DOI 10.1006/gcen.1993.1131; YASUDA A, 1986, ARCH BIOCHEM BIOPHYS, V244, P528, DOI 10.1016/0003-9861(86)90621-1; YASUDA A, 1987, GEN COMP ENDOCR, V66, P280, DOI 10.1016/0016-6480(87)90278-4; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhu Y, 2007, GEN COMP ENDOCR, V150, P395, DOI 10.1016/j.ygcen.2006.10.009	45	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6163	10.1371/journal.pone.0006163	http://dx.doi.org/10.1371/journal.pone.0006163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584915	Green Published, gold, Green Submitted			2022-12-27	WOS:000267806500003
J	Kang, HJ; Bennett, SN; Sumibcay, L; Arai, S; Hope, AG; Mocz, G; Song, JW; Cook, JA; Yanagihara, R				Kang, Hae Ji; Bennett, Shannon N.; Sumibcay, Laarni; Arai, Satoru; Hope, Andrew G.; Mocz, Gabor; Song, Jin-Won; Cook, Joseph A.; Yanagihara, Richard			Evolutionary Insights from a Genetically Divergent Hantavirus Harbored by the European Common Mole (Talpa europaea)	PLOS ONE			English	Article								Background: The discovery of genetically distinct hantaviruses in shrews (Order Soricomorpha, Family Soricidae) from widely separated geographic regions challenges the hypothesis that rodents (Order Rodentia, Family Muridae and Cricetidae) are the primordial reservoir hosts of hantaviruses and also predicts that other soricomorphs harbor hantaviruses. Recently, novel hantavirus genomes have been detected in moles of the Family Talpidae, including the Japanese shrew mole (Urotrichus talpoides) and American shrew mole (Neurotrichus gibbsii). We present new insights into the evolutionary history of hantaviruses gained from a highly divergent hantavirus, designated Nova virus (NVAV), identified in the European common mole (Talpa europaea) captured in Hungary. Methodology/Principal Findings: Pair-wise alignment and comparison of the full-length S- and L-genomic segments indicated moderately low sequence similarity of 54-65% and 46-63% at the nucleotide and amino acid levels, respectively, between NVAV and representative rodent- and soricid-borne hantaviruses. Despite the high degree of sequence divergence, the predicted secondary structure of the NVAV nucleocapsid protein exhibited the characteristic coiled-coil domains at the amino-terminal end, and the L-segment motifs, typically found in hantaviruses, were well conserved. Phylogenetic analyses, using maximum-likelihood and Bayesian methods, showed that NVAV formed a distinct clade that was evolutionarily distant from all other hantaviruses. Conclusions: Newly identified hantaviruses harbored by shrews and moles support long-standing virus-host relationships and suggest that ancestral soricomorphs, rather than rodents, may have been the early or original mammalian hosts.			Kang, HJ (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96822 USA.	yanagiha@pbrc.hawaii.edu	Song, Jin/HHS-8731-2022	Arai, Satoru/0000-0001-5865-0717; Cook, Joseph/0000-0003-3985-0670; Mocz, Gabor/0000-0001-9855-2206	NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR018727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075057] Funding Source: NIH RePORTER; NCRR NIH HHS [G12 RR003061, P20 RR018727] Funding Source: Medline; NIAID NIH HHS [R01 AI075057] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alfadhli A, 2002, J BIOL CHEM, V277, P27103, DOI 10.1074/jbc.M203395200; Alminaite A, 2006, J VIROL, V80, P9073, DOI 10.1128/JVI.00515-06; Arai S, 2008, P NATL ACAD SCI USA, V105, P16296, DOI 10.1073/pnas.0808942105; Arai S, 2008, AM J TROP MED HYG, V78, P348, DOI 10.4269/ajtmh.2008.78.348; Arai S, 2007, EMERG INFECT DIS, V13, P1420, DOI 10.3201/eid1309.070484; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Boudko SP, 2007, J MOL BIOL, V366, P1538, DOI 10.1016/j.jmb.2006.12.046; CAREY DE, 1971, INDIAN J MED RES, V59, P1758; CHARLESTON MA, 1998, TREEMAP 2 0B MACINTO; Charleston NA, 2006, J BIOMED INFORM, V39, P62, DOI 10.1016/j.jbi.2005.08.006; Churchfield S., 1990, NATURAL HIST SHREWS; Clement J., 1994, V5, P295; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DUCHIN JS, 1994, NEW ENGL J MED, V330, P949, DOI 10.1056/NEJM199404073301401; Easterbrook JD, 2007, P NATL ACAD SCI USA, V104, P15502, DOI 10.1073/pnas.0707453104; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; GAVRILOVSKAYA IN, 1983, ARCH VIROL, V75, P313, DOI 10.1007/BF01314898; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gliwicz J, 2002, ACTA THERIOL, V47, P185, DOI 10.1007/BF03192487; Gorman M.L, 1990, NATURAL HIST MOLES; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310; Hughes AL, 2000, MOL BIOL EVOL, V17, P1558, DOI 10.1093/oxfordjournals.molbev.a026254; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232; Kang HJ, 2009, VIROLOGY, V388, P8, DOI 10.1016/j.virol.2009.03.019; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; Klempa B, 2007, EMERG INFECT DIS, V13, P520, DOI 10.3201/eid1303.061198; Kukkonen SKJ, 2005, ARCH VIROL, V150, P533, DOI 10.1007/s00705-004-0414-8; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Mills JN, 1998, AM J TROP MED HYG, V58, P525; Nemirov K, 2002, VIRUS RES, V90, P207, DOI 10.1016/S0168-1702(02)00179-X; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Padula P, 2004, J VIROL, V78, P11972, DOI 10.1128/JVI.78.21.11972-11979.2004; Plyusnin A, 2001, CURR TOP MICROBIOL, V256, P47; Plyusnin A, 1996, J GEN VIROL, V77, P2677, DOI 10.1099/0022-1317-77-11-2677; Plyusnina A, 2009, J GEN VIROL, V90, P205, DOI 10.1099/vir.0.006155-0; Plyusnina A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-4; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sanchez AJ, 2001, VIROLOGY, V286, P345, DOI 10.1006/viro.2001.0983; Sanchez-Villagra MR, 2006, CLADISTICS, V22, P59, DOI 10.1111/j.1096-0031.2006.00087.x; SCHMALJOHN CS, 1983, VIROLOGY, V131, P482, DOI 10.1016/0042-6822(83)90514-7; SCHMALJOHN CS, 1983, J INFECT DIS, V148, P1005, DOI 10.1093/infdis/148.6.1005; Schountz T, 2007, P NATL ACAD SCI USA, V104, P15496, DOI 10.1073/pnas.0707454104; Severson W, 2005, J VIROL, V79, P10032, DOI 10.1128/JVI.79.15.10032-10039.2005; Shinohara A, 2003, MOL PHYLOGENET EVOL, V27, P247, DOI 10.1016/S1055-7903(02)00416-5; Shinohara A, 2004, ZOOL SCI, V21, P1177, DOI 10.2108/zsj.21.1177; Song JW, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-114; Song JW, 2007, EMERG INFECT DIS, V13, P1784, DOI 10.3201/eid1311.070492; Song JW, 2007, EMERG INFECT DIS, V13, P980, DOI 10.3201/eid1307.070031; Song JW, 2009, J VIROL, V83, P6184, DOI 10.1128/JVI.00371-09; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TKACHENKO EA, 1983, ANN SOC BELG MED TR, V63, P267; Tsuchiya K, 2000, GENES GENET SYST, V75, P17, DOI 10.1266/ggs.75.17; Vapalahti O, 1999, J VIROL, V73, P5586, DOI 10.1128/JVI.73.7.5586-5592.1999; Xu XL, 2002, J VIROL, V76, P3301, DOI 10.1128/JVI.76.7.3301-3308.2002; Yadav PD, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-80; YANAGIHARA R, 1990, REV INFECT DIS, V12, P449; YANAGIHARA R, 1988, HDB VIRAL RICKETTSIA, P151; YATES TL, 1978, MAMMALIAN SPECIES, V105, P1; ZELLER HG, 1989, ARCH VIROL, V108, P211, DOI 10.1007/BF01310935; Zou Y, 2008, VIRUS RES, V137, P122, DOI 10.1016/j.virusres.2008.06.012; Zou Y, 2008, J MED VIROL, V80, P680, DOI 10.1002/jmv.21119	74	85	87	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6149	10.1371/journal.pone.0006149	http://dx.doi.org/10.1371/journal.pone.0006149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582155	Green Submitted, Green Published, gold			2022-12-27	WOS:000267806400005
J	Steiner, UK; Van Buskirk, J				Steiner, Ulrich K.; Van Buskirk, Josh			Predator-Induced Changes in Metabolism Cannot Explain the Growth/Predation Risk Tradeoff	PLOS ONE			English	Article								Defence against predators is usually accompanied by declining rates of growth or development. The classical growth/predation risk tradeoff assumes reduced activity as the cause of these declines. However, in many cases these costs cannot be explained by reduced foraging effort or enhanced allocation to defensive structures under predation risk. Here, we tested for a physiological origin of defence costs by measuring oxygen consumption in tadpoles (Rana temporaria) exposed to predation risk over short and long periods of time. The short term reaction was an increase in oxygen consumption, consistent with the "fight-or-flight'' response observed in many organisms. The long term reaction showed the opposite pattern: tadpoles reduced oxygen consumption after three weeks exposure to predators, which would act to reduce the growth cost of predator defence. The results point to an instantaneous and reversible stress response to predation risk. This suggests that the tradeoff between avoiding predators and growing rapidly is not caused by changes in metabolic rate, and must be sought in other behavioural or physiological processes.			Steiner, UK (corresponding author), Univ Zurich, Inst Zool, Zurich, Switzerland.	usteiner@stanford.edu	Steiner, Ulrich/AAQ-2713-2021; Steiner, Ulrich K/C-7099-2015	Steiner, Ulrich/0000-0002-1778-5989; Steiner, Ulrich K/0000-0002-1778-5989; Van Buskirk, Josh/0000-0002-0486-3626	NIA NIH HHS [P01-AG0225000-01] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABEL D, 1992, COMP BIOCHEM PHYS A, V101, P425, DOI 10.1016/0300-9629(92)90491-8; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barreto RE, 2003, BEHAV PROCESS, V60, P235, DOI 10.1016/S0376-6357(02)00127-4; Beckerman AP, 2007, OECOLOGIA, V152, P335, DOI 10.1007/s00442-006-0642-6; Brodin T, 2004, ECOLOGY, V85, P2927, DOI 10.1890/03-3120; FEDER ME, 1981, COMP BIOCHEM PHYS A, V70, P497, DOI 10.1016/0300-9629(81)92561-5; Forstner H., 1983, POLAROGRAPHIC OXYGEN, P111, DOI [10.1007/978-3-642-81863-9_12, DOI 10.1007/978-3-642-81863-9_12]; Grantner A, 1998, J COMP PHYSIOL B, V168, P427, DOI 10.1007/s003600050162; HARVELL CD, 1990, Q REV BIOL, V65, P323, DOI 10.1086/416841; Hawkins LA, 2004, J FISH BIOL, V65, P88, DOI 10.1111/j.0022-1112.2004.00543.x; Holopainen IJ, 1997, J FISH BIOL, V50, P781, DOI 10.1006/jfbi.1996.0344; Imsland AK, 2000, J FISH BIOL, V57, P1213, DOI 10.1111/j.1095-8649.2000.tb00482.x; Laurila A, 2008, ECOLOGY, V89, P1399, DOI 10.1890/07-1521.1; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; McPeek MA, 2004, AM NAT, V163, pE88, DOI 10.1086/382755; McPeek MA, 2001, ECOLOGY, V82, P1535, DOI 10.1890/0012-9658(2001)082[1535:PABRTP]2.0.CO;2; Miles DB, 2007, HORM BEHAV, V51, P548, DOI 10.1016/j.yhbeh.2007.02.005; Noonburg EG, 2005, EVOL ECOL RES, V7, P89; Pernet F, 2008, J EXP BIOL, V211, P969, DOI 10.1242/jeb.014639; R Core Team, 2020, R LANG ENV STAT COMP; Relyea RA, 2003, ECOLOGY, V84, P1840, DOI 10.1890/0012-9658(2003)084[1840:PCAPGT]2.0.CO;2; Rovero F, 1999, ANIM BEHAV, V58, P707, DOI 10.1006/anbe.1999.1176; Sapolsky R.M., 2002, BEHAV ENDOCRINOLOGY, V2nd, P409; Schoeppner NM, 2005, ECOL LETT, V8, P505, DOI 10.1111/j.1461-0248.2005.00744.x; SEMLITSCH RD, 1992, J ANIM ECOL, V61, P353, DOI 10.2307/5327; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; SPITZE K, 1992, AM NAT, V139, P229, DOI 10.1086/285325; Steiner UK, 2007, ANIM BEHAV, V74, P1473, DOI 10.1016/j.anbehav.2007.02.016; Steiner UK, 2007, OECOLOGIA, V152, P201, DOI 10.1007/s00442-006-0645-3; Steiner UK, 2007, AM NAT, V169, P118, DOI 10.1086/509939; Stoks R, 2005, ECOL LETT, V8, P1307, DOI 10.1111/j.1461-0248.2005.00840.x; Stoks R, 2005, J ANIM ECOL, V74, P708, DOI 10.1111/j.1365-2656.2005.00969.x; Stoks R, 2001, OECOLOGIA, V127, P222, DOI 10.1007/s004420000595; TOLLRIAN R, 1995, ECOLOGY, V76, P1691, DOI 10.2307/1940703; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Trussell GC, 2006, ECOLOGY, V87, P2979, DOI 10.1890/0012-9658(2006)87[2979:TFOBER]2.0.CO;2; TUCKER VA, 1975, AM SCI, V63, P413; Van Buskirk J, 2000, J EVOLUTION BIOL, V13, P336; Van Buskirk J, 2003, J HERPETOL, V37, P420, DOI 10.1670/0022-1511(2003)037[0420:TLETTS]2.0.CO;2; Van Buskirk J, 2002, EVOLUTION, V56, P361; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537	46	72	73	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6160	10.1371/journal.pone.0006160	http://dx.doi.org/10.1371/journal.pone.0006160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582147	gold, Green Published, Green Submitted			2022-12-27	WOS:000267806400015
J	Zayats, T; Young, TL; Mackey, DA; Malecaze, F; Calvas, P; Guggenheim, JA				Zayats, Tetyana; Young, Terri L.; Mackey, David A.; Malecaze, Francois; Calvas, Patrick; Guggenheim, Jeremy A.			Quality of DNA Extracted from Mouthwashes	PLOS ONE			English	Article								Background: A cost effective, safe and efficient method of obtaining DNA samples is essential in large scale genetic analyses. Buccal cells are an attractive source of DNA, as their collection is non-invasive and can be carried out by mail. However, little attention has been given to the quality of DNA extracted from mouthwashes. Methodology: Mouthwash-derived DNA was extracted from 500 subjects participating in a genetic study of high myopia. DNA quality was investigated using two standard techniques: agarose gel electrophoresis and quantitative polymerase chain reaction (qPCR). Principal Findings: Whereas the majority of mouthwash-derived DNA samples showed a single band of high molecular weight DNA by gel electrophoresis, 8.9% (95% CI: 7.1-10.7%) of samples contained only a smear of low-to-medium molecular weight, degraded DNA. The odds of DNA degradation in a subject's second mouthwash sample, given degradation of the first, was significantly greater than one (OR = 3.13; 95% CI: 1.22-7.39; Fisher's test P = 0.009), suggesting that DNA degradation was at least partially a subject-specific phenomenon. Approximately 12.4% (95% CI: 10.4-14.4%) of mouthwash-derived DNA failed to PCR amplify efficiently (using an,200 bp microsatellite marker). However, we found there was no significant difference in amplification success rate between DNA samples judged to be degraded or non-degraded by gel electrophoresis (Fisher's test P = 0.5). Conclusions: This study demonstrated that DNA degradation affects a significant minority of saline mouthwashes, and that the phenomenon is partially subject-specific. Whilst the level of degradation did not significantly prevent successful amplification of short PCR fragments, previous studies suggest that such DNA degradation would compromise more demanding applications.			Zayats, T (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, Wales.	guggenheim@cf.ac.uk	Mackey, David A/H-5340-2014	Mackey, David A/0000-0001-7914-4709; Guggenheim, Jeremy/0000-0001-5164-340X	NEI NIH HHS [R01 EY014685] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014685] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Bergen AW, 2005, HUM MUTAT, V26, P262, DOI 10.1002/humu.20213; Cler L, 2006, MOL CELL PROBE, V20, P191, DOI 10.1016/j.mcp.2005.12.003; D'Souza G, 2005, J CLIN MICROBIOL, V43, P5526, DOI 10.1128/JCM.43.11.5526-5535.2005; FAN JB, 2006, ILLUMINA UNIVERSAL B, P57; Farbrother JE, 2004, INVEST OPHTH VIS SCI, V45, P2873, DOI 10.1167/iovs.03-1155; Farbrother JE, 2004, INVEST OPHTH VIS SCI, V45, P2879, DOI 10.1167/iovs.03-1156; Feigelson HS, 2001, CANCER EPIDEM BIOMAR, V10, P1005; Freeman B, 1997, BEHAV GENET, V27, P251, DOI 10.1023/A:1025614231190; Garcia-Closas M, 2001, CANCER EPIDEM BIOMAR, V10, P687; Glei M, 2005, BIOMARKERS, V10, P203, DOI 10.1080/13547500500138963; Haffajee AD, 2001, J CLIN PERIODONTOL, V28, P377, DOI 10.1034/j.1600-051x.2001.028005377.x; Harty LC, 2000, CANCER EPIDEM BIOMAR, V9, P501; Heath EM, 2001, ARCH PATHOL LAB MED, V125, P127; King IB, 2002, CANCER EPIDEM BIOMAR, V11, P1511; KIROV G, 2006, BMC GENOMICS, V7; Konig KG, 2000, INT DENT J, V50, P162, DOI 10.1111/j.1875-595X.2000.tb00555.x; Le Marchand L, 2001, CANCER EPIDEM BIOMAR, V10, P701; LI YJ, 2009, INVESTIGATI IN PRESS; Lum A, 1998, CANCER EPIDEM BIOMAR, V7, P719; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Rudney JD, 2006, ARCH ORAL BIOL, V51, P291, DOI 10.1016/j.archoralbio.2005.09.003; Shiloah J, 2000, J PERIODONTOL, V71, P562, DOI 10.1902/jop.2000.71.4.562; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997	24	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6165	10.1371/journal.pone.0006165	http://dx.doi.org/10.1371/journal.pone.0006165			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582144	Green Published, gold			2022-12-27	WOS:000267806400019
J	Laguna-Torres, VA; Gomez, J; Ocana, V; Aguilar, P; Saldarriaga, T; Chavez, E; Perez, J; Zamalloa, H; Forshey, B; Paz, I; Gomez, E; Ore, R; Chauca, G; Ortiz, E; Villaran, M; Vilcarromero, S; Rocha, C; Chincha, O; Jimenez, G; Villanueva, M; Pozo, E; Aspajo, J; Kochel, T				Alberto Laguna-Torres, V.; Gomez, Jorge; Ocana, Victor; Aguilar, Patricia; Saldarriaga, Tatiana; Chavez, Edward; Perez, Juan; Zamalloa, Hernan; Forshey, Brett; Paz, Irmia; Gomez, Elizabeth; Ore, Roel; Chauca, Gloria; Ortiz, Ernesto; Villaran, Manuel; Vilcarromero, Stalin; Rocha, Claudio; Chincha, Omayra; Jimenez, Gerardo; Villanueva, Miguel; Pozo, Edwar; Aspajo, Jackeline; Kochel, Tadeusz			Influenza-Like Illness Sentinel Surveillance in Peru	PLOS ONE			English	Article							EPIDEMIOLOGY	Background: Acute respiratory illnesses and influenza-like illnesses (ILI) are a significant source of morbidity and mortality worldwide. Despite the public health importance, little is known about the etiology of these acute respiratory illnesses in many regions of South America. In 2006, the Peruvian Ministry of Health (MoH) and the US Naval Medical Research Center Detachment (NMRCD) initiated a collaboration to characterize the viral agents associated with ILI and to describe the clinical and epidemiological presentation of the affected population. Methodology/Principal Findings: Patients with ILI ( fever >= 38 degrees C and cough or sore throat) were evaluated in clinics and hospitals in 13 Peruvian cities representative of the four main regions of the country. Nasal and oropharyngeal swabs, as well as epidemiological and demographic data, were collected from each patient. During the two years of this study ( June 2006 through May 2008), a total of 6,835 patients, with a median age of 13 years, were recruited from 31 clinics and hospitals; 6,308 were enrolled by regular passive surveillance and 527 were enrolled as part of outbreak investigations. At least one respiratory virus was isolated from the specimens of 2,688 (42.6%) patients, with etiologies varying by age and geographical region. Overall the most common viral agents isolated were influenza A virus (25.1%), influenza B virus (9.7%), parainfluenza viruses 1, 2, and 3, (HPIV-1,-2,-3; 3.2%), herpes simplex virus (HSV; 2.6%), and adenoviruses (1.8%). Genetic analyses of influenza virus isolates demonstrated that three lineages of influenza A H1N1, one lineage of influenza A H3N2, and two lineages of influenza B were circulating in Peru during the course of this study. Conclusions: To our knowledge this is the most comprehensive study to date of the etiologic agents associated with ILI in Peru. These results demonstrate that a wide range of respiratory pathogens are circulating in Peru and this fact needs to be considered by clinicians when treating patients reporting with ILI. Furthermore, these data have implications for influenza vaccine design and implementation in South America.			Laguna-Torres, VA (corresponding author), US Naval Med Res Ctr Detachment, Lima, Peru.	alberto.laguna@med.navy.mil	Rocha, Claudio A./N-4440-2017; Vilcarromero, Stalin/H-9263-2019; Gomez, Jorge/E-5258-2012	Rocha, Claudio A./0000-0003-4221-3883; Vilcarromero, Stalin/0000-0002-9097-0638; LAGUNA-TORRES, VICTOR ALBERTO/0000-0002-9507-6301; Ortiz, Ernesto/0000-0002-6485-2005; Pozo, Edwar Jose/0000-0001-7183-5230; chincha, omayra/0000-0001-5016-8555; Paz, Irmia/0000-0003-3926-9982; Chavez-Cruzado, Edward/0000-0001-5379-8624; Gomez, Jorge/0000-0003-1342-3507				[Anonymous], 2002, Wkly Epidemiol Rec, V77, P350; AVILA M, 1990, REV INFECT DIS, V12, pS974; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; da Cunha Antonio Jose Ledo Alves, 2003, Indian Pediatr, V40, P7; Garcia J, 2009, INFLUENZA OTHER RESP, V3, P69, DOI 10.1111/j.1750-2659.2009.00072.x; Garcia-Garcia J, 2006, SALUD PUBLICA MEXICO, V48, P244; *I NAC SAL OF GEN, 2000, INFL; MCMILLAN JA, 1993, PEDIATR INFECT DIS J, V12, P280, DOI 10.1097/00006454-199304000-00004; *MIN SAL PER, 2005, PLAN NAC PREP RESP F; Monto AS, 2002, AM J MED, V112, p4S; OCHOA EG, 1996, B PAN AM HLTH ORG, V30, P106; Portes Silvana A. R., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P337, DOI 10.1590/S0036-46651998000600001; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Saldarriaga Tatiana, 2008, Rev. perú. med. exp. salud publica, V25, P35; Straliotto Selir M., 2002, Rev. Soc. Bras. Med. Trop., V35, P283, DOI 10.1590/S0037-86822002000400002; Swofford DL, 1998, PHYLOGENETIC ANAL US; *WHO, 2007, PROGR MUND OMS GRIP; *WHO, 2007, REC INFL VACC; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Health Organization, 2003, INFL FACT SHEET	22	75	78	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6118	10.1371/journal.pone.0006118	http://dx.doi.org/10.1371/journal.pone.0006118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568433	Green Published, gold, Green Submitted			2022-12-27	WOS:000267572200017
J	Ranjbar, S; Boshoff, HI; Mulder, A; Siddiqi, N; Rubin, EJ; Goldfeld, AE				Ranjbar, Shahin; Boshoff, Helena I.; Mulder, Amara; Siddiqi, Noman; Rubin, Eric J.; Goldfeld, Anne E.			HIV-1 Replication Is Differentially Regulated by Distinct Clinical Strains of Mycobacterium tuberculosis	PLOS ONE			English	Article								Background: Tuberculosis ( TB) is the largest cause of death in human immunodeficiency virus type 1 (HIV-1) infection, having claimed an estimated one third to one half of the 30 million AIDS deaths that have occurred worldwide. Different strains of Mycobacterium tuberculosis (MTb), the causative agent of TB, are known to modify the host immune response in a strain-specific manner. However, a MTb strain-specific impact upon the regulation of HIV-1 replication has not previously been established. Methology/Principal Findings: We isolated normal human peripheral blood mononuclear cells (PBMC) and co-infected them with HIV-1 and with either the well characterized CDC1551 or HN878 MTb clinical isolate. We show that HIV-1 co-infection with the CDC1551 MTb strain results in higher levels of virus replication relative to co-infection with the HN878 MTb strain ex vivo. Furthermore, we show that the distinct pattern of CDC1551 or HN878 induced HIV-1 replication is associated with significantly increased levels of TNF and IL-6, and of the transcription and nuclear translocation of the p65 subunit of the transcription factor NF-kappa B, by CDC1551 relative to HN878. Conclusions/Significance: These results provide a precedent for TB strain-specific effects upon HIV-1 replication and thus for TB strain-specific pathogenesis in the outcome of HIV-1/TB co-infection. MTb strain-specific factors and mechanisms involved in the regulation of HIV-1 during co-infection will be of importance in understanding the basic pathogenesis of HIV-1/TB co-infection.			Ranjbar, S (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	ranjbar@idi.harvard.edu; goldfeld@idi.harvard.edu	Goldfeld, Anne/AAF-1818-2019	Rubin, Eric/0000-0001-5120-962X	Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [HL 059838] Funding Source: Medline; NIAID NIH HHS [P30 AI060354, AI 065285, P30 AI 060354, R56 AI065285, R01 AI065285] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R56AI065285, ZIAAI000783, R01AI065285] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Ait-Ali D, 2008, ENDOCRINOLOGY, V149, P2840, DOI 10.1210/en.2007-1192; Baba M, 2006, ANTIVIR RES, V71, P301, DOI 10.1016/j.antiviral.2006.01.002; Barczak AK, 2005, J INFECT DIS, V192, P600, DOI 10.1086/432006; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Collins KR, 2000, J ACQ IMMUN DEF SYND, V24, P408, DOI 10.1097/00126334-200008150-00002; Collins KR, 2002, J VIROL, V76, P1697, DOI 10.1128/JVI.76.4.1697-1706.2002; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Goldfeld AE, 2008, HDB TUBERCULOSIS IMM; Goletti D, 1996, J IMMUNOL, V157, P1271; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Haraguchi Soichi, 2006, AIDS Res Ther, V3, P8, DOI 10.1186/1742-6405-3-8; Havlir DV, 2001, J CLIN MICROBIOL, V39, P298, DOI 10.1128/JCM.39.1.298-303.2001; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Honda Y, 1998, J EXP MED, V188, P1255, DOI 10.1084/jem.188.7.1255; Hoshino Y, 2002, J EXP MED, V195, P495, DOI 10.1084/jem.20011614; ISRAEL N, 1989, J IMMUNOL, V143, P3956; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Karboul A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-107; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Kinter AL, 2001, MOL MED, V7, P668, DOI 10.1007/BF03401957; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 1999, J IMMUNOL, V162, P6740; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mayaud C, 1999, THORAX, V54, P567, DOI 10.1136/thx.54.7.567; MCCAFFREY PG, 1992, J BIOL CHEM, V267, P1864; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nicod LP, 2007, SWISS MED WKLY, V137, P357; OGARRA A, 2008, HDB TUBERCULOSIS IMM; *ORG WH, 2007, GLOB TUB CONTR SURV; Park SK, 2004, NEPHROL DIAL TRANSPL, V19, P312, DOI 10.1093/ndt/gfg583; Peters W, 2001, P NATL ACAD SCI USA, V98, P7958, DOI 10.1073/pnas.131207398; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Ranjbar S, 2006, PLOS PATHOG, V2, P1176, DOI 10.1371/journal.ppat.0020130; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Saunders BM, 2000, INFECT IMMUN, V68, P3322, DOI 10.1128/IAI.68.6.3322-3326.2000; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Streicher EM, 2007, J CLIN MICROBIOL, V45, P237, DOI 10.1128/JCM.01429-06; Toossi T, 2001, J ACQ IMMUN DEF SYND, V28, P1, DOI 10.1097/00042560-200109010-00001; Toossi Z, 2001, CLIN EXP IMMUNOL, V123, P233, DOI 10.1046/j.1365-2249.2001.01401.x; Toossi Z, 2007, AIDS RES HUM RETROV, V23, P93, DOI 10.1089/aid.2006.0050; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; *UNAIDS, 2006, REP GLOB AIDS EP 200; *UNAIDS, 2007, TB HIV NETW POL CHAN; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Vicenzi E, 2000, J LEUKOCYTE BIOL, V68, P405; Viedt C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015609.31253.7F; Viedt C, 2002, ARTERIOSCL THROM VAS, V22, P914, DOI 10.1161/01.ATV.0000019009.73586.7F; West MJ, 2001, J VIROL, V75, P8524, DOI 10.1128/JVI.75.18.8524-8537.2001; *WORLD OH REP, 2004, P HIV TB C MEK SUB H; Yang XY, 1999, J BIOL CHEM, V274, P27981, DOI 10.1074/jbc.274.39.27981; ZHANG YH, 1995, J CLIN INVEST, V95, P2324, DOI 10.1172/JCI117924	66	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6116	10.1371/journal.pone.0006116	http://dx.doi.org/10.1371/journal.pone.0006116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568431	gold, Green Published, Green Submitted			2022-12-27	WOS:000267572200015
J	Jayanthi, S; Mccoy, MT; Beauvais, G; Ladenheim, B; Gilmore, K; Wood, W; Becker, K; Cadet, JL				Jayanthi, Subramaniam; McCoy, Michael T.; Beauvais, Genevieve; Ladenheim, Bruce; Gilmore, Kristi; Wood, William, III; Becker, Kevin; Cadet, Jean Lud			Methamphetamine Induces Dopamine D1 Receptor-Dependent Endoplasmic Reticulum Stress-Related Molecular Events in the Rat Striatum	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOTHELIAL GROWTH-FACTOR; ACTIVATING TRANSCRIPTION FACTOR-3; FOCAL CEREBRAL-ISCHEMIA; APOPTOTIC CELL-DEATH; HEAT-SHOCK PROTEINS; ER STRESS; HEME OXYGENASE-1; OXIDATIVE STRESS; GENE-EXPRESSION	Methamphetamine (METH) is an illicit toxic psychostimulant which is widely abused. Its toxic effects depend on the release of excessive levels of dopamine (DA) that activates striatal DA receptors. Inhibition of DA-mediated neurotransmission by the DA D1 receptor antagonist, SCH23390, protects against METH-induced neuronal apoptosis. The initial purpose of the present study was to investigate, using microarray analyses, the influence of SCH23390 on transcriptional responses in the rat striatum caused by a single METH injection at 2 and 4 hours after drug administration. We identified 545 out of a total of 22,227 genes as METH-responsive. These include genes which are involved in apoptotic pathways, endoplasmic reticulum (ER) stress, and in transcription regulation, among others. Of these, a total of 172 genes showed SCH23390-induced inhibition of METH-mediated changes. Among these SCH23390-responsive genes were several genes that are regulated during ER stress, namely ATF3, HSP27, Hmox1, HSP40, and CHOP/Gadd153. The secondary goal of the study was to investigate the role of DA D1 receptor stimulation on the expression of genes that participate in ER stress-mediated molecular events. We thus used quantitative PCR to confirm changes in the METH-responsive ER genes identified by the microarray analyses. We also measured the expression of these genes and of ATF4, ATF6, BiP/GRP78, and of GADD34 over a more extended time course. SCH23390 attenuated or blocked METH-induced increases in the expression of the majority of these genes. Western blot analysis revealed METH-induced increases in the expression of the antioxidant protein, Hmox1, which lasted for about 24 hours after the METH injection. Additionally, METH caused DA D1 receptor-dependent transit of the Hmox1 regulator protein, Nrf2, from cytosolic into nuclear fractions where the protein exerts its regulatory functions. When taken together, these findings indicate that SCH23390 can provide protection against neuronal apoptosis by inhibiting METH-mediated DA D1 receptor-mediated ER stress in the rat striatum. Our data also suggest that METH-induced toxicity might be a useful model to dissect molecular mechanisms involved in ER stress-dependent events in the rodent brain.			Jayanthi, S (corresponding author), Natl Inst Drug Abuse, Mol Neuropsychiat Res Branch, NIH, DHHS,Intramural Res Program, Baltimore, MD USA.	jcadet@intra.nida.nih.gov	Jayanthi, Subramaniam/ABI-4023-2020	Becker, Kevin/0000-0002-6794-6656; Jayanthi, Subramaniam/0000-0002-5209-303X	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000616, ZICAG000616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000552, ZIADA000551] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; An JJ, 2008, FEBS J, V275, P1296, DOI 10.1111/j.1742-4658.2008.06291.x; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; BARBER GN, 1994, P NATL ACAD SCI USA, V91, P4278, DOI 10.1073/pnas.91.10.4278; BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; Cadet JL, 2001, SYNAPSE, V41, P40, DOI 10.1002/syn.1058; Calabrese V, 2004, ANTIOXID REDOX SIGN, V6, P895, DOI 10.1089/1523086041798051; Cappon GD, 2000, BRAIN RES, V863, P106, DOI 10.1016/S0006-8993(00)02107-7; Chen J, 2004, J BIOL CHEM, V279, P39317, DOI 10.1074/jbc.M403891200; Chen J, 2009, EUR J NEUROSCI, V29, P287, DOI 10.1111/j.1460-9568.2008.06590.x; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Deng XL, 2001, MOL BRAIN RES, V93, P64, DOI 10.1016/S0169-328X(01)00184-X; DORNER AJ, 1990, J BIOL CHEM, V265, P22029; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ferrier DEK, 2001, EVOL DEV, V3, P263, DOI 10.1046/j.1525-142x.2001.003004263.x; Franklin TB, 2005, INT J HYPERTHER, V21, P379, DOI 10.1080/02656730500069955; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Green TA, 2006, J NEUROSCI, V26, P8235, DOI 10.1523/JNEUROSCI.0880-06.2006; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Hai T, 1999, GENE EXPRESSION, V7, P321; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hill-Kapturczak N, 2007, ANTIOXID REDOX SIGN, V9, P2197, DOI 10.1089/ars.2007.1798; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jayanthi S, 1998, ANN NY ACAD SCI, V844, P92, DOI 10.1111/j.1749-6632.1998.tb08224.x; Jayanthi S, 2001, FASEB J, V15, P1745, DOI 10.1096/fj.01-0025com; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jayanthi S, 2002, MOL PHARMACOL, V61, P1124, DOI 10.1124/mol.61.5.1124; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; KATO H, 1995, BRAIN RES, V679, P1, DOI 10.1016/0006-8993(95)00198-Y; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim YS, 2005, FREE RADICAL BIO MED, V38, P85, DOI 10.1016/j.freeradbiomed.2004.09.031; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; KRAMER JC, 1967, J AMER MED ASSOC, V201, P305, DOI 10.1001/jama.201.5.305; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; LEE TG, 1994, MOL CELL BIOL, V14, P2331, DOI 10.1128/MCB.14.4.2331; Li C, 2007, ANTIOXID REDOX SIGN, V9, P2227, DOI 10.1089/ars.2007.1783; Li HY, 2007, CHEM RES TOXICOL, V20, P1242, DOI 10.1021/tx700076q; Linden T, 1998, NEUROSCI LETT, V247, P103, DOI 10.1016/S0304-3940(98)00278-X; Liu XY, 2008, CELL MOL NEUROBIOL, V28, P769, DOI 10.1007/s10571-007-9219-0; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Makishima T, 2000, J BIOCHEM-TOKYO, V128, P399, DOI 10.1093/oxfordjournals.jbchem.a022767; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; Matus S, 2008, CURR MOL MED, V8, P157, DOI 10.2174/156652408784221324; MAZZARELLA RA, 1990, J BIOL CHEM, V265, P1094; McMahon M, 2001, CANCER RES, V61, P3299; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Meriin AB, 2005, INT J HYPERTHER, V21, P403, DOI 10.1080/02656730500041871; Miyazaki I, 2006, FASEB J, V20, P571, DOI 10.1096/fj.05-4996fje; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; Moussa CEH, 2006, NEUROCHEM INT, V48, P226, DOI 10.1016/j.neuint.2005.09.007; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nakagomi S, 2003, J NEUROSCI, V23, P5187; NAKASHIMA T, 1993, MOL CELL BIOL, V13, P6367, DOI 10.1128/MCB.13.10.6367; Nishii K, 1999, GENES CELLS, V4, P243, DOI 10.1046/j.1365-2443.1999.00256.x; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Oida Y, 2008, BRAIN RES, V1208, P217, DOI 10.1016/j.brainres.2008.02.068; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Paschen W, 1998, METAB BRAIN DIS, V13, P55, DOI 10.1023/A:1020631029168; Paschen W, 2003, J CEREBR BLOOD F MET, V23, P773, DOI 10.1097/01.WCB.0000075009.47474.F9; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sanjay A, 1998, J BIOL CHEM, V273, P26094, DOI 10.1074/jbc.273.40.26094; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Sekine Y, 2006, ARCH GEN PSYCHIAT, V63, P90, DOI 10.1001/archpsyc.63.1.90; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; Shih AY, 2007, J NEUROCHEM, V101, P109, DOI 10.1111/j.1471-4159.2006.04345.x; SUGIMOTO A, 1995, EMBO J, V14, P4434, DOI 10.1002/j.1460-2075.1995.tb00122.x; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tajiri S, 2006, FEBS LETT, V580, P3462, DOI 10.1016/j.febslet.2006.05.021; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; van Muiswinkel FL, 2005, CNS NEUROL DISORD-DR, V4, P267, DOI 10.2174/1568007054038238; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Voss OH, 2007, J BIOL CHEM, V282, P25088, DOI 10.1074/jbc.M701740200; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; Xu WJ, 2005, SYNAPSE, V58, P110, DOI 10.1002/syn.20185; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yang JP, 2009, J INVEST SURG, V22, P29, DOI 10.1080/08941930802566714; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang LJ, 2009, CANCER LETT, V274, P40, DOI 10.1016/j.canlet.2008.08.030; Zourlidou A, 2004, J NEUROCHEM, V88, P1439, DOI 10.1046/j.1471-4159.2003.02273.x	114	67	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6092	10.1371/journal.pone.0006092	http://dx.doi.org/10.1371/journal.pone.0006092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564919	Green Published, Green Submitted, gold			2022-12-27	WOS:000267515700011
J	Luo, HW; Sun, ZY; Arndt, W; Shi, J; Friedman, R; Tang, JJ				Luo, Haiwei; Sun, Zhiyi; Arndt, William; Shi, Jian; Friedman, Robert; Tang, Jijun			Gene Order Phylogeny and the Evolution of Methanogens	PLOS ONE			English	Article							RECONSTRUCTION; ARCHAEA; TREE; GENOMICS; ORIGIN	Methanogens are a phylogenetically diverse group belonging to Euryarchaeota. Previously, phylogenetic approaches using large datasets revealed that methanogens can be grouped into two classes, "Class I'' and "Class II''. However, some deep relationships were not resolved. For instance, the monophyly of "Class I'' methanogens, which consist of Methanopyrales, Methanobacteriales and Methanococcales, is disputable due to weak statistical support. In this study, we use MSOAR to identify common orthologous genes from eight methanogen species and a Thermococcale species (outgroup), and apply GRAPPA and FastME to compute distance-based gene order phylogeny. The gene order phylogeny supports two classes of methanogens, but it differs from the original classification of methanogens by placing Methanopyrales and Methanobacteriales together with Methanosarcinales in Class II rather than with Methanococcales. This study suggests a new classification scheme for methanogens. In addition, it indicates that gene order phylogeny can complement traditional sequence-based methods in addressing taxonomic questions for deep relationships.			Luo, HW (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	hluo2006@gmail.com	Tang, Jijun/ABH-6528-2020; Luo, Haiwei/AAE-1958-2021	Luo, Haiwei/0000-0001-8452-6066; Sun, Zhiyi/0000-0002-6106-5356; Friedman, Robert/0000-0002-1061-4909	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078991, R01GM043940] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abby S, 2007, TRENDS MICROBIOL, V15, P135, DOI 10.1016/j.tim.2007.01.007; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bapteste E, 2008, MOL BIOL EVOL, V25, P83, DOI 10.1093/mlbev/msm229; Bapteste E, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-33; Bapteste E, 2004, TRENDS MICROBIOL, V12, P406, DOI 10.1016/j.tim.2004.07.002; Bapteste Eric, 2005, Archaea, V1, P353, DOI 10.1155/2005/859728; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Belda E, 2005, MOL BIOL EVOL, V22, P1456, DOI 10.1093/molbev/msi134; Blanchette M, 1999, J MOL EVOL, V49, P193, DOI 10.1007/PL00006542; Brochier C, 2000, TRENDS GENET, V16, P529, DOI 10.1016/S0168-9525(00)02142-9; Chen X, 2005, IEEE ACM T COMPUT BI, V2, P302, DOI 10.1109/TCBB.2005.48; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gao B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-86; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; JIANG T, 2007, P 18 ANN S COMB PATT; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Luo HW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003837; McCann A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-312; Moret B M, 2001, Bioinformatics, V17 Suppl 1, pS165; Moret BME, 2002, J COMPUT SYST SCI, V65, P508, DOI 10.1016/S0022-0000(02)00007-7; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Palmer Jeffrey D., 1992, P99; RAUBESON LA, 1992, SCIENCE, V255, P1697, DOI 10.1126/science.255.5052.1697; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Wang LS, 2006, J MOL EVOL, V63, P473, DOI 10.1007/s00239-005-0216-y	31	23	30	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6069	10.1371/journal.pone.0006069	http://dx.doi.org/10.1371/journal.pone.0006069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562076	gold, Green Published, Green Submitted			2022-12-27	WOS:000267465900005
J	Barros, VC; Assumpcao, JG; Cadete, AM; Santos, VC; Cavalcante, RR; Araujo, RN; Pereira, MH; Gontijo, NF				Barros, Veruska Cavalcanti; Assumpcao, Jessica Goes; Cadete, Andre Miranda; Santos, Vania Cristina; Cavalcante, Reginaldo Roris; Araujo, Ricardo Nascimento; Pereira, Marcos Horacio; Gontijo, Nelder Figueiredo			The Role of Salivary and Intestinal Complement System Inhibitors in the Midgut Protection of Triatomines and Mosquitoes	PLOS ONE			English	Article								Saliva of haematophagous arthropods contain biomolecules involved directly or indirectly with the haematophagy process, and among them are encountered some complement system inhibitors. The most obvious function for these inhibitors would be the protection of the midgut against injury by the complement. To investigate this hypothesis, Triatoma brasiliensis nymphs were forced to ingest human serum in conditions in which the protection of midgut by the inhibitors is bypassed. In these conditions, the anterior midgut epithelium was injured by the complement, causing cell death. Once some insects such as Aedes aegypti have no salivary inhibitors, we hypothesized the existence of intestinal inhibitors. The inhibitory activity was investigated in the intestine of A. aegypti as well as in the saliva and intestine of other three triatomine species (T. brasiliensis, T. infestans and Rhodnius prolixus) using an immunological method able to determine the level of deposition of some complement factors (C1q, C3b, or C4b) on the surface of complement activator molecules linked to microplates. This methodology permitted to identify which points along the activation phase of the complement cascade were inhibited. As expected, soluble contents of A. aegypti's intestine was capable to inhibit C3b deposition by the classical and alternative pathways. Saliva or soluble intestinal contents, obtained from triatomines were unable to inhibit C1q deposition by the classical pathway. C4b deposition by the classical pathway was inhibited by the intestinal contents from the three triatomines. On the other hand, only T. brasiliensis saliva inhibited C4b deposition. Both, saliva and intestinal contents from all triatomines were able to inhibit C3b deposition in the classical and alternative pathways. None of the material extracted from the intestinal cell membranes from the triatomines inhibited C3b deposition in the classical pathway. The existence of complement inhibitors may have important biological consequences which are discussed in detail.			Barros, VC (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil.	nelder@icb.ufmg.br	Pereira, Marcos H/A-3774-2012; Gontijo, Nelder F/D-2539-2013; Araujo, Ricardo N/O-1967-2017; Pereira, Marcos Horácio/AAE-7076-2021	Pereira, Marcos H/0000-0003-4843-0088; Gontijo, Nelder F/0000-0003-3357-2497; Araujo, Ricardo N/0000-0002-1272-4386; Pereira, Marcos Horácio/0000-0003-4843-0088				Abdul-Rauf M, 1999, J INVERTEBR PATHOL, V73, P45, DOI 10.1006/jipa.1998.4792; Andrade BB, 2005, AN ACAD BRAS CIENC, V77, P665, DOI 10.1590/S0001-37652005000400008; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Bahia D, 2007, PARASITOL RES, V100, P449, DOI 10.1007/s00436-006-0307-8; Barrington R, 2001, IMMUNOL REV, V180, P5, DOI 10.1034/j.1600-065X.2001.1800101.x; BILLINGSLEY PF, 1990, ANNU REV ENTOMOL, V35, P219, DOI 10.1146/annurev.en.35.010190.001251; Bos IGA, 2002, IMMUNOBIOLOGY, V205, P518, DOI 10.1078/0171-2985-00151; BURTON DR, 1980, NATURE, V288, P338, DOI 10.1038/288338a0; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; CATTY D, 1988, ANTIBODIES PRACTICAL, P19; Cavalcante RR, 2003, PARASITOLOGY, V127, P87, DOI 10.1017/S0031182003003329; Colombara R, 1996, J CAPILLARY ELECTROP, V3, P147; Corena MD, 2005, J EXP BIOL, V208, P3263, DOI 10.1242/jeb.01739; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Devenport Martin, 2005, P297; EIRAS AE, 1991, B ENTOMOL RES, V81, P151, DOI 10.1017/S0007485300051221; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Garcia E.S., 1984, Memorias do Instituto Oswaldo Cruz, V79, P33; GARCIA ES, 1991, PARASITOL TODAY, V7, P240, DOI 10.1016/0169-4758(91)90237-I; Gillespie RD, 2000, PARASITE IMMUNOL, V22, P319, DOI 10.1046/j.1365-3024.2000.00309.x; Gomes RB, 2002, J INFECT DIS, V186, P1530, DOI 10.1086/344733; Gomes RB, 2007, T ROY SOC TROP MED H, V101, P127, DOI 10.1016/j.trstmh.2006.06.002; GROVES WE, 1968, ANAL BIOCHEM, V22, P195, DOI 10.1016/0003-2697(68)90307-2; Hardig Y, 1997, BIOCHEM J, V323, P469; Hostomska J, 2008, VECTOR-BORNE ZOONOT, V8, P443, DOI 10.1089/vbz.2007.0214; Kalvachova P, 1999, J MED ENTOMOL, V36, P341, DOI 10.1093/jmedent/36.3.341; MORGAN PB, 1997, COMPLEMENT PRACTICAL, P105; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Rathinavelu S, 2003, INFECT IMMUN, V71, P822, DOI 10.1128/IAI.71.2.822-829.2003; RIBEIRO JMC, 1987, EXP PARASITOL, V64, P347, DOI 10.1016/0014-4894(87)90046-4; RIBEIRO JMC, 1980, J INSECT PHYSIOL, V26, P303, DOI 10.1016/0022-1910(80)90138-9; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Rohousova I, 2005, PARASITOLOGY, V130, P493, DOI 10.1017/S003118200400681X; Santos VC, 2008, J EXP BIOL, V211, P2792, DOI 10.1242/jeb.019836; Silva F, 2005, AM J TROP MED HYG, V72, P94, DOI 10.4269/ajtmh.2005.72.94; SIM RB, 1997, COMPLEMENT PRACTICAL; Soares AC, 2006, J INSECT PHYSIOL, V52, P468, DOI 10.1016/j.jinsphys.2006.01.003; Terra W. R., 1996, P206; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Villiers CL, 2008, MOL IMMUNOL, V45, P3509, DOI 10.1016/j.molimm.2008.05.015; Villiers MB, 1999, IMMUNOPHARMACOLOGY, V42, P151, DOI 10.1016/S0162-3109(99)00017-X; Villiers MB, 2003, INT IMMUNOL, V15, P91, DOI 10.1093/intimm/dxg014; Wikel SK, 2001, VET PARASITOL, V101, P275, DOI 10.1016/S0304-4017(01)00556-8; [No title captured]	46	39	39	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6047	10.1371/journal.pone.0006047	http://dx.doi.org/10.1371/journal.pone.0006047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557176	Green Published, gold, Green Submitted			2022-12-27	WOS:000267356900009
J	Pfeiffer, T; Hoffmann, R				Pfeiffer, Thomas; Hoffmann, Robert			Large-Scale Assessment of the Effect of Popularity on the Reliability of Research	PLOS ONE			English	Article								Based on theoretical reasoning it has been suggested that the reliability of findings published in the scientific literature decreases with the popularity of a research field. Here we provide empirical support for this prediction. We evaluate published statements on protein interactions with data from high-throughput experiments. We find evidence for two distinctive effects. First, with increasing popularity of the interaction partners, individual statements in the literature become more erroneous. Second, the overall evidence on an interaction becomes increasingly distorted by multiple independent testing. We therefore argue that for increasing the reliability of research it is essential to assess the negative effects of popularity and develop approaches to diminish these effects.			Pfeiffer, T (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA USA.	pfeiffer@fas.harvard.edu	Pfeiffer, Thomas/R-1339-2019	Pfeiffer, Thomas/0000-0002-0592-577X				Cokol M, 2007, EMBO REP, V8, P422, DOI 10.1038/sj.embor.7400970; Duan XJ, 2002, MOL CELL PROTEOMICS, V1, P104, DOI 10.1074/mcp.M100026-MCP200; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; GOODMAN SN, 1988, AM J PUBLIC HEALTH, V78, P1568, DOI 10.2105/AJPH.78.12.1568; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoffmann R, 2005, BIOINFORMATICS, V21, P252, DOI 10.1093/bioinformatics/bti1142; Hoffmann R, 2003, TRENDS GENET, V19, P79, DOI 10.1016/S0168-9525(02)00014-8; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Hoffmann R, 2008, NAT GENET, V40, P1047, DOI 10.1038/ng.f.217; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Pfeiffer T, 2007, P NATL ACAD SCI USA, V104, P12052, DOI 10.1073/pnas.0701315104; Rzhetsky A, 2006, P NATL ACAD SCI USA, V103, P4940, DOI 10.1073/pnas.0600591103; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Waldrop M, 2008, NATURE, V455, P22, DOI 10.1038/455022a; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289	20	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e5996	10.1371/journal.pone.0005996	http://dx.doi.org/10.1371/journal.pone.0005996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551148	gold, Green Published			2022-12-27	WOS:000267356500005
J	Turdi, S; Guo, R; Huff, AF; Wolf, EM; Culver, B; Ren, J				Turdi, Subat; Guo, Rui; Huff, Anna F.; Wolf, Eliza M.; Culver, Bruce; Ren, Jun			Cardiomyocyte Contractile Dysfunction in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article								Objectives: Ample clinical and experimental evidence indicated that patients with Alzheimer's disease display a high incidence of cardiovascular events. This study was designed to examine myocardial histology, cardiomyocyte shortening, intracellular Ca(2+) homeostasis and regulatory proteins, electrocardiogram, adrenergic response, endoplasmic reticulum (ER) stress and protein carbonyl formation in C57 wild-type (WT) mice and an APPswe/PS1dE9 transgenic (APP/PS1) model for Alzheimer's disease. Methods: Cardiomyocyte mechanical properties were evaluated including peak shortening (PS), time-to-PS (TPS), time-to-relengthening (TR), maximal velocity of shortening and relengthening (6dL/dt), intracellular Ca(2+) transient rise and decay. Results: Little histological changes were observed in APP/PS1 myocardium. Cardiomyocytes from APP/PS1 but not APP or PS1 single mutation mice exhibited depressed PS, reduced +/- dL/dt, normal TPS and TR compared with WT mice. Rise in intracellular Ca(2+) was lower accompanied by unchanged resting/peak intracellular Ca(2+) levels and intracellular Ca(2+) decay in APP/PS1 mice. Cardiomyocytes from APP/PS1 mice exhibited a steeper decline in PS at high frequencies. The responsiveness to adrenergic agonists was dampened although beta(1)-adrenergic receptor expression was unchanged in APP/PS1 hearts. Expression of the Ca(2+) regulatory protein phospholamban and protein carbonyl formation were downregulated and elevated, respectively, associated with unchanged SERCA2a, Na(+)-Ca(2+) exchanger and ER stress markers in APP/PS1 hearts. Our further study revealed that antioxidant N-acetylcysteine attenuated the contractile dysfunction in APP/PS1 mice. Conclusions: Our results depicted overt cardiomyocyte mechanical dysfunction in the APP/PS1 Alzheimer's disease model, possibly due to oxidative stress.			Turdi, S (corresponding author), Univ Wyoming, Div Pharmaceut Sci, Coll Hlth Sci, Laramie, WY 82071 USA.	jren@uwyo.edu	Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783	NCRR NIH HHS [5 P20 RR016474, P20 RR016474] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bleumink GS, 2004, AM HEART J, V147, P685, DOI 10.1016/j.ahj.2003.11.016; Brodde OE, 2006, J PHARMACOL SCI, V100, P323, DOI 10.1254/jphs.CRJ06001X; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Doser TA, 2009, CIRCULATION, V119, P1941, DOI 10.1161/CIRCULATIONAHA.108.823799; Estorch M, 2006, Rev Esp Med Nucl, V25, P229, DOI 10.1157/13090655; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Giubilei F, 1998, ALZ DIS ASSOC DIS, V12, P356, DOI 10.1097/00002093-199812000-00017; Gu F, 2008, NEUROSCI LETT, V440, P44, DOI 10.1016/j.neulet.2008.05.050; GUO R, 2009, J MOL CELL CARDIOL; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Heron Melonie, 2007, Natl Vital Stat Rep, V56, P1; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Irie F, 2008, ARCH NEUROL-CHICAGO, V65, P89, DOI 10.1001/archneurol.2007.29; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky Joanna L, 2002, Curr Neurol Neurosci Rep, V2, P457, DOI 10.1007/s11910-002-0073-7; Jindahra Panitha, 2004, Journal of the Medical Association of Thailand, V87, P1176; Li DX, 2006, AM J HUM GENET, V79, P1030, DOI 10.1086/509900; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Martins IJ, 2006, MOL PSYCHIATR, V11, P721, DOI 10.1038/sj.mp.4001854; Nakajima M, 2004, DEV DYNAM, V230, P795, DOI 10.1002/dvdy.20098; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Pasquier F, 2006, DIABETES METAB, V32, P403, DOI 10.1016/S1262-3636(07)70298-7; Picklo MJ, 2002, TOXICOL APPL PHARM, V184, P187, DOI 10.1006/taap.2002.9506; RASKIND MA, 1984, ARCH GEN PSYCHIAT, V41, P343; Reitz C, 2007, ARCH NEUROL-CHICAGO, V64, P1734, DOI 10.1001/archneur.64.12.1734; Ren J, 2003, PHARMACOL RES, V47, P341, DOI 10.1016/S1043-6618(03)00005-7; Ren J, 2007, CIRCULATION, V116, P190; Roher AE, 2005, NEUROLOGY, V65, P974, DOI 10.1212/WNL.65.6.974; Rosendoff C, 2007, AM J GERIATR CARDIOL, V16, P143, DOI 10.1111/j.1076-7460.2007.06696.x; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Takeda T, 2005, FASEB J, V19, P2069, DOI 10.1096/fj.05-3744fje; Taniuchi N, 2007, NEUROREPORT, V18, P1801, DOI 10.1097/WNR.0b013e3282f1c9e9; Valencik ML, 2006, CIRC RES, V99, P1403, DOI 10.1161/01.RES.0000252291.88540.ac; Wada-Isoe K, 2007, J NEUROL SCI, V260, P33, DOI 10.1016/j.jns.2007.03.016; WANG SJ, 1994, AGE AGEING, V23, P400, DOI 10.1093/ageing/23.5.400; WIELAND DM, 1981, J NUCL MED, V22, P22	41	25	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6033	10.1371/journal.pone.0006033	http://dx.doi.org/10.1371/journal.pone.0006033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551139	gold, Green Published, Green Submitted			2022-12-27	WOS:000267356500017
J	Jensen, KB; Lonsdorf, TB; Schalling, M; Kosek, E; Ingvar, M				Jensen, Karin B.; Lonsdorf, Tina B.; Schalling, Martin; Kosek, Eva; Ingvar, Martin			Increased Sensitivity to Thermal Pain Following a Single Opiate Dose Is Influenced by the COMT val(158)met Polymorphism	PLOS ONE			English	Article								Increased pain sensitivity after opioid administration (opioid-induced hyperalgesia) and/or repeated painful stimuli is an individually varying and clinically important phenomenon. The functional polymorphism (val(158)met) of the Catechol-O-methyltransferase (COMT) gene regulates the metabolism of dopamine/noradrenaline. Individuals homozygous for the met(158) allele have been reported to have increased pain sensitivity and there are findings of lower mu-opioid system activation during sustained pain. We hypothesized that met/met individuals would exhibit higher pain sensitization and opioid-induced hyperalgesia in response to repeated pain stimuli and an intravenous injection of an opioid drug. Participants were 43 healthy subjects who went through an experiment where five blocks of pain were induced to the hand using a heat probe. After each stimulus subjects rated the pain on a visual analogue scale (VAS) from 0 mm (no pain) to 100 mm (worst possible pain). Before the second stimulus there was an intravenous injection of a rapid and potent opioid drug. At baseline there was no difference in pain ratings between the COMTval(158)met genotypes, F(2, 39)<1. However, a repeated measures ANOVA for all five stimuli revealed a main effect for COMTval(158) met genotype, F(2, 36) = 4.17, p = 0.024. Met/met individuals reported significantly more pain compared to val/val, p = 0.010. A pairwise comparison of baseline and the opioid intervention demonstrated that analgesia was induced in all groups (p = 0.042) without a separating effect for genotype (n.s). We suggest that the initial response of the descending pain system is not influenced by the COMTval(158)met polymorphism but when the system is challenged the difference is revealed. An important clinical implication of this may be that the COMTval(158)met related differences may be more expressed in individuals where the inhibitory system is already challenged and sensitive, e. g. chronic pain patients. This has to be proven in future studies where the impact of the COMTval(158)met polymorphism on opioid treatment in patients is addressed.			Jensen, KB (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm Brain Inst, Osher Ctr Integrat Med, Stockholm, Sweden.	Karin.B.Jensen@ki.se	Lonsdorf, Tina/K-8657-2017; Jensen, Karin/G-6360-2012; Schalling, Martin/F-1518-2015	Schalling, Martin/0000-0001-5011-2922; Lonsdorf, Tina/0000-0003-1501-4846; Ingvar, Martin/0000-0002-9041-5714; Kosek, Eva/0000-0003-0488-8177; Jensen, Karin/0000-0003-2521-3160				BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002/ana.410040511; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; Drabant EM, 2006, ARCH GEN PSYCHIAT, V63, P1396, DOI 10.1001/archpsyc.63.12.1396; Kim HS, 2004, PAIN, V109, P488, DOI 10.1016/j.pain.2004.02.027; King T, 2005, NEUROSIGNALS, V14, P194, DOI 10.1159/000087658; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Mao Jianren, 2006, Curr Pain Headache Rep, V10, P67, DOI 10.1007/s11916-006-0011-5; Mao JR, 2002, PAIN, V100, P213, DOI 10.1016/S0304-3959(02)00422-0; NAGEL I, 2008, FRONT HUM NEUROSCIEN, V2; Ossipov MH, 2005, BIOPOLYMERS, V80, P319, DOI 10.1002/bip.20254; Petrovic P, 2002, PAIN, V95, P1, DOI 10.1016/S0304-3959(01)00467-5; Rakvag TT, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-64; Rakvag TT, 2005, PAIN, V116, P73, DOI 10.1016/j.pain.2005.03.032; REYESGIBBLY CC, 2007, PAIN, V130, P5; Ross JR, 2008, CANCER-AM CANCER SOC, V112, P1390, DOI 10.1002/cncr.23292; Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	18	84	87	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6016	10.1371/journal.pone.0006016	http://dx.doi.org/10.1371/journal.pone.0006016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547755	gold, Green Published			2022-12-27	WOS:000267347900013
J	Perlman, SB; Morris, JP; Wyk, BCV; Green, SR; Doyle, JL; Pelphrey, KA				Perlman, Susan B.; Morris, James P.; Wyk, Brent C. Vander; Green, Steven R.; Doyle, Jaime L.; Pelphrey, Kevin A.			Individual Differences in Personality Predict How People Look at Faces	PLOS ONE			English	Article							ACCESSIBLE CONSTRUCTS; PERCEPTION; TEMPERAMENT; ATTENTION; PROFILES; EYES	Background: Determining the ways in which personality traits interact with contextual determinants to shape social behavior remains an important area of empirical investigation. The specific personality trait of neuroticism has been related to characteristic negative emotionality and associated with heightened attention to negative, emotionally arousing environmental signals. However, the mechanisms by which this personality trait may shape social behavior remain largely unspecified. Methodology/Principal Findings: We employed eye tracking to investigate the relationship between characteristics of visual scanpaths in response to emotional facial expressions and individual differences in personality. We discovered that the amount of time spent looking at the eyes of fearful faces was positively related to neuroticism. Conclusions/Significance: This finding is discussed in relation to previous behavioral research relating personality to selective attention for trait-congruent emotional information, neuroimaging studies relating differences in personality to amygdala reactivity to socially relevant stimuli, and genetic studies suggesting linkages between the serotonin transporter gene and neuroticism. We conclude that personality may be related to interpersonal interaction by shaping aspects of social cognition as basic as eye contact. In this way, eye gaze represents a possible behavioral link in a complex relationship between genes, brain function, and personality.	[Perlman, Susan B.; Wyk, Brent C. Vander; Pelphrey, Kevin A.] Yale Univ, Yale Child Study Ctr, New Haven, CT 06520 USA; [Morris, James P.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Green, Steven R.; Doyle, Jaime L.] Duke Univ, Brain Imaging & Anal Ctr, Durham, NC USA	Yale University; University of Virginia; Duke University	Perlman, SB (corresponding author), Yale Univ, Yale Child Study Ctr, New Haven, CT 06520 USA.	sperlman@cmu.edu			National Institute of Mental Health [MH071284]; John Merck Scholars award; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH071284, R00MH079617] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); John Merck Scholars award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	A Career Development Award from the National Institute of Mental Health (MH071284) and a John Merck Scholars award to Kevin Pelphrey supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 2006, CURR DIR PSYCHOL SCI, V15, P222, DOI 10.1111/j.1467-8721.2006.00440.x; Asghar AUR, 2008, NEUROPSYCHOLOGIA, V46, P2364, DOI 10.1016/j.neuropsychologia.2008.03.015; BARGH JA, 1988, J PERS SOC PSYCHOL, V55, P599, DOI 10.1037/0022-3514.55.4.599; Barlett F. C., 1932, REMEMBERING STUDY EX; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Beaver JD, 2008, J NEUROSCI, V28, P2719, DOI 10.1523/JNEUROSCI.0033-08.2008; BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250; BRADLEY BP, 2000, BEHAV RES THER, V11, P3789; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Cohen J., 2003, APPL MULTIPLE REGRES; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; COSTA PT, 1991, NEO 5 FACTOR INVENTO; DERRYBERRY D, 1994, J PERS SOC PSYCHOL, V66, P1128, DOI 10.1037/0022-3514.66.6.1128; Ekman P., 2003, UNMASKING FACE GUIDE; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Eysenck H.J., 1970, STRUCTURE HUMAN PERS, V1st ed., DOI 10.4324/9780203753439; Garpenstrand H, 2001, BEHAV NEUROSCI, V115, P358, DOI 10.1037//0735-7044.115.2.358; Gomez R, 2002, EUR J PERSONALITY, V16, P333, DOI 10.1002/per.459; GOTEN CC, 1975, PEDIATRICS, V56, P511; HAITH MM, 1977, SCIENCE, P353; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; ISAAOWITZ DM, 2005, PERS COS PSYCHOL B, V31, P147; ISAAOWITZ DM, 2006, CURR DIR PSYCHOL SCI, V132, P68; JOHN, 1991, COGNITION, V10, P1; KING GA, 1988, SOC COGNITION, V6, P128, DOI 10.1521/soco.1988.6.2.128; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; LESTH KP, 1996, SCIENCE, P1527; McCrae RR, 2005, J PERS SOC PSYCHOL, V89, P407, DOI 10.1037/0022-3514.89.3.407; McCrae RR, 2003, PERSONALITY ADULTHOO, DOI DOI 10.4324/9780203428412; Mischel W, 2002, CURR DIR PSYCHOL SCI, V11, P50, DOI 10.1111/1467-8721.00166; Mischel W, 2004, ANNU REV PSYCHOL, V55, P1, DOI 10.1146/annurev.psych.55.042902.130709; Mischel W., 1977, PERSONALITY CROSSROA; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Pelphrey KA, 2007, SOC COGN AFFECT NEUR, V2, P140, DOI 10.1093/scan/nsm010; REED MA, 1995, PERS INDIV DIFFER, V18, P135, DOI 10.1016/0191-8869(94)00121-8; Scheier MF, 2000, OPTIMISM PESSIMISM I, P189; Segerstrom SC, 2001, PERS SOC PSYCHOL B, V27, P1334, DOI 10.1177/01461672012710009; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Vassallo S, 2009, J VISION, V9, DOI 10.1167/9.3.11; VERNON PE, 1961, PERSONALITY ASSESEME; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617	50	58	58	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5952	10.1371/journal.pone.0005952	http://dx.doi.org/10.1371/journal.pone.0005952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YI	19543398	Green Submitted, Green Published, gold			2022-12-27	WOS:000207566500001
J	Ayres, E; Steltzer, H; Berg, S; Wallenstein, MD; Simmons, BL; Wall, DH				Ayres, Edward; Steltzer, Heidi; Berg, Sarah; Wallenstein, Matthew D.; Simmons, Breana L.; Wall, Diana H.			Tree Species Traits Influence Soil Physical, Chemical, and Biological Properties in High Elevation Forests	PLOS ONE			English	Article							MICROBIAL BIOMASS; COMMUNITY STRUCTURE; EXTRACTION METHOD; PLANT TRAITS; NITROGEN; ROOT; DECOMPOSITION; DIVERSITY; CARBON; SEQUESTRATION	Background: Previous studies have shown that plants often have species-specific effects on soil properties. In high elevation forests in the Southern Rocky Mountains, North America, areas that are dominated by a single tree species are often adjacent to areas dominated by another tree species. Here, we assessed soil properties beneath adjacent stands of trembling aspen, lodgepole pine, and Engelmann spruce, which are dominant tree species in this region and are distributed widely in North America. We hypothesized that soil properties would differ among stands dominated by different tree species and expected that aspen stands would have higher soil temperatures due to their open structure, which, combined with higher quality litter, would result in increased soil respiration rates, nitrogen availability, and microbial biomass, and differences in soil faunal community composition. Methodology/Principal Findings: We assessed soil physical, chemical, and biological properties at four sites where stands of aspen, pine, and spruce occurred in close proximity to one-another in the San Juan Mountains, Colorado. Leaf litter quality differed among the tree species, with the highest nitrogen (N) concentration and lowest lignin: N in aspen litter. Nitrogen concentration was similar in pine and spruce litter, but lignin: N was highest in pine litter. Soil temperature and moisture were highest in aspen stands, which, in combination with higher litter quality, probably contributed to faster soil respiration rates from stands of aspen. Soil carbon and N content, ammonium concentration, and microbial biomass did not differ among tree species, but nitrate concentration was highest in aspen soil and lowest in spruce soil. In addition, soil fungal, bacterial, and nematode community composition and rotifer, collembolan, and mesostigmatid mite abundance differed among the tree species, while the total abundance of nematodes, tardigrades, oribatid mites, and prostigmatid mites did not. Conclusions/Significance: Although some soil characteristics were unaffected by tree species identity, our results clearly demonstrate that these dominant tree species are associated with soils that differ in several physical, chemical, and biotic properties. Ongoing environmental changes in this region, e. g. changes in fire regime, frequency of insect outbreaks, changes in precipitation patterns and snowpack, and land-use change, may alter the relative abundance of these tree species over coming decades, which in turn will likely alter the soils.			Ayres, E (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	edayres@nrel.colostate.edu	Wallenstein, Matthew/C-6441-2008; Wall, Diana H/F-5491-2011; Wallenstein, Matthew D/S-3512-2016; Ayres, Edward/A-4172-2008	Wallenstein, Matthew/0000-0002-6219-1442; Wallenstein, Matthew D/0000-0002-6219-1442; Ayres, Edward/0000-0001-5190-258X	Division Of Environmental Biology [0816720] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; ALEXANDER RR, 1980, FOREST COVER TYPES U, P86; [Anonymous], 2007, IPCC 4 ASSESSMENT RE; Ayres E, 2006, SOIL BIOL BIOCHEM, V38, P183, DOI 10.1016/j.soilbio.2005.04.018; Ayres E, 2004, ECOL LETT, V7, P469, DOI 10.1111/j.1461-0248.2004.00604.x; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Bardgett RD., 2005, THE BIOL OF SOIL, DOI [10.1093/acprof:oso/9780198525035.001.0001, DOI 10.1093/ACPROF:OSO/9780198525035.001.0001]; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Battigelli JP, 2004, CAN J FOREST RES, V34, P1136, DOI [10.1139/x03-267, 10.1139/X03-267]; Binkley D., 1995, Special Publication - Agronomy Society of New Zealand, P1; Binkley D, 1998, BIOGEOCHEMISTRY, V42, P89, DOI 10.1023/A:1005948126251; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Conant RT, 2004, SOIL BIOL BIOCHEM, V36, P945, DOI 10.1016/j.soilbio.2004.02.013; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; CROSSLEY DA, 1991, AGR ECOSYST ENVIRON, V34, P187, DOI 10.1016/0167-8809(91)90104-6; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; DEBYLE NV, 1980, FOREST COVER TYPES U, P96; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Driessen MM, 2004, PEDOBIOLOGIA, V48, P631, DOI 10.1016/j.pedobi.2004.08.002; Eisenhart KS, 2000, CAN J FOREST RES, V30, P1788, DOI 10.1139/cjfr-30-11-1788; Eviner VT, 2004, ECOLOGY, V85, P2215, DOI 10.1890/03-0405; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; FIERER N, 2007, APPL ENV MICROBIOLOG, V73, P8041; FRECKMAN DW, 1993, POLAR BIOL, V13, P483, DOI 10.1007/BF00233139; Gransee A, 2000, J PLANT NUTR SOIL SC, V163, P381, DOI 10.1002/1522-2624(200008)163:4<381::AID-JPLN381>3.0.CO;2-7; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Griffiths BS, 2006, APPL SOIL ECOL, V32, P325, DOI 10.1016/j.apsoil.2005.07.006; Heath J, 2005, SCIENCE, V309, P1711, DOI 10.1126/science.1110700; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hobbie SE, 2006, ECOLOGY, V87, P2288, DOI 10.1890/0012-9658(2006)87[2288:TSEODA]2.0.CO;2; HODDA M, 1994, NEMATOLOGICA, V40, P116, DOI 10.1163/003525994X00085; INGHAM ER, 1989, BIOL FERT SOILS, V8, P29, DOI 10.1007/BF00260513; Innes L, 2004, BIOL FERT SOILS, V40, P7, DOI 10.1007/s00374-004-0748-0; JAMIESON DW, 1996, W SAN JUAN MOUNTAINS, P159; Kardol P, 2007, ECOL MONOGR, V77, P147, DOI 10.1890/06-0502; Kardol P, 2006, ECOL LETT, V9, P1080, DOI 10.1111/j.1461-0248.2006.00953.x; Keen R. A, 1996, W SAN JUAN MOUNTAINS, P113; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Malmstrom CM, 2000, GLOBAL CHANGE BIOL, V6, P35, DOI 10.1046/j.1365-2486.2000.06012.x; Menyailo OV, 2002, PLANT SOIL, V242, P171, DOI 10.1023/A:1016290802518; Morgan P, 2008, ECOLOGY, V89, P717, DOI 10.1890/06-2049.1; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; PAULSON DD, 2006, N SW COLORADO; PFISTER RD, 1980, FOREST COVER TYPES U, P96; Priha O, 1999, BIOL FERT SOILS, V30, P14, DOI 10.1007/s003740050581; Reich PB, 2005, ECOL LETT, V8, P811, DOI 10.1111/j.1461-0248.2005.00779.x; Robertson GP, 1999, LT EC RES NETWK SER, V2, P106; ROVIRA A. D., 1965, P170; RYAN MG, 1990, CAN J FOREST RES, V20, P166, DOI 10.1139/x90-023; RYSER P, 1995, PLANT SOIL, V170, P251, DOI 10.1007/BF00010478; Scallan U, 2008, MOL ECOL RESOUR, V8, P95, DOI 10.1111/j.1471-8286.2007.01901.x; Sims RA, 1996, ENVIRON MONIT ASSESS, V39, P471, DOI 10.1007/BF00396162; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; STUMP LM, 1993, CAN J FOREST RES, V23, P492, DOI 10.1139/x93-067; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VANDERPUTTEN WH, 1993, NATURE, V362, P53; Wallenstein MD, 2007, FEMS MICROBIOL ECOL, V59, P428, DOI 10.1111/j.1574-6941.2006.00260.x; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Worrall JJ, 2008, FOREST ECOL MANAG, V255, P686, DOI 10.1016/j.foreco.2007.09.071; YEATES GW, 1993, J NEMATOL, V25, P315	64	83	91	6	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5964	10.1371/journal.pone.0005964	http://dx.doi.org/10.1371/journal.pone.0005964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536334	Green Published, gold, Green Submitted			2022-12-27	WOS:000267079500013
J	Kretzschmar, M; Mikolajczyk, RT				Kretzschmar, Mirjam; Mikolajczyk, Rafael T.			Contact Profiles in Eight European Countries and Implications for Modelling the Spread of Airborne Infectious Diseases	PLOS ONE			English	Article								Background: For understanding the spread of infectious diseases it is crucial to have knowledge of the patterns of contacts in a population during which the infection can be transmitted. Besides contact rates and mixing between age groups, the way individuals distribute their contacts across different locations may play an important role in determining how infections spread through a population. Methods and Findings: Representative surveys were performed in eight countries to assess the number of social contacts (talking to another person at close distance either with or without physical contact), using a diary approach in which participants recorded individual contacts. The overall sample size was 7290 respondents. We analyzed the reported numbers of contacts per respondent in six different settings (household, work, school, leisure, transportation and others) to define different contact profiles. The identification of the profiles and classification of respondents according to these profiles was conducted using a two-step cluster analysis algorithm as implemented in SPSS. We identified seven distinct contact profiles: respondents having (1) mixed: contacts predominantly at school, during transportation and leisure time, (2) contacts during leisure time, (3) contacts mainly in the household (large family), (4) contacts at work, (5) contacts solely at school, (6) contacts in other places and finally (7) respondents having a low number of contacts in any setting. Similar contact profiles can be found in all eight European countries which participated in the study. The distributions of respondents across the profiles were similar in all countries. The profiles are dominated by work, school and household contacts. But also contacts during leisure activities play an important role in the daily lives of a large fraction of individuals. A surprisingly large number of individuals has only few contacts in all locations. There was a distinct age-dependence in the distribution of the population across contact profiles. Conclusions: In contrast with earlier studies that focussed on the contribution of different age groups to the spread of an infectious disease, our results open up the opportunity to analyze how an infection spreads between locations and how locations as work or school are interconnected via household contacts. Mathematical models that take these local contact patterns into account can be used to assess the effect of intervention measures like school closure and cancelling of leisure activities on the spread of influenza.			Kretzschmar, M (corresponding author), RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	rafael.mikolajczyk@uni-bielefeld.de	Mikolajczyk, Rafael/ABB-5259-2021	Mikolajczyk, Rafael/0000-0003-1271-7204; Kretzschmar, Mirjam/0000-0002-4394-7697				Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; House T, 2008, MATH BIOSCI, V213, P29, DOI 10.1016/j.mbs.2008.01.011; Kanaan MN, 2005, EPIDEMIOL INFECT, V133, P1009, DOI 10.1017/S0950268805004528; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Mikolajczyk RT, 2008, SOC NETWORKS, V30, P127, DOI 10.1016/j.socnet.2007.09.002; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; *SPSS INC, 2001, SPSS 2STEP CLUST COM; *SPSS INC, 2004, 2STEP CLUST AN; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Zhang T., 1996, BIRCH EFFICIENT DATA, P103, DOI 10.1145/233269.233324	20	48	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5931	10.1371/journal.pone.0005931	http://dx.doi.org/10.1371/journal.pone.0005931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536278	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029700009
J	Murat, A; Migliavacca, E; Hussain, SF; Heimberger, AB; Desbaillets, I; Hamou, MF; Ruegg, C; Stupp, R; Delorenzi, M; Hegi, ME				Murat, Anastasia; Migliavacca, Eugenia; Hussain, S. Farzana; Heimberger, Amy B.; Desbaillets, Isabelle; Hamou, Marie-France; Rueegg, Curzio; Stupp, Roger; Delorenzi, Mauro; Hegi, Monika E.			Modulation of Angiogenic and Inflammatory Response in Glioblastoma by Hypoxia	PLOS ONE			English	Article								Glioblastoma are rapidly proliferating brain tumors in which hypoxia is readily recognizable, as indicated by focal or extensive necrosis and vascular proliferation, two independent diagnostic criteria for glioblastoma. Gene expression profiling of glioblastoma revealed a gene expression signature associated with hypoxia-regulated genes. The correlated gene set emerging from unsupervised analysis comprised known hypoxia-inducible genes involved in angiogenesis and inflammation such as VEGF and BIRC3, respectively. The relationship between hypoxia-modulated angiogenic genes and inflammatory genes was associated with outcome in our cohort of glioblastoma patients treated within prospective clinical trials of combined chemoradiotherapy. The hypoxia regulation of several new genes comprised in this cluster including ZNF395, TNFAIP3, and TREM1 was experimentally confirmed in glioma cell lines and primary monocytes exposed to hypoxia in vitro. Interestingly, the cluster seems to characterize differential response of tumor cells, stromal cells and the macrophage/microglia compartment to hypoxic conditions. Most genes classically associated with the inflammatory compartment are part of the NF-kappaB signaling pathway including TNFAIP3 and BIRC3 that have been shown to be involved in resistance to chemotherapy. Our results associate hypoxia-driven tumor response with inflammation in glioblastoma, hence underlining the importance of tumor-host interaction involving the inflammatory compartment.			Murat, A (corresponding author), CHUV, Univ Lausanne Hosp, Lab Brain Tumor Biol & Genet, Lausanne, Switzerland.	Monika.Hegi@chuv.ch	Hegi, Monika/O-4796-2015; Stupp, Roger/L-3303-2019	Hegi, Monika/0000-0003-0855-6495; 	NCI NIH HHS [R01 CA120813] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA120813] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Bostrom P, 2006, ARTERIOSCL THROM VAS, V26, P1871, DOI 10.1161/01.ATV.0000229665.78997.0b; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Bredel M, 2006, J CLIN ONCOL, V24, P274, DOI 10.1200/JCO.2005.02.9405; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Colli S, 1999, THROMB HAEMOSTASIS, V81, P576; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Desbaillets I, 1997, J EXP MED, V186, P1201, DOI 10.1084/jem.186.8.1201; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Fu YC, 2004, BLOOD CELL MOL DIS, V32, P182, DOI 10.1016/j.bcmd.2003.09.002; Fujino T, 2008, J COMP NEUROL, V507, P1831, DOI 10.1002/cne.21649; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Godard S, 2003, CANCER RES, V63, P6613; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Ho CC, 2008, AM J RESP CRIT CARE, V177, P763, DOI 10.1164/rccm.200704-641OC; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Koukourakis MI, 2005, NEOPLASIA, V7, P1, DOI 10.1593/neo.04373; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li HL, 2006, J CELL PHYSIOL, V208, P307, DOI 10.1002/jcp.20665; Manderscheid M, 2001, J AM SOC NEPHROL, V12, P1151, DOI 10.1681/ASN.V1261151; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; Mead EJ, 2007, ENDOCRINOLOGY, V148, P140, DOI 10.1210/en.2006-0818; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Murphy KG, 2005, J NEUROENDOCRINOL, V17, P519, DOI 10.1111/j.1365-2826.2005.01328.x; Nabors LLB, 2003, CANCER RES, V63, P4181; Nomura T, 2005, ONCOL REP, V14, P993; Oh JW, 2001, J IMMUNOL, V166, P2695, DOI 10.4049/jimmunol.166.4.2695; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Raychaudhuri B, 2007, J NEURO-ONCOL, V85, P39, DOI 10.1007/s11060-007-9390-7; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tanaka K, 2004, J BIOL CHEM, V279, P7275, DOI 10.1074/jbc.M310726200; Valdez BC, 2008, LEUKEMIA RES, V32, P1684, DOI 10.1016/j.leukres.2008.01.016; Vaziri SAJ, 2003, ANTICANCER RES, V23, P3657; Vendrell JA, 2007, ONCOGENE, V26, P4656, DOI 10.1038/sj.onc.1210269; Wang N, 1996, J BIOL CHEM, V271, P8837, DOI 10.1074/jbc.271.15.8837; Yabe H, 2008, ONCOL REP, V19, P129; Zeng H, 2007, EUR J IMMUNOL, V37, P2300, DOI 10.1002/eji.200737270	48	84	85	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5947	10.1371/journal.pone.0005947	http://dx.doi.org/10.1371/journal.pone.0005947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536297	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029700017
J	Goldar, A; Marsolier-Kergoat, MC; Hyrien, O				Goldar, Arach; Marsolier-Kergoat, Marie-Claude; Hyrien, Olivier			Universal Temporal Profile of Replication Origin Activation in Eukaryotes	PLOS ONE			English	Article								Although replication proteins are conserved among eukaryotes, the sequence requirements for replication initiation differ between species. In all species, however, replication origins fire asynchronously throughout S phase. The temporal program of origin firing is reproducible in cell populations but largely probabilistic at the single-cell level. The mechanisms and the significance of this program are unclear. Replication timing has been correlated with gene activity in metazoans but not in yeast. One potential role for a temporal regulation of origin firing is to minimize fluctuations in replication end time and avoid persistence of unreplicated DNA in mitosis. Here, we have extracted the population-averaged temporal profiles of replication initiation rates for S. cerevisiae, S. pombe, D. melanogaster, X. laevis and H. sapiens from genome-wide replication timing and DNA combing data. All the profiles have a strikingly similar shape, increasing during the first half of S phase then decreasing before its end. A previously proposed minimal model of stochastic initiation modulated by accumulation of a recyclable, limiting replication-fork factor and fork-promoted initiation of new origins, quantitatively described the observed profiles without requiring new implementations. The selective pressure for timely completion of genome replication and optimal usage of replication proteins that must be imported into the cell nucleus can explain the generic shape of the profiles. We have identified a universal behavior of eukaryotic replication initiation that transcends the mechanisms of origin specification. The population-averaged efficiency of replication origin usage changes during S phase in a strikingly similar manner in a highly diverse set of eukaryotes. The quantitative model previously proposed for origin activation in X. laevis can be generalized to explain this evolutionary conservation.			Goldar, A (corresponding author), CEA, IBiTec S, Gif Sur Yvette, France.	arach.goldar@cea.fr; hyrien@biologie.ens.fr	Hyrien, Olivier/R-5108-2017; goldar, arach/I-8479-2012	Hyrien, Olivier/0000-0001-8879-675X; 				Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Alvino GM, 2007, MOL CELL BIOL, V27, P6396, DOI 10.1128/MCB.00719-07; Bechhoefer J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.098105; Czajkowsky DM, 2008, J MOL BIOL, V375, P12, DOI 10.1016/j.jmb.2007.10.046; Dai JL, 2005, P NATL ACAD SCI USA, V102, P337, DOI 10.1073/pnas.0408811102; Efrat A, 2007, J MATH IMAGING VIS, V27, P203, DOI 10.1007/s10851-006-0647-0; Eshaghi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000722; GAUTHIER MG, 2009, PHYS REV LE IN PRESS; Gilbert DM, 2004, NAT REV MOL CELL BIO, V5, P848, DOI 10.1038/nrm1495; Goldar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002919; Hamlin JL, 2008, J CELL BIOCHEM, V105, P321, DOI 10.1002/jcb.21828; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; Herrick J, 2000, J MOL BIOL, V300, P1133, DOI 10.1006/jmbi.2000.3930; Herrick J, 2002, J MOL BIOL, V320, P741, DOI 10.1016/S0022-2836(02)00522-3; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; HYRIEN O, 1992, NUCLEIC ACIDS RES, V20, P1463, DOI 10.1093/nar/20.7.1463; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; Krasinska L, 2008, EMBO J, V27, P758, DOI 10.1038/emboj.2008.16; Labit H, 2008, NUCLEIC ACIDS RES, V36, P5623, DOI 10.1093/nar/gkn533; LASKEY RA, 1985, J EMBRYOL EXP MORPH, V89, P285; Lucas I, 2000, J MOL BIOL, V296, P769, DOI 10.1006/jmbi.2000.3500; Lygeros J, 2008, P NATL ACAD SCI USA, V105, P12295, DOI 10.1073/pnas.0805549105; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Marheineke K, 2001, J BIOL CHEM, V276, P17092, DOI 10.1074/jbc.M100271200; MCCUNE HJ, 2008, GENETICS; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Patel PK, 2006, MOL BIOL CELL, V17, P308, DOI 10.1091/mbc.E05-07-0657; PATEL PK, 2008, MOL BIOL CELL; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rhind N, 2006, NAT CELL BIOL, V8, P1313, DOI 10.1038/ncb1206-1313; Schwaiger M, 2006, CURR OPIN GENET DEV, V16, P177, DOI 10.1016/j.gde.2006.02.007; SPIESSER TW, 2009, MOL GENET GENOMICS; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wood H, 2005, NAT REV NEUROSCI, V6, P172, DOI 10.1038/nrn1634; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Yang SCH, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041917; Zhang HY, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051903	39	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5899	10.1371/journal.pone.0005899	http://dx.doi.org/10.1371/journal.pone.0005899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521533	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029100014
J	Peyot, ML; Gray, JP; Lamontagne, J; Smith, PJS; Holz, GG; Madiraju, SRM; Prentki, M; Heart, E				Peyot, Marie-Line; Gray, Joshua P.; Lamontagne, Julien; Smith, Peter J. S.; Holz, George G.; Madiraju, S. R. Murthy; Prentki, Marc; Heart, Emma			Glucagon-Like Peptide-1 Induced Signaling and Insulin Secretion Do Not Drive Fuel and Energy Metabolism in Primary Rodent Pancreatic beta-Cells	PLOS ONE			English	Article								Background: Glucagon like peptide-1 (GLP-1) and its analogue exendin-4 (Ex-4) enhance glucose stimulated insulin secretion (GSIS) and activate various signaling pathways in pancreatic beta-cells, in particular cAMP, Ca(2+) and protein kinase-B (PKB/Akt). In many cells these signals activate intermediary metabolism. However, it is not clear whether the acute amplification of GSIS by GLP-1 involves in part metabolic alterations and the production of metabolic coupling factors. Methodology/Prinicipal Findings: GLP-1 or Ex-4 at high glucose caused release (similar to 20%) of the total rat islet insulin content over 1 h. While both GLP-1 and Ex-4 markedly potentiated GSIS in isolated rat and mouse islets, neither had an effect on beta-cell fuel and energy metabolism over a 5 min to 3 h time period. GLP-1 activated PKB without changing glucose usage and oxidation, fatty acid oxidation, lipolysis or esterification into various lipids in rat islets. Ex-4 caused a rise in [Ca(2+)](i) and cAMP but did not enhance energy utilization, as neither oxygen consumption nor mitochondrial ATP levels were altered. Conclusions/Significance: The results indicate that GLP-1 barely affects beta-cell intermediary metabolism and that metabolic signaling does not significantly contribute to GLP-1 potentiation of GSIS. The data also indicate that insulin secretion is a minor energy consuming process in the beta-cell, and that the beta-cell is different from most cell types in that its metabolic activation appears to be primarily governed by a "push'' (fuel substrate driven) process, rather than a "pull'' mechanism secondary to enhanced insulin release as well as to Ca(2+), cAMP and PKB signaling.			Peyot, ML (corresponding author), Univ Montreal, Ctr Hosp, Ctr Rech, Mol Nutr Unit, Montreal, PQ, Canada.	marc.prentki@umontreal.ca	Holz, George G/A-3386-2012	Holz, George/0000-0002-1781-3580; Gray, Joshua/0000-0002-9704-3845; Gray, Joshua/0000-0003-4146-7902; Smith, Peter/0000-0003-4400-6853	NCRR NIH HHS [P41-RR-001395, P41 RR001395] Funding Source: Medline; NIDDK NIH HHS [DK045817, R01 DK069575, R01 DK045817] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045817, R29DK045817, R01DK069575] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ainscow EK, 2002, DIABETES, V51, pS162, DOI 10.2337/diabetes.51.2007.S162; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; BERNE C, 1975, BIOCHEM J, V152, P667, DOI 10.1042/bj1520667; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237; Cazzolli R, 2001, DIABETES, V50, P2210, DOI 10.2337/diabetes.50.10.2210; Chepurny OG, 2007, J BIOMOL SCREEN, V12, P740, DOI 10.1177/1087057107301856; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Cunningham BA, 2003, BIOCHEM J, V369, P173, DOI 10.1042/BJ20021196; Dillon JS, 2005, EXP CLIN ENDOCR DIAB, V113, P182, DOI 10.1055/s-2005-837526; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; ELLIOTT RM, 1993, J ENDOCRINOL, V138, P159, DOI 10.1677/joe.0.1380159; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Girard J, 2008, DIABETES METAB, V34, P550, DOI 10.1016/j.diabet.2008.09.001; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Heart E, 2007, AM J PHYSIOL-ENDOC M, V292, pE1295, DOI 10.1152/ajpendo.00648.2006; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Holz G, 2004, HORM METAB RES, V36, P787, DOI 10.1055/s-2004-826165; Holz GG, 2008, AM J PHYSIOL-CELL PH, V294, pC4, DOI 10.1152/ajpcell.00522.2007; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kang GX, 2005, J PHYSIOL-LONDON, V566, P173, DOI 10.1113/jphysiol.2005.087510; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Maechler P, 2002, CELL MOL LIFE SCI, V59, P1803, DOI 10.1007/PL00012507; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MARYNISSEN G, 1990, METABOLISM, V39, P87, DOI 10.1016/0026-0495(90)90153-4; Massa ML, 2001, J ENDOCRINOL, V171, P551, DOI 10.1677/joe.0.1710551; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; Mulder H, 2004, DIABETES, V53, P122, DOI 10.2337/diabetes.53.1.122; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Osbourn DM, 2005, ANAL CHEM, V77, P6999, DOI 10.1021/ac050326w; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Prentki M, 1996, EUR J ENDOCRINOL, V134, P272, DOI 10.1530/eje.0.1340272; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Richards SK, 2005, J ENDOCRINOL, V187, P225, DOI 10.1677/joe.1.06413; Roche E, 1997, J BIOL CHEM, V272, P3091, DOI 10.1074/jbc.272.5.3091; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; SENER A, 1990, BIOCHIM BIOPHYS ACTA, V1019, P42, DOI 10.1016/0005-2728(90)90122-K; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; Widenmaier SB, 2009, J BIOL CHEM, V284, P10764, DOI 10.1074/jbc.M809116200; Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004; Winzell MS, 2004, HORM METAB RES, V36, P795, DOI 10.1055/s-2004-826166; WOLF BA, 1990, J CLIN INVEST, V85, P482, DOI 10.1172/JCI114463; Xavier GD, 2003, BIOCHEM J, V371, P761; Yaney GC, 2001, DIABETES, V50, P56, DOI 10.2337/diabetes.50.1.56; ZHANG TM, 1994, BIOCHEM MED METAB B, V51, P129, DOI 10.1006/bmmb.1994.1017	63	49	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6221	10.1371/journal.pone.0006221	http://dx.doi.org/10.1371/journal.pone.0006221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593440	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000268035400006
J	Park, JS; Steinbach, SK; Desautels, M; Hemmingsen, SM				Park, Jae-Sook; Steinbach, Sarah K.; Desautels, Michel; Hemmingsen, Sean M.			Essential Role for Schizosaccharomyces pombe pik1 in Septation	PLOS ONE			English	Article							FISSION-YEAST; PHOSPHATIDYLINOSITOL 4-KINASE; CONTRACTILE RING; ACTOMYOSIN RING; EXOCYST COMPLEX; DIVISION SITE; LIGHT-CHAIN; CYTOKINESIS; PROTEINS; CDC4P	Background: Schizosaccharomyces pombe pik1 encodes a phosphatidylinositol 4-kinase, reported to bind Cdc4, but not Cdc4(G107S). Principal Findings: Gene deletion revealed that pik1 is essential. In cells with pik1 deleted, ectopic expression of a loss-of-function allele, created by fusion to a temperature-sensitive dihydrofolate reductase, allowed normal cell proliferation at 25 degrees C. At 36 degrees C, cells arrested with abnormally thick, misplaced or supernumerary septa, indicating a defect late in septation. In addition to being Golgi associated, ectopically expressed GFP-tagged Pik1 was observed at the medial cell plane late in cytokinesis. New alleles, created by site-directed mutagenesis, were expressed ectopically. Lipid kinase and Cdc4-binding activity assays were performed. Pik1(D709A) was kinase-dead, but bound Cdc4. Pik1(R838A) did not bind Cdc4, but was an active kinase. Genomic integration of these substitutions in S. pombe and complementation studies in Saccharomyces cerevisiae pik1-101 cells revealed that D709 is essential in both cases while R838 is dispensable. In S. pombe, ectopic expression of pik1 was dominantly lethal; while, pik1(D709A, R838A) was innocuous, pik1(R838A) was almost innocuous, and pik1(D709A) produced partial lethality and septation defects. The pik1 ectopic expression lethal phenotype was suppressed in cdc4(G107S). Thus, D709 is essential for kinase activity and septation. Conclusions: Pik1 kinase activity is required for septation. The Pik1 R838 residue is required for important protein-protein interactions, possibly with Cdc4.			Park, JS (corresponding author), Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK S7N 0W0, Canada.	Sean.Hemmingsen@nrc-cnrc.gc.ca	PARK, Jae-Sook/H-3016-2012	Steinbach, Sarah/0000-0003-2025-8159				ARMSTRONG J, 1993, MOL BIOL CELL, V4, P583, DOI 10.1091/mbc.4.6.583; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Balasubramanian MK, 1997, METHOD ENZYMOL, V283, P494; Balasubramanian MK, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P243; Balasubramanian MK, 1998, GENETICS, V149, P1265; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brill JA, 2000, DEVELOPMENT, V127, P3855; Chang FS, 2005, J CELL BIOL, V171, P133, DOI 10.1083/jcb.200501086; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; D'souza VM, 2001, CELL STRUCT FUNCT, V26, P555, DOI 10.1247/csf.26.555; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Dekker N, 2004, MOL BIOL CELL, V15, P3903, DOI 10.1091/mbc.E04-04-0319; Demmel L, 2008, MOL BIOL CELL, V19, P1046, DOI 10.1091/mbc.E07-02-0134; Desautels M, 2001, J BIOL CHEM, V276, P5932, DOI 10.1074/jbc.M008715200; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Eng K, 1998, CURR BIOL, V8, P611, DOI 10.1016/S0960-9822(98)70248-9; Escobar-Cabrera E, 2005, BIOCHEMISTRY-US, V44, P12136, DOI 10.1021/bi050641c; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FLANAGAN CA, 1993, SCIENCE, V262, P1444, DOI 10.1126/science.8248783; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Gachet Y, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P225; GARCIABUSTOS JF, 1994, EMBO J, V13, P2352, DOI 10.1002/j.1460-2075.1994.tb06519.x; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Han P, 2002, CYTOTHERAPY, V4, P277, DOI 10.1080/146532402320219790; Hegewald H, 1996, ANAL BIOCHEM, V242, P152, DOI 10.1006/abio.1996.0443; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010; KOHALMI SE, 1997, DIFFERENTIALLY EXPRE, P63; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Mahon ES, 2005, CELL SIGNAL, V17, P857, DOI 10.1016/j.cellsig.2004.11.006; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MCCOLLUM D, 1995, J CELL BIOL, V130, P651, DOI 10.1083/jcb.130.3.651; MORENO S, 1991, METH ENZY, V194, P795; Motegi F, 2000, J CELL SCI, V113, P1813; Naqvi NI, 1999, EMBO J, V18, P854, DOI 10.1093/emboj/18.4.854; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; Rajagopalan S, 2004, METHODS, V33, P206, DOI 10.1016/j.ymeth.2003.11.015; Rajagopalan S, 2003, TRENDS GENET, V19, P403, DOI 10.1016/S0168-9525(03)00149-5; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Schug S A, 1993, Pharmacoeconomics, V3, P260, DOI 10.2165/00019053-199303040-00002; Sipiczki M, 2007, FEMS YEAST RES, V7, P761, DOI 10.1111/j.1567-1364.2007.00266.x; Slupsky CM, 2001, J BIOL CHEM, V276, P5943, DOI 10.1074/jbc.M008716200; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Vjestica A, 2008, MOL BIOL CELL, V19, P1125, DOI 10.1091/mbc.E07-07-0663; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; WALSH JP, 1991, P NATL ACAD SCI USA, V88, P9184, DOI 10.1073/pnas.88.20.9184; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Zhang YJ, 2000, J BIOL CHEM, V275, P35600, DOI 10.1074/jbc.M005575200	64	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6179	10.1371/journal.pone.0006179	http://dx.doi.org/10.1371/journal.pone.0006179			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587793	gold, Green Submitted, Green Published			2022-12-27	WOS:000268035100006
J	Feigel, A; Englander, A; Engel, A				Feigel, Alexander; Englander, Avraham; Engel, Assaf			Sex Is Always Well Worth Its Two-Fold Cost	PLOS ONE			English	Article								Sex is considered as an evolutionary paradox, since its positive contribution to Darwinian fitness remains unverified for some species. Defenses against unpredictable threats (parasites, fluctuating environment and deleterious mutations) are indeed significantly improved by wider genetic variability and by positive epistasis gained by sexual reproduction. The corresponding evolutionary advantages, however, do not overcome universally the barrier of the two-fold cost for sharing half of one's offspring genome with another member of the population. Here we show that sexual reproduction emerges and is maintained even when its Darwinian fitness is twice as low as the fitness of asexuals. We also show that more than two sexes (inheritance of genetic material from three or even more parents) are always evolutionary unstable. Our approach generalizes the evolutionary game theory to analyze species whose members are able to sense the sexual state of their conspecifics and to adapt their own sex consequently, either by switching or by taxis towards the highest concentration of the complementary sex. The widespread emergence and maintenance of sex follows therefore from its co-evolution with the even more widespread environmental sensing abilities.			Feigel, A (corresponding author), Soreq NRC, Yavne, Israel.	sasha@soreq.gov.il	Feigel, Alexander/AAN-3680-2021					Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bergstrom T.C., 2003, INT GAME THEORY REV, V05, P211, DOI [10.1142/S0219198903001021, DOI 10.1142/S0219198903001021]; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; CAVALLISFORZA LL, 1983, P NATL ACAD SCI-BIOL, V80, P2017, DOI 10.1073/pnas.80.7.2017; Ciani AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002282; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; de Visser JAGM, 2007, NAT REV GENET, V8, P139, DOI 10.1038/nrg1985; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Feigel A, 2008, J THEOR BIOL, V254, P768, DOI 10.1016/j.jtbi.2008.07.005; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Hayden EC, 2008, NATURE, V452, P678, DOI 10.1038/452678a; HURST LD, 1992, P ROY SOC B-BIOL SCI, V247, P189, DOI 10.1098/rspb.1992.0027; Jaffe K, 1996, INTERCIENCIA, V21, P259; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Keightley PD, 1998, CURR BIOL, V8, pR235, DOI 10.1016/S0960-9822(98)70148-4; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Maynard Smith J., 1982, pi; Munday PL, 2006, TRENDS ECOL EVOL, V21, P89, DOI 10.1016/j.tree.2005.10.020; Nielsen R, 2006, SCIENCE, V311, P960, DOI 10.1126/science.1124663; NOWAK M, 1990, ACTA APPL MATH, V20, P247, DOI 10.1007/BF00049570; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; NUNNEY L, 1989, EVOLUTION, V43, P245, DOI 10.1111/j.1558-5646.1989.tb04225.x; Otto SP, 1997, GENETICS, V147, P879; Paland S, 2006, SCIENCE, V311, P990, DOI 10.1126/science.1118152; Parker JD, 2004, TRENDS ECOL EVOL, V19, P83, DOI 10.1016/j.tree.2003.10.001; Peck JR, 2000, NATURE, V406, P399, DOI 10.1038/35019055; Skyrms B, 2002, PHILOS SCI, V69, pS104, DOI 10.1086/341838; SMITH JM, 1978, EVOLUTION SEX; STEARNS SG, 1988, EVOLUTION SEX ITS CO; van Doorn GS, 2007, NATURE, V449, P909, DOI 10.1038/nature06178; West SA, 1999, J EVOLUTION BIOL, V12, P1003; Wolinska J, 2008, OIKOS, V117, P1637, DOI 10.1111/j.1600-0706.2008.16760.x	36	1	1	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6012	10.1371/journal.pone.0006012	http://dx.doi.org/10.1371/journal.pone.0006012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582152	Green Published, gold, Green Submitted			2022-12-27	WOS:000267806400001
J	Viswanathan, SR; Mermel, CH; Lu, J; Lu, CW; Golub, TR; Daley, GQ				Viswanathan, Srinivas R.; Mermel, Craig H.; Lu, Jun; Lu, Chi-Wei; Golub, Todd R.; Daley, George Q.			microRNA Expression during Trophectoderm Specification	PLOS ONE			English	Article								Background: Segregation of the trophectoderm from the inner cell mass of the embryo represents the first cell-fate decision of mammalian development. Transcription factors essential for specifying trophectoderm have been identified, but the role of microRNAs (miRNAs) in modulating this fate-choice has been largely unexplored. We have compared miRNA expression in embryonic stem cell (ESC)-derived trophectoderm and in staged murine embryos to identify a set of candidate miRNAs likely to be involved in trophectoderm specification. Results: We profiled embryonic stem cells (ESCs) as they were induced to differentiate into trophectodermal cells by ectopic expression of HRas/Q61L. We also profiled murine embryos at progressive stages of preimplantation development (zygote, 2-cell, 4-cell, 8-cell, morula, and blastocyst), which includes the time window in which the trophectoderm is specified in vivo. Q61L/H Conclusions: We describe miRNA expression changes that occur during trophectoderm specification and validate that our in vitro system faithfully recapitulates trophectoderm specification in vivo. By comparing our in vitro and in vivo datasets, we have identified a minimal set of candidate miRNAs likely to play a role in trophectoderm specification. These miRNAs are predicted to regulate a host of development-associated target genes, and many of these miRNAs have previously reported roles in development and differentiation. Additionally, we highlight a number of miRNAs whose tight developmental regulation may reflect a functional role in other stages of embryogenesis. Our embryo profiling data may be useful to investigators studying trophectoderm specification and other stages of preimplantation development.			Viswanathan, SR (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Viswanathan, Srinivas/ABA-6316-2021; Mermel, Craig/AAZ-7322-2020	Viswanathan, Srinivas/0000-0003-1856-3023; Mermel, Craig/0000-0002-0816-3395	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blakaj A, 2008, J BIOL CHEM, V283, P9505, DOI 10.1074/jbc.R800002200; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen AL, 2008, BIOTECHNOL LETT, V30, P2045, DOI 10.1007/s10529-008-9800-8; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Ding XC, 2008, CELL CYCLE, V7, P3083, DOI 10.4161/cc.7.19.6778; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Johnson MH, 2004, SEMIN CELL DEV BIOL, V15, P583, DOI 10.1016/j.semcdb.2004.04.002; JOHNSON MH, 1981, J CELL BIOL, V91, P303, DOI 10.1083/jcb.91.1.303; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schulman BRM, 2005, DEV DYNAM, V234, P1046, DOI 10.1002/dvdy.20599; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Staun-Ram E, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-56; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813; WILLIAM MS, 2006, MAMMALIAN GENOME V, V17, P833; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yang YH, 2008, DEV DYNAM, V237, P2315, DOI 10.1002/dvdy.21666; Yang YC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S4; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Zernicka-Goetz M, 2006, CURR OPIN GENET DEV, V16, P406, DOI 10.1016/j.gde.2006.06.011; ZIOMEK CA, 1980, CELL, V21, P935, DOI 10.1016/0092-8674(80)90457-2	57	64	66	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6143	10.1371/journal.pone.0006143	http://dx.doi.org/10.1371/journal.pone.0006143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19582159	Green Submitted, Green Published, gold			2022-12-27	WOS:000267806300012
J	Chapalain, A; Chevalier, S; Orange, N; Murillo, L; Papadopoulos, V; Feuilloley, MGJ				Chapalain, Annelise; Chevalier, Sylvie; Orange, Nicole; Murillo, Laurence; Papadopoulos, Vassilios; Feuilloley, Marc G. J.			Bacterial Ortholog of Mammalian Translocator Protein (TSPO) with Virulence Regulating Activity	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; OUTER-MEMBRANE PROTEINS; PSEUDOMONAS-FLUORESCENS; IN-VIVO; BINDING; GROWTH; OPRF; STEROIDOGENESIS; SECONDARY; APOPTOSIS	The translocator protein (TSPO), previously designated as peripheral-type benzodiazepine receptor, is a protein mainly located in the outer mitochondrial membrane of eukaryotic cells. TSPO is implicated in major physiological functions and functionally associated with other proteins such as the voltage-dependent anionic channel, also designated as mitochondrial porin. Surprisingly, a TSPO-related protein was identified in the photosynthetic bacterium Rhodobacter sphaeroides but it was initially considered as a relict of evolution. In the present study we cloned a tspO gene in Pseudomonas fluorescens MF37, a non-photosynthetic eubacterium and we used bioinformatics tools to identify TSPO in the genome of 97 other bacteria. P. fluorescens TSPO was recognized by antibodies against mouse protein and by PK 11195, an artificial ligand of mitochondrial TSPO. As in eukaryotes, bacterial TSPO appears functionally organized as a dimer and the apparent Kd for PK 11195 is in the same range than for its eukaryotic counterpart. When P. fluorescens MF37 was treated with PK 11195 (10(-5) M) adhesion to living or artificial surfaces and biofilm formation activity were increased. Conversely, the apoptotic potential of bacteria on eukaryotic cells was significantly reduced. This effect of PK11195 was abolished in a mutant of P. fluorescens MF37 deficient for its major outer membrane porin, OprF. The present results demonstrate the existence of a bacterial TSPO that shares common structural and functional characteristics with its mammalian counterpart. This protein, apparently involved in adhesion and virulence, reveals the existence of a possible new inter kingdom signalling system and suggests that the human microbiome should be involuntarily exposed to the evolutionary pressure of benzodiazepines and related molecules. This discovery also represents a promising opportunity for the development of alternative antibacterial strategies.			Chapalain, A (corresponding author), Univ Rouen, Lab Cold Microbiol, UPRES, EA4312, Evreux, France.	marc.feuilloley@univ-rouen.fr	Chapalain, Annelise/M-5767-2014; Papadopoulos, Vassilios/AAI-2613-2019	Chapalain, Annelise/0000-0002-3270-0947; Papadopoulos, Vassilios/0000-0002-1183-8568; CHEVALIER, sylvie/0000-0001-6489-438X; MURILLO, Laurence/0000-0002-0934-4227	NIEHS NIH HHS [ES007747, R01 ES007747] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007747] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Azghani AO, 2002, MICROB PATHOGENESIS, V33, P109, DOI 10.1006/mpat.2002.0514; Baughn AD, 2002, P NATL ACAD SCI USA, V99, P4662, DOI 10.1073/pnas.052710199; BellonFontaine MN, 1996, COLLOID SURFACE B, V7, P47, DOI 10.1016/0927-7765(96)01272-6; Bodilis J, 2004, SYST APPL MICROBIOL, V27, P93, DOI 10.1078/0723-2020-00253; Buommino E, 1999, INFECT IMMUN, V67, P4794, DOI 10.1128/IAI.67.9.4794-4800.1999; BURINI JF, 1994, FEMS MICROBIOL LETT, V122, P13, DOI 10.1111/j.1574-6968.1994.tb07136.x; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chapalain A, 2008, CAN J MICROBIOL, V54, P19, DOI [10.1139/W07-110, 10.1139/w07-110]; Cusumano V, 1997, INFECT IMMUN, V65, P1683, DOI 10.1128/IAI.65.5.1683-1687.1997; Davey ME, 2000, APPL ENVIRON MICROB, V66, P5353, DOI 10.1128/AEM.66.12.5353-5359.2000; Delavoie F, 2003, BIOCHEMISTRY-US, V42, P4506, DOI 10.1021/bi0267487; El Hamel C, 2001, BBA-BIOMEMBRANES, V1515, P12, DOI 10.1016/S0005-2736(01)00387-X; Freestone PPE, 2008, ADV APPL MICROBIOL, V64, P75, DOI 10.1016/S0065-2164(08)00402-4; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; GonzalezMarquez H, 1997, MICROBIOL-UK, V143, P1587, DOI 10.1099/00221287-143-5-1587; Hemery G, 2007, J IND MICROBIOL BIOT, V34, P49, DOI 10.1007/s10295-006-0160-x; Joseph-Liauzun E, 1998, J BIOL CHEM, V273, P2146, DOI 10.1074/jbc.273.4.2146; Klebba PE, 2005, J BACTERIOL, V187, P8232, DOI 10.1128/JB.187.24.8232-8236.2005; Lacapere JJ, 2001, BIOCHEM BIOPH RES CO, V284, P536, DOI 10.1006/bbrc.2001.4975; LEFUR G, 1983, LIFE SCI, V32, P1849, DOI 10.1016/0024-3205(83)90063-2; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Lindemann P, 2004, PLANT CELL PHYSIOL, V45, P723, DOI 10.1093/pcp/pch088; Mackenzie C, 2007, ANNU REV MICROBIOL, V61, P283, DOI 10.1146/annurev.micro.61.080706.093402; *MARK ENT INC, US SLEEP MARK; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Mezghani-Abdelmoula S, 2004, MICROBIOL RES, V159, P355, DOI 10.1016/j.micres.2004.08.003; Murail S, 2008, BBA-BIOMEMBRANES, V1778, P1375, DOI 10.1016/j.bbamem.2008.03.012; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Picot L, 2003, MICROB PATHOGENESIS, V35, P95, DOI 10.1016/S0882-4010(03)00092-5; Pimenta AL, 2006, RES MICROBIOL, V157, P885, DOI 10.1016/j.resmic.2006.06.005; Rebiere-Huet J, 2002, FEMS MICROBIOL LETT, V215, P121, DOI 10.1016/S0378-1097(02)00920-5; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Snyder MJ, 1998, CELL TISSUE RES, V294, P161, DOI 10.1007/s004410051166; Stowe-Evans EL, 2004, J BACTERIOL, V186, P4338, DOI 10.1128/JB.186.13.4338-4349.2004; Sugawara E, 1996, J BACTERIOL, V178, P6067, DOI 10.1128/jb.178.20.6067-6069.1996; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; Wyckoff TJO, 2002, MICROBIOL-SGM, V148, P3423, DOI 10.1099/00221287-148-11-3423; Yeliseev AA, 1997, P NATL ACAD SCI USA, V94, P5101, DOI 10.1073/pnas.94.10.5101; YELISEEV AA, 1995, J BIOL CHEM, V270, P21167, DOI 10.1074/jbc.270.36.21167; Yeliseev AA, 2000, J BIOL CHEM, V275, P5657, DOI 10.1074/jbc.275.8.5657; Zisterer DM, 1997, GEN PHARMACOL-VASC S, V29, P305, DOI 10.1016/S0306-3623(96)00473-9	45	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6096	10.1371/journal.pone.0006096	http://dx.doi.org/10.1371/journal.pone.0006096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564920	Green Published, Green Submitted, gold			2022-12-27	WOS:000267515700014
J	Reimer, R; Helmbold, H; Szalay, B; Hagel, C; Hohenberg, H; Deppert, W; Bohn, W				Reimer, Rudolph; Helmbold, Heike; Szalay, Beata; Hagel, Christian; Hohenberg, Heinrich; Deppert, Wolfgang; Bohn, Wolfgang			Nestin Modulates Glucocorticoid Receptor Function by Cytoplasmic Anchoring	PLOS ONE			English	Article								Nestin is the characteristic intermediate filament (IF) protein of rapidly proliferating progenitor cells and regenerating tissue. Nestin copolymerizes with class III IF-proteins, mostly vimentin, into heteromeric filaments. Its expression is downregulated with differentiation. Here we show that a strong nestin expression in mouse embryo tissue coincides with a strong accumulation of the glucocorticoid receptor (GR), a key regulator of growth and differentiation in embryonic development. Microscopic studies on cultured cells show an association of GR with IFs composed of vimentin and nestin. Cells lacking nestin, but expressing vimentin, or cells expressing vimentin, but lacking nestin accumulate GR in the nucleus. Completing these networks with an exogenous nestin, respectively an exogenous vimentin restores cytoplasmic anchoring of GR to the IF system. Thus, heteromeric filaments provide the basis for anchoring of GR. The reaction pattern with phospho-GR specific antibodies and the presence of the chaperone HSC70 suggest that specifically the unliganded receptor is anchored to the IF system. Ligand addition releases GR from IFs and shifts the receptor into the nucleus. Suppression of nestin by specific shRNA abolishes anchoring of GR, induces its accumulation in the nucleus and provokes an irreversible G1/S cell cycle arrest. Suppression of GR prior to that of nestin prevents entry into the arrest. The data give evidence that nestin/vimentin specific anchoring modulates growth suppression by GR. We hypothesize that expression of nestin is a major determinant in suppression of anti-proliferative activity of GR in undifferentiated tissue and facilitates activation of this growth control in a precise tissue and differentiation dependent manner.			Reimer, R (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Martinistr 52, D-2000 Hamburg, Germany.	wolfgang.bohn@hpi.uni-hamburg.de						AKNER G, 1991, J STEROID BIOCHEM, V39, P419, DOI 10.1016/0960-0760(91)90235-W; AKNER G, 1990, EUR J CELL BIOL, V53, P390; Almeida OFX, 2000, FASEB J, V14, P779, DOI 10.1096/fasebj.14.5.779; Bird AD, 2007, J PHYSIOL-LONDON, V585, P187, DOI 10.1113/jphysiol.2007.136796; BODWELL JE, 1995, J STEROID BIOCHEM, V52, P135, DOI 10.1016/0960-0760(94)00157-H; BOHN W, 1992, EXP CELL RES, V201, P1, DOI 10.1016/0014-4827(92)90341-5; BOHN W, 1993, J STRUCT BIOL, V111, P48, DOI 10.1006/jsbi.1993.1035; Bohn W, 1996, SCANNING MICROSCOPY SUPPLEMENT 10, 1996, P285; BOHN W, 1996, SCANNING MICROSCOPY, V10, P293; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonanno G, 2004, TRANSFUSION, V44, P1087, DOI 10.1111/j.1537-2995.2004.03252.x; BUSE P, 1995, J BIOL CHEM, V270, P6505, DOI 10.1074/jbc.270.12.6505; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; CINTRA A, 1993, NEUROENDOCRINOLOGY, V57, P1133, DOI 10.1159/000126480; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; CZAR MJ, 1995, MOL ENDOCRINOL, V9, P1549, DOI 10.1210/me.9.11.1549; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; DANIEL C, 2008, LAB INVEST      0211; DAUVOIS S, 1993, J CELL SCI, V106, P1377; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; ECKELT A, 1992, EUR J CELL BIOL, V58, P319; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Frojdman K, 1997, DIFFERENTIATION, V61, P243, DOI 10.1046/j.1432-0436.1997.6140243.x; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; Gleiberman AS, 2005, DEV DYNAM, V234, P413, DOI 10.1002/dvdy.20536; Ha Y, 2003, ACTA NEUROCHIR, V145, P483, DOI 10.1007/s00701-003-0023-4; Hache RJG, 1999, J BIOL CHEM, V274, P1432, DOI 10.1074/jbc.274.3.1432; Harrell JM, 2004, J BIOL CHEM, V279, P54647, DOI 10.1074/jbc.M406863200; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; KANG KI, 1994, P NATL ACAD SCI USA, V91, P340, DOI 10.1073/pnas.91.1.340; Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; MANNWEILER K, 1982, J MICROSC-OXFORD, V126, P145, DOI 10.1111/j.1365-2818.1982.tb00363.x; MARTINS VR, 1991, MOL ENDOCRINOL, V5, P217, DOI 10.1210/mend-5-2-217; Marvin NJ, 1998, J CELL SCI, V111, P1951; Matthews SG, 1998, DEV BRAIN RES, V107, P123, DOI 10.1016/S0165-3806(98)00008-X; Miller AL, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-18; MIYATA Y, 1991, J BIOL CHEM, V266, P8779; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Morishima Y, 2001, BIOCHEMISTRY-US, V40, P1109, DOI 10.1021/bi002399+; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Neidhardt J, 2003, MOL CELL NEUROSCI, V23, P193, DOI 10.1016/S1044-7431(03)00012-5; Peschle C, 2001, Rev Clin Exp Hematol, V5, P3, DOI 10.1046/j.1468-0734.2001.00029.x; PRATT WB, 1989, CANCER RES, V49, pS2222; Pujols L, 2002, AM J PHYSIOL-CELL PH, V283, pC1324, DOI 10.1152/ajpcell.00363.2001; Ramalingam A, 1997, MOL ENDOCRINOL, V11, P577, DOI 10.1210/me.11.5.577; Reagan LP, 1997, J CHEM NEUROANAT, V13, P149, DOI 10.1016/S0891-0618(97)00031-8; Reichardt HM, 2000, ADV PHARMACOL, V47, P1; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; ROSER K, 1991, EXP CELL RES, V197, P200, DOI 10.1016/0014-4827(91)90423-R; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Sahlgren CM, 2001, J BIOL CHEM, V276, P16456, DOI 10.1074/jbc.M009669200; SANCHEZ ER, 1990, J BIOL CHEM, V265, P20123; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; SCHERRER LC, 1992, BIOCHEMISTRY-US, V31, P10879, DOI 10.1021/bi00159a031; Shibuya S, 2002, NEUROSCIENCE, V114, P905, DOI 10.1016/S0306-4522(02)00323-8; Son GH, 2001, J NEUROCHEM, V79, P1013, DOI 10.1046/j.1471-4159.2001.00634.x; Sousa N, 1999, NEUROSCIENCE, V89, P1079, DOI 10.1016/S0306-4522(98)00311-X; Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881; Svitkina T, 2007, METHOD CELL BIOL, V79, P295, DOI 10.1016/S0091-679X(06)79012-4; SZAPARY D, 1994, J STEROID BIOCHEM, V51, P143, DOI 10.1016/0960-0760(94)90087-6; Vaittinen S, 2001, J NEUROPATH EXP NEUR, V60, P588, DOI 10.1093/jnen/60.6.588; VANDERBILT JN, 1987, MOL ENDOCRINOL, V1, P68, DOI 10.1210/mend-1-1-68; VORGIAS CE, 1988, BIOSCIENCE REP, V8, P193, DOI 10.1007/BF01116464; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Webster JC, 1997, J BIOL CHEM, V272, P9287; Wei LC, 2002, DEV BRAIN RES, V139, P9, DOI 10.1016/S0165-3806(02)00509-6; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wintermantel TA, 2005, J STEROID BIOCHEM, V93, P107, DOI 10.1016/j.jsbmb.2004.12.033; Wintermantel TM, 2005, MOL ENDOCRINOL, V19, P340, DOI 10.1210/me.2004-0068; Yang J, 2001, BBA-GENE STRUCT EXPR, V1520, P251, DOI 10.1016/S0167-4781(01)00275-5; Yaworsky PJ, 1999, DEV BIOL, V205, P309, DOI 10.1006/dbio.1998.9035; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	79	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6084	10.1371/journal.pone.0006084	http://dx.doi.org/10.1371/journal.pone.0006084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562035	Green Submitted, Green Published, gold			2022-12-27	WOS:000267465900015
J	Gahan, ME; Webster, DE; Wesselingh, SL; Strugnell, RA; Yang, J				Gahan, Michelle E.; Webster, Diane E.; Wesselingh, Steven L.; Strugnell, Richard A.; Yang, Ji			Bacterial Antigen Expression Is an Important Component in Inducing an Immune Response to Orally Administered Salmonella-Delivered DNA Vaccines	PLOS ONE			English	Article								Background: The use of Salmonella to deliver heterologous antigens from DNA vaccines is a well-accepted extension of the success of oral Salmonella vaccines in animal models. Attenuated S. typhimurium and S. typhi strains are safe and efficacious, and their use to deliver DNA vaccines combines the advantages of both vaccine approaches, while complementing the limitations of each technology. An important aspect of the basic biology of the Salmonella/DNA vaccine platform is the relative contributions of prokaryotic and eukaryotic expression in production of the vaccine antigen. Gene expression in DNA vaccines is commonly under the control of the eukaryotic cytomegalovirus (CMV) promoter. The aim of this study was to identify and disable putative bacterial promoters within the CMV promoter and evaluate the immunogenicity of the resulting DNA vaccine delivered orally by S. typhimurium. Methodology/Principal Findings: The results reported here clearly demonstrate the presence of bacterial promoters within the CMV promoter. These promoters have homology to the bacterial consensus sequence and functional activity. To disable prokaryotic expression from the CMV promoter a series of genetic manipulations were performed to remove the two major bacterial promoters and add a bacteria transcription terminator downstream of the CMV promoter. S. typhimurium was used to immunise BALB/c mice orally with a DNA vaccine encoding the C-fragment of tetanus toxin (TT) under control of the original or the modified CMV promoter. Although both promoters functioned equally well in eukaryotic cells, as indicated by equivalent immune responses following intramuscular delivery, only the original CMV promoter was able to induce an anti-TT specific response following oral delivery by S. typhimurium. Conclusions: These findings suggest that prokaryotic expression of the antigen and co-delivery of this protein by Salmonella are at least partially responsible for the successful oral delivery of C-fragment DNA vaccines containing the CMV promoter by S. typhimurium.			Gahan, ME (corresponding author), Univ Canberra, Fac Sci Appl, Ctr Biomed Mol & Chem Sci, Bruce, ACT, Australia.	michelle.gahan@canberra.edu.au	Webster, Diane/F-7326-2010	Gahan, Michelle/0000-0002-1511-687X; Strugnell, Richard/0000-0003-0614-5641				Anderson RJ, 2000, VACCINE, V18, P2193, DOI 10.1016/S0264-410X(00)00025-6; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; Darji A, 2000, FEMS IMMUNOL MED MIC, V27, P341; Dietrich G, 2003, CURR OPIN MOL THER, V5, P10; Dunstan SJ, 1999, INFECT IMMUN, V67, P5133, DOI 10.1128/IAI.67.10.5133-5141.1999; FAIRWEATHER NF, 1990, INFECT IMMUN, V58, P1323, DOI 10.1128/IAI.58.5.1323-1326.1990; Flo J, 2001, VACCINE, V19, P1772, DOI 10.1016/S0264-410X(00)00375-3; Gahan ME, 2007, VACCINE, V25, P1476, DOI 10.1016/j.vaccine.2006.10.042; Goussard S, 2003, J MOL MICROB BIOTECH, V6, P211, DOI 10.1159/000077252; HUDSON GS, 1984, J MOL BIOL, V180, P1023, DOI 10.1016/0022-2836(84)90269-9; KEILTY S, 1987, J BIOL CHEM, V262, P6389; KUMAR A, 1993, J MOL BIOL, V232, P406, DOI 10.1006/jmbi.1993.1400; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Levine MM, 1999, VACCINE, V17, pS22, DOI 10.1016/S0264-410X(99)00231-5; Lewin A, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-19; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; Loessner H, 2004, EXPERT OPIN BIOL TH, V4, P157, DOI 10.1517/14712598.4.2.157; Marshall DG, 2000, VACCINE, V18, P1298, DOI 10.1016/S0264-410X(99)00417-X; MULLIGAN ME, 1984, NUCLEIC ACIDS RES, V12, P789, DOI 10.1093/nar/12.1Part2.789; Paglia P, 1998, BLOOD, V92, P3172, DOI 10.1182/blood.V92.9.3172.421k18_3172_3176; Pasetti MF, 1999, CLIN IMMUNOL, V92, P76, DOI 10.1006/clim.1999.4733; Schoen C, 2004, INT J MED MICROBIOL, V294, P319, DOI 10.1016/j.ijmm.2004.03.001; TWIGG AJ, 1980, NATURE, V283, P216, DOI 10.1038/283216a0; Weiner DB, 2008, VACCINE, V26, P5073, DOI 10.1016/j.vaccine.2008.07.024; Xu F, 2004, J DRUG TARGET, V11, P481, DOI 10.1080/10611860410001670053; Yang J, 2004, MOL MICROBIOL, V52, P243, DOI 10.1111/j.1365-2958.2003.03965.x; YANOFSKY C, 1981, NUCLEIC ACIDS RES, V9, P6647, DOI 10.1093/nar/9.24.6647	28	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6062	10.1371/journal.pone.0006062	http://dx.doi.org/10.1371/journal.pone.0006062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557169	Green Published, Green Submitted, gold			2022-12-27	WOS:000267424600010
J	Ratcliff, WC; Hawthorne, P; Travisano, M; Denison, RF				Ratcliff, William C.; Hawthorne, Peter; Travisano, Michael; Denison, R. Ford			When Stress Predicts a Shrinking Gene Pool, Trading Early Reproduction for Longevity Can Increase Fitness, Even with Lower Fecundity	PLOS ONE			English	Article								Background: Stresses like dietary restriction or various toxins increase lifespan in taxa as diverse as yeast, Caenorhabditis elegans, Drosophila and rats, by triggering physiological responses that also tend to delay reproduction. Food odors can reverse the effects of dietary restriction, showing that key mechanisms respond to information, not just resources. Such environmental cues can predict population trends, not just individual prospects for survival and reproduction. When population size is increasing, each offspring produced earlier makes a larger proportional contribution to the gene pool, but the reverse is true when population size is declining. Principal Findings: We show mathematically that natural selection can favor facultative delay in reproduction when environmental cues predict a decrease in total population size, even if lifetime fecundity decreases with delay. We also show that increased reproduction from waiting for better conditions does not increase fitness (proportional representation) when the whole population benefits similarly. Conclusions: We conclude that the beneficial effects of stress on longevity (hormesis) in diverse taxa are a side-effect of delaying reproduction in response to environmental cues that population size is likely to decrease. The reversal by food odors of the effects of dietary restriction can be explained as a response to information that population size is less likely to decrease, reducing the chance that delaying reproduction will increase fitness.			Ratcliff, WC (corresponding author), Univ Minnesota, St Paul, MN 55108 USA.	denis036@umn.edu	Travisano, Michael/AAI-4809-2020	Travisano, Michael/0000-0001-8168-0842; Hawthorne, Peter/0000-0003-1125-5239				Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Anson RM, 2005, AGE, V27, P17, DOI 10.1007/s11357-005-3286-2; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; Fisher RA, 1930, GENETICAL THEORY NAT; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; Gruber J, 2007, ANN NY ACAD SCI, V1100, P530, DOI 10.1196/annals.1395.059; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hercus MJ, 2003, BIOGERONTOLOGY, V4, P149, DOI 10.1023/A:1024197806855; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409; KOMDEUR J, 1992, NATURE, V358, P493, DOI 10.1038/358493a0; Koons DN, 2008, AM NAT, V172, P797, DOI 10.1086/592867; Libert S, 2007, CELL, V131, P1231, DOI 10.1016/j.cell.2007.12.002; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Mattson MP, 2006, TRENDS NEUROSCI, V29, P632, DOI 10.1016/j.tins.2006.09.001; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; PERRIN N, 1990, FUNCT ECOL, V4, P53, DOI 10.2307/2389652; PIANKA ER, 1999, EVOLUTIONARY ECOLGY, P512; RAUSER CL, 2009, EXPT EVOLUTION CONCE; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Tatar M, 1997, EVOLUTION, V51, P1323, DOI [10.2307/2411062, 10.1111/j.1558-5646.1997.tb03980.x]; Voronezhskaya EE, 2004, DEVELOPMENT, V131, P3671, DOI 10.1242/dev.01237; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Wilbur HM, 2006, AM NAT, V168, P398, DOI 10.1086/506258; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	31	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6055	10.1371/journal.pone.0006055	http://dx.doi.org/10.1371/journal.pone.0006055			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557134	Green Published, Green Submitted, gold			2022-12-27	WOS:000267356900014
J	Rapp, UR; Korn, C; Ceteci, F; Karreman, C; Luetkenhaus, K; Serafin, V; Zanucco, E; Castro, I; Potapenko, T				Rapp, Ulf R.; Korn, Christian; Ceteci, Fatih; Karreman, Christiaan; Luetkenhaus, Katharina; Serafin, Valentina; Zanucco, Emanuele; Castro, Ines; Potapenko, Tamara			Myc Is a Metastasis Gene for Non-Small-Cell Lung Cancer	PLOS ONE			English	Article								Background: Metastasis is a process by which cancer cells learn to form satellite tumors in distant organs and represents the principle cause of death of patients with solid tumors. NSCLC is the most lethal human cancer due to its high rate of metastasis. Methodology/Principal Findings: Lack of a suitable animal model has so far hampered analysis of metastatic progression. We have examined c-MYC for its ability to induce metastasis in a C-RAF-driven mouse model for non-small-cell lung cancer. c-MYC alone induced frank tumor growth only after long latency at which time secondary mutations in K-Ras or LKB1 were detected reminiscent of human NSCLC. Combination with C-RAF led to immediate acceleration of tumor growth, conversion to papillary epithelial cells and angiogenic switch induction. Moreover, addition of c-MYC was sufficient to induce macrometastasis in liver and lymph nodes with short latency associated with lineage switch events. Thus we have generated the first conditional model for metastasis of NSCLC and identified a gene, c-MYC that is able to orchestrate all steps of this process. Conclusions/Significance: Potential markers for detection of metastasis were identified and validated for diagnosis of human biopsies. These markers may represent targets for future therapeutic intervention as they include genes such as Gata4 that are exclusively expressed during lung development.			Rapp, UR (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, D-8000 Munich, Germany.	rapp@biochem.mpg.de	Serafin, Valentina/ABD-9083-2020	Castro, Ines/0000-0003-3635-5527; Serafin, Valentina/0000-0001-6283-7728				Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Becker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004230; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Chiloeches A, 2006, CLIN CANCER RES, V12, P1661, DOI 10.1158/1078-0432.CCR-06-0051; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fedorov LM, 2003, CANCER RES, V63, P2268; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Hibi K, 1999, AM J PATHOL, V155, P711, DOI 10.1016/S0002-9440(10)65169-3; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kerkhoff E, 1998, ONCOGENE, V17, P1457, DOI 10.1038/sj.onc.1202185; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Knies-Bamforth UE, 2004, CANCER RES, V64, P6563, DOI 10.1158/0008-5472.CAN-03-3176; Krane CM, 2001, P NATL ACAD SCI USA, V98, P14114, DOI 10.1073/pnas.231273398; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Liao Dezhong Joshua, 2006, J Carcinog, V5, P19, DOI 10.1186/1477-3163-5-19; Liu C, 2002, J BIOL CHEM, V277, P4519, DOI 10.1074/jbc.M107585200; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Rapp UR, 2008, CELL CYCLE, V7, P45, DOI 10.4161/cc.7.1.5203; RAPP UR, 1985, J VIROL, V55, P23, DOI 10.1128/JVI.55.1.23-33.1985; RAPP UR, 2007, NATURE P; Rawlins Emma L, 2008, Proc Am Thorac Soc, V5, P675, DOI 10.1513/pats.200801-006AW; Russell RG, 2004, CANCER RES, V64, P7220, DOI 10.1158/0008-5472.CAN-04-2095; SANDGREN EP, 1991, P NATL ACAD SCI USA, V88, P93, DOI 10.1073/pnas.88.1.93; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Shah U, 2008, CANCER RES, V68, P3562, DOI 10.1158/0008-5472.CAN-07-6620; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; STORM SM, 1993, TOXICOL LETT, V67, P201, DOI 10.1016/0378-4274(93)90056-4; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P328, DOI 10.1513/pats.200711-167DR; Takami Y, 2007, ARTERIOSCL THROM VAS, V27, P2184, DOI 10.1161/ATVBAHA.107.142505; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tran PT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002125; van der Sluis M, 2004, BIOCHEM BIOPH RES CO, V325, P952, DOI 10.1016/j.bbrc.2004.10.108; Wang Y, 2002, MOL GENET GENOMICS, V268, P160, DOI 10.1007/s00438-002-0751-9; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; YOKOTA J, 1988, ONCOGENE, V2, P607; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	49	97	98	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6029	10.1371/journal.pone.0006029	http://dx.doi.org/10.1371/journal.pone.0006029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551151	Green Submitted, gold, Green Published			2022-12-27	WOS:000267356500013
J	Enns, LC; Morton, JF; Treuting, PR; Emond, MJ; Wolf, NS; McKnight, GS; Rabinovitch, PS; Ladiges, WC				Enns, Linda C.; Morton, John F.; Treuting, Piper R.; Emond, Mary J.; Wolf, Norman S.; McKnight, G. S.; Rabinovitch, Peter S.; Ladiges, Warren C.			Disruption of Protein Kinase A in Mice Enhances Healthy Aging	PLOS ONE			English	Article								Mutations that cause a reduction in protein kinase A (PKA) activity have been shown to extend lifespan in yeast. Loss of function of mammalian RII beta, a regulatory subunit of PKA expressed in brain and adipose tissue, results in mice that are lean and insulin sensitive. It was therefore hypothesized that RIIB null (RII beta(-/-)) mice would express anti-aging phenotypes. We conducted lifespan studies using 40 mutant and 40 wild type (WT) littermates of equal gender numbers and found that both the median and maximum lifespans were significantly increased in mutant males compared to WT littermates. The median lifespan was increased from 884 days to 1005 days (p = 0.006 as determined by the log rank test) and the 80% lifespan (defined here as 80% deaths) was increased from 941 days to 1073 days (p = 0.004 as determined by the Wang-Allison test). There was no difference in either median or 80% lifespan in female genotypes. WT mice of both genders became increasingly obese with age, while mutant mice maintained their lean phenotype into old age. Adiposity was found to correlate with lifespan for males only. 50% of male mice between 30 and 35 g, corresponding to about 5% body fat, for either genotype lived over 1000 days. No male mouse outside of this weight range achieved this lifespan. During their last month of life, WT mice began losing weight (a total of 8% and 15% of body weight was lost for males and females, respectively), but RII beta(-/-) male mice maintained their lean body mass to end of life. This attenuation of decline was not seen in female mutant mice. Old male mutant mice were insulin sensitive throughout their life. Both genders showed modestly lower blood glucose levels in old mutants compared to WT. Male mutants were also resistant to age-induced fatty liver. Pathological assessment of tissues from end of life male mutant mice showed a decrease in tumor incidence, decreased severity of renal lesions, and a trend towards a decrease in age-related cardiac pathology. These findings help establish the highly conserved nature of PKA and suggest that disruption of PKA affects physiological mechanisms known to be associated with healthy aging.			Ladiges, WC (corresponding author), Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA.	wladiges@u.washington.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519	NIDDK NIH HHS [U24 DK076126] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076126] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Arnold AP., 2002, HORMONES BRAIN BEHAV, P105, DOI 10.1016/B978-012532104-4/50065-2; Blouin K, 2008, J STEROID BIOCHEM, V108, P272, DOI 10.1016/j.jsbmb.2007.09.001; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Brandon EP, 1998, J NEUROSCI, V18, P3639; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; CEFALU WT, 1995, METABOLISM, V44, P954, DOI 10.1016/0026-0495(95)90251-1; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; DAI DF, 2009, CIRCULATION IN PRESS; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; DOHERTY TJ, 1993, CAN J APPL PHYSIOL, V18, P331, DOI 10.1139/h93-029; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; Enns LC, 2008, CRIT REV EUKAR GENE, V18, P81, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.60; Ferrannini E, 1997, HYPERTENSION, V30, P1144, DOI 10.1161/01.HYP.30.5.1144; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Fried L. P., 1999, PRINCIPLES GERIATRIC, P1387; Fujimoto WY, 1999, DIABETES CARE, V22, P1808, DOI 10.2337/diacare.22.11.1808; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Gatford KL, 1998, J ENDOCRINOL, V157, P373, DOI 10.1677/joe.0.1570373; GRIMBY G, 1983, CLIN PHYSIOL, V3, P209, DOI 10.1111/j.1475-097X.1983.tb00704.x; Harper JM, 2003, MECH AGEING DEV, V124, P801, DOI 10.1016/S0047-6374(03)00133-7; JUANIN J, 2008, EUR J CARDIOV PREV R, V15, pS79; Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lamarche B, 1998, CORONARY ARTERY DIS, V9, P473, DOI 10.1097/00019501-199809080-00002; Lawlor DA, 2007, OBESITY, V15, P1694, DOI 10.1038/oby.2007.202; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 2003, EXP GERONTOL, V38, P807, DOI 10.1016/S0531-5565(03)00113-X; Mauras N, 1996, HORM RES, V45, P74, DOI 10.1159/000184763; McKnight GS, 1998, RECENT PROG HORM RES, V53, P139; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; NAS AV, 2009, GEN ENDOCRINOL, V150, P1235; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Perrot-Sinal TS, 2009, ENDOCRINOLOGY, V150, P1075, DOI 10.1210/en.2008-1586; Planas JV, 1999, J BIOL CHEM, V274, P36281, DOI 10.1074/jbc.274.51.36281; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Roos MR, 1997, MUSCLE NERVE, V20, P679; Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x; Schreyer SA, 2001, DIABETES, V50, P2555, DOI 10.2337/diabetes.50.11.2555; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66; Soderberg S, 2009, INT J OBESITY, V33, P123, DOI 10.1038/ijo.2008.224; Soderberg S, 2004, J INTERN MED, V256, P128, DOI 10.1111/j.1365-2796.2004.01351.x; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Treuting PM, 2008, J GERONTOL A-BIOL, V63, P813, DOI 10.1093/gerona/63.8.813; VANDERVOORT AA, 1989, EUR J APPL PHYSIOL O, V58, P389, DOI 10.1007/BF00643514; Verdery RB, 1997, CLIN GERIATR MED, V13, P769; Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061; Wizemann T. M., 2001, EXPLORING BIOL CONTR; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yki-Jarvinen H, 2005, ANN MED, V37, P347, DOI 10.1080/07853890510037383	57	80	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5963	10.1371/journal.pone.0005963	http://dx.doi.org/10.1371/journal.pone.0005963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536287	gold, Green Published			2022-12-27	WOS:000267079500012
J	Robinson, K; Asawachaicharn, N; Galloway, DA; Grandori, C				Robinson, Kristin; Asawachaicharn, Nichaya; Galloway, Denise A.; Grandori, Carla			c-Myc Accelerates S-Phase and Requires WRN to Avoid Replication Stress	PLOS ONE			English	Article								c-Myc interacts with components of the pre-replication complex and directly regulates DNA replication [1]. However the consequences of this novel c-Myc function on cell cycle dynamics and replication-associated damage are unknown. Here, we show that c-Myc overexpression in primary human fibroblasts markedly accelerates S-phase while c-Myc deficient fibroblasts exhibit a prolonged S-phase. We also show that the Werner DNA helicase protein (WRN) plays a critical role in supporting c-Myc-driven S-phase, as depletion of WRN in c-Myc overexpressing cells increases DNA damage specifically at sites of DNA synthesis. This excess DNA damage activates a "replication stress'' pathway involving ATR, CHK1, CHK2, and p53, leading to rapid senescence of WRN deficient c-Myc overexpressing cells. Indeed, depletion of p53 rescues this senescence response. We propose that WRN functions to repair abnormal replication structures caused by the acceleration of DNA replication by c-Myc. This work provides an additional mechanistic explanation for c-Myc-induced DNA damage and senescence, and reveals a vulnerability of c-Myc overexpressing cells that could potentially be exploited in cancer therapy.			Robinson, K (corresponding author), Fred Hutchinson Canc Res Ctr, Program Canc Biol, 1124 Columbia St, Seattle, WA 98104 USA.	cgrandor@fhcrc.org			NATIONAL CANCER INSTITUTE [R01CA064795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026661] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA064795, CA064795] Funding Source: Medline; NIA NIH HHS [AG026661-03, R01 AG026661] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Benanti JA, 2004, MOL CELL BIOL, V24, P2842, DOI 10.1128/MCB.24.7.2842-2852.2004; Benanti JA, 2007, MOL CANCER RES, V5, P1181, DOI 10.1158/1541-7786.MCR-06-0372; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Choi DH, 2001, FASEB J, V15, P1014, DOI 10.1096/fj.00-0104com; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dhillon KK, 2007, AGING CELL, V6, P53, DOI 10.1111/j.1474-9726.2006.00260.x; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gerbi SA, 2002, CURR OPIN GENET DEV, V12, P243, DOI 10.1016/S0959-437X(02)00292-7; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Karlsson A, 2003, P NATL ACAD SCI USA, V100, P9974, DOI 10.1073/pnas.1732638100; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Koch HB, 2007, CELL CYCLE, V6, P205, DOI 10.4161/cc.6.2.3742; Li L, 2005, J CELL BIOCHEM, V94, P298, DOI 10.1002/jcb.20355; Li Q, 1999, MOL CELL BIOL, V19, P5339; Louis SF, 2005, P NATL ACAD SCI USA, V102, P9613, DOI 10.1073/pnas.0407512102; Mai S, 1996, ONCOGENE, V12, P277; Mai S, 1996, CHROMOSOME RES, V4, P365, DOI 10.1007/BF02257272; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; Pusch O, 1997, ONCOGENE, V15, P649, DOI 10.1038/sj.onc.1201236; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Sakamoto S, 2001, GENES CELLS, V6, P421, DOI 10.1046/j.1365-2443.2001.00433.x; SALK D, 1985, ADV EXP MED BIOL, V190, P305; Shimura T, 2006, ONCOGENE, V25, P5921, DOI 10.1038/sj.onc.1209624; SIDOROVA J, 2008, CELL CYCLE, V7; THIRIET C, 2008, J BIOL CHEM; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8	44	63	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5951	10.1371/journal.pone.0005951	http://dx.doi.org/10.1371/journal.pone.0005951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19554081	Green Published, gold, Green Submitted			2022-12-27	WOS:000267079500002
J	Stolzenberg, N; The, BN; Salducci, MD; Cavalli, L				Stolzenberg, Nicolas; The, Benedicte Nguyen; Salducci, Marie Dominique; Cavalli, Laurent			Influence of Environment and Mitochondrial Heritage on the Ecological Characteristics of Fish in a Hybrid Zone	PLOS ONE			English	Article							INTROGRESSIVE HYBRIDIZATION; NATURAL HYBRIDIZATION; BACK-CALCULATION; GROWTH; ADAPTATION; METABOLISM; MECHANISMS; MORPHOLOGY; SPECIATION; SELECTION	Background: Ecological characteristics (growth, morphology, reproduction) arise from the interaction between environmental factors and genetics. Genetic analysis of individuals' life history traits might be used to improve our understanding of mechanisms that form and maintain a hybrid zone. Methodology/Principal Findings: A fish hybrid zone was used to characterize the process of natural selection. Data were collected during two reproductive periods (2001 and 2002) and 1117 individuals (nase, Chondrostama nasus nasus, sofie C. toxostoma toxostoma and hybrids) were sampled. Reproductive dates of the two parental species overlapped at sympatric sites. The nase had an earlier reproductive period than the sofie; males had longer reproductive periods for both species. Hybridisation between female nase and male sofie was the most likely. Hybrids had a reproductive period similar to the inherited parental mitochondrial type. Growth and reproductive information from different environments has been synthesised following a bayesian approach of the von Bertalanffy model. Hybrid life history traits appear to link with maternal heritage. Hybrid size from the age of two and size at first maturity appeared to be closer to the size of the maternal origin species (nase or sofie). Median growth rates for hybrids were similar and intermediate between those of the parental species. We observed variable life history traits for hybrids and pure forms in the different parts of the hybrid zone. Geometrical analysis of the hybrid fish shape gave evidence of two main morphologies with a link to maternal heritage. Conclusions/Significance: Selective mating seemed to be the underlying process which, with mitochondrial heritage, could explain the evolution of the studied hybrid zone. More generally, we showed the importance of studies on hybrid zones and specifically the study of individuals' ecological characteristics, to improve our understanding of speciation.			Stolzenberg, N (corresponding author), Univ Aix Marseille 1, UMR IMEP 6116, Marseille, France.	laurent.cavalli@univ-provence.fr	Cavalli, Laurent/GVS-6751-2022					Abdoli A, 2007, J FISH BIOL, V70, P1224, DOI 10.1111/j.1095-8649.2007.01400.x; Ahnelt Harald, 1994, Ichthyological Exploration of Freshwaters, V5, P321; Albert V, 2006, MOL ECOL, V15, P1903, DOI 10.1111/j.1365-294X.2006.02917.x; Aldridge G, 2005, NEW PHYTOL, V167, P279, DOI 10.1111/j.1469-8137.2005.01413.x; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; [Anonymous], 1967, ACTA SC NAT BRNO; Arnold ML, 2004, PLANT CELL, V16, P562, DOI 10.1105/tpc.160370; ARNOLD ML, 1992, ANNU REV ECOL SYST, V23, P237, DOI 10.1146/annurev.es.23.110192.001321; ARNOLD ML, 1997, NATURAL HYBRIDIZATIO, P232; Ballard JWO, 2007, EVOLUTION, V61, P1735, DOI 10.1111/j.1558-5646.2007.00133.x; BARNEJEE S, 2004, HIERARCHICAL MODELLI, P472; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Bernatchez L, 1999, BIOL J LINN SOC, V68, P173, DOI 10.1111/j.1095-8312.1999.tb01165.x; Bleeker W, 2001, MOL ECOL, V10, P2013, DOI 10.1046/j.1365-294X.2001.01341.x; Bouchard P, 1998, ANN LIMNOL-INT J LIM, V34, P193, DOI 10.1051/limn/1998018; Brusle J., 2001, BIOL POISSONS EAU DO, P625; Caumul R, 2005, EVOLUTION, V59, P2460; CHAPPAZ R, 1989, CR ACAD SCI SERIES 3, V5, P181; Chenuil A, 2000, FRESHWATER BIOL, V43, P121, DOI 10.1046/j.1365-2427.2000.00531.x; Costedoat C, 2005, BIOL J LINN SOC, V85, P135, DOI 10.1111/j.1095-8312.2005.00478.x; Costedoat C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000357; Crespin L, 2002, J FISH BIOL, V61, P696, DOI 10.1006/jfbi.2002.2092; Crespin L, 1999, BIOL J LINN SOC, V67, P57, DOI 10.1006/bijl.1998.0287; Das J, 2006, BIOESSAYS, V28, P890, DOI 10.1002/bies.20463; DOBZHANSKY T., 1951, Genetics and the origin of species.; Dobzhansky T., 1937; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; DOWLING TE, 1993, NATURE, V362, P444, DOI 10.1038/362444a0; Dryden IL, 1998, STAT SHAPE ANAL; Dykens JA, 1999, DRUG DEVELOP RES, V46, P2, DOI 10.1002/(SICI)1098-2299(199901)46:1<2::AID-DDR2>3.0.CO;2-0; Ellison CK, 2008, EVOLUTION, V62, P631, DOI 10.1111/j.1558-5646.2007.00305.x; Ellison CK, 2006, EVOLUTION, V60, P1382, DOI 10.1111/j.0014-3820.2006.tb01217.x; EVERITT B, 2005, R S PLUS COMPANION M, P221; Fitzpatrick BM, 2007, P NATL ACAD SCI USA, V104, P15793, DOI 10.1073/pnas.0704791104; Folkvord A., 2002, P146; FRANCIS RICC, 1990, J FISH BIOL, V36, P883, DOI 10.1111/j.1095-8649.1990.tb05636.x; GOLZAN RE, ENV BIOL FISHES, V56, P153; GOZLAN RE, 1998, ENV BIOL MORPHODYNAM, P196; Grant BR, 1996, ECOLOGY, V77, P500, DOI 10.2307/2265625; Hagen J, 2001, CAN J FISH AQUAT SCI, V58, P2037, DOI 10.1139/cjfas-58-10-2037; Harrison JS, 2006, MOL BIOL EVOL, V23, P559, DOI 10.1093/molbev/msj058; Hatfield T, 1997, AM NAT, V149, P1009, DOI 10.1086/286036; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Huxel GR, 1999, BIOL CONSERV, V89, P143, DOI 10.1016/S0006-3207(98)00153-0; *IMP COLL MED RES, WINB VERS 1 4 2; Keckeis H., 2001, Archiv fuer Hydrobiologie Supplement, V135, P341; KEITH P, 2001, ATLAS POISSONS EAU D, P388; Kimball S, 2008, J ECOL, V96, P1306, DOI 10.1111/j.1365-2745.2008.01432.x; Klumb RA, 2001, CAN J FISH AQUAT SCI, V58, P352, DOI 10.1139/cjfas-58-2-352; Kovac V, 1999, ENVIRON BIOL FISH, V56, P105, DOI 10.1023/A:1007570716690; LEWONTIN RC, 1966, EVOLUTION, V20, P315, DOI 10.1111/j.1558-5646.1966.tb03369.x; MAIER K, 1995, DISTRIBUTION REPROD; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Monti L, 2001, BIOL J LINN SOC, V72, P391, DOI [10.1006/bijl.2000.0506, 10.1111/j.1095-8312.2001.tb01325.x]; NELVAPASQUAL A, 1985, THESIS U CLAUDE BERN, P365; Philippart J.C., 1981, Annales de la Societe Royale Zoologique de Belgique, V110, P199; Pinheiro J, 2000, MIXED EFFECTS MODELS, DOI [10.1007/978-1-4419-0318-1, DOI 10.1007/978-1-4419-0318-1]; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; Reese CS, 2001, J AM STAT ASSOC, V96, P915, DOI 10.1198/016214501753208618; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RICKER W E, 1975, P382; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; ROBERT C, 1992, ANAL STAT BAYESIENNE, P393; Robinson BW, 2000, ECOLOGY, V81, P2799, DOI 10.1890/0012-9658(2000)081[2799:APAOCR]2.0.CO;2; Rundle HD, 2002, EVOLUTION, V56, P322, DOI 10.1111/j.0014-3820.2002.tb01342.x; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; SCHNUTE J, 1981, CAN J FISH AQUAT SCI, V38, P1128, DOI 10.1139/f81-153; SEBER GAF, 1989, NONLINEAR REGRESSION, P765; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Shields JL, 2008, MAR BIOL, V154, P919, DOI 10.1007/s00227-008-0985-0; Stearns S.C., 1992, pi; TEMPLETON AR, 1981, ANNU REV ECOL SYST, V12, P23, DOI 10.1146/annurev.es.12.110181.000323; Vamosi SM, 2000, J FISH BIOL, V57, P109, DOI 10.1111/j.1095-8649.2000.tb00779.x; Vater M, 1997, BIOLOGIA, V52, P653; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Ward AJW, 2002, BEHAV ECOL SOCIOBIOL, V52, P182, DOI 10.1007/s00265-002-0505-z; Ward AJW, 2001, ANIM BEHAV, V62, P617, DOI 10.1006/anbe.2001.1785; Watano Y, 2004, AM J BOT, V91, P65, DOI 10.3732/ajb.91.1.65; WEBB PW, 1986, T AM FISH SOC, V115, P115, DOI 10.1577/1548-8659(1986)115<115:FLMOEL>2.0.CO;2; Willett CS, 2006, GENETICS, V173, P1465, DOI 10.1534/genetics.105.051011; Williams JH, 2001, HEREDITY, V87, P680, DOI 10.1046/j.1365-2540.2001.00968.x; WOTTON RJ, 1999, ECOLOGY TELEOST FISH, P386	83	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5962	10.1371/journal.pone.0005962	http://dx.doi.org/10.1371/journal.pone.0005962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536286	gold, Green Submitted, Green Published			2022-12-27	WOS:000267079500011
J	Elbarbary, RA; Takaku, H; Uchiumi, N; Tamiya, H; Abe, M; Takahashi, M; Nishida, H; Nashimoto, M				Elbarbary, Reyad A.; Takaku, Hiroaki; Uchiumi, Naoto; Tamiya, Hiroko; Abe, Mayumi; Takahashi, Masayuki; Nishida, Hiroshi; Nashimoto, Masayuki			Modulation of Gene Expression by Human Cytosolic tRNase Z(L) through 5 '-Half-tRNA	PLOS ONE			English	Article							TRANSFER-RNA; OXIDATIVE STRESS; KINASE-II; CLEAVAGE; ENDORIBONUCLEASE; NUCLEOTIDES; DIRECTION; PRODUCT; MIRNAS; HIV-1	A long form (tRNase Z(L)) of tRNA 39 processing endoribonuclease (tRNase Z, or 39 tRNase) can cleave any target RNA at any desired site under the direction of artificial small guide RNA (sgRNA) that mimics a 5'-half portion of tRNA. Based on this enzymatic property, a gene silencing technology has been developed, in which a specific mRNA level can be downregulated by introducing into cells a synthetic 5'-half-tRNA that is designed to form a pre-tRNA-like complex with a part of the mRNA. Recently 5'-half-tRNA fragments have been reported to exist stably in various types of cells, although little is know about their physiological roles. We were curious to know if endogenous 5'-half-tRNA works as sgRNA for tRNase Z(L) in the cells. Here we show that human cytosolic tRNase Z(L) modulates gene expression through 5'-half-tRNA. We found that 5'-half-tRNA(Glu), which co-immunoprecipitates with tRNase Z(L), exists predominantly in the cytoplasm, functions as sgRNA in vitro, and downregulates the level of a luciferase mRNA containing its target sequence in human kidney 293 cells. We also demonstrated that the PPM1F mRNA is one of the genuine targets of tRNase Z(L) guided by 5'-half-tRNA(Glu). Furthermore, the DNA microarray data suggested that tRNase Z(L) is likely to be involved in the p53 signaling pathway and apoptosis.			Elbarbary, RA (corresponding author), Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan.	mnashimoto@nupals.ac.jp		Rzq, kareem/0000-0003-3784-9430				Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Elbarbary RA, 2009, BIOCHEM BIOPH RES CO, V379, P924, DOI 10.1016/j.bbrc.2008.12.173; Habu Y, 2005, NUCLEIC ACIDS RES, V33, P235, DOI 10.1093/nar/gki164; Harvey BP, 2004, J BIOL CHEM, V279, P24889, DOI 10.1074/jbc.M400656200; Jochl C, 2008, NUCLEIC ACIDS RES, V36, P2677, DOI 10.1093/nar/gkn123; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Korver W, 2003, INT J CANCER, V104, P283, DOI 10.1002/ijc.10945; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Moore CA, 2007, DEVELOPMENT, V134, P3145, DOI 10.1242/dev.001214; Nakashima A, 2007, GENE THER, V14, P78, DOI 10.1038/sj.gt.3302841; NASHIMOTO M, 1995, NUCLEIC ACIDS RES, V23, P3642, DOI 10.1093/nar/23.18.3642; NASHIMOTO M, 1993, NUCLEIC ACIDS RES, V21, P4696, DOI 10.1093/nar/21.20.4696; Nashimoto M, 1996, RNA, V2, P523; Nashimoto M, 1999, BIOCHEMISTRY-US, V38, P12089, DOI 10.1021/bi9911942; NASHIMOTO M, 1992, NUCLEIC ACIDS RES, V20, P3737, DOI 10.1093/nar/20.14.3737; Nashimoto M, 2000, FEBS LETT, V472, P179, DOI 10.1016/S0014-5793(00)01462-9; Nashimoto M, 1997, NUCLEIC ACIDS RES, V25, P1148, DOI 10.1093/nar/25.6.1148; Nashimoto M, 1998, NUCLEIC ACIDS RES, V26, P2565, DOI 10.1093/nar/26.11.2565; Noda D, 2006, ONCOGENE, V25, P5591, DOI 10.1038/sj.onc.1209571; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; PFEFFER S, 2003, CURRENT PROTOCOLS MO; Shibata HS, 2005, J BIOL CHEM, V280, P22326, DOI 10.1074/jbc.M502048200; Takaku H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh092; Takaku H, 2004, NUCLEIC ACIDS RES, V32, P4429, DOI 10.1093/nar/gkh774; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Tamura M, 2003, NUCLEIC ACIDS RES, V31, P4354, DOI 10.1093/nar/gkg641; Tan KML, 2001, J BIOL CHEM, V276, P44193, DOI 10.1074/jbc.M105880200; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106	35	98	101	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5908	10.1371/journal.pone.0005908	http://dx.doi.org/10.1371/journal.pone.0005908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526060	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029300003
J	Gray, DJ; Williams, GM; Li, YS; Chen, HG; Forsyth, SJ; Li, RS; Barnett, AG; Guo, JG; Ross, AG; Zheng, F; McManus, DP				Gray, Darren J.; Williams, Gail M.; Li, Yuesheng; Chen, Honggen; Forsyth, Simon J.; Li, Robert S.; Barnett, Adrian G.; Guo, Jiagang; Ross, Allen G.; Zheng Feng; McManus, Donald P.			A Cluster-Randomised Intervention Trial against Schistosoma japonicum in the Peoples' Republic of China: Bovine and Human Transmission	PLOS ONE			English	Article							YANGTZE-RIVER VALLEY; POYANG LAKE; BASE-LINE; ANHUI PROVINCE; INFECTION; EPIDEMIOLOGY; BUFFALOS; VACCINES	Background: Zoonotic schistosomiasis japonica is a major public health problem in China. Bovines, particularly water buffaloes, are thought to play a major role in the transmission of schistosomiasis to humans in China. Preliminary results (1998-2003) of a praziquantel (PZQ)-based pilot intervention study we undertook provided proof of principle that water buffaloes are major reservoir hosts for S. japonicum in the Poyang Lake region, Jiangxi Province. Methods and Findings: Here we present the results of a cluster-randomised intervention trial (2004-2007) undertaken in Hunan and Jiangxi Provinces, with increased power and more general applicability to the lake and marshlands regions of southern China. The trial involved four matched pairs of villages with one village within each pair randomly selected as a control (human PZQ treatment only), leaving the other as the intervention (human and bovine PZQ treatment). A sentinel cohort of people to be monitored for new infections for the duration of the study was selected from each village. Results showed that combined human and bovine chemotherapy with PZQ had a greater effect on human incidence than human PZQ treatment alone. Conclusions: The results from this study, supported by previous experimental evidence, confirms that bovines are the major reservoir host of human schistosomiasis in the lake and marshland regions of southern China, and reinforce the rationale for the development and deployment of a transmission blocking anti-S. japonicum vaccine targeting bovines.			Gray, DJ (corresponding author), Queensland Inst Med Res, Mol Parasitol Lab, Brisbane, Qld 4006, Australia.	donM@qimr.edu.au	McManus, Don/AAC-5394-2020; Gray, Darren/A-8455-2011; Williams, Gail/S-8833-2019; Forsyth, Simon J/N-9522-2013; LI, Yue/GRS-8071-2022; McManus, Donald P./G-2678-2013	McManus, Don/0000-0001-6443-1449; Williams, Gail/0000-0002-4822-5263; Forsyth, Simon J/0000-0002-3100-3584; Ross, Allen/0000-0002-2329-0907; Gray, Darren/0000-0003-3525-1339; Barnett, Adrian/0000-0001-6339-0374	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Balen J, 2007, B WORLD HEALTH ORGAN, V85, P519, DOI 10.2471/BLT.06.034033; *COMM NEA, 1998, CHIN J PARASITOL PAR, V16, P84; Da'Dara AA, 2008, VACCINE, V26, P3617, DOI 10.1016/j.vaccine.2008.04.080; Davis GM, 2002, AM J TROP MED HYG, V66, P359, DOI 10.4269/ajtmh.2002.66.359; DeBont J, 1997, PARASITOL TODAY, V13, P255, DOI 10.1016/S0169-4758(97)01057-0; Fedorko James M., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P343; Gray DJ, 2007, AM J TROP MED HYG, V77, P866, DOI 10.4269/ajtmh.2007.77.866; Gray DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004058; Guo JG, 2006, AM J TROP MED HYG, V74, P335, DOI 10.4269/ajtmh.2006.74.335; Guo JG, 2001, AM J TROP MED HYG, V65, P272, DOI 10.4269/ajtmh.2001.65.272; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Ho Yi-HsuN, 1963, Chinese Medical Journal, V82, P403; Johansen MV, 2000, ACTA TROP, V76, P85, DOI 10.1016/S0001-706X(00)00103-0; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; McManus DP, 2006, PARASITOLOGY, V133, pS43, DOI 10.1017/S0031182006001806; Minggang Chen, 1999, Parasitology International, V48, P11, DOI 10.1016/S1383-5769(99)00004-5; MITCHELL GF, 1990, PARASITOLOGY, V101, P27, DOI 10.1017/S0031182000079713; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; WANG LD, 2006, EPIDEMIC STATUS SCHI; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Wang TP, 2006, INT J PARASITOL, V36, P1317, DOI 10.1016/j.ijpara.2006.06.011; Wang TP, 2006, J PARASITOL, V92, P1088, DOI 10.1645/GE-806R.1; Wang TP, 2005, ACTA TROP, V96, P198, DOI 10.1016/j.actatropica.2005.07.017; WHO, 2006, PREV CHEM HUM HELM; *WHO, 1993, CONTR SCHIST; Williams GM, 2002, ACTA TROP, V82, P253, DOI 10.1016/S0001-706X(02)00017-7; YI XH, 2005, ACTA TROP, V96, P223; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	30	68	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5900	10.1371/journal.pone.0005900	http://dx.doi.org/10.1371/journal.pone.0005900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521532	gold, Green Published			2022-12-27	WOS:000267029100015
J	Gangoso, L; Grande, JM; Lemus, JA; Blanco, G; Grande, J; Donazar, JAa				Gangoso, Laura; Grande, Juan M.; Lemus, Jesus A.; Blanco, Guillermo; Grande, Javier; Donazar, Jose A.			Susceptibility to Infection and Immune Response in Insular and Continental Populations of Egyptian Vulture: Implications for Conservation	PLOS ONE			English	Article							CHLAMYDOPHILA-PSITTACI; ISLAND POPULATIONS; TETRATRICHOMONAS-GALLINARUM; MYCOBACTERIUM-AVIUM; PARASITE ABUNDANCE; SPECIES RICHNESS; PASSERINE BIRDS; CANARY-ISLANDS; DISEASE; EXTINCTION	Background: A generalized decline in populations of Old World avian scavengers is occurring on a global scale. The main cause of the observed crisis in continental populations of these birds should be looked for in the interaction between two factors - changes in livestock management, including the increased use of pharmaceutical products, and disease. Insular vertebrates seem to be especially susceptible to diseases induced by the arrival of exotic pathogens, a process often favored by human activities, and sedentary and highly dense insular scavengers populations may be thus especially exposed to infection by such pathogens. Here, we compare pathogen prevalence and immune response in insular and continental populations of the globally endangered Egyptian vulture under similar livestock management scenarios, but with different ecological and evolutionary perspectives. Methods/Principal Findings: Adult, immature, and fledgling vultures from the Canary Islands and the Iberian Peninsula were sampled to determine a) the prevalence of seven pathogen taxa and b) their immunocompetence, as measured by monitoring techniques (white blood cells counts and immunoglobulins). In the Canarian population, pathogen prevalence was higher and, in addition, an association among pathogens was apparent, contrary to the situation detected in continental populations. Despite that, insular fledglings showed lower leukocyte profiles than continental birds and Canarian fledglings infected by Chlamydophila psittaci showed poorer cellular immune response. Conclusions/Significance: A combination of environmental and ecological factors may contribute to explain the high susceptibility to infection found in insular vultures. The scenario described here may be similar in other insular systems where populations of carrion-eaters are in strong decline and are seriously threatened. Higher susceptibility to infection may be a further factor contributing decisively to the extinction of island scavengers in the present context of global change and increasing numbers of emerging infectious diseases.	[Gangoso, Laura; Donazar, Jose A.] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Gangoso, Laura] Univ Lausanne, Dept Ecol & Evolut, Biophore, Lausanne, Switzerland; [Grande, Juan M.] Univ Saskatchewan, Dept Biol, Saskatoon, SK, Canada; [Lemus, Jesus A.; Blanco, Guillermo; Grande, Javier] CSIC, Museo Ciencias Nat, Dept Evolutionary Ecol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Lausanne; University of Saskatchewan; Consejo Superior de Investigaciones Cientificas (CSIC); Museu de Ciencies Naturals de Barcelona	Gangoso, L (corresponding author), CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	laura.gangoso@unil.ch	Gangoso, Laura/C-6575-2015; Blanco, Guillermo/L-3170-2014	Gangoso, Laura/0000-0002-6205-6769; Blanco, Guillermo/0000-0001-5742-4929; Donazar, Jose Antonio/0000-0002-9433-9755; Grande, Juan Manuel/0000-0002-8183-0780				Andersen AA, 2005, J VET DIAGN INVEST, V17, P479, DOI 10.1177/104063870501700514; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Apanius V, 2000, ECOLOGY, V81, P1959, DOI 10.1890/0012-9658(2000)081[1959:IATEIP]2.0.CO;2; Aranaz A, 1997, SEMIN AVIAN EXOT PET, V6, P9, DOI 10.1016/S1055-937X(97)80036-9; BIBERSTEIN EL, 1999, VET MICROBIOL, P109; *BIRDLIFE INT, 2008, 2008 IUCN RED LIST T; Blanco G, 2004, ENVIRON RES, V94, P94, DOI 10.1016/S0013-9351(03)00120-8; BLANCO G, VULTURES S IN PRESS, V29; Blanco G, 2007, ENVIRON MICROBIOL, V9, P1738, DOI 10.1111/j.1462-2920.2007.01291.x; Blanco G, 2006, J APPL ECOL, V43, P990, DOI 10.1111/j.1365-2664.2006.01200.x; Blanco G, 2006, BIOL J LINN SOC, V88, P383, DOI 10.1111/j.1095-8312.2006.00625.x; Campbell TW, 1995, AVIAN HEMATOLOGY CYT; Carrete M, 2007, BIOL CONSERV, V136, P143, DOI 10.1016/j.biocon.2006.11.025; Carrete M, 2009, ECOL APPL, V19, P840, DOI 10.1890/07-2134.1; Cepicka I, 2005, VET PARASITOL, V128, P11, DOI 10.1016/j.vetpar.2004.11.003; CLAYTON DH, 1997, HOST PARASITE EVOLUT; Crooks KR, 2001, BIOL CONSERV, V98, P55, DOI 10.1016/S0006-3207(00)00141-5; Daoust Pierre-Yves, 2007, P270, DOI 10.1002/9780470344668.ch13; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; de Bellocq JG, 2002, ECOGRAPHY, V25, P173, DOI 10.1034/j.1600-0587.2002.250205.x; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; DELMORAL JC, 2002, MONOGRAFIA SEO BIRDL, V8, P176; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; DOBSON A P, 1988, Conservation Biology, V2, P31, DOI 10.1111/j.1523-1739.1988.tb00333.x; Donazar J.A., 1993, BUITRES IBERICOS BIO; Donazar JA, 2005, J BIOGEOGR, V32, P1701, DOI 10.1111/j.1365-2699.2005.01294.x; Donazar JA, 2002, BIOL CONSERV, V107, P89, DOI 10.1016/S0006-3207(02)00049-6; Epstein JH, 2006, ECOHEALTH, V3, P290, DOI 10.1007/s10393-006-0064-2; Fellah JS, 2008, AVIAN IMMUNOLOGY, P51, DOI 10.1016/B978-012370634-8.50006-8; Feng L, 2005, VET MICROBIOL, V106, P241, DOI 10.1016/j.vetmic.2004.12.021; Foronda P, 2004, PARASITE, V11, P311, DOI 10.1051/parasite/2004113311; Friend M., 1999, FIELD MANUAL WILDLIF, P99; GANGOSO L, 2006, THESIS U SEVILLE SPA; Gangoso L, 2006, BIODIVERS CONSERV, V15, P2231, DOI 10.1007/s10531-004-7181-4; Gangoso L, 2009, ENVIRON POLLUT, V157, P569, DOI 10.1016/j.envpol.2008.09.015; Gerhold RW, 2005, AVIAN DIS, V49, P164, DOI 10.1637/7245-072204R; Gottdenker NL, 2005, BIOL CONSERV, V126, P429, DOI 10.1016/j.biocon.2005.06.025; Grabensteiner E, 2006, VET PARASITOL, V142, P223, DOI 10.1016/j.vetpar.2006.07.011; GRANDE JM, 2006, THESIS U SEVILLE SPA; Green RE, 2004, J APPL ECOL, V41, P793, DOI 10.1111/j.0021-8901.2004.00954.x; Hale KA, 2007, ANIM CONSERV, V10, P2, DOI 10.1111/j.1469-1795.2006.00059.x; Hanssen SA, 2005, P ROY SOC B-BIOL SCI, V272, P1039, DOI 10.1098/rspb.2005.3057; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; Herrmann B, 2006, EMERG INFECT DIS, V12, P330, DOI 10.3201/eid1202.050404; Hille S, 2000, BIRD CONSERV INT, V10, P361, DOI 10.1017/S0959270900000319; Hoenerboff M, 2004, AVIAN DIS, V48, P437, DOI 10.1637/7133; Jain NC, 1993, ESSENTIALS VET HEMAT; Kiesecker JM, 2002, P NATL ACAD SCI USA, V99, P9900, DOI 10.1073/pnas.152098899; Kilpatrick AM, 2006, CONSERV BIOL, V20, P1224, DOI 10.1111/j.1523-1739.2006.00423.x; Koenig R, 2006, SCIENCE, V312, P1591, DOI 10.1126/science.312.5780.1591; Kretzmann MB, 2003, CONSERV GENET, V4, P697, DOI 10.1023/B:COGE.0000006123.67128.86; KUNZE ZM, 1992, J CLIN MICROBIOL, V30, P2366, DOI 10.1128/JCM.30.9.2366-2372.1992; Lafferty KD, 2002, CONSERV BIOL, V16, P593, DOI 10.1046/j.1523-1739.2002.00446.x; LEMUS JA, VULTURES S IN PRESS, V29; Lemus JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001444; LEVISOHN S, 1986, AVIAN PATHOL, V15, P233, DOI 10.1080/03079458608436284; Lindstrom KM, 2004, P ROY SOC B-BIOL SCI, V271, P1513, DOI 10.1098/rspb.2004.2752; Lively C. M., 1995, P421, DOI 10.1017/CBO9780511629396.017; LYLES AM, 1993, J ZOO WILDLIFE MED, V24, P315; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Martin LB, 2004, ECOLOGY, V85, P2323, DOI 10.1890/03-0365; Matson KD, 2006, P ROY SOC B-BIOL SCI, V273, P2267, DOI 10.1098/rspb.2006.3590; MOHIUDDIN SM, 2007, INFECT DIS DOMESTIC; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; *OIE, ENF AN; Pennycott TW, 2002, VET REC, V151, P563, DOI 10.1136/vr.151.19.563; Read AF, 2000, SCIENCE, V290, P1104, DOI 10.1126/science.290.5494.1104; Reavill D.R., 2000, LAB MED AVIAN EXOTIC, V1st ed., P353; Ricklefs RE, 2007, AM NAT, V169, P285, DOI 10.1086/510730; Rodolakis A, 2010, VET MICROBIOL, V140, P382, DOI 10.1016/j.vetmic.2009.03.014; Rondeau G., 2004, VULTURE NEWS, V51, P13; SACK RB, 1986, MANUAL CLIN LAB INMU; Samour, 2004, COLOUR ATLAS FALCON; Santiago-Alarcon D, 2008, J PARASITOL, V94, P584, DOI 10.1645/GE-1351.1; SAVIDGE JA, 1992, J WILDLIFE DIS, V28, P206, DOI 10.7589/0090-3558-28.2.206; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schnebel B, 2005, DEUT TIERARZTL WOCH, V112, P456; Segales J, 2004, VET MICROBIOL, V98, P151, DOI 10.1016/j.vetmic.2003.10.007; Smits JE, 2005, VET PATHOL, V42, P59, DOI 10.1354/vp.42-1-59; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x; Tell LA, 2003, AVIAN DIS, V47, P444, DOI 10.1637/0005-2086(2003)047[0444:DOAMCO]2.0.CO;2; Tella JL, 2001, NATURE, V410, P408, DOI 10.1038/35068717; Thiollay JM, 2002, BIOL CONSERV, V107, P111, DOI 10.1016/S0006-3207(02)00051-4; Thompson J. N., 2005, INTERSPEC INTERACT; Thrall MA, 2004, HEMATOLOGY AMPHIBIAN; Torina A, 2007, J ZOO WILDLIFE MED, V38, P591, DOI 10.1638/2007-0043R1.1; Travis EK, 2006, J WILDLIFE DIS, V42, P133, DOI 10.7589/0090-3558-42.1.133; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Vazquez DP, 2003, ECOL LETT, V6, P1077, DOI 10.1046/j.1461-0248.2003.00534.x; Vitone ND, 2004, EVOL ECOL RES, V6, P183; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Wikelski M, 2004, ECOL SOC, V9; Work TM, 2000, J WILDLIFE DIS, V36, P205, DOI 10.7589/0090-3558-36.2.205; Xirouchakis S, 2002, BIRD CONSERV INT, V12, P269, DOI 10.1017/S0959270902002174	99	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6333	10.1371/journal.pone.0006333	http://dx.doi.org/10.1371/journal.pone.0006333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623256	Green Published, Green Submitted, gold			2022-12-27	WOS:000268260100011
J	Barry, JG; Hardiman, MJ; Bishop, DVM				Barry, Johanna G.; Hardiman, Mervyn J.; Bishop, Dorothy V. M.			Mismatch Response to Polysyllabic Nonwords: A Neurophysiological Signature of Language Learning Capacity	PLOS ONE			English	Article							SHORT-TERM-MEMORY; EVENT-RELATED POTENTIALS; DEVELOPMENTAL LANGUAGE; FREQUENCY DISCRIMINATION; PHONOLOGICAL MEMORY; WORKING-MEMORY; IMPAIRMENT; NEGATIVITY; CHILDREN; REPETITION	Background: The ability to repeat polysyllabic nonwords such as "blonterstaping" has frequently been shown to correlate language learning ability but it is not clear why such a correlation should exist. Three alternative explanations have been offered, stated in terms of differences in: (a) perceptual ability; (b) efficiency of phonological loop functioning; (c) preexisting vocabulary knowledge and/or articulatory skills. In the present study, we used event-related potentials to assess the contributions from these three factors to explaining individual variation in nonword repetition ability. Methodology/Principal Findings: 59 adults who were subdivided according to whether they were good or poor nonword-repeaters participated. Electrophysiologically measured mismatch responses were recorded to changes in consonants as participants passively listened to a repeating four syllable CV-string. The consonant change could occur in one of four positions along the CV-string and we predicted that: (a) if nonword repetition depended purely on auditory discrimination ability, then reduced mismatch responses to all four consonant changes would be observed in the poor nonword-repeaters, (b) if it depended on encoding or decay of information in a capacity-limited phonological store, then a position specific decrease in mismatch response would be observed, (c) if neither cognitive capacity was involved, then the two groups of participants would provide equivalent mismatch responses. Consistent with our second hypothesis, a position specific difference located on the third syllable was observed in the late discriminative negativity (LDN) window (230-630 ms post-syllable onset). Conclusions/Significance: Our data thus confirm that people who are poorer at nonword repetition are less efficient in early processing of polysyllabic speech materials, but this impairment is not attributable to deficits in low level auditory discrimination. We conclude by discussing the significance of the observed relationship between LDN amplitude and nonword repetition ability and describe how this relatively little understood ERP component provides a biological window onto processes required for successful language learning.			Barry, JG (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	johanna@ihr.mrc.ac.uk		Lauwereyns, Jan/0000-0003-0551-2550; Barry, Johanna/0000-0002-3733-8721; Bishop, Dorothy/0000-0002-2448-4033	Medical Research Council [MC_U135097130] Funding Source: Medline; Wellcome Trust [082498, 053335/Z/98/A] Funding Source: Medline; MRC [MC_U135097130] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Archibald LMD, 2007, PSYCHON B REV, V14, P919, DOI 10.3758/BF03194122; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Barry JG, 2007, GENES BRAIN BEHAV, V6, P66, DOI 10.1111/j.1601-183X.2006.00232.x; Barry JG, 2008, BRAIN LANG, V104, P75, DOI 10.1016/j.bandl.2007.02.006; Bishop DVM, 2007, PSYCHOL BULL, V133, P651, DOI 10.1037/0033-2909.133.4.651; Bishop D. V. M, 1989, TEST RECEPTION GRAMM, V2; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Bishop DVM, 1999, J SPEECH LANG HEAR R, V42, P155, DOI 10.1044/jslhr.4201.155; Bishop DVM, 2001, PHILOS T R SOC B, V356, P369, DOI 10.1098/rstb.2000.0770; BISHOP DVM, 1997, UNCOMMON UNDERSTANDI; Burgess N, 1999, PSYCHOL REV, V106, P551, DOI 10.1037/0033-295X.106.3.551; Ceponiene R, 1998, EVOKED POTENTIAL, V108, P345, DOI 10.1016/S0168-5597(97)00081-6; Ceponiene R, 2004, PSYCHOPHYSIOLOGY, V41, P130, DOI 10.1111/j.1469-8986.2003.00138.x; Ceponiene R, 2002, INT J PSYCHOPHYSIOL, V43, P199, DOI 10.1016/S0167-8760(01)00172-6; Ceponiene R, 1999, DEV PSYCHOL, V35, P709, DOI 10.1037/0012-1649.35.3.709; Cheour M, 2001, AUDIOL NEURO-OTOL, V6, P2, DOI 10.1159/000046804; Chiat S, 2001, LANG COGNITIVE PROC, V16, P113, DOI 10.1080/01690960042000012; COWAN N, 1988, PSYCHOL BULL, V104, P163, DOI 10.1037/0033-2909.104.2.163; France SJ, 2002, PERCEPT PSYCHOPHYS, V64, P169, DOI 10.3758/BF03195783; GATHERCOLE SE, 1994, J MEM LANG, V33, P672, DOI 10.1006/jmla.1994.1032; GATHERCOLE SE, 1992, DEV PSYCHOL, V28, P887, DOI 10.1037//0012-1649.28.5.887; Gathercole SE, 1997, DEV PSYCHOL, V33, P966, DOI 10.1037/0012-1649.33.6.966; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Hartley T, 1996, J MEM LANG, V35, P1, DOI 10.1006/jmla.1996.0001; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hill PR, 2004, NEUROREPORT, V15, P2195, DOI 10.1097/00001756-200410050-00010; Horvath J, 2001, COGNITIVE BRAIN RES, V12, P131, DOI 10.1016/S0926-6410(01)00038-6; KAMHI AG, 1986, J SPEECH HEAR DISORD, V51, P337, DOI 10.1044/jshd.5104.337; KORKMAN M, 1994, BRAIN LANG, V47, P96, DOI 10.1006/brln.1994.1044; Korpilahti P, 2001, BRAIN LANG, V76, P332, DOI 10.1006/brln.2000.2426; Kujala T, 2006, EUR J NEUROSCI, V24, P2420, DOI 10.1111/j.1460-9568.2006.05100.x; LANG AH, 1990, PSYCHOPHYSIOLOGICAL, V1, P294; Majerus S, 2004, J MEM LANG, V51, P297, DOI 10.1016/j.jml.2004.05.002; Marcus G, 2006, NAT NEUROSCI, V9, P1226, DOI 10.1038/nn1766; McArthur G M, 2001, Dyslexia, V7, P150; McArthur GM, 2004, J SPEECH LANG HEAR R, V47, P527, DOI 10.1044/1092-4388(2004/041); Naatanen R, 1997, AUDIOL NEURO-OTOL, V2, P341; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SERVICE E, 1992, Q J EXP PSYCHOL-A, V45, P21, DOI 10.1080/14640749208401314; Service E, 2007, MEM COGNITION, V35, P1122, DOI 10.3758/BF03193483; Speciale G, 2004, APPL PSYCHOLINGUIST, V25, P293, DOI 10.1017/S0142716404001146; Stokes SF, 2006, J SPEECH LANG HEAR R, V49, P219, DOI 10.1044/1092-4388(2006/019); Tager-Flusberg H, 2003, PHILOS T R SOC B, V358, P303, DOI 10.1098/rstb.2002.1198; TALLAL P, 1973, NEUROPSYCHOLOGIA, V11, P389, DOI 10.1016/0028-3932(73)90025-0; Tallal P, 2004, NAT REV NEUROSCI, V5, P721, DOI 10.1038/nrn1499; TALLAL P, 1976, J SPEECH HEAR RES, V19, P561, DOI 10.1044/jshr.1903.561; Torgesen J.K., 1999, TOWRE TEST WORD READ; WANG PP, 1994, J CLIN EXP NEUROPSYC, V16, P317, DOI 10.1080/01688639408402641; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Weenink D., 2003, PRAAT DOING PHONETIC; Whitehouse AJO, 2008, J COMMUN DISORD, V41, P319, DOI 10.1016/j.jcomdis.2008.01.002; Zachau S, 2005, NEUROREPORT, V16, P2015, DOI 10.1097/00001756-200512190-00009	57	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6270	10.1371/journal.pone.0006270	http://dx.doi.org/10.1371/journal.pone.0006270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	472GV	19609436	Green Published, gold			2022-12-27	WOS:000268119500005
J	Hu, Z; Pan, XF; Wu, FQ; Ma, LY; Liu, DP; Liu, Y; Feng, TT; Meng, FY; Liu, XL; Jiang, QL; Chen, XQ; Liu, JL; Liu, P; Chen, Z; Chen, SJ; Zhou, GB				Hu, Zheng; Pan, Xiao-Fen; Wu, Fu-Qun; Ma, Li-Yuan; Liu, Da-Peng; Liu, Ying; Feng, Ting-Ting; Meng, Fan-Yi; Liu, Xiao-Li; Jiang, Qian-Li; Chen, Xiao-Qin; Liu, Jing-Lei; Liu, Ping; Chen, Zhu; Chen, Sai-Juan; Zhou, Guang-Biao			Synergy between Proteasome Inhibitors and Imatinib Mesylate in Chronic Myeloid Leukemia	PLOS ONE			English	Article								Background: Resistance developed by leukemic cells, unsatisfactory efficacy on patients with chronic myeloid leukemia (CML) at accelerated and blastic phases, and potential cardiotoxity, have been limitations for imatinib mesylate (IM) in treating CML. Whether low dose IM in combination with agents of distinct but related mechanisms could be one of the strategies to overcome these concerns warrants careful investigation. Methods and Findings: We tested the therapeutic efficacies as well as adverse effects of low dose IM in combination with proteasome inhibitor, Bortezomib (BOR) or proteasome inhibitor I (PSI), in two CML murine models, and investigated possible mechanisms of action on CML cells. Our results demonstrated that low dose IM in combination with BOR exerted satisfactory efficacy in prolongation of life span and inhibition of tumor growth in mice, and did not cause cardiotoxicity or body weight loss. Consistently, BOR and PSI enhanced IM-induced inhibition of long-term clonogenic activity and short-term cell growth of CML stem/progenitor cells, and potentiated IM-caused inhibition of proliferation and induction of apoptosis of BCR-ABL+ cells. IM/BOR and IM/PSI inhibited Bcl-2, increased cytoplasmic cytochrome C, and activated caspases. While exerting suppressive effects on BCR-ABL, E2F1, and beta-catenin, IM/BOR and IM/PSI inhibited proteasomal degradation of protein phosphatase 2A (PP2A), leading to a re-activation of this important negative regulator of BCR-ABL. In addition, both combination therapties inhibited Bruton's tyrosine kinase via suppression of NFkB. Conclusion: These data suggest that combined use of tyrosine kinase inhibitor and proteasome inhibitor might be helpful for optimizing CML treatment.			Hu, Z (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Lab Mol Target Based Therapy Canc, Guangzhou, Guangdong, Peoples R China.	sjchen@stn.sh.cn; gbzhou@ioz.ac.cn	Liu, Xiaoli/HGE-7614-2022; Zhou, Guangbiao/J-6575-2017; Zhou, Guang-Biao/ABG-5795-2021	Zhou, Guangbiao/0000-0002-6327-2316; Zhou, Guang-Biao/0000-0001-6778-7133				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Buchdunger E, 1996, CANCER RES, V56, P100; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Coluccia AML, 2007, EMBO J, V26, P1456, DOI 10.1038/sj.emboj.7601485; Dai Y, 2004, BLOOD, V104, P509, DOI 10.1182/blood-2003-12-4121; Deming PB, 2004, MOL CELL BIOL, V24, P10289, DOI 10.1128/MCB.24.23.10289-10299.2004; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; Di Bacco AMA, 2002, BRIT J HAEMATOL, V117, P588, DOI 10.1046/j.1365-2141.2002.03468.x; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dou QP, 1999, J PHARMACOL EXP THER, V289, P781; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Gatto S, 2003, HAEMATOLOGICA, V88, P853; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hacihanefioglu A, 2008, INT J HEMATOL, V88, P219, DOI 10.1007/s12185-008-0139-7; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HEANEY N, 2007, ASH ANN M, V110, P2943; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kraus M, 2007, LEUKEMIA, V21, P84, DOI 10.1038/sj.leu.2404414; LaMontagne KR, 1998, P NATL ACAD SCI USA, V95, P14094, DOI 10.1073/pnas.95.24.14094; Lassila M, 2004, ARTERIOSCL THROM VAS, V24, P935, DOI 10.1161/01.ATV.0000124105.39900.db; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; LeBlanc R, 2002, CANCER RES, V62, P4996; Magill L, 2004, HAEMATOLOGICA, V89, P1428; MARANTEMENDES GP, 1998, BLOOD, V91, P1700; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Orciuolo E, 2007, BRIT J HAEMATOL, V138, P396, DOI 10.1111/j.1365-2141.2007.06659.x; Park YH, 2006, CANCER LETT, V243, P16, DOI 10.1016/j.canlet.2005.11.014; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Saad SY, 2006, J PHARM PHARMACOL, V58, P567, DOI 10.1211/jpp.58.4.0017; SANCHEZGARCIA I, 1995, P NATL ACAD SCI USA, V92, P5287, DOI 10.1073/pnas.92.12.5287; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Schellings MWM, 2006, HYPERTENSION, V47, P467, DOI 10.1161/01.HYP.0000202487.68969.f7; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Servida F, 2005, LEUKEMIA, V19, P2324, DOI 10.1038/sj.leu.2403987; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Soligo D, 2001, BRIT J HAEMATOL, V113, P126, DOI 10.1046/j.1365-2141.2001.02683.x; STEWART MJ, 1995, LEUKEMIA, V9, P1499; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tong Y, 2004, BLOOD, V104, P4219, DOI 10.1182/blood-2004-04-1433; Topaly J, 2001, LEUKEMIA, V15, P342, DOI 10.1038/sj.leu.2402041; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Villuendas R, 2006, LEUKEMIA, V20, P1047, DOI 10.1038/sj.leu.2404197; Voortman J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-129; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yu CR, 2003, BLOOD, V102, P3765, DOI 10.1182/blood-2003-03-0737; Yu L, 2008, BLOOD, V111, P4617, DOI 10.1182/blood-2007-10-121137; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhou GB, 2007, BLOOD, V109, P3441, DOI 10.1182/blood-2006-06-032250	71	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6257	10.1371/journal.pone.0006257	http://dx.doi.org/10.1371/journal.pone.0006257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606213	gold, Green Submitted, Green Published			2022-12-27	WOS:000268036000013
J	Pelletier, J; Leal, WS				Pelletier, Julien; Leal, Walter S.			Genome Analysis and Expression Patterns of Odorant-Binding Proteins from the Southern House Mosquito Culex pipiens quinquefasciatus	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; MALARIA VECTOR MOSQUITO; PHEROMONE-BINDING; DROSOPHILA-MELANOGASTER; ANOPHELES-GAMBIAE; AEDES-AEGYPTI; IDENTIFICATION; FAMILY; GENES; RECEPTOR	Olfactory-based behaviors in mosquitoes are mediated by odorant-binding proteins (OBPs). They form a multigenic family involved in the peripheral events in insect olfaction, specifically the transport of odorants to membrane-bound odorant receptors. OBPs contribute to the remarkable sensitivity of the insect's olfactory system and may be involved in the selective transport of odorants. We have employed a combination of bioinformatics and molecular approaches to identify and characterize members of the "classic'' OBP family in the Southern House mosquito Culex pipiens quinquefasciatus (=Cx. quinquefasciatus), a vector of pathogens causing several human diseases. By taking advantage of the recently released genome sequences, we have identified fifty-three putative Cx. quinquefasciatus OBP genes by Blast searches. As a first step towards their molecular characterization, expression patterns by RT-PCR revealed thirteen genes that were detected exclusively and abundantly in chemosensory tissues. No clear differences were observed in the transcripts levels of olfactory-specific OBPs between antennae of both sexes using semi-quantitative RT-PCR. Phylogenetic and comparative analysis revealed orthologous of Cx. quinquefasciatus OBPs in Anopheles gambiae and Aedes aegypti. The identification of fifty-three putative OBP genes in Cx. quinquefasciatus highlights the diversity of this family. Tissue-specificity study suggests the existence of different functional classes within the mosquito OBP family. Most genes were detected in chemosensory as well as non chemosensory tissues indicating that they might be encapsulins, but not necessarily olfactory proteins. On the other hand, thirteen "true'' OBP genes were detected exclusively in olfactory tissues and might be involved specifically in the detection of "key'' semiochemicals. Interestingly, in Cx. quinquefasciatus olfactory-specific OBPs belong exclusively to four distinct phylogenetic groups which are particularly well conserved among three mosquito species.			Pelletier, J (corresponding author), Univ Calif Davis, Dept Entomol, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI058267] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; Galindo K, 2001, GENETICS, V159, P1059; Graham LA, 2002, GENE, V292, P43, DOI 10.1016/S0378-1119(02)00672-8; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; HekmatScafe DS, 1997, J NEUROSCI, V17, P1616; Hill SR, 2009, CHEM SENSES, V34, P231, DOI 10.1093/chemse/bjn080; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Iatrou K, 2008, INSECT BIOCHEM MOLEC, V38, P268, DOI 10.1016/j.ibmb.2007.11.008; Ishida Y, 2004, NATURWISSENSCHAFTEN, V91, P426, DOI 10.1007/s00114-004-0551-7; Ishida Y, 2002, J CHEM ECOL, V28, P867, DOI 10.1023/A:1015253214273; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; KEIL TA, 1984, TISSUE CELL, V16, P705, DOI 10.1016/0040-8166(84)90004-1; Kwon HW, 2006, P NATL ACAD SCI USA, V103, P13526, DOI 10.1073/pnas.0601107103; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LAURENCE BR, 1982, J CHEM SOC CHEM COMM, P59, DOI 10.1039/c39820000059; Lautenschlager C, 2005, BIOCHEM BIOPH RES CO, V335, P1044, DOI 10.1016/j.bbrc.2005.07.176; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Li ZX, 2005, ARCH INSECT BIOCHEM, V58, P175, DOI 10.1002/arch.20047; MCIVER SB, 1982, J MED ENTOMOL, V19, P489, DOI 10.1093/jmedent/19.5.489; Melo ACA, 2004, CHEM SENSES, V29, P403, DOI 10.1093/chemse/bjh041; Park SK, 2000, CELL TISSUE RES, V300, P181, DOI 10.1007/s004410050059; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P543, DOI 10.1016/j.ibmb.2004.02.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sengul MS, 2008, INSECT MOL BIOL, V17, P631, DOI 10.1111/j.1365-2583.2008.00837.x; Shanbhag SR, 2001, MICROSC RES TECHNIQ, V55, P297, DOI 10.1002/jemt.1179; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vogt RG, 2002, J CHEM ECOL, V28, P2371, DOI 10.1023/A:1021009311977; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xia YF, 2006, INSECT BIOCHEM MOLEC, V36, P169, DOI 10.1016/j.ibmb.2005.12.003; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu W, 2008, BIOCHEM BIOPH RES CO, V372, P559, DOI 10.1016/j.bbrc.2008.05.087; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007	48	70	78	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6237	10.1371/journal.pone.0006237	http://dx.doi.org/10.1371/journal.pone.0006237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606229	Green Published, gold, Green Submitted			2022-12-27	WOS:000268036000001
J	Kiyota, T; Yamamoto, M; Xiong, HG; Lambert, MP; Klein, WL; Gendelman, HE; Ransohoff, RM; Ikezu, T				Kiyota, Tomomi; Yamamoto, Masaru; Xiong, Huangui; Lambert, Mary P.; Klein, William L.; Gendelman, Howard E.; Ransohoff, Richard M.; Ikezu, Tsuneya			CCL2 Accelerates Microglia-Mediated A beta Oligomer Formation and Progression of Neurocognitive Dysfunction	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; TRANSGENIC MICE; BONE-MARROW; SYNAPTIC PLASTICITY; CLEARANCE; DISEASE; MODEL; OVEREXPRESSION; TRANSMISSION	Background: The linkages between neuroinflammation and Alzheimer's disease (AD) pathogenesis are well established. What is not, however, is how specific immune pathways and proteins affect the disease. To this end, we previously demonstrated that transgenic over-expression of CCL2 enhanced microgliosis and induced diffuse amyloid plaque deposition in Tg2576 mice. This rodent model of AD expresses a Swedish beta-amyloid (A beta) precursor protein mutant. Methodology/Principal Findings: We now report that CCL2 transgene expression accelerates deficits in spatial and working memory and hippocampal synaptic transmission in beta-amyloid precursor protein (APP) mice as early as 2-3 months of age. This is followed by increased numbers of microglia that are seen surrounding Ab oligomers. CCL2 does not suppress Ab degradation. Rather, CCL2 and tumor necrosis factor-alpha directly facilitated A beta uptake, intracellular Ab oligomerization, and protein secretion. Conclusions/Significance: We posit that CCL2 facilitates A beta oligomer formation in microglia and propose that such events accelerate memory dysfunction by affecting A beta seeding in the brain.			Kiyota, T (corresponding author), Univ Nebraska Med Ctr, Ctr Neurovirol & Neurodegenerat Disorders, Omaha, NE USA.	tikezu@unmc.edu	Gendelman, Howard E/G-8242-2012	Ikezu, Tsuneya/0000-0002-3979-8596	NIA NIH HHS [R21 AG032600, R21 AG032600-02, R21 AG032600-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS32151, R37 NS036126, P01 NS043985, R37 NS36126, R01 NS032151] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032151, R37NS036126, P01NS043985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032600] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Galimberti D, 2006, ARCH NEUROL-CHICAGO, V63, P538, DOI 10.1001/archneur.63.4.538; GALIMBERTI D, 2005, NEUROBIOL AGING; Good TA, 1996, P NATL ACAD SCI USA, V93, P15130, DOI 10.1073/pnas.93.26.15130; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Huang DR, 2002, J NEUROSCI, V22, P10633; Ikezu T, 2003, J NEUROCHEM, V85, P925, DOI 10.1046/j.1471-4159.2003.01739.x; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; KARPUS WJ, 1995, J IMMUNOL, V155, P5003; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Poncer JC, 2001, NAT NEUROSCI, V4, P989, DOI 10.1038/nn719; Sautter NB, 2006, JARO-J ASSOC RES OTO, V7, P361, DOI 10.1007/s10162-006-0051-x; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; WISNIEWSKI HM, 1994, NEUROPATH APPL NEURO, V20, P192; Xiong HG, 2004, NEUROBIOL AGING, V25, P905, DOI 10.1016/j.neurobiolaging.2003.09.007; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4; Yamamoto M, 2008, J IMMUNOL, V181, P3877, DOI 10.4049/jimmunol.181.6.3877; Yamamoto M, 2007, J NEUROIMMUNE PHARM, V2, P213, DOI 10.1007/s11481-006-9049-8; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Zink WE, 2002, J NEUROSCI, V22, P2096, DOI 10.1523/JNEUROSCI.22-06-02096.2002	43	80	86	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6197	10.1371/journal.pone.0006197	http://dx.doi.org/10.1371/journal.pone.0006197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593388	Green Submitted, Green Published, gold			2022-12-27	WOS:000268035300010
J	Nolte, IM; Wallace, C; Newhouse, SJ; Waggott, D; Fu, JY; Soranzo, N; Gwilliam, R; Deloukas, P; Savelieva, I; Zheng, DL; Dalageorgou, C; Farrall, M; Samani, NJ; Connell, J; Brown, M; Dominiczak, A; Lathrop, M; Zeggini, E; Wain, LV; Newton-Cheh, C; Eijgelsheim, M; Rice, K; de Bakker, PIW; Pfeufer, A; Sanna, S; Arking, DE; Asselbergs, FW; Spector, TD; Carter, ND; Jeffery, S; Tobin, M; Caulfield, M; Snieder, H; Paterson, AD; Munroe, PB; Jamshidi, Y				Nolte, Ilja M.; Wallace, Chris; Newhouse, Stephen J.; Waggott, Daryl; Fu, Jingyuan; Soranzo, Nicole; Gwilliam, Rhian; Deloukas, Panos; Savelieva, Irina; Zheng, Dongling; Dalageorgou, Chrysoula; Farrall, Martin; Samani, Nilesh J.; Connell, John; Brown, Morris; Dominiczak, Anna; Lathrop, Mark; Zeggini, Eleftheria; Wain, Louise V.; Newton-Cheh, Christopher; Eijgelsheim, Mark; Rice, Kenneth; de Bakker, Paul I. W.; Pfeufer, Arne; Sanna, Serena; Arking, Dan E.; Asselbergs, Folkert W.; Spector, Tim D.; Carter, Nicholas D.; Jeffery, Steve; Tobin, Martin; Caulfield, Mark; Snieder, Harold; Paterson, Andrew D.; Munroe, Patricia B.; Jamshidi, Yalda		Wellcome Trust Case Control Consor; DCCT EDIC Res Grp; QTGEN Consortium; QTSCD Consortium	Common Genetic Variation Near the Phospholamban Gene Is Associated with Cardiac Repolarisation: Meta-Analysis of Three Genome-Wide Association Studies	PLOS ONE			English	Article								To identify loci affecting the electrocardiographic QT interval, a measure of cardiac repolarisation associated with risk of ventricular arrhythmias and sudden cardiac death, we conducted a meta-analysis of three genome-wide association studies (GWAS) including 3,558 subjects from the TwinsUK and BRIGHT cohorts in the UK and the DCCT/EDIC cohort from North America. Five loci were significantly associated with QT interval at P < 1 x 10(-6). To validate these findings we performed an in silico comparison with data from two QT consortia: QTSCD (n = 15,842) and QTGEN (n = 13,685). Analysis confirmed the association between common variants near NOS1AP (P = 1.4 x 10-(83)) and the phospholamban (PLN) gene (P = 1.9 x 10(-29)). The most associated SNP near NOS1AP (rs12143842) explains 0.82% variance; the SNP near PLN (rs11153730) explains 0.74% variance of QT interval duration. We found no evidence for interaction between these two SNPs (P = 0.99). PLN is a key regulator of cardiac diastolic function and is involved in regulating intracellular calcium cycling, it has only recently been identified as a susceptibility locus for QT interval. These data offer further mechanistic insights into genetic influence on the QT interval which may predispose to life threatening arrhythmias and sudden cardiac death.			Nolte, IM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands.	y.jamshidi@sgul.ac.uk	Fu, Jingyuan/E-8980-2012; Paterson, Andrew/AAQ-7511-2020; Dominiczak, Anna F/D-2262-2009; Deloukas, Panos/B-2922-2013; Newhouse, Stephen J/C-9330-2011; Fu, JY/GRR-6179-2022; Fu, Jingyuan/ABE-6868-2020; Asselbergs, Folkert W./ABD-6752-2021; Pfeufer, Arne/B-6634-2013; de Bakker, Paul IW/B-8730-2009; Dominiczak, Anna F/P-9390-2017; Jamshidi, Yalda/AAL-1377-2020; Paterson, Andrew D/A-4088-2011; sanna, serena/H-3009-2019	Paterson, Andrew/0000-0002-9169-118X; Deloukas, Panos/0000-0001-9251-070X; Newhouse, Stephen J/0000-0002-1843-9842; Fu, Jingyuan/0000-0001-5578-1236; Asselbergs, Folkert W./0000-0002-1692-8669; de Bakker, Paul IW/0000-0001-7735-7858; Dominiczak, Anna F/0000-0003-4913-3608; Jamshidi, Yalda/0000-0003-0151-6482; Paterson, Andrew D/0000-0002-9169-118X; sanna, serena/0000-0002-3768-1749; s, hema/0000-0002-3440-9475; Soranzo, Nicole/0000-0003-1095-3852; Wallace, Chris/0000-0001-9755-1703; Munroe, Patricia/0000-0002-4176-2947; Waggott, Daryl/0000-0001-8016-9620; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Wain, Louise/0000-0003-4951-1867; Tobin, Martin/0000-0002-3596-7874; Caulfield, Mark/0000-0001-9295-3594; Zeggini, Eleftheria/0000-0003-4238-659X	Biotechnology and Biological Sciences Research Council [G20234] Funding Source: Medline; British Heart Foundation [FS/05/061/19501, SP/02/001, 06/094, PG02/128] Funding Source: Medline; Medical Research Council [G0400874, G9521010, G9521010D, G0501942] Funding Source: Medline; NCRR NIH HHS [UL1 RR025005, UL1RR025005] Funding Source: Medline; NHGRI NIH HHS [U01HG004402, U01 HG004402] Funding Source: Medline; NHLBI NIH HHS [R01HL59367, N01HC55018, N01-HC-55021, N01-HC-85086, N01HC55015, N01HC85086, N01-HC-55019, N01-HC-75150, N01 HC045133, HL86694, N01 HC035129, K23 HL080025, N01HC55020, R01HL086694, N01HC55222, N01HC85079, R01HL087641, N01HC55022, R01 HL087652, R01 HL086694, N01-HC-55016, N01 HC015103, R01 HL059367, HL054512, N01-HC-55022, K23-HL-080025, U01 HL080295, N01 HC-55222, N01-HC-55020, N01-HC-25195, N02-HL-6-4278, N01HC55019, N01HC75150, N01-HC-55018, N01HC55021, U01 HL054512, N01HC25195, N01-HC-85079, N01HC55016, R01 HL087641, U10 HL054512, N01-HC-55015] Funding Source: Medline; NIA NIH HHS [N01-AG-1-2109] Funding Source: Medline; NIDDK NIH HHS [R01-DK-077510, N01-DK-6-2204, R01 DK077510] Funding Source: Medline; PHS HHS [HHSN268200625226C, 263-MA-410953] Funding Source: Medline; Wellcome Trust [WT088885/Z/09/Z] Funding Source: Medline; Department of Health Funding Source: Medline; MRC [G0501942, G9521010, G0400874] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC075150, N01HC055015, N01HC025195, N01HC085086, N01HC055019, N01HC055222, N01HC055018, N01HC055022, N01HC055016, N01HC045133, N01HC055020, N01HC055021, N01HC015103, N01HC035129, N01HC085079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055018, R01HL087641, U01HL054512, R42HL055018, K23HL080025, R41HL055019, U10HL054512, R01HL059367, R01HL087652, R01HL086694, R01HL064278, U01HL080295] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK062204, R01DK077510] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome Trust); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aarnoudse AJLHJ, 2007, CIRCULATION, V116, P10, DOI 10.1161/CIRCULATIONAHA.106.676783; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Becker ML, 2008, PHARMACOGENET GENOM, V18, P591, DOI 10.1097/FPC.0b013e328300e8c5; Becker ML, 2009, BRIT J CLIN PHARMACO, V67, P61, DOI 10.1111/j.1365-2125.2008.03325.x; Bezzina CR, 2003, CARDIOVASC RES, V59, P27, DOI 10.1016/S0008-6363(03)00342-0; Busjahn A, 1999, CIRCULATION, V99, P3161, DOI 10.1161/01.CIR.99.24.3161; Carter N, 2000, J HUM HYPERTENS, V14, P389, DOI 10.1038/sj.jhh.1001026; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Dalageorgou C, 2008, J CARDIOVASC ELECTR, V19, P386, DOI 10.1111/j.1540-8167.2007.01030.x; Dash R, 2001, J MOL CELL CARDIOL, V33, P1345, DOI 10.1006/jmcc.2001.1394; *DCCT, DIABETES, V35, P530; Dekker JM, 2004, J AM COLL CARDIOL, V43, P565, DOI 10.1016/j.jacc.2003.09.040; del Monte F, 2004, P NATL ACAD SCI USA, V101, P5622, DOI 10.1073/pnas.0305778101; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DeWitt MM, 2006, J AM COLL CARDIOL, V48, P1396, DOI 10.1016/j.jacc.2006.07.016; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; *EDIC, DIABETES CARE, V22, P99; Eijgelsheim M, 2009, HUM MOL GENET, V18, P347, DOI 10.1093/hmg/ddn341; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Gouas L, 2007, EUR J HUM GENET, V15, P974, DOI 10.1038/sj.ejhg.5201866; Gouas L, 2005, EUR J HUM GENET, V13, P1213, DOI 10.1038/sj.ejhg.5201489; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Huber P. J, 1967, P 5 BERK S MATH STAT, V1, P223; Lehtinen AB, 2008, DIABETES, V57, P1108, DOI 10.2337/db07-1365; Li JD, 2006, CIRC RES, V99, P1092, DOI 10.1161/01.RES.0000249369.71709.5c; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Loyer X, 2008, CIRCULATION, V117, P3187, DOI 10.1161/CIRCULATIONAHA.107.741702; Luo S, 2004, J ELECTROCARDIOL, V37, P81, DOI 10.1016/j.jelectrocard.2004.08.030; Luo WS, 1996, CIRC RES, V78, P839, DOI 10.1161/01.RES.78.5.839; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MARJAMAA A, 2008, J INTERN MED; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Minamisawa S, 2003, BIOCHEM BIOPH RES CO, V304, P1, DOI 10.1016/S0006-291X(03)00526-6; Newton-Cheh C, 2007, CIRCULATION, V116, P1128, DOI 10.1161/CIRCULATIONAHA.107.710780; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Patel ND, 2006, EUR J INTERN MED, V17, P235, DOI 10.1016/j.ejim.2005.12.001; Paterson AD, 2007, DIABETES CARE, V30, P2107, DOI 10.2337/dc06-1441; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pfeufer A, 2005, CIRC RES, V96, P693, DOI 10.1161/01.RES.0000161077.53751.e6; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pietila E, 2002, J AM COLL CARDIOL, V40, P511, DOI 10.1016/S0735-1097(02)01979-4; Post W, 2007, HUM HERED, V64, P214, DOI 10.1159/000103630; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raitakari OT, 2009, ANN MED, V41, P144, DOI 10.1080/07853890802392529; RAUTAHARJU PM, 1992, CAN J CARDIOL, V8, P690; Reardon M, 1996, CLIN CARDIOL, V19, P949, DOI 10.1002/clc.4960191209; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Tobin MD, 2008, INT J EPIDEMIOL, V37, P1132, DOI 10.1093/ije/dyn091; Van Spaendonck-Zwarts KY, 2008, PACE, V31, pS46, DOI 10.1111/j.1540-8159.2008.00956.x; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Wu YJ, 1999, AM J PHYSIOL-HEART C, V276, pH2168, DOI 10.1152/ajpheart.1999.276.6.H2168; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Xu YF, 2005, J PHYSIOL-LONDON, V562, P745, DOI 10.1113/jphysiol.2004.076216; YANG H, 1994, J ELECTROCARDIOL, V27, P72, DOI 10.1016/S0022-0736(94)80052-9; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798; NATURE, V447, P661	66	46	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6138	10.1371/journal.pone.0006138	http://dx.doi.org/10.1371/journal.pone.0006138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587794	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000268035100001
J	Chica, C; Diella, F; Gibson, TJ				Chica, Claudia; Diella, Francesca; Gibson, Toby J.			Evidence for the Concerted Evolution between Short Linear Protein Motifs and Their Flanking Regions	PLOS ONE			English	Article								Background: Linear motifs are short modules of protein sequences that play a crucial role in mediating and regulating many protein - protein interactions. The function of linear motifs strongly depends on the context, e. g. functional instances mainly occur inside flexible regions that are accessible for interaction. Sometimes linear motifs appear as isolated islands of conservation in multiple sequence alignments. However, they also occur in larger blocks of sequence conservation, suggesting an active role for the neighbouring amino acids. Results: The evolution of regions flanking 116 functional linear motif instances was studied. The conservation of the amino acid sequence and order/disorder tendency of those regions was related to presence/absence of the instance. For the majority of the analysed instances, the pairs of sequences conserving the linear motif were also observed to maintain a similar local structural tendency and/or to have higher local sequence conservation when compared to pairs of sequences where one is missing the linear motif. Furthermore, those instances have a higher chance to co-evolve with the neighbouring residues in comparison to the distant ones. Those findings are supported by examples where the regulation of the linear motif - mediated interaction has been shown to depend on the modifications ( e. g. phosphorylation) at neighbouring positions or is thought to benefit from the binding versatility of disordered regions. Conclusion: The results suggest that flanking regions are relevant for linear motif - mediated interactions, both at the structural and sequence level. More interestingly, they indicate that the prediction of linear motif instances can be enriched with contextual information by performing a sequence analysis similar to the one presented here. This can facilitate the understanding of the role of these predicted instances in determining the protein function inside the broader context of the cellular network where they arise.			Chica, C (corresponding author), EMBL Heidelberg, Struct & Computat Biol Unit, Heidelberg, Germany.	chica@embl.de		Gibson, Toby James/0000-0003-0657-5166; Chica, Claudia/0000-0002-3758-640X				Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Chica C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-229; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Daughdrill GW, 2007, J MOL EVOL, V65, P277, DOI 10.1007/s00239-007-9011-2; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; Davey NE, 2009, BIOINFORMATICS, V25, P443, DOI 10.1093/bioinformatics/btn664; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Dinkel H, 2007, BIOINFORMATICS, V23, P3297, DOI 10.1093/bioinformatics/btm524; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; GIBSON T, 2009, TRENDS BIOC IN PRESS; Gutman R, 2005, NUCLEIC ACIDS RES, V33, pW255, DOI 10.1093/nar/gki496; Hegyi H, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-65; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Perrodou E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-213; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Takei K, 2005, J BIOCHEM, V137, P243, DOI 10.1093/jb/mvi052; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	43	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6052	10.1371/journal.pone.0006052	http://dx.doi.org/10.1371/journal.pone.0006052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584925	gold, Green Published, Green Submitted			2022-12-27	WOS:000267806500001
J	Fricke, S; Ackermann, M; Stolzing, A; Schimmelpfennig, C; Hilger, N; Jahns, J; Hildebrandt, G; Emmrich, F; Ruschpler, P; Posel, C; Kamprad, M; Sack, U				Fricke, Stephan; Ackermann, Manuela; Stolzing, Alexandra; Schimmelpfennig, Christoph; Hilger, Nadja; Jahns, Jutta; Hildebrandt, Guido; Emmrich, Frank; Ruschpler, Peter; Poesel, Claudia; Kamprad, Manja; Sack, Ulrich			Allogeneic Non-Adherent Bone Marrow Cells Facilitate Hematopoietic Recovery but Do Not Lead to Allogeneic Engraftment	PLOS ONE			English	Article								Background: Non adherent bone marrow derived cells (NA-BMCs) have recently been described to give rise to multiple mesenchymal phenotypes and have an impact in tissue regeneration. Therefore, the effects of murine bone marrow derived NA-BMCs were investigated with regard to engraftment capacities in allogeneic and syngeneic stem cell transplantation using transgenic, human CD4(+), murine CD4(-/-), HLA-DR3(+) mice. Methodology/Principal Findings: Bone marrow cells were harvested from C57Bl/6 and Balb/c wild-type mice, expanded to NA-BMCs for 4 days and characterized by flow cytometry before transplantation in lethally irradiated recipient mice. Chimerism was detected using flow cytometry for MHC-I (H-2D[b], H-2K[d]), mu/huCD4, and huHLA-DR3). Culturing of bone marrow cells in a dexamethasone containing DMEM medium induced expansion of non adherent cells expressing CD11b, CD45, and CD90. Analysis of the CD45(+) showed depletion of CD4(+), CD8(+), CD19(+), and CD117(+) cells. Expanded syngeneic and allogeneic NA-BMCs were transplanted into triple transgenic mice. Syngeneic NA-BMCs protected 83% of mice from death (n = 8, CD4(+) donor chimerism of 5.8 +/- 62.4% [day 40], P < 001). Allogeneic NA-BMCs preserved 62.5% (n = 8) of mice from death without detectable hematopoietic donor chimerism. Transplantation of syngeneic bone marrow cells preserved 100%, transplantation of allogeneic bone marrow cells 33% of mice from death. Conclusions/Significance: NA-BMCs triggered endogenous hematopoiesis and induced faster recovery compared to bone marrow controls. These findings may be of relevance in the refinement of strategies in the treatment of hematological malignancies.			Fricke, S (corresponding author), Fraunhofer Inst Cell Therapy & Immunol IZI, Leipzig, Germany.	stephan.fricke@izi.fraunhofer.de	Stolzing, Alexandra/O-7815-2016; Fricke, Stephan/AAF-1629-2021; Sack, Ulrich/J-6301-2015; Stolzing, Alexandra/S-4208-2019	Stolzing, Alexandra/0000-0002-2975-5736; Sack, Ulrich/0000-0002-7813-0492; Stolzing, Alexandra/0000-0002-2975-5736				Aschan J, 2006, BRIT MED BULL, V77-78, P23, DOI 10.1093/bmb/ldl005; Bacigalupo Andrea, 2002, Haematologica, V87, P4; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; CLARKE E, 1991, EUR J HAEMATOL, V46, P296; Cooke KR, 1998, J CLIN INVEST, V102, P1882, DOI 10.1172/JCI4285; DE RT, 1994, BLOOD, V83, P3795; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dobson KR, 1999, CALCIFIED TISSUE INT, V65, P411, DOI 10.1007/s002239900723; Epperly MW, 2005, EXP HEMATOL, V33, P353, DOI 10.1016/j.exphem.2004.11.010; Ferrara JLM, 2007, BEST PRACT RES CL HA, V20, P91, DOI 10.1016/j.beha.2006.11.004; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FRIEDENSTEIN AJ, 1992, BONE MINER, V18, P199, DOI 10.1016/0169-6009(92)90807-P; Handgretinger R, 2008, CYTOTHERAPY, V10, P443, DOI 10.1080/14653240802251507; Ho VT, 2008, BONE MARROW TRANSPL, V41, P229, DOI 10.1038/sj.bmt.1705899; Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kestendjieva S, 2008, CELL BIOL INT, V32, P724, DOI 10.1016/j.cellbi.2008.02.002; Kim JY, 2005, ONCOL REP, V13, P1177; Laub R, 1999, J EXP ANIM SCI, V39, P122; Laub R, 2001, TRANSPL P, V33, P2182, DOI 10.1016/S0041-1345(01)01934-0; Laub R, 2000, J IMMUNOL METHODS, V246, P37, DOI 10.1016/S0022-1759(00)00288-X; Ma Li-Jun, 2008, Zhonghua Xue Ye Xue Za Zhi, V29, P684; MacVittie TJ, 2005, HEALTH PHYS, V89, P546, DOI 10.1097/01.HP.0000173143.69659.5b; Martino R, 2000, HAEMATOLOGICA, V85, P1165; RICKARD DJ, 1995, BONE, V16, P671, DOI 10.1016/8756-3282(95)00099-Y; SCUTT A, 1995, PROSTAGLANDINS, V49, P383, DOI 10.1016/0090-6980(95)00070-Q; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Spargo LDJ, 2006, INT IMMUNOL, V18, P897, DOI 10.1093/intimm/dxl026; SPRANGERS B, 2008, LEUKEMIA; Stagg J., 2007, V180, P45; 't Anker PS, 2003, EXP HEMATOL, V31, P881, DOI 10.1016/S0301-472X(03)00202-9; Tamura K, 2008, DRUG TODAY, V44, P515, DOI 10.1358/dot.2008.44.7.1230943; Thalmeier K, 2001, CYTOTHERAPY, V3, P245, DOI 10.1080/146532401317070871; Tokcaer-Keskin Z, 2009, CAN J PHYSIOL PHARM, V87, P143, DOI 10.1139/Y08-111; Tschetter JR, 2000, J IMMUNOL, V165, P5987, DOI 10.4049/jimmunol.165.10.5987; Wlodarski KH, 2004, FOLIA BIOL-PRAGUE, V50, P167; ZHANG ZL, 2008, BONE MARROW TRANSPLA; Zhu Guang-Rong, 2003, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V11, P115	38	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6157	10.1371/journal.pone.0006157	http://dx.doi.org/10.1371/journal.pone.0006157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582154	gold, Green Published, Green Submitted			2022-12-27	WOS:000267806400012
J	Xu, HY; Li, ZD; Li, MY; Wang, L; Hong, YH				Xu, Hongyan; Li, Zhendong; Li, Mingyou; Wang, Li; Hong, Yunhan			Boule Is Present in Fish and Bisexually Expressed in Adult and Embryonic Germ Cells of Medaka	PLOS ONE			English	Article								Background: The DAZ family genes boule, daz and dazl encode RNA binding proteins essential for fertility of diverse animals including human. dazl has bisexual expression in both mitotic and meiotic germ cells, whereas daz has male premeiotic expression, and boule is largely a unisexual meiotic regulator. Although boule has been proposed as the ancestor for dazl/daz by gene duplication, it has been identified only in invertebrates and mammals. It has, however, remained unclear when and how the DAZ family has evolved in vertebrates. Methodology and Principal Findings: This study was aimed at identifying and characterizing the DAZ family genes in fish as the basal vertebrate. We show that boule and dazl coexist in medaka and stickleback. Similar to the medaka dazl (Odazl), the medaka boule (Obol) is maternally supplied and segregates with primordial germ cells. Surprisingly, Obol is expressed in adult germ cells at pre-meiotic and meiotic stages of spermatogenesis and oogenesis. However, the maximal meiotic Obol expression in spermatocytes contrasts with the predominant pre-meiotic Odazl expression in spermatogonia, and the diffuse cytoplasmic Obol distribution in early oocytes contrasts with the Odazl concentration in the Balbinani's body. Conclusions: The identification of fish boule and dazl genes provides direct evidence for the early gene duplication during vertebrate evolution. Our finding that Obol exhibits bisexual expression in both embryonic and adult germ cells considerably extends the diversity of boule expression patterns and offers a new insight into the evolutions of DAZ family members, expression patterns and functions in animal fertility.			Xu, HY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbshyh@nus.edu.sg	Hong, Yunhan/D-4197-2009; Test Account, SLB-WOS/E-5790-2010	Li, Mingyou/0000-0002-8729-7964				Aizawa K, 2003, GENE EXPR PATTERNS, V3, P43, DOI 10.1016/S1567-133X(02)00075-3; Brekhman V, 2000, MOL HUM REPROD, V6, P465, DOI 10.1093/molehr/6.5.465; Chang P, 2004, MOL BIOL CELL, V15, P4669, DOI 10.1091/mbc.E04-03-0265; Cheng MH, 1998, DEV BIOL, V204, P567, DOI 10.1006/dbio.1998.9098; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Ditton HJ, 2004, HUM MOL GENET, V13, P2333, DOI 10.1093/hmg/ddh240; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Elis S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-110; Graves JAM, 2002, TRENDS GENET, V18, P517, DOI 10.1016/S0168-9525(02)02772-5; Hashimoto Y, 2004, DEV BIOL, V268, P152, DOI 10.1016/j.ydbio.2003.12.013; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Houston DW, 1998, DEVELOPMENT, V125, P171; Houston DW, 2000, DEVELOPMENT, V127, P447; Huang WJ, 2008, HUM REPROD, V23, P1280, DOI 10.1093/humrep/den099; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; IWAMATSU T, 1988, ZOOL SCI, V5, P20; Johnson AD, 2001, DEV BIOL, V234, P402, DOI 10.1006/dbio.2001.0264; Karashima T, 2000, DEVELOPMENT, V127, P1069; Kloc M, 2005, J CELL SCI, V118, P269, DOI 10.1242/jcs.01637; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Kosaka K, 2007, MECH DEVELOP, V124, P279, DOI 10.1016/j.mod.2007.01.003; Li MY, 2009, MECH DEVELOP, V126, P366, DOI 10.1016/j.mod.2009.02.004; LIU LX, 2009, GENE EXPR P IN PRESS; Maegawa S, 1999, MECH DEVELOP, V81, P223, DOI 10.1016/S0925-4773(98)00242-1; Mandon-Pepin B, 2003, BIOL REPROD, V68, P985, DOI 10.1095/biolreprod.102.008557; Maruyama R, 2005, DEV BIOL, V277, P142, DOI 10.1016/j.ydbio.2004.08.053; Mita K, 2000, MECH DEVELOP, V94, P251, DOI 10.1016/S0925-4773(00)00295-1; Muller F, 2005, ZEBRAFISH, V2, P47, DOI 10.1089/zeb.2005.2.47; Niederberger C, 1997, MAMM GENOME, V8, P277, DOI 10.1007/s003359900409; Olsen LC, 1997, MECH DEVELOP, V66, P95, DOI 10.1016/S0925-4773(97)00099-3; Otori M, 2006, MOL BIOL CELL, V17, P3147, DOI 10.1091/mbc.E05-11-1067; PENG J, 2009, J EXPT ZOOLOGY MOL B, V312, P17; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Seboun E, 1997, GENOMICS, V41, P227, DOI 10.1006/geno.1997.4635; Seligman J, 1998, BIOCHEM BIOPH RES CO, V245, P878, DOI 10.1006/bbrc.1998.8530; Shinomiya A, 2000, DEV GROWTH DIFFER, V42, P317; Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Xu EYJ, 2003, HUM MOL GENET, V12, P169, DOI 10.1093/hmg/ddg017; Xu HY, 2007, GENE EXPR PATTERNS, V7, P332, DOI 10.1016/j.modgep.2006.08.001; Xu HY, 2005, DEV DYNAM, V233, P872, DOI 10.1002/dvdy.20410; YAN Y, 2009, EXP CELL RE IN PRESS; Zhang QB, 2009, MOL GENET GENOMICS, V281, P67, DOI 10.1007/s00438-008-0394-6	46	65	78	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6097	10.1371/journal.pone.0006097	http://dx.doi.org/10.1371/journal.pone.0006097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564913	Green Published, gold, Green Submitted			2022-12-27	WOS:000267515700015
J	Weinberg, EJ; Schoen, FJ; Mofrad, MRK				Weinberg, Eli J.; Schoen, Frederick J.; Mofrad, Mohammad R. K.			A Computational Model of Aging and Calcification in the Aortic Heart Valve	PLOS ONE			English	Article								The aortic heart valve undergoes geometric and mechanical changes over time. The cusps of a normal, healthy valve thicken and become less extensible over time. In the disease calcific aortic stenosis (CAS), calcified nodules progressively stiffen the cusps. The local mechanical changes in the cusps, due to either normal aging or pathological processes, affect overall function of the valve. In this paper, we propose a computational model for the aging aortic valve that connects local changes to overall valve function. We extend a previous model for the healthy valve to describe aging. To model normal/uncomplicated aging, leaflet thickness and extensibility are varied versus age according to experimental data. To model calcification, initial sites are defined and a simple growth law is assumed. The nodules then grow over time, so that the area of calcification increases from one model to the next model representing greater age. Overall valve function is recorded for each individual model to yield a single simulation of valve function over time. This simulation is the first theoretical tool to describe the temporal behavior of aortic valve calcification. The ability to better understand and predict disease progression will aid in design and timing of patient treatments for CAS.			Weinberg, EJ (corresponding author), Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019	/0000-0001-7004-4859				Antonini-Canterin F, 1999, HEART, V82, P9, DOI 10.1136/hrt.82.1.9; Antonini-Canterin F, 2002, J AM COLL CARDIOL, V39, p419A; Bermejo J, 2003, J AM COLL CARDIOL, V41, P142, DOI 10.1016/S0735-1097(02)02627-X; Blais C, 2001, AM J CARDIOL, V88, P45, DOI 10.1016/S0002-9149(01)01584-3; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; CHRISTIE GW, 1995, ANN THORAC SURG, V60, pS156, DOI 10.1016/0003-4975(95)00219-B; Cowell SJ, 2004, AGE AGEING, V33, P538, DOI 10.1093/ageing/afh175; FAGGIANO P, 1992, AM J CARDIOL, V70, P229, DOI 10.1016/0002-9149(92)91280-H; FORD LE, 1990, CIRC RES, V66, P1, DOI 10.1161/01.RES.66.1.1; Garcia D, 2000, CIRCULATION, V101, P765, DOI 10.1161/01.CIR.101.7.765; GORLIN R, 1987, J AM COLL CARDIOL, V10, P920, DOI 10.1016/S0735-1097(87)80289-9; Grande-Allen KJ, 2001, IEEE T BIO-MED ENG, V48, P647, DOI 10.1109/10.923783; Hallquist J.O, 2006, LIVERMORE SOFTW TECH; KIZER J, 2001, J HEART VALVE DIS, P548; Kuusisto J, 2005, HEART, V91, P576, DOI 10.1136/hrt.2004.036848; Lester SJ, 2000, CIRCULATION, V101, P1947, DOI 10.1161/01.CIR.101.16.1947; OTTO CM, 2003, VALVULAR HEART DIS; Piper C, 2003, ANN THORAC SURG, V76, P676, DOI 10.1016/S0003-4975(03)00566-6; Rajamannan NM, 2002, ARTERIOSCL THROM VAS, V22, pA22; Rajamannan NM, 1998, J AM COLL CARDIOL, V31, p3A, DOI 10.1016/S0735-1097(97)83742-4; Rosenhek R, 2004, EUR HEART J, V25, P250; SAHASAKUL Y, 1988, AM J CARDIOL, V62, P424, DOI 10.1016/0002-9149(88)90971-X; Schoen F., 2001, CARDIOVASC PATHOL, P629; Schoen FJ, 2001, CARDIOVASC PATHOL, P402; Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64; THUBRIKAR MJ, 1986, ANN THORAC SURG, V42, P434, DOI 10.1016/S0003-4975(10)60554-1; THUBRIKAR T, 1990, AORTIC VALVE; VanAuker MD, 2006, AM J GERIATR CARDIOL, V15, P277, DOI 10.1111/j.1527-5299.2006.04877.x; Weinberg Eli J, 2007, Cardiovasc Eng, V7, P140, DOI 10.1007/s10558-007-9038-4; Weinberg EJ, 2008, J BIOMECH, V41, P3482, DOI 10.1016/j.jbiomech.2008.08.006; Yacoub N, 2005, NAT CLIN PRACT CARD, V2, P60, DOI 10.1038/ncpcardio0112	31	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5960	10.1371/journal.pone.0005960	http://dx.doi.org/10.1371/journal.pone.0005960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536285	Green Published, gold, Green Submitted			2022-12-27	WOS:000267079500009
J	Barquero-Calvo, E; Conde-Alvarez, R; Chacon-Diaz, C; Quesada-Lobo, L; Martirosyan, A; Guzman-Verri, C; Iriarte, M; Mancek-Keber, M; Jerala, R; Gorvel, JP; Moriyon, I; Moreno, E; Chaves-Olarte, E				Barquero-Calvo, Elias; Conde-Alvarez, Raquel; Chacon-Diaz, Carlos; Quesada-Lobo, Lucia; Martirosyan, Anna; Guzman-Verri, Caterina; Iriarte, Maite; Mancek-Keber, Mateja; Jerala, Roman; Gorvel, Jean Pierre; Moriyon, Ignacio; Moreno, Edgardo; Chaves-Olarte, Esteban			The Differential Interaction of Brucella and Ochrobactrum with Innate Immunity Reveals Traits Related to the Evolution of Stealthy Pathogens	PLOS ONE			English	Article								Background: During evolution, innate immunity has been tuned to recognize pathogen-associated molecular patterns. However, some alpha-Proteobacteria are stealthy intracellular pathogens not readily detected by this system. Brucella members follow this strategy and are highly virulent, but other Brucellaceae like Ochrobactrum are rhizosphere inhabitants and only opportunistic pathogens. To gain insight into the emergence of the stealthy strategy, we compared these two phylogenetically close but biologically divergent bacteria. Methodology/Principal Findings: In contrast to Brucella abortus, Ochrobactrum anthropi did not replicate within professional and non-professional phagocytes and, whereas neutrophils had a limited action on B. abortus, they were essential to control O. anthropi infections. O. anthropi triggered proinflammatory responses markedly lower than Salmonella enterica but higher than B. abortus. In macrophages and dendritic cells, the corresponding lipopolysaccharides reproduced these grades of activation, and binding of O. anthropi lipopolysaccharide to the TLR4 co-receptor MD-2 and NF-kappa B induction laid between those of B. abortus and enteric bacteria lipopolysaccharides. These differences correlate with reported variations in lipopolysaccharide core sugars, sensitivity to bactericidal peptides and outer membrane permeability. Conclusions/Significance: The results suggest that Brucellaceae ancestors carried molecules not readily recognized by innate immunity, so that non-drastic variations led to the emergence of stealthy intracellular parasites. They also suggest that some critical envelope properties, like selective permeability, are profoundly altered upon modification of pathogen-associated molecular patterns, and that this represents a further adaptation to the host. It is proposed that this adaptive trend is relevant in other intracellular alpha-Proteobacteria like Bartonella, Rickettsia, Anaplasma, Ehrlichia and Wolbachia.			Barquero-Calvo, E (corresponding author), Univ Nacl, Escuela Med Vet, Programa Invest Enfermedades Trop, Heredia, Costa Rica.	emoreno@racsa.co.cr; esteban.chaves@ucr.ac.cr	BARQUERO-CALVO, ELIAS/GLU-1867-2022; Moriyon, Ignacio/N-4764-2016; Conde-Álvarez, Raquel/K-5854-2014; Guzman-Verri, Caterina/AAP-3074-2020; Gorvel, Jean-Pierre/O-1332-2018; IRIARTE, MAITE/L-9460-2014; Jerala, Roman/H-9850-2015	BARQUERO-CALVO, ELIAS/0000-0003-4428-3340; Moriyon, Ignacio/0000-0002-4288-0195; Conde-Álvarez, Raquel/0000-0003-0046-3577; Guzman-Verri, Caterina/0000-0003-1036-920X; Gorvel, Jean-Pierre/0000-0002-2829-9804; IRIARTE, MAITE/0000-0002-6726-8920; Jerala, Roman/0000-0002-6337-5251				Acosta F, 2006, FISH SHELLFISH IMMUN, V20, P709, DOI 10.1016/j.fsi.2005.08.011; AMANO KI, 1993, INFECT IMMUN, V61, P4350, DOI 10.1128/IAI.61.10.4350-4355.1993; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Ariza J, 1999, REV MED MICROBIOL, V10, P125; Arora U, 2008, INDIAN J MED MICROBI, V26, P81, DOI 10.4103/0255-0857.38868; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Berman AJ, 1997, AM J OPHTHALMOL, V123, P560, DOI 10.1016/S0002-9394(14)70190-4; BHAT UR, 1991, J BACTERIOL, V173, P2155, DOI 10.1128/JB.173.7.2155-2159.1991; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; CALVO C, 2008, J IND MICROBIOL BIOT; CAROFF M, 1984, INFECT IMMUN, V46, P384, DOI 10.1128/IAI.46.2.384-388.1984; Chaves-Olarte E, 2002, CELL MICROBIOL, V4, P663, DOI 10.1046/j.1462-5822.2002.00221.x; Choi KS, 2004, J INFECT DIS, V189, P1921, DOI 10.1086/386284; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Comerci DJ, 2006, J BACTERIOL, V188, P1929, DOI 10.1128/JB.188.5.1929-1934.2006; Conde-Alvarez R, 2006, CELL MICROBIOL, V8, P1322, DOI 10.1111/j.1462-5822.2006.00712.x; Copin R, 2007, J IMMUNOL, V178, P5182, DOI 10.4049/jimmunol.178.8.5182; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Fenn K, 2006, TRENDS PARASITOL, V22, P60, DOI 10.1016/j.pt.2005.12.012; Forestier C, 2000, J IMMUNOL, V165, P5202, DOI 10.4049/jimmunol.165.9.5202; FOSTER JT, 2009, J BACTERIOL; FRANCIS CL, 1992, MOL MICROBIOL, V6, P3077, DOI 10.1111/j.1365-2958.1992.tb01765.x; Freer E, 1996, J BACTERIOL, V178, P5867, DOI 10.1128/jb.178.20.5867-5876.1996; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; Gill MV, 1997, HEART LUNG, V26, P335, DOI 10.1016/S0147-9563(97)90092-3; Godfroid F, 2000, RES MICROBIOL, V151, P655, DOI 10.1016/S0923-2508(00)90130-X; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; Greven CM, 2001, RETINA-J RET VIT DIS, V21, P279, DOI 10.1097/00006982-200106000-00021; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Gupta RS, 2005, CRIT REV MICROBIOL, V31, P101, DOI 10.1080/10408410590922393; He Y.L., 2002, CHINESE SPACE MED J, V1, P70; Higgins CS, 2001, J ANTIMICROB CHEMOTH, V47, P745, DOI 10.1093/jac/47.6.745; HUDSON L, 1976, P298; Inoue K, 1999, BRIT J OPHTHALMOL, V83, P502; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamontagne J, 2007, J PROTEOME RES, V6, P1519, DOI 10.1021/pr060636a; Lapaque N, 2006, CELL MICROBIOL, V8, P197, DOI 10.1111/j.1462-5822.2005.00609.x; Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003; Lee EH, 1996, INFECT IMMUN, V64, P4211, DOI 10.1128/IAI.64.10.4211-4219.1996; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Mahmood MS, 2000, J INFECTION, V40, P287, DOI 10.1053/jinf.2000.0644; Mancek-Keber M, 2006, FASEB J, V20, P1836, DOI 10.1096/fj.06-5862com; Manterola L, 2005, J BACTERIOL, V187, P5631, DOI 10.1128/JB.187.16.5631-5639.2005; Moreno E, 1998, FEMS MICROBIOL REV, V22, P255, DOI 10.1111/j.1574-6976.1998.tb00370.x; MORENO E, 1990, J BACTERIOL, V172, P3569, DOI 10.1128/jb.172.7.3569-3576.1990; MORENO E, 1981, INFECT IMMUN, V31, P362, DOI 10.1128/IAI.31.1.362-370.1981; Moreno E, 2002, P NATL ACAD SCI USA, V99, P1, DOI 10.1073/pnas.022622699; Moreno E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P315, DOI 10.1007/0-387-30745-1_17; MORIYON I, 1982, J BACTERIOL, V152, P822; Moriyon I, 1998, Int Microbiol, V1, P19; MORIYON I, 2004, INTRACELLULAR PATHOG, P204; Nadjar D, 2001, ANTIMICROB AGENTS CH, V45, P2324, DOI 10.1128/AAC.45.8.2324-2330.2001; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NU AR, 2009, J BIOL CHEM; Ozdemir D, 2006, JPN J INFECT DIS, V59, P264; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Rikihisa Y, 2006, CURR OPIN MICROBIOL, V9, P95, DOI 10.1016/j.mib.2005.12.003; ROMERO C, 1995, J CLIN MICROBIOL, V33, P615, DOI 10.1128/JCM.33.3.615-617.1995; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Sen G, 2005, J IMMUNOL, V175, P3084, DOI 10.4049/jimmunol.175.5.3084; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; Stiakaki E, 2002, PEDIATR INFECT DIS J, V21, P72, DOI 10.1097/00006454-200201000-00018; Tibor A, 2002, INFECT IMMUN, V70, P5540, DOI 10.1128/IAI.70.10.5540-5546.2002; Vaara M, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P31; Velasco J, 1998, INT J SYST BACTERIOL, V48, P759, DOI 10.1099/00207713-48-3-759; Velasco J, 1998, CARBOHYD RES, V306, P283, DOI 10.1016/S0008-6215(97)10029-5; Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000; von Loewenich FD, 2004, EUR J IMMUNOL, V34, P1789, DOI 10.1002/eji.200425250; Weiss DS, 2005, INFECT IMMUN, V73, P5137, DOI 10.1128/IAI.73.8.5137-5143.2005; Weller SA, 2004, APPL ENVIRON MICROB, V70, P2779, DOI 10.1128/AEM.70.5.2779-2785.2004; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yu WL, 1998, J FORMOS MED ASSOC, V97, P106; Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200	83	50	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5893	10.1371/journal.pone.0005893	http://dx.doi.org/10.1371/journal.pone.0005893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529776	gold, Green Published			2022-12-27	WOS:000267029500002
J	Salazar, G; Falcon-Perez, JM; Harrison, R; Faundez, V				Salazar, Gloria; Falcon-Perez, Juan M.; Harrison, Robert; Faundez, Victor			SLC30A3 (ZnT3) Oligomerization by Dityrosine Bonds Regulates Its Subcellular Localization and Metal Transport Capacity	PLOS ONE			English	Article								Non-covalent and covalent homo-oligomerization of membrane proteins regulates their subcellular localization and function. Here, we described a novel oligomerization mechanism affecting solute carrier family 30 member 3/zinc transporter 3 (SLC30A3/ZnT3). Oligomerization was mediated by intermolecular covalent dityrosine bonds. Using mutagenized ZnT3 expressed in PC12 cells, we identified two critical tyrosine residues necessary for dityrosine-mediated ZnT3 oligomerization. ZnT3 carrying the Y372F mutation prevented ZnT3 oligomerization, decreased ZnT3 targeting to synaptic-like microvesicles (SLMVs), and decreased resistance to zinc toxicity. Strikingly, ZnT3 harboring the Y357F mutation behaved as a "gain-of-function'' mutant as it displayed increased ZnT3 oligomerization, targeting to SLMVs, and increased resistance to zinc toxicity. Single and double tyrosine ZnT3 mutants indicate that the predominant dimeric species is formed between tyrosine 357 and 372. ZnT3 tyrosine dimerization was detected under normal conditions and it was enhanced by oxidative stress. Covalent species were also detected in other SLC30A zinc transporters localized in different subcellular compartments. These results indicate that covalent tyrosine dimerization of a SLC30A family member modulates its subcellular localization and zinc transport capacity. We propose that dityrosine-dependent membrane protein oligomerization may regulate the function of diverse membrane protein in normal and disease states.			Salazar, G (corresponding author), Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30322 USA.	gsalaza@emory.edu	Falcon-Perez, Juan M/F-5920-2011	Harrison, Robert/0000-0003-2449-1214; Faundez, Victor/0000-0002-2114-5271; Falcon-Perez, Juan M/0000-0003-3133-0670	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077569, P20GM065762] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM065762, R01 GM077569, P20 GM065762, GM077569] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABDALLA S, 2008, J BIOL CHEM; Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Bagossi P, 1999, J MOL MODEL, V5, P143, DOI 10.1007/s008940050114; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Chen X, 2007, J BIOL CHEM, V282, P32128, DOI 10.1074/jbc.M705337200; Clift-O'Grady L, 1998, METHODS, V16, P150, DOI 10.1006/meth.1998.0662; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; CRAIGE B, 2004, CURR PROTOC CELL BIO, pCH3; Craige B, 2008, MOL BIOL CELL, V19, P1415, DOI 10.1091/mbc.E07-12-1239; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dutzler R, 2004, FEBS LETT, V564, P229, DOI 10.1016/S0014-5793(04)00210-8; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Falcon-Perez JM, 2007, EXP CELL RES, V313, P1473, DOI 10.1016/j.yexcr.2007.02.006; Faundez V, 1997, J CELL BIOL, V138, P505, DOI 10.1083/jcb.138.3.505; Funami K, 2008, J BIOL CHEM, V283, P18283, DOI 10.1074/jbc.M801013200; GARCIACASTINEIRAS S, 1978, SCIENCE, V199, P897, DOI 10.1126/science.622574; GIULIVI C, 1994, METHOD ENZYMOL, V233, P363; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; Harrison R.W., 2003, P INT C COMP SCI ITS, P77; Harrison RW, 1999, J MATH CHEM, V26, P125, DOI 10.1023/A:1019181811090; Harrison RW, 1995, PROTEINS, V23, P463, DOI 10.1002/prot.340230402; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Heinecke JW, 2002, FREE RADICAL BIO MED, V32, P1090, DOI 10.1016/S0891-5849(02)00792-X; Hensley K, 1998, J NEUROSCI, V18, P8126; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; LABELLA F, 1967, BIOCHEM BIOPH RES CO, V26, P748, DOI 10.1016/S0006-291X(67)80137-2; LABELLA F, 1968, BIOCHEM BIOPH RES CO, V30, P333, DOI 10.1016/0006-291X(68)90746-8; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; MURGIA C, 2008, NUTR METAB CARDIOVAS; NEWELLLITWA KA, 2009, MOL BIOL CE IN PRESS; Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Salazar G, 2005, J CELL SCI, V118, P1911, DOI 10.1242/jcs.02319; Salazar G, 2004, MOL BIOL CELL, V15, P575, DOI 10.1091/mbc.E03-06-0401; Salazar G, 2004, J BIOL CHEM, V279, P25430, DOI 10.1074/jbc.M402331200; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; ZALEWSKI PD, 1993, BIOCHEM J, V296, P403, DOI 10.1042/bj2960403	57	46	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5896	10.1371/journal.pone.0005896	http://dx.doi.org/10.1371/journal.pone.0005896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521526	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029100011
J	Wang, L; Oberg, AL; Asmann, YW; Sicotte, H; McDonnell, SK; Riska, SM; Liu, WG; Steer, CJ; Subramanian, S; Cunningham, JM; Cerhan, JR; Thibodeau, SN				Wang, Liang; Oberg, Ann L.; Asmann, Yan W.; Sicotte, Hugues; McDonnell, Shannon K.; Riska, Shaun M.; Liu, Wanguo; Steer, Clifford J.; Subramanian, Subbaya; Cunningham, Julie M.; Cerhan, James R.; Thibodeau, Stephen N.			Genome-Wide Transcriptional Profiling Reveals MicroRNA-Correlated Genes and Biological Processes in Human Lymphoblastoid Cell Lines	PLOS ONE			English	Article							PROLIFERATION PATHWAYS; MAPS MIRMAPS; SMALL RNAS; EXPRESSION; SNP; MECHANISMS; GOMINER	Background: Expression level of many genes shows abundant natural variation in human populations. The variations in gene expression are believed to contribute to phenotypic differences. Emerging evidence has shown that microRNAs (miRNAs) are one of the key regulators of gene expression. However, past studies have focused on the miRNA target genes and used loss-or gain-of-function approach that may not reflect natural association between miRNA and mRNAs. Methodology/Principal Findings: To examine miRNA regulatory effect on global gene expression under endogenous condition, we performed pair-wise correlation coefficient analysis on expression levels of 366 miRNAs and 14,174 messenger RNAs (mRNAs) in 90 immortalized lymphoblastoid cell lines, and observed significant correlations between the two species of RNA transcripts. We identified a total of 7,207 significantly correlated miRNA-mRNA pairs (false discovery rate q<0.01). Of those, 4,085 pairs showed positive correlations while 3,122 pairs showed negative correlations. Gene ontology analyses on the miRNA-correlated genes revealed significant enrichments in several biological processes related to cell cycle, cell communication and signal transduction. Individually, each of three miRNAs (miR-331, -98 and -33b) demonstrated significant correlation with the genes in cell cycle-related biological processes, which is consistent with important role of miRNAs in cell cycle regulation. Conclusions/Significance: This study demonstrates feasibility of using naturally expressed transcript profiles to identify endogenous correlation between miRNA and miRNA. By applying this genome-wide approach, we have identified thousands of miRNA-correlated genes and revealed potential role of miRNAs in several important cellular functions. The study results along with accompanying data sets will provide a wealth of high-throughput data to further evaluate the miRNA-regulated genes and eventually in phenotypic variations of human populations.			Wang, L (corresponding author), Mayo Clin, Dept Lab Med, Rochester, MN 55905 USA.	wang.liang@mayo.edu		Subramanian, Subbaya/0000-0002-2544-480X; McDonnell, Shannon/0000-0001-6201-369X; Cerhan, James/0000-0002-7482-178X	NATIONAL CANCER INSTITUTE [R21CA126786, P50CA091956] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA126786, P50 CA091956, CA91956, R21 CA126786-02, CA126786] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Glinsky GV, 2008, CELL CYCLE, V7, P3564, DOI 10.4161/cc.7.22.7073; Glinsky GV, 2008, CELL CYCLE, V7, P1630, DOI 10.4161/cc.7.11.5976; Glinsky GV, 2008, CELL CYCLE, V7, P3680, DOI 10.4161/cc.7.23.7153; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015	40	60	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5878	10.1371/journal.pone.0005878	http://dx.doi.org/10.1371/journal.pone.0005878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517021	gold, Green Published, Green Submitted			2022-12-27	WOS:000266873100011
J	Bakke, P; Carney, N; DeLoache, W; Gearing, M; Ingvorsen, K; Lotz, M; McNair, J; Penumetcha, P; Simpson, S; Voss, L; Win, M; Heyer, LJ; Campbell, AM				Bakke, Peter; Carney, Nick; DeLoache, Will; Gearing, Mary; Ingvorsen, Kjeld; Lotz, Matt; McNair, Jay; Penumetcha, Pallavi; Simpson, Samantha; Voss, Laura; Win, Max; Heyer, Laurie J.; Campbell, A. Malcolm			Evaluation of Three Automated Genome Annotations for Halorhabdus utahensis	PLOS ONE			English	Article							DNA-REPLICATION; BACTERIAL	Genome annotations are accumulating rapidly and depend heavily on automated annotation systems. Many genome centers offer annotation systems but no one has compared their output in a systematic way to determine accuracy and inherent errors. Errors in the annotations are routinely deposited in databases such as NCBI and used to validate subsequent annotation errors. We submitted the genome sequence of halophilic archaeon Halorhabdus utahensis to be analyzed by three genome annotation services. We have examined the output from each service in a variety of ways in order to compare the methodology and effectiveness of the annotations, as well as to explore the genes, pathways, and physiology of the previously unannotated genome. The annotation services differ considerably in gene calls, features, and ease of use. We had to manually identify the origin of replication and the species-specific consensus ribosome-binding site. Additionally, we conducted laboratory experiments to test H. utahensis growth and enzyme activity. Current annotation practices need to improve in order to more accurately reflect a genome's biological potential. We make specific recommendations that could improve the quality of microbial annotation projects.			Bakke, P (corresponding author), Davidson Coll, Dept Biol, Davidson, NC 28036 USA.	macampbell@davidson.edu	Ingvorsen, Kjeld/J-5290-2013	Simpson, Samantha/0000-0002-4610-8530	Howard Hughes Medical Institute [52005120, 52006292] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Berquist BR, 2003, J BACTERIOL, V185, P5959, DOI 10.1128/JB.185.20.5959-5966.2003; Duggin IG, 2006, J BIOL CHEM, V281, P15029, DOI 10.1074/jbc.R500029200; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Fumoto M, 2002, NUCLEIC ACIDS RES, V30, P66, DOI 10.1093/nar/30.1.66; Grabowski B, 2003, ANNU REV MICROBIOL, V57, P487, DOI 10.1146/annurev.micro.57.030502.090709; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; INGVORSEN K, 1984, ARCH MICROBIOL, V139, P61, DOI 10.1007/BF00692713; IVANOVA NN, 2006, INTEGRAL MICRO UNPUB; JIONG M, 2002, J BACTERIOL, V184, P5733; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LUDWIG W, 1994, FEMS MICROBIOL REV, V15, P155, DOI 10.1111/j.1574-6976.1994.tb00132.x; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Overbeek R, 2007, CHEM REV, V107, P3431, DOI 10.1021/cr068308h; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; THOMPSON LD, 1988, J BIOL CHEM, V263, P17951; Waino M, 2000, INT J SYST EVOL MICR, V50, P183, DOI 10.1099/00207713-50-1-183; Waino M, 2003, EXTREMOPHILES, V7, P87, DOI 10.1007/s00792-002-0299-y; WEBB EC, 1992, ENZYME NOMENCLATURE, P884	20	49	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6291	10.1371/journal.pone.0006291	http://dx.doi.org/10.1371/journal.pone.0006291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617911	Green Published, gold, Green Submitted			2022-12-27	WOS:000268119600004
J	Huynh, DP; Maalouf, M; Silva, AJ; Schweizer, FE; Pulst, SM				Huynh, Duong P.; Maalouf, Marwan; Silva, Alcino J.; Schweizer, Felix E.; Pulst, Stefan M.			Dissociated Fear and Spatial Learning in Mice with Deficiency of Ataxin-2	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TASTE-AVERSION MEMORY; BASOLATERAL AMYGDALA; COGNITIVE DEFICITS; INSULAR CORTEX; GENE; RECEPTOR; EXPRESSION; PROTEIN; SCA2	Mouse models with physiological and behavioral differences attributable to differential plasticity of hippocampal and amygdalar neuronal networks are rare. We previously generated ataxin-2 (Atxn2) knockout mice and demonstrated that these animals lacked obvious anatomical abnormalities of the CNS, but showed marked obesity and reduced fertility. We now report on behavioral changes as a consequence of Atxn2-deficiency. Atxn2-deficiency was associated with impaired long-term potentiation (LTP) in the amygdala, but normal LTP in the hippocampus. Intact hippocampal plasticity was associated behaviorally with normal Morris Water maze testing. Impaired amygdala plasticity was associated with reduced cued and contextual fear conditioning. Conditioned taste aversion, however, was normal. In addition, knockout mice showed decreased innate fear in several tests and motor hyperactivity in open cage testing. Our results suggest that Atxn2-deficiency results in a specific set of behavioral and cellular disturbances that include motor hyperactivity and abnormal fear-related behaviors, but intact hippocampal function. This animal model may be useful for the study of anxiety disorders and should encourage studies of anxiety in patients with spinocerebellar ataxia type 2 (SCA2).			Huynh, DP (corresponding author), Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA.	stefan.pulst@hsc.utah.edu	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494	NIA NIH HHS [R01 AG013622, R01-AG13622] Funding Source: Medline; NIMH NIH HHS [P50-MH0779720] Funding Source: Medline; NINDS NIH HHS [R01 NS033123, K01 NS047548, K01-NS047548-01A4, R01 NS33123] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K01NS047548, R01NS033123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013622] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Al-Ramahi I, 2007, PLOS GENET, V3, P2551, DOI 10.1371/journal.pgen.0030234; Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Bahar A, 2004, EUR J NEUROSCI, V19, P1115, DOI 10.1111/j.0953-816X.2004.03215.x; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Bryant CD, 2006, AM J PHYSIOL-REG I, V291, pR315, DOI 10.1152/ajpregu.00831.2005; Burk K, 1999, BRAIN, V122, P769, DOI 10.1093/brain/122.4.769; Burk K, 2003, J NEUROL, V250, P207, DOI 10.1007/s00415-003-0976-5; Dewachter I, 2009, NEUROBIOL AGING, V30, P241, DOI 10.1016/j.neurobiolaging.2007.06.011; Dhaka A, 2003, J NEUROSCI, V23, P748; Ding HK, 2008, LEARN MEMORY, V15, P290, DOI 10.1101/lm.905008; Furtado S, 2004, MOVEMENT DISORD, V19, P622, DOI 10.1002/mds.20074; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Hermann T, 1995, RNA, V1, P1009; Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007; Huynh DP, 1999, ANN NEUROL, V45, P232, DOI 10.1002/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7; Miranda MI, 2008, LEARN MEMORY, V15, P468, DOI 10.1101/lm.964708; Kiehl TR, 2006, BIOCHEM BIOPH RES CO, V339, P17, DOI 10.1016/j.bbrc.2005.10.186; King BM, 2006, AM J PHYSIOL-REG I, V291, pR1201, DOI 10.1152/ajpregu.00199.2006; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lastres-Becker I, 2008, HUM MOL GENET, V17, P1465, DOI 10.1093/hmg/ddn035; Le Pira F, 2007, J NEUROL, V254, P1455, DOI 10.1007/s00415-007-0548-1; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Miranda MI, 2008, NEUROBIOL LEARN MEM, V90, P54, DOI 10.1016/j.nlm.2008.01.004; Nechiporuk T, 1998, HUM MOL GENET, V7, P1301, DOI 10.1093/hmg/7.8.1301; Neuwald AF, 1998, J MOL MED, V76, P3, DOI 10.1007/s109-1998-8098-0; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Yu FL, 2005, PLOS GENET, V1, P404, DOI 10.1371/journal.pgen.0010041; Zhang H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-38	40	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6235	10.1371/journal.pone.0006235	http://dx.doi.org/10.1371/journal.pone.0006235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	472GW	19617910	Green Published, Green Submitted, gold			2022-12-27	WOS:000268119600001
J	Dalby, AR				Dalby, Andrew R.			A Comparative Proteomic Analysis of the Simple Amino Acid Repeat Distributions in Plasmodia Reveals Lineage Specific Amino Acid Selection	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; LOW-COMPLEXITY REGIONS; GENOME SEQUENCE; FALCIPARUM; DNA; ABUNDANCE; DETERMINANTS; INSTABILITY; STATISTICS; MECHANISMS	Background: Microsatellites have been used extensively in the field of comparative genomics. By studying microsatellites in coding regions we have a simple model of how genotypic changes undergo selection as they are directly expressed in the phenotype as altered proteins. The simplest of these tandem repeats in coding regions are the tri-nucleotide repeats which produce a repeat of a single amino acid when translated into proteins. Tri-nucleotide repeats are often disease associated, and are also known to be unstable to both expansion and contraction. This makes them sensitive markers for studying proteome evolution, in closely related species. Results: The evolutionary history of the family of malarial causing parasites Plasmodia is complex because of the life-cycle of the organism, where it interacts with a number of different hosts and goes through a series of tissue specific stages. This study shows that the divergence between the primate and rodent malarial parasites has resulted in a lineage specific change in the simple amino acid repeat distribution that is correlated to A-T content. The paper also shows that this altered use of amino acids in SAARs is consistent with the repeat distributions being under selective pressure. Conclusions: The study shows that simple amino acid repeat distributions can be used to group related species and to examine their phylogenetic relationships. This study also shows that an outgroup species with a similar A-T content can be distinguished based only on the amino acid usage in repeats, and suggest that this might be a useful feature for proteome clustering. The lineage specific use of amino acids in repeat regions suggests that comparative studies of SAAR distributions between proteomes gives an insight into the mechanisms of expansion and the selective pressures acting on the organism.			Dalby, AR (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	dalby@stats.ox.ac.uk		Dalby, Andrew/0000-0002-3598-8595				Alba MM, 1999, J MOL EVOL, V49, P789, DOI 10.1007/PL00006601; Alba MM, 1999, MOL BIOL EVOL, V16, P1641, DOI 10.1093/oxfordjournals.molbev.a026077; Alba MM, 2001, J MOL EVOL, V52, P249, DOI 10.1007/s002390010153; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; ARDESHIR F, 1990, MOL BIOCHEM PARASIT, V40, P113, DOI 10.1016/0166-6851(90)90085-Z; Bourgon R, 2004, MOL BIOL EVOL, V21, P2161, DOI 10.1093/molbev/msh228; Breman JG, 2001, AM J TROP MED HYG, V64, P1; BRENDEL V, 1992, P NATL ACAD SCI USA, V89, P2002, DOI 10.1073/pnas.89.6.2002; Buldyrev SV, 1998, PHYSICA A, V249, P430, DOI 10.1016/S0378-4371(97)00503-7; Carlton J, 2003, TRENDS PARASITOL, V19, P227, DOI 10.1016/S1471-4922(03)00066-7; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Depledge DP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-122; Depledge DP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-196; DePristo MA, 2006, GENE, V378, P19, DOI 10.1016/j.gene.2006.03.023; Dokholyan NV, 1997, PHYS REV LETT, V79, P5182, DOI 10.1103/PhysRevLett.79.5182; Dokholyan NV, 1998, PHYSICA A, V249, P594, DOI 10.1016/S0378-4371(97)00520-7; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; Feng ZP, 2006, MOL BIOCHEM PARASIT, V150, P256, DOI 10.1016/j.molbiopara.2006.08.011; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Girard MP, 2007, VACCINE, V25, P1567, DOI 10.1016/j.vaccine.2006.09.074; Hancock JM, 2001, MOL BIOL EVOL, V18, P1014, DOI 10.1093/oxfordjournals.molbev.a003873; Hancock JM, 1995, J MOL EVOL, V41, P1038; HOEBEKE M, 2006, RMES FINDING EXCEPTI; Jean L, 2005, MOL BIOCHEM PARASIT, V144, P187, DOI 10.1016/j.molbiopara.2005.07.008; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Karlin S, 2000, ANN APPL PROBAB, V10, P709; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; Kreil DP, 2000, TRENDS BIOCHEM SCI, V25, P270, DOI 10.1016/S0968-0004(00)01594-2; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P5127, DOI 10.1073/pnas.0700429104; Mularoni L, 2007, GENOMICS, V89, P316, DOI 10.1016/j.ygeno.2006.11.011; Nair S, 2007, MOL BIOL EVOL, V24, P562, DOI 10.1093/molbev/msl185; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Pearson CE, 1998, CURR OPIN STRUC BIOL, V8, P321, DOI 10.1016/S0959-440X(98)80065-1; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Pizzi E, 2001, GENOME RES, V11, P218, DOI 10.1101/gr.GR-1522R; Reinert G, 2000, J COMPUT BIOL, V7, P1, DOI 10.1089/10665270050081360; Roy SW, 2006, GENOME RES, V16, P750, DOI 10.1101/gr.4845406; Sarma GN, 2003, J MOL BIOL, V328, P893, DOI 10.1016/S0022-2836(03)00347-4; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X	45	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6231	10.1371/journal.pone.0006231	http://dx.doi.org/10.1371/journal.pone.0006231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597555	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000268035600005
J	Barot, SK; Chung, A; Kim, JJ; Bernstein, IL				Barot, Sabiha K.; Chung, Ain; Kim, Jeansok J.; Bernstein, Ilene L.			Functional Imaging of Stimulus Convergence in Amygdalar Neurons during Pavlovian Fear Conditioning	PLOS ONE			English	Article								Background: Associative conditioning is a ubiquitous form of learning throughout the animal kingdom and fear conditioning is one of the most widely researched models for studying its neurobiological basis. Fear conditioning is also considered a model system for understanding phobias and anxiety disorders. A fundamental issue in fear conditioning regards the existence and location of neurons in the brain that receive convergent information about the conditioned stimulus (CS) and unconditioned stimulus (US) during the acquisition of conditioned fear memory. Convergent activation of neurons is generally viewed as a key event for fear learning, yet there has been almost no direct evidence of this critical event in the mammalian brain. Methodology/Principal Findings: Here, we used Arc cellular compartmental analysis of temporal gene transcription by fluorescence in situ hybridization (catFISH) to identify neurons activated during single trial contextual fear conditioning in rats. To conform to temporal requirements of catFISH analysis we used a novel delayed contextual fear conditioning protocol which yields significant single-trial fear conditioning with temporal parameters amenable to catFISH analysis. Analysis yielded clear evidence that a population of BLA neurons receives convergent CS and US information at the time of the learning, that this only occurs when the CS-US arrangement is supportive of the learning, and that this process requires N-methyl-D-aspartate receptor activation. In contrast, CS-US convergence was not observed in dorsal hippocampus. Conclusions/Significance: Based on the pattern of Arc activation seen in conditioning and control groups, we propose that a key requirement for CS-US convergence onto BLA neurons is the potentiation of US responding by prior exposure to a novel CS. Our results also support the view that contextual fear memories are encoded in the amygdala and that the role of dorsal hippocampus is to process and transmit contextual CS information.			Barot, SK (corresponding author), Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA.	ileneb@u.washington.edu		Kim, Jeansok/0000-0001-7964-106X	NIMH NIH HHS [R01 MH064457, R01 MH64457] Funding Source: Medline; NINDS NIH HHS [R01 NS37040, R01 NS037040] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037040] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggleton JP., 2000, AMYGDALA FUNCTIONAL; Barot SK, 2008, P NATL ACAD SCI USA, V105, P20959, DOI 10.1073/pnas.0808996106; Biedenkapp JC, 2009, LEARN MEMORY, V16, P38, DOI 10.1101/lm.1099109; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; FANSELOW MS, 1984, TRENDS NEUROSCI, V7, P460; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Gould TJ, 2002, BEHAV PHARMACOL, V13, P287, DOI 10.1097/00008877-200207000-00005; Guzowski JF, 2001, CURR OPIN NEUROBIOL, V11, P579, DOI 10.1016/S0959-4388(00)00252-X; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; HOEHNSARIC R, 1991, BIOL PSYCHIAT, V30, P170, DOI 10.1016/0006-3223(91)90171-H; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Kim HC, 2002, IEEE T PLASMA SCI, V30, P188, DOI 10.1109/TPS.2002.1003987; KIM JJ, 1991, BEHAV NEUROSCI, V105, P126, DOI 10.1037/0735-7044.105.1.126; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Landeira-Fernandez J, 2006, BEHAV NEUROSCI, V120, P873, DOI 10.1037/0735-7044.120.4.873; Lee H, 1998, J NEUROSCI, V18, P8444; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MAREN S, 1995, J NEUROSCI, V15, P7548; Maren S, 2000, BEHAV BRAIN RES, V110, P97, DOI 10.1016/S0166-4328(99)00188-6; Matus-Amat P, 2007, BEHAV NEUROSCI, V121, P721, DOI 10.1037/0735-7044.121.4.721; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Moncada D, 2007, J NEUROSCI, V27, P7476, DOI 10.1523/JNEUROSCI.1083-07.2007; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pavlov I.P., 1927, CONDITIONED REFLEXES; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Scicli AP, 2004, BEHAV NEUROSCI, V118, P5, DOI 10.1037/0735-7044.118.1.5; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Watson JB, 1920, J EXP PSYCHOL, V3, P1, DOI 10.1037/h0069608; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907	42	54	54	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6156	10.1371/journal.pone.0006156	http://dx.doi.org/10.1371/journal.pone.0006156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582153	Green Published, Green Submitted, gold			2022-12-27	WOS:000267806400011
J	Walli, A; Teo, SLH; Boustany, A; Farwell, CJ; Williams, T; Dewar, H; Prince, E; Block, BA				Walli, Andreas; Teo, Steven L. H.; Boustany, Andre; Farwell, Charles J.; Williams, Tom; Dewar, Heidi; Prince, Eric; Block, Barbara A.			Seasonal Movements, Aggregations and Diving Behavior of Atlantic Bluefin Tuna (Thunnus thynnus) Revealed with Archival Tags	PLOS ONE			English	Article								Electronic tags were used to examine the seasonal movements, aggregations and diving behaviors of Atlantic bluefin tuna (Thunnus thynnus) to better understand their migration ecology and oceanic habitat utilization. Implantable archival tags (n = 561) were deployed in bluefin tuna from 1996 to 2005 and 106 tags were recovered. Movement paths of the fish were reconstructed using light level and sea-surface-temperature-based geolocation estimates. To quantify habitat utilization we employed a weighted kernel estimation technique that removed the biases of deployment location and track length. Throughout the North Atlantic, high residence times (167633 days) were identified in four spatially confined regions on a seasonal scale. Within each region, bluefin tuna experienced distinct temperature regimes and displayed different diving behaviors. The mean diving depths within the high-use areas were significantly shallower and the dive frequency and the variance in internal temperature significantly higher than during transit movements between the high-use areas. Residence time in the more northern latitude high-use areas was significantly correlated with levels of primary productivity. The regions of aggregation are associated with areas of abundant prey and potentially represent critical foraging habitats that have seasonally abundant prey. Throughout the North Atlantic mean diving depth was significantly correlated with the depth of the thermocline, and dive behavior changed in relation to the stratification of the water column. In this study, with numerous multi-year tracks, there appear to be repeatable patterns of clear aggregation areas that potentially are changing with environmental conditions. The high concentrations of bluefin tuna in predictable locations indicate that Atlantic bluefin tuna are vulnerable to concentrated fishing efforts in the regions of foraging aggregations.			Walli, A (corresponding author), Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA.	walli@geoville.com		Lusseau, David/0000-0003-1245-3747				Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bigelow HB, 1953, FISHES GULF MAINE; BirdLife International, 2004, GLOB PROC TRACK WORK; BLOCK B, 2001, TUNAS ECOLOGICAL PHS; Block BA, 1998, MAR TECHNOL SOC J, V32, P37; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Block BA, 1998, FASEB J, V12, pA676; Bode A, 2004, SCI MAR, V68, P165, DOI 10.3989/scimar.2004.68n1165; BOUSTANY A, 2006, THESIS STANFORD U; BOUSTANY A, 2006, COL VOL SCI PAP ICCA, V89; Boustany AM., 2001, ELECT TAGGING TRACKI, P89, DOI [10.1007/978-94-017-1402-0_4, DOI 10.1007/978-94-017-1402-0_4]; BUTLER CM, 2007, THESIS N CAROLINA ST; BUTLER MJA, 1964, BIOLOGY; CAMPBELL JW, 1992, DEEP-SEA RES, V39, P1669, DOI 10.1016/0198-0149(92)90023-M; CAREY FG, 1984, J EXP BIOL, V109, P1; Carlsson J, 2006, ICES J MAR SCI, V63, P1111, DOI 10.1016/j.icesjms.2006.04.009; Carrera P, 2001, FISH RES, V50, P151, DOI 10.1016/S0165-7836(00)00248-4; Cavaco MH., 2003, B SEA FISHER I, V1, P49; Chase BC, 2002, FISH B-NOAA, V100, P168; Checkley David M. Jr., 1999, Fisheries Oceanography, V8, P22; Cleveland WS., 1993, VISUALIZING DATA; Cort J.L., 1991, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V35, P213; Crocker DE, 2006, MAR ECOL PROG SER, V309, P1, DOI 10.3354/meps309001; Dagorn L, 1999, CAN J FISH AQUAT SCI, V56, P984, DOI 10.1139/cjfas-56-6-984; DEMETRIO G, 2001, COL VOL SCI PAP ICCA, V54, P415; DRAGOVICH A, 1970, T AM FISH SOC, V99, P726, DOI 10.1577/1548-8659(1970)99<726:TFOBTT>2.0.CO;2; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; DUCKLOW HW, 1993, JGOFS N ATLANTIC B 2, P1; EGGLESTON DB, 1990, FISH B-NOAA, V88, P389; Estrada JA, 2005, MAR BIOL, V147, P37, DOI 10.1007/s00227-004-1541-1; Fitzgibbon QP, 2007, J EXP BIOL, V210, P290, DOI 10.1242/jeb.02641; FUSS CM, 1971, P GULF CAR FISH I 24, P19; Garrison LP, 2002, FISH OCEANOGR, V11, P267, DOI 10.1046/j.1365-2419.2002.00205.x; Gray CA, 2003, MAR ECOL PROG SER, V247, P211, DOI 10.3354/meps247211; Gunn J, 2001, ELECT TAGGING TRACKI, P109, DOI 10.1007/978-94-017-1402-0_5; GUNN JS, 2001, TUNAS ECOLOGICAL PHY; HILBORN R, 1992; Hochberg Y, 1987, MULTIPLE COMPARISON; ICCAT, 2005, ICCAT COLL VOL SCI P, VII, P44; *ICCAT, 2001, COL VOL SCI PAP ICCA, V20, P261; *ICCAT, 2006, COL VOL SCI PAP ICCA, V13, P1; Joint I, 2002, J MARINE SYST, V32, P219, DOI 10.1016/S0924-7963(02)00037-4; Kitagawa T, 2000, MAR ECOL PROG SER, V206, P251, DOI 10.3354/meps206251; Kitagawa T, 2004, FISH OCEANOGR, V13, P161, DOI 10.1111/j.1365-2419.2004.00282.x; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; Lutcavage ME, 2000, MAR BIOL, V137, P347, DOI 10.1007/s002270000302; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Magnuson J. J., 1994, ASSESSMENT ATLANTIC; MATTHEWS FD, 1977, SSRF7006 NMFS NOAA, P19; MCCONNELL BJ, 1992, J ZOOL, V226, P271, DOI 10.1111/j.1469-7998.1992.tb03839.x; MCNAY RS, 1994, J WILDLIFE MANAGE, V58, P422, DOI 10.2307/3809312; MENESES I, 1996, J MARINE SCI, V27; MINTA SC, 1992, ECOL APPL, V2, P178, DOI 10.2307/1941774; Musyl M, 2001, ELECT TAGGING TRACKI, P343, DOI [10.1007/978-94-017-1402-0_19, DOI 10.3354/MEPS09899]; NEILSON JD, 2006, COL VOL SCI PAP ICCA, V76; NICHOLSON WR, 1975, 684 SSRF NOAA NMFS; Otis DL, 1999, J WILDLIFE MANAGE, V63, P1039, DOI 10.2307/3802819; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Polovina JJ, 1996, FISH OCEANOGR, V5, P114, DOI 10.1111/j.1365-2419.1996.tb00110.x; RAO RR, 1989, J GEOPHYS RES-OCEANS, V94, P10801, DOI 10.1029/JC094iC08p10801; REYNOLDS TD, 1990, J WILDLIFE MANAGE, V54, P316, DOI 10.2307/3809049; ROBINSON G A, 1970, Bulletins of Marine Ecology, V6, P333; RODRIGUEZMARIN E, 2006, COL VOL SCI PAP ICCA, V59, P858; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rossby T, 1996, REV GEOPHYS, V34, P463, DOI 10.1029/96RG02214; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Sibert JR, 2006, CAN J FISH AQUAT SCI, V63, P2154, DOI 10.1139/F06-114; SILVERMAN BW, 1986, DENSITY ANAL STAT DE; Smyth TJ, 2001, PROG OCEANOGR, V51, P269, DOI 10.1016/S0079-6611(01)00070-2; Sokal RR, 1995, BIOMETRY; Stokesbury MJW, 2004, CAN J FISH AQUAT SCI, V61, P1976, DOI 10.1139/F04-130; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Tilstone GH, 2003, MAR ECOL PROG SER, V252, P89, DOI 10.3354/meps252089; TOWNSEND DW, 1992, J PLANKTON RES, V14, P467, DOI 10.1093/plankt/14.4.467; TURNER SC, 1994, ICCAT COLL VOL SCI P, V42, P170; Walli A., 2007, THESIS U CALIFORNIA; WARLEN SM, 1994, FISH B-NOAA, V92, P420; Welch DW, 1999, CAN J FISH AQUAT SCI, V56, P1317, DOI 10.1139/cjfas-56-7-1317; Whitehead H, 2000, CAN J FISH AQUAT SCI, V57, P223, DOI 10.1139/cjfas-57-1-223; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Wood AG, 2000, J AVIAN BIOL, V31, P278, DOI 10.1034/j.1600-048X.2000.310302.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; *WWF, 2006, PLUND BLUEF TUN MED; [No title captured]	88	125	130	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6151	10.1371/journal.pone.0006151	http://dx.doi.org/10.1371/journal.pone.0006151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582150	Green Published, Green Submitted, gold			2022-12-27	WOS:000267806400007
J	Guo, SG; Shen, XY; Yan, GH; Ma, DZ; Bai, XC; Li, SP; Jiang, Y				Guo, Shuguang; Shen, Xiaoyun; Yan, Gonghong; Ma, Dongzhu; Bai, Xiaochun; Li, Suoping; Jiang, Yu			A MAP Kinase Dependent Feedback Mechanism Controls Rho1 GTPase and Actin Distribution in Yeast	PLOS ONE			English	Article								In the yeast Saccharomyces cerevisiae the guanosine triphosphatase (GTPase) Rho1 controls actin polarization and cell wall expansion. When cells are exposed to various environmental stresses that perturb the cell wall, Rho1 activates Pkc1, a mammalian Protein Kinase C homologue, and Mpk1, a mitogen activated protein kinase (MAPK), resulting in actin depolarization and cell wall remodeling. In this study, we demonstrate a novel feedback loop in this Rho1-mediated Pkc1-MAPK pathway that involves regulation of Rom2, the guanine nucleotide exchange factor of Rho1, by Mpk1, the end kinase of the pathway. This previously unrecognized Mpk1-depedent feedback is a critical step in regulating Rho1 function. Activation of this feedback mechanism is responsible for redistribution of Rom2 and cell wall synthesis activity from the bud to cell periphery under stress conditions. It is also required for terminating Rho1 activity toward the Pkc1-MAPK pathway and for repolarizing actin cytoskeleton and restoring growth after the stressed cells become adapted.			Guo, SG (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA.	yuj5@pitt.edu			NATIONAL CANCER INSTITUTE [R01CA129821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068832] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA129821] Funding Source: Medline; NIGMS NIH HHS [R01 GM068832, GM068832] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2000, J CELL SCI, V113, P2685; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235; Cabib E, 1998, ANNU REV BIOCHEM, V67, P307, DOI 10.1146/annurev.biochem.67.1.307; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Harrison JC, 2001, NAT CELL BIOL, V3, P417, DOI 10.1038/35070104; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1; LEVIN DE, 1994, CELL MOL BIOL RES, V40, P229; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; MADAULE P, 1987, P NATL ACAD SCI USA, V84, P779, DOI 10.1073/pnas.84.3.779; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Manning BD, 1997, MOL BIOL CELL, V8, P1829, DOI 10.1091/mbc.8.10.1829; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MARTIN H, 1993, MOL GEN GENET, V241, P177, DOI 10.1007/BF00280215; Mizunuma M, 1998, NATURE, V392, P303, DOI 10.1038/32695; NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x; Ozaki K, 1996, EMBO J, V15, P2196, DOI 10.1002/j.1460-2075.1996.tb00573.x; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Qadota H, 1996, SCIENCE, V272, P279, DOI 10.1126/science.272.5259.279; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Utsugi T, 2002, GENES CELLS, V7, P1, DOI 10.1046/j.1356-9597.2001.00495.x; Wang HM, 2003, MOL CELL BIOL, V23, P3116, DOI 10.1128/MCB.23.9.3116-3125.2003; WATANABE M, 1994, J BIOL CHEM, V269, P16829; WATANABE Y, 1995, MOL CELL BIOL, V15, P5740; YAMOCHI W, 1994, J CELL BIOL, V125, P1077, DOI 10.1083/jcb.125.5.1077; Zarzov P, 1996, EMBO J, V15, P83, DOI 10.1002/j.1460-2075.1996.tb00336.x	37	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6089	10.1371/journal.pone.0006089	http://dx.doi.org/10.1371/journal.pone.0006089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564916	Green Published, gold, Green Accepted			2022-12-27	WOS:000267515700008
J	Subramanian, SV; Kennedy, MH				Subramanian, S. V.; Kennedy, Malinda H.			Perception of Neighborhood Safety and Reported Childhood Lifetime Asthma in the United States (US): A Study Based on a National Survey	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; COMMUNITY VIOLENCE; BIRTH-COHORT; STRESS; HEALTH; PREVALENCE; EXPRESSION; MORBIDITY; CHILDREN; CONTEXT	Background: Recent studies have emphasized the role of psychosocial stressors as a determinant of asthma, and neighborhoods can be a potential source of such stressors. We investigated the association between parental perception of neighborhood safety and reported lifetime asthma among children. Methodology/Principal Findings: Data for the study came from the 2003-04 National Survey of Children Health (NSCH); a nationally representative cross-sectional sample of children aged 0-17 years. Demographic, socioeconomic and behavioral covariates were included in the study. Models were estimated after taking account of weighting and complex survey design. Parental report of whether the child has ever been diagnosed with asthma by a physician was used to define the outcome. Parental report of perception of neighborhood safety was the main exposure. In unadjusted models, the odds ratio (OR) for reporting asthma associated with living in neighborhoods that were perceived to be sometimes or never safe was 1.36 (95% confidence intervals [CI] 1.21, 1.53) compared to living in neighborhoods that were perceived to be always safe. Adjusting for covariates including exposure to second hand tobacco smoke, mother's self-rated health, child's physical activity and television viewing attenuated this association (OR 1.25, 95% CI 1.08, 1.43). In adjusted models, the increased odds ratio for reporting asthma was also higher among those who perceived neighborhoods as being usually safe (OR 1.15 95% CI 1.06, 1.26), as compared to always safe, suggestive of a dose-response relationship, with the differentials for usually safe and never safe being statistically significant (p = 0.009). Conclusion: Psychosocial stressors may be important risk factors that may impact the pathogenesis of asthma and/or contribute to asthma morbidity by triggering exacerbations through neuroimmunologic mechanisms, as well as social mechanisms.			Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Cambridge, MA 02138 USA.	svsubram@hsph.harvard.edu		Huicho, Luis/0000-0002-5272-5885	NHLBI NIH HHS [K25 HL081275] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; [Anonymous], [No title captured]; Beasley R, 2003, PEDIATR CLIN N AM, V50, P539, DOI 10.1016/S0031-3955(03)00050-6; Blumberg SJ, 2005, VITAL HLTH STAT, V1; BUSSE WE, 1994, AM J RESP CRIT CARE, V151, P249; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Chen E, 2003, PSYCHOSOM MED, V65, P984, DOI 10.1097/01.PSY.0000097340.54195.3C; Chen E, 2007, BRAIN BEHAV IMMUN, V21, P993, DOI 10.1016/j.bbi.2007.03.009; Clougherty JE, 2007, ENVIRON HEALTH PERSP, V115, P1140, DOI 10.1289/ehp.9863; Cohen S, 1997, PSYCHOSOM MED, V59, P213, DOI 10.1097/00006842-199705000-00001; Evans GW, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P365; EZZATIRICE TM, 1999, FED COMM STAT METH R; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; GRAHAM NMH, 1986, AM J EPIDEMIOL, V124, P389, DOI 10.1093/oxfordjournals.aje.a114409; Gupta RS, 2008, J ALLERGY CLIN IMMUN, V121, P639, DOI 10.1016/j.jaci.2007.11.036; Harrison BDW, 1998, THORAX, V53, P519, DOI 10.1136/thx.53.6.519; Jeffrey J, 2006, PUBLIC HEALTH REP, V121, P720, DOI 10.1177/003335490612100612; Kawachi I, 2006, J TRAUMA STRESS, V19, P195, DOI 10.1002/jts.20108; Kawachi I, 2007, J EPIDEMIOL COMMUN H, V61, P3, DOI 10.1136/jech.2005.045203; Kawachi I., 2003, NEIGHBORHOODS HLTH; Keeter S, 2000, PUBLIC OPIN QUART, V64, P125, DOI 10.1086/317759; Maddox L, 2002, ANNU REV MED, V53, P477, DOI 10.1146/annurev.med.53.082901.103921; MITCHELL M, 2005, STRATEGICALLY USING; Moore YF, 2004, IMMUNOGENETICS, V56, P1, DOI 10.1007/s00251-004-0661-6; NADEL JA, 1984, ANNU REV MED, V35, P451, DOI 10.1146/annurev.med.35.1.451; O'Campo P, 2003, AM J EPIDEMIOL, V157, P9, DOI 10.1093/aje/kwf171; O'Neil R, 2001, J APPL DEV PSYCHOL, V22, P135, DOI 10.1016/S0193-3973(01)00073-9; PEARCE N, 1998, ASTHMA EPIDEMIOLOGY; Pedlow S., 2007, MULTIPLE IMPUTATION; Sampson RJ, 2003, PERSPECT BIOL MED, V46, pS53, DOI 10.1353/pbm.2003.0073; Sandberg S, 2000, LANCET, V356, P982, DOI 10.1016/S0140-6736(00)02715-X; Sandel M, 2006, ARCH DIS CHILD, V91, P942, DOI 10.1136/adc.2006.098376; *UCLA, 2008, APPL SURV DAT AN STA, V9; Walker B, 2003, J NATL MED ASSOC, V95, P152; Wolf JM, 2008, BRAIN BEHAV IMMUN, V22, P433, DOI 10.1016/j.bbi.2007.10.016; Wright RJ, 2005, CURR OPIN ALLERGY CL, V5, P23, DOI 10.1097/00130832-200502000-00006; Wright RJ, 1998, THORAX, V53, P1066, DOI 10.1136/thx.53.12.1066; Wright RJ, 2004, J ALLERGY CLIN IMMUN, V113, P1051, DOI 10.1016/j.jaci.2004.03.032; Wright RJ, 2004, AM J PUBLIC HEALTH, V94, P625, DOI 10.2105/AJPH.94.4.625; Wright RJ, 2002, AM J RESP CRIT CARE, V165, P358, DOI 10.1164/ajrccm.165.3.2102016; WRIGHT RJ, 2001, ENV HLTH PERSPECTIVE, V109; Wright RJ, 2007, CHEST, V132, p757S, DOI 10.1378/chest.07-1904; Wright RJ, 2007, PAEDIATR PERINAT EP, V21, P8, DOI 10.1111/j.1365-3016.2007.00879.x; Wright RJ, 2006, CLIN CHEST MED, V27, P413, DOI 10.1016/j.ccm.2006.04.003	44	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6091	10.1371/journal.pone.0006091	http://dx.doi.org/10.1371/journal.pone.0006091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	464OU	19564923	Green Submitted, Green Published, gold			2022-12-27	WOS:000267515700010
J	Guo, XZ; Mak, KK; Taketo, MM; Yang, YZ				Guo, Xizhi; Mak, Kinglun Kingston; Taketo, Makoto M.; Yang, Yingzi			The Wnt/beta-Catenin Pathway Interacts Differentially with PTHrP Signaling to Control Chondrocyte Hypertrophy and Final Maturation	PLOS ONE			English	Article								Sequential proliferation, hypertrophy and maturation of chondrocytes are required for proper endochondral bone development and tightly regulated by cell signaling. The canonical Wnt signaling pathway acts through beta-catenin to promote chondrocyte hypertrophy whereas PTHrP signaling inhibits it by holding chondrocytes in proliferating states. Here we show by genetic approaches that chondrocyte hypertrophy and final maturation are two distinct developmental processes that are differentially regulated by Wnt/beta-catenin and PTHrP signaling. Wnt/beta-catenin signaling regulates initiation of chondrocyte hypertrophy by inhibiting PTHrP signaling activity, but it does not regulate PTHrP expression. In addition, Wnt/beta-catenin signaling regulates chondrocyte hypertrophy in a non-cell autonomous manner and Gdf5/Bmp signaling may be one of the downstream pathways. Furthermore, Wnt/beta-catenin signaling also controls final maturation of hypertrophic chondrocytes, but such regulation is PTHrP signaling-independent.			Guo, XZ (corresponding author), NHGRI, Dev Genet Sect, Bethesda, MD 20892 USA.	yingzi@mail.nih.gov		Mak, Kingston King-Lun/0000-0002-4733-9146; Guo, Xizhi/0000-0001-8047-6049	Intramural NIH HHS Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000187, Z01HG000187] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Chung UI, 1998, P NATL ACAD SCI USA, V95, P13030, DOI 10.1073/pnas.95.22.13030; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Long FX, 2001, DEVELOPMENT, V128, P5099; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; NAKASE T, 1994, BONE MINER, V26, P109, DOI 10.1016/S0169-6009(08)80056-6; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Solomon Lauren A., 2008, Birth Defects Research, V84, P123, DOI 10.1002/bdrc.20124; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161; Tsumaki N, 2002, J BONE MINER RES, V17, P898, DOI 10.1359/jbmr.2002.17.5.898; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; ZHU M, 2008, J BONE MINER RES	36	57	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6067	10.1371/journal.pone.0006067	http://dx.doi.org/10.1371/journal.pone.0006067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557172	Green Published, Green Submitted, gold			2022-12-27	WOS:000267424600015
J	Soderstrom, H; Jarhult, JD; Olsen, B; Lindberg, RH; Tanaka, H; Fick, J				Soderstrom, Hanna; Jarhult, Josef D.; Olsen, Bjorn; Lindberg, Richard H.; Tanaka, Hiroaki; Fick, Jerker			Detection of the Antiviral Drug Oseltamivir in Aquatic Environments	PLOS ONE			English	Article								Oseltamivir (Tamiflu (R)) is the most important antiviral drug available and a cornerstone in the defence against a future influenza pandemic. Recent publications have shown that the active metabolite, oseltamivir carboxylate (OC), is not degraded in sewage treatment plants and is also persistent in aquatic environments. This implies that OC will be present in aquatic environments in areas where oseltamivir is prescribed to patients for therapeutic use. The country where oseltamivir is used most is Japan, where it is used to treat seasonal flu. We measured the levels of OC in water samples from the Yodo River system in the Kyoto and Osaka prefectures, Japan, taken before and during the flu-season 2007/8. No OC was detected before the flu-season but 2-58 ng L(-1) was detected in the samples taken during the flu season. This study shows, for the first time, that low levels of oseltamivir can be found in the aquatic environment. Therefore the natural reservoir of influenza virus, dabbling ducks, is exposed to oseltamivir, which could promote the evolution of viral resistance.			Soderstrom, H (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	jerker.fick@chem.umu.se	Berglund Fick, Jerker/HDO-5788-2022; Lindberg, Richard/C-8882-2013; Jarhult, Josef D./ABE-8149-2020	Jarhult, Josef D./0000-0002-7075-1059; Olsen, Bjorn/0000-0002-4646-691X; Soderstrom, Hanna/0000-0003-1341-7879; Fick, Jerker/0000-0002-3949-7371				ACCINELLI C, 2007, INT J ENVIRON AN CH, V8, P570; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Fick J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000986; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Sacca ML, 2009, CHEMOSPHERE, V75, P28, DOI 10.1016/j.chemosphere.2008.11.060; Singer AC, 2008, ENVIRON HEALTH PERSP, V116, P1563, DOI 10.1289/ehp.11310; Singer AC, 2007, ENVIRON HEALTH PERSP, V115, P102, DOI 10.1289/ehp.9574; Sweetman S. C., 2007, MARTINDALE COMPLETE; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, 2005, WHO DRUG INFORM, V19, P273	14	56	57	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6064	10.1371/journal.pone.0006064	http://dx.doi.org/10.1371/journal.pone.0006064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557131	Green Submitted, Green Published, gold			2022-12-27	WOS:000267424600012
J	Rupp, J; Pfleiderer, L; Jugert, C; Moeller, S; Klinger, M; Dalhoff, K; Solbach, W; Stenger, S; Laskay, T; van Zandbergen, G				Rupp, Jan; Pfleiderer, Lisa; Jugert, Christiane; Moeller, Sonja; Klinger, Matthias; Dalhoff, Klaus; Solbach, Werner; Stenger, Steffen; Laskay, Tamas; van Zandbergen, Ger			Chlamydia pneumoniae Hides inside Apoptotic Neutrophils to Silently Infect and Propagate in Macrophages	PLOS ONE			English	Article								Background: Intracellular pathogens have developed elaborate strategies for silent infection of preferred host cells. Chlamydia pneumoniae is a common pathogen in acute infections of the respiratory tract (e.g. pneumonia) and associated with chronic lung sequelae in adults and children. Within the lung, alveolar macrophages and polymorph nuclear neutrophils (PMN) are the first line of defense against bacteria, but also preferred host phagocytes of chlamydiae. Methodology/Principal Findings: We could show that C. pneumoniae easily infect and hide inside neutrophil granulocytes until these cells become apoptotic and are subsequently taken up by macrophages. C. pneumoniae infection of macrophages via apoptotic PMN results in enhanced replicative activity of chlamydiae when compared to direct infection of macrophages, which results in persistence of the pathogen. Inhibition of the apoptotic recognition of C. pneumoniae infected PMN using PS-masking Annexin A5 significantly lowered the transmission of chlamydial infection to macrophages. Transfer of apoptotic C. pneumoniae infected PMN to macrophages resulted in an increased TGF-beta production, whereas direct infection of macrophages with chlamydiae was characterized by an enhanced TNF-alpha response. Conclusions/Significance: Taken together, our data suggest that C. pneumoniae uses neutrophil granulocytes to be silently taken up by long-lived macrophages, which allows for efficient propagation and immune protection within the human host.			Rupp, J (corresponding author), Univ Lubeck, Inst Med Microbiol & Hyg, Lubeck, Germany.	jan.rupp@uk-sh.de; Ger.Zandbergen@uniklinik-ulm.de	van Zandbergen, Ger/M-1571-2013; Solbach, Werner/O-8582-2015; Poubelle, Patrice E/G-6537-2013; Rupp, Jan/C-8794-2011; Solbach, Werner/F-9217-2012; Laskay, Tamás/E-9190-2013	Solbach, Werner/0000-0002-3608-8652; Rupp, Jan/0000-0001-8722-1233; Laskay, Tamás/0000-0002-4212-8366				Afonso L, 2008, J LEUKOCYTE BIOL, V84, P389, DOI 10.1189/jlb.0108018; Bartels C, 1999, CIRCULATION, V99, P879, DOI 10.1161/01.CIR.99.7.879; Blasi F, 2004, EUR RESPIR J, V23, P499, DOI 10.1183/09031936.04.00001004; Boman J, 1998, J INFECT DIS, V178, P274, DOI 10.1086/517452; Byrne GI, 2004, NAT REV MICROBIOL, V2, P802, DOI 10.1038/nrmicro1007; Byrne GI, 2003, P NATL ACAD SCI USA, V100, P8040, DOI 10.1073/pnas.1533181100; Cirino F, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-23; Dreses-Werringloer U, 2006, AM J MED SCI, V332, P168, DOI 10.1097/00000441-200610000-00003; Gaydos CA, 1996, INFECT IMMUN, V64, P1614, DOI 10.1128/IAI.64.5.1614-1620.1996; Gieffers J, 2004, EUR RESPIR J, V23, P506, DOI 10.1183/09031936.04.00093304; Gieffers J, 2001, CIRCULATION, V103, P351; Gueinzius K, 2008, ATHEROSCLEROSIS, V198, P256, DOI 10.1016/j.atherosclerosis.2007.10.014; Jahn HU, 2000, J INFECT DIS, V182, P1678, DOI 10.1086/317608; KaukorantaTolvanen SSE, 1996, MICROB PATHOGENESIS, V21, P215, DOI 10.1006/mpat.1996.0056; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; MAASS M, 1995, AM J CLIN PATHOL, V103, P141; Maurer AP, 2007, PLOS PATHOG, V3, P752, DOI 10.1371/journal.ppat.0030083; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Peters J, 2005, CELL MICROBIOL, V7, P1099, DOI 10.1111/j.1462-5822.2005.00534.x; Quinn TC, 1999, AM HEART J, V138, pS507, DOI 10.1016/S0002-8703(99)70287-5; REGISTER KB, 1987, INFECT IMMUN, V55, P2420, DOI 10.1128/IAI.55.10.2420-2427.1987; Rodriguez N, 2005, J IMMUNOL, V174, P4836, DOI 10.4049/jimmunol.174.8.4836; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Rupp J, 2005, P NATL ACAD SCI USA, V102, P3447, DOI 10.1073/pnas.0407759102; Rupp J, 2005, FEMS MICROBIOL LETT, V242, P203, DOI 10.1016/j.femsle.2004.11.010; Rupp J, 2003, EUR RESPIR J, V22, P274, DOI 10.1183/09031936.03.00007303; RUPP J, 2007, CELL MICROBIOL; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; van Zandbergen G, 2004, J IMMUNOL, V172, P1768, DOI 10.4049/jimmunol.172.3.1768; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Wizel B, 2002, J IMMUNOL, V169, P2524, DOI 10.4049/jimmunol.169.5.2524; Wolf K, 2005, INFECT IMMUN, V73, P4560, DOI 10.1128/IAI.73.8.4560-4570.2005; Yang J, 2003, INFECT IMMUN, V71, P614, DOI 10.1128/IAI.71.2.614-620.2003; YANG ZP, 1994, J INFECT DIS, V170, P464, DOI 10.1093/infdis/170.2.464; Ying SM, 2006, INFECT IMMUN, V74, P6057, DOI 10.1128/IAI.00760-06	36	50	53	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6020	10.1371/journal.pone.0006020	http://dx.doi.org/10.1371/journal.pone.0006020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547701	Green Published, gold, Green Submitted			2022-12-27	WOS:000267347900015
J	Packer, C; Kosmala, M; Cooley, HS; Brink, H; Pintea, L; Garshelis, D; Purchase, G; Strauss, M; Swanson, A; Balme, G; Hunter, L; Nowell, K				Packer, Craig; Kosmala, Margaret; Cooley, Hilary S.; Brink, Henry; Pintea, Lilian; Garshelis, David; Purchase, Gianetta; Strauss, Megan; Swanson, Alexandra; Balme, Guy; Hunter, Luke; Nowell, Kristin			Sport Hunting, Predator Control and Conservation of Large Carnivores	PLOS ONE			English	Article								Sport hunting has provided important economic incentives for conserving large predators since the early 1970's, but wildlife managers also face substantial pressure to reduce depredation. Sport hunting is an inherently risky strategy for controlling predators as carnivore populations are difficult to monitor and some species show a propensity for infanticide that is exacerbated by removing adult males. Simulation models predict population declines from even moderate levels of hunting in infanticidal species, and harvest data suggest that African countries and U. S. states with the highest intensity of sport hunting have shown the steepest population declines in African lions and cougars over the past 25 yrs. Similar effects in African leopards may have been masked by mesopredator release owing to declines in sympatric lion populations, whereas there is no evidence of overhunting in non-infanticidal populations of American black bears. Effective conservation of these animals will require new harvest strategies and improved monitoring to counter demands for predator control by livestock producers and local communities.			Packer, C (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	packer@umn.edu	Hunter, Luke T.B./H-3324-2019	Hunter, Luke T.B./0000-0001-9653-6544				Anderson CR, 2005, WILDLIFE SOC B, V33, P179, DOI 10.2193/0091-7648(2005)33[179:EEOPTA]2.0.CO;2; [Anonymous], [No title captured]; Bailey T., 1993, AFRICAN LEOPARD ECOL, P429; Balme G.A., 2004, ECOL J, V6, P1; BALME GA, 2009, THESIS U KWAZULU NAT, P1; BALME GA, BIOL CONSER IN PRESS; BARNETT R, 2006, SPORT HUNTING SADC R; Beinart W, 1998, PAST PRESENT, P172; Child B., 2004, PARKS TRANSITION BIO; COOLEY HS, 2008, THESIS WASHINGTON ST; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Craft ME, 2009, P ROY SOC B-BIOL SCI, V276, P1777, DOI 10.1098/rspb.2008.1636; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Czetwertynski SM, 2007, URSUS, V18, P1, DOI 10.2192/1537-6176(2007)18[1:EOHODP]2.0.CO;2; Fryxell JM, 2005, OIKOS, V111, P143, DOI 10.1111/j.0030-1299.2005.13840.x; Garshelis DL, 2006, URSUS, V17, P1, DOI 10.2192/1537-6176(2006)17[1:SAPEOA]2.0.CO;2; Greene C, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P271; Grimm V, 2005, CONSERV BIOL, V19, P578, DOI 10.1111/j.1523-1739.2005.000163.x; Group ICS, 2006, CONSERVATION STRATEG; Hall RJ, 2008, CONSERV LETT, V1, P75, DOI 10.1111/j.1755-263X.2008.00013.x; Haydon DT, 2004, ECOLOGY, V85, P78, DOI 10.1890/02-8001; Hristienko H, 2007, URSUS, V18, P72, DOI 10.2192/1537-6176(2007)18[72:GITSCA]2.0.CO;2; Kissui BM, 2008, ANIM CONSERV, V11, P422, DOI 10.1111/j.1469-1795.2008.00199.x; KNAPP A, 2006, REV EUROPEAN UNIONS; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; Laundre JW, 2000, WILDLIFE SOC B, V28, P963; Leuteritz T.E., 2008, IUCN RED LIST THREAT; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; MAEHR DS, 1992, J WILDLIFE MANAGE, V56, P700, DOI 10.2307/3809463; MARTIN RB, 1988, SURVEY STATUS LEOPAR; Martorello D.A, 2003, P 7 MOUNTAIN LION WO, P129; McLellan BN, 2005, URSUS, V16, P141, DOI 10.2192/1537-6176(2005)016[0141:SSIIGB]2.0.CO;2; Milner-Gulland EJ, 2003, NATURE, V422, P135, DOI 10.1038/422135a; *OR DEP FISH WILDL, 2006, 2006 OREG COUG MAN P; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Packer C., 1988, P363; Packer C, 2001, SCIENCE, V293, P690, DOI 10.1126/science.1062320; PACKER C, 1995, AM NAT, V145, P833, DOI 10.1086/285771; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; Purchase G., 2008, STATE KNOWLEDGE REGA; Riley SJ, 2004, BIOL CONSERV, V119, P575, DOI 10.1016/j.biocon.2004.01.019; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Stoner DC, 2006, J WILDLIFE MANAGE, V70, P1588, DOI 10.2193/0022-541X(2006)70[1588:CELIUI]2.0.CO;2; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; *UNEP WCMC, 2004, GUID INT OUTP CITES; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Whitman K. L., 2007, HUNTERS GUIDE AGING; Woodroffe R, 2001, CONSERV BIOL SER, V5, P61; [No title captured]	51	147	151	4	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5941	10.1371/journal.pone.0005941	http://dx.doi.org/10.1371/journal.pone.0005941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536277	Green Submitted, Green Published, gold			2022-12-27	WOS:000267029700012
J	Sinha, IP; Williamson, PR; Smyth, RL				Sinha, Ian P.; Williamson, Paula R.; Smyth, Rosalind L.			Outcomes in Clinical Trials of Inhaled Corticosteroids for Children with Asthma Are Narrowly Focussed on Short Term Disease Activity	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; BURDEN; BIAS	Background: Little work has been done to determine which outcomes should be measured in randomised controlled trials (RCTs) in children with asthma. Drug regulatory authorities require that short term disease activity is measured, but other outcome domains are not mandatory for licensing and marketing purposes. We aimed to identify whether any domains were underrepresented in RCTs of regular therapies for children with asthma over a 20 year period, and to examine what consistency there was between RCTs in the outcomes used to assess the domains. Methodology/Principal Findings: By searching the Cochrane Central Register of Controlled Trials in January 2008, we identified all parallel-group RCTs, published between January 1988 and December 2007, which assessed inhaled corticosteroids (ICS) as regular therapy for children with asthma. We evaluated how frequently RCTs measured the following pre-defined domains: disease activity; disease damage; functional status; quality of life; health resource utilisation; and adverse effects of therapy. Our initial search identified 1668 abstracts, of which 412 were retrieved in full. 159 RCTs, of which 115 involved only children and 44 involved children and adults, were included in the review. Disease activity was measured in 157 RCTs, adverse effects of ICS in 135, functional status in 25, quality of life in 21, and health resource utilisation in 17. No RCT measured long term disease damage, although two used FEV1 as a measure of 'lung growth'. RCTs were inconsistent in the outcomes used to measure the domains. Conclusions: Short term disease activity is the most frequently measured outcome domain in RCTs in children with asthma. Effects of regular therapies on functional status, quality of life, and long term consequences of asthma are infrequently assessed. A core set of outcomes, developed using consensus techniques, would standardise the measurement of appropriate outcomes in these RCTs. Involving patients would identify outcomes which are most relevant from their perspective.			Sinha, IP (corresponding author), Univ Liverpool, Inst Child Hlth, Liverpool L69 3BX, Merseyside, England.	iansinha79@doctors.org.uk	Williamson, Paula R/B-6425-2016	Williamson, Paula R/0000-0001-9802-6636	Medical Research Council [G0800792] Funding Source: Medline; Department of Health Funding Source: Medline; MRC [G0800792] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altman D.G., 1991, PRACTICAL STATISTIC; Bacharier LB, 2004, AM J RESP CRIT CARE, V170, P426, DOI 10.1164/rccm.200308-1178OC; Barnes PJ, 2004, RESP MED, V98, pS4, DOI 10.1016/j.rmed.2004.07.009; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Clarke M, 2008, PLOS MED, V5, P521, DOI 10.1371/journal.pmed.0050102; Clarke M, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-39; Duncan PW, 2000, STROKE, V31, P1429, DOI 10.1161/01.STR.31.6.1429; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; *EUR MED AG, 2007, REQ CLIN DOC OR INH; *EUR MED AG, 1993, REPL CHLOR MET DOS I; *EUR MED AG, 2002, CLIN INV MED PROD TR; European Medicines Agency, 2004, POINTS CONS REQ CLIN; Gandhi GY, 2008, JAMA-J AM MED ASSOC, V299, P2543, DOI 10.1001/jama.299.21.2543; Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202; Hewlett S, 2005, MUSCULOSKELET CARE, V3, P131, DOI 10.1002/msc.3; *J LIND ALL, 2007, DESCR WORKSH SET PRI; Juniper EF, 2004, EUR RESPIR J, V23, P287, DOI 10.1183/09031936.04.00064204; Martinez FD, 2002, PEDIATRICS, V109, P362; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Mease PJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P952, DOI 10.1002/art.23826; Merkus PJFM, 2004, EUR RESPIR J, V23, P861, DOI 10.1183/09031936.04.00031504; Miller FW, 2001, RHEUMATOLOGY, V40, P1262, DOI 10.1093/rheumatology/40.11.1262; MUIRDEN KD, 1993, J RHEUMATOL, V20, P527; O'Connell EJ, 2004, ALLERGY, V59, P7, DOI 10.1111/j.1398-9995.2004.00563.x; Paton J, 2006, ARCH DIS CHILD, V91, P808, DOI 10.1136/adc.2005.087247; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Pocock S.J., 2013, CLIN TRIALS PRACTICA; Sinha I, 2008, PLOS MED, V5, P569, DOI 10.1371/journal.pmed.0050096; Skoner DP, 2002, PEDIATRICS, V109, P393; Smith MA, 1996, AUST NZ J PUBL HEAL, V20, P69, DOI 10.1111/j.1467-842X.1996.tb01340.x; Stahl E, 2000, RESP MED, V94, P735, DOI 10.1053/rmed.2000.0814; Sterk PJ, 1999, EUR RESPIR J, V14, P1435, DOI 10.1183/09031936.99.14614359; TUGWELL P, 1993, J RHEUMATOL, V20, P555; Tugwell P, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-38; Turk DC, 2008, PAIN, V137, P276, DOI 10.1016/j.pain.2007.09.002; *US DEP HHS, 1994, GUID IND CLIN DEV PR; *US DEP HHS, 2007, GUID IND OR INH INTR; Visser MJ, 2004, EUR RESPIR J, V24, P420, DOI 10.1183/09031936.04.00023904; Williamson PR, 2005, STAT METHODS MED RES, V14, P515, DOI 10.1191/0962280205sm415oa	40	41	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6276	10.1371/journal.pone.0006276	http://dx.doi.org/10.1371/journal.pone.0006276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609438	Green Submitted, Green Published, gold			2022-12-27	WOS:000268119500011
J	Thornhill, DJ; Xiang, Y; Fitt, WK; Santos, SR				Thornhill, Daniel J.; Xiang, Yu; Fitt, William K.; Santos, Scott R.			Reef Endemism, Host Specificity and Temporal Stability in Populations of Symbiotic Dinoflagellates from Two Ecologically Dominant Caribbean Corals	PLOS ONE			English	Article								Background: The dinoflagellate genus Symbiodinium forms symbioses with numerous protistan and invertebrate metazoan hosts. However, few data on symbiont genetic structure are available, hindering predictions of how these populations and their host associations will fair in the face of global climate change. Methodology/Principal Findings: Here, Symbiodinium population structure from two of the Caribbean's ecologically dominant scleractinian corals, Montastraea faveolata and M. annularis, was examined. Tagged colonies on Florida Keys and Bahamian (i.e., Exuma Cays) reefs were sampled from 2003 -2005 and their Symbiodinium diversity assessed via internal transcribed spacer 2 (ITS2) rDNA and three Symbiodinium Clade B-specific microsatellite loci. Generally, the majority of host individuals at a site harbored an identical Symbiodinium ITS2 "type'' B1 microsatellite genotype. Notably, symbiont genotypes were largely reef endemic, suggesting a near absence of dispersal between populations. Relative to the Bahamas, sympatric M. faveolata and M. annularis in the Florida Keys harbored unique Symbiodinium populations, implying regional host specificity in these relationships. Furthermore, within-colony Symbiodinium population structure remained stable through time and environmental perturbation, including a prolonged bleaching event in 2005. Conclusions/Significance: Taken together, the population-level endemism, specificity and stability exhibited by Symbiodinium raises concerns about the long-term adaptive capacity and persistence of these symbioses in an uncertain future of climate change.			Thornhill, DJ (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	thornhill.dan@gmail.com	Santos, Scott R/A-7472-2009					Andras JP, 2009, MOL ECOL RESOUR, V9, P989, DOI 10.1111/j.1755-0998.2009.02549.x; Ayre DJ, 2000, EVOLUTION, V54, P1590; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Bay LK, 2006, MAR BIOL, V149, P1247, DOI 10.1007/s00227-006-0276-6; Benzie JAH, 1997, EVOLUTION, V51, P768, DOI 10.1111/j.1558-5646.1997.tb03660.x; BLANK RJ, 1987, MAR BIOL, V94, P143, DOI 10.1007/BF00392906; Bode M, 2006, MAR ECOL PROG SER, V308, P17, DOI 10.3354/meps308017; Budd AE, 2004, PALEOBIOLOGY, V30, P396, DOI 10.1666/0094-8373(2004)030<0396:OSBAHW>2.0.CO;2; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Carlon DB, 2008, MOL ECOL RESOUR, V8, P870, DOI 10.1111/j.1755-0998.2008.02095.x; Carlos AA, 1999, J PHYCOL, V35, P1054, DOI 10.1046/j.1529-8817.1999.3551054.x; CHANG FH, 1983, NEW ZEAL J MAR FRESH, V17, P279, DOI 10.1080/00288330.1983.9516003; CHANG SS, 1983, MAR BIOL, V76, P219, DOI 10.1007/BF00393021; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; Coffroth MA, 2006, CURR BIOL, V16, pR985, DOI 10.1016/j.cub.2006.10.049; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Coyne J.A., 2004, SPECIATION; DOHERTY PJ, 1995, ECOLOGY, V76, P2373, DOI 10.2307/2265814; Fitt W.K., 1985, PROC 5 TH INT CORAL, V6, P131; FITT WK, 1983, NEW PHYTOL, V94, P421, DOI 10.1111/j.1469-8137.1983.tb03456.x; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Foster NL, 2007, J ANIM ECOL, V76, P384, DOI 10.1111/j.1365-2656.2006.01207.x; FREUDENTHAL HD, 1962, J PROTOZOOL, V9, P45, DOI 10.1111/j.1550-7408.1962.tb02579.x; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; Gou WL, 2003, J EXP MAR BIOL ECOL, V296, P135, DOI 10.1016/S0022-0981(03)00242-9; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Howells EJ, 2009, CORAL REEFS, V28, P215, DOI 10.1007/s00338-008-0450-z; IGLESIASPRIETO R, 1994, MAR ECOL PROG SER, V113, P163, DOI 10.3354/meps113163; Kemp DW, 2008, CORAL REEFS, V27, P289, DOI 10.1007/s00338-007-0333-8; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; Kirk NL, 2009, MAR BIOL, V156, P1609, DOI 10.1007/s00227-009-1196-z; Kirk NL, 2005, BIOL BULL-US, V209, P227, DOI 10.2307/3593112; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Lewis CL, 2004, SCIENCE, V304, P1490, DOI 10.1126/science.1097323; LOEBLICH AR, 1979, J MAR BIOL ASSOC UK, V59, P195, DOI 10.1017/S0025315400046270; Magalon H, 2006, MAR BIOL, V148, P913, DOI 10.1007/s00227-005-0133-z; Manning MM, 2008, LIMNOL OCEANOGR, V53, P1853, DOI 10.4319/lo.2008.53.5.1853; Maruyama T, 1997, MAR BIOL, V127, P473, DOI 10.1007/s002270050035; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; MUSCATINE L, 1979, PROC R SOC SER B-BIO, V204, P131, DOI 10.1098/rspb.1979.0018; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pettay DT, 2007, MOL ECOL NOTES, V7, P1271, DOI 10.1111/j.1471-8286.2007.01852.x; PFIESTER LA, 1987, DINOFLAGELLATE REPRO, P611; Porto I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002160; Richards VP, 2007, MOL ECOL, V16, P139, DOI 10.1111/j.1365-294X.2006.03145.x; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Santos SR, 2004, J PHYCOL, V40, P395, DOI 10.1111/j.1529-8817.2004.03186.x; Santos SR, 2004, MOL ECOL, V13, P459, DOI 10.1046/j.1365-294X.2003.02058.x; Santos SR, 2003, MAR BIOL, V143, P111, DOI 10.1007/s00227-003-1065-0; Santos SR, 2003, BIOL BULL-US, V204, P10, DOI 10.2307/1543491; SCHOENBERG DA, 1980, PROC R SOC SER B-BIO, V207, P405, DOI 10.1098/rspb.1980.0031; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; STEELE RD, 1977, B MAR SCI, V27, P591; STEELE RD, 1975, BIOL BULL, V149, P590, DOI 10.2307/1540389; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; SZMANT AM, 1991, MAR ECOL PROG SER, V74, P13, DOI 10.3354/meps074013; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Thornhill DJ, 2006, CORAL REEFS, V25, P515, DOI 10.1007/s00338-006-0157-y; Thornhill DJ, 2006, J EXP MAR BIOL ECOL, V338, P50, DOI 10.1016/j.jembe.2006.06.032; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Toller WW, 2001, BIOL BULL, V201, P348, DOI 10.2307/1543613; TRENCH RK, 1979, ANNU REV PLANT PHYS, V30, P485, DOI 10.1146/annurev.pp.30.060179.002413; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Yakovleva IM, 2009, MAR ECOL PROG SER, V378, P105, DOI 10.3354/meps07857	75	96	97	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6262	10.1371/journal.pone.0006262	http://dx.doi.org/10.1371/journal.pone.0006262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603078	Green Submitted, Green Published, gold			2022-12-27	WOS:000268035700010
J	Banks, GT; Bros-Facer, V; Williams, HP; Chia, R; Achilli, F; Bryson, JB; Greensmith, L; Fisher, EMC				Banks, Gareth T.; Bros-Facer, Virginie; Williams, Hazel P.; Chia, Ruth; Achilli, Francesca; Bryson, J. Barney; Greensmith, Linda; Fisher, Elizabeth M. C.			Mutant Glycyl-tRNA Synthetase (Gars) Ameliorates SOD1(G93A) Motor Neuron Degeneration Phenotype but Has Little Affect on Loa Dynein Heavy Chain Mutant Mice	PLOS ONE			English	Article								Background: In humans, mutations in the enzyme glycyl-tRNA synthetase (GARS) cause motor and sensory axon loss in the peripheral nervous system, and clinical phenotypes ranging from Charcot-Marie-Tooth neuropathy to a severe infantile form of spinal muscular atrophy. GARS is ubiquitously expressed and may have functions in addition to its canonical role in protein synthesis through catalyzing the addition of glycine to cognate tRNAs. Methodology/Principal Findings: We have recently described a new mouse model with a point mutation in the Gars gene resulting in a cysteine to arginine change at residue 201. Heterozygous Gars(C201R/+) mice have locomotor and sensory deficits. In an investigation of genetic mutations that lead to death of motor and sensory neurons, we have crossed the Gars(C201R/+) mice to two other mutants: the TgSOD1(G93A) model of human amyotrophic lateral sclerosis and the Legs at odd angles mouse (Dync1h1(Loa)) which has a defect in the heavy chain of the dynein complex. We found the Dync1h1(Loa/+); Gars(C201R/+) double heterozygous mice are more impaired than either parent, and this is may be an additive effect of both mutations. Surprisingly, the Gars(C201R) mutation significantly delayed disease onset in the SOD1(G93A); Gars(C201R/+) double heterozygous mutant mice and increased lifespan by 29% on the genetic background investigated. Conclusions/Significance: These findings raise intriguing possibilities for the study of pathogenetic mechanisms in all three mouse mutant strains.			Banks, GT (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, London, England.	e.fisher@prion.ucl.ac.uk	Chia, Ruth/AAF-4900-2021; Fisher, Elizabeth MC/C-2168-2008	Chia, Ruth/0000-0002-4709-7423; Fisher, Elizabeth MC/0000-0003-2850-9936; Bryson, J. Barney/0000-0001-5486-0258; Banks, Gareth/0000-0002-8647-667X	MRC [G0601943, G0500288] Funding Source: UKRI; Medical Research Council [G0601943B] Funding Source: researchfish; Medical Research Council [G0601943, G0500288] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Achilli F, 2005, AMYOTROPH LATERAL SC, V6, P111, DOI 10.1080/14660820510035351; ACHILLI F, 2009, DIS MOD MEC IN PRESS; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Banks GT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-214; BANKS GT, 2008, MAMM GENOME; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; Del Bo R, 2006, NEUROLOGY, V66, P752, DOI 10.1212/01.wnl.0000201275.18875.ac; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Dubourg O, 2006, NEUROLOGY, V66, P1721, DOI 10.1212/01.wnl.0000218304.02715.04; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; James PA, 2006, NEUROLOGY, V67, P1710, DOI 10.1212/01.wnl.0000242619.52335.bc; James PA, 2006, BBA-MOL BASIS DIS, V1762, P986, DOI 10.1016/j.bbadis.2006.04.003; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kawamata H, 2008, J BIOL CHEM, V283, P28321, DOI 10.1074/jbc.M805599200; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; Kieran D, 2004, NEUROSCIENCE, V125, P427, DOI 10.1016/j.neuroscience.2004.01.046; Kunst CB, 2000, GENOMICS, V70, P181, DOI 10.1006/geno.2000.6379; Kunst CB, 1997, NAT GENET, V15, P91, DOI 10.1038/ng0197-91; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Monani UR, 2000, HUM MOL GENET, V9, P2451, DOI 10.1093/hmg/9.16.2451; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Parman Y, 2007, CURR OPIN NEUROL, V20, P542, DOI 10.1097/WCO.0b013e32826fbcb7; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schymick JC, 2007, HUM MOL GENET, V16, pR233, DOI 10.1093/hmg/ddm215; Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590; SKRE H, 1974, CLIN GENET, V6, P98; Sumner CJ, 2007, J CHILD NEUROL, V22, P979, DOI 10.1177/0883073807305787; Teuchert M, 2006, EXP NEUROL, V198, P271, DOI 10.1016/j.expneurol.2005.12.005; Valdmanis PN, 2008, NEUROLOGY, V70, P144, DOI 10.1212/01.wnl.0000296811.19811.db; Van den Bosch L, 2006, CURR NEUROL NEUROSCI, V6, P423, DOI 10.1007/s11910-996-0024-9; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228	41	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6218	10.1371/journal.pone.0006218	http://dx.doi.org/10.1371/journal.pone.0006218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593442	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035400003
J	Monzani, E; Bazzotti, R; Perego, C; La Porta, CAM				Monzani, Elena; Bazzotti, Riccardo; Perego, Carla; La Porta, Caterina A. M.			AQP1 Is Not Only a Water Channel: It Contributes to Cell Migration through Lin7/Beta-Catenin	PLOS ONE			English	Article							BASOLATERAL MEMBRANE; PROTEIN COMPLEX; AQUAPORIN-1; LIN-7; LOCALIZATION; ASSOCIATION; EXPRESSION; ADHESION; LET-23; FAMILY	Background: AQP1 belongs to aquaporins family, water-specific, membrane-channel proteins expressed in diverse tissues. Recent papers showed that during angiogenesis, AQP1 is expressed preferentially by microvessels, favoring angiogenesis via the increase of permeability In particular, in AQP1 null mice, endothelial cell migration is impaired without altering their proliferation or adhesion. Therefore, AQP1 has been proposed as a novel promoter of tumor angiogenesis. Methods/Findings: Using targeted silencing of AQP1 gene expression, an impairment in the organization of F-actin and a reduced migration capacity was demonstrated in human endothelial and melanoma cell lines. Interestingly, we showed, for the first time, that AQP1 co-immunoprecipitated with Lin-7. Lin7-GFP experiments confirmed co-immunoprecipitation. In addition, the knock down of AQP1 decreased the level of expression of Lin-7 and beta-catenin and the inhibition of proteasome contrasted partially such a decrease. Conclusions/Significance: All together, our findings show that AQP1 plays a role inside the cells through Lin-7/beta-catenin interaction. Such a role of AQP1 is the same in human melanoma and endothelial cells, suggesting that AQP1 plays a global physiological role. A model is presented.			Monzani, E (corresponding author), Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy.	caterina.laporta@unimi.it	Monzani, Elena/AAN-2505-2020; Perego, Carla/L-6147-2015; la porta, caterina/K-7345-2013	Perego, Carla/0000-0003-3027-1779; la porta, caterina/0000-0002-3010-8966				ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cavazzin C, 2006, GLIA, V53, P167, DOI 10.1002/glia.20256; Clapp C, 2006, TRENDS ENDOCRIN MET, V17, P1, DOI 10.1016/j.tem.2005.11.009; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Ebnet K, 2003, J CELL SCI, V116, P3879, DOI 10.1242/jcs.00704; ELENAMONZANI, 2007, EUR J CANCER, V43, P935; Endo M, 1999, MICROVASC RES, V58, P89, DOI 10.1006/mvre.1999.2158; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; La Porta CAM, 2002, MELANOMA RES, V12, P297, DOI 10.1097/00008390-200208000-00001; Landon S, 2004, NATURE REV MOL BIOL, V5, P687; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Monzani E, 2007, CURR DRUG TARGETS, V8, P1132, DOI 10.2174/138945007782151342; Oshio K, 2005, NEUROSURGERY, V56, P375, DOI 10.1227/01.NEU.0000148904.57841.6B; PAPDOPOULOS MC, 2008, PFUGER ARCH, V456, P693; Perego C, 1999, EMBO J, V18, P2384, DOI 10.1093/emboj/18.9.2384; Perego C, 2000, EMBO J, V19, P3978, DOI 10.1093/emboj/19.15.3978; Rodriguez A, 2006, FEBS LETT, V580, P4771, DOI 10.1016/j.febslet.2006.07.080; ROSENGREN S, 1994, AM J PHYSIOL-CELL PH, V267, pC1623, DOI 10.1152/ajpcell.1994.267.6.C1623; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Schwab A, 1999, PFLUG ARCH EUR J PHY, V438, P330, DOI 10.1007/s004240050917; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739, DOI 10.1152/ajprenal.2001.280.5.F739; Schwab A, 2007, PFLUG ARCH EUR J PHY, V453, P421, DOI 10.1007/s00424-006-0138-6; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519	33	89	99	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6167	10.1371/journal.pone.0006167	http://dx.doi.org/10.1371/journal.pone.0006167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584911	Green Submitted, Green Published, gold			2022-12-27	WOS:000267806500004
J	Lima, SQ; Hromadka, T; Znamenskiy, P; Zador, AM				Lima, Susana Q.; Hromadka, Tomas; Znamenskiy, Petr; Zador, Anthony M.			PINP: A New Method of Tagging Neuronal Populations for Identification during In Vivo Electrophysiological Recording	PLOS ONE			English	Article								Neural circuits are exquisitely organized, consisting of many different neuronal subpopulations. However, it is difficult to assess the functional roles of these subpopulations using conventional extracellular recording techniques because these techniques do not easily distinguish spikes from different neuronal populations. To overcome this limitation, we have developed PINP (Photostimulation-assisted Identification of Neuronal Populations), a method of tagging neuronal populations for identification during in vivo electrophysiological recording. The method is based on expressing the light-activated channel channelrhodopsin-2 (ChR2) to restricted neuronal subpopulations. ChR2-tagged neurons can be detected electrophysiologically in vivo since illumination of these neurons with a brief flash of blue light triggers a short latency reliable action potential. We demonstrate the feasibility of this technique by expressing ChR2 in distinct populations of cortical neurons using two different strategies. First, we labeled a subpopulation of cortical neurons-mainly fast-spiking interneurons-by using adeno-associated virus (AAV) to deliver ChR2 in a transgenic mouse line in which the expression of Cre recombinase was driven by the parvalbumin promoter. Second, we labeled subpopulations of excitatory neurons in the rat auditory cortex with ChR2 based on projection target by using herpes simplex virus 1 (HSV1), which is efficiently taken up by axons and transported retrogradely; we find that this latter population responds to acoustic stimulation differently from unlabeled neurons. Tagging neurons is a novel application of ChR2, used in this case to monitor activity instead of manipulating it. PINP can be readily extended to other populations of genetically identifiable neurons, and will provide a useful method for probing the functional role of different neuronal populations in vivo.			Lima, SQ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu		Zador, Anthony/0000-0002-8431-9136; Lima, Susana/0000-0003-2446-9869; Znamenskiy, Petr/0000-0002-4658-6807				Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Cauli B, 1997, J NEUROSCI, V17, P3894; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; GAMES KD, 1988, HEARING RES, V34, P1, DOI 10.1016/0378-5955(88)90047-0; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hefti BJ, 2000, J NEUROPHYSIOL, V83, P2626, DOI 10.1152/jn.2000.83.5.2626; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lilley CE, 2001, J VIROL, V75, P4343, DOI 10.1128/JVI.75.9.4343-4356.2001; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Movshon JA, 1996, J NEUROSCI, V16, P7733; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Preston CM, 2000, J GEN VIROL, V81, P1; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Steriade M, 1998, J NEUROPHYSIOL, V79, P483, DOI 10.1152/jn.1998.79.1.483; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Turner JG, 2005, J NEUROPHYSIOL, V94, P2738, DOI 10.1152/jn.00362.2005; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang Guang Lan, 2006, Immunome Res, V2, P3, DOI 10.1186/1745-7580-2-3; Zhang YP, 2008, P NATL ACAD SCI USA, V105, P12039, DOI 10.1073/pnas.0802940105	46	239	240	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6099	10.1371/journal.pone.0006099	http://dx.doi.org/10.1371/journal.pone.0006099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19584920	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000267806400002
J	Xanthoulea, S; Thelen, M; Pottgens, C; Gijbels, MJJ; Lutgens, E; de Winther, MPJ				Xanthoulea, Sofia; Thelen, Melanie; Pottgens, Chantal; Gijbels, Marion J. J.; Lutgens, Esther; de Winther, Menno P. J.			Absence of p55 TNF Receptor Reduces Atherosclerosis, but Has No Major Effect on Angiotensin II Induced Aneurysms in LDL Receptor Deficient Mice	PLOS ONE			English	Article								Background: The aim of the current study was to investigate the role of p55 TNF Receptor (p55 TNFR), the main signaling receptor for the pro-inflammatory cytokine tumor necrosis factor (TNF), in the development of two vascular disorders: atherosclerosis and angiotensin (Ang) II-induced abdominal aortic aneurysms (AAA). Methodology/Principal Findings: p55 TNFR deficient mice were crossed to an LDL receptor deficient background and were induced for the development of either atherosclerosis or AngII-induced AAA, and compared to littermate controls, wild-type for p55 TNFR expression. p55 TNFR deficient mice developed 43% smaller atherosclerotic lesions in the aortic sinuses compared to controls. Moreover, expression of CD68, a macrophage specific marker, exhibited a 50% reduction in the aortic arches. Decreased atherosclerosis correlated with a strong down-regulation in the expression of adhesion molecules, such as VCAM-1 and ICAM-1, by p55 TNFR deficient endothelium. In addition, expression levels of the pro-inflammatory cytokines and chemokines TNF, IL-6, MCP-1 and RANTES were significantly reduced in aortas of p55 TNFR deficient mice. In contrast, in the AngII-induced model of AAA, p55 TNFR deficiency correlated with a slight trend towards increased aneurismal lethality, but the incidence of aortic rupture due to a dissecting aneurysm, and the expansion of the suprarenal aorta were not significantly different compared to controls. Conclusion/Significance: We found that p55 TNFR expression promotes atherosclerosis, among other mechanisms, by enhancing expression of endothelial adhesion molecules, while it seems to have no major role in the development of AngII-induced AAA.			Xanthoulea, S (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Mol Genet, Maastricht, Netherlands.	dewinther@gen.unimaas.nl	de Winther, Menno/E-8721-2012; Lutgens, Esther/E-2919-2010	Lutgens, Esther/0000-0002-2609-5744; xanthoulea, sofia/0000-0003-4700-3404; Thelen, Melanie/0000-0003-0707-5921; de Winther, Menno/0000-0002-4038-6636				Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Blessing E, 2004, ATHEROSCLEROSIS, V176, P227, DOI 10.1016/j.atherosclerosis.2004.05.033; Boesten LSM, 2005, CARDIOVASC RES, V66, P179, DOI 10.1016/j.cardiores.2005.01.001; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Canault M, 2004, ATHEROSCLEROSIS, V172, P211, DOI 10.1016/j.atherosclerosis.2003.10.004; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Deng GG, 2003, CIRC RES, V92, P510, DOI 10.1161/01.RES.0000061571.49375.E1; FEINGOLD KR, 1989, ENDOCRINOLOGY, V124, P2336, DOI 10.1210/endo-124-5-2336; Fiane AE, 2003, CIRCULATION, V108, P849, DOI 10.1161/01.CIR.0000084550.16565.01; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Hamano K, 2003, WORLD J SURG, V27, P476, DOI 10.1007/s00268-002-6690-0; Hui-Yuen JS, 2006, J IMMUNOL, V176, P6294, DOI 10.4049/jimmunol.176.10.6294; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; King VL, 2009, CIRCULATION, V119, P426, DOI 10.1161/CIRCULATIONAHA.108.785949; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Manning MW, 2002, VASC MED, V7, P45, DOI 10.1191/1358863x02vm413ra; MEMON RA, 1993, ENDOCRINOLOGY, V132, P2246, DOI 10.1210/en.132.5.2246; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; Neumann B, 1996, J IMMUNOL, V156, P1587; Newburger Jane W, 2007, Curr Treat Options Cardiovasc Med, V9, P148, DOI 10.1007/s11936-007-0008-3; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Schonbeck U, 2002, AM J PATHOL, V161, P499, DOI 10.1016/S0002-9440(10)64206-X; Schreyer SA, 1996, J BIOL CHEM, V271, P26174, DOI 10.1074/jbc.271.42.26174; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Xanthoulea S, 2005, CURR OPIN LIPIDOL, V16, P536, DOI 10.1097/01.mol.0000180167.15820.ae; XANTHOULEA S, 2008, CARDIOVASC RES; ZERNECKE A, 2008, ARTERIOSCLER THROMB; Zhang LS, 2007, ARTERIOSCL THROM VAS, V27, P1087, DOI 10.1161/01.ATV.0000261548.49790.63	37	39	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6113	10.1371/journal.pone.0006113	http://dx.doi.org/10.1371/journal.pone.0006113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582157	Green Published, Green Submitted, gold			2022-12-27	WOS:000267806400003
J	Zhang, HJ; Wang, YX; Wu, H; Jin, DY; Wen, YM; Zheng, BJ				Zhang, Hao-Jie; Wang, Yong-Xiang; Wu, Hao; Jin, Dong-Yan; Wen, Yu-Mei; Zheng, Bo-Jian			The Y271 and I274 Amino Acids in Reverse Transcriptase of Human Immunodeficiency Virus-1 Are Critical to Protein Stability	PLOS ONE			English	Article								Reverse transcriptase (RT) of human immunodeficiency virus (HIV)-1 plays a key role in initiating viral replication and is an important target for developing anti-HIV drugs. Our previous study showed that two mutations (Y271A and I274A) in the turn RT (Gln(269)-Arg(277))abrogated viral replication, but the replication capacity and RT activity was discordant. In this study, we further investigated why alanine substitutions at these two sites would affect viral replication. We found that both RT activity and RT protein were almost undetectable in viral particles of these two mutants, although the Pr160(gag-pol) mutants were properly expressed, transported and incorporated. Using protease inhibition assay, we demonstrated a correlation between the degradation of the RT mutants and the activity of viral protease. Our native gel analysis indicated that the mutations at 271 and 274 amino acids might cause conformational changes, leading to the formation of higher order oligomers instead of dimers, resulting in increased protein instability and susceptibility to viral protease. Thus, residues 271 and 274 are critical to RT stability and resistance to viral protease. The conservation of the two amino acid residues among different strains of HIV-1 lent further support to this conclusion. The knowledge gained here may prove useful in drug design.			Zhang, HJ (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	ymwen@shmu.edu.cn; bzheng@hkucc.hku.hk	wen, yu/AAJ-7482-2021					Abram ME, 2005, J VIROL, V79, P11952, DOI 10.1128/JVI.79.18.11952-11961.2005; Beard WA, 1996, J BIOL CHEM, V271, P12213, DOI 10.1074/jbc.271.21.12213; BEARD WA, 1994, J BIOL CHEM, V269, P28091; BEBENEK K, 1995, J BIOL CHEM, V270, P19516, DOI 10.1074/jbc.270.33.19516; Bebenek K, 1997, NAT STRUCT BIOL, V4, P194, DOI 10.1038/nsb0397-194; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; COOK PR, 1993, J GEN VIROL, V74, P691, DOI 10.1099/0022-1317-74-4-691; Debyser Z, 1996, PROTEIN SCI, V5, P278; Divita G, 1995, BIOCHEMISTRY-US, V34, P16337, DOI 10.1021/bi00050a014; Gao HQ, 1998, J MOL BIOL, V277, P559, DOI 10.1006/jmbi.1998.1624; GOEL R, 1993, BIOCHEMISTRY-US, V32, P13012, DOI 10.1021/bi00211a009; HAERTLE T, 1988, J BIOL CHEM, V263, P5870; Halwani R, 2003, J VIROL, V77, P3973, DOI 10.1128/JVI.77.7.3973-3984.2003; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; HERMANN T, 1994, NUCLEIC ACIDS RES, V22, P4625, DOI 10.1093/nar/22.22.4625; Hill M, 2005, CURR HIV RES, V3, P73, DOI 10.2174/1570162052772942; HIZI A, 1988, P NATL ACAD SCI USA, V85, P1218, DOI 10.1073/pnas.85.4.1218; Hsiou Y, 1996, STRUCTURE, V4, P853, DOI 10.1016/S0969-2126(96)00091-3; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; JACOBOMOLINA A, 1991, BIOCHEMISTRY-US, V30, P6351, DOI 10.1021/bi00240a001; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LEBOWITZ J, 1994, PROTEIN SCI, V3, P1374, DOI 10.1002/pro.5560030903; Liao WH, 2007, J VIROL, V81, P5155, DOI 10.1128/JVI.01796-06; Lu W, 2006, P NATL ACAD SCI USA, V103, P12540, DOI 10.1073/pnas.0605402103; MITSUYA H, 1990, SCIENCE, V249, P1533, DOI 10.1126/science.1699273; PARK J, 1992, J VIROL, V66, P6304, DOI 10.1128/JVI.66.11.6304-6313.1992; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Powell MD, 1999, J BIOL CHEM, V274, P19885, DOI 10.1074/jbc.274.28.19885; RESTLE T, 1990, J BIOL CHEM, V265, P8986; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; SMITH AJ, 1993, J VIROL, V67, P2266, DOI 10.1128/JVI.67.4.2266-2275.1993; SRINIVASAKUMAR N, 1995, J VIROL, V69, P6106, DOI 10.1128/JVI.69.10.6106-6114.1995; Tachedjian G, 2001, P NATL ACAD SCI USA, V98, P7188, DOI 10.1073/pnas.121055998; Takehisa J, 2007, J VIROL, V81, P7463, DOI 10.1128/JVI.00551-07; Venezia CF, 2006, BIOCHEMISTRY-US, V45, P2779, DOI 10.1021/bi051915z; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Wang YX, 2007, J MED VIROL, V79, P676, DOI 10.1002/jmv.20835; Wang YX, 2007, FEBS LETT, V581, P558, DOI 10.1016/j.febslet.2007.01.024; Wang YX, 2008, BIOCHEM BIOPH RES CO, V377, P915, DOI 10.1016/j.bbrc.2008.10.106; Wapling J, 2005, J VIROL, V79, P10247, DOI 10.1128/JVI.79.16.10247-10257.2005; WILSON W, 1988, CELL, V55, P1159, DOI 10.1016/0092-8674(88)90260-7; Yu Q, 1998, J VIROL, V72, P7676, DOI 10.1128/JVI.72.9.7676-7680.1998; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004; ZHENG BJ, 1993, VACCINE, V11, P1191, DOI 10.1016/0264-410X(93)90042-V	46	137	142	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6108	10.1371/journal.pone.0006108	http://dx.doi.org/10.1371/journal.pone.0006108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578544	Green Published, gold, Green Submitted			2022-12-27	WOS:000267806300001
J	Ammann, CG; Messer, RJ; Peterson, KE; Hasenkrug, KJ				Ammann, Christoph G.; Messer, Ronald J.; Peterson, Karin E.; Hasenkrug, Kim J.			Lactate Dehydrogenase-Elevating Virus Induces Systemic Lymphocyte Activation via TLR7-Dependent IFN alpha Responses by Plasmacytoid Dendritic Cells	PLOS ONE			English	Article								Background: Lactate dehydrogenase-elevating virus (LDV) is a natural infectious agent of mice. Like several other viruses, LDV causes widespread and very rapid but transient activation of both B cells and T cells in lymphoid tissues and the blood. The mechanism of this activation has not been fully described and is the focus of the current studies. Principal Findings: A known inducer of early lymphocyte activation is IFN alpha, a cytokine strongly induced by LDV infection. Neutralization of IFN alpha in the plasma from infected mice ablated its ability to activate lymphocytes in vitro. Since the primary source of virus-induced IFN alpha in vivo is often plasmacytoid dendritic cells (pDC's), we depleted these cells prior to LDV infection and tested for lymphocyte activation. Depletion of pDC's in vivo eradicated both the LDV-induced IFN alpha response and lymphocyte activation. A primary receptor in pDC's for single stranded RNA viruses such as LDV is the toll-like receptor 7 (TLR7) pattern recognition receptor. Infection of TLR7-knockout mice revealed that both the IFN alpha response and lymphocyte activation were dependent on TLR7 signaling in vivo. Interestingly, virus levels in both TLR7 knockout mice and pDC-depleted mice were indistinguishable from controls indicating that LDV is largely resistant to the systemic IFN alpha response. Conclusion: Results indicate that LDV-induced activation of lymphocytes is due to recognition of LDV nucleic acid by TLR7 pattern recognition receptors in pDC's that respond with a lymphocyte-inducing IFN alpha response.			Ammann, CG (corresponding author), NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA.	khasenkrug@nih.gov	Peterson, Karin/D-1492-2016	Peterson, Karin/0000-0003-4177-7249; Ammann, Christoph/0000-0002-6267-1286	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000753, ZIAAI000753] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alsharifi M, 2005, J IMMUNOL, V175, P4635, DOI 10.4049/jimmunol.175.7.4635; ALSHARIFI M, 2008, IMMUNOL CELL BIOL; Alsharifi M, 2006, J IMMUNOL, V177, P3235, DOI 10.4049/jimmunol.177.5.3235; ANDERSON GW, 1995, J NEUROVIROL, V1, P244, DOI 10.3109/13550289509114020; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Braun D, 2002, INT IMMUNOL, V14, P411, DOI 10.1093/intimm/14.4.411; Butchi NB, 2008, J IMMUNOL, V180, P7604, DOI 10.4049/jimmunol.180.11.7604; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; CONTAG CH, 1988, MICROB PATHOGENESIS, V5, P287, DOI 10.1016/0882-4010(88)90101-5; Deonarain R, 2000, J VIROL, V74, P3404, DOI 10.1128/JVI.74.7.3404-3409.2000; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; HOWARD RJ, 1969, NATURE, V221, P873, DOI 10.1038/221873a0; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Le-Thi-Phuong T, 2007, J GEN VIROL, V88, P3063, DOI 10.1099/vir.0.83242-0; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; LOWENTHAL JW, 1988, P NATL ACAD SCI USA, V85, P4468, DOI 10.1073/pnas.85.12.4468; Marques R, 2008, J IMMUNOL, V181, P3432, DOI 10.4049/jimmunol.181.5.3432; NOTKINS AL, 1962, P SOC EXP BIOL MED, V109, P988; ONYEKABA CO, 1989, VIRUS RES, V14, P297, DOI 10.1016/0168-1702(89)90023-3; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; PLAGEMANN PGW, 1995, SPRINGER SEMIN IMMUN, V17, P167; PLAGEMANN PGW, 1992, ADV VIRUS RES, V41, P99, DOI 10.1016/S0065-3527(08)60036-6; RILEY V, 1960, SCIENCE, V132, P545, DOI 10.1126/science.132.3426.545; Robertson SJ, 2008, J VIROL, V82, P408, DOI 10.1128/JVI.01413-07; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; STUECKEMANN JA, 1982, J GEN VIROL, V59, P263, DOI 10.1099/0022-1317-59-2-263; STUECKEMANN JA, 1982, J GEN VIROL, V59, P245, DOI 10.1099/0022-1317-59-2-245; vandenBroek MF, 1997, J IMMUNOL, V159, P1585	33	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6105	10.1371/journal.pone.0006105	http://dx.doi.org/10.1371/journal.pone.0006105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568424	Green Submitted, gold, Green Published			2022-12-27	WOS:000267572200008
J	Long, D; Mu, YG; Yang, DW				Long, Dong; Mu, Yuguang; Yang, Daiwen			Molecular Dynamics Simulation of Ligand Dissociation from Liver Fatty Acid Binding Protein	PLOS ONE			English	Article								The mechanisms of how ligands enter and leave the binding cavity of fatty acid binding proteins (FABPs) have been a puzzling question over decades. Liver fatty acid binding protein (LFABP) is a unique family member which accommodates two molecules of fatty acids in its cavity and exhibits the capability of interacting with a variety of ligands with different chemical structures and properties. Investigating the ligand dissociation processes of LFABP is thus a quite interesting topic, which however is rather difficult for both experimental approaches and ordinary simulation strategies. In the current study, random expulsion molecular dynamics simulation, which accelerates ligand motions for rapid dissociation, was used to explore the potential egress routes of ligands from LFABP. The results showed that the previously hypothesized "portal region" could be readily used for the dissociation of ligands at both the low affinity site and the high affinity site. Besides, one alternative portal was shown to be highly favorable for ligand egress from the high affinity site and be related to the unique structural feature of LFABP. This result lends strong support to the hypothesis from the previous NMR exchange studies, which in turn indicates an important role for this alternative portal. Another less favored potential portal located near the N-terminal end was also identified. Identification of the dissociation pathways will allow further mechanistic understanding of fatty acid uptake and release by computational and/or experimental techniques.	[Long, Dong; Yang, Daiwen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Long, D (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	ygmu@ntu.edu.sg; dbsydw@nus.edu.sg	yang, daiwen/H-8408-2012; Mu, Yuguang/A-9558-2010	yang, daiwen/0000-0002-6804-0071; 				BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Carlsson P, 2006, BIOPHYS J, V91, P3151, DOI 10.1529/biophysj.106.082917; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Friedman R, 2006, BIOPHYS J, V90, P1535, DOI 10.1529/biophysj.105.071571; Friedman R, 2005, BIOCHEMISTRY-US, V44, P4275, DOI 10.1021/bi048236t; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P2278, DOI 10.1021/bi962018l; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; Jenkins AE, 2002, BIOCHEMISTRY-US, V41, P2022, DOI 10.1021/bi015769i; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kirk WR, 1996, BIOPHYS J, V70, P69, DOI 10.1016/S0006-3495(96)79592-9; Likic VA, 2001, PROTEINS, V43, P65, DOI 10.1002/1097-0134(20010401)43:1<65::AID-PROT1018>3.0.CO;2-F; Likic VA, 1999, PROTEIN SCI, V8, P1649, DOI 10.1110/ps.8.8.1649; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Ludemann SK, 2000, J MOL BIOL, V303, P797, DOI 10.1006/jmbi.2000.4154; Mihajlovic M, 2007, PROTEIN SCI, V16, P2042, DOI 10.1110/ps.072875307; Ory J, 1997, J BIOL CHEM, V272, P9793; PIGACHE A, 27 ACS NAT M AN CA U; Richieri GV, 1999, BIOCHEMISTRY-US, V38, P5888, DOI 10.1021/bi982703n; Richieri GV, 1996, J BIOL CHEM, V271, P31068, DOI 10.1074/jbc.271.49.31068; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; Thompson J, 1999, MOL CELL BIOCHEM, V192, P9, DOI 10.1023/A:1006806616963; Thompson J, 1999, BBA-MOL CELL BIOL L, V1441, P117, DOI 10.1016/S1388-1981(99)00146-8; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; Tsfadia Y, 2007, FEBS LETT, V581, P1243, DOI 10.1016/j.febslet.2007.02.033; Velkov T, 2005, J BIOL CHEM, V280, P17769, DOI 10.1074/jbc.M410193200; Wang H, 2002, BIOCHEMISTRY-US, V41, P5453, DOI 10.1021/bi011914g; Winn PJ, 2002, P NATL ACAD SCI USA, V99, P5361, DOI 10.1073/pnas.082522999; Woolf TB, 1998, BIOPHYS J, V74, P694, DOI 10.1016/S0006-3495(98)73995-5; Woolf TB, 2000, BIOPHYS J, V78, P608, DOI 10.1016/S0006-3495(00)76621-5	31	47	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6081	10.1371/journal.pone.0006081	http://dx.doi.org/10.1371/journal.pone.0006081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564911	Green Submitted, gold, Green Published			2022-12-27	WOS:000267515700003
J	Komurov, K; Gunes, MH; White, MA				Komurov, Kakajan; Gunes, Mehmet H.; White, Michael A.			Fine-Scale Dissection of Functional Protein Network Organization by Statistical Network Analysis	PLOS ONE			English	Article								Revealing organizational principles of biological networks is an important goal of systems biology. In this study, we sought to analyze the dynamic organizational principles within the protein interaction network by studying the characteristics of individual neighborhoods of proteins within the network based on their gene expression as well as protein-protein interaction patterns. By clustering proteins into distinct groups based on their neighborhood gene expression characteristics, we identify several significant trends in the dynamic organization of the protein interaction network. We show that proteins with distinct neighborhood gene expression characteristics are positioned in specific localities in the protein interaction network thereby playing specific roles in the dynamic network connectivity. Remarkably, our analysis reveals a neighborhood characteristic that corresponds to the most centrally located group of proteins within the network. Further, we show that the connectivity pattern displayed by this group is consistent with the notion of "rich club connectivity'' in complex networks. Importantly, our findings are largely reproducible in networks constructed using independent and different datasets.			Komurov, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	kkomurov@mdanderson.org						Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Batada NN, 2007, PLOS BIOL, V5, P1202, DOI 10.1371/journal.pbio.0050154; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Komurov K, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100149; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Wasserman S., 1994, SOCIAL NETWORK ANAL, P1, DOI [10. 1017/CBO9780511815478, DOI 10.1017/CBO9780511815478, 10.1017/CBO9780511815478, DOI 10.1017/CB09780511815478]; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426	18	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6017	10.1371/journal.pone.0006017	http://dx.doi.org/10.1371/journal.pone.0006017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19554104	Green Published, gold, Green Submitted			2022-12-27	WOS:000267356500006
J	Beghdadi, W; Porcherie, A; Schneider, BS; Morisset, S; Dubayle, D; Peronet, R; Dy, M; Louis, J; Arrang, JM; Mecheri, S				Beghdadi, Walid; Porcherie, Adeline; Schneider, Bradley S.; Morisset, Severine; Dubayle, David; Peronet, Roger; Dy, Michel; Louis, Jacques; Arrang, Jean-Michel; Mecheri, Salaheddine			Histamine H-3 Receptor-Mediated Signaling Protects Mice from Cerebral Malaria	PLOS ONE			English	Article								Background: Histamine is a biogenic amine that has been shown to contribute to several pathological conditions, such as allergic conditions, experimental encephalomyelitis, and malaria. In humans, as well as in murine models of malaria, increased plasma levels of histamine are associated with severity of infection. We reported recently that histamine plays a critical role in the pathogenesis of experimental cerebral malaria (CM) in mice infected with Plasmodium berghei ANKA. Histamine exerts its biological effects through four different receptors designated H1R, H2R, H3R, and H4R. Principal Findings: In the present work, we explored the role of histamine signaling via the histamine H3 receptor (H3R) in the pathogenesis of murine CM. We observed that the lack of H3R expression (H3R(-/-) mice) accelerates the onset of CM and this was correlated with enhanced brain pathology and earlier and more pronounced loss of blood brain barrier integrity than in wild type mice. Additionally tele-methylhistamine, the major histamine metabolite in the brain, that was initially present at a higher level in the brain of H3R(-/-) mice was depleted more quickly post-infection in H3R(-/-) mice as compared to wild-type counterparts. Conclusions: Our data suggest that histamine regulation through the H3R in the brain suppresses the development of CM. Thus modulating histamine signaling in the central nervous system, in combination with standard therapies, may represent a novel strategy to reduce the risk of progression to cerebral malaria.			Beghdadi, W (corresponding author), Inst Pasteur, Unite Reponses Precoces Parasites & Immunopathol, Paris, France.	smecheri@pasteur.fr	MORISSET, Séverine/S-7450-2017; Mecheri, Salah/M-8315-2013	MORISSET, Séverine/0000-0002-9930-7824; Porcherie, Adeline/0000-0002-8177-2461; Schneider, Bradley S/0000-0001-7642-0018				AIRAKSINEN MS, 1992, J COMP NEUROL, V323, P103, DOI 10.1002/cne.903230109; ARRANG JM, 1991, PEPTIDES, V12, P1113, DOI 10.1016/0196-9781(91)90067-Y; Barone FC, 1997, NEUROSCI BIOBEHAV R, V21, P31, DOI 10.1016/0149-7634(95)00080-1; Beghdadi W, 2008, J EXP MED, V205, P395, DOI 10.1084/jem.20071548; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Belnoue E, 2003, INFECT IMMUN, V71, P3648, DOI 10.1128/IAI.71.6.3648-3651.2003; BERTACCINI G, 1991, ALIMENT PHARM THERAP, V5, P585; BHATTACHARYA U, 1988, INDIAN J MED RES, V88, P558; BURY TB, 1992, ALLERGY, V47, P624, DOI 10.1111/j.1398-9995.1992.tb02385.x; Chen L, 2000, CLIN EXP IMMUNOL, V120, P125, DOI 10.1046/j.1365-2249.2000.01196.x; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; CLAPHAM J, 1994, EUR J PHARMACOL, V259, P107, DOI 10.1016/0014-2999(94)90498-7; Demeure CE, 2005, J IMMUNOL, V174, P3932, DOI 10.4049/jimmunol.174.7.3932; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Elenkov IJ, 1998, J IMMUNOL, V161, P2586; Enwonwu CO, 2000, J NEURAL TRANSM, V107, P1273, DOI 10.1007/s007020070017; Gantner F, 2002, J PHARMACOL EXP THER, V303, P300, DOI 10.1124/jpet.102.036939; GARBARG M, 1989, J NEUROCHEM, V53, P1724, DOI 10.1111/j.1471-4159.1989.tb09237.x; GRAU GE, 1986, J IMMUNOL, V136, P686; Herwig A, 2007, J NEUROENDOCRINOL, V19, P1001, DOI 10.1111/j.1365-2826.2007.01620.x; HILL SJ, 1990, PHARMACOL REV, V42, P45; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; Ichigi J, 1999, J MOL NEUROSCI, V13, P93, DOI 10.1385/JMN:13:1-2:93; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Kaul DK, 1998, AM J TROP MED HYG, V58, P240, DOI 10.4269/ajtmh.1998.58.240; LEURS R, 1995, PHARMACOL THERAPEUT, V66, P413, DOI 10.1016/0163-7258(95)00006-3; Lin JS, 2000, SLEEP MED REV, V4, P471, DOI 10.1053/smrv.2000.0116; MACKEY LJ, 1980, CLIN EXP IMMUNOL, V42, P412; Morgan RK, 2007, J IMMUNOL, V178, P8081, DOI 10.4049/jimmunol.178.12.8081; Morse KL, 2001, J PHARMACOL EXP THER, V296, P1058; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; ORR EL, 1989, J NEUROCHEM, V53, P111, DOI 10.1111/j.1471-4159.1989.tb07301.x; Pais TF, 2005, J NEUROIMMUNOL, V163, P73, DOI 10.1016/j.jneuroim.2005.02.009; Passani MB, 2004, TRENDS PHARMACOL SCI, V25, P618, DOI 10.1016/j.tips.2004.10.003; Pillot C, 2002, NEUROSCIENCE, V114, P173, DOI 10.1016/S0306-4522(02)00135-5; RING J, 1985, HISTAMINE ALLERGIC D, P44; SCHLICKER E, 1994, FUND CLIN PHARMACOL, V8, P128, DOI 10.1111/j.1472-8206.1994.tb00789.x; Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; SCHWARTZ JC, 1992, HISTAMINE RECEPTOR; SCHWARTZ JC, 2002, NEUROPSYCHOPHARMACOL, P179; SENALDI G, 1994, INFECT IMMUN, V62, P1144, DOI 10.1128/IAI.62.4.1144-1149.1994; Serviere J, 2003, TOXICOL LETT, V145, P143, DOI 10.1016/S0378-4274(03)00264-9; STANLEY NC, 1990, J NEUROIMMUNOL, V29, P223, DOI 10.1016/0165-5728(90)90165-J; Stevens DR, 2001, BEHAV BRAIN RES, V124, P105, DOI 10.1016/S0166-4328(01)00219-4; Teuscher C, 2007, P NATL ACAD SCI USA, V104, P10146, DOI 10.1073/pnas.0702291104; Theodorsson A, 2008, NEUROPEPTIDES, V42, P79, DOI 10.1016/j.npep.2007.09.008; TOHYAMA M, 1998, ATLAS NEUROACTIVE SU, P54; Tokita S, 2006, J PHARMACOL SCI, V101, P12, DOI 10.1254/jphs.FMJ06001X4; Toyota H, 2002, MOL PHARMACOL, V62, P389, DOI 10.1124/mol.62.2.389; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Yanez DM, 1996, J IMMUNOL, V157, P1620; Zhang M.-Q., 1997, HISTAMINE H1 RECEPTO, P495; Zhu Y, 2001, MOL PHARMACOL, V59, P434, DOI 10.1124/mol.59.3.434	55	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6004	10.1371/journal.pone.0006004	http://dx.doi.org/10.1371/journal.pone.0006004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547708	gold, Green Submitted, Green Published			2022-12-27	WOS:000267347900003
J	McNeal, JR; Kuehl, JV; Boore, JL; Leebens-Mack, J; dePamphilis, CW				McNeal, Joel R.; Kuehl, Jennifer V.; Boore, Jeffrey L.; Leebens-Mack, Jim; dePamphilis, Claude W.			Parallel Loss of Plastid Introns and Their Maturase in the Genus Cuscuta	PLOS ONE			English	Article								Plastid genome content and arrangement are highly conserved across most land plants and their closest relatives, streptophyte algae, with nearly all plastid introns having invaded the genome in their common ancestor at least 450 million years ago. One such intron, within the transfer RNA trnK-UUU, contains a large open reading frame that encodes a presumed intron maturase, matK. This gene is missing from the plastid genomes of two species in the parasitic plant genus Cuscuta but is found in all other published land plant and streptophyte algal plastid genomes, including that of the nonphotosynthetic angiosperm Epifagus virginiana and two other species of Cuscuta. By examining matK and plastid intron distribution in Cuscuta, we add support to the hypothesis that its normal role is in splicing seven of the eight group IIA introns in the genome. We also analyze matK nucleotide sequences from Cuscuta species and relatives that retain matK to test whether changes in selective pressure in the maturase are associated with intron deletion. Stepwise loss of most group IIA introns from the plastid genome results in substantial change in selective pressure within the hypothetical RNA-binding domain of matK in both Cuscuta and Epifagus, either through evolution from a generalist to a specialist intron splicer or due to loss of a particular intron responsible for most of the constraint on the binding region. The possibility of intron-specific specialization in the X-domain is implicated by evidence of positive selection on the lineage leading to C. nitida in association with the loss of six of seven introns putatively spliced by matK. Moreover, transfer RNA gene deletion facilitated by parasitism combined with an unusually high rate of intron loss from remaining functional plastid genes created a unique circumstance on the lineage leading to Cuscuta subgenus Grammica that allowed elimination of matK in the most species-rich lineage of Cuscuta.			McNeal, JR (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	jmcneal@plantbio.uga.edu	Leebens-Mack, James/AAF-6770-2019; dePamphilis, Claude W/P-6652-2016	Leebens-Mack, James/0000-0003-4811-2231; 	Division Of Environmental Biology [0830009] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Bennett JR, 2006, AM J BOT, V93, P1039, DOI 10.3732/ajb.93.7.1039; BOMMER D, 1993, CURR GENET, V24, P171, DOI 10.1007/BF00324682; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; DOWNIE SR, 1991, EVOLUTION, V45, P1245, DOI [10.2307/2409731, 10.1111/j.1558-5646.1991.tb04390.x]; Downie SR, 1996, SYST BOT, V21, P135, DOI 10.2307/2419744; DumolinLapegue S, 1997, MOL ECOL, V6, P393, DOI 10.1046/j.1365-294X.1997.00193.x; FREYER R, 1995, CURR GENET, V27, P580, DOI 10.1007/BF00314451; FUNK HT, 2007, BMC PLANT BIOL, V7; Guindon S, 2004, P NATL ACAD SCI USA, V101, P12957, DOI 10.1073/pnas.0402177101; HABERHAUSEN G, 1992, MOL GEN GENET, V232, P154, DOI 10.1007/BF00299148; Hibberd JM, 1998, PLANTA, V205, P506, DOI 10.1007/s004250050349; Hubschmann T, 1996, PLANT MOL BIOL, V30, P109, DOI 10.1007/BF00017806; Jenkins BD, 1997, PLANT CELL, V9, P283, DOI 10.1105/tpc.9.3.283; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; LIERE K, 1995, NUCLEIC ACIDS RES, V23, P917, DOI 10.1093/nar/23.6.917; Lohan AJ, 1998, GENETICS, V150, P425; MCNEAL JR, 2007, BMC BIOL, V5; MCNEAL JR, 2007, BMC PLANT BIOL, V7; McPherson MA, 2004, SYST BOT, V29, P296, DOI 10.1600/036364404774195494; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MOHR G, 1993, NUCLEIC ACIDS RES, V21, P4991, DOI 10.1093/nar/21.22.4991; Neyland R, 2001, BRITTONIA, V53, P108, DOI 10.1007/BF02805402; Nickrent DL, 1997, PLANT MOL BIOL, V34, P717, DOI 10.1023/A:1005860632601; Olmstead RG, 2001, AM J BOT, V88, P348, DOI 10.2307/2657024; Sanders ER, 2003, AM J BOT, V90, P628, DOI 10.3732/ajb.90.4.628; Stefanovic S, 2002, AM J BOT, V89, P1510, DOI 10.3732/ajb.89.9.1510; Stefanovic S, 2004, SYST BIOL, V53, P384, DOI 10.1080/10635150490445896; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TAYLOR GW, 1991, CURR GENET, V20, P515, DOI 10.1007/BF00334780; TURMEL M, 2005, BMC BIOL, V3; Vogel J, 1997, J MOL BIOL, V270, P179, DOI 10.1006/jmbi.1997.1115; Vogel J, 1999, NUCLEIC ACIDS RES, V27, P3866, DOI 10.1093/nar/27.19.3866; WIMPEE CF, 1992, CURR GENET, V21, P417, DOI 10.1007/BF00351704; Wolfe AD, 1998, MOL BIOL EVOL, V15, P1243, DOI 10.1093/oxfordjournals.molbev.a025853; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young ND, 1999, ANN MO BOT GARD, V86, P876, DOI 10.2307/2666173; Young ND, 2000, MOL BIOL EVOL, V17, P1933, DOI 10.1093/oxfordjournals.molbev.a026295; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	41	46	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5982	10.1371/journal.pone.0005982	http://dx.doi.org/10.1371/journal.pone.0005982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543388	Green Published, gold, Green Submitted			2022-12-27	WOS:000267237400008
J	Korenromp, EL; Williams, BG; Schmid, GP; Dye, C				Korenromp, Eline L.; Williams, Brian G.; Schmid, George P.; Dye, Christopher			Clinical Prognostic Value of RNA Viral Load and CD4 Cell Counts during Untreated HIV-1 Infection-A Quantitative Review	PLOS ONE			English	Article								Background: The prognostic value of CD4 counts and RNA viral load for identifying treatment need in HIV-infected individuals depends on (a) variation within and among individuals, and (b) relative risks of clinical progression per unit CD4 or RNA difference. Methodology/Principal Findings: We reviewed these measurements across (a) 30 studies, and (b) 16 cohorts of untreated seropositive adults. Median within-population interquartile ranges were 74,000 copies/mL for RNA with no significant change during the course of infection; and 330 cells/mu L for CD4, with a slight proportional increase over infection. Applying measurement and physiological fluctuations observed on chronically infected patients, we estimate that 45% of population-level variation in RNA, and 25% of variation in CD4, were due to within-patient fluctuations. Comparing a patient with RNA at upper 75(th) centile with a patient at median RNA, 5-year relative risks were 1.4 (95% CI 1.2-1.7) for AIDS and 1.5 (1.3-1.9) for death, without change over the course of infection. In contrast, for a patient with CD4 count at the lower 75(th) centile, relative risks increased from 1.0 at seroconversion to maxima of 6.3 (4.4-8.9) for AIDS and 5.5 (2.7-10.1) for death by year 6, when the population median had fallen to 300 cells/mu L. Below 300 cells/mu L, prognostic power did not increase, due to a narrower CD4 range. Conclusions: Findings support the current WHO recommendation (used with clinical criteria) to start antiretroviral treatment in low-income settings at CD4 thresholds of 200-350 cells/mu L, without pre-treatment RNA monitoring - while not precluding earlier treatment based on clinical, socio-demographic or public health criteria.			Korenromp, EL (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	eline.korenromp@theglobalfund.org	Dye, Christopher/AIC-4659-2022	Williams, Brian/0000-0002-3174-4876; Dye, Christopher/0000-0002-2957-1793				Anastos K, 1999, AIDS, V13, P1717, DOI 10.1097/00002030-199909100-00016; Andersson S, 2000, ARCH INTERN MED, V160, P3286, DOI 10.1001/archinte.160.21.3286; Arnaout RA, 1999, P NATL ACAD SCI USA, V96, P11549, DOI 10.1073/pnas.96.20.11549; Auvert B, 2004, JAIDS-J ACQ IMM DEF, V36, P613, DOI 10.1097/00126334-200405010-00010; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Bartlett JA, 1998, J INFECT DIS, V178, P1803, DOI 10.1086/314503; Begaud E, 2003, AIDS RES HUM RETROV, V19, P551, DOI 10.1089/088922203322230914; Begtrup K, 1997, AM J EPIDEMIOL, V145, P629, DOI 10.1093/oxfordjournals.aje.a009160; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; Bogaards JA, 2006, JAIDS-J ACQ IMM DEF, V41, P232, DOI 10.1097/01.qai.0000179457.46809.42; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brambilla D, 1999, AIDS, V13, P2269, DOI 10.1097/00002030-199911120-00009; Day JH, 2004, J INFECT DIS, V190, P1677, DOI 10.1086/424851; Deeks SG, 1997, J INFECT DIS, V176, P514, DOI 10.1086/517278; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; Diomande FVK, 2003, AIDS, V17, pS87, DOI 10.1097/00002030-200317003-00012; Erikstrup C, 2007, JAIDS-J ACQ IMM DEF, V44, P478, DOI 10.1097/QAI.0b013e318032bbcd; Fahey JL, 1998, AIDS, V12, P1581, DOI 10.1097/00002030-199813000-00004; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray CM, 2005, AIDS RES HUM RETROV, V21, P285, DOI 10.1089/aid.2005.21.285; Hallett TB, 2008, PLOS MED, V5, P403, DOI 10.1371/journal.pmed.0050053; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hansmann A, 2005, JAIDS-J ACQ IMM DEF, V38, P335; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; Hubert JB, 2000, AIDS, V14, P123, DOI 10.1097/00002030-200001280-00007; HUGHES MD, 1994, J INFECT DIS, V169, P28, DOI 10.1093/infdis/169.1.28; Katzenstein TL, 1996, AIDS, V10, P167, DOI 10.1097/00002030-199602000-00006; Kelly P, 2002, ACTA TROP, V83, P151, DOI 10.1016/S0001-706X(02)00095-5; LANG W, 1989, J ACQ IMMUN DEF SYND, V2, P63; Lavreys L, 2006, CLIN INFECT DIS, V42, P1333, DOI 10.1086/503258; Lefrere JJ, 1998, J INFECT DIS, V177, P1541, DOI 10.1086/515308; Lepri AC, 1998, AIDS, V12, P1639, DOI 10.1097/00002030-199813000-00011; Lepri AC, 1997, J INFECT DIS, V175, P775, DOI 10.1086/513970; Loubiere S, 2008, ANTIVIR THER, V13, P241; Lyles CM, 1999, J INFECT DIS, V180, P1018, DOI 10.1086/314980; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; MALONE JL, 1990, J ACQ IMMUN DEF SYND, V3, P144; Mehendale SM, 2002, AIDS RES HUM RETROV, V18, P1175, DOI 10.1089/08892220260387913; Mekonnen Y, 2005, J INFECT DIS, V192, P739, DOI 10.1086/432545; Mellors JW, 2007, JAMA-J AM MED ASSOC, V297, P2349, DOI 10.1001/jama.297.21.2349; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Minga A, 2007, B WORLD HEALTH ORGAN, V85, P116, DOI 10.2471/BLT.06.032292; Morgan D, 1999, J ACQ IMMUN DEF SYND, V22, P167; Muller Z, 2004, J CLIN MICROBIOL, V42, P1439, DOI 10.1128/JCM.42.4.1439-1443.2004; Muyldermans G, 2000, CLIN MICROBIOL INFEC, V6, P213, DOI 10.1046/j.1469-0691.2000.00048.x; Nkengasong JN, 2001, J INFECT DIS, V183, P1405, DOI 10.1086/319855; O'Brien TR, 1998, J ACQ IMMUN DEF SYND, V18, P155, DOI 10.1097/00042560-199806010-00007; Paxton WB, 1997, J INFECT DIS, V175, P247, DOI 10.1093/infdis/175.2.247; Pedersen C, 1997, J ACQ IMMUN DEF SYND, V16, P93, DOI 10.1097/00042560-199710010-00004; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Phillips AN, 2007, AIDS, V21, P1717; Raboud JM, 1996, J INFECT DIS, V174, P191, DOI 10.1093/infdis/174.1.191; Rezza G, 2000, J ACQ IMMUN DEF SYND, V25, P56, DOI 10.1097/00126334-200009010-00008; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Rodriguez RJ, 1997, J ACQ IMMUN DEF SYND, V15, P49, DOI 10.1097/00042560-199705010-00008; Rosen S, 2005, PLOS MED, V2, P1098, DOI 10.1371/journal.pmed.0020303; Rouzioux C, 2005, J INFECT DIS, V192, P46, DOI 10.1086/430610; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003; SAKSELA K, 1995, ANN INTERN MED, V123, P641, DOI 10.7326/0003-4819-123-9-199511010-00001; Salamon R, 2002, J ACQ IMMUN DEF SYND, V29, P149, DOI 10.1097/00042560-200202010-00007; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; Soriano V, 1998, J INFECTION, V36, P307, DOI 10.1016/S0163-4453(98)94351-1; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TAYLOR JMG, 1991, AIDS, V5, P159, DOI 10.1097/00002030-199102000-00005; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; Touloumi G, 2004, AIDS, V18, P1697, DOI 10.1097/01.aids.0000131395.14339.f5; Touloumi G, 2003, JAIDS-J ACQ IMM DEF, V34, P76, DOI 10.1097/00126334-200309010-00012; *UNAIDS, 2008, UN ACC SCAL UP PRIOR; *US DEP HHS, 2008, GUID US ANT AG HIV 1; Van Geertruyden JP, 2006, JAIDS-J ACQ IMM DEF, V43, P363; Vijayaraghavan A, 2007, JAIDS-J ACQ IMM DEF, V46, P91; Vitoria M, 2006, ANTIRETROVIRAL THERA; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; WALENSKY RP, 2008, 15 C RETR OPP INF BO; Walson JL, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000102; Williams BG, 1995, EPIDEMIOL INFECT, V115, P603, DOI 10.1017/S0950268800058763; Williams BG, 2006, J INFECT DIS, V194, P1450, DOI 10.1086/508206; Wilson DP, 2006, PLOS MED, V3, P410, DOI 10.1371/journal.pmed.0030160; WINTERS MA, 1993, J CLIN MICROBIOL, V31, P2960, DOI 10.1128/JCM.31.11.2960-2966.1993; Wong KAH, 2007, AIDS PATIENT CARE ST, V21, P106, DOI 10.1089/apc.2006.0037; Yerly S, 1998, ARCH INTERN MED, V158, P247, DOI 10.1001/archinte.158.3.247; MMWR MORB MORTAL WKL, V35, P334; MMWR RECOMM REP, V41, P1; COMMUN DIS REP CDR W, V3, P141	93	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5950	10.1371/journal.pone.0005950	http://dx.doi.org/10.1371/journal.pone.0005950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536329	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029700020
J	Mori, T; Kawachi, H; Imai, C; Sugiyama, M; Kurata, Y; Kishida, O; Nishimura, K				Mori, Tsukasa; Kawachi, Hiroko; Imai, Chiharu; Sugiyama, Manabu; Kurata, Youichi; Kishida, Osamu; Nishimura, Kinya			Identification of a Novel Uromodulin-Like Gene Related to Predator-Induced Bulgy Morph in Anuran Tadpoles by Functional Microarray Analysis	PLOS ONE			English	Article							TAMM-HORSFALL PROTEIN; PHENOTYPIC PLASTICITY; INDUCIBLE DEFENSES; GLYCOSYL-PHOSPHATIDYLINOSITOL; ESCHERICHIA-COLI; CHLORIDE FLUX; GLYCOPROTEIN; BINDING; KIDNEY; TRAFFICKING	Tadpoles of the anuran species Rana pirica can undergo predator-specific morphological responses. Exposure to a predation threat by larvae of the salamander Hynobius retardatus results in formation of a bulgy body (bulgy morph) with a higher tail. The tadpoles revert to a normal phenotype upon removal of the larval salamander threat. Although predator-induced phenotypic plasticity is of major interest to evolutionary ecologists, the molecular and physiological mechanisms that control this response have yet to be elucidated. In a previous study, we identified various genes that are expressed in the skin of the bulgy morph. However, it proved difficult to determine which of these were key genes in the control of gene expression associated with the bulgy phenotype. Here, we show that a novel gene plays an important role in the phenotypic plasticity producing the bulgy morph. A functional microarray analysis using facial tissue samples of control and bulgy morph tadpoles identified candidate functional genes for predator-specific morphological responses. A larger functional microarray was prepared than in the previous study and used to analyze mRNAs extracted from facial and brain tissues of tadpoles from induction-reversion experiments. We found that a novel uromodulin-like gene, which we name here pirica, was up-regulated and that keratin genes were down-regulated as the period of exposure to larval salamanders increased. Pirica consists of a 1296 bp open reading frame, which is putatively translated into a protein of 432 amino acids. The protein contains a zona pellucida domain similar to that of proteins that function to control water permeability. We found that the gene was expressed in the superficial epidermis of the tadpole skin.			Mori, T (corresponding author), Dept Nihon Univ, Lab Marine Mol Biochem, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan.	mori.tsukasa@nihon-u.ac.jp	Kishida, Osamu/B-7970-2011					Acher R, 1997, BIOL CELL, V89, P283, DOI 10.1016/S0248-4900(97)83380-1; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; BACHMANN S, 1990, HISTOCHEMISTRY, V94, P517, DOI 10.1007/BF00272616; BACHMANN S, 1985, HISTOCHEMISTRY, V83, P531, DOI 10.1007/BF00492456; Bankir L, 1987, Adv Nephrol Necker Hosp, V16, P69; Berrigan D., 2004, PHENOTYPIC PLASTICIT, P82; BOX GEP, 1954, ANN MATH STAT, V25, P290, DOI 10.1214/aoms/1177728786; CLARK CW, 1992, AM NAT, V139, P521, DOI 10.1086/285342; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; DULAWA J, 1988, EUR J CLIN INVEST, V18, P87, DOI 10.1111/j.1365-2362.1988.tb01171.x; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P789, DOI 10.2307/2287160; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; FUKUOKA SI, 1991, P NATL ACAD SCI USA, V88, P2898, DOI 10.1073/pnas.88.7.2898; Fukuoka SI, 2001, BIOCHEM BIOPH RES CO, V289, P1044, DOI 10.1006/bbrc.2001.6112; HESS B, 1992, UROL RES, V20, P83, DOI 10.1007/BF00294343; HESSION C, 1987, SCIENCE, V237, P1479, DOI 10.1126/science.3498215; HOWIE AJ, 1993, CELL TISSUE RES, V274, P15, DOI 10.1007/BF00327980; HOWIE AJ, 1991, AM J PHYSIOL, V233, pF438; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kishida O, 2005, EVOL ECOL RES, V7, P619; Kishida O, 2004, OECOLOGIA, V140, P414, DOI 10.1007/s00442-004-1609-0; Kishida O, 2007, ECOLOGY, V88, P1948, DOI 10.1890/07-0132.1; Kishida O, 2006, J ANIM ECOL, V75, P705, DOI 10.1111/j.1365-2656.2006.01091.x; Kokot F, 2000, NEPHRON, V85, P97, DOI 10.1159/000045640; KUMAR S, 1990, KIDNEY INT, V37, P1395, DOI 10.1038/ki.1990.128; LOTE CJ, 1976, PFLUG ARCH EUR J PHY, V362, P181, DOI 10.1007/BF00583645; LOTE CJ, 1974, J PHYSIOL-LONDON, V241, pP27; LOW MG, 1989, FASEB J, V3, P1600, DOI 10.1096/fasebj.3.5.2522071; MATTEY M, 1992, EXPERIENTIA, V48, P975, DOI 10.1007/BF01919145; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; Michimae H, 2005, BIOL LETTERS, V1, P75, DOI 10.1098/rsbl.2004.0242; Michimae H, 2002, EVOLUTION, V56, P2029; Mori T, 2005, BIOCHEM BIOPH RES CO, V330, P1138, DOI 10.1016/j.bbrc.2005.03.091; PARKKINEN J, 1988, INFECT IMMUN, V56, P2623, DOI 10.1128/IAI.56.10.2623-2630.1988; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pigliucci M., 2001, SYN ECO EVO; PRASADAN K, 1995, BBA-GENE STRUCT EXPR, V1260, P328, DOI 10.1016/0167-4781(94)00240-4; REINHART HH, 1990, J INFECT DIS, V162, P1335, DOI 10.1093/infdis/162.6.1335; Relyea RA, 2005, J EVOLUTION BIOL, V18, P856, DOI 10.1111/j.1420-9101.2005.00882.x; Rhodes DCJ, 2000, IMMUNOL CELL BIOL, V78, P474, DOI 10.1111/j.1440-1711.2000.t01-3-.x; ROGAN JC, 1977, AM EDUC RES J, V14, P493, DOI 10.2307/1162346; Scheele GA, 1996, PANCREAS, V12, P1, DOI 10.1097/00006676-199601000-00001; SCHEELE GA, 1994, PANCREAS, V9, P139, DOI 10.1097/00006676-199403000-00001; SCHEINER SM, 1989, J EVOLUTION BIOL, V2, P95, DOI 10.1046/j.1420-9101.1989.2020095.x; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Van Buskirk J, 1997, EVOLUTION, V51, P1983, DOI 10.1111/j.1558-5646.1997.tb05119.x; West-Eberhard Mary Jane, 2003, pi; WINKELSTEIN A, 1990, IMMUNOPHARMACOLOGY, V20, P201, DOI 10.1016/0162-3109(90)90035-D; Ying WZ, 2001, AM J PATHOL, V158, P1859, DOI 10.1016/S0002-9440(10)64142-9	53	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5936	10.1371/journal.pone.0005936	http://dx.doi.org/10.1371/journal.pone.0005936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529781	Green Published, gold			2022-12-27	WOS:000267029500015
J	Skanland, SS; Walchli, S; Brech, A; Sandvig, K				Skanland, Sigrid S.; Walchli, Sebastien; Brech, Andreas; Sandvig, Kirsten			SNX4 in Complex with Clathrin and Dynein: Implications for Endosome Movement	PLOS ONE			English	Article								Background: Sorting nexins (SNXs) constitute a family of proteins classified by their phosphatidylinositol (PI) binding Phox homology (PX) domain. Some members regulate intracellular trafficking. We have here investigated mechanisms underlying SNX4 mediated endosome to Golgi transport. Methodology/Principal Findings: We show that SNX4 forms complexes with clathrin and dynein. The interactions were inhibited by wortmannin, a PI3-kinase inhibitor, suggesting that they form when SNX4 is associated with PI(3) P on endosomes. We further localized the clathrin interacting site on SNX4 to a clathrin box variant. A short peptide containing this motif was sufficient to pull down both clathrin and dynein. Knockdown studies demonstrated that clathrin is not required for the SNX4/dynein interaction. Moreover, clathrin knockdown led to increased Golgi transport of the toxin ricin, as well as redistribution of endosomes. Conclusions/Significance: We discuss the possibility of clathrin serving as a regulator of SNX4-dependent transport. Upon clathrin release, dynein may bind SNX4 and mediate retrograde movement.			Skanland, SS (corresponding author), Univ Oslo, Norwegian Radium Hosp, Fac Div, Ctr Canc Biomed, Oslo, Norway.	ksandvig@radium.uio.no	Skånland, Sigrid S/AAW-4817-2021	Skanland, Sigrid S./0000-0003-1630-356X; Brech, Andreas/0000-0002-9803-1774; Walchli, Sebastien/0000-0001-5869-1746				Bennett EM, 2001, MOL BIOL CELL, V12, P2790, DOI 10.1091/mbc.12.9.2790; Bertelsen V, 2007, EXP CELL RES, V313, P1696, DOI 10.1016/j.yexcr.2007.02.017; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Carlton JG, 2005, J CELL SCI, V118, P4527, DOI 10.1242/jcs.02568; DArrigo A, 1997, EUR J CELL BIOL, V72, P95; DEBRABANDER M, 1977, CELL BIOL INT REP, V1, P177, DOI 10.1016/0309-1651(77)90038-8; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Griffin CT, 2005, P NATL ACAD SCI USA, V102, P15173, DOI 10.1073/pnas.0409558102; Grimmer S, 2005, TRAFFIC, V6, P144, DOI 10.1111/j.1600-0854.2005.00258.x; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Iversen TG, 2003, P NATL ACAD SCI USA, V100, P5175, DOI 10.1073/pnas.0534231100; Iversen TG, 2001, MOL BIOL CELL, V12, P2099, DOI 10.1091/mbc.12.7.2099; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Lauvrak SU, 2006, MOL BIOL CELL, V17, P1096, DOI 10.1091/mbc.E05-08-0766; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Morgan JR, 2000, J NEUROSCI, V20, P8667; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simpson JC, 1998, EXP CELL RES, V239, P293, DOI 10.1006/excr.1997.3921; Skanland SS, 2007, TRAFFIC, V8, P297, DOI 10.1111/j.1600-0854.2006.00527.x; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Vollert CS, 2004, MOL CELL PROTEOMICS, V3, P1053, DOI 10.1074/mcp.M400081-MCP200	40	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5935	10.1371/journal.pone.0005935	http://dx.doi.org/10.1371/journal.pone.0005935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529763	Green Published, gold, Green Submitted			2022-12-27	WOS:000267029500014
J	Magnanou, E; Attia, J; Fons, R; Boeuf, G; Falcon, J				Magnanou, Elodie; Attia, Joel; Fons, Roger; Boeuf, Gilles; Falcon, Jack			The Timing of the Shrew: Continuous Melatonin Treatment Maintains Youthful Rhythmic Activity in Aging Crocidura russula	PLOS ONE			English	Article							WHITE-TOOTHED SHREW; PINEAL MELATONIN; SUNCUS-ETRUSCUS; GENE-EXPRESSION; AGE; INSECTIVORA; EVOLUTION; GLAND; RAT; SENESCENCE	Background: Laboratory conditions nullify the extrinsic factors that determine the wild expected lifespan and release the intrinsic or potential lifespan. Thus, wild animals reared in a laboratory often show an increased lifespan, and consequently an increased senescence phase. Senescence is associated with a broad suite of physiological changes, including a decreased responsiveness of the circadian system. The time-keeping hormone melatonin, an important chemical player in this system, is suspected to have an anti-aging role. The Greater White-toothed shrew Crocidura russula is an ideal study model to address questions related to aging and associated changes in biological functions: its lifespan is short and is substantially increased in captivity; daily and seasonal rhythms, while very marked the first year of life, are dramatically altered during the senescence process which starts during the second year. Here we report on an investigation of the effects of melatonin administration on locomotor activity of aging shrews. Methodology/Principal Findings: 1) The diel fluctuations of melatonin levels in young, adult and aging shrews were quantified in the pineal gland and plasma. In both, a marked diel rhythm (low diurnal concentration; high nocturnal concentration) was present in young animals but then decreased in adults, and, as a result of a loss in the nocturnal production, was absent in old animals. 2) Daily locomotor activity rhythm was monitored in pre-senescent animals that had received either a subcutaneous melatonin implant, an empty implant or no implant at all. In non-implanted and sham-implanted shrews, the rhythm was well marked in adults. A marked degradation in both period and amplitude, however, started after the age of 14-16 months. This pattern was considerably delayed in melatonin-implanted shrews who maintained the daily rhythm for significantly longer. Conclusions: This is the first long term study (>500 days observation of the same individuals) that investigates the effects of continuous melatonin delivery. As such, it sheds new light on the putative anti-aging role of melatonin by demonstrating that continuous melatonin administration delays the onset of senescence. In addition, the shrew appears to be a promising mammalian model for elucidating the precise relationships between melatonin and aging.			Magnanou, E (corresponding author), Univ Paris 06, UMR 7628, Banyuls Sur Mer, France.	elodie.magnanou@obs-banyuls.fr	FALCON, Jack/I-5302-2013	FALCON, Jack/0000-0002-7572-6581; Attia, Joel/0000-0002-6003-8698; Magnanou, Elodie/0000-0002-8375-9682				Aujard F, 2006, CHRONOBIOL INT, V23, P451, DOI 10.1080/07420520500482090; Aujard F, 2001, NEUROSCIENCE, V105, P403, DOI 10.1016/S0306-4522(01)00202-0; Ben Saad MM, 2001, REPRODUCTION, V121, P323, DOI 10.1530/reprod/121.2.323; Biello SM, 2007, AGE, V29, P111; Bondy SC, 2007, NEUROCHEM INT, V50, P571, DOI 10.1016/j.neuint.2006.12.014; Brusco LI, 1998, J AUTONOM NERV SYST, V74, P49, DOI 10.1016/S0165-1838(98)00134-9; Charlesworth B, 2000, GENETICS, V156, P927; Esrefoglu M, 2005, J PINEAL RES, V39, P231, DOI 10.1111/j.1600-079X.2005.00235.x; Ferrari E, 2008, AGEING RES REV, V7, P225, DOI 10.1016/j.arr.2008.07.001; FONS R, 1974, Mammalia, V38, P265, DOI 10.1515/mamm.1974.38.2.265; Fons R, 1997, J EXP BIOL, V200, P1451; FONS R, 1975, VIE MILIEU C BIOL TE, V25, P315; FONS R, 1976, Mammalia, V40, P299, DOI 10.1515/mamm.1976.40.2.299; FONS R, 1988, GRZIMEKS ENZYKLOPADI; GIBBS FP, 1981, ENDOCRINOLOGY, V109, P1796, DOI 10.1210/endo-109-5-1796; HUMBERT W, 1995, J PINEAL RES, V18, P32, DOI 10.1111/j.1600-079X.1995.tb00137.x; JEANMAIREBESANCON F, 1986, ACTA OECOL-OEC APPL, V7, P355; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Kolker DE, 2002, AM J PHYSIOL-REG I, V282, pR1382, DOI 10.1152/ajpregu.00362.2001; KOSTERVANHOFFEN GC, 1993, NEUROBIOL AGING, V14, P565, DOI 10.1016/0197-4580(93)90040-I; LOPEZFUSTER J, 1986, MAMMALIA, V50, P541, DOI 10.1515/mamm.1986.50.4.541; Magri F, 2004, J PINEAL RES, V36, P256, DOI 10.1111/j.1600-079X.2004.00125.x; Miguez JM, 1998, J PINEAL RES, V25, P106, DOI 10.1111/j.1600-079X.1998.tb00547.x; NAGEL A, 1991, RESP PHYSIOL, V85, P139, DOI 10.1016/0034-5687(91)90057-P; PANG SF, 1990, J PINEAL RES, V8, P179, DOI 10.1111/j.1600-079X.1990.tb00678.x; Pearl R., 1928, RATE LIVING; Penev PD, 1997, AM J PHYSIOL-REG I, V273, pR2132, DOI 10.1152/ajpregu.1997.273.6.R2132; Peters T, 1999, J EXP BIOL, V202, P2461; Reiter RJ, 1999, MECH AGEING DEV, V110, P157, DOI 10.1016/S0047-6374(99)00058-5; REITER RJ, 1981, ENDOCRINOLOGY, V109, P1295, DOI 10.1210/endo-109-4-1295; REITER RJ, 1980, SCIENCE, V210, P1372, DOI 10.1126/science.7434032; Ricklefs RE, 2008, FUNCT ECOL, V22, P379, DOI 10.1111/j.1365-2435.2008.01420.x; Rodriguez MI, 2007, J PINEAL RES, V42, P272, DOI 10.1111/j.1600-079X.2006.00416.x; ROENNEBERG T, 1999, J BIOL RHTYTHM, V14; SAINTGIRONS MC, 1978, MAMMALIA, V42, P258; SANDYK R, 1990, INT J NEUROSCI, V52, P85, DOI 10.3109/00207459008994247; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Sharman EH, 2004, J PINEAL RES, V36, P165, DOI 10.1046/j.1600-079X.2003.00112.x; SICART R, 1978, COMP BIOCHEM PHYS B, V61, P77, DOI 10.1016/0305-0491(78)90218-3; Skene DJ, 2003, EXP GERONTOL, V38, P199, DOI 10.1016/S0531-5565(02)00198-5; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Speakman JR, 2002, J NUTR, V132, p1583S, DOI 10.1093/jn/132.6.1583S; Swietoslawski Jacek, 1999, Neuro Endocrinol Lett, V20, P391; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Touitou Y, 1998, THERAPIE, V53, P473; Van Reeth O, 2001, AM J PHYSIOL-REG I, V280, pR1582, DOI 10.1152/ajpregu.2001.280.5.R1582; VOGEL P, 1981, TERRE VIE-REV ECOL A, V35, P97; Von Gall C, 2008, NEUROBIOL AGING, V29, P464, DOI 10.1016/j.neurobiolaging.2006.10.015; WITTING W, 1997, BRAIN RES B, V30, P157; Wu YH, 2005, J PINEAL RES, V38, P145, DOI 10.1111/j.1600-079X.2004.00196.x; Zhao ZY, 2002, CHRONOBIOL INT, V19, P1171, DOI 10.1081/CBI-120015958	52	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5904	10.1371/journal.pone.0005904	http://dx.doi.org/10.1371/journal.pone.0005904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526053	Green Published, gold			2022-12-27	WOS:000267029300001
J	Tanaka, S; Shaikh, IM; Chiocca, EA; Saeki, Y				Tanaka, Shigeru; Shaikh, Imran Mohammed; Chiocca, E. Antonio; Saeki, Yoshinaga			The Gs-Linked Receptor GPR3 Inhibits the Proliferation of Cerebellar Granule Cells during Postnatal Development	PLOS ONE			English	Article								Background: During postnatal murine and rodent cerebellar development, cerebellar granule precursors (CGP) gradually stop proliferating as they differentiate after migration to the internal granule layer (IGL). Molecular events that govern this program remain to be fully elucidated. GPR3 belongs to a family of Gs-linked receptors that activate cyclic AMP and are abundantly expressed in the adult brain. Methodology/Principal Findings: To investigate the role of this orphan receptor in CGP differentiation, we determined that exogenous GPR3 expression in rat cerebellar granule neurons partially antagonized the proliferative effect of Sonic hedgehog (Shh), while endogenous GPR3 inhibition by siRNA stimulated Shh-induced CGP proliferation. In addition, exogenous GPR3 expression in CGPs correlated with increased p27/kip expression, while GPR3 knock-down led to a decrease in p27/kip expression. In wild-type mice, GPR3 expression increased postnatally and its expression was concentrated in the internal granular layer (IGL). In GPR3 2/2 mice, the IGL was widened with increased proliferation of CGPs, as measured by bromodeoxyuridine incorporation. Cell cycle kinetics of GPR3-transfected medulloblastoma cells revealed a G0/G1 block, consistent with cell cycle exit. Conclusions/Significance: These results thus indicate that GPR3 is a novel antiproliferative mediator of CGPs in the postnatal development of murine cerebellum.			Tanaka, S (corresponding author), Hiroshima Univ, Dept Mol & Pharmacol Neurosci, Grad Sch Biomed Sci, Minami Ku, Hiroshima, Japan.	EA.Chiocca@osumc.edu	Tanaka, Shigeru/O-3908-2015	Tanaka, Shigeru/0000-0003-3247-9098				Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Allais A, 2007, EUR J NEUROSCI, V25, P2604, DOI 10.1111/j.1460-9568.2007.05535.x; ALTMAN J, 1985, J COMP NEUROL, V231, P1, DOI 10.1002/cne.902310103; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; BURGOYNE RD, 1988, BRAIN RES, V472, P77; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hatten M E, 1993, Curr Opin Neurobiol, V3, P38, DOI 10.1016/0959-4388(93)90033-U; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Lee J, 1997, DEVELOPMENT, V124, P2537; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Miyazawa K, 2000, J NEUROSCI, V20, P5756, DOI 10.1523/JNEUROSCI.20-15-05756.2000; Nicot A, 2002, J NEUROSCI, V22, P9244; Pons S, 2001, DEVELOPMENT, V128, P1481; Raffel C, 1997, CANCER RES, V57, P842; Raffel C, 2004, NEOPLASIA, V6, P310, DOI 10.1593/neo.03454; Read TA, 2006, ANN NEUROL, V60, P3, DOI 10.1002/ana.20912; SAEKI Y, 1993, FEBS LETT, V336, P317, DOI 10.1016/0014-5793(93)80828-I; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; VOGEL MW, 1989, J NEUROSCI, V9, P3454; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Waschek JA, 2006, ANN NY ACAD SCI, V1070, P120, DOI 10.1196/annals.1317.089; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zhao Q, 2002, P NATL ACAD SCI USA, V99, P5704, DOI 10.1073/pnas.082092399; Zurawel RH, 2000, GENE CHROMOSOME CANC, V27, P44, DOI 10.1002/(SICI)1098-2264(200001)27:1<44::AID-GCC6>3.0.CO;2-V	43	22	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5922	10.1371/journal.pone.0005922	http://dx.doi.org/10.1371/journal.pone.0005922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526062	gold, Green Published			2022-12-27	WOS:000267029300013
J	Lozier, JD; Mills, NJ				Lozier, Jeffrey D.; Mills, Nicholas J.			Ecological Niche Models and Coalescent Analysis of Gene Flow Support Recent Allopatric Isolation of Parasitoid Wasp Populations in the Mediterranean	PLOS ONE			English	Article							BIOLOGICAL-CONTROL AGENTS; CLIMATE-CHANGE; SPECIES DELIMITATION; EMPIRICAL-EVALUATION; MIGRATION RATES; NATURAL ENEMIES; DIVERGENCE; CONSERVATISM; MITOCHONDRIAL; HYMENOPTERA	Background: The integration of multiple complementary approaches is a powerful way to understand the processes of diversification and speciation. The parasitoid wasp Aphidius transcaspicus Telenga (Hymenoptera: Braconidae) is a parasitoid of Hyalopterus aphids across a wide geographic range. This species shows a remarkable degree of genetic structure among western, central, and eastern Mediterranean population clusters. In this paper we attempt to better characterize this genetic structure. Methodology/Principal Findings: We use a Bayesian coalescent analysis of gene flow under the Isolation with Migration model using mitochondrial and microsatellite markers together with climate- based ecological niche models to better understand the genetic structure of A. transcaspicus in the Mediterranean. The coalescent analysis revealed low levels of migration among western and eastern Mediterranean populations (Nm < 1) that were not statistically distinguishable from zero. Niche models showed that localities within population clusters each occupy areas of continuously high environmental suitability, but are separated from each other by large regions of completely unsuitable habitat that could limit dispersal. Overall, environmental characteristics were similar among the population clusters, though significant differences did emerge. Conclusions/Significance: These results support contemporary allopatric isolation of Mediterranean populations of A. transcaspicus, which together with previous analyses indicating partial behaviorally mediated reproductive isolation, suggest that the early stages of cryptic speciation may be in progress.			Lozier, JD (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	jdlozier@life.uiuc.edu		Mills, Nicholas/0000-0001-8885-8674				Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Blackman R.L., 2000, J ECON ENTOMOL, V2; BOLKER B, 2007, EMDBOOK ECOLOGICAL M; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; Castella V, 2000, MOL ECOL, V9, P1761, DOI 10.1046/j.1365-294x.2000.01069.x; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; EXCOFFIER L, 1992, GENETICS, V131, P479; Gantenbein B, 2003, MOL PHYLOGENET EVOL, V28, P119, DOI 10.1016/S1055-7903(03)00031-9; Garrigan D, 2007, GENETICS, V177, P2195, DOI 10.1534/genetics.107.077495; Gevrey M, 2006, J ECON ENTOMOL, V99, P979, DOI 10.1603/0022-0493-99.3.979; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Gutierrez AP, 2008, CLIMATIC CHANGE, V87, pS167, DOI 10.1007/s10584-007-9379-4; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoelmer KA, 2005, BIOL CONTROL, V34, P255, DOI 10.1016/j.biocontrol.2005.05.001; HOPPER KR, 1993, ANNU REV ENTOMOL, V38, P27, DOI 10.1146/annurev.en.38.010193.000331; Horn A, 2006, MOL ECOL, V15, P1603, DOI 10.1111/j.1365-294X.2006.02872.x; HUDSON RR, 1991, OX SURV EVOL BIOL, V1, P44; Kavallieratos NG, 2004, APPL ENTOMOL ZOOL, V39, P527, DOI 10.1303/aez.2004.527; Kavallieratos Nickolas, 1999, Bollettino del Laboratorio di Entomologia Agraria Filippo Silvestri, V55, P105; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Legrand MA, 2004, CRYOLETTERS, V25, P161; Liu SS, 2002, BIOCONTROL, V47, P625, DOI 10.1023/A:1020576128920; LOZIER J, 2007, THESIS U CALIFORNIA; Lozier JD, 2006, MOL ECOL NOTES, V6, P27, DOI 10.1111/j.1471-8286.2005.01126.x; Lozier JD, 2008, BIOL CONTROL, V46, P532, DOI 10.1016/j.biocontrol.2008.05.002; Lozier JD, 2007, EVOLUTION, V61, P1353, DOI 10.1111/j.1558-5646.2007.00110.x; Lozier JD, 2009, BIOL INVASIONS, V11, P299, DOI 10.1007/s10530-008-9248-8; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; MESCHELOFF M, 1990, ISRAEL J ENTOMOL, V24, P51; Messenger P, 1976, THEORY PRACTICE BIOL, P209, DOI DOI 10.1016/B978-0-12-360350-0.50015-5; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Paul JR, 2009, AM NAT, V173, P188, DOI 10.1086/595762; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; R Core Team, 2018, R LANG ENV STAT COMP; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rissler LJ, 2006, AM NAT, V167, P655, DOI 10.1086/503332; Romani R, 2008, J EXP BIOL, V211, P2486, DOI 10.1242/jeb.013177; Roy HE, 2008, EUR J ENTOMOL, V105, P391, DOI 10.14411/eje.2008.049; Ruegg KC, 2006, J BIOGEOGR, V33, P1172, DOI 10.1111/j.1365-2699.2006.01517.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schmitt T, 2005, BIOL J LINN SOC, V85, P419, DOI 10.1111/j.1095-8312.2005.00504.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schug MD, 1998, MOL BIOL EVOL, V15, P1751, DOI 10.1093/oxfordjournals.molbev.a025901; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SMARTT J, 1995, EVOLUTION CROP PLANT, P496; STARY P, 1975, ACTA ENTOMOL BOHEMOS, V72, P156; Ulrichs C, 2008, BIOCONTROL, V53, P881, DOI 10.1007/s10526-007-9143-8; VANDENBOSCH R, 1979, HILGARDIA, V47, P1; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Zalucki MP, 2006, AUST J ENTOMOL, V45, P331, DOI 10.1111/j.1440-6055.2006.00560.x	70	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5901	10.1371/journal.pone.0005901	http://dx.doi.org/10.1371/journal.pone.0005901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521534	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029100016
J	Sehlmeyer, C; Schoning, S; Zwitserlood, P; Pfleiderer, B; Kircher, T; Arolt, V; Konrad, C				Sehlmeyer, Christina; Schoening, Sonja; Zwitserlood, Pienie; Pfleiderer, Bettina; Kircher, Tilo; Arolt, Volker; Konrad, Carsten			Human Fear Conditioning and Extinction in Neuroimaging: A Systematic Review	PLOS ONE			English	Review							POSITRON-EMISSION-TOMOGRAPHY; HUMAN AMYGDALA ACTIVITY; NEURAL RESPONSES; PREFRONTAL CORTEX; FUNCTIONAL NEUROANATOMY; HEMODYNAMIC-RESPONSES; CEREBELLAR ACTIVATION; PARTIAL-REINFORCEMENT; ANTERIOR CINGULATE; ANXIETY DISORDERS	Fear conditioning and extinction are basic forms of associative learning that have gained considerable clinical relevance in enhancing our understanding of anxiety disorders and facilitating their treatment. Modern neuroimaging techniques have significantly aided the identification of anatomical structures and networks involved in fear conditioning. On closer inspection, there is considerable variation in methodology and results between studies. This systematic review provides an overview of the current neuroimaging literature on fear conditioning and extinction on healthy subjects, taking into account methodological issues such as the conditioning paradigm. A Pubmed search, as of December 2008, was performed and supplemented by manual searches of bibliographies of key articles. Two independent reviewers made the final study selection and data extraction. A total of 46 studies on cued fear conditioning and/or extinction on healthy volunteers using positron emission tomography or functional magnetic resonance imaging were reviewed. The influence of specific experimental factors, such as contingency and timing parameters, assessment of conditioned responses, and characteristics of conditioned and unconditioned stimuli, on cerebral activation patterns was examined. Results were summarized descriptively. A network consisting of fear-related brain areas, such as amygdala, insula, and anterior cingulate cortex, is activated independently of design parameters. However, some neuroimaging studies do not report these findings in the presence of methodological heterogeneities. Furthermore, other brain areas are differentially activated, depending on specific design parameters. These include stronger hippocampal activation in trace conditioning and tactile stimulation. Furthermore, tactile unconditioned stimuli enhance activation of pain related, motor, and somatosensory areas. Differences concerning experimental factors may partly explain the variance between neuroimaging investigations on human fear conditioning and extinction and should, therefore, be taken into serious consideration in the planning and the interpretation of research projects.			Sehlmeyer, C (corresponding author), Univ Munster, Dept Psychiat, Munster, Germany.	konradc@uni-muenster.de	Kircher, Tilo/AAT-6480-2020	Kircher, Tilo/0000-0002-2514-2625				Anders S, 2005, EXP BRAIN RES, V162, P213, DOI 10.1007/s00221-004-2145-1; Anderson KC, 2006, BIOL PSYCHIAT, V60, P319, DOI 10.1016/j.biopsych.2006.06.022; [Anonymous], 1981, AUTOSHAPING CONDITIO; Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; Barad M, 2006, BIOL PSYCHIAT, V60, P322, DOI 10.1016/j.biopsych.2006.05.029; Bellgowan PSF, 2006, NEUROIMAGE, V29, P1244, DOI 10.1016/j.neuroimage.2005.08.042; Blair HT, 2005, NEUROSCIENCE, V133, P561, DOI 10.1016/j.neuroscience.2005.02.043; Blaxton TA, 1996, J NEUROSCI, V16, P4032; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; BUCHANAN SL, 1982, J COMP PHYSIOL PSYCH, V96, P755, DOI 10.1037/h0077925; Buchel C, 1999, J NEUROSCI, V19, P10869; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Butler T, 2005, NEUROREPORT, V16, P1233, DOI 10.1097/00001756-200508010-00020; Carlsson K, 2006, NEUROIMAGE, V32, P1804, DOI 10.1016/j.neuroimage.2006.05.027; Carter RM, 2006, NEUROIMAGE, V29, P1007, DOI 10.1016/j.neuroimage.2005.09.011; Cheng DT, 2008, P NATL ACAD SCI USA, V105, P8108, DOI 10.1073/pnas.0800374105; Cheng DT, 2007, LEARN MEMORY, V14, P485, DOI 10.1101/lm.632007; Cheng DT, 2006, BEHAV NEUROSCI, V120, P1187, DOI 10.1037/0735-7044.120.5.1187; Cheng DT, 2003, BEHAV NEUROSCI, V117, P3, DOI 10.1037/0735-7044.117.1.3; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; Dimitrova A, 2004, CLIN NEUROPHYSIOL, V115, P849, DOI 10.1016/j.clinph.2003.11.030; Doronbekov TK, 2005, PSYCHIAT CLIN NEUROS, V59, P155, DOI 10.1111/j.1440-1819.2005.01351.x; Dunsmoor JE, 2008, NEUROIMAGE, V40, P811, DOI 10.1016/j.neuroimage.2007.11.042; Dunsmoor JE, 2007, BEHAV NEUROSCI, V121, P635, DOI 10.1037/0735-7044.121.4.635; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Finger EC, 2007, NEUROPSYCHOPHARMACOL, V32, P206, DOI 10.1038/sj.npp.1301182; Fischer H, 2000, BEHAV NEUROSCI, V114, P671, DOI 10.1037//0735-7044.114.4.671; Fischer H, 2002, EMOTION, V2, P233, DOI 10.1037/1528-3542.2.3.233; Fredrikson M, 1995, NEUROREPORT, V7, P97, DOI 10.1097/00001756-199512000-00023; Freeman JH, 1996, BEHAV BRAIN RES, V80, P123, DOI 10.1016/0166-4328(96)00027-7; Furmark T, 1997, NEUROREPORT, V8, P3957, DOI 10.1097/00001756-199712220-00021; Gallinat J, 2007, NEUROIMAGE, V34, P671, DOI 10.1016/j.neuroimage.2006.10.004; Garpenstrand H, 2001, BEHAV NEUROSCI, V115, P358, DOI 10.1037//0735-7044.115.2.358; Gibbon J., 1981, AUTOSHAPING CONDITIO, P219; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; GUIMARAES FS, 1991, PSYCHOPHARMACOLOGY, V104, P231, DOI 10.1007/BF02244184; HALL JF, 1984, PAVLOVIAN J BIOL SCI, V19, P163; Hamm AO, 2005, INT J PSYCHOPHYSIOL, V57, P5, DOI 10.1016/j.ijpsycho.2005.01.006; Hooker CI, 2008, NEUROPSYCHOLOGIA, V46, P2709, DOI 10.1016/j.neuropsychologia.2008.05.005; HUGDAHL K, 1995, NEUROREPORT, V6, P1723, DOI 10.1097/00001756-199509000-00005; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Kamprath K, 2006, J NEUROSCI, V26, P6677, DOI 10.1523/JNEUROSCI.0153-06.2006; Keightley ML, 2003, NEUROIMAGE, V20, P2031, DOI 10.1016/j.neuroimage.2003.08.022; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; KLUCKEN T, 2008, NEUROSCIENCE; Knight DC, 2006, COGN AFFECT BEHAV NE, V6, P157, DOI 10.3758/CABN.6.2.157; Knight DC, 2004, COGN AFFECT BEHAV NE, V4, P317, DOI 10.3758/CABN.4.3.317; Knight DC, 2005, NEUROIMAGE, V26, P1193, DOI 10.1016/j.neuroimage.2005.03.020; Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004; Knight DC, 1999, NEUROREPORT, V10, P3665, DOI 10.1097/00001756-199911260-00037; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LANG PJ, 1990, INT AFFECTIVE PICTUR; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEONARD DW, 1975, J COMP PHYSIOL PSYCH, V88, P596, DOI 10.1037/h0076419; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; LOGAN CG, 1995, P NATL ACAD SCI USA, V92, P7500, DOI 10.1073/pnas.92.16.7500; Marchand AR, 2004, ARCH ITAL BIOL, V142, P251; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Marschner A, 2008, J NEUROSCI, V28, P9030, DOI 10.1523/JNEUROSCI.1651-08.2008; McEchron MD, 2003, J NEUROSCI, V23, P1535, DOI 10.1523/JNEUROSCI.23-04-01535.2003; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; MOLCHAN SE, 1994, P NATL ACAD SCI USA, V91, P8122, DOI 10.1073/pnas.91.17.8122; Morawetz C, 2008, MAGN RESON IMAGING, V26, P45, DOI 10.1016/j.mri.2007.04.014; Morris JS, 2004, NEUROIMAGE, V22, P372, DOI 10.1016/j.neuroimage.2004.01.012; Morris JS, 1998, P ROY SOC B-BIOL SCI, V265, P649, DOI 10.1098/rspb.1998.0343; Morris JS, 1997, P ROY SOC B-BIOL SCI, V264, P769, DOI 10.1098/rspb.1997.0109; Most SB, 2006, NEUROIMAGE, V31, P934, DOI 10.1016/j.neuroimage.2005.12.031; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Neumann DL, 2006, BIOL PSYCHOL, V73, P175, DOI 10.1016/j.biopsycho.2006.03.004; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; O'Gorman RL, 2006, NEUROIMAGE, V31, P489, DOI 10.1016/j.neuroimage.2005.12.048; Otto MW, 2007, BEHAV MODIF, V31, P32, DOI 10.1177/0145445506295054; Pape HC, 2005, NEURON, V48, P877, DOI 10.1016/j.neuron.2005.12.002; Pape HC, 2005, HIPPOCAMPUS, V15, P874, DOI 10.1002/hipo.20120; Pape HC, 2004, PFLUG ARCH EUR J PHY, V448, P131, DOI 10.1007/s00424-003-1234-5; Pape HC, 2003, ANN NY ACAD SCI, V985, P92; Pape HC, 1998, J NEUROPHYSIOL, V79, P205, DOI 10.1152/jn.1998.79.1.205; Pape HC, 2001, ZOOL-ANAL COMPLEX SY, V104, P232, DOI 10.1078/0944-2006-00029; Pavlov I.P., 1927, CONDITIONED REFLEXES; Petrovic P, 2008, SOC COGN AFFECT NEUR, V3, P109, DOI 10.1093/scan/nsn002; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Pine DS, 2001, BIOL PSYCHIAT, V50, P225, DOI 10.1016/S0006-3223(01)01159-3; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; PROKASY WF, 1963, PSYCHOL REP, V12, P55, DOI 10.2466/pr0.1963.12.1.55; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; RACHMAN S, 1977, BEHAV RES THER, V15, P375, DOI 10.1016/0005-7967(77)90041-9; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rauch AV, 2007, CEREB CORTEX, V17, P2526, DOI 10.1093/cercor/bhl158; Rauch SL, 2005, NEUROREPORT, V16, P1909, DOI 10.1097/01.wnr.0000186599.66243.50; Schafer A, 2005, INT J PSYCHOPHYSIOL, V57, P53, DOI 10.1016/j.ijpsycho.2005.01.011; Schienle A, 2002, NEUROREPORT, V13, P2023, DOI 10.1097/00001756-200211150-00006; Schiller D, 2008, J NEUROSCI, V28, P11517, DOI 10.1523/JNEUROSCI.2265-08.2008; Schnitzler A, 2000, J CLIN NEUROPHYSIOL, V17, P592, DOI 10.1097/00004691-200011000-00005; Schreurs BG, 1997, J NEUROPHYSIOL, V77, P2153, DOI 10.1152/jn.1997.77.4.2153; Schreurs BG, 2001, NEUROBIOL AGING, V22, P237, DOI 10.1016/S0197-4580(00)00224-4; SCHURR BC, 1973, J EXP PSYCHOL, V101, P398, DOI 10.1037/h0035234; Shors TJ, 2004, TRENDS NEUROSCI, V27, P250, DOI 10.1016/j.tins.2004.03.007; Somers JM, 2006, CAN J PSYCHIAT, V51, P100, DOI 10.1177/070674370605100206; Sotres-Bayon F, 2007, NEUROPSYCHOPHARMACOL, V32, P1929, DOI 10.1038/sj.npp.1301316; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Stark R, 2007, NEUROIMAGE, V37, P663, DOI 10.1016/j.neuroimage.2007.05.005; Stein DJ, 2006, METAB BRAIN DIS, V21, P267, DOI 10.1007/s11011-006-9021-6; Stocker T, 2006, NEUROIMAGE, V30, P151, DOI 10.1016/j.neuroimage.2005.09.050; Stoppel C, 2006, GENES BRAIN BEHAV, V5, P34, DOI 10.1111/j.1601-183X.2006.00229.x; Straube T, 2007, NEUROIMAGE, V34, P462, DOI 10.1016/j.neuroimage.2006.08.021; Sugiura M, 2000, NEUROIMAGE, V11, P541, DOI 10.1006/nimg.2000.0564; Svartdal F, 2003, SCAND J PSYCHOL, V44, P55, DOI 10.1111/1467-9450.00321; Tabbert K, 2005, INT J PSYCHOPHYSIOL, V57, P15, DOI 10.1016/j.ijpsycho.2005.01.007; Tabbert K, 2006, NEUROIMAGE, V32, P761, DOI 10.1016/j.neuroimage.2006.03.038; Timmann D, 1996, NEUROREPORT, V7, P2056, DOI 10.1097/00001756-199608120-00041; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Weike AI, 2007, PSYCHOPHYSIOLOGY, V44, P170, DOI 10.1111/j.1469-8986.2006.00469.x; Williams LM, 2005, NEUROIMAGE, V28, P618, DOI 10.1016/j.neuroimage.2005.06.035; Yaguez L, 2005, GASTROENTEROLOGY, V128, P1819, DOI 10.1053/j.gastro.2005.02.068	124	386	393	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5865	10.1371/journal.pone.0005865	http://dx.doi.org/10.1371/journal.pone.0005865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	456TI	19517024	Green Submitted, Green Published, gold			2022-12-27	WOS:000266872900016
J	Kalthoff, D; Breithaupt, A; Helm, B; Teifke, JP; Beer, M				Kalthoff, Donata; Breithaupt, Angele; Helm, Barbara; Teifke, Jens P.; Beer, Martin			Migratory Status Is Not Related to the Susceptibility to HPAIV H5N1 in an Insectivorous Passerine Species	PLOS ONE			English	Article								Migratory birds have evolved elaborate physiological adaptations to travelling, the implications for their susceptibility to avian influenza are however unknown. Three groups of stonechats (Saxicola torquata) from (I) strongly migrating, (II) weakly migrating and (III) non-migrating populations were experimentally infected with HPAIV H5N1. The different bird groups of this insectivorous passerine species were infected in autumn, when the migrating populations clearly exhibit migratory restlessness. Following infection, all animals succumbed to the disease from 3 through 7 days post inoculation. Viral shedding, antigen distribution in tissues, and survival time did not differ between the three populations. However, notably, endothelial tropism of the HPAIV infection was exclusively seen in the group of resident birds. In conclusion, our data document for the first time the high susceptibility of an insectivorous passerine species to H5N1 infection, and the epidemiological role of these passerine birds is probably limited due to their high sensitivity to HPAIV H5N1 infection. Despite pronounced inherited differences in migratory status, the groups were generally indistinguishable in their susceptibility, survival time, clinical symptoms and viral shedding. Nevertheless, the migratory status partly influenced pathogenesis in the way of viral tropism.	[Kalthoff, Donata] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Breithaupt, Angele; Teifke, Jens P.; Beer, Martin] Friedrich Loeffler Inst, Inst Infectol, Greifswald, Germany; [Helm, Barbara] Max Planck Inst Ornithol Seewiesen & Andechs, Andechs, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Max Planck Society	Kalthoff, D (corresponding author), Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany.	Martin.Beer@fli.bund.de	Breithaupt, Angele/B-6155-2013; Breithaupt, Angele/GON-7227-2022	Breithaupt, Angele/0000-0002-6373-5923; Teifke, Jens/0000-0001-7168-4970; Helm, Barbara/0000-0002-6648-1463; Hoffmann, Donata/0000-0003-4552-031X	Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany [1-4.1]	Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany	This study was funded by the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany (FSI project no. 1-4.1) in a national influenza research program. The study was approved by the Federal Ministry for support, however there was no further influence on the study or the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Berthold P, 2001, AUK, V2nd; Boon ACM, 2007, EMERG INFECT DIS, V13, P1720, DOI 10.3201/eid1311.070114; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; GLOBIG A, 2009, TRANSBOUND IN PRESS; Gronesova P, 2008, SCAND J INFECT DIS, V40, P954, DOI 10.1080/00365540802400576; Helm B, 2006, ARDEA, V94, P33; Helm B, 2005, J ORNITHOL, V146, P348, DOI 10.1007/s10336-005-0009-5; Helm B, 2005, ANN NY ACAD SCI, V1046, P216, DOI 10.1196/annals.1343.019; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; Hoffmann B, 2007, J CLIN MICROBIOL, V45, P600, DOI 10.1128/JCM.01681-06; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1132, DOI 10.3201/eid1407.071468; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Klopfleisch R, 2007, VET PATHOL, V44, P261, DOI 10.1354/vp.44-3-261; Klopfleisch R, 2006, VET PATHOL, V43, P463, DOI 10.1354/vp.43-4-463; Kou Z, 2005, J VIROL, V79, P15460, DOI 10.1128/JVI.79.24.15460-15466.2005; Kwon YK, 2005, J WILDLIFE DIS, V41, P618, DOI 10.7589/0090-3558-41.3.618; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Magnino S, 2000, VET REC, V146, P740; Matsuda K, 2004, VET PATHOL, V41, P101, DOI 10.1354/vp.41-2-101; NEWMAN S, 2007, EMPRES WATCH     AUG, P1; NORMILE D, 2006, SCIENCE, V312, P845; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Owen JC, 2006, CONDOR, V108, P389, DOI 10.1650/0010-5422(2006)108[389:SDIICO]2.0.CO;2; Perkins LEL, 2003, VET PATHOL, V40, P14, DOI 10.1354/vp.40-1-14; Peterson AT, 2008, EMERG INFECT DIS, V14, P1644, DOI 10.3201/eid1410.080169; Starick E, 2008, VET MICROBIOL, V128, P243, DOI 10.1016/j.vetmic.2007.10.012; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Stutzenbaker CD, 1986, LEAD POISONING WILD, P88; SUSS J, 1994, ARCH VIROL, V135, P101, DOI 10.1007/BF01309768; Swayne DE, 2000, REV SCI TECH OIE, V19, P463; Tanimura N, 2006, VET PATHOL, V43, P500, DOI 10.1354/vp.43-4-500; TEILKE JP, 2007, VET PATHOL, V44, P137; Weber JM, 2009, J EXP BIOL, V212, P593, DOI 10.1242/jeb.015024; Weber S, 2007, J GEN VIROL, V88, P554, DOI 10.1099/vir.0.82300-0; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wobeser G.A., 1994, INVESTIGATION MANAGE	42	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	4	7							e6170	10.1371/journal.pone.0006170	http://dx.doi.org/10.1371/journal.pone.0006170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YF	19584935	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000207566200001
J	Maher, AC; Fu, MH; Isfort, RJ; Varbanov, AR; Qu, XA; Tarnopolsky, MA				Maher, Amy C.; Fu, Minghua H.; Isfort, Robert J.; Varbanov, Alex R.; Qu, Xiaoyan A.; Tarnopolsky, Mark A.			Sex Differences in Global mRNA Content of Human Skeletal Muscle	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE ACTIVITY; TISSUE GLYCOGEN-METABOLISM; UNCOUPLING PROTEIN-2 GENE; ACTIVATED RECEPTOR-ALPHA; ALDEHYDE DEHYDROGENASES; SUBSTRATE UTILIZATION; GENDER DIFFERENCES; ACYL-COENZYME; FIBER TYPES; ENDURANCE EXERCISE	Women oxidize more fat as compared to men during endurance exercise and several groups have shown that the mRNA content of selected genes related to fat oxidation are higher in women (e. g. hormone sensitive lipase, beta-hydroxyacyl-CoA dehydrogenase, CD36). One of the possible mechanisms is that women tend to have a higher area percentage of type I skeletal muscle fibers as compared with men. Consequently, we hypothesized that sex would influence the basal mRNA and protein content for genes involved in metabolism and the determination of muscle fiber type. Muscle biopsies from the vastus lateralis were collected from healthy men and women. We examined mRNA content globally using Affymetrix GeneChips, and selected genes were examined and/or confirmed by RT-PCR. Furthermore, we examined protein content by Western blot analysis. Stringent gene array analysis revealed 66 differentially expressed genes representing metabolism, mitochondrial function, transport, protein biosynthesis, cell proliferation, signal transduction pathways, transcription and translation. Stringent gene array analysis and RT-PCR confirmed that mRNA for; acyl-coenzyme A acyltransferase 2 (ACAA2), trifunctional protein beta (HADHB), catalase, lipoprotein lipase (LPL), and uncoupling protein-2 (UCP-2) were higher in women. Targeted gene analysis revealed that myosin heavy chain I (MHCI), peroxisome proliferator-activated receptor (PPAR)delta were higher in women compared with men. Surprisingly, there were no significant sex based differences in protein content for HADHB, ACAA2, catalase, PPAR delta, and MHC1. In conclusion, the differences in the basal mRNA content in resting skeletal muscle suggest that men and women are transcriptionally "primed" for known physiological differences in metabolism however the mechanism behind sex differences in fiber type remains to be determined.			Maher, AC (corresponding author), McMaster Univ, Dept Med Sci, Hamilton, ON, Canada.	tarnopol@mcmaster.ca						Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Barbe P, 1998, J CLIN ENDOCR METAB, V83, P2450, DOI 10.1210/jc.83.7.2450; Barreiro E, 2006, FREE RADICAL BIO MED, V41, P797, DOI 10.1016/j.freeradbiomed.2006.05.027; Binnert C, 2000, AM J PHYSIOL-ENDOC M, V279, pE1072, DOI 10.1152/ajpendo.2000.279.5.E1072; BROOKE MH, 1969, NEUROLOGY, V19, P221, DOI 10.1212/WNL.19.3.221; Buemann B, 2001, INT J OBESITY, V25, P467, DOI 10.1038/sj.ijo.0801564; Carter SL, 2001, AM J PHYSIOL-ENDOC M, V280, pE898, DOI 10.1152/ajpendo.2001.280.6.E898; CHAN WCW, 2000, P SOC PHOTO-OPT INS, V1, P2; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Chen YW, 2003, J APPL PHYSIOL, V95, P2485, DOI 10.1152/japplphysiol.01161.2002; Collard F, 2007, BIOCHIMIE, V89, P369, DOI 10.1016/j.biochi.2006.11.005; COSTILL DL, 1976, J APPL PHYSIOL, V40, P149, DOI 10.1152/jappl.1976.40.2.149; DEVRIES MC, 2006, AM J PHYSL REGUL INT; Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949; Duscha BD, 2001, J APPL PHYSIOL, V90, P280, DOI 10.1152/jappl.2001.90.1.280; ELLIS GS, 1994, J APPL PHYSIOL, V77, P209, DOI 10.1152/jappl.1994.77.1.209; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; ESBJORNSSON M, 1993, INT J SPORTS MED, V14, P257, DOI 10.1055/s-2007-1021174; Esbjornsson-Liljedahl M, 1999, J APPL PHYSIOL, V87, P1326, DOI 10.1152/jappl.1999.87.4.1326; Fano G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060; Friedlander AL, 1998, J APPL PHYSIOL, V85, P1175, DOI 10.1152/jappl.1998.85.3.1175; Gagnon I, 2002, BBA-PROTEIN STRUCT M, V1596, P156, DOI 10.1016/S0167-4838(02)00213-3; GAUTHIER JM, 1992, MED SCI SPORT EXER, V24, P1252; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; GREEN HJ, 1984, J NEUROL SCI, V65, P323, DOI 10.1016/0022-510X(84)90095-9; Grimaldi PA, 2003, BIOCHEM SOC T, V31, P1130; Grobet L, 2003, GENESIS, V35, P227, DOI 10.1002/gene.10188; HARDS JM, 1990, CHEST, V97, P1037, DOI 10.1378/chest.97.5.1037; Haslett JN, 2003, NEUROGENETICS, V4, P163, DOI 10.1007/s10048-003-0148-x; Hinkle RT, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-18; Holloway GP, 2008, AM J PHYSIOL-ENDOC M, V294, pE1060, DOI 10.1152/ajpendo.00726.2007; Horton TJ, 1998, J APPL PHYSIOL, V85, P1823, DOI 10.1152/jappl.1998.85.5.1823; HOWEL D, 1994, ANAT REC, V240, P625, DOI 10.1002/ar.1092400418; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Joyce C, 1999, CURR OPIN LIPIDOL, V10, P89, DOI 10.1097/00041433-199904000-00002; KENDRICK ZV, 1987, J APPL PHYSIOL, V63, P492, DOI 10.1152/jappl.1987.63.2.492; KENDRICK ZV, 1991, J APPL PHYSIOL, V71, P1694, DOI 10.1152/jappl.1991.71.5.1694; Kiens B, 2004, J APPL PHYSIOL, V97, P1209, DOI 10.1152/japplphysiol.01278.2003; Kiens B, 1997, MED SCI SPORT EXER, V29, P640, DOI 10.1097/00005768-199705000-00009; KIENS B, 2004, J APPL PHYSL; KOMI PV, 1978, ACTA PHYSIOL SCAND, V103, P210, DOI 10.1111/j.1748-1716.1978.tb06208.x; Urso M, 2006, J APPL PHYSIOL, V101, P1136, DOI 10.1152/japplphysiol.00180.2006; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; MAHONEY DJ, 2005, FASEB J; Maly IP, 1999, HISTOCHEM CELL BIOL, V111, P461, DOI 10.1007/s004180050382; Mannion AF, 1997, J ANAT, V190, P505, DOI 10.1046/j.1469-7580.1997.19040505.x; Melanson EL, 2002, J APPL PHYSIOL, V92, P1045, DOI 10.1152/japplphysiol.00706.2001; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Mittendorfer B, 2002, AM J PHYSIOL-ENDOC M, V283, pE58, DOI 10.1152/ajpendo.00504.2001; Nagy TR, 1996, J APPL PHYSIOL, V80, P1743, DOI 10.1152/jappl.1996.80.5.1743; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003; Orii KE, 1996, BIOCHEM BIOPH RES CO, V219, P773, DOI 10.1006/bbrc.1996.0309; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Porter MM, 2002, J APPL PHYSIOL, V92, P1451, DOI 10.1152/japplphysiol.00744.2001; Riddell MC, 2003, INT J SPORT NUTR EXE, V13, P407, DOI 10.1123/ijsnem.13.4.407; Roepstorff C, 2005, ACTA PHYSIOL SCAND, V184, P215, DOI 10.1111/j.1365-201X.2005.01442.x; Roepstorff C, 2002, AM J PHYSIOL-ENDOC M, V282, pE435, DOI 10.1152/ajpendo.00266.2001; Roepstorff C, 2006, AM J PHYSIOL-ENDOC M, V291, pE1106, DOI 10.1152/ajpendo.00097.2006; Roepstorff C, 2006, J PHYSIOL-LONDON, V574, P125, DOI 10.1113/jphysiol.2006.108720; Roth SM, 2002, PHYSIOL GENOMICS, V10, P181, DOI 10.1152/physiolgenomics.00028.2002; Rudel LL, 2001, CURR OPIN LIPIDOL, V12, P121, DOI 10.1097/00041433-200104000-00005; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; SAKATA R, 2000, J ANIM SCI, V1, P1; Schrauwen P, 2002, J EXP BIOL, V205, P2275; SIMONEAU JA, 1985, CAN J PHYSIOL PHARM, V63, P30, DOI 10.1139/y85-005; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Staron RS, 1997, CAN J APPL PHYSIOL, V22, P307, DOI 10.1139/h97-020; Steffensen CH, 2002, AM J PHYSIOL-ENDOC M, V282, pE634, DOI 10.1152/ajpendo.00078.2001; Sterrenburg E, 2004, NEUROMUSCULAR DISORD, V14, P507, DOI 10.1016/j.nmd.2004.03.008; TARNOPOLSKY LJ, 1990, J APPL PHYSIOL, V68, P302, DOI 10.1152/jappl.1990.68.1.302; TARNOPOLSKY MA, 1995, J APPL PHYSIOL, V78, P1360, DOI 10.1152/jappl.1995.78.4.1360; Tarnopolsky MA, 1997, J APPL PHYSIOL, V83, P1877, DOI 10.1152/jappl.1997.83.6.1877; Urso ML, 2005, ARTERIOSCL THROM VAS, V25, P2560, DOI 10.1161/01.ATV.0000190608.28704.71; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Vina J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385; Yasuda N, 2005, J APPL PHYSIOL, V99, P1085, DOI 10.1152/japplphysiol.00247.2005; YIN SJ, 1994, ALCOHOL CLIN EXP RES, V18, P1256, DOI 10.1111/j.1530-0277.1994.tb00115.x; Yoshioka M, 2007, J MOL ENDOCRINOL, V39, P119, DOI 10.1677/JME-07-0027; Zambon AC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r61; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	90	51	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6335	10.1371/journal.pone.0006335	http://dx.doi.org/10.1371/journal.pone.0006335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623254	Green Published, gold, Green Submitted			2022-12-27	WOS:000268260100013
J	Mhlanga, MM; Bratu, DP; Genovesio, A; Rybarska, A; Chenouard, N; Nehrbass, U; Olivo-Marin, JC				Mhlanga, Musa M.; Bratu, Diana P.; Genovesio, Auguste; Rybarska, Agata; Chenouard, Nicolas; Nehrbass, Ulf; Olivo-Marin, Jean-Christophe			In Vivo Colocalisation of oskar mRNA and Trans-Acting Proteins Revealed by Quantitative Imaging of the Drosophila Oocyte	PLOS ONE			English	Article							MOLECULAR BEACONS; BINDING-PROTEIN; INTRACELLULAR-LOCALIZATION; TRANSLATIONAL REGULATION; POSTERIOR LOCALIZATION; PARTICLE TRACKING; HNRNPA/B HOMOLOG; AXIS FORMATION; STAUFEN; DIFFUSION	Efficient mRNA transport in eukaryotes requires highly orchestrated relationships between nuclear and cytoplasmic proteins. For oskar mRNA, the Drosophila posterior determinant, these spatio-temporal requirements remain opaque during its multi-step transport process. By in vivo covisualization of oskar mRNA with Staufen, its putative trafficking protein, we find oskar mRNA to be present in particles distinct from Staufen for part of its transport. oskar mRNA stably associated with Staufen near the posterior pole. We observe oskar mRNA to oligomerize as hundreds of copies forming large particles which are necessary for its long range transport and localization. We show the formation of these particles occurs in the nurse cell nucleus in an Hrp48-dependent manner. We present a more refined model of oskar mRNA transport in the Drosophila oocyte.			Mhlanga, MM (corresponding author), Inst Pasteur, Dept Biol Cellulaire & Infect, Unite Biol Cellulaire Noyau, Paris, France.	musa@pasteur.fr	Mhlanga, Musa/D-1283-2011; Olivo-Marin, Jean-Christophe/K-4428-2015; GENOVESIO, Auguste/I-1656-2017	Mhlanga, Musa/0000-0003-1381-3409; Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; Genovesio, Auguste/0000-0003-1877-5595; Nehrbass, Ulf/0000-0002-7028-8076				Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; BOUCHAUD JP, 1990, PHYS REV A, V41, P1156, DOI 10.1103/PhysRevA.41.1156; Braat AK, 2004, DEV CELL, V7, P125, DOI 10.1016/j.devcel.2004.06.009; Bratu Diana P., 2006, V319, P1; Bratu DP, 2003, P NATL ACAD SCI USA, V100, P13308, DOI 10.1073/pnas.2233244100; BYCROFT M, 1995, EMBO J, V14, P3563, DOI 10.1002/j.1460-2075.1995.tb07362.x; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Chou TB, 1996, GENETICS, V144, P1673; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Davis I, 2004, NAT CELL BIOL, V6, P285, DOI 10.1038/ncb0404-285; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dirks RW, 2001, HISTOCHEM CELL BIOL, V115, P3, DOI 10.1007/s004180000214; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Farina KL, 2002, TRENDS CELL BIOL, V12, P466, DOI 10.1016/S0962-8924(02)02357-7; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Genovesio A, 2006, IEEE T IMAGE PROCESS, V15, P1062, DOI 10.1109/TIP.2006.872323; GENOVESIO A, 2004, IM PROC 2004 ICIP 04; GENOVESIO A, 2004, BIOM IM MACR NAN 200, P1239; GENOVESIO A, 2004, PATT REC 2004 ICPR 2; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; Gunkel N, 1998, GENE DEV, V12, P1652, DOI 10.1101/gad.12.11.1652; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Hammond LE, 1997, MOL CELL BIOL, V17, P7260, DOI 10.1128/MCB.17.12.7260; Havlin S, 2002, ADV PHYS, V51, P187, DOI 10.1080/00018730110116353; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; KELLEY RL, 1993, GENE DEV, V7, P948, DOI 10.1101/gad.7.6.948; Kim JH, 2005, EJC SUPPL, V3, P208; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Lorenz P, 2000, NUCLEIC ACIDS RES, V28, P582, DOI 10.1093/nar/28.2.582; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Martin SG, 2003, DEVELOPMENT, V130, P4201, DOI 10.1242/dev.00630; MATUNIS EL, 1993, J CELL BIOL, V121, P219, DOI 10.1083/jcb.121.2.219; MATUNIS EL, 1992, J CELL BIOL, V116, P257, DOI 10.1083/jcb.116.2.257; MATUNIS MJ, 1992, J CELL BIOL, V116, P245, DOI 10.1083/jcb.116.2.245; Mhlanga MM, 2005, NUCLEIC ACIDS RES, V33, P1902, DOI 10.1093/nar/gki302; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Palacios IM, 2002, CURR BIOL, V12, pR50, DOI 10.1016/S0960-9822(01)00671-6; Palacios IM, 2001, ANNU REV CELL DEV BI, V17, P569, DOI 10.1146/annurev.cellbio.17.1.569; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Roegiers F, 2000, TRENDS CELL BIOL, V10, P220, DOI 10.1016/S0962-8924(00)01767-0; RONGO C, 1995, DEVELOPMENT, V121, P2737; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Spiller DG, 1998, BLOOD, V91, P4738, DOI 10.1182/blood.V91.12.4738.412k31_4738_4746; Spirin A. S., 1966, Current Topics in Developmental Biology, V1, P1; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tekotte H, 2006, DEV CELL, V10, P280, DOI 10.1016/j.devcel.2006.02.001; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Tyagi S, 2004, BIOPHYS J, V87, P4153, DOI 10.1529/biophysj.104.045153; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	74	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6241	10.1371/journal.pone.0006241	http://dx.doi.org/10.1371/journal.pone.0006241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597554	Green Published, gold			2022-12-27	WOS:000268035600008
J	Kwon, MJ; Oh, E; Lee, S; Roh, MR; Kim, SE; Lee, Y; Choi, YL; In, YH; Park, T; Koh, SS; Shin, YK				Kwon, Mi Jeong; Oh, Ensel; Lee, Seungmook; Roh, Mi Ra; Kim, Si Eun; Lee, Yangsoon; Choi, Yoon-La; In, Yong-Ho; Park, Taesung; Koh, Sang Seok; Shin, Young Kee			Identification of Novel Reference Genes Using Multiplatform Expression Data and Their Validation for Quantitative Gene Expression Analysis	PLOS ONE			English	Article								Normalization of mRNA levels using endogenous reference genes (ERGs) is critical for an accurate comparison of gene expression between different samples. Despite the popularity of traditional ERGs (tERGs) such as GAPDH and ACTB, their expression variability in different tissues or disease status has been reported. Here, we first selected candidate housekeeping genes (HKGs) using human gene expression data from different platforms including EST, SAGE, and microarray, and 13 novel ERGs (nERGs) (ARL8B, CTBP1, CUL1, DIMT1L, FBXW2, GPBP1, LUC7L2, OAZ1, PAPOLA, SPG21, TRIM27, UBQLN1, ZNF207) were further identified from these HKGs. The mean coefficient variation (CV) values of nERGs were significantly lower than those of tERGs and the expression level of most nERGs was relatively lower than high expressing tERGs in all dataset. The higher expression stability and lower expression levels of most nERGs were validated in 108 human samples including formalin-fixed paraffin-embedded (FFPE) tissues, frozen tissues and cell lines, through quantitative real-time RT-PCR (qRT-PCR). Furthermore, the optimal number of nERGs required for accurate normalization was as few as two, while four genes were required when using tERGs in FFPE tissues. Most nERGs identified in this study should be better reference genes than tERGs, based on their higher expression stability and fewer numbers needed for normalization when multiple ERGs are required.			Kwon, MJ (corresponding author), Seoul Natl Univ, Coll Pharm, Dept Pharm, Lab Mol Pathol, Seoul, South Korea.	ykeeshin@snu.ac.kr	Shin, Young Kee/C-8929-2011	Shin, Young Kee/0000-0003-0896-718X; Kwon, Mi Jeong/0000-0002-7599-878X				Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Glenn ST, 2007, BIOTECHNIQUES, V43, P639, DOI 10.2144/000112562; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369; Haverty PM, 2004, BIOINFORMATICS, V20, P3431, DOI 10.1093/bioinformatics/bth421; Hoerndli FJ, 2004, ANAL BIOCHEM, V335, P30, DOI 10.1016/j.ab.2004.08.028; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jin P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-55; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; *LC, 2005, 152005 LC; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Lee SJ, 2002, CRIT REV EUKAR GENE, V12, P297, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i4.40; Lehmann U, 2000, AM J PATHOL, V156, P1855, DOI 10.1016/S0002-9440(10)65059-6; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Ponger L, 2001, GENOME RES, V11, P1854, DOI 10.1101/gr.174501; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Shulzhenko N, 2005, BIOCHEM BIOPH RES CO, V337, P306, DOI 10.1016/j.bbrc.2005.09.048; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Sun M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-1; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; van Ruissen F, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-91; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2004, BIOINFORMATICS, V20, P1170, DOI 10.1093/bioinformatics/bth059; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815	43	87	89	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6162	10.1371/journal.pone.0006162	http://dx.doi.org/10.1371/journal.pone.0006162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19584937	Green Submitted, gold, Green Published			2022-12-27	WOS:000267806400017
J	Ryu, YU; Bradley, NS				Ryu, Young U.; Bradley, Nina S.			Precocious Locomotor Behavior Begins in the Egg: Development of Leg Muscle Patterns for Stepping in the Chick	PLOS ONE			English	Article							SPONTANEOUS RHYTHMIC ACTIVITY; EMBRYONIC DAYS 9; SPINAL-CORD; MOTONEURON ACTIVITY; FICTIVE LOCOMOTION; BURST GENERATION; NEURAL ACTIVITY; MOTILITY; MOVEMENTS; ORGANIZATION	Background: The chicken is capable of adaptive locomotor behavior within hours after hatching, yet little is known of the processes leading to this precocious skill. During the final week of incubation, chick embryos produce distinct repetitive limb movements that until recently had not been investigated. In this study we examined the leg muscle patterns at 3 time points as development of these spontaneous movements unfolds to determine if they exhibit attributes of locomotion reported in hatchlings. We also sought to determine whether the deeply flexed posture and movement constraint imposed by the shell wall modulate the muscle patterns. Methodology/Principal Findings: Synchronized electromyograms for leg muscles, force and video were recorded continuously from embryos while in their naturally flexed posture at embryonic day (E) 15, E18 and E20. We tested for effects of leg posture and constraint by removing shell wall anterior to the foot. Results indicated that by E18, burst onset time distinguished leg muscle synergists from antagonists across a 10-fold range in burst frequencies (1-10 Hz), and knee extensors from ankle extensors in patterns comparable to locomotion at hatching. However, burst durations did not scale with step cycle duration in any of the muscles recorded. Despite substantially larger leg movements after shell removal, the knee extensor was the only muscle to vary its activity, and extensor muscles often failed to participate. To further clarify if the repetitive movements are likely locomotor-related, we examined bilateral coordination of ankle muscles during repetitive movements at E20. In all cases ankle muscles exhibited a bias for left/right alternation. Conclusions/Significance: Collectively, the findings lead us to conclude that the repetitive leg movements in late stage embryos are locomotor-related and a fundamental link in the establishment of precocious locomotor skill. The potential importance of differences between embryonic and posthatching locomotion is discussed.			Ryu, YU (corresponding author), Univ So Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA 90089 USA.	nbradley@usc.edu	Bradley, Nina/F-8830-2014	Bradley, Nina/0000-0002-9674-4834; Ryu, Young Uk/0000-0003-1601-4477	NICHD NIH HHS [R01 HD053367, R01 HD-053367] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053367] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BEKOFF A, 1976, BRAIN RES, V106, P271, DOI 10.1016/0006-8993(76)91025-8; BEKOFF A, 1987, DEV PSYCHOBIOL, V20, P489, DOI 10.1002/dev.420200503; BEKOFF A, 1984, J NEUROSCI, V4, P2659; Bradley NS, 2008, J NEUROPHYSIOL, V99, P1733, DOI 10.1152/jn.01393.2007; Bradley NS, 2005, J NEUROPHYSIOL, V94, P4401, DOI 10.1152/jn.00804.2005; BRADLEY NS, 1990, DEV PSYCHOBIOL, V23, P763, DOI 10.1002/dev.420230802; Bradley NS, 1999, J NEUROPHYSIOL, V81, P1486, DOI 10.1152/jn.1999.81.4.1486; BRADLEY NS, 2003, J NEUROPHYSIOL; Cangiano L, 2003, J NEUROPHYSIOL, V89, P2931, DOI 10.1152/jn.01100.2002; CHAMBERS SH, 1995, EXP BRAIN RES, V103, P218; Chub N, 2006, J NEUROPHYSIOL, V95, P323, DOI 10.1152/jn.00162.2005; Chub N, 1998, J NEUROSCI, V18, P294; Cotel F, 2009, J NEUROSCI, V29, P2748, DOI 10.1523/JNEUROSCI.3462-08.2009; GLOVER JC, 1993, BRAIN RES BULL, V30, P265, DOI 10.1016/0361-9230(93)90254-9; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; HAMBURGE.V, 1966, J EXP ZOOL, V162, P133, DOI 10.1002/jez.1401620202; HAMBURGE.V, 1965, J EXP ZOOL, V159, P1, DOI 10.1002/jez.1401590102; HAMBURGER V, 1967, J EXP ZOOL, V166, P171, DOI 10.1002/jez.1401660203; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMBURGER V, 1963, Q REV BIOL, V38, P342, DOI 10.1086/403941; Hanson MG, 2006, J NEUROSCI, V26, P12769, DOI 10.1523/JNEUROSCI.4170-06.2006; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; HAVERKAMP LJ, 1986, J NEUROSCI, V6, P1338; HAVERKAMP LJ, 1986, J NEUROSCI, V6, P1332; HOY MG, 1985, J NEUROPHYSIOL, V54, P1282, DOI 10.1152/jn.1985.54.5.1282; JACOBSON RD, 1982, J NEUROPHYSIOL, V48, P238, DOI 10.1152/jn.1982.48.1.238; JACOBSON RD, 1982, J NEUROPHYSIOL, V48, P257, DOI 10.1152/jn.1982.48.1.257; Johnston RM, 1996, J COMP PHYSIOL A, V179, P169, DOI 10.1007/BF00222784; KOSHLAND GF, 1989, J NEUROPHYSIOL, V62, P162, DOI 10.1152/jn.1989.62.1.162; Lafreniere-Roula M, 2005, J NEUROPHYSIOL, V94, P1120, DOI 10.1152/jn.00216.2005; MAIER A, 1993, CELL TISSUE RES, V274, P383, DOI 10.1007/BF00318757; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Milner LD, 1999, J NEUROSCI, V19, P3007; Muir GD, 1996, J PHYSIOL-LONDON, V493, P589, DOI 10.1113/jphysiol.1996.sp021406; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; ODonovan MJ, 1997, SEMIN CELL DEV BIOL, V8, P21, DOI 10.1006/scdb.1996.0117; OKADO N, 1985, J COMP NEUROL, V232, P143, DOI 10.1002/cne.902320202; OROSZ MD, 1994, COMPUT BIOL MED, V24, P305, DOI 10.1016/0010-4825(94)90027-2; Sharp AA, 1999, J NEUROPHYSIOL, V82, P2406, DOI 10.1152/jn.1999.82.5.2406; Stein PSG, 2002, J NEUROSCI, V22, P6800; Stein PSG, 2005, J COMP PHYSIOL A, V191, P213, DOI 10.1007/s00359-004-0568-6; Stein PSG, 2004, J NEUROPHYSIOL, V91, P2380, DOI 10.1152/jn.01184.2003; Tabak J, 2000, J NEUROSCI, V20, P3041	43	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6111	10.1371/journal.pone.0006111	http://dx.doi.org/10.1371/journal.pone.0006111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578536	Green Published, Green Submitted, gold			2022-12-27	WOS:000267806300002
J	Morris, PF; Schlosser, LR; Onasch, KD; Wittenschlaeger, T; Austin, R; Provart, N				Morris, Paul Francis; Schlosser, Laura Rose; Onasch, Katherine Diane; Wittenschlaeger, Tom; Austin, Ryan; Provart, Nicholas			Multiple Horizontal Gene Transfer Events and Domain Fusions Have Created Novel Regulatory and Metabolic Networks in the Oomycete Genome	PLOS ONE			English	Article							EVOLUTION; ENZYMES; BIOSYNTHESIS; REDUCTASES; INSIGHTS; REVEALS	Complex enzymes with multiple catalytic activities are hypothesized to have evolved from more primitive precursors. Global analysis of the Phytophthora sojae genome using conservative criteria for evaluation of complex proteins identified 273 novel multifunctional proteins that were also conserved in P. ramorum. Each of these proteins contains combinations of protein motifs that are not present in bacterial, plant, animal, or fungal genomes. A subset of these proteins were also identified in the two diatom genomes, but the majority of these proteins have formed after the split between diatoms and oomycetes. Documentation of multiple cases of domain fusions that are common to both oomycetes and diatom genomes lends additional support for the hypothesis that oomycetes and diatoms are monophyletic. Bifunctional proteins that catalyze two steps in a metabolic pathway can be used to infer the interaction of orthologous proteins that exist as separate entities in other genomes. We postulated that the novel multifunctional proteins of oomycetes could function as potential Rosetta Stones to identify interacting proteins of conserved metabolic and regulatory networks in other eukaryotic genomes. However ortholog analysis of each domain within our set of 273 multifunctional proteins against 39 sequenced bacterial and eukaryotic genomes, identified only 18 candidate Rosetta Stone proteins. Thus the majority of multifunctional proteins are not Rosetta Stones, but they may nonetheless be useful in identifying novel metabolic and regulatory networks in oomycetes. Phylogenetic analysis of all the enzymes in three pathways with one or more novel multifunctional proteins was conducted to determine the probable origins of individual enzymes. These analyses revealed multiple examples of horizontal transfer from both bacterial genomes and the photosynthetic endosymbiont in the ancestral genome of Stramenopiles. The complexity of the phylogenetic origins of these metabolic pathways and the paucity of Rosetta Stones relative to the total number of multifunctional proteins suggests that the proteome of oomycetes has few features in common with other Kingdoms.			Morris, PF (corresponding author), Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA.	pmorris@bgsu.edu		Morris, Paul/0000-0002-2989-041X				Aarts MGM, 1997, PLANT J, V12, P615, DOI 10.1046/j.1365-313X.1997.00615.x; ANANTHARAMANA V, 2007, ANN REV MICROBIOL, V61; Andersson JO, 2006, CURR BIOL, V16, pR804, DOI 10.1016/j.cub.2006.08.042; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bordenstein SR, 2007, CURR BIOL, V17, pR935, DOI 10.1016/j.cub.2007.09.022; Bornberg-Bauer E, 2005, CELL MOL LIFE SCI, V62, P435, DOI 10.1007/s00018-004-4416-1; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dorrance AE, 2003, PLANT DIS, V87, P139, DOI 10.1094/PDIS.2003.87.2.139; Durrens P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000200; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Judelson HS, 2007, ADV GENET, V57, P97, DOI 10.1016/S0065-2660(06)57003-8; Kamburov A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-460; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Machida M, 2006, P NATL ACAD SCI USA, V103, P6753, DOI 10.1073/pnas.0510693103; Makiuchi T, 2007, GENE, V394, P78, DOI 10.1016/j.gene.2007.02.009; MARCOTTE CJV, 2002, APPL BIOINFORMATICS, V2, P1; Martens C, 2008, P NATL ACAD SCI USA, V105, P3427, DOI 10.1073/pnas.0712248105; Miller C, 2000, GENOME BIOL; Moore BD, 2004, TRENDS PLANT SCI, V9, P221, DOI 10.1016/j.tplants.2004.03.005; Nosenko T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-173; Patron NJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-39; Peixoto L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S8-S5; Reyes-Prieto A, 2008, CURR BIOL, V18, P956, DOI 10.1016/j.cub.2008.05.042; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Srere PA, 2000, TRENDS BIOCHEM SCI, V25, P150, DOI 10.1016/S0968-0004(00)01550-4; Tang GL, 2002, PLANT PHYSIOL, V130, P147, DOI 10.1104/pp.005660; Tsoka S, 2000, NAT GENET, V26, P141, DOI 10.1038/79847; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Wolf YI, 2000, GENOME BIOL, V1; Yanai I, 2002, GENOME BIOL, V3; Yiting Y, 2004, FRONT BIOSCI-LANDMRK, V9, P2964, DOI 10.2741/1451; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	42	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6133	10.1371/journal.pone.0006133	http://dx.doi.org/10.1371/journal.pone.0006133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GX	19582169	Green Published, gold, Green Submitted			2022-12-27	WOS:000267806200008
J	Cohen, Z; Lavi, S				Cohen, Zoya; Lavi, Sara			Replication Independent Formation of Extrachromosomal Circular DNA in Mammalian Cell-Free System	PLOS ONE			English	Article								Extrachromosomal circular DNA (eccDNA) is a pool of circular double stranded DNA molecules found in all eukaryotic cells and composed of repeated chromosomal sequences. It was proposed to be involved in genomic instability, aging and alternative telomere lengthening. Our study presents novel mammalian cell-free system for eccDNA generation. Using purified protein extract we show that eccDNA formation does not involve de-novo DNA synthesis suggesting that eccDNA is generated through excision of chromosomal sequences. This process is carried out by sequence-independent enzymes as human protein extract can produce mouse-specific eccDNA from high molecular weight mouse DNA, and vice versa. EccDNA production does not depend on ATP, requires residual amounts of Mg(2+) and is enhanced by double strand DNA breaks.			Cohen, Z (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	lavisara@post.tau.ac.il	Cohen, Zoya/GQQ-8127-2022	Cohen, Zoya/0000-0002-1284-3035				ASSUM G, 1993, HUM GENET, V91, P489; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; BERTELSEN AH, 1982, BIOCHEMISTRY-US, V21, P2076, DOI 10.1021/bi00538a015; Cohen S, 1997, ONCOGENE, V14, P977, DOI 10.1038/sj.onc.1200917; Cohen S, 2003, GENOME RES, V13, P1133, DOI 10.1101/gr.907603; Cohen S, 1996, MOL CELL BIOL, V16, P2002; Cohen S, 1999, MOL CELL BIOL, V19, P6682; Cohen S, 2001, NUCLEIC ACIDS RES, V29, P2542, DOI 10.1093/nar/29.12.2542; Cohen Z, 2006, ONCOGENE, V25, P4515, DOI 10.1038/sj.onc.1209485; DEGROOTE F, 1989, CHROMOSOMA, V98, P201, DOI 10.1007/BF00329684; FAIRMAN MP, 1992, NUCLEIC ACIDS RES, V20, P4145, DOI 10.1093/nar/20.16.4145; GAUBATZ JW, 1990, MUTAT RES, V237, P271, DOI 10.1016/0921-8734(90)90009-G; HARDING RM, 1992, GENETICS, V132, P847; KIYAMA R, 1987, J MOL BIOL, V198, P589, DOI 10.1016/0022-2836(87)90202-6; Kouprina Natalay, 2006, V349, P85; KUNISADA T, 1985, MECH AGEING DEV, V29, P89, DOI 10.1016/0047-6374(85)90050-8; MOTEJLEK K, 1993, MUTAT RES, V293, P205, DOI 10.1016/0921-8777(93)90071-N; OSHEROFF N, 1989, BIOCHEMISTRY-US, V28, P6157, DOI 10.1021/bi00441a005; Park PU, 1999, MOL CELL BIOL, V19, P3848; Regev A, 1998, ONCOGENE, V17, P3455, DOI 10.1038/sj.onc.1202250; Robins P, 1996, J BIOL CHEM, V271, P24257, DOI 10.1074/jbc.271.39.24257; Sambrook J., 2002, MOL CLONING LAB MANU; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; SMITH CA, 1972, J MOL BIOL, V69, P163, DOI 10.1016/0022-2836(72)90222-7; Smith J, 2003, NUCLEIC ACIDS RES, V31, P2157, DOI 10.1093/nar/gkg317	25	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6126	10.1371/journal.pone.0006126	http://dx.doi.org/10.1371/journal.pone.0006126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568438	Green Published, gold, Green Submitted			2022-12-27	WOS:000267572200023
J	Reuse, S; Calao, M; Kabeya, K; Guiguen, A; Gatot, JS; Quivy, V; Vanhulle, C; Lamine, A; Vaira, D; Demonte, D; Martinelli, V; Veithen, E; Cherrier, T; Avettand, V; Poutrel, S; Piette, J; de Launoit, Y; Moutschen, M; Burny, A; Rouzioux, C; De Wit, S; Herbein, G; Rohr, O; Collette, Y; Lambotte, O; Clumeck, N; Van Lint, C				Reuse, Sophie; Calao, Miriam; Kabeya, Kabamba; Guiguen, Allan; Gatot, Jean-Stephane; Quivy, Vincent; Vanhulle, Caroline; Lamine, Aurelia; Vaira, Dolores; Demonte, Dominique; Martinelli, Valerie; Veithen, Emmanuelle; Cherrier, Thomas; Avettand, Veronique; Poutrel, Solene; Piette, Jacques; de Launoit, Yvan; Moutschen, Michel; Burny, Arsene; Rouzioux, Christine; De Wit, Stephane; Herbein, Georges; Rohr, Olivier; Collette, Yves; Lambotte, Olivier; Clumeck, Nathan; Van Lint, Carine			Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; BROMODOMAIN PROTEIN BRD4; LONG TERMINAL REPEAT; HISTONE DEACETYLASE; T-CELLS; VALPROIC ACID; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; P-TEFB	The persistence of transcriptionally silent but replication-competent HIV-1 reservoirs in Highly Active Anti-Retroviral Therapy (HAART)-treated infected individuals, represents a major hurdle to virus eradication. Activation of HIV-1 gene expression in these cells together with an efficient HAART has been proposed as an adjuvant therapy aimed at decreasing the pool of latent viral reservoirs. Using the latently-infected U1 monocytic cell line and latently-infected J-Lat T-cell clones, we here demonstrated a strong synergistic activation of HIV-1 production by clinically used histone deacetylase inhibitors (HDACIs) combined with prostratin, a non-tumor-promoting nuclear factor (NF)-kappa B inducer. In J-Lat cells, we showed that this synergism was due, at least partially, to the synergistic recruitment of unresponsive cells into the expressing cell population. A combination of prostratin+HDACI synergistically activated the 59 Long Terminal Repeat (5'LTR) from HIV-1 Major group subtypes representing the most prevalent viral genetic forms, as shown by transient transfection reporter assays. Mechanistically, HDACIs increased prostratin-induced DNA-binding activity of nuclear NF-kappa B and degradation of cytoplasmic NF-kappa B inhibitor, I kappa Ba. Moreover, the combined treatment prostratin+HDACI caused a more pronounced nucleosomal remodeling in the U1 viral promoter region than the treatments with the compounds alone. This more pronounced remodeling correlated with a synergistic reactivation of HIV-1 transcription following the combined treatment prostratin+HDACI, as demonstrated by measuring recruitment of RNA polymerase II to the 5'LTR and both initiated and elongated transcripts. The physiological relevance of the prostratin+HDACI synergism was shown in CD8(+)-depleted peripheral blood mononuclear cells from HAART-treated patients with undetectable viral load. Moreover, this combined treatment reactivated viral replication in resting CD4(+) T cells isolated from similar patients. Our results suggest that combinations of different kinds of proviral activators may have important implications for reducing the size of latent HIV-1 reservoirs in HAART-treated patients.			Reuse, S (corresponding author), Univ Libre Bruxelles, IBMM, Mol Virol Lab, Gosselies, Belgium.	cvlint@ulb.ac.be	Avettand-Fenoel, Véronique/O-6285-2017; COLLETTE, Yves/F-2270-2013; CHERRIER, Thomas/F-8727-2018; Lambotte, Olivier/GRT-0160-2022	Avettand-Fenoel, Véronique/0000-0002-7022-2990; COLLETTE, Yves/0000-0001-5359-7099; CHERRIER, Thomas/0000-0002-0707-9204; de Launoit, Yvan/0000-0003-1837-9808; Moutschen, Michel/0000-0002-6405-1785; ROHR, Olivier/0000-0001-8992-2025				Adam E, 2003, MOL CELL BIOL, V23, P6200, DOI 10.1128/MCB.23.17.6200-6209.2003; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Biancotto A, 2004, J VIROL, V78, P10507, DOI 10.1128/JVI.78.19.10507-10515.2004; Bisgrove Dwayne, 2005, Expert Rev Anti Infect Ther, V3, P805, DOI 10.1586/14787210.3.5.805; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Bocklandt S, 2003, ANTIVIR RES, V59, P89, DOI 10.1016/S0166-3542(03)00034-2; Brooks DG, 2003, IMMUNITY, V19, P413, DOI 10.1016/S1074-7613(03)00236-X; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Butler IF, 2007, CURR HIV RES, V5, P23, DOI 10.2174/157016207779316297; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 2001, P NATL ACAD SCI USA, V98, P253, DOI 10.1073/pnas.98.1.253; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; COSTELLO R, 1993, EUR J IMMUNOL, V23, P608, DOI 10.1002/eji.1830230304; COSTELLO R, 1993, CELL GROWTH DIFFER, V4, P329; Coull JJ, 2002, J VIROL, V76, P12349, DOI 10.1128/JVI.76.23.12349-12354.2002; Crazzolara R, 2002, BRIT J HAEMATOL, V119, P965, DOI 10.1046/j.1365-2141.2002.03955.x; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Demonte D, 2004, BIOCHEM PHARMACOL, V68, P1231, DOI 10.1016/j.bcp.2004.05.040; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; DOVER GJ, 1994, BLOOD, V84, P339; Duvic M, 2007, EXPERT OPIN INV DRUG, V16, P1111, DOI 10.1517/13543784.16.7.1111; El Kharroubi A, 1998, MOL CELL BIOL, V18, P2535, DOI 10.1128/MCB.18.5.2535; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Gulakowski RJ, 1997, ANTIVIR RES, V33, P87, DOI 10.1016/S0166-3542(96)01004-2; GUSTAFSON KR, 1992, J MED CHEM, V35, P1978, DOI 10.1021/jm00089a006; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Hassan AH, 2001, FRONT BIOSCI, V6, pD1054, DOI 10.2741/Hassan; He GC, 2002, MOL CELL BIOL, V22, P2965, DOI 10.1128/MCB.22.9.2965-2973.2002; Henderson A, 2004, MOL CELL BIOL, V24, P389, DOI 10.1128/MCB.24.1.389-397.2004; Hess-Stumpp H, 2007, INT J BIOCHEM CELL B, V39, P1388, DOI 10.1016/j.biocel.2007.02.009; Hezareh M, 2005, DRUG NEWS PERSPECT, V18, P496, DOI 10.1358/dnp.2005.18.8.944543; Hezareh Marjan, 2004, Antiviral Chemistry & Chemotherapy, V15, P207; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Imai K, 2006, J BIOL CHEM, V281, P12495, DOI 10.1074/jbc.M511773200; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Johnson HE, 2008, J NAT PROD, V71, P2041, DOI 10.1021/np800295m; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Katz RA, 2007, J VIROL, V81, P2592, DOI 10.1128/JVI.01643-06; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Koutroubas G, 2008, MOL CELL BIOL, V28, P926, DOI 10.1128/MCB.01344-07; Kulkosky J, 2004, AIDS RES HUM RETROV, V20, P497, DOI 10.1089/088922204323087741; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Lambotte O, 2004, AIDS, V18, P1147, DOI 10.1097/00002030-200405210-00008; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Marcello A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-7; Margolis David M, 2007, Curr HIV/AIDS Rep, V4, P60, DOI 10.1007/s11904-007-0009-6; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Ott M, 1998, J IMMUNOL, V160, P2872; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Piekarz RL, 2001, BLOOD, V98, P2865, DOI 10.1182/blood.V98.9.2865; PIERRES A, 1988, EUR J IMMUNOL, V18, P685, DOI 10.1002/eji.1830180505; Quivy V, 2002, J VIROL, V76, P11091, DOI 10.1128/JVI.76.21.11091-11103.2002; Quivy Vincent, 2007, Subcell Biochem, V41, P371; Rullas J, 2004, ANTIVIR THER, V9, P545; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Singh M, 2007, CHEMBIOCHEM, V8, P1308, DOI 10.1002/cbic.200600562; Steel A, 2006, AIDS, V20, P1681, DOI 10.1097/01.aids.0000238421.36313.fa; Steger DJ, 1998, P NATL ACAD SCI USA, V95, P12924, DOI 10.1073/pnas.95.22.12924; Sung TL, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-66; Tunnicliff G, 1999, J PHYSIOL PHARMACOL, V50, P347; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; VERDIN E, 1991, J VIROL, V65, P6790, DOI 10.1128/JVI.65.12.6790-6799.1991; Watanabe H, 2006, ONCOGENE, V25, P470, DOI 10.1038/sj.onc.1209068; WEISS A, 1984, J IMMUNOL, V133, P123; Wender PA, 2008, SCIENCE, V320, P649, DOI 10.1126/science.1154690; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; WINSLOW BJ, 1993, VIROLOGY, V196, P849, DOI 10.1006/viro.1993.1545; Witvrouw Myriam, 2003, Antiviral Chemistry & Chemotherapy, V14, P321; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	93	198	208	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6093	10.1371/journal.pone.0006093	http://dx.doi.org/10.1371/journal.pone.0006093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564922	gold, Green Published, Green Submitted			2022-12-27	WOS:000267515700012
J	Rubio-Aliaga, I; Przemeck, GKH; Fuchs, H; Gailus-Durner, V; Adler, T; Hans, W; Horsch, M; Rathkolb, B; Rozman, J; Schrewe, A; Wagner, S; Hoelter, SM; Becker, L; Klopstock, T; Wurst, W; Wolf, E; Klingenspor, M; Ivandic, BT; Busch, DH; Beckers, J; de Angelis, MH				Rubio-Aliaga, Isabel; Przemeck, Gerhard K. H.; Fuchs, Helmut; Gailus-Durner, Valerie; Adler, Thure; Hans, Wolfgang; Horsch, Marion; Rathkolb, Birgit; Rozman, Jan; Schrewe, Anja; Wagner, Sibylle; Hoelter, Sabine M.; Becker, Lore; Klopstock, Thomas; Wurst, Wolfgang; Wolf, Eckhard; Klingenspor, Martin; Ivandic, Boris T.; Busch, Dirk H.; Beckers, Johannes; de Angelis, Martin Hrabe			Dll1 Haploinsufficiency in Adult Mice Leads to a Complex Phenotype Affecting Metabolic and Immunological Processes	PLOS ONE			English	Article								Background: The Notch signaling pathway is an evolutionary conserved signal transduction pathway involved in embryonic patterning and regulation of cell fates during development and self-renewal. Recent studies have demonstrated that this pathway is integral to a complex system of interactions, involving as well other signal transduction pathways, and implicated in distinct human diseases. Delta-like 1 (Dll1) is one of the known ligands of the Notch receptors. The role of the Notch ligands is less well understood. Loss-of-function of Dll1 leads to embryonic lethality, but reduction of Delta-like 1 protein levels has not been studied in adult stage. Methodology/Principal Findings: Here we present the haploinsufficient phenotype of Dll1 and a missense mutant Dll1 allele (Dll1(C413Y)). Haploinsufficiency leads to a complex phenotype with several biological processes altered. These alterations reveal the importance of Dll1 mainly in metabolism, energy balance and in immunology. The animals are smaller, lighter, with altered fat to lean ratio and have increased blood pressure and a slight bradycardia. The animals have reduced cholesterol and triglyceride levels in blood. At the immunological level a subtle phenotype is observed due to the effect and fine-tuning of the signaling network at the different levels of differentiation, proliferation and function of lymphocytes. Moreover, the importance of the proteolytic regulation of the Notch signaling network emphasized. Conclusions/Significance: In conclusion, slight alterations in one player of Notch signaling alter the entire organism, emphasizing the fine-tuning character of this pathway in a high number of processes.			Rubio-Aliaga, I (corresponding author), Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-8050 Freising Weihenstephan, Germany.	beckers@helmholtz-muenchen.de; hrabe@helmholtz-muenchen.de	Rozman, Jan/A-2540-2010; de Angelis, Martin Hrabe/F-5531-2012; Klingenspor, Martin/D-6930-2011; Fuchs, Helmut/M-7347-2014; Beckers, Johannes/K-7237-2012; Przemeck, Gerhard K. H./A-5991-2012; Hölter, Sabine M./N-5868-2014; Becker, Lore/E-3717-2010; Becker, Lore/AAJ-1203-2020; Rathkolb, Birgit/F-7041-2013; Klingenspor, Martin/K-5033-2019; Gailus-Durner, Valerie/M-7337-2014	Rozman, Jan/0000-0002-8035-8904; de Angelis, Martin Hrabe/0000-0002-7898-2353; Klingenspor, Martin/0000-0002-4502-6664; Fuchs, Helmut/0000-0002-5143-2677; Beckers, Johannes/0000-0001-7874-3822; Przemeck, Gerhard K. H./0000-0003-3730-3454; Hölter, Sabine M./0000-0003-4878-5241; Becker, Lore/0000-0002-6890-4984; Wolf, Eckhard/0000-0002-0430-9510; Rubio-Aliaga, Isabel/0000-0003-1051-9511; Wurst, Wolfgang/0000-0003-4422-7410				Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Augustin M, 2005, MAMM GENOME, V16, P405, DOI 10.1007/s00335-004-3028-2; AVENELL A, 1994, EUR J CLIN NUTR, V48, P561; Bedogni G, 2002, ANN HUM BIOL, V29, P559, DOI 10.1080/03014460210137819; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Brown SDM, 2005, NAT GENET, V37, P1155, DOI 10.1038/ng1105-1155; Canalis E, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe17; Carpinelli MR, 2004, P NATL ACAD SCI USA, V101, P6553, DOI 10.1073/pnas.0401496101; Chao J, 2001, BIOL CHEM, V382, P15, DOI 10.1515/BC.2001.003; Chen Z, 1997, J BONE MINER RES, V12, P144, DOI 10.1359/jbmr.1997.12.1.144; Choi JW, 2003, CLIN CHIM ACTA, V333, P79, DOI 10.1016/S0009-8981(03)00190-6; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; Cordes R, 2004, DEVELOPMENT, V131, P1221, DOI 10.1242/dev.01030; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; Elvert R, 2006, INTEGR ZOOL, V1, P122, DOI 10.1111/j.1749-4877.2006.00026.x; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Forsyth S, 2003, GENOMICS, V81, P336, DOI 10.1016/S0888-7543(02)00041-1; Frost HM, 1997, BONE, V21, P211, DOI 10.1016/S8756-3282(97)00124-5; Fuchs H, 2000, MAMM GENOME, V11, P528, DOI 10.1007/s003350010101; Fuchs H., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P13; Fukushima T, 2006, IMMUNITY, V24, P29, DOI 10.1016/j.immuni.2005.12.002; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hahn FM, 1996, ARCH BIOCHEM BIOPHYS, V332, P30, DOI 10.1006/abbi.1996.0312; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; Harper JA, 2003, CLIN GENET, V64, P461, DOI 10.1046/j.1399-0004.2003.00194.x; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hoelter SM, 2008, FRONT BIOSCI-LANDMRK, V13, P5810; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Hu G, 1999, MOL CELL BIOL, V19, P724; Hutchinson S, 2005, J MOL BIOL, V346, P833, DOI 10.1016/j.jmb.2004.11.038; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007; KALAYDJIEV S, 2006, STANDARDS MOUSE MODE, P237; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kiernan AE, 2007, GENETICS, V177, P307, DOI 10.1534/genetics.107.075960; Klempt M, 2006, MAMM GENOME, V17, P93, DOI 10.1007/s00335-005-0119-7; Kobayashi T, 2008, KIDNEY INT, V73, P1240, DOI 10.1038/ki.2008.74; Kohler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Lardelli M, 1996, MECH DEVELOP, V59, P177, DOI 10.1016/0925-4773(96)00589-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leker RR, 2006, PATHOPHYSIOL HAEMO T, V35, P58, DOI 10.1159/000093545; Liu YC, 2007, SEMIN IMMUNOL, V19, P197, DOI 10.1016/j.smim.2007.02.003; Machka C, 2005, GENE EXPR PATTERNS, V6, P94, DOI 10.1016/j.modgep.2005.04.009; Matesic LE, 2006, HUM MOL GENET, V15, P3485, DOI 10.1093/hmg/ddl425; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; Meyer CW, 2007, NATURWISSENSCHAFTEN, V94, P401, DOI 10.1007/s00114-006-0203-1; Meyer CW, 2007, J COMP PHYSIOL B, V177, P183, DOI 10.1007/s00360-006-0120-9; Morrissey J, 2002, J AM SOC NEPHROL, V13, pS14; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Nurmi SM, 2006, ANN NY ACAD SCI, V1090, P318, DOI 10.1196/annals.1378.035; Okabe H, 2003, CANCER RES, V63, P3043; Okamoto M, 2008, J EXP MED, V205, P1087, DOI 10.1084/jem.20072200; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Petkova SB, 2008, PHYSIOL GENOMICS, V34, P304, DOI 10.1152/physiolgenomics.00185.2007; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rubio-Aliaga I, 2007, GENETICS, V175, P1451, DOI 10.1534/genetics.106.067298; Ryu CJ, 2004, MOL CELL BIOL, V24, P7015, DOI 10.1128/MCB.24.16.7015-7023.2004; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sainson RCA, 2006, TRENDS MOL MED, V12, P141, DOI 10.1016/j.molmed.2006.02.001; Schwarz SE, 1998, J BIOL CHEM, V273, P12148, DOI 10.1074/jbc.273.20.12148; Shen B, 2008, HYPERTENSION, V51, P1358, DOI 10.1161/HYPERTENSIONAHA.107.108514; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wang J, 2004, CLIN GENET, V65, P483, DOI 10.1111/j.1399-0004.2004.00250.x; Wang J, 2003, HUM GENET, V112, P404, DOI 10.1007/s00439-003-0906-8; WILKIN DJ, 1990, J BIOL CHEM, V265, P4607; Wilson CB, 2005, SEMIN IMMUNOL, V17, P105, DOI 10.1016/j.smim.2005.01.005; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723	90	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6054	10.1371/journal.pone.0006054	http://dx.doi.org/10.1371/journal.pone.0006054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562077	Green Submitted, gold, Green Published			2022-12-27	WOS:000267465900003
J	Janjetovic, Z; Zmijewski, MA; Tuckey, RC; DeLeon, DA; Nguyen, MN; Pfeffer, LM; Slominski, AT				Janjetovic, Zorica; Zmijewski, Michal A.; Tuckey, Robert C.; DeLeon, Damon A.; Nguyen, Minh N.; Pfeffer, Lawrence M.; Slominski, Andrzej T.			20-Hydroxycholecalciferol, Product of Vitamin D3 Hydroxylation by P450scc, Decreases NF-kappa B Activity by Increasing I kappa B alpha Levels in Human Keratinocytes	PLOS ONE			English	Article							D-RECEPTOR; GENE-EXPRESSION; D ANALOGS; PATHWAY; METABOLISM; SYSTEM; CALCIUM; SKIN; 7-DEHYDROCHOLESTEROL; DIFFERENTIATION	The side chain of vitamin D3 is hydroxylated in a sequential manner by cytochrome P450scc (CYP11A1) to form 20-hydroxycholecalciferol, which can induce growth arrest and differentiation of both primary and immortalized epidermal keratinocytes. Since nuclear factor-kappa B (NF-kappa B) plays a pivotal role in the regulation of cell proliferation, differentiation and apoptosis, we examined the capability of 20-hydroxycholecalciferol to modulate the activity of NF-kappa B, using 1,25-dihydroxycholecalciferol (calcitriol) as a positive control. 20-hydroxycholecalciferol inhibits the activation of NF kappa B DNA binding activity as well as NF-kappa B-driven reporter gene activity in keratinocytes. Also, 20-hydroxycholecalciferol induced significant increases in the mRNA and protein levels of the NF-kappa B inhibitor protein, I kappa B alpha, in a time dependent manner, while no changes in total NF-kappa B-p65 mRNA or protein levels were observed. Another measure of NF-kappa B activity, p65 translocation from the cytoplasm into the nucleus was also inhibited in extracts of 20-hydroxycholecalciferol treated keratinocytes. Increased I kappa B alpha was concomitantly observed in cytosolic extracts of 20-hydroxycholecalciferol treated keratinocytes, as determined by immunoblotting and immunofluorescent staining. In keratinocytes lacking vitamin D receptor (VDR), 20-hydroxycholecalciferol did not affect I kappa B alpha mRNA levels, indicating that it requires VDR for its action on NF-kappa B activity. Comparison of the effects of calcitrol, hormonally active form of vitamin D3, with 20-hydrocholecalciferol show that both agents have a similar potency in inhibiting NF-kappa B. Since NF-kappa B is a major transcription factor for the induction of inflammatory mediators, our findings indicate that 20-hydroxycholecalciferol may be an effective therapeutic agent for inflammatory and hyperproliferative skin diseases.			Janjetovic, Z (corresponding author), Univ Tennessee, Hlth Sci Ctr, Ctr Canc Res, Dept Pathol & Lab Med, Memphis, TN USA.	aslominski@utmem.edu	Tuckey, Robert/H-5983-2014	Slominski, Andrzej/0000-0001-8963-3995; Zmijewski, Michal/0000-0003-2206-3531; Pfeffer, Lawrence/0000-0003-2809-1234; Tuckey, Robert/0000-0002-5022-4729	NCI NIH HHS [R01 CA133322] Funding Source: Medline; NIAMS NIH HHS [R01AR052190, R01 AR052190] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA133322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052190] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bar M, 2007, J INVEST DERMATOL, V127, P206, DOI 10.1038/sj.jid.5700493; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; BIKLE, 2006, VITAMIN D PRODUCTION; Bikle D, 2007, J STEROID BIOCHEM, V103, P396, DOI 10.1016/j.jsbmb.2006.12.063; Bikle DD, 2007, CURR OPIN RHEUMATOL, V19, P383, DOI 10.1097/BOR.0b013e32818e9d58; Bikle DD, 2004, J NUTR, V134, p3472S, DOI 10.1093/jn/134.12.3472S; Bikle DD, 2004, J STEROID BIOCHEM, V89-90, P355, DOI 10.1016/j.jsbmb.2004.03.020; Bikle DD, 2004, J CELL BIOCHEM, V92, P436, DOI 10.1002/jcb.20095; Bikle DD, 2001, MOL CELL ENDOCRINOL, V177, P161, DOI 10.1016/S0303-7207(01)00452-X; Bouillon R, 2006, J STEROID BIOCHEM, V102, P156, DOI 10.1016/j.jsbmb.2006.09.014; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Cohen-Lahav M, 2007, J STEROID BIOCHEM, V103, P558, DOI 10.1016/j.jsbmb.2006.12.093; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Du ZY, 2007, J CELL BIOCHEM, V102, P1087, DOI 10.1002/jcb.21535; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Grone A, 2002, VET IMMUNOL IMMUNOP, V88, P1, DOI 10.1016/S0165-2427(02)00136-8; Gurlek A, 2002, ENDOCR REV, V23, P763, DOI 10.1210/er.2001-0044; Hanissian SH, 2005, BRAIN RES, V1047, P56, DOI 10.1016/j.brainres.2005.04.017; Hanissian SH, 2004, ONCOGENE, V23, P3700, DOI 10.1038/sj.onc.1207448; Hawker NP, 2007, J INVEST DERMATOL, V127, P874, DOI 10.1038/sj.jid.5700624; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2003, RECENT RESULTS CANC, V164, P3; Holick MF, 2003, MAYO CLIN PROC, V78, P1457, DOI 10.4065/78.12.1457; HOLICK MF, 1978, FED PROC, V37, P2567; Holick MF, 2000, CLIN LAB MED, V20, P569; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Lehmann B, 2005, PHOTOCHEM PHOTOBIOL, V81, P1246, DOI 10.1562/2005-02-02-IR-430; Lehmann B, 2004, EXP DERMATOL, V13, P11, DOI 10.1111/j.1600-0625.2004.00257.x; Lehmann B, 1997, J INVEST DERMATOL, V108, P78, DOI 10.1111/1523-1747.ep12285640; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; Liu BG, 2008, CANCER CELL, V14, P212, DOI 10.1016/j.ccr.2008.07.017; Masuda S, 2006, MOL CANCER THER, V5, P797, DOI 10.1158/1535-7163.MCT-05-0539; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nagpal S, 2003, J INVEST DERMATOL, V120, pVIII, DOI 10.1046/j.1523-1747.2003.t01-1-120022.x; Oda Y, 2007, J STEROID BIOCHEM, V103, P776, DOI 10.1016/j.jsbmb.2006.12.069; Pavicevic Z, 2008, J LIPID RES, V49, P724, DOI 10.1194/jlr.M700419-JLR200; Pfeffer LM, 1998, CANCER RES, V58, P2489; Pisarchik A, 2004, EUR J BIOCHEM, V271, P2821, DOI 10.1111/j.1432-1033.2004.04216.x; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Reichrath J, 2003, J CELL BIOCHEM, V89, P6, DOI 10.1002/jcb.10516; Ren Q, 2006, CANCER RES, V66, P5209, DOI 10.1158/0008-5472.CAN-05-4158; Riis JL, 2004, ARCH DERMATOL RES, V296, P195, DOI 10.1007/s00403-004-0509-9; SAITO T, 2008, J STEROID BIOCH MOL; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Slominski A, 2005, CHEM BIOL, V12, P931, DOI 10.1016/j.chembiol.2005.06.010; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski A, 2006, FEBS J, V273, P2891, DOI 10.1111/j.1742-4658.2006.05302.x; Slominski AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004309; Spina CS, 2006, ANTICANCER RES, V26, P2515; Sun J, 2006, AM J PHYSIOL-ENDOC M, V291, pE315, DOI 10.1152/ajpendo.00590.2005; Tuckey RC, 2005, PLACENTA, V26, P273, DOI 10.1016/j.placenta.2004.06.012; TUCKEY RC, 2008, J STEROID BIOCH MOL; TUCKEY RC, 2008, INT J BIOCH CELL BIO; Tuckey RC, 2008, FEBS J, V275, P2585, DOI 10.1111/j.1742-4658.2008.06406.x; Umezawa K, 2006, CANCER SCI, V97, P990, DOI 10.1111/j.1349-7006.2006.00285.x; van den Bemd GJCM, 2002, CURR DRUG TARGETS, V3, P85, DOI 10.2174/1389450023348064; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; WISEMAN H, 1993, FEBS LETT, V326, P285, DOI 10.1016/0014-5793(93)81809-E; Yang CH, 2005, J BIOL CHEM, V280, P31530, DOI 10.1074/jbc.M503120200; Zbytek B, 2004, J ENDOCRINOL, V181, pR1, DOI 10.1677/joe.0.181R001; Zbytek B, 2003, J INVEST DERMATOL, V121, P1496, DOI 10.1111/j.1523-1747.2003.12612.x; Zbytek B, 2006, PEPTIDES, V27, P3276, DOI 10.1016/j.peptides.2006.07.017; ZBYTEK B, 2008, J INVEST DERMATOL; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zmijewski MA, 2008, PHOTOCH PHOTOBIO SCI, V7, P1570, DOI 10.1039/b809005j	74	107	107	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5988	10.1371/journal.pone.0005988	http://dx.doi.org/10.1371/journal.pone.0005988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543524	Green Submitted, gold, Green Published			2022-12-27	WOS:000267237400013
J	Mathiason, CK; Hays, SA; Powers, J; Hayes-Klug, J; Langenberg, J; Dahmes, SJ; Osborn, DA; Miller, KV; Warren, RJ; Mason, GL; Hoover, EA				Mathiason, Candace K.; Hays, Sheila A.; Powers, Jenny; Hayes-Klug, Jeanette; Langenberg, Julia; Dahmes, Sallie J.; Osborn, David A.; Miller, Karl V.; Warren, Robert J.; Mason, Gary L.; Hoover, Edward A.			Infectious Prions in Pre-Clinical Deer and Transmission of Chronic Wasting Disease Solely by Environmental Exposure	PLOS ONE			English	Article								Key to understanding the epidemiology and pathogenesis of prion diseases, including chronic wasting disease (CWD) of cervids, is determining the mode of transmission from one individual to another. We have previously reported that saliva and blood from CWD-infected deer contain sufficient infectious prions to transmit disease upon passage into naive deer. Here we again use bioassays in deer to show that blood and saliva of pre-symptomatic deer contain infectious prions capable of infecting naive deer and that naive deer exposed only to environmental fomites from the suites of CWD-infected deer acquired CWD infection after a period of 15 months post initial exposure. These results help to further explain the basis for the facile transmission of CWD, highlight the complexities associated with CWD transmission among cervids in their natural environment, emphasize the potential utility of blood-based testing to detect pre-clinical CWD infection, and could augur similar transmission dynamics in other prion infections.			Mathiason, CK (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Edward.Hoover@ColoState.edu	Mathiason, Candace/H-9769-2017; Mathiason, Candace K/E-7843-2017	Mathiason, Candace/0000-0002-5920-4556; Mathiason, Candace K/0000-0002-5920-4556	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI25491, N01AI025491] Funding Source: NIH RePORTER; NIAID NIH HHS [N01AI25491] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson CA, 2007, ARCH NEUROL-CHICAGO, V64, P439, DOI 10.1001/archneur.64.3.439; Bartz JC, 2005, J VIROL, V79, P11858, DOI 10.1128/JVI.79.18.11858-11863.2005; Belay ED, 2004, EMERG INFECT DIS, V10, P977, DOI 10.3201/eid1006.031082; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Bosque Patrick J, 2002, Curr Neurol Neurosci Rep, V2, P488, DOI 10.1007/s11910-002-0034-1; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; CLARKE MC, 1976, RES VET SCI, V20, P106, DOI 10.1016/S0034-5288(18)33489-1; Clarke P, 2005, J R SOC INTERFACE, V2, P19, DOI 10.1098/rsif.2004.0017; Collinge J, 1997, NATURE, V389, P526, DOI 10.1038/39116; DeJoia C, 2006, J VIROL, V80, P4546, DOI 10.1128/JVI.80.9.4546-4556.2006; DICKINSO.AG, 1965, HEREDITY, V20, P485, DOI 10.1038/hdy.1965.64; EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15; Garruto RM, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-31; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gould DH, 2003, J VET DIAGN INVEST, V15, P274, DOI 10.1177/104063870301500309; HADLOW WJ, 1974, J INFECT DIS, V129, P559, DOI 10.1093/infdis/129.5.559; HADLOW WJ, 1987, J VIROL, V61, P3235, DOI 10.1128/JVI.61.10.3235-3240.1987; Hewitt P, 2006, TRANSFUS CLIN BIOL, V13, P312, DOI 10.1016/j.tracli.2006.11.006; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Hunter N, 2003, BRIT MED BULL, V66, P171, DOI 10.1093/bmb/66.1.171; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Joly DO, 2006, J WILDLIFE DIS, V42, P578, DOI 10.7589/0090-3558-42.3.578; Kim TY, 2005, J VET MED SCI, V67, P753, DOI 10.1292/jvms.67.753; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Manson JC, 2006, BIOCHEM SOC T, V34, P1155, DOI 10.1042/BST0341155; Manuelidis L, 1997, SCIENCE, V277, P94, DOI 10.1126/science.277.5322.94; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; MaWhinney S, 2006, EMERG INFECT DIS, V12, P1527, DOI 10.3201/eid1210.060019; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; Miller MW, 1998, J WILDLIFE DIS, V34, P532, DOI 10.7589/0090-3558-34.3.532; Miller MW, 2004, J WILDLIFE DIS, V40, P320, DOI 10.7589/0090-3558-40.2.320; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, CURR TOP MICROBIOL, V284, P193; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Peden AH, 2005, FOLIA NEUROPATHOL, V43, P271; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Ryder S, 2004, RES VET SCI, V76, P211, DOI 10.1016/j.rvsc.2003.11.007; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Sigurdson CJ, 2008, J COMP PATHOL, V138, P189, DOI 10.1016/j.jcpa.2008.01.004; Sigurdson CJ, 2002, J GEN VIROL, V83, P2617, DOI 10.1099/0022-1317-83-10-2617; Sohn HJ, 2002, J VET MED SCI, V64, P855, DOI 10.1292/jvms.64.855; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; Spraker TR, 1997, J WILDLIFE DIS, V33, P1, DOI 10.7589/0090-3558-33.1.1; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; *US GEOGR SURV NWH, 2009, MAP CHRON WAST DIS N; *USDA, 2007, PENNS CHRON WAST DIS; Vascellari M, 2007, J VIROL, V81, P4872, DOI 10.1128/JVI.02148-06; *WI DEP NAT RES, 2008, PLAN MAN CHRON WAST; WILL RG, 1996, LANCET, V347, P925; Williams E.S., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P551; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; 2007, EUROSURVEILL, V12	68	138	141	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5916	10.1371/journal.pone.0005916	http://dx.doi.org/10.1371/journal.pone.0005916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529769	Green Published, Green Submitted, gold			2022-12-27	WOS:000267029500006
J	Brancucci, A; Dipinto, R; Mosesso, I; Tommasi, L				Brancucci, Alfredo; Dipinto, Rosanna; Mosesso, Ilaria; Tommasi, Luca			Vowel Identity between Note Labels Confuses Pitch Identification in Non-Absolute Pitch Possessors	PLOS ONE			English	Article							HEMISPHERE SPECIALIZATION; RELATIVE PITCH; SPEECH SOUNDS; PERCEPTION; STIMULI; DISCRIMINATION; MUSICIANS; LATERALIZATION; MEMORY; TONES	The simplest and likeliest assumption concerning the cognitive bases of absolute pitch (AP) is that at its origin there is a particularly skilled function which matches the height of the perceived pitch to the verbal label of the musical tone. Since there is no difference in sound frequency resolution between AP and non-AP (NAP) musicians, the hypothesis of the present study is that the failure of NAP musicians in pitch identification relies mainly in an inability to retrieve the correct verbal label to be assigned to the perceived musical note. The primary hypothesis is that, when asked to identify tones, NAP musicians confuse the verbal labels to be attached to the stimulus on the basis of their phonetic content. Data from two AP tests are reported, in which subjects had to respond in the presence or in the absence of visually presented verbal note labels (fixed Do solmization). Results show that NAP musicians confuse more frequently notes having a similar vowel in the note label. They tend to confuse e. g. a 261 Hz tone (Do) more often with Sol than, e. g., with La. As a second goal, we wondered whether this effect is lateralized, i.e. whether one hemisphere is more responsible than the other in the confusion of notes with similar labels. This question was addressed by observing pitch identification during dichotic listening. Results showed that there is a right hemispheric disadvantage, in NAP but not AP musicians, in the retrieval of the verbal label to be assigned to the perceived pitch. The present results indicate that absolute pitch has strong verbal bases, at least from a cognitive point of view.			Brancucci, A (corresponding author), Univ G DAnnunzio, Dept Biomed Sci, Chieti, Italy.	alfredo.brancucci@unich.it	Tommasi, Luca/F-3638-2012	Tommasi, Luca/0000-0003-0664-714X				Athos EA, 2007, P NATL ACAD SCI USA, V104, P14795, DOI 10.1073/pnas.0703868104; Bermudez P, 2005, J NEUROSCI, V25, P7718, DOI 10.1523/JNEUROSCI.1560-05.2005; Brancucci A, 2005, NEUROPSYCHOLOGIA, V43, P1916, DOI 10.1016/j.neuropsychologia.2005.03.005; Brancucci A, 2004, EUR J NEUROSCI, V19, P2329, DOI 10.1111/j.0953-816X.2004.03302.x; Brancucci A, 2003, NEUROPSYCHOLOGY, V17, P451, DOI 10.1037/0894-4105.17.3.451; Brancucci A, 1999, NEUROPSYCHOLOGIA, V37, P1445, DOI 10.1016/S0028-3932(99)00065-2; Brancucci A, 2008, NEUROPSYCHOLOGIA, V46, P2013, DOI 10.1016/j.neuropsychologia.2008.01.019; BURNS EM, 1994, J ACOUST SOC AM, V96, P2704, DOI 10.1121/1.411447; Della Penna S, 2007, CEREB CORTEX, V17, P2303, DOI 10.1093/cercor/bhl139; Gregersen PK, 2001, AM J MED GENET, V98, P280, DOI 10.1002/1096-8628(20010122)98:3<280::AID-AJMG1083>3.0.CO;2-6; Hamilton RH, 2004, NEUROREPORT, V15, P803, DOI 10.1097/00001756-200404090-00012; Hsieh IH, 2008, HEARING RES, V240, P73, DOI 10.1016/j.heares.2008.01.017; Hugdahl K, 1999, NEUROPSYCHOLOGIA, V37, P431, DOI 10.1016/S0028-3932(98)00101-8; Hugdahl K, 2003, ASYMMETRICAL BRAIN, P441; Jancke L, 2003, COGNITIVE BRAIN RES, V16, P257, DOI 10.1016/S0926-6410(02)00281-1; Keenan JP, 2001, NEUROIMAGE, V14, P1402, DOI 10.1006/nimg.2001.0925; KIMURA D, 1967, CORTEX, V3, P168; Levitin D.J., 1999, INT J COMPUT INT SYS, V4, P255; Levitin DJ, 2005, TRENDS COGN SCI, V9, P26, DOI 10.1016/j.tics.2004.11.007; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; MIYAZAKI K, 1988, PERCEPT PSYCHOPHYS, V44, P501, DOI 10.3758/BF03207484; Paivio, 1986, MENTAL REPRESENTATIO; Roederer JG, 1973, INTRO PHYS PSYCHOPHY; SALMASO D, 1985, CORTEX, V21, P533, DOI 10.1016/S0010-9452(58)80003-9; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; VERCOE BL, 1992, MANUAL AUDIO PROCESS; Ward W.D., 1999, PSYCHOL MUSIC PP, P265, DOI DOI 10.1016/B978-012213564-4/50009-3; Wilson SJ, 2009, CEREB CORTEX, V19, P724, DOI 10.1093/cercor/bhn121; Wu C, 2008, NEUROREPORT, V19, P851, DOI 10.1097/WNR.0b013e3282ff63b1; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085; ZATORRE RJ, 1989, MEM COGNITION, V17, P582, DOI 10.3758/BF03197081	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6327	10.1371/journal.pone.0006327	http://dx.doi.org/10.1371/journal.pone.0006327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	472QP	19621074	Green Published, gold, Green Submitted			2022-12-27	WOS:000268147200014
J	Smith, AJ; Karpova, Y; D'Agostino, R; Willingham, M; Kulik, G				Smith, Adrienne J.; Karpova, Yelena; D'Agostino, Ralph, Jr.; Willingham, Mark; Kulik, George			Expression of the Bcl-2 Protein BAD Promotes Prostate Cancer Growth	PLOS ONE			English	Article								BAD, a pro-apoptotic protein of the Bcl-2 family, has recently been identified as an integrator of several anti-apoptotic signaling pathways in prostate cancer cells. Thus, activation of EGFR, GPCRs or PI3K pathway leads to BAD phosphorylation and inhibition of apoptosis. Increased levels of BAD in prostate carcinomas have also been reported. It appears contradictory that instead of limiting expression of pro-apoptotic protein, prostate cancer cells choose to increase BAD levels while keeping it under tight phosphorylation control. Analysis of the effect of BAD on prostate cancer xenografts has shown that increased BAD expression enhances tumor growth, while knockdown of BAD expression by shRNA inhibits tumor growth. Tissue culture experiments demonstrated that increased BAD expression stimulates proliferation of prostate cancer cells. These results suggest that increased expression of BAD provides a proliferative advantage to prostate tumors, while BAD dephosphorylation increases sensitivity of prostate cancer cells to apoptosis. Combination of proliferative and apoptotic properties prompts prostate cancer cells to be "addicted'' to increased levels of phosphorylated BAD. Thus, kinases that phosphorylate BAD are plausible therapeutic targets; while monitoring BAD phosphorylation could be used to predict tumor response to treatments.			Smith, AJ (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27109 USA.	gkulik@wfubmc.edu	Dagostino, Ralph/C-4060-2017	Dagostino, Ralph/0000-0002-3550-8395	NATIONAL CANCER INSTITUTE [R01CA118329, T32CA079448] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA079448, R01 CA118329] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chattopadhyay A, 2001, ONCOGENE, V20, P4507, DOI 10.1038/sj.onc.1204584; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Djakiew D, 2000, PROSTATE, V42, P150, DOI 10.1002/(SICI)1097-0045(20000201)42:2<150::AID-PROS10>3.0.CO;2-H; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fernando R, 2007, J BIOL CHEM, V282, P28864, DOI 10.1074/jbc.M700785200; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; Hadaschik BA, 2007, UROL ONCOL-SEMIN ORI, V25, P413, DOI 10.1016/j.urolonc.2007.05.010; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Krajewska M, 1996, AM J PATHOL, V148, P1567; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Maslyar DJ, 2001, ONCOGENE, V20, P5087, DOI 10.1038/sj.onc.1204662; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Mok CL, 1999, J EXP MED, V189, P575, DOI 10.1084/jem.189.3.575; Royuela M, 2001, EUR CYTOKINE NETW, V12, P654; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sastry KSR, 2006, J BIOL CHEM, V281, P20891, DOI 10.1074/jbc.M602928200; THALMANN GN, 1994, CANCER RES, V54, P2577; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	24	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6224	10.1371/journal.pone.0006224	http://dx.doi.org/10.1371/journal.pone.0006224			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593445	Green Submitted, Green Published, gold			2022-12-27	WOS:000268035400008
J	Yeh, E; Pinsky, BA; Banaei, N; Baron, EJ				Yeh, Ellen; Pinsky, Benjamin A.; Banaei, Niaz; Baron, Ellen Jo			Hair Sheep Blood, Citrated or Defibrinated, Fulfills All Requirements of Blood Agar for Diagnostic Microbiology Laboratory Tests	PLOS ONE			English	Article							AGALACTIAE CAMP FACTOR; HAEMOPHILUS-INFLUENZAE; CULTURE-MEDIUM; GOAT BLOOD; STORAGE	Background: Blood agar is used for the identification and antibiotic susceptibility testing of many bacterial pathogens. In the developing world, microbiologists use human blood agar because of the high cost and inhospitable conditions for raising wool sheep or horses to supply blood. Many pathogens either fail to grow entirely or exhibit morphologies and hemolytic patterns on human blood agar that confound colony recognition. Furthermore, human blood can be hazardous to handle due to HIV and hepatitis [1,2]. This study investigated whether blood from hair sheep, a hardy, low-maintenance variety of sheep adapted for hot climates, was suitable for routine clinical microbiology studies. Methods and Findings: Hair sheep blood obtained by jugular venipuncture was anticoagulated by either manual defibrination or collection in human blood bank bags containing citrate-phosphate-dextrose. Trypticase soy 5% blood agar was made from both forms of hair sheep blood and commercial defibrinated wool sheep blood. Growth characteristics, colony morphologies, and hemolytic patterns of selected human pathogens, including several streptococcal species, were evaluated. Specialized identification tests, including CAMP test, reverse CAMP test, and satellite colony formation with Haemophilus influenzae and Abiotrophia defectiva were also performed. Mueller-Hinton blood agar plates prepared from the three blood types were compared in antibiotic susceptibility tests by disk diffusion and E-test. Conclusions: The results of all studies showed that blood agar prepared from citrated hair sheep blood is suitable for microbiological tests used in routine identification and susceptibility profiling of human pathogens. The validation of citrated hair sheep blood eliminates the labor-intensive and equipment-requiring process of manual defibrination. Use of hair sheep blood, in lieu of human blood currently used by many developing world laboratories and as an alternative to cost-prohibitive commercial sheep blood, offers the opportunity to dramatically improve the safety and accuracy of laboratory diagnosis of pathogenic bacteria in resource-poor countries.			Yeh, E (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	ejbaron@stanford.edu		Yeh, Ellen/0000-0003-3974-3816; Banaei, Niaz/0000-0001-8501-3000; Pinsky, Benjamin/0000-0001-8751-4810				Anand C, 2000, J CLIN MICROBIOL, V38, P591, DOI 10.1128/JCM.38.2.591-594.2000; Chawdhury FAH, 2006, SEX TRANSM DIS, V33, P181, DOI 10.1097/01.olq.0000187206.69006.6e; Christie R. N. E. Atkins, 1944, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V22, P197; CLARRIDGE J E, 1989, Clinical Microbiology Newsletter, V11, P41, DOI 10.1016/0196-4399(89)90074-3; Clinical and Laboratory Standards Institute, PERF STAND ANT SUSC; EVANS NM, 1974, J MED MICROBIOL, V7, P359, DOI 10.1099/00222615-7-3-359; FRENKEL A, 1961, NATURE, V191, P728, DOI 10.1038/191728a0; GRATTEN M, 1994, J CLIN MICROBIOL, V32, P2871, DOI 10.1128/JCM.32.11.2871-2872.1994; Hogman CF, 1999, TRANSFUS MED REV, V13, P275, DOI 10.1016/S0887-7963(99)80058-3; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Lang SH, 2007, MED MICROBIOL IMMUN, V196, P1, DOI 10.1007/s00430-006-0021-2; Min YH, 2008, ANTIMICROB AGENTS CH, V52, P1782, DOI 10.1128/AAC.01376-07; Murray P, 2007, MANUAL CLIN MICROBIO, P2256; NOTTER DR, 2000, J ANIM SCI S1, V1977, P1; Reidl J, 2000, MOL MICROBIOL, V35, P1573, DOI 10.1046/j.1365-2958.2000.01829.x; RUOFF KL, 1991, CLIN MICROBIOL REV, V4, P184, DOI 10.1128/CMR.4.2.184-190.1991; Russell FM, 2006, J CLIN MICROBIOL, V44, P3346, DOI 10.1128/JCM.02631-05; SCHOENIAN S, 2007, BEGINNERS GUIDE RAIS; STERZIK B, 1985, J GEN MICROBIOL, V131, P817; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; WAYS P, 1964, J LIPID RES, V5, P318	22	22	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6141	10.1371/journal.pone.0006141	http://dx.doi.org/10.1371/journal.pone.0006141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578541	Green Submitted, gold, Green Published			2022-12-27	WOS:000267806300010
J	Rathcke, CN; Holmkvist, J; Husmoen, LLN; Hansen, T; Pedersen, O; Vestergaard, H; Linneberg, A				Rathcke, Camilla Noelle; Holmkvist, Johan; Husmoen, Lise Lotte N.; Hansen, Torben; Pedersen, Oluf; Vestergaard, Henrik; Linneberg, Allan			Association of Polymorphisms of the CHI3L1 Gene with Asthma and Atopy: A Populations-Based Study of 6514 Danish Adults	PLOS ONE			English	Article							RANDOM-ACCESS IMMUNOANALYZER; SERUM YKL-40; PROMOTER REGION; CHITINASE; PROTEIN; INFLAMMATION; SARCOIDOSIS; 3-LIKE-1; DISEASE; LUNG	Background: YKL-40 is a chitinase-like glycoprotein encoded by the chitinase 3-like 1 gene, CHI3L1, localized at chromosome 1q32.1. Increased levels of serum YKL-40 have been reported to be a biomarker for asthma and a reduced lung function. Interestingly, the C-allele of the -131 C -> G (rs4950928) polymorphism of CHI3L1 has been shown to associate with bronchial hyperresponsiveness and reduced lung function suggesting that variations in CHI3L1 may influence risk of asthma. The objective of the present study was to investigate the association of common variation in the CHI3L1 locus with asthma, atopy and lung function in a large population-based sample of adults. Methods/Principal Findings: Eleven single nucleotide polymorphisms (SNPs) of CHI3L1 including rs4950928 were genotyped in 6514 individuals. Asthma was defined as self-reported history of physician-diagnosed asthma. Total IgE and specific IgE to inhalant allergens were measured on serum samples. Lung function was measured by spirometry. Homozygosity of the rs4950928 G allele as compared to homozygosity of the C allele was associated with self-reported physician diagnosed asthma (OR 1.5 (95% CI, 1.00-2.26)) and with prevalence of atopic asthma (OR 1.93 (95% CI, 1.21-3.07)) after adjustment for age, sex, smoking status, socio-economic class and BMI. Carriers of rs883125 G allele had a significantly lower prevalence of atopy (OR 0.82 (CI, 0.72; 0.94)) as compared to homozygosity of the C allele. None of the SNPs examined were significantly associated with FEV1. However, two SNPs (rs10399931 and rs4950930) appeared to be significantly associated with FEV1/FVC-ratio. Subgroup analyses of never-smokers did not consistently influence the associations in an either positively og negatively way. Conclusions: In contrast to previous studies, the rs4950928 G allele, and not the C allele, was found to be associated with asthma. A few other SNPs of the CHI3L1 was found to be significantly associated with atopy and FEV1/FVC ratio, respectively. Thus, more studies seem warranted to establish the role of CHI3L1 gene in asthma and atopy.			Rathcke, CN (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Endocrinol, Copenhagen, Denmark.	cnr@dadlnet.dk	Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020	Pedersen, Oluf/0000-0002-3321-3972; Vestergaard, Henrik/0000-0003-3090-269X; Linneberg, Allan/0000-0002-0994-0184				Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Cobbaert CM, 2005, CLIN CHEM LAB MED, V43, P772, DOI 10.1515/CCLM.2005.132; Couzin J, 2004, SCIENCE, V304, P1577, DOI 10.1126/science.304.5677.1577; De Ceuninck F, 2001, BIOCHEM BIOPH RES CO, V285, P926, DOI 10.1006/bbrc.2001.5253; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Hong JH, 2008, AM J RESP CELL MOL, V39, P530, DOI 10.1165/rcmb.2007-0410OC; Johansen JS, 2000, J HEPATOL, V32, P911, DOI 10.1016/S0168-8278(00)80095-1; Johansen JS, 2005, RESP MED, V99, P396, DOI 10.1016/j.rmed.2004.09.016; Johansen JS, 2006, DAN MED BULL, V53, P172; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kruit A, 2007, RESP MED, V101, P1563, DOI 10.1016/j.rmed.2006.12.006; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Ollert M, 2005, CLIN CHEM, V51, P1241, DOI 10.1373/clinchem.2004.046565; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Sohn MH, 2009, AM J RESP CRIT CARE, V179, P449, DOI 10.1164/rccm.200809-1422OC; World Health Organization, 2004, OB PREV MAN GLOB EP; Zhao XZ, 2007, AM J HUM GENET, V80, P12, DOI 10.1086/510438; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	22	43	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6106	10.1371/journal.pone.0006106	http://dx.doi.org/10.1371/journal.pone.0006106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568425	Green Published, Green Submitted, gold			2022-12-27	WOS:000267572200009
J	Pinne, M; Haake, DA				Pinne, Marija; Haake, David A.			A Comprehensive Approach to Identification of Surface-Exposed, Outer Membrane-Spanning Proteins of Leptospira interrogans	PLOS ONE			English	Article							CHANNEL-FORMING ACTIVITY; LYME-DISEASE SPIROCHETE; BORRELIA-BURGDORFERI; TREPONEMA-PALLIDUM; MOLECULAR-CLONING; INSERTIONAL INACTIVATION; SEQUENCE-ANALYSIS; SIGNAL PEPTIDES; LIPOPROTEIN; PREDICTION	Leptospirosis is a zoonosis with worldwide distribution caused by pathogenic spirochetes belonging to the genus Leptospira. The leptospiral life cycle involves transmission via fresh water and colonization of the renal tubules of their reservoir hosts or infection of accidental hosts, including humans. Bacterial outer membrane proteins (OMPs), particularly those with surface-exposed regions, play crucial roles in virulence mechanisms of pathogens and the adaptation to various environmental conditions, including those of the mammalian host. Little is known about the surface-exposed OMPs in Leptospira, particularly those with outer membrane-spanning domains. Herein, we describe a comprehensive strategy for identification and characterization of leptospiral transmembrane OMPs. The genomic sequence of L. interrogans serovar Copenhageni strain Fiocruz L1-130 allowed us to employ the beta-barrel prediction programs, PRED-TMBB and TMBETA-NET, to identify potential transmembrane OMPs. Several complementary methods were used to characterize four novel OMPs, designated OmpL36, OmpL37, OmpL47 and OmpL54. In addition to surface immunofluorescence and surface biotinylation, we describe surface proteolysis of intact leptospires as an improved method for determining the surface exposure of leptospiral proteins. Membrane integration was confirmed using techniques for removal of peripheral membrane proteins. We also demonstrate deficiencies in the Triton X-114 fractionation method for assessing the outer membrane localization of transmembrane OMPs. Our results establish a broadly applicable strategy for the elucidation of novel surface-exposed outer membrane-spanning proteins of Leptospira, an essential step in the discovery of potential virulence factors, diagnostic antigens and vaccine candidates.			Pinne, M (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA.	mpinne@ucla.edu			NIAID NIH HHS [AI-34431, R21 AI034431, R01 AI034431-12, R29 AI034431, R01 AI034431] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI034431, R21AI034431, R01AI034431] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Bunikis I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000009; Bunikis J, 1999, INFECT IMMUN, V67, P2874, DOI 10.1128/IAI.67.6.2874-2883.1999; Casadio Rita, 2003, Briefings in Bioinformatics, V4, P341, DOI 10.1093/bib/4.4.341; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Cox DL, 1996, P NATL ACAD SCI USA, V93, P7973, DOI 10.1073/pnas.93.15.7973; Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; Cullen PA, 2003, INFECT IMMUN, V71, P2414, DOI 10.1128/IAI.71.5.2414-2421.2003; Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002; EGLI C, 1993, INFECT IMMUN, V61, P1694, DOI 10.1128/IAI.61.5.1694-1699.1993; El-Hage N, 2001, MICROBIOL-SGM, V147, P821, DOI 10.1099/00221287-147-4-821; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; FREUDL R, 1986, J MOL BIOL, V188, P491, DOI 10.1016/0022-2836(86)90171-3; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gamberini M, 2005, FEMS MICROBIOL LETT, V244, P305, DOI 10.1016/j.femsle.2005.02.004; Gromiha MM, 2005, NUCLEIC ACIDS RES, V33, pW164, DOI 10.1093/nar/gki367; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 1999, INFECT IMMUN, V67, P6572; Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998; HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993; Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002; HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991; HAAPASALO M, 1992, INFECT IMMUN, V60, P2058, DOI 10.1128/IAI.60.5.2058-2065.1992; Hazlett KRO, 2005, J BACTERIOL, V187, P6499, DOI 10.1128/JB.187.18.6499-6508.2005; Hazlett KRO, 2001, J EXP MED, V193, P1015, DOI 10.1084/jem.193.9.1015; Hsieh WJ, 2005, FEMS MICROBIOL LETT, V243, P339, DOI 10.1016/j.femsle.2004.12.021; Ishihara K, 2004, FEMS MICROBIOL LETT, V232, P181, DOI 10.1016/S0378-1097(04)00067-9; ITO K, 1991, MOL MICROBIOL, V5, P2243, DOI 10.1111/j.1365-2958.1991.tb02154.x; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koizumi N, 2003, FEMS MICROBIOL LETT, V226, P215, DOI 10.1016/S0378-1097(03)00619-0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; MAHER PA, 1985, P NATL ACAD SCI USA, V82, P958, DOI 10.1073/pnas.82.4.958; Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matsunaga J, 2002, INFECT IMMUN, V70, P323, DOI 10.1128/IAI.70.1.323-334.2002; Matsunaga J, 2006, MICROBIOL-SGM, V152, P3777, DOI 10.1099/mic.0.29162-0; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Morrissey JA, 2002, INFECT IMMUN, V70, P2399, DOI 10.1128/IAI.70.5.2399-2407.2002; Myers CR, 2003, LETT APPL MICROBIOL, V37, P254, DOI 10.1046/j.1472-765X.2003.01389.x; Nally JE, 2005, PROTEOMICS, V5, P144, DOI 10.1002/pmic.200400880; Nally JE, 2001, INFECT IMMUN, V69, P7616, DOI 10.1128/IAI.69.12.7616-7624.2001; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NOORDHOEK GT, 1989, MICROB PATHOGENESIS, V6, P29, DOI 10.1016/0882-4010(89)90005-3; Noppa L, 2001, INFECT IMMUN, V69, P3323, DOI 10.1128/IAI.69.5.3323-3334.2001; Ostberg Y, 2002, J BACTERIOL, V184, P6811, DOI 10.1128/JB.184.24.6811-6819.2002; Parveen N, 2000, MOL MICROBIOL, V35, P1220, DOI 10.1046/j.1365-2958.2000.01792.x; Pinne M, 2004, MICROBIOL-SGM, V150, P549, DOI 10.1099/mic.0.26728-0; Pinne M, 2006, J BACTERIOL, V188, P4207, DOI 10.1128/JB.00302-06; Pinne M, 2007, FEMS MICROBIOL LETT, V266, P241, DOI 10.1111/j.1574-6968.2006.00529.x; PROBERT WS, 1995, INFECT IMMUN, V63, P1933, DOI 10.1128/IAI.63.5.1933-1939.1995; RADOLF JD, 1989, P NATL ACAD SCI USA, V86, P2051, DOI 10.1073/pnas.86.6.2051; RADOLF JD, 1994, J BACTERIOL, V176, P21, DOI 10.1128/JB.176.1.21-31.1994; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Sabarth N, 2002, J BIOL CHEM, V277, P27896, DOI 10.1074/jbc.M204473200; SCHULZ G, 2004, STRUCTURES GEN PORIN; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; SHANG ES, 1995, INFECT IMMUN, V63, P3174, DOI 10.1128/IAI.63.8.3174-3181.1995; Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996; Skare JT, 1996, J BACTERIOL, V178, P4909, DOI 10.1128/jb.178.16.4909-4918.1996; Skare JT, 1997, INFECT IMMUN, V65, P3654, DOI 10.1128/IAI.65.9.3654-3661.1997; Sonrier C, 2000, VACCINE, V19, P86, DOI 10.1016/S0264-410X(00)00129-8; STADER J, 1988, J BACTERIOL, V170, P1973, DOI 10.1128/jb.170.4.1973-1974.1988; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; Thein M, 2008, J BACTERIOL, V190, P7035, DOI 10.1128/JB.00818-08; THOMAS W, 1992, INFECT IMMUN, V60, P3111, DOI 10.1128/IAI.60.8.3111-3116.1992; Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424; Zuerner R, 2000, J MOL MICROB BIOTECH, V2, P455; ZUERNER RL, 1991, MICROB PATHOGENESIS, V10, P311, DOI 10.1016/0882-4010(91)90014-2	84	63	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6071	10.1371/journal.pone.0006071	http://dx.doi.org/10.1371/journal.pone.0006071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562037	Green Submitted, Green Published, gold			2022-12-27	WOS:000267465900007
J	Goh, S; Boberek, JM; Nakashima, N; Stach, J; Good, L				Goh, Shan; Boberek, Jaroslaw M.; Nakashima, Nobutaka; Stach, Jem; Good, Liam			Concurrent Growth Rate and Transcript Analyses Reveal Essential Gene Stringency in Escherichia coli	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; FATTY-ACID ELONGATION; INDUCED-FIT MECHANISM; CELL-DIVISION; MESSENGER-RNA; FTSZ; INHIBITION; EXPRESSION; TRANSFERASE; IDENTIFICATION	Background: Genes essential for bacterial growth are of particular scientific interest. Many putative essential genes have been identified or predicted in several species, however, little is known about gene expression requirement stringency, which may be an important aspect of bacterial physiology and likely a determining factor in drug target development. Methodology/Principal Findings: Working from the premise that essential genes differ in absolute requirement for growth, we describe silencing of putative essential genes in E. coli to obtain a titration of declining growth rates and transcript levels by using antisense peptide nucleic acids (PNA) and expressed antisense RNA. The relationship between mRNA decline and growth rate decline reflects the degree of essentiality, or stringency, of an essential gene, which is here defined by the minimum transcript level for a 50% reduction in growth rate (MTL50). When applied to four growth essential genes, both RNA silencing methods resulted in MTL50 values that reveal acpP as the most stringently required of the four genes examined, with ftsZ the next most stringently required. The established antibacterial targets murA and fabI were less stringently required. Conclusions: RNA silencing can reveal stringent requirements for gene expression with respect to growth. This method may be used to validate existing essential genes and to quantify drug target requirement.			Goh, S (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	lgood@rvc.ac.uk	Goh, Shan/A-7261-2010; Nakashima, Nobutaka/G-3777-2016	Goh, Shan/0000-0002-9028-0303; Nakashima, Nobutaka/0000-0002-5836-9148; Stach, James/0000-0001-8787-2407; Good, Liam/0000-0002-2798-8640				Addinall SG, 2005, J BACTERIOL, V187, P358, DOI 10.1128/JB.187.1.358-365.2005; Baba Tomoya, 2006, Mol Syst Biol, V2; Badarinarayana V, 2001, NAT BIOTECHNOL, V19, P1060, DOI 10.1038/nbt1101-1060; Benson RE, 2003, ANTIMICROB AGENTS CH, V47, P2875, DOI 10.1128/AAC.47.9.2875-2881.2003; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Cox RA, 2007, MICROBIOL-SGM, V153, P3337, DOI 10.1099/mic.0.2007/005868-0; De Lay NR, 2006, J BACTERIOL, V188, P287, DOI 10.1128/JB.188.1.287-296.2006; Dryselius R, 2003, OLIGONUCLEOTIDES, V13, P427, DOI 10.1089/154545703322860753; Dryselius R, 2005, J ANTIMICROB CHEMOTH, V56, P97, DOI 10.1093/jac/dki173; Dryselius R, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-97; Eschenburg S, 2005, J BIOL CHEM, V280, P14070, DOI 10.1074/jbc.M414412200; Flardh K, 1997, MOL MICROBIOL, V24, P927, DOI 10.1046/j.1365-2958.1997.4001762.x; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; GARWIN JL, 1980, J BIOL CHEM, V255, P3263; Goehring NW, 2007, J BACTERIOL, V189, P633, DOI 10.1128/JB.00991-06; Good L, 1998, NAT BIOTECHNOL, V16, P355, DOI 10.1038/nbt0498-355; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Gully D, 2003, FEBS LETT, V548, P90, DOI 10.1016/S0014-5793(03)00746-4; Harry E., 2006, INT REV CYTOL, V253, P27; Harth G, 2007, P NATL ACAD SCI USA, V104, P7199, DOI 10.1073/pnas.0701725104; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Herring CD, 2004, J BACTERIOL, V186, P2673, DOI 10.1128/JB.186.9.2673-2681.2004; JACKOWSKI S, 1983, J BIOL CHEM, V258, P5186; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Kulyte A, 2005, J MOL MICROB BIOTECH, V9, P101, DOI 10.1159/000088840; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAJERUS PW, 1964, P NATL ACAD SCI USA, V51, P1231, DOI 10.1073/pnas.51.6.1231; MARQUARDT JL, 1992, J BACTERIOL, V174, P5748, DOI 10.1128/JB.174.17.5748-5752.1992; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; MCCORMICK JR, 1994, J MOL BIOL, V239, P608, DOI 10.1006/jmbi.1994.1403; MENDIETA J, 2009, J MOL BIOL; Mizyed S, 2005, BIOCHEMISTRY-US, V44, P4011, DOI 10.1021/bi047704w; Myllykallio H, 2003, TRENDS MICROBIOL, V11, P220, DOI 10.1016/S0966-842X(03)00101-X; Nakashima N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl697; Nekhotiaeva N, 2004, MOL THER, V10, P652, DOI 10.1016/j.ymthe.2004.07.006; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Nikravesh A, 2007, MOL THER, V15, P1537, DOI 10.1038/sj.mt.6300209; Palacios P, 1996, MOL MICROBIOL, V20, P1093, DOI 10.1111/j.1365-2958.1996.tb02549.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POWELL GL, 1969, J BIOL CHEM, V244, P5616; Pragman AA, 2007, BIOCHEMISTRY-US, V46, P314, DOI 10.1021/bi0603266; Schonbrunn E, 2000, BIOCHEMISTRY-US, V39, P2164, DOI 10.1021/bi991091j; Tan XX, 2005, ANTIMICROB AGENTS CH, V49, P3203, DOI 10.1128/AAC.49.8.3203-3207.2005; Tasdemir D, 2007, BIOORGAN MED CHEM, V15, P6834, DOI 10.1016/j.bmc.2007.07.032; Tilley LD, 2007, J ANTIMICROB CHEMOTH, V59, P66, DOI 10.1093/jac/dkl444; Tsao DHH, 2006, BIOORGAN MED CHEM, V14, P7953, DOI 10.1016/j.bmc.2006.07.050; Varma A, 2004, J BACTERIOL, V186, P6768, DOI 10.1128/JB.186.20.6768-6774.2004; Vergidis PI, 2008, CURR OPIN INVEST DR, V9, P176; VOSKUIL JLA, 1994, J BACTERIOL, V176, P1886, DOI 10.1128/jb.176.7.1886-1893.1994; Yellaboina S, 2007, GENOME RES, V17, P527, DOI 10.1101/gr.5900607; Yu BJ, 2002, NAT BIOTECHNOL, V20, P1018, DOI 10.1038/nbt740; Zhang Y, 1996, J BACTERIOL, V178, P3614, DOI 10.1128/jb.178.12.3614-3620.1996; Zhang Y, 1998, J BACTERIOL, V180, P3295, DOI 10.1128/JB.180.13.3295-3303.1998; Zhang YM, 2004, J BIOL CHEM, V279, P50969, DOI 10.1074/jbc.M409607200	59	58	62	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6061	10.1371/journal.pone.0006061	http://dx.doi.org/10.1371/journal.pone.0006061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557168	Green Published, Green Submitted, gold			2022-12-27	WOS:000267424600009
J	Resina, S; Prevot, P; Thierry, AR				Resina, Sarah; Prevot, Paul; Thierry, Alain R.			Physico-Chemical Characteristics of Lipoplexes Influence Cell Uptake Mechanisms and Transfection Efficacy	PLOS ONE			English	Article								Background: Formulation of DNA/cationic lipid complexes (lipoplexes) designed for nucleic acid delivery mostly results in positively charged particles which are thought to enter cells by endocytosis. We recently developed a lipoplex formulation called Neutraplex that allows preparation of both cationic and anionic stable complexes with similar lipid content and ultrastructure. Methodology/Principal Findings: To assess whether the global net charge could influence cell uptake and activity of the transported oligonucleotides (ON), we prepared lipoplexes with positive and negative charges and compared: (i) their physicochemical properties by zeta potential analysis and dynamic light scattering, (ii) their cell uptake by fluorescence microscopy and flow cytometry, and (iii) the biological activity of the transported ON using a splicing correction assay. We show that positively or negatively charged lipoplexes enter cells cells using both temperature-dependent and -independent uptake mechanisms. Specifically, positively charged lipoplexes predominantly use a temperature-dependent transport when cells are incubated OptiMEM medium. Anionic lipoplexes favour an energy-independent transport and show higher ON activity than cationic lipoplexes in presence of serum. However, lipoplexes with high positive global net charge and OptiMEM medium give the highest uptake and ON activity levels. Conclusions: These findings suggest that, in addition to endocytosis, lipoplexes may enter cell via a temperature-independent mechanism, which could be mediated by lipid mixing. Such characteristics might arise from the specific lipoplex ultrastructure and should be taken into consideration when developing lipoplexes designed for in vivo or ex vivo nucleic acid transfer.			Resina, S (corresponding author), Univ Montpellier 2, UMR 5235, Dept Def Antivirales & Antitumorales, Lab DIMNP, Montpellier, France.	alain.thierry@sysdiag.cnrs.fr	thierry, alain/F-9492-2014					Abes S, 2006, J CONTROL RELEASE, V110, P595, DOI 10.1016/j.jconrel.2005.10.026; Alino SF, 1996, HUM GENE THER, V7, P531, DOI 10.1089/hum.1996.7.4-531; BARU M, 1995, GENE, V161, P143, DOI 10.1016/0378-1119(95)00281-A; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Caracciolo G, 2006, J PHYS CHEM B, V110, P20829, DOI 10.1021/jp0620926; CHERNOMORDIK LV, 1995, CURR OPIN STRUC BIOL, V5, P541, DOI 10.1016/0959-440X(95)80041-7; de Lima MCP, 1999, MOL MEMBR BIOL, V16, P103; Duzgunes N, 1999, ADV DRUG DELIVER REV, V40, P3, DOI 10.1016/S0169-409X(99)00037-X; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Fletcher S, 2006, J GENE MED, V8, P207, DOI 10.1002/jgm.838; Goryacheva YA, 2005, B EXP BIOL MED+, V140, P733, DOI 10.1007/s10517-006-0069-4; Harashima H, 2001, EUR J PHARM SCI, V13, P85, DOI 10.1016/S0928-0987(00)00211-6; Hofland HEJ, 1996, P NATL ACAD SCI USA, V93, P7305, DOI 10.1073/pnas.93.14.7305; Kang SH, 1998, BIOCHEMISTRY-US, V37, P6235, DOI 10.1021/bi980300h; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Koynova R, 2006, P NATL ACAD SCI USA, V103, P14373, DOI 10.1073/pnas.0603085103; Lavigne C, 2004, METHOD ENZYMOL, V387, P189; Li S, 1997, GENE THER, V4, P891, DOI 10.1038/sj.gt.3300482; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Meryet-Figuieres M, 2007, BIOCHIMIE, V89, P1228, DOI 10.1016/j.biochi.2007.03.017; Midoux P, 2008, CURR GENE THER, V8, P335, DOI 10.2174/156652308786071014; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Ortiz A, 1999, BIOPHYS J, V77, P2003, DOI 10.1016/S0006-3495(99)77041-4; Pires P, 1999, BBA-BIOMEMBRANES, V1418, P71, DOI 10.1016/S0005-2736(99)00023-1; Plank C, 1996, HUM GENE THER, V7, P1437, DOI 10.1089/hum.1996.7.12-1437; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Resina S, 2007, J GENE MED, V9, P498, DOI 10.1002/jgm.1044; Schmutz M, 1999, P NATL ACAD SCI USA, V96, P12293, DOI 10.1073/pnas.96.22.12293; Shi Jing, 2004, Yaoxue Xuebao, V39, P551; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P7128, DOI 10.1073/pnas.80.23.7128; Tavitian B, 2002, PHARM RES-DORDR, V19, P367, DOI 10.1023/A:1015133205457; Templeton NS, 2002, BIOSCIENCE REP, V22, P283; Thierry AR, 2006, BBA-BIOMEMBRANES, V1758, P364, DOI 10.1016/j.bbamem.2005.10.010; Thierry AR, 2009, BBA-GEN SUBJECTS, V1790, P385, DOI 10.1016/j.bbagen.2009.03.017; Thierry AR, 1997, GENE THER, V4, P226, DOI 10.1038/sj.gt.3300350; THIERRY AR, 1993, BIOCHEM BIOPH RES CO, V190, P952, DOI 10.1006/bbrc.1993.1142; THIERRY AR, 1992, NUCLEIC ACIDS RES, V20, P5691, DOI 10.1093/nar/20.21.5691; THIERRY AR, 1995, P NATL ACAD SCI USA, V92, P9742, DOI 10.1073/pnas.92.21.9742; THIERRY AR, SUPRAMOLECULAR UNPUB; Top D, 2005, EMBO J, V24, P2980, DOI 10.1038/sj.emboj.7600767; Tranchant I, 2004, J GENE MED, V6, pS24, DOI 10.1002/jgm.509; Ulrich AS, 2002, BIOSCIENCE REP, V22, P129, DOI 10.1023/A:1020178304031; Wasungu L, 2006, J CONTROL RELEASE, V116, P255, DOI 10.1016/j.jconrel.2006.06.024; WU B, 2009, MOL THER        0310; Zelphati O, 1996, P NATL ACAD SCI USA, V93, P11493, DOI 10.1073/pnas.93.21.11493; Zhang Y, 2007, J CONTROL RELEASE, V117, P281, DOI 10.1016/j.jconrel.2006.11.006; ZHU N, 1993, SCIENCE, V261, P209, DOI 10.1126/science.7687073; Zuhorn IS, 2002, J BIOL CHEM, V277, P18021, DOI 10.1074/jbc.M111257200	50	60	64	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6058	10.1371/journal.pone.0006058	http://dx.doi.org/10.1371/journal.pone.0006058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557145	Green Published, Green Submitted, gold			2022-12-27	WOS:000267424600006
J	Colzato, LS; van den Wildenberg, WPM; Hommel, B				Colzato, Lorenza S.; van den Wildenberg, Wery P. M.; Hommel, Bernhard			Reduced Attentional Scope in Cocaine Polydrug Users	PLOS ONE			English	Article								Cocaine is Europe's second preferred recreational drug after cannabis but very little is known about possible cognitive impairments in the upcoming type of recreational cocaine user (monthly consumption). We asked whether recreational use of cocaine impacts early attentional selection processes. Cocaine-free polydrug controls (n = 18) and cocaine polydrug users (n = 18) were matched on sex, age, alcohol consumption, and IQ (using the Raven's progressive matrices), and were tested by using the Global-Local task to measure the scope of attention. Cocaine polydrug users attended significantly more to local aspects of attended events, which fits with the idea that a reduced scope of attention may be associated with the perpetuation of the use of the drug.			Colzato, LS (corresponding author), Leiden Univ, Inst Psychol Res, Leiden, Netherlands.	colzato@fsw.leidenuniv.nl	Colzato, Lorenza S/H-6296-2013; Hommel, Bernhard/F-8173-2010	Hommel, Bernhard/0000-0003-4731-5125; Colzato, Lorenza/0000-0003-1735-1280				American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Ashby F. G., 2002, EMOTIONAL COGNITION, P245, DOI [DOI 10.1075/AICR.44.11ASH, 10.1075/aicr.44.11ash]; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Bolla KI, 1998, J NEUROPSYCH CLIN N, V10, P280, DOI 10.1176/jnp.10.3.280; Boulougouris V, 2008, PROG BRAIN RES, V172, P517, DOI 10.1016/S0079-6123(08)00925-4; Colzato LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001143; Colzato LS, 2008, NEUROPSYCHOLOGIA, V46, P1570, DOI 10.1016/j.neuropsychologia.2007.12.014; Colzato LS, 2009, NEUROPSYCHOLOGY, V23, P125, DOI 10.1037/a0013821; Colzato LS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003461; Colzato LS, 2005, EUR J NEUROSCI, V21, P591, DOI 10.1111/j.1460-9568.2005.03868.x; Colzato LS, 2004, NEUROSCI LETT, V360, P103, DOI 10.1016/j.neulet.2004.01.054; COLZATO LS, 2009, RECREATIONAL USE COC; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; *EUR MON CTR DRUGS, 2007, STAT DRUGS PROBL EUR; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Franken IHA, 2007, BIOL PSYCHOL, V75, P45, DOI 10.1016/j.biopsycho.2006.11.003; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Kalivas PW, 2003, ANN NY ACAD SCI, V1003, P169, DOI 10.1196/annals.1300.009; Kleven MS, 1996, J PHARMACOL EXP THER, V279, P1211; Kubler A, 2005, EUR J NEUROSCI, V21, P1984, DOI 10.1111/j.1460-9568.2005.04027.x; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Logan GD, 2001, PSYCHOL REV, V108, P393, DOI 10.1037//0033-295X.108.2.393; Logan Gordon D., 1994, P189; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Muller CP, 2007, PROG NEUROBIOL, V81, P133, DOI 10.1016/j.pneurobio.2007.01.001; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Pooley EC, 2007, MOL PSYCHIATR, V12, P556, DOI 10.1038/sj.mp.4001951; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Raven JC, 1988, MANUAL RAVENS PROGR; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; Tripp G, 2008, J CHILD PSYCHOL PSYC, V49, P691, DOI 10.1111/j.1469-7610.2007.01851.x; van der Post J, 2004, J PSYCHOPHARMACOL, V18, P109, DOI 10.1177/0269881104042832; Verdejo-Garcia AJ, 2005, ADDICT BEHAV, V30, P89, DOI 10.1016/j.addbeh.2004.04.015; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Verdejo-Garcia A, 2007, PSYCHOPHARMACOLOGY, V190, P517, DOI 10.1007/s00213-006-0632-8; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Verkes RJ, 2001, PSYCHOPHARMACOLOGY, V153, P196, DOI 10.1007/s002130000563; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406; von Geusau NA, 2004, PSYCHOPHARMACOLOGY, V175, P331, DOI 10.1007/s00213-004-1832-8; Yovel I, 2005, PSYCHOL SCI, V16, P123, DOI 10.1111/j.0956-7976.2005.00792.x	45	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6043	10.1371/journal.pone.0006043	http://dx.doi.org/10.1371/journal.pone.0006043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557181	gold, Green Submitted, Green Published			2022-12-27	WOS:000267356900005
J	Nakamuta, JS; Danoviz, ME; Marques, FLN; dos Santos, L; Becker, C; Goncalves, GA; Vassallo, PF; Schettert, IT; Tucci, PJF; Krieger, JE				Nakamuta, Juliana S.; Danoviz, Maria E.; Marques, Fabio L. N.; dos Santos, Leonardo; Becker, Claudia; Goncalves, Giovana A.; Vassallo, Paula F.; Schettert, Isolmar T.; Tucci, Paulo J. F.; Krieger, Jose E.			Cell Therapy Attenuates Cardiac Dysfunction Post Myocardial Infarction: Effect of Timing, Routes of Injection and a Fibrin Scaffold	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PROGENITOR CELLS; ISCHEMIC-MYOCARDIUM; MUSCLE-CELLS; OPTIMAL TIME; TRANSPLANTATION; HEART; SURVIVAL; REPAIR; INTRACORONARY	Background: Cell therapy approaches for biologic cardiac repair hold great promises, although basic fundamental issues remain poorly understood. In the present study we examined the effects of timing and routes of administration of bone marrow cells (BMC) post-myocardial infarction (MI) and the efficacy of an injectable biopolymer scaffold to improve cardiac cell retention and function. Methodology/Principal Findings: Tc-99m-labeled BMC (6x10(6) cells) were injected by 4 different routes in adult rats: intravenous (IV), left ventricular cavity (LV), left ventricular cavity with temporal aorta occlusion (LV+) to mimic coronary injection, and intramyocardial (IM). The injections were performed 1, 2, 3, or 7 days post-MI and cell retention was estimated by gamma-emission counting of the organs excised 24 hs after cell injection. IM injection improved cell retention and attenuated cardiac dysfunction, whereas IV, LV or LV* routes were somewhat inefficient (< 1%). Cardiac BMC retention was not influenced by timing except for the IM injection that showed greater cell retention at 7 (16%) vs. 1, 2 or 3 (average of 7%) days post-MI. Cardiac cell retention was further improved by an injectable fibrin scaffold at day 3 post-MI (17 vs. 7%), even though morphometric and function parameters evaluated 4 weeks later displayed similar improvements. Conclusions/Significance: These results show that cells injected post-MI display comparable tissue distribution profile regardless of the route of injection and that there is no time effect for cardiac cell accumulation for injections performed 1 to 3 days post-MI. As expected the IM injection is the most efficient for cardiac cell retention, it can be further improved by co-injection with a fibrin scaffold and it significantly attenuates cardiac dysfunction evaluated 4 weeks post myocardial infarction. These pharmacokinetic data obtained under similar experimental conditions are essential for further development of these novel approaches.			Nakamuta, JS (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil.	krieger@incor.usp.br	Schettert, Isolmar/D-1355-2012; Navarro Marques, Fabio Luiz/ABI-7774-2020; Pereira, Alexandre/HHN-1038-2022; dos Santos, Leonardo/B-6509-2013; Krieger, Jose E/C-3117-2011; Marques, Fabio LN/C-4153-2012; Tucci, Paulo/D-1441-2015	Navarro Marques, Fabio Luiz/0000-0001-7383-926X; dos Santos, Leonardo/0000-0002-4340-6364; Krieger, Jose E/0000-0001-5464-1792; Marques, Fabio LN/0000-0001-7383-926X; Tucci, Paulo/0000-0001-9793-670X				Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; de Oliveira SA, 2006, EUR J CARDIO-THORAC, V29, pS259, DOI 10.1016/j.ejcts.2006.02.005; *AM PLC, INS PACKDG CER PROD; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Becker C, 2006, INT J CARDIOL, V113, P348, DOI 10.1016/j.ijcard.2005.11.060; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Chin BB, 2003, NUCL MED COMMUN, V24, P1149, DOI 10.1097/00006231-200311000-00005; Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040; Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762; Collins SD, 2007, CARDIOVASC REVASCULA, V8, P43, DOI 10.1016/j.carrev.2006.11.005; Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011; Fernandez P, 1999, J NUCL MED, V40, P1756; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gowdak LHW, 2008, INT J CARDIOL, V127, P295, DOI 10.1016/j.ijcard.2007.05.048; Halkos ME, 2008, BASIC RES CARDIOL, V103, P525, DOI 10.1007/s00395-008-0741-0; Hodgson DM, 2004, AM J PHYSIOL-HEART C, V287, pH471, DOI 10.1152/ajpheart.01247.2003; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; HOU D, 2005, CIRCULATION S, V1, P156; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Hu XY, 2007, EUR J CARDIO-THORAC, V31, P438, DOI 10.1016/j.ejcts.2006.11.057; Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Jiang CY, 2008, J ZHEJIANG UNIV-SC B, V9, P630, DOI 10.1631/jzus.B0820004; Li RK, 2001, ANN THORAC SURG, V72, P1957, DOI 10.1016/S0003-4975(01)03216-7; Liu YG, 2004, MICROVASC RES, V68, P156, DOI 10.1016/j.mvr.2004.06.008; Lu L, 2004, BIOCHEM BIOPH RES CO, V320, P907, DOI 10.1016/j.bbrc.2004.06.034; Melo LG, 2004, CIRCULATION, V109, P2386, DOI 10.1161/01.CIR.0000128597.37025.00; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; NEIRINCKX RD, 1987, J NUCL MED, V28, P191; Olivares EL, 2004, AM J PHYSIOL-HEART C, V287, pH464, DOI 10.1152/ajpheart.01141.2003; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; Radosevich M, 1997, VOX SANG, V72, P133, DOI 10.1046/j.1423-0410.1997.7230133.x; Reinlib L, 2000, CIRCULATION, V101, pE182; Roy S, 2006, PHYSIOL GENOMICS, V25, P364, DOI 10.1152/physiolgenomics.00013.2006; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schuster MD, 2004, AM J PHYSIOL-HEART C, V287, pH525, DOI 10.1152/ajpheart.00058.2004; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Suzuki K, 2004, FASEB J, V18, P1153, DOI 10.1096/fj.03-1308fje; Tse HF, 2003, LANCET, V361, P47, DOI 10.1016/S0140-6736(03)12111-3; Vandervelde S, 2005, J MOL CELL CARDIOL, V39, P363, DOI 10.1016/j.yjmcc.2005.05.012; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Yasuda T, 2005, J THORAC CARDIOV SUR, V129, P904, DOI 10.1016/j.jtcvs.2004.06.027; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zhang SH, 2004, LIFE SCI, V74, P2853, DOI 10.1016/j.lfs.2003.10.035	49	66	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6005	10.1371/journal.pone.0006005	http://dx.doi.org/10.1371/journal.pone.0006005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547700	Green Submitted, gold, Green Published			2022-12-27	WOS:000267347900004
J	van Peer, AF; Muller, WH; Boekhout, T; Lugones, LG; Wosten, HAB				van Peer, Arend F.; Mueller, Wally H.; Boekhout, Teun; Lugones, Luis G.; Wosten, Han A. B.			Cytoplasmic Continuity Revisited: Closure of Septa of the Filamentous Fungus Schizophyllum commune in Response to Environmental Conditions	PLOS ONE			English	Article								Background: Mycelia of higher fungi consist of interconnected hyphae that are compartmentalized by septa. These septa contain large pores that allow streaming of cytoplasm and even organelles. The cytoplasm of such mycelia is therefore considered to be continuous. Methodology/Principal Findings: Here, we show by laser dissection that septa of Schizophyllum commune can be closed depending on the environmental conditions. The most apical septum of growing hyphae was open when this basidiomycete was grown in minimal medium with glucose as a carbon source. In contrast, the second and the third septum were closed in more than 50% and 90% of the cases, respectively. Interestingly, only 24 and 37% of these septa were closed when hyphae were growing in the absence of glucose. Whether a septum was open or closed also depended on physical conditions of the environment or the presence of toxic agents. The first septum closed when hyphae were exposed to high temperature, to hypertonic conditions, or to the antibiotic nourseothricin. In the case of high temperature, septa opened again when the mycelium was placed back to the normal growth temperature. Conclusions/Significance: Taken together, it is concluded that the septal pores of S. commune are dynamic structures that open or close depending on the environmental conditions. Our findings imply that the cytoplasm in the mycelium of a higher fungus is not continuous perse.			van Peer, AF (corresponding author), Univ Utrecht, Dept Microbiol, Biomembrane Inst, Utrecht, Netherlands.	h.a.b.wosten@uu.nl	Wösten, Han AB/K-2769-2016; Lugones, Luis/J-6065-2016; Boekhout, Teun/F-1552-2010; Müller, Wally/B-8215-2011	Wösten, Han AB/0000-0002-0399-3648; Lugones, Luis/0000-0002-5259-3739; Boekhout, Teun/0000-0002-0476-3609; van Peer, Arend/0000-0001-7023-0045				AYLMORE RC, 1984, J GEN MICROBIOL, V130, P2975; Barr DJS, 2001, MYCOTA, V7, P93; Bauer R, 1997, CAN J BOT, V75, P1273, DOI 10.1139/b97-842; Bauer R, 2006, MYCOL PROG, V5, P41, DOI 10.1007/s11557-006-0502-0; Benny GL, 2001, MYCOTA, V7, P113; BRACKER CE, 1963, MYCOLOGIA, V55, P35, DOI 10.2307/3756380; BRACKER CE, 1964, J CELL BIOL, V21, P152, DOI 10.1083/jcb.21.1.152; DONS JJM, 1979, BIOCHIM BIOPHYS ACTA, V563, P100, DOI 10.1016/0005-2787(79)90011-X; Ghoshroy S, 1997, ANNU REV PLANT PHYS, V48, P25; GIRBARDT M, 1961, ARCH MIKROBIOL, V39, P351, DOI 10.1007/BF00411774; Jedd G, 2000, NAT CELL BIOL, V2, P226, DOI 10.1038/35008652; JENNINGS DH, 1987, BIOL REV, V62, P215, DOI 10.1111/j.1469-185X.1987.tb00664.x; MARKHAM P, 1987, FEMS MICROBIOL LETT, V46, P1; MARKHAM P, 1994, MYCOL RES, V98, P1089, DOI 10.1016/S0953-7562(09)80195-0; McLaughlin DJ, 1995, STUD MYCOL, P91; MOORE RT, 1962, AM J BOT, V49, P86, DOI 10.2307/2439393; MOORE RT, 1975, MYCOLOGIA, V67, P1200, DOI 10.2307/3758843; Muller WH, 1998, MICROBIOL-UK, V144, P1721, DOI 10.1099/00221287-144-7-1721; MULLER WH, 1994, CAN J MICROBIOL, V40, P879; Muller WH, 2000, J STRUCT BIOL, V131, P10, DOI 10.1006/jsbi.2000.4243; OBERWINKLER F, 1982, CAN J BOT, V60, P1726, DOI 10.1139/b82-221; Oparka KJ, 2001, PLANT PHYSIOL, V125, P123, DOI 10.1104/pp.125.1.123; Perkins G, 1997, BIOPHYS J, V72, P533, DOI 10.1016/S0006-3495(97)78693-4; Ruan YL, 2001, PLANT CELL, V13, P47, DOI 10.1105/tpc.13.1.47; SHATKIN AJ, 1959, J BIOPHYS BIOCHEM CY, V6, P423, DOI 10.1083/jcb.6.3.423; TRINCI APJ, 1973, PROTOPLASMA, V80, P57, DOI 10.1007/BF01666351; van Driel KGA, 2008, EUKARYOT CELL, V7, P1865, DOI 10.1128/EC.00125-08; Veenstra RD, 1996, J BIOENERG BIOMEMBR, V28, P327, DOI 10.1007/BF02110109; Yuan P, 2003, NAT STRUCT BIOL, V10, P264, DOI 10.1038/nsb910	29	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5977	10.1371/journal.pone.0005977	http://dx.doi.org/10.1371/journal.pone.0005977			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543400	Green Published, gold			2022-12-27	WOS:000267237600005
J	Bheda, A; Yue, W; Gullapalli, A; Whitehurst, C; Liu, RS; Pagano, JS; Shackelford, J				Bheda, Anjali; Yue, Wei; Gullapalli, Anuradha; Whitehurst, Chris; Liu, Renshui; Pagano, Joseph S.; Shackelford, Julia			Positive Reciprocal Regulation of Ubiquitin C-Terminal Hydrolase L1 and beta-Catenin/TCF Signaling	PLOS ONE			English	Article								Deubiquitinating enzymes (DUBs) are involved in the regulation of distinct critical cellular processes. Ubiquitin C-terminal Hydrolase L1 (UCH L1) has been linked to several neurological diseases as well as human cancer, but the physiological targets and the regulation of UCH L1 expression in vivo have been largely unexplored. Here we demonstrate that UCH L1 up-regulates beta-catenin/TCF signaling: UCH L1 forms endogenous complexes with beta-catenin, stabilizes it and up-regulates beta-catenin/TCF-dependent transcription. We also show that, reciprocally, beta-catenin/TCF signaling up-regulates expression of endogenous UCH L1 mRNA and protein. Moreover, using ChIP assay and direct mutagenesis we identify two TCF4-binding sites on the uch l1 promoter that are involved in this regulation. Since the expression and deubiquitinating activity of UCH L1 are required for its own basic promoter activity, we propose that UCH L1 up-regulates its expression by activation of the oncogenic beta-catenin/TCF signaling in transformed cells.			Bheda, A (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	shackelfordj@yahoo.com		Whitehurst, Christopher/0000-0003-4740-2317	NATIONAL CANCER INSTITUTE [P01CA019014, T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI085545] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA019014, 2-P01-CA19014-26, T32 CA009156] Funding Source: Medline; NIAID NIH HHS [R03 AI085545] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barker N, 2000, BIOESSAYS, V22, P961; Barker N, 2000, ADV CANCER RES, V77, P1; Betarbet R, 2005, EXP NEUROL, V191, pS17, DOI 10.1016/j.expneurol.2004.08.021; BHEDA A, EXPRESSION PRO UNPUB; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DAY INM, 1990, BIOCHEM J, V268, P521, DOI 10.1042/bj2680521; Finley Daniel, 2004, Cell, VS116, pS29, DOI 10.1016/S0092-8674(03)00971-1; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Fukutomi S, 2007, SCAND J GASTROENTERO, V42, P1486, DOI 10.1080/00365520701491173; Hibi K, 1999, AM J PATHOL, V155, P711, DOI 10.1016/S0002-9440(10)65169-3; HOWELL VM, 2008, J CLIN ENDOCRINOL ME; Joaquin M, 2003, CELL MOL LIFE SCI, V60, P2389, DOI 10.1007/s00018-003-3037-4; Jope RS, 2002, MOL PSYCHIATR, V7, pS35, DOI 10.1038/sj.mp.4001017; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; KIM HJ, 2008, ONCOGENE; KOZBOR D, 1982, P NATL ACAD SCI-BIOL, V79, P6651, DOI 10.1073/pnas.79.21.6651; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Loeffler-Ragg J, 2005, EUR J CANCER, V41, P2338, DOI 10.1016/j.ejca.2005.06.014; Long EM, 2003, LUNG CANCER-J IASLC, V42, P9, DOI 10.1016/S0169-5002(03)00279-4; Mandelker DL, 2005, CANCER RES, V65, P4963, DOI 10.1158/0008-5472.CAN-04-3923; Mann DA, 1996, J NEUROCHEM, V66, P35; Miyoshi Y, 2006, CANCER SCI, V97, P523, DOI 10.1111/j.1349-7006.2006.00202.x; OKOCHITAKADA E, 2006, INT J CANC; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Otsuki T, 2004, BRIT J HAEMATOL, V127, P292, DOI 10.1111/j.1365-2141.2004.05205.x; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; ROLEN U, 2008, J CELL MOL MED; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shackelford J, 2005, ESSAYS BIOCHEM, V41, P139, DOI 10.1042/EB0410139; Shackelford J, 2003, P NATL ACAD SCI USA, V100, P15572, DOI 10.1073/pnas.2636947100; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Trowern AR, 1999, NEUROSCI LETT, V272, P25, DOI 10.1016/S0304-3940(99)00479-6; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Yang YC, 2006, ACTA BIOCH BIOPH SIN, V38, P602, DOI 10.1111/j.1745-7270.2006.00205.x	39	39	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5955	10.1371/journal.pone.0005955	http://dx.doi.org/10.1371/journal.pone.0005955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536331	Green Published, Green Submitted, gold			2022-12-27	WOS:000267079500005
J	Zhong, LY; Zeng, GC; Lu, XX; Wang, RC; Gong, GM; Yan, L; Huang, D; Chen, ZW				Zhong, Liyun; Zeng, Gucheng; Lu, Xiaoxu; Wang, Richard C.; Gong, Guangming; Yan, Lin; Huang, Dan; Chen, Zheng W.			NSOM/QD-Based Direct Visualization of CD3-Induced and CD28-Enhanced Nanospatial Coclustering of TCR and Coreceptor in Nanodomains in T Cell Activation	PLOS ONE			English	Article								Direct molecular imaging of nano-spatial relationship between T cell receptor (TCR)/CD3 and CD4 or CD8 co-receptor before and after activation of a primary T cell has not been reported. We have recently innovated application of near-field scanning optical microscopy (NSOM) and immune-labeling quantum dots (QD) to image Ag-specific TCR response during in vivo clonal expansion, and now up-graded the NSOM/QD-based nanotechnology through dipole-polarization and dual-color imaging. Using this imaging system scanning cell-membrane molecules at a best-optical lateral resolution, we demonstrated that CD3, CD4 or CD8 molecules were distinctly distributed as single QD-bound molecules or nano-clusters equivalent to 2-4 QD fluorescence-intensity/size on cell-membrane of un-stimulated primary T cells, and similar to 6-10% of CD3 were co-clustering with CD4 or CD8 as 70-110 nm nano-clusters without forming nano-domains. The ligation of TCR/CD3 on CD4 or CD8 T cells led to CD3 nanoscale co-clustering or interaction with CD4 or CD8 co-receptors forming 200-500 nm nano-domains or >500 nm micro-domains. Such nano-spatial co-clustering of CD3 and CD4 or CD3 and CD8 appeared to be an intrinsic event of TCR/CD3 ligation, not purely limited to MHC engagement, and be driven by Lck phosphorylation. Importantly, CD28 co-stimulation remarkably enhanced TCR/CD3 nanoscale co-clustering or interaction with CD4 coreceptor within nano-or micro-domains on the membrane. In contrast, CD28 co-stimulation did not enhance CD8 clustering or CD3-CD8 co-clustering in nano-domains although it increased molecular number and density of CD3 clustering in the enlarged nano-domains. These nanoscale findings provide new insights into TCR/CD3 interaction with CD4 or CD8 coreceptor in T-cell activation.			Zhong, LY (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Ctr Primate Biomed Res, Chicago, IL 60612 USA.	zchen@uic.edu	Zeng, Gucheng/N-9397-2015		NCRR NIH HHS [R01 RR013601, R01 RR13601] Funding Source: Medline; NHLBI NIH HHS [R01 HL064560, R01 HL64560] Funding Source: Medline; NIAID NIH HHS [U01 AI070426, U01 AI070426] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR013601] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070426] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Alarcon B, 2006, EMBO REP, V7, P490, DOI 10.1038/sj.embor.7400682; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Block MS, 2001, J IMMUNOL, V167, P821, DOI 10.4049/jimmunol.167.2.821; Bosselut R, 1999, J EXP MED, V190, P1517, DOI 10.1084/jem.190.10.1517; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen Y, 2008, J LIPID RES, V49, P2268, DOI 10.1194/jlr.D800031-JLR200; Chen Y, 2008, BLOOD, V111, P4220, DOI 10.1182/blood-2007-07-101691; Chen Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005386; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; de Bakker BI, 2008, J CELL SCI, V121, P627, DOI 10.1242/jcs.019513; Doucey MA, 2003, J BIOL CHEM, V278, P3257, DOI 10.1074/jbc.M208119200; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dunn RC, 1999, CHEM REV, V99, P2891, DOI 10.1021/cr980130e; Enderle T, 1997, P NATL ACAD SCI USA, V94, P520, DOI 10.1073/pnas.94.2.520; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; GASCOIGNE NR, 2001, EXPERT REV MOL MED, P1; GONG G, 2008, BLOOD; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Ianoul A, 2005, NAT CHEM BIOL, V1, P196, DOI 10.1038/nchembio726; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lewis A, 2003, NAT BIOTECHNOL, V21, P1377, DOI 10.1038/nbt898; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Ozcan A, 2006, NANO LETT, V6, P2609, DOI 10.1021/nl062110v; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shen K, 2008, P NATL ACAD SCI USA, V105, P7791, DOI 10.1073/pnas.0710295105; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Teetsov J, 2000, J PHYS CHEM B, V104, P9378, DOI 10.1021/jp0012799; Tokumasu F, 2004, LANGMUIR, V20, P614, DOI 10.1021/la0355388; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Zal T, 2002, IMMUNITY, V16, P521, DOI 10.1016/S1074-7613(02)00301-1; Zamoyska R, 1998, CURR OPIN IMMUNOL, V10, P82, DOI 10.1016/S0952-7915(98)80036-8; Zapata DA, 2004, J BIOL CHEM, V279, P24485, DOI 10.1074/jbc.M311455200; Zeng GC, 2005, PROTEOMICS, V5, P4347, DOI 10.1002/pmic.200500017; Zeng GC, 2009, PROTEOMICS, V9, P1538, DOI 10.1002/pmic.200800528	59	38	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5945	10.1371/journal.pone.0005945	http://dx.doi.org/10.1371/journal.pone.0005945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536289	Green Submitted, Green Published, gold			2022-12-27	WOS:000267029700015
J	Pohlmeyer, EA; Oby, ER; Perreault, EJ; Solla, SA; Kilgore, KL; Kirsch, RF; Miller, LE				Pohlmeyer, Eric A.; Oby, Emily R.; Perreault, Eric J.; Solla, Sara A.; Kilgore, Kevin L.; Kirsch, Robert F.; Miller, Lee E.			Toward the Restoration of Hand Use to a Paralyzed Monkey: Brain-Controlled Functional Electrical Stimulation of Forearm Muscles	PLOS ONE			English	Article								Loss of hand use is considered by many spinal cord injury survivors to be the most devastating consequence of their injury. Functional electrical stimulation (FES) of forearm and hand muscles has been used to provide basic, voluntary hand grasp to hundreds of human patients. Current approaches typically grade pre-programmed patterns of muscle activation using simple control signals, such as those derived from residual movement or muscle activity. However, the use of such fixed stimulation patterns limits hand function to the few tasks programmed into the controller. In contrast, we are developing a system that uses neural signals recorded from a multi-electrode array implanted in the motor cortex; this system has the potential to provide independent control of multiple muscles over a broad range of functional tasks. Two monkeys were able to use this cortically controlled FES system to control the contraction of four forearm muscles despite temporary limb paralysis. The amount of wrist force the monkeys were able to produce in a one-dimensional force tracking task was significantly increased. Furthermore, the monkeys were able to control the magnitude and time course of the force with sufficient accuracy to track visually displayed force targets at speeds reduced by only one-third to one-half of normal. Although these results were achieved by controlling only four muscles, there is no fundamental reason why the same methods could not be scaled up to control a larger number of muscles. We believe these results provide an important proof of concept that brain-controlled FES prostheses could ultimately be of great benefit to paralyzed patients with injuries in the mid-cervical spinal cord.			Pohlmeyer, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	lm@northwestern.edu	Perreault, Eric/B-7632-2009	Kirsch, Robert/0000-0003-2564-1800; Kilgore, Kevin/0000-0002-2642-9855; Oby, Emily/0000-0002-3376-0669	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053603] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS053603] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; CRAGO PE, 1980, IEEE T BIO-MED ENG, V27, P679, DOI 10.1109/TBME.1980.326592; EVARTS EV, 1969, J NEUROPHYSIOL, V32, P375, DOI 10.1152/jn.1969.32.3.375; Hart R L, 1998, IEEE Trans Rehabil Eng, V6, P208, DOI 10.1109/86.681187; Hatsopoulos N, 2004, J NEUROPHYSIOL, V92, P1165, DOI 10.1152/jn.01245.2003; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Holdefer RN, 2002, EXP BRAIN RES, V146, P233, DOI 10.1007/s00221-002-1166-x; HUNTER IW, 1986, BIOL CYBERN, V55, P135; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Kilgore KL, 2008, J HAND SURG-AM, V33A, P539, DOI 10.1016/j.jhsa.2008.01.007; Lauer RT, 1999, NEUROREPORT, V10, P1767, DOI 10.1097/00001756-199906030-00026; Lauer RT, 2000, IEEE T REHABIL ENG, V8, P205, DOI 10.1109/86.847817; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Morrow MM, 2007, J NEUROPHYSIOL, V97, P1786, DOI 10.1152/jn.00150.2006; Mortimer J., 1981, HDB PHYSL NERVOUS SY, VII; Muller-Putz GR, 2005, NEUROSCI LETT, V382, P169, DOI 10.1016/j.neulet.2005.03.021; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Peckham PH, 2001, ARCH PHYS MED REHAB, V82, P1380, DOI 10.1053/apmr.2001.25910; Pfurtscheller G, 2003, NEUROSCI LETT, V351, P33, DOI 10.1016/S0304-3940(03)00947-9; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V82, P313, DOI 10.1016/0013-4694(92)90112-U; POHLMEYER EA, 2007, IEEE P 10 INT C REH; Pohlmeyer EA, 2007, J NEURAL ENG, V4, P369, DOI 10.1088/1741-2560/4/4/003; Popovic MR, 2002, NEUROL RES, V24, P443, DOI 10.1179/016164102101200311; Sanchez JC, 2004, IEEE T BIO-MED ENG, V51, P943, DOI 10.1109/TBME.2004.827061; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Sergio LE, 2005, J NEUROPHYSIOL, V94, P2353, DOI 10.1152/jn.00989.2004; Serruya M, 2003, BIOL CYBERN, V88, P219, DOI 10.1007/s00422-002-0374-6; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; SMITH AM, 1975, EXP BRAIN RES, V23, P315; Taira M, 1996, EXP BRAIN RES, V109, P367; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Westwick DT, 2006, NEURAL COMPUT, V18, P329, DOI 10.1162/089976606775093855; Wu W, 2004, P ANN INT IEEE EMBS, V26, P4126; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585	38	100	103	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5924	10.1371/journal.pone.0005924	http://dx.doi.org/10.1371/journal.pone.0005924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526055	Green Submitted, Green Published, gold			2022-12-27	WOS:000267029300015
J	Swanberg, M; Harnesk, K; Strom, M; Diez, M; Lidman, O; Piehl, F				Swanberg, Maria; Harnesk, Karin; Strom, Mikael; Diez, Margarita; Lidman, Olle; Piehl, Fredrik			Fine Mapping of Gene Regions Regulating Neurodegeneration	PLOS ONE			English	Article								Background: Damage to nerve cells and axons leading to neurodegeneration is a characteristic feature of many neurological diseases. The degree of genetic influence on susceptibility to axotomy-induced neuronal death has so far been unknown. We have examined two gene regions, Vra1 and Vra2, previously linked to nerve cell loss after ventral root avulsion in a rat F2 intercross between the DA and PVG inbred rat strains. Methodology/Principal Findings: In this study, we use two generations (G8 and G10 cohorts) of an advanced intercross line between DA and PVG(av1) to reproduce linkage to Vra1 and to fine-map this region. By isolating the effect from Vra1 in congenic strains, we demonstrate that Vra1 significantly regulates the loss of motoneurons after avulsion. The regulatory effect mediated by Vra1 thus resides in a congenic fragment of 9 megabases. Furthermore, we have used the advanced intercross lines to give more support to Vra2, originally detected as a suggestive QTL. Conclusions/Significance: The results demonstrated here show that naturally occurring allelic variations affect susceptibility to axotomy-induced nerve cell death. Vra1 and Vra2 represent the first quantitative trait loci regulating this phenotype that are characterized and fine mapped in an advanced intercross line. In addition, congenic strains provide experimental evidence for the Vra1 effect on the extent of injury-induced neurodegeneration. Identification of the underlying genetic variations will increase our understanding of the regulation and mechanisms of neurodegeneration.			Swanberg, M (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Clin Neurosci, S-10401 Stockholm, Sweden.	fredrik.piehl@ki.se	Piehl, Fredrik/E-3451-2013	Swanberg, Maria/0000-0002-1829-1008				Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Becanovic K, 2004, SCAND J IMMUNOL, V60, P39, DOI 10.1111/j.0300-9475.2004.01462.x; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Butterfield RJ, 2000, AM J PATHOL, V157, P637, DOI 10.1016/S0002-9440(10)64574-9; CHURCHILL GA, 1994, GENETICS, V138, P963; Griffiths MM, 1999, CURR OPIN IMMUNOL, V11, P689, DOI 10.1016/S0952-7915(99)00038-2; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Lidman O, 2003, J NEUROSCI, V23, P9817; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lorenzana A, 2007, EUR J NEUROSCI, V25, P1998, DOI 10.1111/j.1460-9568.2007.05443.x; Lundberg C, 2001, J COMP NEUROL, V431, P75; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Murata T, 2008, J NEUROL SCI, V267, P66, DOI 10.1016/j.jns.2007.09.038; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Piehl F, 1999, J NEUROIMMUNOL, V101, P87, DOI 10.1016/S0165-5728(99)00136-8; Pratico D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010; Schauwecker PE, 2004, J COMP NEUROL, V477, P96, DOI 10.1002/cne.20245; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Wetzel MK, 2008, NEURON, V59, P708, DOI 10.1016/j.neuron.2008.07.021	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5906	10.1371/journal.pone.0005906	http://dx.doi.org/10.1371/journal.pone.0005906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526058	Green Submitted, Green Published, gold			2022-12-27	WOS:000267029300002
J	Natarajan, S; Jakobsson, E				Natarajan, Shreedhar; Jakobsson, Eric			Functional Equivalency Inferred from "Authoritative Sources'' in Networks of Homologous Proteins	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NUCLEOTIDE-GATED CHANNELS; POTASSIUM CHANNEL; FAMILY; PORE; CLASSIFICATION; IDENTIFICATION; ACTIVATION; DEPENDENCE; GENOMES	A one-on-one mapping of protein functionality across different species is a critical component of comparative analysis. This paper presents a heuristic algorithm for discovering the Most Likely Functional Counterparts (MoLFunCs) of a protein, based on simple concepts from network theory. A key feature of our algorithm is utilization of the user's knowledge to assign high confidence to selected functional identification. We show use of the algorithm to retrieve functional equivalents for 7 membrane proteins, from an exploration of almost 40 genomes form multiple online resources. We verify the functional equivalency of our dataset through a series of tests that include sequence, structure and function comparisons. Comparison is made to the OMA methodology, which also identifies one-on-one mapping between proteins from different species. Based on that comparison, we believe that incorporation of user's knowledge as a key aspect of the technique adds value to purely statistical formal methods.			Natarajan, S (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jake@ncsa.uiuc.edu			Direct For Biological Sciences [0835718] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ERHARD W, 2000, FEBS LETT, V466, P115; EZANA M, 2005, BIOCH BIOPHYSICAL RE, V327, P1131; FLICEK P, 2007, NUCLEIC ACIDS RES; Flynn GE, 2001, NAT REV NEUROSCI, V2, P643, DOI 10.1038/35090015; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Hughes BA, 2008, AM J PHYSIOL-CELL PH, V294, pC423, DOI 10.1152/ajpcell.00393.2007; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; Jackson HA, 2007, PHYSIOL GENOMICS, V29, P231, DOI 10.1152/physiolgenomics.00142.2006; JENSEN LJ, 2007, NUCLEIC ACIDS RES; Jothi R, 2006, BIOINFORMATICS, V22, P779, DOI 10.1093/bioinformatics/btl009; KIM D, 2007, NUCLEIC ACIDS RES, V35, pD61; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUNER P, 2003, TRENDS NEUROSCI, V32, P26; Lee Y, 2002, GENOME RES, V12, P493, DOI 10.1101/gr.212002; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Y, 2006, NEUROSCIENTIST, V12, P199, DOI 10.1177/1073858406287717; Lin ZJ, 2008, J PHYSIOL-LONDON, V586, P5349, DOI 10.1113/jphysiol.2008.159111; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MORENOHAGELSIEB G, 2007, BIOINFORMATICS; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; ROOT MJ, 1993, NEURON, V11, P459, DOI 10.1016/0896-6273(93)90150-P; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Seifert R, 1999, EMBO J, V18, P119, DOI 10.1093/emboj/18.1.119; SEONGHWAN R, 2000, FEBS LETT, V478, P246; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; SPRENGEL R, 2001, GLUTAMATE RECEPTOR C; Sutton KG, 2005, BRIT J PHARMACOL, V146, P702, DOI 10.1038/sj.bjp.0706356; Tasneem A, 2005, GENOME BIOL, V6; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wahl-Schott C, 2005, J BIOL CHEM, V280, P13694, DOI 10.1074/jbc.M413197200; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005	46	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5898	10.1371/journal.pone.0005898	http://dx.doi.org/10.1371/journal.pone.0005898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521530	gold, Green Submitted, Green Published			2022-12-27	WOS:000267029100013
J	Kaddai, V; Gonzalez, T; Keslair, F; Gremeaux, T; Bonnafous, S; Gugenheim, J; Tran, A; Gual, P; Le Marchand-Brustel, Y; Cormont, M				Kaddai, Vincent; Gonzalez, Teresa; Keslair, Frederique; Gremeaux, Thierry; Bonnafous, Stephanie; Gugenheim, Jean; Tran, Albert; Gual, Philippe; Le Marchand-Brustel, Yannick; Cormont, Mireille			Rab4b Is a Small GTPase Involved in the Control of the Glucose Transporter GLUT4 Localization in Adipocyte	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; SMALL G-PROTEINS; 3T3-L1 ADIPOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE; SUBCELLULAR-LOCALIZATION; COMPARTMENT-ABLATION; MOLECULAR-MECHANISMS; REGULATED TRANSPORT; ENDOCYTIC PATHWAY; PLASMA-MEMBRANE	Background: Endosomal small GTPases of the Rab family, among them Rab4a, play an essential role in the control of the glucose transporter GLUT4 trafficking, which is essential for insulin-mediated glucose uptake. We found that adipocytes also expressed Rab4b and we observed a consistent decrease in the expression of Rab4b mRNA in human and mice adipose tissue in obese diabetic states. These results led us to study this poorly characterized Rab member and its potential role in glucose transport. Methodology/Principal Findings: We used 3T3-L1 adipocytes to study by imaging approaches the localization of Rab4b and to determine the consequence of its down regulation on glucose uptake and endogenous GLUT4 location. We found that Rab4b was localized in endosomal structures in preadipocytes whereas in adipocytes it was localized in GLUT4 and in VAMP2-positive compartments, and also in endosomal compartments containing the transferrin receptor (TfR). When Rab4b expression was decreased with specific siRNAs by two fold, an extent similar to its decrease in obese diabetic subjects, we observed a small increase (25%) in basal deoxyglucose uptake and a more sustained increase (40%) in presence of submaximal and maximal insulin concentrations. This increase occurred without any change in GLUT4 and GLUT1 expression levels and in the insulin signaling pathways. Concomitantly, GLUT4 but not TfR amounts were increased at the plasma membrane of basal and insulin-stimulated adipocytes. GLUT4 seemed to be targeted towards its non-endosomal sequestration compartment. Conclusion/Significance: Taken our results together, we conclude that Rab4b is a new important player in the control of GLUT4 trafficking in adipocytes and speculate that difference in its expression in obese diabetic states could act as a compensatory effect to minimize the glucose transport defect in their adipocytes.			Kaddai, V (corresponding author), Ctr Mediterraneen Med Mol, INSERM, Team 7, U895, Nice, France.	cormont@unice.fr	Gual, Philippe/P-9833-2019; Gual, Philippe/M-8787-2017	Gual, Philippe/0000-0001-7393-8356; Gual, Philippe/0000-0001-7393-8356; CORMONT, Mireille/0000-0001-6918-2410; GUGENHEIM, Jean/0000-0002-2624-3014; Gonzalez, Teresa/0000-0001-7558-6833				Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Blot V, 2008, MOL BIOL CELL, V19, P3477, DOI 10.1091/mbc.E08-03-0236; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Cormont M, 1996, MOL CELL BIOL, V16, P6879; Cormont M, 1996, ENDOCRINOLOGY, V137, P3408, DOI 10.1210/en.137.8.3408; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; CORMONT M, 1993, J BIOL CHEM, V268, P19491; Cormont M, 2001, MOL MEMBR BIOL, V18, P213; Cormont M, 2001, BIOCHEM J, V356, P143, DOI 10.1042/0264-6021:3560143; Cormont M, 2001, P NATL ACAD SCI USA, V98, P1637, DOI 10.1073/pnas.031586998; Frei SB, 2006, MOL CELL BIOL, V26, P7299, DOI 10.1128/MCB.02405-05; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; GARVEY WT, 1993, DIABETES, V42, P1773, DOI 10.2337/diabetes.42.12.1773; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Imamura T, 2003, MOL CELL BIOL, V23, P4892, DOI 10.1128/MCB.23.14.4892-4900.2003; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kaddai V, 2008, ACTA PHYSIOL, V192, P75, DOI 10.1111/j.1748-1716.2007.01787.x; KADDAI V, 2008, AM J PHYSIOL-ENDOC M, V192, pE162; Kessler A, 2000, DIABETOLOGIA, V43, P1518, DOI 10.1007/s001250051563; Knight JB, 2000, ENDOCRINOLOGY, V141, P208, DOI 10.1210/en.141.1.208; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Mari M, 2006, J CELL SCI, V119, P1297, DOI 10.1242/jcs.02850; Melvin DR, 1999, BIOCHEMISTRY-US, V38, P1456, DOI 10.1021/bi980988y; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Millar CA, 1997, BIOCHEM SOC T, V25, P974, DOI 10.1042/bst0250974; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Monzo P, 2005, METHOD ENZYMOL, V403, P107, DOI 10.1016/S0076-6879(05)03010-7; Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Smith U, 2002, INT J OBESITY, V26, P897, DOI 10.1038/sj.ijo.0802028; Uhlig M, 2005, MOL CELL ENDOCRINOL, V235, P1, DOI 10.1016/j.mce.2005.02.004; Vollenweider P, 1997, ENDOCRINOLOGY, V138, P4941, DOI 10.1210/en.138.11.4941; Yang J, 1996, BIOCHEM J, V313, P125, DOI 10.1042/bj3130125; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071	45	23	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5257	10.1371/journal.pone.0005257	http://dx.doi.org/10.1371/journal.pone.0005257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19590752	Green Published, Green Submitted, gold			2022-12-27	WOS:000265510800010
J	Luedeling, E; Zhang, MH; Girvetz, EH				Luedeling, Eike; Zhang, Minghua; Girvetz, Evan H.			Climatic Changes Lead to Declining Winter Chill for Fruit and Nut Trees in California during 1950-2099	PLOS ONE			English	Article							TEMPERATURE-DEPENDENCE; DORMANCY BREAKING; MODEL; SIMULATION; IMPACTS; PLANTS	Background: Winter chill is one of the defining characteristics of a location's suitability for the production of many tree crops. We mapped and investigated observed historic and projected future changes in winter chill in California, quantified with two different chilling models (Chilling Hours, Dynamic Model). Methodology/Principal Findings: Based on hourly and daily temperature records, winter chill was modeled for two past temperature scenarios (1950 and 2000), and 18 future scenarios (average conditions during 2041-2060 and 2080-2099 under each of the B1, A1B and A2 IPCC greenhouse gas emissions scenarios, for the CSIRO-MK3, HadCM3 and MIROC climate models). For each scenario, 100 replications of the yearly temperature record were produced, using a stochastic weather generator. We then introduced and mapped a novel climatic statistic, "safe winter chill", the 10% quantile of the resulting chilling distributions. This metric can be interpreted as the amount of chilling that growers can safely expect under each scenario. Winter chill declined substantially for all emissions scenarios, with the area of safe winter chill for many tree species or cultivars decreasing 50-75% by mid-21(st) century, and 90-100% by late century. Conclusions/Significance: Both chilling models consistently projected climatic conditions by the middle to end of the 21(st) century that will no longer support some of the main tree crops currently grown in California, with the Chilling Hours Model projecting greater changes than the Dynamic Model. The tree crop industry in California will likely need to develop agricultural adaptation measures (e. g. low-chill varieties and dormancy-breaking chemicals) to cope with these projected changes. For some crops, production might no longer be possible.			Luedeling, E (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	eluedeling@ucdavis.edu; mhzhang@ucdavis.edu	Girvetz, Evan/B-3533-2010; Luedeling, Eike/I-3269-2019; Luedeling, Eike/A-5662-2012	Luedeling, Eike/0000-0002-7316-3631; Luedeling, Eike/0000-0002-7316-3631				Almorox J, 2005, ENERG CONVERS MANAGE, V46, P1465, DOI 10.1016/j.enconman.2004.07.007; ANCONELLI S, 2002, MICROMETEOROLOGICAL, P1103; Baldocchi D, 2008, CLIMATIC CHANGE, V87, pS153, DOI 10.1007/s10584-007-9367-8; BENNETT J. P., 1949, CALIFORNIA AGRIC, V3, P12; Bennett JP, 1949, CALIF AGR, V4, P12; Chandler WH, 1942, DECIDUOUS ORCHARDS; *CIMIS, 2008, CAL IRR MAN INF SYST; Erez A, 1998, ACTA HORTIC, P507, DOI 10.17660/ActaHortic.1998.465.63; Erez A, 1995, ACTA HORTIC, P81, DOI 10.17660/ActaHortic.1995.395.7; Erez A., 1988, Acta Horticulturae, P76; EREZ A, 1990, ACTA HORTICULTURAE I; FISHMAN S, 1987, J THEOR BIOL, V126, P309, DOI 10.1016/S0022-5193(87)80237-0; FISHMAN S, 1987, J THEOR BIOL, V124, P473, DOI 10.1016/S0022-5193(87)80221-7; *GLCF, 2008, EARTH SCI DAT INT GL; Gradziel TM, 2007, HORTSCIENCE, V42, P1725, DOI 10.21273/HORTSCI.42.7.1725; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Knight T. A., 1801, PHILOS T R SOC LOND, V91, P333; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; LINSLEYNOAKES GC, 1994, SCI HORTIC-AMSTERDAM, V59, P107, DOI 10.1016/0304-4238(94)90077-9; Lobell DB, 2007, CLIMATIC CHANGE, V81, P187, DOI 10.1007/s10584-006-9141-3; Lobell DB, 2006, AGR FOREST METEOROL, V141, P208, DOI 10.1016/j.agrformet.2006.10.006; Lopez G, 2007, CALIF AGR, V61, P31, DOI 10.3733/ca.v061n01p31; LUEDELING E, AGR FOREST MET UNPUB; LUEDELING E, CLIMATIC CH IN PRESS, DOI DOI 10.1007/S10584-10009-19581-10587; LUEDELING E, AGR ECOSYST IN PRESS, DOI DOI 10.1016/J.AGEE.2009.1004.1016; *NCDC, 2008, DAT NAT CLIM DAT CTR; Oukabli Ahmed, 2007, Biotechnologie Agronomie Societe et Environnement, V11, P133; Perez FJ, 2008, CHIL J AGR RES, V68, P198, DOI 10.4067/S0718-58392008000200010; Purkey DR, 2008, CLIMATIC CHANGE, V87, pS109, DOI 10.1007/s10584-007-9375-8; Ruiz D, 2007, ENVIRON EXP BOT, V61, P254, DOI 10.1016/j.envexpbot.2007.06.008; Salvador F. R. de, 2003, Informatore Agrario, V59, P63; SAMISH RM, 1954, ANNU REV PLANT PHYS, V5, P183, DOI 10.1146/annurev.pp.05.060154.001151; Saure M. C., 1985, Horticultural Reviews, V7, P239, DOI 10.1002/9781118060735.ch6; Semenov MA, 2008, CLIM RES, V35, P203, DOI 10.3354/cr00731; Sharma RR, 2006, SCI HORTIC-AMSTERDAM, V109, P118, DOI 10.1016/j.scienta.2006.03.010; Spencer J.W., 1971, SEARCH, V2, P172; Vegis A., 1961, HDB PFLANZENPHYSIOLO, V16, P168; WEINBERGER JH, 1950, P AM SOC HORTIC SCI, V56, P122; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wold S., 1995, CHEMOMETRIC METHODS, P195	40	160	165	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6166	10.1371/journal.pone.0006166	http://dx.doi.org/10.1371/journal.pone.0006166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19606220	Green Submitted, gold, Green Published			2022-12-27	WOS:000268260100001
J	Steinke, D; Zemlak, TS; Hebert, PDN				Steinke, Dirk; Zemlak, Tyler S.; Hebert, Paul D. N.			Barcoding Nemo: DNA-Based Identifications for the Ornamental Fish Trade	PLOS ONE			English	Article							GENETIC DETECTION; BIASED DISPERSAL; REEF; SOFTWARE	Background: Trade in ornamental fishes represents, by far, the largest route for the importation of exotic vertebrates. There is growing pressure to regulate this trade with the goal of ensuring that species are sustainably harvested and that their point of origin is accurately reported. One important element of such regulation involves easy access to specimen identifications, a task that is currently difficult for all but specialists because of the large number of species involved. The present study represents an important first step in making identifications more accessible by assembling a DNA barcode reference sequence library for nearly half of the ornamental fish species imported into North America. Methodology/Principal Findings: Analysis of the cytochrome c oxidase subunit I (COI) gene from 391 species from 8 coral reef locations revealed that 98% of these species exhibit distinct barcode clusters, allowing their unambiguous identification. Most species showed little intra-specific variation (adjusted mean = 0.21%), but nine species included two or three lineages showing much more divergence (2.19-6.52%) and likely represent overlooked species complexes. By contrast, three genera contained a species pair or triad that lacked barcode divergence, cases that may reflect hybridization, young taxa or taxonomic over-splitting. Conclusions/Significance: Although incomplete, this barcode library already provides a new species identification tool for the ornamental fish industry, opening a realm of applications linked to collection practices, regulatory control and conservation.			Steinke, D (corresponding author), Univ Guelph, Biodivers Inst Ontario, Canadian Ctr DNA Barcoding, Guelph, ON N1G 2W1, Canada.	dsteinke@uoguelph.ca	赵, 鹏/B-8401-2009; Steinke, Dirk/D-4700-2009; Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700; Steinke, Dirk/0000-0002-8992-575X				Allen Gerald R., 1991, P1; BARLOW GW, 1974, AM ZOOL, V14, P9; Bekkevold D, 2004, MOL ECOL, V13, P1707, DOI 10.1111/j.1365-294X.2004.02156.x; Berrebi P, 2005, ESTUAR COAST SHELF S, V65, P708, DOI 10.1016/j.ecss.2005.07.008; Bleeker P., 1857, ACTA SOC REGIAE SCI, V2, P1; Cano JM, 2008, MOL ECOL, V17, P3234, DOI 10.1111/j.1365-294X.2008.03837.x; EDWARDS AJ, 1992, ENVIRON CONSERV, V19, P61, DOI 10.1017/S0376892900030265; FAO, 2008, FAO YB; Fessler JL, 2007, MOL PHYLOGENET EVOL, V45, P50, DOI 10.1016/j.ympev.2007.05.018; FOWLER HW, 1946, AUS P ACAD NATURAL S, V98, P123; FROESE R, 2006, WORLD WIDE WEB ELECT; Guiasu RC, 1998, B MAR SCI, V63, P277; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; HINGCO TG, 1991, ICLARM C P, V22, P249; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hutchings JA, 2002, P ROY SOC B-BIOL SCI, V269, P2487, DOI 10.1098/rspb.2002.2176; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jordan DS, 1914, MEM CARNEGIE MUS, V6, P205, DOI DOI 10.5962/BHL.TITLE.43189; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KUITER RH, 1998, J ICHTHYOLOGY AQUATI, V3, P85; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lecchini D, 2006, FISHERIES SCI, V72, P40, DOI 10.1111/j.1444-2906.2006.01114.x; Lima D, 2005, J EXP MAR BIOL ECOL, V320, P211, DOI 10.1016/j.jembe.2004.12.031; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Randall JE, 2001, RAFFLES B ZOOL, V49, P19; Randall John E., 2000, Aqua (Graffignana), V4, P1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rock J, 2008, ANTARCT SCI, V20, P253, DOI 10.1017/S0954102008001120; Steinke D, 2005, PHILOS T R SOC B, V360, P1975, DOI 10.1098/rstb.2005.1729; STEINKE D, 2009, MARINE BIOL IN PRESS; Steinke D, 2009, ICHTHYOL RES, V56, P210, DOI 10.1007/s10228-008-0068-8; Timm J, 2008, MOL PHYLOGENET EVOL, V49, P268, DOI 10.1016/j.ympev.2008.04.024; Victor Benjamin C., 2008, Journal of the Ocean Science Foundation, V1, P1; Victor Benjamin C., 2007, Zootaxa, V1526, P51; Ward R.D., 2008, J FISH BIOL, V73, P1; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, AQUAT BIOL, V3, P71, DOI 10.3354/ab00068; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	40	138	150	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6300	10.1371/journal.pone.0006300	http://dx.doi.org/10.1371/journal.pone.0006300			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621079	Green Submitted, Green Published, gold			2022-12-27	WOS:000268147200007
J	Padron, B; Traveset, A; Biedenweg, T; Diaz, D; Nogales, M; Olesen, JM				Padron, Benigno; Traveset, Anna; Biedenweg, Tine; Diaz, Diana; Nogales, Manuel; Olesen, Jens M.			Impact of Alien Plant Invaders on Pollination Networks in Two Archipelagos	PLOS ONE			English	Article							INVASIONAL MELTDOWN; POLLEN TRANSFER; NESTEDNESS; OPUNTIA	Mutualistic interactions between plants and animals promote integration of invasive species into native communities. In turn, the integrated invaders may alter existing patterns of mutualistic interactions. Here we simultaneously map in detail effects of invaders on parameters describing the topology of both plant-pollinator (bi-modal) and plant-plant (uni-modal) networks. We focus on the invader Opuntia spp., a cosmopolitan alien cactus. We compare two island systems: Tenerife (Canary Islands) and Menorca (Balearic Islands). Opuntia was found to modify the number of links between plants and pollinators, and was integrated into the new communities via the most generalist pollinators, but did not affect the general network pattern. The plant uni-modal networks showed disassortative linkage, i.e. species with many links tended to connect to species with few links. Thus, by linking to generalist natives, Opuntia remained peripheral to network topology, and this is probably why native network properties were not affected at least in one of the islands. We conclude that the network analytical approach is indeed a valuable tool to evaluate the effect of invaders on native communities.			Padron, B (corresponding author), Inst Mediterrani Estudis Avancats CSIC UIB, Mallorca, Balearic Isl, Spain.	beni.padron@uib.es	Nogales, Manuel/I-9831-2014; Traveset, Anna V/D-7802-2011; Olesen, Jens M/A-3011-2009	Nogales, Manuel/0000-0002-5327-3104; Olesen, Jens M/0000-0003-1998-1083; Olesen, Jes/0000-0002-6712-2702				Abe T, 2006, ANN BOT-LONDON, V98, P317, DOI 10.1093/aob/mcl117; Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; ARMBRUSTER WS, 1984, ANN MO BOT GARD, V71, P1, DOI 10.2307/2399053; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; BARBERA G, 1992, ECON BOT, V46, P10, DOI 10.1007/BF02985249; Bartomeus I, 2008, OECOLOGIA, V155, P761, DOI 10.1007/s00442-007-0946-1; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bell JM, 2005, ECOLOGY, V86, P762, DOI 10.1890/04-0694; Bourgeois K, 2005, ECOSCIENCE, V12, P248, DOI 10.2980/i1195-6860-12-2-248.1; Brualdi RA, 1999, OECOLOGIA, V119, P256, DOI 10.1007/s004420050784; Carvalheiro LG, 2008, J APPL ECOL, V45, P1419, DOI 10.1111/j.1365-2664.2008.01518.x; Cox PA, 2000, CONSERV BIOL, V14, P1237, DOI 10.1046/j.1523-1739.2000.00017.x; DUPONT YL, 2009, OIKOS IN PRESS; Feldman TS, 2004, OIKOS, V105, P197, DOI 10.1111/j.0030-1299.2004.12845.x; Foster JT, 2007, CONSERV BIOL, V21, P1248, DOI 10.1111/j.1523-1739.2007.00781.x; FRAGA P, 2004, CATALEG FLORA VASCUL, P368; Gimeno I, 2002, ACTA OECOL, V23, P239, DOI 10.1016/S1146-609X(02)01143-8; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; IZQUIERDO I, 2004, LISTA ESPECIES SILVE; Jakobsson A, 2008, BIOL CONSERV, V141, P136, DOI 10.1016/j.biocon.2007.09.005; Jordano P, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P173; Kenta T, 2007, BIOL CONSERV, V134, P298, DOI 10.1016/j.biocon.2006.07.023; LAVERTY TM, 1992, OECOLOGIA, V89, P502, DOI 10.1007/BF00317156; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; Melian CJ, 2002, ECOL LETT, V5, P705, DOI 10.1046/j.1461-0248.2002.00386.x; Memmott J, 2002, P ROY SOC B-BIOL SCI, V269, P2395, DOI 10.1098/rspb.2002.2174; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; Morales CL, 2006, J ECOL, V94, P171, DOI 10.1111/j.1365-2745.2005.01069.x; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NOOY WD, 2005, EXPLORATORY SOCIAL N; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2006, J THEOR BIOL, V240, P270, DOI 10.1016/j.jtbi.2005.09.014; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Reyes-Aguero JA, 2006, J ARID ENVIRON, V64, P549, DOI 10.1016/j.jaridenv.2005.06.018; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Valido A, 2003, J HERPETOL, V37, P741, DOI 10.1670/15-02AN; Walter TR, 2002, INT J EARTH SCI, V91, P615, DOI 10.1007/s00531-001-0245-8	45	88	92	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6275	10.1371/journal.pone.0006275	http://dx.doi.org/10.1371/journal.pone.0006275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609437	gold, Green Submitted, Green Published			2022-12-27	WOS:000268119500010
J	Deniaud, A; Goulielmakis, A; Coves, J; Pebay-Peyroula, E				Deniaud, Aurelien; Goulielmakis, Aurelie; Coves, Jacques; Pebay-Peyroula, Eva			Differences between CusA and AcrB Crystallisation Highlighted by Protein Flexibility	PLOS ONE			English	Article								Background: Until very recently, AcrB was the only Resistance Nodulation and cell Division transporter for which the structure has been elucidated. Towards a general understanding of this protein family, CusA and AcrB were compared. Methodology/Principal Findings: In dodecylmaltoside, AcrB crystallised in many different conditions, while CusA does not. This could be due to the difference in dynamic between these proteins as judged from limited proteolysis assays. Addition of various compounds, in particular heavy metal cations, stabilises CusA. Conclusion/Significance: This approach could constitute a first step towards CusA crystallisation.			Deniaud, A (corresponding author), Univ Grenoble 1, CNRS, UMR5075, Inst Biol Struct Jean Pierre Ebel,CEA, Grenoble, France.	eva.pebay-peyroula@ibs.fr	Deniaud, Aurelien/L-5093-2019					Breyton C, 2004, FEBS LETT, V564, P312, DOI 10.1016/S0014-5793(04)00227-3; Chabaud E, 1998, BIOCHIMIE, V80, P515, DOI 10.1016/S0300-9084(00)80017-6; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Goldberg M, 1999, J BIOL CHEM, V274, P26065, DOI 10.1074/jbc.274.37.26065; Kiley P, 2005, PLOS BIOL, V3, P1180, DOI 10.1371/journal.pbio.0030230; Lebaupain F, 2006, LANGMUIR, V22, P8881, DOI 10.1021/la061083l; Lemieux MJ, 2003, PROTEIN SCI, V12, P2748, DOI 10.1110/ps.03276603; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; Murakami S, 2003, CURR OPIN STRUC BIOL, V13, P443, DOI 10.1016/S0959-440X(03)00109-X; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Nieves-Alicea R, 1998, BBA-PROTEIN STRUCT M, V1388, P500, DOI 10.1016/S0167-4838(98)00210-6; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Pocanschi CL, 2006, BIOCHEMISTRY-US, V45, P13954, DOI 10.1021/bi0616706; Popot JL, 2003, CELL MOL LIFE SCI, V60, P1559, DOI 10.1007/s00018-003-3169-6; Rich RL, 2000, CURR OPIN BIOTECH, V11, P54, DOI 10.1016/S0958-1669(99)00054-3; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Screpanti E, 2006, J MOL BIOL, V362, P192, DOI 10.1016/j.jmb.2006.07.019; SEEGER MA, 2009, BIOCHEMISTRY; Sendra V, 2006, BIOCHEMISTRY-US, V45, P5557, DOI 10.1021/bi060328q; Stroebel D, 2007, BBA-BIOMEMBRANES, V1768, P1567, DOI 10.1016/j.bbamem.2007.03.008; Su CC, 2006, J BACTERIOL, V188, P7290, DOI 10.1128/JB.00684-06; Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599; von Maltzahn G, 2003, LANGMUIR, V19, P4332, DOI 10.1021/la026526+; Yeh JI, 2005, BIOCHEMISTRY-US, V44, P16912, DOI 10.1021/bi051357o; Zhao XJ, 2006, P NATL ACAD SCI USA, V103, P17707, DOI 10.1073/pnas.0607167103	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6214	10.1371/journal.pone.0006214	http://dx.doi.org/10.1371/journal.pone.0006214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593437	gold, Green Published, Green Submitted			2022-12-27	WOS:000268035300020
J	Riveline, D				Riveline, Daniel			Explaining Lengths and Shapes of Yeast by Scaling Arguments	PLOS ONE			English	Article								Lengths and shapes are approached in different ways in different fields: they serve as a read-out for classifying genes or proteins in cell biology whereas they result from scaling arguments in condensed matter physics. Here, we propose a combined approach with examples illustrated for the fission yeast Schizosaccharomyces pombe.			Riveline, D (corresponding author), Rockefeller Univ, Lab Yeast Genet & Cell Biol, 1230 York Ave, New York, NY 10021 USA.	daniel.riveline@ujf-grenoble.fr	Riveline, Daniel/GXV-6609-2022					Almagro S, 2003, EUROPHYS LETT, V63, P908, DOI 10.1209/epl/i2003-00609-3; [Anonymous], 2005, GOUTTES BULLES PERLE; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Boudaoud A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.018104; Castagnetti S, 2007, J CELL SCI, V120, P2205, DOI 10.1242/jcs.03464; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; Chang F, 2003, NAT CELL BIOL, V5, P294, DOI 10.1038/ncb0403-294; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; D'Arcy Thompson W, 1917, GROWTH FORM; Das M, 2007, MOL BIOL CELL, V18, P2090, DOI 10.1091/mbc.E06-09-0883; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006; Ge WZ, 2005, MOL BIOL CELL, V16, P4124, DOI 10.1091/mbc.e04-11-0976; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Konomi M, 2003, YEAST, V20, P427, DOI 10.1002/yea.974; KURACHI M, 1995, CELL MOTIL CYTOSKEL, V30, P221, DOI 10.1002/cm.970300306; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; MITCHISON JM, 1985, J CELL SCI, V75, P357; MONEY NP, 1992, P NATL ACAD SCI USA, V89, P4245, DOI 10.1073/pnas.89.10.4245; Moseley JB, 2009, CURR OPIN CELL BIOL, V21, P82, DOI 10.1016/j.ceb.2008.12.005; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prost J, 2007, BIOPHYS J, V93, P1124, DOI 10.1529/biophysj.106.098038; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sato M, 1996, CELL STRUCT FUNCT, V21, P167, DOI 10.1247/csf.21.167; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; Sens P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031918; Smith AE, 2000, P NATL ACAD SCI USA, V97, P9871, DOI 10.1073/pnas.97.18.9871; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Takagi T, 2003, J ELECTRON MICROSC, V52, P161, DOI 10.1093/jmicro/52.2.161; Terenna CR, 2008, CURR BIOL, V18, P1748, DOI 10.1016/j.cub.2008.09.047; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529	41	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6205	10.1371/journal.pone.0006205	http://dx.doi.org/10.1371/journal.pone.0006205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593452	gold, Green Published, Green Submitted			2022-12-27	WOS:000268035300015
J	Feng, JN; Sun, GH; Yan, J; Noltner, K; Li, WY; Buzin, CH; Longmate, J; Heston, LL; Rossi, J; Sommer, SS				Feng, Jinong; Sun, Guihua; Yan, Jin; Noltner, Katie; Li, Wenyan; Buzin, Carolyn H.; Longmate, Jeff; Heston, Leonard L.; Rossi, John; Sommer, Steve S.			Evidence for X-Chromosomal Schizophrenia Associated with microRNA Alterations	PLOS ONE			English	Article								Background: Schizophrenia is a severe disabling brain disease affecting about 1% of the population. Individual microRNAs (miRNAs) affect moderate downregulation of gene expression. In addition, components required for miRNA processing and/or function have also been implicated in X-linked mental retardation, neurological and neoplastic diseases, pointing to the wide ranging involvement of miRNAs in disease. Methods and Findings: To explore the role of miRNAs in schizophrenia, 59 microRNA genes on the X-chromosome were amplified and sequenced in males with (193) and without (191) schizophrenia spectrum disorders to test the hypothesis that ultra-rare mutations in microRNA collectively contribute to the risk of schizophrenia. Here we provide the first association of microRNA gene dysfunction with schizophrenia. Eight ultra-rare variants in the precursor or mature miRNA were identified in eight distinct miRNA genes in 4% of analyzed males with schizophrenia. One ultra-rare variant was identified in a control sample (with a history of depression) (8/193 versus 1/191, p = 0.02 by one-sided Fisher's exact test, odds ratio = 8.2). These variants were not found in an additional 7,197 control X-chromosomes. Conclusions: Functional analyses of ectopically expressed copies of the variant miRNA precursors demonstrate loss of function, gain of function or altered expression levels. While confirmation is required, this study suggests that microRNA mutations can contribute to schizophrenia.			Feng, JN (corresponding author), City Hope Natl Med Ctr, Div Mol Genet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	ssommer@medomics.com		Longmate, Jeffrey/0000-0002-0869-7928	NHLBI NIH HHS [HL07470] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007470] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BOTTEMA CDK, 1993, MUTAT RES, V288, P93, DOI 10.1016/0027-5107(93)90211-W; Chan SP, 2007, DEV CELL, V13, P605, DOI 10.1016/j.devcel.2007.10.010; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Jablensky A, 2000, EUR ARCH PSY CLIN N, V250, P274, DOI 10.1007/s004060070002; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Keen-Kim D, 2006, HUM MOL GENET, V15, P3324, DOI 10.1093/hmg/ddl408; Klein ME, 2005, CURR OPIN NEUROBIOL, V15, P507, DOI 10.1016/j.conb.2005.08.011; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Scharf JM, 2008, NEUROLOGY, V70, P1495, DOI 10.1212/01.wnl.0000296833.25484.bb; SOBELL JL, 1993, AM J MED GENET, V48, P28, DOI 10.1002/ajmg.1320480108; SOMMER SS, 1989, MAYO CLIN PROC, V64, P1361, DOI 10.1016/S0025-6196(12)65378-6; SOMMER SS, 1992, BIOTECHNIQUES, V12, P82; Song WJ, 2008, BIOCHEM BIOPH RES CO, V367, P700, DOI 10.1016/j.bbrc.2007.12.117; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Sun GH, 2007, METHOD ENZYMOL, V427, P123, DOI 10.1016/S0076-6879(07)27007-7; Vogel F., 1997, HUMAN GENETICS PROBL; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Ying SY, 2004, GENE, V342, P25, DOI 10.1016/j.gene.2004.07.025	39	84	90	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6121	10.1371/journal.pone.0006121	http://dx.doi.org/10.1371/journal.pone.0006121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568434	Green Published, Green Submitted, gold			2022-12-27	WOS:000267572200019
J	Vallier, L; Touboul, T; Chng, ZZ; Brimpari, M; Hannan, N; Millan, E; Smithers, LE; Trotter, M; Rugg-Gunn, P; Weber, A; Pedersen, RA				Vallier, Ludovic; Touboul, Thomas; Chng, Zhenzhi; Brimpari, Minodora; Hannan, Nicholas; Millan, Enrique; Smithers, Lucy E.; Trotter, Matthew; Rugg-Gunn, Peter; Weber, Anne; Pedersen, Roger A.			Early Cell Fate Decisions of Human Embryonic Stem Cells and Mouse Epiblast Stem Cells Are Controlled by the Same Signalling Pathways	PLOS ONE			English	Article							DEFINITIVE ENDODERM; VISCERAL ENDODERM; NEURAL INDUCTION; SELF-RENEWAL; DIFFERENTIATION; RECEPTOR; GASTRULATION; INHIBITOR; ORGANIZER; MESODERM	Human embryonic stem cells have unique value for regenerative medicine, as they are capable of differentiating into a broad variety of cell types. Therefore, defining the signalling pathways that control early cell fate decisions of pluripotent stem cells represents a major task. Moreover, modelling the early steps of embryonic development in vitro may provide the best approach to produce cell types with native properties. Here, we analysed the function of key developmental growth factors such as Activin, FGF and BMP in the control of early cell fate decisions of human pluripotent stem cells. This analysis resulted in the development and validation of chemically defined culture conditions for achieving specification of human embryonic stem cells into neuroectoderm, mesendoderm and into extra-embryonic tissues. Importantly, these defined culture conditions are devoid of factors that could obscure analysis of developmental mechanisms or render the resulting tissues incompatible with future clinical applications. Importantly, the growth factor roles defined using these culture conditions similarly drove differentiation of mouse epiblast stem cells derived from post implantation embryos, thereby reinforcing the hypothesis that epiblast stem cells share a common embryonic identity with human pluripotent stem cells. Therefore the defined growth factor conditions described here represent an essential step toward the production of mature cell types from pluripotent stem cells in conditions fully compatible with clinical use ant also provide a general approach for modelling the early steps of mammalian embryonic development.			Vallier, L (corresponding author), Univ Cambridge, Dept Surg & Lab Regenerat Med, Cambridge, England.	lv225@cam.ac.uk	Hannan, Nicholas/A-8731-2013; Hannan, Nicholas/ABG-6497-2020; vallier, ludovic/C-6368-2011	Vallier, Ludovic/0000-0002-3848-2602; Hannan, Nicholas/0000-0002-9843-1559; Trotter, Matthew/0000-0003-3702-915X; Rugg-Gunn, Peter/0000-0002-9601-5949	Medical Research Council [G0800784, G0600275, G0701448, G0300723] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0800784, G0600275, G0300723, G0701448] Funding Source: UKRI; Medical Research Council [G0800784B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; BRONS IGM, 2007, NATURE IN PRESS; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Chang CB, 2007, DEVELOPMENT, V134, P3861, DOI 10.1242/dev.007179; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Gu ZY, 1999, DEVELOPMENT, V126, P2551; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JOHANSSON MW, 1995, TECHNIQUES FISH IMMU, V4, P141; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Robb L, 2004, SEMIN CELL DEV BIOL, V15, P543, DOI 10.1016/j.semcdb.2004.04.005; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takaoka K, 2006, DEV CELL, V10, P451, DOI 10.1016/j.devcel.2006.02.017; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	37	192	206	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6082	10.1371/journal.pone.0006082	http://dx.doi.org/10.1371/journal.pone.0006082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564924	gold, Green Submitted, Green Published			2022-12-27	WOS:000267515700004
J	Milenkovic, T; Filippis, I; Lappe, M; Przulj, N				Milenkovic, Tijana; Filippis, Ioannis; Lappe, Michael; Przulj, Natasa			Optimized Null Model for Protein Structure Networks	PLOS ONE			English	Article							RESIDUES; THERMOSTABILITY; PREDICTION; STABILITY; ALGORITHM; TOPOLOGY; PACKING	Much attention has recently been given to the statistical significance of topological features observed in biological networks. Here, we consider residue interaction graphs (RIGs) as network representations of protein structures with residues as nodes and inter-residue interactions as edges. Degree-preserving randomized models have been widely used for this purpose in biomolecular networks. However, such a single summary statistic of a network may not be detailed enough to capture the complex topological characteristics of protein structures and their network counterparts. Here, we investigate a variety of topological properties of RIGs to find a well fitting network null model for them. The RIGs are derived from a structurally diverse protein data set at various distance cut-offs and for different groups of interacting atoms. We compare the network structure of RIGs to several random graph models. We show that 3-dimensional geometric random graphs, that model spatial relationships between objects, provide the best fit to RIGs. We investigate the relationship between the strength of the fit and various protein structural features. We show that the fit depends on protein size, structural class, and thermostability, but not on quaternary structure. We apply our model to the identification of significantly over-represented structural building blocks, i.e., network motifs, in protein structure networks. As expected, choosing geometric graphs as a null model results in the most specific identification of motifs. Our geometric random graph model may facilitate further graph-based studies of protein conformation space and have important implications for protein structure comparison and prediction. The choice of a well-fitting null model is crucial for finding structural motifs that play an important role in protein folding, stability and function. To our knowledge, this is the first study that addresses the challenge of finding an optimized null model for RIGs, by comparing various RIG definitions against a series of network models.			Milenkovic, T (corresponding author), Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92717 USA.	natasha@ics.uci.edu	Filippis, Ioannis/D-7687-2013; Przulj, Natasa/AAO-2850-2020	Przulj, Natasa/0000-0002-1290-853X				Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Artzy-Randrup Yael, 2004, Science, V305, P1107; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Bagler G, 2007, BIOINFORMATICS, V23, P1760, DOI 10.1093/bioinformatics/btm257; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bartoli L, 2007, PHYS BIOL, V4, pL1, DOI 10.1088/1478-3975/4/4/L01; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; COOK SA, 1971, STOC 71, P151, DOI DOI 10.1145/800157.805047; del Sol A, 2005, BIOINFORMATICS, V21, P1311, DOI 10.1093/bioinformatics/bti167; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Fleming PJ, 2000, J MOL BIOL, V299, P487, DOI 10.1006/jmbi.2000.3750; Galzitskaya OV, 2008, PROTEINS, V70, P329, DOI 10.1002/prot.21619; Glyakina AV, 2007, BIOINFORMATICS, V23, P2231, DOI 10.1093/bioinformatics/btm345; GODZIK A, 1994, COMPUT APPL BIOSCI, V10, P587; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; HERINGA J, 1995, PROTEIN ENG, V8, P21, DOI 10.1093/protein/8.1.21; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kamagata K, 2006, J MOL BIOL, V357, P1647, DOI 10.1016/j.jmb.2006.01.072; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mehlhorn K., 1999, LEDA PLATFORM COMBIN; Milenkovic T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-70; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Paszkiewicz KH, 2006, BIOINFORMATICS, V22, P1353, DOI 10.1093/bioinformatics/btl095; PENROSE M, 2003, GEOMETRIC RANDOM GRA; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Przulj N, 2006, J R SOC INTERFACE, V3, P711, DOI 10.1098/rsif.2006.0147; Raghunathan G, 1997, PROTEIN SCI, V6, P2072; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065; Soyer A, 2000, PHYS REV LETT, V85, P3532, DOI 10.1103/PhysRevLett.85.3532; Thibert B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-213; Vassura M, 2007, LECT NOTES ARTIF INT, V4578, P497; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	46	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e5967	10.1371/journal.pone.0005967	http://dx.doi.org/10.1371/journal.pone.0005967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557139	Green Published, Green Submitted, gold			2022-12-27	WOS:000267424600001
J	Uronis, JM; Muhlbauer, M; Herfarth, HH; Rubinas, TC; Jones, GS; Jobin, C				Uronis, Joshua M.; Muehlbauer, Marcus; Herfarth, Hans H.; Rubinas, Tara C.; Jones, Gieira S.; Jobin, Christian			Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility	PLOS ONE			English	Article								It is well established that the intestinal microbiota plays a key role in the pathogenesis of Crohn's disease (CD) and ulcerative colitis (UC) collectively referred to as inflammatory bowel disease (IBD). Epidemiological studies have provided strong evidence that IBD patients bear increased risk for the development of colorectal cancer (CRC). However, the impact of the microbiota on the development of colitis-associated cancer (CAC) remains largely unknown. In this study, we established a new model of CAC using azoxymethane (AOM)-exposed, conventionalized-Il10(-/)-mice and have explored the contribution of the host intestinal microbiota and MyD88 signaling to the development of CAC. We show that 8/13 (62%) of AOM-Il10(-/-) mice developed colon tumors compared to only 3/15 (20%) of AOM-wild-type (WT) mice. Conventionalized AOM-Il10(-/-) mice developed spontaneous colitis and colorectal carcinomas while AOM-WT mice were colitis-free and developed only rare adenomas. Importantly, tumor multiplicity directly correlated with the presence of colitis. Il10(-/)-mice mono-associated with the mildly colitogenic bacterium Bacteroides vulgatus displayed significantly reduced colitis and colorectal tumor multiplicity compared to Il10(-/)-mice. Germ-free AOM-treated Il10 2/2 mice showed normal colon histology and were devoid of tumors. Il10(-/-); Myd88(-/)-mice treated with AOM displayed reduced expression of Il12p40 and Tnfa mRNA and showed no signs of tumor development. We present the first direct demonstration that manipulation of the intestinal microbiota alters the development of CAC. The TLR/MyD88 pathway is essential for microbiota-induced development of CAC. Unlike findings obtained using the AOM/DSS model, we demonstrate that the severity of chronic colitis directly correlates to colorectal tumor development and that bacterial-induced inflammation drives progression from adenoma to invasive carcinoma.			Uronis, JM (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	job@med.unc.edu	Herfarth, Hans/K-7547-2019	Jones, Gieira/0000-0001-9537-6470	NCRR NIH HHS [P40 RR018603] Funding Source: Medline; NIDDK NIH HHS [R01 DK073338, T32 DK007737, R01 DK 47700, R01 DK 73338, P30 DK034987, R01 DK047700, 5 T32 DK007737] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047700, R01DK073338, P30DK034987, T32DK007737] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Chichlowski M, 2009, COMPARATIVE MED, V59, P10; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dave SH, 2007, J IMMUNOL, V179, P7852, DOI 10.4049/jimmunol.179.11.7852; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001; Haller D, 2004, J PEDIATR GASTR NUTR, V38, P123, DOI 10.1097/00005176-200402000-00004; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Jess T, 2006, GASTROENTEROLOGY, V130, P1039, DOI 10.1053/j.gastro.2005.12.037; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; Kraehenbuhl JP, 2004, SCIENCE, V303, P1624, DOI 10.1126/science.1096222; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rubin DT, 2008, INFLAMM BOWEL DIS, V14, P265, DOI 10.1002/ibd.20297; Rutter M, 2004, GASTROENTEROLOGY, V126, P451, DOI 10.1053/j.gastro.2003.11.010; Rutter MD, 2006, GASTROENTEROLOGY, V130, P1030, DOI 10.1053/j.gastro.2005.12.035; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	30	318	344	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6026	10.1371/journal.pone.0006026	http://dx.doi.org/10.1371/journal.pone.0006026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551144	Green Published, Green Submitted, gold			2022-12-27	WOS:000267356500010
J	Roselli, F; Hutzler, P; Wegerich, Y; Livrea, P; Almeida, OFX				Roselli, Francesco; Hutzler, Peter; Wegerich, Yvonne; Livrea, Paolo; Almeida, Osborne F. X.			Disassembly of Shank and Homer Synaptic Clusters Is Driven by Soluble beta-Amyloid(1-40) through Divergent NMDAR-Dependent Signalling Pathways	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; POSTSYNAPTIC DENSITY PROTEINS; LONG-TERM POTENTIATION; A-BETA; NATURAL OLIGOMERS; PSD-95; KINASE; DEGRADATION; ACTIVATION; DOMAIN	Disruption of the postsynaptic density (PSD), a network of scaffold proteins located in dendritic spines, is thought to be responsible for synaptic dysfunction and loss in early-stage Alzheimer's disease (AD). Extending our previous demonstration that derangement of the PSD by soluble amyloid-beta (A beta) involves proteasomal degradation of PSD-95, a protein important for ionotropic glutamate receptor trafficking, we now show that A beta also disrupts two other scaffold proteins, Homer1b and Shank1, that couple PSD-95 with ionotropic and metabotropic glutamate receptors. Treatment of fronto-cortical neurons with soluble A beta results in rapid (within 1 h) and significant thinning of the PSD, decreased synaptic levels of Homer1b and Shank1, and reduced synaptic mGluR1 levels. We show that de novo protein synthesis is required for the declustering effects of A beta on Homer1b (but not Shank1) and that, in contrast to PSD-95, A beta-induced Homer1b and Shank1 cluster disassembly does not depend on proteasome activity. The regulation of Homer1b and Shank1 by A beta diverges in two other respects: i) whereas the activity of both NMDAR and VDCC is required for A beta-induced declustering of Homer1b, A beta-induced declustering of Shank1 only requires NMDAR activity; and ii) whereas the effects of A beta on Homer1b involve engagement of the PI-3K pathway and calcineurin phosphatase (PP2B) activity, those on Shank1 involve activation of the ERK pathway. In summary, soluble Ab recruits discrete signalling pathways to rapidly reduce			Roselli, F (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	fraroselli@mpipsykl.mpg.de; osa@mpipsykl.mpg.de	roselli, francesco/G-6701-2013; Almeida, Osborne F.X. F/E-8402-2010; roselli, francesco/O-8847-2019	Almeida, Osborne F.X. F/0000-0001-7331-6928; roselli, francesco/0000-0001-9935-6899; Livrea, Paolo/0000-0001-7410-3860				Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Baxter AW, 2006, J NEUROSCI, V26, P5456, DOI 10.1523/JNEUROSCI.4101-05.2006; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Ciruela F, 2000, MOL CELL NEUROSCI, V15, P36, DOI 10.1006/mcne.1999.0808; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; Das SS, 2006, J NEUROSCI, V26, P8115, DOI 10.1523/JNEUROSCI.1015-06.2006; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kammermeier PJ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-1; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Okabe S, 2001, J NEUROSCI, V21, P9561, DOI 10.1523/JNEUROSCI.21-24-09561.2001; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Rasband W., 2006, IMAGEJ; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Takagi N, 2003, J NEUROCHEM, V84, P67, DOI 10.1046/j.1471-4159.2003.01500.x; Thomas GM, 2005, P NATL ACAD SCI USA, V102, P15006, DOI 10.1073/pnas.0507476102; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Tyszkiewicz JP, 2005, J NEUROPHYSIOL, V93, P3102, DOI 10.1152/jn.00939.2004; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Van Keuren-Jensen K, 2006, J NEUROSCI, V26, P7575, DOI 10.1523/JNEUROSCI.5083-05.2006; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Waxman EA, 2005, J BIOL CHEM, V280, P29322, DOI 10.1074/jbc.M502080200; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005	58	64	65	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6011	10.1371/journal.pone.0006011	http://dx.doi.org/10.1371/journal.pone.0006011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547699	Green Published, Green Submitted, gold			2022-12-27	WOS:000267347900010
J	Strauss, L; Czystowska, M; Szajnik, M; Mandapathil, M; Whiteside, TL				Strauss, Laura; Czystowska, Malgorzata; Szajnik, Marta; Mandapathil, Magis; Whiteside, Theresa L.			Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; CORD BLOOD; CD28 COSTIMULATION; TYPE-1 CELLS; EXPANSION; IL-2; FOXP3; INTERLEUKIN-10; MAINTENANCE; SUPPRESSION	Background: The immunosuppressive drug rapamycin (RAPA) promotes the expansion of CD4(+) CD25(high)Foxp3(+) regulatory T cells via mechanisms that remain unknown. Here, we studied expansion, IL-2R-gamma chain signaling, survival pathways and resistance to apoptosis in human Treg responding to RAPA. Methodology/Principal Findings: CD4(+)CD25(+) and CD4(+)CD25(neg) T cells were isolated from PBMC of normal controls (n = 21) using AutoMACS. These T cell subsets were cultured in the presence of anti-CD3/CD28 antibodies and 1000 IU/mL IL-2 for 3 to 6 weeks. RAPA (1-100 nM) was added to half of the cultures. After harvest, the cell phenotype, signaling via the PI3K/mTOR and STAT pathways, expression of survival proteins and Annexin V binding were determined and compared to values obtained with freshly-separated CD4(+)CD25(high) and CD4(+)CD25(neg) T cells. Suppressor function was tested in co-cultures with autologous CFSE-labeled CD4(+)CD25(neg) or CD8(+)CD25(neg) T-cell responders. The frequency and suppressor activity of Treg were increased after culture of CD4(+)CD25(+) T cells in the presence of 1-100 nM RAPA (p<0.001). RAPA-expanded Treg were largely CD4(+)CD25(high) Foxp3(+) cells and were resistant to apoptosis, while CD4(+)CD25(neg) T cells were sensitive. Only Treg upregulated anti-apoptotic and down-regulated pro-apoptotic proteins. Treg expressed higher levels of the PTEN protein than CD4(+)CD25(neg) cells. Activated Treg+/-RAPA preferentially phosphorylated STAT5 and STAT3 and did not utilize the PI3K/mTOR pathway. Conclusions/Significance: RAPA favors Treg expansion and survival by differentially regulating signaling, proliferation and sensitivity to apoptosis of human effector T cells and Treg after TCR/IL-2 activation.			Strauss, L (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	whitesidetl@upmc.edu	Czystowska-Kuźmicz, Małgorzata/U-7933-2018; Czystowska-Kuzmicz, Malgorzata/AAC-6989-2020; Mandapathil, Magis/AFL-3260-2022; Czystowska-Kuźmicz, Małgorzata/ABH-3220-2020	Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194; Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194	NCI NIH HHS [P0-1CA109688, P01 CA109688] Funding Source: Medline; NHLBI NIH HHS [HB-37-165] Funding Source: Medline; NIDCR NIH HHS [R01 DE013918, R0-1 DE13918] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA109688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013918] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, DIABETES, V55, P40, DOI 10.2337/diabetes.55.1.40; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Bergmann C, 2007, CANCER RES, V67, P8865, DOI 10.1158/0008-5472.CAN-07-0767; Blazar BR, 2003, BLOOD, V101, P3741, DOI 10.1182/blood-2002-10-3048; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Buckler JL, 2006, J IMMUNOL, V177, P4262, DOI 10.4049/jimmunol.177.7.4262; Coenen JJA, 2006, BLOOD, V107, P1018, DOI 10.1182/blood-2005-07-3032; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Dejaco C, 2006, IMMUNOLOGY, V117, P289, DOI 10.1111/j.1365-2567.2005.02317.x; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Godfrey WR, 2005, BLOOD, V105, P750, DOI 10.1182/blood-2004-06-2467; Golovina TN, 2008, J IMMUNOL, V181, P2855, DOI 10.4049/jimmunol.181.4.2855; Hanash AM, 2005, BLOOD, V105, P1828, DOI 10.1182/blood-2004-08-3213; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hippen KL, 2008, BLOOD, V112, P2847, DOI 10.1182/blood-2008-01-132951; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Kleinewietfeld M, 2009, BLOOD, V113, P827, DOI 10.1182/blood-2008-04-150524; Li LQ, 2005, BLOOD, V106, P3068, DOI 10.1182/blood-2005-04-1531; Liyanage UK, 2006, J IMMUNOTHER, V29, P416, DOI 10.1097/01.cji.0000205644.43735.4e; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Sempere JM, 2007, AIDS REV, V9, P54; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Strauss L, 2007, INT J CANCER, V121, P2473, DOI 10.1002/ijc.23001; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Strauss L, 2007, J IMMUNOL, V178, P320, DOI 10.4049/jimmunol.178.1.320; Strauss L, 2009, J IMMUNOL, V182, P1469, DOI 10.4049/jimmunol.182.3.1469; Trenado A, 2003, J CLIN INVEST, V112, P1688, DOI 10.1172/JCI17702; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Walsh PT, 2006, J CLIN INVEST, V116, P2521, DOI 10.1172/JCI28057; Zeiser R, 2008, CELL CYCLE, V7, P458, DOI 10.4161/cc.7.4.5454; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	46	131	137	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5994	10.1371/journal.pone.0005994	http://dx.doi.org/10.1371/journal.pone.0005994			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543393	gold, Green Published, Green Accepted			2022-12-27	WOS:000267237600008
J	Peruchon, S; Chaoul, N; Burelout, C; Delache, B; Brochard, P; Laurent, P; Cognasse, F; Prevot, S; Garraud, O; Le Grand, R; Richard, Y				Peruchon, Sandrine; Chaoul, Nada; Burelout, Chantal; Delache, Benoit; Brochard, Patricia; Laurent, Pascale; Cognasse, Fabrice; Prevot, Sophie; Garraud, Olivier; Le Grand, Roger; Richard, Yolande			Tissue-Specific B-Cell Dysfunction and Generalized Memory B-Cell Loss during Acute SIV Infection	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CD4(+) T-CELLS; LYMPH-NODES; HIV-1 INFECTION; HUMORAL IMMUNITY; INTERFERON-ALPHA; RHESUS MACAQUES; VIRUS-INFECTION; IFN-ALPHA; EXPRESSION	Background: Primary HIV-infected patients display severe and irreversible damage to different blood B-cell subsets which is not restored by highly efficient anti-retroviral therapy (HAART). Because longitudinal investigations of primary HIV-infection is limited by the availability of lymphoid organs, we studied the tissue-specific B-cell dysfunctions in acutely simian immunodeficiency virus (SIV) mac251-infected Cynomolgus macaques. Methods and Findings: Experiments were performed on three groups of macaques infected for 14, 21 or 28 days and on three groups of animals treated with HAART for two-weeks either initiated at 4 h, 7 or 14 days post-infection (p.i.). We have simultaneously compared changes in B-cell phenotypes and functions and tissue organization of B-cell areas in various lymphoid organs. We showed that SIV induced a steady decline in SIgG-expressing memory (SIgD(-)CD27(+)) B-cells in spleen and lymph nodes during the first 4 weeks of infection, concomitant to selective homing/sequestration of B-cells to the small intestine and spleen. SIV non-specific Ig production was transiently increased before D14p.i., whereas SIV-specific Ig production was only detectable after D14p.i., coinciding with the presence of CD8(+) T-cells and IgG-expressing plasma cells within germinal centres. Transient B-cell apoptosis on D14p.i. and commitment to terminal differentiation contributed to memory B-cell loss. HAART abrogated B-cell apoptosis, homing to the small intestine and SIV-specific Ig production but had minimal effect on early Ig production, increased B-cell proportions in spleen and loss of memory B-cells. Therefore, virus-B-cell interactions and SIV-induced inflammatory cytokines may differently contribute to early B-cell dysfunction and impaired SIV/HIV-specific antibody response. Conclusions: These data establish tissue-specific impairments in B-cell trafficking and functions and a generalized and steady memory B-cell loss in secondary lymphoid organs. Characterization of underlying mechanisms would be helpful in designing new therapeutic strategies to dampen B-cell activation and increases HIV/SIV specific antibody response.			Peruchon, S (corresponding author), Univ Paris 11, Div Immunovirol, Inst Emerging Dis & Innovat Therapies, Atom Energy Commiss,UMR E1, Orsay, France.	yolande.richard-clausse@cea.fr	Cognasse, Fabrice/Z-4401-2019; Chaoul, Nada/AAC-7697-2022	Chaoul, Nada/0000-0002-7844-7377; RICHARD, Yolande/0000-0001-8560-9250				Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Agematsu K, 1997, EUR J IMMUNOL, V27, P2073, DOI 10.1002/eji.1830270835; Badr G, 2005, J IMMUNOL, V175, P302, DOI 10.4049/jimmunol.175.1.302; Badr G, 2005, INT IMMUNOL, V17, P459, DOI 10.1093/intimm/dxh227; Beniguel Lydie, 2004, Clin Dev Immunol, V11, P23, DOI 10.1080/10446670410001670454; Benlhassan-Chahour K, 2003, J VIROL, V77, P12479, DOI 10.1128/JVI.77.23.12479-12493.2003; CAGIGI A, 2008, BLOOD; Cagigi A, 2008, VACCINE, V26, P3016, DOI 10.1016/j.vaccine.2007.11.063; CHAKRABARTI L, 1995, VIROLOGY, V213, P535, DOI 10.1006/viro.1995.0026; Chang WLW, 2007, J IMMUNOL, V178, P1457, DOI 10.4049/jimmunol.178.3.1457; Chong Y, 2004, AIDS RES HUM RETROV, V20, P621, DOI 10.1089/0889222041217455; Chong Y, 2004, AIDS RES HUM RETROV, V20, P219, DOI 10.1089/088922204773004941; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; CLAYETTE P, 1995, J MED PRIMATOL, V24, P94, DOI 10.1111/j.1600-0684.1995.tb00152.x; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Ettinger R, 2007, J IMMUNOL, V178, P2872, DOI 10.4049/jimmunol.178.5.2872; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Forster R, 1997, BLOOD, V90, P520, DOI 10.1182/blood.V90.2.520.520_520_525; Giavedoni LD, 2000, J VIROL, V74, P1648, DOI 10.1128/JVI.74.4.1648-1657.2000; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Ho J, 2006, P NATL ACAD SCI USA, V103, P19436, DOI 10.1073/pnas.0609515103; JOLING P, 1992, AIDS RES HUM RETROV, V8, P2021, DOI 10.1089/aid.1992.8.2021; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Karlsson I, 2007, J VIROL, V81, P13456, DOI 10.1128/JVI.01619-07; Khatissian E, 1996, AIDS RES HUM RETROV, V12, P1273, DOI 10.1089/aid.1996.12.1273; Legendre C, 1998, INT IMMUNOL, V10, P1847, DOI 10.1093/intimm/10.12.1847; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Malaspina A, 2003, J IMMUNOL, V170, P5965, DOI 10.4049/jimmunol.170.12.5965; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Muller G, 2003, IMMUNOL REV, V195, P117, DOI 10.1034/j.1600-065X.2003.00073.x; Nagase H, 2001, CLIN IMMUNOL, V100, P250, DOI 10.1006/clim.2001.5054; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; RACZ P, 1990, LYMPHOLOGY, V23, P85; Reimann KA, 2005, J VIROL, V79, P8878, DOI 10.1128/JVI.79.14.8878-8885.2005; Rodriguez B, 2003, AIDS, V17, P1983, DOI 10.1097/00002030-200309050-00018; Samuelsson A, 1997, AIDS RES HUM RETROV, V13, P1031, DOI 10.1089/aid.1997.13.1031; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Stohl W, 2002, CLIN IMMUNOL, V104, P115, DOI 10.1006/clim.2002.5238; TENNERRACZ K, 1993, AM J PATHOL, V142, P1750; Titanji K, 2005, AIDS, V19, P1947, DOI 10.1097/01.aids.0000191231.54170.89; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Trkola A, 2004, BLOOD, V104, P1784, DOI 10.1182/blood-2004-01-0251; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; Vugmeyster Y, 2004, CYTOM PART A, V61A, P69, DOI 10.1002/cyto.a.20039; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wilkins BS, 2003, HISTOPATHOLOGY, V42, P173, DOI 10.1046/j.1365-2559.2003.01569.x	55	50	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5966	10.1371/journal.pone.0005966	http://dx.doi.org/10.1371/journal.pone.0005966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543531	Green Submitted, Green Published, gold			2022-12-27	WOS:000267237400003
J	Pluchino, S; Zanotti, L; Brambilla, E; Rovere-Querini, P; Capobianco, A; Alfaro-Cervello, C; Salani, G; Cossetti, C; Borsellino, G; Battistini, L; Ponzoni, M; Doglioni, C; Garcia-Verdugo, JM; Comi, G; Manfredi, AA; Martino, G				Pluchino, Stefano; Zanotti, Lucia; Brambilla, Elena; Rovere-Querini, Patrizia; Capobianco, Annalisa; Alfaro-Cervello, Clara; Salani, Giuliana; Cossetti, Chiara; Borsellino, Giovanna; Battistini, Luca; Ponzoni, Maurilio; Doglioni, Claudio; Manuel Garcia-Verdugo, Jose; Comi, Giancarlo; Manfredi, Angelo A.; Martino, Gianvito			Immune Regulatory Neural Stem/Precursor Cells Protect from Central Nervous System Autoimmunity by Restraining Dendritic Cell Function	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SONIC HEDGEHOG; IN-VITRO; T-CELLS; TRANSPLANTATION; PROLIFERATION; MICE; ENCEPHALOMYELITIS; DIFFERENTIATION; PRECURSORS	Background: The systemic injection of neural stem/precursor cells (NPCs) provides remarkable amelioration of the clinicopathological features of experimental autoimmune encephalomyelitis (EAE). This is dependent on the capacity of transplanted NPCs to engage concurrent mechanisms of action within specific microenvironments in vivo. Among a wide range of therapeutic actions alternative to cell replacement, neuroprotective and immune modulatory capacities of transplanted NPCs have been described. However, lacking is a detailed understanding of the mechanisms by which NPCs exert their therapeutic plasticity. This study was designed to identify the first candidate that exemplifies and sustains the immune modulatory capacity of transplanted NPCs. Methodology/Principal Findings: To achieve the exclusive targeting of the peripheral immune system, SJL mice with PLP-induced EAE were injected subcutaneously with NPCs and the treatment commenced prior to disease onset. NPC-injected EAE mice showed significant clinical improvement, as compared to controls. Exogenous NPCs lacking the expression of major neural antigens were reliably (and for long-term) found at the level of draining lymph nodes, while establishing sophisticated anatomical interactions with lymph node cells. Importantly, injected NPCs were never found in organs other than lymph nodes, including the brain and the spinal cord. Draining lymph nodes from transplanted mice showed focal upregulation of major developmental stem cell regulators, such as BMP-4, Noggin and Sonic hedgehog. In lymph nodes, injected NPCs hampered the activation of myeloid dendritic cells (DCs) and steadily restrained the expansion of antigen-specific encephalitogenic T cells. Both ex vivo and in vitro experiments identified a novel highly NPC-specific-BMP-4-dependent-mechanism hindering the DC maturation. Conclusion/Significance: The study described herein, identifies the first member of the TGF beta/BMP family of stem cell regulators as a novel tolerogenic factor released by NPCs. Full exploitation of this pathway as an efficient tool for vaccination therapy in autoimmune inflammatory conditions is underway.			Pluchino, S (corresponding author), Ist Sci San Raffaele, Neuroimmunol Unit, I-20132 Milan, Italy.	pluchino.stefano@hsr.it; martino.gianvito@hsr.it	Manfredi, Angelo A./C-7018-2014; Annalisa, Capobianco/AAN-3844-2020; Borsellino, Giovanna/K-3074-2016; Zanotti, Lucia/AAB-1484-2020; Alfaro-Cervello, Clara/D-1900-2015; BRAMBILLA, ELENA/AAN-3742-2020; martino, gianvito/AAL-2682-2020; Battistini, Luca/D-6920-2014; García-Verdugo, José Manuel/L-8421-2017; Pluchino, Stefano/AAE-9037-2019; Rovere-Querini, Patrizia/J-2340-2012; Battistini, luca/ABE-1882-2021	Manfredi, Angelo A./0000-0001-8370-6970; Borsellino, Giovanna/0000-0002-4227-6481; BRAMBILLA, ELENA/0000-0003-1399-2128; martino, gianvito/0000-0003-1295-9131; Battistini, Luca/0000-0002-6488-4891; García-Verdugo, José Manuel/0000-0001-9872-6499; Pluchino, Stefano/0000-0002-6267-9472; DOGLIONI, Claudio/0000-0002-4969-5216; Alfaro-Cervello, Clara/0000-0002-3737-4028; Cossetti, Chiara/0000-0003-2653-3705				Aharonowiz M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003145; Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Ben-Hur T, 2003, GLIA, V41, P73, DOI 10.1002/glia.10159; Ben-Hur T, 2008, ANN NY ACAD SCI, V1142, P218, DOI 10.1196/annals.1444.014; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; BLOCK GJ, 2008, STEM CELLS; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Fainstein N, 2008, MOL CELL NEUROSCI, V39, P335, DOI 10.1016/j.mcn.2008.07.007; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Garcion E, 2001, DEVELOPMENT, V128, P2485; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Hager-Theodorides AL, 2002, J IMMUNOL, V169, P5496, DOI 10.4049/jimmunol.169.10.5496; Heinke J, 2007, CARDIOVASC RES, V76, P390, DOI 10.1016/j.cardiores.2007.08.003; Herrmann MM, 2005, BLOOD, V106, P1875, DOI 10.1182/blood-2004-12-4607; Horiguchi M, 2000, CYTOKINE, V12, P526, DOI 10.1006/cyto.1999.0577; Kerr JR, 2004, J MED VIROL, V74, P147, DOI 10.1002/jmv.20158; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Maccario R, 2005, HAEMATOLOGICA, V90, P516; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Pope JG, 1996, J IMMUNOL, V156, P4050; Prevosto C, 2007, HAEMATOLOGICA, V92, P881, DOI 10.3324/haematol.11240; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Shukunami C, 2000, FEBS LETT, V469, P83, DOI 10.1016/S0014-5793(00)01251-5; SPAGGIARI GM, 2009, BLOOD; UCCELLI A, 2008, NAT REV IMMUNOL; Valentinis B, 2008, J LEUKOCYTE BIOL, V84, P199, DOI 10.1189/jlb.0807548; Varas A, 2003, TRENDS IMMUNOL, V24, P197, DOI 10.1016/S1471-4906(03)00033-4; Weller RO, 1996, BRAIN PATHOL, V6, P275, DOI 10.1111/j.1750-3639.1996.tb00855.x; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Xiao J, 2005, STEM CELLS DEV, V14, P722, DOI 10.1089/scd.2005.14.722; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; ZEINE R, 1992, J NEUROIMMUNOL, V40, P57, DOI 10.1016/0165-5728(92)90213-5; ZEINE R, 1993, J NEUROIMMUNOL, V44, P85, DOI 10.1016/0165-5728(93)90271-Y; Zhang B, 2009, BLOOD, V113, P46, DOI 10.1182/blood-2008-04-154138; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	53	100	101	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5959	10.1371/journal.pone.0005959	http://dx.doi.org/10.1371/journal.pone.0005959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543526	Green Published, gold, Green Submitted			2022-12-27	WOS:000267237400002
J	van Vuurden, DG; Yazdani, M; Bosma, I; Broekhuizen, AJF; Postma, TJ; Heimans, JJ; van der Valk, P; Aronica, E; Tannous, BA; Wurdinger, T; Kaspers, GJL; Cloos, J				van Vuurden, Dannis G.; Yazdani, Maryam; Bosma, Ingeborg; Broekhuizen, Aart J. F.; Postma, Tjeerd J.; Heimans, Jan J.; van der Valk, Paul; Aronica, Eleonora; Tannous, Bakhos A.; Wurdinger, Thomas; Kaspers, Gertjan J. L.; Cloos, Jacqueline			Attenuated AMPA Receptor Expression Allows Glioblastoma Cell Survival in Glutamate-Rich Environment	PLOS ONE			English	Article								Background: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger AMPA-type glutamate receptors (AMPARs). This commonly results in Na(+) and Ca(2+)-permeability and thereby in excitotoxic cell death of the surrounding neurons. Here we investigated how the GBM cells themselves survive in a glutamate-rich environment. Methods and Findings: In silico analysis of published reports shows down-regulation of all ionotropic glutamate receptors in GBM as compared to normal brain. In vitro, in all GBM samples tested, mRNA expression of AMPAR subunit GluR1, 2 and 4 was relatively low compared to adult and fetal total brain mRNA and adult cerebellum mRNA. These findings were in line with primary GBM samples, in which protein expression patterns were down-regulated as compared to the normal tissue. Furthermore, mislocalized expression of these receptors was found. Sequence analysis of GluR2 RNA in primary and established GBM cell lines showed that the GluR2 subunit was found to be partly unedited. Conclusions: Together with the lack of functional effect of AMPAR inhibition by NBQX our results suggest that down-regulation and afunctionality of AMPARs, enable GBM cells to survive in a high glutamate environment without going into excitotoxic cell death themselves. It can be speculated that specific AMPA receptor inhibitors may protect normal neurons against the high glutamate microenvironment of GBM tumors.			van Vuurden, DG (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pediat Oncol Hematol, Amsterdam, Netherlands.	j.cloos@vumc.nl	Kaspers, Gertjan/ABC-5334-2020; Wurdinger, Thomas/AAA-5645-2022; van Vuurden, Dannis/ACA-6952-2022	Kaspers, Gertjan/0000-0001-7716-8475; Cloos, Jacqueline/0000-0001-9150-8026; Aronica, Eleonora/0000-0002-3542-3770; Van Vuurden, Dannis/0000-0002-1364-9007				Bauer B, 2008, MOL PHARMACOL, V73, P1444, DOI 10.1124/mol.107.041210; Catarzi D, 2007, MED RES REV, V27, P239, DOI 10.1002/med.20084; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; HORIKOSHI T, 1992, CANCER RES, V52, P108; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Labrakakis C, 1998, EUR J NEUROSCI, V10, P2153, DOI 10.1046/j.1460-9568.1998.00226.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; Menuz K, 2008, J NEUROSCI, V28, P8740, DOI 10.1523/JNEUROSCI.1319-08.2008; PURVES D, 2008, NEUROSCIENCE, P126; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rothstein JD, 2002, NAT MED, V8, P938, DOI 10.1038/nm0902-938; Simeone TA, 2004, J CHILD NEUROL, V19, P343, DOI 10.1177/088307380401900507; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Vanhoutte N, 2008, FEBS LETT, V582, P1847, DOI 10.1016/j.febslet.2008.04.053; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999; Yoshioka A, 1996, J NEUROSCI RES, V46, P164; Zhu HJ, 2004, LIFE SCI, V75, P1313, DOI 10.1016/j.lfs.2004.02.027	26	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5953	10.1371/journal.pone.0005953	http://dx.doi.org/10.1371/journal.pone.0005953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536293	Green Published, Green Submitted, gold			2022-12-27	WOS:000267079500003
J	Bentov, Y; Brown, TJ; Akbari, MR; Royer, R; Risch, H; Rosen, B; McLaughlin, J; Sun, P; Zhang, SY; Narod, SA; Casper, RF				Bentov, Yaakov; Brown, Theodore J.; Akbari, Mohammad R.; Royer, Robert; Risch, Harvey; Rosen, Barry; McLaughlin, John; Sun, Ping; Zhang, Shiyu; Narod, Steven A.; Casper, Robert F.			Polymorphic Variation of Genes in the Fibrinolytic System and the Risk of Ovarian Cancer	PLOS ONE			English	Article								Introduction: The etiology of ovarian cancer is largely unknown. One hypothesis is that the inefficient removal of the blood clots and fibrin products which are deposited in the vicinity of the ovary by retrograde menstruation might be associated with an increased risk of ovarian cancer. Several single nucleotide polymorphisms within genes which comprise the fibrinolytic system have been shown to have functional effects on the rate of blood clot degradation. These were considered to be candidate genes in the present study. Aim: We studied the genotype distributions of 12 functional SNPs of four genes (tPA, uPA PAI1 and TAFI) among 775 ovarian cancer cases and 889 controls. Results: No significant associations were seen between any of the ten SNPs and the risk of ovarian cancer as a whole, or in any histologic subgroup. Discussion: Germline known functional variants of genes in the fibrinolytic system are not associated with risk of ovarian cancer.			Bentov, Y (corresponding author), Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada.	Bentov@lunenfeld.ca	Casper, Robert F./E-3775-2013; Narod, Steven A/AAA-6112-2022; Bentov, Yaakov/AAZ-7922-2020; McLaughlin, John R/E-4577-2013; Brown, Theodore J./E-2192-2013	Casper, Robert F./0000-0002-6249-462X; Bentov, Yaakov/0000-0001-9733-3263; Brown, Theodore J./0000-0002-3074-4516				Bajou K, 2004, ONCOGENE, V23, P6986, DOI 10.1038/sj.onc.1207859; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bedaiwy MA, 2006, OBSTET GYNECOL, V108, P162, DOI 10.1097/01.AOG.0000220517.53892.0a; Brinton LA, 1997, AM J OBSTET GYNECOL, V176, P572, DOI 10.1016/S0002-9378(97)70550-7; Carroll VA, 1999, SEMIN THROMB HEMOST, V25, P183, DOI 10.1055/s-2007-994920; Chambers SK, 1998, INT J CANCER, V79, P449; Cufer T, 2002, INT J BIOL MARKER, V17, P33, DOI 10.1177/172460080201700104; HALME J, 1984, OBSTET GYNECOL, V64, P151; Hansen S, 2003, BRIT J CANCER, V88, P102, DOI 10.1038/sj.bjc.6600662; Henry M, 2001, BLOOD, V97, P2053, DOI 10.1182/blood.V97.7.2053; Ho CH, 1999, GYNECOL ONCOL, V75, P397, DOI 10.1006/gyno.1999.5610; Jern C, 1999, ARTERIOSCL THROM VAS, V19, P454, DOI 10.1161/01.ATV.19.2.454; Kjaer SK, 2004, INT J EPIDEMIOL, V33, P596, DOI 10.1093/ije/dyh046; KOBAYASHI H, 1994, CANCER RES, V54, P6539; Koensgen D, 2006, ANTICANCER RES, V26, P1683; Kuhn W, 1999, BRIT J CANCER, V79, P1746, DOI 10.1038/sj.bjc.6690278; La Vecchia C, 2006, EUR J CANCER PREV, V15, P117, DOI 10.1097/01.cej.0000179274.24200.9d; Ladenvall P, 2002, THROMB HAEMOSTASIS, V87, P105; LIU DTY, 1986, BRIT J OBSTET GYNAEC, V93, P859, DOI 10.1111/j.1471-0528.1986.tb07995.x; Maillard C, 2005, NEOPLASIA, V7, P57, DOI 10.1593/neo.04406; Modugno F, 2004, AM J OBSTET GYNECOL, V191, P733, DOI 10.1016/j.ajog.2004.03.035; Morange PE, 2005, J THROMB HAEMOST, V3, P1503, DOI 10.1111/j.1538-7836.2005.01486.x; Nagashima M, 2000, THROMB RES, V98, P333, DOI 10.1016/S0049-3848(00)00184-5; Narod SA, 2001, LANCET, V357, P1467, DOI 10.1016/S0140-6736(00)04642-0; Ness RB, 2002, AM J EPIDEMIOL, V155, P217, DOI 10.1093/aje/155.3.217; OWENSBY DA, 1991, J BIOL CHEM, V266, P4334; Stern RC, 2001, INT J GYNECOL PATHOL, V20, P133, DOI 10.1097/00004347-200104000-00004; Sternlicht MD, 2006, CANCER EPIDEM BIOMAR, V15, P2107, DOI 10.1158/1055-9965.EPI-06-0351; Storm Niels, 2003, Methods Mol Biol, V212, P241; Van Gorp T, 2004, BEST PRACT RES CL OB, V18, P349, DOI 10.1016/j.bpobgyn.2003.03.001	30	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5918	10.1371/journal.pone.0005918	http://dx.doi.org/10.1371/journal.pone.0005918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526059	Green Submitted, gold, Green Published			2022-12-27	WOS:000267029300011
J	Dong, LM; Brennan, P; Karami, S; Hung, RJ; Menashe, I; Berndt, SI; Yeager, M; Chanock, S; Zaridze, D; Matveev, V; Janout, V; Kollarova, H; Bencko, V; Schwartz, K; Davis, F; Navratilova, M; Szeszenia-Dabrowska, N; Mates, D; Colt, JS; Holcatova, I; Boffetta, P; Rothman, N; Chow, WH; Rosenberg, PS; Moore, LE				Dong, Linda M.; Brennan, Paul; Karami, Sara; Hung, Rayjean J.; Menashe, Idan; Berndt, Sonja I.; Yeager, Meredith; Chanock, Stephen; Zaridze, David; Matveev, Vsevolod; Janout, Vladimir; Kollarova, Hellena; Bencko, Vladimir; Schwartz, Kendra; Davis, Faith; Navratilova, Marie; Szeszenia-Dabrowska, Neonila; Mates, Dana; Colt, Joanne S.; Holcatova, Ivana; Boffetta, Paolo; Rothman, Nathaniel; Chow, Wong-Ho; Rosenberg, Philip S.; Moore, Lee E.			An Analysis of Growth, Differentiation and Apoptosis Genes with Risk of Renal Cancer	PLOS ONE			English	Article								We conducted a case-control study of renal cancer (987 cases and 1298 controls) in Central and Eastern Europe and analyzed genomic DNA for 319 tagging single-nucleotide polymorphisms (SNPs) in 21 genes involved in cellular growth, differentiation and apoptosis using an Illumina Oligo Pool All (OPA). A haplotype-based method (sliding window analysis of consecutive SNPs) was used to identify chromosome regions of interest that remained significant at a false discovery rate of 10%. Subsequently, risk estimates were generated for regions with a high level of signal and individual SNPs by unconditional logistic regression adjusting for age, gender and study center. Three regions containing genes associated with renal cancer were identified: caspase 1/5/ 4/12(CASP 1/5/ 4/12), epidermal growth factor receptor (EGFR), and insulin-like growth factor binding protein-3 (IGFBP3). We observed that individuals with CASP1/5/4/12 haplotype (spanning area upstream of CASP1 through exon 2 of CASP5) GGGCTCAGT were at higher risk of renal cancer compared to individuals with the most common haplotype (OR: 1.40, 95% CI: 1.10-1.78, p-value = 0.007). Analysis of EGFR revealed three strong signals within intron 1, particularly a region centered around rs759158 with a global p = 0.006 (GGG: OR: 1.26, 95% CI: 1.04-1.53 and ATG: OR: 1.55, 95% CI: 1.14-2.11). A region in IGFBP3 was also associated with increased risk (global p = 0.04). In addition, the number of statistically significant (p-value, 0.05) SNP associations observed within these three genes was higher than would be expected by chance on a gene level. To our knowledge, this is the first study to evaluate these genes in relation to renal cancer and there is need to replicate and extend our findings. The specific regions associated with risk may have particular relevance for gene function and/or carcinogenesis. In conclusion, our evaluation has identified common genetic variants in CASP1, CASP5, EGFR, and IGFBP3 that could be associated with renal cancer risk.	[Dong, Linda M.; Karami, Sara; Menashe, Idan; Berndt, Sonja I.; Colt, Joanne S.; Rothman, Nathaniel; Chow, Wong-Ho; Rosenberg, Philip S.; Moore, Lee E.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Brennan, Paul] Intl Agcy Res Canc, Lyon, France; [Hung, Rayjean J.; Boffetta, Paolo] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON, Canada; [Yeager, Meredith; Chanock, Stephen] NCI, Core Genotyping Facil, Gaithersburg, MD USA; [Zaridze, David; Matveev, Vsevolod] Inst Carcinogenesis, Moscow, Russia; [Janout, Vladimir; Kollarova, Hellena] Palacky Univ, Olomouc, Czech Republic; [Bencko, Vladimir; Holcatova, Ivana] Inst Hyg & Epidemiol, Prague, Czech Republic; [Schwartz, Kendra] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Detroit, MI USA; [Schwartz, Kendra] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Davis, Faith] Univ Illinois, Dept Biostat & Epidemiol, Chicago, IL 60680 USA; [Navratilova, Marie] Masaryk Memorial Canc Inst, Brno, Czech Republic; [Szeszenia-Dabrowska, Neonila] Inst Occupat Med, Lodz, Poland; [Mates, Dana] Inst Publ Hlth, Bucharest, Romania	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); World Health Organization; International Agency for Research on Cancer (IARC); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Palacky University Olomouc; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Masaryk Memorial Cancer Institute; Nofer Institute of Occupational Medicine	Dong, LM (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	donglm@mail.nih.gov	Menashe, Idan/W-6214-2019; Liao, Linda M/B-3960-2011; Janout, Vladimir/M-5133-2014; Szeszenia-Dabrowska, Neonila/F-7190-2010; Hung, Rayjean J/A-7439-2013; Boffetta, Paolo/AAI-7767-2021; Holcatova, Ivana/C-8327-2017; Bencko, Vladimir/H-8598-2017; Menashe, Idan/AAC-8670-2020; Matveev, Vsevolod B/O-7476-2017; Zaridze, David/K-5605-2013; Berndt, Sonja I/J-8423-2016; Yeager, Meredith/AAA-5322-2020	Liao, Linda M/0000-0002-1923-5294; Boffetta, Paolo/0000-0002-3811-2791; Holcatova, Ivana/0000-0002-1366-0337; Bencko, Vladimir/0000-0003-1935-2228; Menashe, Idan/0000-0003-1961-1461; Matveev, Vsevolod B/0000-0001-7748-9527; Rosenberg, Philip/0000-0001-6349-9126; Kollarova, Helena/0000-0001-6951-6716; mates, dana/0000-0002-6219-9807; Hung, Rayjean/0000-0002-4486-7496	Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics; NATIONAL CANCER INSTITUTE [ZIACP010120] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1991, SCIENCE, V254, P1146, DOI 10.1126/science.1659742; Abe A, 2002, TOHOKU J EXP MED, V198, P181, DOI 10.1620/tjem.198.181; Araujo A, 2007, ONCOLOGIST, V12, P201, DOI 10.1634/theoncologist.12-2-201; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buerger H, 2004, J PATHOL, V203, P545, DOI 10.1002/path.1542; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cheng I, 2007, J CLIN ENDOCR METAB, V92, P3660, DOI 10.1210/jc.2007-0790; Cheng I, 2006, CANCER EPIDEM BIOMAR, V15, P1993, DOI 10.1158/1055-9965.EPI-06-0361; Cheung CW, 2004, KIDNEY INT, V65, P1272, DOI 10.1111/j.1523-1755.2004.00535.x; Chi D. D., 1992, Human Molecular Genetics, V1, P135, DOI 10.1093/hmg/1.2.135; Chow WH, 2008, CANCER J, V14, P288, DOI 10.1097/PPO.0b013e3181867628; Chuang ST, 2008, J UROLOGY, V179, P445, DOI 10.1016/j.juro.2007.09.106; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gebhardt F, 2000, INT J BIOL MARKER, V15, P105, DOI 10.1177/172460080001500120; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hosgood HD, 2008, CARCINOGENESIS, V29, P1938, DOI 10.1093/carcin/bgn178; Hosomi Y, 2003, INT J MOL MED, V12, P443; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Kawai Y, 2007, EUR UROL, V52, P1147, DOI 10.1016/j.eururo.2007.01.073; LEE WS, 1994, J BIOL CHEM, V269, P12032; Levi F, 2008, BJU INT, V101, P949, DOI 10.1111/j.1464-410X.2008.07451.x; LIN J, 2008, CARCINOGENESIS; Liu WQ, 2005, CANCER RES, V65, P46; Maher ER, 1996, BRIT J UROL, V78, P542, DOI 10.1046/j.1464-410X.1996.01749.x; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Mathew A, 2002, EUR J CANCER PREV, V11, P171, DOI 10.1097/00008469-200204000-00010; Moore LE, 2007, CARCINOGENESIS, V28, P1960, DOI 10.1093/carcin/bgm151; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Offman J, 2005, MOL CANCER RES, V3, P251, DOI 10.1158/1541-7786.MCR-04-0182; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Patel AV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002578; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Press OA, 2008, CANCER RES, V68, P3037, DOI 10.1158/0008-5472.CAN-07-2718; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rosenberg PS, 2006, STAT MED, V25, P3134, DOI 10.1002/sim.2407; Rosendahl AH, 2006, KIDNEY INT, V70, P1584, DOI 10.1038/sj.ki.5001805; Schottenfeld D., 2006, CANC EPIDEMIOLOGY PR; Smith WM, 2001, HUM GENET, V109, P146, DOI 10.1007/s004390100563; Soung YH, 2008, HUM PATHOL, V39, P895, DOI 10.1016/j.humpath.2007.10.015; Tabernero J, 2005, ANN ONCOL, V16, P1740, DOI 10.1093/annonc/mdi355; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Yamaguchi T, 2006, DIS COLON RECTUM, V49, P399, DOI 10.1007/s10350-005-0293-4	49	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4895	10.1371/journal.pone.0004895	http://dx.doi.org/10.1371/journal.pone.0004895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19603096	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499000004
J	Tian, HG; Peng, H; Yao, Q; Chen, HX; Xie, Q; Tang, B; Zhang, WQ				Tian, Honggang; Peng, Han; Yao, Qiong; Chen, Hongxin; Xie, Qi; Tang, Bin; Zhang, Wenqing			Developmental Control of a Lepidopteran Pest Spodoptera exigua by Ingestion of Bacteria Expressing dsRNA of a Non-Midgut Gene	PLOS ONE			English	Article							CHITIN SYNTHASE GENE; RNA INTERFERENCE; AMINOPEPTIDASE-N; SYSTEMIC RNAI	Background: RNA interference (RNAi) induced through double stranded RNA (dsRNA) has been used widely to study gene function in insects. Recently, it has been reported that gene knockdown in several insects can be induced successfully through feeding with dsRNA. However, it is still unknown whether phenotypic silencing of genes not expressed in the midgut occurs after ingestion of insect dsRNA. Principal Findings: Using chitin synthase gene A (SeCHSA) as the target gene, which is expressed in the cuticle and tracheae of the lepidopteran pest Spodoptera exigua, we showed that the growth and development of S. exigua larvae fed Escherichia coli expressing dsRNA of SeCHSA was disturbed, resulting in lethality. In the 4th and 5th larval instars, prepupae, and pupae, the mean survival rates of insects fed the dsRNA-containing diet were 88.64%, 74.24%, 68.43% and 62.63% respectively. The survival rates in the 5(th) instar larvae, prepupae and pupae stages were significantly lower than those of all controls, and significant lethality differences were also found between dsSeCHSA treatment and dsControl or ddH(2)O control in the 4(th) instar larvae. The effects of ingesting bacterially expressed dsRNA on transcription of the target gene, tissue structure, and survival rates of insects were dose-dependent. Conclusions: Our results suggest that SeCHSA dsRNA may be useful as a means of insect pest control.			Tian, HG (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lsszwq@mail.sysu.edu.cn	Galdzicki, Michal/F-5682-2010; Kohane, Isaac Kohane/K-3716-2012; Tian, Honggang/AAW-4772-2020; zhang, wenqing/GYA-0786-2022; tian, ze/HDM-4308-2022; Yao, Huiqin/AAX-3787-2020	Galdzicki, Michal/0000-0002-8392-8183; Kohane, Isaac Kohane/0000-0003-2192-5160; Tian, Honggang/0000-0002-2205-0784; Yao, Huiqin/0000-0003-4742-8971; Chen, Hongxin/0000-0002-2955-4619; Wu, Erxi/0000-0002-1680-3639	NIGMS NIH HHS [R01 GM081871] Funding Source: Medline; NLM NIH HHS [2 T15 LM007092-16, T15 LM007092] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Chen X, 2008, B ENTOMOL RES, V98, P613, DOI 10.1017/S0007485308005932; Chen XF, 2007, INSECT BIOCHEM MOLEC, V37, P409, DOI 10.1016/j.ibmb.2007.01.006; Cruz J, 2007, MECH DEVELOP, V124, P180, DOI 10.1016/j.mod.2006.12.003; Cruz J, 2006, DEV BIOL, V297, P158, DOI 10.1016/j.ydbio.2006.06.048; Eleftherianos I, 2006, DEV COMP IMMUNOL, V30, P1099, DOI 10.1016/j.dci.2006.02.008; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Gura T, 2000, NATURE, V404, P804, DOI 10.1038/35009245; Huang JH, 2007, FEBS LETT, V581, P697, DOI 10.1016/j.febslet.2007.01.034; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kato N, 2006, INSECT BIOCHEM MOLEC, V36, P1, DOI 10.1016/j.ibmb.2005.09.003; Kooter JM, 1999, TRENDS PLANT SCI, V4, P340, DOI 10.1016/S1360-1385(99)01467-3; Lennefors BL, 2006, MOL BREEDING, V18, P313, DOI 10.1007/s11032-006-9030-5; Li Guanghong, 2002, Chinese Journal of Biological Control, V18, P132; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Mito T, 2007, DEV BIOL, V303, P202, DOI 10.1016/j.ydbio.2006.11.003; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Orii H, 2003, DEV GENES EVOL, V213, P138, DOI 10.1007/s00427-003-0310-3; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Retnakaran A., 1987, Chitin and benzoylphenyl ureas., P205; Ronco M, 2008, DEV BIOL, V313, P80, DOI 10.1016/j.ydbio.2007.09.059; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tenllado F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-3; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005; Zimoch L, 2005, INSECT BIOCHEM MOLEC, V35, P515, DOI 10.1016/j.ibmb.2005.01.008	38	261	309	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6225	10.1371/journal.pone.0006225	http://dx.doi.org/10.1371/journal.pone.0006225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19381341	Green Submitted, gold, Green Published			2022-12-27	WOS:000268035400009
J	Zhang, HH; Huang, JX; Duvel, K; Boback, B; Wu, SL; Squillace, RM; Wu, CL; Manning, BD				Zhang, Hui H.; Huang, Jingxiang; Duevel, Katrin; Boback, Bernard; Wu, Shulin; Squillace, Rachel M.; Wu, Chin-Lee; Manning, Brendan D.			Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway	PLOS ONE			English	Article								Background: The signaling pathways imposing hormonal control over adipocyte differentiation are poorly understood. While insulin and Akt signaling have been found previously to be essential for adipogenesis, the relative importance of their many downstream branches have not been defined. One direct substrate that is inhibited by Akt-mediated phosphorylation is the tuberous sclerosis complex 2 (TSC2) protein, which associates with TSC1 and acts as a critical negative regulator of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1). Loss of function of the TSC1-TSC2 complex results in constitutive mTORC1 signaling and, through mTORC1-dependent feedback mechanisms and loss of mTORC2 activity, leads to a concomitant block of Akt signaling to its other downstream targets. Methodology/Principal Findings: We find that, despite severe insulin resistance and the absence of Akt signaling, TSC2-deficient mouse embryo fibroblasts and 3T3-L1 pre-adipocytes display enhanced adipocyte differentiation that is dependent on the elevated mTORC1 activity in these cells. Activation of mTORC1 causes a robust increase in the mRNA and protein expression of peroxisome proliferator-activated receptor gamma (PPAR gamma), which is the master transcriptional regulator of adipocyte differentiation. In examining the requirements for different Akt-mediated phosphorylation sites on TSC2, we find that only TSC2 mutants lacking all five previously identified Akt sites fully block insulin-stimulated mTORC1 signaling in reconstituted Tsc2 null cells, and this mutant also inhibits adipogenesis. Finally, renal angiomyolipomas from patients with tuberous sclerosis complex contain both adipose and smooth muscle-like components with activated mTORC1 signaling and elevated PPAR gamma expression. Conclusions/Significance: This study demonstrates that activation of mTORC1 signaling is a critical step in adipocyte differentiation and identifies TSC2 as a primary target of Akt driving this process. Therefore, the TSC1-TSC2 complex regulates the differentiation of mesenchymal cell lineages, at least in part, through its control of mTORC1 activity and PPAR gamma expression.			Zhang, HH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Huang, Jingxiang/B-4515-2008; Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956; Qu, Liang-Hu/0000-0003-3657-2863; Zhou, Hui/0000-0001-9157-3792; Zhang, Hua/0000-0001-9731-2737	NATIONAL CANCER INSTITUTE [R01CA122617, P01CA120964] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA122617-04, R01 CA122617, CA120964, CA122617, P01 CA120964] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Baudry A, 2006, J CELL SCI, V119, P889, DOI 10.1242/jcs.02792; Bell A, 2000, OBES RES, V8, P249, DOI 10.1038/oby.2000.29; Berg CE, 2002, BIOCHEM BIOPH RES CO, V293, P1021, DOI 10.1016/S0006-291X(02)00333-9; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brady MJ, 1999, J BIOL CHEM, V274, P27497, DOI 10.1074/jbc.274.39.27497; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Cho HJ, 2004, BIOCHEM BIOPH RES CO, V321, P942, DOI 10.1016/j.bbrc.2004.07.050; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; El-Chaar D, 2004, INT J OBESITY, V28, P191, DOI 10.1038/sj.ijo.0802554; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; GARVEY WT, 1991, J CLIN INVEST, V87, P1072, DOI 10.1172/JCI115068; GARVEY WT, 1989, SCIENCE, V245, P60, DOI 10.1126/science.2662408; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; HUANG J, 2008, MOL CELL BIOL, V28; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Karbowniczek M, 2003, AM J PATHOL, V162, P491, DOI 10.1016/S0002-9440(10)63843-6; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Li XH, 2005, ACTA PHARMACOL SIN, V26, P1081, DOI 10.1111/j.1745-7254.2005.00161.x; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miki H, 2001, MOL CELL BIOL, V21, P2521, DOI 10.1128/MCB.21.7.2521-2532.2001; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; PEDERSEN O, 1992, J CLIN INVEST, V89, P1964, DOI 10.1172/JCI115804; Pederson T, 2000, BIOCHEM BIOPH RES CO, V276, P162, DOI 10.1006/bbrc.2000.3429; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; [王志刚 WANG Zhigang], 2008, [东北师大学报. 自然科学版, Journal of Northeast Normal University], V40, P1; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	78	286	295	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6189	10.1371/journal.pone.0006189	http://dx.doi.org/10.1371/journal.pone.0006189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19915715	Green Published, Green Submitted, gold			2022-12-27	WOS:000268035300005
J	Doesburg, SM; Green, JJ; McDonald, JJ; Ward, LM				Doesburg, Sam M.; Green, Jessica J.; McDonald, John J.; Ward, Lawrence M.			Rhythms of Consciousness: Binocular Rivalry Reveals Large-Scale Oscillatory Network Dynamics Mediating Visual Perception	PLOS ONE			English	Article							GAMMA-BAND RESPONSES; PHASE SYNCHRONIZATION; NEURONAL RESPONSES; NEURAL ACTIVITY; CORTICAL AREAS; EEG; FREQUENCY; THETA; TASK; INTEGRATION	Consciousness has been proposed to emerge from functionally integrated large-scale ensembles of gamma-synchronous neural populations that form and dissolve at a frequency in the theta band. We propose that discrete moments of perceptual experience are implemented by transient gamma-band synchronization of relevant cortical regions, and that disintegration and reintegration of these assemblies is time-locked to ongoing theta oscillations. In support of this hypothesis we provide evidence that (1) perceptual switching during binocular rivalry is time-locked to gamma-band synchronizations which recur at a theta rate, indicating that the onset of new conscious percepts coincides with the emergence of a new gamma-synchronous assembly that is locked to an ongoing theta rhythm; (2) localization of the generators of these gamma rhythms reveals recurrent prefrontal and parietal sources; (3) theta modulation of gamma-band synchronization is observed between and within the activated brain regions. These results suggest that ongoing theta-modulated-gamma mechanisms periodically reintegrate a large-scale prefrontal-parietal network critical for perceptual experience. Moreover, activation and network inclusion of inferior temporal cortex and motor cortex uniquely occurs on the cycle immediately preceding responses signaling perceptual switching. This suggests that the essential prefrontal-parietal oscillatory network is expanded to include additional cortical regions relevant to tasks and perceptions furnishing consciousness at that moment, in this case image processing and response initiation, and that these activations occur within a time frame consistent with the notion that conscious processes directly affect behaviour.			Doesburg, SM (corresponding author), Univ British Columbia, Dept Psychol, Psychophys & Cognit Neurosci Lab, Vancouver, BC, Canada.	sdoesburg@cw.bc.ca	McDonald, John/P-6966-2015; Green, Jessica/G-1039-2011	Green, Jessica/0000-0003-3570-529X; McDonald, Robert/0000-0002-7273-6549; Ward, Lawrence/0000-0003-4431-5015; Miller, William/0000-0003-0750-6314				Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; Andrews TJ, 2001, TRENDS COGN SCI, V5, P407, DOI 10.1016/S1364-6613(00)01756-3; BARRS BJ, 1997, J CONSC STUDIES, V44, P521; Basar E, 2006, INT J PSYCHOPHYSIOL, V60, P133, DOI 10.1016/j.ijpsycho.2005.12.007; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLAKE RR, 1971, J EXP PSYCHOL, V88, P327, DOI 10.1037/h0030877; Bodovitz S, 2004, MED HYPOTHESES, V62, P1003, DOI 10.1016/j.mehy.2004.01.009; Bodovitz S, 2008, MED HYPOTHESES, V70, P8, DOI 10.1016/j.mehy.2007.05.022; Burgess AP, 2002, INT J PSYCHOPHYSIOL, V46, P91, DOI 10.1016/S0167-8760(02)00108-3; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cosmelli D, 2004, NEUROIMAGE, V23, P128, DOI 10.1016/j.neuroimage.2004.05.008; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; DENNETT DC, 1992, BEHAV BRAIN SCI, V15, P183, DOI 10.1017/S0140525X00068229; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Doesburg SM, 2005, NEUROREPORT, V16, P1139, DOI 10.1097/00001756-200508010-00001; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P9136, DOI 10.1073/pnas.88.20.9136; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fell J, 2002, CONSCIOUS COGN, V11, P114, DOI 10.1006/ccog.2001.0536; Ford JM, 2007, SCHIZOPHRENIA BULL, V33, P848, DOI 10.1093/schbul/sbm062; FRIEN A, 1994, NEUROREPORT, V5, P2273, DOI 10.1097/00001756-199411000-00017; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2002, J NEUROSCI, V22, P3739; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Goffaux V, 2004, NEUROSCI LETT, V354, P14, DOI 10.1016/j.neulet.2003.09.029; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Green JJ, 2008, PLOS BIOL, V6, P730, DOI 10.1371/journal.pbio.0060081; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Gruber T, 2008, BRAIN RES, V1196, P74, DOI 10.1016/j.brainres.2007.12.037; Gruber T, 2002, J COGNITIVE NEUROSCI, V14, P732, DOI 10.1162/08989290260138636; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; John ER, 2002, BRAIN RES REV, V39, P1, DOI 10.1016/S0165-0173(02)00142-X; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Mima T, 2000, CLIN NEUROPHYSIOL, V111, P326, DOI 10.1016/S1388-2457(99)00229-1; Nakatani C, 2005, J COGNITIVE NEUROSCI, V17, P1969, DOI 10.1162/089892905775008706; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rose M, 2005, J NEUROSCI, V25, P10101, DOI 10.1523/JNEUROSCI.2998-05.2005; Rose M, 2006, CEREB CORTEX, V16, P1522, DOI 10.1093/cercor/bhj089; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Scherg M, 2002, J CLIN NEUROPHYSIOL, V19, P91, DOI 10.1097/00004691-200203000-00001; SEARLE JR, 1992, REDISCOVERY MIND, P287; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Srinivasan R, 1999, J NEUROSCI, V19, P5435; Supp GG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000684; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tononi G, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-31; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Ward L. M., 1992, PSYCHOPHYSICAL APPRO, P187; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	81	252	255	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6142	10.1371/journal.pone.0006142	http://dx.doi.org/10.1371/journal.pone.0006142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	468GY	19582165	Green Published, gold, Green Submitted			2022-12-27	WOS:000267806300011
J	Bollen, J; Van de Sompel, H; Hagberg, A; Bettencourt, L; Chute, R; Rodriguez, MA; Balakireva, L				Bollen, Johan; Van de Sompel, Herbert; Hagberg, Aric; Bettencourt, Luis; Chute, Ryan; Rodriguez, Marko A.; Balakireva, Lyudmila			Clickstream Data Yields High-Resolution Maps of Science	PLOS ONE			English	Article							SCIENTIFIC LITERATURE; PUBLICATION DELAYS; USAGE STATISTICS; WEB; IMPACT	Background: Intricate maps of science have been created from citation data to visualize the structure of scientific activity. However, most scientific publications are now accessed online. Scholarly web portals record detailed log data at a scale that exceeds the number of all existing citations combined. Such log data is recorded immediately upon publication and keeps track of the sequences of user requests (clickstreams) that are issued by a variety of users across many different domains. Given these advantages of log datasets over citation data, we investigate whether they can produce high-resolution, more current maps of science. Methodology: Over the course of 2007 and 2008, we collected nearly 1 billion user interactions recorded by the scholarly web portals of some of the most significant publishers, aggregators and institutional consortia. The resulting reference data set covers a significant part of world-wide use of scholarly web portals in 2006, and provides a balanced coverage of the humanities, social sciences, and natural sciences. A journal clickstream model, i.e. a first-order Markov chain, was extracted from the sequences of user interactions in the logs. The clickstream model was validated by comparing it to the Getty Research Institute's Architecture and Art Thesaurus. The resulting model was visualized as a journal network that outlines the relationships between various scientific domains and clarifies the connection of the social sciences and humanities to the natural sciences. Conclusions: Maps of science resulting from large-scale clickstream data provide a detailed, contemporary view of scientific activity and correct the underrepresentation of the social sciences and humanities that is commonly found in citation data.	[Bollen, Johan; Van de Sompel, Herbert; Chute, Ryan; Balakireva, Lyudmila] Los Alamos Natl Lab, Res Lib, Digital Lib Res & Prototyping Team, Los Alamos, NM 87545 USA; [Hagberg, Aric; Bettencourt, Luis; Rodriguez, Marko A.] Los Alamos Natl Lab, Theoretical Div, Math Modeling & Anal Grp, Los Alamos, NM 87545 USA; [Hagberg, Aric; Bettencourt, Luis; Rodriguez, Marko A.] Los Alamos Natl Lab, Ctr Nonlinear Stud, Los Alamos, NM 87545 USA; [Bettencourt, Luis] Santa Fe Inst, Santa Fe, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute	Bollen, J (corresponding author), Los Alamos Natl Lab, Res Lib, Digital Lib Res & Prototyping Team, Los Alamos, NM 87545 USA.	jbollen@lanl.gov	Balakireva, Lyudmila/AAX-9674-2020; Bettencourt, Luis/R-9861-2019	Balakireva, Lyudmila/0000-0002-3919-3634; Van de Sompel, Herbert/0000-0002-0715-6126	Andrew W. Mellon Foundation	Andrew W. Mellon Foundation	This research was funded as part of the MESUR project (http://www.mesur.org/) by the Andrew W. Mellon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar E., 2000, Q J ELECT COMMERCE, V1, P203; AGGARWAL CC, 1998, IEEE DATA ENG B, V21; Aizen J, 2004, P NATL ACAD SCI USA, V101, P5254, DOI 10.1073/pnas.0307539100; BETTENCOURT LMA, 2008, SCIENTOMETR IN PRESS; Bianchini M., 2005, ACM Transactions on Internet Technology, V5, P92, DOI 10.1145/1052934.1052938; Bollen J., 2008, JOINT C DIG LIB JCDL; Bollen J, 2006, SCIENTOMETRICS, V69, P227, DOI 10.1007/s11192-006-0151-8; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Boyack KW, 2002, J AM SOC INF SCI TEC, V53, P764, DOI 10.1002/asi.10066; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Brody T, 2006, J AM SOC INF SCI TEC, V57, P1060, DOI 10.1002/asi.20373; CHEN C, 2007, IEEE ACM JOINT C DIG, P19; Davis PM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a568; Davis PM, 2006, J AM SOC INF SCI TEC, V57, P1243, DOI 10.1002/asi.20405; DEMOYAANEGON F, 2007, J AM SOC INFORM SCI, V58; Egghe L, 2000, J AM SOC INFORM SCI, V51, P158, DOI 10.1002/(SICI)1097-4571(2000)51:2<158::AID-ASI7>3.0.CO;2-X; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; GARFIELD E, 1970, NATURE, V227, P669, DOI 10.1038/227669a0; HARRIS E, 2006, NATURE, V444, P985; Huberman B.A., 2001, LAWS WEB PATTERNS EC; Huberman BA, 1998, SCIENCE, V280, P95, DOI 10.1126/science.280.5360.95; J. Paul Getty Trust, ART ARCH THES; Kleinberg J., 2008, DATA STREAM MANAGEME; Kurtz MJ, 2005, J AM SOC INF SCI TEC, V56, P36, DOI 10.1002/asi.20095; LEYDESDORFF L, 1994, SCIENTOMETRICS, V31; Luwel M, 1998, SCIENTOMETRICS, V41, P29, DOI 10.1007/BF02457964; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Pirolli P. L. T., 1999, World Wide Web, V2, P29, DOI 10.1023/A:1019288403823; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	31	221	224	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4803	10.1371/journal.pone.0004803	http://dx.doi.org/10.1371/journal.pone.0004803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OF	19562078	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496100022
J	Tian, Z; Palmer, N; Schmid, P; Yao, H; Galdzicki, M; Berger, B; Wu, EX; Kohane, IS				Tian, Ze; Palmer, Nathan; Schmid, Patrick; Yao, Hui; Galdzicki, Michal; Berger, Bonnie; Wu, Erxi; Kohane, Isaac S.			A Practical Platform for Blood Biomarker Study by Using Global Gene Expression Profiling of Peripheral Whole Blood	PLOS ONE			English	Article							OLIGONUCLEOTIDE ARRAY DATA; MESSENGER-RNA REDUCTION; SAMPLES; CELLS; PCR	Background: Although microarray technology has become the most common method for studying global gene expression, a plethora of technical factors across the experiment contribute to the variable of genome gene expression profiling using peripheral whole blood. A practical platform needs to be established in order to obtain reliable and reproducible data to meet clinical requirements for biomarker study. Methods and Findings: We applied peripheral whole blood samples with globin reduction and performed genome-wide transcriptome analysis using Illumina BeadChips. Real-time PCR was subsequently used to evaluate the quality of array data and elucidate the mode in which hemoglobin interferes in gene expression profiling. We demonstrated that, when applied in the context of standard microarray processing procedures, globin reduction results in a consistent and significant increase in the quality of beadarray data. When compared to their pre-globin reduction counterparts, post-globin reduction samples show improved detection statistics, lowered variance and increased sensitivity. More importantly, gender gene separation is remarkably clearer in post-globin reduction samples than in pre-globin reduction samples. Our study suggests that the poor data obtained from pre-globin reduction samples is the result of the high concentration of hemoglobin derived from red blood cells either interfering with target mRNA binding or giving the pseudo binding background signal. Conclusion: We therefore recommend the combination of performing globin mRNA reduction in peripheral whole blood samples and hybridizing on Illumina BeadChips as the practical approach for biomarker study.			Tian, Z (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Informat Program, Boston, MA 02115 USA.	bab@mit.edu; erxi.wu@ndsu.edu	Galdzicki, Michal/F-5682-2010; Kohane, Isaac Kohane/K-3716-2012; Tian, Honggang/AAW-4772-2020; zhang, wenqing/GYA-0786-2022; tian, ze/HDM-4308-2022; Yao, Huiqin/AAX-3787-2020	Galdzicki, Michal/0000-0002-8392-8183; Kohane, Isaac Kohane/0000-0003-2192-5160; Tian, Honggang/0000-0002-2205-0784; Yao, Huiqin/0000-0003-4742-8971; Chen, Hongxin/0000-0002-2955-4619; Wu, Erxi/0000-0002-1680-3639	NIGMS NIH HHS [R01 GM081871] Funding Source: Medline; NLM NIH HHS [2 T15 LM007092-16, T15 LM007092] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Chal V, 2005, J CLIN LAB ANAL, V19, P182, DOI 10.1002/jcla.20075; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; Debey S, 2006, GENOMICS, V87, P653, DOI 10.1016/j.ygeno.2005.11.010; Feezor RJ, 2004, PHYSIOL GENOMICS, V19, P247, DOI 10.1152/physiolgenomics.00020.2004; Field LA, 2007, CLIN BIOCHEM, V40, P499, DOI 10.1016/j.clinbiochem.2007.01.004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Liu J, 2006, J MOL DIAGN, V8, P551, DOI 10.2353/jmoldx.2006.060021; Martin KJ, 2001, P NATL ACAD SCI USA, V98, P2646, DOI 10.1073/pnas.041622398; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin LX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-23; Rainen L, 2002, CLIN CHEM, V48, P1883; Team. RDC, 2007, R LANG ENV STAT COMP; Thach DC, 2003, J IMMUNOL METHODS, V283, P269, DOI 10.1016/j.jim.2003.10.004; TIAN Z, 2008, CANC CHEMOTHER PHARM; Witten I. H., 2005, DATA MINING PRACTICA; Wright C, 2008, CLIN CHEM, V54, P396, DOI 10.1373/clinchem.2007.093419; Wu EX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003794	22	261	309	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5157	10.1371/journal.pone.0005157	http://dx.doi.org/10.1371/journal.pone.0005157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381341	Green Published, gold, Green Submitted			2022-12-27	WOS:000265510800002
